[["This study used the InterVA-4 computerised model to assign probable cause of death (CoD) to verbal autopsies (VAs) generated from two rural areas, with a difference in health service provision, within the Matlab Health and Demographic Surveillance site (HDSS).", {"entities": []}], ["This study aimed to compare CoD by gender, as well as discussing possible factors which could influence differences in the distribution of CoD between the two areas.", {"entities": []}], ["Data for this study came from the Matlab the HDSS maintained by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) since 1966.", {"entities": []}], ["In late 1977, icddr,b divided HDSS and implemented a high-quality maternal, newborn and child health and family planning (MNCH-FP) services project in one half, called the icddr,b service area (SA), in addition to the usual public and private MNCH-FP services that serve the other half, called the government SA.", {"entities": []}], ["HDSS field workers registered 12,144 deaths during 2003\u20132010, and trained interviewers obtained VA for 98.9% of them.", {"entities": []}], ["The probabilistic model InterVA-4 probabilistic model (version 4.02) was used to derive probable CoD from VA symptoms.", {"entities": []}], ["Cause-specific mortality rates and fractions were compared across gender and areas.", {"entities": []}], ["Appropriate statistical tests were applied for significance testing.", {"entities": []}], ["Mortality rates due to neonatal causes and communicable diseases (CDs) were lower in the icddr,b SA than in the government SA, where mortality rates due to non-communicable diseases (NCDs) were lower.", {"entities": []}], ["Cause-specific mortality fractions (CSMFs) due to CDs (23.2% versus 18.8%) and neonatal causes (7.4% versus 6%) were higher in the government SA, whereas CSMFs due to NCDs were higher (58.2% versus 50.7%) in the icddr,b SA.", {"entities": []}], ["The rank-order of CSMFs by age group showed marked variations, the largest category being acute respiratory infection/pneumonia in infancy, injury in 1\u20134 and 5\u201314 years, neoplasms in 15\u201349 and 50\u201364 years, and stroke in 65+ years.", {"entities": [[118, 127, "DISEASE"]]}], ["Automated InterVA-4 coding of VA to determine probable CoD revealed the difference in the structure of CoD between areas with prominence of NCDs in both areas.", {"entities": []}], ["Such information can help local planning of health services for prevention and management of disease burden.", {"entities": []}], ["National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality).", {"entities": []}], ["Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges.", {"entities": []}], ["In the present analysis, we use the highly standardised cause of death and risk factor estimates generated through the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) to improve and expand the quantification of personal health-care access and quality for 195 countries and territories from 1990 to 2015.", {"entities": []}], ["We mapped the most widely used list of causes amenable to personal health care developed by Nolte and McKee to 32 GBD causes.", {"entities": []}], ["We accounted for variations in cause of death certification and misclassifications through the extensive data standardisation processes and redistribution algorithms developed for GBD.", {"entities": []}], ["To isolate the effects of personal health-care access and quality, we risk-standardised cause-specific mortality rates for each geography-year by removing the joint effects of local environmental and behavioural risks, and adding back the global levels of risk exposure as estimated for GBD 2015.", {"entities": []}], ["We employed principal component analysis to create a single, interpretable summary measure\u2013the Healthcare Quality and Access (HAQ) Index\u2013on a scale of 0 to 100.", {"entities": []}], ["The HAQ Index showed strong convergence validity as compared with other health-system indicators, including health expenditure per capita ( r =0\u00b788), an index of 11 universal health coverage interventions ( r =0\u00b783), and human resources for health per 1000 ( r =0\u00b777).", {"entities": []}], ["We used free disposal hull analysis with bootstrapping to produce a frontier based on the relationship between the HAQ Index and the Socio-demographic Index (SDI), a measure of overall development consisting of income per capita, average years of education, and total fertility rates.", {"entities": []}], ["This frontier allowed us to better quantify the maximum levels of personal health-care access and quality achieved across the development spectrum, and pinpoint geographies where gaps between observed and potential levels have narrowed or widened over time.", {"entities": []}], ["Between 1990 and 2015, nearly all countries and territories saw their HAQ Index values improve; nonetheless, the difference between the highest and lowest observed HAQ Index was larger in 2015 than in 1990, ranging from 28\u00b76 to 94\u00b76.", {"entities": []}], ["Of 195 geographies, 167 had statistically significant increases in HAQ Index levels since 1990, with South Korea, Turkey, Peru, China, and the Maldives recording among the largest gains by 2015.", {"entities": []}], ["Performance on the HAQ Index and individual causes showed distinct patterns by region and level of development, yet substantial heterogeneities emerged for several causes, including cancers in highest-SDI countries; chronic kidney disease, diabetes, diarrhoeal diseases, and lower respiratory infections among middle-SDI countries; and measles and tetanus among lowest-SDI countries.", {"entities": [[336, 343, "DISEASE"], [224, 238, "DISEASE"], [348, 355, "DISEASE"]]}], ["While the global HAQ Index average rose from 40\u00b77 (95% uncertainty interval, 39\u00b70\u201342\u00b78) in 1990 to 53\u00b77 (52\u00b72\u201355\u00b74) in 2015, far less progress occurred in narrowing the gap between observed HAQ Index values and maximum levels achieved; at the global level, the difference between the observed and frontier HAQ Index only decreased from 21\u00b72 in 1990 to 20\u00b71 in 2015.", {"entities": []}], ["If every country and territory had achieved the highest observed HAQ Index by their corresponding level of SDI, the global average would have been 73\u00b78 in 2015.", {"entities": []}], ["Several countries, particularly in eastern and western sub-Saharan Africa, reached HAQ Index values similar to or beyond their development levels, whereas others, namely in southern sub-Saharan Africa, the Middle East, and south Asia, lagged behind what geographies of similar development attained between 1990 and 2015.", {"entities": []}], ["This novel extension of the GBD Study shows the untapped potential for personal health-care access and quality improvement across the development spectrum.", {"entities": []}], ["Amid substantive advances in personal health care at the national level, heterogeneous patterns for individual causes in given countries or territories suggest that few places have consistently achieved optimal health-care access and quality across health-system functions and therapeutic areas.", {"entities": []}], ["This is especially evident in middle-SDI countries, many of which have recently undergone or are currently experiencing epidemiological transitions.", {"entities": []}], ["The HAQ Index, if paired with other measures of health-system characteristics such as intervention coverage, could provide a robust avenue for tracking progress on universal health coverage and identifying local priorities for strengthening personal health-care quality and access throughout the world.", {"entities": []}], ["Bill & Melinda Gates Foundation.", {"entities": []}], ["Inappropriate activation or inadequate regulation of CD4 trans -acting regulatory locus at chr12q13.2 containing the rs1131017 SNP in the RPS26 gene.", {"entities": [[53, 56, "GENE"], [138, 143, "GENE"]]}], ["Most remarkably, we identify a common missense variant in IL27 , associated with type 1 diabetes that results in decreased functional activity of the protein and reduced expression levels of downstream IRF1 and STAT1 in CD4 Variation in regulatory regions as well as coding regions of the genome can affect the expression of genes.", {"entities": [[58, 62, "GENE"], [202, 206, "GENE"], [211, 216, "GENE"], [220, 223, "GENE"]]}], ["Many of these variants have been associated with different diseases and other traits, but the underlying biological pathways are often left unknown.", {"entities": []}], ["Analysing the effect of single nucleotide polymorphisms (SNPs) on gene expression levels, referred to as expression quantitative trait loci (eQTL), in specific cell types can be used to gain insight into specific mechanisms of disease.", {"entities": []}], ["By analyzing eQTLs in CD4 cis - and trans -acting SNPs in genes associated with several autoimmune diseases.", {"entities": [[22, 25, "GENE"]]}], ["To perform a systematic review, and if possible a meta-analysis, to establish whether depressed patients with co-morbid chronic somatic illnesses are a high risk \u201cdouble trouble\u201d group for depressive recurrence.", {"entities": []}], ["The databases PubMed, EMbase and PsycINFO were systematically searched until the 4 The search generated four articles that fulfilled our inclusion criteria.", {"entities": []}], ["These studies showed no differences in recurrence over one- two- three- and 6.5 years of follow-up for a total of 2010 depressed patients of which 694 patients with a co-morbid chronic somatic illness versus 1316 patients without (Study 1: RR\u200a=\u200a0.49, 95% CI, 0.17\u20131.41 at one year follow-up and RR\u200a=\u200a1.37, 95% CI, 0.78\u20132.41 at two year follow-up; Study 2: RR\u200a=\u200a0.94, 95% CI, 0.65\u20131.36 at two year follow-up; Study 3: RR\u200a=\u200a1.15, 95% CI, 0.40\u20133.27 at one year follow-up; RR\u200a=\u200a1.07, 95% CI, 0.48\u20132.42 at two year follow-up and RR\u200a=\u200a0.99, 95% CI,0.55\u20131.77 at 6.5 years follow-up; Study 4: RR\u200a=\u200a1.16, 95% CI, 0.86\u20131.57 at three year follow-up).", {"entities": []}], ["We found no association between a heightened risk for depressive recurrence and co-morbid chronic somatic illnesses.", {"entities": []}], ["There is a need for more longitudinal studies to justify the current specific treatment advice such as long-term pharmacological maintenance treatment for this presumed \u201cdouble trouble\u201d group.", {"entities": []}], ["Sodium tanshinone IIA sulfonate (STS) is a derivate of tanshinone IIA, a lipophilic compound in Salvia miltiorrhiza .", {"entities": [[33, 36, "GENE"]]}], ["This study aimed to investigate the effect of STS on ion transport in mouse tracheal epithelium and the mechanisms underlying it.", {"entities": [[46, 49, "GENE"]]}], ["Short-circuit current ( I sc ) was measured to evaluate the effect of STS on transepithelial ion transport.", {"entities": [[70, 73, "GENE"]]}], ["Intracellular Ca i ) changes induced by STS in primary cultured mouse tracheal epithelial cells.", {"entities": [[40, 43, "GENE"]]}], ["Results showed that the apical application of STS at mouse trachea elicited an increase of I sc , which was abrogated by atropine, an antagonist of muscarinic acetylcholine receptor (mAChR).", {"entities": [[46, 49, "GENE"]]}], ["By removing ambient Cl I sc was suppressed.", {"entities": []}], ["Moreover, STS elevated the [Ca i in mouse tracheal epithelial cells.", {"entities": [[10, 13, "GENE"]]}], ["As a result, STS stimulated Cl", {"entities": [[13, 16, "GENE"]]}], ["The morbidity and mortality from asthma have markedly increased since the late 1970s.", {"entities": [[33, 39, "DISEASE"]]}], ["The hospitalization rate, an important marker of asthma severity, remains substantial.", {"entities": [[49, 55, "DISEASE"]]}], ["In adults with health care access, we prospectively studied 242 with asthma, aged 18\u201350 years, recruited from a random sample of allergy and pulmonary physician practices in Northern California to identify risk factors for subsequent hospitalization.", {"entities": [[69, 75, "DISEASE"]]}], ["Thirty-nine subjects (16%) reported hospitalization for asthma during the 18-month follow-up period.", {"entities": [[56, 62, "DISEASE"]]}], ["On controlling for asthma severity in multiple logistic regression analysis, non-white race (odds ratio [OR], 3.1; 95% confidence interval [CI], 1.1\u20138.8) and lower income (OR, 1.1 per $10,000 decrement; 95% CI, 0.9\u20131.3) were associated with a higher risk of asthma hospitalization.", {"entities": [[19, 25, "DISEASE"], [258, 264, "DISEASE"]]}], ["The severity-of-asthma score (OR, 3.4 per 5 points; 95%, CI 1.7\u20136.8) and recent asthma hospitalization (OR, 8.3; 95%, CI, 2.1\u201333.4) were also related to higher risk, after adjusting for demographic characteristics.", {"entities": [[16, 22, "DISEASE"], [80, 86, "DISEASE"]]}], ["Reliance on emergency department services for urgent asthma care was also associated with a greater likelihood of hospitalization (OR, 3.2; 95% CI, 1.0\u20139.8).", {"entities": [[53, 59, "DISEASE"]]}], ["In multivariate analysis not controlling for asthma severity, low income was even more strongly related to hospitalization (OR, 1.2 per $10,000 decrement; 95% CI, 1.02\u20131.4).", {"entities": [[45, 51, "DISEASE"]]}], ["In adult asthmatics with access to health care, non-white race, low income, and greater asthma severity were associated with a higher risk of hospitalization.", {"entities": [[88, 94, "DISEASE"]]}], ["Targeted interventions applied to high-risk asthma patients may reduce asthma morbidity and mortality.", {"entities": [[44, 50, "DISEASE"], [71, 77, "DISEASE"]]}], ["Bronchial asthma is an inflammatory disease of the respiratory system.", {"entities": [[10, 16, "DISEASE"]]}], ["However, it may also induce systemic effects.", {"entities": []}], ["Although reports suggest patients with asthma are at increased risk of cardiovascular events, the association between asthma and atherosclerosis is unclear.", {"entities": [[129, 144, "DISEASE"], [39, 45, "DISEASE"], [118, 124, "DISEASE"]]}], ["The aim of the present study was to compare the progression of atherosclerosis between patients with asthma treated with inhaled corticosteroids and healthy controls.", {"entities": [[63, 78, "DISEASE"], [101, 107, "DISEASE"]]}], ["In 102 adult patients with asthma, markers of arterial stiffness (pulse wave velocity and augmentation index) were evaluated by applanation tonometry.", {"entities": [[27, 33, "DISEASE"]]}], ["Structural atherosclerotic changes (intima-media complex thickness and presence of atherosclerotic plaque) were assessed sonographically.", {"entities": []}], ["Lipid profile and fasting glucose level were measured.", {"entities": []}], ["Clinical data concerning the course of asthma, its severity, and management strategy were obtained.", {"entities": [[39, 45, "DISEASE"]]}], ["A group of 102 healthy, age-matched controls were examined according to the same protocol.", {"entities": []}], ["The majority of patients presented well-controlled asthma of moderate severity.", {"entities": [[51, 57, "DISEASE"]]}], ["When adjusted for weight, age, and systolic blood pressure, no significant differences were observed in pulse wave velocity, in augmentation index, or in intima-media complex thickness between groups.", {"entities": []}], ["In controls, atherosclerotic plaque occurred significantly more often than in patients with asthma (p=0.0226).", {"entities": [[92, 98, "DISEASE"]]}], ["Moreover, in patients with asthma, the intima-media complex thickness of the right common carotid artery was significantly correlated with forced expiratory volume in 1 second (R Patients with bronchial asthma presented a decreased risk of atherosclerosis in comparison to healthy controls.", {"entities": [[240, 255, "DISEASE"], [27, 33, "DISEASE"], [203, 209, "DISEASE"]]}], ["Vitiligo is a dreaded disease in India due to its social and cultural consequences.", {"entities": [[0, 8, "DISEASE"]]}], ["PUVA and PUVAsol are the main treatment modalities for vitiligo vulgaris.", {"entities": [[55, 63, "DISEASE"]]}], ["To the best of our knowledge, this is the first case of accidental PUVA burns eventuating in prurigo nodularis lesions to be reported in a female patient who was undergoing home PUVA therapy.", {"entities": []}], ["The itch is so prominent and disabling that the focus of the patient has shifted from treating her vitiligo to ameliorating the pruritus.", {"entities": [[99, 107, "DISEASE"]]}], ["Angiostrongylus cantonensis ( A. cantonensis ) infection can result in increased risk of eosinophilic meningitis.", {"entities": [[102, 112, "DISEASE"], [89, 112, "DISEASE"]]}], ["Accumulation of eosinophils and inflammation can result in the A. cantonensis infection playing an important role in brain tissue injury during this pathological process.", {"entities": []}], ["However, underlying mechanisms regarding the transcriptomic responses during brain tissue injury caused by A. cantonensis infection are yet to be elucidated.", {"entities": []}], ["This study is aimed at identifying some genomic and transcriptomic factors influencing the accumulation of eosinophils and inflammation in the mouse brain infected with A. cantonensis .", {"entities": []}], ["An infected mouse model was prepared based on our laboratory experimental process, and then the mouse brain RNA Libraries were constructed for deep Sequencing with Illumina Genome Analyzer.", {"entities": []}], ["The raw data was processed with a bioinformatics\u2019 pipeline including Refseq genes expression analysis using cufflinks, annotation and classification of RNAs, lncRNA prediction as well as analysis of co-expression network.", {"entities": []}], ["The analysis of Refseq data provides the measure of the presence and prevalence of transcripts from known and previously unknown genes.", {"entities": []}], ["This study showed that Cys-Cys (CC) type chemokines such as CCL2, CCL8, CCL1, CCL24, CCL11, CCL7, CCL12 and CCL5 were elevated significantly at the late phase of infection.", {"entities": [[60, 64, "GENE"], [66, 70, "GENE"], [72, 76, "GENE"], [78, 83, "GENE"], [85, 90, "GENE"], [92, 96, "GENE"], [108, 112, "GENE"]]}], ["The up-regulation of CCL2 indicated that the worm of A. cantonensis had migrated into the mouse brain at an early infection phase.", {"entities": [[21, 25, "GENE"]]}], ["CCL2 could be induced in the brain injury during migration and CCL2 might play a major role in the neuropathic pain caused by A. cantonensis infection.", {"entities": [[0, 4, "GENE"], [63, 67, "GENE"], [0, 4, "GENE"], [63, 67, "GENE"]]}], ["The up-regulated expression of IL-4, IL-5, IL-10, and IL-13 showed Th2 cell predominance in immunopathological reactions at late infection phase in response to infection by A. cantonensis .", {"entities": []}], ["These different cytokines can modulate and inhibit each other and function as a network with the specific potential to drive brain eosinophilic inflammation.", {"entities": []}], ["The increase of ATF-3 expression at 21 dpi suggested the injury of neuronal cells at late phase of infection.", {"entities": []}], ["1217 new potential lncRNA were candidates of interest for further research.", {"entities": []}], ["These cytokine networks play an important role in the development of central nervous system inflammation caused by A. cantonensis infection.", {"entities": []}], ["The online version of this article (doi:10.1186/s13071-015-0939-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is a heterogeneous disease characterized by chronic airway inflammation.", {"entities": [[0, 6, "DISEASE"]]}], ["CD4(+) T-helper 9 (Th9) cells are closely linked to asthma, helping to regulate inflammation and immunity.", {"entities": [[52, 58, "DISEASE"], [0, 3, "GENE"]]}], ["Epidemiological studies showed that mycobacteria infections are negatively associated with asthma.", {"entities": [[91, 97, "DISEASE"]]}], ["Our previous research showed that inactivated Mycobacterium phlei nebulization alleviated the airway hyperresponsiveness and inflammation of asthma.", {"entities": [[141, 147, "DISEASE"]]}], ["However, the relationship between Th9 cells and mycobacteria remains unknown.", {"entities": []}], ["Here, we evaluated the relationship between Mycobacterium vaccae nebulization and Th9 cells in asthmatic mice.", {"entities": []}], ["Eighteen Balb/c mice were randomized into 3 groups of 6 mice each (normal control group, asthma control group, and nebulization asthma group [Neb.", {"entities": [[89, 95, "DISEASE"], [128, 134, "DISEASE"]]}], ["group was nebulized with M .", {"entities": []}], ["vaccae one month before establishment of the asthmatic model with ovalbumin (OVA) sensitization, and the normal and asthma control groups were nebulized with phosphate-buffered saline.", {"entities": [[116, 122, "DISEASE"]]}], ["The hyperresponsiveness of the mouse airways was assessed using a non-invasive lung function machine.", {"entities": []}], ["Lung airway inflammation was evaluated by hematoxylin and eosin and periodic acid-Schiff staining.", {"entities": []}], ["Cytokine interlukin-9 (IL-9) concentration and OVA-specific IgE in the bronchoalveolar lavage fluid were measured by enzyme-linked immunosorbent assays.", {"entities": []}], ["The percentages of \u03b3\u03b4TCR M .", {"entities": []}], ["vaccae nebulization.", {"entities": []}], ["The mechanism could involve M .", {"entities": []}], ["vaccae -mediated effects on induction of IL-9 secretion and suppression of IL-10 secretion from \u03b3\u03b4T cells.", {"entities": []}], ["\u03b3\u03b4T cells showed prominent IL-10 expression, indicating that they possibly belong to the Th9 family.", {"entities": []}], ["The objective of this study was to establish the effectiveness of interventions to reduce frequent emergency department (ED) use among a general adult high ED-use population.", {"entities": []}], ["Systematic review of the literature from 1950-January 2015.", {"entities": []}], ["Studies were included if they: had a control group (controlled trials or comparative cohort studies), were set in an ED or acute care facility, and examined the impact of an intervention to reduce frequent ED use in a general adult population.", {"entities": []}], ["Studies reporting non-original data or focused on a specific patient population were excluded.", {"entities": []}], ["Study design, patient population, intervention, the frequency of ED visits, and costs of frequent ED use and/or interventions were extracted and narratively synthesized.", {"entities": []}], ["Among 17 included articles, three intervention categories were identified: case management (n = 12), individualized care plans (n = 3), and information sharing (n = 2).", {"entities": []}], ["Ten studies examining case management reported reductions in mean (-0.66 to -37) or median (-0.1 to -20) number of ED visits after 12-months; one study reported an increase in mean ED visits (+2.79); and one reported no change.", {"entities": []}], ["Of these, 6 studies also reported reduced hospital costs.", {"entities": []}], ["Only 1 study evaluating individualized care plans examined ED utilization and found no change in median ED visits post-intervention.", {"entities": []}], ["Costs following individualized care plans were also only evaluated in 1 study, which reported savings in hospital costs of $742/patient.", {"entities": []}], ["Evidence was mixed regarding information sharing: 1 study reported no change in mean ED visits and did not examine costs; whereas the other reported a decrease in mean ED visits (-16.9) and ED cost savings of $15,513/patient.", {"entities": []}], ["The impact of all three frequent-user interventions was modest.", {"entities": []}], ["Case management had the most rigorous evidence base, yielded moderate cost savings, but with variable reductions in ED use.", {"entities": []}], ["Future studies evaluating non-traditional interventions, tailoring to patient subgroups or socio-cultural contexts, are warranted.", {"entities": []}], ["Respiratory diseases account for about 25% of all pediatric consultations, and 10% of these are for asthma.", {"entities": [[100, 106, "DISEASE"]]}], ["The other main pediatric respiratory diseases, in terms of incidence, are bronchiolitis, acute bronchitis and respiratory infections.", {"entities": [[74, 87, "DISEASE"], [95, 105, "DISEASE"]]}], ["Oral corticosteroids, in particular prednisolone, are often used to treat acute respiratory diseases given their anti-inflammatory effects.", {"entities": []}], ["However, the efficacy of treatment with oral corticosteroids differs among the various types of pediatric respiratory diseases.", {"entities": []}], ["Notably, also the adverse effects of corticosteroid treatment can differ depending on dosage, duration of treatment and type of corticosteroid administered \u2014 a case in point being growth retardation in long-course treatment.", {"entities": []}], ["A large body of data has accumulated on this topic.", {"entities": []}], ["In this article, we have reviewed the data and guidelines related to the role of oral corticosteroids in the treatment and management of pediatric bronchiolitis, wheezing, asthma and croup in the attempt to provide guidance for physicians.", {"entities": [[183, 188, "DISEASE"], [172, 178, "DISEASE"], [147, 160, "DISEASE"]]}], ["Also included is a section on the management of acute respiratory failure in children.", {"entities": [[54, 73, "DISEASE"]]}], ["Previous studies have observed associations between air pollution and heart disease.", {"entities": [[70, 83, "DISEASE"]]}], ["Susceptibility to air pollution effects has been examined mostly with a test of effect modification, but little evidence is available whether air pollution distorts cardiovascular risk factor distribution.", {"entities": []}], ["This paper aims to examine distributional and heterogeneous effects of air pollution on known cardiovascular biomarkers.", {"entities": []}], ["A total of 1,112 men from the Normative Aging Study and residents of the greater Boston, Massachusetts, area with mean age of 69 years at baseline were included in this study during the period 1995\u20132013.", {"entities": []}], ["We used quantile regression and random slope models to investigate distributional effects and heterogeneity in the traffic-related responses on blood pressure, heart rate variability, repolarization, lipids, and inflammation.", {"entities": []}], ["We considered 28-day averaged exposure to particle number, PM2.5 black carbon, and PM2.5 mass concentrations (measured at a single monitor near the site of the study visits).", {"entities": []}], ["We observed some evidence suggesting distributional effects of traffic-related pollutants on systolic blood pressure, heart rate variability, corrected QT interval, low density lipoprotein (LDL) cholesterol, triglyceride, and intercellular adhesion molecule-1 (ICAM-1).", {"entities": []}], ["For example, among participants with LDL cholesterol below 80 mg/dL, an interquartile range increase in PM2.5 black carbon exposure was associated with a 7-mg/dL (95% CI: 5, 10) increase in LDL cholesterol, while among subjects with LDL cholesterol levels close to 160 mg/dL, the same exposure was related to a 16-mg/dL (95% CI: 13, 20) increase in LDL cholesterol.", {"entities": []}], ["We observed similar heterogeneous associations across low versus high percentiles of the LDL distribution for PM2.5 mass and particle number.", {"entities": []}], ["These results suggest that air pollution distorts the distribution of cardiovascular risk factors, and that, for several outcomes, effects may be greatest among individuals who are already at high risk.", {"entities": []}], ["Bind MA, Peters A, Koutrakis P, Coull B, Vokonas P, Schwartz J.", {"entities": []}], ["Quantile regression analysis of the distributional effects of air pollution on blood pressure, heart rate variability, blood lipids, and biomarkers of inflammation in elderly American men: the Normative Aging Study.", {"entities": []}], ["Environ Health Perspect 124:1189\u20131198;\u2002http://dx.doi.org/10.1289/ehp.1510044", {"entities": []}], ["In the financing of a national health system, where pharmaceutical spending is one of the main cost containment targets, predicting pharmacy costs for individuals and populations is essential for budget planning and care management.", {"entities": []}], ["Although most efforts have focused on risk adjustment applying diagnostic data, the reliability of this information source has been questioned in the primary care setting.", {"entities": []}], ["We sought to assess the usefulness of incorporating pharmacy data into claims-based predictive models (PMs).", {"entities": []}], ["Developed primarily for the U.S. health care setting, a secondary objective was to evaluate the benefit of a local calibration in order to adapt the PMs to the Spanish health care system.", {"entities": []}], ["The population was drawn from patients within the primary care setting of Aragon, Spain (n = 84,152).", {"entities": []}], ["Diagnostic, medication and prior cost data were used to develop PMs based on the Johns Hopkins ACG methodology.", {"entities": []}], ["Model performance was assessed through r-squared statistics and predictive ratios.", {"entities": []}], ["The capacity to identify future high-cost patients was examined through c-statistic, sensitivity and specificity parameters.", {"entities": []}], ["The PMs based on pharmacy data had a higher capacity to predict future pharmacy expenses and to identify potential high-cost patients than the models based on diagnostic data alone and a capacity almost as high as that of the combined diagnosis-pharmacy-based PM.", {"entities": []}], ["PMs provided considerably better predictions when calibrated to Spanish data.", {"entities": []}], ["Understandably, pharmacy spending is more predictable using pharmacy-based risk markers compared with diagnosis-based risk markers.", {"entities": []}], ["Pharmacy-based PMs can assist plan administrators and medical directors in planning the health budget and identifying high-cost-risk patients amenable to care management programs.", {"entities": []}], ["The notion that oxidative stress plays a role in virtually every human disease and environmental exposure has become ingrained in everyday knowledge.", {"entities": []}], ["However, mounting evidence regarding the lack of specificity of biomarkers traditionally used as indicators of oxidative stress in human disease and exposures now necessitates re-evaluation.", {"entities": []}], ["To prioritize these re-evaluations, published literature was comprehensively analyzed in a meta-analysis to quantitatively classify the levels of systemic oxidative damage across human disease and in response to environmental exposures.", {"entities": []}], ["In this meta-analysis, the F 2 -isoprostane, 8-iso-PGF 2\u03b1 , was specifically chosen as the representative marker of oxidative damage.", {"entities": []}], ["To combine published values across measurement methods and specimens, the standardized mean differences (Hedges\u2019 g) in 8-iso-PGF 2\u03b1 levels between affected and control populations were calculated.", {"entities": []}], ["The meta-analysis resulted in a classification of oxidative damage levels as measured by 8-iso-PGF 2\u03b1 across 50 human health outcomes and exposures from 242 distinct publications.", {"entities": []}], ["Relatively small increases in 8-iso-PGF 2\u03b1 levels (g<0.8) were found in the following conditions: hypertension (g=0.4), metabolic syndrome (g=0.5), asthma (g=0.4), and tobacco smoking (g=0.7).", {"entities": [[98, 110, "DISEASE"], [130, 138, "DISEASE"], [148, 154, "DISEASE"]]}], ["In contrast, large increases in 8-iso-PGF 2\u03b1 levels were observed in pathologies of the kidney, e.g.", {"entities": []}], [", chronic renal insufficiency (g=1.9), obstructive sleep apnoea (g=1.1), and pre-eclampsia (g=1.1), as well as respiratory tract disorders, e.g.", {"entities": [[81, 90, "DISEASE"], [77, 90, "DISEASE"]]}], [", cystic fibrosis (g=2.3).", {"entities": [[2, 17, "DISEASE"]]}], ["In conclusion, we have established a quantitative classification for the level of 8-iso-PGF 2\u03b1 generation in different human pathologies and exposures based on a comprehensive meta-analysis of published data.", {"entities": []}], ["This analysis provides knowledge on the true involvement of oxidative damage across human health outcomes as well as utilizes past research to prioritize those conditions requiring further scrutiny on the mechanisms of biomarker generation.", {"entities": []}], ["fx1 \u2022 Oxidative damage is highly variable in human conditions as measured by F 2 -isoprostanes.", {"entities": []}], ["\u2022 Respiratory tract and urogenital diseases have the highest F 2 -isoprostanes.", {"entities": []}], ["\u2022 Cancer and cardiovascular diseases have surprisingly low F 2 -isoprostanes.", {"entities": []}], ["Oxidative damage is highly variable in human conditions as measured by F 2 -isoprostanes.", {"entities": []}], ["Respiratory tract and urogenital diseases have the highest F 2 -isoprostanes.", {"entities": []}], ["Cancer and cardiovascular diseases have surprisingly low F 2 -isoprostanes.", {"entities": []}], ["Fluorescent and luminescent probes are essential to both in vitro molecular assays and in vivo imaging techniques, and have been extensively used to measure biological function.", {"entities": []}], ["However, little is known about the biological activity, thus potential interferences with the assay results, of these probe molecules.", {"entities": []}], ["Here we show that D-luciferin, one of the most widely used bioluminescence substrates, is a partial agonist for G protein-coupled receptor-35 (GPR35).", {"entities": [[143, 148, "GENE"]]}], ["Label-free phenotypic profiling using dynamic mass redistribution (DMR) assays showed that D-luciferin led to a DMR signal in native HT-29 cells, whose characteristics are similar to those induced by known GPR35 agonists including zaprinast and pamoic acid.", {"entities": [[206, 211, "GENE"]]}], ["DMR assays further showed that D-luciferin is a partial agonist competitive to several known GPR35 agonists and antagonists.", {"entities": [[93, 98, "GENE"]]}], ["D-luciferin was found to cause the phosphorylation of ERK that was suppressed by known GPR35 antagonists, and also result in \u03b2-arrestin translocation signal but with low efficacy.", {"entities": [[87, 92, "GENE"]]}], ["These results not only suggest that D-luciferin is a partial agonist of GPR35, but also will evoke careful interpretation of biological data obtained using molecular and in vivo imaging assays when these probe molecules are used.", {"entities": [[72, 77, "GENE"]]}], ["This study examined behavioral changes in households after participation in a home environmental assessment.", {"entities": []}], ["Home assessment visits by a trained coach, which involved a walk-through in the home with the home residents, were conducted in 36 homes.", {"entities": []}], ["The walk-through included a list of recommended behavioral changes that the residents could make to reduce their exposures to home pollutants in areas such as dust control, moisture problems, indoor air, hazardous household products, and hobbies.", {"entities": []}], ["Recruited households were surveyed 3 months after the home assessment to evaluate their implementation of the recommendations.", {"entities": []}], ["Following the home visits, 31 of 36 households reported making at least one behavioral change, and 41% of the recommendations made by the volunteer coaches were implemented.", {"entities": []}], ["In conclusion, this study found that the majority of the households who participated in the home assessment reported implementing at least one recommendation.", {"entities": []}], ["This home health promotional method was effective in influencing behavioral changes.", {"entities": []}], ["Chlorination destroys pathogens in swimming pool water, but by-products of chlorination can cause human illness.", {"entities": []}], ["We investigated outbreaks of ocular and respiratory symptoms associated with chlorinated indoor swimming pools at two hotels.", {"entities": []}], ["We interviewed registered guests and companions who stayed at hotels X and Y within 2 days of outbreak onset.", {"entities": []}], ["We performed bivariate and stratified analyses, calculated relative risks (RR), and conducted environmental investigations of indoor pool areas.", {"entities": []}], ["Of 77 guests at hotel X, 47 (61%) completed questionnaires.", {"entities": []}], ["Among persons exposed to the indoor pool area, 22 (71%) of 31 developed ocular symptoms [RR = 24; 95% confidence interval (CI), 1.5\u2013370], and 14 (45%) developed respiratory symptoms (RR = 6.8; 95% CI, 1.0\u201347) with a median duration of 10 hr (0.25\u201324 hr).", {"entities": [[238, 240, "GENE"], [250, 252, "GENE"], [238, 240, "GENE"], [250, 252, "GENE"]]}], ["We interviewed 30 (39%) of 77 registered persons and 59 unregistered companions at hotel Y.", {"entities": []}], ["Among persons exposed to the indoor pool area, 41 (59%) of 69 developed ocular symptoms (RR = 24; 95% CI, 1.5\u2013370), and 28 (41%) developed respiratory symptoms (RR = 17; 95% CI, 1.1\u2013260) with a median duration of 2.5 hr (2 min\u201314 days).", {"entities": [[217, 219, "GENE"]]}], ["Four persons sought medical care.", {"entities": []}], ["During the outbreak, the hotel X\u2019s ventilation system malfunctioned.", {"entities": []}], ["Appropriate water and air samples were not available for laboratory analysis.", {"entities": []}], ["Indoor pool areas were associated with illness in these outbreaks.", {"entities": []}], ["A large proportion of bathers were affected; symptoms were consistent with chloramine exposure and were sometimes severe.", {"entities": []}], ["Improved staff training, pool maintenance, and pool area ventilation could prevent future outbreaks.", {"entities": []}], ["Depression is a chronic mental health condition that affects millions of individuals worldwide.", {"entities": []}], ["It is well-established that psychological stress plays an integral role in depression and that depression has numerous negative health outcomes.", {"entities": []}], ["However, a closer look at components of stress vulnerabilities and depression is required to allow for the development and testing of appropriate interventions.", {"entities": []}], ["This article describes a conceptual framework about the complex and bidirectional relationship between stress vulnerability, depression, and health outcomes in women.", {"entities": []}], ["The authors elucidate how the framework can be applied in clinical research about cellular aging and on the mechanisms of complementary and alternative medicine (CAM) for depression, using yoga as an example of a CAM modality.", {"entities": []}], ["The proposed conceptual framework may be helpful for adding depth to the body of knowledge about the use of mind-body therapies for individuals at high risk of stress vulnerability and/or depression.", {"entities": []}], ["The ocean is a rich resource of flora, fauna, food, and biological products.", {"entities": []}], ["We found a wild-type bacterial strain, Pseudoalteromonas sp.", {"entities": []}], ["M2, from marine water and isolated various secondary metabolites.", {"entities": []}], ["Pseudane-VII is a compound isolated from the Pseudoalteromonas sp.", {"entities": []}], ["M2 metabolite that possesses anti-melanogenic activity.", {"entities": []}], ["Inflammation is a response of the innate immune system to microbial infections.", {"entities": []}], ["Macrophages have a critical role in fighting microbial infections and inflammation.", {"entities": []}], ["Recent studies reported that various compounds derived from natural products can regulate immune responses including inflammation.", {"entities": []}], ["However, the anti-inflammatory effects and mechanism of pseudane-VII in macrophages are still unknown.", {"entities": []}], ["In this study, we investigated the anti-inflammatory effects of pseudane-VII.", {"entities": []}], ["In present study, lipopolysaccharide (LPS)-induced nitric oxide (NO) production was significantly decreased by pseudane-VII treatment at 6 \u03bcM.", {"entities": []}], ["Moreover, pseudane-VII treatment dose-dependently reduced mRNA levels of pro-inflammatory cytokines including inos , cox-2 , il-1\u03b2 , tnf-\u03b1 , and il-6 in LPS-stimulated macrophages.", {"entities": []}], ["Pseudane-VII also diminished iNOS protein levels and IL-1\u03b2 secretion.", {"entities": []}], ["In addition, Pseudane-VII elicited anti-inflammatory effects by inhibiting ERK, JNK, p38, and nuclear factor (NF)-\u03baB-p65 phosphorylation.", {"entities": []}], ["Consistently, pseudane-VII was also shown to inhibit the LPS-stimulated release of IL-1\u03b2 and expression of iNOS in mice.", {"entities": []}], ["These results suggest that pseudane-VII exerted anti-inflammatory effects on LPS-stimulated macrophage activation via inhibition of ERK, JNK, p38 MAPK phosphorylation, and pro-inflammatory gene expression.", {"entities": []}], ["These findings may provide new approaches in the effort to develop anti-inflammatory therapeutics.", {"entities": []}], ["We performed a Phenome-Wide Association Study (PheWAS) to identify interrelationships between the immune system genetic architecture and a wide array of phenotypes from two de-identified electronic health record (EHR) biorepositories.", {"entities": []}], ["We selected variants within genes encoding critical factors in the immune system and variants with known associations with autoimmunity.", {"entities": []}], ["To define case/control status for EHR diagnoses, we used International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes from 3,024 Geisinger Clinic MyCode TNF ) and ankyrin-related genes associated with acute and chronic sinusitis and acute respiratory tract infection.", {"entities": [[239, 248, "DISEASE"], [173, 176, "GENE"]]}], ["The two most significant associations identified were for the C6orf10 SNP rs6910071 and \u201crheumatoid arthritis\u201d (ICD-9 code category 714) (p METAL = 2.58 x 10 ATN1 SNP rs2239167 and \u201cdiabetes mellitus, type 2\u201d (ICD-9 code category 250) (p METAL = 6.39 x 10", {"entities": [[89, 109, "DISEASE"], [100, 109, "DISEASE"], [182, 199, "DISEASE"], [62, 69, "GENE"], [158, 162, "GENE"]]}], ["Alternate day modified fasting (ADMF) is an effective strategy for weight loss in obese adults.", {"entities": []}], ["The objective of this study was to examine the dietary and physical activity adaptations that occur during short-term ADMF, and to determine how these modulations affect rate of weight loss.", {"entities": []}], ["Sixteen obese subjects (12 women/4 men) completed a 10-week trial consisting of 3 phases: 1) 2-week control phase, 2) 4-week ADMF controlled feeding phase, and 3) 4-week ADMF self-selected feeding phase.", {"entities": []}], ["Body weight decreased ( P < 0.001) by 5.6 \u00b1 1.0 kg post-treatment.", {"entities": []}], ["Energy intake on the fast day was 26 \u00b1 3% of baseline needs (501 \u00b1 28 kcal/d).", {"entities": []}], ["No hyperphagic response occurred on the feed day (95 \u00b1 6% of baseline needs consumed, 1801 \u00b1 226 kcal/d).", {"entities": []}], ["Daily energy restriction (37 \u00b1 7%) was correlated to rate of weight loss ( r = 0.42, P = 0.01).", {"entities": []}], ["Dietary fat intake decreased (36% to 33% of kcal, P < 0.05) with dietary counseling, and was related to rate of weight loss ( r = 0.38, P = 0.03).", {"entities": []}], ["Hunger on the fast day decreased ( P < 0.05) by week 2, and remained low.", {"entities": []}], ["Habitual physical activity was maintained throughout the study (fast day: 6416 \u00b1 851 steps/d; feed day: 6569 \u00b1 910 steps/d).", {"entities": []}], ["These findings indicate that obese subjects quickly adapt to ADMF, and that changes in energy/macronutrient intake, hunger, and maintenance of physical activity play a role in influencing rate of weight loss by ADMF.", {"entities": []}], ["Background .", {"entities": []}], ["Both IL-9 and miR-200a are involved in the pathogenesis of cancers; however, the role of IL-9 in pancreatic cancer and the possible underlying mechanisms remain unknown.", {"entities": [[97, 114, "DISEASE"], [108, 114, "DISEASE"], [14, 22, "GENE"]]}], ["The aim of this study was to investigate the effect of IL-9 on pancreatic cancer cells and its interaction with miR-200a.", {"entities": [[63, 80, "DISEASE"], [74, 80, "DISEASE"], [112, 120, "GENE"]]}], ["Pancreatic cancer cells (PANC-1 and AsPC-1) were treated with IL-9 and the expression of miR-200a and \u03b2 -catenin in pancreatic cancer cells was measured.", {"entities": [[0, 17, "DISEASE"], [116, 133, "DISEASE"], [11, 17, "DISEASE"], [127, 133, "DISEASE"], [89, 97, "GENE"]]}], ["\u03b2 -Catenin was examined as a target gene of miR-200a in pancreatic cancer cells.", {"entities": [[56, 73, "DISEASE"], [67, 73, "DISEASE"], [44, 52, "GENE"]]}], ["The interaction between IL-9 and miR-200a in pancreatic cancer cells was determined by infecting miR-200a mimics prior to IL-9 treatment and then measuring miR-200a and \u03b2 -catenin expression.", {"entities": [[45, 62, "DISEASE"], [56, 62, "DISEASE"], [33, 41, "GENE"], [97, 105, "GENE"], [156, 164, "GENE"], [33, 41, "GENE"], [97, 105, "GENE"], [156, 164, "GENE"], [33, 41, "GENE"], [97, 105, "GENE"], [156, 164, "GENE"]]}], ["IL-9 significantly promoted the proliferation, invasion, and migration of pancreatic cancer cells; however, the effect on pancreatic cancer cell apoptosis was insignificant.", {"entities": [[74, 91, "DISEASE"], [122, 139, "DISEASE"], [85, 91, "DISEASE"], [133, 139, "DISEASE"]]}], ["\u03b2 -Catenin was verified as a target gene of miR-200a in pancreatic cancer cells.", {"entities": [[56, 73, "DISEASE"], [67, 73, "DISEASE"], [44, 52, "GENE"]]}], ["Overexpression of miR-200a in pancreatic cancer cells significantly attenuated proliferation and metastasis and reduced \u03b2 -catenin expression.", {"entities": [[30, 47, "DISEASE"], [41, 47, "DISEASE"], [18, 26, "GENE"]]}], ["IL-9 treatment of pancreatic cancer cells decreased miR-200a expression and increased \u03b2 -catenin expression.", {"entities": [[18, 35, "DISEASE"], [29, 35, "DISEASE"], [52, 60, "GENE"]]}], ["The effect of miR-200a on pancreatic cancer cells decreased following IL-9 treatment.", {"entities": [[26, 43, "DISEASE"], [37, 43, "DISEASE"], [14, 22, "GENE"]]}], ["Conclusions .", {"entities": []}], ["IL-9 promotes proliferation and metastasis in pancreatic cancer cells; this effect may partly involve regulation of the miR-200a/ \u03b2 -catenin axis.", {"entities": [[46, 63, "DISEASE"], [57, 63, "DISEASE"]]}], ["Disease management programs are increasingly used to manage costs of patients with chronic disease.", {"entities": []}], ["We sought to examine the clinical characteristics and measure the health care expenditures of patients most likely to be targeted by disease management programs.", {"entities": []}], ["Retrospective analysis of prospectively obtained data.", {"entities": []}], ["A general medicine practice with both faculty and residents at an urban academic medical center.", {"entities": []}], ["Five thousand eight hundred sixty-one patients enrolled in the practice for at least 1\u00a0year.", {"entities": []}], ["Annual cost of diseases targeted by disease management.", {"entities": []}], ["Patients\u2019 clinical and demographic information were collected from a computer system used to manage patients.", {"entities": []}], ["Data included diagnostic information, medications, and resource usage over 1\u00a0year.", {"entities": []}], ["We looked at 10 common diseases targeted by disease management programs.", {"entities": []}], ["Unadjusted annual median costs for chronic diseases ranged between $1,100 and $1,500.", {"entities": []}], ["Congestive heart failure ($1,500), stroke ($1,500), diabetes ($1,500), and cancer ($1,400) were the most expensive.", {"entities": [[75, 81, "DISEASE"]]}], ["As comorbidity increased, annual adjusted costs increased exponentially.", {"entities": []}], ["Those with comorbidity scores of 2 or more accounted for 26% of the population but 50% of the overall costs.", {"entities": []}], ["Costs for individual chronic conditions vary within a relatively narrow range.", {"entities": []}], ["However, the costs for patients with multiple coexisting medical conditions increase rapidly.", {"entities": []}], ["Reducing health care costs will require focusing on patients with multiple comorbid diseases, not just single diseases.", {"entities": []}], ["The overwhelming impact of comorbidity on costs raises significant concerns about the potential ability of disease management programs to limit the costs of care.", {"entities": []}], ["Hypoglycemia is one of the major factors limiting implementation of tight glycemic control in patients with type 1 diabetes and is associated with increased morbidity and mortality during intensive insulin treatment.", {"entities": [[0, 12, "DISEASE"]]}], ["\u03b2-2 Adrenergic receptor (AR) agonists have been reported to diminish nocturnal hypoglycemia; however, whether long-acting inhaled \u03b2-2 AR agonists could potentially be used to treat or prevent hypoglycemia has not been established.", {"entities": [[79, 91, "DISEASE"], [192, 204, "DISEASE"]]}], ["Seven patients with type 1 diabetes and seven healthy control subjects received inhaled formoterol (48 \u03bcg), a highly specific \u03b2-2 AR agonist, or a placebo during a hyperinsulinemic-hypoglycemic clamp study to evaluate its capacity to antagonize the effect of insulin.", {"entities": []}], ["In a second set of studies, five subjects with type 1 diabetes received inhaled formoterol to assess its effect as a preventive therapy for insulin-induced hypoglycemia.", {"entities": [[156, 168, "DISEASE"]]}], ["During a hyperinsulinemic-hypoglycemic clamp, compared with placebo, inhaled formoterol decreased the glucose infusion rate required to maintain plasma glucose at a target level by 45\u201350% ( P < 0.05).", {"entities": []}], ["There was no significant effect on glucagon, epinephrine, cortisol, or growth hormone release ( P = NS).", {"entities": []}], ["Furthermore, in volunteers with type 1 diabetes 1 h after increasing basal insulin delivery twofold, glucose levels dropped to 58 \u00b1 5 mg/dL, whereas hypoglycemia was prevented by inhaled formoterol ( P < 0.001).", {"entities": [[149, 161, "DISEASE"]]}], ["Inhalation of the \u03b2-2 AR\u2013specific agonist formoterol may be useful in the prevention or treatment of acute hypoglycemia and thus may help patients with type 1 diabetes achieve optimal glucose control more safely.", {"entities": [[107, 119, "DISEASE"]]}], ["Breastfeeding has been linked to a reduction in the prevalence of allergy and asthma.", {"entities": [[78, 84, "DISEASE"]]}], ["However, studies on this relationship vary in outcome, which may partly be related to differences in breast milk composition.", {"entities": []}], ["In particular breast milk composition may differ between allergic and non-allergic mothers.", {"entities": []}], ["Important components that may be involved are breast milk proteins, as these are known to regulate immune development in the newborn.", {"entities": []}], ["The objective of this study was therefore to explore differences in the proteins of breast milk from 20 allergic and non-allergic mothers.", {"entities": []}], ["The results from this comparison may then be used to generate hypotheses on proteins associated with allergy in their offspring.", {"entities": []}], ["Milk samples from allergic and non-allergic mothers were obtained from the PIAMA project, a prospective birth cohort study on incidence, risk factors, and prevention of asthma and inhalant allergy.", {"entities": [[169, 175, "DISEASE"]]}], ["Non-targeted proteomics technology, based on liquid chromatography and mass spectrometry, was used to compare breast milk from allergic and non-allergic mothers.", {"entities": []}], ["Nineteen proteins, out of a total of 364 proteins identified in both groups, differed significantly in concentration between the breast milk of allergic and non-allergic mothers.", {"entities": []}], ["Protease inhibitors and apolipoproteins were present in much higher concentrations in breast milk of allergic than non-allergic mothers.", {"entities": []}], ["These proteins have been suggested to be linked to allergy and asthma.", {"entities": [[63, 69, "DISEASE"]]}], ["The non-targeted milk proteomic analysis employed has provided new targets for future studies on the relation between breast milk composition and allergy.", {"entities": []}], ["Recently, academic studies suggest that global growth of airway allergic disease has a close association with dietary changes including reduced consumption of fiber.", {"entities": []}], ["Therefore, appropriate dietary fiber supplementation might be potential to prevent airway allergic disease (AAD).", {"entities": []}], ["We investigated whether dietary fiber intake suppressed the induction of AAD and tried to elucidate the possible underlying mechanisms.", {"entities": []}], ["The control mice and AAD model mice fed with 4% standard-fiber chow, while low-fiber group of mice fed with a 1.75% low-fiber chow.", {"entities": []}], ["The two fiber-intervened groups including mice, apart from a standard-fiber diet, were also intragastric (i.g.)", {"entities": []}], ["administrated daily with poorly fermentable cellulose or readily fermentable pectin (0.4% of daily body weight), respectively.", {"entities": []}], ["All animals except normal mice were sensitized and challenged with ovalbumin (OVA) to induce airway allergic inflammation.", {"entities": []}], ["Hallmarks of AAD were examined by histological analysis and ELISA.", {"entities": []}], ["The variation in intestinal bacterial composition was assessed by qualitative analysis of 16S ribosomal DNA (rDNA) content in fecal samples using real-time PCR.", {"entities": []}], ["Low-fiber diet aggravated inflammatory response in ovalbumin-induced allergic mice, whereas dietary fiber intake significantly suppressed the allergic responses, attenuated allergic symptoms of nasal rubbing and sneezing, decreased the pathology of eosinophil infiltration and goblet cell metaplasia in the nasal mucosa and lung, inhibited serum OVA-specific IgE levels, and lowered the levels of Th2 cytokines in NALF and BALF, but, increased Th1 (IFN-\u03b3) cytokines.", {"entities": []}], ["Additionally, dietary fiber intake also increased the proportion of Bacteroidetes and Actinobacteria, and decreased Firmicutes and Proteobacteria.", {"entities": []}], ["Levels of probiotic bacteria, such as Lactobacillus and Bifidobacterium , were upgraded significantly.", {"entities": []}], ["Long-term deficiency of dietary fiber intake increases the susceptibility to AAD, whereas proper fiber supplementation promotes effectively the balance of Th1/Th2 immunity and then attenuates allergic inflammatory responses significantly, as well as optimizes the structure of intestinal microbiota, which suggests potential for novel preventive and therapeutic intervention.", {"entities": []}], ["Leukotriene E 4 (LTE 4 ), the most stable of the cysteinyl leukotrienes (cysLTs), binds poorly to classical type 1 and 2 cysLT receptors although in asthmatic individuals it may potently induce bronchial constriction, airway hyperresponsiveness and inflammatory cell influx to the lung.", {"entities": []}], ["A recent study has suggested that the purinergic receptor P2Y 12 is required for LTE 4 mediated pulmonary inflammation in a mouse model of asthma and signals in response to cysLTs.", {"entities": [[139, 145, "DISEASE"]]}], ["The aim of the study was to characterise the responsiveness of human P2Y 12 to cysteinyl leukotrienes.", {"entities": []}], ["Models of human CysLT 1 , CysLT 2 and P2Y 12 overexpressed in HEK293, CHO cells and human platelets were used and responsiveness to different agonists was measured using intracellular calcium, cAMP and \u03b2-arrestin recruitment assays.", {"entities": []}], ["CysLTs induced concentration dependent calcium mobilisation in cells overexpressing CysLT 1 and CysLT 2 but failed to induce any calcium response in cells expressing P2Y 12 or P2Y 12 + G\u03b1 16 .", {"entities": []}], ["In contrast, selective P2Y 12 agonists ADP and 2-MeS-ADP induced specific calcium flux in cells expressing P2Y 12 + G\u03b1 16 .", {"entities": []}], ["Similarly, specific response to 2-MeS-ADP, but not to cysLTs was also observed in cells expressing P2Y 12 when intracellular cAMP and \u03b2-arrestin signalling were analysed.", {"entities": []}], ["Platelets were used as a model of human primary cells expressing P2Y 12 to analyse potential signalling and cell activation through P2Y 12 receptor or receptor heterodimers but no specific LTE 4 responses were observed.", {"entities": []}], ["These results show that LTE 4 as well as other cysLTs do not activate intracellular signalling acting through P2Y 12 and suggest that another LTE 4 specific receptor has yet to be identified.", {"entities": []}], ["Scientific knowledge is in constant development.", {"entities": []}], ["Consequently, regular review to assure the trustworthiness of clinical guidelines is required.", {"entities": []}], ["However, there is still a lack of preferred reporting items of the updating process in updated clinical guidelines.", {"entities": []}], ["The present article describes the development process of the Checklist for the Reporting of Updated Guidelines (CheckUp).", {"entities": []}], ["We developed an initial list of items based on an overview of research evidence on clinical guideline updating, the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument, and the advice of the CheckUp panel ( n = 33 professionals).", {"entities": []}], ["A multistep process was used to refine this list, including an assessment of ten existing updated clinical guidelines, interviews with key informants (response rate: 54.2%; 13/24), a three-round Delphi consensus survey with the CheckUp panel (33 participants), and an external review with clinical guideline methodologists (response rate: 90%; 53/59) and users (response rate: 55.6%; 10/18).", {"entities": []}], ["CheckUp includes 16 items that address (1) the presentation of an updated guideline, (2) editorial independence, and (3) the methodology of the updating process.", {"entities": []}], ["In this article, we present the methodology to develop CheckUp and include as a supplementary file an explanation and elaboration document.", {"entities": []}], ["CheckUp can be used to evaluate the completeness of reporting in updated guidelines and as a tool to inform guideline developers about reporting requirements.", {"entities": []}], ["Editors may request its completion from guideline authors when submitting updated guidelines for publication.", {"entities": []}], ["Adherence to CheckUp will likely enhance the comprehensiveness and transparency of clinical guideline updating for the benefit of patients and the public, health care professionals, and other relevant stakeholders.", {"entities": []}], ["Pablo Alonso-Coello and colleagues describe a checklist to guide the reporting of clinical guideline updates.", {"entities": []}], ["The CD30/CD30L signalling system has been implicated in the pathogenesis of several autoimmune and inflammatory conditions.", {"entities": []}], ["In rheumatoid arthritis (RA), soluble CD30 (sCD30) levels reflect the recruitment of CD30", {"entities": [[3, 23, "DISEASE"], [14, 23, "DISEASE"]]}], ["Clusters of infectious diseases are frequently detected late.", {"entities": []}], ["Real-time, detailed information about an evolving cluster and possible associated conditions is essential for local policy makers, travelers planning to visit the area, and the local population.", {"entities": []}], ["This is currently illustrated in the Zika virus outbreak.", {"entities": []}], ["In the Netherlands, ICARES (Integrated Crisis Alert and Response System) has been developed and tested on three syndromes as an automated, real-time tool for early detection of clusters of infectious diseases.", {"entities": []}], ["From local general practices, General Practice Out-of-Hours services and a hospital, the numbers of routinely used syndrome codes for three piloted tracts i.e., respiratory tract infection, hepatitis and encephalitis/meningitis, are sent on a daily basis to a central unit of infectious disease control.", {"entities": [[115, 123, "DISEASE"], [190, 199, "DISEASE"], [204, 216, "DISEASE"], [217, 227, "DISEASE"]]}], ["Historic data combined with information about patients\u2019 syndromes, age cohort, gender and postal code area have been used to detect clusters of cases.", {"entities": []}], ["During the first 2\u00a0years, two out of eight alerts appeared to be a real cluster.", {"entities": []}], ["The first was part of the seasonal increase in Enterovirus encephalitis and the second was a remarkably long lasting influenza season with high peak incidence.", {"entities": [[117, 126, "DISEASE"], [59, 71, "DISEASE"]]}], ["This tool is believed to be the first flexible automated, real-time cluster detection system for infectious diseases, based on physician information from both general practitioners and hospitals.", {"entities": []}], ["ICARES is able to detect and follow small regional clusters in real time and can handle any diseases entity that is regularly registered by first line physicians.", {"entities": []}], ["Its value will be improved when more health care institutions agree to link up with ICARES thus improving further the signal-to-noise ratio.", {"entities": []}], ["The purpose of this study was to investigate the clinical efficacy and safety of a fixed-dose combination of mometasone furoate/formoterol fumarate (MF/F) administered via a metered-dose inhaler in subjects with moderate-to-very severe chronic obstructive pulmonary disease (COPD).", {"entities": [[236, 273, "DISEASE"]]}], ["This multicenter, double-blind, placebo-controlled trial had a 26-week treatment period and a 26-week safety extension.", {"entities": []}], ["Subjects (n = 1196), at least 40 years old, were current or ex-smokers randomized to twice-daily inhaled MF/F 400/10 \u03bcg, MF/F 200/10 \u03bcg, MF 400 \u03bcg, F 10 \u03bcg, or placebo.", {"entities": []}], ["The trial\u2019s co-primary endpoints were mean changes from baseline, as area under the curve (AUC), in forced expiratory volume (FEV 1 ) over 0\u201312 hours (AUC 0\u201312 h FEV 1 ) with MF/F versus MF, and in morning (AM) pre-dose (trough) FEV 1 with MF/F versus F after 13 weeks of treatment.", {"entities": [[126, 129, "GENE"], [162, 165, "GENE"], [229, 232, "GENE"], [126, 129, "GENE"], [162, 165, "GENE"], [229, 232, "GENE"], [126, 129, "GENE"], [162, 165, "GENE"], [229, 232, "GENE"]]}], ["Key secondary endpoints were the effects of MF/F on respiratory health status using the Saint George\u2019s Respiratory Questionnaire (SGRQ), symptom-free nights, partly stable COPD at 26 weeks, and time to first COPD exacerbation.", {"entities": []}], ["The largest improvements in AUC 0\u201312 h FEV 1 were observed with MF/F 400/10 \u03bcg and MF/F 200/10 \u03bcg.", {"entities": [[39, 42, "GENE"]]}], ["Serial spirometry results demonstrated that bronchodilator effects with MF/F occurred rapidly (within 5 minutes), persisted for 12 hours after dosing, and were sustained over the 26-week treatment period.", {"entities": []}], ["Similar findings were observed for AM pre-dose FEV 1 , for which effects were further investigated, excluding subjects whose AM FEV 1 data were incorrectly collected after 2 days from the last dose of study treatment.", {"entities": [[47, 50, "GENE"], [128, 131, "GENE"], [47, 50, "GENE"], [128, 131, "GENE"]]}], ["Improvements in SGRQ scores surpassed the minimum clinically important difference of more than four units with both MF/F treatments.", {"entities": []}], ["At 26 weeks, no notable between-treatment differences in the occurrence and nature of adverse events (AEs) were reported.", {"entities": []}], ["No unexpected AEs were observed.", {"entities": []}], ["Overall, 90 subjects reported AEs considered to be treatment-related, the most common of which were lenticular opacities, dysphonia, and oral candidiasis.", {"entities": [[137, 153, "DISEASE"], [142, 153, "DISEASE"]]}], ["In conclusion, MF/F treatments improved lung function and respiratory health status, reduced exacerbations, and were well tolerated in subjects with moderate-to-very severe COPD.", {"entities": []}], ["The impact of interventions on the progressive course of COPD is currently assessed by the slope of the annual decline in FEV 1 determined from serial measurements of the post-, in preference to the pre-, bronchodilator FEV 1 .", {"entities": [[122, 125, "GENE"], [220, 223, "GENE"], [122, 125, "GENE"], [220, 223, "GENE"]]}], ["We therefore compared the yearly slope and the variability of the slope of the pre- versus the post-bronchodilator FEV 1 in men and women with mild to moderate COPD who participated in the 5-year Lung Health Study (LHS).", {"entities": [[115, 118, "GENE"]]}], ["Data were analyzed from 4484 of the 5887 LHS participants who had measurements of pre- and post-bronchodilator FEV 1 at baseline (screening visit 2) and all five annual visits.", {"entities": [[111, 114, "GENE"]]}], ["The annual rate of decline in FEV 1 (\u00b1SE) measured pre- and post-bronchodilator from the first to the fifth annual visit was estimated separately using a random coefficient model adjusted for relevant covariates.", {"entities": [[30, 33, "GENE"]]}], ["Analyses were performed separately within each of the three randomized intervention groups.", {"entities": []}], ["In addition, individual rates of decline in pre- and post-bronchodilator FEV 1 were also determined for each participant.", {"entities": [[73, 76, "GENE"]]}], ["Furthermore, sample sizes were estimated for determining the significance of differences in slopes of decline between different interventions using pre- versus post-bronchodilator measurements.", {"entities": []}], ["Within each intervention group, mean adjusted and unadjusted slope estimates were slightly higher for the pre- than the post-bronchodilator FEV 1 (range of differences 2.6-5.2 ml/yr) and the standard errors around these estimates were only minimally higher for the pre- versus the post-bronchodilator FEV 1 (range 0.05-0.11 ml/yr).", {"entities": [[140, 143, "GENE"], [301, 304, "GENE"], [140, 143, "GENE"], [301, 304, "GENE"]]}], ["Conversely, the standard deviations of the mean FEV 1 determined at each annual visit were consistently slightly higher (range of differences 0.011 to 0.035 L) for the post- compared to the pre-bronchodilator FEV 1 .", {"entities": [[48, 51, "GENE"], [209, 212, "GENE"], [48, 51, "GENE"], [209, 212, "GENE"]]}], ["Within each group, the proportion of individual participants with a statistically significant slope was similar (varying by only 1.4 to 2.7%) comparing the estimates from the pre- versus the post-bronchodilator FEV 1 .", {"entities": [[211, 214, "GENE"]]}], ["However, sample size estimates were slightly higher when the pre- compared to the post-bronchodilator value was used to determine the significance of specified differences in slopes between interventions.", {"entities": []}], ["Serial measurements of the pre-bronchodilator FEV 1 are generally sufficient for comparing the impact of different interventions on the annual rate of change in FEV 1 .", {"entities": [[46, 49, "GENE"], [161, 164, "GENE"], [46, 49, "GENE"], [161, 164, "GENE"]]}], ["Phthalate exposures are hypothesized to increase obesity; however, prior research has been largely cross-sectional.", {"entities": [[49, 56, "DISEASE"]]}], ["We evaluated associations between prenatal phthalate exposures and body mass index (BMI) at child ages 5 and 7 years.", {"entities": []}], ["Nine metabolites of six phthalates\u2014di(2-ethylhexyl) phthalate (DEHP), di-n-octyl-, di-iso-butyl-, di-n-butyl-, butylbenzyl-, and diethyl phthalates\u2014were measured in spot urine samples collected from pregnant African-American and Dominican women during their third trimester, and from their children at ages 3 and 5 years.", {"entities": []}], ["To reduce multiple comparison issues, we initially used principal component analysis (PCA) to identify major patterns of natural log (ln)-transformed metabolite concentrations.", {"entities": []}], ["Height and weight were assessed at ages 5 and 7 years, and fat mass and waist circumference at age 7.", {"entities": []}], ["Linearized generalized estimating equation analyses related maternal component scores to child anthropometric outcomes at ages 5 (n = 326) and 7 (n = 330) years.", {"entities": []}], ["PCA identified a DEHP component and a non-DEHP component.", {"entities": []}], ["In boys, higher maternal non-DEHP, but not DEHP, component scores were associated with lower BMI z-score (\u03b2 = \u20130.30; 95% CI: \u20130.50, \u20130.10, n = 156), lower fat percentage (\u03b2 = \u20131.62; 95% CI: \u20132.91, \u20130.34, n = 142), and smaller waist circumference (\u03b2 = \u20132.02; 95% CI: \u20133.71, \u20130.32, n = 124).", {"entities": []}], ["No significant associations with anthropometric outcomes were seen in girls (for BMI z-score, \u03b2 = 0.07; 95% CI: \u20130.18, 0.31, n = 181).", {"entities": []}], ["Interactions between sex and non-DEHP component association with outcomes were statistically significant (p < 0.01).", {"entities": []}], ["Contrary to hypotheses, prenatal non-DEHP phthalate exposures were associated with lower BMI z-score, waist circumference, and fat mass in boys during early childhood.", {"entities": []}], ["Maresca MM, Hoepner LA, Hassoun A, Oberfield SE, Mooney SJ, Calafat AM, Ramirez J, Freyer G, Perera FP, Whyatt RM, Rundle AG.", {"entities": []}], ["Prenatal exposure to phthalates and childhood body size in an urban cohort.", {"entities": []}], ["Environ Health Perspect 124:514\u2013520; http://dx.doi.org/10.1289/ehp.1408750", {"entities": []}], ["The aim of this study was to compare the health care costs for patients using additional homeopathic treatment (homeopathy group) with the costs for those receiving usual care (control group).", {"entities": []}], ["Cost data provided by a large German statutory health insurance company were retrospectively analysed from the societal perspective (primary outcome) and from the statutory health insurance perspective.", {"entities": []}], ["Patients in both groups were matched using a propensity score matching procedure based on socio-demographic variables as well as costs, number of hospital stays and sick leave days in the previous 12 months.", {"entities": []}], ["Total cumulative costs over 18 months were compared between the groups with an analysis of covariance (adjusted for baseline costs) across diagnoses and for six specific diagnoses (depression, migraine, allergic rhinitis, asthma, atopic dermatitis, and headache).", {"entities": [[203, 220, "DISEASE"], [230, 247, "DISEASE"], [193, 201, "DISEASE"], [212, 220, "DISEASE"], [222, 228, "DISEASE"], [237, 247, "DISEASE"]]}], ["Data from 44,550 patients (67.3% females) were available for analysis.", {"entities": []}], ["From the societal perspective, total costs after 18 months were higher in the homeopathy group (adj.", {"entities": []}], ["mean: EUR 7,207.72 [95% CI 7,001.14\u20137,414.29]) than in the control group (EUR 5,857.56 [5,650.98\u20136,064.13]; p<0.0001) with the largest differences between groups for productivity loss (homeopathy EUR 3,698.00 [3,586.48\u20133,809.53] vs. control EUR 3,092.84 [2,981.31\u20133,204.37]) and outpatient care costs (homeopathy EUR 1,088.25 [1,073.90\u20131,102.59] vs. control EUR 867.87 [853.52\u2013882.21]).", {"entities": []}], ["Group differences decreased over time.", {"entities": []}], ["For all diagnoses, costs were higher in the homeopathy group than in the control group, although this difference was not always statistically significant.", {"entities": []}], ["Compared with usual care, additional homeopathic treatment was associated with significantly higher costs.", {"entities": []}], ["These analyses did not confirm previously observed cost savings resulting from the use of homeopathy in the health care system.", {"entities": []}], ["There is a need for more powerful methods to identify low-effect SNPs that contribute to hereditary COPD pathogenesis.", {"entities": []}], ["We hypothesized that SNPs contributing to COPD risk through cis -regulatory effects are enriched in genes comprised by bronchial epithelial cell (BEC) expression patterns associated with COPD.", {"entities": []}], ["To test this hypothesis, normal BEC specimens were obtained by bronchoscopy from 60 subjects: 30 subjects with COPD defined by spirometry (FEV1/FVC <\u20090.7, FEV1% <\u200980%), and 30 non-COPD controls.", {"entities": []}], ["Targeted next generation sequencing was used to measure total and allele-specific expression of 35 genes in genome maintenance (GM) genes pathways linked to COPD pathogenesis, including seven TP53 and CEBP transcription factor family members.", {"entities": [[192, 196, "GENE"]]}], ["Shrinkage linear discriminant analysis (SLDA) was used to identify COPD-classification models.", {"entities": []}], ["COPD GWAS were queried for putative cis -regulatory SNPs in the targeted genes.", {"entities": []}], ["On a network basis, TP53 and CEBP transcription factor pathway gene pair network connections, including key DNA repair gene ERCC5, were significantly different in COPD subjects (e.g., Wilcoxon rank sum test for closeness, p -value\u2009=\u20095.0E-11).", {"entities": [[20, 24, "GENE"], [124, 129, "GENE"]]}], ["ERCC5 SNP rs4150275 association with chronic bronchitis was identified in a set of Lung Health Study (LHS) COPD GWAS SNPs restricted to those in putative regulatory regions within the targeted genes, and this association was validated in the COPDgene non-hispanic white (NHW) GWAS.", {"entities": [[45, 55, "DISEASE"], [0, 5, "GENE"]]}], ["ERCC5 SNP rs4150275 is linked (D\u2019\u2009=\u20091) to ERCC5 SNP rs17655 which displayed differential allelic expression (DAE) in BEC and is an expression quantitative trait locus (eQTL) in lung tissue ( p \u00a0=\u20093.2E-7).", {"entities": [[0, 5, "GENE"], [42, 47, "GENE"], [0, 5, "GENE"], [42, 47, "GENE"]]}], ["SNPs in linkage (D\u2019\u2009=\u20091) with rs17655 were predicted to alter miRNA binding (rs873601).", {"entities": []}], ["A classifier model that comprised gene features CAT, CEBPG, GPX1, KEAP1, TP73, and XPA had pooled 10-fold cross-validation receiver operator characteristic area under the curve of 75.4% (95% CI: 66.3%\u201389.3%).", {"entities": [[53, 58, "GENE"], [60, 64, "GENE"], [66, 71, "GENE"], [73, 77, "GENE"], [83, 86, "GENE"]]}], ["The prevalence of DAE was higher than expected ( p \u00a0=\u20090.0023) in the classifier genes.", {"entities": []}], ["GM genes comprised by COPD-associated BEC expression patterns were enriched for SNPs with cis -regulatory function, including a putative cis -rSNP in ERCC5 that was associated with COPD risk.", {"entities": [[150, 155, "GENE"]]}], ["These findings support additional total and allele-specific expression analysis of gene pathways with high prior likelihood for involvement in COPD pathogenesis.", {"entities": []}], ["The online version of this article (10.1186/s12890-018-0603-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is associated with airway narrowing in response to bronchoconstricting stimuli and increased airway smooth muscle (ASM) mass.", {"entities": [[0, 6, "DISEASE"]]}], ["In addition, some studies have suggested impaired \u03b2-agonist induced ASM relaxation in asthmatics, but the mechanism is not known.", {"entities": []}], ["To characterize the potential defect in \u03b2-agonist induced cAMP in ASM derived from asthmatic in comparison to non-asthmatic subjects and to investigate its mechanism.", {"entities": []}], ["We examined \u03b2 2 -adrenergic (\u03b2 2 AR) receptor expression and basal \u03b2-agonist and forskolin (direct activator of adenylyl cyclase) stimulated cAMP production in asthmatic cultured ASM (n\u200a=\u200a15) and non-asthmatic ASM (n\u200a=\u200a22).", {"entities": []}], ["Based on these results, PDE activity, PDE4D expression and cell proliferation were determined.", {"entities": [[38, 43, "GENE"]]}], ["In the presence of IBMX, a pan PDE inhibitor, asthmatic ASM had \u223c50% lower cAMP production in response to isoproterenol, albuterol, formoterol, and forskolin compared to non-asthmatic ASM.", {"entities": []}], ["However when PDE4 was specifically inhibited, cAMP production by the agonists and forskolin was normalized in asthmatic ASM.", {"entities": []}], ["We then measured the amount and activity of PDE4, and found \u223c2-fold greater expression and activity in asthmatic ASM compared to non-asthmatic ASM.", {"entities": []}], ["Furthermore, inhibition of PDE4 reduced asthmatic ASM proliferation but not that of non-asthmatic ASM.", {"entities": []}], ["Decreased \u03b2-agonist induced cAMP in ASM from asthmatics results from enhanced degradation due to increased PDE4D expression.", {"entities": [[107, 112, "GENE"]]}], ["Clinical manifestations of this dysregulation would be suboptimal \u03b2-agonist-mediated bronchodilation and possibly reduced control over increasing ASM mass.", {"entities": []}], ["These phenotypes appear to be \u201chard-wired\u201d into ASM from asthmatics, as they do not require an inflammatory environment in culture to be observed.", {"entities": []}], ["Q fever is an emerging infectious disease among US soldiers serving in Iraq.", {"entities": []}], ["Three patients have had atypical manifestations, including 2 patients with acute cholecystitis and 1 patient with acute respiratory distress syndrome.", {"entities": [[141, 149, "DISEASE"], [81, 94, "DISEASE"]]}], ["Providers must be aware of Q fever\u2019s signs and symptoms to avoid delays in treatment.", {"entities": []}], ["Physical exercise reduces glucose levels and glucose variability in patients with type 2 diabetes.", {"entities": []}], ["Acute inspiratory muscle exercise has been shown to reduce these parameters in a small group of patients with type 2 diabetes, but these results have yet to be confirmed in a well-designed study.", {"entities": []}], ["The aim of this study is to investigate the effect of acute inspiratory muscle exercise on glucose levels, glucose variability, and cardiovascular autonomic function in patients with type 2 diabetes.", {"entities": []}], ["This study will use a randomized clinical trial crossover design.", {"entities": []}], ["A total of 14 subjects will be recruited and randomly allocated to two groups to perform acute inspiratory muscle loading at 2\u00a0% of maximal inspiratory pressure (PImax, placebo load) or 60\u00a0% of PImax (experimental load).", {"entities": []}], ["Inspiratory muscle training could be a novel exercise modality to be used to decrease glucose levels and glucose variability.", {"entities": []}], ["ClinicalTrials.gov NCT02292810 .", {"entities": []}], ["Increased mast cell (MC) density and changes in their distribution in airway tissues is thought to contribute significantly to the pathophysiology of asthma.", {"entities": [[150, 156, "DISEASE"]]}], ["However, the time sequence for these changes and how they impact small airway function in asthma is not fully understood.", {"entities": [[90, 96, "DISEASE"]]}], ["The aim of the current study was to characterise temporal changes in airway MC density and correlate these changes with functional airway responses in sheep chronically challenged with house dust mite (HDM) allergen.", {"entities": []}], ["MC density was examined on lung tissue from four spatially separate lung segments of allergic sheep which received weekly challenges with HDM allergen for 0, 8, 16 or 24 weeks.", {"entities": []}], ["Lung tissue was collected from each segment 7 days following the final challenge.", {"entities": []}], ["The density of tryptase-positive and chymase-positive MCs (MC T and MC TC respectively) was assessed by morphometric analysis of airway sections immunohistochemically stained with antibodies against MC tryptase and chymase.", {"entities": []}], ["MC T and MC TC density was increased in small bronchi following 24 weeks of HDM challenges compared with controls (P<0.05).", {"entities": []}], ["The MC TC /MC T ratio was significantly increased in HDM challenged sheep compared to controls (P<0.05).", {"entities": []}], ["MC T and MC TC density was inversely correlated with allergen-induced increases in peripheral airway resistance after 24 weeks of allergen exposure (P<0.05).", {"entities": []}], ["MC T density was also negatively correlated with airway responsiveness after 24 challenges (P<0.01).", {"entities": []}], ["MC T and MC TC density in the small airways correlates with better lung function in this sheep model of chronic asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["Whether this finding indicates that under some conditions mast cells have protective activities in asthma, or that other explanations are to be considered requires further investigation.", {"entities": [[99, 105, "DISEASE"]]}], ["Asthma heterogeneity is multidimensional and requires additional tools to unravel its complexity.", {"entities": [[0, 6, "DISEASE"]]}], ["Computed tomography (CT)\u2013assessed proximal airway remodeling and air trapping in asthmatic patients might provide new insights into underlying disease mechanisms.", {"entities": []}], ["The aim of this study was to explore novel, quantitative, CT-determined asthma phenotypes.", {"entities": [[72, 78, "DISEASE"]]}], ["Sixty-five asthmatic patients and 30 healthy subjects underwent detailed clinical, physiologic characterization and quantitative CT analysis.", {"entities": []}], ["Factor and cluster analysis techniques were used to determine 3 novel, quantitative, CT-based asthma phenotypes.", {"entities": [[94, 100, "DISEASE"]]}], ["Patients with severe and mild-to-moderate asthma demonstrated smaller mean right upper lobe apical segmental bronchus (RB1) lumen volume (LV) in comparison with healthy control subjects (272.3 mm P \u00a0= .007) but no difference in RB1 wall volume (WV).", {"entities": [[42, 48, "DISEASE"], [119, 122, "GENE"], [228, 231, "GENE"], [119, 122, "GENE"], [228, 231, "GENE"]]}], ["Air trapping measured based on mean lung density expiratory/inspiratory ratio was greater in patients with severe and mild-to-moderate asthma compared with that seen in healthy control subjects (0.861 [SD, 0.05)], 0.866 [SD, 0.07], and 0.830 [SD, 0.06], respectively; P \u00a0= .04).", {"entities": [[135, 141, "DISEASE"]]}], ["The fractal dimension of the segmented airway tree was less in asthmatic patients compared with that seen in control subjects ( P \u00a0= .007).", {"entities": []}], ["Three novel, quantitative, CT-based asthma clusters were identified, all of which demonstrated air trapping.", {"entities": [[36, 42, "DISEASE"]]}], ["Cluster 1 demonstrates increased RB1 WV and RB1 LV but decreased RB1 percentage WV.", {"entities": [[33, 36, "GENE"], [44, 47, "GENE"], [65, 68, "GENE"], [33, 36, "GENE"], [44, 47, "GENE"], [65, 68, "GENE"], [33, 36, "GENE"], [44, 47, "GENE"], [65, 68, "GENE"]]}], ["On the contrary, cluster 3 subjects have the smallest RB1 WV and LV values but the highest RB1 percentage WV values.", {"entities": [[54, 57, "GENE"], [91, 94, "GENE"], [54, 57, "GENE"], [91, 94, "GENE"]]}], ["There is a lack of proximal airway remodeling in cluster 2 subjects.", {"entities": []}], ["Quantitative CT analysis provides a new perspective in asthma phenotyping, which might prove useful in patient selection for novel therapies.", {"entities": [[55, 61, "DISEASE"]]}], ["To examine the relationships of strenuous and hazardous working conditions and rotating shifts that involve night working with life expectancy in good perceived health and life expectancy without chronic disease.", {"entities": []}], ["The sample contained male gas and electricity workers from the French GAZEL cohort (n=13\u2005393).", {"entities": []}], ["Six measures of physical working conditions were examined: Self-reports from 1989 and 1990 of ergonomic strain, physical danger, rotating shifts that involve night working and perceived physical strain; company records of workplace injuries and a job-exposure matrix of chemical exposures.", {"entities": []}], ["Partial healthy life expectancies (age 50\u201375) relating to (1) self-rated health and (2) chronic health conditions, obtained from annual questionnaires (1989\u20132014) and company records, were estimated using multistate life tables.", {"entities": []}], ["The analyses were adjusted for social class and occupational grade.", {"entities": []}], ["Participants with physically strenuous jobs and who had experienced industrial injuries had shorter partial life expectancy.", {"entities": []}], ["More physically demanding and dangerous work was associated with fewer years of life spent in good self-rated health and without chronic conditions, with the exception of shift work including nights, where the gradient was reversed.", {"entities": []}], ["Strenuous and hazardous work may contribute to lost years of good health in later life, which has implications for individuals' quality of life as well as healthcare use and labour market participation.", {"entities": []}], ["Cystic fibrosis (CF) is characterized by acute pulmonary exacerbations (APE).", {"entities": []}], ["The CF nasal airway exhibits a similar ion transport defect as the lung, and colonization, infection, and inflammation within the nasal passages are common among CF patients.", {"entities": []}], ["Nasal lavage fluid (NLF) is a minimally invasive means to collect upper airway samples.", {"entities": []}], ["We collected NLF at the onset and resolution of CF APE and compared a 27-plex cytokine profile to stable CF outpatients and normal controls.", {"entities": []}], ["We also tested IP-10 levels in the bronchoalveolar lavage fluid (BALF) of CF patients.", {"entities": []}], ["Well-differentiated murine sinonasal monolayers were exposed to bacterial stimulus, and IP-10 levels were measured to test epithelial secretion.", {"entities": []}], ["Subjects hospitalized for APE had elevated IP-10 (2582 pg/mL [95% CL of mean: 818,8165], N=13) which significantly decreased (647 pg/mL [357,1174], P<0.05, N =13) following antimicrobial therapy.", {"entities": []}], ["Stable CF outpatients exhibited intermediately elevated levels (680 pg/mL [281,1644], N=13) that were less than CF inpatients upon admission (P=0.056) but not significantly different than normal controls (342 pg/mL [110,1061]; P=0.3, N=10).", {"entities": []}], ["IP-10 was significantly increased in CF BALF (2673 pg/mL [1306,5458], N=10) compared to healthy post-lung transplant patients (8.4 pg/mL [0.03,2172], N=5, P<0.001).", {"entities": []}], ["IP-10 levels from well-differentiated CF murine nasal epithelial monolayers exposed to Pseudomonas PAO-1 bacteria-free prep or LPS (100 nM) apically for 24 hours were significantly elevated (1159 \u00b1 147, P<0.001 for PAO-1; 1373 \u00b1 191, P<0.001 for LPS vs. 305 \u00b1 68 for vehicle controls).", {"entities": []}], ["Human sino-nasal epithelial cells derived from CF patients had a similar response to LPS (34% increase, P<0.05, N=6).", {"entities": []}], ["IP-10 is elevated in the nasal lavage of CF patients with APE and responds to antimicrobial therapy.", {"entities": []}], ["IP-10 is induced by airway epithelia following stimulation with bacterial pathogens in a murine model.", {"entities": []}], ["Additional research regarding IP-10 as a potential biomarker is warranted.", {"entities": []}], ["Chronic lung disease of prematurity/bronchopulmonary dysplasia ( BPD ) is the leading cause of perinatal morbidity in developed countries.", {"entities": [[8, 20, "DISEASE"]]}], ["Inflammation is a prominent finding.", {"entities": []}], ["Currently available interventions have associated toxicities and limited efficacy.", {"entities": []}], ["While BPD often resolves in childhood, survivors of preterm birth are at risk for acquired respiratory disease in early life and are more likely to develop chronic obstructive pulmonary disease ( COPD ) in adulthood.", {"entities": [[156, 193, "DISEASE"]]}], ["We previously cloned Crispld2 (Lgl1), a glucocorticoid\u2010regulated mesenchymal secretory protein that modulates lung branching and alveogenesis through mesenchymal\u2013epithelial interactions.", {"entities": [[21, 29, "GENE"]]}], ["Absence of Crispld2 is embryonic lethal.", {"entities": [[11, 19, "GENE"]]}], ["Heterozygous Crispld2+/\u2212 mice display features of BPD , including distal airspace enlargement, disruption of elastin, and neonatal lung inflammation.", {"entities": []}], ["CRISPLD 2 also plays a role in human fetal lung fibroblast cell expansion, migration, and mesenchymal\u2013epithelial signaling.", {"entities": []}], ["This study assessed the effects of endogenous and exogenous CRISPLD 2 on expression of proinflammatory mediators in human fetal and adult (normal and COPD ) lung fibroblasts and epithelial cells.", {"entities": []}], ["CRISPLD 2 expression was upregulated in a lipopolysaccharide ( LPS )\u2010induced human fetal lung fibroblast line ( MRC 5).", {"entities": []}], ["LPS \u2010induced upregulation of the proinflammatory cytokines IL \u20108 and CCL 2 was exacerbated in MRC 5\u2010 CRISPLD 2 RNA suppression of endogenous CRISPLD 2 in adult lung fibroblasts ( HLF s) led to augmented expression of IL \u20108, IL \u20106, CCL 2.", {"entities": [[179, 182, "GENE"]]}], ["LPS \u2010stimulated expression of proinflammatory mediators by human lung epithelial HAE o\u2010 cells was attenuated by purified secretory CRISPLD 2.", {"entities": []}], ["RNA sequencing results from HLF \u2010 CRISPLD 2 CRISPLD 2 in extracellular matrix and in inflammation.", {"entities": [[28, 31, "GENE"]]}], ["Our data suggest that suppression of CRISPLD 2 increases the risk of lung inflammation in early life and adulthood.", {"entities": []}], ["Bronchiectasis is a permanent and debilitating sequel to chronic or severe airway injury, however, diseases associated with this condition are poorly defined.", {"entities": [[0, 14, "DISEASE"]]}], ["To evaluate results of diagnostic tests used to document bronchiectasis and to characterize underlying or concurrent disease processes.", {"entities": [[57, 71, "DISEASE"]]}], ["Eighty\u2010six dogs that had bronchoscopy performed and a diagnosis of bronchiectasis.", {"entities": [[67, 81, "DISEASE"]]}], ["Retrospective case series.", {"entities": []}], ["Radiographs, computed tomography, and bronchoscopic findings were evaluated for features of bronchiectasis.", {"entities": [[92, 106, "DISEASE"]]}], ["Clinical diagnoses of pneumonia (aspiration, interstitial, foreign body, other), eosinophilic bronchopneumopathy ( EBP ), and inflammatory airway disease ( IAD ) were made based on results of history, physical examination, and diagnostic testing, including bronchoalveolar lavage fluid analysis and microbiology.", {"entities": [[22, 31, "DISEASE"], [115, 118, "GENE"]]}], ["Bronchiectasis was diagnosed in 14% of dogs (86/621) that had bronchoscopy performed.", {"entities": [[0, 14, "DISEASE"]]}], ["Dogs ranged in age from 0.5 to 14 years with duration of signs from 3 days to 10 years.", {"entities": []}], ["Bronchiectasis was documented during bronchoscopy in 79/86 dogs (92%), thoracic radiology in 50/83 dogs (60%), and CT in 34/34 dogs (100%).", {"entities": [[0, 14, "DISEASE"]]}], ["Concurrent airway collapse was detected during bronchoscopy in 50/86 dogs (58%), and focal or multifocal mucus plugging of segmental or subsegmental bronchi was found in 41/86 dogs (48%).", {"entities": []}], ["Final diagnoses included pneumonia (45/86 dogs, 52%), EBP (10/86 dogs, 12%) and IAD (31/86 dogs, 36%).", {"entities": [[25, 34, "DISEASE"], [54, 57, "GENE"]]}], ["Bacteria were isolated in 24/86 cases (28%), with Streptococcus spp, Pasteurella spp, enteric organisms, and Stenotrophomonas isolated most frequently.", {"entities": []}], ["Bronchiectasis can be anticipated in dogs with infectious or inflammatory respiratory disease.", {"entities": [[0, 14, "DISEASE"]]}], ["Advanced imaging and bronchoscopy are useful in making the diagnosis and identifying concurrent respiratory disease.", {"entities": []}], ["Adipose tissues are closely connected with the immune system.", {"entities": []}], ["It has been suggested that metabolic syndromes such as type 2 diabetes, arteriosclerosis and liver steatosis can be attributed to adipose tissue inflammation characterized by macrophage infiltration.", {"entities": [[72, 88, "DISEASE"]]}], ["To understand a physiological and pathological role of natural killer T (NKT) cells on inflammation in adipose tissue, we characterized a subset of NKT cells in abdominal and subcutaneous adipose tissues in C57BL/6J mice fed normal or high-fat diets.", {"entities": []}], ["NKT cells comprised a larger portion of lymphocytes in adipose tissues compared with the spleen and peripheral blood, with epididymal adipose tissue having the highest number of NKT cells.", {"entities": []}], ["Furthermore, some NKT cells in adipose tissues expressed higher levels of CD69 and intracellular interferon-\u03b3, whereas the V\u03b2 repertoires of NKT cells in adipose tissues were similar to other cells.", {"entities": [[74, 78, "GENE"]]}], ["In obese mice fed a high-fat diet, adipose tissue inflammation had little effect on the V\u03b2 repertoire of NKT cells in epididymal adipose tissues.", {"entities": []}], ["We speculate that the NKT cells in adipose tissues may form an equivalent subset in other tissues and that these subsets are likely to participate in adipose tissue inflammation.", {"entities": []}], ["Additionally, the high expression level of CD69 and intracellular IFN-\u03b3 raises the possibility that NKT cells in adipose tissue may be stimulated by some physiological mechanism.", {"entities": [[43, 47, "GENE"]]}], ["The dynamics of swimming microorganisms is strongly affected by solid\u2010liquid and air\u2010liquid interfaces.", {"entities": []}], ["In this paper, we characterize the motion of both single bacteria and microcolonies at an air\u2010liquid interface.", {"entities": []}], ["Both of them follow circular trajectories.", {"entities": []}], ["Single bacteria preferentially show a counter\u2010clockwise motion, in agreement with previous experimental and theoretical findings.", {"entities": []}], ["Instead, no preferential rotation direction is observed for microcolonies suggesting that their motion is due to a different physical mechanism.", {"entities": []}], ["We propose a simple mechanical model where the microcolonies move like rafts constrained to the air\u2010liquid interface.", {"entities": []}], ["Finally, we observed that the microcolony growth is due to the aggregation of colliding single\u2010swimmers, suggesting that the microcolony formation resembles a condensation process where the first nucleus originates by the collision between two single\u2010swimmers.", {"entities": []}], ["Implications of microcolony splitting and aggregation on biofilm growth and dispersion at air\u2010liquid interface are discussed.", {"entities": []}], ["Superoxide anion (O 2 \u2009 2 \u2009 2 \u2009 In vivo protocols were approved by the animal Ethical Committee of the University of Florence.", {"entities": []}], ["Pain was measured by paw pressure and hind limb weight bearing alterations tests.", {"entities": []}], ["MnL4 (15\u2009mg\u2009kg 2", {"entities": []}], ["We describe an outbreak of sudden health problems in workers at a Danish grass seed plant after exposure to a particularly dusty lot of grass seeds.", {"entities": []}], ["The seeds are called problematic seeds.", {"entities": []}], ["The association between development of organic dust toxic syndrome (ODTS) and the handling of grass seeds causing exposure was assessed in a four-step model: (i) identification of exposure source, (ii) characterization of the emission of bioaerosols from the problematic and reference seeds, (iii) personal and stationary exposure measurement at the plant and (iv) repeated health examinations.", {"entities": [[58, 66, "DISEASE"]]}], ["The grass seeds were identified as the exposure source; the emissions of some bioaerosol components were up to 10 Aspergillus fumigatus m A. fumigatus occurred when working with a dusty lot of grass seed.", {"entities": []}], ["Suspicion should be elicited by seeds stored without being properly dried and by seeds producing more dust than usually.", {"entities": []}], ["Lymphatic filariasis (LF) is known to be associated with an increased production of IL-10.", {"entities": [[10, 20, "DISEASE"]]}], ["The role of the other IL-10 family members in the pathogenesis of infection and/or disease is not known.", {"entities": []}], ["We examined the expression patterns of IL-10 family members \u2013 IL-19, IL-24 and IL-26 in LF.", {"entities": []}], ["We demonstrate that both CD4 Our findings, therefore, suggest that IL-19 and IL-24 are associated with the regulation of immune responses in active filarial infection and potentially with protection against development of pathology, while IL-26 is predominantly associated with pathology in LF.", {"entities": [[25, 28, "GENE"]]}], ["Lymphatic filariasis afflicts over 120 million people worldwide.", {"entities": [[10, 20, "DISEASE"]]}], ["While the infection is mostly clinically asymptomatic, approximately 40 million people suffer from overt, morbid clinical pathology, characterized by swelling of the scrotal area and lower limbs (hydrocele and lymphedema).", {"entities": [[196, 205, "DISEASE"], [210, 220, "DISEASE"]]}], ["Host immunologic factors that influence the pathogenesis of disease in these individuals are not completely understood.", {"entities": []}], ["Epigenetic modifications work with genetic mechanisms to determine transcriptional activity and, while somatically heritable they are also reversible, making them good therapeutic candidates.", {"entities": []}], ["Epigenetic changes can precede disease pathology and thus are diagnostic indicators for risk, and can act as prognostic indicators for disease progression.", {"entities": []}], ["Histone deacetylase inhibitors and DNA methylation inhibitors have been FDA approved for several years and are clinically successful.", {"entities": []}], ["More recently, histone methylation and microRNAs have also gained attention as potential therapeutic targets.", {"entities": []}], ["The presence of multiple epigenetic aberrations within a diseased tissue and the abilities of cells to develop resistance suggest that combination therapies may be most beneficial.", {"entities": []}], ["This review will focus on recent examples of using epigenetic modifications to evaluate disease risk, progression and clinical response and will describe the latest clinical advances in epigenetic therapies concentrating on treatments which combine epigenetic therapeutics with each other and with cytotoxic agents to increase clinical response.", {"entities": []}], ["Previous studies, which relied on hypothetical cases and chart reviews, have questioned the inter-rater reliability of the ASA physical status (ASA-PS) scale.", {"entities": []}], ["We therefore conducted a retrospective cohort study to evaluate its inter-rater reliability and validity in clinical practice.", {"entities": []}], ["The cohort included all adult patients (\u226518 yr) who underwent elective non-cardiac surgery at a quaternary-care teaching institution in Toronto, Ontario, Canada, from March 2010 to December 2011.", {"entities": []}], ["We assessed inter-rater reliability by comparing ASA-PS scores assigned at the preoperative assessment clinic vs the operating theatre.", {"entities": []}], ["We also assessed the validity of the ASA-PS scale by measuring its association with patients' preoperative characteristics and postoperative outcomes.", {"entities": []}], ["The cohort included 10 864 patients, of whom 5.5% were classified as ASA I, 42.0% as ASA II, 46.7% as ASA III, and 5.8% as ASA IV.", {"entities": []}], ["The ASA-PS score had moderate inter-rater reliability ( \u03ba 0.61), with 67.0% of patients ( n =7279) being assigned to the same ASA-PS class in the clinic and operating theatre, and 98.6% ( n =10 712) of paired assessments being within one class of each other.", {"entities": []}], ["The ASA-PS scale was correlated with patients' age (Spearman's \u03c1 , 0.23), Charlson comorbidity index ( \u03c1 =0.24), revised cardiac risk index ( \u03c1 =0.40), and hospital length of stay ( \u03c1 =0.16).", {"entities": []}], ["It had moderate ability to predict in-hospital mortality (receiver-operating characteristic curve area 0.69) and cardiac complications (receiver-operating characteristic curve area 0.70).", {"entities": []}], ["Consistent with its inherent subjectivity, the ASA-PS scale has moderate inter-rater reliability in clinical practice.", {"entities": []}], ["It also demonstrates validity as a marker of patients' preoperative health status.", {"entities": []}], ["Regulatory dendritic cells (DCregs) represent a potential therapeutic tool for assessing a variety of immune overreaction conditions; however, current approaches for generating DCregs for therapeutic purposes are limited.", {"entities": []}], ["We attempted to generate and characterize DCregs from murine induced pluripotent stem (iPS) cells.", {"entities": []}], ["The iPS cells co-cultured with OP9 cells displayed mesodermally differentiated flat colonies.", {"entities": []}], ["GM-CSF drove most of the colonies exhibiting a differentiated morphology.", {"entities": []}], ["Thereafter, cells became morphologically heterologous under the effects of TGF-\u03b2 and IL-10.", {"entities": []}], ["Most of the floating cells developed an irregular shape with areas of protrusion.", {"entities": []}], ["The generated iPS-DCregs demonstrated high CD11b/c and low CD40, CD80, CD86 and MHC-II expressions with a high antigen uptake ability and poor T-cell stimulatory function.", {"entities": [[59, 63, "GENE"], [65, 69, "GENE"], [71, 75, "GENE"]]}], ["Importantly, iPS-DCregs showed immune responsiveness regulation effects both in vitro and in vivo and the ability to generate regulatory T-cells in vitro .", {"entities": []}], ["Our result illustrates a feasible approach for generating functional DCregs from murine iPS cells.", {"entities": []}], ["The impact of the gut microbiota on immune homeostasis within the gut and, importantly, also at systemic sites has gained tremendous research interest over the last few years.", {"entities": []}], ["The intestinal microbiota is an integral component of a fascinating ecosystem that interacts with and benefits its host on several complex levels to achieve a mutualistic relationship.", {"entities": []}], ["Host-microbial homeostasis involves appropriate immune regulation within the gut mucosa to maintain a healthy gut while preventing uncontrolled immune responses against the beneficial commensal microbiota potentially leading to chronic inflammatory bowel diseases (IBD).", {"entities": []}], ["Furthermore, recent studies suggest that the microbiota composition might impact on the susceptibility to immune-mediated disorders such as autoimmunity and allergy.", {"entities": []}], ["Understanding how the microbiota modulates susceptibility to these diseases is an important step toward better prevention or treatment options for such diseases.", {"entities": []}], ["Current recommendations to consider initiation of palliative care (PC) in COPD patients are often based on an expected poor prognosis.", {"entities": [[67, 69, "GENE"]]}], ["However, this approach is not evidence-based, and which and when COPD patients should start PC is controversial.", {"entities": [[92, 94, "GENE"]]}], ["We aimed to assess whether current suggested recommendations for initiating PC were sufficiently reliable.", {"entities": [[76, 78, "GENE"]]}], ["We identified prognostic variables proposed in the literature for initiating PC; then, we ascertained their relationship with 1-year mortality, and finally, we validated their utility in our cohort of 697 patients hospitalized for COPD exacerbation.", {"entities": [[77, 79, "GENE"]]}], ["From 24 articles of 499 screened, we selected 20 variables and retrieved 48 original articles in which we were able to calculate the relationship between each of them and 1-year mortality.", {"entities": []}], ["The number of studies where 1-year mortality was detailed for these variables ranged from 9 for previous hospitalizations or FEV 1 \u226430% to none for albumin \u226425 mg/dL.", {"entities": [[125, 128, "GENE"]]}], ["The percentage of 1-year mortality in the literature for these variables ranged from 5% to 60%.", {"entities": []}], ["In the validation cohort study, the prevalence of these proposed variables ranged from 8% to 64%; only 10 of the 18 variables analyzed in our cohort reached statistical significance with Cox regression analysis, and none overcame an area under the curve \u22650.7.", {"entities": []}], ["We conclude that none of the suggested criteria for initiating PC based on an expected poor vital prognosis in COPD patients in the short or medium term offers sufficient reliability, and consequently, they should be avoided as exclusive criteria for considering PC or at least critically appraised.", {"entities": [[63, 65, "GENE"], [263, 265, "GENE"], [63, 65, "GENE"], [263, 265, "GENE"]]}], ["Epithelial-mesenchymal transition (EMT) has been proposed as a mechanism in the progression of airway diseases and cancer.", {"entities": [[115, 121, "DISEASE"]]}], ["Here, we explored the role of acetylcholine (ACh) and the pathway involved in the process of EMT, as well as the effects of mAChRs antagonist.", {"entities": []}], ["Human lung epithelial cells were stimulated with carbachol, an analogue of ACh, and epithelial and mesenchymal marker proteins were evaluated using western blot and immunofluorescence analyses.", {"entities": []}], ["Decreased E-cadherin expression and increased vimentin and \u03b1-SMA expression induced by TGF-\u03b21 in alveolar epithelial cell (A549) were significantly abrogated by the non-selective mAChR antagonist atropine and enhanced by the acetylcholinesterase inhibitor physostigmine.", {"entities": []}], ["An EMT event also occurred in response to physostigmine alone.", {"entities": []}], ["Furthermore, ChAT express and ACh release by A549 cells were enhanced by TGF-\u03b21.", {"entities": []}], ["Interestingly, ACh analogue carbachol also induced EMT in A549 cells as well as in bronchial epithelial cells (16HBE) in a time- and concentration-dependent manner, the induction of carbachol was abrogated by selective antagonist of M1 (pirenzepine) and M3 (4-DAMP) mAChRs, but not by M2 (methoctramine) antagonist.", {"entities": []}], ["Moreover, carbachol induced TGF-\u03b21 production from A549 cells concomitantly with the EMT process.", {"entities": []}], ["Carbachol-induced EMT occurred through phosphorylation of Smad2/3 and ERK, which was inhibited by pirenzepine and 4-DAMP.", {"entities": []}], ["Our findings for the first time indicated that mAChR activation, perhaps via M1 and M3 mAChR, induced lung epithelial cells to undergo EMT and provided insights into novel therapeutic strategies for airway diseases in which lung remodeling occurs.", {"entities": []}], ["Reducing health care costs requires the ability to identify patients most likely to incur high costs.", {"entities": []}], ["Our objective was to evaluate the ability of the Charlson comorbidity score to predict the individuals who would incur high costs in the subsequent year and to contrast its predictive ability with other commonly used predictors.", {"entities": []}], ["We contrasted the prior year Charlson comorbidity index, costs, Diagnostic Cost Group (DCG) and hospitalization as predictors of subsequent year costs from claims data of fund that provides comprehensive health benefits to a large union of health care workers.", {"entities": []}], ["Total costs in the subsequent year was the principal outcome.", {"entities": []}], ["Of the 181,764 predominantly Black and Latino beneficiaries, 70% were adults (mean age 45.7 years; 62% women).", {"entities": []}], ["As the comorbidity index increased, total yearly costs increased significantly (P<.001).", {"entities": []}], ["At lower comorbidity, the costs were similar across different chronic diseases.", {"entities": []}], ["Using regression to predict total costs, top 5 The comorbidity index predicted health costs in the subsequent year, performing as well as prior cost and DCG in identifying those in the top 5% or 10%.", {"entities": []}], ["The comorbidity index can be used prospectively to identify patients who are likely to incur high costs.", {"entities": []}], ["ClinicalTrials.gov NCT01761253", {"entities": []}], ["Africa faces an urgent but 'neglected epidemic' of chronic disease.", {"entities": []}], ["In some countries stroke, hypertension, diabetes and cancers cause a greater number of adult medical admissions and deaths compared to communicable diseases such as HIV/AIDS or tuberculosis.", {"entities": [[26, 38, "DISEASE"], [177, 189, "DISEASE"]]}], ["Experts propose a three-pronged solution consisting of epidemiological surveillance, primary prevention and secondary prevention.", {"entities": []}], ["In addition, interventions must be implemented through 'multifaceted multi-institutional' strategies that make efficient use of limited economic and human resources.", {"entities": []}], ["Epidemiological surveillance has been prioritised over primary and secondary prevention.", {"entities": []}], ["We discuss the challenge of developing effective primary and secondary prevention to tackle Africa's chronic disease epidemic through in-depth case studies of Ghanaian and Cameroonian responses.", {"entities": []}], ["A review of chronic disease research, interventions and policy in Ghana and Cameroon instructed by an applied psychology conceptual framework.", {"entities": []}], ["Data included published research and grey literature, health policy initiatives and reports, and available information on lay community responses to chronic diseases.", {"entities": []}], ["There are fundamental differences between Ghana and Cameroon in terms of 'multi-institutional and multi-faceted responses' to chronic diseases.", {"entities": []}], ["Ghana does not have a chronic disease policy but has a national health insurance policy that covers drug treatment of some chronic diseases, a culture of patient advocacy for a broad range of chronic conditions and mass media involvement in chronic disease education.", {"entities": []}], ["Cameroon has a policy on diabetes and hypertension, has established diabetes clinics across the country and provided training to health workers to improve treatment and education, but lacks community and media engagement.", {"entities": [[38, 50, "DISEASE"]]}], ["In both countries churches provide public education on major chronic diseases.", {"entities": []}], ["Neither country has conducted systematic evaluation of the impact of interventions on health outcomes and cost-effectiveness.", {"entities": []}], ["Both Ghana and Cameroon require a comprehensive and integrative approach to chronic disease intervention that combines structural, community and individual strategies.", {"entities": []}], ["We outline research and practice gaps and best practice models within and outside Africa that can instruct the development of future interventions.", {"entities": []}], ["Pathogenic Burkholderia rely on host factors for efficient intracellular replication and are highly refractory to antibiotic treatment.", {"entities": []}], ["To identify host genes that are required by Burkholderia spp.", {"entities": []}], ["during infection, we performed a RNA interference (RNAi) screen of the human kinome and identified 35 host kinases that facilitated Burkholderia thailandensis intracellular survival in human monocytic THP-1 cells.", {"entities": []}], ["We validated a selection of host kinases using imaging flow cytometry to assess efficiency of B. thailandensis survival in the host upon siRNA-mediated knockdown.", {"entities": []}], ["We focused on the role of the novel protein kinase C isoform, PKC-\u03b7, in Burkholderia infection and characterized PKC-\u03b7/MARCKS signaling as a key event that promotes the survival of unopsonized B. thailandensis CDC2721121 within host cells.", {"entities": []}], ["While infection of lung epithelial cells with unopsonized Gram-negative bacteria stimulated phosphorylation of Ser175/160 in the MARCKS effector domain, siRNA-mediated knockdown of PKC-\u03b7 expression reduced the levels of phosphorylated MARCKS by >3-fold in response to infection with Bt CDC2721121.", {"entities": [[129, 135, "GENE"], [235, 241, "GENE"], [129, 135, "GENE"], [235, 241, "GENE"]]}], ["We compared the effect of the conventional PKC-\u03b1 and novel PKC-\u03b7 isoforms on the growth of B. thailandensis CDC2721121 within monocytic THP-1 cells and found that \u226575% knock-down of PRKCH transcript levels reduced intracellular bacterial load 100% more efficiently when compared to growth in cells siRNA-depleted of the classical PKC-\u03b1, suggesting that the PKC-\u03b7 isoform can specifically mediate Burkholderia intracellular survival.", {"entities": [[182, 187, "GENE"]]}], ["Based on imaging studies of intracellular B. thailandensis , we found that PKC-\u03b7 function stimulates phagocytic pathways that promote B. thailandensis escape into the cytoplasm leading to activation of autophagosome flux.", {"entities": []}], ["Identification of host kinases that are targeted by Burkholderia during infection provides valuable molecular insights in understanding Burkholderia pathogenesis, and ultimately, in designing effective host-targeted therapies against infectious disease caused by intracellular pathogens.", {"entities": []}], ["Staphylococcal enterotoxin B (SEB) is a potent immunomodulator and implicated with pathogenesis of inflammatory diseases mediated by Th1 or Th2 dominant immune responses.", {"entities": []}], ["The objective of this study is to determine a possible association between rhinosinusitis derived SEB and pathogenesis of food allergy (FA).", {"entities": [[122, 134, "DISEASE"]]}], ["The study included chronic rhinosinusitis (CRS) patients with FA (N = 46) or without FA (N = 33).", {"entities": []}], ["Controls included FA patients without CRS (N = 26) and healthy volunteers (N = 25).", {"entities": []}], ["In CRS patients, we assessed the parameters associated with FA including prick skin test (PST) reactivity to food allergens, serum levels of allergen-specific IgE and cytokines (IL-4, IL-13, IFN-\u00ce Two months following sinus surgery, we observed statistically significant reduction in PST and oral challenge reactivity in CRS patients with FA in parallel to decrease in serum levels of Th2 cytokines (IL-4 and IL-13) and allergen specific IgE.", {"entities": []}], ["Improvement of reactivity to food allergens was positively associated with decline in SEB concentrations in the sinus lavage and stool samples.", {"entities": []}], ["In vitro study results also indicated a role of SEB in aggravation of Th2 skewed responses to food allergens.", {"entities": []}], ["Such changes were not observed in CRS-non FA patients or control FA patients.", {"entities": []}], ["The rhinosinusitis derived SEB plays a certain role in the pathogenesis of FA by augmenting and/or maintaining polarized Th2 responses.", {"entities": []}], ["Removal of SEB-producing pathogens from the rhinosinuses may be beneficial for attenuating the FA symptoms in patients with CRS-FA.", {"entities": []}], ["Schizophrenia is a chronic condition that impacts significantly not only on the individual and family, but the disorder also has wider consequences for society in terms of significant costs to the economy.", {"entities": [[0, 13, "DISEASE"]]}], ["This highly prevalent condition affects approximately 1% of the worldwide population, yet there are few therapeutic options.", {"entities": []}], ["The predominant treatment strategy for schizophrenia is anti-psychotic medication (with or without additional talking therapy) even though this approach lacks efficacy in managing the negative symptoms of the condition, is not effective in one-third of the patient group and the side effects of the medication can be severe and debilitating.", {"entities": [[39, 52, "DISEASE"]]}], ["In recent years, a number of pathophysiological processes have been identified in groups of people with schizophrenia including oxidative stress, one-carbon metabolism and immune-mediated responses.", {"entities": [[104, 117, "DISEASE"]]}], ["A number of studies have shown that these altered physiological mechanisms can be ameliorated by nutritional interventions in some individuals with schizophrenia.", {"entities": [[148, 161, "DISEASE"]]}], ["This review briefly describes the aforementioned processes and outlines research that has investigated the utility of nutritional approaches as an adjunct to anti-psychotic medication including antioxidant and vitamin B supplementation, neuroprotective and anti-inflammatory nutrients and exclusion diets.", {"entities": []}], ["Whilst none of these interventions provides a \u2018one-size-fits-all\u2019 therapeutic solution, we suggest that a personalised approach warrants research attention as there is growing agreement that schizophrenia is a spectrum disorder that develops from the interplay between environmental and genetic factors.", {"entities": [[191, 204, "DISEASE"]]}], ["The online version of this article (doi:10.1186/1475-2891-13-91) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We examined sociodemographic trends in emergency department ED visits and postvisit health care for anxiety and stress disorders.", {"entities": []}], ["Emergency department visits (N = 11,289) by children younger than 18 years were extracted from population-based administrative databases from Alberta, Canada (2002\u20132011).", {"entities": []}], ["We examined health services use by demographics and socioeconomic proxy (First Nations status, family subsidy type: government, human services program, none).", {"entities": []}], ["We calculated visit rates and described physician visits after discharge (n = 8075 children).", {"entities": []}], ["Multivariable survival analyses (with 95% confidence intervals [CIs]) estimate time to first physician visit and ED return.", {"entities": []}], ["During 2002\u20132011, visit rates increased by age, First Nations, and subsidy status.", {"entities": []}], ["The largest increase was for children (all ages) from families receiving government subsidy (491.43/100,000, P < 0.001).", {"entities": []}], ["Thirty days after an index visit, most physician follow-up visits were made by children aged 15 to 17 years (61.0%) and from families receiving no subsidy (66.5%).", {"entities": []}], ["The median time to physician follow-up for First Nations children was 32 days (95% CI, 27\u201337) compared with 19 days for children from families receiving government subsidy whose median time was shortest (95% CI, 18\u201323).", {"entities": []}], ["Children (all ages) in the government and human services program subsidy groups and those who had First Nations status returned earlier to the ED compared with children in the no subsidy group.", {"entities": []}], ["Adolescents had high ED use and physician follow-up, whereas First Nations children and those from families receiving subsidy (all ages) had high ED use and low physician follow-up.", {"entities": []}], ["Efforts to improve disorder identification and treatment among high ED user groups and low physician follow-up user groups are needed.", {"entities": []}], ["The purpose of this study was to determine the incidence and seasonal distribution of viral etiological agents and to compare their clinical manifestations and disease severity, including single and co infections.", {"entities": []}], ["Multiplex reverse-transcription PCR was performed for the detection of viruses in nasopharyngeal aspirat.", {"entities": []}], ["Disease severity was grouped using a categorization index as very mild/mild, and moderate/severe.", {"entities": []}], ["Clinical and laboratory characteristics of hospitalized children with viral respiratory tract infection were analyzed.", {"entities": []}], ["Viral pathogens were detected in 103/155 (66.5%) of patients.", {"entities": []}], ["In order of frequency, identified pathogens were respiratory syncytial virus (32.0%), adenovirus (26.2%), parainfluenza viruses type 1\u20134 (19.4%), rhinovirus (18.4%), influenza A and B (12.6%), human metapneumovirus (12.6%), coronavirus (2.9%), and bocavirus (0.9%).", {"entities": [[166, 175, "DISEASE"]]}], ["Coinfections were present in 21 samples.", {"entities": []}], ["Most of the children had very mild (38.8%) and mild disease (37.9%).", {"entities": []}], ["Severity of illness was not worse with coinfections.", {"entities": []}], ["The most common discharge diagnoses were \"URTI\" with or without LRTI/asthma (n=58).", {"entities": [[69, 75, "DISEASE"]]}], ["Most viruses exhibited strong seasonal patterns.", {"entities": []}], ["Leukocytosis (22.2%) and neutrophilia (36.6%) were most commonly detected in patients with adenovirus and rhinovirus (p<0.05).", {"entities": []}], ["Monocytosis was the most remarkable finding in the patients (n=48, 53.3%), especially in patients with adenovirus (p<0.05).", {"entities": []}], ["RSV and RhV were associated with higher severity of illness in hospitalized children.", {"entities": []}], ["RSV found to account for half of LRTI hospitalizations.", {"entities": []}], ["In AdV and FluA and B infections, fever lasted longer than in other viruses.", {"entities": []}], ["Coinfections were detected in 21 of the patients.", {"entities": []}], ["The presence of coinfections was not associated with increased disease severity.", {"entities": []}], ["To quantitatively assess time-series studies of daily nitrogen dioxide (NO 2 ) and mortality and hospital admissions which also controlled for particulate matter (PM) to determine whether or to what extent the NO 2 associations are independent of PM.", {"entities": []}], ["A systematic review and meta-analysis.", {"entities": []}], ["Time-series studies\u2014published in peer-reviewed journals worldwide, up to May 2011\u2014that reported both single-pollutant and two-pollutant model estimates for NO 2 and PM were ascertained from bibliographic databases (PubMed, EMBASE and Web of Science) and reviews.", {"entities": []}], ["Random-effects summary estimates were calculated globally and stratified by different geographical regions, and effect modification was investigated.", {"entities": []}], ["Mortality and hospital admissions for various cardiovascular or respiratory diseases in different age groups in the general population.", {"entities": []}], ["60 eligible studies were identified, and meta-analysis was conducted on 23 outcomes.", {"entities": []}], ["Two-pollutant model study estimates generally showed that the NO 2 associations were independent of PM mass.", {"entities": []}], ["For all-cause mortality, a 10\u2005\u00b5g/m 2 was associated with a 0.78% (95% CI 0.47% to 1.09%) increase in the risk of death, which reduced to 0.60% (0.33% to 0.87%) after control for PM.", {"entities": []}], ["Heterogeneity between geographical region-specific estimates was removed by control for PM (I 2 : from 0.51% (0.29% to 0.74%) to 0.18% (\u22120.11% to 0.47%) per 10\u2005\u00b5g/m 10 and 0.74% (0.34% to 1.14%) to 0.54% (\u22120.25% to 1.34%) for PM 2.5 .", {"entities": []}], ["The association between short-term exposure to NO 2 and adverse health outcomes is largely independent of PM mass.", {"entities": []}], ["Further studies should attempt to investigate whether this is a generic PM effect or whether it is modified by the source and physicochemical characteristics of PM.", {"entities": []}], ["This finding strengthens the argument for NO 2 having a causal role in health effects.", {"entities": []}], ["Due to advances in diagnostic techniques, clinicians are more frequently performing influenza diagnostic tests and referring to their test results ahead of the administration of neuraminidase inhibitors (NAIs).", {"entities": [[84, 93, "DISEASE"]]}], ["To investigate the clinical significance of the time from symptom onset to laboratory diagnosis, we reviewed the clinical characteristics of adult patients with influenza who had an early laboratory diagnosis (ED) or a late laboratory diagnosis (LD) at one of four tertiary care centers during a seasonal outbreak of influenza.", {"entities": [[161, 170, "DISEASE"], [317, 326, "DISEASE"]]}], ["Clinical data were collected from 1,405 adults during the 2013 to 2014 influenza season.", {"entities": [[71, 80, "DISEASE"]]}], ["A patient was regarded as receiving an ED or LD if he/she received an influenza diagnostic test at 0 to 1 or 4 to 7 days after symptom onset, respectively.", {"entities": [[70, 79, "DISEASE"]]}], ["Early NAI therapy and late NAI therapy were defined as the administration of NAI \u2264 2 or > 2 days after symptom onset, respectively.", {"entities": []}], ["Nearly half of the patients (47.0%) received an ED (n = 661), whereas 13.5% (n = 190) received a LD.", {"entities": []}], ["Patients with a LD had initial symptoms of cough, sputum production, and dyspnea and experienced pneumonia, antibiotic therapy, hospitalization, and admission to the intensive care unit more often than those with an ED.", {"entities": [[97, 106, "DISEASE"]]}], ["NAI therapy and early NAI therapy were less frequent in patients with a LD than those with an ED.", {"entities": []}], ["Of the analyzed baseline characteristics, age \u2265 50 years, influenza B infection, and diagnosis using a polymerase chain reaction test were significantly associated with a LD.", {"entities": [[58, 67, "DISEASE"]]}], ["LD was associated with inappropriate antiviral therapy and complicated presenting features in adult patients with seasonal influenza.", {"entities": [[123, 132, "DISEASE"]]}], ["ED of influenza should be emphasized, especially for older adults.", {"entities": [[6, 15, "DISEASE"]]}], ["These compounds may serve as starting points for the design of more potent poliovirus inhibitors.", {"entities": []}], ["In 1988, the World Health Assembly launched the Global Polio Eradication Initiative, which aimed to use large-scale vaccination with the oral vaccine to eradicate polio worldwide by the year 2000.", {"entities": []}], ["Although important progress has been made, polio remains endemic in several countries.", {"entities": []}], ["Also, the current control measures will likely be inadequate to deal with problems that may arise in the postpolio era.", {"entities": []}], ["A panel convoked by the National Research Council concluded that the use of antiviral drugs may be essential in the polio eradication strategy.", {"entities": []}], ["We here report on a comparative study of the antipoliovirus activity of a selection of molecules that have previously been reported to be inhibitors of picornavirus replication and discuss their potential use, alone or in combination, for the treatment or prophylaxis of poliovirus infection.", {"entities": []}], ["Asthma is a complex disease characterized by airway hyperresponsiveness (AHR) and chronic airway inflammation.", {"entities": [[0, 6, "DISEASE"], [73, 76, "GENE"]]}], ["Epidemiologic studies have demonstrated that exposures to environmental factors such as ambient particulate matter (PM), a major air pollutant, contribute to increased asthma prevalence and exacerbations.", {"entities": [[168, 174, "DISEASE"]]}], ["We investigated pathophysiologic responses to Baltimore, Maryland, ambient PM (median diameter, 1.78 \u03bcm) in a murine model of asthma and attempted to identify PM-specific genomic/molecular signatures.", {"entities": [[126, 132, "DISEASE"]]}], ["We exposed ovalbumin (OVA)-sensitized A/J mice intratracheally to PM (20 mg/kg), and assayed both AHR and bronchoalveolar lavage (BAL) on days 1, 4, and 7 after PM exposure.", {"entities": [[98, 101, "GENE"]]}], ["Lung gene expression profiling was analyzed in OVA- and PM-challenged mice.", {"entities": []}], ["Consistent with this murine model of asthma, we observed significant increases in airway responsiveness in OVA-treated mice, with PM exposure inducing significant changes in AHR in both naive mice and OVA-induced asthmatic mice.", {"entities": [[37, 43, "DISEASE"], [174, 177, "GENE"]]}], ["PM evoked eosinophil and neutrophil infiltration into airways, elevated BAL protein content, and stimulated secretion of type 1 T helper (T H 1) cytokines [interferon-\u03b3, interleukin-6 (IL-6), tumor necrosis factor-\u03b1] and T H 2 cytokines (IL-4, IL-5, eotaxin) into murine airways.", {"entities": []}], ["Furthermore, PM consistently induced expression of genes involved in innate immune responses, chemotaxis, and complement system pathways.", {"entities": []}], ["This study is consistent with emerging epidemiologic evidence and indicates that PM exposure evokes proinflammatory and allergic molecular signatures that may directly contribute to the asthma susceptibility in naive subjects and increased severity in affected asthmatics.", {"entities": [[186, 192, "DISEASE"]]}], ["Epithelial ovarian cancer is the most aggressive and deadly form of ovarian cancer and is the most lethal gynecological malignancy worldwide; therefore, efforts to elucidate the molecular factors that lead to epithelial ovarian cancer are essential to better understand this disease.", {"entities": [[11, 25, "DISEASE"], [68, 82, "DISEASE"], [220, 234, "DISEASE"], [19, 25, "DISEASE"], [76, 82, "DISEASE"], [228, 234, "DISEASE"]]}], ["Recent studies reveal that tumor cells release cell-secreted vesicles called exosomes and these exosomes can transfer RNAs and miRNAs to distant sites, leading to cell transformation and tumor development.", {"entities": []}], ["The RNA-binding protein LIN28 is a known marker of stem cells and when expressed in cancer, it is associated with poor tumor outcome.", {"entities": [[84, 90, "DISEASE"]]}], ["We hypothesized that high LIN28 expressing ovarian cancer cells secrete exosomes that can be taken up by nontumor cells and cause changes in gene expression and cell behavior associated with tumor development.", {"entities": [[43, 57, "DISEASE"], [51, 57, "DISEASE"]]}], ["IGROV1 cells were found to contain high LIN28A and secrete exosomes that were taken up by HEK293 cells.", {"entities": [[40, 46, "GENE"]]}], ["Moreover, exposure to these IGROV1 secreted exosomes led to significant increases in genes involved in Epithelial-to-Mesenchymal Transition (EMT), induced HEK293 cell invasion and migration.", {"entities": []}], ["These changes were not observed with exosomes secreted by OV420 cells, which contain no detectable amounts of LIN28A or LIN28B.", {"entities": [[110, 116, "GENE"], [120, 126, "GENE"]]}], ["No evidence was found of LIN28A transfer from IGROV1 exosomes to HEK293 cells.", {"entities": [[25, 31, "GENE"]]}], ["The invasion of activated fibroblasts is a key mechanism of tissue fibrosis pathology.", {"entities": []}], ["The recognition and uptake of apoptotic cells can induce the anti-fibrogenic programming of macrophages.", {"entities": []}], ["We demonstrate that after interacting with apoptotic cells, macrophages secrete bioactive molecules that antagonize TGF-\u03b21-induced increases in myofibroblast (fibroproliferative) phenotypic markers and reduce the enhanced invasive capacity of TGF-\u03b21- or EGF-treated mouse lung fibroblasts (MLg).", {"entities": []}], ["Furthermore, numerous treatment strategies prevented the anti-fibrotic effects of conditioned media, including transfection of macrophages with COX-2 or RhoA siRNAs or treatment of MLg cells with receptor antagonists for prostaglandin E 2 (PGE 2 ), PGD 2 , or hepatocyte growth factor (HGF).", {"entities": [[153, 157, "GENE"], [249, 252, "GENE"], [286, 289, "GENE"]]}], ["Additionally, administration of apoptotic cells in vivo inhibited the bleomycin-mediated invasive capacity of primary fibroblasts, as well as adhesion and extracellular matrix protein mRNA expression.", {"entities": []}], ["These data suggest that the anti-fibrogenic programming of macrophages by apoptotic cells can be used as a novel tool to control the progressive fibrotic reaction.", {"entities": []}], ["Celiac disease (CD) is an autoimmune condition affecting the small intestine, triggered by the ingestion of gluten, the protein fraction of wheat, barley, and rye.", {"entities": []}], ["There is a strong linkage between CD and HLA-DQ2 and HLA-DQ8 haplotypes.", {"entities": []}], ["Multiple case reports and small series suggest concordance between CD and other autoimmune disorders.", {"entities": []}], ["This paper provides a brief overview of the pathogenesis of CD and reviews the literature regarding associations between CD and other autoimmune diseases, including the potential effects of gluten-free diet therapy on the prevention or amelioration of associated diseases.", {"entities": []}], ["The clostridial neurotoxin family consists of tetanus neurotoxin and seven distinct botulinum neurotoxins which cause the diseases tetanus and botulism.", {"entities": [[46, 53, "DISEASE"], [131, 138, "DISEASE"], [143, 151, "DISEASE"]]}], ["The extreme potency of these toxins primarily relies not only on their ability to specifically enter motoneurons but also on the activity their catalytic domains display inside presynaptic motoneuronal terminals.", {"entities": []}], ["Subsequent to neurotoxin binding and endocytosis the catalytic domains become translocated across endosomal membranes and proteolyze unique peptide bonds of one of three soluble N -ethylmaleimide-sensitive fusion protein attachment receptors (SNAREs), vesicle associated membrane protein/synaptobrevin, synaptosome associated protein of 25 kDa, or syntaxin.", {"entities": []}], ["As these substrate proteins are core components of the vesicular membrane fusion apparatus, cleavage of any of the substrate molecules results in the blockade of neurotransmitter release.", {"entities": []}], ["This review summarizes the present knowledge about the molecular basis of the specific substrate recognition and cleavage mechanism and assesses the feasibility of reengineering catalytic domains to hydrolyze non-substrate members of the three SNARE families in order to expand the therapeutic application of botulinum neurotoxins.", {"entities": []}], ["Objectives : Modern management of myeloma has significantly improved survival, with increasing numbers of patients living beyond a decade.", {"entities": [[34, 41, "DISEASE"]]}], ["However, little is known about the long-term cardiovascular and respiratory status of intensively treated and multiply relapsed survivors.", {"entities": []}], ["Methods : We performed detailed cardiovascular and respiratory evaluations in patients with intensively treated, advanced but stable myeloma.", {"entities": [[133, 140, "DISEASE"]]}], ["All patients had received at least two lines of treatment, including at least one haematopoietic stem cell transplantation procedure, but had stable, controlled disease and were off active treatment at the time of evaluation.", {"entities": []}], ["Results : Thirty-two patients with a median duration of 6 years (range 2\u201312) from original diagnosis of myeloma and three lines (range 2\u20136) of treatment were evaluated.", {"entities": [[104, 111, "DISEASE"]]}], ["Despite normal physical examination in the majority, there was a high prevalence of sub-clinical cardiac and respiratory dysfunction, reflected by abnormalities of electrocardiography (45%), echocardiography (50%), serum N-terminal pro-B-type natriuretic peptide level (NT-pro-BNP, 50%), and pulmonary function testing (45%).", {"entities": []}], ["NT-pro-BNP level correlated negatively with quality of life ( P \u2009=\u20090.012) and positively with serum ferritin ( P \u2009=\u20090.027).", {"entities": []}], ["Dyspnoea score correlated with BMI ( P \u2009=\u20090.001).", {"entities": []}], ["Risk factors for cardiovascular disease (obesity, hypertension, hyperlipidaemia, and hyperinsulinaemia) were common.", {"entities": [[50, 62, "DISEASE"], [41, 48, "DISEASE"]]}], ["Discussion : Even in the absence of overt clinical features, the majority of intensively treated long-term survivors of myeloma have established cardiovascular and/or respiratory dysfunction, above levels expected in the general population of a similar age.", {"entities": [[120, 127, "DISEASE"]]}], ["Conclusion : This study supports routine screening and lifestyle modification combined with primary and secondary preventive strategies to reduce cardiovascular and respiratory disease and to preserve quality of life in transplanted myeloma patients.", {"entities": [[233, 240, "DISEASE"]]}], ["Roles of lung volumes in asthma remain controversial.", {"entities": [[25, 31, "DISEASE"]]}], ["We aimed to evaluate the efficacy of lung volumes in differentiating asthma severity levels.", {"entities": [[69, 75, "DISEASE"]]}], ["Consecutive outpatients with chronic persistent asthma were enrolled, and body plethysmography (BP) and helium dilution (HD) were performed simultaneously to extract RV%pred, TLC%pred, and RV/TLC.", {"entities": [[48, 54, "DISEASE"]]}], ["Significant negative correlations were found between FEV 1 %pred and RV%pred (r\u2009=\u2009\u22120.557, P\u2009<\u20090.001), TLC%pred (r\u2009=\u2009\u22120.387, P\u2009<\u20090.001), and RV/TLC (r\u2009=\u2009\u22120.485, P\u2009<\u20090.001) measured by BP, as well as difference in volumes between these two techniques (\u0394RV%pred, \u0394TLC%pred and \u0394RV/TLC).", {"entities": [[53, 56, "GENE"]]}], ["In mild and moderate asthma, AUC of RV%pred detected by BP and \u0394TLC%pred was 0.723 (95%CI 0.571\u20130.874, P\u2009=\u20090.005) and 0.739 (95%CI 0.607\u20130.872, P\u2009=\u20090.002) with sensitivity and specificity being 79.41% and 88.24%, and 65.22% and 56.52% at cut-off of 145.40% and 14.23%, respectively.", {"entities": [[21, 27, "DISEASE"]]}], ["In moderate and severe asthma, AUC of RV%pred detected by BP and \u0394TLC%pred was 0.782 (95%CI 0.671\u20130.893, P\u2009<\u20090.001) and 0.788 (95%CI 0.681\u20130.894, P\u2009<\u20090.002) with sensitivity and specificity being 77.78% and 97.22%, and 73.53% and 52.94% at cut-off of 179.85% and 20.22%, respectively.", {"entities": [[23, 29, "DISEASE"]]}], ["In conclusion, lung volumes are reliable complement of FEV 1 in identifying asthma severity levels.", {"entities": [[76, 82, "DISEASE"], [55, 58, "GENE"]]}], ["South Africa is committed to health reforms that strengthen primary health care.", {"entities": []}], ["Preparing future doctors to work in primary care teams with other professionals is a priority, and medical schools have shifted towards community-based and decentralised training of medical students.", {"entities": []}], ["To evaluate the effect on student performance of the Practical Approach to Care Kit (PACK) (an integrated decision-making tool for adult primary care) during the final phase of medical student training at Stellenbosch University.", {"entities": []}], ["Clinical rotations in family medicine at clinics in the Western Cape.", {"entities": []}], ["Mixed methods involving a quasi-experimental study and focus group interviews.", {"entities": []}], ["Student examination performance was compared between groups with and without exposure to the PACK during their clinical training.", {"entities": []}], ["Student groups exposed to PACK were interviewed at the end of their rotations.", {"entities": []}], ["Student performance in examinations was significantly better in those exposed to the PACK.", {"entities": []}], ["Students varied from using the PACK overtly or covertly during the consultation to checking up on decisions made after the consultation.", {"entities": []}], ["Some felt that the PACK was more suitable for nurses or more junior students.", {"entities": []}], ["Although tutors openly endorsed PACK, very few modelled the use of PACK in their clinical practice.", {"entities": []}], ["The use of PACK in the final phase of undergraduate medical education improved their performance in primary care.", {"entities": []}], ["Students might be more accepting and find the tool more useful in the earlier clinical rotations.", {"entities": []}], ["Supervisors should be trained further in how to incorporate the use of the PACK in their practice and educational conversations.", {"entities": []}], ["Asystasia gangentica ( A. gangetica ) belongs to the family Acanthaceae.", {"entities": []}], ["It is used to treat hypertension, rheumatism, asthma, diabetes mellitus, and as an anthelmintic in South Africa, India, Cameroun, Nigeria, and Kenya respectively.", {"entities": [[20, 32, "DISEASE"], [46, 52, "DISEASE"], [54, 71, "DISEASE"]]}], ["It has also been reported to inhibit the angiotensin I converting enzyme (ACE) in-vitro .", {"entities": []}], ["Therefore, the aim of this study is to investigate the in-vivo effect of aqueous leaf extract (ALE) of A. gangetica on the blood pressure (BP) and heart rate (HR) in anaesthetized male spontaneously hypertensive rats (SHR); and to elucidate possible mechanism(s) by which it acts.", {"entities": [[159, 161, "GENE"]]}], ["The ALE of A. gangetica (10\u2013400 mg/kg), angiotensin I human acetate salt hydrate (ANG I, 3.1\u2013100 \u03bcg/kg) and angiotensin II human (ANG II, 3.1\u201350 \u03bcg/kg) were administered intravenously.", {"entities": [[82, 85, "GENE"], [130, 133, "GENE"], [82, 85, "GENE"], [130, 133, "GENE"]]}], ["The BP and HR were measured via a pressure transducer connecting the femoral artery to a Powerlab and a computer for recording.", {"entities": [[11, 13, "GENE"]]}], ["A. gangetica significantly (p<0.05), and dose-dependently reduced the systolic, diastolic, and mean arterial BP.", {"entities": []}], ["The significant (p<0.05) reductions in HR were not dose-dependent.", {"entities": [[39, 41, "GENE"]]}], ["Both ANG I and ANG II increased the BP dose-dependently.", {"entities": [[5, 8, "GENE"], [15, 18, "GENE"], [5, 8, "GENE"], [15, 18, "GENE"]]}], ["Co-infusion of A. gangetica (200 mg/kg) with either ANG I or ANG II significantly (p<0.05) suppressed the hypertensive effect of both ANG I and ANG II respectively, and was associated with reductions in HR.", {"entities": [[52, 55, "GENE"], [61, 64, "GENE"], [134, 137, "GENE"], [144, 147, "GENE"], [52, 55, "GENE"], [61, 64, "GENE"], [134, 137, "GENE"], [144, 147, "GENE"], [52, 55, "GENE"], [61, 64, "GENE"], [134, 137, "GENE"], [144, 147, "GENE"], [52, 55, "GENE"], [61, 64, "GENE"], [134, 137, "GENE"], [144, 147, "GENE"], [203, 205, "GENE"]]}], ["A. gangetica ALE reduced BP and HR in the SHR.", {"entities": [[32, 34, "GENE"]]}], ["The reduction in BP may be a result of actions of the ALE on the ACE, the ANG II receptors and the heart rate.", {"entities": [[74, 77, "GENE"]]}], ["To estimate the prevalence of respiratory symptoms in individuals with type 2 diabetes, as compared to the general population.", {"entities": []}], ["Between 2007 and \ufeff2010 the screening questionnaire of GEIRD (Gene Environment Interactions in Respiratory Diseases) study was administered to two samples of Verona general population, aged respectively 45-64\u00a0years and 65-84\u00a0years, and to a convenience sample of individuals with type 2 diabetes, consequently recruited at the local Diabetes Centre.", {"entities": []}], ["Ninety-four and 165 people with type 2 diabetes, aged respectively 45-64 and 65-84\u00a0years, were compared with 676 and 591 subjects in the same age range from the general population.", {"entities": []}], ["The influence of type 2 diabetes on respiratory symptoms was evaluated by logistic regression models, controlling for sex, age (45-54, 55-64, 65-74, 75-84\u00a0years), education level, smoking habits and heavy vehicle traffic exposure and adjusting standard errors of ORs for intra-sample correlation.", {"entities": []}], ["Compared to the general population, dyspnoea limiting walking pace on level ground (grade 2 dyspnoea) was more frequently reported by people with type 2 diabetes, irrespective of age ( p \u00a0<\u00a00.001), while self-reported chronic cough/phlegm was more common in those aged 45-64\u00a0years ( p \u00a0=\u00a00.02).", {"entities": []}], ["These results were confirmed by multivariable analysis: compared to their counterparts from the general population, people with type 2 diabetes aged 45-54\u00a0years showed an increased risk of reporting grade 2 dyspnoea (OR\u00a0=\u00a03.92, 95% CI 3.28-4.68) or chronic cough/phlegm (OR\u00a0=\u00a01.69, 1.60-1.78).", {"entities": []}], ["Similar figures held significant at older ages (75-84\u00a0years), although partially blunted (dyspnoea: OR\u00a0=\u00a01.79, 1.68-1.91; chough/phlegm: OR\u00a0=\u00a01.09, 1.03-1.16).", {"entities": []}], ["As such, the interaction between age class and type 2 diabetes was significant for both respiratory disorders.", {"entities": []}], ["The proportion of self-reported dyspnoea among individuals with type 2 diabetes significantly increased across incremental body-mass index (BMI), from 15.4 to 25.4% and further to 41.3% respectively in normoweight, overweight and obese patients ( p \u00a0=\u00a00.048).", {"entities": []}], ["People with type 2 diabetes more frequently reported grade 2 dyspnoea and chronic cough/phlegm than the general population of the same age, although presenting similar smoking habits.", {"entities": []}], ["Diabetes appears to anticipate the lung ageing process, recorded in the general population.", {"entities": []}], ["The increased occurrence of dyspnoea at incremental BMI among individuals with type 2 diabetes may reflect both cardiovascular and respiratory impairment in this high-risk patient population.", {"entities": []}], ["Beta (\u03b2)-blockers are under-prescribed in patients with heart failure (HF) and concurrent chronic obstructive pulmonary disease (COPD) due to concerns about adverse pulmonary effects and a poor understanding of the effects of these drugs.", {"entities": [[90, 127, "DISEASE"]]}], ["We aimed to evaluate the survival effects of \u03b2-blockers in patients with coexistent HF and COPD.", {"entities": []}], ["Using the Taiwan National Health Insurance Research Database, we conducted a nationwide population-based study.", {"entities": []}], ["Patients with coexistent HF and COPD diagnosed between 2000 and 2009 were enrolled.", {"entities": []}], ["Doses of the 3 \u03b2-blockers proven to be beneficial to HF (carvedilol, bisoprolol, and metoprolol) during the study period were extracted.", {"entities": []}], ["The primary endpoint was cumulative survival.", {"entities": []}], ["Patients were followed until December 31, 2009.", {"entities": []}], ["The study included 11,558 subjects, with a mean follow-up period of 4.07 years.", {"entities": []}], ["After adjustment for age, sex, comorbidities, and severity of HF and COPD, bisoprolol use showed a dose\u2013response survival benefit [low dose: adjusted hazard ratio (HR)\u200a=\u200a0.76, 95% confidence interval (CI)\u200a=\u200a0.59\u20130.97, P \u200a=\u200a0.030; high dose: adjusted HR\u200a=\u200a0.40, 95% CI\u200a=\u200a0.26\u20130.63, P \u200a<\u200a0.001] compared with nonusers, whereas no survival difference was observed for carvedilol or metoprolol.", {"entities": [[164, 166, "GENE"], [250, 252, "GENE"], [164, 166, "GENE"], [250, 252, "GENE"]]}], ["Compared with patients with HF alone, this special HF\u200a+\u200aCOPD cohort received significantly fewer targeted \u03b2-blockers (108.8 vs 137.3 defined daily doses (DDDs)/person-year, P \u200a<\u200a0.001) and bisoprolol (57.9 vs 70.8\u200aDDDs/person-year, P \u200a<\u200a0.001).", {"entities": []}], ["In patients with coexisting HF and COPD, this study demonstrated a dose\u2013response survival benefit of bisoprolol use, but not of carvedilol or metoprolol use.", {"entities": []}], ["Inflammation is a complex process that implies the interaction between cells and molecular mediators, which, when not properly \u201ctuned,\u201d can lead to disease.", {"entities": []}], ["When inflammation affects the eye, it can produce severe disorders affecting the superficial and internal parts of the visual organ.", {"entities": []}], ["The nucleoside adenosine and nucleotides including adenine mononucleotides like ADP and ATP and dinucleotides such as P 4 A), and P 5 A) are present in different ocular locations and therefore they may contribute/modulate inflammatory processes.", {"entities": []}], ["Adenosine receptors, in particular A 2A adenosine receptors, present anti-inflammatory action in acute and chronic retinal inflammation.", {"entities": []}], ["Regarding the A 3 receptor, selective agonists like N", {"entities": []}], ["Self-management has received growing attention as an effective approach for long-term condition management.", {"entities": []}], ["Little is known about which outcomes of supported self-management are valued by patients, their families, health professionals and those who commission self-management services.", {"entities": []}], ["This study systematically reviewed published empirical evidence in accordance with PRISMA guidelines to determine the outcomes of self-management valued by these key stakeholder groups, using three prominent exemplar conditions: colorectal cancer, diabetes and stroke.", {"entities": [[229, 246, "DISEASE"], [240, 246, "DISEASE"]]}], ["To systematically review the literature to identify which generic outcomes of self-management have been targeted and are considered important using three exemplar conditions (colorectal cancer, diabetes and stroke), which collectively have a range of features that are likely to be representative of generic self-management issues.", {"entities": [[175, 192, "DISEASE"], [186, 192, "DISEASE"]]}], ["Systematic searching of nine electronic databases was conducted in addition to hand searches of review articles.", {"entities": []}], ["Abstracts were identified against inclusion criteria and appraised independently by two reviewers, using a critical appraisal tool.", {"entities": []}], ["Synthesis of findings was conducted using mixed research synthesis.", {"entities": []}], ["Over 20,536 abstracts were screened.", {"entities": []}], ["41 studies which met the review criteria were fully retrieved and appraised.", {"entities": []}], ["The majority of evidence related to diabetes.", {"entities": []}], ["Few studies directly focussed on stakeholders\u2019 views concerning desired self-management outcomes; the majority of evidence was derived from studies focusing upon the experience of self-management.", {"entities": []}], ["The views of health care commissioners were absent from the literature.", {"entities": []}], ["We identified that self-management outcomes embrace a range of indicators, from knowledge, skills, and bio-psychosocial markers of health through to positive social networks.", {"entities": []}], ["Patients\u2019, families\u2019, health professionals\u2019 and commissioners\u2019 views regarding which outcomes of self-management are important have not been clearly elicited.", {"entities": []}], ["The extent to which bio-psychosocial indicators relate to successful self-management from the perspectives of all groups of stakeholders is unknown.", {"entities": []}], ["Further investigation regarding which self-management outcomes are considered important by all stakeholders is necessary to guide the commissioning and design of future self-management services.", {"entities": []}], ["Here we present, for the first time, a glossary of biometeorological terms.", {"entities": []}], ["The glossary aims to address the need for a reliable source of biometeorological definitions, thereby facilitating communication and mutual understanding in this rapidly expanding field.", {"entities": []}], ["A total of 171 terms are defined, with reference to 234 citations.", {"entities": []}], ["It is anticipated that the glossary will be revisited in coming years, updating terms and adding new terms, as appropriate.", {"entities": []}], ["The glossary is intended to provide a useful resource to the biometeorology community, and to this end, readers are encouraged to contact the lead author to suggest additional terms for inclusion in later versions of the glossary as a result of new and emerging developments in the field.", {"entities": []}], ["Recent reports indicate that over the next decade rates of chronic obstructive pulmonary disease (COPD) in women will exceed those in men in the western world, though in most jurisdictions, women continue to smoke less compared with men.", {"entities": [[59, 96, "DISEASE"]]}], ["Whether female adult smokers are biologically more susceptible to COPD is unknown.", {"entities": []}], ["This study reviewed the available evidence to determine whether female adult smokers have a faster decline in forced expiratory volume in one second (FEV 1 ) compared with male adult smokers and whether age modifies the relationship between cigarette smoke and lung function decline.", {"entities": [[150, 153, "GENE"]]}], ["A systematic review and a meta-analysis was performed of population-based cohort studies that had a follow-up period of at least 3 years, measured FEV 1 on at least two different time points, and presented FEV 1 data stratified by gender and smoking status in adults.", {"entities": [[147, 150, "GENE"], [206, 209, "GENE"], [147, 150, "GENE"], [206, 209, "GENE"]]}], ["Of the 646 potentially relevant articles, 11 studies met these criteria and were included in the analyses (N = 55 709 participants).", {"entities": []}], ["There was heterogeneity in gender-related results across the studies.", {"entities": []}], ["However, on average current smokers had a faster annual decline rate in FEV 1 % predicted compared with never and former smokers.", {"entities": [[72, 75, "GENE"]]}], ["Female current smokers had with increasing age a significantly faster annual decline in FEV 1 % predicted than male current smokers (linear regression analysis, R 1 % predicted in male and female former and never smokers (p = 0.775 and p = 0.326, respectively).", {"entities": [[88, 91, "GENE"]]}], ["As female smokers age, they appear to experience an accelerated decline in FEV 1 % predicted compared with male smokers.", {"entities": [[75, 78, "GENE"]]}], ["Future research powered specifically on gender-related changes in lung function is needed to confirm these early findings.", {"entities": []}], ["To understand the clinical characteristics and the diagnostic procedures in pediatric patients with eosinophilic esophagitis and to evaluate the sensitivity of the patients to food and inhalant allergens.", {"entities": [[113, 124, "DISEASE"], [100, 124, "DISEASE"]]}], ["A cross-sectional study was performed in 35 children with eosinophilic esophagitis during the time period from January 2010 to January 2011.", {"entities": [[71, 82, "DISEASE"], [58, 82, "DISEASE"]]}], ["The clinical and epidemiological data were obtained using a questionnaire and medical chart analysis.", {"entities": []}], ["The body mass index for age was used for the nutritional evaluation (via the Z score).", {"entities": []}], ["The sensitivity to foods and inhalants was evaluated by performing a skin prick test and atopy patch test.", {"entities": []}], ["Patients (35 in total, median age 10 years) with a diagnosis of eosinophilic esophagitis were evaluated.", {"entities": [[77, 88, "DISEASE"], [64, 88, "DISEASE"]]}], ["The most prevalent symptoms in the patients were vomiting (71.4%) and abdominal pain (51.4%).", {"entities": []}], ["Endoscopic alterations were observed in 97.2% of the patients.", {"entities": []}], ["A good nutritional state was observed in 82.8% of the children.", {"entities": []}], ["The tests demonstrated the presence of food sensitivities and/or aeroallergens in 27 (77.1%) patients, whereas 8 (22.9%) patients did not test positive in any of the tests performed.", {"entities": []}], ["Among the patients with positive tests, 24 (68.5%) exhibited sensitivity to aeroallergens and 16 (45.7%) were sensitive to foods.", {"entities": []}], ["The comparison between the sensitive and insensitive groups displayed statistically significant results with respect to sex, symptom prevalence, and 24-hour esophageal pH monitoring.", {"entities": []}], ["The patients evaluated in this study displayed clinical characteristics of eosinophilic esophagitis similar to those reported in the literature.", {"entities": [[88, 99, "DISEASE"], [75, 99, "DISEASE"]]}], ["The sensitivity to foods determined by the tests was less than that observed in prior studies; however, a marked sensitivity to aeroallergens was observed.", {"entities": []}], ["The different allergen sensitivity profiles observed in this study suggests that, similar to asthma, the eosinophiic esophagitis disease may exhibit several phenotypes.", {"entities": [[117, 128, "DISEASE"], [93, 99, "DISEASE"]]}], ["Human T cell helper/inducer clones were used to induce IgE synthesis in B cells from both allergic and nonallergic donors.", {"entities": []}], ["An alloreactive T cell clone, activated by recognition of specific HLA-DR antigens, stimulated peripheral blood B cells from both allergic and nonallergic donors to synthesize IgE antibody.", {"entities": []}], ["B cells of allergic donors differed from those of nonallergic donors in their requirements for induction of IgE synthesis.", {"entities": []}], ["Induction of IgE synthesis in B cells from nonallergic individuals occurred only under conditions of cognate interaction, in which the B cells expressed the alloantigen recognized by the T cells.", {"entities": []}], ["In contrast, IgE synthesis in B cells from allergic donors occurred under conditions of cognate interaction with T cells as well as bystander conditions where the B cells did not express the alloantigen recognized by the T cell clones and where the T cell clones were stimulated by third-party monocytes bearing the relevant alloantigens.", {"entities": []}], ["Furthermore, bystander stimulation of IgE synthesis in allergic donors occurred in the presence of tetanus toxoid (TT) antigen-specific T cell clones activated by the appropriate TT-pulsed monocytes.", {"entities": [[99, 106, "DISEASE"]]}], ["In contrast to the differing requirements of B cells from normal vs. allergic subjects for the induction of IgE synthesis, these B cells did not differ in their requirements for the induction of IgG synthesis.", {"entities": []}], ["IgG synthesis was induced in all B cells under conditions of cognate interaction with the T cells as well as under conditions of bystander stimulation.", {"entities": []}], ["These results suggest that cognate T-B cell interactions may be important in the development of IgE immune responses in the normal host.", {"entities": []}], ["Previous cross-sectional studies have suggested that the mode of delivery can influence the composition of oral microflora.", {"entities": []}], ["The aim of this prospective study was to compare the salivary colonization in vaginally delivered children with children delivered by Caesarian section (C-section) during their first 6\u00a0months of life.", {"entities": []}], ["The study group consisted of 149 consecutively enrolled infants, delivered either vaginally ( n \u2009=\u200996) or by C-section ( n \u2009=\u200953) that volunteered after consent of their parents.", {"entities": []}], ["Saliva samples were collected within 2\u00a0days after birth and then after 1, 3, and 6\u00a0months.", {"entities": []}], ["A saliva sample from the mothers was obtained 6\u00a0months after delivery.", {"entities": []}], ["The parents were asked to complete a questionnaire on socioeconomic factors, lifestyle, and hygiene at baseline and throughout the study period.", {"entities": []}], ["All samples were analyzed with 13 pre-determined bacterial probes using checkerboard DNA-DNA hybridization.", {"entities": []}], ["The groups were balanced at baseline concerning all relevant background factors.", {"entities": []}], ["Gram-positive streptococci ( S. mitis, S. salivarius ) displayed the highest counts in both groups but a greater diversity was observed in the vaginally delivered group.", {"entities": []}], ["A. naeslundi, A. odontolytics, F. nucleatum and L. salivarius were only detected among the vaginally delivered infants.", {"entities": []}], ["The prevalence of S. sanguinis, S. gordoni, R. denticariosa, and B. dentinum increased by age in both groups but the prevalence was significantly lower in the C-section group ( p \u2009<\u20090.05).", {"entities": []}], ["There was a link between the mothers and their offspring\u2019s concerning the salivary microbial profile.", {"entities": []}], ["The microbial composition in saliva differs by the mode of delivery during the first six months of life.", {"entities": []}], ["Mental illness represents an important public health problem.", {"entities": []}], ["Local-level data concerning mental illness in different populations (e.g., socio-demographics and residence \u2013 metropolitan/urban/rural) provides the evidence-base for public health authorities to plan, implement and evaluate control programs.", {"entities": []}], ["This paper describes prevalence and covariates of psychiatric conditions in Georgia populations in three defined geographic areas.", {"entities": []}], ["Data came from the Georgia population-based random-digit-dialing study investigating unwellness and chronic fatigue syndrome (CFS) in Georgia populations of three defined geographic areas (metropolitan, urban, and rural).", {"entities": [[100, 124, "DISEASE"], [116, 124, "DISEASE"]]}], ["Respondents were screened for symptoms of fatigue, sleep, cognition, and pain at household screening interviews, and a randomly selected sample completed detailed individual phone interviews.", {"entities": []}], ["Based on the detailed phone interviews, we conducted one-day clinical evaluations of 292 detailed interview participants classified as unwell with a probable CFS (i.e.", {"entities": []}], ["CFS-like; a functional somatic syndrome), 268 classified as other unwell, and 223 well (matched to CFS-like ).", {"entities": [[31, 39, "DISEASE"]]}], ["Clinical evaluation included psychiatric classification by means of the Structured Clinical Interview for DSM (SCID).", {"entities": []}], ["To derive prevalence estimates we used sample weighting to account for the complexity of the multistage sampling design.", {"entities": []}], ["We used 2- and 3-way table analyses to examine socio-demographic and urbanicity specific associations and multiple logistic regression to calculate adjusted odds ratios.", {"entities": []}], ["Anxiety and mood disorders were the most common psychiatric conditions.", {"entities": []}], ["Nineteen percent of participants suffered a current anxiety disorder, 18% a mood disorder and 10% had two or more conditions.", {"entities": [[52, 68, "DISEASE"], [76, 89, "DISEASE"]]}], ["There was a significant linear trend in occurrence of anxiety or mood disorders from well to CFS-like .", {"entities": []}], ["The most common anxiety disorders were post-traumatic stress disorder (PTSD) (6.6%) and generalized anxiety disorder (GAD) (5.8%).", {"entities": [[39, 69, "DISEASE"], [88, 116, "DISEASE"], [100, 116, "DISEASE"]]}], ["Logistic regression showed that lower education and female sex contributed significantly to risk for both PTSD and GAD.", {"entities": []}], ["In addition, rural/urban residence and Hispanic ethnicity were associated with PTSD.", {"entities": []}], ["We defined moderate to severe depression as Major Depressive Disorder or a Zung score >60 and logistic regression found lower education to be significantly associated but sex, age and urbanicity were not.", {"entities": []}], ["Overall occurrence of anxiety and mood disorders in Georgia mirrored national findings.", {"entities": []}], ["However, PTSD and GAD occurred at twice the published national rates (3.6 and 2.7%, respectively).", {"entities": []}], ["State and local prevalence and associations with education, sex and urbanicity comprise important considerations for developing control programs.", {"entities": []}], ["The increased prevalence of anxiety and mood disorders in people with a functional somatic syndrome (or CFS-like illness) is important for primary care providers, who should consider additional psychiatric screening or referral of individuals presenting with somatoform symptoms.", {"entities": [[91, 99, "DISEASE"]]}], ["The objective of the study was to investigate the impact on the quality of life of people living close to a municipal wastewater treatment plant.", {"entities": []}], ["A case control study, including 235 inhabitants living within a 500\u2009m radius by a municipal wastewater treatment plant (cases) and 97 inhabitants living in a different area (controls), was conducted.", {"entities": []}], ["A standardized questionnaire was self-completed by the participants which examined the general health perception and the overall life satisfaction.", {"entities": []}], ["Also, the concentration of airborne pathogenic microorganisms in aerosol samples collected around the wastewater treatment plant was investigated.", {"entities": []}], ["Significant risk for symptoms such as headache, unusual tiredness, and concentration difficulties was recorded and an increased possibility for respiratory and skin diseases was reported.", {"entities": []}], ["A high rate of the cases being irritable and moody was noticed.", {"entities": []}], ["Significantly higher gastrointestinal symptoms were also reported among the cases in relation to the controls.", {"entities": []}], ["The prevalence of pathogenic airborne microorganisms originating from the wastewater treatment plant was reported in high numbers in sampling points close to the wastewater treatment plant.", {"entities": []}], ["More analytical epidemiological investigations are needed to determine the cause as well as the burden of the diseases to inhabitants living surrounding the wastewater treatment plant.", {"entities": []}], ["Peritoneal carcinomatosis from a gastrointestinal carcinoid tumour is rare and the long-term management and prognosis have not been clearly defined.", {"entities": []}], ["The natural history is different from gastrointestinal adenocarcinoma, although its capacity to invade regional lymph nodes and generate distal metastasis can make the management more complex.", {"entities": [[55, 69, "DISEASE"]]}], ["Whilst the development of carcinomatosis is uncommonly reported, it may be higher than expected.", {"entities": []}], ["A 63 years-old woman underwent emergency surgery in 1993 for right iliac fossa pain and a mass that was found to be an ileal carcinoid tumour.", {"entities": []}], ["Over the next ten years, further surgery was required for disseminated disease with peritoneal carcinomatosis and liver metastasis.", {"entities": []}], ["Systemic chemotherapy had little effect, although Somatostatin was used effectively to relieve symptoms caused by the disseminated disease (flushing and diarrhoea).", {"entities": []}], ["Peritoneal carcinomatosis from carcinoid tumours is not well documented in the literature.", {"entities": []}], ["Aggressive surgery must be performed in order to control the disease since chemotherapy has not been reported to be effective.", {"entities": []}], ["With repeated surgery long-term survival can be achieved in these patients.", {"entities": []}], ["High frequency chest wall oscillation (HFCWO) is used for airway mucus clearance.", {"entities": []}], ["The objective of this study was to evaluate the use of HFCWO early in the treatment of adults hospitalized for acute asthma or chronic obstructive pulmonary disease (COPD).", {"entities": [[127, 164, "DISEASE"], [117, 123, "DISEASE"]]}], ["Randomized, multi-center, double-masked phase II clinical trial of active or sham treatment initiated within 24 hours of hospital admission for acute asthma or COPD at four academic medical centers.", {"entities": [[150, 156, "DISEASE"]]}], ["Patients received active or sham treatment for 15 minutes three times a day for four treatments.", {"entities": []}], ["Medical management was standardized across groups.", {"entities": []}], ["The primary outcomes were patient adherence to therapy after four treatments (minutes used/60 minutes prescribed) and satisfaction.", {"entities": []}], ["Secondary outcomes included change in Borg dyspnea score (\u2265 1 unit indicates a clinically significant change), spontaneously expectorated sputum volume, and forced expired volume in 1 second.", {"entities": []}], ["Fifty-two participants were randomized to active (n = 25) or sham (n = 27) treatment.", {"entities": []}], ["Patient adherence was similarly high in both groups (91% vs. 93%; p = 0.70).", {"entities": []}], ["Patient satisfaction was also similarly high in both groups.", {"entities": []}], ["After four treatments, a higher proportion of patients in the active treatment group had a clinically significant improvement in dyspnea (70.8% vs. 42.3%, p = 0.04).", {"entities": []}], ["There were no significant differences in other secondary outcomes.", {"entities": []}], ["HFCWO is well tolerated in adults hospitalized for acute asthma or COPD and significantly improves dyspnea.", {"entities": [[57, 63, "DISEASE"]]}], ["The high levels of patient satisfaction in both treatment groups justify the need for sham controls when evaluating the use of HFCWO on patient-reported outcomes.", {"entities": []}], ["Additional studies are needed to more fully evaluate the role of HFCWO in improving in-hospital and post-discharge outcomes in this population.", {"entities": []}], ["ClinicalTrials.gov: NCT00181285", {"entities": []}], ["Although association between respiratory syncytial virus infection and later asthma development has been established, little is known about the role of other respiratory viruses.", {"entities": [[77, 83, "DISEASE"]]}], ["Rhinovirus was considered a mild pathogen of the upper respiratory tract but current evidence suggests that rhinovirus is highly prevalent among children with lower respiratory tract infections (LRTI).", {"entities": []}], ["The aim of the study was to evaluate whether LRTI hospitalization associated with rhinovirus during infancy was associated with an increased risk of wheezing \u2013 a proxy measure of asthma \u2013 during childhood.", {"entities": [[179, 185, "DISEASE"]]}], ["During a 12 months period, all infants <1 year admitted to Manhi\u00e7a District Hospital with symptoms of LRTI who survived the LRTI episode, were enrolled in the study cohort.", {"entities": []}], ["Nasopharyngeal aspirates were collected on admission for viral determination and study infants were classified according to presence or not of rhinovirus.", {"entities": []}], ["The study cohort was passively followed-up at the Manhi\u00e7a District Hospital for up to 4 years and 9 months to evaluate the association between LRTI associated with rhinovirus in infancy and wheezing during childhood.", {"entities": []}], ["A total of 220 infants entered the cohort; 25% of them had rhinovirus detected during the LRTI episode as opposed to 75% who tested negative for rhinovirus.", {"entities": []}], ["After adjusting for sex and age and HIV infection at recruitment, infants hospitalized with LRTI associated with rhinovirus had higher incidence of subsequent visits with wheezing within the year following hospitalization [Rate ratio=1.68, (95% confidence interval=1.02-2.75); Wald test p-value = 0.039].", {"entities": []}], ["No evidence of increased incidence rate of visits with wheezing was observed for the remaining follow-up period.", {"entities": []}], ["Our data suggest a short term increased risk of wheezing after an initial episode of LRTI with RV.", {"entities": []}], ["We used the FBAT (family-based association test) software to test for association between 300 individual single-nucleotide polymorphisms and P1 (a latent trait of Kofendred Personality Disorder) in 100 simulated replicates of the Aipotu population.", {"entities": []}], ["Using the Genetic Analysis Workshop 14 dataset, we calculated the power of FBAT to detect linkage disequilibrium on chromosome 3 (D2).", {"entities": []}], ["Also, we calculated the false-positive rate on chromosome 1, which contains a true locus (D1) but no linkage disequilibrium was simulated between the trait and all the surrounding single-nucleotide polymorphisms.", {"entities": []}], ["We were able to detect the associations between phenotype P1 and three adjacent markers B03T3056 (average p -value = 0.0002), B03T3057 (average p -value = 0.00072), and B03T3058 (average p -value = 0.0038) with power of 98%, 87%, 71% on chromosome 3, respectively.", {"entities": []}], ["The overall false positve rate to detect association was 0.06 on chromosome 1.", {"entities": []}], ["The power to detect a significant association in 100 nuclear families affected with the latent trait of Kofendred Personality Disorder by using FBAT was reasonable (based on 100 replicates).", {"entities": []}], ["In the future, we will compare the performance of FBAT with alternative approaches, such as using FBAT-generalized estimating equations methods to test for association in families affected with complex traits.", {"entities": []}], ["To explore the equity of utilization of inpatient health care at rural Tanzanian health centers through the use of a short wealth questionnaire.", {"entities": []}], ["Patients admitted to four rural health centers in the Kigoma Region of Tanzania from May 2008 to May 2009 were surveyed about their illness, asset ownership and demographics.", {"entities": []}], ["Principal component analysis was used to compare the wealth of the inpatients to the wealth of the region's general population, using data from a previous population-based survey.", {"entities": []}], ["Among inpatients, 15.3% were characterized as the most poor, 19.6% were characterized as very poor, 16.5% were characterized as poor, 18.9% were characterized as less poor, and 29.7% were characterized as the least poor.", {"entities": []}], ["The wealth distribution of all inpatients (p < 0.0001), obstetric inpatients (p < 0.0001), other inpatients (p < 0.0001), and fee-exempt inpatients (p < 0.001) were significantly different than the wealth distribution in the community population, with poorer patients underrepresented among inpatients.", {"entities": []}], ["The wealth distribution of pediatric inpatients (p = 0.2242) did not significantly differ from the population at large.", {"entities": []}], ["The findings indicated that while current Tanzanian health financing policies may have improved access to health care for children under five, additional policies are needed to further close the equity gap, especially for obstetric inpatients.", {"entities": []}], ["The role of mast cells in contractile bronchial smooth muscle activity has been evaluated in a model of chronic obstructive pulmonary disease induced in rats that were intermittently exposed to nitrogen dioxide (NO 2 ) for 60 days.", {"entities": [[104, 141, "DISEASE"]]}], ["Starting from the 31st day, one group of rats inhaled sodium cromoglycate before exposure to NO 2 to stabilize mast cell membranes.", {"entities": []}], ["The second group (control) was not treated.", {"entities": []}], ["Isometric smooth muscle contraction was analysed in isolated bronchial samples in response to nerve and smooth muscle stimulation.", {"entities": []}], ["Histological analysis revealed large numbers of mast cells in lung tissue of COPD model rats.", {"entities": []}], ["The inhibition of mast cell degranulation by sodium cromoglycate prevented the development of nerve-stimulated bronchial smooth muscle hyperactivity in COPD model rats.", {"entities": []}], ["Histamine or adenosine-induced hyperactivity on nerve stimulation was also inhibited by sodium cromoglycate in bronchial smooth muscle in both control and COPD model rats.", {"entities": []}], ["This suggests that the mechanism of contractile activity enhancement of bronchial wall smooth muscle cells may be mediated through the activation of resident mast cells transmembrane adenosine receptors resulting in their partial degranulation, with the released histamine acting upon histamine H1-receptors which trigger reflex pathways via intramural ganglion neurons.", {"entities": []}], ["Southwestern Ontario (SWO) in Canada has been known as a 'hot spot' in terms of environmental exposure and potential effects.", {"entities": []}], ["We chose to study 3 major cities in SWO in this paper.", {"entities": []}], ["We compared age-standardized hospital admission ratios of Sarnia and Windsor to London, and to generate hypotheses about potential pollutant-induced health effects in the 'Chemical Valley', Sarnia.", {"entities": []}], ["The number of daily hospital admissions was obtained from all hospitals in London, Windsor and Sarnia from January 1, 1996 to December 31, 2000.", {"entities": []}], ["We used indirect age adjustment method to obtain standardized admissions ratios for males and females and we chose London as the reference population.", {"entities": []}], ["This process of adjustment was to apply the age-specific admission rates of London to the population of Sarnia and Windsor in order to yield expected admissions.", {"entities": []}], ["The observed number of admissions was then compared to the expected admissions in terms of a ratio.", {"entities": []}], ["These standardized admissions ratios and their corresponding confidence intervals were calculated for Sarnia and Windsor.", {"entities": []}], ["Our findings showed that Sarnia and Windsor had significantly higher age-adjusted hospital admissions rates compared to London.", {"entities": []}], ["This finding was true for all admissions, and especially pronounced for cardiovascular and respiratory admissions.", {"entities": []}], ["For example, in 1996, the observed number of admissions in Sarnia was 3.11 (CI: 2.80, 3.44) times for females and 2.83 (CI: 2.54, 3.14) times for males as would be expected by using London's admission rates.", {"entities": []}], ["Since hospital admissions rates were significantly higher in 'Chemical Valley' as compared to both London and Windsor, we hypothesize that these higher rates are pollution related.", {"entities": []}], ["A critical look at the way ambient air quality and other pollutants are monitored in this area is warranted.", {"entities": []}], ["Further epidemiological research is needed to verify our preliminary indications of harmful effects in people living in 'Chemical Valley'.", {"entities": []}], ["Highly active anti-retroviral therapy (HAART) is the current HIV/AIDS treatment modality.", {"entities": []}], ["Despite the fact that HAART is very effective in suppressing HIV-1 replication and reducing the mortality of HIV/AIDS patients, it has become increasingly clear that HAART does not offer an ultimate cure to HIV/AIDS.", {"entities": []}], ["The high cost of the HAART regimen has impeded its delivery to over 90% of the HIV/AIDS population in the world.", {"entities": []}], ["This reality has urgently called for the need to develop inexpensive alternative anti-HIV/AIDS therapy.", {"entities": []}], ["This need has further manifested by recent clinical trial failures in anti-HIV-1 vaccines and microbicides.", {"entities": []}], ["In the current study, we characterized a panel of extracts of traditional Chinese medicinal herbal plants for their activities against HIV-1 replication.", {"entities": []}], ["Crude and fractionated extracts were prepared from various parts of nine traditional Chinese medicinal herbal plants in Hainan Island, China.", {"entities": []}], ["These extracts were first screened for their anti-HIV activity and cytotoxicity in human CD4+ Jurkat cells.", {"entities": []}], ["Then, a single-round pseudotyped HIV-luciferase reporter virus system (HIV-Luc) was used to identify potential anti-HIV mechanisms of these extracts.", {"entities": []}], ["Two extracts, one from Euphorbiaceae , Trigonostema xyphophylloides (TXE) and one from Dipterocarpaceae , Vatica astrotricha (VAD) inhibited HIV-1 replication and syncytia formation in CD4+ Jurkat cells, and had little adverse effects on host cell proliferation and survival.", {"entities": []}], ["TXE and VAD did not show any direct inhibitory effects on the HIV-1 RT enzymatic activity.", {"entities": []}], ["Treatment of these two extracts during the infection significantly blocked infection of the reporter virus.", {"entities": []}], ["However, pre-treatment of the reporter virus with the extracts and treatment of the extracts post-infection had little effects on the infectivity or gene expression of the reporter virus.", {"entities": []}], ["These results demonstrate that TXE and VAD inhibit HIV-1 replication likely by blocking HIV-1 interaction with target cells, i.e., the interaction between gp120 and CD4/CCR5 or gp120 and CD4/CXCR4 and point to the potential of developing these two extracts to be HIV-1 entry inhibitors.", {"entities": []}], ["Calculation of individual risk is the cornerstone of effective cardiovascular prevention.", {"entities": []}], ["arriba is a software to estimate the individual risk to suffer a cardiovascular event in 10 years.", {"entities": []}], ["Prognosis and the absolute effects of pharmacological and lifestyle interventions help the patient make a well-informed decision.", {"entities": []}], ["The risk calculation algorithm currently used in arriba is based on the Framingham risk algorithm calibrated to the German setting.", {"entities": []}], ["The objective of this study is to evaluate and adapt the algorithm for the target population in primary care in Germany.", {"entities": []}], ["arriba -pro will be conducted within the primary care scheme provided by a large health care insurer in Baden-W\u00fcrttemberg, Germany.", {"entities": []}], ["Patients who are counseled with arriba by their general practitioners (GPs) will be included in the arriba -pro cohort.", {"entities": []}], ["Exposure data from the consultation with arriba such as demographic data and risk factors will be recorded automatically by the practice software and transferred to the study centre.", {"entities": []}], ["Information on relevant prescription drugs (effect modifiers) and cardiovascular events (outcomes) will be derived from administrative sources.", {"entities": []}], ["The study is unique in simulating a therapy na\u00efve cohort, matching exactly research and application setting, using a robust administrative data base, and, finally, including patients with known cardiovascular disease who have been excluded from previous studies.", {"entities": []}], ["The study is registered with Deutsches Register Klinischer Studien (DRKS00004633).", {"entities": []}], ["We present a web engine boosted fluorescence in-situ hybridization (webFISH) algorithm using a genome-wide sequence similarity search to design target-specific single-copy and repetitive DNA FISH probes.", {"entities": []}], ["The webFISH algorithm featuring a user-friendly interface ( http://www.webfish2.org/ ) maximizes the coverage of the examined sequences with FISH probes by considering locally repetitive sequences absent from the remainder of the genome.", {"entities": []}], ["The highly repetitive human immunoglobulin heavy chain sequence was analyzed using webFISH to design three sets of FISH probes.", {"entities": []}], ["These allowed direct simultaneous detection of class switch recombination in both immunoglobulin-heavy chain alleles in single cells from a population of cultured primary B cells.", {"entities": []}], ["It directly demonstrated asynchrony of the class switch recombination in the two alleles in structurally preserved nuclei while permitting parallel readout of protein expression by immunofluorescence staining.", {"entities": []}], ["This novel technique offers the possibility of gaining unprecedented insight into the molecular mechanisms involved in class switch recombination.", {"entities": []}], ["Boys present with higher proportions of immature/na\u00efve CD5 in utero might be involved in the mechanism for delayed peripheral B-cell maturation in boys.", {"entities": [[55, 58, "GENE"]]}], ["Supplemental Digital Content is available in the text The uncomfortable symptoms of atopic dermatitis (AD) often trigger psychological stress.", {"entities": [[84, 101, "DISEASE"], [91, 101, "DISEASE"]]}], ["We investigated the association between AD severity and outpatient visits to psychiatrists using Korean National Health Insurance claims data from 2004 to 2013.", {"entities": []}], ["This was a retrospective cohort analysis; we estimated hazard ratios (HRs).", {"entities": []}], ["Of the 266,182 subjects, 18,290 (6.9%) had a history of visiting a psychiatrist, and 25,419 (9.5%) were diagnosed with AD.", {"entities": []}], ["Compared with the subjects without AD, subjects with AD had a higher HR for visiting a psychiatrist (3.70, 95% confidence interval [CI]:48 3.43\u20133.98), and this significantly increased as the complexity of the AD medications increased.", {"entities": [[69, 71, "GENE"]]}], ["Subjects who received topical treatments plus a systematic steroid (HR: 4.88, 95% CI: 4.51\u20135.27) and those who received topical treatments plus a systematic steroid plus a systematic calcineurin inhibitor (HR: 9.56, 95% CI: 4.29\u201321.28) had higher HRs compared with those without AD.", {"entities": [[68, 70, "GENE"], [206, 208, "GENE"], [68, 70, "GENE"], [206, 208, "GENE"]]}], ["Severe AD patients exhibited greater psychological stress than those without AD or with mild AD symptoms.", {"entities": []}], ["Moreover, medication diversity may represent an efficient and low-cost method by which to identify a vulnerable population.", {"entities": []}], ["Liver fibrosis is characterized by the deposition and increased turnover of extracellular matrix.", {"entities": []}], ["This process is controlled by matrix metalloproteinases (MMPs), whose expression and activity dynamically change during injury progression.", {"entities": []}], ["MMP-19, one of the most widely expressed MMPs, is highly expressed in liver; however, its contribution to liver pathology is unknown.", {"entities": []}], ["The aim of this study was to elucidate the role of MMP-19 during the development and resolution of fibrosis by comparing the response of MMP-19-deficient (MMP19KO) and wild-type mice upon chronic liver CCl 4 -intoxication.", {"entities": []}], ["We show that loss of MMP-19 was beneficial during liver injury, as plasma ALT and AST levels, deposition of fibrillar collagen, and phosphorylation of SMAD3, a TGF-\u00df1 signaling molecule, were all significantly lower in MMP19KO mice.", {"entities": [[151, 156, "GENE"]]}], ["The ameliorated course of the disease in MMP19KO mice likely results from a slower rate of basement membrane destruction and ECM remodeling as the knockout mice maintained significantly higher levels of type IV collagen and lower expression and activation of MMP-2 after 4 weeks of CCl 4 -intoxication.", {"entities": []}], ["Hastened liver regeneration in MMP19KO mice was associated with slightly higher IGF-1 mRNA expression, slightly increased phosphorylation of Akt kinase, decreased TGF-\u00df1 mRNA levels and significantly reduced SMAD3 phosphorylation.", {"entities": [[208, 213, "GENE"]]}], ["In addition, primary hepatocytes isolated from MMP19KO mice showed impaired responsiveness towards TGF-\u00df1 stimulation, resulting in lower expression of Snail1 and vimentin mRNA.", {"entities": []}], ["Thus, MMP-19-deficiency improves the development of hepatic fibrosis through the diminished replacement of physiological extracellular matrix with fibrotic deposits in the beginning of the injury, leading to subsequent changes in TGF-\u00df and IGF-1 signaling pathways.", {"entities": []}], ["To associate the nutritional status and the self-perception of nutritional status with the use of licit drugs among adolescents.", {"entities": []}], ["A cross-sectional study was conducted in which 210 adolescents answered a questionnaire on alcohol and tobacco experimentation and self-perceptions about their nutritional status.", {"entities": []}], ["The correspondence between the adolescents' perception of their own nutritional status and actual nutritional status was analyzed, as well as associations between nutritional status, self-perception of nutritional status, gender, age, and presence of smokers at home with alcohol and tobacco use.", {"entities": []}], ["The variables were analyzed separately in a bivariate analysis and, subsequently, a multivariate analysis determined the factors associated with drug use.", {"entities": []}], ["The study included 210 adolescents with a median age of 148 months; 56.6% were females.", {"entities": []}], ["Of the total sample, 6.6% have tried cigarettes, and 20% have tried alcohol; 32.3% had BMI Z -Score \u22651, 12.85% had BMI Z -Score \u22652, and 50.7% had a correct perception of his/her weight.", {"entities": []}], ["After a multivariate analysis, only the self-perception about weight statistically influenced experimentation of tobacco, and patients who identified themselves as having very high weight were more likely to experiment tobacco ( odds ratio (OR) 13.57; confidence interval (95% CI) 2.05-89.8; p =0.007); regarding alcohol use, adolescents who identified themselves as having high weight were 2.4 times more likely to experiment with alcohol than adolescents that identified themselves as having normal weight (95% CI 1.08-5.32, p =0.031).", {"entities": []}], ["Adolescents with self-perception of excess weight may constitute a risk group for alcohol and tobacco use.", {"entities": []}], ["Associar o estado nutricional e a autopercep\u00e7\u00e3o do estado nutricional com a experimenta\u00e7\u00e3o de drogas l\u00edcitas em adolescentes.", {"entities": []}], ["Estudo transversal no qual 210 adolescentes responderam a um question\u00e1rio sobre experimenta\u00e7\u00e3o de \u00e1lcool e tabaco e sobre suas autopercep\u00e7\u00f5es nutricionais.", {"entities": []}], ["Foi analisada a concord\u00e2ncia entre autopercep\u00e7\u00e3o nutricional do adolescente e seu estado nutricional, bem como associa\u00e7\u00f5es entre o estado nutricional, a autopercep\u00e7\u00e3o nutricional, sexo, idade e presen\u00e7a de tabagistas em casa com a experimenta\u00e7\u00e3o de \u00e1lcool e tabaco.", {"entities": []}], ["As vari\u00e1veis foram analisadas separadamente em an\u00e1lise bivariada e, a seguir, an\u00e1lise m\u00faltipla determinou fatores associados \u00e0 experimenta\u00e7\u00e3o.", {"entities": []}], ["Participaram do estudo 210 adolescentes com mediana de idade de 148 meses, 56,6% do sexo feminino.", {"entities": []}], ["Do total da amostra, 6,6% j\u00e1 experimentaram cigarro e 20% j\u00e1 experimentaram \u00e1lcool; 32,3% tinham Z-escore IMC\u22651 e 12,85% tinham Z-escore IMC\u22652 e 50,7% acertaram suas classifica\u00e7\u00f5es nutricionais.", {"entities": []}], ["Ap\u00f3s an\u00e1lise multivariada, apenas a autoimagem sobre o peso influenciou estatisticamente na experimenta\u00e7\u00e3o de fumo.", {"entities": []}], ["Pacientes que se identificavam com peso muito alto apresentaram maior chance de experimenta\u00e7\u00e3o de fumo ( odds ratio (OR) 13,57; intervalo de confian\u00e7a (95% IC) 2,05-89,8; p =0,007); em rela\u00e7\u00e3o ao uso de \u00e1lcool, adolescentes que se identificavam com peso alto apresentaram chance de uso de \u00e1lcool 2,40 vezes maior do que crian\u00e7as que se viam com peso normal (IC 95% 1,08-5,32; p =0,031).", {"entities": []}], ["Adolescentes com autopercep\u00e7\u00e3o de excesso de peso podem constituir um grupo de risco para a experimenta\u00e7\u00e3o de \u00e1lcool e tabaco.", {"entities": []}], ["Use of disease-modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) may prevent joint damage and potentially reduce joint replacement surgeries.", {"entities": [[58, 78, "DISEASE"], [69, 78, "DISEASE"]]}], ["We assessed the association between RA drug use and joint replacement in Quebec, Canada.", {"entities": []}], ["A cohort of new-onset RA patients was identified from Quebec\u2019s physician billing and hospitalization databases from 2002\u20132011.", {"entities": []}], ["The outcome was defined using procedure codes submitted by orthopedic surgeons.", {"entities": []}], ["Medication use was obtained from pharmacy databases.", {"entities": []}], ["We used alternative Cox regression models with time-dependent variables measuring the cumulative effects of past use during different time windows (one model focussing on the first year after cohort entry) for methotrexate (MTX), and other DMARDs.", {"entities": []}], ["Models were adjusted for baseline sociodemographics, co-morbidity and prior health service use, time-dependent cumulative use of other drugs (anti-tumor necrosis factor [anti-TNF] agents, other biologics, cyclooxygenase-2 inhibitors [COXIBs], nonselective nonsteroidal antiinflammatory drugs [NSAIDs], and systemic steroids), and markers of disease severity.", {"entities": []}], ["During follow-up, 608 joint replacements occurred among 11,333 patients (median follow-up: 4.6\u00a0years).", {"entities": []}], ["The best-fitting model relied on the cumulative early use (within the first year after cohort entry) of MTX and of other DMARDs, with an interaction between MTX and other DMARDs.", {"entities": []}], ["In this model, greater exposure within the first year, to either MTX (adjusted hazard ratio, HR\u2009=\u20090.95 per 1\u00a0month, 95\u00a0% confidence interval, 95\u00a0% CI 0.93-0.97) or other DMARDs (HR\u2009=\u20090.97, 95 % CI 0.95-0.99) was associated with longer time to joint replacement.", {"entities": [[93, 95, "GENE"], [178, 180, "GENE"], [93, 95, "GENE"], [178, 180, "GENE"]]}], ["Our results suggest that longer exposure to either methotrexate (MTX) or other DMARDs within the first year after RA diagnosis is associated with longer time to joint replacement surgery.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-015-0713-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In high-income countries, substantial differences exist in vaccine uptake relating to socioeconomic status, gender, ethnic group, geographic location and religious belief.", {"entities": []}], ["This paper updates a 2009 systematic review on effective interventions to decrease vaccine uptake inequalities in light of new technologies applied to vaccination and new vaccine programmes (eg, human papillomavirus in adolescents).", {"entities": []}], ["We searched MEDLINE, Embase, ASSIA, The Campbell Collaboration, CINAHL, The Cochrane Database of Systematic Reviews, Eppi Centre, Eric and PsychINFO for intervention, cohort or ecological studies conducted at primary/community care level in children and young people from birth to 19\u2005years in OECD countries, with vaccine uptake or coverage as outcomes, published between 2008 and 2015.", {"entities": []}], ["The 41 included studies evaluated complex multicomponent interventions (n=16), reminder/recall systems (n=18), outreach programmes (n=3) or computer-based interventions (n=2).", {"entities": []}], ["Complex, locally designed interventions demonstrated the best evidence for effectiveness in reducing inequalities in deprived, urban, ethnically diverse communities.", {"entities": []}], ["There is some evidence that postal and telephone reminders are effective, however, evidence remains mixed for text-message reminders, although these may be more effective in adolescents.", {"entities": []}], ["Interventions that escalated in intensity appeared particularly effective.", {"entities": []}], ["Computer-based interventions were not effective.", {"entities": []}], ["Few studies targeted an inequality specifically, although several reported differential effects by the ethnic group.", {"entities": []}], ["Locally designed, multicomponent interventions should be used in urban, ethnically diverse, deprived populations.", {"entities": []}], ["Some evidence is emerging for text-message reminders, particularly in adolescents.", {"entities": []}], ["Further research should be conducted in the UK and Europe with a focus on reducing specific inequalities.", {"entities": []}], ["Completing a course in Immunology is expected to improve health care knowledge (HCK), which in turn is anticipated to influence a healthy lifestyle (HLS), controlled use of health care services (HCS) and an awareness of emerging health care concerns (HCC).", {"entities": [[80, 83, "GENE"]]}], ["This cross-sectional study was designed to determine whether these interrelationships are empirically supported.", {"entities": []}], ["Participants involved in this study were government servants from two ministries in Malaysia (n = 356) and university students from a local university (n = 147).", {"entities": []}], ["Participants were selected using the non-random purposive sampling method.", {"entities": []}], ["Data were collected using a self-developed questionnaire, which had been validated in a pilot study involving similar subjects.", {"entities": []}], ["The questionnaire items were analyzed using Rasch analysis, SPSS version 21 and AMOS version 22.", {"entities": []}], ["Results have shown that participants who followed a course in Immunology (CoI) had a higher primary HCK (Mean = 0.69 logit, SD = 1.29 logits) compared with those who had not (Mean = -0.27logit, SD = 1.26 logits).", {"entities": [[100, 103, "GENE"]]}], ["Overall, there were significant correlations among the HLS, the awareness of emerging HCC, and the controlled use of HCS ( p <0.001).", {"entities": []}], ["However, no significant correlations were observed between primary HCK and the other variables.", {"entities": [[67, 70, "GENE"]]}], ["However, significant positive correlation was observed between primary HCK and controlled use of HCS for the group without CoI.", {"entities": [[71, 74, "GENE"]]}], ["Path analysis showed that the awareness of emerging HCC exerted a positive influence on controlled use of HCS (\u03b2 = 0.156, p < .001) and on HLS (\u03b2 = 0.224, p < .001).", {"entities": []}], ["These findings suggest that having CoI helps increase primary HCK which influences controlled use of HCS but does not necessarily influence HLS.", {"entities": [[62, 65, "GENE"]]}], ["Hence, introducing Immunology at various levels of education and increasing the public awareness of emerging HCC might help to improve population health en masse .", {"entities": []}], ["In addition, further investigations on the factors affecting HLS is required to provide a better understanding on the relationship between primary HCK and HLS.", {"entities": [[147, 150, "GENE"]]}], ["Objectives To derive and validate a new clinical risk prediction algorithm (QThrombosis, www.qthrombosis.org ) to estimate individual patients\u2019 risk of venous thromboembolism.", {"entities": []}], ["Design Prospective open cohort study using routinely collected data from general practices.", {"entities": []}], ["Cox proportional hazards models used in derivation cohort to derive risk equations evaluated at 1 and 5 years.", {"entities": []}], ["Measures of calibration and discrimination undertaken in validation cohort.", {"entities": []}], ["Setting 564 general practices in England and Wales contributing to the QResearch database.", {"entities": []}], ["Participants Patients aged 25-84 years, with no record of pregnancy in the preceding 12 months or any previous venous thromboembolism, and not prescribed oral anticoagulation at baseline: 2\u2009314\u2009701 in derivation cohort and 1\u2009240\u2009602 in validation cohort.", {"entities": []}], ["Outcomes Incident cases of venous thromboembolism, either deep vein thrombosis or pulmonary embolism, recorded in primary care records or linked cause of death records.", {"entities": [[82, 100, "DISEASE"]]}], ["Results The derivation cohort included 14\u2009756 incident cases of venous thromboembolism from 10\u2009095\u2009199 person years of observation (rate of 14.6 per 10\u2009000 person years).", {"entities": []}], ["The validation cohort included 6913 incident cases from 4\u2009632\u2009694 person years of observation (14.9 per 10\u2009000 person years).", {"entities": []}], ["Independent predictors included in the final model for men and women were age, body mass index, smoking status, varicose veins, congestive cardiac failure, chronic renal disease, cancer, chronic obstructive pulmonary disease, inflammatory bowel disease, hospital admission in past six months, and current prescriptions for antipsychotic drugs.", {"entities": [[226, 252, "DISEASE"], [187, 224, "DISEASE"], [112, 126, "DISEASE"], [179, 185, "DISEASE"]]}], ["We also included oral contraceptives, tamoxifen, and hormone replacement therapy in the final model for women.", {"entities": []}], ["The risk prediction equation explained 33% of the variation in women and 34% in men in the validation cohort evaluated at 5 years The D statistic was 1.43 for women and 1.45 for men.", {"entities": []}], ["The receiver operating curve statistic was 0.75 for both sexes.", {"entities": []}], ["The model was well calibrated.", {"entities": []}], ["Conclusions We have developed and validated a new risk prediction model that quantifies absolute risk of thrombosis at 1 and 5 years.", {"entities": []}], ["It can help identify patients at high risk of venous thromboembolism for prevention.", {"entities": []}], ["The algorithm is based on simple clinical variables which the patient is likely to know or which are routinely recorded in general practice records.", {"entities": []}], ["The algorithm could be integrated into general practice clinical computer systems and used to risk assess patients before hospital admission or starting medication which might increase the risk of venous thromboembolism.", {"entities": []}], ["Diabetes mellitus is highly prevalent and can lead to serious complications and mortality.", {"entities": []}], ["Patient education can help to avoid negative outcomes, but up to half of the patients do not participate.", {"entities": []}], ["The aim of this study was to analyze patients' attitudes towards diabetes education in order to identify barriers to participation and develop strategies for better patient education.", {"entities": []}], ["We conducted a qualitative study.", {"entities": []}], ["Seven GP practices were purposively selected based on socio-demographic data of city districts in Hamburg, Germany.", {"entities": []}], ["Study participants were selected by their GPs in order to increase participation.", {"entities": []}], ["Semi-structured face-to-face interviews were conducted with 14 patients.", {"entities": []}], ["Interviews were audiotaped and transcribed verbatim.", {"entities": []}], ["The sample size was determined by data saturation.", {"entities": []}], ["Data were analysed by qualitative content analysis.", {"entities": []}], ["Categories were determined deductively and inductively.", {"entities": []}], ["The interviews yielded four types of barriers: 1) Statements and behaviour of the attending physician influence the patients' decisions about diabetes education.", {"entities": []}], ["2) Both, a good state of health related to diabetes and physical/psychosocial comorbidity can be reasons for non-participation.", {"entities": []}], ["3) Manifold motivational factors were discussed.", {"entities": []}], ["They ranged from giving low priority to diabetes to avoidance of implications of diabetes education as being confronted with illness narratives of others.", {"entities": []}], ["4) Barriers also include aspects of the patients' knowledge and activity.", {"entities": []}], ["First, physicians should encourage patients to participate in diabetes education and argue that they can profit even if actual treatment and examination results are promising.", {"entities": []}], ["Second, patients with other priorities, psychic comorbidity or functional limitations might profit more from continuous individualized education adapted to their specific situation instead of group education.", {"entities": []}], ["Third, it might be justified that patients do not participate in diabetes education if they have slightly increased blood sugar values only and no risk for harmful consequences or if they already have sufficient knowledge on diabetes.", {"entities": []}], ["Filaggrin is a major protein in the epidermis.", {"entities": []}], ["Several mutations in the filaggrin gene ( FLG ) have been associated with a number of conditions.", {"entities": [[42, 45, "GENE"]]}], ["Filaggrin is expressed in the tympanic membrane and could alter its mechanical properties, but the relationship between genetic variation in FLG and hearing has not yet been tested.", {"entities": [[141, 144, "GENE"]]}], ["We examined whether loss-of function mutations R501X and 2282del4 in the FLG gene affected hearing in children.", {"entities": [[73, 76, "GENE"]]}], ["Twenty eight hearing variables representing five different aspects of hearing at age nine years in 5,377 children from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort were tested for association with these mutations.", {"entities": []}], ["No evidence of association was found between R501X or 2282del4 (or overall FLG mutation carrier status) and any of the hearing phenotypes analysed.", {"entities": [[75, 78, "GENE"]]}], ["In conclusion, carrier status for common filaggrin mutations does not affect hearing in children.", {"entities": []}], ["To investigate the impact of whole body C5a receptor (C5aR) deficiency on energy metabolism and fat storage.", {"entities": []}], ["Male wildtype (WT) and C5aR knockout (C5aRKO) mice were fed a low fat (CHOW) or a high fat high sucrose diet-induced obesity (DIO) diet for 14 weeks.", {"entities": [[117, 124, "DISEASE"]]}], ["Body weight and food intake were measured weekly.", {"entities": []}], ["Indirect calorimetry, dietary fatload clearance, insulin and glucose tolerance tests were also evaluated.", {"entities": []}], ["Liver, muscle and adipose tissue mRNA gene expression were measured by RT-PCR.", {"entities": []}], ["At week one and 12, C5aRKO mice on DIO had increased oxygen consumption.", {"entities": []}], ["After 12 weeks, although food intake was comparable, C5aRKO mice had lower body weight (\u22127% CHOW, \u221212% DIO) as well as smaller gonadal (\u221238% CHOW, \u221236% DIO) and inguinal (\u221229% CHOW, \u221230% DIO) fat pads than their WT counterparts.", {"entities": []}], ["Conversely, in WT mice, C5aR was upregulated in DIO vs CHOW diets in gonadal adipose tissue, muscle and liver, while C5L2 mRNA expression was lower in C5aRKO on both diet.", {"entities": []}], ["Furthermore, blood analysis showed lower plasma triglyceride and non-esterified fatty acid levels in both C5aRKO groups, with faster postprandial triglyceride clearance after a fatload.", {"entities": []}], ["Additionally, C5aRKO mice showed lower CD36 expression in gonadal and muscle on both diets, while DGAT1 expression was higher in gonadal (CHOW) and liver (CHOW and DIO) and PPAR \u03b3 was increased in muscle and liver.", {"entities": [[39, 43, "GENE"], [98, 103, "GENE"]]}], ["These observations point towards a role (either direct or indirect) for C5aR in energy expenditure and fat storage, suggesting a dual role for C5aR in metabolism as well as in immunity.", {"entities": []}], ["Human rhinoviruses (HRVs) are responsible for more than half of all cases of the common cold and cost billions of USD annually in medical visits and missed school and work.", {"entities": [[81, 92, "DISEASE"]]}], ["An assessment was made of the antiviral activities and mechanisms of action of paeonol (PA) and 1,2,3,4,6-penta- O -galloyl-\u03b2-D-glucopyranose (PGG) from Paeonia lactiflora root toward HRV-2 and HRV-4 in MRC5 cells using a tetrazolium method and real-time quantitative reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assay.", {"entities": []}], ["Results were compared with those of a reference control ribavirin.", {"entities": []}], ["Based on 50% inhibitory concentration values, PGG was 13.4 and 18.0 times more active toward HRV-2 (17.89 \u03bcM) and HRV-4 (17.33 \u03bcM) in MRC5 cells, respectively, than ribavirin.", {"entities": []}], ["The constituents had relatively high selective index values (3.3\u2013>8.5).", {"entities": []}], ["The 100 \u03bcg/mL PA and 20 \u03bcg/mL PGG did not interact with the HRV-4 particles.", {"entities": []}], ["These constituents inhibited HRV-4 infection only when they were added during the virus inoculation (0 h), the adsorption period of HRVs, but not after 1 h or later.", {"entities": []}], ["Moreover, the RNA replication levels of HRVs were remarkably reduced in the MRC5 cultures treated with these constituents.", {"entities": []}], ["These findings suggest that PGG and PA may block or reduce the entry of the viruses into the cells to protect the cells from the virus destruction and abate virus replication, which may play an important role in interfering with expressions of rhinovirus receptors (intercellular adhesion molecule-1 and low-density lipoprotein receptor), inflammatory cytokines (interleukin (IL)-6, IL-8, tumor necrosis factor, interferon beta, and IL-1\u03b2), and Toll-like receptor, which resulted in diminishing symptoms induced by HRV.", {"entities": []}], ["Global efforts to reduce the level of synthetic drugs justify further studies on P .", {"entities": []}], ["lactiflora root-derived materials as potential anti-HRV products or lead molecules for the prevention or treatment of HRV.", {"entities": []}], ["The aims of this study were to verify the feasibility of respiratory function tests and to assess their validity in the diagnosis of respiratory disorders in young children.", {"entities": []}], ["We performed spirometry and collected information on health and parents' lifestyle on a sample of 960 children aged 3\u20136.", {"entities": []}], ["The cooperation rate was 95.3%.", {"entities": []}], ["Among the valid tests, 3 or more acceptable curves were present in 93% of cases.", {"entities": []}], ["The variability was 5% within subjects in 90.8% of cases in all the parameters.", {"entities": []}], ["We propose regression equations for FVC (Forced Vital Capacity), FEV1, FEV0.5, FEV0.75 (Forced Expiratory Volume in one second, in half a second and in 3/4 of a second), and for Maximum Expiratory Flows at different lung volume levels (MEF75, 50, 25).", {"entities": []}], ["All parameters are consistent with the main reference values reported in literature.", {"entities": []}], ["The discriminating ability of respiratory parameters versus symptoms always shows a high specificity (>95%) and a low sensitivity (<20%) with the highest OR (10.55; IC95% 4.42\u201325.19) for MEF75.", {"entities": []}], ["The ability of FEV0.75 to predict FEV1 was higher than that of FEV0.50: FEV0.75 predicts FEV1 with a determination coefficient of 0.95.", {"entities": []}], ["Our study confirms the feasibility of spirometry in young children; however some of the current standards are not well suited to this age group.", {"entities": []}], ["Moreover, in this restricted age group the various reference values have similar behaviour.", {"entities": []}], ["Several studies have reported the prevalence of tinnitus among general populations; however, most of these studies were conducted in Europe or the United States.", {"entities": []}], ["We estimated the prevalence of tinnitus among the general adult population in Japan.", {"entities": []}], ["The subjects were participants in the Takayama Study, a population-based cohort study.", {"entities": []}], ["In 2002, a total of 14 423 adults (6450 men and 7973 women) aged 45 to 79 years responded to a self-administered questionnaire that inquired about history of tinnitus, which was defined as episodes lasting longer than 5 minutes, excluding those occurring immediately after noise exposure.", {"entities": []}], ["Respondents were also asked about the loudness and severity of tinnitus.", {"entities": []}], ["Overall, 11.9% of the subjects reported having tinnitus; the percentage was somewhat higher among men (13.2%) than women (10.8%).", {"entities": []}], ["The prevalence of tinnitus increased with age in both sexes.", {"entities": []}], ["Approximately 0.4% of the overall population reported that tinnitus had a severe effect on their ability to lead a normal life.", {"entities": []}], ["Medical history of hypertension or ischemic heart diseases, use of steroid or antihypertensive medication, and employment as a factory worker or machine operator were associated with tinnitus status in both men and women.", {"entities": [[19, 31, "DISEASE"]]}], ["Tinnitus is relatively common in Japan.", {"entities": []}], ["Although the use of various definitions of tinnitus in different studies makes it difficult to compare prevalence among populations, the present prevalence estimate was similar to those in studies in Europe and the United States.", {"entities": []}], ["Intracellular bacterium, Mycobacterium tuberculosis ( M. tb ), infects specifically macrophages as host cells.", {"entities": [[39, 51, "DISEASE"]]}], ["IRAK-M, a member of IRAK family, is a negative regulator in TLR signaling and specifically expresses in monocytes and macrophages.", {"entities": []}], ["The role of IRAK-M in intracellular growth of M. tb and macrophage polarization was explored, for deeply understanding the pathogenesis of M. tb , the significance of IRAK-M to innate immunity and pathogen-host interaction.", {"entities": []}], ["IRAK-M expression was detected in M. tb infected macrophages and in human lung tissue of pulmonary tuberculosis with immunofluorescence staining, Western blot and immunohistochemistry.", {"entities": [[99, 111, "DISEASE"], [89, 111, "DISEASE"]]}], ["IRAK-M knock-down and over-expressing cell strains were constructed and intracellular survival of M. tb was investigated by acid-fast staining and colony forming units.", {"entities": []}], ["Molecular markers of M1-type (pSTAT1 and iNOS) and M2-type (pSTAT6 and Arg-1) macrophages were detected using Western blot in IRAK-M knockdown U937 cells infected with M. tb H37Rv.", {"entities": []}], ["U937 cells were stimulated with immunostimulant CpG7909 into M1 status and then infected with M. tb H37Rv.", {"entities": []}], ["Expression of IRAK-M, IRAK-4 and iNOS was detected with immunofluorescence staining and Western blot, to evaluate the effect of IRAK-M to CpG directed M1-type polarization of macrophages during M. tb infection.", {"entities": []}], ["Molecules related with macrophage\u2019s bactericidal ability such as Hif-1 and phosphorylated ERK1/2 were detected with immunohistochemistry and Western blot.", {"entities": []}], ["IRAK-M increased in M. tb infected macrophage cells and also in human lung tissue of pulmonary tuberculosis.", {"entities": [[95, 107, "DISEASE"], [85, 107, "DISEASE"]]}], ["IRAK-M over-expression resulted in higher bacterial load, while IRAK-M interference resulted in lower bacterial load in M. tb infected cells.", {"entities": []}], ["During M. tb infection, IRAK-M knockdown induced M1-type, while inhibited M2-type polarization of macrophage.", {"entities": []}], ["M1-type polarization of U937 cells induced by CpG7909 was inhibited by M. tb infection, which was reversed by IRAK-M knockdown in U937 cells.", {"entities": []}], ["IRAK-M affected Hif-1 and MAPK signaling cascade during M. tb infection.", {"entities": []}], ["Conclusively, IRAK-M might alter the polarity of macrophages, to facilitate intracellular survival of M. tb and affect Th1-type immunity of the host, which is helpful to understanding the pathogenesis of M. tb .", {"entities": []}], ["Tumour necrosis factor-alpha ( TNF-\u03b1 )- 308 promoter gene polymorphism has been shown to be associated with several autoimmune disorders and infections such as tuberculosis.", {"entities": [[160, 172, "DISEASE"]]}], ["There is no study on TNF-\u03b1 gene polymorphism in Takayasu's arteritis (TA) till date.", {"entities": []}], ["We aimed to study this polymorphism in TA, a granulomatous vasculitis, probably triggered by Mycobacterium tuberculosis .", {"entities": [[107, 119, "DISEASE"], [59, 69, "DISEASE"]]}], ["TNF-\u03b1 - 308 gene polymorphism was studied in 34 patients with TA and 39 healthy controls recruited from Christian Medical College, India.", {"entities": []}], ["PCR was done followed by enzyme digestion.", {"entities": []}], ["G and A polymorphisms were analysed.", {"entities": []}], ["Occurrence of alleles in the disease group was compared with controls as well as with historical controls.", {"entities": []}], ["GG allele was most frequent in TA and in controls.", {"entities": []}], ["GA allele was detected in four controls but only in one patient who was the oldest in the study group.", {"entities": []}], ["AA polymorphism was detected in one control but not in TA.", {"entities": []}], ["When compared with controls from other populations, it was found that our allelic frequency was similar to that in Japan as well as from USA with mixed population.", {"entities": []}], ["However, predominantly Caucasian population studied from Netherlands, Germany and England, where TA is rare, had a higher frequency of A allele as compared to our controls.", {"entities": []}], ["Our preliminary results indicated that G allele at TNF-\u03b1 - 308 was more common in TA patients and controls similar to that in other Indian as well as Japanese population.", {"entities": []}], ["Compared to the western population, A allele was relatively less common in our study subjects.", {"entities": []}], ["\u2018Big data\u2019 are accumulating in a multitude of domains and offer novel opportunities for research.", {"entities": []}], ["The role of these resources in mental health investigations remains relatively unexplored, although a number of datasets are in use and supporting a range of projects.", {"entities": []}], ["We sought to review big data resources and their use in mental health research to characterise applications to date and consider directions for innovation in future.", {"entities": []}], ["A narrative review.", {"entities": []}], ["Clear disparities were evident in geographic regions covered and in the disorders and interventions receiving most attention.", {"entities": []}], ["We discuss the strengths and weaknesses of the use of different types of data and the challenges of big data in general.", {"entities": []}], ["Current research output from big data is still predominantly determined by the information and resources available and there is a need to reverse the situation so that big data platforms are more driven by the needs of clinical services and service users.", {"entities": []}], ["Adhesion of leukocytes to endothelial cells plays an important role in neuroinflammation.", {"entities": []}], ["Therefore, suppression of the expression of adhesion molecules in brain endothelial cells may inhibit neuroinflammation.", {"entities": []}], ["Chrysin (5,7-dihydroxyflavone) is a flavonoid component of propolis, blue passion flowers, and fruits.", {"entities": []}], ["In the present study, we examined the effects of chrysin on lipopolysaccharide (LPS)-induced expression of vascular cell adhesion molecule-1 (VCAM-1) in mouse cerebral vascular endothelial (bEnd.3) cells.", {"entities": []}], ["In bEnd.3 cells, LPS increased mRNA expression of VCAM-1 in a time-dependent manner, and chrysin significantly decreased LPS-induced mRNA expression of VCAM-1.", {"entities": []}], ["Chrysin also reduced VCAM-1 protein expression in a concentration-dependent manner.", {"entities": []}], ["Furthermore, chrysin blocked adhesion of monocytes to bEnd.3 cells exposed to LPS.", {"entities": []}], ["Nuclear factor-\u03baB (NF-\u03baB), p38 mitogen-activated protein kinase (MAPK), and c-Jun N-terminal kinase, which are all activated by LPS, were significantly inhibited by chrysin.", {"entities": []}], ["These results indicate that chrysin inhibits the expression of VCAM-1 in brain endothelial cells by inhibiting NF-\u03baB translocation and MAPK signaling, resulting in the attenuation of leukocyte adhesion to endothelial cells.", {"entities": []}], ["The anti-inflammatory effects of chrysin suggest a possible therapeutic application of this agent to neurodegenerative diseases, such as multiple sclerosis, septic encephalopathy, and allergic encephalomyelitis.", {"entities": [[137, 155, "DISEASE"], [193, 210, "DISEASE"]]}], ["Objective .", {"entities": []}], ["To evaluate whether serum titers of second-generation anticyclic citrullinated peptide antibodies (anti-CCP2) are associated with the severity and extent of interstitial lung disease in rheumatoid arthritis (RA-ILD).", {"entities": [[186, 206, "DISEASE"], [157, 182, "DISEASE"], [197, 206, "DISEASE"], [170, 182, "DISEASE"]]}], ["In across-sectional study, 39 RA-ILD patients confirmed by high-resolution computed tomography (HRCT) were compared with 42 RA without lung involvement (RA only).", {"entities": []}], ["Characteristics related to RA-ILD were assessed in all of the patients and serum anti-CCP2 titers quantified.", {"entities": []}], ["Higher anti-CCP2 titers were found in RA-ILD compared with RA only (medians 77.9 versus 30.2\u2009U/mL, P < 0.001).", {"entities": []}], ["In the logistic regression analysis after adjustment for age, disease duration (DD), smoke exposure, disease activity, functioning, erythrocyte sedimentation rate, and methotrexate (MTX) treatment duration, the characteristics associated with RA-ILD were higher anti-CCP2 titers ( P = 0.003) and + RF ( P = 0.002).", {"entities": []}], ["In multivariate linear regression, the variables associated with severity of ground-glass score were anti-CCP2 titers ( P = 0.02) and with fibrosis score DD ( P = 0.01), anti-CCP2 titers ( P < 0.001), and MTX treatment duration ( P < 0.001).", {"entities": []}], ["Conclusions .", {"entities": []}], ["Anti-CCP2 antibodies are markers of severity and extent of RA-ILD in HRCT.", {"entities": []}], ["Further longitudinal studies are required to identify if higher anti-CCP2 titers are associated with worst prognosis in RA-ILD.", {"entities": []}], ["Sampling of airborne ragweed and other pollen grains in the City of New York is described as it took place during the months of August and September 1973.", {"entities": []}], ["Three sampling stations participated in the program.", {"entities": []}], ["This effort was meant to serve as the forerunner of a citywide volunteer pollen sampling network based on the cooperation of existing health care providing institutions, schools, and stations of the operational sampling network of the New York City Department of Air Resources.", {"entities": []}], ["Monitoring stations were set up on the roof of Cooper Union School of Engineering at 51 Astor Place in downtown Manhattan, at the Boyce Thompson Institute for Plant Research, Inc. at Yonkers, N.Y. and use was made of the data supplied by Middlesex General Hospital, New Brunswick, N.J.", {"entities": []}], ["Seasonal results of ragweed pollen sampling, undertaken at the downtown New York City location of Cooper Union with the swing-shield intermittant rotoslide sampler, are similar to those of studies undertaken in the 1940's and 1950's with the Durham slide sampler in the New York metropolitan area.", {"entities": []}], ["Comparison of the collected data with converted data obtained in 1979 at Long Island Jewish-Hillside Medical Center with the aid of a Durham gravity slide sampler shows the trend similarity of the data collected by us in 1973 and those obtained in 1979.", {"entities": []}], ["Collected data of the 1973 ragweed season were supplied to the New York City news media on a daily basis, as a much appreciated service to the public.", {"entities": []}], ["Little is known about the significance of haemoglobin genotype in dengue fever severity.", {"entities": []}], ["This study was undertaken to determine the case fatality ratio and the impact of genotype in patients with sickle cell disease and confirmed dengue fever.", {"entities": []}], ["This retrospective analysis included 40 patients with confirmed dengue and sickle cell disease, during the study period (2010\u20132012).", {"entities": []}], ["There was a significantly higher case fatality ratio, 12.5% among patients with either haemoglobin SC disease or homozygous SS disease when compared to that of the general population 0.41% (p\u00a0<\u00a00.0001).", {"entities": []}], ["The unadjusted odds of dying among those with haemoglobin SC disease compared with the group with homozygous SS disease was OR\u00a0=\u00a04.4 (95% CI 0.6 to 31.7).", {"entities": []}], ["The predictors of mortality independent of sickle cell disease genotype were haemoglobin concentration at presentation OR\u00a0=\u00a00.57 (95% CI, 0.35 to 0.94) and the change in haemoglobin concentration from steady state OR\u00a0=\u00a00.59 (95% CI, 0.37 to 0.94).", {"entities": []}], ["Adjusting for haemoglobin concentration at presentation increased the risk of death for the SC genotype relative to SS genotype OR\u00a0=\u00a013.4 (95% CI 1.1 to 160.3).", {"entities": []}], ["The risk of fatal dengue may be higher among patients with a relatively mild genotype (haemoglobin SC).", {"entities": []}], ["\u2022 Dengue Fever case fatality ratio was 12.5%( p\u00a0<\u00a00.0001) in persons with Sickle Cell Disease.", {"entities": []}], ["\u2022 The odds of dying from dengue and SC disease was 4.4 (95% CI 0.6 to 31.7).", {"entities": []}], ["Dengue Fever case fatality ratio was 12.5%( p\u00a0<\u00a00.0001) in persons with Sickle Cell Disease.", {"entities": []}], ["The odds of dying from dengue and SC disease was 4.4 (95% CI 0.6 to 31.7).", {"entities": []}], ["Pathogen detection using DNA microarrays has the potential to become a fast and comprehensive diagnostics tool.", {"entities": []}], ["However, since pathogen detection chips currently utilize random primers rather than specific primers for the RT-PCR step, bias inherent in random PCR amplification becomes a serious problem that causes large inaccuracies in hybridization signals.", {"entities": []}], ["In this paper, we study how the efficiency of random PCR amplification affects hybridization signals.", {"entities": []}], ["We describe a model that predicts the amplification efficiency of a given random primer on a target viral genome.", {"entities": []}], ["The prediction allows us to filter false-negative probes of the genome that lie in regions of poor random PCR amplification and improves the accuracy of pathogen detection.", {"entities": []}], ["Subsequently, we propose LOMA, an algorithm to generate random primers that have good amplification efficiency.", {"entities": []}], ["Wet-lab validation showed that the generated random primers improve the amplification efficiency significantly.", {"entities": []}], ["The blind use of a random primer with attached universal tag (random-tagged primer) in a PCR reaction on a pathogen sample may not lead to a successful amplification.", {"entities": []}], ["Thus, the design of random-tagged primers is an important consideration when performing PCR.", {"entities": []}], ["This study investigated the role of the JAK2/STAT3/SOCS pathway in type 2 diabetes mellitus (T2DM) and macrovascular complications (DV) (T2DM+DV) conditions.", {"entities": [[74, 91, "DISEASE"], [67, 91, "DISEASE"]]}], ["Human umbilical vein endothelial cells (HUVECs) were co-cultured with human monocytes (THP-1) and exposed to peripheral blood sera from 30 T2DM patients, 30 patients with T2DM+DV and 30 healthy controls; the groups were divided into the control, T2DM, DV, T2DM+AG490 and DV+AG490 groups.", {"entities": []}], ["Chemotaxis of treated HUVECs toward THP-1 cells was assessed using Transwell migration.", {"entities": []}], ["The mRNA expression of JAK2, STAT3, VEGF and FLT1 was evaluated using RT-PCR, whereas the protein levels of ICAM-1, p-JAK2, JAK2, STAT3, p-STAT3, SOCS1 and SOCS3 were determined using western blotting.", {"entities": [[23, 27, "GENE"], [118, 122, "GENE"], [124, 128, "GENE"], [29, 34, "GENE"], [130, 135, "GENE"], [139, 144, "GENE"], [45, 49, "GENE"], [23, 27, "GENE"], [118, 122, "GENE"], [124, 128, "GENE"], [29, 34, "GENE"], [130, 135, "GENE"], [139, 144, "GENE"], [146, 151, "GENE"], [156, 161, "GENE"]]}], ["p-STAT3 was observed using immunofluorescence.", {"entities": []}], ["The IL-1\u03b2 concentrations were assessed by ELISA.", {"entities": []}], ["AG90 was used as a specific inhibitor of JAK2/STAT3 signaling.", {"entities": []}], ["The chemotaxis assays revealed a migratory order of DV>DM>control, and AG490 treatment decreased chemotaxis.", {"entities": []}], ["Additionally, p-STAT3 fluorescence was noticeably increased in the DM group and more so in the DV group.", {"entities": []}], ["The mRNA expression of JAK2, STAT3, VEGF and FLT1 and the protein levels of ICAM-1, p-JAK2, p-STAT3, SOCS1 and SOCS3 were significantly higher in the T2DM and DV groups than in the control group and in the AG490-treated groups than in the untreated groups.", {"entities": [[23, 27, "GENE"], [86, 90, "GENE"], [29, 34, "GENE"], [94, 99, "GENE"], [45, 49, "GENE"], [101, 106, "GENE"], [111, 116, "GENE"]]}], ["The supernatant concentrations of IL-1\u03b2 in the DV and T2DM groups were higher than those in the control group, and treatment with AG490 decreased the IL-1\u03b2 concentration.", {"entities": []}], ["The JAK2/STAT3/SOCS axis contributes to the development of DV by mediating inflammation associated with vascular endothelial cells and/or monocytes.", {"entities": []}], ["This study aimed to determine which coping strategies are associated with better quality of life (QOL) in adolescents with asthma.", {"entities": [[123, 129, "DISEASE"]]}], ["Furthermore, because coping can mediate the effects of health stressors on QOL, this study also examined the indirect effect of asthma severity on QOL via coping.", {"entities": [[128, 134, "DISEASE"]]}], ["Between January and May 2003, 553 Dutch adolescents with asthma (aged 12\u20136 years) completed questionnaires assessing coping strategies, symptom severity, overall QOL and positive QOL domain (positive effects of asthma domain).", {"entities": [[57, 63, "DISEASE"], [211, 217, "DISEASE"]]}], ["The relations between symptom severity, coping strategies and QOL were tested with structural equation modelling (SEM).", {"entities": []}], ["Symptom severity affected overall and positive QOL, both directly and indirectly via coping.", {"entities": []}], ["The coping strategies restricted lifestyle and worrying about asthma were associated with poorer overall QOL.", {"entities": [[62, 68, "DISEASE"]]}], ["The use of the coping strategies restricted lifestyle , positive reappraisal , and information seeking was related to increased scores on the positive QOL domain, whereas hiding asthma was related to lower scores on the positive QOL domain.", {"entities": [[178, 184, "DISEASE"]]}], ["The findings of this study suggest that coping mediates the effect of symptoms of asthma on QOL among adolescents with asthma.", {"entities": [[82, 88, "DISEASE"], [119, 125, "DISEASE"]]}], ["Several suggestions for interventions to improve asthma-specific QOL are discussed.", {"entities": [[49, 55, "DISEASE"]]}], ["Appropriate in utero growth is essential for offspring development and is a critical contributor to long-term health.", {"entities": []}], ["Fetal growth is largely dictated by the availability of nutrients in maternal circulation and the ability of these nutrients to be transported into fetal circulation via the placenta.", {"entities": []}], ["Substrate flux across placental gradients is dependent on the accessibility and activity of nutrient-specific transporters.", {"entities": []}], ["Changes in the expression and activity of these transporters is implicated in cases of restricted and excessive fetal growth, and may represent a control mechanism by which fetal growth rate attempts to match availability of nutrients in maternal circulation.", {"entities": []}], ["This review provides an overview of placenta nutrient transport with an emphasis on macro-nutrient transporters.", {"entities": []}], ["It highlights the changes in expression and activity of these transporters associated with common pregnancy pathologies, including intrauterine growth restriction, macrosomia, diabetes and obesity, as well as the potential impact of maternal diet.", {"entities": [[189, 196, "DISEASE"]]}], ["Molecular signaling pathways linking maternal nutrient availability and placenta nutrient transport are discussed.", {"entities": []}], ["How sexual dimorphism affects fetal growth strategies and the placenta\u2019s response to an altered intrauterine environment is considered.", {"entities": []}], ["Further knowledge in this area may be the first step in the development of targeted interventions to help optimize fetal growth.", {"entities": []}], ["Adherence to inhalation therapy is a critical determinant of the success of chronic obstructive pulmonary disease (COPD) management.", {"entities": [[76, 113, "DISEASE"]]}], ["However, in practice, nonadherence to inhalation therapy is very common in COPD patients.", {"entities": []}], ["The effects of adherence to inhalation therapy in COPD have not been fully studied, and less is known about the relationship between medication adherence and quality of life in COPD.", {"entities": []}], ["Our aim is to assess the factors that contribute to adherence to inhalation therapy and examine their correlation with quality of life.", {"entities": []}], ["A cross-sectional analysis of 88 COPD patients was performed using a self-reported adherence questionnaire with responses on a 5-point Likert scale.", {"entities": []}], ["Of the 88 patients who were potential participants, 55 (63%) responded with usable information.", {"entities": []}], ["The only significant factor associated with the overall mean adherence score was receiving repeated instruction about inhalation techniques ( P = 0.032).", {"entities": []}], ["Of the 55 respondents, 22 (40.0%) were given repeated verbal instruction and/or demonstrations of inhalation technique by a respiratory physician.", {"entities": []}], ["Significant correlations were found between the overall mean adherence score and the health-related quality of life score (St George\u2019s Respiratory Questionnaire: total, r = \u22120.35, P = 0.023; symptoms, r = \u22120.43, P = 0.002; impacts, r = \u22120.35, P = 0.011).", {"entities": []}], ["Furthermore, patients with repeated instruction showed better quality of life scores than those who did not receive instruction (total, P = 0.030; symptoms, P = 0.038; impacts, P = 0.019).", {"entities": []}], ["Repeated instruction for inhalation techniques may contribute to adherence to therapeutic regimens, which relates to better health status in COPD.", {"entities": []}], ["Food allergy is estimated to affect 3\u20134% of adults in the US, but there are limited educational resources for primary care physicians.", {"entities": [[0, 12, "DISEASE"]]}], ["The goal of this study was to develop and pilot a food allergy educational resource based upon a needs survey of non-allergist healthcare providers.", {"entities": [[50, 62, "DISEASE"]]}], ["A survey was undertaken to identify educational needs and preferences for providers, with a focus on physicians caring for adults and teenagers, including emergency medicine providers.", {"entities": []}], ["The results of the survey were used to develop a teaching program that was subsequently piloted on primary care and emergency medicine physicians.", {"entities": []}], ["Knowledge base tests and satisfaction surveys were administered to determine the effectiveness of the educational program.", {"entities": []}], ["Eighty-two physicians (response rate, 65%) completed the needs assessment survey.", {"entities": []}], ["Areas of deficiency and educational needs identified included: identification of potentially life-threatening food allergies, food allergy diagnosis, and education of patients about treatment (food avoidance and epinephrine use).", {"entities": [[126, 138, "DISEASE"]]}], ["Small group, on-site training was the most requested mode of education.", {"entities": []}], ["A slide set and narrative were developed to address the identified needs.", {"entities": []}], ["Twenty-six separately enrolled participants were administered the teaching set.", {"entities": []}], ["Pre-post knowledge base scores increased from a mean of 38% correct to 64% correct (p < 0.001).", {"entities": []}], ["Ability to correctly demonstrate the use of epinephrine self injectors increased significantly.", {"entities": []}], ["Nearly all participants (>95%) indicated that the teaching module increased their comfort with recognition and management of food allergy.", {"entities": [[125, 137, "DISEASE"]]}], ["Our pilot food allergy program, developed based upon needs assessments, showed strong participant satisfaction and educational value.", {"entities": [[10, 22, "DISEASE"]]}], ["Objective To obtain in-depth information about the views of patients and physicians on suffering in patients who requested euthanasia in whom the request was not granted or granted but not performed.", {"entities": []}], ["Design In-depth interviews with a topic list.", {"entities": []}], ["Setting Patients\u2019 homes and physicians\u2019 offices.", {"entities": []}], ["Participants 10 patients who explicitly requested euthanasia but whose request was not granted or performed and eight physicians of these patients; and eight physicians of patients who had requested euthanasia but had died before the request had been granted or performed or had died after the request was refused by the physician or after the patient had withdrawn his or her request.", {"entities": []}], ["Results Not all patients who requested euthanasia thought their suffering was unbearable, although they had a lasting wish to die.", {"entities": []}], ["Patients and physicians seemed to agree about this.", {"entities": []}], ["In cases in which patients said they suffered unbearably there was less agreement about what constitutes unbearable suffering; patients put more emphasis on psychosocial suffering, such as dependence and deterioration, whereas physicians referred more often to physical suffering.", {"entities": []}], ["In some cases the physician thought that the suffering was not unbearable because the patient\u2019s behaviour seemed incompatible with unbearable suffering\u2014for instance, because the patient was still reading books.", {"entities": []}], ["Conclusions Patients do not always think that their suffering is unbearable, even if they have a lasting wish to die.", {"entities": []}], ["Physicians seem to have a narrower perspective on unbearable suffering than patients and than case law suggests.", {"entities": []}], ["In an attempt to solve the problem of different perspectives, physicians should take into account the different aspects of suffering as described in the literature and a framework for assessing the suffering of patients who ask for euthanasia.", {"entities": []}], ["Considering that physical activity is associated with healthy ageing and helps to delay, prevent, or manage a plethora of non-communicable diseases in older adults, there is a need to investigate the factors that influence physical activity participation in this population.", {"entities": []}], ["Thus, we investigated physical activity correlates among community-dwelling older adults (aged \u226550 years) in six low- and middle-income countries.", {"entities": []}], ["Cross-sectional data were analyzed from the World Health Organization\u2019s Study on Global Ageing and Adult Health.", {"entities": []}], ["Physical activity was assessed by the Global Physical Activity Questionnaire.", {"entities": []}], ["Participants were dichotomized into low (i.e., not meeting 150 minutes of moderate physical activity per week) and moderate-to-high physically active groups.", {"entities": []}], ["Associations between physical activity and a range of correlates were examined using multivariable logistic regressions.", {"entities": []}], ["The overall prevalence (95%CI) of people not meeting recommended physical activity levels in 34,129 participants (mean age 62.4 years, 52.1% female) was 23.5% (22.3%-24.8%).", {"entities": []}], ["In the multivariable analysis, older age and unemployment were significant sociodemographic correlates of low physical activity.", {"entities": []}], ["Individuals with low body mass index (<18.5kg/m Our data illustrates that a multitude of factors influence physical activity target achievement in older adults, which can inform future interventions across low- and middle-income countries to assist people of this age group to engage in regular physical activity.", {"entities": []}], ["Future prospective cohort studies are also required to investigate the directionality and mediators of the relationships observed.", {"entities": []}], ["The U.S. Food and Drug Administration granted accelerated approval to pembrolizumab for the treatment of patients with metastatic non-small cell lung cancer whose tumors express programmed death-ligand 1.", {"entities": [[145, 156, "DISEASE"], [150, 156, "DISEASE"]]}], ["This work discusses the data supporting the approval decision, specifically highlighting the incorporation of a companion diagnostic in the key study and the optimal dose of pembrolizumab.", {"entities": []}], ["On October 2, 2015, the U.S. Food and Drug Administration (FDA) granted accelerated approval for pembrolizumab, a breakthrough therapy-designated drug, for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors express programmed death-ligand 1 (PD-L1), as determined by an FDA-approved test, and who have disease progression on or after platinum-containing chemotherapy or targeted therapy against anaplastic lymphoma kinase or epidermal growth factor receptor, if appropriate.", {"entities": [[213, 224, "DISEASE"], [445, 453, "DISEASE"], [218, 224, "DISEASE"]]}], ["This indication was approved concurrently with the PD-L1 immunohistochemistry 22C3 pharmDx, a companion diagnostic test for patient selection based on PD-L1 tumor expression.", {"entities": []}], ["The accelerated approval was granted based on durable objective response rate (ORR) and an acceptable toxicity profile demonstrated in a multicenter, open-label trial enrolling 550 patients with metastatic NSCLC.", {"entities": []}], ["The efficacy population comprised 61 patients with tumors identified as strongly positive for PD-L1, and the confirmed ORR as determined by blinded independent central review was 41% (95% confidence interval: 28.6%, 54.3%); all were partial responses.", {"entities": []}], ["At the time of the analysis, responses were ongoing in 21 of 25 patients (84%), with 11 patients (44%) having response duration of \u22656 months.", {"entities": []}], ["The most commonly occurring (\u226520%) adverse reactions included fatigue, decreased appetite, dyspnea, and cough.", {"entities": []}], ["The most frequent (\u22652%) serious adverse drug reactions were pleural effusion, pneumonia, dyspnea, pulmonary embolism, and pneumonitis.", {"entities": [[78, 87, "DISEASE"], [98, 116, "DISEASE"]]}], ["Immune-mediated adverse reactions occurred in 13% of patients and included pneumonitis, colitis, hypophysitis, and thyroid disorders.", {"entities": []}], ["The accelerated approval regulations describe approval of drugs and biologic products for serious and life-threatening illnesses based on a surrogate endpoint likely to predict clinical benefit.", {"entities": []}], ["Under these regulations, a confirmatory trial or trials is required to verify and describe the benefit of pembrolizumab for patients with metastatic NSCLC.", {"entities": []}], ["This report presents key information on the U.S. Food and Drug Administration (FDA) accelerated approval of pembrolizumab for the treatment of patients with metastatic non-small cell lung cancer whose tumors express programmed death-ligand 1, as determined by an FDA-approved test, and who have disease progression on or after platinum-containing chemotherapy or targeted therapy against anaplastic lymphoma kinase or epidermal growth factor receptor, if appropriate.", {"entities": [[183, 194, "DISEASE"], [399, 407, "DISEASE"], [188, 194, "DISEASE"]]}], ["The report discusses the data supporting the approval decision, specifically highlighting the incorporation of a companion diagnostic in the key study and the optimal dose of pembrolizumab.", {"entities": []}], ["Mode of delivery (vaginal or cesarean section) is thought to affect gut microbiota, which in turn may affect psychological well-being.", {"entities": []}], ["As such, mode of delivery is potentially a modifiable factor for psychological well-being.", {"entities": []}], ["Here we examined the association of mode of delivery with child and adolescent psychological well-being.", {"entities": []}], ["We used multivariable linear regression in a population-representative Hong Kong Chinese birth cohort, \u201cChildren of 1997,\u201d to examine the adjusted associations of mode of delivery with behavioral problems assessed from parent-reported Rutter score at ~7 (n\u2009=\u20096294) and ~11 years (n\u2009=\u20095598), self-esteem assessed from self-reported Culture-Free Self-Esteem Inventory score at ~11 years (n\u2009=\u20096937) and depressive symptoms assessed from self-reported Patient Health Questionnaire-9 score at ~13 years (n\u2009=\u20095797).", {"entities": []}], ["Cesarean Section (CS) was associated with children born in private hospitals, boys, and firstborns, higher maternal body mass index, higher maternal age, preeclampsia, higher socioeconomic position (SEP) and maternal birth in Hong Kong.", {"entities": [[18, 20, "GENE"]]}], ["CS was unrelated to behavior, self-esteem and depressive symptoms adjusted for infant characteristics (sex, gestational age, birthweight, parity and breast feeding), maternal characteristics (mother\u2019s age and place of birth) and SEP.", {"entities": [[0, 2, "GENE"]]}], ["In a developed non-Western setting, mode of delivery was not clearly associated with childhood or early\u00a0adolescent psychological well-being.", {"entities": []}], ["Activin A, a member of the transforming growth factor beta superfamily, acts as a pro-inflammatory factor in acute phase response, and influences the pathological progress of neutrophil-mediated disease.", {"entities": []}], ["However, whether activin A can exert an effect on the activities of neutrophils remains unclear.", {"entities": []}], ["In this study, we found that the release of activin A was enhanced from neutrophils of mouse when stimulated with lipopolysaccharide.", {"entities": []}], ["Furthermore, neutrophils were not only the source of activin A but also the target cells in response to activin A, in which canonical activin signalling components existed, and levels of ACTRIIA, SMAD3 and p-SMAD3 proteins were elevated in activin A-treated neutrophils.", {"entities": [[196, 201, "GENE"], [208, 213, "GENE"]]}], ["Next, the role of activin A was determined in regulation of neutrophils activities.", {"entities": []}], ["Our data revealed that activin A induced O 2 in vivo Smad3 knockdown.", {"entities": [[53, 58, "GENE"]]}], ["In summary, these data demonstrate that activin A can exert an effect on neutrophils activation in an autocrine/paracrine manner through Smad3 signalling, suggesting that activin A is an important regulator of neutrophils.", {"entities": [[137, 142, "GENE"]]}], ["Phosphorylated sphingolipids [ceramide-1-phosphate (C1P) and sphingosine-1-phosphate (S1P)] have emerged as key regulators of cell growth, survival, migration, and inflammation 2 \u03b1 (cPLA 2 \u03b1), the rate-limiting releaser of arachidonic acid used for pro-inflammatory eicosanoid production trans -Golgi/TGN, nucleus, and plasma membrane.", {"entities": []}], ["RNAi-induced CPTP depletion elevates C1P steady-state levels and alters Golgi cisternae stack morphology.", {"entities": []}], ["The resulting C1P decrease in plasma membranes and increase in the Golgi complex stimulates cPLA 2 \u03b1 release of arachidonic acid, triggering pro-inflammatory eicosanoid generation.", {"entities": []}], ["Jaagsiekte sheep retrovirus (JSRV) is the causative agent of ovine pulmonary adenocarcinoma (OPA), a transmissible neoplastic disease of sheep.", {"entities": [[77, 91, "DISEASE"]]}], ["OPA is an economically important veterinary disease and is also a valuable naturally occurring animal model of human lung cancer, with which it shares a similar histological appearance and the activation of common cell signaling pathways.", {"entities": [[117, 128, "DISEASE"], [122, 128, "DISEASE"]]}], ["Interestingly, the JSRV Env protein is directly oncogenic and capable of driving cellular transformation in vivo and in vitro .", {"entities": []}], ["Previous studies of JSRV infection in cell culture have been hindered by the lack of a permissive cell line for the virus.", {"entities": []}], ["Here, we investigated the ability of JSRV to infect slices of ovine lung tissue cultured ex vivo .", {"entities": []}], ["We describe the use of precision cut lung slices from healthy sheep to study JSRV infection and transformation ex vivo .", {"entities": []}], ["Following optimization of the culture system we characterized JSRV infection of lung slices and compared the phenotype of infected cells to natural field cases and to experimentally-induced OPA tumors from sheep.", {"entities": []}], ["JSRV was able to infect cells within lung slices, to produce new infectious virions and induce cell proliferation.", {"entities": []}], ["Immunohistochemical labeling revealed that infected lung slice cells express markers of type II pneumocytes and phosphorylated Akt and ERK1/2.", {"entities": []}], ["These features closely resemble the phenotype of natural and experimentally-derived OPA in sheep, indicating that lung slice culture provides an authentic ex vivo model of OPA.", {"entities": []}], ["We conclude that we have established an ex vivo model of JSRV infection.", {"entities": []}], ["This model will be valuable for future studies of JSRV replication and early events in oncogenesis and provides a novel platform for studies of JSRV-induced lung cancer.", {"entities": [[157, 168, "DISEASE"], [162, 168, "DISEASE"]]}], ["Dyes are known to be a causative agent of occupational asthma in workers exposed to them.", {"entities": [[55, 61, "DISEASE"]]}], ["We have evaluated respiratory symptoms among textile workers.", {"entities": []}], ["The study population comprised 106 exposed workers and a control (unexposed) group.", {"entities": []}], ["Data were collected by a questionnaire.", {"entities": []}], ["PFTs (Pulmonary Function Test) were performed.", {"entities": []}], ["Among the exposed workers 36.8% defined phlegm.", {"entities": []}], ["Respiratory symptoms were not significantly different between two groups.", {"entities": []}], ["The employment duration of the exposed workers with phlegm was longer than those without phlegm ( p = 0.027).", {"entities": []}], ["The mean % predicted of FEF 25\u201375 of the exposed workers was found to be significantly lower than the control (unexposed) group ( p = 0.01).", {"entities": []}], ["Our study suggests that textile dyeing might cause respiratory symptoms in workers.", {"entities": []}], ["With the increasing recognition of the importance of the non-skeletal effects of vitamin D (VitD), more and more attention has been drawn to VitD status in early life.", {"entities": []}], ["However, the VitD status of newborns and factors that influence VitD levels in Shanghai, China, remain unclear.", {"entities": []}], ["A total of 1030 pregnant women were selected from two hospitals in Shanghai, one of the largest cities in China located at 31\u00a0degrees north latitude.", {"entities": []}], ["Umbilical cord serum concentrations of 25-hydroxy vitamin D [25(OH)D] were measured by LC-MS-MS, and questionnaires were used to collect information.", {"entities": []}], ["The median cord serum 25(OH)D concentration was 22.4 ng/mL; the concentration lower than 20 ng/mL accounted for 36.3% of the participants, and the concentration lower than 30 ng/mL for 84.1%.", {"entities": []}], ["A multivariable logistic regression model showed that the determinants of low 25(OH)D status were being born during autumn or winter months and a lack of VitD-related multivitamin supplementation.", {"entities": []}], ["The relative risk was 1.7 for both autumn (95% CI, 1.1\u20132.6) and winter (95% CI, 1.1\u20132.5) births ( p < 0.05).", {"entities": []}], ["VitD-related multivitamin supplementation more than once a day during pregnancy reduced the risk of VitD deficiency [adjusted OR (aOR) = 0.6, 95% CI (0.45\u20131.0) for VitD supplementation] ( p < 0.05).", {"entities": []}], ["VitD deficiency and insufficiency are common in newborns in Shanghai, China, and are independently associated with season and VitD supplementation.", {"entities": []}], ["Our findings may assist future efforts to correct low levels of 25(OH)D in Shanghai mothers and their newborn children.", {"entities": []}], ["The aim of this study was to use fractal dimension (FD) analysis on multidetector CT (MDCT) images for quantifying the morphological changes of the pulmonary artery tree in patients with pulmonary hypertension (PH).", {"entities": [[197, 209, "DISEASE"], [187, 209, "DISEASE"]]}], ["Fourteen patients with PH and 17 patients without PH as controls were studied.", {"entities": []}], ["All of the patients underwent contrast-enhanced helical CT and transthoracic echocardiography.", {"entities": []}], ["The pulmonary artery trees were generated using post-processing software, and the FD and projected image area of the pulmonary artery trees were determined with ImageJ software in a personal computer.", {"entities": []}], ["The FD, the projected image area and the pulmonary artery pressure (PAP) were statistically evaluated in the two groups.", {"entities": []}], ["The FD, the projected image area and the PAP of the patients with PH were higher than those values of the patients without PH ( p < 0.05, t -test).", {"entities": []}], ["There was a high correlation of FD with the PAP ( r = 0.82, p < 0.05, partial correlation analysis).", {"entities": []}], ["There was a moderate correlation of FD with the projected image area ( r = 0.49, p < 0.05, partial correlation analysis).", {"entities": []}], ["There was a correlation of the PAP with the projected image area ( r = 0.65, p < 0.05, Pearson correlation analysis).", {"entities": []}], ["The FD of the pulmonary arteries in the PH patients was significantly higher than that of the controls.", {"entities": []}], ["There is a high correlation of FD with the PAP.", {"entities": []}], ["Single nucleotide polymorphisms (SNPs) in toll-like receptor (TLR) genes TLR2 - 4 and TLR7 - 9 , but not in TLR1 and TLR6 , have been previously evaluated regarding HIV acquisition and disease progression in various populations, most of which were European.", {"entities": [[73, 77, "GENE"], [86, 90, "GENE"], [108, 112, "GENE"], [117, 121, "GENE"]]}], ["In the present study, we examined associations between a total of 41 SNPs in 8 TLR genes ( TLR1-4 , TLR6 - 9 ) and HIV status in North American subjects (total n = 276 [Caucasian, n = 102; African American, n = 150; other, n = 24]).", {"entities": [[100, 104, "GENE"]]}], ["Stratification of the data by self-identified race revealed that a total of 9 SNPs in TLR1 , TLR4 , TLR6 , and TLR8 in Caucasians, and 2 other SNPs, one each in TLR4 and TLR8 , in African Americans were significantly associated with HIV status at P < 0.05.", {"entities": [[86, 90, "GENE"], [93, 97, "GENE"], [161, 165, "GENE"], [100, 104, "GENE"], [111, 115, "GENE"], [170, 174, "GENE"], [93, 97, "GENE"], [161, 165, "GENE"], [111, 115, "GENE"], [170, 174, "GENE"]]}], ["Concordant with the odds ratios of these SNPs, significant differences were observed in the SNP allele frequencies between HIV+ and HIV\u2212 subjects.", {"entities": []}], ["Finally, in Caucasians, certain haplotypes of single ( TLR1 , TLR4 ) and heterodimer ( TLR2 _ TLR6 ) genes may be inferred as \u201csusceptible\u201d or \u201cprotective\u201d.", {"entities": [[55, 59, "GENE"], [62, 66, "GENE"], [87, 91, "GENE"], [94, 98, "GENE"]]}], ["Our study provides in-depth insight into the associations between TLR variants, particularly TLR1 and TLR6 , and HIV status in North Americans, and suggests that these associations may be race-specific.", {"entities": [[93, 97, "GENE"], [102, 106, "GENE"]]}], ["We demonstrated that a recombinant banana lectin (rBanLec), which structural characteristics and physiological impacts highly resemble those reported for its natural counterparts, binds murine peritoneal macrophages and specifically modulates their functional characteristics.", {"entities": []}], ["By using rBanLec in concentrations ranging from 1 \u03bcg to 10 \u03bcg to stimulate resident (RMs) and thioglycollate-elicited (TGMs) peritoneal macrophages from BALB/c and C57BL/6 mice, we have shown that effects of rBanLec stimulation depend on its concentration but also on the functional status of macrophages and their genetic background.", {"entities": []}], ["rBanLec, in a positive dose-dependent manner, promotes the proliferation of TGMs from both BALB/c and C57BL/6 mice, while its mitogenic influence on RMs is significantly lower (BALB/c mice) or not detectable (C57BL/6 mice).", {"entities": []}], ["In all peritoneal macrophages, irrespective of their type and genetic background, rBanLec, in a positive dose dependent manner, enhances the secretion of IL-10.", {"entities": []}], ["rBanLec stimulation of RMs from both BALB/c and C57BL/6 resulted in a positive dose-dependent promotion of proinflammatory phenotype (enhancement of NO production and IL-12 and TNF\u03b1 secretion, reduction of arginase activity).", {"entities": []}], ["Positive dose-dependent skewing toward proinflammatory phenotype was also observed in TGMs from C57BL/6 mice.", {"entities": []}], ["However, the enhancement of rBanLec stimulation promotes skewing of TGMs from BALB/c mice towards anti-inflammatory profile (reduction of NO production and IL-12 secretion, enhancement of arginase activity and TGF\u03b2 and IL-4 secretion).", {"entities": []}], ["Moreover, we established that rBanLec binds oligosaccharide structures of TLR2 and CD14 and that blocking of signaling via these receptors significantly impairs the production of TNF\u03b1 and NO in BALB/c macrophages.", {"entities": [[74, 78, "GENE"], [83, 87, "GENE"]]}], ["Since the outcome of rBanLec stimulation depends on rBanLec concentration as well as on the functional characteristics of its target cells and their genetic background, further studies are needed to investigate its effects under physiological and specific pathological conditions.", {"entities": []}], ["Maternal stress in early life has been associated with the development of asthma in children, although it is unclear whether there are any critical periods of exposure.", {"entities": [[74, 80, "DISEASE"]]}], ["The association of asthma with prenatal exposure to maternal stress has not been reported.", {"entities": [[19, 25, "DISEASE"]]}], ["We tested whether prenatal and postnatal anxiety and/or depression in pregnant women predicted the risk of their offspring developing asthma in childhood.", {"entities": [[134, 140, "DISEASE"]]}], ["The Avon Longitudinal Study of Parents and Children is a population-based birth cohort recruited during pregnancy.", {"entities": []}], ["Data were available on maternal anxiety scores and asthma at age 7\u00bd years in 5810 children.", {"entities": [[51, 57, "DISEASE"]]}], ["Anxiety was assessed at 18 and 32 weeks of gestation by using the validated Crown-Crisp Experiential Index.", {"entities": []}], ["Asthma was defined at age 7\u00bd years as doctor-diagnosed asthma with current symptoms or treatment in the previous 12 months.", {"entities": [[0, 6, "DISEASE"], [55, 61, "DISEASE"]]}], ["Multivariable logistic regression was used to determine the association of prenatal anxiety with asthma (odds ratio; 95% CI).", {"entities": [[97, 103, "DISEASE"]]}], ["Independent of postnatal anxiety and adjusted for a number of likely confounders, there was a higher likelihood of asthma at age 7\u00bd years (odds ratio, 1.64; 95% CI, 1.25-2.17) in children of mothers in the highest compared with lowest quartile of anxiety scores at 32 weeks of gestation, with evidence for a dose-response ( P value for trend <0.001).", {"entities": [[115, 121, "DISEASE"]]}], ["Maternal anxiety symptoms as an indicator of stress during fetal life may program the development of asthma during childhood.", {"entities": [[101, 107, "DISEASE"]]}], ["Dendritic cells (DC) have the potential to instigate a tumour-specific immune response, but their ability to prime na\u00efve lymphocytes depends on their activation status.", {"entities": []}], ["Thus, for tumour immunotherapy to be effective, the provision of appropriate DC activation stimuli such as Toll-like receptor (TLR) agonists is crucial in order to overcome immunosuppression associated with the tumour microenvironment.", {"entities": []}], ["To address this, we investigated how ovarian carcinoma (OC)-associated ascites impedes activation of DC by TLR agonists.", {"entities": [[45, 54, "DISEASE"], [37, 54, "DISEASE"]]}], ["Our results show that ascites reduces the TLR-mediated up-regulation of CD86 and partially inhibits the production of the pro-inflammatory cytokines interleukin 6 (IL-6), IL-12 and tumour necrosis factor \u03b1 (TNF\u03b1) in monocyte-derived DC from healthy controls.", {"entities": [[72, 76, "GENE"]]}], ["We further observe an impaired T cell stimulatory capacity of DC upon activation with TLR agonists in the presence of ascites, indicating that their functionality is affected by the immunosuppressive factors.", {"entities": []}], ["We identify IL-10 and prostaglandin E2 (PGE 2 ) as the pivotal immunosuppressive components in OC-associated ascites compromising TLR-mediated DC activation.", {"entities": []}], ["Interestingly, IL-10 is present in both ascites from patients with malignant OC and in peritoneal fluid from patients with benign ovarian conditions and both fluids have similar ability to reduce TLR-mediated DC activation.", {"entities": []}], ["However, depletion of IL-10 from ascites revealed that the presence of paracrine IL-10 is not crucial for ascites-mediated suppression of DC activation in response to TLR activation.", {"entities": []}], ["Unlike IL-10, PGE 2 is absent from peritoneal fluid of patients with benign conditions and selectively reduces TNF\u03b1 induction in response to TLR-mediated activation in the presence of OC-associated ascites.", {"entities": []}], ["Our study highlights PGE 2 as an immunosuppressive component of the malignant OC microenvironment rendering PGE 2 a potentially important target for immunotherapy in OC.", {"entities": []}], ["Asthma-chronic obstructive pulmonary disorder (COPD) overlap (ACO) is characterized by the coexistence of features of both asthma and COPD and is associated with rapid progress and a poor prognosis.", {"entities": [[0, 6, "DISEASE"], [123, 129, "DISEASE"]]}], ["Thus, the early recognition of ACO is crucial.", {"entities": []}], ["We sought to explore the plasma levels of biomarkers associated with asthma (periostin, TSLP and YKL-40), COPD (NGAL) and their possible correlation with lung function, the bronchodilator response and radiographic imaging in patients with asthma, COPD and with features of ACO.", {"entities": [[69, 75, "DISEASE"], [239, 245, "DISEASE"], [88, 92, "GENE"]]}], ["We enrolled 423 subjects from 6 clinical centers.", {"entities": []}], ["All participants underwent blood\u00a0collection, lung function measurements, bronchodilator response tests and high-resolution CT.\u00a0Correlations of the plasma biomarkers with lung function, the bronchodilator response and percentemphysema were calculated by Spearman\u2019s rank correlation and multivariate stepwise regressionanalysis.", {"entities": []}], ["1) Patients with features of ACO had lower plasma YKL-40 than COPD patients and a moderate elevated plasma level of NGAL compared with asthma patients.", {"entities": [[135, 141, "DISEASE"]]}], ["2) Patients with features of ACO had an intermediate degree of airflow obstruction, the bronchodilator response and emphysema between patients with COPD and asthma.", {"entities": [[157, 163, "DISEASE"]]}], ["3) Plasma YKL-40 was negatively correlated with lung function and with the bronchodilator response, and plasma NGAL was positively correlated with the extent of emphysema.", {"entities": []}], ["Plasma YKL-40 is a promising candidate for distinguishing between patients with features of ACO and COPD patients, while plasma NGAL may be a valuable biomarker for differentiating between patients with features of ACO and asthma patients.", {"entities": [[223, 229, "DISEASE"]]}], ["ChiCTR-OOC-16009221.", {"entities": []}], ["While intensive efforts have been made for the treatment of cancer, this disease is still the second leading cause of death in many countries.", {"entities": [[60, 66, "DISEASE"]]}], ["Metastatic breast cancer, late-stage colon cancer, malignant melanoma, multiple myeloma, and other forms of cancer are still essentially incurable in most cases.", {"entities": [[80, 87, "DISEASE"], [71, 87, "DISEASE"], [11, 24, "DISEASE"], [37, 49, "DISEASE"], [61, 69, "DISEASE"], [18, 24, "DISEASE"], [43, 49, "DISEASE"], [108, 114, "DISEASE"]]}], ["Recent advances in genomic technologies have permitted the simultaneous evaluation of DNA sequence-based alterations together with copy number gains and losses.", {"entities": []}], ["The requirement for a multi-targeting approach is the common theme that emerges from these studies.", {"entities": []}], ["Therefore, the combination of new targeted biological and cytotoxic agents is currently under investigation in multimodal treatment regimens.", {"entities": []}], ["Similarly, a combinational principle is applied in traditional Chinese medicine, as formulas consist of several types of medicinal herbs or minerals, in which one represents the principal component, and the others serve as adjuvant ones that assist the effects, or facilitate the delivery, of the principal component.", {"entities": []}], ["In Western medicine, approximately 60 different arsenic preparations have been developed and used in pharmacological history.", {"entities": []}], ["In traditional Chinese medicines, different forms of mineral arsenicals (orpiment\u2014As 2 S 3 , realgar\u2014As 4 S 4 , and arsenolite\u2014arsenic trioxide, As 2 O 3 ) are used, and realgar alone is included in 22 oral remedies that are recognized by the Chinese Pharmacopeia Committee (2005).", {"entities": []}], ["It is known that a significant portion of some forms of mineral arsenicals is poorly absorbed into the body, and would be unavailable to cause systemic damage.", {"entities": []}], ["This review primary focuses on the application of arsenic sulfide (realgar) for treatment of various forms of cancer in vitro and in vivo .", {"entities": [[110, 116, "DISEASE"]]}], ["To quantify the effect of strategies to improve retention in randomised trials.", {"entities": []}], ["Systematic review and meta-analysis.", {"entities": []}], ["Sources searched: MEDLINE, EMBASE, PsycINFO, DARE, CENTRAL, CINAHL, C2-SPECTR, ERIC, PreMEDLINE, Cochrane Methodology Register, Current Controlled Trials metaRegister, WHO trials platform, Society for Clinical Trials (SCT) conference proceedings and a survey of all UK clinical trial research units.", {"entities": []}], ["Included trials were randomised evaluations of strategies to improve retention embedded within host randomised trials.", {"entities": []}], ["The primary outcome was retention of trial participants.", {"entities": []}], ["Data from trials were pooled using the fixed-effect model.", {"entities": []}], ["Subgroup analyses were used to explore the heterogeneity and to determine whether there were any differences in effect by the type of strategy.", {"entities": []}], ["38 retention trials were identified.", {"entities": []}], ["Six broad types of strategies were evaluated.", {"entities": []}], ["Strategies that increased postal questionnaire responses were: adding, that is, giving a monetary incentive (RR 1.18; 95% CI 1.09 to 1.28) and higher valued incentives (RR 1.12; 95% CI 1.04 to 1.22).", {"entities": []}], ["Offering a monetary incentive, that is, an incentive given on receipt of a completed questionnaire, also increased electronic questionnaire response (RR 1.25; 95% CI 1.14 to 1.38).", {"entities": []}], ["The evidence for shorter questionnaires (RR 1.04; 95% CI 1.00 to 1.08) and questionnaires relevant to the disease/condition (RR 1.07; 95% CI 1.01 to 1.14) is less clear.", {"entities": []}], ["On the basis of the results of single trials, the following strategies appeared effective at increasing questionnaire response: recorded delivery of questionnaires (RR 2.08; 95% CI 1.11 to 3.87); a \u2018package\u2019 of postal communication strategies (RR 1.43; 95% CI 1.22 to 1.67) and an open trial design (RR 1.37; 95% CI 1.16 to 1.63).", {"entities": []}], ["There is no good evidence that the following strategies impact on trial response/retention: adding a non-monetary incentive (RR=1.00; 95% CI 0.98 to 1.02); offering a non-monetary incentive (RR=0.99; 95% CI 0.95 to 1.03); \u2018enhanced\u2019 letters (RR=1.01; 95% CI 0.97 to 1.05); monetary incentives compared with offering prize draw entry (RR=1.04; 95% CI 0.91 to 1.19); priority postal delivery (RR=1.02; 95% CI 0.95 to 1.09); behavioural motivational strategies (RR=1.08; 95% CI 0.93 to 1.24); additional reminders to participants (RR=1.03; 95% CI 0.99 to 1.06) and questionnaire question order (RR=1.00, 0.97 to 1.02).", {"entities": []}], ["Also based on single trials, these strategies do not appear effective: a telephone survey compared with a monetary incentive plus questionnaire (RR=1.08; 95% CI 0.94 to 1.24); offering a charity donation (RR=1.02, 95% CI 0.78 to 1.32); sending sites reminders (RR=0.96; 95% CI 0.83 to 1.11); sending questionnaires early (RR=1.10; 95% CI 0.96 to 1.26); longer and clearer questionnaires (RR=1.01, 0.95 to 1.07) and participant case management by trial assistants (RR=1.00; 95% CI 0.97 to 1.04).", {"entities": []}], ["Most of the trials evaluated questionnaire response rather than ways to improve participants return to site for follow-up.", {"entities": []}], ["Monetary incentives and offers of monetary incentives increase postal and electronic questionnaire response.", {"entities": []}], ["Some strategies need further evaluation.", {"entities": []}], ["Application of these results would depend on trial context and follow-up procedures.", {"entities": []}], ["Human rhinovirus (HRV) is an important causative agent of acute respiratory tract infections (ARTIs).", {"entities": []}], ["The roles of specific HRV genotypes in patients suffering from ARTIs have not been well established.", {"entities": []}], ["We recruited 147 adult inpatients with community-acquired pneumonia (CAP) and 291 adult outpatients with upper ARTIs (URTIs).", {"entities": [[58, 67, "DISEASE"]]}], ["Respiratory pathogens were screened via PCR assays.", {"entities": []}], ["HRV was detected in 42 patients, with 35 species A, five B and two C. Seventeen genotypes were identified, and HRV-A21 ranked the highest (9/42, 21.4%).", {"entities": []}], ["The HRV-A21-positive infections were detected in four patients with CAP and in five with URTIs, all without co-infections.", {"entities": []}], ["The HRV-A21 genome sequenced in this study contained 12 novel coding polymorphisms in viral protein (VP) 1, VP2 EF loop, VP3 knob and 3D regions.", {"entities": []}], ["The infections of HRV-A21 virus obtained in this study could not be neutralized by antiserum of HRV-A21 prototype strain (VR-1131), indicating remarkable antigenic variation.", {"entities": []}], ["Metagenomic analysis showed the HRV-A21 reads were dominant in bronchoalveolar lavage fluid of the three HRV-A21-positive patients with severe CAP, in which two dead.", {"entities": []}], ["Our results highlight an unexpected infection of genotype HRV-A21 in the clinic, indicating the necessity of precise genotyping and surveillance of HRVs to improve the clinical management of ARTIs.", {"entities": []}], ["None of current diagnostic methods has been proven to be a reliable tool for gastro-esophageal reflux disease (GERD).", {"entities": []}], ["Pepsin in saliva has been proposed as a promising diagnostic biomarker for gastro-esophageal reflux.", {"entities": []}], ["We aimed to determine the diagnostic value of salivary pepsin detection for GERD.", {"entities": []}], ["Two hundred and fifty patients with symptoms suggestive of GERD and 35 asymptomatic healthy volunteers provided saliva on morning waking, after lunch and dinner for pepsin determination using the Peptest lateral flow device.", {"entities": []}], ["All patients underwent 24-h multichannel intraluminal impedance pH (24-h MII-pH) monitoring and upper gastrointestinal endoscopy.", {"entities": []}], ["Based on 24-h MII-pH and endoscopy study, patients were defined as GERD (abnormal MII-pH results and/or reflux esophagitis) and non-GERD otherwise.", {"entities": [[111, 122, "DISEASE"]]}], ["Patients with GERD had a higher prevalence of pepsin in saliva and higher pepsin concentration than patients with non-GERD and healthy controls ( P < 0.001 for all).", {"entities": []}], ["The pepsin test had a sensitivity of 73% and a specificity of 88.3% for diagnosing GERD using the optimal cut-off value of 76\u00a0ng/mL.", {"entities": []}], ["Postprandial saliva samples collected when the symptoms occurred had a more powerful ability to identify GERD.", {"entities": []}], ["Salivary pepsin test had moderate diagnostic value for GERD.", {"entities": []}], ["It may be a promising tool to replace the use of currently invasive tools with advantages of non-invasive, easy to perform and cost effective.", {"entities": []}], ["ChiCTR-DDD-16009506 (date of registration: October 20, 2016).", {"entities": []}], ["Patient participation is an important indicator of quality care.", {"entities": []}], ["Currently, there is little evidence to support the belief that participation in care is possible for patients during the acute postoperative period.", {"entities": []}], ["Previous work indicates that there is very little opportunity for patients to participate in care in the acute context.", {"entities": []}], ["Patients require both capability, in terms of having the required knowledge and understanding of how they can be involved in their care, and the opportunity, facilitated by clinicians, to engage in their acute postoperative care.", {"entities": []}], ["This cluster randomised crossover trial aims to test whether a multimedia intervention improves patient participation in the acute postoperative context, as determined by pain intensity and recovery outcomes.", {"entities": []}], ["A total of 240 patients admitted for primary total knee replacement surgery will be invited to participate in a cluster randomised, crossover trial and concurrent process evaluation in at least two wards at a major non-profit private hospital in Melbourne, Australia.", {"entities": []}], ["Patients admitted to the intervention ward will receive the multimedia intervention daily from Day 1 to Day 5 (or day of discharge, if prior).", {"entities": []}], ["The intervention will be delivered by nurses via an iPad\u2122, comprising information on the goals of care for each day following surgery.", {"entities": []}], ["Patients admitted to the control ward will receive usual care as determined by care pathways currently in use across the organization.", {"entities": []}], ["The primary endpoint is the \u201cworst pain experienced in the past 24\u00a0h\u201d on Day 3 following TKR surgery.", {"entities": []}], ["Pain intensity will be measured using the numerical rating scale.", {"entities": []}], ["Secondary outcomes are interference of pain on activities of daily living, length of stay in hospital, function and pain following TKR surgery, overall satisfaction with hospitalisation, postoperative complications and hospital readmission.", {"entities": []}], ["The results of this study will contribute to our understanding of the effectiveness of interventions that provide knowledge and opportunity for patient participation during postoperative in-hospital care in actually increasing participation, and the impact of participation on patient outcomes.", {"entities": []}], ["The results of this study will also provide data about the barriers and enablers to participation in the acute care context.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry ACTRN12614000340639 Trial Registration date 31/03/2014.", {"entities": []}], ["Environmental factors play a major role on atopic dermatitis (AD) which shows a constant rise in prevalence in western countries over the last decades.", {"entities": [[43, 60, "DISEASE"], [50, 60, "DISEASE"]]}], ["The Hygiene Hypothesis suggesting an inverse relationship between incidence of infections and the increase in atopic diseases in these countries, is one of the working hypothesis proposed to explain this trend.", {"entities": []}], ["This study tested the efficacy and safety of oral administration of the bacterial lysate OM-85 (Broncho-Vaxom Children aged 6 months to 7 years, with confirmed AD diagnosis, were randomized in a double-blind, placebo-controlled trial to receive, in addition to conventional treatment with emollients and topical corticosteroids, 3.5mg of the bacterial extract OM-85 or placebo daily for 9 months.", {"entities": []}], ["The primary end-point was the difference between groups in the occurrence of new flares (NF) during the study period, evaluated by Hazard Ratio (HR) derived from conditional Cox proportional hazard regression models accounting for repeated events.", {"entities": [[145, 147, "GENE"]]}], ["Among the 179 randomized children, 170 were analysed, 88 in the OM-85 and 82 in the placebo group.", {"entities": []}], ["As expected most children in both treatment groups experienced at least 1 NF during the study period (75 (85%) patients in the OM-85 group and 72 (88%) in the placebo group).", {"entities": []}], ["Patients treated with OM-85 as adjuvant therapy had significantly fewer and delayed NFs (HR of repeated flares = 0.80; 95% confidence interval (CI): 0.67\u20130.96), also when potential confounding factors, as family history of atopy and corticosteroids use, were taken into account (HR = 0.82; 95% CI: 0.69\u20130.98).", {"entities": [[89, 91, "GENE"], [279, 281, "GENE"], [89, 91, "GENE"], [279, 281, "GENE"]]}], ["No major side effect was reported, with comparable and good tolerability for OM-85 and placebo.", {"entities": []}], ["Results show an adjuvant therapeutic effect of a well standardized bacterial lysate OM-85 on established AD.", {"entities": []}], ["Vitamin C is an important low-molecular weight antioxidant at the air-lung interface.", {"entities": []}], ["Despite its critical role as a sacrificial antioxidant, little is known about its transport into the respiratory tract lining fluid (RTLF), or the underlying airway epithelial cells.", {"entities": []}], ["While several vitamin C transporters have been identified, such as sodium-ascorbate cotransporters (SVCT1/2) and glucose transporters (GLUTs), the latter transporting dehydroascorbate, knowledge of their protein distribution within the human lung is limited, in the case of GLUTs or unknown for SVCTs.", {"entities": []}], ["Protein expression of vitamin C transporters (SVCT1/2 and GLUT1-4) was examined by immunohistochemistry in endobronchial biopsies, and by FACS in airway leucocytes from lavage fluid, obtained from 32 volunteers; 16 healthy and 16 mild asthmatic subjects.", {"entities": []}], ["In addition, antioxidant concentrations were determined in RTLF.", {"entities": []}], ["The study was performed at one Swedish centre.", {"entities": []}], ["The primary outcome measure was to establish the location of vitamin C transporters in the human airways.", {"entities": []}], ["As secondary outcome measures, RTLF vitamin C concentration was measured and related to transporter expression, as well as bronchial epithelial inflammatory and goblet cells numbers.", {"entities": []}], ["Positive staining was identified for SVCT1 and 2 in the vascular endothelium.", {"entities": []}], ["SVCT2 and GLUT2 were present in the apical bronchial epithelium, where SVCT2 staining was predominately localised to goblet cells and inversely related to RTLF vitamin C concentrations.", {"entities": []}], ["This experimental study is the first to demonstrate protein expression of GLUT2 and SVCT2 in the human bronchial epithelium.", {"entities": []}], ["A negative correlation between SVCT2-positive goblet cells and bronchial RTLF vitamin C concentrations suggests a possible role for goblet cells in regulating the extracellular vitamin C pool.", {"entities": []}], ["In the present study, well-defined one-dimensional (1D) rod-like strontium vanadate (SrV 2 O 6 ) was prepared by simple hydrothermal method without using any other surfactants/templates.", {"entities": []}], ["The successful formation of rod-like SrV 2 O 6 was confirmed by various analytical and spectroscopic techniques.", {"entities": []}], ["Interestingly, for the first time the dual role of as-prepared rod-like SrV 2 O 6 were employed as an electrochemical sensor for the detection of caffeic acid (CA) as well as visible light active photocatalyst for the degradation of metronidazole (MNZ) antibiotic drug.", {"entities": []}], ["As an electrochemical sensor, the SrV 2 O 6 modified glassy carbon electrode (GCE) demonstrated a superior electrocatalytic activity for the detection of CA by chronoamperometry and cyclic voltammetry (CVs).", {"entities": []}], ["In addition, the electrochemical sensor exhibited a good current response for CA with excellent selectivity, wide linear response range, lower detection limit and sensitivity of 0.01\u2013207\u2009\u00b5M, 4\u2009nM and 2.064 \u03bcA \u03bcM 2 O 6 showed highly efficient and versatile photocatalytic performances for the degradation of MNZ, which degrades above 98% of MNZ solution under visible light irradiation within 60\u2009min.", {"entities": []}], ["The obtained results evidenced that the improvement of rod-like SrV 2 O 6 might be a resourceful electrocatalyst and photocatalyst material in the probable applications of environmental and biomedical applications.", {"entities": []}], ["CX3CL1 (fractalkine) is the only member of the CX3C (delta) subfamily of chemokines which is unique and combines the properties of both chemoattractant and adhesion molecules.", {"entities": [[0, 6, "GENE"]]}], ["The two-form ligand can exist either in a soluble form, like all other chemokines, and as a membrane-anchored molecule.", {"entities": []}], ["CX3CL1 discloses its biological properties through interaction with one dedicated CX3CR1 receptor which belongs to a family of G protein-coupled receptors (GPCR).", {"entities": [[0, 6, "GENE"], [82, 88, "GENE"]]}], ["The CX3CL1/CX3CR1 axis acts in many physiological phenomena including those occurring in the central nervous system (CNS), by regulating the interactions between neurons, microglia, and immune cells.", {"entities": []}], ["Apart from the role under physiological conditions, the CX3CL1/CX3CR1 axis was implied to have a role in different neuropathologies such as traumatic brain injury (TBI) and spinal cord injury (SCI).", {"entities": []}], ["CNS injuries represent a serious public health problem, despite improvements in therapeutic management.", {"entities": []}], ["To date, no effective treatment has been determined, so they constitute a leading cause of death and severe disability.", {"entities": []}], ["The course of TBI and SCI has two consecutive poorly demarcated phases: the initial, primary injury and secondary injury.", {"entities": []}], ["Recent evidence has implicated the role of the CX3CL1/CX3CR1 axis in neuroinflammatory processes occurring after CNS injuries.", {"entities": []}], ["The importance of the CX3CL1/CX3CR1 axis in the pathophysiology of TBI and SCI in the context of systemic and direct local immune response is still under investigation.", {"entities": []}], ["This paper, based on a review of the literature, updates and summarizes the current knowledge about CX3CL1/CX3CR1 axis involvement in TBI and SCI pathogenesis, indicating possible molecular and cellular mechanisms with a potential target for therapeutic intervention.", {"entities": []}], ["It is known that there is an increase in the prevalence of allergy and that allergic diseases have a negative impact on individuals' health-related quality of life (HRQL).", {"entities": []}], ["However, research in this field is mainly focused on individuals with verified allergy, i.e.", {"entities": []}], ["leaving out those with self-reported allergy-like conditions but with no doctor-diagnosis.", {"entities": []}], ["Furthermore, studies on food hypersensitivity and quality of life are scarce.", {"entities": []}], ["In order to receive information about the extent to which adolescent females and males experience allergy-like conditions and the impact of these conditions on their everyday life, the present study aimed to investigate the magnitude of self-reported allergy-like conditions in adolescence and to evaluate their HRQL.", {"entities": []}], ["Special focus was put on food hypersensitivity as a specific allergy-like condition and on gender differences.", {"entities": []}], ["In connection with lessons completed at the children's school, a study-specific questionnaire and the generic instrument SF-36 were distributed to 1488 adolescents, 13\u201321 years old (response rate 97%).", {"entities": []}], ["Sixty-four per cent of the respondents reported some kind of allergy-like condition: 46% reported hypersensitivity to defined substances and 51% reported allergic diseases (i.e.", {"entities": []}], ["asthma/wheezing, eczema/rash, rhino-conjunctivitis).", {"entities": [[36, 50, "DISEASE"], [0, 6, "DISEASE"]]}], ["A total of 19% reported food hypersensitivity.", {"entities": []}], ["Females more often reported allergy-like conditions compared with males (p < 0.001).", {"entities": []}], ["The adolescents with allergy-like conditions reported significantly lower HRQL (p < 0.001) in seven of the eight SF-36 health scales compared with adolescents without such conditions, regardless of whether the condition had been doctor-diagnosed or not.", {"entities": []}], ["Most adolescents suffered from complex allergy-like conditions.", {"entities": []}], ["The results indicate a need to consider the psychosocial impact of allergy-like conditions during school age.", {"entities": []}], ["Further research is needed to elucidate the gender differences in this area.", {"entities": []}], ["A team approach addressing better understanding of how allergy-like conditions impair the HRQL may improve the management of the adolescent's health problems, both in health-care services and in schools.", {"entities": []}], ["Moraxella catarrhalis is one of the three most common causative bacterial pathogens of otitis media, however no effective vaccine against M. catarrhalis has been developed so far.", {"entities": [[87, 99, "DISEASE"]]}], ["To identify M. catarrhalis vaccine candidate antigens, we used carefully selected sera from children with otitis media and healthy individuals to screen small-fragment genomic libraries that are expressed to display frame-selected peptides on a bacterial cell surface.", {"entities": [[106, 118, "DISEASE"]]}], ["This ANTIGENome technology led to the identification of 214 antigens, 23 of which were selected by in vitro or in vivo studies for additional characterization.", {"entities": []}], ["Eight of the 23 candidates were tested in a Moraxella mouse pulmonary clearance model, and 3 of these antigens induced significantly faster bacterial clearance compared to adjuvant or to the previously characterized antigen OmpCD.", {"entities": []}], ["The most significant protection data were obtained with the antigen MCR_1416 (Msp22), which was further investigated for its biological function by in vitro studies suggesting that Msp22 is a heme binding protein.", {"entities": []}], ["This study comprises one of the most exhaustive studies to identify potential vaccine candidate antigens against the bacterial pathogen M. catarrhali s.", {"entities": []}], ["Little is known about the effects of personal and other characteristics of care recipients on the behaviour of carers.", {"entities": []}], ["The aim of this study is to examine the association between the main chronic (disabling) condition of care recipients and the likelihood of their (matched) primary carers aged 15\u201364 years being out of the labour force.", {"entities": []}], ["We conducted a retrospective analysis of cross-sectional data from the Australian Bureau of Statistics 2009 Survey of Disability, Ageing and Carers (SDAC) for people aged 15\u201364 years.", {"entities": []}], ["We estimated the rates of exit from the labour force for primary carers and non-carers; rates of chronic disease occurrence for care recipients living with their main carers; odds ratios of primary carers being out of the labour force associated with the main chronic condition of their care recipient who lives with them.", {"entities": []}], ["From the 2009 SDAC, we identified 1,268 out of 37,186 eligible participants who were primary carers of a care recipient who lived with them.", {"entities": []}], ["Of these, 628 (49.5%) were out of the labour force.", {"entities": []}], ["Most common diseases of care recipients were: back problems (12%); arthritis and related disorders (10%); diseases of the nervous system (such as multiple sclerosis, epilepsy, cerebral palsy) (7.4%); and conditions originating in the perinatal period or congenital malformations, deformations and chromosomal abnormalities (5.1%).", {"entities": [[146, 164, "DISEASE"], [176, 190, "DISEASE"], [67, 76, "DISEASE"]]}], ["When adjusted for age, sex, education and whether have a long term chronic condition of informal carers, the five conditions of care recipients associated with the highest odds of their carers being out of the labour force were: head injury/acquired brain damage; neoplasms, blood diseases, disorders of the immune system; leg/knee/foot/hip damage from injury/accident; dementia, Parkinson\u2019s disease, Alzheimer\u2019s disease; and diseases of the musculoskeletal system and connective tissue (osteoporosis).", {"entities": [[370, 378, "DISEASE"], [488, 500, "DISEASE"]]}], ["This study identifies the type of conditions that have the greatest impact on the labour force participation of informal carers \u2013 previously unavailable information for Australia.", {"entities": []}], ["Australia, like most developed countries, is facing several skills shortages and an ageing population.", {"entities": []}], ["These governments will need to adopt novel and more wholistic approaches to increase the labour force participation of diverse groups.", {"entities": []}], ["Informal carers are one such group.", {"entities": []}], ["Adolescent obesity is rapidly becoming more prevalent and is associated with chronic health conditions and psychosocial morbidity.", {"entities": [[11, 18, "DISEASE"]]}], ["Lifestyle intervention is often ineffective in morbidly obese adolescents, and bariatric surgery is gradually becoming an accepted treatment.", {"entities": []}], ["However, little is known about long-term results.", {"entities": []}], ["Hospital charts of patients who had undergone gastric banding more than 5 years ago at an age of 18 years or younger, were retrospectively analyzed.", {"entities": []}], ["Weight loss, complications, reoperations, and comorbidity reduction were assessed as well as health status, food behavior, and personality.", {"entities": []}], ["BMI loss in 10 adolescents was 10.7 kg/m Laparoscopic adjustable gastric banding in morbidly obese adolescents had a failure rate of 40s%, but was a successful therapy in the other 60s% without major adverse events.", {"entities": []}], ["Follow-up longer than 36 months was crucial for optimal evaluation of weight loss and reoperation rate.", {"entities": []}], ["The optimal method of identifying people with asthma from electronic health records in primary care is not known.", {"entities": [[46, 52, "DISEASE"]]}], ["The aim of this study is to determine the positive predictive value (PPV) of different algorithms using clinical codes and prescription data to identify people with asthma in the United Kingdom Clinical Practice Research Datalink (CPRD).", {"entities": [[165, 171, "DISEASE"]]}], ["684 participants registered with a general practitioner (GP) practice contributing to CPRD between 1 December 2013 and 30 November 2015 were selected according to one of eight predefined potential asthma identification algorithms.", {"entities": [[197, 203, "DISEASE"]]}], ["A questionnaire was sent to the GPs to confirm asthma status and provide additional information to support an asthma diagnosis.", {"entities": [[47, 53, "DISEASE"], [110, 116, "DISEASE"]]}], ["Two study physicians independently reviewed and adjudicated the questionnaires and additional information to form a gold standard for asthma diagnosis.", {"entities": [[134, 140, "DISEASE"]]}], ["The PPV was calculated for each algorithm.", {"entities": []}], ["684 questionnaires were sent, of which 494 (72%) were returned and 475 (69%) were complete and analysed.", {"entities": []}], ["All five algorithms including a specific Read code indicating asthma or non-specific Read code accompanied by additional conditions performed well.", {"entities": [[62, 68, "DISEASE"]]}], ["The PPV for asthma diagnosis using only a specific asthma code was 86.4% (95% CI 77.4% to 95.4%).", {"entities": [[12, 18, "DISEASE"], [51, 57, "DISEASE"]]}], ["Extra information on asthma medication prescription (PPV 83.3%), evidence of reversibility testing (PPV 86.0%) or a combination of all three selection criteria (PPV 86.4%) did not result in a higher PPV.", {"entities": [[21, 27, "DISEASE"]]}], ["The algorithm using non-specific asthma codes, information on reversibility testing and respiratory medication use scored highest (PPV 90.7%, 95%\u2009CI (82.8% to 98.7%), but had a much lower identifiable population.", {"entities": [[33, 39, "DISEASE"]]}], ["Algorithms based on asthma symptom codes had low PPVs (43.1% to 57.8%)%).", {"entities": [[20, 26, "DISEASE"]]}], ["People with asthma can be accurately identified from UK primary care records using specific Read codes.", {"entities": [[12, 18, "DISEASE"]]}], ["The inclusion of spirometry or asthma medications in the algorithm did not clearly improve accuracy.", {"entities": [[31, 37, "DISEASE"]]}], ["The protocol for this research was approved by the Independent Scientific Advisory Committee (ISAC) for MHRA Database Research (protocol number15_257) and the approved protocol was made available to the journal and reviewers during peer review.", {"entities": []}], ["Generic ethical approval for observational research using the CPRD with approval from ISAC has been granted by a Health Research Authority Research Ethics Committee (East Midlands\u2014Derby, REC reference number 05/MRE04/87).", {"entities": []}], ["The results will be submitted for publication and will be disseminated through research conferences and peer-reviewed journals.", {"entities": []}], ["Responsiveness of cells to alpha-toxin (Hla) from Staphylococcus aureus appears to occur in a cell-type dependent manner.", {"entities": [[40, 43, "GENE"]]}], ["Here, we compare two human bronchial epithelial cell lines, i.e.", {"entities": []}], ["Hla-susceptible 16HBE14o- and Hla-resistant S9 cells, by a quantitative multi-omics strategy for a better understanding of Hla-induced cellular programs.", {"entities": []}], ["Phosphoproteomics revealed a substantial impact on phosphorylation-dependent signaling in both cell models and highlights alterations in signaling pathways associated with cell-cell and cell-matrix contacts as well as the actin cytoskeleton as key features of early rHla-induced effects.", {"entities": []}], ["Along comparable changes in down-stream activity of major protein kinases significant differences between both models were found upon rHla-treatment including activation of the epidermal growth factor receptor EGFR and mitogen-activated protein kinases MAPK1/3 signaling in S9 and repression in 16HBE14o- cells.", {"entities": [[210, 214, "GENE"]]}], ["System-wide transcript and protein expression profiling indicate induction of an immediate early response in either model.", {"entities": []}], ["In addition, EGFR and MAPK1/3-mediated changes in gene expression suggest cellular recovery and survival in S9 cells but cell death in 16HBE14o- cells.", {"entities": [[13, 17, "GENE"]]}], ["Strikingly, inhibition of the EGFR sensitized S9 cells to Hla indicating that the cellular capacity of activation of the EGFR is a major protective determinant against Hla-mediated cytotoxic effects.", {"entities": [[30, 34, "GENE"], [121, 125, "GENE"], [58, 61, "GENE"], [168, 171, "GENE"], [30, 34, "GENE"], [121, 125, "GENE"]]}], ["Overexposure to prenatal glucocorticoid (GC) disturbs hypothalamic-pituitary-adrenocortical axis-associated neuroendocrine metabolism and susceptibility to metabolic syndrome.", {"entities": [[166, 174, "DISEASE"], [41, 43, "GENE"]]}], ["A high-fat (HF) diet is a major environmental factor that can cause metabolic syndrome.", {"entities": [[78, 86, "DISEASE"]]}], ["We aimed to investigate whether prenatal GC plus a postnatal HF diet could alter immune programming in rat offspring.", {"entities": [[41, 43, "GENE"]]}], ["Pregnant Sprague-Dawley rats were given intraperitoneal injections of dexamethasone or saline at 14\u201321 days of gestation.", {"entities": []}], ["Male offspring were then divided into four groups: vehicle, prenatal dexamethasone exposure, postnatal HF diet (VHF), and prenatal dexamethasone exposure plus a postnatal HF diet (DHF).", {"entities": []}], ["The rats were sacrificed and adaptive immune function was evaluated.", {"entities": []}], ["Compared to the vehicle, the DHF group had lower interferon gamma (IFN-\u03b3) production by splenocytes at postnatal day 120.", {"entities": []}], ["Decreases in H3K9 acetylation and H3K36me3 levels at the IFN-\u03b3 promoter correlated with decreased IFN-\u03b3 production.", {"entities": []}], ["The impaired IFN-\u03b3 production and aberrant site-specific histone modification at the IFN-\u03b3 promoter by prenatal dexamethasone treatment plus a postnatal HF diet resulted in resilience at postnatal day 180.", {"entities": []}], ["Prenatal dexamethasone and a postnatal HF diet decreased IFN-\u03b3 production through a site-specific and an age-dependent histone modification.", {"entities": []}], ["These findings suggest a mechanism by which prenatal exposure to GC and a postnatal environment exert effects on fetal immunity programming.", {"entities": [[65, 67, "GENE"]]}], ["Although inequalities in health and socioeconomic status have an important influence on childhood educational performance, the interactions between these multiple factors relating to variation in educational outcomes at micro-level is unknown, and how to evaluate the many possible interactions of these factors is not well established.", {"entities": []}], ["This paper aims to examine multi-dimensional deprivation factors and their impact on childhood educational outcomes at micro-level, focusing on geographic areas having widely different disparity patterns, in which each area is characterised by six deprivation domains ( Income , Health , Geographical Access to Services , Housing , Physical Environment , and Community Safety ).", {"entities": []}], ["Traditional health statistical studies tend to use one global model to describe the whole population for macro-analysis .", {"entities": []}], ["In this paper, we combine linked educational and deprivation data across small areas (median population of 1500), then use a local modelling technique, the Takagi-Sugeno fuzzy system, to predict area educational outcomes at ages 7 and 11.", {"entities": []}], ["We define two new metrics, \u201c Micro-impact of Domain \u201d and \u201c Contribution of Domain \u201d, to quantify the variations of local impacts of multidimensional factors on educational outcomes across small areas.", {"entities": []}], ["The two metrics highlight differing priorities.", {"entities": []}], ["Our study reveals complex multi-way interactions between the deprivation domains, which could not be provided by traditional health statistical methods based on single global model.", {"entities": []}], ["We demonstrate that although Income has an expected central role, all domains contribute, and in some areas Health , Environment , Access to Services , Housing and Community Safety each could be the dominant factor.", {"entities": []}], ["Thus the relative importance of health and socioeconomic factors varies considerably for different areas, depending on the levels of each of the other factors, and therefore each component of deprivation must be considered as part of a wider system.", {"entities": []}], ["Childhood educational achievement could benefit from policies and intervention strategies that are tailored to the local geographic areas' profiles.", {"entities": []}], ["While the incidence of pertussis has increased in adolescents and adults in recent years in the U.S., little is known about the incidence and economic burden of pertussis in older adults.", {"entities": [[23, 32, "DISEASE"], [161, 170, "DISEASE"]]}], ["This study provides evidence of the incidence of pertussis and direct medical charges associated with pertussis episodes of care (PEOCs) in adults aged 50\u2009years and older in the U.S. PEOCs were divided into periods before and after the initial pertussis diagnosis was made (i.e., the index date) to capture any conditions immediately preceding the pertussis diagnosis that may have represented misdiagnoses and subsequent conditions that may have represented sequelae.", {"entities": [[49, 58, "DISEASE"], [102, 111, "DISEASE"], [244, 253, "DISEASE"], [348, 357, "DISEASE"]]}], ["Data were extracted from IMS's recently acquired SDI databases of longitudinal, patient-level practitioner claims and hospital operational billing records collected from private practitioners and hospitals, respectively, across the U.S.", {"entities": []}], ["Patients 50\u2009years and older with one or more ICD-9-CM diagnoses for pertussis/whooping cough and/or a laboratory test positive for Bordetella pertussis between 1/1/2006 and 10/31/2010 were eligible for study inclusion.", {"entities": [[68, 77, "DISEASE"], [142, 151, "DISEASE"]]}], ["Resource utilization and charges (i.e., unadjudicated claims) associated with the patient's physician and hospital care were analyzed.", {"entities": []}], ["The nationally projected incidence of pertussis was estimated using a subsample of patients with the required data necessary for projection.", {"entities": [[38, 47, "DISEASE"]]}], ["Estimated incidence of diagnosed pertussis ranged from 2.1-4.6 cases per 100,000 people across the two age groups (50\u201364 and [greater than or equal to] 65) during the years 2006 to 2010.", {"entities": [[33, 42, "DISEASE"]]}], ["The analysis of charges included 5,748 patients [greater than or equal to] 50\u2009years of age with pertussis.", {"entities": [[96, 105, "DISEASE"]]}], ["Average charges across the entire episode of care were $1,835 and $14,428 per patient in the outpatient and inpatient settings, respectively.", {"entities": []}], ["The average number of outpatient (i.e., private practitioner) visits was 2 per patient in both the pre-index and post-index periods.", {"entities": []}], ["In the U.S., the incidence of diagnosed pertussis in adults 50\u2009years and older has increased between 2006 and 2010.", {"entities": [[40, 49, "DISEASE"]]}], ["Healthcare utilization and charges associated with pertussis are substantial, suggesting the need for additional prevention and control strategies and a higher degree of clinical awareness on the part of health care providers.", {"entities": [[51, 60, "DISEASE"]]}], ["Additional research regarding pertussis in older populations is needed to substantiate these findings.", {"entities": [[30, 39, "DISEASE"]]}], ["Pancreatic islet transplantation has been considered for many years a promising therapy for beta-cell replacement in patients with type-1 diabetes despite that long-term clinical results are not as satisfactory.", {"entities": []}], ["This fact points to the necessity of designing strategies to improve and accelerate islets engraftment, paying special attention to events assuring their revascularization.", {"entities": []}], ["Fibroblasts constitute a cell population that collaborates on tissue homeostasis, keeping the equilibrium between production and degradation of structural components as well as maintaining the required amount of survival factors.", {"entities": []}], ["Our group has developed a model for subcutaneous islet transplantation using a plasma-based scaffold containing fibroblasts as accessory cells that allowed achieving glycemic control in diabetic mice.", {"entities": []}], ["Transplanted tissue engraftment is critical during the first days after transplantation, thus we have gone in depth into the graft-supporting role of fibroblasts during the first ten days after islet transplantation.", {"entities": []}], ["All mice transplanted with islets embedded in the plasma-based scaffold reversed hyperglycemia, although long-term glycemic control was maintained only in the group transplanted with the fibroblasts-containing scaffold.", {"entities": [[81, 94, "DISEASE"]]}], ["By gene expression analysis and histology examination during the first days we could conclude that these differences might be explained by overexpression of genes involved in vessel development as well as in \u03b2-cell regeneration that were detected when fibroblasts were present in the graft.", {"entities": []}], ["Furthermore, fibroblasts presence correlated with a faster graft re-vascularization, a higher insulin-positive area and a lower cell death.", {"entities": []}], ["Therefore, this work underlines the importance of fibroblasts as accessory cells in islet transplantation, and suggests its possible use in other graft-supporting strategies.", {"entities": []}], ["Many types of tree pollen trigger seasonal allergic illness, but their population-level impacts on allergy and asthma morbidity are not well established, likely due to the paucity of long records of daily pollen data that allow analysis of multi-day effects.", {"entities": [[111, 117, "DISEASE"]]}], ["Our objective in this study was therefore to determine the impacts of individual spring tree pollen types on over-the-counter allergy medication sales and asthma emergency department (ED) visits.", {"entities": [[155, 161, "DISEASE"]]}], ["Nine clinically-relevant spring tree pollen genera (elm, poplar, maple, birch, beech, ash, sycamore/London planetree, oak, and hickory) measured in Armonk, NY, were analyzed for their associations with over-the-counter allergy medication sales and daily asthma syndrome ED visits from patients\u2019 chief complaints or diagnosis codes in New York City during March 1 Mid-spring pollen types (maple, birch, beech, ash, oak, and sycamore/London planetree) showed the strongest significant associations with both outcomes, with cumulative rate ratios up to 2.0 per 0-to-98 Tree pollen peaking in mid-spring exhibit substantive impacts on allergy, and asthma exacerbations, particularly in children.", {"entities": [[261, 269, "DISEASE"], [254, 260, "DISEASE"], [644, 650, "DISEASE"]]}], ["Given the narrow time window of these pollen peak occurrences, public health and clinical approaches to anticipate and reduce allergy/asthma exacerbation should be developed.", {"entities": [[134, 140, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12940-015-0057-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["COPD exacerbation is characterized by worsening of symptoms, warranting change in treatment.", {"entities": []}], ["Systemic and airway inflammation play roles in the pathogenesis of COPD exacerbation.", {"entities": []}], ["We hypothesized whether increased serum inflammatory biomarkers are associated with the clinical outcomes of COPD exacerbation caused by different infectious pathogens.", {"entities": []}], ["COPD patients with exacerbation were recruited from a hospital emergency department during 2014\u20132015.", {"entities": []}], ["Serum procalcitonin (PCT) and C-reactive protein (CRP) were measured.", {"entities": [[50, 53, "GENE"]]}], ["Dyspnea, eosinopenia, consolidation, acidemia, and atrial fibrillation (DECAF) score was calculated for predicting mortality.", {"entities": []}], ["Multiplex polymerase chain reaction was carried out for respiratory viral assay from nasopharyngeal swabs, and sputum bacterial culture was also performed.", {"entities": []}], ["Hospital mortality, invasive mechanical ventilation requirement, and length of hospital stay (LOS) were evaluated, and their associations with clinical characteristics, DECAF score, and serum biomarkers were examined.", {"entities": []}], ["A total of 62 COPD patients were enrolled.", {"entities": []}], ["These patients were classified as Global Initiative for Obstructive Lung Disease (GOLD) stage 2, 3, and 4 in 12.9%, 6.4%, and 80.7% of cases, respectively.", {"entities": []}], ["Isolated bacterial exacerbation was recovered in 30.6% of exacerbation episodes: Klebsiella pneumoniae was the most commonly identified bacteria.", {"entities": []}], ["Viral pathogens and coinfections were noted in 9.6% and 16.1% of exacerbated patients, respectively.", {"entities": []}], ["Influenza was the most commonly detected viral pathogen.", {"entities": []}], ["Serum biomarkers and DECAF score for viruses, bacteria, coinfection, and noninfectious causes of exacerbations were similar.", {"entities": []}], ["Neither DECAF score nor serum biomarkers were able to differentiate patients with and without mortality or requiring mechanical ventilation.", {"entities": []}], ["Increased serum PCT was noted in patients with LOS \u22657 days when compared with those with LOS <7 days (0.38 ng/mL vs 0.1 ng/mL; P =0.035).", {"entities": []}], ["Increased serum PCT is associated with longer LOS in COPD exacerbation.", {"entities": []}], ["However, CRP and DECAF score play limited roles in predicting clinical outcome and lack an association with causes of exacerbation.", {"entities": [[9, 12, "GENE"]]}], ["Ethiopia lacks a complete vital registration system that would assist in measuring disease burden and risk factors.", {"entities": []}], ["We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015) estimates to describe the mortality burden from communicable, non-communicable, and other diseases in Ethiopia over the last 25\u00a0years.", {"entities": []}], ["GBD 2015 mainly used cause of death ensemble modeling to measure causes of death by age, sex, and year for 195 countries.", {"entities": []}], ["We report numbers of deaths and rates of years of life lost (YLL) for communicable, maternal, neonatal, and nutritional (CMNN) disorders, non-communicable diseases (NCDs), and injuries with 95% uncertainty intervals (UI) for Ethiopia from 1990 to 2015.", {"entities": []}], ["CMNN causes of death have declined by 65% in the last two-and-a-half decades.", {"entities": []}], ["Injury-related causes of death have also decreased by 70%.", {"entities": []}], ["Deaths due to NCDs declined by 37% during the same period.", {"entities": []}], ["Ethiopia showed a faster decline in the burden of four out of the five leading causes of age-standardized premature mortality rates when compared to the overall sub-Saharan African region and the Eastern sub-Saharan African region: lower respiratory infections, tuberculosis, HIV/AIDS, and diarrheal diseases; however, the same could not be said for ischemic heart disease and other NCDs.", {"entities": [[350, 372, "DISEASE"], [359, 372, "DISEASE"], [262, 274, "DISEASE"]]}], ["Non-communicable diseases, together, were the leading causes of age-standardized mortality rates, whereas CMNN diseases were leading causes of premature mortality in 2015.", {"entities": []}], ["Although lower respiratory infections, tuberculosis, and diarrheal disease were the leading causes of age-standardized death rates, they showed major declines from 1990 to 2015.", {"entities": [[39, 51, "DISEASE"]]}], ["Neonatal encephalopathy, iron-deficiency anemia, protein-energy malnutrition, and preterm birth complications also showed more than a 50% reduction in burden.", {"entities": [[49, 76, "DISEASE"], [30, 47, "DISEASE"], [41, 47, "DISEASE"]]}], ["HIV/AIDS-related deaths have also decreased by 70% since 2005.", {"entities": []}], ["Ischemic heart disease, hemorrhagic stroke, and ischemic stroke were among the top causes of premature mortality and age-standardized death rates in Ethiopia in 2015.", {"entities": [[0, 22, "DISEASE"], [9, 22, "DISEASE"]]}], ["Ethiopia has been successful in reducing deaths related to communicable, maternal, neonatal, and nutritional deficiency diseases and injuries by 65%, despite unacceptably high maternal and neonatal mortality rates.", {"entities": []}], ["However, the country\u2019s performance regarding non-communicable diseases, including cardiovascular disease, diabetes, cancer, and chronic respiratory disease, was minimal, causing these diseases to join the leading causes of premature mortality and death rates in 2015.", {"entities": [[116, 122, "DISEASE"]]}], ["While the country is progressing toward universal health coverage, prevention and control strategies in Ethiopia should consider the double burden of common infectious diseases and non-communicable diseases: lower respiratory infections, diarrhea, tuberculosis, HIV/AIDS, cardiovascular disease, cancer, and diabetes.", {"entities": [[248, 260, "DISEASE"], [238, 246, "DISEASE"], [296, 302, "DISEASE"]]}], ["Prevention and control strategies should also pay special attention to the leading causes of premature mortality and death rates caused by non-communicable diseases: cardiovascular disease, cancer, and diabetes.", {"entities": [[190, 196, "DISEASE"]]}], ["Measuring further progress requires a data revolution in generating, managing, analyzing, and using data for decision-making and the creation of a full vital registration system in the country.", {"entities": []}], ["The alteration of resting tension (RT) from 0.5 g to 2.5 g increased significantly airway smooth muscle contractions induced by acetylcholine (ACh) in rabbit trachea.", {"entities": []}], ["The decrease in extracellular calcium concentration [Ca o from 2 mM to 0.2 mM reduced ACh-induced contractions only at 2.5 g RT with no effect at 0.5 g RT.", {"entities": []}], ["The nonselective inhibitor of nitric oxide synthase (NOS), N o from 2 mM to 0.2 mM abolished the effect of L-NAME on ACh-induced contractions.", {"entities": []}], ["The NO precursor L-arginine or the tyrosine kinase inhibitors erbstatin A and genistein had no effect on ACh-induced contractions obtained at 2.5 g RT.", {"entities": []}], ["Our results suggest that in airways, RT affects ACh-induced contractions by modulating the activity of epithelial NOS in a calcium-dependent, tyrosine-phosphorylation-independent way.", {"entities": []}], ["Hemorrhagic shock (HS) following trauma is a leading cause of death among persons under the age of 40.", {"entities": []}], ["During HS the body undergoes systemic warm ischemia followed by reperfusion during medical intervention.", {"entities": [[43, 51, "DISEASE"]]}], ["Ischemia/reperfusion (I/R) results in a disruption of cellular metabolic processes that ultimately lead to tissue and organ dysfunction or failure.", {"entities": [[0, 8, "DISEASE"]]}], ["Resistance to I/R injury is a characteristic of hibernating mammals.", {"entities": []}], ["The present study sought to identify circulating metabolites in the rat as biomarkers for metabolic alterations associated with poor outcome after HS.", {"entities": []}], ["Arctic ground squirrels (AGS), a hibernating species that resists I/R injury independent of decreased body temperature (warm I/R), was used as a negative control.", {"entities": []}], ["Male Sprague-Dawley rats and AGS were subject to HS by withdrawing blood to a mean arterial pressure (MAP) of 35 mmHg and maintaining the low MAP for 20 min before reperfusing with Ringers.", {"entities": []}], ["The animals\u2019 temperature was maintained at 37\u00b10.5\u00b0C for the duration of the experiment.", {"entities": []}], ["Plasma samples were taken immediately before hemorrhage and three hours after reperfusion.", {"entities": []}], ["Hydrophilic and lipid metabolites from plasma were then analyzed via An increase in circulating metabolites indicative of anaerobic metabolism and activation of glycolytic pathways is associated with poor prognosis after HS in rats.", {"entities": []}], ["These same biomarkers are absent in AGS after HS with warm I/R.", {"entities": []}], ["Population-based studies have shown that migraineurs have reduced HRQoL independent of depression.", {"entities": []}], ["Furthermore, HRQoL is reduced with increasing migraine attack frequency.", {"entities": [[46, 54, "DISEASE"]]}], ["In both population-based and clinic-based studies, CDH patients have reduced HRQoL, most marked in subjects with analgesic overuse.", {"entities": []}], ["In one population-based study, no difference in HRQoL was found between patients with transformed migraine (TM) and patients with CTTH.", {"entities": [[98, 106, "DISEASE"]]}], ["However, the number of patients in this study was relatively small.", {"entities": []}], ["In a clinic-based study, SF-36 scores in patients with chronic daily headache (CDH) depended on the percentage of the type of patients in the sample: the greater the proportion of patientsa with TM, the more impaired the SF-36 scores.", {"entities": []}], ["Haemoptysis is a common clinical symptom.", {"entities": []}], ["A small proportion of patients present with haemoptysis and normal chest radiograph.", {"entities": []}], ["The investigation strategy for this group of patients is unclear.", {"entities": []}], ["The aim of this study is to see whether further investigations for this group of patients are justified.", {"entities": []}], ["A retrospective analysis was conducted of consecutive patients presenting with haemoptysis and normal chest radiograph over a period of 56 months irrespective of their smoking status.", {"entities": []}], ["These patients were investigated by CT of the thorax and fibreoptic bronchoscopy.", {"entities": []}], ["275 episodes of haemoptysis with normal chest radiograph were investigated further in 270 patients (60% males).", {"entities": []}], ["The median age was 60 years.", {"entities": []}], ["Twenty-six patients were diagnosed to have respiratory tract malignancies (larynx, 1; trachea, 1; lung, 22; carcinoid, 1; and leiomyoma, 1).", {"entities": [[126, 135, "DISEASE"]]}], ["Eight (31%) of the 26 patients with respiratory tract malignancy had radical treatment.", {"entities": []}], ["Fibreoptic bronchoscopy was diagnostic of cancer in 14 (54%) of the 26 patients with malignancy.", {"entities": [[42, 48, "DISEASE"]]}], ["CT of the thorax was suggestive of cancer in 24 (96%) of the 25 patients with malignancy.", {"entities": [[35, 41, "DISEASE"]]}], ["It is concluded that further investigation of haemoptysis in smokers is justified regardless of the amount or frequency of haemoptysis based on a 9.6% rate of malignancy in this consecutive series.", {"entities": []}], ["It is recommended that these patients are investigated with CT of the thorax followed by fibreoptic bronchoscopy.", {"entities": []}], ["Genetic susceptibility plays a key role in the development of nasopharyngeal carcinoma (NPC) and in fact the disease presents with an unusually high incidence in certain regions of the world like North Africa.", {"entities": [[77, 86, "DISEASE"]]}], ["We investigated the association between polymorphism of the Transforming growth factor-\u03b21 (TGF-\u03b21) and risk of NPC in North Africa.", {"entities": []}], ["TGF-\u03b21 is a multifunctional cytokine that acts as both a tumor suppressor and a stimulator of cancer development; it has been shown to influence risk of numerous other carcinomas including lung, breast and prostate cancer.", {"entities": [[94, 100, "DISEASE"], [215, 221, "DISEASE"], [206, 221, "DISEASE"]]}], ["TGF-\u03b21 polymorphisms C-509T and T869C were studied in a large North African sample of 384 NPC cases and 361 controls, matched for age, sex and urban or rural residence in childhood.", {"entities": []}], ["Genotypes were determined using polymerase chain reaction\u2013restriction fragment length polymorphism.", {"entities": []}], ["No association was observed between individual single nucleotide polymorphisms or their haplotypes and NPC susceptibility (for TGF-\u03b21 C-509T: OR\u2009=\u20090.74; 95\u00a0% CI 0.46\u2009\u2212\u20091.18; for TGF-\u03b21 T869C: OR\u2009=\u20090.86; 95\u00a0% CI 0.56\u2009\u2212\u20091.31), even when the samples were stratified by age, gender and TNM stage.", {"entities": []}], ["Contrary to what has been observed in Asian samples, in our North African sample, the TGF-\u03b21 C-509T and T869C polymorphisms did not substantially influence NPC susceptibility.", {"entities": []}], ["The online version of this article (doi:10.1186/s12881-016-0337-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Systematic bibliography analysis of about the last 17 years on multiple chemical sensitivity (MCS) was carried out in order to detect new diagnostic and epidemiological evidence.", {"entities": [[63, 92, "DISEASE"]]}], ["The MCS is a complex syndrome that manifests as a result of exposure to a low level of various common contaminants.", {"entities": [[21, 29, "DISEASE"]]}], ["The etiology, diagnosis, and treatment are still debated among researchers.", {"entities": []}], ["Querying PubMed, Web of Science, Scopus, Cochrane library, both using some specific MESH terms combined with MESH subheadings and through free search, even by Google.", {"entities": []}], ["The studies were analyzed by verifying 1) the typology of study design; 2) criteria for case definition; 3) presence of attendances in the emergency departments and hospital admissions, and 4) analysis of the risk factors.", {"entities": []}], ["With this review, we give some general considerations and hypothesis for possible future research.", {"entities": []}], ["Patient\u2010centred communication is a key component of patient centredness in medical care.", {"entities": []}], ["Therefore, adequate education in and assessment of patient\u2010centred communication skills are necessary.", {"entities": []}], ["In general, feedback on communication skills is most effective when it is provided directly and is systematic.", {"entities": []}], ["This calls for adequate measurement instruments.", {"entities": []}], ["The aim of this study was to provide a systematic review of existing instruments that measure patient centredness in doctor\u2013patient communication and can be used to provide direct feedback.", {"entities": []}], ["A systematic review was conducted using an extensive validated search strategy for measurement instruments in PubMed, EMBASE , Psyc INFO and CINAHL .", {"entities": []}], ["The databases were searched from their inception to 1 July 2016.", {"entities": []}], ["Articles describing the development or evaluation of the measurement properties of instruments that measure patient centredness (by applying three or more of the six dimensions of a published definition of patient centredness) in doctor\u2013patient communication and that can be used for the provision of direct feedback were included.", {"entities": []}], ["The methodological quality of measurement properties was evaluated using the COSMIN checklist.", {"entities": []}], ["Thirteen articles describing 14 instruments measuring patient centredness in doctor\u2013patient communication were identified.", {"entities": []}], ["These studies cover a wide range of settings and patient populations, and vary in the dimensions of patient centredness applied and in methodological quality on aspects of reliability and validity.", {"entities": []}], ["This review gives a comprehensive overview of all instruments available for the measurement of patient centredness in doctor\u2013patient communication that can be used for the provision of direct feedback and are described in the literature.", {"entities": []}], ["Despite the widely felt need for valid and reliable instruments for the measurement of patient\u2010centred communication, most of the instruments currently available have not been thoroughly investigated.", {"entities": []}], ["Therefore, we recommend further research into and enhancement of existing instruments in terms of validity and reliability, along with enhancement of their generalisability, responsiveness and aspects of interpretability in different contexts (real patients, simulated patients, doctors in different specialties, etc.).", {"entities": []}], ["Comprehensibility and feasibility should also be taken into account.", {"entities": []}], ["The aims of the present study are to describe the characteristics of rheumatoid arthritis (RA) patients selected for tocilizumab (TCZ), compare the \u201creal-world\u201d effectiveness of TCZ and tumour necrosis factor inhibitors (TNFi) when used as a first biologic and assess the influence of past biologic exposure/concurrent methotrexate (MTX) therapy on post-TCZ treatment outcomes.", {"entities": [[69, 89, "DISEASE"], [80, 89, "DISEASE"]]}], ["The British Society for Rheumatology Biologics Register (BSRBR-RA) is a prospective cohort study following RA patients starting biologics in the UK.", {"entities": []}], ["This includes patients starting TCZ as first or subsequent biologic, alongside biologic-na\u00efve patients starting TNFi.", {"entities": []}], ["Six-month disease activity and 1-year drug survival were compared between biologic-na\u00efve patients starting TCZ versus TNFi and first-line versus subsequent TCZ users and TCZ users with MTX versus without using regression models adjusted by propensity score.", {"entities": []}], ["Two hundred seventeen patients started TCZ, and 2419 started TNFi as first biologic.", {"entities": []}], ["Seven hundred seventy-seven started TCZ after other biologics.", {"entities": []}], ["First-line TCZ users had a higher prevalence of pulmonary fibrosis and cancer history than TNFi users.", {"entities": [[48, 66, "DISEASE"], [71, 77, "DISEASE"]]}], ["The first-line TCZ users were more likely to achieve DAS28 remission at 6\u00a0months than first-line TNFi, but other improvement markers were similar.", {"entities": []}], ["The treatment response at 6\u00a0months was similar between subsequent-line TCZ users and first-line users after adjusting for baseline patient differences.", {"entities": []}], ["Concurrent MTX use was not associated with treatment response in either first- or subsequent-line TCZ users.", {"entities": []}], ["TCZ has been primarily used as subsequent-line biologic in the UK.", {"entities": []}], ["When used as first line, the response appears similar to that observed in patients starting TNFi, suggesting that clinical response alone should not decide between initial biologic therapies.", {"entities": []}], ["The online version of this article (doi:10.1007/s10067-016-3485-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To investigate the range of pathologies treated by pancreas preserving distal duodenectomy (PPDD) and present the outcome of follow-up.", {"entities": []}], ["Neoplastic lesions of the duodenum are treated conventionally by pancreaticoduodenectomy.", {"entities": []}], ["Lesions distal to the major papilla may be suitable for a pancreas-preserving distal duodenectomy, potentially reducing morbidity and mortality.", {"entities": []}], ["We present our experience with this procedure.", {"entities": []}], ["Selective intraoperative duodenoscopy assessed the relationship of the papilla to the lesion.", {"entities": []}], ["After duodenal mobilisation and confirmation of the site of the lesion, the duodenum was transected distal to the papilla and beyond the duodenojejunal flexure and a side-to-side duodeno-jejunal anastomosis was formed.", {"entities": []}], ["Patients were identified from a prospectively maintained database and outcomes determined from digital health records with a dataset including demographics, co-morbidities, mode of presentation, preoperative imaging and assessment, nutritional support needs, technical operative details, blood transfusion requirements, length of stay, pathology including lymph node yield and lymph node involvement, length of follow-up, complications and outcomes.", {"entities": []}], ["Related published literature was also reviewed.", {"entities": []}], ["Twenty-four patients had surgery with the intent of performing PPDD from 2003 to 2016.", {"entities": []}], ["Nineteen underwent PPDD successfully.", {"entities": []}], ["Two patients planned for PPDD proceeded to formal pancreaticoduodenectomy (PD) while three had unresectable disease.", {"entities": []}], ["Median post-operative follow-up was 32 mo.", {"entities": []}], ["Pathologies resected included duodenal adenocarcinoma ( n = 6), adenomas ( n = 5), gastrointestinal stromal tumours ( n = 4) and lipoma, bleeding duodenal diverticulum, locally advanced colonic adenocarcinoma and extrinsic compression ( n = 1 each).", {"entities": [[39, 53, "DISEASE"], [194, 208, "DISEASE"], [129, 135, "DISEASE"]]}], ["Median postoperative length of stay (LOS) was 8 d and morbidity was low [pain and nausea/vomiting ( n = 2), anastomotic stricture ( n = 1), pneumonia ( n = 1), and overwhelming post-splenectomy sepsis ( n = 1, asplenic patient)].", {"entities": [[140, 149, "DISEASE"]]}], ["PPDD was associated with a significantly shorter LOS than a contemporaneous PD series [PPDD 8 (6-14) d vs PD 11 (10-16) d, median (IQR), P = 0.026].", {"entities": []}], ["The 30-d mortality was zero and 16 of 19 patients are alive to date.", {"entities": []}], ["One patient died of recurrent duodenal adenocarcinoma 18 mo postoperatively and two died of unrelated disease (at 2 mo and at 8 years respectively).", {"entities": [[39, 53, "DISEASE"]]}], ["PPDD is a versatile operation that can provide definitive treatment for a range of duodenal pathologies including adenocarcinoma.", {"entities": [[114, 128, "DISEASE"]]}], ["Because of its relevance to the functioning of the central nervous system, brain-derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of different neuropsychiatric diseases.", {"entities": [[110, 114, "GENE"]]}], ["Whether the BDNF level can be a marker of brain dysfunction and thus predict mortality in critically ill patients is not known.", {"entities": [[12, 16, "GENE"]]}], ["Thus we aimed to determine whether the plasma levels of BDNF are associated with morbidity and mortality in critically ill patients.", {"entities": [[56, 60, "GENE"]]}], ["Healthy volunteers ( n = 40) and consecutive patients older than 18 years ( n = 76) admitted for more than 24 hours in an Intensive Care Unit (ICU) in a University hospital between July and October 2010 were included in the present study.", {"entities": []}], ["First blood samples were collected within 12 hours of enrollment (D0), and a second sample, 48 hours after (D2) for determination of plasma BDNF levels.", {"entities": [[140, 144, "GENE"]]}], ["The relation between BDNF levels and mortality was the primary outcome.", {"entities": [[21, 25, "GENE"]]}], ["The secondary outcomes were the relation between BDNF levels and delirium and coma-free days (DCFD) and ICU and hospital length of stay (LOS).", {"entities": [[49, 53, "GENE"]]}], ["Admission plasma levels of BDNF were higher in ICU patients when compared with healthy volunteers (1,536 (962) versus 6,565 (2,838) pg/ml).", {"entities": [[27, 31, "GENE"]]}], ["The mean BDNF D2 was significantly lower in nonsurvivor patients (5,865 (2,662) versus 6,741 (2,356) pg/ml).", {"entities": [[9, 13, "GENE"]]}], ["After adjusting for covariates, BDNF levels, the need for mechanical ventilation, and sepsis were associated with mortality.", {"entities": [[32, 36, "GENE"]]}], ["Even in patients without clinically detectable brain dysfunction, lower BDNF D2 levels were associated with mortality.", {"entities": [[72, 76, "GENE"]]}], ["BDNF D2 had a mild correlation to DCFD ( r = 0.44), but not to ICU and hospital LOS.", {"entities": [[0, 4, "GENE"]]}], ["In addition, plasma BDNF did not correlate to different plasma cytokines and platelets levels.", {"entities": [[20, 24, "GENE"]]}], ["The plasma levels of BDNF were independently associated with mortality, even in the absence of clinically detectable brain dysfunction.", {"entities": [[21, 25, "GENE"]]}], ["Deteriorative environmental conditions in environmental justice (EJ) communities not only post direct health risks such as chronic illnesses, but also cause emotional distress such as anxiety, fear, and anger among residents, which may further exacerbate health risks.", {"entities": []}], ["This study applies a descriptive phenomenological method to explore and describe the emotional experience of residents living in Ironbound, a known EJ community located in Newark, New Jersey.", {"entities": []}], ["Twenty-three residents participated in the study.", {"entities": []}], ["Four essential themes regarding the residents\u2019 emotional experiences were elicited from 43 interviews: (1) being worried about the harmful effects of the surrounding pollution; (2) being distressed by the known historical pollution sources; (3) being frustrated by the unheard voices and/or lack of responses; and (4) being angered by the ongoing pollution sources.", {"entities": []}], ["Participants not only expressed their emotions of worry, distress, frustration, and anger in detail but also described reasons or situations that provoked such negative emotions.", {"entities": []}], ["Such detailed depictions provide insights into potential meaningful strategies to improve residents\u2019 psychological wellbeing by alleviating negative emotions and meaningfully engaging residents in developing, implementing, and enforcing environmental laws, regulations, and policies to achieve EJ goals.", {"entities": []}], ["Platelet-activating factor (PAF) has been long believed to be associated with many pathophysiological processes during septic shock.", {"entities": []}], ["Here we present novel activities for PAF in protecting mice against LPS-mediated endotoxic shock.", {"entities": []}], ["In vivo PAF treatment immediately after LPS challenge markedly improved the survival rate against mortality from endotoxic shock.", {"entities": []}], ["Administration of PAF prominently attenuated LPS-induced organ injury, including profound hypotension, excessive polymorphonuclear neutrophil infiltration, and severe multiple organ failure.", {"entities": []}], ["In addition, PAF treatment protects against LPS-induced lymphocytes apoptosis.", {"entities": []}], ["These protective effects of PAF was correlated with significantly decreases in the production of the inflammatory mediators such as TNF-\u03b1, IL-1\u03b2, IL-12, and IFN-\u03b3, while increasing production of the anti-inflammatory cytokine IL-10 in vivo and in vitro .", {"entities": []}], ["Taken together, these results suggest that PAF may protect mice against endotoxic shock via a complex mechanism involving modulation of inflammatory and anti-inflammatory mediators.", {"entities": []}], ["Genetic effects on asthma of genes in the T-helper 2 (Th2) pathway may interact with epigenetic factors including DNA methylation.", {"entities": [[19, 25, "DISEASE"]]}], ["We hypothesized that interactions between genetic variants and methylation in genes in this pathway ( IL4 , IL4R , IL13 , GATA3 , and STAT6 ) influence asthma risk, that such influences are age-dependent, and that methylation of some CpG sites changes over time in accordance with asthma transition.", {"entities": [[152, 158, "DISEASE"], [281, 287, "DISEASE"], [102, 105, "GENE"], [108, 112, "GENE"], [115, 119, "GENE"], [122, 127, "GENE"], [134, 139, "GENE"]]}], ["We tested these hypotheses in subsamples of girls from a population-based birth cohort established on the Isle of Wight, UK, in 1989.", {"entities": []}], ["Logistic regression models were applied to test the interaction effect of DNA methylation and SNP on asthma within each of the five genes.", {"entities": [[101, 107, "DISEASE"]]}], ["Bootstrapping was used to assess the models identified.", {"entities": []}], ["From 1,361 models fitted at each age of 10 and 18\u00a0years, 8 models, including 4 CpGs and 8 SNPs, showed potential associations with asthma risk.", {"entities": [[131, 137, "DISEASE"]]}], ["Of the 4 CpGs, methylation of cg26937798 ( IL4R ) and cg23943829 ( IL4 ) changes between ages 10 and 18 (both higher at 10; P \u2009=\u20099.14\u2009\u00d7\u200910 At age 10, the odds of asthma tended to decrease as cg12405139 ( GATA3 ) methylation increased (log-OR\u2009=\u2009\u221212.15; P \u2009=\u20090.049); this effect disappeared by age 18.", {"entities": [[162, 168, "DISEASE"], [43, 47, "GENE"], [67, 70, "GENE"], [204, 209, "GENE"]]}], ["At age 18, methylation of cg09791102 ( IL4R ) was associated with higher risk of asthma among subjects with genotype GG compared to AG ( P \u2009=\u20090.003), increased cg26937798 methylation among subjects with rs3024685 ( IL4R ) genotype AA ( P \u2009=\u20090.003) or rs8832 ( IL4R ) genotype GG ( P \u2009=\u20090.01) was associated with a lower asthma risk; these CpGs had no effect at age 10.", {"entities": [[81, 87, "DISEASE"], [320, 326, "DISEASE"], [39, 43, "GENE"], [215, 219, "GENE"], [260, 264, "GENE"], [39, 43, "GENE"], [215, 219, "GENE"], [260, 264, "GENE"], [39, 43, "GENE"], [215, 219, "GENE"], [260, 264, "GENE"]]}], ["Increasing cg26937798 methylation over time possibly reduced the risk of positive asthma transition (asthma-free at age 10\u2009\u2192\u2009asthma at age 18; log-OR\u2009=\u2009\u22123.11; P \u2009=\u20090.069) and increased the likelihood of negative transition (asthma at age 10\u2009\u2192\u2009asthma-free at age 18; log-OR\u2009=\u20093.97; P \u2009=\u20090.074).", {"entities": [[82, 88, "DISEASE"], [101, 107, "DISEASE"], [125, 131, "DISEASE"], [224, 230, "DISEASE"], [243, 249, "DISEASE"]]}], ["The interaction of DNA methylation and SNPs in Th2 pathway genes is likely to contribute to asthma risk.", {"entities": [[92, 98, "DISEASE"]]}], ["This effect may vary with age.", {"entities": []}], ["Methylation of some CpGs changed over time, which may influence asthma transition.", {"entities": [[64, 70, "DISEASE"]]}], ["To compare cancer screening and flu vaccination among persons with and without unhealthy substance use.", {"entities": [[11, 17, "DISEASE"]]}], ["The authors analysed data from 4804 women eligible for mammograms, 4414 eligible for Papanicolou (Pap) smears, 7008 persons eligible for colorectal cancer (CRC) screening and 7017 persons eligible for flu vaccination.", {"entities": [[137, 154, "DISEASE"], [148, 154, "DISEASE"]]}], ["All patients were screened for unhealthy substance use.", {"entities": []}], ["The main outcome was completion of cancer screening and flu vaccination.", {"entities": [[35, 41, "DISEASE"]]}], ["Among the 9995 patients eligible for one or more of the preventive services of interest, 10% screened positive for unhealthy substance use.", {"entities": []}], ["Compared with women without unhealthy substance use, women with unhealthy substance use received mammograms less frequently (75.4% vs 83.8%; p<0.0001), but Pap smears no less frequently (77.9% vs 78.1%).", {"entities": []}], ["Persons with unhealthy substance use received CRC screening no less frequently (61.7% vs 63.4%), yet received flu vaccination less frequently (44.7% vs 50.4%; p=0.01).", {"entities": []}], ["In multivariable analyses, women with unhealthy substance use were less likely to receive mammograms (adjusted odds ratio 0.68; 95% CI 0.52 to 0.89), and persons with unhealthy substance use were less likely to receive flu vaccination (adjusted odds ratio 0.81; 95% CI 0.67 to 0.97).", {"entities": []}], ["Unhealthy substance use is a risk factor for not receiving all appropriate preventive health services.", {"entities": []}], ["Do persons with unhealthy substance use receive breast, cervical and colorectal cancer screening less frequently than persons without unhealthy substance use?", {"entities": [[69, 86, "DISEASE"], [80, 86, "DISEASE"]]}], ["Do persons with unhealthy substance use receive flu vaccination less frequently than persons without unhealthy substance use?", {"entities": []}], ["Women with unhealthy substance use are less likely to receive mammograms than women without unhealthy substance use.", {"entities": []}], ["Persons with unhealthy substance use are less likely to receive flu vaccination than persons without unhealthy substance use.", {"entities": []}], ["Unhealthy substance use is not a risk factor for not receiving cervical or colorectal cancer screening.", {"entities": [[75, 92, "DISEASE"], [86, 92, "DISEASE"]]}], ["Strengths: the study used validated measures of unhealthy substance use and encompassed a wide range of substance-use severity.", {"entities": []}], ["Limitations: the findings from our sample of an inner-city patient population with health insurance and access to care who receive primary care at an urban safety-net hospital may not be generalisable to other patient populations.", {"entities": []}], ["The study cannot determine whether unhealthy substance use causes patients not to receive certain services, or whether screening, brief intervention and substance-use treatment led some patients to complete screenings or vaccination.", {"entities": []}], ["The study did not obtain records of services performed outside Boston Medical Center, and relied on patient self-report of substance use.", {"entities": []}], ["A large body of evidence has now accumulated describing the advantages of multiple breath washout tests over conventional spirometry in cystic fibrosis (CF).", {"entities": [[136, 151, "DISEASE"]]}], ["Although the majority of studies have used exogenous sulphur hexafluoride (SF 6 ) as the tracer gas this has also led to an increased interest in nitrogen washout tests, despite the differences between these methods.", {"entities": []}], ["The impact of body nitrogen excreted across the alveoli has previously been ignored.", {"entities": []}], ["A two-compartment lung model was developed that included ventilation heterogeneity and dead space (DS) effects, but also incorporated experimental data on nitrogen excretion.", {"entities": []}], ["The model was used to assess the impact of nitrogen excretion on washout progress and accuracy of functional residual capacity (FRC) and lung clearance index (LCI) measurements.", {"entities": []}], ["Excreted nitrogen had a small effect on accuracy of FRC (1.8%) in the healthy adult model.", {"entities": []}], ["The error in LCI calculated with true FRC was greater (6.3%), and excreted nitrogen contributed 21% of the total nitrogen concentration at the end of the washout.", {"entities": []}], ["Increasing DS and ventilation heterogeneity both caused further increase in measurement error.", {"entities": []}], ["LCI was increased by 6\u201313% in a CF child model, and excreted nitrogen increased the end of washout nitrogen concentration by 24\u201349%.", {"entities": []}], ["Excreted nitrogen appears to have complex but clinically significant effects on washout progress, particularly in the presence of abnormal gas mixing.", {"entities": []}], ["This may explain much of the previously described differences in washout outcomes between SF 6 and nitrogen.", {"entities": []}], ["Despite its reported pro-inflammatory activity, cyclooxygenase (COX)-2 has been proposed to play a protective role in asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["Accordingly, COX-2 might be down-regulated in the airway cells of asthmatics.", {"entities": []}], ["This, together with results of experiments to assess the impact of COX-2 blockade in ovalbumin (OVA)-sensitized mice in vivo, led us to propose a novel experimental approach using house dust mite (HDM)-sensitized mice in which we mimicked altered regulation of COX-2.", {"entities": []}], ["Allergic inflammation was induced in BALBc mice by intranasal exposure to HDM for 10 consecutive days.", {"entities": []}], ["This model reproduces spontaneous exposure to aeroallergens by asthmatic patients.", {"entities": []}], ["In order to impair, but not fully block, COX-2 production in the airways, some of the animals received an intranasal antisense oligonucleotide.", {"entities": []}], ["Lung COX-2 expression and activity were measured along with bronchovascular inflammation, airway reactivity, and prostaglandin production.", {"entities": []}], ["We observed impaired COX-2 mRNA and protein expression in the lung tissue of selective oligonucleotide-treated sensitized mice.", {"entities": []}], ["This was accompanied by diminished production of mPGE synthase and PGE 2 in the airways.", {"entities": []}], ["In sensitized mice, the oligonucleotide induced increased airway hyperreactivity (AHR) to methacholine, but a substantially reduced bronchovascular inflammation.", {"entities": [[82, 85, "GENE"]]}], ["Finally, mRNA levels of hPGD synthase remained unchanged.", {"entities": [[24, 28, "GENE"]]}], ["Intranasal antisense therapy against COX-2 in vivo mimicked the reported impairment of COX-2 regulation in the airway cells of asthmatic patients.", {"entities": []}], ["This strategy revealed an unexpected novel dual effect: inflammation was improved but AHR worsened.", {"entities": [[86, 89, "GENE"]]}], ["This approach will provide insights into the differential regulation of inflammation and lung function in asthma, and will help identify pharmacological targets within the COX-2/PG system.", {"entities": [[106, 112, "DISEASE"]]}], ["An increase in autoimmune diseases poses a socioeconomic challenge worldwide.", {"entities": []}], ["Predisposing genetic risk has been identified, yet environmental factors make up a significant part of the risk in disease initiation and propagation.", {"entities": []}], ["Next to improved hygiene and a gross reduction of infections, changes in dietary habits are one of the most evident Western lifestyle factors potentially associated with the increase in autoimmune diseases.", {"entities": []}], ["Growing evidence suggests that particularly a typical \u2018Western diet\u2019, rich in saturated fat and salt and related pathologies can have a profound impact on local and systemic immune responses under physiologic and autoimmune conditions such as in multiple sclerosis (MS).", {"entities": [[246, 264, "DISEASE"]]}], ["In this review, we discuss recent findings on environmental factors influencing autoimmunity with an emphasis on the impact of \u2018Western diet\u2019 on immune homeostasis and gut microbiota in MS.", {"entities": []}], ["Single nucleotide polymorphisms (SNPs) can lead to the susceptibility and onset of diseases through their effects on gene expression at the posttranscriptional level.", {"entities": []}], ["Recent findings indicate that SNPs could create, destroy, or modify the efficiency of miRNA binding to the 3'UTR of a gene, resulting in gene dysregulation.", {"entities": []}], ["With the rapidly growing number of published disease-associated SNPs (dSNPs), there is a strong need for resources specifically recording dSNPs on the 3'UTRs and their nucleotide distance from miRNA target sites.", {"entities": []}], ["We present here miRdSNP, a database incorporating three important areas of dSNPs, miRNA target sites, and diseases.", {"entities": []}], ["miRdSNP provides a unique database of dSNPs on the 3'UTRs of human genes manually curated from PubMed.", {"entities": []}], ["The current release includes 786 dSNP-disease associations for 630 unique dSNPs and 204 disease types.", {"entities": []}], ["miRdSNP annotates genes with experimentally confirmed targeting by miRNAs and indexes miRNA target sites predicted by TargetScan and PicTar as well as potential miRNA target sites newly generated by dSNPs.", {"entities": []}], ["A robust web interface and search tools are provided for studying the proximity of miRNA binding sites to dSNPs in relation to human diseases.", {"entities": []}], ["Searches can be dynamically filtered by gene name, miRBase ID, target prediction algorithm, disease, and any nucleotide distance between dSNPs and miRNA target sites.", {"entities": []}], ["Results can be viewed at the sequence level showing the annotated locations for miRNA target sites and dSNPs on the entire 3'UTR sequences.", {"entities": []}], ["The integration of dSNPs with the UCSC Genome browser is also supported.", {"entities": []}], ["miRdSNP provides a comprehensive data source of dSNPs and robust tools for exploring their distance from miRNA target sites on the 3'UTRs of human genes.", {"entities": []}], ["miRdSNP enables researchers to further explore the molecular mechanism of gene dysregulation for dSNPs at posttranscriptional level.", {"entities": []}], ["miRdSNP is freely available on the web at http://mirdsnp.ccr.buffalo.edu .", {"entities": []}], ["This was a diagnostic accuracy study to develop an algorithm based on administrative database codes that identifies patients with Chronic Rhinosinusitis (CRS) who have endoscopic sinus surgery (ESS).", {"entities": []}], ["From January 1 During the study period, 347 cases and 185,007 controls were identified.", {"entities": []}], ["The predictive model assigned cases to all encounters that contained at least one CRS ICD-10 diagnostic code and at least one ESS CCI procedural code.", {"entities": []}], ["Compared to the reference standard, the algorithm was very accurate: sensitivity 96.0% (95%CI 93.2\u201397.7), specificity 100% (95% CI 99.9\u2013100), and positive predictive value 95.4% (95%CI 92.5\u201397.3).", {"entities": []}], ["Internal validation using chart review for the following year revealed similar accuracy: sensitivity 98.9% (95%CI 95.8\u201399.8), specificity 97.1% (95%CI 93.4\u201398.8), and positive predictive value 96.9% (95%CI 93.0\u201399.8).", {"entities": []}], ["A simple model based on administrative database codes accurately identified ESS-CRS encounters.", {"entities": []}], ["This model can be used in population-based cohorts to study longitudinal outcomes for the ESS-CRS population.", {"entities": []}], ["The proposed biosynthetic pathways to ladder polyethers of polyketide origin and oxasqualenoids of terpenoid origin share a dramatic epoxide-opening cascade as a key step.", {"entities": []}], ["Polycyclic structures generated in these biosynthetic pathways display biological effects ranging from potentially therapeutic properties to extreme lethality.", {"entities": []}], ["Much of the structural complexity of ladder polyether and oxasqualenoid natural products can be traced to these hypothesized cascades.", {"entities": []}], ["In this review we summarize how such epoxide-opening cascade reactions have been used in the synthesis of ladder polyethers and oxasqualenoid natural products.", {"entities": []}], ["A previously healthy 55-year-old man with H1N1 influenza A presented with severe respiratory failure and cardiac arrest.", {"entities": [[81, 100, "DISEASE"], [47, 56, "DISEASE"]]}], ["Following the return of spontaneous circulation, venovenous extracorporeal membrane oxygenation was required to maintain oxygenation.", {"entities": []}], ["On day 2, bronchoscopy revealed a bloody bronchial cast obstructing the right main bronchus.", {"entities": []}], ["A pathological examination revealed that it was composed of intrabronchial and intra-alveolar hemorrhagic tissue.", {"entities": []}], ["Unfortunately, the patient died due to severe brain ischemia; a subsequent autopsy revealed marked alveolar hemorrhage.", {"entities": [[46, 60, "DISEASE"], [52, 60, "DISEASE"]]}], ["It is possible that anticoagulant therapy, alveolar collapse, and neuromuscular blocking agents provoked cast development in this case.", {"entities": []}], ["TNF\u03b1 may contribute to the pathophysiology of airway inflammation.", {"entities": []}], ["For example, we have recently shown that nasal administration of TNF\u03b1 produces late phase co-appearance of granulocyte and plasma exudation markers on the mucosal surface.", {"entities": []}], ["The objective of the present study was to examine indices of granulocyte presence and activity in response to intranasal TNF\u03b1 challenge.", {"entities": []}], ["Healthy subjects and patients with allergic rhinitis (examined out of season) were subjected to nasal challenge with TNF\u03b1 (10 \u03bcg) in a sham-controlled and crossover design.", {"entities": [[35, 52, "DISEASE"], [44, 52, "DISEASE"]]}], ["Nasal lavages were carried out prior to and 24 hours post challenge.", {"entities": []}], ["Nasal biopsies were obtained post challenge.", {"entities": []}], ["Nasal lavage fluid levels of myeloperoxidase (MPO) and eosinophil cationic protein (ECP) were analyzed as indices of neutrophil and eosinophil activity.", {"entities": [[46, 49, "GENE"]]}], ["Moreover, IL-8 and \u03b1 2 -macroglobulin were analyzed as markers of pro-inflammatory cytokine production and plasma exudation.", {"entities": []}], ["Nasal biopsy numbers of neutrophils and eosinophils were monitored.", {"entities": []}], ["Nasal lavage fluid levels of MPO recorded 24 hours post TNF\u03b1 challenge were increased in healthy subjects (p = 0.0081) and in patients with allergic rhinitis (p = 0.0081) ( c.f .", {"entities": [[140, 157, "DISEASE"], [149, 157, "DISEASE"], [29, 32, "GENE"]]}], ["sham challenge).", {"entities": []}], ["Similarly, \u03b1 2 -macroglobulin was increased in healthy subjects (p = 0.014) and in patients with allergic rhinitis (p = 0.0034).", {"entities": [[97, 114, "DISEASE"], [106, 114, "DISEASE"]]}], ["Lavage fluid levels of ECP and IL-8 were not affected by TNF\u03b1 challenge.", {"entities": []}], ["TNF\u03b1 increased the numbers of subepithelial neutrophils (p = 0.0021), but not the numbers of eosinophils.", {"entities": []}], ["TNF\u03b1 produces a nasal inflammatory response in humans that is characterised by late phase (i.e., 24 hours post challenge) neutrophil activity and plasma exudation.", {"entities": []}], ["Respiratory symptoms are associated with accelerated lung function decline, and increased hospitalization and mortality rates in the general population.", {"entities": []}], ["Although several environmental risk factors for respiratory symptoms are known, knowledge on genetic risk factors is lacking.", {"entities": []}], ["We aim to identify genetic variants associated with respiratory symptoms by genome-wide association (GWA) analyses.", {"entities": []}], ["We conducted the first GWA study on cough, dyspnea and phlegm among 7,976 participants in the LifeLines I cohort and used the LifeLines II cohort ( n\u2009= \u20095,260) and the Vlagtwedde-Vlaardingen cohort ( n\u2009= \u20091,529) for replication.", {"entities": []}], ["We identified 50 SNPs that were assessed for replication.", {"entities": []}], ["Rs16918212, located in the alpha-2-macroglobulin pseudogene 1 ( A2MP1 ), was associated with cough in both the identification (odds ratio (OR)\u2009=\u20090.72, p\u2009= \u20095.41\u2009\u00d7\u200910 p\u2009= \u00a00.033).", {"entities": []}], ["No other significant replicated associations were found.", {"entities": []}], ["Given that only 1 out of 50 SNPs showed significant replication (i.e.", {"entities": []}], ["2%) we conclude that we did not find a convincing association between genetic markers and respiratory symptoms.", {"entities": []}], ["Since, environmental exposures are important risk factors for respiratory symptoms, the next step is to perform a genome-wide interaction (GWI) study to identify genetic susceptibility loci for respiratory symptoms in interaction with known harmful environmental exposures.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0495-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The deleterious effects of ambient air pollution on human health have been consistently documented by many epidemiologic studies worldwide, and it has been calculated that globally at least seven million deaths are annually attributable to the effects of air pollution.", {"entities": []}], ["The major air pollutants emitted into the atmosphere by a number of natural processes and human activities include nitrogen oxides, volatile organic compounds, and particulate matter.", {"entities": []}], ["In addition to the poor ambient air quality, there is increasing evidence that indoor air pollution also poses a serious threat to human health, especially in low-income countries that still use biomass fuels as an energy resource.", {"entities": []}], ["This review summarizes the current knowledge on ambient air pollution in financially deprived populations.", {"entities": []}], ["Rhinovirus, the most common cause of upper respiratory tract infections, has been implicated in asthma exacerbations and possibly asthma deaths.", {"entities": [[96, 102, "DISEASE"], [130, 136, "DISEASE"]]}], ["Although the method of transmission of rhinoviruses is disputed, several studies have demonstrated that aerosol transmission is a likely method of transmission among adults.", {"entities": []}], ["As a first step in studies of possible airborne rhinovirus transmission, we developed methods to detect aerosolized rhinovirus by extending existing technology for detecting infectious agents in nasal specimens.", {"entities": []}], ["We aerosolized rhinovirus in a small aerosol chamber.", {"entities": []}], ["Experiments were conducted with decreasing concentrations of rhinovirus.", {"entities": []}], ["To determine the effect of UV irradiation on detection of rhinoviral aerosols, we also conducted experiments in which we exposed aerosols to a UV dose of 684 mJ/m We obtained positive results from filter samples that had collected at least 1.3 TCID 50 of aerosolized rhinovirus.", {"entities": []}], ["Ultraviolet irradiation of airborne virus at doses much greater than those used in upper-room UV germicidal irradiation applications did not inhibit subsequent detection with the RT-PCR assay.", {"entities": []}], ["The air sampling and extraction methodology developed in this study should be applicable to the detection of rhinovirus and other airborne viruses in the indoor air of offices and schools.", {"entities": []}], ["This method, however, cannot distinguish UV inactivated virus from infectious viral particles.", {"entities": []}], ["Respiratory symptoms are common in the general population, and their presence is related to Health-related quality of life (HRQoL).", {"entities": []}], ["The objective was to describe the association of respiratory symptoms with HRQoL in subjects with and without asthma or COPD and to investigate the role of atopy, bronchial hyperresponsiveness (BHR), and lung function in HRQoL.", {"entities": [[110, 116, "DISEASE"]]}], ["The European Community Respiratory Health Survey (ECRHS) I and II provided data on HRQoL, lung function, respiratory symptoms, asthma, atopy, and BHR from 6009 subjects.", {"entities": [[127, 133, "DISEASE"]]}], ["Generic HRQoL was assessed through the physical component summary (PCS) score and the mental component summary (MCS) score of the SF-36.", {"entities": []}], ["Factor analyses and linear regressions adjusted for age, gender, smoking, occupation, BMI, comorbidity, and study centre were conducted.", {"entities": []}], ["Having breathlessness at rest in ECRHS II was associated with mean score (95% CI) impairment in PCS of -8.05 (-11.18, -4.93).", {"entities": []}], ["Impairment in MCS score in subjects waking up with chest tightness was -4.02 (-5.51, -2.52).", {"entities": []}], ["The magnitude of HRQoL impairment associated with respiratory symptoms was similar for subjects with and without asthma/COPD.", {"entities": [[113, 119, "DISEASE"]]}], ["Adjustments for atopy, BHR, and lung function did not explain the association of respiratory symptoms and HRQoL in subjects without asthma and/or COPD.", {"entities": [[132, 138, "DISEASE"]]}], ["Subjects with respiratory symptoms had poorer HRQoL; including subjects without a diagnosis of asthma or COPD.", {"entities": [[95, 101, "DISEASE"]]}], ["These findings suggest that respiratory symptoms in the absence of a medical diagnosis of asthma or COPD are by no means trivial, and that clarifying the nature and natural history of respiratory symptoms is a relevant challenge.", {"entities": [[90, 96, "DISEASE"]]}], ["Several community studies have estimated the prevalence of common respiratory symptoms like cough, dyspnoea, and wheeze in adults [ Respiratory symptoms are important markers of the risk of having or developing disease.", {"entities": []}], ["Respiratory symptoms have been shown to be predictors for lung function decline [ The common occurrence of respiratory symptoms calls for attention to how these symptoms affect health also in subjects with no diagnosis of obstructive airways disease.", {"entities": []}], ["Impaired HRQoL in the presence of respiratory symptoms have been found in two population-based studies [ The ECRHS is a randomly sampled, multi-cultural, population based cohort study.", {"entities": []}], ["The ECRHS included measurements of atopy, bronchial hyperresponsiveness (BHR), and lung function, and offers a unique opportunity to investigate how respiratory symptoms affect HRQoL among subjects both with and without obstructive lung disease.", {"entities": [[220, 244, "DISEASE"], [232, 244, "DISEASE"]]}], ["In the present paper we aimed to: 1) Describe the relationship between respiratory symptoms and HRQoL in an international adult general population and: 2) To assess whether this relationship varied with presence of asthma and/or COPD, or presence of objective functional markers like atopy and BHR.", {"entities": [[215, 221, "DISEASE"]]}], ["The revised International Health Regulations (2005) require that countries develop plans for chemical threats.", {"entities": []}], ["In 2012, the World Health Assembly reported that most countries had not yet achieved \u2018adequate capacity'.", {"entities": []}], ["We review the evolution of chemical hazards services in the United Kingdom, the result of 15 years of grass-roots pressure and an accumulating weight of chemical incidents that eventually convinced the UK Department of Health of the need for a new national public health function, culminating, in 2003, in the creation of the Chemical Hazards Division of the new Health Protection Agency.", {"entities": []}], ["Ten years later, public health services are again being radically reorganized with the creation of Public Health England, potentially destabilizing health protection arrangements and creating confusion among roles in managing chemical emergencies.", {"entities": []}], ["Incorporating health protection into a broader public health organization, however, offers a new opportunity to broaden the scope of health protection services to embrace prevention of non-infectious environmental diseases.", {"entities": []}], ["Clinicians are increasingly using electronic sources of evidence to support clinical decision-making; however, there are multiple demands on clinician time, and summarised and synthesised evidence is needed.", {"entities": []}], ["Clinical Answers (CA) have been developed to address this need; the CA is a synthesised evidence-based summary that supports point-of-care clinical decision-making.", {"entities": []}], ["The aim of this paper is to report on a survey used to test and improve the CA format.", {"entities": []}], ["An online survey was sent to pediatricians via e-mail and posted on a child health clinical standards website.", {"entities": []}], ["Quantitative data analysis consisted primarily of descriptive statistics; qualitative data analysis consisted of content analysis.", {"entities": []}], ["Eighty-three pediatricians responded to the survey.", {"entities": []}], ["Most respondents found the CA useful or very useful (93%) and agreed or strongly agreed that the layout was effective and allowed them to quickly locate critical information (82%).", {"entities": []}], ["Quantitative and qualitative data suggested that respondents thought there should be less detail in the linked figures and tables (p = 0.0002), but overall respondents seemed to think there was an appropriate level of detail in most sections of the CA.", {"entities": []}], ["Based on the quantitative and qualitative survey responses, major and minor modifications to the CA format were implemented, such as removing forest plots, adding links in each addendum to bring the user back to the front page, and adding an 'Implications for practice' section to the CA.", {"entities": []}], ["Findings suggest that CAs will be a useful tool for pediatricians; thus, the research team has now begun creating CAs to assist busy clinicians in their day-to-day clinical practice by providing high-quality information for decision-making at the point-of-care.", {"entities": []}], ["Adenoviruses are the second most prevalent cause of acute lower respiratory infection of viral origin in children under four years of age in Buenos Aires, Argentina.", {"entities": []}], ["The purpose of this study was to analyze the clinical features and outcome of acute lower respiratory infection associated with different adenovirus genotypes in children.", {"entities": []}], ["Twenty-four cases of acute lower respiratory infection and adenovirus diagnosis reported in a pediatric unit during a two-year period were retrospectively reviewed.", {"entities": []}], ["Adenovirus was detected by antigen detection and isolation in HEp-2 cells.", {"entities": []}], ["Adenovirus DNA from 17 isolates was studied by restriction enzyme analysis with Bam HI and Sma I. Subgenus b was found in 82.3% of the cases, and subgenus c in 17.7%.", {"entities": []}], ["Within subgenus b, only genotype 7 was detected, with genomic variant 7h in 85.7% (12/14) and genomic variant 7i in 14.3% (2/14).", {"entities": []}], ["Mean age was 8.8 \u00b1; 6 months, and male to female ratio was 3.8: 1.", {"entities": []}], ["At admission, pneumonia was observed in 71% of the cases and bronchiolitis in 29%.", {"entities": [[14, 23, "DISEASE"], [61, 74, "DISEASE"]]}], ["Malnutrition occurred in 37% of the cases; tachypnea in 79%; chest indrawing in 66%; wheezing in 58%; apneas in 16%; and conjunctivitis in 29%.", {"entities": [[121, 135, "DISEASE"]]}], ["Blood cultures for bacteria and antigen detection of other respiratory viruses were negative.", {"entities": []}], ["During hospitalization, fatality rate was 16.7% (4 /24).", {"entities": []}], ["Of the patients who died, three had Ad 7h and one Ad 7i.", {"entities": []}], ["Thus, fatality rate for adenovirus type 7 reached 28.6% (4/14).", {"entities": []}], ["These results show the predominance of adenovirus 7 and high lethality associated with the genomic variants 7h and 7i in children hospitalized with acute lower respiratory infection.", {"entities": []}], ["The patients\u2019 inhalation flow pattern is one of the significant determinants for clinical performance of inhalation therapy.", {"entities": []}], ["However, the development of inhalation flow meters for various inhalation devices has been unable to keep up with the increasing number of newly launched inhalation devices.", {"entities": []}], ["In the present study, we developed simple attachment orifices for the inhalation flow pattern monitoring system, which are suitable for all commercial inhalers, and investigated the efficacy of the system on the clinical inhalation instruction for patients co-prescribed dry powder inhaler (DPI) and soft mist inhaler (SMI).", {"entities": []}], ["First, we constructed simple attachment orifices that were adjusted for 13 commercial inhalers, and examined the correlation between orifice and inhalation device.", {"entities": []}], ["Second, the inhalation flow patterns (peak inspiratory flow rate, PIFR; inhalation duration time, DT) of patients prescribed a combination of DPI and SMI were monitored before and after inhalation instruction.", {"entities": []}], ["The inhalation resistance of commercial inhalers are listed in the following order; Twincaps", {"entities": []}], ["To examine the effect of an outdoor smokefree law in parks and on beaches on observed smoking in selected venues.", {"entities": []}], ["The study involved repeated observations in selected parks and beaches in Vancouver, British Columbia, Canada.", {"entities": []}], ["The main outcome measure was changes in observed smoking rates in selected venues from prelaw to 12 months postlaw.", {"entities": []}], ["No venue was 100% smokefree at the 12-month postlaw observation time point.", {"entities": []}], ["There was a significant decrease in observed smoking rates in all venues from prelaw to 12-month postlaw (prelaw mean smoking rate=20.5 vs 12-month mean smoking rate=4.7, p=0.04).", {"entities": []}], ["In stratified analysis by venue, the differences between the prelaw and 12-month smoking rates decreased significantly in parks (prelaw mean smoking rate=37.1 vs 12-month mean smoking rate=6.5, p=0.01) but not in beaches (prelaw mean smoking rate=2.9 vs 12-month mean smoking rate=1.0, p=0.1).", {"entities": []}], ["Smokefree policies in outdoor recreational venues have the potential to decrease smoking in these venues.", {"entities": []}], ["The effectiveness of such policies may differ by the type and usage of the venue; for instance, compliance may be better in venues that are used more often and have enforcement.", {"entities": []}], ["Future studies may further explore factors that limit and foster the enforcement of such policies in parks and beaches.", {"entities": []}], ["Early diagnosis of leptomeningeal carcinomatosis (LMC) is necessary to improve outcomes of this formidable disease.", {"entities": []}], ["However, cerebrospinal fluid (CSF) cytology is frequently false negative.", {"entities": []}], ["We examined whether CSF metabolome profiles can be used to differentiate patients with LMC from patients having a risk for development of LMC.", {"entities": []}], ["A total of 10,905 LMIs were evaluated using PCA-DA.", {"entities": []}], ["The LMIs defined Group 2 with a sensitivity of 85% and a specificity of 91%.", {"entities": []}], ["After selecting 33 LMIs, including diacetylspermine and fibrinogen fragments, the CSF metabolomics profile had a sensitivity of 100% and a specificity of 93% for discriminating Group 1b from the other groups.", {"entities": []}], ["After selecting 21 LMIs, including phosphatidylcholine, the CSF metabolomics profile differentiated LMC (Group 2) patients from the high-risk groups of Group 3 and Group 4 with 100% sensitivity and 100% specificity.", {"entities": []}], ["We prospectively collected CSF from five groups of patients: Group 1a, systemic cancer; Group 1b, no tumor; Group 2, LMC; Group 3, brain metastasis; Group 4, brain tumor other than brain metastasis.", {"entities": [[80, 86, "DISEASE"]]}], ["All metabolites in the CSF samples were detected as low-mass ions (LMIs) using mass spectrometry.", {"entities": []}], ["Principal component analysis-based discriminant analysis (PCA-DA) and two search algorithms were used to select the LMIs that differentiated the patient groups of interest from controls.", {"entities": []}], ["Analysis of CSF metabolite profiles could be used to diagnose LMC and exclude patients at high-risk of LMC with a 100% accuracy.", {"entities": []}], ["We expect a future validation trial to evaluate CSF metabolic profiles supporting CSF cytology.", {"entities": []}], ["Keratinocytes express the bitter taste receptors TAS2R1 and TAS2R38.", {"entities": [[49, 55, "GENE"], [60, 67, "GENE"]]}], ["Amarogentin as an agonist for TAS2R1 and other TAS2Rs promotes keratinocyte differentiation.", {"entities": [[30, 36, "GENE"]]}], ["Similarly, mast cells are known to express bitter taste receptors.", {"entities": []}], ["The aim of this study was to assess whether bitter compounds display immunomodulatory effects on these immunocompetent cells in the skin, so that they might be a target in chronic inflammatory diseases such as atopic dermatitis and psoriasis.", {"entities": [[232, 241, "DISEASE"], [210, 227, "DISEASE"], [217, 227, "DISEASE"]]}], ["Here, we investigated the impact of amarogentin on substance P-induced release of histamine and TNF- \u03b1 from the human mast cell line LAD-2.", {"entities": []}], ["Furthermore, the effect of amarogentin on HaCaT keratinocytes costimulated with TNF- \u03b1 and histamine was investigated.", {"entities": []}], ["Amarogentin inhibited in LAD-2 cells substance P-induced production of newly synthesized TNF- \u03b1 , but the degranulation and release of stored histamine were not affected.", {"entities": []}], ["In HaCaT keratinocytes histamine and TNF- \u03b1 induced IL-8 and MMP-1 expression was reduced by amarogentin to a similar extent as with azelastine.", {"entities": []}], ["In conclusion amarogentin displays immunomodulatory effects in the skin by interacting with mast cells and keratinocytes.", {"entities": []}], ["Apoptosis is an evolutionarily conserved and tightly regulated cell death modality.", {"entities": []}], ["It serves important roles in physiology by sculpting complex tissues during embryogenesis and by removing effete cells that have reached advanced age or whose genomes have been irreparably damaged.", {"entities": []}], ["Apoptosis culminates in the rapid and decisive removal of cell corpses by efferocytosis, a term used to distinguish the engulfment of apoptotic cells from other phagocytic processes.", {"entities": []}], ["Over the past decades, the molecular and cell biological events associated with efferocytosis have been rigorously studied, and many eat-me signals and receptors have been identified.", {"entities": []}], ["The externalization of phosphatidylserine (PS) is arguably the most emblematic eat-me signal that is in turn bound by a large number of serum proteins and opsonins that facilitate efferocytosis.", {"entities": []}], ["Under physiological conditions, externalized PS functions as a dominant and evolutionarily conserved immunosuppressive signal that promotes tolerance and prevents local and systemic immune activation.", {"entities": []}], ["Pathologically, the innate immunosuppressive effect of externalized PS has been hijacked by numerous viruses, microorganisms, and parasites to facilitate infection, and in many cases, establish infection latency.", {"entities": []}], ["PS is also profoundly dysregulated in the tumor microenvironment and antagonizes the development of tumor immunity.", {"entities": []}], ["In this review, we discuss the biology of PS with respect to its role as a global immunosuppressive signal and how PS is exploited to drive diverse pathological processes such as infection and cancer.", {"entities": [[193, 199, "DISEASE"]]}], ["Finally, we outline the rationale that agents targeting PS could have significant value in cancer and infectious disease therapeutics.", {"entities": [[91, 97, "DISEASE"]]}], ["Overcoming spaceflight-induced (patho)physiologic adaptations is a major challenge preventing long-term deep space exploration.", {"entities": []}], ["RNA interference (RNAi) has emerged as a promising therapeutic for combating diseases on Earth; however the efficacy of RNAi in space is currently unknown.", {"entities": []}], ["Caenorhabditis elegans were prepared in liquid media on Earth using standard techniques and treated acutely with RNAi or a vector control upon arrival in Low Earth Orbit.", {"entities": []}], ["After culturing during 4 and 8 d spaceflight, experiments were stopped by freezing at \u221280\u00b0C until analysis by mRNA and microRNA array chips, microscopy and Western blot on return to Earth.", {"entities": []}], ["Ground controls (GC) on Earth were simultaneously grown under identical conditions.", {"entities": [[17, 19, "GENE"]]}], ["After 8 d spaceflight, mRNA expression levels of components of the RNAi machinery were not different from that in GC (e.g., Dicer, Argonaute, Piwi; P >0.05).", {"entities": [[114, 116, "GENE"]]}], ["The expression of 228 microRNAs, of the 232 analysed, were also unaffected during 4 and 8 d spaceflight ( P >0.05).", {"entities": []}], ["In spaceflight, RNAi against green fluorescent protein ( gfp ) reduced chromosomal gfp expression in gonad tissue, which was not different from GC.", {"entities": [[144, 146, "GENE"]]}], ["RNAi against rbx-1 also induced abnormal chromosome segregation in the gonad during spaceflight as on Earth.", {"entities": []}], ["Finally, culture in RNAi against lysosomal cathepsins prevented degradation of the muscle-specific \u03b1-actin protein in both spaceflight and GC conditions.", {"entities": [[139, 141, "GENE"]]}], ["Treatment with RNAi works as effectively in the space environment as on Earth within multiple tissues, suggesting RNAi may provide an effective tool for combating spaceflight-induced pathologies aboard future long-duration space missions.", {"entities": []}], ["Furthermore, this is the first demonstration that RNAi can be utilised to block muscle protein degradation, both on Earth and in space.", {"entities": []}], ["Subclinical systemic microvascular dysfunction exists in asymptomatic patients with type 1 diabetes.", {"entities": []}], ["We hypothesized that microangiopathy, resulting from long-standing systemic hyperglycemia and hyperinsulinemia, may be generalized to the brain, resulting in changes in cerebral blood flow (CBF) and metabolism in these patients.", {"entities": [[76, 89, "DISEASE"]]}], ["We performed dynamic [ 2 O and [ d -glucose brain positron emission tomography scans to measure CBF and cerebral glucose metabolism (CMR glu ), respectively, in 30 type 1 diabetic patients and 12 age-matched healthy controls after an overnight fast.", {"entities": []}], ["Regions of interest were automatically delineated on coregistered magnetic resonance images and full kinetic analysis was performed.", {"entities": []}], ["Plasma glucose and insulin levels were higher in patients versus controls.", {"entities": []}], ["Total gray matter CBF was 9%, whereas CMR glu was 21% lower in type 1 diabetic subjects versus control subjects.", {"entities": []}], ["We conclude that at real-life fasting glucose and insulin levels, type 1 diabetes is associated with decreased resting cerebral glucose metabolism, which is only partially explained by the decreased CBF.", {"entities": []}], ["These findings suggest that mechanisms other than generalized microangiopathy account for the altered CMR glu observed in well-controlled type 1 diabetes.", {"entities": []}], ["Enterovirus 68 (EV68) was first isolated in 1962.", {"entities": []}], ["Very few cases of EV68 infection were described over the ensuing 40 years.", {"entities": []}], ["However, in the past few years, an increase in severe respiratory tract infections associated with EV68 has been reported.", {"entities": []}], ["We identified two clusters of EV68 infection in South London, UK, one each in the autumn/winters of 2009 and 2010.", {"entities": []}], ["Sequence comparison showed significant homology of the UK strains with those from other countries including the Netherlands, Japan and the Philippines, which reported EV68 outbreaks between 2008 and 2010.", {"entities": []}], ["Phylogenetic analysis of all available VP1 sequences indicated the presence of two modern EV68 lineages.", {"entities": []}], ["The 2010 UK strains belonged to lineage 2.", {"entities": []}], ["Lineage 1 could be further divided into two sub-lineages: some Japanese and Dutch strains collected between 2004 and 2010 form a distinct sub-lineages (sub-lineage 1.1), whereas other strains from the UK, Japan, Netherlands and Philippines collected between 2008 and 2010 represent sub-lineage 1.2.", {"entities": []}], ["The UK 2009 strains together with several Dutch and Japanese strains from 2009/2010 represents one variant (1.2.1), whereas those from the Philippines a second variant (1.2.2).", {"entities": []}], ["Based on specific deletions and substitutions, we suggest rules for the assignment of lineages and sub-lineages.", {"entities": []}], ["Molecular epidemiological analysis indicates rapid recent evolution of EV68 and this may explain the recent findings of a global resurgence of EV68.", {"entities": []}], ["Continuous global monitoring of the clinical and molecular epidemiology of EV68 is recommended.", {"entities": []}], ["Introduction: Some studies report that atopic patients have a greater frequency of delayed-type sensitization than non-atopic patients.", {"entities": []}], ["Objective: To determine the influence of the atopic condition on delayed sensitization to dental materials.", {"entities": []}], ["Design: cross-sectional study.", {"entities": []}], ["Methods: Forty (40) atopic subjects and forty (40) non-atopic subjects, of both sexes, between 20 and 65 years of age were included.", {"entities": []}], ["The determination of delayed sensitization to dental materials was performed using patch test.", {"entities": []}], ["An oral exam was also carried out to check for lesions of the oral mucosa.", {"entities": []}], ["Results: 61.25% of the patients were positive for delayed-type sensitization to one or more allergens, being palladium chloride (21.25%), ammoniated mercury (20%), benzoyl peroxide (12.5%) and amalgam (10%) the most frequent.", {"entities": []}], ["The frequency of sensitization was 67.5% in the group of atopic patients, compared to 55% in the non atopic group (p>0.05).", {"entities": []}], ["The materials with the greatest difference of sensitization in atopic compared to non-atopic patients were ammoniated mercury, benzoyl peroxide, amalgam and Bisphenol A Dimethacrylate (BIS-GMA).", {"entities": []}], ["Conclusion: The atopic condition is not related to a higher frequency of delayed sensitization to a battery of dental materials.", {"entities": []}], ["Key words: Patch test, delayed-type sensitization, allergy contact, atopia, dental materials.", {"entities": []}], ["Air pollution in S\u00e3o Paulo is constantly being measured by the State of Sao Paulo Environmental Agency, however there is no information on the variation between places with different traffic densities.", {"entities": []}], ["This study was intended to identify a gradient of exposure to traffic-related air pollution within different areas in S\u00e3o Paulo to provide information for future epidemiological studies.", {"entities": []}], ["We measured NO 2 using Palmes' diffusion tubes in 36 sites on streets chosen to be representative of different road types and traffic densities in S\u00e3o Paulo in two one-week periods (July and August 2000).", {"entities": []}], ["In each study period, two tubes were installed in each site, and two additional tubes were installed in 10 control sites.", {"entities": []}], ["Average NO 2 concentrations were related to traffic density, observed on the spot, to number of vehicles counted, and to traffic density strata defined by the city Traffic Engineering Company (CET).", {"entities": []}], ["Average NO 2 concentrations were 63\u03bcg/m p < 0.001).", {"entities": []}], ["The differences in NO 2 levels between heavy and local traffic sites are large enough to suggest the use of a more refined classification of exposure in epidemiological studies in the city.", {"entities": []}], ["Number of vehicles counted, traffic density observed on the spot and traffic density strata defined by the CET might be used as a proxy for traffic exposure in S\u00e3o Paulo when more accurate measurements are not available.", {"entities": []}], ["The Xpert MTB/RIF assay was introduced for timely and accurate detection of tuberculosis (TB).", {"entities": [[76, 88, "DISEASE"]]}], ["The aim of this study was to determine the diagnostic accuracy and turnaround time (TAT) of Xpert MTB/RIF assay in clinical practice in South Korea.", {"entities": []}], ["We retrospectively reviewed the medical records of patients in whom Xpert MTB/RIF assay using sputum were requested.", {"entities": []}], ["The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for the diagnosis of pulmonary tuberculosis (PTB) and detection of rifampicin resistance were calculated.", {"entities": [[129, 141, "DISEASE"], [119, 141, "DISEASE"]]}], ["In addition, TAT of Xpert MTB/RIF assay was compared with those of other tests.", {"entities": []}], ["Total 681 patients in whom Xpert MTB/RIF assay was requested were included in the analysis.", {"entities": []}], ["The sensitivity, specificity, PPV and NPV of Xpert MTB/RIF assay for diagnosis of PTB were 79.5% (124/156), 100.0% (505/505), 100.0% (124/124) and 94.0% (505/537), respectively.", {"entities": []}], ["Those for the detection of rifampicin resistance were 57.1% (8/14), 100.0% (113/113), 100.0% (8/8) and 94.9% (113/119), respectively.", {"entities": []}], ["The median TAT of Xpert MTB/RIF assay to the report of results and results confirmed by physicians in outpatient settings were 0 (0\u20131) and 6 (3\u20137) days, respectively.", {"entities": []}], ["Median time to treatment after initial evaluation was 7 (4\u20139) days in patients with Xpert MTB/RIF assay, but was 21 (7\u201333.5) days in patients without Xpert MTB/RIF assay.", {"entities": []}], ["Xpert MTB/RIF assay showed acceptable sensitivity and excellent specificity for the diagnosis of PTB and detection of rifampicin resistance in areas with intermediate TB burden.", {"entities": []}], ["Additionally, the assay decreased time to the initiation of anti-TB drugs through shorter TAT.", {"entities": []}], ["After Chernobyl and Fukushima Da\u00ef Chi, two major nuclear accidents, large amounts of radionuclides were released in the environment, mostly caesium 137 (", {"entities": []}], ["Exposure to pollutants including metals and particulate air pollution can alter DNA methylation.", {"entities": []}], ["Yet little is known about intra-individual changes in DNA methylation over time in relationship to environmental exposures.", {"entities": []}], ["Therefore, we evaluated the effects of acute- and chronic metal-rich PM 2.5 exposures on DNA methylation.", {"entities": []}], ["Thirty-eight male boilermaker welders participated in a panel study for a total of 54 person days.", {"entities": []}], ["Whole blood was collected prior to any welding activities (pre-shift) and immediately after the exposure period (post-shift).", {"entities": []}], ["The percentage of methylated cytosines (%mC) in LINE-1, Alu, and inducible nitric oxide synthase gene ( iNOS ) were quantified using pyrosequencing.", {"entities": []}], ["Personal PM 2.5 (particulate matter with an aerodynamic diameter\u2009\u2264\u20092.5\u00a0\u03bcm) was measured over the work-shift.", {"entities": []}], ["A questionnaire assessed job history and years worked as a boilermaker.", {"entities": []}], ["Linear mixed models with repeated measures evaluated associations between DNA methylation, PM 2.5 concentration (acute exposure), and years worked as a boilermaker (chronic exposure).", {"entities": []}], ["PM 2.5 exposure was associated with increased methylation in the promoter region of the iNOS gene (\u03b2\u2009=\u20090.25, SE: 0.11, p-value\u2009=\u20090.04).", {"entities": []}], ["Additionally, the number of years worked as a boilermaker was associated with increased iNOS methylation (\u03b2\u2009=\u20090.03, SE: 0.01, p-value\u2009=\u20090.03).", {"entities": []}], ["No associations were observed for Alu or LINE-1.", {"entities": []}], ["Acute and chronic exposure to PM 2.5 generated from welding activities was associated with a modest change in DNA methylation of the iNOS gene.", {"entities": []}], ["Future studies are needed to confirm this association and determine if the observed small increase in iNOS methylation are associated with changes in NO production or any adverse health effect.", {"entities": []}], ["The potential benefits of the introduction of electronic and mobile health (mHealth) information technologies, to support the safe delivery of intravenous chemotherapy or oral anticancer therapies, could be exponential in the context of a highly integrated computerized system.", {"entities": []}], ["Here we describe a safe therapy mobile (STM) system for the safe delivery of intravenous chemotherapy, and a home monitoring system for monitoring and managing toxicity and improving adherence in patients receiving oral anticancer therapies at home.", {"entities": []}], ["The STM system is fully integrated with the electronic oncological patient record.", {"entities": []}], ["After the prescription of chemotherapy, specific barcodes are automatically associated with the patient and each drug, and a bedside barcode reader checks the patient, nurse, infusion bag, and drug sequence in order to trace the entire administration process, which is then entered in the patient\u2019s record.", {"entities": []}], ["The usability and acceptability of the system was investigated by means of a modified questionnaire administered to nurses.", {"entities": []}], ["The home monitoring system consists of a mobile phone or tablet diary app, which allows patients to record their state of health, the medications taken, their side effects, and a Web dashboard that allows health professionals to check the patient data and monitor toxicity and treatment adherence.", {"entities": [[70, 73, "GENE"]]}], ["A built-in rule-based alarm module notifies health care professionals of critical conditions.", {"entities": []}], ["Initially developed for chronic patients, the system has been subsequently customized in order to monitor home treatments with capecitabine or sunitinib in cancer patients (Onco-TreC).", {"entities": [[156, 162, "DISEASE"]]}], ["The STM system never failed to match the patient/nurse/drug sequence association correctly, and proved to be accurate and reliable in tracing and recording the entire administration process.", {"entities": []}], ["The questionnaires revealed that the users were generally satisfied and had a positive perception of the system\u2019s usefulness and ease of use, and the quality of their working lives.", {"entities": []}], ["The pilot studies with the home monitoring system with 43 chronic patients have shown that the approach is reliable and useful for clinicians and patients, but it is also necessary to pay attention to the expectations that mHealth solutions may raise in users.", {"entities": []}], ["The Onco-TreC version has been successfully laboratory tested, and is now ready for validation.", {"entities": []}], ["The STM and Onco-TreC systems are fully integrated with our complex and composite information system, which guarantees privacy, security, interoperability, and real-time communications between patients and health professionals.", {"entities": []}], ["They need to be validated in order to confirm their positive contribution to the safer administration of anticancer drugs.", {"entities": []}], ["Background: Older adults make up 13% of the U.S. population, but are projected to account for 20% by 2040.", {"entities": []}], ["Coinciding with this demographic shift, the rate of climate change is accelerating, bringing rising temperatures; increased risk of floods, droughts, and wildfires; stronger tropical storms and hurricanes; rising sea levels; and other climate-related hazards.", {"entities": []}], ["Older Americans are expected to be located in places that may be relatively more affected by climate change, including coastal zones and large metropolitan areas.", {"entities": []}], ["Objective: The objective of this review is to assess the vulnerability of older Americans to climate change and to identify opportunities for adaptation.", {"entities": []}], ["Methods: We performed an extensive literature survey and summarized key findings related to demographics; climate stressors relevant to older adults; factors contributing to exposure, sensitivity, and adaptive capacity; and adaptation strategies.", {"entities": []}], ["Discussion: A range of physiological and socioeconomic factors make older adults especially sensitive to and/or at risk for exposure to heat waves and other extreme weather events (e.g., hurricanes, floods, droughts), poor air quality, and infectious diseases.", {"entities": []}], ["Climate change may increase the frequency or severity of these events.", {"entities": []}], ["Conclusions: Older Americans are likely to be especially vulnerable to stressors associated with climate change.", {"entities": []}], ["Although a growing body of evidence reports the adverse effects of heat on the health of older adults, research gaps remain for other climate-related risks.", {"entities": []}], ["We need additional study of the vulnerability of older adults and the interplay of vulnerability, resilience, and adaptive responses to projected climate stressors.", {"entities": []}], ["The Human Respiratory Syncytial Virus (hRSV) is a major cause of acute lower respiratory tract infections (ARTIs) and high rates of hospitalizations in children and in the elderly worldwide.", {"entities": []}], ["Symptoms of hRSV infection include bronchiolitis and pneumonia.", {"entities": [[53, 62, "DISEASE"], [35, 48, "DISEASE"]]}], ["The lung pathology observed during hRSV infection is due in part to an exacerbated host immune response, characterized by immune cell infiltration to the lungs.", {"entities": []}], ["HRSV is an enveloped virus, a member of the Pneumoviridae family, with a non-segmented genome and negative polarity-single RNA that contains 10 genes encoding for 11 proteins.", {"entities": []}], ["These include the Fusion protein (F), the Glycoprotein (G), and the Small Hydrophobic (SH) protein, which are located on the virus surface.", {"entities": []}], ["In addition, the Nucleoprotein (N), Phosphoprotein (P) large polymerase protein (L) part of the RNA-dependent RNA polymerase complex, the M2-1 protein as a transcription elongation factor, the M2-2 protein as a regulator of viral transcription and (M) protein all of which locate inside the virion.", {"entities": []}], ["Apart from the structural proteins, the hRSV genome encodes for the non-structural 1 and 2 proteins (NS1 and NS2).", {"entities": []}], ["HRSV has developed different strategies to evade the host immunity by means of the function of some of these proteins that work as virulence factors to improve the infection in the lung tissue.", {"entities": []}], ["Also, hRSV NS-1 and NS-2 proteins have been shown to inhibit the activation of the type I interferon response.", {"entities": []}], ["Furthermore, the hRSV nucleoprotein has been shown to inhibit the immunological synapsis between the dendritic cells and T cells during infection, resulting in an inefficient T cell activation.", {"entities": []}], ["Here, we discuss the hRSV virulence factors and the host immunological features raised during infection with this virus.", {"entities": []}], ["Acupuncture is increasingly used worldwide.", {"entities": []}], ["It is becoming more accepted by both patients and healthcare providers.", {"entities": []}], ["However, the current understanding of its adverse events (AEs) is fragmented.", {"entities": []}], ["We conducted this overview to collect all systematic reviews (SRs) on the AEs of acupuncture and related therapies.", {"entities": []}], ["MEDLINE and EMBASE were searched from inception to December 2015.", {"entities": []}], ["Methodological quality of included reviews was assessed with a validated instrument.", {"entities": []}], ["Evidence was narratively reported.", {"entities": []}], ["Seventeen SRs covering various types of acupuncture were included.", {"entities": []}], ["Methodological quality of the reviews was overall mediocre.", {"entities": []}], ["Four major categories of AEs were identified, which are organ or tissue injuries (13 reviews, median: 36 cases, median deaths: 4), infections (11 reviews, median: 17 cases, median deaths: 0.5), local AEs or reactions (12 reviews, median: 8.5 cases, no deaths were reported), and other complications such as dizziness or syncope (11 reviews, median: 21 cases, no deaths were reported).", {"entities": []}], ["Minor and serious AEs can occur during the use of acupuncture and related modalities, contrary to the common impression that acupuncture is harmless.", {"entities": []}], ["Serious AEs are rare, but need significant attention as mortality can be associated with them.", {"entities": []}], ["Referrals should consider acupuncturists\u2019 training credibility, and patient safety should be a core part of acupuncture education.", {"entities": []}], ["To assess the risk factors, incidence and severity of adverse drug reactions in in-patients.", {"entities": []}], ["This prospective study evaluated 472 patients treated at a teaching hospital in Brazil between 2010 and 2013 by five medical specialties: Internal Medicine, General Surgery, Geriatrics, Neurology, and Clinical Immunology and Allergy.", {"entities": []}], ["The following variables were assessed: patient age, gender, comorbidities, family history of hypersensitivity, personal and family history of atopy, number of prescribed drugs before and during hospitalization, hospital diagnoses, days of hospitalization.", {"entities": []}], ["The patients were visited every other day, and medical records were reviewed by the investigators to detect adverse drug reactions.", {"entities": []}], ["There were a total of 94 adverse drug reactions in 75 patients.", {"entities": []}], ["Most reactions were predictable and of moderate severity.", {"entities": []}], ["The incidence of adverse drug reactions was 16.2%, and the incidence varied, according to the medical specialty; it was higher in Internal Medicine (30%).", {"entities": []}], ["Antibiotics were the most commonly involved medication.", {"entities": []}], ["Chronic renal failure, longer hospital stay, greater number of diagnoses and greater number of medications upon admission were risk factors.", {"entities": []}], ["For each medication introduced during hospitalization, there was a 10% increase in the rate of adverse drug reaction.", {"entities": []}], ["In the present study, the probability of observing an adverse drug reaction was 1 in 104 patients per day.", {"entities": []}], ["Adverse drug reactions are frequent and potentially serious and should be better monitored in patients with chronic renal failure or prolonged hospitalization and especially in those on \u2018polypharmacy\u2019 regimens.", {"entities": []}], ["The rational use of medications plays an important role in preventing adverse drug reactions.", {"entities": []}], ["Chest pain is a common complaint and reason for consultation in primary care.", {"entities": []}], ["Traditional textbooks still assign pain localization a certain discriminative role in the differential diagnosis of chest pain.", {"entities": []}], ["The aim of our study was to synthesize pain drawings from a large sample of chest pain patients and to examine whether pain localizations differ for different underlying etiologies.", {"entities": []}], ["We conducted a cross-sectional study including 1212 consecutive patients with chest pain recruited in 74 primary care offices in Germany.", {"entities": []}], ["Primary care providers (PCPs) marked pain localization and radiation of each patient on a pictogram.", {"entities": []}], ["After 6\u00a0months, an independent interdisciplinary reference panel reviewed clinical data of every patient, deciding on the etiology of chest pain at the time of patient recruitment.", {"entities": []}], ["PCP drawings were entered in a specially designed computer program to produce merged pain charts for different etiologies.", {"entities": []}], ["Dissimilarities between individual pain localizations and differences on the level of diagnostic groups were analyzed using the Hausdorff distance and the C-index.", {"entities": []}], ["Pain location in patients with coronary heart disease (CHD) did not differ from the combined group of all other patients, including patients with chest wall syndrome (CWS), gastro-esophageal reflux disease (GERD) or psychogenic chest pain.", {"entities": [[40, 53, "DISEASE"], [31, 53, "DISEASE"], [157, 165, "DISEASE"]]}], ["There was also no difference in chest pain location between male and female CHD patients.", {"entities": []}], ["Pain localization is not helpful in discriminating CHD from other common chest pain etiologies.", {"entities": []}], ["Semaphorin-7A is a glycosylphosphatidylinositol-anchored protein, initially characterized as an axon guidance protein.", {"entities": []}], ["Semaphorin-7A also contributes to immune cell regulation and may be an essential pro-fibrotic factor when expressed by non-fibroblast cell types (exogenous).", {"entities": []}], ["In mouse models, semaphorin-7A was shown to be important for TGF-\u00df1-induced pulmonary fibrosis characterized by myofibroblast accumulation and extracellular matrix deposition, but the cell-specific role of semaphorin-7A was not examined in fibroblasts.", {"entities": [[76, 94, "DISEASE"]]}], ["The purpose of this study is to determine semaphorin-7A expression by fibroblasts and to investigate the function of endogenously expressed semaphorin-7A in primary human lung fibroblasts (HLF).", {"entities": [[189, 192, "GENE"]]}], ["Herein, we show that non-fibrotic HLF expressed high levels of cell surface semaphorin-7A with little dependence on the percentage of serum or recombinant TGF-\u00df1.", {"entities": [[34, 37, "GENE"]]}], ["Semaphorin-7A siRNA strongly decreased semaphorin-7A mRNA expression and reduced cell surface semaphorin-7A.", {"entities": []}], ["Reduction of semaphorin-7A induced increased proliferation and migration of non-fibrotic HLF.", {"entities": [[89, 92, "GENE"]]}], ["Also, independent of the presence of TGF-\u00df1, the decline of semaphorin-7A by siRNA was associated with increased \u03b1-smooth muscle actin production and gene expression of periostin, fibronectin, laminin, and serum response factor (SRF), indicating differentiation into a myofibroblast.", {"entities": [[229, 232, "GENE"]]}], ["Conversely, overexpression of semaphorin-7A in the NIH3T3 fibroblast cell line reduced the production of pro-fibrotic markers.", {"entities": []}], ["The inverse association between semaphorin-7A and pro-fibrotic fibroblast markers was further analyzed using HLF from idiopathic pulmonary fibrosis (IPF) (n = 6) and non-fibrotic (n = 7) lungs.", {"entities": [[129, 147, "DISEASE"], [118, 147, "DISEASE"], [109, 112, "GENE"]]}], ["Using these 13 fibroblast lines, we observed that semaphorin-7A and periostin expression were inversely correlated.", {"entities": []}], ["In conclusion, our study indicates that endogenous semaphorin-7A in HLF plays a role in maintaining fibroblast homeostasis by preventing up-regulation of pro-fibrotic genes.", {"entities": [[68, 71, "GENE"]]}], ["Therefore, endogenous and exogenous semaphorin-7A may have opposite effects on the fibroblast phenotype.", {"entities": []}], ["Evidence of characteristics of Japanese patients with diabetes from a large-scale population is necessary.", {"entities": []}], ["Few studies have compared glycaemic controls, complications and comorbidities between type 1 and 2 diabetic patients.", {"entities": []}], ["This paper focuses on illustrating a clinical picture of Japanese diabetic patients and comparing glycaemic control and prognoses between type 1 and 2 diabetes using multi-institutional data.", {"entities": []}], ["The BioBank Japan Project enrolled adult type 1 and 2 diabetic patients between fiscal years 2003 and 2007.", {"entities": []}], ["We have presented characteristics, controls of serum glucose, cholesterol and blood pressure, prevalence of complications and comorbidities and survival curves.", {"entities": []}], ["We have also shown glycaemic controls according to various individual profiles of diabetic patients.", {"entities": []}], ["A total of 558 type 1 diabetic patients and 30,834 type 2 diabetic patients participated in this study.", {"entities": []}], ["The mean glycated haemoglobin A1c was higher in type 1 diabetes than in type 2 diabetes.", {"entities": []}], ["In the type 1 diabetic patients, the glycated haemoglobin A1c had no consistent trend according to age and body mass index.", {"entities": []}], ["The Kaplan\u2013Meier estimates represented a longer survival time from baseline with type 1 diabetes than with type 2 diabetes.", {"entities": []}], ["Compared with type 1 diabetic patients, type 2 diabetic patients had double the prevalence of macrovascular complications.", {"entities": []}], ["This work has revealed detailed plasma glucose levels of type 1 and 2 diabetic patients according to age, body mass index, blood pressure, serum cholesterol levels and smoking and drinking habits.", {"entities": []}], ["Our data have also shown that the prognosis is worse for type 2 diabetes than for type 1 diabetes in Japan.", {"entities": []}], ["\u2022 Detailed glycaemic control data of diabetic patients are necessary.", {"entities": []}], ["\u2022 Few studies have compared the survival times between type 1 and 2 diabetes.", {"entities": []}], ["\u2022 Higher glycated HbA1c was observed in type 1 than in type 2 diabetes.", {"entities": []}], ["\u2022 Data showed higher hazard ratio of mortality in type 1 than in type 2 diabetes.", {"entities": []}], ["\u2022 Fewer macrovascular complications accompany type 1 than type 2 diabetes.", {"entities": []}], ["Detailed glycaemic control data of diabetic patients are necessary.", {"entities": []}], ["Few studies have compared the survival times between type 1 and 2 diabetes.", {"entities": []}], ["Higher glycated HbA1c was observed in type 1 than in type 2 diabetes.", {"entities": []}], ["Data showed higher hazard ratio of mortality in type 1 than in type 2 diabetes.", {"entities": []}], ["Fewer macrovascular complications accompany type 1 than type 2 diabetes.", {"entities": []}], ["Many epidemiological studies have suggested that a variety of medical illnesses are associated with suicide.", {"entities": []}], ["Investigating the time-varying pattern of medical care utilization prior to death in suicides motivated by physical illnesses would be helpful for developing suicide prevention programs for patients with physical illnesses.", {"entities": []}], ["Suicides motivated by physical illnesses were identified by the investigator's note from the National Police Agency, which was linked to the data from the Health Insurance Review and Assessment.", {"entities": []}], ["We investigated the time-varying patterns of medical care utilization during 1 year prior to suicide using repeated-measures data analysis after adjustment for age, gender, area of residence, and socioeconomic status.", {"entities": []}], ["Among 1994 suicides for physical illness, 1893 (94.9%) suicides contacted any medical care services and 445 (22.3%) suicides contacted mental health care during 1 year prior to suicide.", {"entities": []}], ["The number of medical care visits and individual medical expenditures increased as the date of suicide approached ( p <0.001).", {"entities": []}], ["The number of medical care visits for psychiatric disorders prior to suicide significantly increased only in 40- to 64-year-old men ( p =0.002), women <40 years old ( p =0.011) and women 40 to 64 years old ( p =0.021) after adjustment for residence, socioeconomic status, and morbidity.", {"entities": []}], ["Most of the suicides motivated by physical illnesses contacted medical care during 1 year prior to suicide, but many of them did not undergo psychiatric evaluation.", {"entities": []}], ["This underscores the need for programs to provide psychosocial support to patients with physical illnesses.", {"entities": []}], ["The primary aim of treatment of a patient who has developed metastatic disease is palliation.", {"entities": []}], ["The objectives of the current study are to describe and quantify the clinical management of women with metastatic breast cancer from the diagnosis of metastatic disease until death and to analyze differences between age groups.", {"entities": [[114, 127, "DISEASE"], [121, 127, "DISEASE"]]}], ["Data were collected from the medical files of all patients (n = 116) who had died after December 31, 1999, after a diagnosis of metastatic breast cancer in two teaching hospitals in the south of the Netherlands.", {"entities": [[139, 152, "DISEASE"], [146, 152, "DISEASE"]]}], ["Of the 116 patients included in our study, 10 (9%) already had metastatic disease at diagnosis and 106 developed distant disease after the diagnosis of localized breast cancer.", {"entities": [[162, 175, "DISEASE"], [169, 175, "DISEASE"]]}], ["Before they died, 70% of the 116 patients developed metastases in one or more bones, 50% in the lung and/or pleura, 50% in the abdominal viscera, 23% in the central nervous system, and 19% in the skin.", {"entities": []}], ["Patients younger than 50 years were much more likely to develop metastases in the central nervous system than patients 50 years and older.", {"entities": []}], ["Seventy-seven (66%) of the 116 patients with metastatic breast cancer received chemotherapy.", {"entities": [[56, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["This proportion decreased with age (p = 0.005), as did the number of schemes per patient.", {"entities": []}], ["Together, they received 132 chemotherapy schemes, of which 35 (27%) resulted in partial remission or stabilization of the disease process.", {"entities": []}], ["Ninety-eight patients (84%) received hormonal treatment.", {"entities": []}], ["This proportion did not differ between the three age groups.", {"entities": []}], ["Together, they received 216 hormonal treatments, 38 (16%) of which resulted in partial remission or stabilization of the disease process.", {"entities": []}], ["Seventy-nine patients (68%) received palliative radiotherapy.", {"entities": []}], ["This proportion decreased with age (p = 0.03).", {"entities": []}], ["Together, they underwent 216 courses, 176 (77%) of which resulted in relief of the complaints.", {"entities": []}], ["Patients aged 70 years and older are less likely to receive chemotherapy or radiotherapy.", {"entities": []}], ["Part of this difference could be explained by their shorter survival time after the diagnosis of metastatic disease and their lower risk of developing brain and bone metastases.", {"entities": []}], ["However, more research is needed to understand the age-related differences in the treatment of metastatic breast cancer, and especially how comorbidity and frailty limit therapeutic choices.", {"entities": [[106, 119, "DISEASE"], [113, 119, "DISEASE"]]}], ["Polymorphisms of several candidate genes have been studied and associated with the development of chronic obstructive pulmonary disease (COPD).", {"entities": [[98, 135, "DISEASE"]]}], ["One such candidate is the SERPINE2 (Serpin peptidase inhibitor, clade E member 2) gene.", {"entities": [[26, 34, "GENE"]]}], ["To assess whether the SERPINE2 gene is associated with COPD in a Chinese Han population.", {"entities": [[22, 30, "GENE"]]}], ["Samples were collected from a Chinese Han population and analyzed for the association of single nucleotide polymor phisms (SNPs) or haplotypes of SERPINE2 gene with COPD in a case-control study.", {"entities": [[146, 154, "GENE"]]}], ["Three SNPs including rs840088 G/A in intron 1, rs1438831 A/G in 5' upstream sequence and rs3795879 G/A in intron 3 were detected using the polymerase chain reaction (PCR)-based restriction fragment length polymorphism technique in 409 COPD subjects and 411 controls.", {"entities": []}], ["Genotyping of the SREPINE2 polymorphisms at positions rs840088, rs1438831and rs3795879 was performed.", {"entities": []}], ["We found that none of the rs840088G/A, rs1438831G/A and rs3795879 G/A polymorphisms were associated with the disease.", {"entities": []}], ["The p -values were 0.630, 0.208 and 0.398 respectively.", {"entities": []}], ["Our data suggested that there was no significant association between SERPINE2 polymorphism and COPD susceptibility in the Chinese Han population.", {"entities": [[69, 77, "GENE"]]}], ["Short-term fasting (48 hours) was shown to be effective in protecting normal cells and mice but not cancer cells against high dose chemotherapy, termed Differential Stress Resistance (DSR), but the feasibility and effect of fasting in cancer patients undergoing chemotherapy is unknown.", {"entities": [[100, 106, "DISEASE"], [235, 241, "DISEASE"]]}], ["Here we describe 10 cases in which patients diagnosed with a variety of malignancies had voluntarily fasted prior to (48-140 hours) and/or following (5-56 hours) chemotherapy.", {"entities": []}], ["None of these patients, who received an average of 4 cycles of various chemotherapy drugs in combination with fasting, reported significant side effects caused by the fasting itself other than hunger and lightheadedness.", {"entities": []}], ["Chemotherapy associated toxicity was graded according to the Common Terminology Criteria for Adverse Events (CTCAE) of the National Cancer Institute (NCI).", {"entities": [[132, 138, "DISEASE"]]}], ["The six patients who underwent chemotherapy with or without fasting reported a reduction in fatigue, weakness, and gastrointestinal side effects while fasting.", {"entities": []}], ["In those patients whose cancer progression could be assessed, fasting did not prevent the chemotherapy-induced reduction of tumor volume or tumor markers.", {"entities": [[24, 30, "DISEASE"]]}], ["Although the 10 cases presented here suggest that fasting in combination with chemotherapy is feasible, safe, and has the potential to ameliorate side effects caused by chemotherapies, they are not meant to establish practice guidelines for patients undergoing chemotherapy.", {"entities": []}], ["Only controlled-randomized clinical trials will determine the effect of fasting on clinical outcomes including quality of life and therapeutic index.", {"entities": []}], ["The diaphragm has sensory innervation from mechanoreceptors with myelinated axons entering the spinal cord via the phrenic nerve that project to the thalamus and somatosensory cortex.", {"entities": []}], ["It was hypothesized that phrenic nerve afferent (PnA) projection to the central nervous system is via the spinal dorsal column pathway.", {"entities": []}], ["A single N1 peak of the CDP was found in the C4 and C7 spinal segments.", {"entities": [[52, 54, "GENE"]]}], ["Three peaks (N1, N2, and N3) were found in the C5 and C6 segments.", {"entities": [[47, 49, "GENE"], [54, 56, "GENE"]]}], ["No CDP was recorded at C8 dorsal spinal cord surface in cats.", {"entities": []}], ["These results demonstrate PnA activation of neurons in the cervical spinal cord.", {"entities": []}], ["Three populations of myelinated PnA (Group I, Group II, and Group III) enter the cat's cervical spinal segments that supply the phrenic nerve", {"entities": []}], ["Untreated depression during pregnancy increases the risk of morbidity and mortality in the mother and child.", {"entities": []}], ["Therefore, specific treatments are required for this population.", {"entities": []}], ["The study aimed to investigating the effect of antidepressant medication used during pregnancy with reference to the risk of preterm birth (PTB) and low birth weight (LBW).", {"entities": []}], ["A population-based study was carried out with data provided by the healthcare utilization database of Lombardy, an Italian region with about ten million inhabitants.", {"entities": []}], ["The study included 384,673 births from 2005 to 2010.", {"entities": []}], ["Maternal use of antidepressants before and during pregnancy was investigated.", {"entities": []}], ["Log-binomial regression was used to estimate the association between the use of antidepressants during pregnancy, compared to the non-use or use just before pregnancy, and the prevalence ratio of PTB and LBW.", {"entities": []}], ["Women who used antidepressants during pregnancy had a 20% (95% CI: 10\u201340%) increased prevalence of both PTB and LBW compared to those who never used antidepressants.", {"entities": []}], ["There was no evidence that women who used antidepressants during pregnancy had a higher prevalence of the considered outcomes compared to women who used antidepressants before pregnancy, but stopped during pregnancy.", {"entities": []}], ["Such findings were confirmed by considering separately the effects of SSRIs and other antidepressants together.", {"entities": []}], ["Our findings suggest that depression in itself, rather than antidepressant medication, might be implicated in the causal pathway of PTB and LBW.", {"entities": []}], ["Kaposi's sarcoma-associated herpesvirus (KSHV) establishes life-long infection by evading clearance by the host immune system.", {"entities": [[9, 16, "DISEASE"]]}], ["In de novo infection and lytic replication, KSHV escapes cytotoxic T cells and NK cells through downregulation of MHC class-I and ICAM-1 molecules and associated antigens involved in forming and sustaining the immunological synapse.", {"entities": []}], ["However, the efficacy of such mechanisms in the context of the predominantly latent KSHV infection reported in Kaposi's sarcoma (KS) lesions is unclear.", {"entities": [[120, 127, "DISEASE"]]}], ["Using primary dermal fibroblasts in a novel in vitro model of chronic latent KSHV infection, we generated target cells with viral loads similar to those in spindle cells extracted from KS lesions.", {"entities": []}], ["We show that latently KSHV-infected fibroblasts had normal levels of MHC-class I, ICAM-1, HLA-E and NKG2D ligand expression, were resistant to NK-cell natural cytotoxicity and were highly susceptible to killing by cytokine-activated immunocompetent NK cells.", {"entities": [[90, 95, "GENE"]]}], ["KSHV-infected fibroblasts expressed normal levels of IFN-\u03b3R1 and responded to exogenous IFN-\u03b3 by upregulating MHC class I, ICAM-1 and HLA-E and resisting activated NK-cell killing.", {"entities": [[134, 139, "GENE"]]}], ["These data demonstrate that physiologically relevant levels of latent KSHV infection in primary cells cause limited activation of resting NK cells and confer little specific resistance to control by activated NK cells.", {"entities": []}], ["Parametric response mapping (PRM) of paired CT lung images has been shown to improve the phenotyping of COPD by allowing for the visualization and quantification of non-emphysematous air trapping component, referred to as functional small airways disease (fSAD).", {"entities": []}], ["Although promising, large variability in the standard method for analyzing PRM", {"entities": []}], ["Since 1950, traditional Chinese medicine (TCM) cupping therapy has been applied as a formal modality in hospitals throughout China and elsewhere in the world.", {"entities": []}], ["Based on a previous systematic literature review of clinical studies on cupping therapy, this study presents a thorough review of randomized controlled trials (RCTs) to evaluate the therapeutic effect of cupping therapy.", {"entities": []}], ["Six databases were searched for articles published through 2010.", {"entities": []}], ["RCTs on cupping therapy for various diseases were included.", {"entities": []}], ["Studies on cupping therapy combined with other TCM treatments versus non-TCM therapies were excluded.", {"entities": []}], ["135 RCTs published from 1992 through 2010 were identified.", {"entities": []}], ["The studies were generally of low methodological quality.", {"entities": []}], ["Diseases for which cupping therapy was commonly applied were herpes zoster, facial paralysis (Bell palsy), cough and dyspnea, acne, lumbar disc herniation, and cervical spondylosis.", {"entities": [[126, 130, "DISEASE"], [76, 92, "DISEASE"], [169, 180, "DISEASE"], [61, 74, "DISEASE"]]}], ["Wet cupping was used in most trials, followed by retained cupping, moving cupping, and flash cupping.", {"entities": []}], ["Meta-analysis showed cupping therapy combined with other TCM treatments was significantly superior to other treatments alone in increasing the number of cured patients with herpes zoster, facial paralysis, acne, and cervical spondylosis.", {"entities": [[206, 210, "DISEASE"], [188, 204, "DISEASE"], [225, 236, "DISEASE"], [173, 186, "DISEASE"]]}], ["No serious adverse effects were reported in the trials.", {"entities": []}], ["Numerous RCTs on cupping therapy have been conducted and published during the past decades.", {"entities": []}], ["This review showed that cupping has potential effect in the treatment of herpes zoster and other specific conditions.", {"entities": [[73, 86, "DISEASE"]]}], ["However, further rigorously designed trials on its use for other conditions are warranted.", {"entities": []}], ["Allergic rhinitis is one of the most common diseases of adult and pediatric age, associated with grass pollen (GP) allergy in >50% cases, with a consistent impact on quality of life of affected patients.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["A grass allergen tablet, containing standardized extract derived from Timothy grass ( Phleum pratense ) pollen and ~15 \u03bcg major allergen P. pratense (rPhl p 5), may be the future of allergen-specific immunotherapy (IT) for GP allergy.", {"entities": []}], ["The aim of this review was to critically evaluate the role of Timothy GP extract IT for the management of allergic rhinitis.", {"entities": [[106, 123, "DISEASE"], [115, 123, "DISEASE"]]}], ["For this purpose, we have tried to analyze potential mechanisms of action at the basis of Timothy GP extract, we have reviewed efficacy studies to establish potential benefits and clinical response, and we have also evaluated safety and tolerability profiles and patient focus perspective, such as quality of life, satisfaction and acceptability, and compliance to this IT.", {"entities": []}], ["To explore the views and experiences of patients on the care they have received while enrolled on the Northumberland High Risk Patient Programme (NHRPP).", {"entities": []}], ["This programme involved case finding of frail patients using a multidisciplinary team (MDT)-led community case management programme, and support of patients through care planning and regular reviews using primary, community, secondary and social care professionals.", {"entities": []}], ["A qualitative study using semistructured interviews, which were digitally recorded, transcribed and subject to thematic analysis.", {"entities": []}], ["Community patients receiving primary care in the county of Northumberland, England.", {"entities": []}], ["23 participants took part, of which 16 were patients enrolled on the NHRPP, and 7 carers.", {"entities": []}], ["GP practices were selected purposively by size, deprivation and location, and patients identified and invited by General Practitioners to participate.", {"entities": []}], ["4 main themes emerged from the data: awareness and understanding of the NHRPP, confidence in the primary healthcare team, limitations of home care and the active role of being a patient.", {"entities": []}], ["Despite having a low level of awareness of the details of the NHRPP, participants did think that its broad aim made sense.", {"entities": []}], ["Participants discussed their high level of satisfaction with their care and access to team members.", {"entities": []}], ["However, some limitations of alternatives to hospital care were identified, including the need to consider psychological as well as medical needs, the importance of overnight care and the needs of those without informal carers.", {"entities": []}], ["Finally, participants discussed the active nature of being a patient under the NHRPP if they were to contribute fully to planning and managing their own care.", {"entities": []}], ["This study has identified that a programme of MDT-led case management was generally very well received by patients and their families.", {"entities": []}], ["However, a number of factors were identified that could improve the implementation of the programme and further research needs to be undertaken to address these.", {"entities": []}], ["A detailed case study from the field of social entrepreneurship is used to illustrate the network approach, which does not require more resources but rather makes better use of existing resources.", {"entities": []}], ["Leaders in public health can use networks to overcome some of the barriers that inhibit the widespread adoption of a population health approach to community health.", {"entities": []}], ["Public health leaders who embrace social entrepreneurship may be better able to accomplish their missions by building their networks rather than just their organizations.", {"entities": []}], ["Probiotics are defined as live microorganisms, which when administered in adequate amounts, confer a health benefit on the host.", {"entities": []}], ["Health benefits have mainly been demonstrated for specific probiotic strains of the following genera: Lactobacillus , Bifidobacterium , Saccharomyces , Enterococcus , Streptococcus , Pediococcus, Leuconostoc , Bacillus , Escherichia coli .", {"entities": []}], ["The human microbiota is getting a lot of attention today and research has already demonstrated that alteration of this microbiota may have far-reaching consequences.", {"entities": []}], ["One of the possible routes for correcting dysbiosis is by consuming probiotics.", {"entities": []}], ["The credibility of specific health claims of probiotics and their safety must be established through science-based clinical studies.", {"entities": []}], ["This overview summarizes the most commonly used probiotic microorganisms and their demonstrated health claims.", {"entities": []}], ["As probiotic properties have been shown to be strain specific, accurate identification of particular strains is also very important.", {"entities": []}], ["On the other hand, it is also demonstrated that the use of various probiotics for immunocompromised patients or patients with a leaky gut has also yielded infections, sepsis, fungemia, bacteraemia.", {"entities": []}], ["Although the vast majority of probiotics that are used today are generally regarded as safe and beneficial for healthy individuals, caution in selecting and monitoring of probiotics for patients is needed and complete consideration of risk-benefit ratio before prescribing is recommended.", {"entities": []}], ["Fungal spores and plant pollen cause respiratory diseases in susceptible individuals, such as asthma, allergic rhinitis and hypersensitivity pneumonitis.", {"entities": [[102, 119, "DISEASE"], [111, 119, "DISEASE"], [94, 100, "DISEASE"]]}], ["Aeroallergen monitoring networks are an important part of treatment strategies, but unfortunately traditional analysis is time consuming and expensive.", {"entities": []}], ["We have explored the use of infrared spectroscopy of pollen and spores for an inexpensive and rapid characterization of aeroallergens.", {"entities": []}], ["The study is based on measurement of spore and pollen samples by single reflectance attenuated total reflectance Fourier transform infrared spectroscopy (SR-ATR FTIR).", {"entities": []}], ["The experimental set includes 71 spore (Basidiomycota) and 121 pollen (Pinales, Fagales and Poales) samples.", {"entities": []}], ["Along with fresh basidiospores, the study has been conducted on the archived samples collected within the last 50 years.", {"entities": []}], ["The spectroscopic-based methodology enables clear spectral differentiation between pollen and spores, as well as the separation of confamiliar and congeneric species.", {"entities": []}], ["In addition, the analysis of the scattering signals inherent in the infrared spectra indicates that the FTIR methodology offers indirect estimation of morphology of pollen and spores.", {"entities": []}], ["The analysis of fresh and archived spores shows that chemical composition of spores is well preserved even after decades of storage, including the characteristic taxonomy-related signals.", {"entities": []}], ["Therefore, biochemical analysis of fungal spores by FTIR could provide economical, reliable and timely methodologies for improving fungal taxonomy, as well as for fungal identification and monitoring.", {"entities": []}], ["This proof of principle study shows the potential for using FTIR as a rapid tool in aeroallergen studies.", {"entities": []}], ["In addition, the presented method is ready to be immediately implemented in biological and ecological studies for direct measurement of pollen and spores from flowers and sporocarps.", {"entities": []}], ["Previous findings suggest a link between neuroinflammatory processes and suicidality.", {"entities": []}], ["Despite several lines of evidence supporting this link, including increased pro-inflammatory markers in blood-, cerebrospinal fluid (CSF)- and in post-mortem brain samples from suicidal individuals, the underlying mechanisms remain poorly understood.", {"entities": []}], ["In this pilot study, we explored the possibility that autoimmune encephalopathies might be found among suicide attempters.", {"entities": []}], ["We analysed the presence of six different autoantibodies ( N -methyl-D-aspartate receptor, the \u03b1-amino-3-hydroxy-5-methyl-4-isoxazol-propionic acid receptor, the \u03b3-amino-butyric acid B-receptor, the leucine-rich, glioma-inactivated 1, the contactin-associated protein-like 2, and the dipeptidyl-peptidase-like protein-6), all previously associated with psychopathology, in CSF samples from 29 unmedicated suicide attempters.", {"entities": []}], ["Five of these subjects had high CSF/serum albumin ratio, indicative of increased blood-brain-barrier permeability.", {"entities": []}], ["We were not able to detect any of these autoantibodies in the CSF samples.", {"entities": []}], ["These pilot data do not support a role for autoimmune encephalopathies in suicidal behaviour, although the presence of lower levels of these autoantibodies cannot be ruled out in these patients.", {"entities": []}], ["Bronchiolitis is a major cause of hospitalization among infants.", {"entities": [[0, 13, "DISEASE"]]}], ["Severe bronchiolitis is associated with later asthma, suggesting a common genetic predisposition.", {"entities": [[46, 52, "DISEASE"], [7, 20, "DISEASE"]]}], ["Genetic background of bronchiolitis is not well characterized.", {"entities": [[22, 35, "DISEASE"]]}], ["To identify polymorphisms associated with bronchiolitis, we conducted a genome-wide association study (GWAS) in which 5,300,000 single nucleotide polymorphisms (SNPs) were tested for association in a Finnish\u2013Swedish population of 217 children hospitalized for bronchiolitis and 778 controls.", {"entities": [[42, 55, "DISEASE"], [260, 273, "DISEASE"]]}], ["The most promising SNPs (n\u2009=\u200977) were genotyped in a Dutch replication population of 416 cases and 432 controls.", {"entities": []}], ["Finally, we used a set of 202 Finnish bronchiolitis cases to further investigate candidate SNPs.", {"entities": [[38, 51, "DISEASE"]]}], ["We did not detect genome-wide significant associations, but several suggestive association signals ( p \u2009<\u200910 p \u2009<\u20090.05).", {"entities": []}], ["Of them, rs269094 was an expression quantitative trait locus (eQTL) for KCND3 , previously shown to be associated with occupational asthma.", {"entities": [[132, 138, "DISEASE"], [72, 77, "GENE"]]}], ["In the additional set of Finnish cases, the association for another SNP (rs9591920) within a noncoding RNA locus was further strengthened.", {"entities": []}], ["Our results provide a first genome-wide examination of the genetics underlying bronchiolitis.", {"entities": [[79, 92, "DISEASE"]]}], ["These preliminary findings require further validation in a larger sample size.", {"entities": []}], ["Chronic helminth infections, such as schistosomes, are negatively associated with allergic disorders.", {"entities": []}], ["Here, using B cell IL-10-deficient mice, Schistosoma mansoni -mediated protection against experimental ovalbumin-induced allergic airway inflammation (AAI) was shown to be specifically dependent on IL-10-producing B cells.", {"entities": []}], ["To study the organs involved, we transferred B cells from lungs, mesenteric lymph nodes or spleen of OVA-infected mice to recipient OVA-sensitized mice, and showed that both lung and splenic B cells reduced AAI, but only splenic B cells in an IL-10-dependent manner.", {"entities": []}], ["Although splenic B cell protection was accompanied by elevated levels of pulmonary FoxP3 in vivo ablation of FoxP3 in vitro .", {"entities": [[83, 88, "GENE"], [109, 114, "GENE"], [83, 88, "GENE"], [109, 114, "GENE"]]}], ["Indeed, transfer of CD1d Schistosoma haematobium -infected Gabonese children compared to uninfected children and these cells produced elevated levels of IL-10.", {"entities": [[20, 24, "GENE"]]}], ["Importantly, the number of IL-10-producing CD1d", {"entities": [[43, 47, "GENE"]]}], ["Chronic respiratory infections are a leading global cause of morbidity and mortality.", {"entities": []}], ["However, the molecular triggers that cause respiratory pathogens to adopt persistent and often untreatable lifestyles during infection remain largely uncharacterised.", {"entities": []}], ["Recently, bile aspiration caused by gastro-oesophageal reflux (GOR) has emerged as a significant complication associated with respiratory disease, and cystic fibrosis (CF) in particular.", {"entities": [[151, 166, "DISEASE"]]}], ["Based on our previous finding that the physiological concentrations of bile influence respiratory pathogens towards a chronic lifestyle in vitro, we investigated the impact of bile aspiration on the lung microbiome of respiratory patients.", {"entities": []}], ["Sputum samples ( n \u2009=\u200925) obtained from a cohort of paediatric CF patients were profiled for the presence of bile acids using high-resolution liquid chromatography\u2013mass spectrometry (LC-MS).", {"entities": []}], ["Pyrosequencing was performed on a set of ten DNA samples that were isolated from bile aspirating ( n \u2009=\u20095) and non-bile aspirating ( n \u2009=\u20095) patients.", {"entities": []}], ["Both denaturing gradient gel electrophoresis (DGGE) and pyrosequencing revealed significantly reduced biodiversity and richness in the sputum samples from bile aspirating patients when compared with non-aspirating patients.", {"entities": []}], ["Families and genera associated with the pervasive CF microbiome dominated aspirating patients, while bacteria associated with the healthy lung were most abundant in non-aspirating patients.", {"entities": []}], ["Bile aspiration linked to GOR is emerging as a major host trigger of chronic bacterial infections.", {"entities": []}], ["The markedly reduced biodiversity and increased colonisation by dominant proteobacterial CF-associated pathogens observed in the sputum of bile aspirating patients suggest that bile may play a major role in disease progression in CF and other respiratory diseases.", {"entities": []}], ["The online version of this article (doi:10.1007/s10096-014-2133-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Medicinal plants are widely used for the treatment of different infectious diseases.", {"entities": []}], ["Infectious diseases caused by bacteria have a large impact on public health.", {"entities": []}], ["This study aimed to determine the in vitro antibacterial activity of the medicinal plants traditionally used in Vietnam against the bacterial strains associated with infectious diseases.", {"entities": []}], ["Methanol extracts of twelve Vietnamese medicinal plants were tested for their antibacterial activity against five bacterial species including Gram-positive bacteria ( Bacillus cereus , Bacillus subtilis , and Staphylococcus aureus ) and Gram-negative bacteria ( Escherichia coli and Pseudomonas aeruginosa ) using the broth microdilution method.", {"entities": []}], ["All the plant extracts showed antibacterial activity, especially against Gram-positive bacteria ( Bacillus cereus, Bacillus subtilis, and Staphylococcus aureus ).", {"entities": []}], ["Baeckea frutescens extract revealed a potent activity against the Gram-positive bacteria with the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of 62.5\u00a0\u03bcg/ml.", {"entities": []}], ["High activity against all the three Gram-positive bacteria was also observed for the extracts of Cratoxylum formosum ssp.", {"entities": []}], ["pruniflorum, Pogostemon cablin, and Pedilanthus tithymaloides with MICs of 125, 125 and 250\u00a0\u03bcg/ml and MBCs of 125\u2013250, 125\u2013250 and 250\u2013500\u00a0\u03bcg/ml, respectively.", {"entities": []}], ["The extracts of C. formosum ssp.", {"entities": []}], ["pruniflorum and P. tithymaloides showed a broad-spectrum antibacterial activity against all the bacteria tested with the MICs of 125\u20132,000\u00a0\u03bcg/ml.", {"entities": []}], ["This study indicates clear evidence supporting the traditional use of the plants in treating infectious diseases related to bacteria.", {"entities": []}], ["In particular, these plant species showed moderate to high antibacterial activity against the Gram-positive bacteria tested.", {"entities": []}], ["People with neurodevelopmental disorders and intellectual disabilities have much greater health care needs.", {"entities": []}], ["Mainly staying indoors, such people generally have low 25-hydroxyvitamin D (25(OH)D) concentrations.", {"entities": []}], ["The Vitamin D Task Force of the American Academy of Developmental Medicine and Dentistry (AADMD) reviewed the evidence of 25(OH)D concentrations that benefit the health of persons with developmental disabilities.", {"entities": []}], ["Maintaining recommended optimal serum 25(OH)D concentrations year long will benefit skeletal development in infants, children, and adolescents, and benefit musculoskeletal health and neuromuscular coordination in adult patients, and decrease risk of falls.", {"entities": []}], ["Maintaining optimal concentrations decreases risks and severities of autoimmune diseases, cardiovascular disease, many types of cancer, dementia, types 1 and 2 diabetes mellitus, and respiratory tract infections.", {"entities": [[136, 144, "DISEASE"], [128, 134, "DISEASE"], [160, 177, "DISEASE"]]}], ["Other benefits include improved dental and oral health and improved physical performance.", {"entities": []}], ["The Task Force recommends that 25(OH)D concentrations for optimal health to be in the range of 75 to 125 nmol/L, which can be achieved using between 800 and 4000 IU/day vitamin D 3 and sensible exposure to solar UVB radiation.", {"entities": []}], ["The paper also discusses the potential risks of higher 25(OH)D concentrations, the evidence from and limitations of randomized controlled trials, and the recommendations by various groups and agencies.", {"entities": []}], ["Activation of T lymphocytes, for which potassium channels are essential, is involved in the development of hypertension.", {"entities": [[107, 119, "DISEASE"]]}], ["In this study, we explored the inhibitory effects of telmisartan on the culture and proliferation of and Kv1.3 potassium channel expression in peripheral blood CD4 CD4 The IL-6 and IL-17 expression levels were significantly higher in the blood of the hypertensive Kazakh patients than in the healthy Kazakh people.", {"entities": [[160, 163, "GENE"], [164, 167, "GENE"], [160, 163, "GENE"], [164, 167, "GENE"]]}], ["Telmisartan inhibited T-lymphocytic proliferation, as well as the mRNA and protein expression of the Kv1.3 potassium channel in CD4 Telmisartan may potentially regulate hypertensive inflammatory responses by inhibiting T-lymphocytic proliferation and Kv1.3 potassium channel expression in CD4", {"entities": [[128, 131, "GENE"], [289, 292, "GENE"], [128, 131, "GENE"], [289, 292, "GENE"]]}], ["We tested the hypothesis that patients with difficult asthma have an increased frequency of certain genotypes that predispose them to asthma exacerbations and poor asthma control.", {"entities": [[54, 60, "DISEASE"], [134, 140, "DISEASE"], [164, 170, "DISEASE"]]}], ["A total of 180 Caucasian children with confirmed asthma diagnosis were selected from two phenotypic groups; difficult (n\u200a=\u200a112) versus mild/moderate asthma (n\u200a=\u200a68) groups.", {"entities": [[49, 55, "DISEASE"], [149, 155, "DISEASE"]]}], ["All patients were screened for 19 polymorphisms in 9 candidate genes to evaluate their association with difficult asthma.", {"entities": [[114, 120, "DISEASE"]]}], ["The results indicated that LTA4H A-9188>G, TNF\u03b1 G-308>A and IL-4R\u03b1 A1727>G polymorphisms were significantly associated with the development of difficult asthma in paediatric patients (p<0.001, p\u200a=\u200a0.019 and p\u200a=\u200a0.037, respectively).", {"entities": [[153, 159, "DISEASE"], [27, 32, "GENE"]]}], ["Haplotype analysis also revealed two haplotypes (ATA haplotype of IL-4R\u03b1 A1199>C, IL-4R\u03b1 T1570>C and IL-4R\u03b1 A1727>G and CA haplotype of TNF\u03b1 C-863>A and TNF\u03b1 G-308>A polymorphisms) which were significantly associated with difficult asthma in children (p\u200a=\u200a0.04 and p\u200a=\u200a0.018, respectively).", {"entities": [[232, 238, "DISEASE"]]}], ["The study revealed multiple SNPs and haplotypes in LTA4H, TNF\u03b1 and IL4-R\u03b1 genes which constitute risk factors for the development of difficult asthma in children.", {"entities": [[143, 149, "DISEASE"], [51, 56, "GENE"]]}], ["Of particular interest is the LTA4H A-9188>G polymorphism which has been reported, for the first time, to have strong association with severe asthma in children.", {"entities": [[142, 148, "DISEASE"], [30, 35, "GENE"]]}], ["Our results suggest that screening for patients with this genetic marker could help characterise the heterogeneity of responses to leukotriene-modifying medications and, hence, facilitate targeting these therapies to the subset of patients who are most likely to gain benefit.", {"entities": []}], ["To investigate the respiratory infectious phenotypes and their impact on length of stay (LOS) and the COPD Assessment Test (CAT) Scale in acute exacerbation of COPD (AECOPD).", {"entities": []}], ["We categorized 81 eligible patients into bacterial infection, viral infection, coinfection, and non-infectious groups.", {"entities": []}], ["The respiratory virus examination was determined by a liquid bead array xTAG Respiratory Virus Panel in pharyngeal swabs, while bacterial infection was studied by conventional sputum culture.", {"entities": []}], ["LOS and CAT as well as demographic information were recorded.", {"entities": []}], ["Viruses were detected in 38 subjects, bacteria in 17, and of these, seven had both.", {"entities": []}], ["Influenza virus was the most frequently isolated virus, followed by enterovirus/rhinovirus, coronavirus, bocavirus, metapneumovirus, parainfluenza virus types 1, 2, 3, and 4, and respiratory syncytial virus.", {"entities": [[0, 9, "DISEASE"]]}], ["Bacteriologic analyses of sputum showed that Pseudomonas aeruginosa was the most common bacteria, followed by Acinetobacter baumannii , Klebsiella , Escherichia coli , and Streptococcus pneumoniae .", {"entities": []}], ["The longest LOS and the highest CAT score were detected in coinfection group.", {"entities": []}], ["CAT score was positively correlated with LOS.", {"entities": []}], ["Respiratory infection is a common causative agent of exacerbations in COPD.", {"entities": []}], ["Respiratory coinfection is likely to be a determinant of more severe acute exacerbations with longer LOS.", {"entities": []}], ["CAT score may be a predictor of longer LOS in AECOPD.", {"entities": []}], ["For patients with chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), exacerbations are life-threatening events causing acute respiratory distress that can even lead to hospitalization and death.", {"entities": [[49, 86, "DISEASE"]]}], ["Although a great deal of effort has been put into research of exacerbations and potential treatment options, the exact underlying mechanisms are yet to be deciphered and no therapy that effectively targets the excessive inflammation is available.", {"entities": []}], ["In this study, we report that interleukin-1\u03b2 (IL-1\u03b2) and interleukin-17A (IL-17A) are key mediators of neutrophilic inflammation in influenza-induced exacerbations of chronic lung inflammation.", {"entities": [[132, 141, "DISEASE"]]}], ["Using a mouse model of disease, our data shows a role for IL-1\u03b2 in mediating lung dysfunction, and in driving neutrophilic inflammation during the whole phase of viral infection.", {"entities": []}], ["We further report a role for IL-17A as a mediator of IL-1\u03b2 induced neutrophilia at early time points during influenza-induced exacerbations.", {"entities": [[108, 117, "DISEASE"]]}], ["Blocking of IL-17A or IL-1 resulted in a significant abrogation of neutrophil recruitment to the airways in the initial phase of infection or at the peak of viral replication, respectively.", {"entities": []}], ["Therefore, IL-17A and IL-1\u03b2 are potential targets for therapeutic treatment of viral exacerbations of chronic lung inflammation", {"entities": []}], ["Understanding the differences in the risk judgments of residents of industrial communities potentially provides insights into how to develop appropriate risk communication strategies.", {"entities": []}], ["This study aimed to explore citizens\u2019 fundamental understanding of risk-related judgments and to identify the factors contributing to perceived risks.", {"entities": []}], ["An exploratory model was created to investigate the public\u2019s risk judgments.", {"entities": []}], ["In this model, the relationship between laypeople\u2019s perceived risks and the factors related to the physical nature of risks (such as perceived probability of environmental contamination, probability of receiving impacts, and severity of catastrophic consequences) were examined by means of multiple regression analysis.", {"entities": []}], ["Psychological factors, such as the ability to control the risks, concerns, experiences, and perceived benefits of industrial development were also included in the analysis.", {"entities": []}], ["The Maptaphut industrial area in Rayong Province, Thailand was selected as a case study.", {"entities": []}], ["A survey of 181 residents of communities experiencing different levels of hazardous gas contamination revealed rational risk judgments by inhabitants of high-risk and moderate-risk communities, based on their perceived probability of contamination, probability of receiving impacts, and perceived catastrophic consequences.", {"entities": []}], ["However, risks assessed by people in low-risk communities could not be rationally explained and were influenced by their collective experiences.", {"entities": []}], ["Secretory phospholipase A2 group IIA (sPLA2-IIA) has been identified as a biomarker of atherosclerosis in observational and animal studies.", {"entities": [[87, 102, "DISEASE"]]}], ["The protein is encoded by the PLA2G2A gene and the aim of this study was to test the functionality of two PLA2G2A non-coding SNPs, rs11573156 C>G and rs3767221 T>G where the rare alleles have been previously associated with higher and lower sPLA2-IIA levels respectively.", {"entities": [[30, 37, "GENE"], [106, 113, "GENE"], [30, 37, "GENE"], [106, 113, "GENE"]]}], ["Luciferase assays, electrophoretic mobility shift assays (EMSA), and RNA expression by RT-PCR were used to examine allelic differences.", {"entities": []}], ["For rs3767221 the G allele showed \u223c55% lower luciferase activity compared to the T allele (T\u200a=\u200a62.1 (95% CI 59.1 to 65.1) G\u200a=\u200a27.8 (95% CI 25.0 to 30.6), p\u200a=\u200a1.22\u00d710 PLA2G2A (1.67\u00d710 Both SNPs are functional and provide useful tools for Mendelian Randomisation to determine whether the relationship between sPLA2-IIA and coronary heart disease is causal.", {"entities": [[330, 343, "DISEASE"], [321, 343, "DISEASE"], [166, 173, "GENE"]]}], ["Our understanding of immunity has historically been informed by studying heritable mutations in both the adaptive and innate immune responses, including primary immunodeficiency and autoimmune diseases.", {"entities": []}], ["Recent advances achieved through the application of genomic and epigenomic approaches are reshaping the study of immune dysfunction and opening up new avenues for therapeutic interventions.", {"entities": []}], ["Moreover, applying genomic techniques to resolve functionally important genetic variation between individuals is providing new insights into immune function in health.", {"entities": []}], ["This review describes progress in the study of rare variants and primary immunodeficiency diseases arising from whole-exome sequencing (WES), and discusses the application, success, and challenges of applying genome-wide association studies (GWAS) to disorders of immune function and how they may inform more rational use of therapeutics.", {"entities": []}], ["In addition, the application of expression quantitative-trait mapping to immune phenotypes, progress in understanding MHC disease associations, and insights into epigenetic mechanisms at the interface of immunity and the environment are reviewed.", {"entities": []}], ["Glucocorticoids are universally used in the treatment of acute lymphoblastic leukemia (ALL), and leukemia cell resistant to glucocorticoids confers a poor prognosis.", {"entities": [[77, 85, "DISEASE"], [97, 105, "DISEASE"], [63, 85, "DISEASE"]]}], ["To elucidate mechanisms of glucocorticoid resistance, we determined the sensitivity to prednisolone of primary leukemia cells from 444 newly diagnosed ALL patients, revealing significantly higher expression of caspase 1 (CASP1) and its activator NLRP3 in glucocorticoid resistant leukemia cells, due to significantly lower somatic methylation of CASP1 and NLRP3 promoters.", {"entities": [[111, 119, "DISEASE"], [280, 288, "DISEASE"], [246, 251, "GENE"], [356, 361, "GENE"], [246, 251, "GENE"], [356, 361, "GENE"]]}], ["Over-expression of CASP1 resulted in cleavage of the glucocorticoid receptor, diminished glucocorticoid-induced transcriptional response and increased glucocorticoid resistance.", {"entities": []}], ["Knockdown or inhibition of CASP1 significantly increased glucocorticoid receptor levels and mitigated glucocorticoid resistance in CASP1 overexpressing ALL.", {"entities": []}], ["Our findings establish a new mechanism by which the NLRP3/CASP1 inflammasome modulates cellular levels of the glucocorticoid receptor and diminishes cell sensitivity to glucocorticoids.", {"entities": []}], ["The broad impact on glucocorticoid transcriptional response suggests this mechanism could also modify glucocorticoid effects in other diseases.", {"entities": []}], ["To investigate the patient's experience of the trajectory to receiving a diagnosis of pulmonary arterial hypertension (PAH) and inform the provision of care for this patient group.", {"entities": [[105, 117, "DISEASE"]]}], ["Qualitative study using in-depth one-to-one interviews and pictorial representations.", {"entities": []}], ["Data were analysed using thematic analysis.", {"entities": []}], ["Participants were interviewed in their own homes across England.", {"entities": []}], ["30 patients with a diagnosis of pulmonary hypertension (18 participants were women, mean age 56 and range 26-80\u2002years and time since diagnosis ranged from a few months to more than 12\u2002years) participated.", {"entities": [[42, 54, "DISEASE"], [32, 54, "DISEASE"]]}], ["All participants, regardless of the time since diagnosis, vividly described the process from manifestation of symptoms to receiving a confirmed diagnosis.", {"entities": []}], ["The authors present data using three major themes: (i) making sense of symptoms, (ii) process of elimination and (iii) being diagnosed with PAH.", {"entities": []}], ["Making sense of symptoms represented an early period of perseverance\u2014people tried to carry-on as usual despite \u2018unexplained breathlessness\u2019.", {"entities": []}], ["As time progressed, this period was punctuated by critical events that triggered seeking medical advice.", {"entities": []}], ["Once medical contact had been made, patients described a period of \u2018elimination\u2019 and convoluted contact with the medical profession.", {"entities": []}], ["Dyspnoea misdiagnosis was a key factor that delayed the PAH diagnosis.", {"entities": []}], ["Diagnosis disclosure by some medical professionals was also viewed as lacking empathy.", {"entities": []}], ["More positive experiences were relayed when the medical team disclosing the diagnosis acknowledged previous limitations.", {"entities": []}], ["A lack of awareness of this illness from both the sufferer themselves and the medical profession emerged as a central theme and led to prolonged periods of being misdiagnosed.", {"entities": []}], ["The application of a diagnostic pathway for unexplained dyspnoea that alerts practitioners to rare conditions could expedite the process of correct diagnosis.", {"entities": []}], ["What is the patient's experience to receiving a diagnosis of pulmonary hypertension?", {"entities": [[71, 83, "DISEASE"], [61, 83, "DISEASE"]]}], ["What are the key patient and healthcare professional factors that prolong diagnosis?", {"entities": []}], ["There is a lack of awareness of this illness from both the sufferer themselves and the medical profession.", {"entities": []}], ["A diagnostic pathway for unexplained dyspnoea may assist professionals to increase initial suspicion that less known conditions, such as PAH, may be present.", {"entities": []}], ["The pre-diagnostic journey can have long lasting effects on the individual and should form part of the patient's care pathway following referral to the specialist PAH centre.", {"entities": []}], ["This is the first study to explore the PAH pre-diagnostic journey.", {"entities": []}], ["Data were collected using in-depth interviews incorporated with a novel approach of collecting pictorial representations.", {"entities": []}], ["Given the role that medical professionals play in the patients' trajectory to diagnosis, their inclusion would be warranted in future studies.", {"entities": []}], ["The need for novel biomarkers that could aid in non-small cell lung cancer (NSCLC) detection, together with the relevance of Matrix Metalloproteases (MMPs) -1, -2, -7, -9 and -10 in lung tumorigenesis, prompted us to assess the diagnostic usefulness of these MMPs and the Tissue Inhibitor of Metalloproteinase (TIMP) -1 in NSCLC patients.", {"entities": [[63, 74, "DISEASE"], [68, 74, "DISEASE"]]}], ["Markers were evaluated in an initial study cohort (19 NSCLC cases and 19 healthy controls).", {"entities": []}], ["Those that better performed were analyzed in a larger sample including patients with benign lung diseases.", {"entities": []}], ["Serum MMPs and TIMP-1 were determined by multiplexed immunoassays.", {"entities": []}], ["Logistic regression was employed for multivariate analysis of biomarker combinations.", {"entities": []}], ["MMPs and TIMP-1 were elevated in the serum of NSCLC patients compared to healthy controls.", {"entities": []}], ["MMP-1, -7 and -9 performed at best and were further evaluated in the sample including benign pathologies, corroborating the superiority of MMP-9 in NSCLC discrimination, also at early-stage NSCLC.", {"entities": []}], ["The optimal diagnostic value was obtained with the model including MMP-9, gender, age and smoking history, that demonstrated an AUC of 0.787, 85.54% sensitivity and 64.89% specificity.", {"entities": []}], ["Our results suggest that MMP-9 is a potential biomarker for NSCLC diagnosis and its combined measurement with other biomarkers could improve NSCLC detection.", {"entities": []}], ["The online version of this article (10.1186/s12885-017-3842-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["It remains challenging to predict regulatory variants in particular tissues or cell types due to highly context-specific gene regulation.", {"entities": []}], ["By connecting large-scale epigenomic profiles to expression quantitative trait loci (eQTLs) in a wide range of human tissues/cell types, we identify critical chromatin features that predict variant regulatory potential.", {"entities": []}], ["We present cepip, a joint likelihood framework, for estimating a variant\u2019s regulatory probability in a context-dependent manner.", {"entities": []}], ["Our method exhibits significant GWAS signal enrichment and is superior to existing cell type-specific methods.", {"entities": []}], ["Furthermore, using phenotypically relevant epigenomes to weight the GWAS single-nucleotide polymorphisms, we improve the statistical power of the gene-based association test.", {"entities": []}], ["The online version of this article (doi:10.1186/s13059-017-1177-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is a very common disease, but primary tracheal tumors are extremely rare in children.", {"entities": [[0, 6, "DISEASE"]]}], ["Wheezing is not pathognomonic, but is the typical presentation of asthma and could also be found in patients with tracheal tumors.", {"entities": [[66, 72, "DISEASE"]]}], ["This report describes a 12-year-old boy with a previous history of frequent asthma attacks and experienced responses to antiasthma treatment.", {"entities": [[76, 82, "DISEASE"]]}], ["He was admitted to the hospital due to persistent wheezing and progressive dyspnea.", {"entities": []}], ["Hyperinflation in the bilateral lungs was detected on chest x-ray, but without other significant findings.", {"entities": []}], ["Chest computed tomography revealed a mass at the carina.", {"entities": []}], ["Tracheal mucoepidermoid carcinoma was diagnosed by histopathological assessment.", {"entities": [[24, 33, "DISEASE"], [9, 33, "DISEASE"]]}], ["Despite the rarity of tracheal tumors, chest computed tomography scans should be performed in the first place for children presenting persistent wheezing and having poor response to antiasthma treatment to rule out the other alternative diagnosis.", {"entities": []}], ["Coexistence of other diseases such as tracheal tumor in asthmatic patients should be considered.", {"entities": []}], ["Nasal polyposis (NP) is characterized by chronic mucosal inflammation with infiltrating eosinophils.", {"entities": []}], ["Eosinophil-mediated tissue remodeling may be involved in NP pathogenesis; therefore, improved understanding of tissue remodeling may result the identification of novel pathways and therapeutic strategies.", {"entities": []}], ["The present study aimed to investigate the pathological changes occurring during tissue remodeling in NP, in order to assess the role of intercellular adhesion molecule-1 (ICAM-1) in localized tissue remodeling and the potential association between ICAM-1 expression and markers of eosinophil activation.", {"entities": []}], ["A total of 28 eligible patients and 10 healthy controls participated in the current study.", {"entities": []}], ["Nasal mucosal tissues of these subjects were retrospectively evaluated for mucosal remodeling using histopathological staining.", {"entities": []}], ["ICAM-1 and eosinophil cationic protein (ECP) expression levels were determined by immunohistochemical analysis.", {"entities": []}], ["Compared with the healthy controls, all the specimens from NP patients presented substantial epithelial damage, skewed cellular distribution with a reduced density of goblet cells, an increased density of subepithelial gland and increased subepithelial collagen deposition.", {"entities": []}], ["In addition, the NP specimens exhibited significantly higher eosinophil infiltration and ICAM-1 expression compared with the controls.", {"entities": []}], ["Positive correlations were observed between ICAM-1 and ECP expression levels (P=0.010), as well as between extracellular collagen deposition and ICAM-1 (P=0.010) and ECP (P=0.012) expression levels in the NP specimens, but not in the control specimens.", {"entities": []}], ["Morphological evidence demonstrated eosinophil-mediated tissue remodeling in NP tissues.", {"entities": []}], ["ICAM-1 expression in activated eosinophils was associated with NP remodeling, indicating the possibility that ICAM-1 may regulate NP remodeling.", {"entities": []}], ["Tobacco smoking is a well-recognised risk factor for many diseases [1].", {"entities": []}], ["This study assesses the extent of smoking-attributable hospitalisation in the Northern Territory (NT) Aboriginal and non-Aboriginal populations, and examines smoking-attributable hospitalisation trends for the years 1998/99 to 2008/09.", {"entities": []}], ["Hospital discharge data were used for the analysis.", {"entities": []}], ["The proportion of conditions attributable to tobacco smoking was calculated using the aetiological fraction method.", {"entities": []}], ["Age-adjusted smoking-attributable hospitalisation rates were calculated to describe the impact of tobacco smoking on the health of Territorians.", {"entities": []}], ["A negative binominal regression model was applied to examine trends in smoking-attributable hospitalisations.", {"entities": []}], ["Aboriginal Territorians were found to have higher rates of smoking-attributable hospitalisation, with Aboriginal males more than three times and Aboriginal females more than four times more likely to be hospitalised for smoking-attributable conditions than their non-Aboriginal counterparts.", {"entities": []}], ["The age-adjusted hospitalisation rate for Aboriginal males increased by 31% and for Aboriginal females by 18% during the study period.", {"entities": []}], ["There were more modest increases for NT non-Aboriginal males and females (5% and 17% respectively).", {"entities": []}], ["The increase among Aboriginal males occurred up until 2005/06 followed by moderation in the trend.", {"entities": []}], ["There were small reductions in smoking-attributable hospitalisation rates among all populations in younger age groups (less than 25\u2009years).", {"entities": []}], ["Aboriginal Territorians experience much higher smoking-attributable hospitalisation rates than non-Aboriginal Territorians.", {"entities": []}], ["The scale of the smoking burden and suggestion of recent moderation among Aboriginal men reinforce the importance of tobacco control interventions that are designed to meet the needs of the NT\u2019s diverse population groups.", {"entities": []}], ["Preventing smoking and increasing smoking cessation rates remain priorities for public health interventions in the NT.", {"entities": []}], ["The biological mechanisms by which cleaning products and disinfectants\u2014an emerging risk factor\u2014affect respiratory health remain incompletely evaluated.", {"entities": []}], ["Studying genes by environment interactions (G \u00d7 E) may help identify new genes related to adult-onset asthma.", {"entities": [[102, 108, "DISEASE"]]}], ["We identified interactions between genetic polymorphisms of a large set of genes involved in the response to oxidative stress and occupational exposures to low molecular weight (LMW) agents or irritants on adult-onset asthma.", {"entities": [[218, 224, "DISEASE"]]}], ["Our data came from three large European cohorts: Epidemiological Family-based Study of the Genetics and Environment of Asthma (EGEA), Swiss Cohort Study on Air Pollution and Lung and Heart Disease in Adults (SAPALDIA), and European Community Respiratory Health Survey in Adults (ECRHS).", {"entities": [[119, 125, "DISEASE"]]}], ["A candidate pathway\u2013based strategy identified 163 genes involved in the response to oxidative stress and potentially related to exposures to LMW agents/irritants.", {"entities": []}], ["Occupational exposures were evaluated using an asthma job-exposure matrix and job-specific questionnaires for cleaners and healthcare workers.", {"entities": [[47, 53, "DISEASE"]]}], ["Logistic regression models were used to detect G \u00d7 E interactions, adjusted for age, sex, and population ancestry, in 2,599 adults (mean age, 47 years; 60% women, 36% exposed, 18% asthmatics).", {"entities": []}], ["p-Values were corrected for multiple comparisons.", {"entities": []}], ["Ever exposure to LMW agents/irritants was associated with current adult-onset asthma [OR = 1.28 (95% CI: 1.04, 1.58)].", {"entities": [[78, 84, "DISEASE"]]}], ["Eight single nucleotide polymorphism (SNP) by exposure interactions at five loci were found at p < 0.005: PLA2G4A (rs932476, chromosome 1), near PLA2R1 (rs2667026, chromosome 2), near RELA (rs931127, rs7949980, chromosome 11), PRKD1 (rs1958980, rs11847351, rs1958987, chromosome 14), and PRKCA (rs6504453, chromosome 17).", {"entities": [[106, 113, "GENE"], [145, 151, "GENE"], [184, 188, "GENE"], [227, 232, "GENE"], [288, 293, "GENE"]]}], ["Results were consistent across the three studies and after accounting for smoking.", {"entities": []}], ["Using a pathway-based selection process, we identified novel genes potentially involved in adult asthma by interaction with occupational exposure.", {"entities": [[97, 103, "DISEASE"]]}], ["These genes play a role in the NF-\u03baB pathway, which is involved in inflammation.", {"entities": []}], ["Rava M, Ahmed I, Kogevinas M, Le Moual N, Bouzigon E, Curjuric I, Dizier MH, Dumas O, Gonzalez JR, Imboden M, Mehta AJ, Tubert-Bitter P, Zock JP, Jarvis D, Probst-Hensch NM, Demenais F, Nadif R. 2017.", {"entities": []}], ["Genes interacting with occupational exposures to low molecular weight agents and irritants on adult-onset asthma in three European studies.", {"entities": [[106, 112, "DISEASE"]]}], ["Environ Health Perspect 125:207\u2013214;\u2002http://dx.doi.org/10.1289/EHP376", {"entities": []}], ["A pilot experimentation of a telemonitoring system for chronic care patients is conducted in the Bilbao Primary Care Health Region (Basque Country, Spain).", {"entities": []}], ["It seems important to understand the factors related to healthcare professionals\u2019 acceptance of this new technology in order to inform its extension to the whole healthcare system.", {"entities": []}], ["This study aims to examine the psychosocial factors related to telemonitoring acceptance among healthcare professionals and to apply a theory-based instrument.", {"entities": []}], ["A validated questionnaire, based on an extension of the Technology Acceptance Model (TAM), was distributed to a total of 605 nurses, general practitioners and paediatricians.", {"entities": []}], ["Logistic regression analysis was performed to test the theoretical model.", {"entities": []}], ["Adjusted odds ratios (OR) and their 95% confidence intervals (CI) were computed.", {"entities": []}], ["A response rate of 44.3% was achieved.", {"entities": []}], ["The original TAM model was good at predicting intention to use the telemonitoring system.", {"entities": []}], ["However, the extended model, that included other theoretical variables, was more powerful.", {"entities": []}], ["Perceived Usefulness, Compatibility, and Facilitators were the significant predictors of intention.", {"entities": []}], ["A detailed analysis showed that intention to use telemonitoring was best predicted by healthcare professionals\u2019 beliefs that they would obtain adequate training and technical support and that telemonitoring would require important changes in their practice.", {"entities": []}], ["The extended TAM explained a significant portion of the variance in healthcare professionals' intention to use a telemonitoring system for chronic care patients in primary care.", {"entities": []}], ["The perception of facilitators in the organisational context is the most important variable to consider for increasing healthcare professionals\u2019 intention to use the new technology.", {"entities": []}], ["Please cite this paper as: Phungoen et\u00a0al .", {"entities": []}], ["(2011) Clinical factors predictive of PCR positive in pandemic H1N1 2009 influenza virus infection.", {"entities": [[73, 82, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 5(6), e558\u2013e562.", {"entities": [[0, 9, "DISEASE"]]}], ["Objective\u2002 Pandemic H1N1 2009 influenza virus (H1N1) has been spreading globally.", {"entities": [[30, 39, "DISEASE"]]}], ["Clinical features might be predictive and may be different among countries.", {"entities": []}], ["Even though the PCR test is a confirmatory test for this viral infection, it is expensive and limited in most Thai health care facilities.", {"entities": []}], ["We studied predictive factors of PCR positive in H1N1 suspected patients.", {"entities": []}], ["Methods\u2002 Consecutive patients who had influenza\u2010like illness less than seven days and had been tested for H1N1 by the real\u2010time PCR method between May and July 2009 were enrolled.", {"entities": [[38, 47, "DISEASE"]]}], ["Clinical data was collected and compared between those who had positive and negative PCR tests.", {"entities": []}], ["Results\u2002 There were 6494 patients had flu\u2010like symptoms.", {"entities": []}], ["Of those, 166 patients were done PCR test and 75 patients (45\u00b718%) had positive PCR test.", {"entities": []}], ["There were four predictors for positive PCR test including history of contact with confirmed H1N1 patients, headache, body temperature, and coryza with the adjusted odds ratio (95% confidence interval) of 2\u00b784 (1\u00b709\u20137\u00b740), 6\u00b725 (1\u00b742\u201327\u00b749), 1\u00b769 (1\u00b708\u20132\u00b766), and 0\u00b731 (0\u00b712\u20130\u00b779), respectively.", {"entities": []}], ["Conclusions\u2002 Clinical factors can be both suggestive and protective factors for H1N1 infection.", {"entities": []}], ["These factors may be helpful in clinical practice to assess the possibility of the H1N1 infection in people who are at risk; particularly in resource\u2010limited health care facilities.", {"entities": []}], ["Overexpression of matrix-metalloproteinases (MMPs) has been shown to lead to tissue damage in equine recurrent airway obstruction (RAO), as a misbalance with their natural inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), occurs.", {"entities": []}], ["This favors irreversible pulmonary fibrosis formation.", {"entities": [[25, 43, "DISEASE"]]}], ["Increased levels of MMPs, TIMPs or altered ratios between them can be used as biomarkers of respiratory disease.", {"entities": []}], ["We hypothesized that levels of MMPs, TIMPs and their ratios correlate with improvement in clinical findings and bronchoalveolar lavage fluid (BALF) cytology after 10\u00a0days of inhalative glucocorticoid therapy and environmental dust reduction (EDR) and may be used to monitor treatment success.", {"entities": []}], ["Ten horses with a history of RAO participated in a prospective clinical study.", {"entities": []}], ["Clinical and cytological scoring was performed before and after inhalative therapy using budesonide (1500\u00a0\u03bcg BID over 10\u00a0days) and EDR (bedding of wood shavings and wet hay as roughage).", {"entities": []}], ["Gelatin zymography was performed for qualitative and semi-quantitative evaluation of MMP-2 and MMP-9 in BALF supernatant, while fluorimetry was used to evaluate MMP-8 activity.", {"entities": []}], ["Additionally, specific equine ELISA assays were used for quantitative assessment of MMP-2, MMP-9, TIMP-1 and TIMP-2.", {"entities": []}], ["A significant reduction in the total and several single parameters of the clinical score were found after 10\u00a0days of inhalative therapy and EDR.", {"entities": []}], ["The concentrations of MMP-2, MMP-9, TIMP-1 and TIMP-2 (ELISA) as well as their activities (MMP-2 and MMP-9 zymography and MMP-8 fluorimetry) were significantly decreased after therapy.", {"entities": []}], ["Significant improvements in MMP-8/TIMP-1 and MMP-8/TIMP-2 ratios were also found, differences between other ratios before and after therapy were insignificant.", {"entities": []}], ["Metalloproteinases and their inhibitors, in particular MMP-9 and TIMP-2, are valuable markers for clinical improvement in RAO.", {"entities": []}], ["The NLRP3-interleukin1\u03b2 (IL1\u03b2) signaling pathway is involved in monosodium urate (MSU)-mediated inflammation.", {"entities": []}], ["The aim of this present study was to determine whether single nucleotide polymorphisms (SNPs) in the NLRP3 gene are associated with susceptibility to gouty arthritis (GA) and whether these SNPs alter the expression of components of the NLRP3-IL1\u03b2 signaling pathway.", {"entities": [[156, 165, "DISEASE"], [101, 106, "GENE"], [236, 241, "GENE"]]}], ["The rs10754558, rs4612666, and rs1539019 SNPs were detected in 583 patients with GA and 459 healthy subjects.", {"entities": []}], ["NLRP3 and IL1\u03b2 mRNA levels in peripheral blood mononuclear cells (PBMCs) and serum IL1\u03b2 levels were measured in different genotype carriers, and correlations between the NLRP3 SNPs and NLRP3 mRNA, IL1\u03b2 mRNA, and serum IL1\u03b2 levels were investigated.", {"entities": [[0, 5, "GENE"], [170, 175, "GENE"], [185, 190, "GENE"], [0, 5, "GENE"], [170, 175, "GENE"], [185, 190, "GENE"], [0, 5, "GENE"], [170, 175, "GENE"], [185, 190, "GENE"]]}], ["The GG genotype of NLRP3 rs10754558 was found to be significantly associated with patients with GA compared to the healthy control subjects via multivariate logistic regression analysis (adjusted OR\u00a0=\u00a02.68, P \u00a0=\u00a00.006).", {"entities": [[19, 24, "GENE"]]}], ["The CGA haplotypes were independently associated with patients with GA compared to the healthy control subjects (adjusted OR\u00a0=\u00a01.968, P \u00a0=\u00a00.02).", {"entities": [[4, 7, "GENE"]]}], ["The levels of NLRP3 mRNA, IL1\u03b2 mRNA, and serum IL1\u03b2 in the patients with GA were significantly different among the three genotypes of rs10754558 (all P\u00a0< \u00a00.01).", {"entities": [[14, 19, "GENE"]]}], ["The GG genotype of rs10754558 and the CGA haplotype of rs4612666-C, rs10754558-G, and rs1539019-A are both independent risk factors for primary GA development.", {"entities": [[38, 41, "GENE"]]}], ["The rs10754558 polymorphism might participate in regulating immune and inflammation responses in patients with GA by influencing the expression of components of the NLRP3 inflammasome.", {"entities": [[165, 170, "GENE"]]}], ["Future multicenter studies aimed at replicating these findings in an independent population as well as functional tests will aid in further defining the role of these SNPs in the development of GA.", {"entities": []}], ["Intestinal differentiation in the endometrium is rare with only case reports in the international literature.", {"entities": []}], ["We describe a case of simultaneous endocervical and intestinal-type mucinous differentiation with goblet cells arising in a FIGO grade 1 endometrioid adenocarcinoma.", {"entities": [[150, 164, "DISEASE"]]}], ["The patient had no involvement of the myometrium, cervix, or extra-uterine sites.", {"entities": []}], ["There were no intestinal metaplastic changes of the endocervical canal.", {"entities": []}], ["The etiology of this change is unknown, although recent reports suggest an association with hyperestrogenism.", {"entities": []}], ["The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1209512176931698", {"entities": []}], ["Although life expectancy estimation is vital to decision making for localized prostate cancer, there are few, if any, valid and usable tools.", {"entities": [[87, 93, "DISEASE"], [78, 93, "DISEASE"]]}], ["Our goal was to create and validate a prediction model for other cause mortality in localized prostate cancer patients that could aid clinician\u2019s initial treatment decisions at the point of care.", {"entities": [[103, 109, "DISEASE"], [94, 109, "DISEASE"]]}], ["We combined an adjusted Social Security Administration table with a subset of comorbidities from a UK actuarial life expectancy model.", {"entities": []}], ["Life tables were adjusted on the basis of survival data from a cohort of almost 10,000 radical prostatectomy patients treated at four major US academic institutions.", {"entities": []}], ["Comorbidity-specific odds ratios were calculated and incorporated with baseline risk of mortality.", {"entities": []}], ["We externally validated the model on 2898 patients from the Prostate Cancer Outcomes Study, which included men diagnosed with prostate cancer in six SEER cancer registries.", {"entities": [[69, 75, "DISEASE"], [135, 141, "DISEASE"], [154, 160, "DISEASE"], [60, 75, "DISEASE"], [126, 141, "DISEASE"]]}], ["These men had sufficient follow-up for our endpoints of 10- and 15-year mortality and also had self-reported comorbidity data.", {"entities": []}], ["Life expectancy for prostate cancer patients were close to that of a typical US man who was 3\u00a0years younger.", {"entities": [[29, 35, "DISEASE"], [20, 35, "DISEASE"]]}], ["On external validation, 10- and 15-year concordance indexes were 0.724 and 0.726, respectively.", {"entities": []}], ["Our model exhibited excellent calibration.", {"entities": []}], ["Taking into account differences between how comorbidities are used in the model versus how they were recorded in the validation cohort, calibration would improve for most patients, but there would be overestimation of the risk of death in the oldest and sickest patients.", {"entities": []}], ["We successfully created and externally validated a new life expectancy prediction model that, while imperfect, has clear advantages to any alternative.", {"entities": []}], ["We urge consideration of its use in counseling patients with localized prostate cancer.", {"entities": [[80, 86, "DISEASE"], [71, 86, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12916-016-0572-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Supplemental Digital Content is available in the text Enterovirus (EV) infection is common among children and adolescents.", {"entities": []}], ["Few studies have investigated the relationship of depression after EV infection.", {"entities": []}], ["This study explores an association between EV infection and subsequent depression in children and adolescents and assesses the risk of depression after EV infection with central nervous system involvement in a nationwide population-based retrospective cohort.", {"entities": []}], ["A random sample of 1,000,000 people was derived from Taiwan National Health Insurance Research Database and we identified enrollees less than 18 years with EV infection before 2005 and followed up until December 2009.", {"entities": []}], ["A total 48,010 cases with EV infection and 48,010 healthy controls matched for sex, age, and residence were obtained.", {"entities": []}], ["Association between EV infection and depression risk was assessed by Cox proportional hazards models to determine the hazard ratios (HRs) and confidence intervals (CIs).", {"entities": []}], ["We further stratified EV infection into with central nervous system (CNS) involvement and without and compared with matched cohort.", {"entities": []}], ["Children and adolescents with EV infection had no elevated risk of depression compared with healthy controls (adjusted HR, aHR\u200a=\u200a1.00, 95% CI: 0.83\u20131.21).", {"entities": [[119, 121, "GENE"], [123, 126, "GENE"]]}], ["However, CNS EV infection was associated with increased risk of depression (aHR\u200a=\u200a1.62, 95% CI: 1.02\u20132.58) in the fully adjusted Cox regression model.", {"entities": [[76, 79, "GENE"]]}], ["To the best of our knowledge, this is the first study investigating depression in children and adolescents with CNS EV infection.", {"entities": []}], ["The results suggested that children and adolescents with CNS EV infection were a susceptible group for subsequent depressive disorders.", {"entities": []}], ["Communities of practice are based on the idea that learning involves a group of people exchanging experiences and knowledge.", {"entities": []}], ["The e-MPODERA project aims to assess the effectiveness of a virtual community of practice aimed at improving primary healthcare professional attitudes to the empowerment of patients with chronic diseases.", {"entities": []}], ["This paper describes the protocol for a cluster randomized controlled trial.", {"entities": []}], ["We will randomly assign 18 primary-care practices per participating region of Spain (Catalonia, Madrid and Canary Islands) to a virtual community of practice or to usual training.", {"entities": []}], ["The primary-care practice will be the randomization unit and the primary healthcare professional will be the unit of analysis.", {"entities": []}], ["We will need a sample of 270 primary healthcare professionals (general practitioners and nurses) and 1382 patients.", {"entities": []}], ["We will perform randomization after professionals and patients are selected.", {"entities": []}], ["We will ask the intervention group to participate for 12\u00a0months in a virtual community of practice based on a web 2.0 platform.", {"entities": []}], ["We will measure the primary outcome using the Patient-Provider Orientation Scale questionnaire administered at baseline and after 12\u00a0months.", {"entities": []}], ["Secondary outcomes will be the sociodemographic characteristics of health professionals, sociodemographic and clinical characteristics of patients, the Patient Activation Measure questionnaire for patient activation and outcomes regarding use of the virtual community of practice.", {"entities": []}], ["We will calculate a linear mixed-effects regression to estimate the effect of participating in the virtual community of practice.", {"entities": []}], ["This cluster randomized controlled trial will show whether a virtual intervention for primary healthcare professionals improves attitudes to the empowerment of patients with chronic diseases.", {"entities": []}], ["ClicalTrials.gov, NCT02757781 .", {"entities": []}], ["Registered on 25 April 2016.", {"entities": []}], ["Protocol Version .", {"entities": []}], ["PI15.01 22 January 2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-2232-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Declining participation in epidemiological studies has been reported in recent decades and may lead to biased prevalence estimates and selection bias.", {"entities": []}], ["The aim of the study was to identify possible causes and effects of non-response in a population-based study of respiratory health in Norway.", {"entities": []}], ["The Telemark study is a longitudinal study that began with a cross-sectional survey in 2013.", {"entities": []}], ["In 2013, a random sample of 50\u2005000 inhabitants aged 16\u201350\u2005years, living in Telemark county, received a validated postal questionnaire.", {"entities": []}], ["The response rate was 33%.", {"entities": []}], ["In this study, a random sample of 700 non-responders was contacted first by telephone and then by mail.", {"entities": []}], ["Response rates, prevalence and OR of asthma and respiratory symptoms based on exposure to vapours, gas, dust or fumes (VGDF) and smoking.", {"entities": [[37, 43, "DISEASE"]]}], ["Causes of non-response.", {"entities": []}], ["A total of 260 non-responders (37%) participated.", {"entities": []}], ["Non-response was associated with younger age, male sex, living in a rural area and past smoking.", {"entities": []}], ["The prevalence was similar for responders and non-responders for physician-diagnosed asthma and several respiratory symptoms.", {"entities": [[85, 91, "DISEASE"]]}], ["The prevalence of chronic cough and use of asthma medication was overestimated in the Telemark study, and adjusted prevalence estimates were 17.4% and 5%, respectively.", {"entities": [[43, 49, "DISEASE"]]}], ["Current smoking was identified as a risk factor for respiratory symptoms among responders and non-responders, while occupational VGDF exposure was a risk factor only among responders.", {"entities": []}], ["The Breslow-Day test detected heterogeneity between productive cough and occupational VGDF exposure among responders.", {"entities": []}], ["The Telemark study provided valid estimates for physician-diagnosed asthma and several respiratory symptoms, while it was necessary to adjust prevalence estimates for chronic cough and use of asthma medication.", {"entities": [[68, 74, "DISEASE"], [192, 198, "DISEASE"]]}], ["Reminder letters had little effect on risk factor associations.", {"entities": []}], ["Selection bias should be considered in future investigations of the relationship between respiratory outcomes and exposures.", {"entities": []}], ["Public pressure has increasingly emphasized the need to ensure the continuing quality of care provided by health professionals over their careers.", {"entities": []}], ["Health profession's regulatory authorities, mandated to be publicly accountable for safe and effective care, are revising their quality assurance programs to focus on regular evaluations of practitioner performance.", {"entities": []}], ["New methods for routine screening of performance are required and the use of administrative data for measuring performance on quality of care indicators has been suggested as one attractive option.", {"entities": []}], ["Preliminary studies have shown that community pharmacy claims databases contain the information required to operationalize quality of care indicators.", {"entities": []}], ["The purpose of this project was to determine the feasibility of routine use of information from these databases by regulatory authorities to screen the quality of care provided at community pharmacies.", {"entities": []}], ["Information from the Canadian province of Quebec's medication insurance program provided data on prescriptions dispensed in 2002 by more than 5000 pharmacists in 1799 community pharmacies.", {"entities": []}], ["Pharmacy-specific performance rates were calculated on four quality of care indicators: two safety indicators (dispensing of contra-indicated benzodiazepines to seniors and dispensing of nonselective beta-blockers to patients with respiratory disease) and two effectiveness indicators (dispensing asthma or hypertension medications to non-compliant patients).", {"entities": [[307, 319, "DISEASE"], [297, 303, "DISEASE"]]}], ["Descriptive statistics were used to summarize performance.", {"entities": []}], ["Reliable estimates of performance could be obtained for more than 90% of pharmacies.", {"entities": []}], ["The average rate of dispensing was 4.3% (range 0 - 42.5%) for contra-indicated benzodiazepines, 15.2% (range 0 - 100%) for nonselective beta-blockers to respiratory patients, 10.7% (range 0 - 70%) for hypertension medications to noncompliant patients, and 43.3% (0 - 91.6%) for short-acting beta-agonists in over-use situations.", {"entities": [[201, 213, "DISEASE"]]}], ["There were modest correlations in performance across the four indicators.", {"entities": []}], ["Nine pharmacies (0.5%) performed in the lowest quartile in all four of the indicators, and 5.3% (n = 95) performed in the lowest quartile on three of four indicators.", {"entities": []}], ["Routinely collected pharmacy claims data can be used to monitor indicators of the quality of care provided in community pharmacies, and may be useful in future to identify underperforming pharmacists, measure the impact of policy changes and determine predictors of best practices.", {"entities": []}], ["Strokes are commonly preceded by transient ischemic attacks (TIAs).", {"entities": []}], ["TIA is often associated with metabolic syndrome (causing chronic inflammation), resulting in a proinflammatory- and procoagulant-environment.", {"entities": [[39, 47, "DISEASE"]]}], ["The aim of this study was to determine whether platelet- and fibrin network-morphology or coagulation profiles of individuals that suffered a TIA in the presence of metabolic syndrome was altered when compared to healthy individuals.", {"entities": [[175, 183, "DISEASE"]]}], ["The study consisted of 40 voluntary participants.", {"entities": []}], ["Twenty individuals that suffered a TIA in the previous 48\u00a0h with at least two metabolic syndrome risk factors present and twenty healthy age-matched controls.", {"entities": [[88, 96, "DISEASE"]]}], ["Scanning electron- and atomic force microscopy was used to study platelet- and fibrin-morphology, atomic force microscopy was used to study platelet- and fibrin fiber-elasticity and thromboelastography p -value of less than 0.05 was considered statistically significant.", {"entities": []}], ["Platelets of the control group appeared spherical with few pseudopodia present while the platelets of the TIA individuals presented with numerous pseudopodia and spreading, indicating activation.", {"entities": []}], ["Platelet aggregation was also present.", {"entities": []}], ["The fibrin networks of the healthy individuals consist of thick and thin fibers that form an organized network of fibers.", {"entities": []}], ["The fibrin networks of the TIA individuals appeared less organized with less taut fibers.", {"entities": []}], ["Fibrin fiber thickness was found to be significantly increased in the TIA group ( p -value <0.001) when compared to healthy controls.", {"entities": []}], ["The thicker fibers formed irregular networks with thick masses of fibrin fibers.", {"entities": []}], ["Platelet and fibrin fiber elasticity was found to be significantly lower in the experimental group ( p -value 0.0042 and p -value 0.0007 respectively).", {"entities": []}], ["The hemostatic profiles of the diseased individuals did not differ significantly ( p -value\u2009>\u20090.05) from the healthy controls, indicating a normal functioning coagulation cascade.", {"entities": []}], ["The findings indicate that pathological clot formation is not caused by alterations in the coagulation cascade but rather by the premature activation of platelets (as a result of chronic inflammation) that in turn causes altered fibrin formation.", {"entities": []}], ["Experimental evidence indicates that certain drugs, that are secondary or tertiary amines or amides, form N -nitroso compounds in the presence of nitrite in an acidic environment.", {"entities": []}], ["Nitrosatable drugs have been associated with birth defects in a few epidemiologic studies.", {"entities": []}], ["This study describes the prevalence and patterns of nitrosatable drug use among U.S. women during early pregnancy and examines maternal factors associated with such use.", {"entities": []}], ["Data were analyzed from the National Birth Defects Prevention Study and included 6807 mothers who gave birth to babies without major congenital malformations during 1997 to 2005.", {"entities": []}], ["Information was collected by telephone interview about medication use, demographic factors, and maternal health.", {"entities": []}], ["Drugs taken during the first trimester were classified according to nitrosatability, amine and amide functional groups, and primary indication of use.", {"entities": []}], ["Approximately 24% of the women took one or more nitrosatable drugs during the first trimester, including 12.4%, 12.2%, and 7.6% who respectively took secondary amines, tertiary amines, or amides.", {"entities": []}], ["Five of the ten most commonly taken drugs were available over the counter.", {"entities": []}], ["Women who were non-Hispanic white (29.5%), with 1 year or more college education (27.3%) or 40 years or older (28.8%) had the highest prevalence of use.", {"entities": []}], ["Supplemental vitamin C, an inhibitor of nitrosation, was not taken by 41.6% and 19.3% of nitrosatable drug users during the first and second months of pregnancy, respectively.", {"entities": []}], ["In this U.S. population, ingestion of drugs classified as nitrosatable was common during the first trimester of pregnancy, especially among non-Hispanic white, more educated, and older mothers.", {"entities": []}], ["Birth Defects Research (Part A) 2011.", {"entities": []}], ["\u00a9 2011 Wiley-Liss, Inc.", {"entities": []}], ["The anti-HLA-E IgG2a mAbs, TFL-006 and TFL-007, reacted with all HLA-I antigens, similar to the therapeutic preparations of IVIg.", {"entities": []}], ["Indeed, IVIg lost its HLA reactivity, when its HLA-E reactivity was adsorbed out.", {"entities": [[22, 25, "GENE"], [47, 50, "GENE"], [47, 52, "GENE"]]}], ["US-FDA approved IVIg to reduce antibodies in autoimmune diseases.", {"entities": []}], ["But the mechanism underlying IVIg-mediated antibody reduction could not be ascertained due to the presence of other polyclonal antibodies.", {"entities": []}], ["In spite of it, the cost prohibitive high or low IVIg is administered to patients waiting for donor organ and for allograft recipients for lowering antiallograft antibodies.", {"entities": []}], ["A mAb that could mimic IVIg in lowering Abs, with defined mechanism of action, would be highly beneficial for patients.", {"entities": []}], ["Demonstrably, the anti-HLA-E mAbs mimicked several functions of IVIg relevant to suppressing the antiallograft Abs.", {"entities": []}], ["The mAbs suppressed activated T cells and anti-HLA antibody production by activated B cells, which were dose-wise superior to IVIg.", {"entities": []}], ["The anti-HLA-E mAb expanded CD4+, CD25+, and Foxp", {"entities": []}], ["Cells resident in certain hollow organs are subjected routinely to large transient stretches, including every adherent cell resident in lungs, heart, great vessels, gut, and bladder.", {"entities": []}], ["We have shown recently that in response to a transient stretch the adherent eukaryotic cell promptly fluidizes and then gradually resolidifies, but mechanism is not yet understood.", {"entities": []}], ["In the isolated human bladder smooth muscle cell, here we applied a 10% transient stretch while measuring cell traction forces, elastic modulus, F-actin imaging and the F-actin/G-actin ratio.", {"entities": []}], ["Immediately after a transient stretch, F-actin levels and cell stiffness were lower by about 50%, and traction forces were lower by about 70%, both indicative of prompt fluidization.", {"entities": []}], ["Within 5min, F-actin levels recovered completely, cell stiffness recovered by about 90%, and traction forces recovered by about 60%, all indicative of resolidification.", {"entities": []}], ["The extent of the fluidization response was uninfluenced by a variety of signaling inhibitors, and, surprisingly, was localized to the unstretch phase of the stretch-unstretch maneuver in a manner suggestive of cytoskeletal catch bonds.", {"entities": []}], ["When we applied an \u201cunstretch-restretch\u201d (transient compression), rather than a \u201cstretch-unstretch\u201d (transient stretch), the cell did not fluidize and the actin network did not depolymerize.", {"entities": []}], ["Taken together, these results implicate extremely rapid actin disassembly in the fluidization response, and slow actin reassembly in the resolidification response.", {"entities": []}], ["In the bladder smooth muscle cell, the fluidization response to transient stretch occurs not through signaling pathways, but rather through release of increased tensile forces that drive acute disassociation of actin.", {"entities": []}], ["Scabies is a parasitic disease due to infestation of skin by the burrowing mite Sarcoptes scabiei.", {"entities": [[0, 7, "DISEASE"]]}], ["Scabies is a major public health problem and endemic in resource poor communities worldwide affecting over 100 million people.", {"entities": [[0, 7, "DISEASE"]]}], ["Associated bacterial infections cause substantial morbidity, and in severe cases can lead to renal and cardiac diseases.", {"entities": []}], ["Mite infestation of the skin causes localised cutaneous inflammation, pruritus, skin lesions, and allergic and inflammatory responses are mounted by the host against the mite and its products.", {"entities": []}], ["Our current understanding of the immune and inflammatory responses associated with the clinical manifestations in scabies is far outweighed by the significant global impact of the disease.", {"entities": [[114, 121, "DISEASE"]]}], ["This review aims to provide a better understanding of human immune responses to S. scabiei in ordinary and crusted scabies phenotypes.", {"entities": [[115, 122, "DISEASE"]]}], ["Macrophage migration inhibitory factor (Mif) is highly expressed in type 1 diabetes mellitus (T1DM).", {"entities": [[68, 92, "DISEASE"], [75, 92, "DISEASE"], [40, 43, "GENE"]]}], ["However, there is limited information about how Mif influences the activation of macrophages (M \u03c6 ) and dendritic cells (DC) in T1DM.", {"entities": [[48, 51, "GENE"]]}], ["To address this issue, we induced T1DM by administering multiple low doses of streptozotocin (STZ) to Mif\u2212/\u2212 or wild-type (Wt) BALB/c mice.", {"entities": []}], ["We found that Mif\u2212/\u2212 mice treated with STZ ( Mif\u2212/\u2212 STZ) developed lower levels of hyperglycemia, inflammatory cytokines, and specific pancreatic islet antigen- (PIAg-) IgG and displayed reduced cellular infiltration into the pancreatic islets compared to Wt mice treated with STZ (WtSTZ).", {"entities": [[83, 96, "DISEASE"]]}], ["Moreover, M \u03c6 and DC from Mif\u2212/\u2212 STZ displayed lower expression of MHC-II, costimulatory molecules CD80, CD86, and CD40, Toll-like receptor- (TLR-) 2, and TLR-4 than WtSTZ.", {"entities": [[99, 103, "GENE"], [105, 109, "GENE"], [115, 119, "GENE"]]}], ["These changes were associated with a reduced capacity of M \u03c6 and DC from Mif\u2212/\u2212 STZ to induce proliferation in ovalbumin-specific T cells.", {"entities": []}], ["All the deficiencies observed in Mif\u2212/\u2212 STZ were recovered by exogenous administration of recombinant Mif.", {"entities": [[33, 36, "GENE"], [102, 105, "GENE"]]}], ["These findings suggest that Mif plays a role in the molecular mechanisms of M \u03c6 and DC activation and drives T cell responses involved in the pathology of T1DM.", {"entities": [[28, 31, "GENE"]]}], ["Therefore, Mif is a potential therapeutic target to reduce the pathology of T1DM.", {"entities": [[11, 14, "GENE"]]}], ["Home-based asthma environmental education for parents of asthmatic children is needed since many health professionals lack the time to offer it.", {"entities": [[11, 17, "DISEASE"]]}], ["However, developing targeted and tailored education is important in order to address the individual needs of participants.", {"entities": []}], ["This nonrandomized longitudinal study examined knowledge on asthma with an Asthma and Healthy Homes educational intervention training offered to parents of children from low income families who reside in the Rio Grande Valley of Texas.", {"entities": [[60, 66, "DISEASE"], [75, 81, "DISEASE"]]}], ["Eighty-nine parents received the training and pre- and posttest surveys were used to measure knowledge outcomes.", {"entities": []}], ["A standardized assessment on asthma triggers was used to identify the different triggers each child was exposed to, and a follow-up survey was conducted 6 months after the educational intervention to identify how many parents reported household and behavior changes as a result of the training.", {"entities": [[29, 35, "DISEASE"]]}], ["Results showed significant changes in behavior by participants as a result of the training received.", {"entities": []}], ["This study suggests that these behavioral changes are attributed to the dual \u201ctargeted\u201d and \u201ctailored\u201d educational interventions delivered to parents which resulted in a greater understanding of how to manage asthma by eliminating asthma triggers in their respective homes.", {"entities": [[209, 215, "DISEASE"], [231, 237, "DISEASE"]]}], ["The continual monitoring of population health-related quality of life (HRQoL) with validated instruments helps public health agencies assess, protect, and promote population health.", {"entities": []}], ["This study aimed to determine norms for the French adolescent and adult general population for the Duke Health Profile (DUKE) questionnaire in a large representative community sample.", {"entities": []}], ["We randomly selected 17,733 French people aged 12 to 75 years old in 2 steps, by households and individuals, from the National Health Barometer 2005, a periodic population study by the French National Institute for Prevention and Health Education.", {"entities": []}], ["Quality of life and other data were collected by computer-assisted telephone interview.", {"entities": []}], ["Normative data for the French population were analyzed by age, gender and self-reported chronic disease.", {"entities": []}], ["Globally, function scores (best HRQoL=100) for physical, mental, social, and general health, as well as perceived health and self-esteem, were 72.3 (SEM 0.2), 74.6 (0.2), 66.8 (0.1), 71.3 (0.1), 71.3 (0.3), 76.5 (0.1), respectively.", {"entities": []}], ["Dysfunction scores (worst HRQoL=100) for anxiety, depression, pain and disability domains were 30.9 (0.1), 27.6 (0.2), 34.3 (0.3), 3.1 (0.1), respectively.", {"entities": []}], ["The French norms for adolescents and adults for the DUKE could be used as a reference for other studies assessing HRQoL, for specific illnesses, in France and for international comparisons.", {"entities": []}], ["It is known that self-reported health (SRH) declines with increasing age and that comorbidity increases with age.", {"entities": []}], ["We wished to examine how age transfers its effect to SRH through comorbid disease and mental illness and whether these processes remained stable from 1994 until 2008.", {"entities": []}], ["The hypothesis is that ageing and/or the increased age-related burden of pathology explains the declining SRH.", {"entities": []}], ["The Troms\u00f8 Study (TS) is a cohort study using a survey approach with repeated physical examinations.", {"entities": []}], ["It was conducted in the municipality of Troms\u00f8, Norway, from 1974 to 2008.", {"entities": []}], ["A total of 21\u2005199 women and 19\u2005229 men participated.", {"entities": []}], ["SRH is the outcome of interest.", {"entities": []}], ["We calculated and compared the effect sizes of age, comorbidity and mental health symptoms using multimediator analysis based on OLS regression.", {"entities": []}], ["Ageing had a negative impact on SRH, but the total effect of age decreased from 1994 to 2007.", {"entities": []}], ["We assessed the direct effect of age and then the proportion of indirect age-related effects through physical illness and mental health symptoms on the total effect.", {"entities": []}], ["The direct effect of age represented 79.3% of the total effect in 1994 and decreased to 58.8% in 2007.", {"entities": []}], ["Physical illness emerged as an increasingly important factor and increased its influence from 15.7% to 41.2% of the total effect.", {"entities": []}], ["Age alone had a protective effect on mental health symptoms and this increased (2.5% to 17.3%), but we found a stronger association between mental health symptoms and physical disease in the later waves of the study (increasing from 3.7% to 14.8%).", {"entities": []}], ["The results suggest that the effect on SRH of mental health symptoms caused by physical illness is an increasing public health problem.", {"entities": []}], ["Treatment and care for specific medical conditions must therefore focus more strongly on how these conditions affect the patient's mental health and address these concerns accordingly.", {"entities": []}], ["Skin and soft tissue infections (SSTIs) are common infections occurring in ambulatory and inpatient settings.", {"entities": []}], ["The extent of complications associated with these infections by diabetes status is not well established.", {"entities": []}], ["Using a very large repository database, we examined medical and pharmacy claims of individuals aged 0\u201364 between 2005 and 2010 enrolled in U.S. health plans.", {"entities": []}], ["Diabetes, SSTIs, and SSTI-associated complications were identified by ICD-9 codes.", {"entities": []}], ["SSTIs were stratified by clinical category and setting of initial diagnosis.", {"entities": []}], ["We identified 2,227,401 SSTI episodes, 10% of which occurred in diabetic individuals.", {"entities": []}], ["Most SSTIs were initially diagnosed in ambulatory settings independent from diabetes status.", {"entities": []}], ["Abscess/cellulitis was the more common SSTI group in diabetic and non-diabetic individuals (66% and 59%, respectively).", {"entities": [[8, 18, "DISEASE"]]}], ["There were differences in the frequencies of SSTI categories between diabetic and non-diabetic individuals (p<0.01).", {"entities": []}], ["Among SSTIs diagnosed in ambulatory settings, the SSTI-associated complication rate was over five times higher in people with diabetes than in people without diabetes (4.9% vs. 0.8%, p<0.01) and SSTI-associated hospitalizations were 4.9% and 1.1% in patients with and without diabetes, respectively.", {"entities": []}], ["Among SSTIs diagnosed in the inpatient setting, bacteremia/endocarditis/septicemia/sepsis was the most common associated complication occurring in 25% and 16% of SSTIs in patients with and without diabetes, respectively (p<0.01).", {"entities": [[59, 71, "DISEASE"]]}], ["Among persons with SSTIs, we found SSTI-associated complications were five times higher and SSTI-associated hospitalizations were four times higher, in patients with diabetes compared to those without diabetes.", {"entities": []}], ["SSTI prevention efforts in individuals with diabetes may have significant impact on morbidity and healthcare resource utilization.", {"entities": []}], ["Environmental Tobacco Smoke (ETS) was classified as human carcinogen (K1) by the German Research Council in 1998.", {"entities": []}], ["According to epidemiological studies, the relative risk especially for lung cancer might be twice as high in persons who have never smoked but who are in the highest exposure category, for example hospitality workers.", {"entities": [[71, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["In order to implement these results in the German regulations on occupational illnesses, a valid method is needed to retrospectively assess the cumulative ETS exposure in the hospitality environment.", {"entities": []}], ["A literature-based review was carried out to locate a method that can be used for the German hospitality sector.", {"entities": []}], ["Studies assessing ETS exposure using biological markers (for example urinary cotinine, DNA adducts) or questionnaires were excluded.", {"entities": []}], ["Biological markers are not considered relevant as they assess exposure only over the last hours, weeks or months.", {"entities": []}], ["Self-reported exposure based on questionnaires also does not seem adequate for medico-legal purposes.", {"entities": []}], ["Therefore, retrospective exposure assessment should be based on mathematical models to approximate past exposure.", {"entities": []}], ["For this purpose a validated model developed by Repace and Lowrey was considered appropriate.", {"entities": []}], ["It offers the possibility of retrospectively assessing exposure with existing parameters (such as environmental dimensions, average number of smokers, ventilation characteristics and duration of exposure).", {"entities": []}], ["The relative risk of lung cancer can then be estimated based on the individual cumulative exposure of the worker.", {"entities": [[21, 32, "DISEASE"], [26, 32, "DISEASE"]]}], ["In conclusion, having adapted it to the German hospitality sector, an existing mathematical model appears to be capable of approximating the cumulative exposure.", {"entities": []}], ["However, the level of uncertainty of these approximations has to be taken into account, especially for diseases with a long latency period such as lung cancer.", {"entities": [[147, 158, "DISEASE"], [152, 158, "DISEASE"]]}], ["Despite regulatory efforts to formalize guidance policies on biosimilars, there remains a need to educate healthcare stakeholders on the acknowledged definition of biosimilarity and the data that underpin it.", {"entities": []}], ["The objectives of the study were to systematically collate published data for monoclonal antibodies and fusion protein biosimilars indicated for cancer, chronic inflammatory diseases, and other indications, and to explore differences in the type and weight (quantity and quality) of available evidence.", {"entities": [[145, 151, "DISEASE"]]}], ["MEDLINE, Embase, and ISI Web of Science were searched to September 2015.", {"entities": []}], ["Conference proceedings ( n \u00a0=\u00a017) were searched 2012 to July 2015.", {"entities": []}], ["Included studies were categorized by originator, study type, and indication.", {"entities": []}], ["To assess data strength and validity, risk of bias assessments were undertaken.", {"entities": []}], ["Across therapeutic areas, 43 named (marketed or proposed) biosimilars were identified for adalimumab, abciximab, bevacizumab, etanercept, infliximab, omalizumab, ranibizumab, rituximab, and trastuzumab originators.", {"entities": []}], ["Infliximab CT-P13, SB2, and etanercept SB4 biosimilars have the greatest amount of published evidence of similarity with their originators, based on results of clinical studies involving larger numbers of patients or healthy subjects ( N \u00a0=\u00a01405, 743, and 734, respectively).", {"entities": []}], ["Published data were also retrieved for marketed intended copies of etanercept and rituximab.", {"entities": []}], ["This unbiased synthesis of the literature exposed significant differences in the extent of published evidence between molecules at preclinical, clinical, and post-marketing stages of development, providing clinicians and payers with a consolidated view of the available data and remaining gaps.", {"entities": []}], ["The online version of this article (doi:10.1007/s40259-016-0199-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Exercise tolerance is an important parameter in patients with COPD and a primary goal of treatment is to reduce dyspnea to facilitate physical activities and improve health-related quality of life.", {"entities": []}], ["This review examines the link between expiratory flow limitation and dyspnea to explain the rationale for the use of bronchodilators and review the characteristics of different types of exercise tests, with specific focus on which tests are likely to show a response to bronchodilators.", {"entities": []}], ["An earlier literature search of studies published up to 1999 assessed the effects of bronchodilatort therapy on dypsnea and exercise tolerance among patients with COPD.", {"entities": []}], ["This current review examines the clinical evidence published since 1999.", {"entities": []}], ["Thirty-one randomized studies of exercise tolerance associated with short- and long-acting \u03b2 2 -agonists and anticholinergics were identified.", {"entities": []}], ["Evidence for the efficacy of bronchodilators in enhancing exercise capacity is often contradictory and possibly depends on the exercise test and study methodology.", {"entities": []}], ["However, further studies should confirm the benefit of long-acting bronchodilators in improving spontaneous everyday physical activities.", {"entities": []}], ["Glucose concentrations of normal human airway surface liquid are ~12.5 times lower than blood glucose concentrations indicating that glucose uptake by epithelial cells may play a role in maintaining lung glucose homeostasis.", {"entities": []}], ["We have therefore investigated potential glucose uptake mechanisms in non-polarised and polarised H441 human airway epithelial cells and bronchial biopsies.", {"entities": []}], ["We detected mRNA and protein for glucose transporter type 2 (GLUT2) and glucose transporter type 4 (GLUT4) in non-polarised cells but GLUT4 was not detected in the plasma membrane.", {"entities": []}], ["In polarised cells, GLUT2 protein was detected in both apical and basolateral membranes.", {"entities": []}], ["Furthermore, GLUT2 protein was localised to epithelial cells of human bronchial mucosa biopsies.", {"entities": []}], ["In non-polarised H441 cells, uptake of d -glucose and deoxyglucose was similar.", {"entities": []}], ["Uptake of both was inhibited by phloretin indicating that glucose uptake was via GLUT-mediated transport.", {"entities": []}], ["Phloretin-sensitive transport remained the predominant route for glucose uptake across apical and basolateral membranes of polarised cells and was maximal at 5\u201310\u00a0mM glucose.", {"entities": []}], ["We could not conclusively demonstrate sodium/glucose transporter-mediated transport in non-polarised or polarised cells.", {"entities": []}], ["Our study provides the first evidence that glucose transport in human airway epithelial cells in vitro and in vivo utilises GLUT2 transporters.", {"entities": []}], ["We speculate that these transporters could contribute to glucose uptake/homeostasis in the human airway.", {"entities": []}], ["Dioscorea batatas is widely used in Asia as a herbal medicine or food product with potential health benefits.", {"entities": []}], ["There have been several reports of occupational asthma caused by inhalation of D. batatas dust.", {"entities": [[48, 54, "DISEASE"]]}], ["However, there has been no report of systemic allergic reactions after oral administration of D. batatas .", {"entities": []}], ["Two patients with D. batatas allergy were enrolled.", {"entities": []}], ["One had experienced severe urticaria and angioedema after indigestion, and the other had been exposed to D. batatas dust and was diagnosed as having occupational asthma.", {"entities": [[27, 36, "DISEASE"], [162, 168, "DISEASE"], [41, 51, "DISEASE"]]}], ["Both patients had high serum-specific IgE and IgG4 antibodies to D. batatas .", {"entities": []}], ["And IgE immunoblot demonstrated that both sera bound to a 27-kDa protein with an IgE-binding motif, which was revealed by 2-D-electrophoresis to have the sequence Asn-Val-Glu-Asp-Glu-Phe-Ser-X-Ile-Glu-Gly-Asn-Pro-X-X-Pro-Glu-Asn-X-Gly (pI 6.40, 6.04).", {"entities": []}], ["In conclusion, discorin from D. batatas (DB3S) was identified as the major allergen of D. batatas in patients sensitized via an oral or inhalant route.", {"entities": []}], ["A significant unmet need exists for accurate, reproducible, noninvasive diagnostic tools to assess and monitor portal hypertension (PHT).", {"entities": [[118, 130, "DISEASE"], [111, 130, "DISEASE"]]}], ["We report the first use of quantitative MRI markers for the haemodynamic assessment of nonselective beta-blockers (NSBB) in PHT.", {"entities": []}], ["In a randomized parallel feasibility study in 22 adult patients with PHT and a clinical indication for NSBB, we acquired haemodynamic data at baseline and after 4 weeks of NSBB (propranolol or carvedilol) using phase-contrast MR angiography (PC-MRA) in selected intra-abdominal vessels.", {"entities": []}], ["T1 mapping of liver and spleen was undertaken to assess changes in tissue composition.", {"entities": []}], ["Target NSBB dose was achieved in 82%.", {"entities": []}], ["There was a substantial reduction from baseline in mean average flow in the superior abdominal aorta after 4 weeks of NSBB therapy (4.49 \u00b1 0.98 versus 3.82 \u00b1 0.86\u2009L/min, P = 0.03) but there were no statistically significant differences in flow in any other vessels, even in patients with >25% decrease in heart rate (47% of patients).", {"entities": []}], ["Mean percentage change in liver and spleen T1 following NSBB was small and highly variable.", {"entities": []}], ["In conclusion, PC-MRA was able to detect reduction in cardiac output by NSBB but did not detect significant changes in visceral blood flow or T1.", {"entities": []}], ["This trial was registered with the ISRCTN registry ( ISRCTN98001632 ).", {"entities": []}], ["Sophorolipids (SL) are amphiphilic biosurfactant molecules consisting of a disaccharide sophorose with one fatty acid at the C1 position and optional acetylation at the C6\u2019and C6\u201d positions.", {"entities": [[169, 171, "GENE"], [176, 178, "GENE"], [169, 171, "GENE"], [176, 178, "GENE"]]}], ["They exist in a closed ring lactonic (LSL) or open acidic (ASL) structure Sophorolipids are produced in crude mixtures in economically viable amounts by the yeast Starmerella bombicola and used in a variety of consumer products.", {"entities": [[59, 62, "GENE"]]}], ["Varying levels of anti- proliferative and anti-cancer activity of crude sophorolipid mixtures are described in a number of tumor cell lines in vitro .", {"entities": [[47, 53, "DISEASE"]]}], ["However, significant inter-study variation exists in the composition of sophorolipid species as well as other biologically active compounds in these mixtures, which makes interpretation of in vitro and in vivo studies difficult.", {"entities": []}], ["We produced a 96% pure C18:1 lactonic sophorolipid that dose-dependently reduces the viability of colorectal cancer, as well as normal human colonic and lung cell lines in vitro .", {"entities": [[98, 115, "DISEASE"], [109, 115, "DISEASE"]]}], ["Oral administration of vehicle-only; or lactonic sophorolipids (50 mg/kg for 70 days), to Apc vs 70.50 \u00b1 7.8: p < 0.05) and size (modal size 2mm vs 4mm) of intestinal polyps.", {"entities": [[90, 93, "GENE"]]}], ["Lactonic administration resulted in a systematic effect via reduced hematocrit (49.5 \u00b1 1.0 vs 28.2 \u00b1 2.0 vs : p<0.03) and splenomegaly (0.56 \u00b1 0.03g vs 0.71 \u00b1 0.04g; p<0.01) confirming exacerbation of disease progression in this model.", {"entities": []}], ["The functionality of bare polylactide-co-glycolide (PLGA) nanoparticles is limited to drug depot or drug solubilization in their hard cores.", {"entities": []}], ["They have inherent weaknesses as a drug-delivery system.", {"entities": []}], ["For instance, when administered intravenously, the nanoparticles undergo rapid clearance from systemic circulation before reaching the site of action.", {"entities": []}], ["Furthermore, plain PLGA nanoparticles cannot distinguish between different cell types.", {"entities": []}], ["Recent research shows that surface functionalization of nanoparticles and development of new nanoparticulate dosage forms help overcome these delivery challenges and improve in vivo performance.", {"entities": []}], ["Immense research efforts have propelled the development of diverse functional PLGA-based nanoparticulate delivery systems.", {"entities": []}], ["Representative examples include PEGylated micelles/nanoparticles (PEG, polyethylene glycol), polyplexes, polymersomes, core-shell\u2013type lipid-PLGA hybrids, cell-PLGA hybrids, receptor-specific ligand-PLGA conjugates, and theranostics.", {"entities": []}], ["Each PLGA-based nanoparticulate dosage form has specific features that distinguish it from other nanoparticulate systems.", {"entities": []}], ["This review focuses on fundamental concepts and practices that are used in the development of various functional nanoparticulate dosage forms.", {"entities": []}], ["We describe how the attributes of these functional nanoparticulate forms might contribute to achievement of desired therapeutic effects that are not attainable using conventional therapies.", {"entities": []}], ["Functional PLGA-based nanoparticulate systems are expected to deliver chemotherapeutic, diagnostic, and imaging agents in a highly selective and effective manner.", {"entities": []}], ["Bronchioles are critical zones in cigarette smoke (CS)-induced lung inflammation.", {"entities": [[51, 53, "GENE"]]}], ["However, there have been few studies on the in vivo dynamics of cytokine gene expression in bronchiolar epithelial cells in response to CS.", {"entities": [[136, 138, "GENE"]]}], ["We subjected C57BL/6J mice to CS (whole body exposure, 90 min/day) for various periods, and used laser capture microdissection to isolate bronchiolar epithelial cells for analysis of mRNA by quantitative reverse transcription-polymerase chain reaction.", {"entities": [[30, 32, "GENE"]]}], ["We detected enhanced expression of keratinocyte-derived chemokine (KC), macrophage inflammatory protein-2 (MIP-2), tumor necrosis factor-\u03b1 (TNF-\u03b1), and interleukin-1\u03b2 (IL-1\u03b2) by bronchial epithelial cells after 10 consecutive days of CS exposure.", {"entities": [[234, 236, "GENE"]]}], ["This was mirrored by increases in neutrophils and KC, MIP-2, TNF-\u03b1, and IL-1\u03b2 proteins in the bronchoalveolar lavage (BAL) fluid.", {"entities": []}], ["The initial inhalation of CS resulted in rapid and robust upregulation of KC and MIP-2 with concomitant DNA oxidation within 1 hr, followed by a return to control values within 3 hrs.", {"entities": [[26, 28, "GENE"], [127, 129, "GENE"]]}], ["In contrast, after CS exposure for 10 days, this initial surge was not observed.", {"entities": [[19, 21, "GENE"]]}], ["As the CS exposure was extended to 4, 12, 18 and 24 weeks, the bronchiolar KC and MIP-2 expression and their levels in BAL fluid were relatively dampened compared to those at 10 days.", {"entities": [[7, 9, "GENE"]]}], ["However, neutrophils in BAL fluid continuously increased up to 24 weeks, suggesting that neutrophil accumulation as a result of long-term CS exposure became independent of KC and MIP-2.", {"entities": [[138, 140, "GENE"]]}], ["These findings indicate variable patterns of bronchiolar epithelial cytokine expression depending on the duration of CS exposure, and that complex mechanisms govern bronchiolar molecular dynamics in vivo .", {"entities": [[117, 119, "GENE"]]}], ["Bangladesh is facing serious shortage of trained health professionals.", {"entities": []}], ["In the pluralistic healthcare system of Bangladesh, formal health care providers constitute only 5\u00a0% of the total workforce; the rest are informal health care providers.", {"entities": []}], ["Information Communication Technologies (ICTs) are increasingly seen as a powerful tool for linking the community with formal healthcare providers.", {"entities": []}], ["Our study assesses an intervention that linked village doctors (a cadre of informal health care providers practising modern medicine) to formal doctors through call centres from the perspective of the village doctors who participated in the intervention.", {"entities": []}], ["The study was conducted in Chakaria, a remote rural area in south-eastern Bangladesh during April\u2013May 2013.", {"entities": []}], ["Twelve village doctors were selected purposively from a pool of 55 village doctors who participated in the mobile health (mHealth) intervention.", {"entities": []}], ["In depth interviews were conducted to collect data.", {"entities": []}], ["The data were manually analysed using themes that emerged.", {"entities": []}], ["The village doctors talked about both business benefits (access to formal doctors, getting support for decision making, and being entitled to call trained doctors) and personal benefits (both financial and non-financial).", {"entities": []}], ["Some of the major barriers mentioned were technical problems related to accessing the call centre, charging consultation fees, and unfamiliarity with the call centre physicians.", {"entities": []}], ["Village doctors saw many benefits to having a business relationship with the trained doctors that the mHealth intervention provided.", {"entities": []}], ["mHealth through call centres has the potential to ensure consultation services to populations through existing informal healthcare providers in settings with a shortage of qualified healthcare providers.", {"entities": []}], ["Pathogen-associated molecular patterns (PAMPs) trigger host immune response by activating pattern recognition receptors like toll-like receptors (TLRs).", {"entities": []}], ["However, the mechanism whereby several pathogens, including viruses, activate TLRs via a non-PAMP mechanism is unclear.", {"entities": []}], ["Endogenous \u201cinflammatory mediators\u201d called damage-associated molecular patterns (DAMPs) have been implicated in regulating immune response and inflammation.", {"entities": []}], ["However, the role of DAMPs in inflammation/immunity during virus infection has not been studied.", {"entities": []}], ["We have identified a DAMP molecule, S100A9 (also known as Calgranulin B or MRP-14), as an endogenous non-PAMP activator of TLR signaling during influenza A virus (IAV) infection.", {"entities": [[144, 153, "DISEASE"], [36, 42, "GENE"]]}], ["S100A9 was released from undamaged IAV-infected cells and extracellular S100A9 acted as a critical host-derived molecular pattern to regulate inflammatory response outcome and disease during infection by exaggerating pro-inflammatory response, cell-death and virus pathogenesis.", {"entities": [[0, 6, "GENE"], [72, 78, "GENE"], [0, 6, "GENE"], [72, 78, "GENE"]]}], ["Genetic studies showed that the DDX21-TRIF signaling pathway is required for S100A9 gene expression/production during infection.", {"entities": [[77, 83, "GENE"]]}], ["Furthermore, the inflammatory activity of extracellular S100A9 was mediated by activation of the TLR4-MyD88 pathway.", {"entities": [[56, 62, "GENE"]]}], ["Our studies have thus, underscored the role of a DAMP molecule (i.e.", {"entities": []}], ["extracellular S100A9) in regulating virus-associated inflammation and uncovered a previously unknown function of the DDX21-TRIF-S100A9-TLR4-MyD88 signaling network in regulating inflammation during infection.", {"entities": [[14, 20, "GENE"], [128, 134, "GENE"]]}], ["The lung disease severity following influenza A virus (IAV) infection is dependent on the extent of inflammation in the respiratory tract.", {"entities": [[36, 45, "DISEASE"], [4, 16, "DISEASE"]]}], ["Severe inflammation in the lung manifests in development of pneumonia.", {"entities": [[60, 69, "DISEASE"]]}], ["Therefore, it is very critical to identify cellular factors and dissect the molecular/cellular mechanism controlling inflammation in the respiratory tract during IAV infection.", {"entities": []}], ["Knowledge derived from these studies will be instrumental in development of therapeutics to combat the lung disease associated with IAV infection.", {"entities": [[103, 115, "DISEASE"]]}], ["Towards that end, in the current study we have identified a cellular factor S100A9 which is responsible for enhanced inflammation during IAV infection.", {"entities": [[76, 82, "GENE"]]}], ["In addition, we have characterized a signal transduction pathway involving various cellular receptors and signaling adaptors that are involved in mediating S100A9-dependent inflammatory response.", {"entities": []}], ["Thus, our studies have illuminated a cellular/molecular mechanism that can be intervened by therapeutics to reduce and control IAV-associated lung inflammatory disease like pneumonia.", {"entities": [[173, 182, "DISEASE"]]}], ["Atopic dermatitis (AD) is an inflammatory, chronically relapsing, and intensively pruritic skin disease that affect 10\u201330% of the global population.", {"entities": [[91, 103, "DISEASE"], [7, 17, "DISEASE"]]}], ["Angelicae dahuricae Radix (ADR) has been reported to be anti-inflammatory in Korean Medicine.", {"entities": []}], ["In the present study, we investigated whether ADR suppresses the progression of AD in animal model.", {"entities": []}], ["AD was induced by 2, 4-Dinitrochlorobenzene (DNCB).", {"entities": []}], ["ADR was orally administered to mice to study the effect of ADR on AD.", {"entities": []}], ["Histological Analysis, immunohistochemistry, blood analysis, RT-PCR, and ELISA assay were performed.", {"entities": []}], ["ADR significantly suppressed AD-like symptoms in BALB/c mice: ADR decreased skin thickness and spleen weight of mice.", {"entities": []}], ["ADR reduced infiltration of mast cells, inflammatory cells and CD4+ cells into mouse skin.", {"entities": []}], ["ADR lowered the number of WBCs in the blood of mice.", {"entities": []}], ["ADR reduced the levels of IgE, IL-6, IL-10 and IL-12 in mice serum.", {"entities": []}], ["ADR down-regulated mRNA expression of IL-4, IL-6 and TNF-\u03b1 in mouse skin tissue.", {"entities": []}], ["Our present study clearly indicates that ADR suppresses the progression of AD induced by DNCB in BALB/c mice.", {"entities": []}], ["This suggests that ADR might be a useful drug for the treatment of AD.", {"entities": []}], ["Quantitative polymerase chain reaction (qPCR) is the most specific and reliable method for determination of mRNA gene expression.", {"entities": []}], ["Crucial point for its accurate normalization is the choice of appropriate internal control genes (ICGs).", {"entities": []}], ["In the present work we determined and compare the expression of eight commonly used ICGs in lymphocytes from 26 patients with amyotrophic lateral sclerosis (ALS) and 30 control subjects.", {"entities": [[126, 155, "DISEASE"], [138, 155, "DISEASE"]]}], ["Peripheral blood mononuclear cells (PBMCs) before and after immortalization by EBV transfection (lymphoblast cell lines\u2014LCLs) were used for qPCR analysis.", {"entities": []}], ["LCLs were studied before and after liquid nitrogen cryopreservation and culturing (groups LCL1 and LCL2, respectively).", {"entities": []}], ["qPCR data of 8 ICGs expression was analyzed by BestKeeper, NormFinder and geNorm methods.", {"entities": []}], ["All studied genes ( 18SRNA , ACTB , B2M , GUSB , GAPDH , HPRT1 , MT-ATP6 and RPS17 ) were expressed in PBMCs, whereas only first four in LCLs.", {"entities": [[29, 33, "GENE"], [36, 39, "GENE"], [42, 46, "GENE"], [49, 54, "GENE"], [57, 62, "GENE"], [65, 72, "GENE"], [77, 82, "GENE"]]}], ["LCLs cryopreservation had no effect on ICGs expression.", {"entities": []}], ["Comprehensive ranking indicated RPS17 with MT-ATP6 as the best ICGs for qPCR in PBMCs of control and ALS subjects, and RPS17 with 18RNA or MT-ATP6 in LCLs from ALS.", {"entities": [[32, 37, "GENE"], [119, 124, "GENE"], [43, 50, "GENE"], [139, 146, "GENE"], [32, 37, "GENE"], [119, 124, "GENE"], [43, 50, "GENE"], [139, 146, "GENE"]]}], ["In PBMCs 18RNA shouldn\u2019t be used as ICG.", {"entities": []}], ["In this work, we report the antibacterial and modulatory activity of Lantana montevidensis Briq.", {"entities": []}], ["The antibacterial activities of leaf (LELm) and root (RELm) extracts alone or in association with aminoglycosides were determined by a microdilution test.", {"entities": []}], ["Multiresistant strains of Escherichia coli (Ec 27) and Staphylococcus aureus (Sa 358) were used.", {"entities": []}], ["The results show the inhibitory activity of LELm against E. coli (minimal inhibitory concentration [MIC] 16 \u03bcg/mL) and S. aureus (MIC 128 \u03bcg/mL).", {"entities": []}], ["The synergistic effect of the extracts and aminoglycosides was verified too.", {"entities": []}], ["The maximum effects were obtained with RELm with gentamicin against E. coli with MIC reduction (312 to 2 \u03bcL).", {"entities": []}], ["The data from this study are indicative of the activity antibacterial of extracts of L. montevidensis and its potential in modifying the resistance of aminoglycosides.", {"entities": []}], ["The anti-anginal efficacy of ivabradine is well established.", {"entities": []}], ["We describe a post hoc analysis in the ADDITIONS database to investigate effectiveness and tolerability of ivabradine in combination with beta-blocker in patients with angina who have had a percutaneous coronary intervention (PCI).", {"entities": []}], ["ADDITIONS was a non-interventional, multicenter prospective study including 2,330 patients with stable angina.", {"entities": []}], ["In addition to beta-blocker, patients were treated with ivabradine in approved dosages for 4\u00a0months.", {"entities": []}], ["We divided the population according to whether they had previously had a PCI or not, and explored the effect of ivabradine on heart rate, number of weekly angina attacks, frequency of nitrate consumption, as well as quality of life (QoL) and tolerability.", {"entities": []}], ["Data were available for 2,319 patients, of whom 51.4% had previously had a PCI.", {"entities": []}], ["There was no difference in the effect of ivabradine on mean heart rate between patients with a previous PCI [64.4\u00a0\u00b1\u00a07.6\u00a0beats per minute (bpm)] than those without (66.8\u00a0\u00b1\u00a08.5\u00a0bpm) at 4\u00a0months (both P \u00a0<\u00a00.0001).", {"entities": []}], ["Similarly, the number of angina attacks decreased from 1.9\u00a0\u00b1\u00a02.4 to 0.5\u00a0\u00b1\u00a01.5 per week in patients with a previous PCI and 1.5\u00a0\u00b1\u00a02.0 to 0.3\u00a0\u00b1\u00a01.0 per week in patients without a previous PCI (both P \u00a0<\u00a00.0001).", {"entities": []}], ["The frequency of nitrate consumption fell from 2.7\u00a0\u00b1\u00a03.7 to 1.0\u00a0\u00b1\u00a01.9 per week and 1.8\u00a0\u00b1\u00a02.8 to 0.6\u00a0\u00b1\u00a01.5 per week (both P \u00a0<\u00a00.0001) in patients with and without a previous PCI, respectively.", {"entities": []}], ["There was no difference in the improvements in Canadian Cardiovascular Society class of angina, QoL, and physicians\u2019 assessment of effectiveness and tolerability between patients with a previous PCI and those without.", {"entities": []}], ["Ivabradine is an effective and well-tolerated anti-anginal treatment in patients with stable angina after PCI.", {"entities": []}], ["Ivabradine reduced the frequency of weekly angina attacks and nitrate consumption, led to an improvement in Canadian Cardiovascular Society class and a substantial improvement in the QoL of stable angina patients.", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-015-0182-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The impact of air pollution on the respiratory system has been estimated on the basis of respiratory symptoms and lung function.", {"entities": []}], ["However; few studies have compared lung inflammation in healthy and asthmatics children exposed to high levels of air pollution.", {"entities": []}], ["The aim of the study was to elucidate the modulatory effect of air pollution on Cysteinyl-leukotrienes (Cys-LTs) levels in exhaled breath condensate (EBC) among healthy and asthmatic children.", {"entities": []}], ["We performed a cross-sectional comparative study.", {"entities": []}], ["Children between 7\u201312 years of age, asthmatics and non-asthmatics, residents of a city with high levels of PM 10 were included.", {"entities": []}], ["In all cases, forced spirometry, Cys-LTs levels in EBC, and the International Study of Asthma and Allergies in Childhood questionnaire were evaluated.", {"entities": [[87, 93, "DISEASE"]]}], ["We also obtained average of PM 10 , CO, SO 2 and O 3 levels during the period of the study by the State Institute of Ecology.", {"entities": []}], ["We studied 103 children (51 asthmatics and 52 non-asthmatics).", {"entities": []}], ["Cys-LTs levels were higher in asthmatics than in non-asthmatics (77.3 \u00b1 21.6 versus 60.3 \u00b1 26.8 pg/ml; p = 0.0005).", {"entities": []}], ["Also, Cys-LTs levels in children with intermittent asthma were lower than in children with persistent asthma (60.4 \u00b1 20.4 versus 84.7 \u00b1 19.2 pg/ml; p = 0.0001).", {"entities": [[51, 57, "DISEASE"], [102, 108, "DISEASE"]]}], ["In the multiple regression model, factors associated with levels of Cys-LTs were passive smoking (\u03b2 = 13.1, p 0.04) and to be asthmatic (\u03b2 = 11.5, p 0.03).", {"entities": []}], ["Cys-LTs levels are higher in asthmatic children than in healthy children in a contaminated city and its levels are also associated with passive smoking.", {"entities": []}], ["Kaempferol is a flavonol with broad bioactivity of anti-oxidant, anti-cancer, anti-diabetic, anti-microbial, cardio-protective and anti-asthma.", {"entities": [[136, 142, "DISEASE"], [70, 76, "DISEASE"]]}], ["Microbial synthesis of kaempferol is a promising strategy because of the low content in primary plant source.", {"entities": []}], ["In this study, the biosynthesis pathway of kaempferol was constructed in the budding yeast Saccharomyces cerevisiae to produce kaempferol de novo, and several biological measures were taken for high production.", {"entities": []}], ["Firstly, a high efficient flavonol synthases (FLS) from Populus deltoides was introduced into the biosynthetic pathway of kaempferol.", {"entities": []}], ["Secondly, a S. cerevisiae recombinant was constructed for de novo synthesis of kaempferol, which generated about 6.97\u00a0mg/L kaempferol from glucose.", {"entities": []}], ["To further promote kaempferol production, the acetyl-CoA biosynthetic pathway was overexpressed and p -coumarate was supplied as substrate, which improved kaempferol titer by about 23 and 120%, respectively.", {"entities": []}], ["Finally, a fed-batch process was developed for better kaempferol fermentation performance, and the production reached 66.29\u00a0mg/L in 40\u00a0h. The titer of kaempferol in our engineered yeast is 2.5 times of the highest reported titer.", {"entities": []}], ["Our study provides a possible strategy to produce kaempferol using microbial cell factory.", {"entities": []}], ["The online version of this article (doi:10.1186/s12934-017-0774-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The informal sector is the dominant area of employment and the economy for any developing country including Bangladesh.", {"entities": []}], ["The cost of productivity loss due to absence from work or presenteeism with illness has rarely been examined in the Bangladesh context.", {"entities": []}], ["This current study, therefore, attempted to examine the impact of ill health of informal sector workers on labor productivity, future earning, and healthcare-related expenditure.", {"entities": []}], ["A cross-sectional survey was conducted among three occupational groups of informal workers (rickshaw pullers, shopkeepers and restaurant workers) that were generally found in all urban areas in Bangladesh.", {"entities": []}], ["A total of 557 informal workers were surveyed for this study.", {"entities": []}], ["Most of the respondents (57%) reported that they had been affected by some type of illness for the last six months.", {"entities": []}], ["The overall average healthcare expenditure of informal workers was US$48.34, while restaurant workers expended more (US$53.61).", {"entities": []}], ["Self reported sickness absenteeism was highest (50.37days) in the case of shop keepers, followed by rickshaw pullers (49.31 days), in the last six months.", {"entities": []}], ["Considering the income loss due to illness in the past six months, the rickshaw pullers were exposed to the highest income loss (US$197.15), followed by the shop keepers (US$151.39).", {"entities": []}], ["Although the informal sector contributes the most to the economy of Bangladesh, the workers in this sector have hardly any financial protection.", {"entities": []}], ["This study provides critical clues to providing financial and social protection to informal sector workers in Bangladesh.", {"entities": []}], ["Develop a risk index to estimate the likelihood of life\u2010threatening respiratory depression or overdose among medical users of prescription opioids.", {"entities": []}], ["A case\u2010control analysis of administrative health care data from the Veterans\u2019 Health Administration identified 1,877,841 patients with a pharmacy record for an opioid prescription between October 1, 2010 and September 30, 2012.", {"entities": []}], ["Overdose or serious opioid\u2010induced respiratory depression (OSORD) occurred in 817.", {"entities": []}], ["Ten controls were selected per case ( n \u2009=\u20098,170).", {"entities": []}], ["Items for an OSORD risk index (RIOSORD) were selected through logistic regression modeling, with point values assigned to each predictor.", {"entities": []}], ["Modeling of risk index scores produced predicted probabilities of OSORD; risk classes were defined by the predicted probability distribution.", {"entities": []}], ["Fifteen variables most highly associated with OSORD were retained as items, including mental health disorders and pharmacotherapy; impaired drug metabolism or excretion; pulmonary disorders; specific opioid characteristics; and recent hospital visits.", {"entities": []}], ["The average predicted probability of experiencing OSORD ranged from 3% in the lowest risk decile to 94% in the highest, with excellent agreement between predicted and observed incidence across risk classes.", {"entities": []}], ["The model's C\u2010statistic was 0.88 and Hosmer\u2013Lemeshow goodness\u2010of\u2010fit statistic 10.8 ( P \u2009>\u20090.05).", {"entities": []}], ["RIOSORD performed well in identifying medical users of prescription opioids within the Veterans\u2019 Health Administration at elevated risk of overdose or life\u2010threatening respiratory depression, those most likely to benefit from preventive interventions.", {"entities": []}], ["This novel, clinically practical, risk index is intended to provide clinical decision support for safer pain management.", {"entities": []}], ["It should be assessed, and refined as necessary, in a more generalizable population, and prospectively evaluated.", {"entities": []}], ["The aim of this study was to verify the possible interactions between ethanol extracts of Amburana cearensis A. C. Smith and Anadenanthera macrocarpa (Benth.)", {"entities": []}], ["Brenan, combined with six antimicrobial drugs against multiresistant strains of Staphylococcus aureus and Escherichia coli isolated from humans.", {"entities": []}], ["The antibacterial activity of the extracts was determined using the minimum inhibitory concentration (MIC).", {"entities": []}], ["The microdilution assay was performed to verify the interactions between the natural products and the antibiotics using a subinhibitory concentration.", {"entities": []}], ["The activity of amikacin associated with the extract of Anadenanthera macrocarpa against EC 27 was enhanced, demonstrating an MIC reduction from 128 to 4\u2009 \u03bc g/mL.", {"entities": []}], ["Among the \u03b2 -lactams, no potentiation on its activity was observed, with exception to the antagonism of the natural products with ampicillin against S. aureus 358.", {"entities": []}], ["The tachykinins are implicated in neurogenic inflammation and the neuropeptide substance P in particular has been shown to be a proinflammatory mediator.", {"entities": []}], ["A role for the tachykinins in host response to lung challenge has been previously demonstrated but has been focused predominantly on the release of the tachykinins from nerves innervating the lung.", {"entities": []}], ["We have previously demonstrated the most dramatic phenotype described for the substance P encoding gene preprotachykinin-A ( PPT-A ) to date in controlling the host immune response to the murine gammaherpesvirus 68, in the lung.", {"entities": []}], ["In this study we have utilised transgenic mice engineered to co-ordinately express the beta-galactosidase marker gene along with PPT-A to facilitate the tracking of PPT-A expression.", {"entities": []}], ["Using a combination of these mice and conventional immunohistology we now demonstrate that PPT-A gene expression and substance P peptide are induced in cells of the respiratory tract including tracheal, bronchiolar and alveolar epithelial cells and macrophages after viral infection.", {"entities": []}], ["This induction was observed 24h post infection, prior to observable inflammation and the expression of pro-inflammatory chemokines in this model.", {"entities": []}], ["Induced expression of the PPT-A gene and peptide persisted in the lower respiratory tract through day 7 post infection.", {"entities": []}], ["Non-neuronal PPT-A expression early after infection may have important clinical implications for the progression or management of lung disease or infection aside from the well characterised later involvement of the tachykinins during the inflammatory response.", {"entities": [[130, 142, "DISEASE"]]}], ["Viruses can persistently infect differentiated cells through regulation of expression of both their own genes and those of the host cell, thereby evading detection by the host\u2019s immune system and achieving residence in a non-lytic state.", {"entities": []}], ["Models in vitro with cell lines are useful tools in understanding the mechanisms associated with the establishment of viral persistence.", {"entities": []}], ["In particular, a model to study respiratory syncytial virus (RSV) persistence in a murine macrophage-like cell line has been established.", {"entities": []}], ["Compared to non-infected macrophages, macrophages persistently infected with RSV show altered expression both of genes coding for cytokines and trans-membrane proteins associated with antigen uptake and of genes related to cell survival.", {"entities": []}], ["The biological changes associated with altered gene expression in macrophages as a consequence of persistent RSV infection are summarized.", {"entities": []}], ["To investigate decision making in patients with primary restless legs syndrome (RLS) with and without augmentation treated with dopaminergic medication.", {"entities": [[70, 78, "DISEASE"]]}], ["A total of 64 non-demented RLS patients treated with dopaminergic medication with and without augmentation were included in this study.", {"entities": []}], ["We used an information sampling task to assess how much evidence participants gather before making a decision.", {"entities": []}], ["Performance was compared to the results of 21 healthy controls.", {"entities": []}], ["All patients with and without augmentation gathered less information than healthy controls before making a decision (p<0.001), but there was no difference between the two patient groups (p = 1.0).", {"entities": []}], ["Furthermore, both patient groups made more irrational decisions (e.g.", {"entities": []}], ["decisions against the evidence they had at the time) than healthy controls (p\u22640.002).", {"entities": []}], ["In addition, RLS patients with augmentation made significantly more irrational decisions than RLS patients without augmentation (p = 0.037) and controls (p<0.001).", {"entities": []}], ["Our results show that RLS patients treated with dopaminergic drugs, regardless of having augmentation or not, jumped to conclusions and decided significantly more often against the evidence they had at the time of their decision.", {"entities": []}], ["However, those with augmentation performed worse than all other groups and made more often irrational decisions, a phenomenon which is also common in patients with substance abuse or behavioural addictions.", {"entities": [[164, 179, "DISEASE"]]}], ["Thus, jumping to conclusions and deciding with a higher degree of uncertainty as well as irrational decision making is more common in RLS patients treated with dopaminergic medication particularly in those with augmentation.", {"entities": []}], ["Tachykinins substance P, neurokinin A and neurokinin B seem to account for asthma pathophysiology by mediating neurogenic inflammation and several aspects of lung mechanics.", {"entities": [[75, 81, "DISEASE"]]}], ["These neuropeptides act mainly by their receptors NK1, NK2 and NK3, respectively which may be targets for new asthma therapy.", {"entities": [[110, 116, "DISEASE"]]}], ["This review systematically examines randomized controlled trials evaluating the effect of tachykinins receptors antagonism on asthma.", {"entities": [[126, 132, "DISEASE"]]}], ["Symptoms, airway inflammation, lung function and airway inflammation were considered as outcomes.", {"entities": []}], ["We searched the Cochrane Airways Group Specialized Register of Asthma Trials, Cochrane Database of Systematic Reviews, MEDLINE/PubMed and EMBASE.", {"entities": [[63, 69, "DISEASE"]]}], ["The search is as current as June 2010.", {"entities": []}], ["Quality rating of included studies followed the Cochrane Collaboration and GRADE Profiler approaches.", {"entities": []}], ["However, data were not pooled together due to different measures among the studies.", {"entities": []}], ["Our systematic review showed the potential of NK receptor antagonist to decrease airway responsiveness and to improve lung function.", {"entities": []}], ["However, effects on airway inflammation and asthma symptoms were poorly or not described.", {"entities": [[44, 50, "DISEASE"]]}], ["The limited available evidence suggests that tachykinin receptors antagonists may decrease airway responsiveness and improve lung function in patients with asthma.", {"entities": [[156, 162, "DISEASE"]]}], ["Further large randomized trials are still required.", {"entities": []}], ["Measures that bolster the resolution phase of infectious diseases may offer new opportunities for improving outcome.", {"entities": []}], ["Here we show that inactivation of microbial lipopolysaccharides (LPS) can be required for animals to recover from the innate immune tolerance that follows exposure to Gram-negative bacteria.", {"entities": []}], ["When wildtype mice are exposed to small parenteral doses of LPS or Gram-negative bacteria, their macrophages become reprogrammed (tolerant) for a few days before they resume normal function.", {"entities": []}], ["Mice that are unable to inactivate LPS, in contrast, remain tolerant for several months; during this time they respond sluggishly to Gram-negative bacterial challenge, with high mortality.", {"entities": []}], ["We show here that prolonged macrophage reprogramming is maintained in vivo by the persistence of stimulatory LPS molecules within the cells' in vivo environment, where na\u00efve cells can acquire LPS via cell-cell contact or from the extracellular fluid.", {"entities": []}], ["The findings provide strong evidence that inactivation of a stimulatory microbial molecule can be required for animals to regain immune homeostasis following parenteral exposure to bacteria.", {"entities": []}], ["Measures that disable microbial molecules might enhance resolution of tissue inflammation and help restore innate defenses in individuals recovering from many different infectious diseases.", {"entities": []}], ["We showed previously that mice lacking acyloxyacyl hydrolase (AOAH), the host enzyme that inactivates Gram-negative bacterial lipopolysaccharides (LPS), are unable to regain normal immune responsiveness for many weeks/months after they are exposed in vivo to a small amount of LPS or Gram-negative bacteria.", {"entities": [[62, 66, "GENE"]]}], ["The many possible explanations for slow recovery included long-lasting epigenetic changes in macrophages or other host cells, chronically stimulated cells that produce certain mediators, and persistent signaling by internalized LPS within macrophages.", {"entities": []}], ["Using several in vivo techniques to study peritoneal macrophages, we found that none of these mechanisms was correct.", {"entities": []}], ["Rather, prolonged recovery is caused by intact LPS that remains in the environment where macrophages live and can pass from one cell to another in vivo .", {"entities": []}], ["This is the first evidence that the persistence of a bioactive microbial agonist, per se, can prevent resolution of inflammation in vivo .", {"entities": []}], ["It also identifies the stimulatory microbial molecule as a realistic target for intervention \u2013 in further support, we found that providing recombinant AOAH can be partially preventive.", {"entities": [[151, 155, "GENE"]]}], ["In a larger sense, showing that chemical inactivation of one important microbial signaling molecule is required for full recovery should encourage efforts to find out whether disabling other microbial agonists (chitin, lipopeptides, flagella, others) also benefits infected animals.", {"entities": []}], ["Allergic rhinitis is a frequent presenting problem in primary care in the UK, and has increased in prevalence over the last 30 years.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["When symptomatic, patients report significant reduction in their quality of life and impairment in school and work performance.", {"entities": []}], ["Achieving adequate symptom control is pivotal to successful allergic rhinitis management, and relies mostly on pharmacotherapy.", {"entities": [[60, 77, "DISEASE"], [69, 77, "DISEASE"]]}], ["While it is recognised that most mild-moderate allergic rhinitis symptoms can be managed successfully in primary care, important gaps in general practitioner training in relation to allergic rhinitis have been identified.", {"entities": [[47, 64, "DISEASE"], [182, 199, "DISEASE"], [56, 64, "DISEASE"], [191, 199, "DISEASE"]]}], ["With the availability of new effective combination therapies, such as the novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in a single device (Dymista\u00ae; Meda), the majority of allergic rhinitis symptoms can be treated in the primary care setting.", {"entities": [[211, 228, "DISEASE"], [220, 228, "DISEASE"]]}], ["The primary objective of this consensus statement is to improve diagnosis and treatment of allergic rhinitis in primary care, and offer guidance on appropriate referral of difficult-to-treat patients into secondary care.", {"entities": [[91, 108, "DISEASE"], [100, 108, "DISEASE"]]}], ["The guidance provided herein outlines a sequential treatment pathway for allergic rhinitis in primary care that incorporates a considered approach to improve the management of allergic rhinitis symptoms and improve compliance and patient satisfaction with therapy.", {"entities": [[73, 90, "DISEASE"], [176, 193, "DISEASE"], [82, 90, "DISEASE"], [185, 193, "DISEASE"]]}], ["Adherence with this care pathway has the potential to limit the cost of providing effective allergic rhinitis management in the UK by avoiding unnecessary treatments and investigations, and avoiding the need for costly referrals to secondary care in the majority of allergic rhinitis cases.", {"entities": [[92, 109, "DISEASE"], [266, 283, "DISEASE"], [101, 109, "DISEASE"], [275, 283, "DISEASE"]]}], ["The fundamentals presented in this consensus article should apply in most health-care settings.", {"entities": []}], ["The sharp rise in foodbank use in Britain over the past five years suggests a proliferation of food insecurity that could herald a public health crisis.", {"entities": []}], ["However, trends in foodbank use rely on imperfect figures that do not distinguish between single and repeat visits.", {"entities": []}], ["Consequently, the true prevalence of foodbank use in Britain is unknown.", {"entities": []}], ["By identifying repeat visits, this study provides the first estimate of the proportion of people using foodbanks.", {"entities": []}], ["Using data on referrals to West Cheshire Foodbank in the UK, this study offers a case study of 7769 referrals to one foodbank between 2013 and 2015.", {"entities": []}], ["Foodbank use was explored in descriptive statistics, then negative binomial regression models were used to identify the household characteristics associated with the number of foodbank visits.", {"entities": []}], ["Between 0.9 and 1.3% of people in West Cheshire sought assistance from West Cheshire Foodbank between 2013 and 2015.", {"entities": []}], ["If scaled up nationally, this would equate to an estimated 850,000 people across Britain.", {"entities": []}], ["The number of total recipients increased by 29% between 2013 and 2015, while the number of unique recipients rose by 14%.", {"entities": []}], ["Multivariate analysis revealed that a larger number of visits were recorded in 2015 and among working-age and one-person households, while households referred due to domestic abuse and unemployment made fewer visits.", {"entities": []}], ["Food insecurity has emerged as a crucial challenge facing UK health professionals and policymakers.", {"entities": []}], ["This study provides the first estimate of the proportion of individuals receiving emergency food in a single case study location, and demonstrates that foodbank use is becoming more prevalent, although headline figures overstate the scale of this growth.", {"entities": []}], ["The potential nutrition and wider health consequences of reliance on emergency food \u2013 especially among those using foodbanks on multiple occasions \u2013 warns of an unfolding public health crisis.", {"entities": []}], ["The online version of this article (10.1186/s12889-017-4847-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The attack on the World Trade Center (WTC) created an acute environmental disaster of enormous magnitude.", {"entities": []}], ["This study characterizes the environmental exposures resulting from destruction of the WTC and assesses their effects on health.", {"entities": []}], ["Methods include ambient air sampling; analyses of outdoor and indoor settled dust; high-altitude imaging and modeling of the atmospheric plume; inhalation studies of WTC dust in mice; and clinical examinations, community surveys, and prospective epidemiologic studies of exposed populations.", {"entities": []}], ["WTC dust was found to consist predominantly (95%) of coarse particles and contained pulverized cement, glass fibers, asbestos, lead, polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and polychlorinated furans and dioxins.", {"entities": []}], ["Airborne particulate levels were highest immediately after the attack and declined thereafter.", {"entities": []}], ["Particulate levels decreased sharply with distance from the WTC.", {"entities": []}], ["Dust pH was highly alkaline (pH 9.0-11.0).", {"entities": []}], ["Mice exposed to WTC dust showed only moderate pulmonary inflammation but marked bronchial hyperreactivity.", {"entities": []}], ["Evaluation of 10,116 firefighters showed exposure-related increases in cough and bronchial hyperreactivity.", {"entities": []}], ["Evaluation of 183 cleanup workers showed new-onset cough (33%), wheeze (18%), and phlegm production (24%).", {"entities": []}], ["Increased frequency of new-onset cough, wheeze, and shortness of breath were also observed in community residents.", {"entities": []}], ["Follow-up of 182 pregnant women who were either inside or near the WTC on 11 September showed a 2-fold increase in small-for-gestational-age (SGA) infants.", {"entities": []}], ["In summary, environmental exposures after the WTC disaster were associated with significant adverse effects on health.", {"entities": []}], ["The high alkalinity of WTC dust produced bronchial hyperreactivity, persistent cough, and increased risk of asthma.", {"entities": [[108, 114, "DISEASE"]]}], ["Plausible causes of the observed increase in SGA infants include maternal exposures to PAH and particulates.", {"entities": []}], ["Future risk of mesothelioma may be increased, particularly among workers and volunteers exposed occupationally to asbestos.", {"entities": []}], ["Continuing follow-up of all exposed populations is required to document the long-term consequences of the disaster.", {"entities": []}], ["Time-related biases in observational studies of drug effects have been described extensively in different therapeutic areas but less so in diabetes.", {"entities": []}], ["Immortal time bias, time-window bias, and time-lag bias all tend to greatly exaggerate the benefits observed with a drug.", {"entities": []}], ["These time-related biases are described and shown to be prominent in observational studies that have associated metformin with impressive reductions in the incidence of and mortality from cancer.", {"entities": [[188, 194, "DISEASE"]]}], ["As a consequence, metformin received much attention as a potential anticancer agent; these observational studies sparked the conduction of randomized, controlled trials of metformin as cancer treatment.", {"entities": [[185, 191, "DISEASE"]]}], ["However, the spectacular effects reported in these studies are compatible with time-related biases.", {"entities": []}], ["We found that 13 observational studies suffered from immortal time bias; 9 studies had not considered time-window bias, whereas other studies did not consider inherent time-lagging issues when comparing the first-line treatment metformin with second- or third-line treatments.", {"entities": []}], ["These studies, subject to time-related biases that are avoidable with proper study design and data analysis, led to illusory extraordinarily significant effects, with reductions in cancer risk with metformin ranging from 20 to 94%.", {"entities": [[181, 187, "DISEASE"]]}], ["Three studies that avoided these biases reported no effect of metformin use on cancer incidence.", {"entities": [[79, 85, "DISEASE"]]}], ["Although observational studies are important to better understand the effects of drugs, their proper design and analysis is essential to avoid major time-related biases.", {"entities": []}], ["With respect to metformin, the scientific evidence of its potential beneficial effects on cancer would need to be reassessed critically before embarking on further long and expensive trials.", {"entities": [[90, 96, "DISEASE"]]}], ["Over the recent decades complementary and alternative medicine (CAM) use within and outside of the public health care system in Norway has increased.", {"entities": []}], ["The aim of this study is to describe to what extent CAM is offered in Norwegian hospitals in 2013 and investigate possible changes since 2008.", {"entities": []}], ["In January 2013 a one-page questionnaire was sent to the medical director of all included hospitals ( n \u2009=\u200980).", {"entities": []}], ["He/she was asked to report whether or not one or more specific CAM therapies were offered in the hospital.", {"entities": []}], ["Fifty-nine (73.8\u00a0%) hospitals responded and form the basis for the analyses.", {"entities": []}], ["CAM was offered in 64.4\u00a0% of the responding hospitals.", {"entities": []}], ["No major differences were found between public and private, or between somatic and psychiatric, hospitals.", {"entities": []}], ["Acupuncture was the most frequent CAM method offered, followed by art- and expression therapy and massage.", {"entities": []}], ["The proportion of hospitals offering CAM has increased from 50.5\u00a0% in 2008 to 64.4\u00a0% in 2013 ( p \u2009=\u20090.089).", {"entities": []}], ["The largest increase was found in psychiatric hospitals where 76.5\u00a0% of hospitals offered CAM in 2013 compared to 28.6\u00a0% in 2008 ( p \u2009=\u20090.003).", {"entities": []}], ["A small decrease was found in the proportion of hospitals offering acupuncture between 2008 (41.4\u00a0%) and 2013 (37.3\u00a0%).", {"entities": []}], ["A majority of Norwegian hospitals offer some sort of CAM.", {"entities": []}], ["The largest increase since 2008 was found in psychiatric hospitals.", {"entities": []}], ["Psychiatric hospitals seem to have established a practice of offering CAM to their patients similar to the practice in somatic hospitals.", {"entities": []}], ["This could indicate a shift in the attitude with regard to CAM in psychiatric hospitals.", {"entities": []}], ["Background: Associations of higher indoor carbon dioxide (CO 2 ) concentrations with impaired work performance, increased health symptoms, and poorer perceived air quality have been attributed to correlation of indoor CO 2 with concentrations of other indoor air pollutants that are also influenced by rates of outdoor-air ventilation.", {"entities": []}], ["Objectives: We assessed direct effects of increased CO 2 , within the range of indoor concentrations, on decision making.", {"entities": []}], ["Methods: Twenty-two participants were exposed to CO 2 at 600, 1,000, and 2,500 ppm in an office-like chamber, in six groups.", {"entities": []}], ["Each group was exposed to these conditions in three 2.5-hr sessions, all on 1 day, with exposure order balanced across groups.", {"entities": []}], ["At 600 ppm, CO 2 came from outdoor air and participants\u2019 respiration.", {"entities": []}], ["Higher concentrations were achieved by injecting ultrapure CO 2 .", {"entities": []}], ["Ventilation rate and temperature were constant.", {"entities": []}], ["Under each condition, participants completed a computer-based test of decision-making performance as well as questionnaires on health symptoms and perceived air quality.", {"entities": []}], ["Participants and the person administering the decision-making test were blinded to CO 2 level.", {"entities": []}], ["Data were analyzed with analysis of variance models.", {"entities": []}], ["Results: Relative to 600 ppm, at 1,000 ppm CO 2 , moderate and statistically significant decrements occurred in six of nine scales of decision-making performance.", {"entities": []}], ["At 2,500 ppm, large and statistically significant reductions occurred in seven scales of decision-making performance (raw score ratios, 0.06\u20130.56), but performance on the focused activity scale increased.", {"entities": []}], ["Conclusions: Direct adverse effects of CO 2 on human performance may be economically important and may limit energy-saving reductions in outdoor air ventilation per person in buildings.", {"entities": []}], ["Confirmation of these findings is needed.", {"entities": []}], ["Respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and viral pneumonia in infants and young children.", {"entities": [[82, 91, "DISEASE"], [76, 91, "DISEASE"], [58, 71, "DISEASE"]]}], ["Administration of a formalin inactivated vaccine against RSV to children in the 1960s resulted in increased morbidity and mortality in vaccine recipients who subsequently contracted RSV.", {"entities": []}], ["This incident precluded development of subunit RSV vaccines for infants for over 30 years, because the mechanism of illness was never clarified.", {"entities": []}], ["An RSV vaccine for infants is still not available.", {"entities": []}], ["Here, we demonstrate that enhanced RSV disease is mediated by immune complexes and abrogated in complement component C3 and B cell\u2013deficient mice but not in controls.", {"entities": [[117, 119, "GENE"]]}], ["Further, we show correlation with the enhanced disease observed in children by providing evidence of complement activation in postmortem lung sections from children with enhanced RSV disease.", {"entities": []}], ["The Chronic Dispensing Unit (CDU) is an out-sourced, public sector centralised dispensing service that has been operational in the Western Cape Province in South Africa since 2005.", {"entities": []}], ["The CDU dispenses medicines for stable patients with chronic conditions.", {"entities": []}], ["The aim is to reduce pharmacists\u2019 workload, reduce patient waiting times and decongest healthcare facilities.", {"entities": []}], ["Our objectives are to describe the intervention\u2019s scope, illustrate its interface with the health system and describe its processes and outcomes.", {"entities": []}], ["Secondly, to quantify the magnitude of missed appointments by enrolled patients and to describe the implications thereof in order to inform a subsequent in-depth empirical study on the underlying causes.", {"entities": []}], ["We adopted a case study design in order to elicit the programme theory underlying the CDU strategy.", {"entities": []}], ["We consulted 15 senior and middle managers from the provincial Department of Health who were working closely with the intervention and the contractor using focus group discussions and key informant interviews.", {"entities": []}], ["In addition, relevant literature, and policy and programme documents were reviewed and analysed.", {"entities": []}], ["We found that the CDU scope has significantly expanded over the last 10\u00a0years owing to technological advancements.", {"entities": []}], ["As such, in early 2015, the CDU produced nearly 300,000 parcels monthly.", {"entities": []}], ["Medicines supply, patient enrollment\u00a0processes, healthcare professionals' compliance to legislation and policies, mechanisms for medicines distribution, management of non-collected medicines (emanating from patients\u2019 missed appointments) and the array of actors involved are\u00a0all central to the CDU\u2019s functioning.", {"entities": []}], ["Missed appointments by patients are a problem, affecting an estimated 8 %\u201312\u00a0% of patients each month.", {"entities": []}], ["However, the causes have not been investigated thoroughly.", {"entities": []}], ["Implications of missed appointments include a cost to government for services rendered by the contractor, potential losses due to expired medicines, additional workload for the contractor and healthcare facility staff and potential negative therapeutic outcomes\u00a0for patients.", {"entities": []}], ["The CDU demonstrates innovation in a context of overwhelming demand for dispensing medicines for chronic conditions.", {"entities": []}], ["However, it is not a panacea to address access-to-medicines related challenges.", {"entities": []}], ["A multi-level assessment that is currently underway\u00a0will provide more insights on how existing challenges can be addressed.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-1164-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study evaluates the psychometric properties of the Child and Parent versions of the German CFQ-R (Cystic Fibrosis Questionnaire Revised), a disease-specific measure of Health-Related Quality of Life (HRQoL) in children with cystic fibrosis (CF).", {"entities": [[103, 118, "DISEASE"], [229, 244, "DISEASE"]]}], ["Self-Rating is combined with proxy-rating by parents in the use of the questionnaire.", {"entities": []}], ["136 children with CF (6 - 13 years) and their parents were recruited to evaluate internal consistency (Cronbach's \u03b1) and validity, 20 children and parents to examine reproducibility (ICC).", {"entities": []}], ["Cronbach's \u03b1 is high in all but two dimensions of the Child version (\u03b1 = 0.23-0.77) and for all dimensions of the Parent version (\u03b1 = 0.69-0.89).", {"entities": []}], ["For both questionnaires, reproducibility is moderate to high (ICC = 0.50-0.94).", {"entities": []}], ["Factor analysis shows loadings of >0.4 in the majority of items.", {"entities": []}], ["Higher HRQoL is reported by children with mild disease compared to those with moderate/severe disease and by boys compared to girls.", {"entities": []}], ["Convergence between self-rating and proxy-rating depends on the dimension.", {"entities": []}], ["The German CFQ-R, Child and Parent versions, are reliable and valid measures of HRQoL.", {"entities": []}], ["They should be administered in combination as both, child and parent, provide important information.", {"entities": []}], ["The measure offers a new patient-reported outcome for clinical purposes as well as for national and international studies in schoolchildren.", {"entities": []}], ["Particulate matter air pollution has been associated with adverse health effects.", {"entities": []}], ["The fraction of ambient particles that are mainly responsible for the observed health effects is still a matter of controversy.", {"entities": []}], ["Better characterization of the health relevant particle fraction will have major implications for air quality policy since it will determine which sources should be controlled.", {"entities": []}], ["The RUPIOH study, an EU-funded multicentre study, was designed to examine the distribution of various ambient particle metrics in four European cities (Amsterdam, Athens, Birmingham, Helsinki) and assess their health effects in participants with asthma or COPD, based on a detailed exposure assessment.", {"entities": [[246, 252, "DISEASE"]]}], ["In this paper the association of central site measurements with respiratory symptoms and restriction of activities is examined.", {"entities": []}], ["At each centre a panel of participants with either asthma or COPD recorded respiratory symptoms and restriction of activities in a diary for six months.", {"entities": [[51, 57, "DISEASE"]]}], ["Exposure assessment included simultaneous measurements of coarse, fine and ultrafine particles at a central site.", {"entities": []}], ["Data on gaseous pollutants were also collected.", {"entities": []}], ["The associations of the 24-hour average concentrations of air pollution indices with the health outcomes were assessed in a hierarchical modelling approach.", {"entities": []}], ["A city specific analysis controlling for potential confounders was followed by a meta-analysis to provide overall effect estimates.", {"entities": []}], ["A 10 \u03bcg/m The observed associations with coarse particles are in agreement with the findings of toxicological studies.", {"entities": []}], ["Together they suggest it is prudent to regulate also coarse particles in addition to fine particles.", {"entities": []}], ["Clostridium difficile is the most common cause of healthcare-acquired infection; the real-world impacts of some proposed C. difficile prevention processes are unknown.", {"entities": []}], ["We conducted a population-based retrospective cohort study of all patients admitted to acute care hospitals between April 2011 and March 2012 in Ontario, Canada.", {"entities": []}], ["Hospital prevention practices were determined by survey of infection control programmes; responses were linked to patient-level risk factors and C. difficile outcomes in Ontario administrative databases.", {"entities": []}], ["Multivariable generalised estimating equation (GEE) regression models were used to assess the impact of selected understudied hospital prevention processes on the patient-level risk of C. difficile infection, accounting for patient risk factors, baseline C. difficile rates and structural hospital characteristics.", {"entities": []}], ["C. difficile infections complicated 2341 of 653\u2005896 admissions (3.6 per 1000 admissions).", {"entities": []}], ["Implementation of the selected C. difficile prevention practices was variable across the 159 hospitals with isolation of all patients at onset of diarrhoea reported by 43 (27%), auditing of antibiotic stewardship compliance by 26 (16%), auditing of cleaning practices by 115 (72%), on-site diagnostic testing by 74 (47%), vancomycin as first-line treatment by 24 (15%) and reporting rates to senior leadership by 52 (33%).", {"entities": []}], ["None of these processes were associated with a significantly reduced risk of C. difficile after adjustment for baseline C. difficile rates, structural hospital characteristics and patient-level factors.", {"entities": []}], ["Patient-level factors were strongly associated with C. difficile risk, including age, comorbidities, non-elective and medical admissions.", {"entities": []}], ["In the largest study to date, selected hospital prevention strategies were not associated with a statistically significant reduction in patients\u2019 risk of C. difficile infection.", {"entities": []}], ["These prevention strategies have either limited effectiveness or were ineffectively implemented during the study period.", {"entities": []}], ["To develop an algorithm to measure the dimensions of an airway oriented obliquely on a volumetric CT, as well as assess the effect of the imaging parameters on the correct measurement of the airway dimension.", {"entities": []}], ["An airway phantom with 11 poly-acryl tubes of various lumen diameters and wall thicknesses was scanned using a 16-MDCT (multidetector CT) at various tilt angles (0, 30, 45, and 60\u00b0).", {"entities": []}], ["The CT images were reconstructed at various reconstruction kernels and thicknesses.", {"entities": []}], ["The axis of each airway was determined using the 3D thinning algorithm, with images perpendicular to the axis being reconstructed.", {"entities": []}], ["The luminal radius and wall thickness was measured by the full-width-half-maximum method.", {"entities": []}], ["The influence of the CT parameters (the size of the airways, obliquity on the radius and wall thickness) was assessed by comparing the actual dimension of each tube with the estimated values.", {"entities": []}], ["The 3D thinning algorithm correctly determined the axis of the oblique airway in all tubes (mean error: 0.91 \u00b1 0.82\u00b0).", {"entities": []}], ["A sharper reconstruction kernel, thicker image thickness and larger tilt angle of the airway axis resulted in a significant decrease of the measured wall thickness and an increase of the measured luminal radius.", {"entities": []}], ["Use of a standard kernel and a 0.75-mm slice thickness resulted in the most accurate measurement of airway dimension, which was independent of obliquity.", {"entities": []}], ["The airway obliquity and imaging parameters have a strong influence on the accuracy of the airway wall measurement.", {"entities": []}], ["For the accurate measurement of airway thickness, the CT images should be reconstructed with a standard kernel and a 0.75 mm slice thickness.", {"entities": []}], ["Inflammation is a manifestation of a wide range of disorders which include; arthritis, atherosclerosis, Alzheimer\u2019s disease, inflammatory bowel syndrome, physical injury and infection amongst many others.", {"entities": [[87, 102, "DISEASE"], [144, 152, "DISEASE"], [76, 85, "DISEASE"]]}], ["Common treatment modalities are usually non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, paracetamol, indomethacin and ibuprofen as well as corticosteroids such as prednisone.", {"entities": []}], ["These however, may be associated with a host of side effects due to non-selectivity for cyclooxygenase (COX) enzymes involved in inflammation and those with selectivity may be highly priced.", {"entities": []}], ["Thus, there is a continuing search for safe and effective anti-inflammatory molecules from natural sources.", {"entities": []}], ["Research has confirmed that iridoids exhibit promising anti-inflammatory activity which may be beneficial in the treatment of inflammation.", {"entities": []}], ["Iridoids are secondary metabolites present in various plants, especially in species belonging to the Apocynaceae, Lamiaceae, Loganiaceae, Rubiaceae, Scrophulariaceae and Verbenaceae families.", {"entities": []}], ["Many of these ethnobotanicals have an illustrious history of traditional use alluding to their use to treat inflammation.", {"entities": []}], ["Although iridoids exhibit a wide range of pharmacological activities such as cardiovascular, hepatoprotection, hypoglycaemic, antimutagenic, antispasmodic, anti-tumour, antiviral, immunomodulation and purgative effects this review will acutely focus on their anti-inflammatory properties.", {"entities": []}], ["The paper aims to present a summary for the most prominent iridoid-containing plants for which anti-inflammatory activity has been demonstrated in vitro and / or in vivo .", {"entities": []}], ["Garo Hills represents one of earliest human habitation in Bangladesh preserving its ancient cultures due to the geographic location.", {"entities": []}], ["It is situated in the most northern part of Durgapur sub-district having border with Meghalaya of India.", {"entities": []}], ["Durgapur is rich in ethnic diversity with Garo and Hajong as the major ethnic groups along with Bangalee settlers from the mainstream population.", {"entities": []}], ["Thus the ethnomedicinal practice in Garo Hills is considered rich as it encompasses three different groups.", {"entities": []}], ["Present survey was undertaken to compile the medicinal plant usage among the various communities of the Garo Hills.", {"entities": []}], ["The ethnomedicinal data was collected through open and focussed group discussions, and personal interviews using semi-structured questionnaire.", {"entities": []}], ["A total of 185 people were interviewed, including the three community people and their traditional health practitioners (THPs).", {"entities": []}], ["The usage of the plants were further analysed and are presented as use value ( UV ), informant consensus factor ( ICF ) and fidelity level ( FL ).", {"entities": []}], ["A total of 71 plants from 46 families and 64 genera were documented during our survey.", {"entities": []}], ["Gastrointestinal disorders represented the major ailment category with the use of 36 plant species followed by dermatological problems (25 species).", {"entities": []}], ["The ICF ranged from 0.90 to 0.99, with an average value of 0.96.", {"entities": []}], ["Leaves (41) were the principle source of medication followed by fruits (27).", {"entities": []}], ["Trees (33) were the major plant type used in the ethnobotanical practice.", {"entities": []}], ["A total of 25 plants showed high FL (70.91 to 100\u00a0%) with 12 plants showing maximum FL (100\u00a0%).", {"entities": []}], ["A number of the plants appear to have unique ethnomedicinal uses.", {"entities": []}], ["Present investigation revealed a rich traditional practice in the studied region, which provides primary health care to the local community.", {"entities": []}], ["This compilation of the ethnobotanical knowledge can help researchers to identify the uses of various medicinal plants that have a long history of use.", {"entities": []}], ["Asian dust is a seasonal meteorological phenomenon caused by the displacement of atmospheric pollutants from the Mongolian and Chinese deserts.", {"entities": []}], ["Although the frequency of Asian dust events and atmospheric dust levels have steadily increased in the eastern Asia region, the effects on human health remain poorly understood.", {"entities": []}], ["In the present study, the impact of Asian dust on human health was determined in terms of allergic reactions.", {"entities": []}], ["A total of 25 healthy volunteers were tested for a relationship between serum immunoglobulin E (IgE) levels and subjective symptoms during a 3-day Asian dust event recorded in April 2012.", {"entities": []}], ["They filled daily questionnaires on the severity of nasal, pharyngeal, ocular, respiratory, and skin symptoms by a self-administered visual analog scale.", {"entities": []}], ["Serum levels of non-specific IgE and 33 allergen-specific IgE molecules were analyzed.", {"entities": []}], ["Spearman rank-correlation analysis revealed significant positive associations between nasal symptom scores and 2 microbial-specific IgE levels ( Penicillium and Cladosporium ).", {"entities": []}], ["Microbes migrate vast distances during Asian dust events by attaching themselves to dust particles.", {"entities": []}], ["Therefore, some of these symptoms may be associated with type 1 allergic reactions to certain type of microbes.", {"entities": []}], ["Molecular biological modalities with better detection rates have been applied to identify the bacteria causing infectious diseases.", {"entities": []}], ["Approximately 10\u201348% of bacterial pathogens causing community-acquired pneumonia are not identified using conventional cultivation methods.", {"entities": [[71, 80, "DISEASE"]]}], ["This study evaluated the bacteriological causes of community-acquired pneumonia using a cultivation-independent clone library analysis of the 16S ribosomal RNA gene of bronchoalveolar lavage specimens, and compared the results with those of conventional cultivation methods.", {"entities": [[70, 79, "DISEASE"]]}], ["Patients with community-acquired pneumonia were enrolled based on their clinical and radiological findings.", {"entities": [[33, 42, "DISEASE"]]}], ["Bronchoalveolar lavage specimens were collected from pulmonary pathological lesions using bronchoscopy and evaluated by both a culture-independent molecular method and conventional cultivation methods.", {"entities": []}], ["For the culture-independent molecular method, approximately 600 base pairs of 16S ribosomal RNA genes were amplified using polymerase chain reaction with universal primers, followed by the construction of clone libraries.", {"entities": []}], ["The nucleotide sequences of 96 clones randomly chosen for each specimen were determined, and bacterial homology was searched.", {"entities": []}], ["Conventional cultivation methods, including anaerobic cultures, were also performed using the same specimens.", {"entities": []}], ["In addition to known common pathogens of community-acquired pneumonia [ Streptococcus pneumoniae (18.8%), Haemophilus influenzae (18.8%), Mycoplasma pneumoniae (17.2%)], molecular analysis of specimens from 64 patients with community-acquired pneumonia showed relatively higher rates of anaerobes (15.6%) and oral bacteria (15.6%) than previous reports.", {"entities": [[60, 69, "DISEASE"], [243, 252, "DISEASE"]]}], ["Our findings suggest that anaerobes and oral bacteria are more frequently detected in patients with community-acquired pneumonia than previously believed.", {"entities": [[119, 128, "DISEASE"]]}], ["It is possible that these bacteria may play more important roles in community-acquired pneumonia.", {"entities": [[87, 96, "DISEASE"]]}], ["Early lifestyle intervention with overweight and obese adolescents could help to avoid serious health events in early adulthood, ultimately alleviating some of the strain on the public health system due to obesity-related morbidity.", {"entities": [[206, 213, "DISEASE"]]}], ["Commercial weight loss programs have wide reach into the community setting, and have demonstrated success in long term weight management in adults, beyond that of current public health care.", {"entities": []}], ["Commercial weight-management programs have not been evaluated as a method of delivery for overweight and obese adolescents.", {"entities": []}], ["This study aims to evaluate the efficacy of a new adolescent weight management program in a commercial environment.", {"entities": []}], ["One hundred and forty adolescents, 13 to 17\u00a0years old, will be randomised to either a weight management program intervention or a wait-listed group for 12\u00a0weeks.", {"entities": []}], ["The commercial program will consist of a combined dietary and lifestyle approach targeting improved health behaviours for weight-loss or weight-stability.", {"entities": []}], ["Participants will be overweight or obese (above the 85 This independent evaluation of a weight management program for adolescents, delivered in a commercial setting, will provide initial evidence for the effectiveness of such programs; which may offer adolescents an avenue of weight-management with ongoing support prior to the development of obesity related co-morbidities.", {"entities": [[344, 351, "DISEASE"]]}], ["The protocol for this study is registered with the International Clinical Trials Registry ISRCTN13602313 .", {"entities": []}], ["Chirality is a key factor in the safety and efficacy of many drug products and thus the production of single enantiomers of drug intermediates and drugs has become increasingly important in the pharmaceutical industry.", {"entities": []}], ["There has been an increasing awareness of the enormous potential of microorganisms and enzymes derived there from for the transformation of synthetic chemicals with high chemo-, regio- and enatioselectivities.", {"entities": []}], ["In this article, biocatalytic processes are described for the synthesis of chiral alcohols and unntural aminoacids for pharmaceuticals.", {"entities": []}], ["Only a minority of adolescents reporting symptoms above case-levels on screenings for mental health seeks and receives help from specialist health services.", {"entities": []}], ["The objective of this study was to a) examine help-seeking for symptoms of anxiety and depression in relation to symptom load dimensionally, b) identify the level of specialization in mental health among service-providers, and c) identify associations between mental health problems and contact with different types of health services.", {"entities": []}], ["This cross-sectional school-based study (response-rate 88%, n = 11154) is based on Norwegian health surveys among 15 and 16 year olds.", {"entities": []}], ["We found a dose-response association between symptom-load and help seeking.", {"entities": []}], ["Only 34% of individuals with mental symptom-load above 99 It might not be reasonable to argue that all adolescents with case-level mental health problems are in need of treatment.", {"entities": []}], ["However, concerning the 99", {"entities": []}], ["Glaucoma is the leading cause of irreversible blindness in the world.", {"entities": [[46, 55, "DISEASE"], [0, 8, "DISEASE"]]}], ["Estimated to affect 60 million people worldwide, this figure is expected to rise to 80 million by 2020.", {"entities": []}], ["Untreated, glaucoma leads to visual decay and eventually to blindness, and can significantly reduce quality of life.", {"entities": [[60, 69, "DISEASE"], [11, 19, "DISEASE"]]}], ["First-line treatment in patients with primary open-angle glaucoma and exfoliative glaucoma is topical medical therapy with ocular hypotensives as eye drops.", {"entities": [[57, 65, "DISEASE"], [82, 90, "DISEASE"], [46, 65, "DISEASE"]]}], ["However, eye drops have several disadvantages including cost, possible local and systemic side effects, and adherence and perseverance issues.", {"entities": []}], ["Randomised controlled trials have demonstrated that selective laser trabeculoplasty is equally as effective in lowering intraocular pressure as eye drops.", {"entities": []}], ["However, the impact of these two treatment modalities from the patient and economic perspectives has not been adequately determined.", {"entities": []}], ["Thus, it remains unclear whether topical medical therapy or selective laser trabeculoplasty should be recommended as first-line treatment for glaucoma.", {"entities": [[142, 150, "DISEASE"]]}], ["This protocol describes an international, multi-centre, randomised controlled trial to determine the optimum first-line therapy for people with primary open-angle glaucoma and exfoliative glaucoma.", {"entities": [[163, 171, "DISEASE"], [188, 196, "DISEASE"], [152, 171, "DISEASE"]]}], ["This study will compare the effect of selective laser trabeculoplasty and topical medication with respect to patients\u2019 generic and glaucoma-specific quality of life.", {"entities": [[131, 139, "DISEASE"]]}], ["The trial will also provide a detailed cost-effectiveness analysis and compare the clinical effectiveness with respect to the degree of intraocular pressure lowering and rates of treatment failure.", {"entities": []}], ["Research coordinators in each centre will identify and recruit previously untreated patients with primary open-angle glaucoma and exfoliative glaucoma.", {"entities": [[117, 125, "DISEASE"], [142, 150, "DISEASE"], [106, 125, "DISEASE"]]}], ["Those who meet the eligibility criteria will be invited to enter a randomised controlled trial with either selective laser trabeculoplasty or topical ocular hypotensive therapy, according to a stepped regimen.", {"entities": []}], ["Outcome assessment will be measured at 6 weeks and at 6, 12, and 24 months post-treatment.", {"entities": []}], ["Regular clinic follow-ups will continue as clinically indicated between study outcome visits.", {"entities": []}], ["The Glaucoma Initial Treatment Study is the first multi-centred RCT to determine the optimum first-line therapy for people with glaucoma.", {"entities": [[4, 12, "DISEASE"], [128, 136, "DISEASE"]]}], ["Our trial will have an unprecedented capacity to meaningfully transform the treatment and management of glaucoma in Australia and overseas.", {"entities": [[104, 112, "DISEASE"]]}], ["ACTRN12611000720910 ; Date registered: 11 July 2011", {"entities": []}], ["Bee venom (BV) is one of the alternative medicines that have been widely used in the treatment of chronic inflammatory diseases.", {"entities": []}], ["We previously demonstrated that BV induces immune tolerance by increasing the population of regulatory T cells (Tregs) in immune disorders.", {"entities": []}], ["However, the major component and how it regulates the immune response have not been elucidated.", {"entities": []}], ["We investigated whether bee venom phospholipase A2 (bvPLA2) exerts protective effects that are mediated via Tregs in OVA\u2010induced asthma model.", {"entities": [[129, 135, "DISEASE"]]}], ["bvPLA2 was administered by intraperitoneal injection into control and OVA\u2010challenged mice.", {"entities": []}], ["The Treg population, total and differential bronchoalveolar lavage fluid (BALF) cell count, Th2 cytokines, and lung histological features were assessed.", {"entities": []}], ["Treg depletion was used to determine the involvement of Treg migration and the reduction of asthmatic symptoms.", {"entities": []}], ["The CD206\u2010dependence of bvPLA2\u2010treated suppression of airway inflammation was evaluated in OVA\u2010challenged CD206", {"entities": []}], ["Glucocorticoids affect peripheral immune responses, including modulation of T-cell activation, differentiation, and apoptosis.", {"entities": []}], ["The quantity and quality of T-cell receptor (TCR)-triggered intracellular signals modulate T-cell function.", {"entities": []}], ["Thus, glucocorticoids may affect T cells by interfering with the TCR signaling cascade.", {"entities": []}], ["The purpose of the study was to search for glucocorticoid-modulated kinases downstream of the TCR.", {"entities": []}], ["Gene modulation in lymphoid cells either treated with glucocorticoids or from glucocorticoid-treated mice was studied using a RNase protection assay, real-time PCR, and western blotting.", {"entities": []}], ["The sensitivity of genetically modified thymocytes to glucocorticoid-induced apoptosis was studied by performing hypotonic propidium iodide staining and flow cytometry.", {"entities": []}], ["The Student\u2019s t-test was employed for statistical evaluation.", {"entities": []}], ["We found that transcription of Itk, a non-receptor tyrosine kinase of the Tec family, was up-regulated in a mouse T-cell hybridoma by the synthetic glucocorticoid dexamethasone.", {"entities": [[31, 34, "GENE"]]}], ["In contrast, dexamethasone down-regulated the expression of Txk, a Tec kinase that functions redundantly with Itk, and Lck, the Src kinase immediately downstream of the TCR.", {"entities": [[60, 63, "GENE"], [110, 113, "GENE"], [119, 122, "GENE"], [128, 131, "GENE"]]}], ["We investigated the expression of Itk , Txk , and Lck in thymocytes and mature lymphocytes following in vitro and in vivo dexamethasone treatment at different time points and doses.", {"entities": [[34, 37, "GENE"], [40, 43, "GENE"], [50, 53, "GENE"]]}], ["Kinase expression was differentially modulated and followed distinct kinetics.", {"entities": []}], ["Itk was up-regulated in all cell types and conditions tested.", {"entities": [[0, 3, "GENE"]]}], ["Txk was strongly up-regulated in mature lymphocytes but only weakly up-regulated or non-modulated in thymocytes in vitro or in vivo, respectively.", {"entities": [[0, 3, "GENE"]]}], ["Conversely, Lck was down-regulated in thymocytes, but not modulated or up-regulated in mature lymphocytes in the different experimental conditions.", {"entities": [[12, 15, "GENE"]]}], ["This complex behaviour correlates with the presence of both positive and negative glucocorticoid responsive elements (GRE and nGRE, respectively) in the Itk, Txk and Lck genes.", {"entities": [[153, 156, "GENE"], [158, 161, "GENE"], [166, 169, "GENE"]]}], ["To investigate the function associated with Itk up-regulation, dexamethasone-induced apoptosis of thymocytes from Itk -deficient mice was evaluated.", {"entities": [[44, 47, "GENE"], [114, 117, "GENE"], [44, 47, "GENE"], [114, 117, "GENE"]]}], ["Our results demonstrated that Itk deficiency causes increased sensitivity to dexamethasone but not to other pro-apoptotic stimuli.", {"entities": [[30, 33, "GENE"]]}], ["Modulation of Itk , Txk , and Lck in thymocytes and mature lymphocytes is another mechanism by which glucocorticoids modulate T-cell activation and differentiation.", {"entities": [[14, 17, "GENE"], [20, 23, "GENE"], [30, 33, "GENE"]]}], ["Itk up-regulation plays a protective role in dexamethasone-treated thymocytes.", {"entities": [[0, 3, "GENE"]]}], ["Ingestion of water has been associated with general wellbeing.", {"entities": []}], ["When water intake is insufficient, symptoms such as thirst, fatigue and impaired memory result.", {"entities": []}], ["Currently there are no instruments to assess water consumption associated with wellbeing.", {"entities": []}], ["The objective of our study was to develop and validate such an instrument in urban, low socioeconomic, adult Mexican population.", {"entities": []}], ["To construct the Water Ingestion-Related Wellbeing Instrument (WIRWI), a qualitative study in which wellbeing related to everyday practices and experiences in water consumption were investigated.", {"entities": []}], ["To validate the WIRWI a formal, five-process procedure was used.", {"entities": []}], ["Face and content validation were addressed, consistency was assessed by exploratory and confirmatory psychometric factor analyses, repeatability, reproducibility and concurrent validity were assessed by conducting correlation tests with other measures of wellbeing such as a quality of life instrument, the SF-36, and objective parameters such as urine osmolality, 24-hour urine total volume and others.", {"entities": []}], ["The final WIRWI is composed of 17 items assessing physical and mental dimensions.", {"entities": []}], ["Items were selected based on their content and face validity.", {"entities": []}], ["Exploratory and confirmatory factor analyses yielded Cronbach's alpha of 0.87 and 0.86, respectively.", {"entities": []}], ["The final confirmatory factor analysis demonstrated that the model estimates were satisfactory for the constructs.", {"entities": []}], ["Statistically significant correlations with the SF-36, total liquid consumption and simple water consumption were observed.", {"entities": []}], ["The resulting WIRWI is a reliable tool for assessing wellbeing associated with consumption of plain water in Mexican adults and could be useful for similar groups.", {"entities": []}], ["Nocardia sp.", {"entities": []}], ["causes a variety of clinical presentations.", {"entities": []}], ["The incidence of nocardiosis varies geographically according to several factors, such as the prevalence of HIV infections, transplants, neoplastic and rheumatic diseases, as well as climate, socio-economic conditions and laboratory procedures for Nocardia detection and identification.", {"entities": [[17, 28, "DISEASE"]]}], ["In Brazil the paucity of clinical reports of Nocardia infections suggests that this genus may be underestimated as a cause of human diseases and/or either neglected or misidentified in laboratory specimens.", {"entities": []}], ["Accurate identification of Nocardia species has become increasingly important for clinical and epidemiological investigations.", {"entities": []}], ["In this study, seven clinical Nocardia isolates were identified by multilocus sequence analysis (MLSA) and their antimicrobial susceptibility was also determined.", {"entities": []}], ["Most Nocardia isolates were associated to pulmonary disease.", {"entities": []}], ["The majority of Brazilian human isolates in cases reported in literature were identified as Nocardia sp.", {"entities": []}], ["Molecular characterization was used for species identification of Nocardia nova , Nocardia cyriacigeorgica , Nocardia asiatica and Nocardia exalbida/gamkensis .", {"entities": []}], ["Data indicated that molecular analysis provided a different Nocardia speciation than the initial biochemical identification for most Brazilian isolates.", {"entities": []}], ["All Nocardia isolates showed susceptibility to trimethoprim-sulfamethoxazole, the antimicrobial of choice in the treatment nocardiosis.", {"entities": [[123, 134, "DISEASE"]]}], ["N. nova isolated from different clinical specimens from one patient showed identical antimicrobial susceptibility patterns and two distinct clones.", {"entities": []}], ["Although Brazil is the world's fifth-largest country in terms of land mass and population, pulmonary, extrapulmonary and systemic forms of nocardiosis were reported in only 6 of the 26 Brazilian states from 1970 to 2013.", {"entities": [[139, 150, "DISEASE"]]}], ["A least 33.8% of these 46 cases of nocardiosis proved fatal.", {"entities": [[35, 46, "DISEASE"]]}], ["Interestingly, coinfection by two clones may occur in patients presenting nocardiosis.", {"entities": [[74, 85, "DISEASE"]]}], ["Nocardia infection may be more common throughout the Brazilian territory and in other developing tropical countries than is currently recognized and MLSA should be used more extensively as an effective method for Nocardia identification.", {"entities": []}], ["Nocardiosis is an in common and potentially life-threatening infection.", {"entities": [[0, 11, "DISEASE"]]}], ["Most cases occur in immunocompromised patients, and a delay in establishing the diagnosis is due to the difficulties in clinical diagnosis and in cultivating and detecting Nocardia .", {"entities": []}], ["Growth of Nocardia species in culture media is slow and incubation should be carried out for at least two weeks to detection this microorganism from clinical specimens.", {"entities": []}], ["Accordingly, high levels of suspicion on the part of the clinician and of experience on the part of laboratory personnel are essential for detection of nocardiosis.", {"entities": [[152, 163, "DISEASE"]]}], ["In Brazil, clinical reports of Nocardia infections are scarce and the knowledge of the clinical impact of nocardiosis is fragmentary, suggesting that this genus may be underestimated as a cause of human diseases and/or neglected.", {"entities": [[106, 117, "DISEASE"]]}], ["In this study conventional biochemical method led to the misidentification of Brazilian isolates.", {"entities": []}], ["Herein, molecular characterization of four loci was precisely identified as N. nova , N. cyriacigeorgica , N. asiatica and N. exalbida or N. gamkensis species.", {"entities": []}], ["To the best of our knowledge, these are the first reported cases of human infection due to these Nocardia species in Brazil.", {"entities": []}], ["Molecular methods offer a time-saving and accurate identification of the Nocardia genus at the species level and thus, play an important role in the diagnosis and treatment of nocardiosis.", {"entities": [[176, 187, "DISEASE"]]}], ["Despite Cryptostegia grandiflora Roxb.", {"entities": []}], ["(Apocynaceae) leaves are widely used in folk Caribbean Colombian medicine for their anti-inflammatory effects, there are no studies that support this traditional use.", {"entities": []}], ["Therefore, this work aimed to evaluate the effect of the total extract and primary fractions obtained from Cryptostegia grandiflora leaves, using in vivo and in vitro models of inflammation, and further get new insights on the mechanisms involved in this activity.", {"entities": []}], ["Ethanolic extract of Cryptostegia grandiflora leaves, and its corresponding ether and dichloromethane fractions, significantly reduced inflammation and myeloperoxidase activity (MPO) in ear tissue of mice treated with 12- O -tetradecanoyl-phorbol-13-acetate (TPA).", {"entities": [[178, 181, "GENE"]]}], ["Histological analysis revealed a reduction of edema and leukocyte infiltration.", {"entities": []}], ["Complementarily, we demonstrated that extract and fractions reduced nitric oxide (NO\u2022) and prostaglandin E2 (PGE2) production in LPS-stimulated RAW 264.7 macrophages, as well as scavenging activity on DPPH and ABTS radicals.", {"entities": []}], ["Our results demonstrated for the first time the anti-inflammatory activity of Cryptostegia grandiflora leaves, supporting its traditional use.", {"entities": []}], ["This activity was related to inhibition of MPO activity, and PGE2 and NO\u2022 production.", {"entities": [[43, 46, "GENE"]]}], ["These mechanisms and its antioxidant activity could contribute, at least in part, to the anti-inflammatory effect showed by this plant.", {"entities": []}], ["We had shown that COPD women expressed more dyspnea than men for the same degree of airway obstruction.", {"entities": []}], ["Evaluate gender differences in respiratory factors associated with dyspnea in COPD patients.", {"entities": []}], ["In a FEV 1 % matched population of 100 men and women with COPD we measured: age, MMRC, FEV 1 , FVC, TLC, IC/TLC, PaO 2 , PaCO 2 , D LCO , P imax , P 0.1 , Ti/Ttot, BMI, ffmi, 6MWD and VAS scale before and after the test, the Charlson score and the SGRQ.", {"entities": [[5, 8, "GENE"], [87, 90, "GENE"], [5, 8, "GENE"], [87, 90, "GENE"]]}], ["We estimated the association between these parameters and MMRC scores.", {"entities": []}], ["Multivariate analysis determined the independent strength of those associations.", {"entities": []}], ["MMRC correlated with: BMI (men:-0.29, p = 0.04; women:-0.28, p = 0.05), ffmi (men:-0.39, p = 0.01), FEV 1 % (men:-0.64, p < 0.001; women:-0.29, p = 0.04), FVC % (men:-0.45, p = 0.001; women:-0.33, p = 0.02), IC/TLC (men:-0.52, p < 0.001; women: -0.27, p = 0.05), PaO 2 (men:-0.59, p < 0.001), PaCO 2 (men:0.27, p = 0.05), D LCO (men:-0.54, p < 0.001), P 0.1 /P imax (men:0.46, p = 0.002; women:0.47, p = 0.005), dyspnea measured with the Visual Analog Scale before (men:0.37, p = 0.04; women:0.52, p = 0.004) and after 6MWD (men:0.52, p = 0.002; women:0.48, p = 0.004) and SGRQ total (men:0.50, p < 0.001; women:0.59, p < 0.001).", {"entities": [[100, 103, "GENE"]]}], ["Regression analysis showed that P 0.1 /P imax in women (r CO , PaO 2 and P 0.1 /P imax in men (r In mild to severe COPD patients attending a pulmonary clinic, P 0.1 /P imax was the unique predictor of MMRC scores only in women.", {"entities": []}], ["Respiratory factors explain most of the variations of MMRC scores in men but not in women.", {"entities": []}], ["Factors other than the respiratory ones should be included in the evaluation of dyspnea in women with COPD.", {"entities": []}], ["Total iron intake is not strongly associated with iron stores, but haem iron intake may be more predictive.", {"entities": []}], ["Haem iron is not available in most nutrient databases, so experimentally determined haem contents were applied to an Australian Food Frequency Questionnaire (FFQ) to estimate haem iron intake in a representative sample of young women (25\u201330 years).", {"entities": []}], ["The association between dietary haem iron intakes and incident self-reported diagnosed iron deficiency over six years of follow-up was examined.", {"entities": []}], ["Haem iron contents for Australian red meats, fish, and poultry were applied to haem-containing foods in the Dietary Questionnaire for Epidemiological Studies V2 (DQESv2) FFQ.", {"entities": []}], ["Haem iron intakes were calculated for 9076 women from the Australian Longitudinal Study on Women\u2019s Health (ALSWH) using the DQESv2 dietary data from 2003.", {"entities": []}], ["Logistic regression was used to examine the association between haem iron intake (2003) and the incidence of iron deficiency in 2006 and 2009.", {"entities": []}], ["Multiple logistic regression showed baseline haem iron intake was a statistically significant predictor of iron deficiency in 2006 (Odds Ratio (OR): 0.91; 95% Confidence Interval (CI): 0.84\u20130.99; p -value: 0.020) and 2009 (OR: 0.89; 95% CI: 0.82\u20130.99; p -value: 0.007).", {"entities": []}], ["Using the energy-adjusted haem intake made little difference to the associations.", {"entities": []}], ["Higher haem iron intake is associated with reduced odds of iron deficiency developing in young adult Australian women.", {"entities": []}], ["Multidrug resistance-associated protein 1 (MRP1), a member of the ATP-binding cassette (ABC) superfamily of transporters, plays an important role in normal lung physiology by protecting cells against oxidative stress and toxic xenobiotics.", {"entities": []}], ["The present study investigates the effects of allyl isothiocyanate (AITC) on MRP1 mRNA and MRP1 protein expression and transporter activity in the immortalised human bronchial epithelial cell line 16HBE14o-.", {"entities": []}], ["MRP1 mRNA and MRP1 protein expression in 16HBE14o- cells that were treated with allyl isothiocyanate were analysed by real-time PCR assay and Western blotting.", {"entities": []}], ["The transport of carboxyfluorescein, a known MRP1 substrate, was measured by functional flow cytometry to evaluate MRP1 activity.", {"entities": []}], ["Treatment with AITC at concentrations of 5\u201340\u2009 \u03bc M increased MRP1 protein levels in a concentration-dependent manner.", {"entities": []}], ["AITC treatments at concentrations of 1\u201340\u2009 \u03bc M caused concentration-dependent increases in MRP1 mRNA levels that were up to seven times greater than the levels found in control cells.", {"entities": []}], ["Finally, AITC treatment at concentrations of 5\u201340\u2009 \u03bc M significantly increased MRP1-dependent efflux in 16HBE14o- cells.", {"entities": []}], ["These results suggest that AITC can increase the expression and activity of MRP1 in 16HBE14o- cells in a concentration-dependent manner.", {"entities": []}], ["The upregulation of MRP1 activity and expression by AITC could produce therapeutic effects in the treatment of lung disease.", {"entities": [[111, 123, "DISEASE"]]}], ["Severe dengue infection often has unpredictable clinical progressions and outcomes.", {"entities": []}], ["Obesity may play a role in the deterioration of dengue infection due to stronger body immune responses.", {"entities": [[0, 7, "DISEASE"]]}], ["Several studies found that obese dengue patients have a more severe presentation with a poorer prognosis.", {"entities": []}], ["However, the association was inconclusive due to the variation in the results of earlier studies.", {"entities": []}], ["Therefore, we conducted a systematic review and meta-analysis to explore the relationship between obesity and dengue severity.", {"entities": [[98, 105, "DISEASE"]]}], ["We performed a systematic search of relevant studies on Ovid (MEDLINE), EMBASE, the Cochrane Library, Web of Science, Scopus and grey literature databases.", {"entities": []}], ["At least two authors independently conducted the literature search, selecting eligible studies, and extracting data.", {"entities": []}], ["Meta-analysis using random-effects model was conducted to compute the pooled odds ratio with 95% confidence intervals (CI).", {"entities": []}], ["We obtained a total of 13,333 articles from the searches.", {"entities": []}], ["For the final analysis, we included a total of fifteen studies among pediatric patients.", {"entities": []}], ["Three cohort studies, two case-control studies, and one cross-sectional study found an association between obesity and dengue severity.", {"entities": [[107, 114, "DISEASE"]]}], ["In contrast, six cohort studies and three case-control studies found no significant relationship between obesity and dengue severity.", {"entities": [[105, 112, "DISEASE"]]}], ["Our meta-analysis revealed that there was 38 percent higher odds (Odds Ratio = 1.38; 95% CI:1.10, 1.73) of developing severe dengue infection among obese children compared to non-obese children.", {"entities": []}], ["We found no heterogeneity found between studies.", {"entities": []}], ["The differences in obesity classification, study quality, and study design do not modify the association between obesity and dengue severity.", {"entities": [[19, 26, "DISEASE"], [113, 120, "DISEASE"]]}], ["This review found that obesity is a risk factor for dengue severity among children.", {"entities": [[23, 30, "DISEASE"]]}], ["The result highlights and improves our understanding that obesity might influence the severity of dengue infection.", {"entities": [[58, 65, "DISEASE"]]}], ["Dengue fever, an Aedes mosquito-borne viral infection, is a self-limiting or asymptomatic viral infection.", {"entities": []}], ["In its severe form, severe dengue, the symptoms include organ failure, life-threatening bleeding, and shock.", {"entities": []}], ["Patients with obesity were found to be at higher risks of developing complications and severe dengue infection compared to non-obese patients.", {"entities": [[14, 21, "DISEASE"]]}], ["Our systematic review and meta-analysis critically compared the available shreds of evidence related to obesity and severe forms of dengue infection.", {"entities": [[104, 111, "DISEASE"]]}], ["A total of fifteen studies that include nine cohort studies, five case-control studies, and one cross-sectional study were reviewed to explore the association between obesity and dengue severity.", {"entities": [[167, 174, "DISEASE"]]}], ["The results indicated that obese patients have higher odds of developing severe dengue infection compared to non-obese patients.", {"entities": []}], ["This review highlighted the importance of obesity in the progression of dengue infection.", {"entities": [[42, 49, "DISEASE"]]}], ["With increasing prevalence of obese individual as well as expanding areas that were at high risk for dengue infection, obesity may play a role in increasing the burden and mortality related to dengue infection.", {"entities": [[119, 126, "DISEASE"]]}], ["Further large-scale prospective studies in regions with high prevalence of dengue infections would provide additional information and some better discernment on the relevance of obesity in dengue infection.", {"entities": [[178, 185, "DISEASE"]]}], ["Chronic unresolved inflammation plays a causal role in the development of advanced atherosclerosis, but the mechanisms that prevent resolution in atherosclerosis remain unclear.", {"entities": [[83, 98, "DISEASE"], [146, 161, "DISEASE"]]}], ["Here, we use targeted mass spectrometry to identify specialized pro-resolving lipid mediators (SPM) in histologically-defined stable and vulnerable regions of human carotid atherosclerotic plaques.", {"entities": []}], ["The levels of SPMs, particularly resolvin D1 (RvD1), and the ratio of SPMs to pro-inflammatory leukotriene B 4 (LTB 4 ), are significantly decreased in the vulnerable regions.", {"entities": [[112, 115, "GENE"]]}], ["SPMs are also decreased in advanced plaques of fat-fed Ldlr 4 ratio to that of less advanced lesions and promotes plaque stability, including decreased lesional oxidative stress and necrosis, improved lesional efferocytosis, and thicker fibrous caps.", {"entities": [[55, 59, "GENE"], [245, 249, "GENE"]]}], ["These findings provide molecular support for the concept that defective inflammation resolution contributes to the formation of clinically dangerous plaques and offer a mechanistic rationale for SPM therapy to promote plaque stability.", {"entities": []}], ["Atherosclerosis progression is linked to inflammatory processes in the blood vessel wall.", {"entities": [[0, 15, "DISEASE"]]}], ["Here, the authors show that, with the progression of atherosclerosis, the resolution of inflammation is impaired as the result of an imbalance between specialized pro-resolving lipid mediators and leukotrienes.", {"entities": [[53, 68, "DISEASE"]]}], ["Osteopontin is known to play important roles in various diseases including vascular disorders.", {"entities": []}], ["However, little is known about its expression and function in vascular adventitial fibroblasts.", {"entities": []}], ["Adventitial fibroblasts have been shown to play a key role in pathological vascular remodeling associating with various vascular disorders.", {"entities": []}], ["In this study, we measured activation of Osteopontin and its biological functions in cultured adventitial fibroblasts and injured rat carotid injury arteries induced by balloon angioplasty.", {"entities": []}], ["Our results showed that angiotensin II and aldosterone increased Osteopontin expression in adventitial fibroblasts in a time- and concentration-dependent manner.", {"entities": []}], ["MAPKs and AP-1 pathways were involved in Osteopontin upregulation.", {"entities": []}], ["In addition, Adventitial fibroblast migration stimulated by Angiotensin II and aldosterone required OPN expression.", {"entities": []}], ["Perivascular delivery of antisense oligonucleotide for Osteopontin suppressed neointimal formation post-injury.", {"entities": []}], ["We concluded that upregulation of Osteopontin expression in adventitial fibroblasts might be important in the pathogenesis of vascular remodeling after arterial injury.", {"entities": []}], ["To investigate the roles of the neuropeptides vasoactive intestinal peptide (VIP), substance P (SP), and calcitonin gene-related peptide (CGRP) in chronic gastritis and duodenitis in children.", {"entities": [[155, 164, "DISEASE"], [169, 179, "DISEASE"], [77, 80, "GENE"]]}], ["Biopsy samples from the gastric and duodenal mucosa of 52 patients and 30 control subjects were obtained.", {"entities": []}], ["Samples were taken for pathological examination, immunohistochemical staining, enzyme activity measurements and quantitative measurements of tissue peptide levels.", {"entities": []}], ["We observed differential effects of the disease on peptide levels, which were somewhat different from previously reported changes in chronic gastritis in adults.", {"entities": [[141, 150, "DISEASE"]]}], ["Specifically, SP was increased and CGRP and VIP were decreased in patients with gastritis.", {"entities": [[80, 89, "DISEASE"], [44, 47, "GENE"]]}], ["The changes were more prominent at sites where gastritis was severe, but significant changes were also observed in neighboring areas where gastritis was less severe.", {"entities": [[47, 56, "DISEASE"], [139, 148, "DISEASE"]]}], ["Furthermore, the degree of changes was correlated with the pathological grade of the disease.", {"entities": []}], ["The expression of CD10, the enzyme primarily involved in SP hydrolysis, was also decreased in patients with duodenitis.", {"entities": [[108, 118, "DISEASE"]]}], ["Based on these findings, we propose that decreased levels of VIP and CGRP and increased levels of SP contribute to pathological changes in gastric mucosa.", {"entities": [[61, 64, "GENE"]]}], ["Hence, new treatments targeting these molecules may have therapeutic and preventive effects.", {"entities": []}], ["The vitamin D receptor (VDR) mediates the major cellular activities of vitamin D and regulates various signaling pathways implicated in cancer development and progression.", {"entities": [[136, 142, "DISEASE"], [24, 27, "GENE"]]}], ["VDR variants have been found associated with the risk of developing melanoma; however, previous epidemiological studies are inconsistent.", {"entities": [[68, 76, "DISEASE"], [0, 3, "GENE"]]}], ["We have systematically reviewed the published epidemiological literature and conducted a meta-analysis to assess associations between common VDR variants and melanoma risk.", {"entities": [[158, 166, "DISEASE"], [141, 144, "GENE"]]}], ["We identified 10 eligible studies that evaluated six VDR variants (Apa1, Bsm1, Cdx2, EcoRV, Fok1, and Taq1) in a total of 4,961 melanoma patients and 4,605 controls.", {"entities": [[128, 136, "DISEASE"], [53, 56, "GENE"], [79, 83, "GENE"]]}], ["The pooled estimates identified two variants\u2014Fok1 and Bsm1\u2014as significantly associated with melanoma risk, but not for the other four variants Apa1, Cdx2, EcorV and Taq1.", {"entities": [[92, 100, "DISEASE"], [149, 153, "GENE"]]}], ["For Fok1, the pooled OR was 1.18 (95% CI\u2009=\u20091.06-1.30; I The VDR variants Fok1 and Bsm1 may influence the susceptibility to developing melanoma, though further studies are needed to verify these conclusions.", {"entities": [[134, 142, "DISEASE"], [60, 63, "GENE"]]}], ["Major clinical gaps impede the evidence-based treatment of chronic obstructive pulmonary disease (COPD) in the primary care setting.", {"entities": [[59, 96, "DISEASE"]]}], ["Studies are needed to measure the effectiveness of continuing medical education (CME) on improving physician competency and performance toward evidence-based COPD care.", {"entities": []}], ["Between September 26, 2009 and December 12, 2009, 769 primary care physicians participated in a series of 12 regional, live, interactive, case-based, multiformat, half-day CME programs on COPD.", {"entities": []}], ["A subgroup of randomly selected participants (n = 50) and demographically matched nonparticipants (n = 50) completed surveys that included case vignettes, a validated tool for measuring physician performance in clinical practice.", {"entities": []}], ["Cohen\u2019s d was used to calculate the magnitude of difference between participants and nonparticipants in the delivery of evidence-based care.", {"entities": []}], ["Physicians who participated in CME programs were 50% more likely to provide evidence-based COPD care than physicians who did not participate.", {"entities": []}], ["Compared with nonparticipants, participating physicians were more likely to recognize COPD correctly in a patient presenting with dyspnea (74% versus 94%, P = 0.007), recognize that women may have a greater susceptibility than men to the toxic effects of smoking (54% versus 90%, P < 0.001), and identify the mechanisms of action of emerging therapies (33% versus 65%, P = 0.003).", {"entities": []}], ["Physicians who participated in a half-day regional CME program on COPD diagnosis, staging, and treatment were significantly more likely than nonparticipants to deliver evidence-based COPD care.", {"entities": []}], ["With multiformat, interactive, focused educational interventions, physicians can make diagnostic and therapeutic choices in the primary care setting that align more closely with current guidelines and clinical evidence in COPD management.", {"entities": []}], ["Tuberculosis (TB) remains a global threat in the 21st century.", {"entities": [[0, 12, "DISEASE"]]}], ["Traditional studies of the disease are focused on the single pathogen Mycobacterium tuberculosis .", {"entities": [[84, 96, "DISEASE"]]}], ["Recent studies have revealed associations of some diseases with an imbalance in the microbial community.", {"entities": []}], ["Characterization of the TB microbiota could allow a better understanding of the disease.", {"entities": []}], ["Here, the sputum microbiota in TB infection was examined by using 16S rRNA pyrosequencing.", {"entities": []}], ["A total of 829,873 high-quality sequencing reads were generated from 22 TB and 14 control sputum samples.", {"entities": []}], ["Firmicutes , Proteobacteria , Bacteroidetes , Actinobacteria , and Fusobacteria were the five major bacterial phyla recovered, which together composed over 98% of the microbial community.", {"entities": []}], ["Proteobacteria and Bacteroidetes were more represented in the TB samples and Firmicutes was more predominant in the controls.", {"entities": []}], ["Sixteen major bacterial genera were recovered.", {"entities": []}], ["Streptococcus , Neisseria and Prevotella were the most predominant genera, which were dominated by several operational taxonomic units grouped at a 97% similarity level.", {"entities": []}], ["Actinomyces , Fusobacterium , Leptotrichia , Prevotella , Streptococcus , and Veillonella were found in all TB samples, possibly representing the core genera in TB sputum microbiota.", {"entities": []}], ["The less represented genera Mogibacterium , Moryella and Oribacterium were enriched statistically in the TB samples, while a genus belonging to the unclassified Lactobacillales was enriched in the controls.", {"entities": []}], ["The diversity of microbiota was similar in the TB and control samples.", {"entities": []}], ["The composition and diversity of sputum microbiota in TB infection was characterized for the first time by using high-throughput pyrosequencing.", {"entities": []}], ["It lays the framework for examination of potential roles played by the diverse microbiota in TB pathogenesis and progression, and could ultimately facilitate advances in TB treatment.", {"entities": []}], ["Glucocorticoid induction of pulmonary surfactant involves a mesenchyme-derived protein first characterized in 1978 by Smith and termed fibroblast-pneumocyte factor (FPF).", {"entities": []}], ["Despite a number of agents having been postulated as being FPF, its identity has remained obscure.", {"entities": []}], ["In the past decade three strong candidates for FPF have arisen.", {"entities": []}], ["This review examines the evidence that keratinocyte growth factor (KGF), leptin or neuregulin-1\u03b2 (NRG-1\u03b2) act as FPF or components of it.", {"entities": []}], ["As with FPF production, glucocorticoids enhance the concentration of each of these agents in fibroblast-conditioned media.", {"entities": []}], ["Moreover, each stimulates the synthesis of surfactant-associated phospholipids and proteins in type II pneumocytes.", {"entities": []}], ["Further, some have unique activities, for example, KGF also minimizes lung injury through enhanced epithelial cell proliferation and NRG-1\u03b2 enhances surfactant phospholipid secretion and \u03b2-adrenergic receptor activity in type II cells.", {"entities": []}], ["However, even though these agents have attributes in common with FPF, it is inappropriate to specify any one of these agents as FPF.", {"entities": []}], ["Rather, it appears that each contributes to separate mesenchymal-epithelial signaling mechanisms involved in different aspects of lung development.", {"entities": []}], ["Given that the production of pulmonary surfactant is essential for postnatal survival, it is reasonable to suggest that several mechanisms independently regulate surfactant synthesis.", {"entities": []}], ["Modulation and suppression of the immune response of the host by nematode parasites have been reported extensively and the migration inhibitory factor (MIF) is identified as one of the major immunomodulator.", {"entities": [[152, 155, "GENE"]]}], ["In the present study, we cloned and produced recombinant MIF protein from the small ruminant\u2019s nematode parasite Haemonchus contortus (rHCMIF-1), and investigated its immunomodulatory effects on goat monocyte.", {"entities": [[57, 60, "GENE"]]}], ["Enzymatic assays indicated that rHCMIF-1 possessed tautomerase activity.", {"entities": []}], ["Immunohistochemical test demonstrated that the native HCMIF-1 protein was predominantly localized at the body surface and internal surface of the worm\u2019s gut.", {"entities": []}], ["We demonstrated that rHCMIF-1 could be distinguished by antisera from goats experimentally infected with H. contortus and could bind by goat monocytes.", {"entities": []}], ["The immunomodulatory effects of HCMIF-1 on cytokine secretion, MHC molecule expression, NO production and phagocytosis were observed by co-incubation of rHCMIF-1 with goat monocytes.", {"entities": []}], ["The results showed that the interaction of rHCMIF-1 decreased the production of TNF-\u03b1, IL-1\u03b2 and IL-12p40, where as, it significantly increased the secretion of IL-10 and TGF \u03b2 in goat monocytes.", {"entities": []}], ["After rHCMIF-1 exposure, the expression of MHC-II on goat monocytes was inhibited.", {"entities": []}], ["Moreover, rHCMIF-1 could down-regulate the LPS induced NO production of goat monocytes.", {"entities": []}], ["Phagocytotic assay by FITC-dextran internalization showed that rHCMIF-1 could inhibit the phagocytosis of goat monocytes.", {"entities": []}], ["Our findings provided potential targetas immunoregulator, and will be helpful to elucidate the molecular basis of host\u2013parasite interactions and search for new potential protein as vaccine and drug target candidate.", {"entities": []}], ["We examined the effects of an intensive lifestyle intervention (ILI), compared with a diabetes support and education (DSE) control intervention, on long-term changes in depression symptoms, antidepressant medication (ADM) use, and health-related quality of life (HRQoL) in overweight/obese individuals with type 2 diabetes.", {"entities": [[118, 121, "GENE"], [217, 220, "GENE"]]}], ["Look AHEAD was a multisite randomized controlled trial of 5,145 overweight/obese participants assigned to ILI (designed to produce weight loss) or DSE and followed for a median of 9.6 years.", {"entities": [[147, 150, "GENE"]]}], ["The Beck Depression Inventory (BDI) was administered at baseline, annually at years 1\u20134, and again at year 8.", {"entities": []}], ["Mean BDI scores and incidence of BDI scores \u226510, indicative of likely mild or greater depression, were examined.", {"entities": []}], ["Annually through year 10, participants reported their ADM use and completed the Medical Outcomes Study Short Form 36 (SF-36) questionnaire, which yields physical component summary (PCS) and mental component summary (MCS) scores.", {"entities": [[54, 57, "GENE"]]}], ["ILI significantly reduced the incidence of mild or greater depression symptoms (BDI scores \u226510) compared with DSE (hazard ratio [HR] = 0.85; 95% CI 0.75\u20130.97; P = 0.0145).", {"entities": [[110, 113, "GENE"], [129, 131, "GENE"]]}], ["Although SF-36 PCS scores worsened over time in both groups, ILI participants reported better physical function than DSE throughout the first 8 years (all P values <0.01).", {"entities": [[117, 120, "GENE"]]}], ["There were no significant differences between treatment arms in the proportion of participants who used ADMs or in SF-36 MCS scores.", {"entities": []}], ["ILI for overweight/obese patients with type 2 diabetes may reduce the risk of developing clinically significant symptoms of depression and preserve physical HRQoL.", {"entities": []}], ["These findings should be considered when evaluating the potential benefits of ILIs.", {"entities": []}], ["Protocadherin-1 ( PCDH1 ) is a novel susceptibility gene for airway hyperresponsiveness, first identified in families exposed to cigarette smoke and is expressed in bronchial epithelial cells.", {"entities": [[18, 23, "GENE"]]}], ["Here, we asked how mouse Pcdh1 expression is regulated in lung structural cells in vivo under physiological conditions, and in both short-term cigarette smoke exposure models characterized by airway inflammation and hyperresponsiveness and chronic cigarette smoke exposure models.", {"entities": [[25, 30, "GENE"]]}], ["Pcdh1 gene-structure was investigated by Rapid Amplification of cDNA Ends.", {"entities": [[0, 5, "GENE"]]}], ["Pcdh1 mRNA and protein expression was investigated by qRT-PCR, western blotting using isoform-specific antibodies.", {"entities": [[0, 5, "GENE"]]}], ["We observed 87% conservation of the Pcdh1 nucleotide sequence, and 96% conservation of the Pcdh1 protein sequence between men and mice.", {"entities": [[36, 41, "GENE"], [91, 96, "GENE"], [36, 41, "GENE"], [91, 96, "GENE"]]}], ["We identified a novel Pcdh1 isoform encoding only the intracellular signalling motifs.", {"entities": [[22, 27, "GENE"]]}], ["Cigarette smoke exposure for 4 consecutive days markedly reduced Pcdh1 mRNA expression in lung tissue (3 to 4-fold), while neutrophilia and airway hyperresponsiveness was induced.", {"entities": [[65, 70, "GENE"]]}], ["Moreover, Pcdh1 mRNA expression in lung tissue was reduced already 6 hours after an acute cigarette-smoke exposure in mice.", {"entities": [[10, 15, "GENE"]]}], ["Chronic exposure to cigarette smoke induced loss of Pcdh1 protein in lung tissue after 2 months, while Pcdh1 protein levels were no longer reduced after 9 months of cigarette smoke exposure.", {"entities": [[52, 57, "GENE"], [103, 108, "GENE"], [52, 57, "GENE"], [103, 108, "GENE"]]}], ["We conclude that Pcdh1 is highly homologous to human PCDH1 , encodes two transmembrane proteins and one intracellular protein, and is regulated by cigarette smoke exposure in vivo .", {"entities": [[17, 22, "GENE"], [53, 58, "GENE"], [17, 22, "GENE"], [53, 58, "GENE"]]}], ["Phong et al.", {"entities": []}], ["show that depending on the expression of p-Lyn, mast cell activation by antigen can result in dichotomous effects on mast cell function and signaling that can be accentuated by Tim-3 ligation.", {"entities": []}], ["T cell (or transmembrane) immunoglobulin and mucin domain protein 3 (Tim-3) has attracted significant attention as a novel immune checkpoint receptor (ICR) on chronically stimulated, often dysfunctional, T cells.", {"entities": []}], ["Antibodies to Tim-3 can enhance antiviral and antitumor immune responses.", {"entities": []}], ["Tim-3 is also constitutively expressed by mast cells, NK cells and specific subsets of macrophages and dendritic cells.", {"entities": []}], ["There is ample evidence for a positive role for Tim-3 in these latter cell types, which is at odds with the model of Tim-3 as an inhibitory molecule on T cells.", {"entities": []}], ["At this point, little is known about the molecular mechanisms by which Tim-3 regulates the function of T cells or other cell types.", {"entities": []}], ["We have focused on defining the effects of Tim-3 ligation on mast cell activation, as these cells constitutively express Tim-3 and are activated through an ITAM-containing receptor for IgE (Fc\u03b5RI), using signaling pathways analogous to those in T cells.", {"entities": []}], ["Using a variety of gain- and loss-of-function approaches, we find that Tim-3 acts at a receptor-proximal point to enhance Lyn kinase-dependent signaling pathways that modulate both immediate-phase degranulation and late-phase cytokine production downstream of Fc\u03b5RI ligation.", {"entities": [[122, 125, "GENE"]]}], ["It is imperative for any dermatology resident to have a good knowledge of the various triads in dermatology.", {"entities": []}], ["For an easy grasp over this topic, we have grouped the various triads on the basis of their etiologies.", {"entities": []}], ["Sea cucumbers, belonging to the class Holothuroidea , are marine invertebrates, habitually found in the benthic areas and deep seas across the world.", {"entities": []}], ["They have high commercial value coupled with increasing global production and trade.", {"entities": []}], ["Sea cucumbers, informally named as b\u00eache-de-mer, or gamat, have long been used for food and folk medicine in the communities of Asia and Middle East.", {"entities": []}], ["Nutritionally, sea cucumbers have an impressive profile of valuable nutrients such as Vitamin A, Vitamin B1 (thiamine), Vitamin B2 (riboflavin), Vitamin B3 (niacin), and minerals, especially calcium, magnesium, iron and zinc.", {"entities": []}], ["A number of unique biological and pharmacological activities including anti-angiogenic, anticancer, anticoagulant, anti-hypertension, anti-inflammatory, antimicrobial, antioxidant, antithrombotic, antitumor and wound healing have been ascribed to various species of sea cucumbers.", {"entities": [[120, 132, "DISEASE"]]}], ["Therapeutic properties and medicinal benefits of sea cucumbers can be linked to the presence of a wide array of bioactives especially triterpene glycosides (saponins), chondroitin sulfates, glycosaminoglycan (GAGs), sulfated polysaccharides, sterols (glycosides and sulfates), phenolics, cerberosides, lectins, peptides, glycoprotein, glycosphingolipids and essential fatty acids.", {"entities": []}], ["This review is mainly designed to cover the high-value components and bioactives as well as the multiple biological and therapeutic properties of sea cucumbers with regard to exploring their potential uses for functional foods and nutraceuticals.", {"entities": []}], ["The inhabitants of mountainous terrains depend on folk therapies to treat various ailments; however lack of plant based research and geographical constraints set the traditional knowledge in jeopardy.", {"entities": []}], ["Present study is the first documentation on traditional uses of plant species by the inhabitants of the\u00a0Shigar Valley, Karakorum Range, Northern Pakistan.", {"entities": []}], ["Ethnobotanical data were collected over a period from July, 2013 to October, 2016 from 84 respondents, using semi structured questionnaire.", {"entities": []}], ["Quantitative indices such as relative frequency citation (RFCs) and fidelity level (FL) were intended to evaluate the importance of medicinal plant species.", {"entities": []}], ["In total 84 plant species belonging to 36 families and 72 genera were recorded.", {"entities": []}], ["Fabaceae was dominant with 7 species, followed by Asteraceae, Lamiaceae and Rosacea (6 species each).", {"entities": []}], ["Leaves, root, flowers, seeds and fruits were the frequently utilized plant parts, whereas among drug formulations, decoction (49%) was ranked first.", {"entities": []}], ["Majority of the plant species were used to treat abdominal, respiratory and dermal ailments (31, 12 and 12, respectively).", {"entities": []}], ["RFCs value ranged 0.477 to 0.11 for Tanacetum falconeri and Allium carolinianum, respectively; while Hippophe rhamnoides and Thymus linearis depicted 100% FL.", {"entities": []}], ["Comparative assessment with previous reports revealed that traditional uses of 26% plant species counting Hedyserum falconeri, Aconitum violoceum var.", {"entities": []}], ["weileri, Arnebia guttata, Biebersteinia odora, Clematis alpine var.", {"entities": []}], ["sibirica, Corydalis adiantifolia and Saussurea simpsoniana were reported for the first time.", {"entities": []}], ["The endemic medicinal plant species and traditional knowledge of Balti community living in extremely high mountains area were explored for the first time.", {"entities": []}], ["A comprehensive survey of this region could be significant to drive the existing knowledge in market circuit with sustainable collection, and to evaluate economic potential of the plant species.", {"entities": []}], ["Additionally, social livelihood could be reinforced through establishing collection sites, transformation and drying centres for micro and macro marketing of medicinal plant species.", {"entities": []}], ["Plants and people interaction in the Karakorum Mountains", {"entities": []}], ["To describe patterns of frequent attendance in Australian primary care, and identify the prospective risk factors for persistent frequent attendance.", {"entities": []}], ["This study draws on data from the Personality and Total Health (PATH) Through Life Project, a representative community cohort study of residents from the Canberra region of Australia.", {"entities": []}], ["Participants were assessed on 3 occasions over 8\u2005years.", {"entities": []}], ["The survey assessed respondents\u2019 experience of chronic physical conditions, self-reported health, symptoms of common mental disorders, personality, life events, sociodemographic characteristics and self-reported medication use.", {"entities": []}], ["A balanced sample was used in analysis, comprising 1734 respondents with 3 waves of data.", {"entities": []}], ["The survey data for each respondent were individually linked to their administrative health service use data which were used to generate an objective measure of general practitioner (GP) consultations in the 12\u2005months surrounding their interview date.", {"entities": []}], ["Respondents in the (approximate) highest decile of attenders on number of GP consultations over a 12-month period at each time point were defined as frequent attenders (FAs).", {"entities": [[169, 172, "GENE"]]}], ["Baseline FAs (8.4%) were responsible for 33.4% of baseline consultations, while persistent FAs (3.6%) for 15.5% of all consultations over the 3 occasions.", {"entities": [[9, 12, "GENE"], [91, 94, "GENE"], [9, 12, "GENE"], [91, 94, "GENE"]]}], ["While there was considerable movement between FA status over time, consistency was greater than expected by chance alone.", {"entities": []}], ["While there were many factors that differentiated non-FAs from FAs in general, persistent frequent attendance was specifically associated with gender, baseline reports of depression, self-reported physical conditions and disability, and medication use.", {"entities": [[54, 57, "GENE"], [63, 66, "GENE"]]}], ["The degree of persistence in GP consultations was limited.", {"entities": []}], ["The findings of this study contribute to our understanding of the risk factors that predict subsequent persistent frequent attendance in primary care.", {"entities": []}], ["However, further detailed investigation of longitudinal patterns of frequent attendance and consideration of time-varying determinants of frequent attendance is required.", {"entities": []}], ["Neutrophils are widely recognized to play an important role in acute inflammatory responses, and recent evidence has expanded their role to modulating chronic inflammatory and autoimmune diseases.", {"entities": []}], ["Reactive oxygen species (ROS) and microbicidal compounds released from neutrophils that are recruited to the site of inflammation contribute to the pathogenesis of multiple inflammation-associated diseases such as chronic obstructive pulmonary disease, atherosclerosis, and hepatitis.", {"entities": [[253, 268, "DISEASE"], [214, 251, "DISEASE"], [274, 283, "DISEASE"]]}], ["Marine organisms are a valuable source of bioactive compounds with potential for industrial and pharmaceutical application.", {"entities": []}], ["Marine natural products that inhibit neutrophil activation could be used as drugs for the treatment of inflammatory diseases.", {"entities": []}], ["Numerous studies investigating marine natural products have reported novel anti-inflammatory agents.", {"entities": []}], ["Nevertheless, the detailed mechanisms underlying their actions, which could facilitate our understanding of the molecular events occurring in neutrophils, have not been reported in most of the associated research studies.", {"entities": []}], ["Therefore, in this review, we will present marine products that inhibit neutrophil-associated inflammation.", {"entities": []}], ["Furthermore, we will be limiting the detailed discussion to agents with well-investigated molecular targets.", {"entities": []}], ["Increasingly, policymakers in Europe and around the world are realizing the importance of healthy indoor environments for public health.", {"entities": []}], ["Certain member states of the European Union (EU) have already achieved successes in improving indoor environmental quality, such as controlling certain contaminants (e.g., environmental tobacco smoke) or developing nationwide policies that address indoor air generally.", {"entities": []}], ["However, a common European approach to achieving healthy indoor environments is desirable for several reasons including providing a broader recognition of the problem of unhealthy indoor air, setting a policy example for all 27 EU member states, and achieving greater public health equity across the different European nations.", {"entities": []}], ["In this article we address the question \u201cWhy is it so difficult in the EU to develop a coherent approach on indoor environment?\u201d We identify and describe four main barriers: a ) the subsidiarity principle in EU policymaking, introducing decentralization of decision making to the member states; b ) fragmentation of the topic of the indoor environment; c ) the differences in climate and governance among different member states that make a common policy difficult; and d ) economic issues.", {"entities": []}], ["We discuss potential lessons and recommendations from EU and U.S. successes in achieving healthier indoor environments through various policy mechanisms.", {"entities": []}], ["Airway abnormalities and lung tissue citrullination are found in both rheumatoid arthritis (RA) patients and individuals at-risk for disease development.", {"entities": [[70, 90, "DISEASE"], [81, 90, "DISEASE"]]}], ["This suggests the possibility that the lung could be a site of autoimmunity generation in RA, perhaps in response to microbiota changes.", {"entities": []}], ["We therefore sought to test whether the RA lung microbiome contains distinct taxonomic features associated with local and/or systemic autoimmunity.", {"entities": []}], ["16S rRNA gene high-throughput sequencing was utilized to compare the bacterial community composition of bronchoalveolar lavage fluid (BAL) in patients with early, disease-modifying anti-rheumatic drugs (DMARD)-na\u00efve RA, patients with lung sarcoidosis, and healthy control subjects.", {"entities": [[239, 250, "DISEASE"]]}], ["Samples were further assessed for the presence and levels of anti-citrullinated peptide antibodies (including fine specificities) in both BAL and serum.", {"entities": []}], ["The BAL microbiota of RA patients was significantly less diverse and abundant when compared to healthy controls, but similar to sarcoidosis patients.", {"entities": [[128, 139, "DISEASE"]]}], ["This distal airway dysbiosis was attributed to the reduced presence of several genus (i.e., Actynomyces and Burkhordelia ) as well as reported periodontopathic taxa, including Treponema , Prevotella , and Porphyromonas .", {"entities": []}], ["While multiple clades correlated with local and systemic levels of autoantibodies, the genus Pseudonocardia and various related OTUs were the only taxa overrepresented in RA BAL and correlated with higher disease activity and erosions.", {"entities": []}], ["Distal airway dysbiosis is present in untreated early RA and similar to that detected in sarcoidosis lung inflammation.", {"entities": [[89, 100, "DISEASE"]]}], ["This community perturbation, which correlates with local and systemic autoimmune/inflammatory changes, may potentially drive initiation of RA in a proportion of cases.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-016-0206-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Matrix metalloproteinases (MMPs) are a family of more than twenty five secreted and membrane-bound zinc-endopeptidases which can degrade extracellular matrix (ECM) components.", {"entities": []}], ["They also play important roles in a variety of biological and pathological processes.", {"entities": []}], ["Matrix metalloproteinase inhibitors (MMPIs) have been identified as potential therapeutic candidates for metastasis, arthritis, chronic inflammation and wrinkle formation.", {"entities": [[117, 126, "DISEASE"]]}], ["Up to present, more than 20,000 new compounds have been isolated from marine organisms, where considerable numbers of these naturally occurring derivatives are developed as potential candidates for pharmaceutical application.", {"entities": []}], ["Eventhough the quantity of marine derived MMPIs is less when compare with the MMPIs derived from terrestrial materials, huge potential for bioactivity of these marine derived MMPIs has lead to large number of researches.", {"entities": []}], ["Saccharoids, flavonoids and polyphones, fatty acids are the most important groups of MMPIs derived from marine natural products.", {"entities": []}], ["In this review we focus on the progress of MMPIs from marine natural products.", {"entities": []}], ["The purpose of this study was to examine the effects of carvedilol therapy on autonomic control of the heart and QT-interval dispersion (QTd) among children with idiopathic dilated cardiomyopathy (DCM) whose symptoms were not adequately controlled with standard congestive heart failure therapy.", {"entities": [[262, 286, "DISEASE"], [181, 195, "DISEASE"], [173, 195, "DISEASE"]]}], ["Patients with DCM who were treated with carvedilol were enrolled in the study.", {"entities": []}], ["All patients had undergone carvedilol therapy in addition to standard therapy for at least 6 months.", {"entities": []}], ["Clinical, echocardiographic, and electrocardiographic parameters, and 24-h Holter records of patients were retrospectively evaluated before and after carvedilol treatment.", {"entities": []}], ["A total 34 patients (mean age: 7.4\u00b14.3 years) with DCM were analyzed in the study.", {"entities": []}], ["The median follow-up period was 9.5 months.", {"entities": []}], ["After the 6 months of carvedilol therapy the clinical score significantly improved, left ventricular ejection fraction (LVEF) and fractional shortening (LVFS) significantly increased, and left ventricle end-diastolic dimensions and end-systolic dimensions significantly decreased.", {"entities": []}], ["There were statistically significant increases in mean SDNN, SDANN, rMSSD, and pNN50 ( p =0.002, p =0.001, p =0.008, and p =0.026, respectively).", {"entities": []}], ["After the carvedilol therapy, SDNN was correlated with the clinical score, heart rate, LVEF, LVFS, and total premature ventricular contractions (PVCs).", {"entities": []}], ["In addition, rMSSD and pNN50 were correlated with heart rate, LVEF and LVFS.", {"entities": []}], ["A significant reduction was observed in QTc-minimum, QTc-maximum, and QTd values (434.9\u00b140.7 vs. 416.1\u00b136.5, 497.8\u00b143.6 vs. 456.3\u00b141.7, 58.6\u00b117.1 vs. 49.3\u00b115.6; p <0.001, p =0.001, and p =0.008, respectively).", {"entities": []}], ["QTd was significantly related to PVCs ( r =0.62, p =0.02).", {"entities": []}], ["We conclude that the addition of carvedilol to standard therapy can improve clinical symptoms and heart rate variability, and reduce in arrhythmia markers in children with DCM.", {"entities": []}], ["We hypothesize that perinatal exposures, in particular the human microbiome and maternal nutrition during pregnancy, interact with the genetic predisposition to cause an abnormal immune modulation in early life towards a trajectory to chronic inflammatory diseases such as asthma and others.", {"entities": [[273, 279, "DISEASE"]]}], ["The aim of this study is to explore these interactions by conducting a longitudinal study in an unselected cohort of pregnant women and their offspring with emphasis on deep clinical phenotyping, exposure assessment, and biobanking.", {"entities": []}], ["Exposure assessments focus on the human microbiome.", {"entities": []}], ["Nutritional intervention during pregnancy in randomized controlled trials are included in the study to prevent disease and to be able to establish causal relationships.", {"entities": []}], ["Pregnant women from eastern Denmark were invited during 2008\u20132010 to a novel unselected \u2018 COPSAC 2010 \u2019 cohort.", {"entities": []}], ["The women visited the clinic during pregnancy weeks 24 and 36.", {"entities": []}], ["Their children were followed at the clinic with deep phenotyping and collection of biological samples at nine regular visits until the age of 3 and at acute symptoms.", {"entities": []}], ["Randomized controlled trials of high\u2010dose vitamin D and fish oil supplements were conducted during pregnancy, and a trial of azithromycin for acute lung symptoms was conducted in the children with recurrent wheeze.", {"entities": []}], ["Seven hundred and thirty\u2010eight mothers were recruited from week 24 of gestation, and 700 of their children were included in the birth cohort.", {"entities": []}], ["The cohort has an over\u2010representation of atopic parents.", {"entities": []}], ["The participant satisfaction was high and the adherence equally high with 685 children (98%) attending the 1 year clinic visit and 667 children (95%) attending the 2 year clinic visit.", {"entities": []}], ["The COPSAC 2010 birth cohort study provides longitudinal clinical follow\u2010up with highly specific end\u2010points, exposure assessments, and biobanking.", {"entities": []}], ["The cohort has a high adherence rate promising strong data to elucidate the interaction between genomics and the exposome in perinatal life leading to lifestyle\u2010related chronic inflammatory disorders such as asthma.", {"entities": [[208, 214, "DISEASE"]]}], ["The area of Gela was included among the 57 Italian polluted sites of national interest for environmental remediation because of its widespread contamination from a petrochemical complex.", {"entities": []}], ["The present study investigates mortality and morbidity of the cohort of Gela petrochemical workers with the aim of disentangling occupational from residential risk.", {"entities": []}], ["Mortality was assessed for 5,627 men hired from 1960, year of the plant start-up, to 1993; it was followed up for vital status in the period 1960\u20132002.", {"entities": []}], ["Morbidity was analysed for 5,431 workers neither dead nor lost to follow-up from 1960 to 2001 and was based on Hospital Discharge Records in the period 2001\u20132006.", {"entities": []}], ["The work experience was classified in terms of job categories such as blue collars , white collars , and both \u2013 workers who shifted from blue to white collar (95%) or vice versa.", {"entities": []}], ["An ad hoc mobility model was applied to define qualitative categories of residence in Gela, as residents and commuters .", {"entities": []}], ["Standardized Mortality Ratios (SMRs) and Mortality Rate Ratios (MRRs) were computed, the latter by using a Poisson regression model.", {"entities": []}], ["Morbidity was analyzed in terms of Hospital Discharge Odds Ratios (HDORs) through a logistic regression model.", {"entities": []}], ["While performing the internal comparisons, white collars was the reference category for the job analysis, and commuters was the reference category for the residential analysis.", {"entities": []}], ["In the light of epidemiological evidence about health risk from petrochemical industries in both occupational and environmental settings, and/or on the basis of information about occupational and residential contamination and health risk in the area of Gela, noteworthy results are shown for lung cancer [MRR: 2.11 ( CI 90%; 0.96-4.63) in blue collars ; 1.71 (1.09-2.69) in residents ], respiratory diseases [HDOR: 2.0 (1.0-3.0) in blue collars ; 1.4 (0.96-2.06) in residents ] and genitourinary diseases [HDOR: 1.34 (1.06-1.68) in blue collars ; 1.23 (1.04-1.45) in residents ].", {"entities": [[292, 303, "DISEASE"], [297, 303, "DISEASE"]]}], ["The results support a role of the exposures in the occupational and residential settings, the latter due to the local ascertained contamination, in affecting the workers\u2019 health.", {"entities": []}], ["These results underline the urgent need of water, soil, air and food-chain monitoring programs, to discover active sources of exposure and consequently define public health interventions.", {"entities": []}], ["This study was aimed to explore parents\u2019 experience of assisting children affected by tuberous sclerosis complex (TSC) with subependymal giant-cell astrocytoma (SEGA) manifestation, in order to understand their caring needs and expectation of support.", {"entities": [[148, 159, "DISEASE"], [86, 104, "DISEASE"]]}], ["The study was designed according to the qualitative method of interpretative description and implied two sequential phases of data collection.", {"entities": []}], ["The first phase was based on in-depth interviews with 18 Italian caregivers of children living with TSC.", {"entities": []}], ["The second phase of the research was based on an online forum with 30 caregivers of children living with TSC.", {"entities": []}], ["48 Italian caregivers, assisting patients with TSC with SEGA manifestation have been involved in the study.", {"entities": []}], ["When a TSC diagnosis is made, the whole family is affected psychologically.", {"entities": []}], ["TSC has a great impact on families\u2019 quality of life and on their ability to cope with the disease and support the child's ability to recover and reach an acceptable level of well-being.", {"entities": []}], ["Caregivers report the experience of losing control and the feeling of loneliness and abandon from the healthcare system.", {"entities": []}], ["Families of children affected by TSC need targeted psychosocial assistance in order to support patients and caregivers and facilitate their social integration.", {"entities": []}], ["Multiple myeloma (MM) is a disease of cell cycle dysregulation while cell cycle modulation can be a target for MM therapy.", {"entities": [[9, 16, "DISEASE"]]}], ["In this study we investigated the effects and mechanisms of action of a sesquiterpene lactone 6- O -angeloylplenolin (6-OAP) on MM cells.", {"entities": []}], ["MM cells were exposed to 6-OAP and cell cycle distribution were analyzed.", {"entities": []}], ["The role for cyclin B1 to play in 6-OAP-caused mitotic arrest was tested by specific siRNA analyses in U266 cells.", {"entities": []}], ["MM.1S cells co-incubated with interleukin-6 (IL-6), insulin-like growth factor-I (IGF-I), or bone marrow stromal cells (BMSCs) were treated with 6-OAP.", {"entities": []}], ["The effects of 6-OAP plus other drugs on MM.1S cells were evaluated.", {"entities": []}], ["The in vivo therapeutic efficacy and pharmacokinetic features of 6-OAP were tested in nude mice bearing U266 cells and Sprague-Dawley rats, respectively.", {"entities": []}], ["We found that 6-OAP suppressed the proliferation of dexamethasone-sensitive and dexamethasone-resistant cell lines and primary CD138+ MM cells.", {"entities": []}], ["6-OAP caused mitotic arrest, accompanied by activation of spindle assembly checkpoint and blockage of ubiquitiniation and subsequent proteasomal degradation of cyclin B1.", {"entities": []}], ["Combined use of 6-OAP and bortezomib induced potentiated cytotoxicity with inactivation of ERK1/2 and activation of JNK1/2 and Casp-8/-3.", {"entities": []}], ["6-OAP overcame the protective effects of IL-6 and IGF-I on MM cells through inhibition of Jak2/Stat3 and Akt, respectively.", {"entities": []}], ["6-OAP inhibited BMSCs-facilitated MM cell expansion and TNF-\u03b1-induced NF-\u03baB signal.", {"entities": []}], ["Moreover, 6-OAP exhibited potent anti-MM activity in nude mice and favorable pharmacokinetics in rats.", {"entities": []}], ["These results indicate that 6-OAP is a new cell cycle inhibitor which shows therapeutic potentials for MM.", {"entities": []}], ["Asthma and chronic obstructive pulmonary disease (COPD) are chronic inflammatory diseases of the airway, although the drivers and site of the inflammation differ between diseases.", {"entities": [[11, 48, "DISEASE"], [0, 6, "DISEASE"]]}], ["Asthmatics with a neutrophilic airway inflammation are associated with a poor response to corticosteroids, whereas asthmatics with eosinophilic inflammation respond better to corticosteroids.", {"entities": []}], ["Biologicals targeting the Th2-eosinophil nexus such as anti\u2013interleukin (IL)-4, anti\u2013IL-5, and anti\u2013IL-13 are ineffective in asthma as a whole but are more effective if patients are selected using cellular (eg, eosinophils) or molecular (eg, periostin) biomarkers.", {"entities": [[125, 131, "DISEASE"]]}], ["This highlights the key role of individual inflammatory mediators in driving the inflammatory response and for accurate disease phenotyping to allow greater understanding of disease and development of patient-oriented antiasthma therapies.", {"entities": []}], ["In contrast to asthmatic patients, corticosteroids are relatively ineffective in COPD patients.", {"entities": []}], ["Despite stratification of COPD patients, the results of targeted therapy have proved disappointing with the exception of recent studies using CXC chemokine receptor (CXCR)2 antagonists.", {"entities": []}], ["Currently, several other novel mediator-targeted drugs are undergoing clinical trials.", {"entities": []}], ["As with asthma specifically targeted treatments may be of most benefit in specific COPD patient endotypes.", {"entities": [[8, 14, "DISEASE"]]}], ["The use of novel inflammatory mediator-targeted therapeutic agents in selected patients with asthma or COPD and the detection of markers of responsiveness or nonresponsiveness will allow a link between clinical phenotypes and pathophysiological mechanisms to be delineated reaching the goal of endotyping patients.", {"entities": [[93, 99, "DISEASE"]]}], ["There are indications that informal caregiving negatively impacts caregivers\u2019 mental health, but this was hardly examined using diagnoses of mental disorders and most studies used convenience samples without including non-caregivers as reference group.", {"entities": []}], ["We examine whether informal caregivers more often have any emotional disorder, i.e.", {"entities": []}], ["mood or anxiety disorder, than non-caregivers.", {"entities": [[8, 24, "DISEASE"]]}], ["Identify key risk indicators for any emotional disorder among informal caregivers in the general population.", {"entities": []}], ["Data were used from the second wave of the Netherlands Mental Health Survey and Incidence Study-2 (NEMESIS-2), a nationally representative face-to-face survey (n\u2009=\u20095,303; aged 21\u201368).", {"entities": []}], ["Respondents were defined as informal caregiver when they provided unpaid care in the 12\u00a0months preceding the second wave to a family member, partner or friend who needed care because of physical or mental problems, or ageing.", {"entities": []}], ["Twelve-month DSM-IV diagnoses of emotional disorders were assessed using the Composite International Diagnostic Interview 3.0.", {"entities": []}], ["Key risk indicators were identified using the following aspects: prevalence, odds ratio, attributable risk proportion, and number needed to treat.", {"entities": []}], ["Sociodemographic, caregiving-related and other characteristics were considered as risk indicators.", {"entities": []}], ["In the past year, 31.1% of the respondents provided informal care, which ranged in time spent (8 or more hours/week: 32.1%) and duration (longer than 1\u00a0year: 48.7%).", {"entities": []}], ["Informal caregiving was not associated with having any 12-month emotional disorder.", {"entities": []}], ["Among caregivers, giving care to a first-degree relative, partner or close friend and giving emotional support increased the risk for any emotional disorder.", {"entities": []}], ["Moreover, using all aspects, target groups were identified for prevention: caregivers without a job, living without a partner, and with a lack of social support.", {"entities": []}], ["Although informal caregivers do not have an increased risk of emotional disorders, key risk indicators were identified using four aspects.", {"entities": []}], ["Especially informal caregivers with limited resources (unemployment, living without a partner, lack of social support) may benefit from targeted prevention whereas general prevention measures may be desirable for carers with a burdensome care situation (giving care to a close loved one or providing emotional support).", {"entities": []}], ["Available evidence on the bioactive, nutritional and putative detrimental properties of gut microbial metabolites has been evaluated to support a more integrated view of how prebiotics might affect host health throughout life.", {"entities": []}], ["The present literature inventory targeted evidence for the physiological and nutritional effects of metabolites, for example, SCFA, the potential toxicity of other metabolites and attempted to determine normal concentration ranges.", {"entities": []}], ["Furthermore, the biological relevance of more holistic approaches like faecal water toxicity assays and metabolomics and the limitations of faecal measurements were addressed.", {"entities": []}], ["Existing literature indicates that protein fermentation metabolites (phenol, p -cresol, indole, ammonia), typically considered as potentially harmful, occur at concentration ranges in the colon such that no toxic effects are expected either locally or following systemic absorption.", {"entities": []}], ["The endproducts of saccharolytic fermentation, SCFA, may have effects on colonic health, host physiology, immunity, lipid and protein metabolism and appetite control.", {"entities": []}], ["However, measuring SCFA concentrations in faeces is insufficient to assess the dynamic processes of their nutrikinetics.", {"entities": []}], ["Existing literature on the usefulness of faecal water toxicity measures as indicators of cancer risk seems limited.", {"entities": [[89, 95, "DISEASE"]]}], ["In conclusion, at present there is insufficient evidence to use changes in faecal bacterial metabolite concentrations as markers of prebiotic effectiveness.", {"entities": []}], ["Integration of results from metabolomics and metagenomics holds promise for understanding the health implications of prebiotic microbiome modulation but adequate tools for data integration and interpretation are currently lacking.", {"entities": []}], ["Similarly, studies measuring metabolite fluxes in different body compartments to provide a more accurate picture of their nutrikinetics are needed.", {"entities": []}], ["We previously reported that interleukin (IL)-4 upregulates the expression of leukotriene C 4 synthase (LTC 4 S) by human cord blood\u2013derived mast cells (hMCs), augments their high-affinity Fc receptor for IgE (Fc\u03b5RI)-dependent generation of eicosanoids and cytokines, and induces a calcium flux in response to cysteinyl leukotrienes (cys-LTs) and uridine diphosphate (UDP) that is blocked by cys-LT receptor antagonists.", {"entities": []}], ["We speculated that this IL-4\u2013dependent, receptor-mediated response to the cys-LTs and UDP might induce cytokine generation by hMCs without concomitant exocytosis.", {"entities": []}], ["Unlike hMCs maintained in cytoprotective stem cell factor (SCF) alone, hMCs primed for 5 d with IL-4 responded to UDP (1 \u03bcM), LTC 4 (100 nM), and LTD 4 (100 nM) by producing IL-5, tumor necrosis factor (TNF)-\u03b1, and especially large quantities of macrophage inflammatory protein (MIP)-1\u03b2 de novo at 6 h, preceded by the induced expression of the corresponding mRNAs.", {"entities": [[203, 206, "GENE"], [279, 282, "GENE"]]}], ["Cys-LT\u2013 and UDP-mediated cytokine production by the primed hMCs occurred without histamine release or PGD 2 generation and was inhibited by the CysLT1 receptor antagonist MK571.", {"entities": [[102, 105, "GENE"]]}], ["Additionally, pretreatment of hMCs with MK571 or with the cys-LT biosynthetic inhibitor MK886 decreased IL-5 and TNF-\u03b1 production in response to IgE receptor cross-linkage, implying a positive feedback by endogenously produced cys-LTs.", {"entities": []}], ["Cys-LTs and UDP thus orchestrate a novel, IL-4\u2013regulated, non-IgE\u2013dependent hMC activation for cytokine gene induction that could be initiated by microbes, cellular injury, or neurogenic or inflammatory signals; and this pathobiologic event would not be recognized in tissue studies where hMC activation is classically defined by exocytosis.", {"entities": []}], ["The KIDSCREEN-10 index and the Child Health Utility 9D (CHU9D) are two recently developed generic instruments for the measurement of health-related quality of life in children and adolescents.", {"entities": []}], ["Whilst the CHU9D is a preference based instrument developed specifically for application in cost-utility analyses, the KIDSCREEN-10 is not currently suitable for application in this context.", {"entities": []}], ["This paper provides an algorithm for mapping the KIDSCREEN-10 index onto the CHU9D utility scores.", {"entities": []}], ["A sample of 590 Australian adolescents (aged 11\u201317) completed both the KIDSCREEN-10 and the CHU9D.", {"entities": []}], ["Several econometric models were estimated, including ordinary least squares estimator, censored least absolute deviations estimator, robust MM-estimator and generalised linear model, using a range of explanatory variables with KIDSCREEN-10 items scores as key predictors.", {"entities": []}], ["The predictive performance of each model was judged using mean absolute error (MAE) and root mean squared error (RMSE).", {"entities": []}], ["The MM-estimator with stepwise-selected KIDSCREEN-10 items scores as explanatory variables had the best predictive accuracy using MAE, whilst the equivalent ordinary least squares model had the best predictive accuracy using RMSE.", {"entities": []}], ["The preferred mapping algorithm (i.e.", {"entities": []}], ["the MM-estimate with stepwise selected KIDSCREEN-10 item scores as the predictors) can be used to predict CHU9D utility from KIDSCREEN-10 index with a high degree of accuracy.", {"entities": []}], ["The algorithm may be usefully applied within cost-utility analyses to generate cost per quality adjusted life year estimates where KIDSCREEN-10 data only are available.", {"entities": []}], ["Nausea and vomiting in pregnancy (NVP) is a condition that commonly affects women in the first trimester of pregnancy.", {"entities": []}], ["Despite frequently leading to emergency department (ED) visits, little evidence exists to characterize the nature of ED visits or to guide its treatment in the ED.", {"entities": []}], ["Our objectives were to evaluate the treatment of NVP in the ED and to identify factors that predict return visits to the ED for NVP.", {"entities": []}], ["We conducted a retrospective database analysis using the electronic medical record from a single, large academic hospital.", {"entities": []}], ["Demographic and treatment variables were collected using a chart review of 113 ED patient visits with a billing diagnosis of \u201cnausea and vomiting in pregnancy\u201d or \u201chyperemesis gravidarum.\u201d Logistic regression analysis was used with a primary outcome of return visit to the ED for the same diagnoses.", {"entities": []}], ["There was wide treatment variability of nausea and vomiting in pregnancy patients in the ED.", {"entities": []}], ["Of the 113 patient visits, 38 (33.6%) had a return ED visit for NVP.", {"entities": []}], ["High gravidity (OR 1.31, 95% CI [1.06\u20131.61]), high parity (OR 1.50 95% CI [1.12\u20132.00]), and early gestational age (OR 0.74 95% CI [0.60\u20130.90]) were associated with an increase in return ED visits in univariate logistic regression models, while only early gestational age (OR 0.74 95% CI [0.59\u20130.91]) was associated with increased return ED visits in a multiple regression model.", {"entities": []}], ["Admission to the hospital was found to decrease the likelihood of return ED visits (p=0.002).", {"entities": []}], ["NVP can be difficult to manage and has a high ED return visit rate.", {"entities": []}], ["Optimizing care with aggressive, standardized treatment in the ED and upon discharge, particularly if factors predictive of return ED visits are present, may improve quality of care and reduce ED utilization for this condition.", {"entities": []}], ["Animal studies of acute lung injury (ALI) suggest nebulised heparin may limit damage from fibrin deposition in the alveolar space and microcirculation.", {"entities": []}], ["No human studies have been undertaken to date.", {"entities": []}], ["We assessed the feasibility, safety and potential anticoagulant effects of administration of nebulised heparin to patients with ALI.", {"entities": []}], ["An open label phase 1 trial of four escalating doses of nebulised heparin was performed.", {"entities": []}], ["A total of 16 ventilated patients with ALI were studied.", {"entities": []}], ["The first group was administered a total of 50,000 U/day, the second group 100,000 U/day, the third group 200,000 U/day and the fourth group 400,000 U/day.", {"entities": []}], ["Assessments of lung function included the PaO 2 /FiO 2 ratio, lung compliance and the alveolar dead space fraction.", {"entities": []}], ["Monitoring of anticoagulation included the activated partial thromboplastin time (APTT) and the thrombin clotting time.", {"entities": []}], ["Bronchoalveolar lavage fluid was collected and the prothrombin fragment and tissue plasminogen activator levels were assessed.", {"entities": []}], ["Analysis of variance was used to compare the effects of dose.", {"entities": []}], ["No serious adverse events occurred for any dose.", {"entities": []}], ["The changes over time for the PaO 2 /FiO 2 ratio, lung compliance and the alveolar dead space fraction levels were similar for all doses.", {"entities": []}], ["A trend to increased APTT and thrombin clotting time levels was present with higher doses ( P = 0.09 and P = 0.1, respectively).", {"entities": []}], ["For the highest dose, the APTT reached 64 seconds; following cessation of nebulised heparin, the APTT fell to 39 seconds ( P = 0.06).", {"entities": []}], ["In bronchoalveolar lavage samples a trend to reduced prothrombin fragment levels was present with higher doses ( P = 0.1), while tissue plasminogen activator levels were similar for all doses.", {"entities": []}], ["Administration of nebulised heparin to mechanically ventilated patients with ALI is feasible.", {"entities": []}], ["Nebulised heparin was not associated with any serious adverse events, and at higher doses it increased APTT levels.", {"entities": []}], ["Larger trials are required to further investigate the safety and efficacy of nebulised heparin.", {"entities": []}], ["In these trials due consideration must be given to systemic anticoagulant effects.", {"entities": []}], ["Australian Clinical trials registry ACTRN12606000388516.", {"entities": []}], ["The use of placebo interventions outside clinical trials is ethically, professionally and legally controversial.", {"entities": []}], ["Little is known about the frequency and circumstances of placebo use in clinical practice.", {"entities": []}], ["Our aim was to summarize the available empirical studies addressing these issues.", {"entities": []}], ["We searched PubMed and EMBASE from inception to July 2009 in order to identify cross-sectional surveys, qualitative or longitudinal studies among health care professionals, students or patients which investigated at least one of the following issues - frequency of placebo use or attitudes to, or motivations for, the use of placebo interventions.", {"entities": []}], ["At least two reviewers extracted information on the study methods, participants and findings.", {"entities": []}], ["Descriptive summaries were prepared in an iterative process by at least two reviewers per study.", {"entities": []}], ["Twenty-two studies from 12 different countries met the inclusion criteria.", {"entities": []}], ["Most studies had relevant shortcomings.", {"entities": []}], ["The proportion of respondents reporting that they had applied 'pure' placebos (for example, saline injection) during their professional life varied between 17% and 80% among physicians and between 51% and 100% among nurses, but it seems that the actual frequency of such use seems to be rare.", {"entities": []}], ["The use of 'impure' or 'active' placebos (for example, antibiotics for viral infections) is likely to be much more frequent.", {"entities": []}], ["However, it is impossible to make a reliable estimation because there is no agreement of what an impure placebo might be.", {"entities": []}], ["Studies using qualitative methods or asking participants to judge case examples suggest that motivations and attitudes towards placebo use are complex and health care providers are often faced with a dilemma.", {"entities": []}], ["Although the available evidence is incomplete and confusing at times there can be little doubt that the prevalence of placebo use outside of clinical trials is not negligible and that views and attitudes on placebos use differ considerably among individuals, both health care professionals and patients.", {"entities": []}], ["Further research is needed to clarify these issues.", {"entities": []}], ["Integrated Environmental Health Impact Assessment (IEHIA) can be considered as an element in the third phase of environmental risk management.", {"entities": []}], ["Its focus is on providing inclusive descriptions of multiple impacts from multiple stressors in such a way that they can be evaluated against the potential societal benefits of the causes of the stressors.", {"entities": []}], ["This paper emphasises some differences and difficulties in the integration across professional paradigms and scientific fields, across stakeholder perspectives and differences in impact indicators that emanate from these different fields and paradigms.", {"entities": []}], ["The tetracyclic triterpene euphol is the main constituent found in the sap of Euphorbia tirucalli .", {"entities": []}], ["This plant is widely known in Brazilian traditional medicine for its use in the treatment of several kinds of cancer, including leukaemia, prostate and breast cancers.", {"entities": [[110, 116, "DISEASE"]]}], ["Here, we investigated the effect of euphol on experimental models of colitis and the underlying mechanisms involved in its action.", {"entities": []}], ["Colitis was induced in mice either with dextran sulfate sodium (DSS) or with 2,4,6-trinitrobenzene sulfonic acid (TNBS), and the effect of euphol (3, 10 and 30 mg/kg) on colonic injury was assessed.", {"entities": []}], ["Pro-inflammatory mediators and cytokines were measured by immunohistochemistry, enzyme-Linked immunoabsorbent assay (ELISA), real time-polymerase chain reaction (RT-PCR) and flow cytometry.", {"entities": []}], ["Preventive and therapeutic oral administration of euphol attenuated both DSS- and TNBS-induced acute colitis as observed by a significant reduction of the disease activity index (DAI), histological/microscopic damage score and myeloperoxidase (MPO) activity in colonic tissue.", {"entities": [[244, 247, "GENE"]]}], ["Likewise, euphol treatment also inhibited colon tissue levels and expression of IL-1\u03b2, CXCL1/KC, MCP-1, MIP-2, TNF-\u03b1 and IL-6, while reducing NOS2, VEGF and Ki67 expression in colonic tissue.", {"entities": [[142, 146, "GENE"]]}], ["This action seems to be likely associated with inhibition of activation of nuclear factor-\u03baB (NF-\u03baB).", {"entities": []}], ["In addition, euphol decreased LPS-induced MCP-1, TNF-\u03b1, IL-6 and IFN-\u03b3, but increased IL-10 secretion from bone marrow-derived macrophages in vitro .", {"entities": []}], ["Of note, euphol, at the same schedule of treatment, markedly inhibited both selectin (P- and E-selectin) and integrin (ICAM-1, VCAM-1 and LFA-1) expression in colonic tissue.", {"entities": []}], ["Together, these results clearly demonstrated that orally-administered euphol, both preventive or therapeutic treatment were effective in reducing the severity of colitis in two models of chemically-induced mouse colitis and suggest this plant-derived compound might be a potential molecule in the management of inflammatory bowel diseases.", {"entities": []}], ["22q11.2 deletion syndrome (22q11.2DS) is the most common microdeletion disorder, affecting an estimated 1\u2009:\u20092000\u20134000 live births.", {"entities": [[17, 25, "DISEASE"]]}], ["Patients with 22q11.2DS have a broad spectrum of phenotypic abnormalities which generally includes congenital cardiac abnormalities, palatal anomalies, and immunodeficiency.", {"entities": []}], ["Additional findings, such as skeletal anomalies and autoimmune disorders, can confer significant morbidity in a subset of patients.", {"entities": []}], ["22q11.2DS is a contiguous gene DS and over 40 genes are deleted in patients; thus deletion of several genes within this region contributes to the clinical features.", {"entities": []}], ["Mutations outside or on the remaining 22q11.2 allele are also known to modify the phenotype.", {"entities": []}], ["We utilised whole exome, targeted exome and/or Sanger sequencing to examine the genome of 17 patients with 22q11.2 deletions and phenotypic features found in <10% of affected individuals.", {"entities": []}], ["In four unrelated patients, we identified three novel mutations in SNAP29 , the gene implicated in the autosomal recessive condition cerebral dysgenesis, neuropathy, ichthyosis and keratoderma (CEDNIK).", {"entities": [[154, 164, "DISEASE"]]}], ["SNAP29 maps to 22q11.2 and encodes a soluble SNARE protein that is predicted to mediate vesicle fusion at the endoplasmic reticulum or Golgi membranes.", {"entities": []}], ["This work confirms that the phenotypic variability observed in a subset of patients with 22q11.2DS is due to mutations on the non-deleted chromosome, which leads to unmasking of autosomal recessive conditions such as CEDNIK, Kousseff, and a potentially autosomal recessive form of Opitz G/BBB syndrome.", {"entities": [[293, 301, "DISEASE"]]}], ["Furthermore, our work implicates SNAP29 as a major modifier of variable expressivity in 22q11.2 DS patients.", {"entities": []}], ["To determine the role of gap junctions (GJs) in hypoxic pulmonary vasoconstriction (HPV).", {"entities": []}], ["Studies were performed in rat isolated intrapulmonary arteries (IPAs) mounted on a myograph and in anaesthetized rats.", {"entities": []}], ["Hypoxia induced a biphasic HPV response in IPAs preconstricted with prostaglandin F 2\u03b1 (PGF 2\u03b1 , 3 \u00b5M) or 20 mM K These results imply that GJs are critically involved in the signalling pathways leading to Rho kinase-dependent Ca", {"entities": [[88, 91, "GENE"]]}], ["BACKGROUND: Different forms of chronic airway inflammation may involve diverse pathogenic elements.", {"entities": []}], ["In general, deficient defence response is a feature of chronic obstructive pulmonary disease (COPD), whereas distorted immunoregulatory mechanisms lead to development of asthmatic symptoms.", {"entities": [[55, 92, "DISEASE"]]}], ["In addition to diverse effector mechanisms, the cellular and humoral elements participating in the development of immune response may appear to be different in COPD and bronchial asthma (BA) patients.", {"entities": [[179, 185, "DISEASE"]]}], ["AIMS: To evaluate the immunoregulatory properties of T cells and monocytes in cultures of peripheral blood mononuclear cells (PBMC) and to determine the chosen cytokine profiles in COPD and BA patients.", {"entities": []}], ["METHODS: The microcultures of PBMC from COPD and BA patients were assessed for the T-cell response to mitogens, saturation of interleukin (IL)-2 receptors, T-cell suppressive activity and monokine influence on lymphocyte proliferation.", {"entities": []}], ["Concomitantly, the cytokine (IL-1beta, interleukin-1 receptor antagonist, tumour necrosis factor-alpha, IL-4, IL-6, IL-8) concentrations were determined in the serum, the broncho-alveolar lavage fluid and in the culture supernatants.", {"entities": []}], ["RESULTS: The T-lymphocyte reactions (response to phytohaemagglutinin, IL-2 receptor saturation, suppressive activity) were lower in BA patients than in COPD patients.", {"entities": []}], ["Reversely, the immunogenic activity of monocytes (IL-1beta versus IL-1ra production) was higher in BA patients than in COPD patients.", {"entities": []}], ["The highest values of cytokine concentrations were found in the culture supernatants.", {"entities": []}], ["The concentrations of tumour necrosis factor-alpha, IL-4, IL-6 and IL-8 were significantly higher and the concentration of IL-1ra was lower in BA patients than in COPD patients.", {"entities": []}], ["CONCLUSION: The assessments of cellular immunoregulatory properties and cytokine profiles in the cultures of blood mononuclear cells may prove helpful for diagnostic and therapeutic discrimination between BA and COPD patients.", {"entities": []}], ["Identification and treatment of unrecognised asthmatics in the community is important for improving the health of the individual and minimising cost and quality of life burden.", {"entities": []}], ["It is not practical to offer clinical diagnostic assessment to whole communities, and a simple tool such as a questionnaire is required to identify a smaller target group.", {"entities": []}], ["Conventional questionnaire screening methods which separate individuals into positive and negative categories have resulted in large numbers of individuals requiring clinical assessment.", {"entities": []}], ["This study has therefore developed and tested a weighted scoring system that prioritises those most urgently in need, based on their questionnaire responses.", {"entities": []}], ["A stratified random sample of adult respondents to a general practice postal questionnaire survey were categorised 'asthmatic' or 'non-asthmatic' according to three expert physicians' opinions.", {"entities": []}], ["Based on this categorisation, logistic regression was used to derive weights reflecting the relative importance of each question in predicting asthma, allowing calculation of weighted scores reflecting likelihood of asthma.", {"entities": [[143, 149, "DISEASE"], [216, 222, "DISEASE"]]}], ["Respondents scoring higher than a chosen threshold would be offered diagnostic examination.", {"entities": []}], ["Age and presence of wheeze were most influential (weight 3) and overall weighted scores ranged from -1 to 13.", {"entities": []}], ["Positive predictive values (PPV) were estimated.", {"entities": []}], ["For example, setting the threshold score at nine gave an estimated PPV for asthma diagnosis of 93.5%, a threshold score of seven corresponded to PPV 78.8%.", {"entities": [[75, 81, "DISEASE"]]}], ["PPV estimates were supported by examining 145 individuals from a new survey.", {"entities": []}], ["Weighted scoring of questionnaire responses provides a method for evaluating the priority level of an individual 'at a glance', minimising the resource wastage of examining false positives.", {"entities": []}], ["To enhance guideline-based non-surgical management of hip or knee osteoarthritis (OA), a multidisciplinary, stepped-care strategy has been implemented in primary care in a region of the Netherlands.", {"entities": [[66, 80, "DISEASE"]]}], ["To facilitate this implementation, the self-management booklet \u201cCare for Osteoarthritis\u201d was developed and introduced.", {"entities": [[73, 87, "DISEASE"]]}], ["The aim of the booklet was to educate patients about OA, to enhance the patient\u2019s active role in the treatment course, and to improve the communication with health care providers.", {"entities": []}], ["To successfully introduce the booklet on a large scale we assessed barriers and facilitators for patients to using this booklet.", {"entities": []}], ["Seventeen primary care patients with hip or knee OA who received the self-management booklet participated in this qualitative study using semi-structured interviews.", {"entities": []}], ["Purposive sampling was used to ensure diversity of the patients\u2019 view about the booklet.", {"entities": []}], ["The interviews were transcribed verbatim and analysed using a thematic analysis approach.", {"entities": []}], ["Three core themes with patient perceived barriers and facilitators to use the booklet emerged from the interviews: 1) the role of health care providers, 2) the patient\u2019s perceptions about OA and its manageability, and 3) the patient\u2019s perceptions about the usefulness of the booklet and patient\u2019s information needs.", {"entities": []}], ["Regarding the first theme, a barrier was the lack of encouragement from health care providers to use the booklet in the treatment course of OA.", {"entities": []}], ["Moreover, patients had doubts concerning the health care providers\u2019 endorsement of non-surgical treatment for OA.", {"entities": []}], ["Barriers from the second theme were: thinking that OA is not treatable or that being pro-active during the treatment course is not important.", {"entities": []}], ["In contrast, being convinced about the importance of an active participation in the treatment course was a facilitator.", {"entities": []}], ["Third, patients\u2019 perceptions about the usefulness of the booklet and patients\u2019 information needs were both identified as barriers as well as facilitators for booklet use.", {"entities": []}], ["This study contributes to the understanding of patient perceived barriers and facilitators to use a self-management booklet in the treatment course of OA.", {"entities": []}], ["The results offer practical starting points to tailor the implementation activities of the booklet nationwide and to introduce comparable educational tools in OA primary care or in other chronic diseases.", {"entities": []}], ["Exposure to ozone, which is a major component of air pollution, induces a form of asthma that occurs in the absence of adaptive immunity.", {"entities": [[82, 88, "DISEASE"]]}], ["Although ozone-induced asthma is characterized by airway neutrophilia, and not eosinophilia, it is nevertheless associated with airway hyperreactivity (AHR), which is a cardinal feature of asthma.", {"entities": [[79, 91, "DISEASE"], [23, 29, "DISEASE"], [189, 195, "DISEASE"], [152, 155, "GENE"]]}], ["Because AHR induced by allergens requires the presence of natural killer T (NKT) cells, we asked whether ozone-induced AHR had similar requirements.", {"entities": [[8, 11, "GENE"], [119, 122, "GENE"], [8, 11, "GENE"], [119, 122, "GENE"]]}], ["We found that repeated exposure of wild-type (WT) mice to ozone induced severe AHR associated with an increase in airway NKT cells, neutrophils, and macrophages.", {"entities": [[79, 82, "GENE"]]}], ["Surprisingly, NKT cell\u2013deficient (CD1d", {"entities": [[34, 38, "GENE"]]}], ["The burden of non-communicable diseases (NCDs) is increasing in sub-Saharan Africa, but data available for intervention planning are inadequate.", {"entities": []}], ["We determined the prevalence of selected NCDs and HIV infection, and NCD risk factors in northwestern Tanzania and southern Uganda.", {"entities": []}], ["A population-based cross-sectional survey was conducted, enrolling households using multistage sampling with five strata per country (one municipality, two towns, two rural areas).", {"entities": []}], ["Consenting adults (\u226518\u00a0years) were interviewed using the WHO STEPS survey instrument, examined, and tested for HIV and diabetes mellitus (DM).", {"entities": [[119, 136, "DISEASE"]]}], ["Adjusting for survey design, we estimated population prevalences of hypertension, DM, obstructive pulmonary disease, cardiac failure, epilepsy and HIV, and investigated factors associated with hypertension using logistic regression.", {"entities": [[68, 80, "DISEASE"], [193, 205, "DISEASE"]]}], ["Across strata, hypertension prevalence ranged from 16\u00a0% (95\u00a0% confidence interval (CI): 12\u00a0% to 22\u00a0%) to 17\u00a0% (CI: 14\u00a0% to 22\u00a0%) in Tanzania, and from 19\u00a0% (CI: 14\u00a0% to 26\u00a0%) to 26\u00a0% (CI: 23\u00a0% to 30\u00a0%) in Uganda.", {"entities": [[15, 27, "DISEASE"]]}], ["It was high in both urban and rural areas, affecting many young participants.", {"entities": []}], ["The prevalence of DM (1\u00a0% to 4\u00a0%) and other NCDs was generally low.", {"entities": []}], ["HIV prevalence ranged from 6\u00a0% to 10\u00a0% in Tanzania, and 6\u00a0% to 12\u00a0% in Uganda.", {"entities": []}], ["Current smoking was reported by 12\u00a0% to 23\u00a0% of men in different strata, and 1\u00a0% to 3\u00a0% of women.", {"entities": []}], ["Problem drinking (defined by Alcohol Use Disorder Identification Test criteria) affected 6\u00a0% to 15\u00a0% men and 1\u00a0% to 6\u00a0% women.", {"entities": []}], ["Up to 46\u00a0% of participants were overweight, affecting women more than men and urban more than rural areas.", {"entities": []}], ["Most patients with hypertension and other NCDs were unaware of their condition, and hypertension in treated patients was mostly uncontrolled.", {"entities": [[19, 31, "DISEASE"], [84, 96, "DISEASE"]]}], ["Hypertension was associated with older age, male sex, being divorced/widowed, lower education, higher BMI and, inversely, with smoking.", {"entities": [[0, 12, "DISEASE"]]}], ["The high prevalence of NCD risk factors and unrecognized and untreated hypertension represent major problems.", {"entities": [[71, 83, "DISEASE"]]}], ["The low prevalence of DM and other preventable NCDs provides an opportunity for prevention.", {"entities": []}], ["HIV prevalence was in line with national data.", {"entities": []}], ["In Tanzania, Uganda and probably elsewhere in Africa, major efforts are needed to strengthen health services for the PREVENTION, early detection and treatment of chronic diseases.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-015-0357-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Allergen specific immunotherapy (SIT) is the practice of administering gradually increasing doses of the specific causative allergen to reduce the clinical reactivity of allergic subjects, and is the only treatment targeting the causes of hypersensitivity and not only the symptoms, as done by drugs.", {"entities": []}], ["The traditional, subcutaneous immunotherapy (SCIT) was burdened by the problem of systemic reactions which may be sometimes severe and - though very rarely - even fatal.", {"entities": []}], ["This was the background to develop non injections routes for SIT and particularly sublingual immunotherapy (SLIT), that emerged as a real treatment option for respiratory allergy.", {"entities": []}], ["A number of studies was conducted to evaluate efficacy and safety of SLIT, the first meta-analysis - including 22 placebo-controlled trials - concluded for positive results in both issues, but the number of studies on children was too low to draw definite conclusions.", {"entities": []}], ["Since then, many other studies became available and make possible to analyze SLIT in children in its well defined aspects as well as in sides still requiring more solid data.", {"entities": []}], ["Objective .", {"entities": []}], ["To assess the neuroradiological findings of children with congenital hypothyroidism (CHT) compared to healthy controls (HC).", {"entities": [[69, 83, "DISEASE"], [58, 83, "DISEASE"]]}], ["Patients and Methods .", {"entities": []}], ["Thirty children with CHT, mean age 12.5 \u00b1 1.6 years, 14 (44.8%) males, were compared with 38 HC mean age 11.7 \u00b1 1.7 years, 16 (45.7%) males.", {"entities": []}], ["Clinical data were collected from medical charts and questionnaires seeking information on family history, birth and perinatal period events, medications, and overall health history.", {"entities": []}], ["Neurocognitive function was assessed for global intelligence, visual and verbal memory, and executive functioning using standardized tests.", {"entities": []}], ["Neuroimaging was performed using 1.5\u2009T magnetic resonance imaging and assessed by two pediatric radiologists.", {"entities": []}], ["Children with CHT had a similar proportion of incidental findings as did the children in the HC group, at 43.3% and 39.5%, respectively, P = 0.69.", {"entities": []}], ["Abnormalities of the sellar region were reported in 13.3% of CHT group and 7.9% of HC group, P = 0.46.", {"entities": []}], ["Other incidental findings included cerebellar ectopia, choroidal fissure and pineal cysts, and multiple increased signal intensity foci.", {"entities": []}], ["Neuroradiological findings were not associated with clinical and neurocognitive abnormalities.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Neuroimaging of children with CHT demonstrated a similar incidence of structural abnormalities as in the healthy population.", {"entities": []}], ["There is no association between those findings and neurocognitive function.", {"entities": []}], ["Livestock and poultry operations that feed large numbers of animals are common.", {"entities": []}], ["Facility capacity varies, but it is not uncommon for facilities to house 1,000 swine with multiple barns at a single site, feedlots to house 50,000 cattle, and poultry houses to house 250,000 hens.", {"entities": []}], ["There is primary research that suggests livestock facilities that confine animals indoors for feeding can represent a health hazard for surrounding communities.", {"entities": []}], ["In this protocol, we describe a review about the association between proximity to animal-feeding operations (AFOs) and the health of individuals in nearby communities.", {"entities": []}], ["A systematic review of the topic was published by some members of our group in 2010.", {"entities": []}], ["The purpose of this review is to update that review.", {"entities": []}], ["The populations of interest are people living in communities near livestock production facilities.", {"entities": []}], ["Outcomes of interest are any health outcome measured in humans such as respiratory disease, gastrointestinal disease, and mental health.", {"entities": []}], ["Measures of antibiotic resistance in people from the communities compared to measures of resistance found in animals and the environment on animal-feeding operations will also be summarized.", {"entities": []}], ["The exposure of interest will be exposure to livestock production using a variety of metrics such as distance from facilities, endotoxin levels, and measures of odor.", {"entities": []}], ["Electronic searches will be conducted using MEDLINE and MEDLINE In-Process (via OvidSP), CAB Abstracts (via Web of Knowledge), and Science Citation Index (via Web of Knowledge).", {"entities": []}], ["No language or date restriction will be applied.", {"entities": []}], ["We will access the risk of bias using a pilot version of a tool developed by the Methods Groups of the Cochrane Collaboration for non-randomized interventions.", {"entities": []}], ["We propose to conduct a meta-analysis for each health metric (e.g., combining all respiratory disease outcomes, combining all gastrointestinal outcomes).", {"entities": []}], ["A planned subgroup analysis will be based on the domains of the risk of bias.", {"entities": []}], ["This systematic review will provide synthesis of current evidence reporting the association between living near an animal-feeding operation and human health.", {"entities": []}], ["PROSPERO CRD42014010521", {"entities": []}], ["The study was undertaken to determine transmission of Mycobacterium tuberculosis within the prison environment.", {"entities": [[68, 80, "DISEASE"]]}], ["In total, 168 Aba Federal prison inmates in Nigeria were evaluated for tuberculosis (TB) by sputum-smear microscopy and sputum culture, simultaneously, and for HIV status by serology.", {"entities": [[71, 83, "DISEASE"]]}], ["They were subsequently followed up for one year for fresh Mycobacterium -associated infection by tuberculin skin testing or for development of TB and for HIV infection or AIDS.", {"entities": []}], ["Ninety-one (54.2%) of the 168 prison inmates had infection due to Mycobacterium , and three (3.3%) of them were sputum-smear- and culture-positive while 41 (24.4%), including one (2.4%) with concomitant TB, were HIV-infected.", {"entities": []}], ["In a one-year follow-up study, 11 (19.3%) of 57 tuberculin skin test (TST)- and HIV-negative inmates became TST-positive and one (1.8%) HIV-positive, eight (13.8%) of the 58 TST-positive but HIV-negative inmates developed TB, and one (1.7%) became HIV-infected: six (24.0%) of 25 TST- and HIV-positive inmates developed TB while five (33.3%) of 15 TST-negative but HIV-positive inmates became TST-positive, and one (6.7%) progressed to AIDS.", {"entities": []}], ["The duration of imprisonment did not influence the rates of infection, and the transmission of Mycobacterium tuberculosis did not necessarily require sharing a cell with a TB case.", {"entities": [[109, 121, "DISEASE"]]}], ["Modern metal-on-metal hip resurfacing implants are being increasingly used for young and active patients, although the long-term outcome and failure mechanisms of these implants are still unknown.", {"entities": []}], ["In this consecutive revision case series, early failures of femoral implants (at < 4 years) were studied.", {"entities": []}], ["3 revisions were done due to a fracture of the femoral neck and 1 due to loosening and varus position of the femoral component.", {"entities": []}], ["Femoral heads were removed en bloc 2\u201346 months after the primary operation, embedded in methylmethacrylate, sectioned, stained, and analyzed as whole-mount specimens in 4 55\u201362-year-old patients with osteoarthritis.", {"entities": [[200, 214, "DISEASE"]]}], ["Histopathology was characterized by new but also partly healed trabecular microfractures, bone demineralization, cysts, metallosis, and abnormal formation of new woven bone.", {"entities": []}], ["All samples displayed signs of notching, osteoporosis, and aseptic necrosis, which seemed to have been the main reason for the subsequent development and symptoms of the patients and revision operations of the hips.", {"entities": [[41, 53, "DISEASE"]]}], ["Based on these early revision cases, it appears that aseptic necrosis is a common cause of early loosening of resurfacing hip implants.", {"entities": []}], ["Maternal glucose levels during pregnancy impact the developing fetus, affecting metabolic health early and later in life.", {"entities": []}], ["Both genetic and environmental factors influence maternal metabolism, but little is known about the genetic mechanisms that alter glucose metabolism during pregnancy.", {"entities": []}], ["Here we report that haplotypes previously associated with gestational hyperglycemia in the third trimester disrupt regulatory element activity and reduce expression of the nearby HKDC1 gene.", {"entities": [[70, 83, "DISEASE"], [179, 184, "GENE"]]}], ["We further find that experimentally reducing or increasing HKDC1 expression reduces or increases hexokinase activity, respectively, in multiple cellular models; and that purified HKDC1 protein has hexokinase activity in vitro .", {"entities": [[59, 64, "GENE"], [179, 184, "GENE"], [59, 64, "GENE"], [179, 184, "GENE"]]}], ["Together, these results suggest a novel mechanism of gestational glucose regulation in which the effects of genetic variants in multiple regulatory elements alter glucose homeostasis by coordinately reducing expression of the novel hexokinase HKDC1 .", {"entities": [[243, 248, "GENE"]]}], ["In humans and mice naturally occurring CD4 DNA-Microarray analyses of human as well as murine conventional CD4 curfy mice and performing FoxP3 ChIP-Seq experiments using activated human T lymphocytes, we show that the expression and maturation of miR-155 seem to be not necessarily regulated by FoxP3.", {"entities": [[39, 42, "GENE"], [107, 110, "GENE"], [39, 42, "GENE"], [107, 110, "GENE"], [137, 142, "GENE"], [295, 300, "GENE"], [247, 254, "GENE"], [137, 142, "GENE"], [295, 300, "GENE"]]}], ["In order to address the functional relevance of elevated miR-155 levels, we transfected miR-155 inhibitors or mature miR-155 RNAs into freshly-isolated human and mouse primary CD4 Investigation of FoxP3 downstream targets, certainly of bound and regulated miRNAs revealed the associated function between the master regulator FoxP3 and miRNAs as regulators itself.", {"entities": [[57, 64, "GENE"], [88, 95, "GENE"], [117, 124, "GENE"], [57, 64, "GENE"], [88, 95, "GENE"], [117, 124, "GENE"], [57, 64, "GENE"], [88, 95, "GENE"], [117, 124, "GENE"], [176, 179, "GENE"], [197, 202, "GENE"], [325, 330, "GENE"], [197, 202, "GENE"], [325, 330, "GENE"]]}], ["miR-155 is shown to be crucially involved in nTreg cell mediated tolerance by regulating the susceptibility of conventional human as well as murine CD4", {"entities": [[0, 7, "GENE"], [148, 151, "GENE"]]}], ["It is increasingly evident that human diseases are not isolated from each other.", {"entities": []}], ["Understanding how different diseases are related to each other based on the underlying biology could provide new insights into disease etiology, classification, and shared biological mechanisms.", {"entities": []}], ["We have taken a computational approach to studying disease relationships through 1) systematic identification of disease associated genes by literature mining, 2) associating diseases to biological pathways where disease genes are enriched, and 3) linking diseases together based on shared pathways.", {"entities": []}], ["We identified 4,195 candidate disease associated genes for 1028 diseases.", {"entities": []}], ["On average, about 50% of disease associated genes of a disease are statistically mapped to pathways.", {"entities": []}], ["We generated a disease network which consists of 591 diseases and 6,931 disease relationships.", {"entities": []}], ["We examined properties of this network and provided examples of novel disease relationships which cannot be readily captured through simple literature search or gene overlap analysis.", {"entities": []}], ["Our results could potentially provide insights into the design of novel, pathway-guided therapeutic interventions for diseases.", {"entities": []}], ["Use of immunosuppressive drugs post organ transplantation, and prolonged use of glucorticoids for other conditions have been associated with subsequent risk of certain malignancies, that is, skin cancers and lymphoma.", {"entities": [[208, 216, "DISEASE"]]}], ["There is evidence that the incidence of bladder cancer is also elevated among organ transplant recipients, however, it is unknown whether other groups of patients, that is, those taking oral glucocorticoids, likewise are at an increased risk.", {"entities": [[48, 54, "DISEASE"]]}], ["In a population-based case\u2013control study in New Hampshire, USA, we compared the use of glucocorticoids in 786 bladder cancer cases and in 1083 controls.", {"entities": [[118, 124, "DISEASE"]]}], ["We used unconditional logistic regression analysis to compute adjusted odds ratios (ORs) associated with oral glucocorticoid use.", {"entities": []}], ["In our analysis, the risk of bladder cancer was related to a history of prolonged oral glucocorticoid use (OR=1.85, 95% CI=1.24\u20132.76, adjusted for age, gender and smoking).", {"entities": [[37, 43, "DISEASE"]]}], ["Associations with oral glucocorticoid use were stronger for invasive tumours (OR=2.12, 95% CI=1.17\u20133.85) and tumours with high (3+) p53 staining intensity (OR=2.35, 95% CI=1.26\u20134.36).", {"entities": []}], ["Our results raise the possibility of an increased risk of bladder cancer from systemic use of glucocorticoids, and a potential role of immune surveillance in bladder cancer aetiology.", {"entities": [[66, 72, "DISEASE"], [166, 172, "DISEASE"]]}], ["We have recently reported that human pregnancy is characterized by a 10- to 20-fold elevation of eosinophil major basic protein (MBP) immunoreactivity in maternal blood.", {"entities": [[129, 132, "GENE"]]}], ["Here we show, by immunofluorescence, that placental tissue specifically binds antibody to MBP in and around the placental X cells and placental-site giant cells and, using thin plastic sections, that placenta has no infiltrating eosinophils.", {"entities": [[90, 93, "GENE"]]}], ["The X cells line the inner aspects of placental septal cysts, and the cyst fluid, obtained by aspiration, contains immunoreactive MBP at concentrations of 100 micrograms/ml, a sixfold greater concentration than the highest levels measured in maternal blood.", {"entities": [[130, 133, "GENE"]]}], ["The soluble MBP immunoreactivities in placental homogenates and in maternal serum chromatograph identically on Sephadex G-50, and both these gestational MBP molecules migrate as though substantially larger than the MBP found in serum from patients with hypereosinophilic syndrome or purified from the eosinophil granule.", {"entities": [[271, 279, "DISEASE"], [12, 15, "GENE"], [153, 156, "GENE"], [215, 218, "GENE"], [12, 15, "GENE"], [153, 156, "GENE"], [215, 218, "GENE"], [12, 15, "GENE"], [153, 156, "GENE"], [215, 218, "GENE"]]}], ["Our inability to demonstrate eosinophils in maternal blood or placental tissue, coupled with the large quantities of immunoreactive MBP highly localized in placental cysts and the chromatographic behavior of this molecule, suggest that the MBP detected in human gestation is produced by placenta.", {"entities": [[132, 135, "GENE"], [240, 243, "GENE"], [132, 135, "GENE"], [240, 243, "GENE"]]}], ["Small observational studies have found that isolated right heart failure (IRHF) is prevalent among women of sub-Saharan Africa.", {"entities": []}], ["Further, several risk factors for the development of IRHF have been identified.", {"entities": []}], ["However, no similar studies have been conducted in Kenya.", {"entities": []}], ["We hypothesized that specific environmental exposures and comorbidities were associated with IRHF in women of western Kenya.", {"entities": []}], ["We conducted a case-control study at a referral hospital in western Kenya.", {"entities": []}], ["Cases were defined as women at least 35 years old with IRHF.", {"entities": []}], ["Control subjects were similarly aged volunteers without IRHF.", {"entities": []}], ["Exclusion criteria in both groups included history of tobacco use, tuberculosis, or thromboembolic disease.", {"entities": [[67, 79, "DISEASE"]]}], ["Participants underwent echocardiography, spirometry, 6-min walk test, rest/exercise oximetry, respiratory health interviews, and human immunodeficiency virus (HIV) testing.", {"entities": []}], ["Home visits were performed to evaluate kitchen ventilation, fuel use, and cook smoke exposure time, all surrogate measures of indoor air pollution (IAP).", {"entities": []}], ["A total of 31 cases and 65 control subjects were enrolled.", {"entities": []}], ["Surrogate measures of indoor air pollution were not associated with IRHF.", {"entities": []}], ["However, lower forced expiratory volume at 1 s percent predicted (adjusted odds ratio [AOR]: 2.02, 95% confidence interval [CI]: 1.27 to 3.20; p = 0.004), HIV positivity (AOR: 40.4, 95% CI: 3.7 to 441; p < 0.01), and self-report of exposure to occupational dust (AOR: 3.9, 95% CI: 1.14 to 14.2; p = 0.04) were associated with IRHF.", {"entities": []}], ["In an analysis of subgroups of participants with and without these factors, lower kitchen ventilation was significantly associated with IRHF among participants without airflow limitation (AOR: 2.63 per 0.10 unit lower ventilation, 95% CI: 1.06 to 6.49; p = 0.04), without HIV (AOR: 2.55, 95% CI: 1.21 to 5.37; p = 0.02), and without occupational dust exposure (AOR: 2.37, 95% CI: 1.01 to 5.56; p = 0.05).", {"entities": []}], ["In this pilot study among women of western Kenya, lower kitchen ventilation, airflow limitation, HIV, and occupational dust exposure were associated with IRHF, overall or in participant subgroups.", {"entities": []}], ["Direct or indirect causality requires further study.", {"entities": []}], ["Molecular-based diagnostic techniques can compensate for the inherent limitations of culture-based microbiology and provide a more comprehensive description of an entire community of bacteria at a particular anatomical site.", {"entities": []}], ["Using culture-independent DNA-based molecular techniques, the aim of the present study was to characterize, differentiate, and compare the composition of lower airway bacterial microbiome between clinically stable and acutely infected patients with bronchiectasis experiencing exacerbation.", {"entities": [[249, 263, "DISEASE"]]}], ["Patients with clinically stable bronchiectasis and those experiencing acutely exacerbated bronchiectasis were recruited.", {"entities": [[32, 46, "DISEASE"], [90, 104, "DISEASE"]]}], ["All patients underwent bronchoscopy.", {"entities": []}], ["Paired sputum and bronchoalveolar lavage (BAL) samples were collected for microbiological tests.", {"entities": []}], ["Molecular analysis was performed for BAL samples using 16S ribosomal RNA (rRNA) gene sequencing.", {"entities": []}], ["The mean age of the 14 recruited patients was 60 years (range 42 to 78 years), and nine (64%) were female.", {"entities": []}], ["Using quantitative culture and 16S rRNA sequencing, the common organisms identified from 14 BAL samples were Haemophilus influenzae , Pseudomonas aeruginosa and Moraxella catarrhalis , and Prevotella .", {"entities": []}], ["Molecular techniques revealed Prevotella and Veillonella as potentially pathogenic anaerobic species.", {"entities": []}], ["16S rRNA gene sequencing yielded similar relative abundances and distributions of taxa in the stable and exacerbated bronchiectasis groups.", {"entities": [[117, 131, "DISEASE"]]}], ["Alpha diversity with richness, Simpson\u2019s and Shannon indices, and beta diversity using principal coordinate analysis revealed no significant differences in lung microbiome between patients with clinically stable and exacerbated bronchiectasis.", {"entities": [[228, 242, "DISEASE"]]}], ["Culture-based microbiological and molecular-based techniques did not reveal significant differences in the lung microbiome of patients who were clinically stable and those experiencing exacerbated bronchiectasis.", {"entities": [[197, 211, "DISEASE"]]}], ["Patient-specific microbial communities were dominated by one or several genera, regardless of clinical status.", {"entities": []}], ["DNA sequencing could identify potentially pathogenic organisms unable to be identified using microbiological methods.", {"entities": []}], ["Mobile health (mHealth) services cannot easily adapt to users\u2019 unique needs.", {"entities": []}], ["We used simulations of text messaging (SMS) for improving medication adherence to demonstrate benefits of interventions using reinforcement learning (RL).", {"entities": [[39, 42, "GENE"]]}], ["We used Monte Carlo simulations to estimate the relative impact of an intervention using RL to adapt SMS adherence support messages in order to more effectively address each non-adherent patient\u2019s adherence barriers, e.g., forgetfulness versus side effect concerns.", {"entities": [[101, 104, "GENE"]]}], ["SMS messages were assumed to improve adherence only when they matched the barriers for that patient.", {"entities": [[0, 3, "GENE"]]}], ["Baseline adherence and the impact of matching messages were estimated from literature review.", {"entities": []}], ["RL-SMS was compared in common scenarios to simple reminders, random messages, and standard tailoring.", {"entities": []}], ["RL could produce a 5\u201314\u00a0% absolute improvement in adherence compared to current approaches.", {"entities": []}], ["When adherence barriers are not accurately reported, RL can recognize which barriers are relevant for which patients.", {"entities": []}], ["When barriers change, RL can adjust message targeting.", {"entities": []}], ["RL can detect when messages are sent too frequently causing burnout.", {"entities": []}], ["RL systems could make mHealth services more effective.", {"entities": []}], ["The online version of this article (doi:10.1007/s12160-014-9634-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Protease-Activated Receptor-2 (PAR-2), a G protein coupled receptor activated by serine proteases, is widely expressed in humans and is involved in inflammation.", {"entities": []}], ["PAR-2 activation in the airways plays an important role in the development of allergic airway inflammation.", {"entities": []}], ["PAR-2 expression is known to be upregulated in the epithelium of asthmatic subjects, but its expression on immune and inflammatory cells in patients with asthma has not been studied.", {"entities": [[154, 160, "DISEASE"]]}], ["We recruited 12 severe and 24 mild/moderate asthmatics from the University of Alberta Hospital Asthma Clinics and collected baseline demographic information, medication use and parameters of asthma severity.", {"entities": [[95, 101, "DISEASE"], [191, 197, "DISEASE"]]}], ["PAR-2 expression on blood inflammatory cells was analyzed by flow cytometry.", {"entities": []}], ["Subjects with severe asthma had higher PAR-2 expression on CD14 PAR-2 expression is increased on CD14", {"entities": [[21, 27, "DISEASE"], [59, 63, "GENE"], [97, 101, "GENE"], [59, 63, "GENE"], [97, 101, "GENE"]]}], ["ASTERIA I was a 40-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous omalizumab as add-on therapy for 24 weeks in patients with chronic idiopathic urticaria/spontaneous urticaria (CIU/CSU) who remained symptomatic despite H 1 antihistamine treatment at licensed doses.", {"entities": [[206, 215, "DISEASE"], [228, 237, "DISEASE"]]}], ["Patients aged 12\u201375 years with CIU/CSU who remained symptomatic despite treatment with approved doses of H 1 antihistamines were randomized (1:1:1:1) in a double-blind manner to subcutaneous omalizumab 75\u2009mg, 150\u2009mg, or 300\u2009mg or placebo every 4 weeks for 24 weeks followed by 16 weeks of follow-up.", {"entities": []}], ["The primary end point was change from baseline in weekly itch severity score (ISS) at week 12.", {"entities": []}], ["Among randomized patients ( N =319: placebo n =80, omalizumab 75\u2009mg n =78, 150\u2009mg n =80, 300\u2009mg n =81), 262 (82.1%) completed the study.", {"entities": []}], ["Compared with placebo ( n =80), mean weekly ISS was reduced from baseline to week 12 by an additional 2.96 points (95% confidence interval (CI): \u22124.71 to \u22121.21; P =0.0010), 2.95 points (95% CI: \u22124.72 to \u22121.18; P =0.0012), and 5.80 points (95% CI: \u22127.49 to \u22124.10; P <0.0001) in the omalizumab 75-mg ( n =77), 150-mg ( n =80), and 300-mg groups ( n =81), respectively.", {"entities": []}], ["The omalizumab 300-mg group met all nine secondary end points, including a significant decrease in the duration of time to reach minimally important difference response (\u2a7e5-point decrease) in weekly ISS ( P <0.0001) and higher percentages of patients with well-controlled symptoms (urticaria activity score over 7 days (UAS7) \u2a7d6: 51.9% vs. 11.3% P <0.0001) and complete response (UAS7=0: 35.8% vs. 8.8% P <0.0001) versus placebo.", {"entities": [[282, 291, "DISEASE"]]}], ["During the 24-week treatment period, 2 (2.9%), 3 (3.4%), 0, and 4 (5.0%) patients in the omalizumab 75-mg, 150-mg, 300-mg, and placebo groups, respectively, experienced a serious adverse event.", {"entities": []}], ["Omalizumab 300\u2009mg administered subcutaneously every 4 weeks reduced weekly ISS and other symptom scores versus placebo in CIU/CSU patients who remained symptomatic despite treatment with approved doses of H 1 antihistamines.", {"entities": []}], ["Medicinal plants (MPs) used by traditional healers (THs) were investigated in Megera and adjacent subdistricts (kebeles) of Dalle District, Sidama Zone, southern Ethiopia.", {"entities": []}], ["The objective of the study was to identify and record MPs and their traditional uses in the treatment of various human ailments with emphasis on malignancies and other most frequently reported diseases.", {"entities": []}], ["Traditional medicinal knowledge held by 20 THs was investigated following standard ethnobotanical approaches.", {"entities": []}], ["Guided field walk, free listing, rigorous individual interviews with extended discussions, and local market surveys were employed to obtain information.", {"entities": []}], ["Preference rankings, paired comparisons, use value (UV) index, frequency of citation (FC), fidelity level (FL), and informant consensus factor (ICF) matrices were engaged to identify MPs used to treat malignancies and the other most prevalent human ailments.", {"entities": []}], ["Seventy-one MP species belonging to 63 genera and 46 families, used to treat 39 human ailments, were recorded.", {"entities": []}], ["A high proportion of the species recovered was shrubs (35.2%); while 64.7% were retrieved from the wild habitat.", {"entities": []}], ["Leaves were the main part of the MPs used (42.9%), followed by fruits/seeds (13%); all preparations were made from fresh materials and about 27.9% involved boiling.", {"entities": []}], ["The frequent route of delivery was oral (77.9%), followed by dermal (17.6%).", {"entities": []}], ["About 40.8% of the MPs were used for treating two or more ailments.", {"entities": []}], ["About 19.7% of the MPs were used to treat malignancies (ICF\u2009=\u20090.86) among which the plant species Sideroxylon oxyacanthum was the most frequently used (FL\u2009=\u200970%).", {"entities": []}], ["The species Podocarpus falcatus and Hagenia abyssinica were preferred to treat jaundice and deworm in helminthiases, respectively.", {"entities": []}], ["The study area is very rich in plant biodiversity, and the herbal medicine is an integral part of the traditional healthcare system.", {"entities": []}], ["The MPs are exposed to various destructive anthropogenic activities, and this situation calls for integrated conservation measures.", {"entities": []}], ["Furthermore, the rich ethnomedicinal knowledge held by the Sidama community at large and TM practitioners, in particular, needs an in-depth study and documentation.", {"entities": []}], ["Investigations of the MPs with high ICF, FL, and UVs to malignancies, jaundice, and helminthiases could possibly contribute to future drug development efforts.", {"entities": []}], ["We report the symptoms beginning with weakness and the clinical courses of a patient who was diagnosed with an intradural extramedullary bronchogenic cyst.", {"entities": []}], ["The patient was a 44-year-old man visited the Department of Physical Medicine and Rehabilitation for walking difficulties characterized by limping due to muscle weakness of left lower extremity for 5 months and atrophy in left calf muscle.", {"entities": []}], ["Lumbar spine MRI was repeated, since radiating pain in the left hip and posterior thigh with low back pain developed 16 months later.", {"entities": []}], ["Intraspinal mass of T12 and L1 levels that was not found in the first MRI was newly found in the follow-up MRI.", {"entities": []}], ["Total tumor removal was conducted with laminectomy.", {"entities": []}], ["It was finally diagnosed as an intradural extramedullary bronchogenic cyst on the basis of the pathological analysis results.", {"entities": []}], ["His left calf circumference was increased compared to before surgery the radiating pain also disappeared.", {"entities": []}], ["If the patient's MRI findings are not correlated with the electrophysiologic and physical examination findings, additional MRI should be accompanied with other tests for an early detection.", {"entities": []}], ["Evidence for environmental causes of asthma is limited, especially among African Americans.", {"entities": [[37, 43, "DISEASE"]]}], ["To look for systematic differences in early life domestic exposures between inner-city preschool children with and without asthma, we performed a study of home indoor air pollutants and allergens.", {"entities": [[123, 129, "DISEASE"]]}], ["Children 2\u20136 years of age were enrolled in a cohort study in East Baltimore, Maryland.", {"entities": []}], ["From the child\u2019s bedroom, air was monitored for 3 days for particulate matter \u2264 2.5 and \u2264 10 \u03bcm in aerodynamic diameter (PM 2.5 , PM 10 ), nitrogen dioxide, and ozone.", {"entities": []}], ["Median baseline values were compared for children with ( n = 150) and without ( n = 150) asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["Housing characteristics related to indoor air pollution were assessed by caregiver report and home inspection.", {"entities": []}], ["In addition, indoor allergen levels were measured in settled dust.", {"entities": []}], ["Children were 58% male, 91% African American, and 88% with public health insurance.", {"entities": []}], ["Housing characteristics related to pollutant exposure and bedroom air pollutant concentrations did not differ significantly between asthmatic and control subjects [median: PM 2.5 , 28.7 vs. 28.5 \u03bcg/m 10 , 43.6 vs. 41.4 \u03bcg/m 2 , 21.6 vs. 20.9 ppb; O 3 , 1.4 vs. 1.8 ppb; all p > 0.05].", {"entities": []}], ["Settled dust allergen levels (cat, dust mite, cockroach, dog, and mouse) were also similar in bedrooms of asthmatic and control children.", {"entities": []}], ["Exposures to common home indoor pollutants and allergens are similar for inner-city preschool children with and without asthma.", {"entities": [[120, 126, "DISEASE"]]}], ["Although these exposures may exacerbate existing asthma, this study does not support a causative role of these factors for risk of developing childhood asthma.", {"entities": [[49, 55, "DISEASE"], [152, 158, "DISEASE"]]}], ["Health reforms in service improvement have included the use of nurse practitioners.", {"entities": []}], ["In rural emergency departments, nurse practitioners work to the full scope of their expanded role across all patient acuities including those presenting with undifferentiated chest pain.", {"entities": []}], ["Currently, there is a paucity of evidence regarding the effectiveness of emergency nurse practitioner service in rural emergency departments.", {"entities": []}], ["Inquiry into the safety and quality of the service, particularly regarding the management of complex conditions is a priority to ensure that this service improvement model meets health care needs of rural communities.", {"entities": []}], ["This study used a prospective, longitudinal nested cohort study of rural emergency departments in Queensland, Australia.", {"entities": []}], ["Sixty-one consecutive adult patients with chest pain who presented between November 2014 and February 2016 were recruited into the study cohort.", {"entities": []}], ["A nested cohort of 41 participants with suspected or confirmed acute coronary syndrome were identified.", {"entities": [[78, 86, "DISEASE"]]}], ["The primary outcome was adherence to guidelines and diagnostic accuracy of electrocardiograph interpretation for the nested cohort.", {"entities": []}], ["Secondary outcomes included service indicators of waiting times, diagnostic accuracy as measured by unplanned representation rates, satisfaction with care, quality-of-life, and functional status.", {"entities": []}], ["Data were examined and compared for differences for participants managed by emergency nurse practitioners and those managed in the standard model of care.", {"entities": []}], ["The median waiting time was 8.0\u00a0min (IQR 20) and length-of-stay was 100.0\u00a0min (IQR 64).", {"entities": []}], ["Participants were 2.4 times more likely to have an unplanned representation if managed by the standard service model.", {"entities": []}], ["The majority of participants (91.5%) were highly satisfied with the care that they received, which was maintained at 30-day follow-up measurement.", {"entities": []}], ["In the evaluation\u00a0of quality of life and functional status, summary scores for the SF-12 were comparable with previous studies.", {"entities": []}], ["No differences were demonstrated between service models.", {"entities": []}], ["There was a high level of adherence to clinical guidelines for the emergency nurse practitioner service model and a concomitant high level of diagnostic accuracy.", {"entities": []}], ["Nurse practitioner service demonstrated comparable effectiveness to that of the standard care model in the evaluation of the service indicators and patient reported outcomes.", {"entities": []}], ["These findings provide a foundation for the beginning evaluation of rural emergency nurse practitioner service in the delivery of safe and effective beyond the setting of minor injury and illness presentations.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry, ACTRN12616000823471 (Retrospectively registered).", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-017-2395-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Motivation: As ArrayExpress and other repositories of genome-wide experiments are reaching a mature size, it is becoming more meaningful to search for related experiments, given a particular study.", {"entities": []}], ["We introduce methods that allow for the search to be based upon measurement data, instead of the more customary annotation data.", {"entities": []}], ["The goal is to retrieve experiments in which the same biological processes are activated.", {"entities": []}], ["This can be due either to experiments targeting the same biological question, or to as yet unknown relationships.", {"entities": []}], ["Results: We use a combination of existing and new probabilistic machine learning techniques to extract information about the biological processes differentially activated in each experiment, to retrieve earlier experiments where the same processes are activated and to visualize and interpret the retrieval results.", {"entities": []}], ["Case studies on a subset of ArrayExpress show that, with a sufficient amount of data, our method indeed finds experiments relevant to particular biological questions.", {"entities": []}], ["Results can be interpreted in terms of biological processes using the visualization techniques.", {"entities": []}], ["Availability: The code is available from http://www.cis.hut.fi/projects/mi/software/ismb09 .", {"entities": []}], ["Contact: jose.caldas@tkk.fi", {"entities": []}], ["A literature review was conducted to obtain a high-level view of the value of telemedicine in the management of five common chronic diseases (asthma, COPD, diabetes, heart failure, hypertension).", {"entities": [[181, 193, "DISEASE"], [142, 148, "DISEASE"]]}], ["A total of 141 randomised controlled trials (RCTs) was identified, in which 148 telemedicine interventions of various kinds had been tested in a total of 37,695 patients.", {"entities": []}], ["The value of each intervention was categorised in terms of the outcomes specified by the investigators in that trial, i.e.", {"entities": []}], ["no attempt was made to extract a common outcome from all studies, as would be required for a conventional meta-analysis.", {"entities": []}], ["Summarizing the value of these interventions shows, first, that most studies have reported positive effects ( n = 108), and almost none have reported negative effects ( n = 2).", {"entities": []}], ["This suggests publication bias.", {"entities": []}], ["Second, there were no significant differences between the chronic diseases, i.e.", {"entities": []}], ["telemedicine seems equally effective (or ineffective) in the diseases studied.", {"entities": []}], ["Third, most studies have been relatively short-term (median duration 6 months).", {"entities": []}], ["It seems unlikely that in a chronic disease, any intervention can have much effect unless applied for a long period.", {"entities": []}], ["Finally, there have been very few studies of cost-effectiveness.", {"entities": []}], ["Thus the evidence base for the value of telemedicine in managing chronic diseases is on the whole weak and contradictory.", {"entities": []}], ["Smoking prevalence is frequently estimated on the basis of self-reported smoking status.", {"entities": []}], ["That can lead to an underestimation of smoking rates.", {"entities": []}], ["The aim of this study was to evaluate the difference between self-reported smoking status and that determined through the use of objective measures of smoking at a pulmonary outpatient clinic.", {"entities": []}], ["This was a cross-sectional study involving 144 individuals: 51 asthma patients, 53 COPD patients, 20 current smokers, and 20 never-smokers.", {"entities": [[63, 69, "DISEASE"]]}], ["Smoking status was determined on the basis of self-reports obtained in interviews, as well as through tests of exhaled carbon monoxide (eCO) and urinary cotinine.", {"entities": []}], ["All of the asthma patients and COPD patients declared they were not current smokers.", {"entities": [[11, 17, "DISEASE"]]}], ["In the COPD and asthma patients, the median urinary cotinine concentration was 167 ng/mL (range, 2-5,348 ng/mL) and 47 ng/mL (range, 5-2,735 ng/mL), respectively (p < 0.0001), whereas the median eCO level was 8 ppm (range, 0-31 ppm) and 5 ppm (range, 2-45 ppm), respectively (p < 0.05).", {"entities": [[16, 22, "DISEASE"]]}], ["In 40 (38%) of the patients with asthma or COPD (n = 104), there was disagreement between the self-reported smoking status and that determined on the basis of the urinary cotinine concentration, a concentration > 200 ng/mL being considered indicative of current smoking.", {"entities": [[33, 39, "DISEASE"]]}], ["In 48 (46%) of those 104 patients, the self-reported non-smoking status was refuted by an eCO level > 6 ppm, which is also considered indicative of current smoking.", {"entities": []}], ["In 30 (29%) of the patients with asthma or COPD, the urinary cotinine concentration and the eCO level both belied the patient claims of not being current smokers.", {"entities": [[33, 39, "DISEASE"]]}], ["Our findings suggest that high proportions of smoking pulmonary patients with lung disease falsely declare themselves to be nonsmokers.", {"entities": [[78, 90, "DISEASE"]]}], ["The accurate classification of smoking status is pivotal to the treatment of lung diseases.", {"entities": []}], ["Objective measures of smoking could be helpful in improving clinical management and counseling.", {"entities": []}], ["Enterovirus genus includes multiple important human pathogens, such as poliovirus, coxsackievirus, enterovirus (EV) A71, EV-D68 and rhinovirus.", {"entities": []}], ["Infection with EVs can cause numerous clinical conditions including poliomyelitis, meningitis and encephalitis, hand-foot-and-mouth disease, acute flaccid paralysis, diarrhea, myocarditis and respiratory illness.", {"entities": [[68, 81, "DISEASE"], [126, 139, "DISEASE"], [176, 187, "DISEASE"], [98, 110, "DISEASE"], [83, 93, "DISEASE"], [166, 174, "DISEASE"]]}], ["EVs, which are positive-sense single-stranded RNA viruses, trigger activation of the host antiviral innate immune responses through pathogen recognition receptors such as retinoic acid-inducible gene (RIG-I)-likeand Toll-like receptors.", {"entities": []}], ["In turn, EVs have developed sophisticated strategies to evade host antiviral responses.", {"entities": []}], ["In this review, we discuss the interplay between the host innate immune responses and EV infection, with a primary focus on host immune detection and protection against EV infection and viral strategies to evade these antiviral immune responses.", {"entities": []}], ["To assess whether HOUSES (HOUsing-based index of socioeconomic status (SES)) is associated with risk of and mortality after rheumatoid arthritis (RA).", {"entities": [[124, 144, "DISEASE"], [135, 144, "DISEASE"]]}], ["We conducted a population-based case\u2013control study which enrolled population-based RA cases and their controls without RA.", {"entities": []}], ["The study was performed in Olmsted County, Minnesota.", {"entities": []}], ["Study participants were all residents of Olmsted County, Minnesota, with RA identified using the 1987 American College of Rheumatology criteria for RA from 1 January 1988, to 31 December 2007, using the auspices of the Rochester Epidemiology Project.", {"entities": []}], ["For each patient with RA, one control was randomly selected from Olmsted County residents of similar age and gender without RA.", {"entities": []}], ["The disease status was RA cases and their matched controls in relation to HOUSES as an exposure.", {"entities": []}], ["As a secondary aim, post-RA mortality among only RA cases was an outcome event.", {"entities": []}], ["The associations of SES measured by HOUSES with the study outcomes were assessed using logistic regression and Cox models.", {"entities": []}], ["HOUSES, as a composite index, was formulated based on a summed z-score for housing value, square footage and number of bedrooms and bathrooms.", {"entities": []}], ["Of the eligible 604 participants, 418 (69%) were female; the mean age was 56\u00b115.6\u2005years.", {"entities": []}], ["Lower SES, as measured by HOUSES, was associated with the risk of developing RA (0.5\u00b13.8 for controls vs \u22120.2\u00b13.1 for RA cases, p=0.003), adjusting for age, gender, calendar year of RA index date, smoking status and BMI.", {"entities": []}], ["The lowest quartile of HOUSES was significantly associated with increased post-RA mortality compared to higher quartiles of HOUSES (HR 1.74; 95% CI 1.10 to 2.74; p=0.017) in multivariate analysis.", {"entities": [[132, 134, "GENE"]]}], ["Lower SES, as measured by HOUSES, is associated with increased risk of RA and mortality after RA.", {"entities": []}], ["HOUSES may be a useful tool for health disparities research concerning rheumatological outcomes when conventional SES measures are unavailable.", {"entities": []}], ["\u201cOnce development was ended\u2026in the adult centers, the nerve paths are something fixed and immutable.", {"entities": []}], ["Everything may die, nothing may be regenerated,\u201d wrote Santiago Ram\u00f3n y Cajal, a Spanish neuroanatomist and Nobel Prize winner and the father of modern neuroscience.", {"entities": []}], ["This statement was the central dogma in neuroscience for a long time.", {"entities": []}], ["However, in the 1960s, neural stem cells (NSCs) were discovered.", {"entities": []}], ["Since then, our knowledge about NSCs has continued to grow.", {"entities": []}], ["This review focuses on our current knowledge about NSCs and their surrounding microenvironment.", {"entities": []}], ["In addition, the clinical application of NSCs for the treatment of various central nervous system diseases is also summarized.", {"entities": []}], ["The London Chest Activities of Daily Living Scale measures the impact of breathlessness on both activity and social functioning.", {"entities": []}], ["However, the London Chest Activities of Daily Living Scale is not routinely used in patients with advanced disease.", {"entities": []}], ["To assess the psychometric properties of the London Chest Activities of Daily Living Scale in patients with refractory breathlessness due to advanced disease.", {"entities": []}], ["A cross-sectional secondary analysis of data from a randomised controlled parallel-group, pragmatic, single-blind fast-track trial (randomised controlled trial) investigating the effectiveness of an integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness, known as the Breathlessness Support Service (NCT01165034).", {"entities": []}], ["All patients completed the following questionnaires: the London Chest Activities of Daily Living Scale, Chronic Respiratory Questionnaire, the Palliative care Outcome Scale, Palliative care Outcome Scale\u2013symptoms, the Hospital Anxiety and Depression Scale and breathlessness measured on a numerical rating scale.", {"entities": []}], ["Data quality, scaling assumptions, acceptability, internal consistency and construct validity of the London Chest Activities of Daily Living Scale were determined using standard psychometric approaches.", {"entities": []}], ["Breathless patients with advanced malignant and non-malignant disease.", {"entities": []}], ["A total of 88 patients were studied, primary diagnosis included; chronic obstructive pulmonary disease = 53, interstitial lung disease = 17, cancer = 18.", {"entities": [[65, 102, "DISEASE"], [109, 134, "DISEASE"], [122, 134, "DISEASE"], [141, 147, "DISEASE"]]}], ["Median (range) London Chest Activities of Daily Living Scale total score was 46.5 (14\u201367).", {"entities": []}], ["No floor or ceiling effect was observed for the London Chest Activities of Daily Living Scale total score.", {"entities": []}], ["Internal consistency was good, and Cronbach\u2019s alpha for the London Chest Activities of Daily Living Scale total score was 0.90.", {"entities": []}], ["Construct validity was good with 13 out of 15 a priori hypotheses met.", {"entities": []}], ["Psychometric analyses suggest that the London Chest Activities of Daily Living Scale is acceptable, reliable and valid in patients with advanced disease and refractory breathlessness.", {"entities": []}], ["The reach and representativeness are seldom examined in worksite weight loss studies.", {"entities": []}], ["This paper describes and illustrates a method for directly assessing the reach and representativeness of a internet-based worksite weight loss program.", {"entities": []}], ["A brief health survey (BHS) was administered, between January 2008 and November 2009, to employees at 19 worksites in Southwest Virginia.", {"entities": []}], ["The BHS included demographic, behavioral, and health questions.", {"entities": []}], ["All employees were blinded to the existence of a future weight loss program until the completion of the BHS.", {"entities": []}], ["The BHS has a participation rate of 66 percent and the subsequent weight loss program has a participation rate of 30 percent.", {"entities": []}], ["Employees from higher income households, with higher education levels and health literacy proficiency were significantly more likely to participate in the program (p's < .01).", {"entities": []}], ["Worksite weight loss programs should include targeted marketing strategies to engage employees with lower income, education, and health literacy.", {"entities": []}], ["The objective of this study was to examine the impact of smoking on respiratory diseases, hypertension and myocardial infarction, with a particular focus from a life-course perspective.", {"entities": [[90, 102, "DISEASE"], [107, 128, "DISEASE"]]}], ["In this study, 28,577 males from a Chinese longitudinal survey were analysed.", {"entities": []}], ["The effects of smoking on the risk of respiratory diseases, hypertension and myocardial infarction were assessed from a life-course perspective and a current view separately.", {"entities": [[60, 72, "DISEASE"], [77, 98, "DISEASE"]]}], ["No significant associations were found between smoking and the risk of incident respiratory diseases, hypertension and myocardial infarction in the group younger than 35.", {"entities": [[102, 114, "DISEASE"], [119, 140, "DISEASE"]]}], ["Among study participants aged between 36\u201355 and 56\u201380, smoking was positively associated with the risk of incident respiratory diseases, hypertension and myocardial infarction from the life-course perspective, and the risk increased with age.", {"entities": [[137, 149, "DISEASE"], [154, 175, "DISEASE"]]}], ["In contrast, the results from a current view showed inverse associations between smoking and the risk of the diseases mentioned above.", {"entities": []}], ["Our findings highlight that it is essential to quantify the effects of smoking from a life-course perspective in future research and to suggest that smokers quit smoking as soon as possible, regardless of the temporary side effects of quitting.", {"entities": []}], ["Obese asthmatics tend to have poorly controlled asthma, and resistance to standard asthma controller medications.", {"entities": [[48, 54, "DISEASE"], [83, 89, "DISEASE"]]}], ["The purpose of this study was to determine the efficacy of pioglitazone, an anti-diabetic medication which can alter circulating adipokines and have direct effects on asthmatic inflammation, in the treatment of asthma in obesity.", {"entities": [[221, 228, "DISEASE"], [211, 217, "DISEASE"]]}], ["A two-center, 12-week, randomized, placebo-controlled, double-blinded trial.", {"entities": []}], ["Treatments were randomly assigned with concealment of allocation.", {"entities": []}], ["The primary outcome was difference in change in airway reactivity between participants assigned to pioglitazone versus placebo at 12\u00a0weeks.", {"entities": []}], ["Twenty-three participants were randomized to treatment, 19 completed the study.", {"entities": []}], ["Median airway reactivity, measured by PC 20 to methacholine was 1.99 (IQR 3.08) and 1.60 (5.91) mg/ml in placebo and pioglitazone group at baseline, and 2.37 (15.22) and 5.08 (7.42) mg/ml after 12\u00a0weeks, p \u2009=\u20090.38.", {"entities": [[38, 40, "GENE"]]}], ["There was no difference in exhaled nitric oxide, asthma control or lung function between treatment groups over the 12\u00a0week trial.", {"entities": [[49, 55, "DISEASE"]]}], ["Participants assigned to pioglitazone gained a significant amount more weight than those assigned to placebo (pioglitazone group mean weight 113.6, CI 94.5-132.7\u00a0kg at randomization and 115.9, CI 96.9-135.1 at 12\u00a0weeks; placebo mean weight 127.5, CI 108.4 \u2013 146.6\u00a0kg at randomization and 124.5, CI 105.4 \u2013 143.6\u00a0kg at 12\u00a0weeks; p \u2009=\u20090.04).", {"entities": []}], ["This pilot study suggests limited efficacy for pioglitazone in the treatment of poorly controlled asthma in obesity, and also the potential for harm, given the weight gain in those assigned to active treatment, and the association between increased weight and worse outcomes in asthma.", {"entities": [[108, 115, "DISEASE"], [98, 104, "DISEASE"], [278, 284, "DISEASE"]]}], ["Clinicaltrials.gov (NCT00634036)", {"entities": []}], ["The aim of this study was to investigate the predicting value of miR-146a/b for acute exacerbation chronic obstructive pulmonary disease (AECOPD) and COPD, and to explore their associations with inflammatory cytokines in AECOPD and stable COPD patients.", {"entities": [[99, 136, "DISEASE"]]}], ["One hundred six AECOPD, 122 stable COPD patients, and 110 health volunteers with age and sex matched to total COPD patients (AECOPD and stable COPD) were enrolled.", {"entities": []}], ["Blood samples were collected from all participants.", {"entities": []}], ["Relative expression of miR-146a/b was determined by real-time polymerase chain reaction.", {"entities": []}], ["Tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), interleukin-6 (IL-6), interleukin-8 (IL-8), leukotriene B4 (LTB-4) expression in serum from AECOPD and stable COPD patients were assessed using commercial ELISA kit.", {"entities": []}], ["Serum levels of miR-146a and miR-146b were down regulated in AECOPD patients compared with stable COPD patients and HCs.", {"entities": [[16, 24, "GENE"]]}], ["miR-146a and miR-146b are of good values for predicting the risk of AECOPD in HCs with AUC of 0.702 and 0.715.", {"entities": [[0, 8, "GENE"]]}], ["Additionally, miR-146a and miR-146b could distinguish AECOPD from stable COPD patients with AUC of 0.670 and 0.643.", {"entities": [[14, 22, "GENE"]]}], ["In AECOPD patients, levels of miR-146a in AECOPD patients were negatively associated with TNF-\u03b1, IL-6, IL-8, and LTE-4 expression.", {"entities": [[30, 38, "GENE"]]}], ["In stable COPD patients, miR-146a expressions were negatively correlated with TNF-\u03b1, IL-1\u03b2, IL-6, IL-8, and LTE-4 levels.", {"entities": [[25, 33, "GENE"]]}], ["And, the expressions of miR-146b in AECOPD patients were negatively associated with IL-1\u03b2 and LTB-4 expression.", {"entities": []}], ["While in stable COPD patients, miR-146b expressions were only negatively correlated with TNF-\u03b1 level.", {"entities": []}], ["In conclusion, miR-146a and miR-146b were negatively correlated with inflammatory cytokines, and could be promising biomarkers for predicting the risk of AECOPD in stable COPD patients and healthy individuals.", {"entities": [[15, 23, "GENE"]]}], ["Observational and experimental studies of the diagnostic task have demonstrated the importance of the first hypotheses that come to mind for accurate diagnosis.", {"entities": []}], ["A prototype decision support system (DSS) designed to support GPs\u2019 first impressions has been integrated with a commercial electronic health record (EHR) system.", {"entities": []}], ["To evaluate the prototype DSS in a high-fidelity simulation.", {"entities": []}], ["Within-participant design: 34 GPs consulted with six standardised patients (actors) using their usual EHR.", {"entities": []}], ["On a different day, GPs used the EHR with the integrated DSS to consult with six other patients, matched for difficulty and counterbalanced.", {"entities": []}], ["Entering the reason for encounter triggered the DSS, which provided a patient-specific list of potential diagnoses, and supported coding of symptoms during the consultation.", {"entities": []}], ["At each consultation, GPs recorded their diagnosis and management.", {"entities": []}], ["At the end, they completed a usability questionnaire.", {"entities": []}], ["The actors completed a satisfaction questionnaire after each consultation.", {"entities": []}], ["There was an 8\u20139% absolute improvement in diagnostic accuracy when the DSS was used.", {"entities": []}], ["This improvement was significant (odds ratio [OR] 1.41, 95% confidence interval [CI] = 1.13 to 1.77, P <0.01).", {"entities": []}], ["There was no associated increase of investigations ordered or consultation length.", {"entities": []}], ["GPs coded significantly more data when using the DSS (mean 12.35 with the DSS versus 1.64 without), and were generally satisfied with its usability.", {"entities": []}], ["Patient satisfaction ratings were the same for consultations with and without the DSS.", {"entities": []}], ["The DSS prototype was successfully employed in simulated consultations of high fidelity, with no measurable influences on patient satisfaction.", {"entities": []}], ["The substantially increased data coding can operate as motivation for future DSS adoption.", {"entities": []}], ["Emergency departments are important safety nets for people who live in rural areas.", {"entities": []}], ["Moreover, a serious problem in access to healthcare services has emerged in these regions.", {"entities": []}], ["The challenges of providing access to quality rural emergency care include recruitment and retention issues, lack of advanced imagery technology, lack of specialist support and the heavy reliance on ambulance transport over great distances.", {"entities": []}], ["The Quebec Ministry of Health and Social Services published a new version of the Emergency Department Management Guide , a document designed to improve the emergency department management and to humanise emergency department care and services.", {"entities": []}], ["In particular, the Guide recommends solutions to problems that plague rural emergency departments.", {"entities": [[63, 69, "DISEASE"]]}], ["Unfortunately, no studies have evaluated the implementation of the proposed recommendations.", {"entities": []}], ["To develop a comprehensive portrait of all rural emergency departments in Quebec, data will be gathered from databases at the Quebec Ministry of Health and Social Services, the Quebec Trauma Registry and from emergency departments and ambulance services managers.", {"entities": []}], ["Statistics Canada data will be used to describe populations and rural regions.", {"entities": []}], ["To evaluate the use of the 2006 Emergency Department Management Guide and the implementation of its various recommendations, an online survey and a phone interview will be administered to emergency department managers.", {"entities": []}], ["Two online surveys will evaluate quality of work life among physicians and nurses working at rural emergency departments.", {"entities": []}], ["Quality-of-care indicators will be collected from databases and patient medical files.", {"entities": []}], ["Data will be analysed using statistical (descriptive and inferential) procedures.", {"entities": []}], ["This protocol has been approved by the CSSS Alphonse\u2013Desjardins research ethics committee (Project MP-HDL-1213-011).", {"entities": []}], ["The results will be published in peer-reviewed scientific journals and presented at one or more scientific conferences.", {"entities": []}], ["Most casinos owned by sovereign American Indian nations allow smoking, even in U.S. states such as California where state laws restrict workplace smoking.", {"entities": []}], ["Collaborations between casinos and public health workers are needed to promote smoke-free policies that protect workers and patrons from secondhand tobacco smoke (SHS) exposure and risks.", {"entities": []}], ["Over seven years, a coalition of public health professionals provided technical assistance to the Redding Rancheria tribe in Redding, California in establishing a smoke-free policy at the Win-River Resort and Casino.", {"entities": []}], ["The coalition provided information to the casino general manager that included site-specific measurement of employee and visitor PM 2.5 personal exposure, area concentrations of airborne nicotine and PM 2.5 , visitor urinary cotinine, and patron and staff opinions (surveys, focus groups, and a Town Hall meeting).", {"entities": []}], ["The manager communicated results to tribal membership, including evidence of high SHS exposures and support for a smoke-free policy.", {"entities": []}], ["Subsequently, in concert with hotel expansion, the Redding Rancheria Tribal Council voted to accept a 100% restriction of smoking inside the casino, whereupon PM 2.5 exposure in main smoking areas dropped by 98%.", {"entities": []}], ["A 70% partial-smoke-free policy was instituted ~1 year later in the face of revenue loss.", {"entities": []}], ["The success of the collaboration in promoting a smoke-free policy, and the key element of air quality feedback, which appeared to be a central driver, may provide a model for similar efforts.", {"entities": []}], ["Objectives To evaluate the effects of a government insurance program covering tertiary care for people below the poverty line in Karnataka, India, on out-of-pocket expenditures, hospital use, and mortality.", {"entities": []}], ["Design Geographic regression discontinuity study.", {"entities": []}], ["Setting 572 villages in Karnataka, India.", {"entities": []}], ["Participants 31 476 households (22 796 below poverty line and 8680 above poverty line) in 300 villages where the scheme was implemented and 28 633 households (21 767 below poverty line and 6866 above poverty line) in 272 neighboring matched villages ineligible for the scheme.", {"entities": []}], ["Intervention A government insurance program (Vajpayee Arogyashree scheme) that provided free tertiary care to households below the poverty line in about half of villages in Karnataka from February 2010 to August 2012.", {"entities": []}], ["Main outcome measure Out-of-pocket expenditures, hospital use, and mortality.", {"entities": []}], ["Results Among households below the poverty line, the mortality rate from conditions potentially responsive to services covered by the scheme (mostly cardiac conditions and cancer) was 0.32% in households eligible for the scheme compared with 0.90% among ineligible households just south of the eligibility border (difference of 0.58 percentage points, 95% confidence interval 0.40 to 0.75; P<0.001).", {"entities": [[172, 178, "DISEASE"]]}], ["We found no difference in mortality rates for households above the poverty line (households above the poverty line were not eligible for the scheme), with a mortality rate from conditions covered by the scheme of 0.56% in eligible villages compared with 0.55% in ineligible villages (difference of 0.01 percentage points, \u22120.03 to 0.03; P=0.95).", {"entities": []}], ["Eligible households had significantly reduced out-of-pocket health expenditures for admissions to hospitals with tertiary care facilities likely to be covered by the scheme (64% reduction, 35% to 97%; P<0.001).", {"entities": []}], ["There was no significant increase in use of covered services, although the point estimate of a 44.2% increase approached significance (\u22125.1% to 90.5%; P=0.059).", {"entities": []}], ["Both reductions in out-of-pocket expenditures and potential increases in use might have contributed to the observed reductions in mortality.", {"entities": []}], ["Conclusions Insuring poor households for efficacious but costly and underused health services significantly improves population health in India.", {"entities": []}], ["Metformin use reduces the incidence and severity of stroke in patients with type 2 diabetes mellitus ( DM ).", {"entities": [[83, 100, "DISEASE"], [76, 100, "DISEASE"]]}], ["The benefits of metformin for stroke have not been examined in hemodialysis patients with DM .", {"entities": []}], ["Using the National Health Insurance Research Database, we identified 17\u00a0760 patients with DM and new\u2010onset hemodialysis between 2001 and 2013.", {"entities": []}], ["Of these, 1898 patients hospitalized for either ischemic or hemorrhagic stroke were matched to 7592 control patients according to sex, age, and year of initial hemodialysis therapy by using incidence sampling.", {"entities": []}], ["The association between metformin use and stroke risk was estimated using conditional logistic regression after adjustment for hemodialysis frequency, comorbidity, and prescribed medications.", {"entities": []}], ["Metformin use was recorded before the date of stroke admission and the date of pseudostroke of the case and control patients, respectively.", {"entities": []}], ["Results showed that hemodialysis patients with ischemic stroke were more likely to use metformin than the controls 1\u00a0year before the date of stroke admission (adjusted odds ratio: 1.64; 95% confidence interval, 1.32\u20132.04).", {"entities": []}], ["The association was evident within 90\u00a0days before the index date (adjusted odds ratio: 1.81; 95% confidence interval, 1.27\u20132.60).", {"entities": []}], ["The results were consistent with those of hemodialysis patients with hemorrhagic stroke.", {"entities": []}], ["Metformin use remained a risk factor for stroke in patients treated with antihypertensive, sulfonylurea, and antiplatelet drugs.", {"entities": []}], ["This nested case\u2013control study is the first to show that metformin use is associated with stroke risk in hemodialysis patients with DM .", {"entities": []}], ["We suggest that metformin should not be used by hemodialysis patients with DM .", {"entities": []}], ["Since the beginning of the 20th century there has been a scientific debate about the potential effects of air ions on biological tissues, wellbeing and health.", {"entities": []}], ["Effects on the cardiovascular and respiratory system as well as on mental health have been described.", {"entities": []}], ["In recent years, there has been a renewed interest in this topic.", {"entities": []}], ["In an experimental indoor setting we conducted a double-blind cross-over trial to determine if higher levels of air ions, generated by a special wall paint, affect cognitive performance, wellbeing, lung function, and cardiovascular function.", {"entities": []}], ["Twenty healthy non-smoking volunteers (10 female, 10 male) participated in the study.", {"entities": []}], ["Levels of air ions, volatile organic compounds and indoor climate factors were determined by standardized measurement procedures.", {"entities": []}], ["Air ions affected the autonomous nervous system (in terms of an increase of sympathetic activity accompanied by a small decrease of vagal efferent activity): In the test room with higher levels of air ions (2194/cm vs. 1038/cm", {"entities": []}], ["Epidemiological studies have consistently shown associations between elevated concentrations of urban particulate matter ( UPM ) air pollution and exacerbations of asthma and chronic obstructive pulmonary disease, which are both associated with viral respiratory infections.", {"entities": [[175, 212, "DISEASE"], [164, 170, "DISEASE"]]}], ["The effects of UPM on dendritic cell ( DC ) \u2010stimulated CD 4 T lymphocytes have been investigated previously, but little work has focused on CD 8 T\u2010lymphocyte responses despite their importance in anti\u2010viral immunity.", {"entities": []}], ["To address this, we examined the effects of UPM on DC \u2010stimulated naive CD 8 T\u2010cell responses.", {"entities": []}], ["Expression of the maturation/activation markers CD 83, CCR 7, CD 40 and MHC class I on human myeloid DC s ( mDC s) was characterized by flow cytometry after stimulation with UPM in vitro in the presence/absence of granulocyte\u2013macrophage colony\u2010stimulating factor ( GM \u2010 CSF ).", {"entities": []}], ["The capacity of these mDC s to stimulate naive CD 8 T\u2010lymphocyte responses in allogeneic co\u2010culture was then assessed by measuring T\u2010cell cytokine secretion using cytometric bead array, and proliferation and frequency of interferon\u2010 \u03b3 ( IFN \u2010 \u03b3 )\u2010producing T lymphocytes by flow cytometry.", {"entities": []}], ["Treatment of mDC s with UPM increased expression of CD 83 and CCR 7, but not MHC class I.", {"entities": []}], ["In allogeneic co\u2010cultures, UPM treatment of mDC s enhanced CD 8 T\u2010cell proliferation and the frequency of IFN \u2010 \u03b3 \u03b1 , interleukin\u201013, Granzyme A and Granzyme B were also increased.", {"entities": []}], ["GM \u2010 CSF alone, and in concert with UPM , enhanced many of these T\u2010cell functions.", {"entities": []}], ["The PM \u2010induced increase in Granzyme A was confirmed in a human experimental diesel exposure study.", {"entities": []}], ["These data demonstrate that UPM treatment of mDC s enhances priming of naive CD 8 T lymphocytes and increases production of pro\u2010inflammatory cytokines.", {"entities": []}], ["Such UPM \u2010induced stimulation of CD 8 cells may potentiate T\u2010lymphocyte cytotoxic responses upon concurrent airway infection, increasing bystander damage to the airways.", {"entities": []}], ["As a potent bronchodilator, the anti-inflammatory effects of tiotropium and its interaction with budesonide against cadmium-induced acute pulmonary inflammation were investigated.", {"entities": []}], ["Compared to values obtained in rats exposed to cadmium, cytological analysis indicated a significant decrease of total cell and neutrophil counts and protein concentration in bronchoalveolar lavage fluid (BALF) in rats pretreated with tiotropium (70\u03bcg/15ml or 350\u03bcg/15ml).", {"entities": []}], ["Zymographic tests showed a decrease of MMP-2 activity in BALF in rats pretreated only with high concentration of tiotropium.", {"entities": []}], ["Histological examination revealed a significant decrease of the severity and extent of inflammatory lung injuries in rats pretreated with both tested concentrations of tiotropium.", {"entities": []}], ["Though tiotropium (70\u03bcg/15ml) or budesonide (250\u03bcg/15ml) could not reduce cadmium-induced bronchial hyper-responsiveness, their combination significantly decreased bronchial contractile response to methacholine.", {"entities": []}], ["These two drugs separately decreased the neutrophil number and protein concentration in BALF but no significant interaction was observed when both drugs were combined.", {"entities": []}], ["Although no inhibitory effects on MMP-2 and MMP-9 was observed in rats pretreated with budesonide alone, the combination with the ineffective dose of tiotropium induced a significant reduction on these parameters.", {"entities": []}], ["The inhibitory effect of tiotropium on lung injuries was not influenced by budesonide which alone induced a limited action on the severity and extent of inflammatory sites.", {"entities": []}], ["Our findings show that tiotropium exerts anti-inflammatory effects on cadmium-induced acute neutrophilic pulmonary inflammation.", {"entities": []}], ["The combination of tiotropium with budesonide inhibits cadmium-induced inflammatory injuries with a synergistic interaction on MMP-2 and MMP-9 activity and airway hyper-responsiveness.", {"entities": []}], ["Our aim in the present study was to compare patients presenting with gastroesophageal reflux disease in the presence or absence of mild-grade esophagitis (grade I or II according to the Savary-Miller classification).", {"entities": [[142, 153, "DISEASE"], [69, 100, "DISEASE"]]}], ["Between 2005 and 2007, 215 patients with gastroesophageal reflux disease (67 with reflux associated with grade I or II esophagitis and 148 without esophagitis) were evaluated at the Department of Surgery, University Hospital Tor Vergata, Rome, and were included in the present study.", {"entities": [[119, 130, "DISEASE"], [147, 158, "DISEASE"], [41, 72, "DISEASE"]]}], ["The evaluations consisted of clinical interviews, endoscopy of the high digestive tract, esophageal manometry and pH monitoring.", {"entities": []}], ["There was no significant difference between the two groups with regard to age, sex or symptoms.", {"entities": []}], ["The incidence of heartburn associated with noncardiac chest pain was greater in the esophagitis group than in the dysphagia group.", {"entities": [[84, 95, "DISEASE"]]}], ["The incidence of hiatal hernia was similar in both groups.", {"entities": []}], ["Although the motor pattern was similar in both groups, the length of the abdominal esophagus was greater in patients without esophagitis (1.6 cm vs 1.1 cm; P \u2009<\u20090.05).", {"entities": [[125, 136, "DISEASE"]]}], ["The reflux pattern was nearly identical in both groups.", {"entities": []}], ["Gastroesophageal reflux without esophagitis must be regarded not as a milder form of the disease but as part of a single disease.", {"entities": [[32, 43, "DISEASE"]]}], ["Furthermore, these patients often demonstrate lower rates of symptom improvement after antireflux treatment in comparison with patients with erosive esophagitis.", {"entities": [[149, 160, "DISEASE"]]}], ["Therefore, further trials to assess the treatment algorithm for these patients are warranted.", {"entities": []}], ["In October 2009, the first case of pandemic influenza A(H1N1)pdm09 (pH1N1) was confirmed in Kigali, Rwanda and countrywide dissemination occurred within several weeks.", {"entities": [[44, 53, "DISEASE"]]}], ["We describe clinical and epidemiological characteristics of this epidemic.", {"entities": []}], ["From October 2009 through May 2010, we undertook epidemiologic investigations and response to pH1N1.", {"entities": []}], ["Respiratory specimens were collected from all patients meeting the WHO case definition for pH1N1, which were tested using CDC\u2019s real time RT-PCR protocol at the Rwandan National Reference Laboratory (NRL).", {"entities": [[200, 203, "GENE"]]}], ["Following documented viral transmission in the community, testing focused on clinically severe and high-risk group suspect cases.", {"entities": []}], ["From October 9, 2009 through May 31, 2010, NRL tested 2,045 specimens.", {"entities": [[43, 46, "GENE"]]}], ["In total, 26% (n\u200a=\u200a532) of specimens tested influenza positive; of these 96% (n\u200a=\u200a510) were influenza A and 4% (n\u200a=\u200a22) were influenza B.", {"entities": [[44, 53, "DISEASE"], [92, 101, "DISEASE"], [125, 134, "DISEASE"]]}], ["Of cases testing influenza A positive, 96.8% (n\u200a=\u200a494), 3% (n\u200a=\u200a15), and 0.2% (n\u200a=\u200a1) were A(H1N1)pdm09, Seasonal A(H3) and Seasonal A(non-subtyped), respectively.", {"entities": [[17, 26, "DISEASE"]]}], ["Among laboratory-confirmed cases, 263 (53.2%) were children <15 years and 275 (52%) were female.", {"entities": []}], ["In total, 58 (12%) cases were hospitalized with mean duration of hospitalization of 5 days (Range: 2\u201315 days).", {"entities": []}], ["All cases recovered and there were no deaths.", {"entities": []}], ["Overall, 339 (68%) confirmed cases received oseltamivir in any setting.", {"entities": []}], ["Among all positive cases, 26.9% (143/532) were among groups known to be at high risk of influenza-associated complications, including age <5 years 23% (122/532), asthma 0.8% (4/532), cardiac disease 1.5% (8/532), pregnancy 0.6% (3/532), diabetes mellitus 0.4% (2/532), and chronic malnutrition 0.8% (4/532).", {"entities": [[88, 97, "DISEASE"], [162, 168, "DISEASE"], [237, 254, "DISEASE"]]}], ["Rwanda experienced a PH1N1 outbreak which was epidemiologically similar to PH1N1 outbreaks in the region.", {"entities": []}], ["Unlike seasonal influenza, children <15 years were the most affected by pH1N1.", {"entities": [[16, 25, "DISEASE"]]}], ["Lessons learned from the outbreak response included the need to strengthen integrated disease surveillance, develop laboratory contingency plans, and evaluate the influenza sentinel surveillance system.", {"entities": [[163, 172, "DISEASE"]]}], ["Allergic airways disease is a consequence of a Th2 response to an allergen leading to a series of manifestations such as production of allergen-specific IgE, inflammatory infiltrates in the airways, and airway hyper-reactivity (AHR).", {"entities": [[228, 231, "GENE"]]}], ["Several strategies have been reported for tolerance induction to allergens leading to protection from allergic airways disease.", {"entities": []}], ["We now show that CD4 blockade at the time of house dust mite sensitization induces antigen-specific tolerance in mice.", {"entities": [[17, 20, "GENE"]]}], ["Tolerance induction is robust enough to be effective in pre-sensitized animals, even in those where AHR was pre-established.", {"entities": [[100, 103, "GENE"]]}], ["Tolerant mice are protected from airways eosinophilia, Th2 lung infiltration, and AHR.", {"entities": [[41, 53, "DISEASE"], [82, 85, "GENE"]]}], ["Furthermore, anti-CD4 treated mice remain immune competent to mount immune responses, including Th2, to unrelated antigens.", {"entities": []}], ["Our findings, therefore, describe a strategy for tolerance induction potentially applicable to other immunogenic proteins besides allergens.", {"entities": []}], ["It has been suggested that children with same-sex attracted parents score well in psychosocial aspects of their health, however questions remain about the impact of stigma on these children.", {"entities": []}], ["Research to date has focused on lesbian parents and has been limited by small sample sizes.", {"entities": []}], ["This study aims to describe the physical, mental and social wellbeing of Australian children with same-sex attracted parents, and the impact that stigma has on them.", {"entities": []}], ["A cross-sectional survey, the Australian Study of Child Health in Same-Sex Families, was distributed in 2012 to a convenience sample of 390 parents from Australia who self-identified as same-sex attracted and had children aged 0-17 years.", {"entities": []}], ["Parent-reported, multidimensional measures of child health and wellbeing and the relationship to perceived stigma were measured.", {"entities": []}], ["315 parents completed the survey (completion rate\u2009=\u200981%) representing 500 children.", {"entities": []}], ["80% of children had a female index parent while 18% had a male index parent.", {"entities": []}], ["Children in same-sex parent families had higher scores on measures of general behavior, general health and family cohesion compared to population normative data (\u03b2\u2009=\u20092.93, 95% CI\u2009=\u20090.35 to 5.52, P\u2009=\u2009.03; \u03b2\u2009=\u20095.60, 95% CI\u2009=\u20092.69 to 8.52, P\u2009=\u2009<.001; and \u03b2\u2009=\u20096.01, 95% CI\u2009=\u20092.84 to 9.17, P\u2009=\u2009<.001 respectively).", {"entities": []}], ["There were no significant differences between the two groups for all other scale scores.", {"entities": []}], ["Physical activity, mental health, and family cohesion were all negatively associated with increased stigma (\u03b2\u2009=\u2009-3.03, 95% CI\u2009=\u2009-5.86 to -0.21, P\u2009=\u2009.04; \u03b2\u2009=\u2009-10.45, 95% CI\u2009=\u2009-18.48 to -2.42, P\u2009=\u2009.01; and \u03b2\u2009=\u2009-9.82, 95% CI\u2009=\u2009-17.86 to -1.78, P\u2009=\u2009.02 respectively) and the presence of emotional symptoms was positively associated with increased stigma (\u03b2 =0.94, 95% CI\u2009=\u20090.08 to 1.81, P\u2009=\u2009.03).", {"entities": []}], ["Australian children with same-sex attracted parents score higher than population samples on a number of parent-reported measures of child health.", {"entities": []}], ["Perceived stigma is negatively associated with mental health.", {"entities": []}], ["Through improved awareness of stigma these findings play an important role in health policy, improving child health outcomes.", {"entities": []}], ["Granzyme B (GrB) is a pro-apoptotic serine protease that contributes to immune-mediated target cell apoptosis.", {"entities": []}], ["However, during inflammation, GrB accumulates in the extracellular space, retains its activity, and is capable of cleaving extracellular matrix (ECM) proteins.", {"entities": []}], ["Recent studies have implicated a pathogenic extracellular role for GrB in cardiovascular disease, yet the pathophysiological consequences of extracellular GrB activity remain largely unknown.", {"entities": []}], ["The objective of this study was to identify proteoglycan (PG) substrates of GrB and examine the ability of GrB to release PG-sequestered TGF-\u03b21 into the extracellular milieu.", {"entities": []}], ["Three extracellular GrB PG substrates were identified; decorin, biglycan and betaglycan.", {"entities": []}], ["As all of these PGs sequester active TGF-\u03b21, cytokine release assays were conducted to establish if GrB-mediated PG cleavage induced TGF-\u03b21 release.", {"entities": []}], ["Our data confirmed that GrB liberated TGF-\u03b21 from all three substrates as well as from endogenous ECM and this process was inhibited by the GrB inhibitor 3,4-dichloroisocoumarin.", {"entities": []}], ["The released TGF-\u03b21 retained its activity as indicated by the induction of SMAD-3 phosphorylation in human coronary artery smooth muscle cells.", {"entities": []}], ["In addition to contributing to ECM degradation and the loss of tissue structural integrity in vivo , increased extracellular GrB activity is also capable of inducing the release of active TGF-\u03b21 from PGs.", {"entities": []}], ["Nonsteroidal anti-inflammatory drugs (NSAIDs) are a family of COX1 and COX2 inhibitors used to reduce the synthesis of pro-inflammatory mediators.", {"entities": []}], ["In addition, inflammation often leads to a harmful generation of nitric oxide.", {"entities": []}], ["Efforts are being done in discovering safer NSAIDs molecules capable of inhibiting the synthesis of pro-inflammatory lipid mediators and nitric oxide to reduce the side effects associated with long term therapies.", {"entities": []}], ["The analogue of arachidonic acid (AA), 2-hydroxy-arachidonic acid (2OAA), was designed to inhibit the activities of COX1 and COX2 and it was predicted to have similar binding energies as AA for the catalytic sites of COX1 and COX2.", {"entities": []}], ["The interaction of AA and 2OAA with COX1 and COX2 was investigated calculating the free energy of binding and the Fukui function.", {"entities": []}], ["Toxicity was determined in mouse microglial BV-2 cells.", {"entities": []}], ["COX1 and COX2 (PGH2 production) activities were measured in vitro.", {"entities": []}], ["COX1 and COX2 expression in human macrophage-like U937 cells were carried out by Western blot, immunocytochemistry and RT-PCR analysis.", {"entities": []}], ["NO production (Griess method) and iNOS (Western blot) were determined in mouse microglial BV-2 cells.", {"entities": []}], ["The comparative efficacy of 2OAA, ibuprofen and cortisone in lowering TNF-\u03b1 serum levels was determined in C57BL6/J mice challenged with LPS.", {"entities": []}], ["We show that the presence of the \u2013OH group reduces the likelihood of 2OAA being subjected to H* abstraction in COX, without altering significantly the free energy of binding.", {"entities": []}], ["The 2OAA inhibited COX1 and COX2 activities and the expression of COX2 in human U937 derived macrophages challenged with LPS.", {"entities": []}], ["In addition, 2OAA inhibited iNOS expression and the production of NO in BV-2 microglial cells.", {"entities": []}], ["Finally, oral administration of 2OAA decreased the plasma TNF-\u03b1 levels in vivo.", {"entities": []}], ["These findings demonstrate the potential of 2OAA as a NSAID.", {"entities": []}], ["Silica nanoparticles (SiNPs) have numerous beneficial properties and are extensively used in cosmetics and food industries as anti-caking, densifying and hydrophobic agents.", {"entities": []}], ["However, the increasing exposure levels experienced by the general population and the ability of SiNPs to penetrate cells and tissues have raised concerns about possible toxic effects of this material.", {"entities": []}], ["Although SiNPs are known to affect the function of the airway epithelium, the molecular targets of these particles remain largely unknown.", {"entities": []}], ["Given that SiNPs interact with the plasma membrane of epithelial cells we hypothesized that they may affect the function of Transient Receptor Potential Vanilloid 4 (TRPV4), a cation-permeable channel that regulates epithelial barrier function.", {"entities": [[166, 171, "GENE"]]}], ["The main aims of this study were to evaluate the effects of SiNPs on the activation of TRPV4 and to determine whether these alter the positive modulatory action of this channel on the ciliary beat frequency in airway epithelial cells.", {"entities": [[87, 92, "GENE"]]}], ["Using fluorometric measurements of intracellular Ca i ) we found that SiNPs inhibit activation of TRPV4 by the synthetic agonist GSK1016790A in cultured human airway epithelial cells 16HBE and in primary cultured mouse tracheobronchial epithelial cells.", {"entities": [[98, 103, "GENE"]]}], ["Inhibition of TRPV4 by SiNPs was confirmed in intracellular Ca i , but in a TRPV4-independent manner.", {"entities": [[14, 19, "GENE"], [76, 81, "GENE"]]}], ["SiNPs enhanced the activation of the capsaicin receptor TRPV1, demonstrating that these particles have a specific inhibitory action on TRPV4 activation.", {"entities": [[56, 61, "GENE"], [135, 140, "GENE"]]}], ["Finally, we found that SiNPs abrogate the increase in ciliary beat frequency induced by TRPV4 activation in mouse airway epithelial cells.", {"entities": [[88, 93, "GENE"]]}], ["Our results show that SiNPs inhibit TRPV4 activation, and that this effect may impair the positive modulatory action of the stimulation of this channel on the ciliary function in airway epithelial cells.", {"entities": [[36, 41, "GENE"]]}], ["These findings unveil the cation channel TRPV4 as a primary molecular target of SiNPs.", {"entities": [[41, 46, "GENE"]]}], ["There is a paucity of data about the clinical characteristics that help identify patients at high risk of influenza infection upon ICU admission.", {"entities": [[106, 115, "DISEASE"]]}], ["We aimed to identify predictors of influenza infection in patients admitted to ICUs during the 2007/2008 and 2008/2009 influenza seasons and the second wave of the 2009 H1N1 influenza pandemic as well as to identify populations with increased likelihood of seasonal and pandemic 2009 influenza (pH1N1) infection.", {"entities": [[35, 44, "DISEASE"], [119, 128, "DISEASE"], [174, 183, "DISEASE"], [284, 293, "DISEASE"]]}], ["Six Toronto acute care hospitals participated in active surveillance for laboratory-confirmed influenza requiring ICU admission during periods of influenza activity from 2007 to 2009.", {"entities": [[94, 103, "DISEASE"], [146, 155, "DISEASE"]]}], ["Nasopharyngeal swabs were obtained from patients who presented to our hospitals with acute respiratory or cardiac illness or febrile illness without a clear nonrespiratory aetiology.", {"entities": []}], ["Predictors of influenza were assessed by multivariable logistic regression analysis and the likelihood of influenza in different populations was calculated.", {"entities": [[14, 23, "DISEASE"], [106, 115, "DISEASE"]]}], ["In 5,482 patients, 126 (2.3%) were found to have influenza.", {"entities": [[49, 58, "DISEASE"]]}], ["Admission temperature \u226538\u00b0C (odds ratio (OR) 4.7 for pH1N1, 2.3 for seasonal influenza) and admission diagnosis of pneumonia or respiratory infection (OR 7.3 for pH1N1, 4.2 for seasonal influenza) were independent predictors for influenza.", {"entities": [[77, 86, "DISEASE"], [186, 195, "DISEASE"], [229, 238, "DISEASE"], [115, 124, "DISEASE"]]}], ["During the peak weeks of influenza seasons, 17% of afebrile patients and 27% of febrile patients with pneumonia or respiratory infection had influenza.", {"entities": [[25, 34, "DISEASE"], [141, 150, "DISEASE"], [102, 111, "DISEASE"]]}], ["During the second wave of the 2009 pandemic, 26% of afebrile patients and 70% of febrile patients with pneumonia or respiratory infection had influenza.", {"entities": [[142, 151, "DISEASE"], [103, 112, "DISEASE"]]}], ["The findings of our study may assist clinicians in decision making regarding optimal management of adult patients admitted to ICUs during future influenza seasons.", {"entities": [[145, 154, "DISEASE"]]}], ["Influenza testing, empiric antiviral therapy and empiric infection control precautions should be considered in those patients who are admitted during influenza season with a diagnosis of pneumonia or respiratory infection and are either febrile or admitted during weeks of peak influenza activity.", {"entities": [[0, 9, "DISEASE"], [150, 159, "DISEASE"], [278, 287, "DISEASE"], [187, 196, "DISEASE"]]}], ["Integrin adhesion receptors mediate cell\u2013cell and cell\u2013extracellular matrix interactions, which control cell morphology and migration, differentiation, and tissue integrity.", {"entities": []}], ["Integrins recruit multimolecular adhesion complexes to their cytoplasmic domains, which provide structural and mechanosensitive signaling connections between the extracellular and intracellular milieux.", {"entities": []}], ["The different functions of specific integrin heterodimers, such as \u03b14\u03b21 and \u03b15\u03b21, have been attributed to distinct signal transduction mechanisms that are initiated by selective recruitment of adhesion complex components to integrin cytoplasmic tails.", {"entities": []}], ["Here, we report the isolation of ligand-induced adhesion complexes associated with wild-type \u03b14\u03b21 integrin, an activated \u03b14\u03b21 variant in the absence of the \u03b1 cytoplasmic domain (X4C0), and a chimeric \u03b14\u03b21 variant with \u03b15 leg and cytoplasmic domains (\u03b14P\u03b15L), and the cataloguing of their proteomes by MS.", {"entities": []}], ["Using hierarchical clustering and interaction network analyses, we detail the differential recruitment of proteins and highlight enrichment patterns of proteins to distinct adhesion complexes.", {"entities": []}], ["We identify previously unreported components of integrin adhesion complexes and observe receptor-specific enrichment of molecules with previously reported links to cell migration and cell signaling processes.", {"entities": []}], ["Furthermore, we demonstrate colocalization of MYO18A with active integrin in migrating cells.", {"entities": [[46, 52, "GENE"]]}], ["These datasets provide a resource for future studies of integrin receptor-specific signaling events.", {"entities": []}], ["Attrition is a potential source of bias in cohort studies.", {"entities": []}], ["Although attrition may be inevitable in cohort studies of older people, there is little empirical evidence as to whether bias due to such attrition is also inevitable.", {"entities": []}], ["Anonymised primary care data, routinely collected in clinical practice and independent of any cohort research study, represents an ideal unselected comparison dataset with which to compare primary care data from consenting responders to a cohort study.", {"entities": []}], ["Our objective was to use this method as a novel means to assess if (i) responders at follow-up stages in a cohort study remain representative of responders at baseline and (ii) attrition biases estimates of longitudinal associations.", {"entities": []}], ["We compared primary care consultation morbidities and prescription prevalences among circa 32,000 patients aged 50+ who contribute to an anonymised general practice database (Consultations in Primary Care Archive (CiPCA)) with those from patients aged 50+ in the North Staffordshire Osteoarthritis Project (NorStOP) cohort, United Kingdom (2002\u20132008; n\u200a=\u200a16,159).", {"entities": [[283, 297, "DISEASE"]]}], ["8,197 (51%) persons responded to the NorStOP baseline survey and consented to medical record review.", {"entities": []}], ["5,121 and 3,311 responded at 3- and 6-year follow-ups.", {"entities": []}], ["Differences in consulting prevalence of non-musculoskeletal morbidities between NorStOP responders and CiPCA comparison population did not increase over the two follow-up points except for ischaemic heart disease.", {"entities": [[199, 212, "DISEASE"]]}], ["Differences observed at baseline for osteoarthritis-related consultations were generally unchanged at the two follow-ups (standardised prevalence ratios for osteoarthritis (1.09\u20131.13) and joint pain (1.12\u20131.23)).", {"entities": [[37, 51, "DISEASE"], [157, 171, "DISEASE"]]}], ["Age and gender adjusted associations between baseline consultation for chronic morbidity and future new osteoarthritis and related consultations were similar in CiPCA (adjusted Hazard Ratio: 1.40; 95% Confidence Interval: 1.34,1.47) and NorStOP 6-year responders (1.32; 1.15,1.51).", {"entities": [[104, 118, "DISEASE"]]}], ["There was little evidence that responders at follow-ups represented any further selection bias to that present at baseline.", {"entities": []}], ["Attrition in cohort studies of older people does not inevitably indicate bias.", {"entities": []}], ["Microscopic colitis (MC) is a disease manifested by diarrhoea and is divided into collagenous and lymphocytic colitis.", {"entities": []}], ["The aetiology is unknown, but auto-immunity is suggested.", {"entities": []}], ["Auto-antibodies have been only rarely examined in this entity.", {"entities": []}], ["The aim of the study was to examine the prevalence of auto-antibodies, and to examine associations between the presence of antibodies and clinical findings.", {"entities": []}], ["Women with MC verified by biopsy and younger than 73 years, at any Department of Gastroenterology, in the district of Sk\u00e5ne, between 2002 and 2010 were invited to participate in this study.", {"entities": []}], ["The patients were asked to complete both a questionnaire describing their medical history and the Gastrointestinal Symptom Rating Scale (GSRS).", {"entities": []}], ["Blood samples were collected.", {"entities": []}], ["Anti-nuclear antibodies (ANA), anti-neutrophil cytoplasmic antibodies (ANCA), anti-Saccharomyces cerevisiae antibodies (ASCA), and antibodies against glutamic acid decarboxylase (anti-GAD), islet antigens-like insulin 2 (anti-IA2), thyroid peroxidase (anti-TPO), and thyrotropin receptor (TRAK) were analysed.", {"entities": []}], ["Of 240 women identified, 133 were finally included in the study, median age 63 (59\u201367) years.", {"entities": []}], ["Apart from the MC diagnosis, 52% also suffered from irritable bowel syndrome, 31% from hypertension and 31% from allergy.", {"entities": [[87, 99, "DISEASE"], [52, 76, "DISEASE"], [68, 76, "DISEASE"]]}], ["The prevalence of ANA (14%), ASCA IgG (13%), and anti-TPO antibodies (14%) for these patients was slightly higher than for the general population, and were found together with other concomitant diseases.", {"entities": []}], ["Patients had more of all gastrointestinal symptoms compared with norm values, irrespective of antibody expression.", {"entities": []}], ["Women with MC have a slightly increased prevalence of some auto-antibodies.", {"entities": []}], ["These antibodies are not associated with symptoms, but are expressed in patients with concomitant diseases, obscuring the pathophysiology and clinical picture of MC.", {"entities": []}], ["Sensitization to specific olive pollen-allergens (Ole e 2 and 10) has been correlated with a clinical pattern of asthma.", {"entities": [[113, 119, "DISEASE"]]}], ["This study analyzes the association between several polymorphims of TNFA ( G-308A , C-857T , and C-1031T ), IL10 ( C-571A and A-1117G ), and TGFB ( C-509-T ) and these sensitizations.", {"entities": [[108, 112, "GENE"]]}], ["These polymorphisms were genotyped by allelic discrimination, in olive pollen-allergic patients (phenotyped for specific Ole e 2 and 10 sensitizations) and healthy controls.", {"entities": []}], ["Levels of serum-soluble cytokines were correlated with specific genotypes and clinical phenotypes.", {"entities": []}], ["The results showed that heterozygous TGFB C-509T genotype, besides having the lowest sera TGF- levels, was significantly increased in olive pollen-allergic patients compared with controls.", {"entities": []}], ["According specific sensitizations, CC genotype of IL10 C - 571A could be a protective factor for Ole e 2 sensitization and mainly for asthmatic Ole e 2 sensitized patients compared with asthmatic non-Ole e 2 sensitized patients (OR: 0.26, P = 0.008).", {"entities": [[50, 54, "GENE"]]}], ["In contrast, heterozygous CA genotype was increased in Ole e 2 asthmatic subjects compared to asthmatic non-Ole e 2 sensitized patients.", {"entities": []}], ["Lastly, heterozygous TNFA G-308A genotype was associated with Ole e 10 sensitization (OR: 2.5, P = 0.04).", {"entities": []}], ["In conclusion, these results suggest a role of TGF- \u03b2 1 in olive-pollen sensitization and TNF- \u03b1 and IL-10 genotypes in the asthma induced by specific olive-pollen allergens.", {"entities": [[124, 130, "DISEASE"]]}], ["New therapeutic strategies to modulate the immune response of human and equine allergic asthma are still under extensive investigation.", {"entities": [[79, 94, "DISEASE"], [88, 94, "DISEASE"]]}], ["Immunomodulating agents stimulating T\u2010regulatory cells offer new treatment options beyond conventional symptomatic treatment or specific immunotherapy for human and equine allergic airway diseases, with the goal of a homoeostatic T\u2010helper cell balance.", {"entities": []}], ["The aim of this study was to evaluate the effects of a nebulized gelatin nanoparticle\u2010CpG formulation (CpG\u2010GNP) with and without specific allergens for the treatment of spontaneous allergic equine asthma as a model for human asthma.", {"entities": [[197, 203, "DISEASE"], [225, 231, "DISEASE"]]}], ["Twenty equine asthma\u2010affected horses were treated either with CpG\u2010GNP alone or CpG\u2010GNP with allergens.", {"entities": [[14, 20, "DISEASE"]]}], ["Two specific allergens were selected for each horse based on history and an in\u2010vitro test.", {"entities": []}], ["Each horse received seven administrations of the respective nebulized composition and was examined before treatment, immediately after and 6 weeks after the treatment course.", {"entities": []}], ["Clinical parameters such as breathing rate, indirect interpleural measurement, arterial blood gases, amount of tracheal mucus and percentage of neutrophils and cytokines in tracheal washes and serum samples were evaluated.", {"entities": []}], ["Treatment with CpG\u2010GNP alone as well as in combinations with relevant allergens resulted in clinical improvement of nasal discharge, breathing rate, amount of secretion and viscosity, neutrophil percentage and partial oxygen pressure directly after and 6 weeks after treatment.", {"entities": []}], ["There were no significant differences between the two treatments in clinical parameters or local cytokine profiles in the tracheal wash fluid (IL\u201010, IFN\u2010g, and IL\u201017).", {"entities": []}], ["IL\u20104 concentrations decreased significantly in both groups.", {"entities": []}], ["Nonspecific CpG\u2010GNP\u2010based immunotherapy shows potential as a treatment for equine and possibly also human allergic asthma.", {"entities": [[106, 121, "DISEASE"], [115, 121, "DISEASE"]]}], ["Asthma is a disease of varying severity and differing disease mechanisms.", {"entities": [[0, 6, "DISEASE"]]}], ["To date, studies aimed at stratifying asthma into clinically useful phenotypes have produced a number of phenotypes that have yet to be assessed for stability and to be validated in independent cohorts.", {"entities": [[38, 44, "DISEASE"]]}], ["The aim of this study was to define and validate, for the first time ever, clinically driven asthma phenotypes using two independent, severe asthma cohorts: ADEPT and U-BIOPRED.", {"entities": [[93, 99, "DISEASE"], [141, 147, "DISEASE"]]}], ["Fuzzy partition-around-medoid clustering was performed on pre-specified data from the ADEPT participants ( n \u2009=\u2009156) and independently on data from a subset of U-BIOPRED asthma participants ( n \u2009=\u200982) for whom the same variables were available.", {"entities": [[170, 176, "DISEASE"]]}], ["Models for cluster classification probabilities were derived and applied to the 12-month longitudinal ADEPT data and to a larger subset of the U-BIOPRED asthma dataset ( n \u2009=\u2009397).", {"entities": [[153, 159, "DISEASE"]]}], ["High and low type-2 inflammation phenotypes were defined as high or low Th2 activity, indicated by endobronchial biopsies gene expression changes downstream of IL-4 or IL-13.", {"entities": []}], ["Four phenotypes were identified in the ADEPT (training) cohort, with distinct clinical and biomarker profiles.", {"entities": []}], ["Phenotype 1 was \u201cmild, good lung function, early onset\u201d, with a low-inflammatory, predominantly Type-2, phenotype.", {"entities": []}], ["Phenotype 2 had a \u201cmoderate, hyper-responsive, eosinophilic\u201d phenotype , with moderate asthma control, mild airflow obstruction and predominant Type-2 inflammation.", {"entities": [[87, 93, "DISEASE"]]}], ["Phenotype 3 had a \u201cmixed severity, predominantly fixed obstructive, non-eosinophilic and neutrophilic\u201d phenotype, with moderate asthma control and low Type-2 inflammation.", {"entities": [[128, 134, "DISEASE"]]}], ["Phenotype 4 had a \u201csevere uncontrolled, severe reversible obstruction, mixed granulocytic\u201d phenotype, with moderate Type-2 inflammation.", {"entities": []}], ["These phenotypes had good longitudinal stability in the ADEPT cohort.", {"entities": []}], ["They were reproduced and demonstrated high classification probability in two subsets of the U-BIOPRED asthma cohort.", {"entities": [[102, 108, "DISEASE"]]}], ["Focusing on the biology of the four clinical independently-validated easy-to-assess ADEPT asthma phenotypes will help understanding the unmet need and will aid in developing tailored therapies.", {"entities": [[90, 96, "DISEASE"]]}], ["NCT01274507 (ADEPT), registered October 28, 2010 and NCT01982162 (U-BIOPRED), registered October 30, 2013.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-016-0482-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Treatment of asthma does not always comply with asthma guidelines (AG).", {"entities": [[13, 19, "DISEASE"], [48, 54, "DISEASE"]]}], ["This may be rooted in direct or indirect resistance on the doctors\u2019 and/or patients\u2019 side or be caused by the healthcare system.", {"entities": []}], ["To assess whether patients\u2019 concepts and attitudes are really an implementation barrier for AG, we analysed the patients\u2019 perspective of a \u201cgood asthma therapy\u201d and contrasted their wishes with current recommendations.", {"entities": [[145, 151, "DISEASE"]]}], ["Using a qualitative exploratory design, topic centred focus group (FG) discussions were performed until theoretical saturation was reached.", {"entities": []}], ["Inclusion criteria were an asthma diagnosis and age above 18.", {"entities": [[27, 33, "DISEASE"]]}], ["FG sessions were recorded audio-visually and analysed via a mapping technique and content analysis performed according to Mayring (supported by MAXQDA\u00ae).", {"entities": []}], ["Participants\u2019 speech times and the proportion of time devoted to different themes were calculated using the Videograph System\u00ae and related to the content analysis.", {"entities": []}], ["Thirteen men and 24 women aged between 20 and 77 from rural and urban areas attended five FG.", {"entities": []}], ["Some patients had been recently diagnosed with asthma, others years previously or in childhood.", {"entities": [[47, 53, "DISEASE"]]}], ["The following topics were addressed: (a) concern about or rejection of therapy components, particularly corticosteroids, which sometimes resulted in autonomous uncommunicated medication changes, (b) lack of time or money for optimal treatment, (c) insufficient involvement in therapy choices and (d) a desire for greater empowerment, (e) suboptimal communication between healthcare professionals and (f) difficulties with recommendations conflicting with daily life.", {"entities": []}], ["Primarily, (g) participants wanted more time with doctors to discuss difficulties and (h) all aspects of living with an impairing condition.", {"entities": []}], ["We identified some important patient driven barriers to implementing AG recommendations.", {"entities": []}], ["In order to advance AG implementation and improve asthma treatment, the patients\u2019 perspective needs to be considered before drafting new versions of AG.", {"entities": [[50, 56, "DISEASE"]]}], ["These issues should be addressed at the planning stage.", {"entities": []}], ["DRKS00000562 (German Clinical Trials Registry).", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-016-0346-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In this prospective study, we examined changes in renal function during 6 years of follow-up in relation to baseline lead levels, diabetes, and hypertension among 448 middle-age and elderly men, a subsample of the Normative Aging Study.", {"entities": [[144, 156, "DISEASE"]]}], ["Lead levels were generally low at baseline, with mean blood lead, patella lead, and tibia lead values of 6.5 \u03bcg/dL, 32.4 \u03bcg/g, and 21.5 \u03bcg/g, respectively.", {"entities": []}], ["Six percent and 26% of subjects had diabetes and hypertension at baseline, respectively.", {"entities": [[49, 61, "DISEASE"]]}], ["In multivariate-adjusted regression analyses, longitudinal increases in serum creatinine (SCr) were associated with higher baseline lead levels but these associations were not statistically significant.", {"entities": []}], ["However, we observed significant interactions of blood lead and tibia lead with diabetes in predicting annual change in SCr.", {"entities": []}], ["For example, increasing the tibia lead level from the midpoints of the lowest to the highest quartiles (9\u201334 \u03bcg/g) was associated with an increase in the rate of rise in SCr that was 17.6-fold greater in diabetics than in nondiabetics (1.08 mg/dL/10 years vs. 0.062 mg/dL/10 years; p < 0.01).", {"entities": []}], ["We also observed significant interactions of blood lead and tibia lead with diabetes in relation to baseline SCr levels (tibia lead only) and follow-up SCr levels.", {"entities": []}], ["A significant interaction of tibia lead with hypertensive status in predicting annual change in SCr was also observed.", {"entities": []}], ["We conclude that longitudinal decline of renal function among middle-age and elderly individuals appears to depend on both long-term lead stores and circulating lead, with an effect that is most pronounced among diabetics and hypertensives, subjects who likely represent particularly susceptible groups.", {"entities": []}], ["Herbs and other dietary supplements are among the most commonly used complementary medical therapies.", {"entities": []}], ["However, clinicians generally have limited knowledge, confidence and communication about herbs and dietary supplements (HDS).", {"entities": []}], ["We compared diverse clinicians' expertise about HDS to better target future curricula.", {"entities": []}], ["We conducted a cross-sectional survey of physicians, pharmacists, nurses, dietitians and trainees in these professions prior to e-curriculum about HDS in 2004\u20132005.", {"entities": []}], ["The survey had 28 questions about knowledge, 19 questions about their confidence and 11 questions about their communication practices about HDS.", {"entities": []}], ["Of the 1,268 participants, 25% were male; the average age was 40 years.", {"entities": []}], ["Mean scores were 66% correct for knowledge; 53/95 on the confidence scale and 2.2 out of possible 10 on the communication practices scale.", {"entities": []}], ["On average, scores were lowest for those who used fewer HDS; and trainees and nurses compared with physicians, pharmacists and dietitians (P<0.01 for all comparisons).", {"entities": []}], ["Clinicians have moderate levels of knowledge and confidence, but poor communication skills about HDS.", {"entities": []}], ["Future curricula about HDS should target nurses, students, practitioners and those not currently using HDS.", {"entities": []}], ["Research is needed to determine the most cost-effective educational strategies for diverse health professionals.", {"entities": []}], ["Previous data indicate a rapidly increasing prevalence of obesity and overweight among English children and an emerging socioeconomic gradient in prevalence.", {"entities": [[58, 65, "DISEASE"]]}], ["The main aim of this study was to update prevalence trends among school-age children and assess the changing socioeconomic gradient.", {"entities": []}], ["A series of nationally representative household-based health surveys conducted between 1997 and 2007 in England.", {"entities": []}], ["15,271 white children (7880 boys) aged 5 to 10 years with measured height and weight.", {"entities": []}], ["Height and weight were directly measured by trained fieldworkers.", {"entities": []}], ["Overweight (including obesity) and obesity prevalence were calculated using the international body mass index cut-offs.", {"entities": [[22, 29, "DISEASE"], [35, 42, "DISEASE"]]}], ["Socioeconomic position (SEP) score was a composite score based on income and social class.", {"entities": []}], ["Multiple linear regression assessed the prevalence odds with time point (1997/8, 2000/1, 2002/3, 2004/5, 2006/7) as the main exposure.", {"entities": []}], ["Linear interaction terms of time by SEP were also tested for.", {"entities": []}], ["There are signs that the overweight and obesity trend has levelled off from 2002/3 to 2006/7.", {"entities": [[40, 47, "DISEASE"]]}], ["The odds ratio (OR) for overweight in 2006/7 compared to 2002/3 was 0.99 (95% CI 0.88 to 1.11) and for obesity OR = 1.06 (0.86 to 1.29).", {"entities": [[103, 110, "DISEASE"]]}], ["The socioeconomic gradient has increased in recent years, particularly 2006/7.", {"entities": []}], ["Compared to 1997/8, the 2006/7 age and sex-adjusted OR for overweight was 1.88 (1.52 to 2.33) in low SEP, 1.25 (1.04 to 1.50) in middle SEP, and 1.13 (0.86 to 1.48) in high SEP children.", {"entities": []}], ["Childhood obesity and overweight prevalence among school-age children in England has stabilised in recent years, but children from lower socio-economic strata have not benefited from this trend.", {"entities": [[10, 17, "DISEASE"]]}], ["There is an urgent need to reduce socio-economic disparities in childhood overweight and obesity.", {"entities": [[89, 96, "DISEASE"]]}], ["Epidemiologic studies have reported an association between proximity to highway traffic and increased cardiopulmonary illnesses.", {"entities": []}], ["We investigated the effect of size-fractionated particulate matter (PM), obtained at different distances from a highway, on acute cardiopulmonary toxicity in mice.", {"entities": []}], ["We collected PM for 2 weeks in July\u2013August 2006 using a three-stage (ultrafine, < 0.1 \u03bcm; fine, 0.1\u20132.5 \u03bcm; coarse, 2.5\u201310 \u03bcm) high-volume impactor at distances of 20 m [near road (NR)] and 275 m [far road (FR)] from an interstate highway in Raleigh, North Carolina.", {"entities": []}], ["Samples were extracted in methanol, dried, diluted in saline, and then analyzed for chemical constituents.", {"entities": []}], ["Female CD-1 mice received either 25 or 100 \u03bcg of each size fraction via oropharyngeal aspiration.", {"entities": []}], ["At 4 and 18 hr postexposure, mice were assessed for pulmonary responsiveness to inhaled methacholine, biomarkers of lung injury and inflammation; ex vivo cardiac pathophysiology was assessed at 18 hr only.", {"entities": [[12, 14, "GENE"], [197, 199, "GENE"], [12, 14, "GENE"], [197, 199, "GENE"]]}], ["Overall chemical composition between NR and FR PM was similar, although NR samples comprised larger amounts of PM, endotoxin, and certain metals than did the FR samples.", {"entities": []}], ["Each PM size fraction showed differences in ratios of major chemical classes.", {"entities": []}], ["Both NR and FR coarse PM produced significant pulmonary inflammation irrespective of distance, whereas both NR and FR ultrafine PM induced cardiac ischemia\u2013reperfusion injury.", {"entities": [[147, 155, "DISEASE"]]}], ["On a comparative mass basis, the coarse and ultrafine PM affected the lung and heart, respectively.", {"entities": []}], ["We observed no significant differences in the overall toxicity end points and chemical makeup between the NR and FR PM.", {"entities": []}], ["The results suggest that PM of different size-specific chemistry might be associated with different toxicologic mechanisms in cardiac and pulmonary tissues.", {"entities": []}], ["A key feature of lung fibrosis is the accumulation of myofibroblasts.", {"entities": []}], ["Interleukin 13 (IL-13) is a pro-fibrotic mediator that directly and indirectly influences the activation of myofibroblasts.", {"entities": []}], ["Transforming growth factor beta (TGF-\u03b2) promotes the differentiation of fibroblasts into myofibroblasts, and can be regulated by IL-13.", {"entities": []}], ["However, IL-13\u2019s downstream signaling pathways are not completely understood.", {"entities": []}], ["We previously reported that the transcription factor Yin Yang 1 (YY1) is upregulated in fibroblasts treated with TGF-\u03b2 and in the lungs of mice and patients with pulmonary fibrosis.", {"entities": [[162, 180, "DISEASE"], [65, 68, "GENE"]]}], ["Moreover, YY1 directly regulates collagen and alpha smooth muscle actin (\u03b1-SMA) expression in fibroblasts.", {"entities": [[10, 13, "GENE"]]}], ["However, it is not known if IL-13 regulates fibroblast activation through YY1 expression.", {"entities": [[74, 77, "GENE"]]}], ["We hypothesize that IL-13 up-regulates YY1 expression through regulation of AKT activation, leading to fibroblast activation.", {"entities": [[39, 42, "GENE"]]}], ["In this study we found that YY1 was upregulated by IL-13 in lung fibroblasts in a dose- and time-dependent manner, resulting in increased \u03b1-SMA.", {"entities": [[28, 31, "GENE"]]}], ["Conversely, knockdown of YY1 blocked IL-13-induced \u03b1-SMA expression in fibroblasts.", {"entities": [[25, 28, "GENE"]]}], ["Furthermore, AKT phosphorylation was increased in fibroblasts treated with IL-13, and AKT overexpression upregulated YY1, whereas blockade of AKT phosphorylation suppressed the induction of YY1 by IL-13 in vitro .", {"entities": [[117, 120, "GENE"], [190, 193, "GENE"], [117, 120, "GENE"], [190, 193, "GENE"]]}], ["In vivo YY1 was upregulated in fibrotic lungs from CC10-IL-13 transgenic mice compared to that from wild-type littermates, which was associated with increased AKT phosphorylation.", {"entities": [[8, 11, "GENE"]]}], ["Taken together, these findings demonstrate that IL-13 is a potent stimulator and activator of fibroblasts, at least in part, through AKT-mediated YY1 activation.", {"entities": [[146, 149, "GENE"]]}], ["To investigate if the first national insecticide-treated bed-net campaign in Burkina Faso, done in 2010, was followed by a decrease in childhood malaria in a district with high baseline transmission of the disease.", {"entities": [[145, 152, "DISEASE"]]}], ["We obtained data on the prevalence of Plasmodium falciparum parasitaemia in children aged 2 weeks to 36 months from malaria surveys in 2009 and 2011.", {"entities": [[116, 123, "DISEASE"]]}], ["We assessed morbidity in children younger than 5\u00a0years by comparing data from the Nouna health district\u2019s health management information system before and after the campaign in 2010.", {"entities": []}], ["We analysed mortality data from 2008 to 2012 from Nouna\u2019s health and demographic surveillance system.", {"entities": []}], ["The bed-net campaign was associated with an increase in the reported use of insecticide-treated nets.", {"entities": []}], ["In 2009, 73% (630/869) of children reportedly slept under nets.", {"entities": []}], ["In 2011, 92% (449/487) did.", {"entities": []}], ["The campaign had no effect on the proportion of young children with P. falciparum parasitaemia after the rainy season; 52% (442/858) in 2009 and 53% (263/499) in 2011.", {"entities": []}], ["Cases of malaria increased markedly after the campaign, as did the number of children presenting with other diseases.", {"entities": [[9, 16, "DISEASE"]]}], ["The campaign was not associated with any changes in child mortality.", {"entities": []}], ["The 2010 insecticide-treated net campaign in Burkina Faso was not associated with a decrease in care-seeking for malaria or all-cause mortality in children younger than 5\u00a0years.", {"entities": [[113, 120, "DISEASE"]]}], ["The most likely explanation is the high coverage of nets in the study area before the campaign which could have had an effect on mosquito vectors, limiting the campaign\u2019s impact.", {"entities": []}], ["Graphene oxide (GO) is a promising nanomaterial for potential application in the versatile field of biomedicine.", {"entities": []}], ["Graphene-based nanomaterials have been reported to modulate the functionality of immune cells in culture and to induce pulmonary inflammation in mice.", {"entities": []}], ["Evidence pertaining to the interaction between graphene-based nanomaterials and the immune system in vivo remains scarce.", {"entities": []}], ["The present study investigated the effect of polyethylene glycol-coated GO (PEG-GO) on antigen-specific immunity in vivo.", {"entities": []}], ["BALB/c mice were intravenously administered with a single dose of PEG-GO (0.5 or 1 mg/kg) 1 hour before ovalbumin (OVA) sensitization, and antigen-specific antibody production and splenocyte reactivity were measured 7 days later.", {"entities": []}], ["Exposure to PEG-GO significantly attenuated the serum level of OVA-specific immunoglobulin E. The production of interferon-\u03b3 and interleukin-4 by splenocytes restimulated with OVA in culture was enhanced by treatment with PEG-GO.", {"entities": []}], ["In addition, PEG-GO augmented the metabolic activity of splenocytes restimulated with OVA but not with the T-cell mitogen concanavalin A.", {"entities": []}], ["Collectively, these results demonstrate that systemic exposure to PEG-GO modulates several aspects of antigen-specific immune responses, including the serum production of immunoglobulin E and T-cell functionality.", {"entities": []}], ["Epidemiologic studies suggest a positive association between fine particulate matter and arterial blood pressure, but the results have been inconsistent.", {"entities": []}], ["We investigated the effect of ambient particles on systemic hemodynamics during a 5-hr exposure to concentrated ambient air particles (CAPs) or filtered air (FA) in conscious canines.", {"entities": [[135, 139, "GENE"]]}], ["Thirteen dogs were repeatedly exposed via permanent tracheostomy to CAPs (358.1 \u00b1 306.7 \u03bcg/m n = 10 dogs, 19 CAPs days, 20 FA days).", {"entities": [[68, 72, "GENE"], [109, 113, "GENE"], [68, 72, "GENE"], [109, 113, "GENE"]]}], ["In additional experiments, we administered \u03b1-adrenergic blockade before exposure ( n = 8 dogs, 16 CAPs days, 15 FA days).", {"entities": [[98, 102, "GENE"]]}], ["Blood pressure, heart rate, rate\u2013pressure product, and baroreceptor reflex sensitivity responses were compared using linear mixed-effects models.", {"entities": []}], ["CAPs exposure increased systolic blood pressure (2.7 \u00b1 1.0 mmHg, p = 0.006), diastolic blood pressure (4.1 \u00b1 0.8 mmHg; p < 0.001), mean arterial pressure (3.7 \u00b1 0.8 mmHg; p < 0.001), heart rate (1.6 \u00b1 0.5 bpm; p < 0.001), and rate\u2013pressure product (539 \u00b1 110 bpm \u00d7 mmHg; p < 0.001), and decreased pulse pressure (\u22121.7 \u00b1 0.7 mmHg, p = 0.02).", {"entities": [[0, 4, "GENE"]]}], ["These changes were accompanied by a 20 \u00b1 6 msec/mmHg ( p = 0.005) increase in baroreceptor reflex sensitivity after CAPs versus FA.", {"entities": [[116, 120, "GENE"]]}], ["After \u03b1-adrenergic blockade, responses to CAPs and FA no longer differed significantly.", {"entities": [[42, 46, "GENE"]]}], ["Controlled exposure to ambient particles elevates arterial blood pressure.", {"entities": []}], ["Increased peripheral vascular resistance may mediate these changes, whereas increased baroreceptor reflex sensitivity may compensate for particle-induced alterations in blood pressure.", {"entities": []}], ["The aim of the study is to compare the available reference values and the six-minute walk test equations in healthy children/adolescents.", {"entities": []}], ["Our systematic review was planned and performed in accordance with the PRISMA guidelines.", {"entities": []}], ["We included all studies that established reference values for the six-minute walk test in healthy children/adolescents.", {"entities": []}], ["To perform this review, a research was performed in PubMed, EMBASE (via SCOPUS) and Cochrane (LILACS), Bibliographic Index Spanish in Health Sciences, Organization Collection Pan-American Health Organization, Publications of the World Health Organization and Scientific Electronic Library Online (SciELO) via Virtual Health Library until June 2015 without language restriction.", {"entities": []}], ["The initial research identified 276 abstracts.", {"entities": []}], ["Twelve studies met the inclusion criteria and were fully reviewed and approved by both reviewers.", {"entities": []}], ["None of the selected studies presented sample size calculation.", {"entities": []}], ["Most of the studies recruited children and adolescents from school.", {"entities": []}], ["Six studies reported the use of random samples.", {"entities": []}], ["Most studies used a corridor of 30 meters.", {"entities": []}], ["All studies followed the American Thoracic Society guidelines to perform the six-minute walk test.", {"entities": []}], ["The walked distance ranged 159 meters among the studies.", {"entities": []}], ["Of the 12 included studies, 7 (58%) reported descriptive data and 6 (50%) established reference equation for the walked distance in the six-minute walk test.", {"entities": []}], ["The reference value for the six-minute walk test in children and adolescents ranged substantially from studies in different countries.", {"entities": []}], ["A reference equation was not provided in all studies, but the ones available took into account well established variables in the context of exercise performance, such as height, heart rate, age and weight.", {"entities": []}], ["Countries that did not established reference values for the six-minute walk test should be encouraged to do because it would help their clinicians and researchers have a more precise interpretation of the test.", {"entities": []}], ["The World Health Organization recommends high-dose vitamin A supplementation (VAS) for children above six months of age in low-income countries.", {"entities": []}], ["VAS has been associated with up-regulation of the Th2 response.", {"entities": []}], ["We aimed to determine if VAS is associated with atopy in childhood.", {"entities": []}], ["Infants in Guinea-Bissau were randomly allocated VAS or placebo, either at six and nine months of age, or only at nine months of age.", {"entities": []}], ["At six months of age, children were furthermore randomized to measles vaccine or inactivated polio vaccine.", {"entities": [[62, 69, "DISEASE"]]}], ["At nine months of age all children received measles vaccine.", {"entities": [[44, 51, "DISEASE"]]}], ["Children were revisited seven years later and skin prick testing was performed.", {"entities": []}], ["Atopy was defined as a skin prick reaction \u22653\u00a0mm.", {"entities": []}], ["40 of 263 children (15%) were atopic.", {"entities": []}], ["Overall VAS had no significant effect on the risk of atopy (Prevalence Ratio 1.23; 95% CI 0.69-2.18).", {"entities": []}], ["The Prevalence Ratio was 1.60 (0.66-3.90) for males and 1.00 (0.46-2.15) for females.", {"entities": []}], ["There was no significant effect of VAS in infancy on atopy later in childhood.", {"entities": []}], ["The role of infant VAS in the development of atopy is still unclear.", {"entities": []}], ["Transportation-related injuries are a leading cause of pediatric death, and effective interventions are limited.", {"entities": []}], ["Otto the Auto is a website offering engaging, interactive activities.", {"entities": []}], ["We evaluated Otto among a sample of sixty-nine 4- and 5-year-old children, who participated in a randomized parallel group design study.", {"entities": []}], ["Following baseline evaluation, children engaged with either Otto or a control website for 2 weeks and then were re-evaluated.", {"entities": []}], ["Children who used Otto failed to show increases in transportation safety knowledge or behavior compared to the control group, although there was a dosage effect whereby children who engaged in the website more with parents gained safer behavior patterns.", {"entities": []}], ["We conclude Otto may have some efficacy when engaged by children with their parents, but continued efforts to develop and refine engaging, effective, theory-driven strategies to teach children transportation safety, including via internet, should be pursued.", {"entities": []}], ["Daily variations in ambient particulate air pollution are associated with variations in respiratory lung function.", {"entities": []}], ["It has been suggested that the effects of particulate matter may be due to particles in the ultrafine (0.01-0.1 microm) size range.", {"entities": []}], ["Because previous studies on ultrafine particles only used self-monitored peak expiratory flow rate (PEFR), we assessed the associations between particle mass and number concentrations in several size ranges measured at a central site and measured (biweekly) spirometric lung function among a group of 54 adult asthmatics (n = 495 measurements).", {"entities": []}], ["We also compared results to daily morning, afternoon, and evening PEFR measurements done at home (n = 7,672-8,110 measurements).", {"entities": []}], ["The median (maximum) 24 hr number concentrations were 14,500/cm(3) (46,500/cm(3)) ultrafine particles and 800/cm(3) (2,800/cm(3)) accumulation mode (0.1-1 microm) particles.", {"entities": [[24, 26, "GENE"]]}], ["The median (maximum) mass concentration of PM(2.5) (particulate matter < 2.5 microm) and PM(10) (particulate matter < 10 microm in aerodynamic diameter) were 8.4 microg/m(3) (38.3 microg/m(3)) and 13.5 microg/m(3) (73.7 microg/m(3)), respectively.", {"entities": []}], ["The number of accumulation mode particles was consistently inversely associated with PEFR in spirometry.", {"entities": []}], ["Inverse, but nonsignificant, associations were observed with ultrafine particles, and no associations were observed with large particles (PM(10)).", {"entities": []}], ["Compared to the effect estimates for self-monitored PEFR, the effect estimates for spirometric PEFR tended to be larger.", {"entities": []}], ["The standard errors were also larger, probably due to the lower number of spirometric measurements.", {"entities": []}], ["The present results support the need to monitor the particle number and size distributions in urban air in addition to mass.", {"entities": []}], ["Metabolic demand and altered supply of essential nutrients is poorly characterised in patients with advanced cancer.", {"entities": [[109, 115, "DISEASE"]]}], ["A possible imbalance or deficiency of essential fatty acids is suggested by reported beneficial effects of fish oil supplementation.", {"entities": []}], ["To assess fatty acid status (composition of plasma and neutrophil phospholipids) in advanced cancer patients before and after 14 days of supplementation (12\u00b11\u2009g\u2009day n =23).", {"entities": [[93, 99, "DISEASE"]]}], ["Fatty acid composition of plasma phospholipids and the major phospholipid classes of isolated neutrophils were determined using gas liquid chromatography.", {"entities": []}], ["At baseline, patients with advanced cancer exhibited low levels (<30% of normal values) of plasma phospholipids and constituent fatty acids and elevated 20\u200a:\u200a4 n -6 content in neutrophil phospholipids.", {"entities": [[36, 42, "DISEASE"]]}], ["High n -6/ n -3 fatty acid ratios in neutrophil and plasma phospholipids were inversely related to body mass index.", {"entities": []}], ["Fish oil supplementation raised eicosapentaenoic acid and docosahexaenoic acid content in plasma but not neutrophil phospholipids.", {"entities": []}], ["20\u200a:\u200a4 n -6 content was reduced in neutrophil PI following supplementation with fish oil.", {"entities": []}], ["Change in body weight during the supplementation period related directly to increases in eicosapentaenoic acid in plasma.", {"entities": []}], ["Advanced cancer patients have alterations in lipid metabolism potentially due to nutritional status and/or chemotherapy.", {"entities": [[9, 15, "DISEASE"]]}], ["Potential obstacles in fatty acid utilisation must be addressed in future trials aiming to improve outcomes using nutritional intervention with fish oils.", {"entities": []}], ["British Journal of Cancer (2002) 87 , 1370\u20131378.", {"entities": [[19, 25, "DISEASE"]]}], ["doi: 10.1038/sj.bjc.6600659 www.bjcancer.com \u00a9 2002 Cancer Research UK", {"entities": [[52, 58, "DISEASE"]]}], ["Alteration in respiratory activity and mitochondrial DNA (mtDNA) transcription seems to be an important feature of cancer cells.", {"entities": [[115, 121, "DISEASE"]]}], ["Leukotriene D 4 (LTD 4 ) is a proinflammatory mediator implicated in the pathology of chronic inflammation and cancer.", {"entities": [[111, 117, "DISEASE"]]}], ["We have shown earlier that LTD 4 causes translocation of \u03b2 -catenin both to the mitochondria, in which it associates with the survival protein Bcl-2 identifying a novel role for \u03b2 -catenin in cell survival, and to the nucleus in which it activates the TCF/LEF transcription machinery.", {"entities": []}], ["Here we have used non-transformed intestinal epithelial Int 407 cells and Caco-2 colon cancer cells, transfected or not with wild type and mutated (S33Y) \u03b2 -catenin to analyse its effect on mitochondria activity.", {"entities": [[81, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["We have measured the ATP/ADP ratio, and transcription of the mtDNA genes ND2, ND6 and 16\u2009s in these cells stimulated or not with LTD 4 .", {"entities": []}], ["We have shown for the first time that LTD 4 triggers a cellular increase in NADPH dehydrogenase activity and ATP/ADP ratio.", {"entities": []}], ["In addition, LTD 4 significantly increased the transcription of mtDNA genes.", {"entities": []}], ["Overexpression of wild-type \u03b2 -catenin or a constitutively active \u03b2 -catenin mutant mimicked the effect of LTD 4 on ATP/ADP ratio and mtDNA transcription.", {"entities": []}], ["These elevations in mitochondrial activity resulted in increased reactive oxygen species levels and subsequent activations of the p65 subunit of NF- \u03ba B.", {"entities": []}], ["The present novel data show that LTD 4 , presumably through \u03b2 -catenin accumulation in the mitochondria, affects mitochondrial activity, lending further credence to the idea that inflammatory signalling pathways are intrinsically linked with potential oncogenic signals.", {"entities": []}], ["Air cleanliness in operating theatres (OTs) is an important factor for preserving the health of both the patient and the medical staff.", {"entities": []}], ["Particle contamination in OTs depends mainly on the surgery process, ventilation principle, personnel clothing systems and working routines.", {"entities": []}], ["In many open surgical operations, electrosurgical tools (ESTs) are used for tissue cauterization.", {"entities": []}], ["ESTs generate a significant airborne contamination, as surgical smoke.", {"entities": []}], ["Surgical smoke is a work environment quality problem.", {"entities": []}], ["Ordinary surgical masks and OT ventilation systems are inadequate to control this problem.", {"entities": []}], ["This research work is based on numerous monitoring campaigns of ultrafine particle concentrations in OTs, equipped with upward displacement ventilation or with a downward unidirectional airflow system.", {"entities": []}], ["Measurements performed during ten real surgeries highlight that the use of ESTs generates a quite sharp and relevant increase of particle concentration in the surgical area as well within the entire OT area.", {"entities": []}], ["The measured contamination level in the OTs are linked to surgical operation, ventilation principle, and ESTs used.", {"entities": []}], ["A better knowledge of airborne contamination is crucial for limiting the personnel\u2019s exposure to surgical smoke.", {"entities": []}], ["Research results highlight that downward unidirectional OTs can give better conditions for adequate ventilation and contaminant removal performances than OTs equipped with upward displacement ventilation systems.", {"entities": []}], ["Gastroschisis (GS) is a congenital abdominal wall defect that results in the development of GS-related intestinal dysfunction (GRID).", {"entities": []}], ["Transforming growth factor-\u03b2, a pro-inflammatory cytokine, has been shown to cause organ dysfunction through alterations in vascular and airway smooth muscle.", {"entities": []}], ["The purpose of this study was to evaluate the effects of TGF-\u03b23 on intestinal smooth muscle function and contractile gene expression.", {"entities": []}], ["Archived human intestinal tissue was analyzed using immunohistochemistry and RT-PCR for TGF-\u03b2 isoforms and markers of smooth muscle gene and micro-RNA contractile phenotype.", {"entities": []}], ["Intestinal motility was measured in neonatal rats\u00a0\u00b1\u00a0TGF-\u03b23 (0.2 and 1\u00a0mg/kg).", {"entities": []}], ["Human intestinal smooth muscle cells (hiSMCs) were incubated with fetal bovine serum \u00b1100\u00a0ng/ml of TGF-\u03b2 3 isoforms for 6, 24 and 72\u00a0h. The effects of TGF-\u03b23 on motility, hiSMC contractility and hiSMC contractile phenotype gene and micro-RNA expression were measured using transit, collagen gel contraction assay and RT-PCR analysis.", {"entities": []}], ["Data are expressed as mean\u00a0\u00b1\u00a0SEM, ANOVA ( n \u00a0=\u00a06\u20137/group).", {"entities": []}], ["GS infants had increased immunostaining of TGF-\u03b23 and elevated levels of micro-RNA 143 & 145 in the intestinal smooth muscle.", {"entities": []}], ["Rats had significantly decreased intestinal transit when exposed to TGF-\u03b23 in a dose-dependent manner compared with Sham animals.", {"entities": []}], ["TGF-\u03b23 significantly increased hiSMC gel contraction and contractile protein gene and micro-RNA expression.", {"entities": []}], ["TGF-\u03b23 contributed to intestinal dysfunction at the organ level, increased contraction at the cellular level and elevated contractile gene expression at the molecular level.", {"entities": []}], ["A hyper-contractile response may play a role in the persistent intestinal dysfunction seen in GRID.", {"entities": []}], ["To investigate the performance of parent-reported data in identifying physician-confirmed asthma.", {"entities": [[90, 96, "DISEASE"]]}], ["Validation study using linkage between the Avon Longitudinal Study of Parents and Children (ALSPAC) and electronic patient records held within the General Practice Research Database (GPRD).", {"entities": []}], ["Participants were those eligible to participate in ALSPAC who also had a record in the GPRD; this included 765 individuals, just under 4% of ALSPAC-eligible participants.", {"entities": []}], ["The analysis was based on 141 participants with complete parent-reported asthma data.", {"entities": [[73, 79, "DISEASE"]]}], ["The main GPRD outcome measure was whether a child had a diagnosis of asthma before they were nine.", {"entities": [[69, 75, "DISEASE"]]}], ["Parent-reported measures were doctor diagnosis of asthma (before mean age 7.5\u2005years), various outcomes based on wheezing and breathlessness recorded longitudinally between 6\u2005months and 8.5\u2005years.", {"entities": [[50, 56, "DISEASE"]]}], ["Secondary outcomes were bronchial hyper-responsiveness (BHR), forced expiratory volume in 1\u2005s/forced vital capacity ratio and skin prick test responses.", {"entities": []}], ["Among the 141 participants with complete parent-reported data, 26 (18%) had an asthma diagnosis before age nine.", {"entities": [[79, 85, "DISEASE"]]}], ["Using general practitioner (GP)-recorded asthma as the gold standard, the question \u2018Has a doctor ever diagnosed your child with asthma?\u2019 was both sensitive (88.5%) and specific (95.7%).", {"entities": [[41, 47, "DISEASE"], [128, 134, "DISEASE"]]}], ["\u2018Ever wheezed\u2019 had the highest sensitivity (100%) but low specificity (60%).", {"entities": []}], ["More specific definitions were obtained by restricting to those who had wheezed on more than one occasion, experienced frequent wheeze and/or wheezed after the age of 3, but these measures had low sensitivities.", {"entities": []}], ["BHR only identified 50% of those with a GP-recorded diagnosis.", {"entities": []}], ["Parental reports of a doctor's diagnosis agree well with a GP-recorded diagnosis.", {"entities": []}], ["High specificity for asthma can be achieved by using detailed wheezing questions, although these definitions are likely to exclude mild cases of asthma.", {"entities": [[21, 27, "DISEASE"], [145, 151, "DISEASE"]]}], ["Our study shows that linkage between observational studies and electronic patient records has the potential to enhance epidemiological research.", {"entities": []}], ["Cigarette smoking remains a major health concern worldwide, and many of the adverse effects of cigarette smoke (CS) can be attributed to its abundant electrophilic aldehydes, such as acrolein (2-propenal).", {"entities": [[112, 114, "GENE"]]}], ["Previous studies indicate that acrolein readily reacts with thioredoxin reductase 1 (TrxR1), a critical enzyme involved in regulation of thioredoxin (Trx)-mediated redox signaling, by alkylation at its selenocysteine (Sec) residue.", {"entities": []}], ["Because alkylation of Sec within TrxR1 has significant implications for its enzymatic function, we explored the potential importance of TrxR1 alkylation in acrolein-induced activation or injury of bronchial epithelial cells.", {"entities": []}], ["Exposure of human bronchial epithelial HBE1 cells to acrolein (1\u201330\u00a0\u03bcM) resulted in dose-dependent loss of TrxR thioredoxin reductase activity, which coincided with its alkylation, as determined by biotin hydrazide labeling, and was independent of initial GSH status.", {"entities": [[39, 43, "GENE"]]}], ["To test the involvement of TrxR1 in acrolein responses in HBE1 cells, we suppressed TrxR1 using siRNA silencing or augmented TrxR1 by cell supplementation with sodium selenite.", {"entities": [[58, 62, "GENE"]]}], ["Acrolein exposure of HBE1 cells induced dose-dependent activation of the MAP kinases, extracellular regulated \u25ba Acrolein is an important thiol-reactive electrophile in cigarette smoke.", {"entities": [[21, 25, "GENE"]]}], ["\u25ba Acrolein-induced alterations in redox systems in airway epithelial cells include inactivation of thioredoxin reductase (TrxR).", {"entities": []}], ["\u25ba Acrolein-induced alkylation of TrxR results in both loss and gain-of-function.", {"entities": []}], ["\u25ba Acrolein-dependent alkylation of TrxR and thioredoxin depends on TrxR expression.", {"entities": []}], ["\u25ba TrxR expression dictates the ability of acrolein to activate MAPK signaling pathways.", {"entities": []}], ["Polytetrafluoroethylene is ubiquitous in materials commonly used in cooking and industrial applications.", {"entities": []}], ["Overheated polytetrafluoroethylene can generate toxic fumes, inducing acute pulmonary edema in some cases.", {"entities": [[76, 91, "DISEASE"]]}], ["However, neither the etiology nor the radiological features of this condition have been determined.", {"entities": []}], ["For clarification, we report an illustrative case, together with the first comprehensive literature review.", {"entities": []}], ["A previously healthy 35-year-old Japanese man who developed severe dyspnea presented to our hospital.", {"entities": []}], ["He had left a polytetrafluoroethylene-coated pan on a gas-burning stove for 10\u00a0hours while unconscious.", {"entities": []}], ["Upon admission, he was in severe respiratory distress.", {"entities": []}], ["A chest computed tomographic scan showed massive bilateral patchy consolidations with ground-glass opacities and peripheral area sparing.", {"entities": []}], ["A diagnosis of polytetrafluoroethylene fume\u2013induced pulmonary edema was made.", {"entities": [[52, 67, "DISEASE"]]}], ["He was treated with non-invasive positive pressure ventilation and a neutrophil elastase inhibitor, which dramatically alleviated his symptoms and improved his oxygenation.", {"entities": []}], ["He was discharged without sequelae on hospital day 11.", {"entities": []}], ["A literature review was performed to survey all reported cases of polytetrafluoroethylene fume\u2013induced pulmonary edema.", {"entities": [[103, 118, "DISEASE"]]}], ["We searched the PubMed, Embase, Web of Science and OvidSP databases for reports posted between the inception of the databases and 30 September 2014, as well as several Japanese databases (Ichushi Web, J-STAGE, Medical Online, and CiNii).", {"entities": []}], ["Two radiologists independently interpreted all chest computed tomographic images.", {"entities": []}], ["Eighteen relevant cases (including the presently reported case) were found.", {"entities": []}], ["Our search revealed that (1) systemic inflammatory response syndrome was frequently accompanied by pulmonary edema, and (2) common computed tomography findings were bilateral ground-glass opacities, patchy consolidation and peripheral area sparing.", {"entities": [[60, 68, "DISEASE"], [99, 114, "DISEASE"]]}], ["Pathophysiological and radiological features were consistent with the exudative phase of acute respiratory distress syndrome.", {"entities": [[116, 124, "DISEASE"]]}], ["However, the contrast between the lesion and the spared peripheral area was striking and was distinguishable from the common radiological features of acute respiratory distress syndrome.", {"entities": [[177, 185, "DISEASE"]]}], ["The essential etiology of polytetrafluoroethylene fume\u2013induced pulmonary edema seems to be increased pulmonary vascular permeability caused by an inflammatory response to the toxic fumes.", {"entities": [[63, 78, "DISEASE"]]}], ["The radiological findings that distinguish polytetrafluoroethylene fume\u2013induced pulmonary edema can be bilateral ground-glass opacity or a patchy consolidation with clear sparing of the peripheral area.", {"entities": [[80, 95, "DISEASE"]]}], ["The family plays a vital role in shaping adolescent behaviours.", {"entities": []}], ["The present study investigated the associations between family structure and substance use among Hong Kong Chinese adolescents.", {"entities": []}], ["A total of 32,961 Form 1 to 5 (grade 7-12 in the US) Hong Kong students participated in the Youth Smoking Survey in 2003-4.", {"entities": []}], ["An anonymous questionnaire was used to obtain information about family structure, daily duration of parent-child conversation, smoking, alcohol drinking and drug use.", {"entities": []}], ["Logistic regression was used to calculate the adjusted odds ratios (OR) for each substance use by family structure.", {"entities": []}], ["Adjusting for sex, age, type of housing, parental smoking and school, adolescents from non-intact families were significantly more likely to be current smokers (OR = 1.62), weekly drinkers (OR = 1.72) and ever drug users (OR = 1.72), with significant linear increases in ORs from maternal, paternal to no-parent families compared with intact families.", {"entities": []}], ["Furthermore, current smoking (OR = 1.41) and weekly drinking (OR = 1.46) were significantly more common among adolescents from paternal than maternal families.", {"entities": []}], ["After adjusting for parent-child conversation time, the ORs for non-intact families remained significant compared with intact families, but the paternal-maternal differences were no longer significant.", {"entities": []}], ["Non-intact families were associated with substance use among Hong Kong Chinese adolescents.", {"entities": []}], ["The apparently stronger associations with substance use in paternal than maternal families were probably mediated by the poorer communication with the father.", {"entities": []}], ["This study explores the views of pregnant women and clinicians regarding discussion of exposure to phthalate plasticizers during pregnancy, subsequent to the 2011 Health Canada ban of certain phthalates at a concentration greater than 1000\u00a0mg/kg in baby toys.", {"entities": []}], ["This occurred with no regulation of products to which pregnant women are exposed, such as food packaging and cosmetics.", {"entities": []}], ["Pregnant women, physicians and midwives were recruited through posters and pamphlets in prenatal clinics in Southwestern Ontario for a semi-structured interview.", {"entities": []}], ["All interviews were audiotaped, transcribed, and subjected to rigorous qualitative analysis through a grounded theory approach, supported by NVIVO\u2122 software.", {"entities": []}], ["Themes emerged from line by line, open, and axial coding in an iterative manner.", {"entities": []}], ["Theoretical sufficiency was reached after 23 pregnant women and 11 clinicians had been interviewed.", {"entities": []}], ["The themes (and subthemes from which they arose) were: Theme I-Information Provision (IA-Sources of Information, IB-Standardization, IC-Constraints, ID-Role of Government); Theme II-Risk (IIA-Significant Risk, IIB-Perceived Relevance, IIC-Reconciliation); and Theme III- Factors Influencing Level of Concern (IIIA-Current Knowledge, IIIB-Demographic Factors).", {"entities": []}], ["To respond to the increasing media and research attention regarding risk of phthalates to women, and pregnant women in particular, national professional organizations should provide patient information.", {"entities": []}], ["This could include pamphlets on what a pregnant woman should know about phthalates and how they can be avoided, as well as information to clinicians to facilitate this discussion.", {"entities": []}], ["Airborne particles have been linked to pulmonary oxidative stress and inflammation.", {"entities": []}], ["Because these effects may be particularly great for traffic-related particles, we examined associations between particle exposures and exhaled nitric oxide (FE NO ) in a study of 44 senior citizens, which involved repeated trips aboard a diesel bus.", {"entities": []}], ["Samples of FE NO collected before and after the trips were regressed against microenvironmental and ambient particle concentrations using mixed models controlling for subject, day, trip, vitamins, collection device, mold, pollen, room air nitric oxide, apparent temperature, and time to analysis.", {"entities": []}], ["Although ambient concentrations were collected at a fixed location, continuous group-level personal samples characterized microenvironmental exposures throughout facility and trip periods.", {"entities": []}], ["In pre-trip samples, both microenvironmental and ambient exposures to fine particles were positively associated with FE NO .", {"entities": []}], ["For example, an interquartile increase of 4 \u03bcg/m 2.5 concentration was associated with a 13% [95% confidence interval (CI), 2\u201324%) increase in FE NO .", {"entities": []}], ["After the trips, however, FE NO concentrations were associated pre-dominantly with microenvironmental exposures, with significant associations for concentrations measured throughout the whole day.", {"entities": []}], ["Associations with exposures during the trip also were strong and statistically significant with a 24% (95% CI, 15\u201334%) increase in FE NO predicted per interquartile increase of 9 \u03bcg/m 2.5 .", {"entities": []}], ["Although pre-trip findings were generally robust, our post-trip findings were sensitive to several influential days.", {"entities": []}], ["Fine particle exposures resulted in increased levels of FE NO in elderly adults, suggestive of increased airway inflammation.", {"entities": []}], ["These associations were best assessed by microenvironmental exposure measurements during periods of high personal particle exposures.", {"entities": []}], ["We treated human lung epithelial cells, type BEAS-2B, with 10\u201380 \u03bcg/cm 2.5 from different sites showed a wide range of potency for inducing the release of the proinflammatory cytokines interleukin-6 (IL-6) and IL-8 in vitro .", {"entities": []}], ["Univariate regression and multivariate redundancy analysis were used to test for correlation of viability and cytokine release with the concentrations of 40 elements, 7 ions, and 8 carbon fractions.", {"entities": []}], ["The particles showed positive correlation between IL-6 release and the elemental and pyrolyzable carbon fractions, and the strongest correlation involving crustal elements was between IL-6 release and the aluminum:silicon ratio.", {"entities": []}], ["The observed correlations between low-volatility organic components of soil- and road-derived dusts and the cytokine release by BEAS-2B cells are relevant for investigation of mechanisms linking specific air pollution particle types with the initiating events leading to airway inflammation in sensitive populations.", {"entities": []}], ["Proxy respondents are frequently used in surveys, including those assessing health-related quality of life (HRQOL).", {"entities": []}], ["In cancer, most research involving proxies has been undertaken with paired proxy-patient populations, where proxy responses are compared to patient responses for the same individual.", {"entities": [[3, 9, "DISEASE"]]}], ["In these populations, proxy-patient differences are small and suggest proxy underestimation of patient HRQOL.", {"entities": []}], ["In practice, however, proxy responses will only be used when patient responses are not available.", {"entities": []}], ["The difference between proxy and patient reports of patient HRQOL where patients are not able to report for themselves in cancer is not known.", {"entities": [[122, 128, "DISEASE"]]}], ["The objective of this study was to evaluate the difference between patient and proxy reports of patient HRQOL in a large national cancer survey, and determine if this difference could be mitigated by adjusting for clinical and sociodemographic information about patients.", {"entities": [[130, 136, "DISEASE"]]}], ["Data were from the Cancer Care Outcomes Research and Surveillance (CanCORS) study.", {"entities": [[19, 25, "DISEASE"]]}], ["Patients or their proxies were recruited within 3\u20136\u00a0months of diagnosis with lung or colorectal cancer.", {"entities": [[85, 102, "DISEASE"], [96, 102, "DISEASE"]]}], ["HRQOL was measured using the SF-12 mental and physical composite scales.", {"entities": []}], ["Differences of \u00bd SD (=5 points) were considered clinically significant.", {"entities": []}], ["The primary independent variable was proxy status.", {"entities": []}], ["Linear regression models were used to adjust for patient sociodemographic and clinical covariates, including cancer stage, patient age and education, and patient co-morbidities.", {"entities": [[109, 115, "DISEASE"]]}], ["Of 6471 respondents, 1011 (16%) were proxies.", {"entities": []}], ["Before adjustment, average proxy-reported scores were lower for both physical (\u22126.7 points, 95% CI -7.4 to \u22125.9) and mental (\u22126 points, 95% CI -6.7 to \u22125.2) health.", {"entities": []}], ["Proxy-reported scores remained lower after adjustment (physical: \u22125.8 points, \u22126.6 to \u22125; mental: \u22125.8 points, \u22126.6 to 5).", {"entities": []}], ["Proxy-patient score differences remained clinically and statistically significant, even after adjustment for sociodemographic and clinical variables.", {"entities": []}], ["Proxy-reported outcome scores for both physical and mental health were clinically and significantly lower than patient-reported scores for these outcomes.", {"entities": []}], ["The size of the proxy-patient score differences was not affected by the health domain, and adjustment for sociodemographic and clinical variables had minimal impact.", {"entities": []}], ["Acute lung injury (ALI) and its severe manifestation of acute respiratory distress syndrome (ARDS) are well-known illnesses.", {"entities": [[83, 91, "DISEASE"]]}], ["Uncontrolled and self-amplified pulmonary inflammation lies at the center of the pathology of this disease.", {"entities": []}], ["Emodin, the bio-active coxund of herb Radix rhizoma Rhei, shows potent anti-inflammatory properties through inactivation of nuclear factor-\u03baB (NF-\u03baB).", {"entities": []}], ["The aim of this study was to evaluate the effect of emodin on lipopolysaccharide (LPS)-induced ALI in mice, and its potential bio-mechanism.", {"entities": []}], ["In our study, BALB/c mice were stimulated with LPS to induce ALI.", {"entities": []}], ["After 72 h of LPS stimulation, pulmonary pathological changes, lung injury scores, pulmonary edema, myeloperoxidase (MPO) activity, total cells, neutrophils, macrophages, TNF-\u03b1, IL-6 and IL-1\u03b2 in bronchoalveolar lavage fluid (BALF), and MCP-1 and E-selectin expression were notably attenuated by emodin in mice.", {"entities": [[83, 98, "DISEASE"], [117, 120, "GENE"]]}], ["Meanwhile, our data also revealed that emodin significantly inhibited the LPS-enhanced the phosphorylation of NF-\u03baB p65 and NF-\u03baB p65 DNA binding activity in lung.", {"entities": []}], ["Our data indicates that emodin potently inhibits LPS-induced pulmonary inflammation, pulmonary edema and MCP-1 and E-selectin expression, and that these effects were very likely mediated by inactivation of NF-\u03baB in mice.", {"entities": [[85, 100, "DISEASE"]]}], ["These results suggest a therapeutic potential of emodin as an anti-inflammatory agent for ALI/ARDS treatment.", {"entities": []}], ["Vitamin D has immunomodulatory properties giving it the potential to affect microbial colonization of the intestinal tract.", {"entities": []}], ["We investigated whether maternal vitamin D supplemention, maternal plasma 25-hydroxyvitamin D concentration, or direct supplementation of the infant influences key bacterial taxa within microbiota of one month old infants.", {"entities": []}], ["Infant and maternal vitamin D supplement use was ascertained via questionnaires.", {"entities": []}], ["Maternal plasma 25-hydroxyvitamin D was determined at approximately the 36 Bifidobacterium spp., Escherichia coli , Clostridium difficile , Bacteroides fragilis group, Lactobacillus spp.", {"entities": []}], ["and total bacteria were quantified with real-time polymerase chain reaction assays targeting 16S rRNA gene sequences.", {"entities": []}], ["The association between vitamin D exposure and prevalence or abundance of a specific bacterial group or species was analyzed using logistic or linear regression, respectively.", {"entities": []}], ["There was a statistically significant negative linear trend between counts of Bifidobacterium spp.", {"entities": []}], ["and levels of maternal vitamin D supplementation and maternal 25-hydroxyvitamin D quintiles, respectively.", {"entities": []}], ["In addition, a positive linear trend between quintile groups and B .", {"entities": []}], ["fragilis group counts was observed.", {"entities": []}], ["Lower counts of C .", {"entities": []}], ["difficile were associated with vitamin D supplementation of breast fed infants whose mothers were more likely to adhere to an alternative lifestyle in terms of, e .", {"entities": []}], ["g ., dietary habits.", {"entities": []}], ["These data suggest that vitamin D influences the abundance of several key bacterial taxa within the infant microbiota.", {"entities": []}], ["Given that intestinal microbiotic homeostasis may be an important factor in the prevention of immune mediated diseases and that vitamin D status is a modifiable factor, further investigation of the impact of postnatal vitamin D supplementation should be conducted in older infants.", {"entities": []}], ["Graft-versus-host disease (GVHD) is a major barrier to successful allogeneic hematopoietic cell transplantation and is largely mediated by activated donor lymphocytes.", {"entities": []}], ["Lymphotoxin (LT)-\u03b1 is expressed by subsets of activated T and B cells, and studies in preclinical models demonstrated that targeted depletion of these cells with a mouse anti-LT-\u03b1 monoclonal antibody (mAb) was efficacious in inhibiting inflammation and autoimmune disease.", {"entities": [[13, 15, "GENE"], [175, 177, "GENE"]]}], ["Here we demonstrate that LT-\u03b1 is also upregulated on activated human donor lymphocytes in a xenogeneic model of GVHD and targeted depletion of these donor cells ameliorated GVHD.", {"entities": []}], ["A depleting humanized anti-LT-\u03b1 mAb, designated MLTA3698A, was generated that specifically binds to LT-\u03b1 in both the soluble and membrane-bound forms, and elicits antibody-dependent cellular cytotoxicity (ADCC) activity in vitro .", {"entities": []}], ["Using a human peripheral blood mononuclear cell transplanted SCID (Hu-SCID) mouse model of GVHD, the anti-human LT-\u03b1 mAb specifically depleted activated LT-expressing human donor T and B cells, resulting in prolonged survival of the mice.", {"entities": []}], ["A mutation in the Fc region, rendering the mAb incapable of mediating ADCC, abolished all in vitro and in vivo effects.", {"entities": []}], ["These data support a role for using a depleting anti-LT-\u03b1 antibody in treating immune diseases such as GVHD and autoimmune diseases.", {"entities": []}], ["The Toxics Exposure Assessment Columbia\u2013Harvard (TEACH) project assessed exposures and cancer risks from urban air pollutants in a population of high school teenagers in New York City (NYC) and Los Angeles (LA).", {"entities": [[87, 93, "DISEASE"]]}], ["Forty-six high school students participated in NYC and 41 in LA, most in two seasons in 1999 and 2000, respectively.", {"entities": []}], ["Personal, indoor home, and outdoor home 48-hr samples of volatile organic compounds (VOCs), aldehydes, particulate matter with aerodynamic diameter \u2264 2.5 \u03bcm, and particle-bound elements were collected.", {"entities": []}], ["Individual cancer risks for 13 VOCs and 6 particle-bound elements were calculated from personal concentrations and published cancer unit risks.", {"entities": [[11, 17, "DISEASE"], [125, 131, "DISEASE"]]}], ["The median cumulative risk from personal VOC exposures for this sample of NYC high school students was 666 per million and was greater than the risks from ambient exposures by a factor of about 5.", {"entities": []}], ["In the LA sample, median cancer risks from VOC personal exposures were 486 per million, about a factor of 4 greater than ambient exposure risks.", {"entities": [[25, 31, "DISEASE"]]}], ["The VOCs with the highest cancer risk included 1,4-dichlorobenzene, formaldehyde, chloroform, acetaldehyde, and benzene.", {"entities": [[26, 32, "DISEASE"]]}], ["Of these, benzene had the greatest contributions from outdoor sources.", {"entities": []}], ["All others had high contributions from indoor sources.", {"entities": []}], ["The cumulative risks from personal exposures to the elements were an order of magnitude lower than cancer risks from VOC exposures.", {"entities": [[99, 105, "DISEASE"]]}], ["Most VOCs had median upper-bound lifetime cancer risks that exceeded the U.S. Environmental Protection Agency (EPA) benchmark of 1 \u00d7 10", {"entities": [[42, 48, "DISEASE"]]}], ["Asthma is one of the most common chronic diseases in the world, and previous studies have reported low levels of control.", {"entities": [[0, 6, "DISEASE"]]}], ["Recent developments in the availability and use of online sources of information about asthma might add to patients\u2019 knowledge and help improve control.", {"entities": [[87, 93, "DISEASE"]]}], ["To investigate whether asthma control has improved by assessing levels of symptoms, exacerbations and Global Initiative for Asthma-defined control in a real-life population of patients who use the Internet and social media, as well as evaluate patient perception of control and attitudes to asthma.", {"entities": [[23, 29, "DISEASE"], [124, 130, "DISEASE"], [291, 297, "DISEASE"]]}], ["Online surveys were conducted among 8,000 patients with asthma (aged 18\u201350 years, \u2a7e2 prescriptions in the previous 2 years, use of social media) from 11 European countries.", {"entities": [[56, 62, "DISEASE"]]}], ["Levels of asthma control were low: 45% of respondents had uncontrolled asthma.", {"entities": [[10, 16, "DISEASE"], [71, 77, "DISEASE"]]}], ["Acute exacerbations were common: 44% of respondents reported having used oral steroids for asthma in the previous 12 months, 24% had visited an emergency department and 12% had been hospitalised.", {"entities": [[91, 97, "DISEASE"]]}], ["More than 80% of respondents (overall, and among those with a history of exacerbations) considered their asthma to be controlled.", {"entities": [[105, 111, "DISEASE"]]}], ["Of those who had an exacerbation requiring oral steroids, 75% regarded their asthma as not serious.", {"entities": [[77, 83, "DISEASE"]]}], ["Asthma control in Europe remains poor; symptoms and exacerbations are common.", {"entities": [[0, 6, "DISEASE"]]}], ["Many patients regard their asthma as controlled and not serious despite experiencing symptoms and exacerbations.", {"entities": [[27, 33, "DISEASE"]]}], ["There is a need to assess patients\u2019 control, risk and inhaler technique, and to ensure that patients are prescribed, and take, appropriate treatments.", {"entities": []}], ["The aim of this study was to evaluate short-term safety and tolerability of fingolimod in a real-world population with relapsing multiple sclerosis, focusing on cardiac safety during treatment initiation.", {"entities": [[129, 147, "DISEASE"]]}], ["Patients received fingolimod 0.5\u00a0mg once daily for four\u00a0months.", {"entities": []}], ["Patients excluded from the pivotal studies with certain pre-existing cardiac conditions or baseline cardiac findings (PCCs), and those receiving beta blockers (BBs) and/or calcium channel blockers (CCBs), were eligible.", {"entities": []}], ["Heart rate (HR) and electrical conduction events were monitored using ambulatory electrocardiography for at least 6\u00a0h after the first dose.", {"entities": [[12, 14, "GENE"]]}], ["Of 2,417 enrolled patients, 2,282 (94.4\u00a0%) completed the study.", {"entities": []}], ["Fingolimod initiation was associated with a transient, mostly asymptomatic decrease in HR.", {"entities": [[87, 89, "GENE"]]}], ["Bradycardia adverse events occurred in 0.6\u00a0% of patients and were more frequent in individuals receiving BBs/CCBs (3.3\u00a0%) than in other patient subgroups (0.5\u20131.4\u00a0%); most events were asymptomatic, and all patients recovered without pharmacological intervention.", {"entities": []}], ["In the 6\u00a0h post-dose, the incidences of Mobitz type I second-degree atrioventricular block (AVB) and 2:1 AVB were higher in patients with PCCs (4.1 and 2.0\u00a0%, respectively) than in those without (0.9 and 0.3\u00a0%, respectively); at pre-dose screening, patients with PCCs had the same incidence of Mobitz type I second-degree AVB (4.1\u00a0%) and a slightly lower incidence of 2:1 AVB (0.7\u00a0%) than 6\u00a0h post-dose.", {"entities": []}], ["All recorded conduction abnormalities were asymptomatic.", {"entities": []}], ["This study adds to the evidence showing that cardiac effects during fingolimod initiation remain consistent with those known from previous, controlled studies, even if patients with PCCs are included.", {"entities": []}], ["The online version of this article (doi:10.1007/s00415-013-7115-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to ask whether there are shared ideas about what good health care looks like that apply across different populations and conditions.", {"entities": []}], ["Do priorities among \u201cseldom heard\u201d groups differ from mainstream views and, if so, how might we understand these differences?", {"entities": []}], ["Focus groups were recruited with the help of our study patient representatives.", {"entities": []}], ["Participants discussed and prioritized a set of eight \u201ccore components\u201d of good care.", {"entities": []}], ["We recorded and transcribed the data for thematic analysis.", {"entities": []}], ["We recruited people who are seldom heard in health and policy research for separate focus group discussions (one each with illegal drug users, Irish Travellers, migrant workers, young men and learning disabled people).", {"entities": []}], ["We also ran a reference group of educated, older adults and an online group with people with long\u2010term conditions.", {"entities": []}], ["There were few differences in what participants thought was important in health care but considerable differences in their expectations that they might personally receive good care.", {"entities": []}], ["Differences related to participants' previous experiences.", {"entities": []}], ["The drug users group reported particularly poor experiences and low expectations of good care.", {"entities": []}], ["Differences in what is regarded as an entitlement or privilege in health care underline the persistence of structural and relational differences in how services are experienced.", {"entities": []}], ["While we can be reassured that core aspects of care are similarly prioritized across different patient groups, including those who are seldom heard, a more intractable challenge remains: how to provide equitable health care for marginalized groups in an unequal society.", {"entities": []}], ["An important but understudied component of Canada's health system is alternative care.", {"entities": []}], ["The objective of this paper is to examine the geographic and socio-demographic characteristics of alternative care consultation in Ontario, Canada's largest province.", {"entities": []}], ["Data is drawn from the Canadian Community Health Survey (CCHS Cycle 3.1, 2005) for people aged 18 or over (n = 32,598) who had a consultation with an alternative health care provider.", {"entities": []}], ["Four groups of consultations are examined: (1) all consultations (2) massage therapy (3) acupuncture, and (4) homeopath/naturopath.", {"entities": []}], ["Descriptive statistics, mapping and logistic regression modeling are employed to analyze the data and to compare modalities of alternative health care use.", {"entities": []}], ["In 2005, more than 1.2 million adults aged 18 or over consulted an alternative health care provider, representing about 13% of the total population of Ontario.", {"entities": []}], ["The analysis revealed a varied geographic pattern of consultations across the province.", {"entities": []}], ["Consultations were fairly even across the urban to rural continuum and rural residents were just as likely to consult a provider as their urban counterparts.", {"entities": []}], ["From a health perspective, people with a chronic condition, lower health status and self-perceived unmet health care needs were more likely to see an alternative health provider.", {"entities": []}], ["Women with chronic conditions such as fibromyalgia, high blood pressure, chronic fatigue syndrome and chemical sensitivities were more likely to see an alternative provider if they felt their health care needs were not being met.", {"entities": [[73, 97, "DISEASE"], [89, 97, "DISEASE"], [38, 50, "DISEASE"]]}], ["The analysis revealed that geography is not a factor in determining alternative health care consultations in Ontario.", {"entities": []}], ["By contrast, there is a strong association between these consultations and socio-demographic characteristics particularly age, sex, education, health and self-perceived unmet health care needs.", {"entities": []}], ["The results underscore the importance of women's health needs as related to alternative care use.", {"entities": []}], ["The paper concludes that there is a need for more place-specific research that explores the reasons why people use specific types of alternative health care as tied to socio-economic status, health, place of residence, and knowledge of these treatments.", {"entities": []}], ["Periodontal diseases are inflammatory processes that occur following the influx of neutrophils into the periodontal tissues in response to the subgingival bacterial biofilm.", {"entities": []}], ["Current literature suggests that while neutrophils are protective and prevent bacterial infections, they also appear to contribute to damage of the periodontal tissues.", {"entities": []}], ["In the present study we compare the gene expression profile changes in neutrophils as they migrate from the circulation into the oral tissues in patients with chronic periodontits and matched healthy subjects.", {"entities": []}], ["We hypothesized that oral neutrophils in periodontal disease patients will display a disease specific transcriptome that differs from the oral neutrophil of healthy subjects.", {"entities": [[41, 60, "DISEASE"]]}], ["Venous blood and oral rinse samples were obtained from healthy subjects and chronic periodontitis patients for neutrophil isolation.", {"entities": [[84, 97, "DISEASE"]]}], ["mRNA was isolated from the neutrophils, and gene expression microarray analysis was completed.", {"entities": []}], ["Results were confirmed for specific genes of interest by qRT-PCR and Western Blot analysis.", {"entities": []}], ["Chronic periodontitis patients presented with increased recruitment of neutrophils to the oral cavity.", {"entities": [[8, 21, "DISEASE"]]}], ["Gene expression analysis revealed differences in the expression levels of genes from several biological pathways.", {"entities": []}], ["Using hierarchical clustering analysis, we found that the apoptosis network was significantly altered in patients with chronic inflammation in the oral cavity, with up-regulation of pro-survival members of the Bcl-2 family and down-regulation of pro-apoptosis members in the same compartment.", {"entities": []}], ["Additional functional analysis confirmed that the percentages of viable neutrophils are significantly increased in the oral cavity of chronic periodontitis patients.", {"entities": [[142, 155, "DISEASE"]]}], ["Oral neutrophils from patients with periodontal disease displayed an altered transcriptome following migration into the oral tissues.", {"entities": [[36, 55, "DISEASE"]]}], ["This resulted in a pro-survival neutrophil phenotype in chronic periodontitis patients when compared with healthy subjects, resulting in a longer-lived neutrophil.", {"entities": [[64, 77, "DISEASE"]]}], ["This is likely to impact the severity and length of the inflammatory response in this oral disease.", {"entities": []}], ["Febrile respiratory illness (FRI) has a high impact on public health and global economics and poses a difficult challenge for differential diagnosis.", {"entities": []}], ["A particular issue is the detection of genetically diverse pathogens, i.e.", {"entities": []}], ["human rhinoviruses (HRV) and enteroviruses (HEV) which are frequent causes of FRI. Resequencing Pathogen Microarray technology has demonstrated potential for differential diagnosis of several respiratory pathogens simultaneously, but a high confidence design method to select probes for genetically diverse viruses is lacking.", {"entities": []}], ["Using HRV and HEV as test cases, we assess a general design strategy for detecting and serotyping genetically diverse viruses.", {"entities": []}], ["A minimal number of probe sequences (26 for HRV and 13 for HEV), which were potentially capable of detecting all serotypes of HRV and HEV, were determined and implemented on the Resequencing Pathogen Microarray RPM-Flu v.30/31 ( Tessarae RPM-Flu ).", {"entities": []}], ["The specificities of designed probes were validated using 34 HRV and 28 HEV strains.", {"entities": []}], ["All strains were successfully detected and identified at least to species level.", {"entities": []}], ["33 HRV strains and 16 HEV strains could be further differentiated to serotype level.", {"entities": []}], ["This study provides a fundamental evaluation of simultaneous detection and differential identification of genetically diverse RNA viruses with a minimal number of prototype sequences.", {"entities": []}], ["The results demonstrated that the newly designed RPM-Flu v.30/31 can provide comprehensive and specific analysis of HRV and HEV samples which implicates that this design strategy will be applicable for other genetically diverse viruses.", {"entities": []}], ["Viruses can persist in differentiated cells ( i.e.", {"entities": []}], [", macrophages) over long periods of time, altering host cells functions but not inducing their death.", {"entities": []}], ["We had previously reported that, in early passages (14\u201340) of a murine macrophage-like cell line persistently infected with respiratory syncytial virus (RSV) (M\u0278P), Fc\u03b3R-mediated phagocytosis and expression of Fc\u03b3RIIB/RIII on the cell membrane were increased with respect to mock-infected macrophages (M\u0278N).", {"entities": []}], ["In this work, we explored the mechanism underlying such effects.", {"entities": []}], ["Increases in Fc\u03b3R expression and Fc\u03b3R-mediated phagocytosis are preserved after more than 87 passages of the persistently infected culture.", {"entities": []}], ["We analyzed the expression of Fc\u03b3R isoforms at both mRNA and protein levels, and found out that RSV persistence distinctly affects the expression of Fc\u03b3R isoforms.", {"entities": []}], ["We also observed that the increase in Fc\u03b3Rs expression results neither from soluble factors (cytokines) or viral products released by the infected cells, nor from an increase in the rate of Fc\u03b3R internalization.", {"entities": []}], ["Our results suggest that RSV persistence in macrophages induce intracellular effects that have an impact on Fc\u03b3Rs gene expression at both mRNA and protein levels, and that the characteristics of RSV persistence were preserved for over 87 passages.", {"entities": []}], ["Treadmill exercise and airway clearance with the Flutter\u00ae device have previously been shown to improve mucus clearance mechanisms in people with cystic fibrosis (CF) but have not been compared.", {"entities": [[145, 160, "DISEASE"]]}], ["It is therefore not known if treadmill exercise is an adequate form of airway clearance that could replace established airway clearance techniques, such as the Flutter\u00ae.", {"entities": []}], ["The aim of this study was to evaluate respiratory flow, sputum properties and subjective responses of treadmill exercise and Flutter\u00ae therapy, compared to resting breathing (control).", {"entities": []}], ["Twenty-four adults with mild to severe CF lung disease (FEV 1 28\u201386% predicted) completed a three-day randomised, controlled, cross-over study.", {"entities": [[42, 54, "DISEASE"], [56, 59, "GENE"]]}], ["Interventions consisted of 20\u00a0min of resting breathing (control), treadmill exercise at 60% of the participant\u2019s peak oxygen consumption and Flutter\u00ae therapy.", {"entities": []}], ["Respiratory flow was measured during the interventions.", {"entities": []}], ["Sputum properties (solids content and mechanical impedance) and subjective responses (ease of expectoration and sense of chest congestion) were measured before, immediately after the interventions and after 20\u00a0min of recovery.", {"entities": []}], ["Treadmill exercise and Flutter\u00ae resulted in similar significant increases in peak expiratory flow, but only Flutter\u00ae created an expiratory airflow bias (i.e.", {"entities": []}], ["peak expiratory flow was at least 10% higher than peak inspiratory flow).", {"entities": []}], ["Treadmill exercise and Flutter\u00ae therapy resulted in similar significant reductions in sputum mechanical impedance, but only treadmill exercise caused a transient increase in sputum hydration.", {"entities": []}], ["Treadmill exercise improved ease of expectoration and Flutter\u00ae therapy improved subjective sense of chest congestion.", {"entities": []}], ["A single bout of treadmill exercise and Flutter\u00ae therapy were equally effective in augmenting mucus clearance mechanisms in adults with CF.", {"entities": []}], ["Only longer term studies, however, will determine if exercise alone is an adequate form of airway clearance therapy that could replace other airway clearance techniques.", {"entities": []}], ["Australian and New Zealand Clinical Trials Registry, Registration number # ACTRN12609000168257 , Retrospectively registered (Date submitted to registry 26/2/2009, First participant enrolled 27/2/2009, Date registered 6/4/2009).", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-016-0360-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Little is known about the prevalence and clinical importance of potentially inappropriate prescribing instances (PIPs) in the very old (>80\u00a0years).", {"entities": []}], ["The main objective was to describe the prevalence of PIPs according to START (Screening Tool to Alert doctors to Right Treatment; omissions) and,STOPP (Screening Tool of Older Person\u2019s Prescriptions; over/misuse) and the Beers list (over/misuse).", {"entities": []}], ["Secondary objectives were to identify determinants if PIPs and to assess the clinical importance to modify the treatment in case of PIPs.", {"entities": []}], ["Cross-sectional analysis of baseline data of the BELFRAIL cohort, which included 567 Belgian patients aged 80 and older in primary care.", {"entities": []}], ["Two independent researchers applied the screening tools to the study population to detect PIPs.", {"entities": []}], ["Next, a multidisciplinary panel of experts rated the clinical importance of the PIPs on a subsample of 50 patients.", {"entities": []}], ["In this very old population (median age 84\u00a0years, 63\u00a0% female), the screening detected START-PIPs in 59\u00a0% of patients, STOPP-PIPs in 41\u00a0% and Beers-PIPs in 32\u00a0%.", {"entities": []}], ["Assessment of the clinical importance revealed that the most frequent PIPs were of moderate or major importance.", {"entities": []}], ["In 28\u00a0% of the subsample, the relevance of the PIP was challenged by the global medical, functional and social background of the patient hence the validity of some criteria was questioned.", {"entities": []}], ["Potentially inappropriate prescribing is highly prevalent in the very old.", {"entities": []}], ["A good understanding of the patients\u2019 medical, functional and social context is crucial to assess the actual appropriateness of drug treatment.", {"entities": []}], ["Hypertonic saline aerosols are being used increasingly for bronchial provocation testing and induction of sputum.", {"entities": []}], ["The aims of this study were to assess the response to challenge with 3% hypertonic saline administered via a ultrasonic nebulizer in patients with asthma, and to evaluate relationship between % fall of FEV1 during induction of sputum (osmotic airway hyperresponsiveness; osmotic AHR) and biochemical markers of induced sputum.", {"entities": [[147, 153, "DISEASE"], [279, 282, "GENE"]]}], ["We investigated changes in FEV1 in response to inhaling ultrasonically nebulized 3% saline in 25 patients with asthma and 10 control subjects.", {"entities": [[111, 117, "DISEASE"]]}], ["FEV1 was measured before, during, and after induction of sputum.", {"entities": []}], ["We used fluoroimmunoassay to detect eosinophil cationic protein (ECP), immunohistochemical staining to detect EG2+ (secretory form of ECP) eosinophils, and a sandwich ELISA to detect interleukin (IL)-5.", {"entities": []}], ["Protein concentration was determined by using bicinchoninic acid protein assay reagent.", {"entities": []}], ["Asthmatics, compared with controls, had significantly higher osmotic AHR.", {"entities": [[69, 72, "GENE"]]}], ["Moderate to severe asthmatics had significantly higher osmotic AHR compared to mild asthmatics.", {"entities": [[63, 66, "GENE"]]}], ["Osmotic AHR was significantly correlated with the proportion of eosinophils, the levels of ECP, EG2+ eosinophils, IL-5, and proteins.", {"entities": [[8, 11, "GENE"]]}], ["These data suggest that osmotic AHR is closely related to the clinical status and biochemical markers of sputum supernatant in asthmatic patients.", {"entities": [[32, 35, "GENE"]]}], ["The characteristics of mesenchymal stem cells (MSCs) derived from human turbinates (hTMSCs) have not been investigated in allergic rhinitis.", {"entities": [[122, 139, "DISEASE"], [131, 139, "DISEASE"]]}], ["We evaluated the influence of allergic state of the donor on the characteristics, proliferation, and differentiation potential of hTMSCs, compared with hTMSCs derived from non-allergic patients.", {"entities": []}], ["hTMSCs were isolated from five non-allergic and five allergic patients.", {"entities": []}], ["The expression of toll-like receptors (TLRs) in hTMSCs was measured by FACS, and cell proliferation was measured using a cell counting kit.", {"entities": []}], ["Cytokine secretion was analyzed using multiplex immunoassays.", {"entities": []}], ["The osteogenic, chondrogenic, and adipogenic differentiation potentials of hTMSCs were evaluated by histology and gene expression analysis.", {"entities": []}], ["In allergic patients, FACS analysis showed that TLR3 and TLR4 were more highly expressed on the surface of hTMSCs than TLR2 and TLR5.", {"entities": [[48, 52, "GENE"], [57, 61, "GENE"], [119, 123, "GENE"], [128, 132, "GENE"]]}], ["The proliferation of hTMSCs was not influenced by the presence of TLR priming.", {"entities": []}], ["The expression of IL-6, IL-8, IL-12, IP-10, and RANTES was upregulated after the TLR4 priming.", {"entities": [[81, 85, "GENE"]]}], ["The differentiation potential of hTMSCs was not influenced by TLR priming.", {"entities": []}], ["These characteristics of hTMSCs were similar to those of hTMSCs from non-allergic patients.", {"entities": []}], ["We conclude that the allergic condition of the donor does not influence TLR expression, proliferation, or immunomodulatory potential of hTMSCs.", {"entities": []}], ["Inflammation is part of our body's response to tissue injury and pathogens.", {"entities": []}], ["It helps to recruit various immune cells to the site of inflammation and activates the production of mediators to mobilize systemic protective processes.", {"entities": []}], ["However, chronic inflammation can increase the risk of diseases like cancer.", {"entities": [[69, 75, "DISEASE"]]}], ["Apart from cytokines and chemokines, lipid mediators, particularly sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P), contribute to inflammation and cancer.", {"entities": [[160, 166, "DISEASE"]]}], ["S1P is an important player in inflammation-associated colon cancer progression.", {"entities": [[54, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["On the other hand, C1P has been recognized to be involved in cancer cell growth, migration, survival, and inflammation.", {"entities": [[61, 67, "DISEASE"]]}], ["However, whether C1P is involved in inflammation-associated cancer is not yet established.", {"entities": [[60, 66, "DISEASE"]]}], ["In contrast, few studies have also suggested that S1P and C1P are involved in anti-inflammatory pathways regulated in certain cell types.", {"entities": []}], ["Ceramide is the substrate for ceramide kinase (CERK) to yield C1P, and sphingosine is phosphorylated to S1P by sphingosine kinases (SphKs).", {"entities": [[47, 51, "GENE"]]}], ["Biological functions of sphingolipid metabolites have been studied extensively.", {"entities": []}], ["Ceramide is associated with cell growth inhibition and enhancement of apoptosis while S1P and C1P are associated with enhancement of cell growth and survival.", {"entities": []}], ["Altogether, S1P and C1P are important regulators of ceramide level and cell fate.", {"entities": []}], ["This review focuses on S1P and C1P involvement in inflammation and cancer with emphasis on recent progress in the field.", {"entities": [[67, 73, "DISEASE"]]}], ["To describe the socio-demographic factors associated with exposure to second-hand smoke (SHS) in different settings (home, leisure, and workplace).", {"entities": []}], ["We analysed cross-sectional data on self-reported SHS exposure in 1059 non-daily smokers interviewed in the Cornell\u00e0 Health Interview Survey Follow-up Study in 2002.", {"entities": []}], ["We calculated age-adjusted prevalence rates and prevalence rate ratios of SHS exposure at home, at the workplace, during leisure time, and in any of these settings.", {"entities": []}], ["The age-standardized prevalence rate of SHS exposure in any setting was 69.5% in men and 62.9% in women.", {"entities": []}], ["Among men, 25.9% reported passive smoking at home, 55.1% during leisure time, and 34.0% at the workplace.", {"entities": []}], ["Among women, prevalence rates in these settings were 34.1%, 44.3% and 30.1%, respectively.", {"entities": []}], ["Overall exposure to SHS decreased with age in both men and women.", {"entities": []}], ["In men, SHS exposure was related to marital status, physical activity, smoking, and alcohol intake.", {"entities": []}], ["In women, SHS exposure was related to educational level, marital status, occupational status, self-perceived health, smoking-related illness, and alcohol intake.", {"entities": []}], ["The prevalence of SHS exposure in this population was high.", {"entities": []}], ["The strongest association with exposure were found for age and occupational status in men, and age and educational level in women.", {"entities": []}], ["Genotype imputation, used in genome-wide association studies to expand coverage of single nucleotide polymorphisms (SNPs), has performed poorly in African Americans compared to less admixed populations.", {"entities": []}], ["Overall, imputation has typically relied on HapMap reference haplotype panels from Africans (YRI), European Americans (CEU), and Asians (CHB/JPT).", {"entities": []}], ["The 1000 Genomes project offers a wider range of reference populations, such as African Americans (ASW), but their imputation performance has had limited evaluation.", {"entities": []}], ["Using 595 African Americans genotyped on Illumina\u2019s HumanHap550v3 BeadChip, we compared imputation results from four software programs (IMPUTE2, BEAGLE, MaCH, and MaCH-Admix) and three reference panels consisting of different combinations of 1000 Genomes populations (February 2012 release): (1) 3 specifically selected populations (YRI, CEU, and ASW); (2) 8 populations of diverse African (AFR) or European (AFR) descent; and (3) all 14 available populations (ALL).", {"entities": []}], ["Based on chromosome 22, we calculated three performance metrics: (1) concordance (percentage of masked genotyped SNPs with imputed and true genotype agreement); (2) imputation quality score (IQS; concordance adjusted for chance agreement, which is particularly informative for low minor allele frequency [MAF] SNPs); and (3) average r2hat (estimated correlation between the imputed and true genotypes, for all imputed SNPs).", {"entities": [[305, 308, "GENE"]]}], ["Across the reference panels, IMPUTE2 and MaCH had the highest concordance (91%\u201393%), but IMPUTE2 had the highest IQS (81%\u201383%) and average r2hat (0.68 using YRI+ASW+CEU, 0.62 using AFR+EUR, and 0.55 using ALL).", {"entities": []}], ["Imputation quality for most programs was reduced by the addition of more distantly related reference populations, due entirely to the introduction of low frequency SNPs (MAF\u22642%) that are monomorphic in the more closely related panels.", {"entities": []}], ["While imputation was optimized by using IMPUTE2 with reference to the ALL panel (average r2hat\u200a=\u200a0.86 for SNPs with MAF>2%), use of the ALL panel for African American studies requires careful interpretation of the population specificity and imputation quality of low frequency SNPs.", {"entities": [[116, 119, "GENE"]]}], ["Previous studies identified CD147 as the chemotactic receptor on inflammatory leukocytes for extracellular cyclophilins (eCyp).", {"entities": []}], ["However, CD147 is not known to associate with signal transducing molecules, so other transmembrane proteins, such as proteoglycans, integrins, and CD98, were suggested as receptor or co-receptor for eCyp.", {"entities": []}], ["CD147 is ubiquitously expressed on many cell types, but relationship between the level of CD147 expression and cellular responses to eCyp has never been analyzed.", {"entities": []}], ["Given the role of eCyp in pathogenesis of many diseases, it is important to know whether cellular responses to eCyp are regulated at the level of CD147 expression.", {"entities": []}], ["Here, we manipulated CD147 expression levels on HeLa cells using RNAi and investigated the signalling and chemotactic responses to eCypA.", {"entities": []}], ["Both Erk activation and chemotaxis correlated with the level of CD147 expression, with cells exhibiting low level expression being practically unresponsive to eCypA.", {"entities": []}], ["Our results provide the first demonstration of a chemotactic response of HeLa cells to eCypA, establish a correlation between the level of CD147 expression and the magnitude of cellular responses to eCypA, and indicate that CD147 may be a limiting factor in the receptor complex determining cyclophilin-induced Erk activation and cell migration.", {"entities": []}], ["Objectives To determine the extent to which secondary drug prevention for patients with stroke in routine primary care varies by sex, age, and socioeconomic circumstances, and to quantify the effect of secondary drug prevention on one year mortality by sociodemographic group.", {"entities": []}], ["Design Cohort study using individual patient data from the health improvement network primary care database.", {"entities": []}], ["Setting England.", {"entities": []}], ["Participants 12\u2009830 patients aged 50 or more years from 113 general practices who had a stroke between 1995 and 2005 and who survived the first 30 days after the stroke.", {"entities": []}], ["Main outcome measures Multivariable associations between odds of receiving secondary prevention after a stroke, and sex, age group, and socioeconomic circumstances; hazard ratios for all cause mortality from 31 days after the stroke and within the first year among patients receiving treatment and by social group; and probabilities of one year mortality for social factors of interest and treatment.", {"entities": []}], ["Results Only 25.6% of men and 20.8% of women received secondary prevention.", {"entities": []}], ["Receipt of secondary prevention did not vary by socioeconomic circumstances or by sex.", {"entities": []}], ["Older patients were, however, substantially less likely to receive treatment.", {"entities": []}], ["The adjusted odds ratio for 80-89 year olds compared with 50-59 year olds was 0.53 (95% confidence interval 0.41 to 0.69).", {"entities": []}], ["This was because older people were less likely to receive lipid lowering drugs\u2014for example, the adjusted odds ratio for 80-89 year olds compared with 50-59 year olds was 0.44 (95% confidence interval 0.33 to 0.59).", {"entities": []}], ["Secondary prevention was associated with a 50% reduction in mortality risk (adjusted hazard ratio 0.50, 95% confidence interval 0.42 to 59).", {"entities": []}], ["On average, mortality within the first year was 5.7% for patients receiving treatment compared with 11.1% for patients not receiving treatment.", {"entities": []}], ["There was little evidence that the effect of treatment differed between the social groups examined.", {"entities": []}], ["Conclusion Under-treatment among older people with stroke in routine primary care cannot be justified given the lack of evidence on variations in effectiveness of treatment by age.", {"entities": []}], ["Background and Objective .", {"entities": []}], ["The concentration of exhaled nitric oxide (eNO), reflecting the activity of inducible NO synthase in airway epithelium, has been found to increase in patients with obstructive sleep apnea (OSA).", {"entities": []}], ["This study aimed to measure eNO concentration in patients with suspected OSA and to correlate different eNO parameters with clinical and sleep apnea characteristics.", {"entities": []}], ["In this cross-sectional study, all patients underwent in-lab overnight polysomnography (PSG) and eNO measurement using a method of multiple flow rates before and after PSG (pre- and post-PSG).", {"entities": []}], ["According to the result of PSG, 82 persons were divided into two groups: control subjects ( n = 30; 54 \u00b1 14 years) and patients with OSA defined as apnea-hypopnea index (AHI) \u2265 5/hour ( n = 52; 53 \u00b1 12 years).", {"entities": []}], ["Body mass index (BMI) and neck and abdomen circumferences of OSA patients were significantly higher than those from control subjects.", {"entities": []}], ["In OSA group, post-PSG alveolar NO concentration (CANO) (5.3 \u00b1 1.9\u2009ppb) was significantly higher than pre-PSG CANO (4.0 \u00b1 1.7\u2009ppb; P < 0.001).", {"entities": []}], ["Significant correlations have been found between CANO and AHI ( P < 0.001) and between CANO and nadir SpO 2 ( P < 0.05).", {"entities": []}], ["The daytime CANO value of more than 4.1\u2009ppb can be used to screen symptomatic subjects for the presence of OSA with a high specificity of 93.3%.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Our findings indicate CANO as a surrogate marker for OSA in persons with suggestive symptoms.", {"entities": []}], ["Exposure to air pollution impairs aspects of endothelial function such as flow-mediated dilation (FMD).", {"entities": []}], ["Outdoor exercisers are frequently exposed to air pollution, but how exercising in air pollution affects endothelial function and how these effects are modified by exercise intensity are poorly understood.", {"entities": []}], ["Therefore, the purpose of this study was to determine the effects of low-intensity and high-intensity cycling with diesel exhaust (DE) exposure on FMD, blood pressure, plasma nitrite and nitrate (NOx) and endothelin-1.", {"entities": []}], ["Eighteen males performed 30-minute trials of low or high-intensity cycling (30% and 60% of power at VO 2peak ) or a resting control condition.", {"entities": []}], ["For each subject, each trial was performed once while breathing filtered air (FA) and once while breathing DE (300ug/m 2.5 , six trials in total).", {"entities": []}], ["Preceding exposure, immediately post-exposure, 1 hour and 2 hours post-exposure, FMD, blood pressure and plasma endothelin-1 and NOx concentrations were measured.", {"entities": []}], ["Data were analyzed using repeated-measures ANOVA and linear mixed model.", {"entities": []}], ["Following exercise in DE, plasma NOx significantly increased and was significantly greater than FA (p<0.05).", {"entities": []}], ["Two hours following DE exposure, endothelin-1 was significantly less than FA (p = 0.037) but exercise intensity did not modify this response.", {"entities": []}], ["DE exposure did not affect FMD or blood pressure.", {"entities": []}], ["Our results suggest that exercising in DE did not adversely affect plasma NO X , endothelin-1, FMD and blood pressure.", {"entities": []}], ["Therefore, recommendations for healthy individuals to moderate or avoid exercise during bouts of high pollution appear to have no acute protective effect.", {"entities": []}], ["Tobacco exposure has been linked with sinonasal pathology and may be associated with allergic sensitization.", {"entities": []}], ["This study evaluates the association between exposure to active smoking or secondhand smoke (SHS) and the prevalence of rhinitis and allergic sensitization in the US adult population.", {"entities": [[120, 128, "DISEASE"]]}], ["Cross-sectional study in 4,339 adults aged 20\u201385 in the National Health and Nutrition Examination Survey, 2005\u20132006.", {"entities": []}], ["Never smoking was defined as reported lifetime smoking less than 100 cigarettes and serum cotinine levels <10ng/ml, while active smoking was defined as self-reported smoking or serum cotinine concentrations > 10 ng/mL.", {"entities": []}], ["Self-reported rhinitis was based on symptoms during the past 12 months, and allergen sensitization was defined as a positive response to any of the 19 specific IgE antigens tested.", {"entities": [[14, 22, "DISEASE"]]}], ["Almost half of the population (43%) had detectable levels of IgE specific to at least one inhaled allergen and 32% reported a history of rhinitis.", {"entities": [[137, 145, "DISEASE"]]}], ["After multivariate adjustment, there was a statistically significant association between the highest serum cotinine tertile and rhinitis in active smokers (OR 1.42; 95%CI 1.00\u20132.00).", {"entities": [[128, 136, "DISEASE"]]}], ["The association between active smoking and rhinitis was stronger in individuals without allergic sensitization (OR 2.47; 95%CI 1.44\u20134.23).", {"entities": [[43, 51, "DISEASE"]]}], ["There was a statistically significant association between increasing cotinine tertiles and decreased odds of inhaled allergen sensitization (p-trend <.01).", {"entities": []}], ["Tobacco smoke exposure was associated with increased prevalence of rhinitis symptoms, but not with allergic sensitization.", {"entities": [[67, 75, "DISEASE"]]}], ["The results indicate that the relationship between tobacco smoke exposure and sinonasal pathology in adults may be independent of allergic sensitization.", {"entities": []}], ["Curcumin (diferuloylmethane) is a polyphenol derived from the Curcuma longa plant, commonly known as turmeric.", {"entities": []}], ["Curcumin has been used extensively in Ayurvedic medicine for centuries, as it is nontoxic and has a variety of therapeutic properties including anti-oxidant, analgesic, anti-inflammatory and antiseptic activity.", {"entities": []}], ["More recently curcumin has been found to possess anti-cancer activities via its effect on a variety of biological pathways involved in mutagenesis, oncogene expression, cell cycle regulation, apoptosis, tumorigenesis and metastasis.", {"entities": [[54, 60, "DISEASE"]]}], ["Curcumin has shown anti-proliferative effect in multiple cancers, and is an inhibitor of the transcription factor NF-\u03baB and downstream gene products (including c-myc, Bcl-2, COX-2, NOS, Cyclin D1, TNF-\u03b1, interleukins and MMP-9).", {"entities": []}], ["In addition, curcumin affects a variety of growth factor receptors and cell adhesion molecules involved in tumor growth, angiogenesis and metastasis.", {"entities": []}], ["Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and treatment protocols include disfiguring surgery, platinum-based chemotherapy and radiation, all of which may result in tremendous patient morbidity.", {"entities": [[28, 37, "DISEASE"], [14, 37, "DISEASE"], [71, 77, "DISEASE"]]}], ["As a result, there is significant interest in developing adjuvant chemotherapies to augment currently available treatment protocols, which may allow decreased side effects and toxicity without compromising therapeutic efficacy.", {"entities": []}], ["Curcumin is one such potential candidate, and this review presents an overview of the current in vitro and in vivo data supporting its therapeutic activity in head and neck cancer as well as some of the challenges concerning its development as an adjuvant chemotherapeutic agent.", {"entities": [[173, 179, "DISEASE"]]}], ["Case-control genetic studies of complex human diseases can be confounded by population stratification.", {"entities": []}], ["This issue can be addressed using panels of ancestry informative markers (AIMs) that can provide substantial population substructure information.", {"entities": []}], ["Previously, we described a panel of 128 SNP AIMs that were designed as a tool for ascertaining the origins of subjects from Europe, Sub-Saharan Africa, Americas, and East Asia.", {"entities": []}], ["In this study, genotypes from Human Genome Diversity Panel populations were used to further evaluate a 93 SNP AIM panel, a subset of the 128 AIMS set, for distinguishing continental origins.", {"entities": []}], ["Using both model-based and relatively model-independent methods, we here confirm the ability of this AIM set to distinguish diverse population groups that were not previously evaluated.", {"entities": []}], ["This study included multiple population groups from Oceana, South Asia, East Asia, Sub-Saharan Africa, North and South America, and Europe.", {"entities": []}], ["In addition, the 93 AIM set provides population substructure information that can, for example, distinguish Arab and Ashkenazi from Northern European population groups and Pygmy from other Sub-Saharan African population groups.", {"entities": []}], ["These data provide additional support for using the 93 AIM set to efficiently identify continental subject groups for genetic studies, to identify study population outliers, and to control for admixture in association studies.", {"entities": []}], ["Background: During the early postnatal period, the impact of nutrition on DNA methylation has not been well studied in humans.", {"entities": []}], ["The aim was to quantify the relationship between one-carbon metabolism nutrient intake during the first three years of life and global DNA methylation levels at four years.", {"entities": []}], ["Design: Childhood dietary intake was assessed using infant feeding questionnaires, food frequency questionnaires, 4-day weighed food records and 24-h food records.", {"entities": []}], ["The dietary records were used to estimate the intake of methionine, folate, vitamins B2, B6 and B12 and choline.", {"entities": []}], ["The accumulative nutrient intake specific rank from three months to three years of age was used for analysis.", {"entities": []}], ["Global DNA methylation (%5-methyl cytosines (%5-mC)) was measured in buccal cells at four years of age, using an enzyme-linked immunosorbent assay (ELISA) commercial kit.", {"entities": []}], ["Linear regression models were used to quantify the statistical relationships.", {"entities": []}], ["Results: Data were collected from 73 children recruited from the Women and their Children\u2019s Health (WATCH) study.", {"entities": []}], ["No association was found between one-carbon metabolism nutrient intake and global DNA methylation levels ( P 0.05).", {"entities": []}], ["Global DNA methylation levels in males were significantly higher than in females (median %5-mC: 1.82 vs. 1.03, males and females respectively, ( P 0.05)).", {"entities": []}], ["Conclusion: No association was found between the intake of one-carbon metabolism nutrients during the early postnatal period and global DNA methylation levels at age four years.", {"entities": []}], ["Higher global DNA methylation levels in males warrants further investigation.", {"entities": []}], ["In our present study we tested the health effects among women of controlled exposures to volatile organic compounds (VOCs), with and without ozone (O 3 ), and psychological stress.", {"entities": []}], ["Each subject was exposed to the following three conditions at 1-week intervals (within-subject factor): VOCs (26 mg/m 3 (26 mg/m 3 was shown to produce irritating compounds including aldehydes, hydrogen peroxide, organic acids, secondary organic aerosols, and ultrafine particles (particulate matter with aerodynamic diameter < 0.1 \u03bcm).", {"entities": []}], ["Exposure to VOCs with and without O 3 did not result in significant subjective or objective health effects.", {"entities": []}], ["Psychological stress significantly increased salivary cortisol and symptoms of anxiety regardless of exposure condition.", {"entities": []}], ["Neither lung function nor neurobehavioral performance was compromised by exposure to VOCs or VOCs + O 3 .", {"entities": []}], ["Although numerous epidemiologic studies suggest that symptoms are significantly increased among workers in buildings with poor ventilation and mixtures of VOCs, our acute exposure study was not consistent with these epidemiologic findings.", {"entities": []}], ["Stress appears to be a more significant factor than chemical exposures in affecting some of the health end points measured in our present study.", {"entities": []}], ["This is a critical review on research conducted in the field of pulmonary delivery of liposomes.", {"entities": []}], ["Issues relating to the mechanism of nebulisation and liposome composition were appraised and correlated with literature reports of liposome formulations used in clinical trials to understand the role of liposome size and composition on therapeutic outcome.", {"entities": []}], ["A major highlight was liposome inhalation for the treatment of lung cancers.", {"entities": []}], ["Many in vivo studies that explored the potential of liposomes as anticancer carrier systems were evaluated, including animal studies and clinical trials.", {"entities": []}], ["Liposomes can entrap anticancer drugs and localise their action in the lung following pulmonary delivery.", {"entities": []}], ["The safety of inhaled liposomes incorporating anticancer drugs depends on the anticancer agent used and the amount of drug delivered to the target cancer in the lung.", {"entities": [[147, 153, "DISEASE"]]}], ["The difficulty of efficient targeting of liposomal anticancer aerosols to the cancerous tissues within the lung may result in low doses reaching the target site.", {"entities": []}], ["Overall, following the success of liposomes as inhalable carriers in the treatment of lung infections, it is expected that more focus from research and development will be given to designing inhalable liposome carriers for the treatment of other lung diseases, including pulmonary cancers.", {"entities": []}], ["The successful development of anticancer liposomes for inhalation may depend on the future development of effective aerosolisation devices and better targeted liposomes to maximise the benefit of therapy and reduce the potential for local and systemic adverse effects.", {"entities": []}], ["Osteoarthritis-related joint pain is prevalent and potentially disabling.", {"entities": []}], ["United Kingdom clinical guidelines suggest that patients should be supported to self-manage in primary care settings.", {"entities": []}], ["However, the processes and mechanisms that influence patient consultation decisions for joint pain are not comprehensively understood.", {"entities": []}], ["We recruited participants ( N = 22) from an existing longitudinal survey to take part in in-depth interviews and a diary study.", {"entities": []}], ["We found that consultation decisions and illness actions were ongoing social processes.", {"entities": []}], ["The need for and benefits of consulting were weighed against the value of consuming the time of a professional who was considered an expert.", {"entities": []}], ["We suggest that how general practitioners manage consultations influences patient actions and is part of a broader process of defining the utility and moral worth of consulting.", {"entities": []}], ["Recognizing these factors will improve self-management support and consultation outcomes.", {"entities": []}], ["Studies conducted in Western countries suggest that early age at menarche and early age at menopause are both associated with increased total mortality, but limited data are available for Asian populations.", {"entities": []}], ["We examined associations of age at menarche and natural menopause and duration of the reproductive span with mortality in a population-based cohort study of Chinese women.", {"entities": []}], ["We evaluated the effects of age at menarche, age at natural menopause, and number of reproductive years on total and cause-specific mortality among 31,955 naturally menopausal Chinese women who participated in the Shanghai Women's Health Study, a population-based, prospective cohort study.", {"entities": []}], ["A total of 3,158 deaths occurred during a median follow-up of 11.2 years.", {"entities": []}], ["Results from Cox proportional hazards models showed that younger age at menopause (<46.64 years) was associated with higher risk of total mortality ( P trend \u200a=\u200a0.02).", {"entities": []}], ["Younger age at menarche (<14 years) was associated with higher risk of mortality from stroke ( P trend \u200a=\u200a0.03) and diabetes ( P trend \u200a=\u200a0.02) but lower risk of mortality from respiratory system cancer ( P trend \u200a=\u200a0.01).", {"entities": [[177, 202, "DISEASE"], [196, 202, "DISEASE"]]}], ["Women with a shorter reproductive span had lower risk of mortality from gynecological cancers ( P trend \u200a=\u200a0.03).", {"entities": []}], ["Our study found that menstrual characteristics are important predictors of mortality, suggesting an important role of sex hormones in biological aging.", {"entities": []}], ["The persistent excess in adverse outcomes by ethnicity highlights the need for improved public health responses.", {"entities": []}], ["Evidence suggests that indigenous populations have suffered disproportionately from past influenza pandemics.", {"entities": [[89, 98, "DISEASE"]]}], ["To examine any such patterns for M\u0101ori in New Zealand, we searched the literature and performed new analyses by using additional datasets.", {"entities": []}], ["The M\u0101ori death rate in the 1918 pandemic (4,230/100,000 population) was 7.3\u00d7 the European rate.", {"entities": []}], ["In the 1957 pandemic, the M\u0101ori death rate (40/100,000) was 6.2\u00d7 the European rate.", {"entities": []}], ["In the 2009 pandemic, the M\u0101ori rate was higher than the European rate (rate ratio 2.6, 95% confidence interval 1.3\u20135.3).", {"entities": []}], ["These findings suggest some decline in pandemic-related ethnic inequalities in death rates over the past century.", {"entities": []}], ["Nevertheless, the persistent excess in adverse outcomes for M\u0101ori, and for Pacific persons residing in New Zealand, highlights the need for improved public health responses.", {"entities": []}], ["Background.", {"entities": []}], ["Two important issues in the aging kidney are mitochondrial dysfunction and oxidative stress.", {"entities": []}], ["An Nrf2 activator, resveratrol, is known to have various effects.", {"entities": []}], ["Resveratrol may prevent inflammation and oxidative stress by activating Nrf2 and SIRT1 signaling.", {"entities": [[81, 86, "GENE"]]}], ["We examined whether resveratrol could potentially ameliorate the cellular condition, such as renal injury due to cellular oxidative stress and mitochondrial dysfunction caused by aging.", {"entities": []}], ["Male 18-month-old C57BL/6 mice were used.", {"entities": []}], ["Resveratrol (40 mg/kg) was administered to aged mice for 6 months.", {"entities": []}], ["We compared histological changes, oxidative stress, and aging-related protein expression in the kidney between the resveratrol-treated group (RSV) and the control group (cont).", {"entities": []}], ["We performed experiments using small-interfering RNAs (siRNAs) for Nrf2 and SIRT1 in cultured HK2 cells.", {"entities": [[76, 81, "GENE"], [94, 97, "GENE"]]}], ["Resveratrol improved renal function, proteinuria, histological changes and inflammation in aging mice.", {"entities": [[37, 48, "DISEASE"]]}], ["Also, expression of Nrf2-HO-1-NOQ-1 signaling and SIRT1-AMPK-PGC-1\u03b1 signaling was increased in the RSV group.", {"entities": []}], ["Transfection with Nrf2 and SIRT1 siRNA prevented resveratrol-induced anti-oxidative effect in HK2 cells in media treated with H 2 O 2 .", {"entities": [[27, 32, "GENE"], [94, 97, "GENE"]]}], ["Conclusions.", {"entities": []}], ["Activation of the Nrf2 and SIRT1 signaling pathways ameliorated oxidative stress and mitochondrial dysfunction.", {"entities": [[27, 32, "GENE"]]}], ["Pharmacological targeting of Nrf2 signaling molecules may reduce the pathologic changes of aging in the kidney.", {"entities": []}], ["This study compared the waist circumference (WC) measurements of Chinese children at different sites to determine the relationship between WC measurements and body fat.", {"entities": []}], ["WC was measured at five sites in 255 subjects aged 9\u201319 years: immediately below the lowest rib (WC1), at the narrowest waist (WC2), the midpoint between the lowest rib and the iliac crest (WC3), 1\u2009cm above the umbilicus (WC4), and immediately above the iliac crest (WC5).", {"entities": []}], ["Body fat mass (FM), body fat percentage (% BF), body fat mass in the trunk (FM in the trunk), and fat percentage in the trunk (% BF in the trunk) were determined by dual-energy X-ray absorptiometry.", {"entities": []}], ["The WCs were then compared through ANOVA with repeated measurement.", {"entities": []}], ["The relationship of WC of each site with FM, % BF, FM in the trunk, and % BF in the trunk was examined through partial correlation.", {"entities": []}], ["The WCs exhibited the following pattern: WC2 < WC1 < WC3 < WC4 < WC5 ( p < 0.001) in males and WC2 < WC1 < WC4, WC3 < WC5 ( p < 0.001) in females.", {"entities": []}], ["The measured WCs were strongly correlated with FM, % BF, FM in the trunk, and % BF in the trunk.", {"entities": []}], ["The WC measurements at five commonly used sites among Chinese children are different from one another.", {"entities": []}], ["Results indicate that standardizing the anatomic point for the WC measurements is necessary.", {"entities": []}], ["Overweight and obesity is a problem in children in particular and determining pathways of transmission is important in prevention.", {"entities": [[15, 22, "DISEASE"]]}], ["We aimed to examine associations for body mass index (BMI) across three generations of the same families.", {"entities": []}], ["Members of 556 families in the Lifeways Cross-Generation Cohort Study 2001\u20132014.", {"entities": []}], ["Community-based study with linkage to health records in the Republic of Ireland.", {"entities": []}], ["Employing a novel mixed-method approach which adjusts for age and familial group, BMI correlations were estimated at three ages of the index child, that is, at birth and at ages 5 and 9.", {"entities": []}], ["Height was also examined for comparative purposes.", {"entities": []}], ["Correlation of offspring's BMI with that of the mother increased with age (correlation coefficient 0.15 increasing to 0.28, p value <0.001 in all cases) while no consistent pattern was seen with offspring and fathers.", {"entities": []}], ["There was an association also with each parent and their own mother.", {"entities": []}], ["Offspring's BMI was correlated to a lesser extent with that of the maternal grandmother while for girls only there was an association with that of the paternal grandmother at ages 0 and 5 (correlation coefficients 0.25, 0.28, p values 0.02, 0.01, respectively).", {"entities": []}], ["In contrast, height of the child was strongly associated with those of all family members at age 5, but at birth and at age 9 only there was an association with those of the parents and the paternal grandfather.", {"entities": []}], ["Correlation of offspring's height with those of the mother and father increased with age.", {"entities": []}], ["The results suggest that BMI is predominantly associated with the maternal line, possibly either with intrauterine development, or inherited through the X chromosome, or both, while height is a more complex trait with genetic influences of the parents and that of the paternal grandfather predominating.", {"entities": []}], ["Early-life respiratory viral infections, notably with respiratory syncytial virus (RSV), increase the risk of subsequent development of childhood asthma.", {"entities": [[146, 152, "DISEASE"]]}], ["The purpose of this study was to assess whether early-life infection with a species-specific model of RSV and subsequent allergen exposure predisposed to the development of features of asthma.", {"entities": [[185, 191, "DISEASE"]]}], ["We employed a unique combination of animal models in which BALB/c mice were neonatally infected with pneumonia virus of mice (PVM, which replicates severe RSV disease in human infants) and following recovery, were intranasally sensitised with ovalbumin.", {"entities": [[101, 110, "DISEASE"]]}], ["Animals received low-level challenge with aerosolised antigen for 4 weeks to elicit changes of chronic asthma, followed by a single moderate-level challenge to induce an exacerbation of inflammation.", {"entities": [[103, 109, "DISEASE"]]}], ["We then assessed airway inflammation, epithelial changes characteristic of remodelling, airway hyperresponsiveness (AHR) and host immunological responses.", {"entities": [[116, 119, "GENE"]]}], ["Allergic airway inflammation, including recruitment of eosinophils, was prominent only in animals that had recovered from neonatal infection with PVM and then been sensitised and chronically challenged with antigen.", {"entities": []}], ["Furthermore, only these mice exhibited an augmented Th2-biased immune response, including elevated serum levels of anti-ovalbumin IgE and IgG 1 as well as increased relative expression of Th2-associated cytokines IL-4, IL-5 and IL-13.", {"entities": []}], ["By comparison, development of AHR and mucous cell change were associated with recovery from PVM infection, regardless of subsequent allergen challenge.", {"entities": [[30, 33, "GENE"]]}], ["Increased expression of IL-25, which could contribute to induction of a Th2 response, was demonstrable in the lung following PVM infection.", {"entities": []}], ["Signalling via the IL-4 receptor \u03b1 chain was crucial to the development of allergic inflammation, mucous cell change and AHR, because all of these were absent in receptor-deficient mice.", {"entities": [[121, 124, "GENE"]]}], ["In contrast, changes of remodelling were evident in mice that received chronic allergen challenge, regardless of neonatal PVM infection, and were not dependent on signalling via the IL-4 receptor.", {"entities": []}], ["In this mouse model, interaction between early-life viral infection and allergen sensitisation/challenge is essential for development of the characteristic features of childhood asthma, including allergic inflammation and a Th2-biased immune response.", {"entities": [[178, 184, "DISEASE"]]}], ["The single nucleotide polymorphism rs9939609 of the gene FTO , which encodes fat mass and obesity\u2013associated protein, is strongly associated with obesity and type 2 diabetes (T2D) in multiple populations; however, the underlying mechanism of this association is unclear.", {"entities": [[90, 97, "DISEASE"], [146, 153, "DISEASE"], [57, 60, "GENE"]]}], ["The present study aimed to investigate FTO genotype\u2013dependent metabolic changes in obesity and T2D.", {"entities": [[83, 90, "DISEASE"], [39, 42, "GENE"]]}], ["To elucidate metabolic dysregulation associated with disease risk genotype, genomic and metabolomic datasets were recruited from 2,577 participants of the Korean Association REsource (KARE) cohort, including 40 homozygous carriers of the FTO risk allele (AA), 570 heterozygous carriers (AT), and 1,967 participants carrying no risk allele (TT).", {"entities": [[238, 241, "GENE"]]}], ["A total of 134 serum metabolites were quantified using a targeted metabolomics approach.", {"entities": []}], ["Through comparison of various statistical methods, seven metabolites were identified that are significantly altered in obesity and T2D based on the FTO risk allele (adjusted p < 0.05).", {"entities": [[119, 126, "DISEASE"], [148, 151, "GENE"]]}], ["These identified metabolites are relevant to phosphatidylcholine metabolic pathway, and previously reported to be metabolic markers of obesity and T2D.", {"entities": [[135, 142, "DISEASE"]]}], ["In conclusion, using metabolomics with the information from genome-wide association studies revealed significantly altered metabolites depending on the FTO genotype in complex disorders.", {"entities": [[152, 155, "GENE"]]}], ["This study may contribute to a better understanding of the biological mechanisms linking obesity and T2D.", {"entities": [[89, 96, "DISEASE"]]}], ["In this article we critically review the economic literature on the effects of environmental changes on public health, in both the developed and the developing world.", {"entities": []}], ["We first focus on the economic methodologies that are available for the evaluation of the effects (social costs and benefits) of environmental changes (degradation/preservation) on public health.", {"entities": []}], ["Then, we explain how the monetary valuations of these effects can feed back in the construction of economic policy for creating agent-specific incentives for more efficient public health management, which is also equitable and environmentally sustainable.", {"entities": []}], ["Our exposition is accompanied by a synthesis of the available quantitative empirical results.", {"entities": []}], ["This article is part of a series written for people responsible for making decisions about health policies and programmes and for those who support these decision makers .", {"entities": []}], ["After a policy decision has been made, the next key challenge is transforming this stated policy position into practical actions.", {"entities": []}], ["What strategies, for instance, are available to facilitate effective implementation, and what is known about the effectiveness of such strategies?", {"entities": []}], ["We suggest five questions that can be considered by policymakers when implementing a health policy or programme.", {"entities": []}], ["These are: 1.", {"entities": []}], ["What are the potential barriers to the successful implementation of a new policy?", {"entities": []}], ["What strategies should be considered in planning the implementation of a new policy in order to facilitate the necessary behavioural changes among healthcare recipients and citizens?", {"entities": []}], ["What strategies should be considered in planning the implementation of a new policy in order to facilitate the necessary behavioural changes in healthcare professionals?", {"entities": []}], ["What strategies should be considered in planning the implementation of a new policy in order to facilitate the necessary organisational changes?", {"entities": []}], ["What strategies should be considered in planning the implementation of a new policy in order to facilitate the necessary systems changes?", {"entities": []}], ["Initial reports in May 2009 of the novel influenza strain H1N1pdm estimated a case fatality rate (CFR) of 0.6%, similar to that of seasonal influenza.", {"entities": [[41, 50, "DISEASE"], [140, 149, "DISEASE"]]}], ["In July 2009, however, Argentina reported 3056 cases with 137 deaths, representing a CFR of 4.5%.", {"entities": []}], ["Potential explanations for increased CFR included virus reassortment or genetic drift, or infection of a more vulnerable population.", {"entities": []}], ["Virus genomic sequencing of 26 Argentinian samples representing both severe and mild disease indicated no evidence of reassortment, mutations associated with resistance to antiviral drugs, or genetic drift that might contribute to virulence.", {"entities": []}], ["Furthermore, no evidence was found for increased frequency of risk factors for H1N1pdm disease.", {"entities": []}], ["We examined nasopharyngeal swab samples (NPS) from 199 cases of H1N1pdm infection from Argentina with MassTag PCR, testing for 33 additional microbial agents.", {"entities": [[41, 44, "GENE"]]}], ["The study population consisted of 199 H1N1pdm-infected subjects sampled between 23 June and 4 July 2009.", {"entities": []}], ["Thirty-nine had severe disease defined as death (n\u200a=\u200a20) or hospitalization (n\u200a=\u200a19); 160 had mild disease.", {"entities": []}], ["At least one additional agent of potential pathogenic importance was identified in 152 samples (76%), including Streptococcus pneumoniae (n\u200a=\u200a62); Haemophilus influenzae (n\u200a=\u200a104); human respiratory syncytial virus A (n\u200a=\u200a11) and B (n\u200a=\u200a1); human rhinovirus A (n\u200a=\u200a1) and B (n\u200a=\u200a4); human coronaviruses 229E (n\u200a=\u200a1) and OC43 (n\u200a=\u200a2); Klebsiella pneumoniae (n\u200a=\u200a2); Acinetobacter baumannii (n\u200a=\u200a2); Serratia marcescens (n\u200a=\u200a1); and Staphylococcus aureus (n\u200a=\u200a35) and methicillin-resistant S. aureus (MRSA, n\u200a=\u200a6).", {"entities": []}], ["The presence of S. pneumoniae was strongly correlated with severe disease.", {"entities": []}], ["S. pneumoniae was present in 56.4% of severe cases versus 25% of mild cases; more than one-third of H1N1pdm NPS with S. pneumoniae were from subjects with severe disease (22 of 62 S. pneumoniae -positive NPS, p\u200a=\u200a0.0004).", {"entities": [[108, 111, "GENE"], [204, 207, "GENE"], [108, 111, "GENE"], [204, 207, "GENE"]]}], ["In subjects 6 to 55 years of age, the adjusted odds ratio (OR) of severe disease in the presence of S. pneumoniae was 125.5 (95% confidence interval [CI], 16.95, 928.72; p<0.0001).", {"entities": []}], ["The association of S. pneumoniae with morbidity and mortality is established in the current and previous influenza pandemics.", {"entities": [[105, 114, "DISEASE"]]}], ["However, this study is the first to demonstrate the prognostic significance of non-invasive antemortem diagnosis of S. pneumoniae infection and may provide insights into clinical management.", {"entities": []}], ["LinkMedica-Heart is a novel Internet based program intended to support people who seek to improve their life style by means of changes in diet and physical activity.", {"entities": []}], ["The program is currently under evaluation in a clinical study and the present study is a feasibility test of the LinkMedica-Heart Internet based program.", {"entities": []}], ["The aim of this study was to evaluate LinkMedica-Heart, an Internet based program we designed for support and maintenance of patient-led life style changes.", {"entities": []}], ["The feasibility study of LinkMedica-Heart presented here is a qualitative study.", {"entities": []}], ["Nine general practitioners were invited to participate.", {"entities": []}], ["Each practitioner was asked to introduce LinkMedica-Heart to not less than two patients, with a maximum of five patients per practitioner.", {"entities": []}], ["Patients and general practitioners were both asked to participate in testing the program for a period of 6 months.", {"entities": []}], ["At the end of 6 months, evaluation meetings were held with the general practitioners, and separate interviews took place with some of the participating patients who were selected by the GPs.", {"entities": []}], ["Five general practitioners and 25 patients participated in the study.", {"entities": []}], ["The general practitioners and the patients were enthusiastic about the prospect of an Internet based life style change program.", {"entities": []}], ["However, the program was not able to sustain patient loyalty over an extended period.", {"entities": []}], ["The doctors found that the program was much too complicated to navigate and that the results from the program could not be trusted.", {"entities": []}], ["The patients in contrast had fewer complaints about the program design, but found that the advice given by the program was too elaborate and detailed and, in general, did not add to the patient's knowledge on life style change.", {"entities": []}], ["Our study confirms that there is a need for, and a receptive attitude toward a Web-based program that supports people who want to improve their life style and health.", {"entities": []}], ["LinkMedica-Heart in its present form does not satisfy these needs.", {"entities": []}], ["We suggest a number of design changes and improvements to the program.", {"entities": []}], ["Patients with infertility are a high risk group in depression and anxiety.", {"entities": [[14, 25, "DISEASE"]]}], ["However, an existing theoretically and empirically validated model of stressors, stress, and mental symptoms specific for infertile patients is still a void.", {"entities": []}], ["This study aimed to determine the related factors and their relational structures that affect the level of depressive and anxiety symptoms among infertile patients.", {"entities": []}], ["A cross-sectional sample of 400 infertility outpatients seeking reproduction treatments in three teaching hospitals across Taiwan participated in the structured questionnaire survey in 2011.", {"entities": [[32, 43, "DISEASE"]]}], ["The hypothesized model comprising 10 latent variables was tested by Structural Equation Modeling using AMOS 17.", {"entities": []}], ["Goodness-of-fit indexes, including \u03c7 The relational structures were identified and named as the Stressors Stress Symptoms Model, clinically applied to predict anxiety and depression from various stressors.", {"entities": []}], ["Assessing sources and level of infertility-related stress and implementing culturally-sensitive counseling with an emphasis on positive personal value may assist in preventing the severity of depression and anxiety.", {"entities": [[31, 42, "DISEASE"]]}], ["Breast cancer is the leading cause of death from cancer among women in Germany.", {"entities": [[0, 13, "DISEASE"], [7, 13, "DISEASE"], [49, 55, "DISEASE"]]}], ["Despite its clinical and economic relevance, no attributable costs for breast cancer have been reported for Germany so far.", {"entities": [[71, 84, "DISEASE"], [78, 84, "DISEASE"]]}], ["The objective of this study is to estimate age-specific breast cancer attributable health expenditures for Germany.", {"entities": [[56, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["Sickness fund data from 1999 representing about 26 million insured (i.e.", {"entities": []}], ["32% of the total German population) have been analysed using generalized additive models and the error propagation law.", {"entities": []}], ["Costs have been inflated to 2010.", {"entities": []}], ["Breast cancer attributable costs decreased with age.", {"entities": [[0, 13, "DISEASE"], [7, 13, "DISEASE"]]}], ["Among breast cancer patients aged 30\u201345 years, about 90% of all health expenditures were due to breast cancer, whereas in breast cancer patients aged 80\u201390 years, about 50% were due to breast cancer.", {"entities": [[6, 19, "DISEASE"], [96, 109, "DISEASE"], [122, 135, "DISEASE"], [185, 198, "DISEASE"], [13, 19, "DISEASE"], [103, 109, "DISEASE"], [129, 135, "DISEASE"], [192, 198, "DISEASE"]]}], ["Breast cancer attributable costs amounted to about \u20ac9,000 annually for patients below 55 years of age and declined to about \u20ac3,000 in 90-year-old breast cancer patients.", {"entities": [[0, 13, "DISEASE"], [146, 159, "DISEASE"], [7, 13, "DISEASE"], [153, 159, "DISEASE"]]}], ["This analysis provides estimates of attributable breast cancer costs in Germany.", {"entities": [[49, 62, "DISEASE"], [56, 62, "DISEASE"]]}], ["Compared with the international literature, the estimates were plausible but had a tendency to underestimate breast cancer attributable costs.", {"entities": [[109, 122, "DISEASE"], [116, 122, "DISEASE"]]}], ["Within six months of the discovery of X-ray in 1895, the technology was used to scan the interior of the human body, paving the way for many innovations in the field of medicine, including an ultrasound device in 1950, a CT scanner in 1972, and MRI in 1980.", {"entities": []}], ["More recent decades have witnessed developments such as digital imaging using a picture archiving and communication system, computer-aided detection/diagnosis, organ-specific workstations, and molecular, functional, and quantitative imaging.", {"entities": []}], ["One of the latest technical breakthrough in the field of radiology has been imaging genomics and robotic interventions for biopsy and theragnosis.", {"entities": []}], ["This review provides an engineering perspective on these developments and several other megatrends in radiology.", {"entities": []}], ["Involvement of patients in decision-making about medication is currently being advocated.", {"entities": []}], ["This study examined (the concordance between) inflammatory arthritis patients\u2019 preferred and perceived involvement in decision-making in general, and in four specific decisions about Disease-Modifying Anti-Rheumatic Drugs (DMARDs).", {"entities": [[59, 68, "DISEASE"]]}], ["Furthermore, this study examined how patients\u2019 involvement is related to satisfaction about decision-making and which factors are related to preferred roles, perceived roles and concordance.", {"entities": []}], ["Using a cross-sectional survey, 894 patients diagnosed with Rheumatoid Arthritis, Psoriatic Arthritis or Ankylosing Spondylitis were sent a questionnaire which focused on medical decisions in general and on four specific decisions: (a) starting with a traditional DMARD; (b) starting to inject methotrexate; (c) starting a biological DMARD; and (d) decreasing or stopping a DMARD.", {"entities": [[71, 80, "DISEASE"], [92, 101, "DISEASE"]]}], ["For each decision preferred and perceived involvement in decision-making was assessed using the Control Preference Scale.", {"entities": []}], ["Concordance was calculated by subtracting the scores for perceived role from scores for the preferred role.", {"entities": []}], ["Furthermore, satisfaction with the decision process and socio-demographic, health-related, patient-related and physician-related variables were assessed.", {"entities": []}], ["The response rate was 58%.", {"entities": []}], ["For all decisions, most patients (59%-63%) preferred Shared Decision-Making (SDM).", {"entities": []}], ["SDM was perceived frequently (26%-55%) and patients\u2019 preferences were met in 54% of the respondents.", {"entities": []}], ["Yet, in some specific decisions, 26% to 54% of patients would have liked more participation.", {"entities": []}], ["Perceiving less participation then preferred was associated with less satisfaction with the decision-process, but perceiving more participation than preferred was not.", {"entities": []}], ["Our results did not reveal any meaningful models to predict preferred or perceived participation in decision-making in general or with reference to specific decisions about DMARDs.", {"entities": []}], ["Most arthritis patients prefer to be involved in decisions about their medication and SDM is perceived frequently.", {"entities": [[5, 14, "DISEASE"]]}], ["Yet, in some specific decisions patient participation can be further improved.", {"entities": []}], ["Patients especially prefer more participation in decision-making regarding starting a first traditional DMARD, which occurs most commonly in newly diagnosed patients.", {"entities": []}], ["Whereas perceiving too little participation was associated with decreased satisfaction, perceiving too much participation was not.", {"entities": []}], ["Therefore, rheumatologists should urge patients to participate in every medical decision.", {"entities": []}], ["The immigrant population has increased greatly in Spain in recent years to the point where immigrants made up 12% of the infant population in 2008.", {"entities": []}], ["There is little information available on the profile of this group with regard to prescription drug utilization in universal public health care systems such as that operating in Spain.", {"entities": []}], ["This work studies the overall and specific differences in prescription drug utilization between the immigrant and Spanish population.", {"entities": []}], ["Use was made of the Aragonese Health Service databases for 2006.", {"entities": []}], ["The studied population comprises 159,908 children aged 0-14 years, 13.6% of whom are foreign nationals.", {"entities": []}], ["Different utilization variables were calculated for each group.", {"entities": []}], ["Prescription-drug consumption is measured in Defined Daily Doses (DDD) and DDD/1000 persons/day/(DID).", {"entities": []}], ["A total of 833,223 prescriptions were studied.", {"entities": []}], ["Utilization is lower for immigrant children than in Spanish children for both DID (66.27 v. 113.67) and average annual expense (\u20ac21.55 v. \u20ac41.14).", {"entities": []}], ["Immigrant children consume fewer prescription drugs than Spanish children in all of the therapy groups, with the most prescribed (in DID) being: respiratory system, anti-infectives for systemic use, nervous system, sensory organs.", {"entities": []}], ["Significant differences were observed in relation to the type of drugs and the geographical background of immigrants.", {"entities": []}], ["Prescription drug utilization is much greater in Spanish children than in immigrant children, particularly with reference to bronchodilators (montelukast and terbutaline) and attention-disorder hyperactivity drugs such as methylphenidate.", {"entities": []}], ["There are important differences regarding drug type and depending on immigrants' geographical backgrounds that suggest there are social, cultural and access factors underlying these disparities.", {"entities": []}], ["The role of M2 polarized macrophages (M\u03a6) during the allergic airway inflammation has been discussed in various animal models.", {"entities": []}], ["However, their presence and relevance during the chronic and acute phase of allergic airway inflammation in humans has not been fully elucidated so far.", {"entities": []}], ["In the present study we phenotypically characterized macrophages with regard to M2 polarization in mice, a human in vitro and a human ex vivo model with primary lung cells after endobronchial provocation.", {"entities": []}], ["Macrophages remained polarized beyond clearance of the acute allergic airway inflammation in mice.", {"entities": []}], ["Alveolar macrophages of asthmatics revealed increased mRNA expression of CCL13, CCL17 and CLEC10A in response to allergen challenge as well as increased surface expression of CD86.", {"entities": [[73, 78, "GENE"], [80, 85, "GENE"], [90, 97, "GENE"], [175, 179, "GENE"]]}], ["Further, mRNA expression of CCL13, CCL17, and CLEC10A was increased in asthmatics at baseline compared to healthy subjects.", {"entities": [[28, 33, "GENE"], [35, 40, "GENE"], [46, 53, "GENE"]]}], ["The mRNA expression of CCL17 and CLEC10A correlated significantly with the degree of eosinophilia (each P\u2009<\u2009.01).", {"entities": [[85, 97, "DISEASE"], [23, 28, "GENE"], [33, 40, "GENE"]]}], ["Furthermore, macrophages from asthmatics released significant amounts of CCL17 protein in vitro which was also found increased in BAL fluid after allergen provocation.", {"entities": [[73, 78, "GENE"]]}], ["This study supports previous findings of M2 macrophage polarization in asthmatic subjects during the acute course of the allergic inflammation and provides evidence for their contribution to the Th2 inflammation.", {"entities": []}], ["Obesity is a complex and multifactorial disease, which likely comprises multiple subtypes.", {"entities": [[0, 7, "DISEASE"]]}], ["Emerging data have linked chemical exposures to obesity.", {"entities": [[48, 55, "DISEASE"]]}], ["As organismal response to environmental exposures includes altered gene expression, identifying the regulatory epigenetic changes involved would be key to understanding the path from exposure to phenotype and provide new tools for exposure detection and risk assessment.", {"entities": []}], ["In this report, we summarize published data linking early-life exposure to the heavy metals, cadmium and lead, to obesity.", {"entities": [[114, 121, "DISEASE"]]}], ["We also discuss potential mechanisms, as well as the need for complete coverage in epigenetic screening to fully identify alterations.", {"entities": []}], ["The keys to understanding how metal exposure contributes to obesity are improved assessment of exposure and comprehensive establishment of epigenetic profiles that may serve as markers for exposures.", {"entities": [[60, 67, "DISEASE"]]}], ["Recent studies suggest that formaldehyde (FA) could be synthesized endogeneously and transient receptor potential (TRP) channel might be the sensor of FA.", {"entities": []}], ["However, the physiological significance is still unclear.", {"entities": []}], ["The present study investigated the FA induced epithelial Cl I SC in intact rat trachea tissue but not in the primary cultured epithelial cells.", {"entities": []}], ["Western blot and immunofluorescence analysis identified TRPV-1 expression in rat tracheal nerve ending.", {"entities": []}], ["Capsazepine (CAZ), a TRPV-1 specific antagonist significantly blocked the I SC induced by FA.", {"entities": []}], ["The TRPV-1 agonist capsaicin (Cap) induced an increase of I SC , which was similar to the I SC induced by FA.", {"entities": []}], ["L-703606, an NK-1 specific inhibitor and propranolol, an adrenalin \u03b2 receptor inhibitor significantly abolished the I SC induced by FA or Cap.", {"entities": []}], ["In the ion substitute analysis, FA could not induce I SC in the absence of extracelluar Cl I SC induced by FA could be blocked by the non-specific Cl i-172 , but not by the Ca I SC .", {"entities": []}], ["Our results suggest that FA-induced epithelial I SC response is mediated by nerve, involving the activation of TRPV-1 and release of adrenalin as well as substance P.", {"entities": []}], ["Only few longitudinal studies on the course of asthma among adults have been carried out.", {"entities": [[47, 53, "DISEASE"]]}], ["The aim of the present prospective study, carried out between 2000 and 2009 in Italy, is to assess asthma remission and control in adults with asthma, as well as their determinants.", {"entities": [[99, 105, "DISEASE"], [143, 149, "DISEASE"]]}], ["All the subjects with current asthma (21\u201347 years) identified in 2000 in the Italian Study on Asthma in Young Adults in 6 Italian centres were followed up.", {"entities": [[30, 36, "DISEASE"], [94, 100, "DISEASE"]]}], ["Asthma remission was assessed at follow-up in 2008\u20132009 (n\u200a=\u200a214), asthma control at baseline and follow-up.", {"entities": [[0, 6, "DISEASE"], [67, 73, "DISEASE"]]}], ["Asthma remission and control were related to potential determinants by a binomial logistic and a multinomial logistic model.", {"entities": [[0, 6, "DISEASE"]]}], ["Separate models for remission were used for men and women.", {"entities": []}], ["The estimate of the proportion of subjects who were in remission was 29.7% (95%CI: 14.4%;44.9%).", {"entities": []}], ["Men who were not under control at baseline had a very low probability of being in remission at follow-up (OR\u200a=\u200a0.06; 95%CI:0.01;0.33) when compared to women (OR\u200a=\u200a0.40; 95%CI:0.17;0.94).", {"entities": []}], ["The estimates of the proportion of subjects who were under control, partial control or who were not under control in our sample were 26.3% (95%CI: 21.2;31.3%), 51.6% (95%CI: 44.6;58.7%) and 22.1% (95%CI: 16.6;27.6%), respectively.", {"entities": []}], ["Female gender, increasing age, the presence of chronic cough and phlegm and partial or absent asthma control at baseline increased the risk of uncontrolled asthma at follow-up.", {"entities": [[94, 100, "DISEASE"], [156, 162, "DISEASE"]]}], ["Asthma remission was achieved in nearly 1/3 of the subjects with active asthma in the Italian adult population, whereas the proportion of the subjects with controlled asthma among the remaining subjects was still low.", {"entities": [[0, 6, "DISEASE"], [72, 78, "DISEASE"], [167, 173, "DISEASE"]]}], ["To compare the safety and efficacy of high frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation (CV) for early intervention in adult respiratory distress syndrome (ARDS), a multi-centre randomized trial in four intensive care units was conducted.", {"entities": [[183, 191, "DISEASE"], [156, 191, "DISEASE"]]}], ["Patients with ARDS were randomized to receive either HFOV or CV.", {"entities": []}], ["In both treatment arms a priority was given to maintain lung volume while minimizing peak pressures.", {"entities": []}], ["CV ventilation strategy was aimed at reducing tidal volumes.", {"entities": []}], ["In the HFOV group, an open lung strategy was used.", {"entities": []}], ["Respiratory and circulatory parameters were recorded and clinical outcome was determined at 30 days of follow up.", {"entities": []}], ["The study was prematurely stopped.", {"entities": []}], ["Thirty-seven patients received HFOV and 24 patients CV (average APACHE II score 21 and 20, oxygenation index 25 and 18 and duration of mechanical ventilation prior to randomization 2.1 and 1.5 days, respectively).", {"entities": []}], ["There were no statistically significant differences in survival without supplemental oxygen or on ventilator, mortality, therapy failure, or crossover.", {"entities": []}], ["Adjustment by a priori defined baseline characteristics showed an odds ratio of 0.80 (95% CI 0.22\u20132.97) for survival without oxygen or on ventilator, and an odds ratio for mortality of 1.15 (95% CI 0.43\u20133.10) for HFOV compared with CV.", {"entities": []}], ["The response of the oxygenation index (OI) to treatment did not differentiate between survival and death.", {"entities": []}], ["In the HFOV group the OI response was significantly higher than in the CV group between the first and the second day.", {"entities": []}], ["A post hoc analysis suggested that there was a relatively better treatment effect of HFOV compared with CV in patients with a higher baseline OI.", {"entities": []}], ["No significant differences were observed, but this trial only had power to detect major differences in survival without oxygen or on ventilator.", {"entities": []}], ["In patients with ARDS and higher baseline OI, however, there might be a treatment benefit of HFOV over CV.", {"entities": []}], ["More research is needed to establish the efficacy of HFOV in the treatment of ARDS.", {"entities": []}], ["We suggest that future studies are designed to allow for informative analysis in patients with higher OI.", {"entities": []}], ["Retinal neovascularization, which is the pathological growth of new blood vessels, is associated with retinopathy of prematurity, neovascular age-related macular degeneration, diabetic retinopathy and retinal vein occlusion.", {"entities": [[176, 196, "DISEASE"], [102, 128, "DISEASE"], [154, 174, "DISEASE"], [201, 223, "DISEASE"]]}], ["In this study, we evaluated the effect of an extract of Cnidium officinale Makino (COE) and its bioactive compound, butylidenephthalide (BP), on the migration and tube formation of human umbilical vein endothelial cells (HUVECs), and on retinal pathogenic neovascularization in the oxygen-induced retinopathy (OIR) mouse model .", {"entities": []}], ["The HUVECs were incubated with COE and BP (0.1\u201310\u00a0\u03bcg/ml).", {"entities": []}], ["The mice were exposed to 75\u00a0% oxygen for 5\u00a0days starting on the 7 COE and BP inhibit the HUVECs migration and the tube formation in a dose-dependent manner.", {"entities": []}], ["In addition, COE significantly decreased retinal neovascularization in the OIR mice.", {"entities": []}], ["COE reduced the expression levels of AREG, ANG, DLL4, Endostatin, IGFBP-2 and VEGF.", {"entities": [[37, 41, "GENE"], [43, 46, "GENE"], [48, 52, "GENE"]]}], ["Additionally, BP also inhibited the retinal neovascularization and down-regulated the expression of AREG, ANG, DLL4 and VEGF.", {"entities": [[100, 104, "GENE"], [106, 109, "GENE"], [111, 115, "GENE"]]}], ["These results suggest that COE and BP exerts antiangiogenic effects on retinal neovascularization by inhibiting the expression of AREG, ANG, DLL4 and VEGF, indicating that antiangiogenic activities of COE may be in part due to its bioactive compound, BP.", {"entities": [[130, 134, "GENE"], [136, 139, "GENE"], [141, 145, "GENE"]]}], ["The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands.", {"entities": []}], ["The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory diseases.", {"entities": []}], ["As of 2008, 14,926 subjects aged 45\u00a0years or over comprise the Rotterdam Study cohort.", {"entities": []}], ["Since 2016, the cohort is being expanded by persons aged 40\u00a0years and over.", {"entities": []}], ["The findings of the Rotterdam Study have been presented in over 1500 research articles and reports (see www.erasmus-epidemiology.nl/rotterdamstudy ).", {"entities": []}], ["This article gives the rationale of the study and its design.", {"entities": []}], ["It also presents a summary of the major findings and an update of the objectives and methods.", {"entities": []}], ["Multimorbidity has been linked to a variety of negative outcomes although as yet, there has been little research on its association with loneliness.", {"entities": []}], ["This study examined the association between physical multimorbidity (\u2265 2 physical diseases) and loneliness in the general population and its potential mediators.", {"entities": []}], ["Data came from the Adult Psychiatric Morbidity Survey 2007 (N = 7403, aged \u226516 years).", {"entities": []}], ["Information was obtained on 20 doctor diagnosed physical conditions that were present in the previous year.", {"entities": []}], ["An item from the Social Functioning Questionnaire (SFQ) was used to obtain information on loneliness.", {"entities": []}], ["Multivariable logistic regression analysis was used to examine associations.", {"entities": []}], ["An increasing number of physical diseases was associated with higher odds for loneliness.", {"entities": []}], ["Compared to no physical diseases, the odds ratio (OR) (95% confidence interval: CI) for loneliness increased from 1.34 (1.13\u20131.59) to 2.82 (2.11\u20133.78) between one and \u22655 physical diseases.", {"entities": []}], ["This association was particularly strong in the youngest age group (i.e.", {"entities": []}], ["16\u201344 years).", {"entities": []}], ["The loneliness-physical multimorbidity association was significantly mediated by stressful life events (% mediated 11.1%-30.5%), anxiety (30.2%), and depression (15.4%).", {"entities": []}], ["Physical multimorbidity is associated with increased odds for loneliness.", {"entities": []}], ["Prospective research is now needed to further elucidate this association and the factors that underlie it.", {"entities": []}], ["Few studies have examined the natural course of early COPD.", {"entities": []}], ["The aim of this study was to observe the natural course of early COPD patients.", {"entities": []}], ["We also aimed to analyze medical utilization and costs for early COPD during a 6-year period.", {"entities": []}], ["Patients with early COPD were selected from Korean National Health and Nutrition Examination Survey (KNHANES) data.", {"entities": []}], ["We linked the KNHANES data of patients with early COPD to National Health Insurance data.", {"entities": []}], ["A total of 2,397 patients were enrolled between 2007 and 2012.", {"entities": []}], ["The mean forced expiratory volume in 1 second (FEV 1 ) was 78.6%, and the EuroQol five dimensions questionnaire (EQ-5D) index value was 0.9.", {"entities": [[47, 50, "GENE"]]}], ["In total, 110 patients utilized health care for COPD in 2007, and this number increased to 179 in 2012.", {"entities": []}], ["The total mean number of days used per person increased from 4.9 in 2007 to 7.8 in 2012.", {"entities": []}], ["The total medical cost per person also increased from 248.8 US dollar (USD) in 2007 to 780.6 USD in 2013.", {"entities": []}], ["A multiple linear regression revealed that age, lower body mass index, lower FEV 1 (%), and lower EQ-5D score were significantly associated with medical costs.", {"entities": [[77, 80, "GENE"]]}], ["Even in early COPD patients, some of them eventually progressed and utilized health care for COPD.", {"entities": []}], ["Whether vexing clinical decision-making dilemmas can be partly addressed by recent advances in genomics is unclear.", {"entities": []}], ["For example, when to initiate highly active antiretroviral therapy (HAART) during HIV-1 infection remains a clinical dilemma.", {"entities": []}], ["This decision relies heavily on assessing AIDS risk based on the CD4 CCR5 , the major HIV coreceptor, and the gene copy number of CCL3L1 , a potent CCR5 ligand and HIV-suppressive chemokine.", {"entities": [[65, 68, "GENE"], [69, 73, "GENE"], [148, 152, "GENE"], [130, 136, "GENE"], [69, 73, "GENE"], [148, 152, "GENE"]]}], ["Therefore, we determined whether accounting for both genetic and laboratory markers provided an improved means of assessing AIDS risk.", {"entities": []}], ["In a prospective, single-site, ethnically-mixed cohort of 1,132 HIV-positive subjects, we determined the AIDS risk conveyed by the laboratory and genetic markers separately and in combination.", {"entities": []}], ["Subjects were assigned to a low, moderate or high genetic risk group (GRG) based on variations in CCL3L1 and CCR5 .", {"entities": [[98, 104, "GENE"], [109, 113, "GENE"]]}], ["The predictive value of the CCL3L1-CCR5 GRGs, as estimated by likelihood ratios, was equivalent to that of the laboratory markers.", {"entities": []}], ["GRG status also predicted AIDS development when the laboratory markers conveyed a contrary risk.", {"entities": []}], ["Additionally, in two separate and large groups of HIV CCL3L1-CCR5 genetic markers together provided more prognostic information than either marker alone.", {"entities": []}], ["Furthermore, GRGs independently predicted the time interval from seroconversion to CD4 The combination of the laboratory and genetic markers captures a broader spectrum of AIDS risk than either marker alone.", {"entities": [[83, 86, "GENE"]]}], ["By tracking a unique aspect of AIDS risk distinct from that captured by the laboratory parameters, CCL3L1-CCR5 genotypes may have utility in HIV clinical management.", {"entities": []}], ["These findings illustrate how genomic information might be applied to achieve practical benefits of personalized medicine.", {"entities": []}], ["Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid into prostaglandins.", {"entities": []}], ["COX-2 is mainly induced at sites of inflammation in response to proinflammatory cytokines such as interleukin-1\u03b1/\u03b2, interferon-\u03b3 and tumor necrosis factor-\u03b1 produced by inflammatory cells.", {"entities": []}], ["The aim of this study was to investigate the possible modulating effect of the functional COX-2 polymorphisms \u22121195 A\u2192G and \u2212 765G\u2192C on the risk for development of inflammatory bowel disease (IBD) in a Dutch population.", {"entities": [[164, 190, "DISEASE"]]}], ["Genomic DNA of 525 patients with Crohn's disease (CD), 211 patients with ulcerative colitis (UC) and 973 healthy controls was genotyped for the \u22121195 A\u2192G (rs689466) and \u2212 765G\u2192C (rs20417) polymorphisms.", {"entities": [[73, 91, "DISEASE"]]}], ["Distribution of genotypes in patients and controls were compared and genotype-phenotype interactions were investigated.", {"entities": []}], ["The genotype distribution of the \u22121195A\u2192G polymorphism was not different between the patients with CD or UC and the control group.", {"entities": []}], ["The \u2212 765GG genotype was more prevalent in CD patients compared to controls with an OR of 1.33 (95%CI 1.04\u20131.69, p<0.05).", {"entities": []}], ["The \u2212765GC and \u2212765CC genotype carriers showed a tendency to be less frequent in patients with CD compared to controls, with ORs of 0.78 (95%CI: 0.61\u20131.00) and 0.49 (95%CI 0.22\u20131.08), respectively.", {"entities": []}], ["Combining homozygous and heterozygous patients with the \u2212765C allele showed a reduced risk for developing CD, with an OR of 0.75 (95%CI: 0.59\u20130.96).", {"entities": []}], ["In the context of this, the G \u22121195 G \u2212765 /A \u22121195 C \u2212765 diplotype was significantly less common in patients with CD compared to controls, with an OR of 0.62 (95%CI: 0.39\u20130.98).", {"entities": []}], ["For UC however, such an effect was not observed.", {"entities": []}], ["No correlation was found between COX-2 diplotypes and clinical characteristics of IBD.", {"entities": []}], ["The \u2212 765G\u2192C polymorphism was associated with a reduced risk for developing Crohn's disease in a Dutch population.", {"entities": []}], ["Engineered nanomaterials (ENMs) incorporated into toner formulations of printing equipment become airborne during consumer use.", {"entities": []}], ["Although information on the complex physicochemical and toxicological properties of both toner powders and printer-emitted particles (PEPs) continues to grow, most toxicological studies have not used the actual PEPs but rather have primarily used raw toner powders, which are not representative of current exposures experienced at the consumer level during printing.", {"entities": []}], ["We assessed the biological responses of a panel of human cell lines to PEPs.", {"entities": []}], ["Three physiologically relevant cell lines\u2014small airway epithelial cells (SAECs), macrophages (THP-1 cells), and lymphoblasts (TK6 cells)\u2014were exposed to PEPs at a wide range of doses (0.5\u2013100 \u03bcg/mL) corresponding to human inhalation exposure durations at the consumer level of 8 hr or more.", {"entities": [[279, 281, "GENE"]]}], ["Following treatment, toxicological parameters reflecting distinct mechanisms were evaluated.", {"entities": []}], ["PEPs caused significant membrane integrity damage, an increase in reactive oxygen species (ROS) production, and an increase in pro-inflammatory cytokine release in different cell lines at doses equivalent to exposure durations from 7.8 to 1,500 hr.", {"entities": [[245, 247, "GENE"]]}], ["Furthermore, there were differences in methylation patterns that, although not statistically significant, demonstrate the potential effects of PEPs on the overall epigenome following exposure.", {"entities": []}], ["The in vitro findings obtained in this study suggest that laser printer\u2013emitted engineered nanoparticles may be deleterious to lung cells and provide preliminary evidence of epigenetic modifications that might translate to pulmonary disorders.", {"entities": []}], ["Pirela SV, Miousse IR, Lu X, Castranova V, Thomas T, Qian Y, Bello D, Kobzik L, Koturbash I, Demokritou P. 2016.", {"entities": []}], ["Effects of laser printer\u2013emitted engineered nanoparticles on cytotoxicity, chemokine expression, reactive oxygen species, DNA methylation, and DNA damage: a comprehensive in vitro analysis in human small airway epithelial cells, macrophages, and lymphoblasts.", {"entities": []}], ["Environ Health Perspect 124:210\u2013219;\u2002 http://dx.doi.org/10.1289/ehp.1409582", {"entities": []}], ["The expression of glucocorticoid-receptor (GR) seems to be a key mechanism in the regulation of glucocorticoid (GC) sensitivity and is potentially involved in cases of GC resistance or hypersensitivity.", {"entities": [[112, 114, "GENE"], [168, 170, "GENE"], [112, 114, "GENE"], [168, 170, "GENE"]]}], ["The aim of this study is to describe a method for quantitation of GR alpha isoform (GR\u03b1) expression using real-time PCR (qrt-PCR) with analytical capabilities to monitor patients, offering standard-curve reproducibility as well as intra- and inter-assay precision.", {"entities": []}], ["Standard-curves were constructed by employing standardized Jurkat cell culture procedures, both for GR\u03b1 and BCR (breakpoint cluster region), as a normalizing gene.", {"entities": [[108, 111, "GENE"]]}], ["We evaluated standard-curves using five different sets of cell culture passages, RNA extraction, reverse transcription, and qrt-PCR quantification.", {"entities": []}], ["Intra-assay precision was evaluated using 12 replicates of each gene, for 2 patients, in a single experiment.", {"entities": []}], ["Inter-assay precision was evaluated on 8 experiments, using duplicate tests of each gene for two patients.", {"entities": []}], ["Standard-curves were reproducible, with CV (coefficient of variation) of less than 11%, and Pearson correlation coefficients above 0,990 for most comparisons.", {"entities": []}], ["Intra-assay and inter-assay were 2% and 7%, respectively.", {"entities": []}], ["This is the first method for quantitation of GR\u03b1 expression with technical characteristics that permit patient monitoring, in a fast, simple and robust way.", {"entities": []}], ["Genomics research findings on asthma are reported with increasing frequency.", {"entities": [[30, 36, "DISEASE"]]}], ["As these findings are incorporated into existing knowledge of disease etiology and pathogenesis, the implications for public health practice need to be considered.", {"entities": []}], ["In 2003, the University of Washington Center for Genomics and Public Health initiated a project to synthesize information about asthma genomics, to examine its relevance to public health research and practice, and to communicate findings to a public health practice audience.", {"entities": [[128, 134, "DISEASE"]]}], ["This goal was achieved through review of the scientific literature, formation of a working group, and consultations with professionals and community organizations.", {"entities": []}], ["This paper describes the methods used to conduct these professional and community consultations, referred to as the asthma consultative process, and discusses the lessons learned from this activity.", {"entities": [[116, 122, "DISEASE"]]}], ["A field experiment was conducted to quantify pollen mediated gene flow (PMGF) from glyphosate-resistant (GR) to glyphosate-susceptible (GS) giant ragweed under simulated field conditions using glyphosate resistance as a selective marker.", {"entities": []}], ["Field experiments were conducted in a concentric design with the GR giant ragweed pollen source planted in the center and GS giant ragweed pollen receptors surrounding the center in eight directional blocks at specified distances (between 0.1 and 35\u2009m in cardinal and ordinal directions; and additional 50\u2009m for ordinal directions).", {"entities": []}], ["Seeds of GS giant ragweed were harvested from the pollen receptor blocks and a total of 100,938 giant ragweed plants were screened with glyphosate applied at 2,520\u2009g ae ha", {"entities": []}], ["Cholangiocarcinoma is a serious public health in Thailand with increasing incidence and mortality rates.", {"entities": [[0, 18, "DISEASE"]]}], ["The present study aimed to investigate cytotoxic activities of crude ethanol extracts of a total of 28 plants and 5 recipes used in Thai folklore medicine against human cholangiocarcinoma (CL-6), human laryngeal (Hep-2), and human hepatocarcinoma (HepG2) cell lines in vitro.", {"entities": [[169, 187, "DISEASE"]]}], ["Cytotoxic activity of the plant extracts against the cancerous cell lines compared with normal cell line (renal epithelial cell: HRE) were assessed using MTT assay.", {"entities": []}], ["5-fluorouracil was used as a positive control.", {"entities": []}], ["The IC 50 (concentration that inhibits cell growth by 50%) and the selectivity index (SI) were calculated.", {"entities": []}], ["The extracts from seven plant species ( Atractylodes lancea , Kaempferia galangal , Zingiber officinal , Piper chaba , Mesua ferrea , Ligusticum sinense , Mimusops elengi ) and one folklore recipe (Pra-Sa-Prao-Yhai) exhibited promising activity against the cholangiocarcinoma CL-6 cell line with survival of less than 50% at the concentration of 50 \u03bcg/ml.", {"entities": [[257, 275, "DISEASE"]]}], ["Among these, the extracts from the five plants and one recipe ( Atractylodes lancea , Kaempferia galangal , Zingiber officinal , Piper chaba , Mesua ferrea , and Pra-Sa-Prao-Yhai recipe) showed potent cytotoxic activity with mean IC 50 values of 24.09, 37.36, 34.26, 40.74, 48.23 and 44.12 \u03bcg/ml, respectively.", {"entities": []}], ["All possessed high activity against Hep-2 cell with mean IC 50 ranging from 18.93 to 32.40 \u03bcg/ml.", {"entities": []}], ["In contrast, activity against the hepatoma cell HepG2 varied markedly; mean IC 50 ranged from 9.67 to 115.47 \u03bcg/ml.", {"entities": []}], ["The only promising extract was from Zingiber officinal (IC 50 = 9.67 \u03bcg/ml).", {"entities": []}], ["The sensitivity of all the four cells to 5-FU also varied according to cell types, particularly with CL-6 cell (IC 50 = 757 micromolar).", {"entities": []}], ["The extract from Atractylodes lancea appears to be both the most potent and most selective against cholangiocarcinoma (IC 50 = 24.09 \u03bcg/ml, SI = 8.6).", {"entities": [[99, 117, "DISEASE"]]}], ["The ethanolic extracts from five plants and one folklore recipe showed potent cytotoxic activity against CL-6 cell.", {"entities": []}], ["Sensitivity to other cancerous cell lines varied according to cell types and the hepatocarcinoma cell line.", {"entities": []}], ["HepG2 appears to be the most resistant to the tested extracts.", {"entities": []}], ["Regulatory T cells (Tregs) are a subset of T cells that play an important role in modulating T effector responses during infectious challenges.", {"entities": []}], ["The aim of this study was to evaluate possible associations between regulatory gene polymorphisms and the risk of uncomplicated malaria and the control of Plasmodium falciparum parasite density levels.", {"entities": [[128, 135, "DISEASE"]]}], ["Twelve regulatory single nucleotide polymorphisms (SNPs) in the promoter regions of FOXP3 (ss270137548, rs11091253), IL10RA (rs56356146, rs7925112), IL10RB (rs8178433, rs8178435, rs999788), STAT6 (rs3024941, rs3024943, rs3024944) and TNFRSF18 (ss2080581728, rs3753344) were genotyped in a cohort of Congolese children.", {"entities": [[84, 89, "GENE"], [117, 123, "GENE"], [149, 155, "GENE"], [190, 195, "GENE"], [234, 242, "GENE"]]}], ["Studied subjects were followed up (passively) during one year.", {"entities": []}], ["The children who experienced one or several clinical episodes were genotyped as \u201cuncomplicated malaria\u201d group (n=179) and those children who did not experience any episode were genotyped as \u201casymptomatic children\u201d group (n=138).", {"entities": [[95, 102, "DISEASE"]]}], ["The prevalence of rs3024944CC genotype of STAT6 was significantly higher in the group of asymptomatic children compared to that of uncomplicated malaria ( P =0.003).", {"entities": [[145, 152, "DISEASE"], [42, 47, "GENE"]]}], ["Similarly, the minor allele rs3024944C was more prevalent in the group of asymptomatic children ( P =0.019).", {"entities": []}], ["Two novel SNPs were observed including -163T/G (ss491228441) in IL10RA gene and -163C/T (ss491228440) in TNFRSF18 gene.", {"entities": [[64, 70, "GENE"], [105, 113, "GENE"]]}], ["The genotype ss491228441TT and the minor allele ss491228441G of the IL10RA were more frequent in the group of asymptomatic children ( P =0.006 and P =0.007, respectively).", {"entities": [[68, 74, "GENE"]]}], ["The genotype rs11091253CT of the FOXP3 was associated with high parasite density levels.", {"entities": [[33, 38, "GENE"]]}], ["In addition, a new promoter IL10RA variant (ss491228441) contributes to shield against mild malaria.", {"entities": [[92, 99, "DISEASE"], [28, 34, "GENE"]]}], ["The study indicated that the STAT6 promoter polymorphism rs3024944 was associated with uncomplicated malaria, whereas the FOXP3 promoter variant rs11091253 was associated with significant P. falciparum parasitaemia levels.", {"entities": [[101, 108, "DISEASE"], [29, 34, "GENE"], [122, 127, "GENE"]]}], ["These genetic data may contribute to the understanding of molecular mechanisms that regulate immune response to P. falciparum infections.", {"entities": []}], ["Age related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly populations worldwide.", {"entities": [[76, 85, "DISEASE"], [12, 32, "DISEASE"]]}], ["Inflammation, among many factors, has been suggested to play an important role in AMD pathogenesis.", {"entities": []}], ["Recent studies have demonstrated a strong genetic association between AMD and complement factor H (CFH), the down-regulatory factor of complement activation.", {"entities": [[99, 102, "GENE"]]}], ["Elevated levels of complement activating molecules including complement component 5a (C5a) have been found in the serum of AMD patients.", {"entities": []}], ["Our aim is to study whether C5a can impact human T cells and its implication in AMD.", {"entities": []}], ["Human peripheral blood mononuclear cells (PBMCs) were isolated from the blood of exudative form of AMD patients using a Ficoll gradient centrifugation protocol.", {"entities": []}], ["Intracellular staining and enzyme-linked immunosorbent assays were used to measure protein expression.", {"entities": []}], ["Apoptotic cells were detected by staining of cells with the annexin-V and TUNEL technology and analyzed by a FACS Caliber flow cytometer.", {"entities": []}], ["SNP genotyping was analyzed by TaqMan genotyping assay using the Real-time PCR system 7500.", {"entities": []}], ["We show that C5a promotes interleukin (IL)-22 and IL-17 expression by human CD4 Our results support the notion that C5a may be one of the factors contributing to the elevated serum IL-22 and IL-17 levels in AMD patients.", {"entities": [[76, 79, "GENE"]]}], ["The possible involvement of IL-22 and IL-17 in the inflammation that contributes to AMD may herald a new approach to treat AMD.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a respiratory syndrome characterized by progressive, partially reversible airway obstruction and lung hyperinflation.", {"entities": [[62, 70, "DISEASE"]]}], ["COPD has a substantial burden which is seen in both patient quality of life and healthcare costs.", {"entities": []}], ["One proposed method of minimizing this burden is the implementation of clinical pathways (CPWs).", {"entities": []}], ["CPWs aim to guide evidence-based practice and improve the interaction between health services.", {"entities": []}], ["They bring the best available evidence to a range of healthcare professionals by adapting evidence-based clinical guidelines to a local context and detailing the essential steps in the assessment and care of patients.", {"entities": []}], ["The aim of this systematic review is to synthesize existing literature on the effects of CPWs for the treatment or management of COPD.", {"entities": []}], ["We will screen search hits from search strategies developed for a Cochrane Effective Practice and Organisation of Care (EPOC) systematic review on the use of CPWs in primary care and a Cochrane EPOC review on the use of CPWs in hospitals.", {"entities": []}], ["These searches were run in a range of databases.", {"entities": []}], ["Studies will be screened independently by two reviewers.", {"entities": []}], ["All studies identified by our search strategy will be considered regardless of study design as long as they meet the operational definition for clinical pathways developed by Kinsman et al.", {"entities": []}], ["(BMC Medicine 8, 2010) and focus on the treatment or management of COPD.", {"entities": []}], ["All included studies will be evaluated for risk of bias utilizing methodologies set out by the Cochrane collaboration.", {"entities": []}], ["Data regarding patient, professional and systems outcomes will be extracted from all included studies.", {"entities": []}], ["Data will be presented in both narrative and tabular form.", {"entities": []}], ["The systematic review outlined in this protocol aims to identify, assess and synthesise all available evidence on the effects of CPWs regarding the treatment and management of COPD.", {"entities": []}], ["As a result, this review will provide an evidence base for decision makers regarding the practicality, cost effectiveness, patient benefit and best practices regarding the implementation of CPWs for the care of COPD.", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-016-0311-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["It has been suggested that smoking asthmatics benefit less from corticosteroid treatment than never-smoking asthmatics.", {"entities": []}], ["We investigated differences in blood and sputum inflammatory profiles between ex-, current-, and never-smokers and assessed their ICS treatment response after 2-week and 1-year treatment.", {"entities": []}], ["We analyzed FEV 1 , PC 20 methacholine and PC 20 AMP, (differential) cell counts in sputum and blood in ex-, current- and never-smokers at baseline (n=114), after 2-week treatment with fluticasone 500 or 2000 \u03bcg/day (n=76) and after 1-year treatment with fluticasone 500 \u03bcg/day or a variable dose of fluticasone based on a self-management plan (n=64).", {"entities": [[12, 15, "GENE"], [20, 22, "GENE"], [43, 45, "GENE"], [20, 22, "GENE"], [43, 45, "GENE"]]}], ["A total of 114 patients were included (29 ex-, 30 current- and 55 never-smokers.", {"entities": []}], ["At baseline, ex- and current-smokers had less eosinophils in sputum and blood than never-smokers.", {"entities": []}], ["Blood neutrophil counts were higher in current- than in never-smokers.", {"entities": []}], ["A higher number of cigarettes smoked daily was associated with lower blood and sputum eosinophils.", {"entities": []}], ["After 2-week ICS treatment, FEV 1 %predicted improved less in current-smokers than never-smokers (2.4% versus 8.1%, p=0.010) and ex-smokers tended to improve less than never-smokers (4.1%, p=0.067).", {"entities": [[28, 31, "GENE"]]}], ["In contrast, no differences in ICS treatment response in lung function or inflammatory cells were found between the three groups after 1 year.", {"entities": []}], ["Ex- and current-smokers have less eosinophils and more neutrophils in their sputum and blood than never-smokers.", {"entities": []}], ["Although ex- and current-smokers have a reduced short-term corticosteroid treatment response, we did not find a difference in their long-term treatment response.", {"entities": []}], ["Diesel exhaust particles (DEPs) are the main components of ambient particulate materials, including polyaromatic hydrocarbons (PAHs), n-PAHs, heavy metals, and gaseous materials.", {"entities": []}], ["Many epidemiological, clinical, and toxicological studies have shown that ambient particles, including DEPs, are associated with respiratory disorders, such as asthma, allergic rhinitis, and lung cancer.", {"entities": [[168, 185, "DISEASE"], [191, 202, "DISEASE"], [177, 185, "DISEASE"], [160, 166, "DISEASE"], [196, 202, "DISEASE"]]}], ["However, the relationship between the biological response to DEPs and their chemical composition remains unclear.", {"entities": []}], ["In this study, we investigated the physicochemical properties of DEPs before toxicological studies, and then administered a single intratracheal instillation of DEPs to mice.", {"entities": []}], ["The mice were then killed 1, 7, 14 and 28 days after DEP exposure to observe the biological responses induced by DEPs over time.", {"entities": []}], ["Our findings suggest that DEPs engulfed into cells induced a Th2-type inflammatory response followed by DNA damage, whereas DEPs not engulfed into cells induced a Th1-type inflammatory response.", {"entities": []}], ["Further, the physicochemical properties, including surface charge, particle size, and chemical composition, of DEPs play a crucial role in determining the biological responses to DEPs.", {"entities": []}], ["Consequently, we suggest that the biological response to DEPs depend on cell-particle interaction and the physicochemical properties of the particles.", {"entities": []}], ["Interleukin 17A ( IL17A ) plays a key role in host defense against microbial infection including Gram-positive bacteria.", {"entities": [[18, 23, "GENE"]]}], ["Genetic factors contribute to the host defense, but the role of IL17A single nucleotide polymorphisms (SNPs) has not yet been investigated in severe sepsis.", {"entities": [[64, 69, "GENE"]]}], ["Therefore, we hypothesized that SNPs in the IL17A gene alter susceptibility to infection and clinical outcome of severe sepsis.", {"entities": [[44, 49, "GENE"]]}], ["We tested for the association of IL17A SNPs with susceptibility to infection and clinical outcome of severe sepsis using two cohorts of European ancestry (derivation cohort, St Paul's Hospital (SPH), n = 679; validation cohort, Vasopressin and Septic Shock Trial (VASST), n = 517).", {"entities": [[33, 38, "GENE"]]}], ["The primary outcome variable was susceptibility to Gram-positive bacterial infection.", {"entities": []}], ["The secondary outcome variable was 28-day mortality.", {"entities": []}], ["Of four tested IL17A tag SNPs (rs4711998, rs8193036, rs2275913, rs1974226), rs1974226 SNP was associated with altered susceptibility to Gram-positive infection in the derivation SPH cohort (corrected P = 0.014).", {"entities": [[15, 20, "GENE"]]}], ["Patients having the rs1974226 GG genotype were more susceptible to Gram-positive infection, compared to AG/AA genotype in the two cohorts of severe sepsis (SPH, P = 0.0036, odds ratio (OR) 2.19, 95% confidence interval (CI) 1.28-3.72; VASST, P = 0.011, OR 1.95, 95%CI 1.16-3.27) and in the subgroup having lung infection ( P = 0.017, OR 1.90, 95%CI 1.12-3.21).", {"entities": []}], ["Furthermore, the IL17A rs1974226 G allele was associated with increased 28-day mortality in two cohorts (SPH, adjusted OR 1.44, 95%CI 1.04-2.02, P = 0.029; VASST, adjusted OR 1.67, 95%CI 1.17-2.40, P = 0.0052).", {"entities": [[17, 22, "GENE"]]}], ["IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and 28-day mortality of severe sepsis.", {"entities": [[0, 5, "GENE"]]}], ["Computed tomography (CT) plays a pivotal role in the detection, characterization, and staging of lung cancer and other thoracic malignancies.", {"entities": [[97, 108, "DISEASE"], [102, 108, "DISEASE"]]}], ["Since the introduction of clinically viable dual-energy CT techniques, substantial evidence has accumulated on the use of this modality for imaging chest malignancies.", {"entities": []}], ["This article describes the principles of dual-energy CT along with suitable image acquisition, reconstruction, and postprocessing strategies for oncologic applications in the chest.", {"entities": []}], ["The potential of dual-energy CT techniques for the detection, characterization, staging, and surveillance of chest malignancy, as well as the limitations of this modality are discussed.", {"entities": []}], ["Primary biliary cirrhosis (PBC) is a disease with genetic and environmental pathogenetic background.", {"entities": []}], ["Chemicals, infectious agents, hormone therapy, reproductive history and surgical interventions have been implicated in the induction of PBC.", {"entities": []}], ["Familial PBC has been documented in first degree relatives (FDR).", {"entities": []}], ["Most cohort studies are genetically heterogeneous.", {"entities": []}], ["Our study aimed to determine eventual lifestyle or disease associations and familial occurrence rates in a genetically homogeneous and geographically defined population of PBC patients.", {"entities": []}], ["111 consenting PBC patients, were compared with 115 FDR and 149 controls matched for age, sex, Cretan origin and residence.", {"entities": []}], ["All participants completed a questionnaire regarding demographics, lifestyle, medical, surgical and reproductive history.", {"entities": []}], ["Significant variables on the univariate analysis were analyzed by multivariate analysis using a forward step-wise logistic regression model.", {"entities": []}], ["Dyslipidaemia was found in 69.4% of patients, 60% of FDR and 40.9% of controls (p\u2009<\u20090.0001 and p\u2009=\u20090.003 respectively), autoimmune diseases in 36.9% of patients, 30.4% of FDR and 13.4% of controls (p\u2009<\u20090.0001 and p\u2009=\u20090.011 respectively).", {"entities": []}], ["Hashimoto\u2019s disease (p\u2009=\u20090.003), Raynaud syndrome (p\u2009=\u20090.023) and Sj\u00f6gren syndrome (p\u2009=\u20090.044) were significantly associated with PBC.", {"entities": [[41, 49, "DISEASE"], [74, 82, "DISEASE"]]}], ["On multivariate analysis statistically significant associations were found with primary educational level (AOR 2.304, 95% CI 1.024-5.181), cholecystectomy (AOR 2.927, 95% CI 1.347-6.362) and the presence of at least another autoimmune disease (AOR 3.318, 95% CI 1.177-6.22).", {"entities": []}], ["Cancer history was more frequent in patients than in controls (p\u2009=\u20090.033).", {"entities": []}], ["Familial PBC was found to be 9.9%.", {"entities": []}], ["Dyslipidaemia and autoimmune diseases were significantly increased not only in patients as expected but also in their FDR.", {"entities": []}], ["An increased prevalence of malignancies was found in patients.", {"entities": []}], ["Primary educational level, cholecystectomy and the presence of at least another autoimmune disease were found as putative risk factors for PBC.", {"entities": []}], ["No association was found with smoking, urinary tract infection or reproductive history.", {"entities": []}], ["The reported high familial occurrence of PBC could imply screening with AMA of FDR with at least another autoimmune disease.", {"entities": []}], ["An imbalance in the generation of pro-inflammatory leukotrienes, and counter-regulatory lipoxins is present in severe asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["We measured leukotriene B 4 (LTB 4 ), and lipoxin A 4 (LXA 4 ) production by alveolar macrophages (AMs) and studied the impact of corticosteroids.", {"entities": [[29, 32, "GENE"]]}], ["AMs obtained by fiberoptic bronchoscopy from 14 non-asthmatics, 12 non-severe and 11 severe asthmatics were stimulated with lipopolysaccharide (LPS,10 \u03bcg/ml) with or without dexamethasone (10 4 and LXA 4 were measured by enzyme immunoassay.", {"entities": []}], ["LXA 4 biosynthesis was decreased from severe asthma AMs compared to non-severe (p < 0.05) and normal subjects (p < 0.001).", {"entities": [[45, 51, "DISEASE"]]}], ["LXA 4 induced by LPS was highest in normal subjects and lowest in severe asthmatics (p < 0.01).", {"entities": []}], ["Basal levels of LTB 4 were decreased in severe asthmatics compared to normal subjects (p < 0.05), but not to non-severe asthma.", {"entities": [[120, 126, "DISEASE"], [16, 19, "GENE"]]}], ["LPS-induced LTB 4 was increased in severe asthma compared to non-severe asthma (p < 0.05).", {"entities": [[42, 48, "DISEASE"], [72, 78, "DISEASE"], [12, 15, "GENE"]]}], ["Dexamethasone inhibited LPS-induced LTB 4 and LXA 4 , with lesser suppression of LTB 4 in severe asthma patients (p < 0.05).", {"entities": [[97, 103, "DISEASE"], [36, 39, "GENE"], [81, 84, "GENE"], [36, 39, "GENE"], [81, 84, "GENE"]]}], ["There was a significant correlation between LPS-induced LXA 4 and FEV 1 (% predicted) (r s = 0.60; p < 0.01).", {"entities": [[66, 69, "GENE"]]}], ["Decreased LXA 4 and increased LTB 4 generation plus impaired corticosteroid sensitivity of LPS-induced LTB 4 but not of LXA 4 support a role for AMs in establishing a pro-inflammatory balance in severe asthma.", {"entities": [[202, 208, "DISEASE"], [30, 33, "GENE"], [103, 106, "GENE"], [30, 33, "GENE"], [103, 106, "GENE"]]}], ["We earlier reported spontaneous features of asthma in Vasoactive Intestinal Peptide knockout mice (VIP KO): 1) peribronchiolar airway inflammation, with accumulation of lymphocytes and eosinophils, 2) pro-inflammatory cytokine production of IL-5, IL-6, with IFN-\u03b3, and 3) airway hyper-responsiveness to inhaled methacholine.", {"entities": [[44, 50, "DISEASE"], [99, 102, "GENE"]]}], ["In human asthma, a phenotype with sulfite sensitivity leads to airway inflammation and hyper-responsiveness to inhaled sulfites, and is associated with upregulation of anti-oxidant protein lung carbonyl reductase.", {"entities": [[9, 15, "DISEASE"]]}], ["For the present experiments, we examined the role of VIP in modulating anti-oxidant genes and their proteins, including lung carbonyl reductase.", {"entities": [[53, 56, "GENE"]]}], ["Four male VIP KO mice and four wild-type age- and gender matched mice had lungs examined for whole genome microarray and a proteomics approach using mass spectrometry.", {"entities": [[10, 13, "GENE"]]}], ["The proteomics analysis revealed that a novel variant of anti-oxidant protein lung carbonyl reductase (car3) was uniquely and markedly elevated in the VIP KO mice.", {"entities": [[151, 154, "GENE"]]}], ["RT-PCR indicated that carbonic anhydrase 3, which is an anti-oxidant protein, was elevated in the VIP KO mice.", {"entities": [[98, 101, "GENE"]]}], ["These data support the concept that VIP influences the endogenous oxidant/antioxidant balance.", {"entities": [[36, 39, "GENE"]]}], ["One potential implication is that VIP and its analogues may be used to treat inflammatory diseases, including asthma.", {"entities": [[110, 116, "DISEASE"], [34, 37, "GENE"]]}], ["While most studies focused solely on the comparison between informal caregivers and non-caregivers, little is known about the relation between caregiving time or caregiving activities and lifestyle factors.", {"entities": []}], ["Thus, the aim of this study was to examine whether informal caregiving time and type of caregiving activities are associated with body mass index (BMI) and the frequency of sporting activities among informal caregivers.", {"entities": []}], ["Cross-sectional data were gathered from the German Ageing Survey, a nationally representative study among community-dwelling individuals aged \u226540 that includes a total of n \u00a0=\u00a01380 people who provide informal care services.", {"entities": []}], ["Self-reported BMI and self-reported frequency of sporting activities (daily; several times a week; once a week; 1-3 times a month; less often; never) were used as dependent variables.", {"entities": []}], ["The average time of providing informal care per week as well as four different caregiving activities (help around the house; looking after someone; performing nursing care services; help in another way) were included as independent variables.", {"entities": []}], ["Multiple ordinal and linear regressions were used to estimate the association between caregiving factors and the frequency of sporting activities and BMI, respectively.", {"entities": []}], ["Among the 1380 informal caregivers, 65% provided help around the house, 83% looked after people, 28% provided nursing care services, and 68% provided any other help.", {"entities": []}], ["Bivariate analyses showed that sporting activities and BMI differed by status of providing nursing care services, whereas the other three types of informal caregiving were not associated with BMI nor frequency of sporting activities except for the latter and provision of help around the house.", {"entities": []}], ["Multiple regressions showed that BMI increased with caregiving time and performing nursing care services, whereas it was not associated with the other three caregiving activities.", {"entities": []}], ["Likewise, the frequency of sporting activities decreased only with caregiving time and performing nursing care services.", {"entities": []}], ["The present study revealed that caregiving time and performing nursing care services are associated with a higher BMI and a decreased frequency of sporting activities.", {"entities": []}], ["As both, a higher BMI and fewer sporting activities are in turn related to various adverse health outcomes, this knowledge should be taken into account when planning informal caregiving.", {"entities": []}], ["The online version of this article (10.1186/s12889-017-4786-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Impact of bone mesenchymal stem cell (BMSC) transfusion on chronic smoking-induced lung inflammation is poorly understood.", {"entities": []}], ["In this study, a rat model of smoking-related lung injury was induced and the rats were treated with vehicle or BMSCs for two weeks.", {"entities": []}], ["Different subsets of CD4+ T cells, cytokines, and anti-elastin in the lungs as well as the lung injury were characterized.", {"entities": []}], ["Serum and lung inducible nitric oxide synthase (iNOS) and STAT5 phosphorylation in lymphocytes from lung tissue were also analyzed.", {"entities": []}], ["Results indicated that transfusion of BMSCs significantly reduced the chronic smoking-induced lung injury, inflammation, and levels of lung anti-elastin in rats.", {"entities": []}], ["The frequency of Th1 and Th17 cells and the levels of IL-2, IL-6, IFN- \u03b3 , TNF- \u03b1 , IL-17, IP-10, and MCP-1 increased, but the frequency of Tregs and IL-10 decreased.", {"entities": []}], ["Transfusion of BMSCs significantly modulated the imbalance of immune responses by mitigating chronic smoking-increased Th1 and Th17 responses, but enhancing Treg responses in the lungs of rats.", {"entities": []}], ["Transfusion of BMSCs limited chronic smoking-related reduction in the levels of serum and lung iNOS and mitigated smoking-induced STAT5 phosphorylation in lymphocytes from lung tissue.", {"entities": []}], ["BMSCs negatively regulated smoking-induced autoimmune responses in the lungs of rats and may be promising for the intervention of chronic smoking-related lung injury.", {"entities": []}], ["Lethal Toxin Neutralizing Factor (LTNF) obtained from Opossum serum ( Didephis virginiana ) is known to exhibit toxin-neutralizing activity for envenomation caused by animals, plants and bacteria.", {"entities": []}], ["Small synthetic peptide- LT10 (10mer) derived from N-terminal fraction of LTNF exhibit similar anti-lethal and anti-allergic property.", {"entities": []}], ["In our in silico study, we identified Insulin Degrading Enzyme (IDE) as a potential target of LT10 peptide followed by molecular docking and molecular dynamic (MD) simulation studies which revealed relatively stable interaction of LT10 peptide with IDE.", {"entities": []}], ["Moreover, their detailed interaction analyses dictate IDE-inhibitory interactions of LT10 peptide.", {"entities": []}], ["This prediction ofLT10 peptide as a novel putative IDE-inhibitor suggests its possible role in anti-diabetic treatment since IDE- inhibitors are known to assist treatment of Diabetes mellitus by enhancing insulin signalling.", {"entities": []}], ["Furthermore, series of structure based peptidomimetics were designed from LT10 peptide and screened for their inhibitory interactions which ultimately led to a small set of peptidomimetic inhibitors of IDE.", {"entities": []}], ["These peptidomimetic thus might provide a new class of IDE-inhibitors, those derived from LT10 peptide.", {"entities": []}], ["To explore the impact of ocular surface insults on the immunomodulatory capacity and phenotype of corneal epithelial cells (CECs) with a focus on epithelial\u2013mesenchymal transition (EMT).", {"entities": []}], ["Corneas were harvested from mice 6 days following scratch injury, ragweed pollen\u2013induced allergy, or herpes simplex virus type 1 (HSV-1) infection and compared to healthy tissue controls.", {"entities": [[101, 115, "DISEASE"]]}], ["Corneas were enzymatically digested and CECs phenotypically characterized using flow cytometry.", {"entities": []}], ["CECs were defined as epithelial cell adhesion molecule (EpCAM)-positive CD45-negative cells.", {"entities": [[56, 61, "GENE"]]}], ["CECs were assessed by PCR to evaluate EMT-associated transcripts.", {"entities": []}], ["Recombinant HSV-1 and transgenic mice were utilized to investigate the role of vascular endothelial growth factor A (VEGFA) on the phenotype observed.", {"entities": [[117, 122, "GENE"]]}], ["The immunomodulatory potential of CECs was assessed in coculture assays with ovalbumin-specific CD4 T cells.", {"entities": [[96, 99, "GENE"]]}], ["Ectopic expression of classic \u201cmyeloid\u201d antigens Ly6G, CCR2, and CX3CR1 was identified in CEC subsets from all groups with evidence supporting an underlying partial EMT event resulting from loss of cell\u2013cell contacts.", {"entities": [[55, 59, "GENE"], [65, 71, "GENE"]]}], ["Corneal HSV-1 infection induced Ly6C expression and major histocompatibility complex (MHC)-II upregulation in CECs through a VEGFA-linked mechanism.", {"entities": []}], ["These Ly6C This study characterizes a novel immunomodulatory CEC phenotype with possible implications for immune privilege, chronic inflammation, and tissue fibrosis.", {"entities": []}], ["Moreover, the identification of CECs masquerading with multiple \u201cmyeloid\u201d antigens warrants careful evaluation of flow cytometry data involving corneal digests.", {"entities": []}], ["To describe symptoms and lung function in patients registered with asthma or chronic obstructive pulmonary disease (COPD) in primary care and to examine how spirometry findings fit with general practitioners\u2019 (GPs) diagnoses.", {"entities": [[77, 114, "DISEASE"], [67, 73, "DISEASE"]]}], ["Patients aged \u226540 years with a diagnosis of asthma or COPD registered in the electronic medical record during the previous 5 years were recruited at seven GP offices in Norway in 2009\u20132010.", {"entities": [[44, 50, "DISEASE"]]}], ["Registered diagnosis, spirometry results, comorbidity, and reported symptoms were compared.", {"entities": []}], ["Among 376 patients, 62% were women.", {"entities": []}], ["Based on Global Initiative for Chronic Obstructive Lung Diseases criteria, a spirometry diagnosis of COPD could be made in 68.1% of the patients with a previous COPD diagnosis and in 17.1% of those diagnosed with asthma only (P < 0.001).", {"entities": [[213, 219, "DISEASE"]]}], ["The \u03ba agreement between last clinical diagnosis of COPD and COPD based on spirometry was 0.50.", {"entities": []}], ["A restrictive spirometry pattern was found in 19.4% and more frequently in patients diagnosed with both asthma and COPD (23.9%) than in patients diagnosed with COPD only (6.8%, P = 0.003).", {"entities": [[104, 110, "DISEASE"]]}], ["The ability of GPs to differentiate between asthma and COPD seems to have considerably improved during the last decade, probably due to the dissemination of spirometry and guidelines for COPD diagnosis.", {"entities": [[44, 50, "DISEASE"]]}], ["A diagnosis of COPD that cannot be confirmed by spirometry represents a challenge in clinical practice, in particular when a restrictive pattern on spirometry is found.", {"entities": []}], ["Stress-induced cardiomyopathy (sCMP) is characterized by transient wall-motion abnormalities involving the left ventricular apex and mid-ventricle that are precipitated by emotional or physical stress.", {"entities": [[15, 29, "DISEASE"]]}], ["As the heart and kidney influence each other\u2019s function through bidirectional pathways, sCMP can induce renal dysfunction or be induced by renal dysfunction.", {"entities": []}], ["This study reviewed the clinical characteristics and outcomes of patients with confirmed sCMP associated with renal dysfunction.", {"entities": []}], ["We conducted a retrospective analysis of the medical records of all patients from our institution who were diagnosed with sCMP from March 2010 to April 2012.", {"entities": []}], ["Each patient\u2019s demographic characteristics, presenting symptoms, triggering events, electrocardiographic characteristics, laboratory data, echocardiographic study findings, cardiac catheterization data, and outcomes were reviewed.", {"entities": []}], ["Among 30 patients who were diagnosed with sCMP, 7 patients had associated renal dysfunction.", {"entities": []}], ["Three patients were on maintenance hemodialysis (HD) and 4 patients had acute kidney injury (AKI).", {"entities": []}], ["Their mean ejection fraction was 35.2% at initial echocardiography, and 57.2% at follow-up echocardiography.", {"entities": []}], ["Pericardial effusion was detected in all HD patients initially; these patients were treated with intensive HD for suspected under-dialysis status.", {"entities": []}], ["In patients with AKI, the mean peak serum creatinine was 4.17\u00a0mg/dL.", {"entities": []}], ["Two patients were treated with continuous renal replacement therapy.", {"entities": []}], ["One patient required maintenance HD, and 1 patient died.", {"entities": []}], ["Two patients had full renal recovery to their baseline renal function at 7 and 14\u00a0days.", {"entities": []}], ["Patients with renal dysfunction including those with AKI and those undergoing HD can develop sCMP, renal function must be closely monitored in patients with sCMP.", {"entities": []}], ["Additionally, it should be considered that patients on HD who develop sCMP may be under-dialyzed.", {"entities": []}], ["Chronic diseases are becoming increasingly important in sub-Saharan Africa (SSA).", {"entities": []}], ["The current density and distribution of health workforce suggest that SSA cannot respond to the growing demand for chronic disease care, together with the frequent infectious diseases.", {"entities": []}], ["Innovative approaches are therefore needed to rapidly expand the health workforce.", {"entities": []}], ["In this article, we discuss the evidences in support of nurse-led strategies for chronic disease management in SSA, with a focus on hypertension and diabetes mellitus.", {"entities": [[132, 144, "DISEASE"], [149, 166, "DISEASE"]]}], ["Handoffs are defined as verbal and written communications during patient care transitions.", {"entities": []}], ["With the passage of recent ACMGE work hour rules further limiting the hours interns can spend in the hospital, many fear that more handoffs will occur, putting patient safety at risk.", {"entities": []}], ["The issue of handoffs has not been studied in the neurosurgical literature.", {"entities": []}], ["A validated, 20-question online-survey was sent to neurosurgical residents in all 98 accredited U.S. neurosurgery programs.", {"entities": []}], ["Survey results were analyzed using tabulations.", {"entities": []}], ["449 surveys were completed yielding a 56% response rate.", {"entities": []}], ["63% of neurosurgical residents surveyed had not received formal instruction in what constitutes an effective handoff; 24% believe there is high to moderate variability among their co-residents in terms of the quality of the handoff provided; 55% experience three or more interruptions during handoffs on average.", {"entities": []}], ["90% of neurosurgical residents surveyed say that handoff most often occurs in a quiet, private area and 56% report a high level of comfort for knowing the potential acute, critical issues affecting a patient when receiving a handoff.", {"entities": []}], ["There needs to be more focused education devoted to learning effective patient-care handoffs in neurosurgical training programs.", {"entities": []}], ["Increasingly, handing off a patient adequately and safely is becoming a required skill of residency.", {"entities": []}], ["Influenza is a major respiratory pathogen, which exerts a huge human and economic toll on society.", {"entities": [[0, 9, "DISEASE"]]}], ["Influenza is a vaccine preventable disease, however, the vaccine strains must be annually updated due to the continuous antigenic changes in the virus.", {"entities": [[0, 9, "DISEASE"]]}], ["Inactivated influenza vaccines have been used for over 50 years and have an excellent safety record.", {"entities": [[12, 21, "DISEASE"]]}], ["Annual vaccination is therefore recommended for all individuals with serious medical conditions, like COPD, and protects the vaccinee against influenza illness and also against hospitalization and death.", {"entities": [[142, 151, "DISEASE"]]}], ["In COPD patients, influenza infection can lead to exacerbations resulting in reduced quality of life, hospitalization and death in the most severe cases.", {"entities": [[18, 27, "DISEASE"]]}], ["Although there is only limited literature on the use of influenza vaccination solely in COPD patients, there is clearly enough evidence to recommend annual vaccination in this group.", {"entities": [[56, 65, "DISEASE"]]}], ["This review will focus on influenza virus and prophylaxis with inactivated influenza vaccines in COPD patients and other \u201cat risk\u201d groups to reduce morbidity, save lives, and reduce health care costs.", {"entities": [[26, 35, "DISEASE"], [75, 84, "DISEASE"]]}], ["Determinants of exhaled nitric oxide (FeNO) need to be understood better to maximize the value of FeNO measurement in clinical practice and research.", {"entities": []}], ["Our aim was to identify significant predictors of FeNO in an initial cross-sectional survey of southern California schoolchildren, part of a larger longitudinal study of asthma incidence.", {"entities": [[170, 176, "DISEASE"]]}], ["During one school year, we measured FeNO at 100 ml/sec flow, using a validated offline technique, in 2568 children of age 7\u201310 yr. We estimated online (50 ml/sec flow) FeNO using a prediction equation from a separate smaller study with adjustment for offline measurement artifacts, and analyzed its relationship to clinical and demographic characteristics.", {"entities": []}], ["FeNO was lognormally distributed with geometric means ranging from 11 ppb in children without atopy or asthma to 16 ppb in children with allergic asthma.", {"entities": [[137, 152, "DISEASE"], [103, 109, "DISEASE"], [146, 152, "DISEASE"]]}], ["Although effects of atopy and asthma were highly significant, ranges of FeNO for children with and without those conditions overlapped substantially.", {"entities": [[30, 36, "DISEASE"]]}], ["FeNO was significantly higher in subjects aged > 9, compared to younger subjects.", {"entities": []}], ["Asian-American boys showed significantly higher FeNO than children of all other sex/ethnic groups; Hispanics and African-Americans of both sexes averaged slightly higher than non-Hispanic whites.", {"entities": []}], ["Increasing height-for-age had no significant effect, but increasing weight-for-height was associated with decreasing FeNO.", {"entities": []}], ["FeNO measured offline is a useful biomarker for airway inflammation in large population-based studies.", {"entities": []}], ["Further investigation of age, ethnicity, body-size, and genetic influences is needed, since they may contribute to substantial variation in FeNO.", {"entities": []}], ["The insertion of central venous access devices, such as totally implantable venous access ports (TIVAPs), is routine in patients who need a safe and permanent venous access.", {"entities": []}], ["The number of port implantations is increasing due to the development of innovative adjuvant and neo-adjuvant therapies.", {"entities": []}], ["Currently, two different strategies are being routinely used: surgical cut-down of the cephalic vein (vena section) and direct puncture of the subclavian vein.", {"entities": []}], ["The aim of this trial is to identify the strategy for the implantation of TIVAPs with the lowest risk of pneumothorax and haemothorax.", {"entities": [[105, 117, "DISEASE"]]}], ["The PORTAS-3 trial is designed as a multicentre, randomised controlled trial to compare two implantation strategies.", {"entities": []}], ["A total of 1,154 patients will be randomised after giving written informed consent.", {"entities": []}], ["Patients must be over 18\u00a0years of age and scheduled for primary implantation of a TIVAP on the designated side.", {"entities": []}], ["The primary endpoint will be the frequency of pneumothorax and haemothorax after insertion of a TIVAP by one of two different strategies.", {"entities": [[46, 58, "DISEASE"]]}], ["The experimental intervention is as follows: open strategy, defined as surgical cut-down of the cephalic vein, supported by a rescue technique if necessary, and in the case of failure, direct puncture of the subclavian vein.", {"entities": []}], ["The control intervention is as follows: direct puncture of the subclavian vein using the Seldinger technique guided by sonography, fluoroscopy or landmark technique.", {"entities": []}], ["The trial duration is approximately 36\u00a0months, with a recruitment period of 18\u00a0months and a follow-up period of 30\u00a0days.", {"entities": []}], ["The PORTAS-3 trial will compare two different TIVAP implantation strategies with regard to their individual risk of postoperative pneumothorax and haemothorax.", {"entities": [[130, 142, "DISEASE"]]}], ["Since TIVAP implantation is one of the most common procedures in general surgery, the results will be of interest for a large community of surgeons as well as oncologists and general practitioners.", {"entities": []}], ["The pragmatic trial design ensures that the results will be generalizable to a wide range of patients.", {"entities": []}], ["The trial protocol was registered on 28 August 2014 with the German Clinical Trials Register (DRKS00004900) .", {"entities": []}], ["The World Health Organization\u2019s Universal Trial Number is U1111-1142-4420.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-015-0643-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Dichlorodiphenyltrichloroethane (DDT) was used worldwide until the 1970s, when concerns about its toxic effects, its environmental persistence, and its concentration in the food supply led to use restrictions and prohibitions.", {"entities": []}], ["In 2001, more than 100 countries signed the Stockholm Convention on Persistent Organic Pollutants (POPs), committing to eliminate the use of 12 POPs of greatest concern.", {"entities": []}], ["However, DDT use was allowed for disease vector control.", {"entities": []}], ["In 2006, the World Health Organization and the U.S. Agency for International Development endorsed indoor DDT spraying to control malaria.", {"entities": [[129, 136, "DISEASE"]]}], ["To better inform current policy, we reviewed epidemiologic studies published from 2003 to 2008 that investigated the human health consequences of DDT and/or DDE (dichlorodiphenyldichloroethylene) exposure.", {"entities": []}], ["We conducted a PubMed search in October 2008 and retrieved 494 studies.", {"entities": []}], ["Use restrictions have been successful in lowering human exposure to DDT, but blood concentrations of DDT and DDE are high in countries where DDT is currently being used or was more recently restricted.", {"entities": []}], ["The recent literature shows a growing body of evidence that exposure to DDT and its breakdown product DDE may be associated with adverse health outcomes such as breast cancer, diabetes, decreased semen quality, spontaneous abortion, and impaired neurodevelopment in children.", {"entities": [[161, 174, "DISEASE"], [168, 174, "DISEASE"]]}], ["Although we provide evidence to suggest that DDT and DDE may pose a risk to human health, we also highlight the lack of knowledge about human exposure and health effects in communities where DDT is currently being sprayed for malaria control.", {"entities": [[226, 233, "DISEASE"]]}], ["We recommend research to address this gap and to develop safe and effective alternatives to DDT.", {"entities": []}], ["There is growing interest in theory-driven, qualitative and mixed-method approaches to systematic review as an alternative to (or to extend and supplement) conventional Cochrane-style reviews.", {"entities": []}], ["These approaches offer the potential to expand the knowledge base in policy-relevant areas - for example by explaining the success, failure or mixed fortunes of complex interventions.", {"entities": []}], ["However, the quality of such reviews can be difficult to assess.", {"entities": []}], ["This study aims to produce methodological guidance, publication standards and training resources for those seeking to use the realist and/or meta-narrative approach to systematic review.", {"entities": []}], ["We will: [a] collate and summarise existing literature on the principles of good practice in realist and meta-narrative systematic review; [b] consider the extent to which these principles have been followed by published and in-progress reviews, thereby identifying how rigour may be lost and how existing methods could be improved; [c] using an online Delphi method with an interdisciplinary panel of experts from academia and policy, produce a draft set of methodological steps and publication standards; [d] produce training materials with learning outcomes linked to these steps; [e] pilot these standards and training materials prospectively on real reviews-in-progress, capturing methodological and other challenges as they arise; [f] synthesise expert input, evidence review and real-time problem analysis into more definitive guidance and standards; [g] disseminate outputs to audiences in academia and policy.", {"entities": []}], ["The outputs of the study will be threefold: 1.", {"entities": []}], ["Quality standards and methodological guidance for realist and meta-narrative reviews for use by researchers, research sponsors, students and supervisors 2.", {"entities": []}], ["A 'RAMESES' (Realist and Meta-review Evidence Synthesis: Evolving Standards) statement (comparable to CONSORT or PRISMA) of publication standards for such reviews, published in an open-access academic journal.", {"entities": []}], ["A training module for researchers, including learning outcomes, outline course materials and assessment criteria.", {"entities": []}], ["Realist and meta-narrative review are relatively new approaches to systematic review whose overall place in the secondary research toolkit is not yet fully established.", {"entities": []}], ["As with all secondary research methods, guidance on quality assurance and uniform reporting is an important step towards improving quality and consistency of studies.", {"entities": []}], ["Background: Heart failure (HF) diagnosis as reported in primary care medical records is not always properly confirmed and could result in over-registration.", {"entities": []}], ["Objectives: To determine the proportion of registered HF that can be confirmed with information from primary care medical records and to analyse related factors.", {"entities": []}], ["Methods: A cross-sectional study.", {"entities": []}], ["The medical records of 595 HF patients attended in two primary healthcare centres in Barcelona (Spain) were revised and validated by a team of experts who classified diagnosis into confirmed, unconfirmed, and misdiagnosis.", {"entities": []}], ["Variables potentially related to the confirmation of the diagnosis were analysed.", {"entities": []}], ["The revision of medical records and data collection took place from 15 January to 31 March 2014.", {"entities": []}], ["Results: Mean (standard deviation) age was 78 (10) years and 58% were women.", {"entities": []}], ["The diagnosis could be confirmed in 53.6% of patients.", {"entities": []}], ["Factors associated with a greater probability of having a confirmed diagnosis were age (yearly OR: 0.97, 95%CI: 0.95\u20130.99), cardiologist follow-up (OR: 3.66, 95%CI: 2.46\u20135.48), history of ischaemic heart disease (OR: 2.18, 95%CI: 1.36\u20132.48), atrial fibrillation (OR: 2.01, 95%CI: 1.34\u20133.03), and prescription of loop diuretics (OR: 3.24, 95%CI: 2.14\u20134.89).", {"entities": [[198, 211, "DISEASE"]]}], ["Conclusion: Only in half of the patients labelled as HF in primary care medical records could this diagnosis be further confirmed.", {"entities": []}], ["Variables regularly registered in clinical practice could help general practitioners identify those patients requiring a revision of their HF diagnosis.", {"entities": []}], ["Our first ever Open Highlights explores recent Open Access research into the complex relationship between host and pathogen during the course of an infection, and the factors that determine its eventual outcome.", {"entities": []}], ["The cytokine midkine (MK) is pathologically implicated in progressive chronic kidney disease (CKD) and its systemic consequences and has potential as both a biomarker and therapeutic target.", {"entities": [[78, 92, "DISEASE"]]}], ["To date, there are no published data on MK levels in patients with different stages of CKD.", {"entities": []}], ["This study aims to quantify MK levels in patients with CKD and to identify any correlation with CKD stage, cause, progression, comorbid disease or prescribed medication.", {"entities": []}], ["In this observational, single-centre study, demographic data were collected, and serum and urine assayed from 197 patients with CKD and 19 healthy volunteers in an outpatient setting.", {"entities": []}], ["The median serum and urine MK level in volunteers was 754 pg/mL (IQR: 554\u20131025) and 239 pg/mL (IQR: 154\u2013568), respectively.", {"entities": []}], ["Compared with serum MK in stage 1 CKD (660 pg/mL, IQR: 417\u2013893), serum MK increased in stage 3 (1878 pg/mL, IQR: 1188\u20132756; p<0.001), 4 (2768 pg/mL, IQR: 2065\u20134735; p<0.001) and 5 (4816 pg/mL, IQ: 37477807; p<0.001).", {"entities": []}], ["Urine MK levels increased from stage 1 CKD (343 pg/mL, IQR: 147\u2013437) to stage 3 (1007 pg/mL, IQR: 465\u20132766; p=0.07), 4 (2961 pg/mL, IQR: 1368\u20135686; p=0.005) and 5 (6722 pg/mL, IQR: 3796\u201310 060; p=0.001).", {"entities": []}], ["Fractional MK excretion (FeMK) increased from stage 1 CKD (0.159, IQR: 0.145\u20130.299) to stage 3 (1.024, IQR: 0.451\u20131.886, p=0.047), 4 (3.39, IQR: 2.10\u20135.82, p=0.004) and 5 (11.95, IQR: 5.36\u201324.41, p<0.001).", {"entities": []}], ["When adjusted for estimated glomerular filtration rate, neither serum nor urine MK correlated with primary CKD diagnosis or CKD progression (small sample).", {"entities": []}], ["There was a positive correlation between protein:creatinine ratio and FeMK (p=0.003).", {"entities": []}], ["Angiotensin blockade (adjusted for proteinuria) was associated with lower urine MK (p=0.018) and FeMK (p=0.025).", {"entities": [[35, 46, "DISEASE"]]}], ["MK levels sequentially rise with CKD stage beyond stage 2, and our data support existing animal evidence for an MK/renin angiotensin-system/proteinuria relationship.", {"entities": [[140, 151, "DISEASE"]]}], ["To what extent this is related to renal clearance versus pathology, or the consequences of chronically elevated MK levels requires further exploration.", {"entities": []}], ["Accurate diagnosis of respiratory infections requires serologic analysis and PCR of serum.", {"entities": []}], ["Human bocavirus (HBoV) is a widespread respiratory virus.", {"entities": []}], ["To improve diagnostic methods, we conducted immunoglobulin (Ig) G and IgM enzyme immunoassays with recombinant virus\u2013like particles of HBoV as antigen.", {"entities": []}], ["Acute-phase and follow-up serum samples from 258 wheezing children and single serum samples from 115 healthy adults in Finland were examined.", {"entities": []}], ["Our assays had a sensitivity of 97% and a specificity of 99.5%.", {"entities": []}], ["Of adults, 96% had immunity; none had an acute infection.", {"entities": []}], ["Of 48 children with serologically diagnosed acute HBoV infections, 45 were viremic and 35 had virus in nasopharyngeal aspirates (NPAs).", {"entities": []}], ["Of 39 HBoV NPA PCR\u2013positive children co-infected with another virus, 64% had a serologically verified HBoV infection.", {"entities": []}], ["HBoV caused illness of longer duration than rhinovirus and of equal severity to that of respiratory syncytial virus.", {"entities": []}], ["Among children with bronchiolitis, >25% had acute HBoV infections.", {"entities": [[20, 33, "DISEASE"]]}], ["Accurate HBoV diagnosis requires serologic analysis or PCR of serum; PCR of NPAs alone is insufficient.", {"entities": []}], ["The gastrointestinal tract (GIT) represents the largest interface between the human organism and the external environment.", {"entities": []}], ["In the lumen and upper part of the mucus layer, this organ hosts an enormous number of microorganisms whose composition affects the functions of the epithelial barrier and the gut immune system.", {"entities": []}], ["Consequentially, the microorganisms in the GIT influence the health status of the organism.", {"entities": []}], ["Probiotics are living microorganisms which, in specific conditions, confer a health benefit to the host.", {"entities": []}], ["Among others, probiotics have immunomodulatory properties that usually act directly by (a) increasing the activity of macrophages or natural killer cells, (b) modulating the secretion of immunoglobulins or cytokines, or indirectly by (c) enhancing the gut epithelial barrier, (d) altering the mucus secretion, and (e) competitive exclusion of other (pathogenic) bacteria.", {"entities": []}], ["This review focuses on specific bacteria strains with indirect immunomodulatory properties.", {"entities": []}], ["Particularly, we describe here the mechanisms through which specific probiotics enhance the gut epithelial barrier and modulate mucus production.", {"entities": []}], ["Moreover, we describe the antimicrobial properties of specific bacteria strains.", {"entities": []}], ["Recent data suggest that multiple pathologies are associated with an unbalanced gut microflora (dysbiosis).", {"entities": []}], ["Although the cause-effect relationship between pathology and gut microflora is not yet well established, consumption of specific probiotics may represent a powerful tool to re-establish gut homeostasis and promote gut health.", {"entities": []}], ["High-temperature, controlled incineration and thermal treatment of contaminated soils, sediments, and wastes at Superfund sites are often preferred methods of remediation of contaminated sites under the p -dioxins and dibenzofurans; and toxic metals (e.g., chromium VI) have historically been the focus of combustion and health effects research.", {"entities": []}], ["However, fine particulate matter (PM) and ultrafine PM, which have been documented to be related to cardiovascular disease, pulmonary disease, and cancer, have more recently become the focus of research.", {"entities": [[147, 153, "DISEASE"]]}], ["Fine PM and ultrafine PM are effective delivery agents for PAHs, CHCs, and toxic metals.", {"entities": []}], ["In addition, it has recently been realized that brominated hydrocarbons (including brominated/chlorinated dioxins), redox-active metals, and redox-active persistent free radicals are also associated with PM emissions from combustion and thermal processes.", {"entities": []}], ["In this article, we discuss the origin of each of these classes of pollutants, the nature of their association with combustion-generated PM, and the mechanisms of their known and potential health impacts.", {"entities": []}], ["Helminth infection may be protective against allergy and account for the low prevalence of allergy in developing countries.", {"entities": []}], ["We studied prospectively the prevalence of allergy in Ethiopian immigrants with heavy helminth infection on arrival in Israel, and again after a year of adjustment to an urban industrialized setting, to explore the roles of helminth infection, changed environment and background immunity on the manifestations of allergy.", {"entities": []}], ["126 newly arrived Ethiopian immigrants were studied at baseline and 115 after a year of follow up in Israel.", {"entities": []}], ["Allergic symptoms, Skin prick tests (SPT), Tuberculin (PPD) skin tests, stool and blood samples were obtained for determining parasites, blood IgE and eosinophil levels, respectively.", {"entities": []}], ["Anti-helminthic therapy was offered to the entire infected individuals, but only 50/108 (46.3%) took the medication.", {"entities": []}], ["At baseline, there was a significant negative association between helminth infection and allergy, 4/18 (22.2%) of uninfected participants were allergic compared to 7/108 (6.5%) of helminth-infected participants (p = 0.028), as well as between helminth infection and SPT reactivity, 12/18 (66.6%) of uninfected participants compared to 43/108 (39.8%) of helminth-infected participants (p = 0.033).", {"entities": []}], ["After one year, a significant general increase in allergy and SPT was observed.", {"entities": []}], ["While only 11/126 (8.7%) were allergic at baseline, 30/115 (26.1%) became allergic at follow-up (p<0.0001), and while 55/126 (43.7%) were SPT+ at baseline, 79/115 (68.7%) became SPT+ at follow-up (p<0.001).", {"entities": []}], ["A twofold increase in allergen sensitization was also observed after one year in Israel, particularly for dust mites, grasses and olive tree (p<0.001).", {"entities": []}], ["These results show that: a) Helminth infection is significantly associated with low allergy and low SPT reactivity; b) One year after immigration to Israel, allergy and SPT reactivity increased significantly in all immigrants; c) Higher increases in positive SPT and allergy were observed after a year in the group that remained infected with helminths, even though they had a lowered helminth load; d) The reasons for the increased allergy one year after immigration needs further investigation but probably reflects the combined influence of the decreased helminth load and novel environmental factors.", {"entities": []}], ["The role of intestinal parasitic infections in allergy is of great interest since it has been suggested that they suppress the development of allergy.", {"entities": []}], ["Urbanization has also been claimed to cause allergy because of air pollution and higher exposure to allergens.", {"entities": []}], ["The present study took advantage of the special opportunity presented by the recent Ethiopian immigration to Israel in order to study this question.", {"entities": []}], ["A cohort of newly arrived Ethiopian immigrants to Israel, highly infected with parasites, was studied prospectively for the presence of allergy and response to allergens on arrival and after a year of follow up in Israel.", {"entities": []}], ["The results showed clearly a significant inverse association between the presence of parasitic infections and allergy on arrival, while after a year of living in Israel, accompanied by a lowered parasitic infection load, a general increase of allergy was observed in all immigrant groups, and not only in those that had parasitic infections on arrival.", {"entities": []}], ["These results lend support to the suppressive effect of intestinal parasites on allergy, but suggest that additional factors, most probably environmental, also play a role in the generation of allergy.", {"entities": []}], ["To get a comprehensive understanding about the relationship between obstructive sleep apnea (OSA) and asthma by reviewing the epidemiology, pathophysiology, and clinical manifestation and then summarizing the latest progress on diagnosis and treatment.", {"entities": [[102, 108, "DISEASE"]]}], ["Articles referred in this review were mainly collected from a comprehensive search of the PubMed published in English from 1990 to 2015 with the terms \u201cOSA\u201d and \u201casthma\u201d as the main keywords.", {"entities": [[162, 168, "DISEASE"]]}], ["Highly regarded older publications were also included.", {"entities": []}], ["Information about the features of the two diseases in common, the pathophysiologic association between them and their current treatments from the literature search were identified, retrieved, and summarized.", {"entities": []}], ["Both OSA and asthma are very prevalent conditions.", {"entities": [[13, 19, "DISEASE"]]}], ["The incidences of them have kept on rising in recent years.", {"entities": []}], ["Asthma is often accompanied by snoring and apnea, and OSA often combines with asthma, as well.", {"entities": [[0, 6, "DISEASE"], [78, 84, "DISEASE"]]}], ["They have many predisposing and aggravating factors in common.", {"entities": []}], ["Possible shared direct mechanistic links between them include mechanical effects, intermittent hypoxia, nerve reflex, inflammation, leptin, etc.", {"entities": []}], ["Indirect mechanistic links include medication, nose diseases, smoking, obesity, and gastroesophageal reflux disease.", {"entities": [[71, 78, "DISEASE"], [84, 115, "DISEASE"]]}], ["Since OSA presents many similar features with nocturnal asthma, some scholars termed them as a sole syndrome \u2013 \u201calternative overlap syndrome,\u201d and proved that asthma symptoms in those patients could be improved through the treatment of continuous positive airway pressure.", {"entities": [[100, 108, "DISEASE"], [132, 140, "DISEASE"], [56, 62, "DISEASE"], [159, 165, "DISEASE"]]}], ["OSA and asthma are closely associated in pathogenesis, symptoms, and therapies.", {"entities": [[8, 14, "DISEASE"]]}], ["With the growing awareness of the relationship between them, we should raise our vigilance on the coexistence of OSA in those difficult-to-control asthmatic patients.", {"entities": []}], ["Further studies are still needed to guide the clinical works.", {"entities": []}], ["There is a recognized gap in the evidence base relating to the nature and components of interventions to address the psycho-social needs of HIV positive young people.", {"entities": []}], ["We used mixed methods research to strengthen a community support group intervention for HIV positive young people based in Harare, Zimbabwe.", {"entities": []}], ["A quantitative questionnaire was administered to HIV positive Africaid support group attendees.", {"entities": []}], ["Afterwards, qualitative data were collected from young people aged 15\u201318 through tape-recorded in-depth interviews (n\u200a=\u200a10), 3 focus group discussions (FGDs) and 16 life history narratives.", {"entities": []}], ["Data were also collected from caregivers, health care workers, and community members through FGDs (n\u200a=\u200a6 groups) and in-depth interviews (n\u200a=\u200a12).", {"entities": []}], ["Quantitative data were processed and analysed using STATA 10.", {"entities": []}], ["Qualitative data were analysed using thematic analysis.", {"entities": []}], ["229/310 young people completed the quantitative questionnaire (74% participation).", {"entities": []}], ["Median age was 14 (range 6\u201318 years); 59% were female.", {"entities": []}], ["Self-reported adherence to antiretrovirals was sub-optimal.", {"entities": []}], ["Psychological well being was poor (median score on Shona Symptom Questionnaire 9/14); 63% were at risk of depression.", {"entities": []}], ["Qualitative findings suggested that challenges faced by positive children include verbal abuse, stigma, and discrimination.", {"entities": []}], ["While data showed that support group attendance is helpful, young people stressed that life outside the confines of the group was more challenging.", {"entities": []}], ["Caregivers felt ill-equipped to support the children in their care.", {"entities": []}], ["These data, combined with a previously validated conceptual framework for family-centred interventions, were used to guide the development of the existing programme of adolescent support groups into a more comprehensive evidence-based psychosocial support programme encompassing caregiver and household members.", {"entities": []}], ["This study allowed us to describe the lived experiences of HIV positive young people and their caregivers in Zimbabwe.", {"entities": []}], ["The findings contributed to the enhancement of Africaid\u2019s existing programme of support to better promote psychological well being and ART adherence.", {"entities": []}], ["Diabetes mellitus is becoming increasingly common in sub-Saharan Africa.", {"entities": []}], ["Autonomic dysfunction contributes to morbidity and mortality in diabetic patients.", {"entities": []}], ["Data on autonomic dysfunction in the African population is scarce, and no reference values for standardized autonomic function tests are available.", {"entities": []}], ["The aim of this study was to establish cut off values for five easy-to-use cardiovascular autonomic function tests that may be suitable for resource-poor settings.", {"entities": []}], ["We recruited 276 healthy African individuals, 156 men and 120 women, aged > 20 years.", {"entities": []}], ["Participants were tested for (1) resting heart rate (HR), (2) HR variation in response to deep breathing, (3) HR response to standing, and (4) postural changes in systolic and diastolic blood pressure (SBP and DBP).", {"entities": [[53, 55, "GENE"], [62, 64, "GENE"], [110, 112, "GENE"], [53, 55, "GENE"], [62, 64, "GENE"], [110, 112, "GENE"], [53, 55, "GENE"], [62, 64, "GENE"], [110, 112, "GENE"], [210, 213, "GENE"]]}], ["Respective cut-off values were calculated according to the 95th or 5th percentile.", {"entities": []}], ["Taking an association of the autonomic test results with gender and age into consideration, we defined the following cut-off values: resting HR (bpm) \u2265 89 for men and \u2265 97 for women; HR (bpm) in response to deep breathing \u2264 13, \u2264 11, \u2264 9, \u2264 8, and \u2264 7 for age groups 20\u201329, 30\u201339, 40\u201349, 50\u201359, and 60+ years, respectively; HR (bpm) in response to standing \u2264 14 for 20\u201329 years, and \u2264 11 for 30+ years; postural decreases in SBP \u2265 17 mmHg for all age groups; and postural decreases in DBP (mmHg) \u2265 2 for men and \u2265 5 for women.", {"entities": [[141, 143, "GENE"], [183, 185, "GENE"], [324, 326, "GENE"], [141, 143, "GENE"], [183, 185, "GENE"], [324, 326, "GENE"], [141, 143, "GENE"], [183, 185, "GENE"], [324, 326, "GENE"], [485, 488, "GENE"]]}], ["The test battery revealed cut-off values different from those measured in Caucasians.", {"entities": []}], ["Further studies are recommended a) to assess whether these cut off values are generally applicable, and b) to establish population specific reference values for Africans.", {"entities": []}], ["Recent genome-wide association studies (GWAS) for asthma have been successful in identifying novel associations which have been well replicated.", {"entities": [[50, 56, "DISEASE"]]}], ["The aim of this study is to identify the genetic variants that influence predisposition towards asthma in an ethnic Chinese population in Singapore using a GWAS approach.", {"entities": [[96, 102, "DISEASE"]]}], ["A two-stage GWAS was performed in case samples with allergic asthma, and in control samples without asthma and atopy.", {"entities": [[52, 67, "DISEASE"], [61, 67, "DISEASE"], [100, 106, "DISEASE"]]}], ["In the discovery stage, 490 case and 490 control samples were analysed by pooled genotyping.", {"entities": []}], ["Significant associations from the first stage were evaluated in a replication cohort of 521 case and 524 control samples in the second stage.", {"entities": []}], ["The same 980 samples used in the discovery phase were also individually genotyped for purposes of a combined analysis.", {"entities": []}], ["An additional 1445 non-asthmatic atopic control samples were also genotyped.", {"entities": []}], ["19 promising SNPs which passed our genome-wide P value threshold of 5.52 \u00d7 10 P = 1.48 \u00d7 10 AG = 0.526 (0.369-0.700), OR AA = 0.480 (0.361-0.639)) and at the allelic level ( P = 9.56 \u00d7 10 These findings reveal the association of a PERLD1 as a novel asthma candidate gene and reinforce the involvement of genes on the 17q12-21 chromosomal region in the etiology of asthma.", {"entities": [[249, 255, "DISEASE"], [364, 370, "DISEASE"]]}], ["Measuring population health is important to evaluate the impact of interventions, to monitor the changes in health status, and to predict the need for health care.", {"entities": []}], ["A number of tools have been developed to measure quality of life and health-related quality of life.", {"entities": []}], ["According with the current taxonomy, the questionnaires may be classified as generic or specific, multidimensional or global.", {"entities": []}], ["Recently, advances in the field of health outcome assessment have resulted in a new generation of approaches and measures that are based on a novel approach called dynamic health assessment.", {"entities": []}], ["Through this approach, subjects or patients answer only those questions relevant to their evaluation, in contrast to the fixed approach in which the number of questions is a priori determined.", {"entities": []}], ["The dynamic headache impact test (HIT) that evaluates several dimensions such as ability to function on the job, at school, and in social situations, is presented and its value with respect to other fixed migraine-specific questionnaires is discussed.", {"entities": [[205, 213, "DISEASE"]]}], ["Cysteinyl leukotrienes (cysLTs) are produced predominantly by cells of the innate immune system, especially basophils, eosinophils, mast cells, and monocytes/macrophages.", {"entities": []}], ["Notwithstanding potent bronchoconstrictor activity, cysLTs are also proinflammatory consequent to their autocrine and paracrine interactions with G-protein-coupled receptors expressed not only on the aforementioned cell types, but also on Th2 lymphocytes, as well as structural cells, and to a lesser extent neutrophils and CD8 in vitro , as well as an overview of both the current clinical applications of these agents and potential future applications based on preclinical and early clinical studies.", {"entities": []}], ["Patient portals have the potential to support self-management for chronic diseases and improve health outcomes.", {"entities": []}], ["With the rapid rise in adoption of patient portals spurred by meaningful use incentives among safety net health systems (a health system or hospital providing a significant level of care to low-income, uninsured, and vulnerable populations), it is important to understand the readiness and willingness of patients and caregivers in safety net settings to access their personal health records online.", {"entities": []}], ["To explore patient and caregiver perspectives on online patient portal use before its implementation at San Francisco General Hospital, a safety net hospital.", {"entities": []}], ["We conducted 16 in-depth interviews with chronic disease patients and caregivers who expressed interest in using the Internet to manage their health.", {"entities": []}], ["Discussions focused on health care experiences, technology use, and interest in using an online portal to manage health tasks.", {"entities": []}], ["We used open coding to categorize all the barriers and facilitators to portal use, followed by a second round of coding that compared the categories to previously published findings.", {"entities": []}], ["In secondary analyses, we also examined specific barriers among 2 subgroups: those with limited health literacy and caregivers.", {"entities": []}], ["We interviewed 11 patients and 5 caregivers.", {"entities": []}], ["Patients were predominantly male (82%, 9/11) and African American (45%, 5/11).", {"entities": []}], ["All patients had been diagnosed with diabetes and the majority had limited health literacy (73%, 8/11).", {"entities": []}], ["The majority of caregivers were female (80%, 4/5), African American (60%, 3/5), caregivers of individuals with diabetes (60%, 3/5), and had adequate health literacy (60%, 3/5).", {"entities": []}], ["A total of 88% (14/16) of participants reported interest in using the portal after viewing a prototype.", {"entities": []}], ["Major perceived barriers included security concerns, lack of technical skills/interest, and preference for in-person communication.", {"entities": []}], ["Facilitators to portal use included convenience, health monitoring, and improvements in patient-provider communication.", {"entities": []}], ["Participants with limited health literacy discussed more fundamental barriers to portal use, including challenges with reading and typing, personal experience with online security breaches/viruses, and distrust of potential security measures.", {"entities": []}], ["Caregivers expressed high interest in portal use to support their roles in interpreting health information, advocating for quality care, and managing health behaviors and medical care.", {"entities": []}], ["Despite concerns about security, difficulty understanding medical information, and satisfaction with current communication processes, respondents generally expressed enthusiasm about portal use.", {"entities": []}], ["Our findings suggest a strong need for training and support to assist vulnerable patients with portal registration and use, particularly those with limited health literacy.", {"entities": []}], ["Efforts to encourage portal use among vulnerable patients should directly address health literacy and security/privacy issues and support access for caregivers.", {"entities": []}], ["From the first day of imprisonment, prisoners are exposed to and expose other prisoners to various communicable diseases, many of which are vaccine-preventable.", {"entities": []}], ["The risk of acquiring these diseases during the prison sentence exceeds that of the general population.", {"entities": []}], ["This excess risk may be explained by various causes; some due to the structural and logistical problems of prisons and others to habitual or acquired behaviors during imprisonment.", {"entities": []}], ["Prison is, for many inmates, an opportunity to access health care, and is therefore an ideal opportunity to update adult vaccination schedules.", {"entities": []}], ["The traditional idea that prisons are intended to ensure public safety should be complemented by the contribution they can make in improving community health, providing a more comprehensive vision of safety that includes public health.", {"entities": []}], ["An appropriate diagnostic process is crucial for managing patients with acute heart failure (AHF) in emergency department (ED).", {"entities": []}], ["Our study aims to describe the characteristics and therapeutic management of patients admitted to the ED for dyspnea suspected to have AHF, their in-hospital pathway of care and their in-hospital outcome.", {"entities": []}], ["Consecutive patients admitted in 26 French ED for dyspnea suspected to be the consequence of AHF, prior to in hospital diagnostic test, were prospectively included at the time of their admission in the DeFSSICA Survey.", {"entities": []}], ["Clinical characteristics at admission were recorded by the ED physicians.", {"entities": []}], ["At discharge from ED, patients were categorized as AHF or non-AHF based on the final diagnosis reported in the discharge summary.", {"entities": []}], ["The completeness of the data was controlled by the local investigator.", {"entities": []}], ["From 16/6/2014 to 7/7/2014, 699 patients were included, of whom 537 (77\u00a0%) had a final diagnosis of AHF at discharge.", {"entities": []}], ["Patients with AHF were older (median 83 vs 79\u00a0years, p \u2009=\u20090.0007), more likely to have hypertension (71\u00a0% vs 57\u00a0%, p \u2009=\u20090.002), chronic HF (54\u00a0% vs 37\u00a0%, p \u2009=\u20090.0004), atrial fibrillation (45\u00a0% vs 34\u00a0%, p \u2009=\u20090.02) and history of hospitalization for AHF in the previous year (40\u00a0% vs 18\u00a0%, p \u2009<\u20090.0001) when compared to patients without AHF.", {"entities": [[87, 99, "DISEASE"]]}], ["Furosemide and oxygen were used in approximately 2/3 of the patients in the ED (respectively 75 and 68\u00a0%) whereas nitrates were in 19\u00a0% of the patients.", {"entities": []}], ["Diagnostic methods used to confirm AHF included biochemistry (100\u00a0%), pro-B-type natriuretic peptide (90\u00a0%), electrocardiography (98\u00a0%), chest X-ray (94\u00a0%), and echography (15\u00a0%) which only 18\u00a0% of lung ultrasound.", {"entities": []}], ["After the ED visit, 13\u00a0% of AHF patients were transferred to the intensive care unit, 28\u00a0% in cardiology units and 12\u00a0% in geriatric units.", {"entities": []}], ["In-hospital mortality was lower in AHF vs non-AHF patients (5.6\u00a0% vs 14\u00a0%, p \u2009=\u20090.003).", {"entities": []}], ["DeFSSICA, a large French observational survey of acute HF, provides information on HF presentation and the French pathway of care.", {"entities": []}], ["Patients in DeFSSICA were elderly, with a median age of 83 years.", {"entities": []}], ["Compared with the French OFICA study, patients in DeFSSICA were more likely to have hypertension (71 % vs 62 %) and atrial fibrillation (45 % vs 38 %).", {"entities": [[84, 96, "DISEASE"]]}], ["As atrial fibrillation and a rapid heart rate have been closely linked to mortality, detection of atrial fibrillation should be considered systematically.The limited use of nitrates in DeFSSICA may be related to the median SBP of 140 (121\u2013160) mmHg.", {"entities": []}], ["However, our use of nitrates was similar to those in the EAHFE (20.7 %) and OPTIMIZE-HF (14.3 %) registries.", {"entities": []}], ["In line with guidelines, the proportions of patients who underwent ECG, biological analysis, or chest X-ray were all >90 % in DeFSSICA.", {"entities": []}], ["Similarly, BNP or pro-BNP was measured in 93 % of patients, compared with 82 % of patients in the OFICA study.", {"entities": []}], ["Although BNP may be helpful when the diagnosis of HF is in doubt, ultrasound remains the gold standard.", {"entities": []}], ["The use of ultrasound in the ED has been reported to accelerate the diagnosis of HF and the initiation of treatment, and shorten the length of stay.", {"entities": []}], ["In-hospital mortality of HF patients in DeFSSICA was 6.4 %, slightly lower than in the OFICA study (8.2 %).", {"entities": []}], ["Improved interdisciplinary cooperation has been highlighted as a key factor for the improvement of HF patient care.", {"entities": []}], ["DeFSSICA shows that patients admitted for dyspnea suspected to be the consequence of AHF are mostly elderly.", {"entities": []}], ["The diagnosis of AHF is difficult to ascertain based on clinical presentation in patients with dyspnea.", {"entities": []}], ["Novel diagnostic techniques such as thoracic ultrasound are warranted to provide the right treatment to the right patients in the ED as early as possible.", {"entities": []}], ["The online version of this article (doi:10.1186/s13049-016-0300-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Viral respiratory infections activate the innate immune response in the airway epithelium through Toll-like receptors (TLRs) and induce airway inflammation, which causes acute exacerbation of asthma.", {"entities": [[192, 198, "DISEASE"]]}], ["Although increases in IL-17A expression were observed in the airway of severe asthma patients, the interaction between IL-17A and TLR activation in airway epithelium remains poorly understood.", {"entities": [[78, 84, "DISEASE"]]}], ["In this study, we demonstrated that IL-17A and polyI:C, the ligand of TLR3, synergistically induced the expression of proinflammatory cytokines and chemokines (G-CSF, IL-8, CXCL1, CXCL5, IL-1F9), but not type I interferon (IFN-\u03b11, -\u03b2) in primary culture of normal human bronchial epithelial cells.", {"entities": [[70, 74, "GENE"], [173, 178, "GENE"], [180, 185, "GENE"]]}], ["Synergistic induction after co-stimulation with IL-17A and polyI:C was observed from 2 to 24 hours after stimulation.", {"entities": []}], ["Treatment with cycloheximide or actinomycin D had no effect, suggesting that the synergistic induction occurred without de novo protein synthesis or mRNA stabilization.", {"entities": []}], ["Inhibition of the TLR3, TLR/TIR-domain-containing adaptor-inducing interferon \u03b2 (TRIF), NF-\u03baB, and IRF3 pathways decreased the polyI:C- and IL-17A/polyI:C-induced G-CSF and IL-8 mRNA expression.", {"entities": [[18, 22, "GENE"], [99, 103, "GENE"]]}], ["Comparing the levels of mRNA induction between co-treatment with IL-17A/polyI:C and treatment with polyI:C alone, blocking the of NF-\u03baB pathway significantly attenuated the observed synergism.", {"entities": []}], ["In western blotting analysis, activation of both NF-\u03baB and IRF3 was observed in treatment with polyI:C and co-treatment with IL-17A/polyI:C; moreover, co-treatment with IL-17A/polyI:C augmented I\u03baB-\u03b1 phosphorylation as compared to polyI:C treatment alone.", {"entities": [[59, 63, "GENE"]]}], ["Collectively, these findings indicate that IL-17A and TLR3 activation cooperate to induce proinflammatory responses in the airway epithelium via TLR3/TRIF-mediated NF-\u03baB/IRF3 activation, and that enhanced activation of the NF-\u03baB pathway plays an essential role in synergistic induction after co-treatment with IL-17A and polyI:C in vitro .", {"entities": [[54, 58, "GENE"], [145, 149, "GENE"]]}], ["To estimate, among privately insured youth in the U.S., medical expenditures associated with diabetes and the difference in medical expenditures between individuals with insulin-treated diabetes mellitus (ITDM) and with non-ITDM (NITDM).", {"entities": [[186, 203, "DISEASE"]]}], ["Using the 2007 MarketScan commercial claims and encounter database, we analyzed data for 49,356 youth (aged \u226419 years) who were continuously enrolled in fee-for-service health plans.", {"entities": []}], ["Youth with diabetes (cases) were identified from inpatient, outpatient, and pharmaceutical drug claims.", {"entities": []}], ["Each case was matched with five controls (without diabetes) by age (\u00b12 years), sex, census region, and urban versus rural residence.", {"entities": []}], ["We used regression models to estimate medical expenditures in total and by component (inpatient, outpatient, and medication).", {"entities": []}], ["The predicted mean annual total per-person medical expenditures were $9,061 for youth with diabetes and $1,468 for those without, an excess of $7,593 for those with diabetes; of which, 43% was for prescription drugs.", {"entities": []}], ["The predicted mean annual total expenditures were $9,333 for ITDM youth and $5,683 for NITDM youth, respectively, an excess of $3,650 for those with ITDM diabetes, of which 59% was for prescription drugs.", {"entities": []}], ["The excess medical expenditures associated with diabetes, ITDM in particular, among youth are substantial.", {"entities": []}], ["Our estimates of excess expenditures can be used to assess the economic burden of diabetes overall and by diabetes treatment mode.", {"entities": []}], ["Our estimated excess expenditure for NITDM may be used for evaluating the economic efficiency of interventions aimed at preventing type 2 diabetes in U.S. youth.", {"entities": []}], ["Molecular microbiological analysis of airway samples in asthma has demonstrated an altered microbiome in comparison to healthy controls.", {"entities": [[56, 62, "DISEASE"]]}], ["Such changes may have relevance to treatment-resistant severe asthma, particularly those with neutrophilic airway inflammation, as bacteria might be anticipated to activate the innate immune response, a process that is poorly steroid responsive.", {"entities": [[62, 68, "DISEASE"]]}], ["An understanding of the relationship between airway bacterial presence and dominance in severe asthma may help direct alternative treatment approaches.", {"entities": [[95, 101, "DISEASE"]]}], ["We aimed to use a culture independent analysis strategy to describe the presence, dominance and abundance of bacterial taxa in induced sputum from treatment resistant severe asthmatics and correlate findings with clinical characteristics and airway inflammatory markers.", {"entities": []}], ["Induced sputum was obtained from 28 stable treatment-resistant severe asthmatics.", {"entities": []}], ["The samples were divided for supernatant IL-8 measurement, cytospin preparation for differential cell count and Terminal Restriction Fragment Length Polymorphism (T-RFLP) profiling for bacterial community analysis.", {"entities": []}], ["In 17/28 patients, the dominant species within the airway bacterial community was Moraxella catarrhalis or a member of the Haemophilus or Streptococcus genera .", {"entities": []}], ["Colonisation with these species was associated with longer asthma disease duration (mean (SD) 31.8 years (16.7) vs 15.6 years (8.0), p\u200a=\u200a0.008), worse post-bronchodilator percent predicted FEV 1 (68.0% (24.0) vs 85.5% (19.7), p\u200a=\u200a0.025) and higher sputum neutrophil differential cell counts (median (IQR) 80% (67\u201383) vs 43% (29\u201367), p\u200a=\u200a0.001).", {"entities": [[59, 65, "DISEASE"], [189, 192, "GENE"]]}], ["Total abundance of these organisms significantly and positively correlated with sputum IL-8 concentration and neutrophil count.", {"entities": []}], ["Airway colonisation with potentially pathogenic micro-organisms in asthma is associated with more severe airways obstruction and neutrophilic airway inflammation.", {"entities": [[67, 73, "DISEASE"]]}], ["This altered colonisation may have a role in the development of an asthma phenotype that responds less well to current asthma therapies.", {"entities": [[67, 73, "DISEASE"], [119, 125, "DISEASE"]]}], ["Background: Low socioeconomic status is consistently associated with reduced physical and mental health, but the mechanisms remain unclear.", {"entities": []}], ["Increased levels of urban air pollutants interacting with parental stress have been proposed to explain health disparities in respiratory disease, but the impact of such interactions on mental health is unknown.", {"entities": []}], ["Objectives: We aimed to determine whether prenatal air pollution exposure and stress during pregnancy act synergistically on offspring to induce a neuroinflammatory response and subsequent neurocognitive disorders in adulthood.", {"entities": []}], ["Methods: Mouse dams were intermittently exposed via oropharyngeal aspiration to diesel exhaust particles (DEP; 50 \u03bcg \u00d7 6 doses) or vehicle throughout gestation.", {"entities": []}], ["This exposure was combined with standard housing or nest material restriction (NR; a novel model of maternal stress) during the last third of gestation.", {"entities": []}], ["Results: Adult (postnatal day 60) offspring of dams that experienced both stressors (DEP and NR) displayed increased anxiety, but only male offspring of this group had impaired cognition.", {"entities": []}], ["Furthermore, maternal DEP exposure increased proinflammatory interleukin (IL)-1\u03b2 levels within the brains of adult males but not females, and maternal DEP and NR both decreased anti-inflammatory IL-10 in male, but not female, brains.", {"entities": []}], ["Similarly, only DEP/NR males showed increased expression of the innate immune recognition gene toll-like receptor 4 ( Tlr4 ) and its downstream effector, caspase-1.", {"entities": [[118, 122, "GENE"]]}], ["Conclusions: These results show that maternal stress during late gestation increases the susceptibility of offspring\u2014particularly males\u2014to the deleterious effects of prenatal air pollutant exposure, which may be due to a synergism of these factors acting on innate immune recognition genes and downstream neuroinflammatory cascades within the developing brain.", {"entities": []}], ["Citation: Bolton JL, Huff NC, Smith SH, Mason SN, Foster WM, Auten RL, Bilbo SD.", {"entities": []}], ["Maternal stress and effects of prenatal air pollution on offspring mental health outcomes in mice.", {"entities": []}], ["Environ Health Perspect 121:1075\u20131082;\u2002 http://dx.doi.org/10.1289/ehp.1306560", {"entities": []}], ["Animal models should display important characteristics of the human disease.", {"entities": []}], ["Sheep have been considered particularly useful to study allergic airway responses to common natural antigens causing human asthma.", {"entities": [[123, 129, "DISEASE"]]}], ["A rationale of this study was to establish a model of ovine precision-cut lung slices (PCLS) for the in vitro measurement of airway responses in newborn and adult animals.", {"entities": []}], ["We hypothesized that differences in airway reactivity in sheep are present at different ages.", {"entities": []}], ["Lambs were delivered spontaneously at term (147d) and adult sheep lived till 18 months.", {"entities": []}], ["Viability of PCLS was confirmed by the MTT-test.", {"entities": []}], ["To study airway provocations cumulative concentration-response curves were performed with different allergic response mediators and biogenic amines.", {"entities": []}], ["In addition, electric field stimulation, passive sensitization with house dust mite (HDM) and mast cells staining were evaluated.", {"entities": []}], ["PCLS from sheep were viable for at least three days.", {"entities": []}], ["PCLS of newborn and adult sheep responded equally strong to methacholine and endothelin-1.", {"entities": []}], ["The responses to serotonin, leukotriene D 4 and U46619 differed with age.", {"entities": []}], ["No airway contraction was evoked by histamine, except after cimetidine pretreatment.", {"entities": []}], ["In response to EFS, airways in PCLS from adult and newborn sheep strongly contracted and these contractions were atropine sensitive.", {"entities": [[15, 18, "GENE"]]}], ["Passive sensitization with HDM evoked a weak early allergic response in PCLS from adult and newborn sheep, which notably was prolonged in airways from adult sheep.", {"entities": []}], ["Only few mast cells were found in the lungs of non-sensitized sheep at both ages.", {"entities": []}], ["PCLS from sheep lungs represent a useful tool to study pharmacological airway responses for at least three days.", {"entities": []}], ["Sheep seem well suited to study mechanisms of cholinergic airway contraction.", {"entities": []}], ["The notable differences between newborn and adult sheep demonstrate the importance of age in such studies.", {"entities": []}], ["One of many types of injuries following an earthquake is spinal cord injury (SCI) which is a life-long medically complex injury and high-cost health problem.", {"entities": []}], ["Despite several negative consequences, some persons with SCI are resilient enough to achieve positive adjustment, greater acceptance, and better quality of life.", {"entities": []}], ["Since resilience is influenced by several factors and can vary by context, it is beneficial to explore factors that affect the resilience of people who sustained spinal cord injury from the 2015 earthquake in Nepal.", {"entities": []}], ["A descriptive cross-sectional study included 82 participants from the Spinal Injury Rehabilitation Center and communities in Nepal.", {"entities": []}], ["Participants completed the Demographic and Injury-related Questionnaire, Connor-Davidson Resilience Scale, Multidimensional Scale of Perceived Social Support, Moorong Self-efficacy Scale, Intrinsic Spirituality Scale, and Patient Health Questionnaire-9.", {"entities": []}], ["Pearson\u2019s correlation and point biserial correlation analyses were performed to examine associations between resilience and independent variables.", {"entities": []}], ["A hierarchical regression analysis was used to identify the influence of certain factors.", {"entities": []}], ["Findings indicated significant associations between resilience and social support ( r \u2009=\u20090.42, p \u2009<\u20090.001), self-efficacy ( r \u2009=\u20090.53, p \u2009<\u20090.001), depressive mood ( r \u2009=\u2009\u2212\u20090.50, p \u2009<\u20090.001) and demographic variables which included sex ( r \u2009=\u20090.47, p \u2009<\u20090.001), employment ( r \u2009=\u20090.27, p \u2009=\u20090.016), and current living location ( r \u2009=\u20090.24, p \u2009=\u20090.029).", {"entities": []}], ["There was a non-significant association between resilience and spirituality ( r \u2009=\u2009\u2212\u20090.12, p \u2009>\u20090.05).", {"entities": []}], ["In hierarchical regression analysis, an overall regression model explained 46% of the variance in resilience.", {"entities": []}], ["Self-efficacy (\u03b2\u00a0 = \u00a00.28, p \u2009=\u20090.007) and depressive mood (\u03b2\u00a0 = \u2009\u2212\u20090.24, p \u2009=\u20090.016) significantly determined resilience after controlling the effect of demographic variables.", {"entities": []}], ["Among the demographic factors, being male significantly explained the variance in resilience (\u03b2\u00a0 = \u00a00.31, p \u2009=\u20090.001).", {"entities": []}], ["Multiple psychosocial and demographic factors were associated with resilience in people who sustained an earthquake-related SCI.", {"entities": []}], ["Mental health professionals should demonstrate concern and consider such factors in allocating care in this group.", {"entities": []}], ["Development of intervention research concerning resilience is recommended to strengthen resilience in order to improve rehabilitation outcomes and enhance reintegration of individuals with SCI into their communities.", {"entities": []}], ["We describe a new method for imaging leukocytes in vivo by exciting the endogenous protein fluorescence in the ultraviolet (UV) spectral region where tryptophan is the major fluorophore.", {"entities": []}], ["Two-photon excitation near 590 nm allows noninvasive optical sectioning through the epidermal cell layers into the dermis of mouse skin, where leukocytes can be observed by video-rate microscopy to interact dynamically with the dermal vascular endothelium.", {"entities": []}], ["Inflammation significantly enhances leukocyte rolling, adhesion, and tissue infiltration.", {"entities": []}], ["After exiting the vasculature, leukocytes continue to move actively in tissue as observed by time-lapse microscopy, and are distinguishable from resident autofluorescent cells that are not motile.", {"entities": []}], ["Because the new method alleviates the need to introduce exogenous labels, it is potentially applicable for tracking leukocytes and monitoring inflammatory cellular reactions in humans.", {"entities": []}], ["Variation at regulatory elements, identified through hypersensitivity to digestion by DNase I, is believed to contribute to variation in complex traits, but the extent and consequences of this variation are poorly characterized.", {"entities": []}], ["Analysis of terminally differentiated erythroblasts in eight inbred strains of mice identified reproducible variation at approximately 6% of DNase I hypersensitive sites (DHS).", {"entities": []}], ["Only 30% of such variable DHS contain a sequence variant predictive of site variation.", {"entities": []}], ["Nevertheless, sequence variants within variable DHS are more likely to be associated with complex traits than those in non-variant DHS, and variants associated with complex traits preferentially occur in variable DHS.", {"entities": []}], ["Changes at a small proportion (less than 10%) of variable DHS are associated with changes in nearby transcriptional activity.", {"entities": []}], ["Our results show that whilst DNA sequence variation is not the major determinant of variation in open chromatin, where such variants exist they are likely to be causal for complex traits.", {"entities": []}], ["Regulatory sites of the genome affect gene expression and complex traits, including disease susceptibility.", {"entities": []}], ["Variable regulatory sites are potentially interesting because they are a likely cause of phenotypic variation, providing a bridge between sequence and transcriptional variation.", {"entities": []}], ["In this paper we identify regions of the genome where DNA is not wrapped up in chromatin (hence potentially regulatory) in eight inbred strains of mice.", {"entities": []}], ["We compare sites that vary among strains and compare them to non-variable sites.", {"entities": []}], ["We show that more than half of variable sites cannot be attributed to local sequence variation.", {"entities": []}], ["Functional consequences (in terms of readily detectable changes in gene expression) are associated with less than 10% of variable DNase I hypersensitive sites.", {"entities": []}], ["We show that variable sites are enriched for sequence variants contributing to complex traits in mice.", {"entities": []}], ["Combined with TCR stimuli, extracellular cytokine signals initiate the differentiation of naive CD4", {"entities": [[96, 99, "GENE"]]}], ["For the last 50 years, the economic and industrial development of the nations of Central and Eastern Europe has been achieved at the cost of environmental degradation.", {"entities": []}], ["The health risks posed by this pollution to children and the steps necessary to ameliorate such risks are only beginning to be investigated.", {"entities": []}], ["At a recent conference in Poland, sponsored in part by the National Institute of Environmental Health Sciences, participants from 11 countries in the region, together with scientists from Western Europe and the United States, met to share information regarding pediatric environmental health in Central and Eastern Europe, to consider methodologic issues in the design and conduct of such studies, and to discuss preventive strategies.", {"entities": []}], ["This report summarizes the deliberations, outlines problem areas such as heavy metals and air pollution, delineates research and training needs to help Central and Eastern Europeans deal more effectively with such problems, and recommends specific future actions and collaborative efforts.", {"entities": []}], ["The objective of this study was to make use of a quantitative and qualitative approach comparing the systemic renin-angiotensin system (RAS) of hypertensive black and white African men by using RAS equilibrium analysis.", {"entities": []}], ["This sub-study involved 23 black ( n = 15) and white ( n = 8) hypertensive men aged 39.5\u201341 years, living in the North West Province of South Africa.", {"entities": []}], ["The RAS-Fingerprinting was determined with LC-MS/MS quantification of angiotensin peptides.", {"entities": []}], ["Blood pressure and other variables were determined with known methods.", {"entities": []}], ["The main finding of this study was the significant lower Ang I (<5.0 and 45.1 pg/ml; p = 0.005) and Ang II (15.6 and 123.9 pg/ml; p \u2a7d 0.001) encountered in the hypertensive black African men compared to their white counterparts.", {"entities": [[57, 60, "GENE"], [100, 103, "GENE"], [57, 60, "GENE"], [100, 103, "GENE"]]}], ["Levels of Ang 1-5 (downstream metabolite of Ang 1-7) (1.8 and 3.0 pg/ml), were detected in black and white hypertensive men, respectively.", {"entities": [[10, 13, "GENE"], [44, 47, "GENE"], [10, 13, "GENE"], [44, 47, "GENE"]]}], ["The observed differences between circulating RAS components, which are reflected via equilibrium angiotensin levels, point to a distinctive molecular regulation of the RAAS in the two study cohorts.", {"entities": []}], ["The increased peripheral resistance observed in hypertensive black individuals might take over a dominant role in control of blood pressure in this study population.", {"entities": []}], ["A novel highly sensitive LC-MS/MS method resolved the issue of peptide recovery variations during sample preparation by using internal standards for each individual angiotensin metabolite.", {"entities": []}], ["The impact of influenza on young children can be severe and even fatal.", {"entities": [[14, 23, "DISEASE"]]}], ["Influenza vaccination (IV) has been shown to be effective in reducing complications of influenza among children.", {"entities": [[0, 9, "DISEASE"], [87, 96, "DISEASE"]]}], ["This study investigated the prevalence and factors of IV among children aged 6-23\u00a0months in Hong Kong.", {"entities": []}], ["A sample of 401 Chinese parents of children aged 6-23\u00a0months were interviewed at local Maternal and Child Health Centers.", {"entities": []}], ["Socio-demographic information, variables related to Health Belief Model, including perceptions about the child\u2019s chance of contracting influenza, perceived harm of influenza on children, perceived benefits and side-effects of IV, having received recommendations from health professionals to uptake IV, and IV behaviors of the children were measured.", {"entities": [[135, 144, "DISEASE"], [164, 173, "DISEASE"]]}], ["Multivariate analysis was used to examine factors associated with IV behaviors of children.", {"entities": []}], ["Only 9% of the children had ever been vaccinated.", {"entities": []}], ["Among those parents who had heard of IV (92.0%), substantial proportions perceived that IV could reduce the risk of influenza-induced complications (70.5%), hospitalization (70.5%) and death (65.9%).", {"entities": [[116, 125, "DISEASE"]]}], ["Relatively few of the participants believed that IV had no side effects (17.1%) and even less had been recommended by health care professionals to uptake IV (10.6%).", {"entities": []}], ["Results from multivariate analysis showed that physician recommendations were associated with a higher likelihood for IV among younger children, whilst parental perceptions of the side effects of IV was associated with a lower likelihood for IV.", {"entities": []}], ["The prevalence of IV among children aged 6-23\u00a0months in Hong Kong was very low.", {"entities": []}], ["Promotion of IV with the component of physician recommendations and parents\u2019 knowledge about IV safety for this group is warranted.", {"entities": []}], ["Novel chemical entities (NCEs) may be investigated for emetic liability in a range of unpleasant experiments involving retching, vomiting or conditioned taste aversion/food avoidance in sentient animals.", {"entities": []}], ["We have used a range of compounds with known emetic /aversive properties to examine the possibility of using the social amoeba, Dictyostelium discoideum , for research into identifying and understanding emetic liability, and hence reduce adverse animal experimentation in this area.", {"entities": []}], ["Twenty eight emetic or taste aversive compounds were employed to investigate the acute (10 min) effect of compounds on Dictyostelium cell behaviour (shape, speed and direction of movement) in a shallow chemotaxic gradient (Dunn chamber).", {"entities": []}], ["Compound concentrations were chosen based on those previously reported to be emetic or aversive in in vivo studies and results were recorded and quantified by automated image analysis.", {"entities": []}], ["Dictyostelium cell motility was rapidly and strongly inhibited by four structurally distinct tastants (three bitter tasting compounds - denatonium benzoate, quinine hydrochloride, phenylthiourea, and the pungent constituent of chilli peppers - capsaicin).", {"entities": []}], ["In addition, stomach irritants (copper chloride and copper sulphate), and a phosphodiesterase IV inhibitor also rapidly blocked movement.", {"entities": []}], ["A concentration-dependant relationship was established for five of these compounds, showing potency of inhibition as capsaicin (IC 50 \u200a=\u200a11.9\u00b14.0 \u00b5M) > quinine hydrochloride (IC 50 \u200a=\u200a44.3\u00b16.8 \u00b5M) > denatonium benzoate (IC 50 \u200a=\u200a129\u00b14 \u00b5M) > phenylthiourea (IC 50 \u200a=\u200a366\u00b15 \u00b5M) > copper sulphate (IC 50 \u200a=\u200a1433\u00b13 \u00b5M).", {"entities": []}], ["In contrast, 21 compounds within the cytotoxic and receptor agonist/antagonist classes did not affect cell behaviour.", {"entities": []}], ["Further analysis of bitter and pungent compounds showed that the effect on cell behaviour was reversible and not cytotoxic, suggesting an uncharacterised molecular mechanism of action for these compounds.", {"entities": []}], ["These results therefore demonstrate that Dictyostelium has potential as a non-sentient model in the analysis of the molecular effects of tastants, although it has limited utility in identification of emetic agents in general.", {"entities": []}], ["Cigarette smoking is an important risk factor for pulmonary arterial hypertension (PAH) in chronic obstructive pulmonary disease (COPD).", {"entities": [[69, 81, "DISEASE"], [91, 128, "DISEASE"]]}], ["Chymase has been shown to function in the enzymatic production of angiotensin II (AngII) and the activation of transforming growth factor (TGF)-\u03b21 in the cardiovascular system.", {"entities": []}], ["The aim of this study was to determine the potential role of chymase in cigarette smoke-induced pulmonary artery remodeling and PAH.", {"entities": []}], ["Hamsters were exposed to cigarette smoke; after 4 months, lung morphology and tissue biochemical changes were examined using immunohistochemistry, Western blotting, radioimmunoassay and reverse-transcription polymerase chain reaction.", {"entities": []}], ["Our results show that chronic cigarette smoke exposure significantly induced elevation of right ventricular systolic pressures (RVSP) and medial hypertrophy of pulmonary arterioles in hamsters, concurrent with an increase of chymase activity and synthesis in the lung.", {"entities": []}], ["Elevated Ang II levels and enhanced TGF-\u03b21/Smad signaling activation were also observed in smoke-exposed lungs.", {"entities": [[9, 12, "GENE"]]}], ["Chymase inhibition with chymostatin reduced the cigarette smoke-induced increase in chymase activity and Ang II concentration in the lung, and attenuated the RVSP elevation and the remodeling of pulmonary arterioles.", {"entities": [[105, 108, "GENE"]]}], ["Chymostatin did not affect angiotensin converting enzyme (ACE) activity in hamster lungs.", {"entities": []}], ["These results suggest that chronic cigarette smoke exposure can increase chymase activity and expression in hamster lungs.", {"entities": []}], ["The capability of activated chymase to induce Ang II formation and TGF-\u03b21 signaling may be part of the mechanism for smoking-induced pulmonary vascular remodeling.", {"entities": [[46, 49, "GENE"]]}], ["Thus, our study implies that blockade of chymase might provide benefits to PAH smokers.", {"entities": []}], ["Past evidence has suggested a role of artificial sweeteners in allergic disease; yet, the evidence has been inconsistent and unclear.", {"entities": []}], ["To examine relation of intake of artificially-sweetened beverages during pregnancy with child asthma and allergic rhinitis at 18 months and 7 years.", {"entities": [[105, 122, "DISEASE"], [114, 122, "DISEASE"], [94, 100, "DISEASE"]]}], ["We analyzed data from 60,466 women enrolled during pregnancy in the prospective longitudinal Danish National Birth Cohort between 1996 and 2003.", {"entities": []}], ["At the 25th week of gestation we administered a validated Food Frequency Questionnaire which asked in detail about intake of artificially-sweetened soft drinks.", {"entities": []}], ["At 18 months, we evaluated child asthma using interview data.", {"entities": [[33, 39, "DISEASE"]]}], ["We also assessed asthma and allergic rhinitis through a questionnaire at age 7 and by using national registries.", {"entities": [[28, 45, "DISEASE"], [37, 45, "DISEASE"], [17, 23, "DISEASE"]]}], ["Current asthma was defined as self-reported asthma diagnosis and wheeze in the past 12 months.", {"entities": [[8, 14, "DISEASE"], [44, 50, "DISEASE"]]}], ["We examined the relation between intake of artificially-sweetened soft drinks and child allergic disease outcomes and present here odds ratios with 95% CI comparing daily vs. no intake.", {"entities": []}], ["At 18 months, we found that mothers who consumed more artificially-sweetened non-carbonated soft drinks were 1.23 (95% CI: 1.13, 1.33) times more likely to report a child asthma diagnosis compared to non-consumers.", {"entities": [[171, 177, "DISEASE"]]}], ["Similar results were found for child wheeze.", {"entities": []}], ["Consumers of artificially-sweetened carbonated drinks were more likely to have a child asthma diagnosis in the patient (1.30, 95% CI: 1.01, 1.66) and medication (1.13, 95% CI: 0.98, 1.29) registry, as well as self-reported allergic rhinitis (1.31, 95% CI: 0.98, 1.74) during the first 7 years of follow-up.", {"entities": [[223, 240, "DISEASE"], [232, 240, "DISEASE"], [87, 93, "DISEASE"]]}], ["We found no associations for sugar-sweetened soft drinks.", {"entities": []}], ["Carbonated artificially-sweetened soft drinks were associated with registry-based asthma and self-reported allergic rhinitis, while early childhood outcomes were related to non-carbonated soft drinks.", {"entities": [[107, 124, "DISEASE"], [116, 124, "DISEASE"], [82, 88, "DISEASE"]]}], ["These results suggest that consumption of artificially-sweetened soft drinks during pregnancy may play a role in offspring allergic disease development.", {"entities": []}], ["Emigration has contributed to a shortage of doctors in many sub-Saharan African countries.", {"entities": []}], ["Specialty training is highly valued by doctors and a potential tool for retention.", {"entities": []}], ["Yet not all types of training may be valued equally.", {"entities": []}], ["In the first study to examine preferences for postgraduate training in depth, we carried out a discrete choice experiment as part of a cross-sectional survey of all Malawian doctors within seven years of graduation and not yet in specialty training.", {"entities": []}], ["Over August 2012 to March 2013, 148 doctors took part out of 153 eligible in Malawi.", {"entities": []}], ["Despite evidence that specialty training is highly sought after, Malawian junior doctors would not accept all types of training.", {"entities": []}], ["Doctors preferred timely training outside of Malawi in core specialties (internal medicine, general surgery, paediatrics, obstetrics & gynaecology).", {"entities": []}], ["Specialty preferences are particularly strong, with most junior doctors requiring nearly double their monthly salary to accept training all in Malawi and over six-fold to accept training in ophthalmology (representing a bundle of unpopular but priority specialties).", {"entities": []}], ["In contrast, the location of work before training did not significantly influence most doctors' choices when guaranteed specialty training.", {"entities": []}], ["Using a latent class model, we identified four subgroups of junior doctors with distinct preferences.", {"entities": []}], ["Policy simulations showed that these preferences could be leveraged by policymakers to improve retention in exchange for guaranteed specialty training, however incentivising the uptake of training in priority specialties will only be effective in those with more flexible preferences.", {"entities": []}], ["These results indicate that indiscriminate expansion of postgraduate training to slow emigration of doctors from sub-Saharan African countries may not be effective unless doctors' preferences are taken into account.", {"entities": []}], ["\u2022 Specialty training is valued by doctors and could be used to prevent emigration.", {"entities": []}], ["\u2022 Not all training, however, may be valued equally.", {"entities": []}], ["\u2022 Junior doctors preferred timely training outside Malawi in popular specialties.", {"entities": []}], ["\u2022 Latent class modelling identified four groups with distinct training preferences.", {"entities": []}], ["\u2022 Policy simulations show that these could be leveraged to improve retention.", {"entities": []}], ["Specialty training is valued by doctors and could be used to prevent emigration.", {"entities": []}], ["Not all training, however, may be valued equally.", {"entities": []}], ["Junior doctors preferred timely training outside Malawi in popular specialties.", {"entities": []}], ["Latent class modelling identified four groups with distinct training preferences.", {"entities": []}], ["Policy simulations show that these could be leveraged to improve retention.", {"entities": []}], ["Hemorrhoids is one of the most common gastrointestinal diseases.", {"entities": []}], ["There are several therapeutic options associated with some complications.", {"entities": []}], ["Therefore, researchers look for traditional medicines as a potential resource for introduction of new natural drugs.", {"entities": []}], ["The current study reports an evidence-based review of herbal remedies for hemorrhoids in traditional Persian medicine.", {"entities": []}], ["A comprehensive survey about hemorrhoids on the most important manuscripts of traditional Persian medicine was done.", {"entities": []}], ["Then, scientific data banks were searched for possible related properties of each herb in the conventional medicine.", {"entities": []}], ["We reported some historical aspects of traditional Persian medicine view on classification, examination, and predisposing factors of hemorrhoids.", {"entities": []}], ["In addition, we have reported 105 medicinal plants belonging to 51 families.", {"entities": []}], ["More than half of the reported herbs exhibited anti-inflammatory and analgesic effects.", {"entities": []}], ["Although lack of human studies regarding the mentioned herbs is noted, positive results from experimental findings can be considered for new drug discovery supported by traditional and medieval experiences.", {"entities": []}], ["Interleukin 17 (IL-17) is a pleiotropic cytokine that acts on both immune and non-immune cells and is generally implicated in inflammatory and autoimmune diseases.", {"entities": []}], ["Although IL-17 as well as their source, mainly but not limited to Th17 cells, is also abundant in the inflamed intestine, the role of IL-17 in inflammatory bowel disease remains controversial.", {"entities": [[143, 169, "DISEASE"]]}], ["In the present study, by using IL-17 knockout (KO) mice, we investigated the role of IL-17 in colitis, with special focus on the macrophage subpopulations.", {"entities": []}], ["Here we show that IL-17KO mice had increased susceptibility to DSS-induced colitis which was associated with decrease in expression of mRNAs implicated in M2 and/or wound healing macrophages, such as IL-10, IL-1 receptor antagonist, arginase 1, cyclooxygenase 2, and indoleamine 2,3-dioxygenase.", {"entities": []}], ["Lamina propria leukocytes from inflamed colon of IL-17KO mice contained fewer CD11b", {"entities": []}], ["Using an in vitro cytotoxicity assay based on the release of 51Cr from cultured porcine thoracic aortic and pulmonary arterial endothelial cells, we have demonstrated that cotton bracts tannin is a potent endothelial cell cytotoxin.", {"entities": []}], ["It produces dose-dependent lethal injury to both types of endothelial cells with the aortic cells being somewhat more sensitive to tannin-mediated injury than the pulmonary arterial cells.", {"entities": []}], ["Cytotoxic injury to the cells was biphasic.", {"entities": []}], ["During the first 3 hr of exposure to tannin, no lethal injury was detected.", {"entities": [[19, 21, "GENE"]]}], ["However, during this period, profound changes in morphology were observed suggesting sublethal injury to the cells preceded the ultimate toxic damage.", {"entities": []}], ["Comparison of the cytotoxicity dose curves for aqueous bracts extracts with those for tannin demonstrated that tannin was the major cytotoxin present in bracts.", {"entities": []}], ["There has been a marked increase in the use of complementary and alternative medicine (CAM) in recent years worldwide.", {"entities": []}], ["In Germany, apart from 'Heilpraktiker' (= state-licensed, non-medical CAM practitioners), some general practitioners (GPs) provide CAM in their practices.", {"entities": []}], ["This paper aims to explore the attitudes of GPs about the role of CAM in Germany, in relation to the healthcare system, quality of care, medical education and research.", {"entities": []}], ["Furthermore, experiences of GPs integrating CAM in their daily practice were explored.", {"entities": []}], ["Using a qualitative methodological approach 3 focus groups with a convenience sample of 17 GPs were conducted.", {"entities": []}], ["The discussions were transcribed verbatim and analysed using qualitative content analysis.", {"entities": []}], ["The majority of the participating GPs had integrated one or more CAM therapies into their every-day practice.", {"entities": []}], ["Four key themes were identified based on the topics covered in the focus groups: the role of CAM within the German healthcare system, quality of care, education and research.", {"entities": []}], ["Within the theme 'role of CAM within the healthcare system' there were five categories: integration of CAM, CAM in the Statutory Health Insurance, modernisation of the Statutory Health Insurance Act, individual healthcare services and 'Heilpraktiker'.", {"entities": []}], ["Regarding quality of care there were two broad groups of GPs: those who thought patients would benefit from standardizing CAM and those who feared that quality control would interfere with the individual approach of CAM.", {"entities": []}], ["The main issues identified relating to research and education were the need for the development of alternative research strategies and the low quality of existing CAM education respectively.", {"entities": []}], ["The majority of the participating GPs considered CAM as a reasonable complementary approach within primary care.", {"entities": []}], ["The study increased our understanding of GPs attitudes about the role of CAM within the German healthcare system and the use of 'Heilpraktiker' as a competing CAM-provider.", {"entities": []}], ["It seems to be a need for increased funding for research, better education and remuneration by the Statutory Health Insurance in order to improve access to 'Integrative medicine' in Germany.", {"entities": []}], ["Humidity is one of the main environmental factors affecting the emission rate and key parameters of formaldehyde and volatile organic compounds (VOCs) from building materials.", {"entities": []}], ["Meanwhile, the initial emittable concentration ( C m,0 ) is proved to be the most sensitive key parameter to the emission behaviours.", {"entities": []}], ["However, there is no report on the relationship between humidity and C m,0 .", {"entities": []}], ["In this paper, C m,0 of formaldehyde and hexaldehyde from a type of medium density fiberboard in absolute humidity (AH) range of 4.6\u201319.6\u2009g/m C m,0 is dramatically dependent on AH, increased by 10 and 2 times for formaldehyde and hexaldehyde when AH rising from 4.6\u2009g/m C m,0 and AH is obtained based on the measured results.", {"entities": []}], ["In addition, a correlation characterizing the association of emission rate and AH is derived.", {"entities": []}], ["The effectiveness of the correlation is verified with our experimental results as well as data from literature.", {"entities": []}], ["With the correlations, the C m,0 or emission rate different from the test AH conditions can be conveniently obtained.", {"entities": []}], ["This study should be useful for predicting the emission characteristics of humidity changing scenarios and for source control.", {"entities": []}], ["To investigate the association of frailty syndrome with socioeconomic and health variables among older adults.", {"entities": [[42, 50, "DISEASE"]]}], ["This is a cross-sectional, observational and analytical household research conducted with a sample of 1,609 urban elderly.", {"entities": []}], ["We used: semi-structured questionnaire, scales (Katz, Lawton and shortened version of Geriatric Depression Scale) and Fragility Phenotype proposed by Fried.", {"entities": []}], ["Descriptive analysis was performed along with a bivariate and multinomial logistic regression model ( p <0.05).", {"entities": []}], ["The prevalence of pre-frailty condition was 52.0% and the fragility corresponded to 13.6%.", {"entities": []}], ["Pre-frailty and frailty associated factors were, respectively: age range between 70-79 years and \u226580 years; one to four morbidities and five or more morbidities categories; functional disability for basic and instrumental activities of daily life and depression indicative; whilst lack of a companion or income and female gender were only associated to pre-frailty.", {"entities": []}], ["The conditions of pre-frailty and frailty levels were elevated with negative effects on the health of the elderly.", {"entities": []}], ["Matrix metalloproteinase-9 (MMP-9) is a 92 kDa zinc-dependant endopeptidase that degrades components of the extracellular matrix.", {"entities": []}], ["Increased expression of MMP-9 is implicated in many pathological conditions including metastatic cancer, multiple sclerosis, and atherosclerosis.", {"entities": [[129, 144, "DISEASE"], [105, 123, "DISEASE"], [97, 103, "DISEASE"]]}], ["Although it has been widely noted that interferon-\u03b2 (IFN\u03b2) downregulates both the basal and phorbol 12-myristate 13-acetate (PMA)-induced MMP-9 expression at the transcriptional level, the molecular mechanism of this repression is poorly understood.", {"entities": []}], ["In the present study we identify a novel mechanism for repression of MMP-9 transcription by IFN\u03b2 in HT1080 fibrosarcoma cells.", {"entities": [[107, 119, "DISEASE"]]}], ["Using reporter assays with promoter deletion constructs we show that IFN\u03b2\u2019s inhibitory effects require a region of the promoter between \u2212154 and \u221272, which contains an AP-1 binding site.", {"entities": []}], ["Chromatin immunoprecipitation (ChIP) studies indicate that IFN\u03b2 increases histone deacetylase (HDAC)-1 recruitment to the MMP-9 promoter and reduces histone H3 acetylation, in addition to reduced NF-\u03baB recruitment.", {"entities": []}], ["ChIP analysis shows that IFN\u03b2 induced HDAC1 recruitment to the MMP-9 promoter and IFN\u03b2 mediated transcriptional repression is lost when the AP-1 binding site is inactivated by a point mutation.", {"entities": [[38, 43, "GENE"]]}], ["Altogether, our results establish that the repression of MMP-9 transcription in response to IFN\u03b2 occurs by the recruitment of HDAC1 via the proximal AP-1 binding site.", {"entities": [[126, 131, "GENE"]]}], ["The pro-inflammatory mediator leukotriene B 4 (LTB 4 ) is implicated in the pathologies of an array of diseases and thus represents an attractive therapeutic target.", {"entities": [[47, 50, "GENE"]]}], ["The enzyme leukotriene A 4 hydrolase (LTA 4 H) catalyses the distal step in LTB 4 synthesis and hence inhibitors of this enzyme have been actively pursued.", {"entities": [[38, 41, "GENE"], [76, 79, "GENE"]]}], ["Despite potent LTA 4 H inhibitors entering clinical trials all have failed to show efficacy.", {"entities": [[15, 18, "GENE"]]}], ["We recently identified a secondary anti-inflammatory role for LTA 4 H in degrading the neutrophil chemoattractant Pro-Gly-Pro (PGP) and rationalized that the failure of conventional LTA 4 H inhibitors may be that they inadvertently prevented PGP degradation.", {"entities": [[62, 65, "GENE"], [182, 185, "GENE"], [127, 130, "GENE"], [242, 245, "GENE"], [62, 65, "GENE"], [182, 185, "GENE"], [127, 130, "GENE"], [242, 245, "GENE"]]}], ["We demonstrate that these inhibitors do indeed fail to discriminate between the dual activities of LTA 4 H, and enable PGP accumulation in mice.", {"entities": [[99, 102, "GENE"], [119, 122, "GENE"]]}], ["Accordingly, we have developed novel compounds that potently inhibit LTB 4 generation whilst leaving PGP degradation unperturbed.", {"entities": [[69, 72, "GENE"], [101, 104, "GENE"]]}], ["These novel compounds could represent a safer and superior class of LTA 4 H inhibitors for translation into the clinic.", {"entities": [[68, 71, "GENE"]]}], ["One of the main pharmacological problems today in the treatment of chronic inflammation diseases consists of the fact that anti-inflammatory drugs usually exhibit side effects.", {"entities": []}], ["The natural products offer a great hope in the identification of bioactive lead compounds and their development into drugs for treating inflammatory diseases.", {"entities": []}], ["Computer-aided drug design has proved to be a very useful tool for discovering new drugs and, specifically, Molecular Topology has become a good technique for such a goal.", {"entities": []}], ["A topological-mathematical model, obtained by linear discriminant analysis, has been developed for the search of new anti-inflammatory natural compounds.", {"entities": []}], ["An external validation obtained with the remaining compounds (those not used in building up the model), has been carried out.", {"entities": []}], ["Finally, a virtual screening on natural products was performed and 74 compounds showed actual anti-inflammatory activity.", {"entities": []}], ["From them, 54 had been previously described as anti-inflammatory in the literature.", {"entities": []}], ["This can be seen as a plus in the model validation and as a reinforcement of the role of Molecular Topology as an efficient tool for the discovery of new anti-inflammatory natural compounds.", {"entities": []}], ["Hypertension is as prevalent in many developing countries, as in the developed world and is the leading cause of cardiovascular morbidity and mortality in Africa.", {"entities": [[0, 12, "DISEASE"]]}], ["The control of hypertension in this resource limited setting is inadequate, a situation that translates into poorer outcomes in form of increasing incidences of stroke, heart failure, kidney failure and therefore early cardiovascular death.", {"entities": [[15, 27, "DISEASE"], [184, 198, "DISEASE"]]}], ["This was a chart review of all the patients seen during the months of September 2012 to February 2013.", {"entities": []}], ["We determined the level of blood pressure control, basic investigations documented as well as the choice of hypertensive treatment among patients attending a hypertension clinic in a national referral hospital, Mulago.", {"entities": [[158, 170, "DISEASE"]]}], ["Of the 741 patients whose charts were reviewed the median age was 60\u00a0years, Inter quartile range (IQR) was 51\u201371.", {"entities": []}], ["Six hundred forty-two (86.6%) were females.", {"entities": []}], ["Blood pressure (BP) control defined as BP lowering to at least 140/90 was seen in only 198 (26.7%) patients.", {"entities": []}], ["Biophysical measurement documentation was very low especially for waist and hip circumference at 0.3%.", {"entities": []}], ["Majority of patients, 476 (64.2%) had at least one documented investigation for the complications of hypertension.", {"entities": [[101, 113, "DISEASE"]]}], ["Only 103 (13.9%) had all investigations documented in their charts.", {"entities": []}], ["The investigations included; complete blood count (CBC), urinalysis, renal function tests (RFTs), Chest X-Ray (CXR), echocardiography (Echo) and electrocardiography (ECG).", {"entities": []}], ["The commonly documented investigations were RFTs (45.5%), ECG (45.2%) and Echo (44.2%).", {"entities": []}], ["The commonly prescribed anti hypertensive medications were; Angiotensin receptor blockers (ARBs)/Angiotensin converting enzyme inhibitors (ACEI) (72.74%), calcium channel blockers (72.3%) and thiazide diuretics (68.6%).", {"entities": []}], ["Majority of patients were receiving three anti hypertensive medications 313 (42.2%), with 149 (43.6%) of these, on an ACEI/ARB, a calcium channel blocker and a thiazide diuretic.", {"entities": []}], ["Blood pressure control is suboptimal in a tertiary clinic setting at Mulago hospital and documentation of investigations is inadequate.", {"entities": []}], ["ARB/ACEI, Calcium channel blockers and thiazide diuretics were the commonly prescribed anti hypertensive medications.", {"entities": []}], ["There is a great need to investigate for renal and cardiac complications as well as exploring reasons for inadequate blood pressure control and consider appropriate interventions to avert bad outcomes.", {"entities": []}], ["Group 2 innate lymphoid cells (ILC2s) are regarded as a novel population of lineage-negative cells that induce innate Type 2 responses by producing the critical Th2-type cytokines interleukin (IL)-5 and IL-13.", {"entities": []}], ["ILC2s as key players in the development of allergic rhinitis (AR) have been proved, however, the effect of subcutaneous immunotherapy (SCIT) with dermatophagoides pteronyssinus extract (Der p-SCIT) on ILC2s in AR patients is not clear.", {"entities": [[43, 60, "DISEASE"], [52, 60, "DISEASE"]]}], ["This study aimed to investigate the response of ILC2s of peripheral blood in house dust mites (HDM)-sensitized Chinese patients with AR who received SCIT with Der P extract.", {"entities": []}], ["Seven healthy controls without symptoms of AR who had negative reactions to any of the allergens from skin-prick testing, nine patients diagnosed with persistent AR according to the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines, and 24 AR patients who received Der p-SCIT for 1.0\u20133.5 years were recruited for the study.", {"entities": [[182, 199, "DISEASE"], [191, 199, "DISEASE"]]}], ["ILC2s in the peripheral blood were evaluated using flow cytometry.", {"entities": []}], ["The severity of their symptoms of all participants was rated based on the Total 5 symptom score.", {"entities": []}], ["Among 40 participants, 9 AR patients were assigned to the untreated group, 24 AR patients receiving Der p-SCIT were assigned to the immunotherapy group, and 7 healthy controls without symptoms of AR were assigned to healthy control group.", {"entities": []}], ["The mean Total 5 symptom score of immunotherapy group was significantly lower than that of untreated group (4.3 \u00b1 1.4 vs. 10.1 \u00b1 2.5, P < 0.001).", {"entities": []}], ["Similarly, the levels of ILC2s in the peripheral blood of immunotherapy group were significantly reduced compared with that in untreated group ( P < 0.001), but were not significantly different from healthy controls ( P = 0.775).", {"entities": []}], ["Further subgroup analysis based on the duration of SCIT therapy (1.0\u20132.0 years [SCIT 1-2 ], 2.0\u20133.0 years [SCIT 2-3 ], and 3.0\u20133.5 years [SCIT 3-3.5 ]) showed that the percentage of ILC2s was not significantly different between SCIT 1-2 , SCIT 2-3 , and SCIT 3-3.5 groups (SCIT 1-2 vs. SCIT 2-3 : P = 0.268; SCIT 1-2 vs. SCIT 3-3.5 : P = 0.635; and SCIT 2-3 vs. SCIT 3-3.5 : P = 0.787).", {"entities": []}], ["The present study highlighted the suppression of Der p-SCIT on ILC2s in HDM-AR patients.", {"entities": []}], ["ILC2s identified in peripheral blood can be used as an effective biomarker for Der p-SCIT.", {"entities": []}], ["To investigate the proposed synergistic teratogenic effect of use of selective serotonin receptor inhibitors (SSRI) together with sedatives or hypnotics, primarily benzodiazepines, during pregnancy.", {"entities": []}], ["Cohort study of congenital malformations after maternal use of SSRI, sedatives/hypnotics or the combination of the two drug categories.", {"entities": []}], ["Swedish national health registers.", {"entities": []}], ["A total of 10\u2005511 infants born of women who had used SSRI drugs but no other central nervous system (CNS)-active drug, 1000 infants born of women who had used benzodiazepines and no other CNS-active drug, and 406 infants whose mothers had used both SSRI and benzodiazepines but no other CNS-active drug.", {"entities": []}], ["None of the three groups showed a higher risk for any relatively severe congenital malformation or any cardiac defect when comparison was made with the general population risk (adjusted risk ratio (RR) for the combination of SSRI and benzodiazepines and a relatively severe malformation=1.17 (95% CI 0.70 to 1.73).", {"entities": []}], ["Similar results were obtained for the combination of SSRI with other sedative/hypnotic drugs.", {"entities": []}], ["The previously stated increased risk associated with the combined use of these drug categories, notably for a cardiac defect, could not be replicated.", {"entities": []}], ["The health effects of economic resources (eg, education, employment, and living place) and psychological assets (eg, self-efficacy, perceived control over life, anger control, and emotions) are well-known.", {"entities": []}], ["This article summarizes the results of a growing body of evidence documenting Blacks\u2019 diminished return, defined as a systematically smaller health gain from economic resources and psychological assets for Blacks in comparison to Whites.", {"entities": []}], ["Due to structural barriers that Blacks face in their daily lives, the very same resources and assets generate smaller health gain for Blacks compared to Whites.", {"entities": []}], ["Even in the presence of equal access to resources and assets, such unequal health gain constantly generates a racial health gap between Blacks and Whites in the United States.", {"entities": []}], ["In this paper, a number of public policies are recommended based on these findings.", {"entities": []}], ["First and foremost, public policies should not merely focus on equalizing access to resources and assets, but also reduce the societal and structural barriers that hinder Blacks.", {"entities": []}], ["Policy solutions should aim to reduce various manifestations of structural racism including but not limited to differential pay, residential segregation, lower quality of education, and crime in Black and urban communities.", {"entities": []}], ["As income was not found to follow the same pattern demonstrated for other resources and assets (ie, income generated similar decline in risk of mortality for Whites and Blacks), policies that enforce equal income and increase minimum wage for marginalized populations are essential.", {"entities": []}], ["Improving quality of education of youth and employability of young adults will enable Blacks to compete for high paying jobs.", {"entities": []}], ["Policies that reduce racism and discrimination in the labor market are also needed.", {"entities": []}], ["Without such policies, it will be very difficult, if not impossible, to eliminate the sustained racial health gap in the United States.", {"entities": []}], ["To evaluate the effectiveness and safety of accelerated corneal collagen cross-linking (ACXL) in patients below 14 years of age with progressive keratoconus.", {"entities": [[145, 156, "DISEASE"]]}], ["Materials and Methods .", {"entities": []}], ["Thirty eyes of 18 patients with established progressive keratoconus underwent preoperative and postoperative visual acuity assessment, topography, and specular microscopy prior to ACXL and were followed up for 24 months.", {"entities": [[56, 67, "DISEASE"]]}], ["Mean age of the patients was 12.7 years with ten males and eight females.", {"entities": []}], ["There was an improvement in the mean postoperative uncorrected distant visual acuity (from 0.76 \u00b1 0.26 to 0.61 \u00b1 0.25; P = 0.005), mean corrected distant visual acuity (from 0.24 \u00b1 0.19 to 0.12 \u00b1 0.12; P < 0.001), mean spherical refraction (from \u22123.04\u2009DS \u00b1 3.60 to \u22122.38\u2009DS \u00b1 3.37; P = 0.28), mean cylinder (from \u22123.63\u2009DC \u00b1 1.82 to \u22122.80\u2009DC \u00b1 1.48; P = 0.008), and spherical equivalent (from \u22124.70\u2009D \u00b1 3.86 to \u22123.75\u2009D \u00b1 3.49; P = 0.15).", {"entities": []}], ["Three eyes of two patients with vernal keratoconjunctivitis (VKC) showed progression.", {"entities": [[39, 59, "DISEASE"]]}], ["There were no intra- or postoperative complications.", {"entities": []}], ["Conclusion.", {"entities": []}], ["In pediatric patients ACXL is an effective and safe procedure for the management of keratoconus.", {"entities": [[84, 95, "DISEASE"]]}], ["Optimal management of VKC is important to arrest the progression of keratoconus.", {"entities": [[68, 79, "DISEASE"]]}], ["There are increasing numbers of randomised trials and systematic reviews examining the efficacy of interventions designed to bring about a change in clinical practice.", {"entities": []}], ["The findings of this research are being used to guide strategies to increase the uptake of evidence into clinical practice.", {"entities": []}], ["Knowledge of the outcomes measured by these trials is vital not only for the interpretation and application of the work done to date, but also to inform future research in this expanding area of endeavour and to assist in collation of results in systematic reviews and meta-analyses.", {"entities": []}], ["The objective of this review was to identify methods used to measure change in the clinical practices of health professionals following an intervention aimed at increasing the uptake of evidence into practice.", {"entities": []}], ["All published trials included in a recent, comprehensive Health Technology Assessment of interventions to implement clinical practice guidelines and change clinical practice (n = 228) formed the sample for this study.", {"entities": []}], ["Using a standardised data extraction form, one reviewer (SH), extracted the relevant information from the methods and/or results sections of the trials.", {"entities": []}], ["Measures of a change of health practitioner behaviour were the most common, with 88.8% of trials using these as outcome measures.", {"entities": []}], ["Measures that assessed change at a patient level, either actual measures of change or surrogate measures of change, were used in 28.8% and 36.7% of studies (respectively).", {"entities": []}], ["Health practitioners' knowledge and attitudes were assessed in 22.8% of the studies and changes at an organisational level were assessed in 17.6%.", {"entities": []}], ["Most trials of interventions aimed at changing clinical practice measured the effect of the intervention at the level of the practitioner, i.e.", {"entities": []}], ["did the practitioner change what they do, or has their knowledge of and/or attitude toward that practice changed?", {"entities": []}], ["Less than one-third of the trials measured, whether or not any change in practice, resulted in a change in the ultimate end-point of patient health status.", {"entities": []}], ["Vascular disease, manifesting as myocardial infarction and stroke, is a major cause of morbidity and mortality, especially in low- and middle-income countries.", {"entities": [[33, 54, "DISEASE"], [0, 16, "DISEASE"]]}], ["Current estimates are that only one in six patients have good adherence to medications and very few have sufficient health literacy.", {"entities": []}], ["Our aim is to explore the effectiveness and acceptability of Prescription Interactive Voice Response (IVR) Talking Prescriptions (Talking Rx) and SMS reminders in increasing medication adherence and health literacy in Pakistani patients with vascular disease.", {"entities": [[242, 258, "DISEASE"], [146, 149, "GENE"]]}], ["This is a randomized, controlled, single center trial.", {"entities": []}], ["Adult participants, with access to a cell phone and a history of vascular disease, taking multiple risk-modifying medications (inclusive of anti-platelets and statins) will be selected from cerebrovascular and cardiovascular clinics.", {"entities": [[65, 81, "DISEASE"]]}], ["They will be randomized in a 1:1 ratio via a block design to the intervention or the control arm with both groups having access to a helpline number to address their queries in addition to standard of care as per institutional guidelines.", {"entities": []}], ["Participants in the intervention group will also have access to Interactive Voice Response (IVR) technology tailored to their respective prescriptions in the native language (Urdu) and will have the ability to hear information about their medication dosage, correct use, side effects, mechanism of action and how and why they should use their medication, as many times as they like.", {"entities": []}], ["Participants in the intervention arm will also receive scheduled SMS messages reminding them to take their medications.", {"entities": [[65, 68, "GENE"]]}], ["The primary outcome measure will be the comparison of the difference in adherence to anti-platelet and statin medication between baseline and at 3-month follow-up in each group measured by the Morisky Medication Adherence Scale.", {"entities": []}], ["To ascertain the impact of our intervention on health literacy, we will also compare a local content-validated and modified version of Test of Health Literacy in Adults (TOFHLA) between the intervention and the control arm.", {"entities": []}], ["We estimate that a sample size of 86 participants in each arm will be able to detect a difference of 1 point on the MMAS with a power of 90\u00a0% and significance level of 5\u00a0%.", {"entities": []}], ["Accounting for an attrition rate of 15\u00a0%, we plan to enroll 100 participants in each arm (total study population\u2009=\u2009200).", {"entities": []}], ["We hypothesize that a linguistically tailored health IT intervention based on IVR and SMS will be associated with an improvement in adherence (to anti-platelet and lipid-lowering medications) and an improvement in health literacy in Pakistani patients with vascular disease.", {"entities": [[257, 273, "DISEASE"], [86, 89, "GENE"]]}], ["This innovative study will provide early data for the feasibility of the use of IT based prescriptions in an lower middle incorme country setting with limited numeracy and literacy skills.", {"entities": []}], ["Clinical Trials.gov: NCT02354040 \u2212 2 February 2015 The online version of this article (doi:10.1186/s13063-016-1244-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cases of macrolide-resistant Mycoplasma pneumoniae have increased rapidly since 2000, especially in Asia.", {"entities": []}], ["Patients infected with macrolide-resistant M pneumoniae usually present with severe M pneumoniae pneumonia.", {"entities": [[97, 106, "DISEASE"]]}], ["The aim of this study was to identify indicators for whether children at an early stage of M pneumoniae infection develop mild or severe pneumonia.", {"entities": [[137, 146, "DISEASE"]]}], ["Herein, we retrospectively reviewed 2 pediatric cases caused by macrolide-resistant M pneumoniae , but with markedly different severity of pneumonia.", {"entities": [[139, 148, "DISEASE"]]}], ["First, we compared the clinical courses of the patients, then isolated the pathogens and tested their response to macrolides, then finally, carried out whole genome sequencing of these isolates.", {"entities": []}], ["Despite the difference in clinical presentation of the infection, both isolates exhibited a high level of resistance to macrolide antibiotics.", {"entities": []}], ["Analysis of clinical data showed that the erythrocyte sedimentation rate in blood samples of the patients in the early stages of disease varied greatly.", {"entities": []}], ["Genome sequence analysis revealed single nucleotide polymorphisms mainly focused on adhesin P1, which is involved in the pathogenicity of M pneumoniae .", {"entities": []}], ["The differences of erythrocyte sedimentation rate in the early stage of M pneumoniae pneumonia and mutations in P1 protein may help us to distinguish between severe or mild disease after infection with macrolide-resistant M pneumoniae .", {"entities": [[85, 94, "DISEASE"]]}], ["These findings could lead to the development of screening assays that will allow us to distinguish severe or mild M pneumoniae pneumonia early.", {"entities": [[127, 136, "DISEASE"]]}], ["Antigen transport from the airway mucosa to the thoracic lymph nodes (TLNs) was studied in vivo by intratracheal instillation of fluorescein isothiocyanate (FITC)-conjugated macromolecules.", {"entities": []}], ["After instillation, FITC", {"entities": []}], ["Increased respiratory rate (tachypnea) is frequently observed as a clinical sign of influenza pneumonia in pediatric patients admitted to the hospital.", {"entities": [[84, 93, "DISEASE"], [94, 103, "DISEASE"]]}], ["We previously demonstrated that influenza infection of adult cotton rats ( Sigmodon hispidus ) also results in tachypnea and wanted to establish whether this clinical sign was observed in infected infant cotton rats.", {"entities": [[32, 41, "DISEASE"]]}], ["We hypothesized that age-dependent differences in lung mechanics result in differences in ventilatory characteristics following influenza infection.", {"entities": [[128, 137, "DISEASE"]]}], ["Lung tidal volume, dynamic elastance, resistance, and pleural pressure were measured in a resistance and compliance system on mechanically-ventilated anesthestized young (14\u201328 day old) and adult (6\u201312 week old) cotton rats.", {"entities": []}], ["Animals at the same age were infected with influenza virus, and breathing rates and other respiratory measurements were recorded using a whole body flow plethysmograph.", {"entities": [[43, 52, "DISEASE"]]}], ["Adult cotton rats had significantly greater tidal volume (TV), and lower resistance and elastance than young animals.", {"entities": []}], ["To evaluate the impact of this increased lung capacity and stiffening on respiratory disease, young and adult animals were infected intra-nasally with influenza A/Wuhan/359/95.", {"entities": [[151, 160, "DISEASE"]]}], ["Both age groups had increased respiratory rate and enhanced pause ( Penh ) during infection, suggesting lower airway obstruction.", {"entities": []}], ["However, in spite of significant tachypnea, the infant (unlike the adult) cotton rats maintained the same tidal volume, resulting in an increased minute volume.", {"entities": []}], ["In addition, the parameters that contribute to Penh were different: while relaxation time between breaths and time of expiration was decreased in both age groups, a disproportionate increase in peak inspiratory and expiratory flow contributed to the increase in Penh in infant animals.", {"entities": []}], ["While respiratory rate is increased in both adult and infant influenza-infected cotton rats, the volume of air exchanged per minute (minute volume) is increased in the infant animals only.", {"entities": [[61, 70, "DISEASE"]]}], ["This is likely to be a consequence of greater lung elastance in the very young animals.", {"entities": []}], ["This model replicates many respiratory features of humans and consequently may be a useful tool to investigate new strategies to treat respiratory disease in influenza-infected infants.", {"entities": [[158, 167, "DISEASE"]]}], ["Phospholipase A2 (sPLA2), pivotal for allergic and inflammatory response, hydrolyses phosphatidylcholine (PC) to lysophosphatidylcholine (LPC).", {"entities": [[106, 108, "GENE"]]}], ["In present study, the role of LPC in allergic airway disease manifestation was studied using mouse model.", {"entities": []}], ["Balb/c mice were immunized using cockroach extract (CE) and LPC release was blocked by sPLA2 inhibitor.", {"entities": []}], ["Airway hyperresponse (AHR), lung-histology, total and differential leukocyte count (TLC&DLC), Th2 type cytokines, sPLA2 activity and LPC levels in bronchoalveolar lavage fluid (BALF) were measured.", {"entities": [[22, 25, "GENE"]]}], ["Exogenous LPC was given to the mice with or without CE sensitization, to demonstrate its role in allergic airway disease manifestation.", {"entities": []}], ["Anti-CD1d antibody was given to study the involvement of natural killer T (NKT) cells in LPC induced response.", {"entities": []}], ["AHR, lung-inflammation, TLC, DLC, Th2 type cytokines, sPLA2 activity and LPC levels were increased on CE challenge.", {"entities": [[0, 3, "GENE"]]}], ["sPLA2 activity and LPC release was blocked by sPLA2-inhibitor, which decreased AHR, and inflammatory parameters.", {"entities": [[79, 82, "GENE"]]}], ["Exogenous LPC with or without CE sensitization increased above parameters.", {"entities": []}], ["CE challenge or LPC exposure increased LY49C via CD1d-restricted LY49C", {"entities": []}], ["Patients who have common variable immunodeficiency (CVID) and granulomatous/lymphocytic interstitial lung disease (GLILD) are at high risk for early mortality and B cell lymphomas.", {"entities": [[18, 50, "DISEASE"], [88, 113, "DISEASE"], [101, 113, "DISEASE"]]}], ["Infection with human herpes virus type 8 (HHV8), a B cell lymphotrophic virus, is linked to lymphoproliferative disorders in people who have secondary immunodeficiencies.", {"entities": []}], ["Therefore, we determined the prevalence of HHV8 infection in CVID patients with GLILD.", {"entities": []}], ["Genomic DNA isolated from peripheral blood mononuclear cells was screened by nested- and real time-quantitative PCR (QRT-PCR) for the presence of HHV8 genome.", {"entities": []}], ["It was positive in 6/9 CVID patients with GLILD (CVID-GLILD), 1/21 CVID patients without GLILD (CVID-control), and no patients receiving intravenous gamma globulin ( n = 13) or normal blood donors ( n = 20).", {"entities": []}], ["Immunohistochemistry (IHC) demonstrated expression of the latency-associated nuclear antigen-1 (LANA-1) in the biopsies of the lung, liver, and bone marrow of four patients with CVID-GLILD.", {"entities": []}], ["One CVID-GLILD patient developed a B cell lymphoma during the course of the study.", {"entities": [[42, 50, "DISEASE"]]}], ["QRT-PCR demonstrated high copy number of HHV8 genome and IHC showed diffuse staining for LANA-1 in the malignant lymph node.", {"entities": []}], ["HHV8 infection may be an important factor in the pathogenesis of the interstitial lung disease and lymphoproliferative disorders in patients with CVID.", {"entities": [[69, 94, "DISEASE"], [82, 94, "DISEASE"]]}], ["It is important to understand the risk factors for fetal and neonatal mortality which is a major contributor to high under five deaths globally.", {"entities": []}], ["Fetal and neonatal mortality is a sensitive indicator of maternal health in society.", {"entities": []}], ["This study aimed to examine the risk factors for fetal and early neonatal mortality at the Moi Teaching and Referral Hospital in Kenya.", {"entities": []}], ["This was a case-control study.", {"entities": []}], ["Cases were fetal and early neonatal deaths (n\u2009=\u2009200).", {"entities": []}], ["The controls were infants born alive immediately preceding and following the cases (n\u2009=\u2009400).", {"entities": []}], ["Bivariate comparisons and multiple logistic regression analyses were undertaken.", {"entities": []}], ["The odds of having 0-1 antenatal visits relative to 2-3 visits were higher for cases than controls (Adjusted Odds Ratio (AOR)\u2009=\u20094.5; 95% CI: 1.2-16.7; p\u2009=\u20090.03)).", {"entities": []}], ["There were lower odds among cases of having a doctor rather than a midwife as a birth attendant (AOR\u2009=\u20090.2; 95% CI: 0.1-0.6; p\u2009<\u20090.01).", {"entities": []}], ["The odds of mothers having Premature Rupture of Membranes (AOR\u2009=\u20094.1; 95% CI: 1.4-12.1; p\u2009=\u20090.01), haemorrhage (AOR\u2009=\u20094.8; 95% CI: 1.1-21.9; p\u2009=\u20090.04) and dystocia (AOR\u2009=\u20093.6; 95% CI: 1.2-10.9; p\u2009=\u20090.02) were higher for the cases compared with the controls.", {"entities": []}], ["The odds of gestational age less than 37 weeks (AOR\u2009=\u20097.0; 95% CI 2.4-20.4) and above 42 weeks (AOR\u2009=\u200916.2; 95% CI 2.8-92.3) compared to 37-42 weeks, were higher for cases relative to controls (p\u2009<\u20090.01).", {"entities": []}], ["Cases had higher odds of being born with congenital malformations (AOR\u2009=\u20096.3; 95% CI: 1.2-31.6; p\u2009=\u20090.04) and with Apgar scores of below six at five minutes (AOR\u2009=\u200926.4; 95% CI: 6.1-113.8; p\u2009<\u20090.001).", {"entities": []}], ["Interventions that focus on educating mothers on antenatal attendance, screening, monitoring and management of maternal conditions during the antenatal period should be strengthened.", {"entities": []}], ["Doctor attendance at each birth and for emergency admissions is important to ensure early neonatal survival and avert potential risk factors for mortality.", {"entities": []}], ["Sphingolipids are membrane components and signaling molecules.", {"entities": []}], ["Nutrient-sensitive TORC1 inhibition stimulates the kinase Npr1 to phosphorylate Orm proteins and thereby up-regulate complex sphingolipid synthesis.", {"entities": [[58, 62, "GENE"]]}], ["This appears to be a physiological response to starvation to up-regulate the nutrient-scavenging permease Gap1.", {"entities": []}], ["The evolutionarily conserved Orm1 and Orm2 proteins mediate sphingolipid homeostasis.", {"entities": [[29, 33, "GENE"], [38, 42, "GENE"]]}], ["However, the homologous Orm proteins and the signaling pathways modulating their phosphorylation and function are incompletely characterized.", {"entities": []}], ["Here we demonstrate that inhibition of nutrient-sensitive target of rapamycin complex 1 (TORC1) stimulates Orm phosphorylation and synthesis of complex sphingolipids in Saccharomyces cerevisiae .", {"entities": []}], ["TORC1 inhibition activates the kinase Npr1 that directly phosphorylates and activates the Orm proteins.", {"entities": [[38, 42, "GENE"]]}], ["Npr1-phosphorylated Orm1 and Orm2 stimulate de novo synthesis of complex sphingolipids downstream of serine palmitoyltransferase.", {"entities": [[20, 24, "GENE"], [29, 33, "GENE"]]}], ["Complex sphingolipids in turn stimulate plasma membrane localization and activity of the nutrient scavenging general amino acid permease 1.", {"entities": []}], ["Thus activation of Orm and complex sphingolipid synthesis upon TORC1 inhibition is a physiological response to starvation.", {"entities": []}], ["Little is known about the mechanisms explaining an increased perception of heart symptoms in congenital heart disease (ConHD).", {"entities": [[104, 117, "DISEASE"]]}], ["In the present study, it was suggested that a combination of high trait anxiety and disease history increases the perception of heart symptoms.", {"entities": []}], ["It was tested whether false heart cues will result in an increased perception of heart symptoms in patients with ConHD and anxiety.", {"entities": []}], ["Thirty-six patients with ConHD and 44 healthy controls performed two exercise tasks.", {"entities": []}], ["During one of the exercise tasks, participants were exposed to a false heart cue consisting of false heart rate feedback (regular or irregular).", {"entities": []}], ["Perceived heart symptoms were assessed and heart rate, arterial partial pressure of CO 2 , and respirator rate were monitored continuously.", {"entities": []}], ["In line with the predictions, false heart rate feedback resulted in an increased perception of heart symptoms in high trait anxious patients with ConHD that could not be explained by acute heart dysfunction.", {"entities": []}], ["However, unexpectedly, this effect was not observed immediately after the false heart rate feedback task but after a second exercise task without false feedback.", {"entities": []}], ["The results suggest that not the sole presence of ConHD but ConHD in combination with high trait anxiety results in a vulnerability to overperceive heart symptoms.", {"entities": []}], ["Allergen specific immunotherapy (ASI) is a well-documented treatment for allergic asthma, rhinitis and allergy to bee venoms.", {"entities": [[73, 88, "DISEASE"], [90, 98, "DISEASE"], [82, 88, "DISEASE"]]}], ["Immunotherapy with subcutaneous injections of allergens extracts has proved beneficial in reducing symptoms of allergic rhinitis and asthma.", {"entities": [[111, 128, "DISEASE"], [120, 128, "DISEASE"], [133, 139, "DISEASE"]]}], ["Side effects due to specific immunotherapy in short term have been largely documented.", {"entities": []}], ["These effects were various but were usually mild.", {"entities": []}], ["Fatal reactions are less frequent.", {"entities": []}], ["We reported a case of a woman, with a history of allergic asthma under specific desensitization protocol who developed an acute multi-organ failure (MOF) consecutive to administration of ASI (Alustal", {"entities": [[49, 64, "DISEASE"], [58, 64, "DISEASE"]]}], ["The majority of the genetic variance of systemic lupus erythematosus (SLE) remains unexplained by the common disease-common variant hypothesis.", {"entities": [[49, 68, "DISEASE"], [40, 68, "DISEASE"]]}], ["Rare variants, which are not detectable by genome-wide association studies because of their low frequencies, are predicted to explain part of this \u201dmissing heritability.\u201d However, recent studies identifying rare variants within known disease-susceptibility loci have failed to show genetic associations because of their extremely low frequencies, leading to the questioning of the contribution of rare variants to disease susceptibility.", {"entities": []}], ["A common (minor allele frequency = 17.4% in cases) nonsynonymous coding variant rs1143679 (R77H) in ITGAM (CD11b), which forms half of the heterodimeric integrin receptor, complement receptor 3 (CR3), is robustly associated with SLE and has been shown to impair CR3-mediated phagocytosis.", {"entities": [[100, 105, "GENE"]]}], ["We resequenced ITGAM in 73 SLE cases and identified two previously unidentified, case-specific nonsynonymous variants, F941V and G1145S.", {"entities": [[15, 20, "GENE"]]}], ["Both variants were genotyped in 2,107 and 949 additional SLE cases, respectively, to estimate their frequencies in a disease population.", {"entities": []}], ["An in vitro model was used to assess the impact of F941V and G1145S, together with two nonsynonymous ITGAM polymorphisms, A858V (rs1143683) and M441T (rs11861251), on CR3-mediated phagocytosis.", {"entities": [[101, 106, "GENE"]]}], ["A paired two-tailed t test was used to compare the phagocytic capabilities of each variant with that of wild-type CR3.", {"entities": []}], ["Both rare variants, F941V and G1145S, significantly impair CR3-mediated phagocytosis in an in vitro model (61% reduction, P = 0.006; 26% reduction, P = 0.0232).", {"entities": []}], ["However, neither of the common variants, M441T and A858V, had an effect on phagocytosis.", {"entities": []}], ["Neither rare variant was observed again in the genotyping of additional SLE cases, suggesting that there frequencies are extremely low.", {"entities": []}], ["Our results add further evidence to the functional importance of ITGAM in SLE pathogenesis through impaired phagocytosis.", {"entities": [[65, 70, "GENE"]]}], ["Additionally, this study provides a new example of the identification of rare variants in common-allele-associated loci, which, because of their extremely low frequencies, are not statistically associated.", {"entities": []}], ["However, the demonstration of their functional effects adds support to their contribution to disease risk, and questions the current notion of dismissing the contribution of very rare variants on purely statistical analyses.", {"entities": []}], ["Valuations of depression are useful to evaluate depression interventions offered to patients with chronic somatic conditions.", {"entities": []}], ["The only classification system to describe depression developed specifically for valuation purposes is the McSad, but it has not been used among somatic patients.", {"entities": []}], ["The aim of this study was to test the construct validity of the McSad among diabetes and cancer patients and then to compare the McSad to the commonly used EuroQol \u2013 5 Dimensions (EQ-5D Cross-sectional data were collected online from 114 diabetes and 195 cancer patients; additionally, 241 cancer patients completed part of the survey on paper.", {"entities": [[89, 95, "DISEASE"], [255, 261, "DISEASE"], [290, 296, "DISEASE"]]}], ["Correlational analyses were performed to test the construct validity.", {"entities": []}], ["Specifically, we hypothesized high correlations of the McSad domains with depression (Center for Epidemiological Studies Depression Scale (CES-D) and the Patient Health Questionnaire (PHQ-9)).", {"entities": []}], ["We also expected low/moderate correlations with self-esteem (Rosenberg Self-Esteem scale - RSE) and extraversion (Eysenck Personality Questionnaire Extraversion scale - EPQ-e).", {"entities": []}], ["Multiple linear regression analyses were run so that the proportion of variance in depression scores (CES-D, PHQ-9) explained by the McSad could be compared to the proportion explained by the EQ-5D classification system.", {"entities": []}], ["As expected, among all patients groups, we found moderate to high correlations for the McSad domains with the CES-D (.41 to .70) and the PHQ-9 (.52 to .76); we also found low to moderate correlations with the RSE (-.21 to .-48) and the EPQ-e (.18 to .31).", {"entities": []}], ["Linear regression analyses showed that the McSad explained a greater proportion of variance in depression (CES-D, PHQ-9) (Diabetes: 73%, 82%; Cancer: 72%, 72%) than the EQ-5D classification system (Diabetes: 47%, 59%; Cancer: 51%, 47%).", {"entities": [[142, 148, "DISEASE"], [218, 224, "DISEASE"]]}], ["Findings support the construct validity of the McSad among patients with somatic conditions and demonstrate that it performs better than the EQ-5D classification system to reflect the range of depression states.", {"entities": []}], ["For future valuation purposes, the McSad classification system could therefore be recommended to describe depression as experienced by patients with a chronic medical condition.", {"entities": []}], ["The prevalence of chronic non-communicable diseases (NCDs) is increasing worldwide.", {"entities": []}], ["NCDs are the leading cause of both morbidity and mortality, and it is estimated that by 2030, they will be responsible for 80% of deaths across the world.", {"entities": []}], ["The Genomes for Life (GCAT) project is a long-term prospective cohort study that was designed to integrate and assess the role of epidemiological, genomic and epigenomic factors in the development of major chronic diseases in Catalonia, a north-east region of Spain.", {"entities": [[22, 26, "GENE"]]}], ["At the end of 2017, the GCAT Study will have recruited 20 000 participants aged 40\u201365 years.", {"entities": [[24, 28, "GENE"]]}], ["Participants who agreed to take part in the study completed a self-administered computer-driven questionnaire, and underwent blood pressure, cardiac frequency and anthropometry measurements.", {"entities": []}], ["For each participant, blood plasma, blood serum and white blood cells are collected at baseline.", {"entities": []}], ["The GCAT Study has access to the electronic health records of the Catalan Public Healthcare System.", {"entities": [[4, 8, "GENE"]]}], ["Participants will be followed biannually at least 20 years after recruitment.", {"entities": []}], ["Among all GCAT participants, 59.2% are women and 83.3% of the cohort identified themselves as Caucasian/white.", {"entities": [[10, 14, "GENE"]]}], ["More than half of the participants have higher education levels, 72.2% are current workers and 42.1% are classified as overweight (body mass index \u226525\u2009and <30\u2009kg/m The first follow-up study started in December 2017 and will end by March 2018.", {"entities": []}], ["Residences of all subjects will be geocoded during the following year.", {"entities": []}], ["Several genomic analyses are ongoing, and metabolomic and genomic integrations will be performed to identify underlying genetic variants, as well as environmental factors that influence metabolites.", {"entities": []}], ["The minimal clinically important difference (MCID) defines to what extent change on a health status instrument is clinically relevant, which aids scientists and physicians in measuring therapy effects.", {"entities": []}], ["This is the first study that aimed to establish the MCID of the Clinical chronic obstructive pulmonary disease (COPD) Questionnaire (CCQ), the COPD Assessment Test (CAT) and the St George\u2019s Respiratory Questionnaire (SGRQ) in the same pulmonary rehabilitation population using multiple approaches.", {"entities": [[73, 110, "DISEASE"]]}], ["In total, 451 COPD patients participated in a 3-week Pulmonary Rehabilitation (PR) programme (58 years, 65% male, 43 pack-years, GOLD stage II/III/IV 50/39/11%).", {"entities": []}], ["Techniques used to assess the MCID were anchor-based approaches, including patient-referencing, criterion-referencing and questionnaire-referencing, and the distribution-based methods standard error of measurement (SEM), 1.96SEM and half standard deviation (0.5s.d.).", {"entities": []}], ["Patient- and criterion-referencing led to MCID estimates of 0.56 and 0.62 (CCQ); 3.12 and 2.96 (CAT); and 8.40 and 9.28 (SGRQ).", {"entities": []}], ["Questionnaire-referencing suggested MCID ranges of 0.28\u20130.61 (CCQ), 1.46\u20133.08 (CAT) and 6.86\u20139.47 (SGRQ).", {"entities": []}], ["The SEM, 1.96SEM and 0.5s.d.", {"entities": []}], ["were 0.29, 0.56 and 0.46 (CCQ); 3.28, 6.43 and 2.80 (CAT); 5.20, 10.19 and 6.06 (SGRQ).", {"entities": []}], ["Pooled estimates were 0.52 (CCQ), 3.29 (CAT) and 7.91 (SGRQ) for improvement.", {"entities": []}], ["MCID estimates differed depending on the method used.", {"entities": []}], ["Pooled estimates suggest clinically relevant improvements needing to exceed 0.40 on the CCQ, 3.00 on the CAT and 7.00 on the SGRQ for moderate to very severe COPD patients.", {"entities": []}], ["The MCIDs of the CAT and SGRQ in the literature might be too low, leading to overestimation of treatment effects for patients with COPD.", {"entities": []}], ["Many cases of congenital toxoplasmosis can be prevented provided that pregnant women following hygienic measures to avert risk of infection and to reduce severity of the condition if primary prevention failed.", {"entities": [[25, 38, "DISEASE"], [14, 38, "DISEASE"]]}], ["This descriptive exploratory study aimed to assess the risk behavior and knowledge related to toxoplasmoisis among Saudi pregnant women attending primary health care centers (PHCs) in Al Hassa, Saudi Arabia and to determine socio-demographic characteristics related to risk behavior and knowledge.", {"entities": []}], ["All Saudi pregnant women attending antenatal care at randomly selected six urban and four rural PHCs were approached.", {"entities": []}], ["Those agreed to participate were interviewed using a pre-tested structured questionnaire collecting data regarding socio-demographic, obstetric history, toxoplasmosis risk behaviors and related knowledge.", {"entities": [[153, 166, "DISEASE"]]}], ["Of the included pregnant women, 234 (26.8%) have fulfilled the criteria for toxoplasmosis preventive behavior recommended by Centers for Disease Prevention and Control to prevent congenital toxoplasmosis, while 48.9% reported at least one risk behavior and 24.3% reported \u2265 two risk behaviors.", {"entities": [[76, 89, "DISEASE"], [190, 203, "DISEASE"], [179, 203, "DISEASE"]]}], ["Logistic regression model revealed that pregnant women aged 20 to <30 years and those with previous history of unfavorable pregnancy outcome were more likely to follow toxoplasmosis preventive behavior.", {"entities": [[168, 181, "DISEASE"]]}], ["Toxoplasmosis-related knowledge showed that many women had identified the role of cats in disease transmission while failed to identify other risk factors including consumption of undercooked meats, unwashed fruits and vegetables, and contacting with soil.", {"entities": [[0, 13, "DISEASE"]]}], ["Predictors for pregnant women to be knowledgeable towards toxoplasmosis included those aged 30 to <40 years (OR=1.53), with \u2265 secondary education (OR=1.96), had previous unfavorable pregnancy outcomes (OR=1.88) and investigated for toxoplasmosis (OR=2.08) as reveled by multivariate regression model.", {"entities": [[58, 71, "DISEASE"], [232, 245, "DISEASE"]]}], ["Pregnant women in Al Hasas, Saudi Arabia, are substantially vulnerable to toxoplasmosis infection as they are lacking the necessary preventive behavior.", {"entities": [[74, 87, "DISEASE"]]}], ["A sizable portion have no sufficient knowledge for primary prevention of congenital toxoplasmosis, health education at primary care is necessary to avert the potential toxoplasmosis related complications especially in the neonates.", {"entities": [[84, 97, "DISEASE"], [168, 181, "DISEASE"], [73, 97, "DISEASE"]]}], ["Monocyte chemoattractant protein-1 (MCP-1) is one of the key chemokines that play important roles in diverse inflammatory and chronic pain conditions.", {"entities": []}], ["Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic and debilitating inflammatory condition of the urinary bladder characterized by the hallmark symptoms of pelvic pain and voiding dysfunction.", {"entities": [[35, 43, "DISEASE"], [13, 21, "DISEASE"]]}], ["To facilitate IC/BPS research, we used transgenic technology to develop a novel urothelial MCP-1 secretion mouse model (URO-MCP-1).", {"entities": []}], ["A transgene consisting of the uroplakin II gene promoter and the mouse MCP-1 coding sequence with a secretory element was constructed and microinjected.", {"entities": []}], ["URO-MCP-1 mice were found to express MCP-1 mRNA in the bladder epithelium and MCP-1 protein in the urine, and developed bladder inflammation 24 hours after intravesical administration of a single sub-noxious dose of lipopolysaccharide (LPS).", {"entities": []}], ["The inflamed bladders of URO-MCP-1 mice exhibited elevated mRNAs for interleukin (IL)-1\u00df, IL-6, substance P precursor, and nerve growth factor as well as increased macrophage infiltration.", {"entities": []}], ["In parallel with these phenotypic changes, URO-MCP-1 mice manifested significant functional changes at days 1 and 3 after cystitis induction.", {"entities": [[122, 130, "DISEASE"]]}], ["These functional changes included pelvic pain as measured by von Frey filament stimulation and voiding dysfunction (increased urinary frequency, reduced average volume voided per micturition, and reduced maximum volume voided per micturition) as measured by micturition cages.", {"entities": []}], ["Micturition changes remained evident at day 7 after cystitis induction, although these changes were not statistically significant.", {"entities": [[52, 60, "DISEASE"]]}], ["Control wild-type C57BL/6 mice manifested no clear changes in histological, biochemical and behavioral features after similar cystitis induction with LPS.", {"entities": [[126, 134, "DISEASE"]]}], ["Taken together, our results indicate that URO-MCP-1 mice are hypersensitive to bladder irritants such as LPS and develop pelvic pain and voiding dysfunction upon cystitis induction, providing a novel model for IC/BPS research.", {"entities": [[162, 170, "DISEASE"]]}], ["Chemokines (CK) provide directional cues that mediate the recruitment of leukocytes to sites of inflammation.", {"entities": []}], ["Broad-spectrum blockade of the CC-CK family, using the vaccinia virus 35K protein, has been shown to cause a potent reduction of systemic inflammation in models of atherosclerosis, vein graft disease and arthritis.", {"entities": [[164, 179, "DISEASE"], [204, 213, "DISEASE"], [55, 63, "DISEASE"]]}], ["We have used a cell membrane-targeted form of 35K, Mem35K, to probe whether cell-associated blockade of chemokine response is sufficient to reduce cell recruitment in inflammation.", {"entities": []}], ["In Tie2cre mice, activation of a flox-stop Mem35K transgene directed conditional expression of Mem35K in leukocytes and endothelial cells, confirmed by Western blotting, flow cytometry and immunofluorescence microscopy.", {"entities": []}], ["This conditional Mem35K expression was sufficient to increase cell surface CCL5 binding and reduce chemotaxis in vitro to CCL5, CCL2 and CCL3 but not to non-CC-CK chemoattractants, LTB4, C5a or chemerin.", {"entities": [[75, 79, "GENE"], [122, 126, "GENE"], [75, 79, "GENE"], [122, 126, "GENE"], [128, 132, "GENE"], [137, 141, "GENE"]]}], ["However, in vivo monocyte recruitment into the peritoneum driven by zymosan or CC-chemokine injection, which was demonstrated to be CC-CK dependent using CCR2\u2212/\u2212 mice, was not reduced by Mem35K expression, despite the expression of functional Mem35K protein.", {"entities": []}], ["These findings highlight differing requirements for cell-associated anti-inflammatory activity in in vitro and in vivo models.", {"entities": []}], ["Mem35K is a cell-associated CC-chemokine binding protein.", {"entities": []}], ["Conditional Mem35K transgenic mice show expression Mem35K in leukocytes.", {"entities": []}], ["Mem35K blocks in vitro primary macrophage chemotaxis specifically towards CC-chemokines.", {"entities": []}], ["Mem35K expression is not sufficient to reduce inflammation in vivo.", {"entities": []}], ["The requirements for anti-inflammatory activity in vitro and in vivo are different.", {"entities": []}], ["Mem35K is a cell-associated CC-chemokine binding protein.", {"entities": []}], ["Conditional Mem35K transgenic mice show expression Mem35K in leukocytes.", {"entities": []}], ["Mem35K blocks in vitro primary macrophage chemotaxis specifically towards CC-chemokines.", {"entities": []}], ["Mem35K expression is not sufficient to reduce inflammation in vivo.", {"entities": []}], ["The requirements for anti-inflammatory activity in vitro and in vivo are different.", {"entities": []}], ["The online version of this article (doi:10.1007/s00109-014-1194-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Dendritic cells (DCs) are the most important antigen presenting cells to activate na\u00efve T cells, which results in the case of Type 1 allergies in a Type 2 helper T cell (Th2)-driven specific immune response towards allergens.", {"entities": []}], ["So far, a number of different subsets of specialized DCs in different organs have been identified.", {"entities": []}], ["In the recent past methods to study the interaction of DCs with allergenic proteins, their different uptake and processing mechanisms followed by the presentation to T cells were developed.", {"entities": []}], ["The following review aims to summarize the most important characteristics of DC subsets in the context of allergic diseases, and highlights the recent findings.", {"entities": []}], ["These detailed studies can contribute to a better understanding of the pathomechanisms of allergic diseases and contribute to the identification of key factors to be addressed for therapeutic interventions.", {"entities": []}], ["The objective of this study was to investigate prebiotic potential, chemical composition, and antioxidant capacity of spice extracts.", {"entities": []}], ["Seven culinary spices including black pepper, cayenne pepper, cinnamon, ginger, Mediterranean oregano, rosemary, and turmeric were extracted with boiling water.", {"entities": []}], ["Major chemical constituents were characterized by RP\u2010HPLC\u2010DAD method and antioxidant capacity was determined by measuring colorimetrically the extent to scavenge ABTS radical cations.", {"entities": []}], ["Effects of spice extracts on the viability of 88 anaerobic and facultative isolates from intestinal microbiota were determined by using Brucella agar plates containing serial dilutions of extracts.", {"entities": []}], ["A total of 14 phenolic compounds, a piperine, cinnamic acid, and cinnamaldehyde were identified and quantitated.", {"entities": []}], ["Spice extracts exhibited high antioxidant capacity that correlated with the total amount of major chemicals.", {"entities": []}], ["All spice extracts, with the exception of turmeric, enhanced the growth of Bifidobacterium spp.", {"entities": []}], ["and Lactobacillus spp.", {"entities": []}], ["All spices exhibited inhibitory activity against selected Ruminococcus species.", {"entities": []}], ["Cinnamon, oregano, and rosemary were active against selected Fusobacterium strains and cinnamon, rosemary, and turmeric were active against selected Clostridium spp.", {"entities": []}], ["Some spices displayed prebiotic\u2010like activity by promoting the growth of beneficial bacteria and suppressing the growth of pathogenic bacteria, suggesting their potential role in the regulation of intestinal microbiota and the enhancement of gastrointestinal health.", {"entities": []}], ["The identification and quantification of spice\u2010specific phytochemicals provided insight into the potential influence of these chemicals on the gut microbial communities and activities.", {"entities": []}], ["Future research on the connections between spice\u2010induced changes in gut microbiota and host metabolism and disease preventive effect in animal models and humans is needed.", {"entities": []}], ["Francisella tularensis is a facultative intracellular bacterium and the causative agent of tularemia.", {"entities": [[91, 100, "DISEASE"]]}], ["Development of novel vaccines and therapeutics for tularemia has been hampered by the lack of understanding of which immune components are required to survive infection.", {"entities": [[51, 60, "DISEASE"]]}], ["Defining these requirements for protection against virulent F. tularensis , such as strain SchuS4, has been difficult since experimentally infected animals typically die within 5 days after exposure to as few as 10 bacteria.", {"entities": []}], ["Such a short mean time to death typically precludes development, and therefore assessment, of immune responses directed against virulent F. tularensis .", {"entities": []}], ["To enable identification of the components of the immune system that are required for survival of virulent F. tularensis , we developed a convalescent model of tularemia in C57Bl/6 mice using low dose antibiotic therapy in which the host immune response is ultimately responsible for clearance of the bacterium.", {"entities": [[160, 169, "DISEASE"]]}], ["Using this model we demonstrate \u03b1\u03b2TCR F. tularensis and provides evidence that this model will be a useful tool for better understanding the dynamics of tularemia infection.", {"entities": [[153, 162, "DISEASE"]]}], ["To assess the intra- and inter-rater agreement of chart abstractors from multiple sites involved in the evaluation of an Asthma Care Program (ACP).", {"entities": [[121, 127, "DISEASE"]]}], ["For intra-rater agreement, 110 charts randomly selected from 1,433 patients enrolled in the ACP across eight Ontario communities were re-abstracted by 10 abstractors.", {"entities": []}], ["For inter-rater agreement, data abstractors reviewed a set of eight fictitious charts.", {"entities": []}], ["Data abstraction involved information pertaining to six categories: physical assessment, asthma control, spirometry, asthma education, referral visits, and medication side effects.", {"entities": [[89, 95, "DISEASE"], [117, 123, "DISEASE"]]}], ["Percentage agreement and the kappa statistic (\u03ba) were used to measure agreement.", {"entities": []}], ["Sensitivity and specificity estimates were calculated comparing results from all raters against the gold standard.", {"entities": []}], ["Intra-rater re-abstraction yielded an overall kappa of 0.81.", {"entities": []}], ["Kappa values for the chart abstraction categories were: physical assessment (\u03ba 0.84), asthma control (\u03ba 0.83), spirometry (\u03ba 0.84), asthma education (\u03ba 0.72), referral visits (\u03ba 0.59) and medication side effects (\u03ba 0.51).", {"entities": [[86, 92, "DISEASE"], [132, 138, "DISEASE"]]}], ["Inter-rater abstraction of the fictitious charts produced an overall kappa of 0.75, sensitivity of 0.91 and specificity of 0.89.", {"entities": []}], ["Abstractors demonstrated agreement for physical assessment (\u03ba 0.88, sensitivity and specificity 0.95), asthma control (\u03ba 0.68, sensitivity 0.89, specificity 0.85), referral visits (\u03ba 0.77, sensitivity 0.88, specificity 0.95), and asthma education (\u03ba 0.49, sensitivity 0.87, specificity 0.77).", {"entities": [[103, 109, "DISEASE"], [230, 236, "DISEASE"]]}], ["Though collected by multiple abstractors, the results show high sensitivity and specificity and substantial to excellent inter- and intra-rater agreement, assuring confidence in the use of chart abstraction for evaluating the ACP.", {"entities": []}], ["Ground-level ozone is a potent airway irritant and a determinant of respiratory morbidity.", {"entities": []}], ["Susceptibility to the health effects of ambient ozone may be influenced by both intrinsic and extrinsic factors, such as neighborhood socioeconomic status (SES).", {"entities": []}], ["Questions remain regarding the manner and extent that factors such as SES influence ozone-related health effects, particularly across different study areas.", {"entities": []}], ["Using a 2-stage modeling approach we evaluated neighborhood SES as a modifier of ozone-related pediatric respiratory morbidity in Atlanta, Dallas, & St. Louis.", {"entities": []}], ["We acquired multi-year data on emergency department (ED) visits among 5\u201318 year olds with a primary diagnosis of respiratory disease in each city.", {"entities": []}], ["Daily concentrations of 8-h maximum ambient ozone were estimated for all ZIP Code Tabulation Areas (ZCTA) in each city by fusing observed concentration data from available network monitors with simulations from an emissions-based chemical transport model.", {"entities": []}], ["In the first stage, we used conditional logistic regression to estimate ZCTA-specific odds ratios (OR) between ozone and respiratory ED visits, controlling for temporal trends and meteorology.", {"entities": []}], ["In the second stage, we combined ZCTA-level estimates in a Bayesian hierarchical model to assess overall associations and effect modification by neighborhood SES considering categorical and continuous SES indicators (e.g., ZCTA-specific levels of poverty).", {"entities": []}], ["We estimated ORs and 95% posterior intervals (PI) for a 25\u00a0ppb increase in ozone.", {"entities": []}], ["The hierarchical model combined effect estimates from 179 ZCTAs in Atlanta, 205 ZCTAs in Dallas, and 151 ZCTAs in St. Louis.", {"entities": []}], ["The strongest overall association of ozone and pediatric respiratory disease was in Atlanta (OR\u2009=\u20091.08, 95% PI: 1.06, 1.11), followed by Dallas (OR\u2009=\u20091.04, 95% PI: 1.01, 1.07) and St. Louis (OR\u2009=\u20091.03, 95% PI: 0.99, 1.07).", {"entities": []}], ["Patterns of association across levels of neighborhood SES in each city suggested stronger ORs in low compared to high SES areas, with some evidence of non-linear effect modification.", {"entities": []}], ["Results suggest that ozone is associated with pediatric respiratory morbidity in multiple US cities; neighborhood SES may modify this association in a non-linear manner.", {"entities": []}], ["In each city, children living in low SES environments appear to be especially vulnerable given positive ORs and high underlying rates of respiratory morbidity.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-017-0244-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Medical professionalism as a set of behaviours that transcends personal values, beliefs and attitudes to incorporate ethical and moral principles is considered a covenant between society and the practice of medicine.", {"entities": []}], ["The Bachelor of Clinical Medical Practice (BCMP) a three year professional degree was launched at the University of the Witwatersrand in January 2009 in response to a documented shortage of doctors especially in the rural areas of South Africa.", {"entities": []}], ["The BCMP programme is unique in its offering as it requires a teaching approach that meets the needs of an integrated curriculum, providing for an accelerated transition from the classroom to the patient\u2019s bedside.", {"entities": []}], ["Following five week attachments in designated District Education Campuses, 25 final year BCMP students were required to reflect individually on the covenant that exists between society and the practice of medicine based on their daily interactions with health care workers and patients for three of the five rotations in a one page document.", {"entities": []}], ["A retrospective, descriptive case study employed qualitative methods to group emerging themes from 71 portfolios.", {"entities": []}], ["Ethical clearance was obtained from the Human Research Ethics Committee at the University of the Witwatersrand.", {"entities": []}], ["As an outcome of an ethical analysis, the majority of BCMP students reflected on the determinants of accountable and responsible practice (N=54).", {"entities": []}], ["The commitment to the Oath became significant with a personalised reference to patients \u2018 as my patients \u2019.", {"entities": []}], ["Students acknowledged professional health care workers (HCWs) who demonstrated commitment to core values of good practice as they recognised the value of constantly reflecting as a skill (n=51).", {"entities": []}], ["As the students reflected on feeling like \u2018 guinea pigs \u2019 (n=25) migrating through periods of uncertainity to become \u2018 teachable learners \u2019, they made ethical judgements that demonstrated the development of their moral integrity.", {"entities": []}], ["A few students felt vulnerable in instances where they were pressured into \u2018 pushing the line\u2019.", {"entities": []}], ["Through their portfolio narratives, BCMP students showed a willingness to shape their evolving journeys of moral growth and personal development.", {"entities": []}], ["This study has highlighted as an ongoing challenge the need to identify a process by which professionalism is sustained by HCWs to benefit health sciences students.", {"entities": []}], ["The Whole School, Whole Community, Whole Child (WSCC) model calls for greater collaboration across the community, school, and health sectors to meet the needs and support the full potential of each child.", {"entities": []}], ["This article reports on how 3 states and 2 local school districts have implemented aspects of the WSCC model through collaboration, leadership and policy creation, alignment, and implementation.", {"entities": []}], ["We searched state health and education department websites, local school district websites, state legislative databases, and sources of peer-reviewed and gray literature to identify materials demonstrating adoption and implementation of coordinated school health, the WSCC model, and associated policies and practices in identified states and districts.", {"entities": []}], ["We conducted informal interviews in each state and district to reinforce the document review.", {"entities": []}], ["States and local school districts have been able to strategically increase collaboration, integration, and alignment of health and education through the adoption and implementation of policy and practice supporting the WSCC model.", {"entities": []}], ["Successful utilization of the WSCC model has led to substantial positive changes in school health environments, policies, and practices.", {"entities": []}], ["Collaboration among health and education sectors to integrate and align services may lead to improved efficiencies and better health and education outcomes for students.", {"entities": []}], ["Soluble ICAM-1 (sICAM-1) is an endothelium-derived inflammatory marker that has been associated with diverse conditions such as myocardial infarction, diabetes, stroke, and malaria.", {"entities": [[173, 180, "DISEASE"], [128, 149, "DISEASE"]]}], ["Despite evidence for a heritable component to sICAM-1 levels, few genetic loci have been identified so far.", {"entities": []}], ["To comprehensively address this issue, we performed a genome-wide association analysis of sICAM-1 concentration in 22,435 apparently healthy women from the Women's Genome Health Study.", {"entities": []}], ["While our results confirm the previously reported associations at the ABO and ICAM1 loci, four novel associations were identified in the vicinity of NFKBIK (rs3136642, P\u200a=\u200a5.4\u00d710 PNPLA3 (rs738409, P\u200a=\u200a5.8\u00d710 RELA (rs1049728, P\u200a=\u200a2.7\u00d710 SH2B3 (rs3184504, P\u200a=\u200a2.9\u00d710 NFKBIB and RELA , are involved in NFKB signaling pathway; PNPLA3 is known for its association with fatty liver disease; and SH3B2 has been associated with a multitude of traits and disease including myocardial infarction.", {"entities": [[364, 383, "DISEASE"], [370, 383, "DISEASE"], [464, 485, "DISEASE"], [70, 73, "GENE"], [78, 83, "GENE"], [179, 185, "GENE"], [323, 329, "GENE"], [208, 212, "GENE"], [276, 280, "GENE"], [236, 241, "GENE"], [265, 271, "GENE"], [208, 212, "GENE"], [276, 280, "GENE"], [179, 185, "GENE"], [323, 329, "GENE"]]}], ["These associations provide insights into the genetic regulation of sICAM-1 levels and implicate these loci in the regulation of endothelial function.", {"entities": []}], ["Soluble Intercellular Adhesion Molecule 1 (sICAM-1) is an inflammatory marker that has been associated with several common diseases such as diabetes, heart disease, stroke, and malaria.", {"entities": [[150, 163, "DISEASE"], [177, 184, "DISEASE"]]}], ["While it is known that blood concentrations of sICAM-1 are at least partially genetically determined, our current knowledge of which genes mediate this effect is limited.", {"entities": []}], ["Taking advantage of technologies allowing us to interrogate genetic variation on a whole-genome basis, we found that variation in the NFKBIK , PNPLA3 , RELA , and SH2B3 genes are important determinant of sICAM-1 blood concentrations.", {"entities": [[143, 149, "GENE"], [152, 156, "GENE"], [163, 168, "GENE"]]}], ["The NFKBIB and RELA genes are involved in regulation of inflammation.", {"entities": [[4, 10, "GENE"], [15, 19, "GENE"]]}], ["These observations are significant because this is the first report of genetic association within these extensively studied inflammation genes.", {"entities": []}], ["The PNPLA3 gene has previously been associated with liver disease, and the SH2B3 gene has been associated with a multitude of traits including cardiovascular disease.", {"entities": [[52, 65, "DISEASE"], [4, 10, "GENE"], [75, 80, "GENE"]]}], ["Extension of these associations to sICAM-1 adds to the intriguing diversity of effects of these genes.", {"entities": []}], ["The enhanced release of reactive oxygen species from activated neutrophils plays important role in the pathogenesis of inflammatory bowel disease.", {"entities": [[119, 145, "DISEASE"]]}], ["We previously reported that radon inhalation activates antioxidative functions in various organs of mice.", {"entities": []}], ["In this study, we examined the protective effects of radon inhalation on dextran sulfate sodium- (DSS) induced colitis in mice which were subjected to DSS for 7 days.", {"entities": []}], ["Mice were continuously treated with air only (sham) or radon at a concentration of 2000\u2009Bq/m", {"entities": []}], ["Glassy carbon electrode (GCE) was modified with metal oxides (MO\u2009=\u2009Fe 3 O 4 , ZnO) nanoparticles doped phthalocyanine (Pc) and functionalized MWCNTs, and the electrocatalytic properties were studied.", {"entities": [[119, 121, "GENE"]]}], ["Successful synthesis of the metal oxide nanoparticles and the MO/Pc/MWCNT composite were confirmed using FTIR, Raman and SEM techniques.", {"entities": []}], ["The electrodes were characterized using cyclic voltammetry (CV) technique.", {"entities": []}], ["The electrocatalytic behaviour of the electrode towards epinephrine (EP) and norepinephrine (NE) oxidation was investigated using CV and DPV.", {"entities": []}], ["Result showed that GCE-MWCNT/Fe 3 O 4 /2,3-Nc, GCE-MWCNT/Fe 3 O 4 29H,31H-Pc, GCE-MWCNT/ZnO/2,3-Nc and GCE-MWCNT/ZnO/29H,31H-Pc electrodes gave enhanced EP and NE current response.", {"entities": []}], ["Stability study indicated that the four GCE-MWCNT/MO/Pc modified electrodes were stable against electrode fouling effect with the percentage NE current drop of 5.56\u20135.88% after 20 scans.", {"entities": []}], ["GCE-MWCNT/Fe 3 O 4 /29H,31H-Pc gave the lowest limit of detection (4.6\u2009\u03bcM) towards EP while MWCNT/ZnO/29H,31H-Pc gave the lowest limit of detection (1.7\u2009\u03bcM) towards NE.", {"entities": []}], ["The limit of detection and sensitivity of the electrodes compared well with literature.", {"entities": []}], ["Electrocatalytic oxidation of EP and NE on GCE-MWCNT/MO/Pc electrodes was diffusion controlled with some adsorption of electro-oxidation reaction intermediates products.", {"entities": []}], ["The electrodes were found to be electrochemically stable, reusable and can be used for the analysis of EP and NE in real life samples.", {"entities": []}], ["Despite attention to the health of low-income children in Head Start, little is known about the health of adults working for the program.", {"entities": []}], ["The objective of our study was to compare the physical and mental health of women working in Pennsylvania Head Start programs with the health of US women who have similar sociodemographic characteristics.", {"entities": []}], ["We used data from a web-based survey in 2012 in which 2,199 of 3,375 (65.2%) staff in 66 Pennsylvania Head Start programs participated.", {"entities": []}], ["For the 2,122 female respondents, we determined the prevalence of fair or poor health status, frequent (\u226514 d/mo) unhealthy days, frequent (\u226510 d/y) work absences due to illness, diagnosed depression, and 3 or more of 6 physical health conditions.", {"entities": []}], ["We compared these prevalences with those found in 2 national samples of employed women of similar age, education, race/ethnicity, and marital status.", {"entities": []}], ["Among Head Start staff, 85.7% were non-Hispanic white, 62.4% were married, and 60.3% had completed college.", {"entities": []}], ["The prevalence (% [95% confidence interval]) of several health indicators was higher in Head Start staff than in the national samples: fair or poor health (14.6% [13.1%\u201316.1%] vs 5.1% [4.5%\u20135.6%]), frequent unhealthy days (28.3% [26.3%\u201330.2%] vs 14.5% [14.1%\u201314.9%]), diagnosed depression (23.5% [21.7%\u201325.3%] vs 17.6% [17.1%\u201318.0%]), and 3 or more physical health conditions (21.8% [20.0%\u201323.6%] vs 12.6% [11.7%\u201313.5%]).", {"entities": []}], ["Women working with children in Head Start programs have poorer physical and mental health than do US women who have similar sociodemographic characteristics.", {"entities": []}], ["Caffeine use is increasing worldwide.", {"entities": []}], ["The underlying motivations are mainly concentration and memory enhancement and physical performance improvement.", {"entities": []}], ["Coffee and caffeine-containing products affect the cardiovascular system, with their positive inotropic and chronotropic effects, and the central nervous system, with their locomotor activity stimulation and anxiogenic-like effects.", {"entities": []}], ["Thus, it is of interest to examine whether these effects could be detrimental for health.", {"entities": []}], ["Furthermore, caffeine abuse and dependence are becoming more and more common and can lead to caffeine intoxication, which puts individuals at risk for premature and unnatural death.", {"entities": []}], ["The present review summarizes the main findings concerning caffeine\u2019s mechanisms of action (focusing on adenosine antagonism, intracellular calcium mobilization, and phosphodiesterases inhibition), use, abuse, dependence, intoxication, and lethal effects.", {"entities": []}], ["It also suggests that the concepts of toxic and lethal doses are relative, since doses below the toxic and/or lethal range may play a causal role in intoxication or death.", {"entities": []}], ["This could be due to caffeine\u2019s interaction with other substances or to the individuals' preexisting metabolism alterations or diseases.", {"entities": []}], ["Chronic rhinosinusitis (CRS) is a highly prevalent disease characterized by mucosal inflammation of the nose and paranasal sinuses.", {"entities": []}], ["CRS can be divided into two main categories, CRS with nasal polyps (NPs; CRSwNP) and CRS without NPs (CRSsNP).", {"entities": [[68, 71, "GENE"], [97, 100, "GENE"], [68, 71, "GENE"], [97, 100, "GENE"]]}], ["Although the pathophysiology of CRS remains unclear, DNA methylation has been implicated in the etiology of CRSwNP.", {"entities": []}], ["The aim of the present study was to elucidate whether DNA methylation of specific genes is involved in the development of NPs.", {"entities": [[122, 125, "GENE"]]}], ["In total, 18 individuals were included in the present study, and were divided into three groups: CRSwNP (n=7), CRSsNP (n=7) and healthy controls (n=4).", {"entities": []}], ["NP tissues were obtained from the seven patients with CRSwNP and biopsies of the inferior turbinate mucosa from all three groups were used as controls.", {"entities": []}], ["Methylated genes detected by methyl-CpG-binding domain sequencing were validated by methylation-specific polymerase chain reaction (PCR), bisulfite sequencing, and reverse transcription-quantitative PCR (RT-qPCR).", {"entities": []}], ["Methyl-CpG-binding domain sequencing identified 43,674 CpG islands in 518 genes.", {"entities": []}], ["The promotor regions of 10 and 30 genes were hypermethylated and hypomethylated, respectively, in NP samples compared with controls.", {"entities": []}], ["The top four genes with altered hypomethylation in NP tissues were, Keratin 19 ( KRT19 ), nuclear receptor subfamily 2 group F member 2 ( NR2F2 ), A Disintegrin-like And Metallopeptidase (Reprolysin Type) with Thrombospondin type 1 motif 1 ( ADAMTS1 ) and zinc finger protein 222 ( ZNF222 ).", {"entities": [[81, 86, "GENE"], [138, 143, "GENE"], [242, 249, "GENE"], [282, 288, "GENE"]]}], ["RT-qPCR demonstrated that the expression levels of KRT19 , NR2F2 and ADAMTS1 were significantly increased in NP tissues; however, there was no difference in the levels of ZNF222 between NP and control tissues.", {"entities": [[51, 56, "GENE"], [59, 64, "GENE"], [69, 76, "GENE"], [171, 177, "GENE"]]}], ["Further studies are required to confirm the relevance of these epigenetic modifications in the mechanisms underlying NP formation.", {"entities": []}], ["Breast cancer patients commonly report using >1 form of complementary and alternative medicine (CAM).", {"entities": [[0, 13, "DISEASE"], [7, 13, "DISEASE"]]}], ["However, few studies have attempted to analyze predictors and outcomes of multiple CAM modalities.", {"entities": []}], ["We sought to group breast cancer patients by clusters of type and intensity of complementary and alternative medicine (CAM) use following diagnosis.", {"entities": [[19, 32, "DISEASE"], [26, 32, "DISEASE"]]}], ["Detailed CAM use following breast cancer diagnosis was assessed in 2002\u20132003 among 764 female residents of Long Island, New York diagnosed with breast cancer in 1996\u20131997.", {"entities": [[27, 40, "DISEASE"], [144, 157, "DISEASE"], [34, 40, "DISEASE"], [151, 157, "DISEASE"]]}], ["Latent class analysis (LCA) was applied to CAM modalities while taking into account frequency and intensities.", {"entities": []}], ["Four distinct latent classes of CAM use emerged: 1) \u201cLow-dose supplement users\u201d (40\u00a0%), who used only common nutritional supplements; 2) \u201cVitamin/mineral supplement users\u201d (39\u00a0%), using an abundance of supplements in addition to other practices; 3) \u201cMind-body medicine users\u201d (12\u00a0%), with near-universal use of supplements, mind-body medicine techniques, and massage; and 4) \u201cMulti-modality high-dose users\u201d (9\u00a0%), who were highly likely to use nearly all types of CAM.", {"entities": []}], ["Predictors of membership in classes with substantial CAM use included younger age, more education, higher income, Jewish religion, ideal body mass index, higher fruit and vegetable intake, higher levels of physical activity, receipt of adjuvant chemotherapy, and prior use of oral contraceptives.", {"entities": []}], ["LCA identified important subgroups of breast cancer patients characterized by varying degrees of complementary therapy use.", {"entities": [[38, 51, "DISEASE"], [45, 51, "DISEASE"]]}], ["Further research should explore the reproducibility of these classes and investigate the association between latent class membership and breast cancer outcomes.", {"entities": [[137, 150, "DISEASE"], [144, 150, "DISEASE"]]}], ["The U.S. foreclosure crisis intensified markedly during the Great Recession of 2007-09, and currently an estimated five percent of U.S. residential properties are more than 90 days past due or in the process of foreclosure.", {"entities": []}], ["Yet there has been no systematic assessment of the effects of foreclosure on health and mental health.", {"entities": []}], ["I applied systematic search terms to PubMed and PsycINFO to identify quantitative or qualitative studies about the relationship between home foreclosure and health or mental health.", {"entities": []}], ["After screening the titles and abstracts of 930 publications and reviewing the full text of 76 articles, dissertations, and other reports, I identified 42 publications representing 35 unique studies about foreclosure, health, and mental health.", {"entities": []}], ["The majority of studies (32 [91%]) concluded that foreclosure had adverse effects on health or mental health, while three studies yielded null or mixed findings.", {"entities": []}], ["Only two studies examined the extent to which foreclosure may have disproportionate impacts on ethnic or racial minority populations.", {"entities": []}], ["Home foreclosure adversely affects health and mental health through channels operating at multiple levels: at the individual level, the stress of personally experiencing foreclosure was associated with worsened mental health and adverse health behaviors, which were in turn linked to poorer health status; at the community level, increasing degradation of the neighborhood environment had indirect, cross-level adverse effects on health and mental health.", {"entities": []}], ["Early intervention may be able to prevent acute economic shocks from eventually developing into the chronic stress of foreclosure, with all of the attendant benefits this implies for health and mental health status.", {"entities": []}], ["Programs designed to encourage early return of foreclosed properties back into productive use may have similar health and mental health benefits.", {"entities": []}], ["The development of IgE-mediated allergic diseases is influenced by many factors, including genetic and environmental factors such as pollution and farming, but also by nutrition.", {"entities": []}], ["In the last decade, substantial progress has been made in our understanding of the impact that nutrition can have on allergic diseases.", {"entities": []}], ["Many studies have addressed the effect of breastfeeding, pre-, pro- and synbiotics, vitamins and minerals, fiber, fruit and vegetables, cow\u2019s milk, and n-3 fatty acids, on the development of allergies.", {"entities": []}], ["In addition, nutrition can also have indirect effects on allergic sensitization.", {"entities": []}], ["This includes the diet of pregnant and breastfeeding women, which influences intrauterine development, as well as breastmilk composition.", {"entities": []}], ["These include the diet of pregnant and breastfeeding women that influences intrauterine development as well as breastmilk composition, effects of food processing that may enhance allergenicity of foods, and effects via modulation of the intestinal microbiota and their metabolites.", {"entities": []}], ["This editorial review provides a brief overview of recent developments related to nutrition and the development and management of allergic diseases.", {"entities": []}], ["Our laboratory has been comparing the activity of a water extract of cotton bract (CBE) with the isolated trachealis smooth muscle of the dog, guinea pig, and cat.", {"entities": []}], ["CBE induced contractions that were not mediated by 5-hydroxytryptamine (5-HT), histamine, or muscarinic receptors.", {"entities": []}], ["The active agent(s) in CBE was dialyzable (less than 14,000 molecular weight), and substantial activity was retained after low-temperature ashing.", {"entities": []}], ["CBE potentiated contractions of dog trachealis to histamine and 5-HT and relaxation responses to isoproterenol, whereas it had no effect on responses to methacholine and KCl.", {"entities": []}], ["In the guinea pig trachealis, CBE reduced responsiveness to KCl, potentiated relaxations to adenosine and ATP, and did not alter the responses to the remaining agents.", {"entities": []}], ["Responses of cat trachealis to KCl and isoproterenol were potentiated by CBE, while those to 5-HT were unaffected.", {"entities": []}], ["Neurogenic cholinergic contractile responses were potentiated by CBE in the trachealis of the dog, but not of the guinea pig, while neurogenic relaxations were potentiated by CBE in guinea pig trachealis but not in the dog trachealis.", {"entities": []}], ["There are thus marked species differences in the acute effects of CBE on airway smooth muscle.", {"entities": []}], ["Due to recent interest in the possible involvement of bacterial endotoxins in the etiology of byssinosis, we examined the effects of E. coli lipopolysaccharide (LPS) in guinea pig trachealis.", {"entities": [[94, 104, "DISEASE"]]}], ["An initial examination revealed that LPS potentiated responses to histamine, but not those to methacholine and isoproterenol.", {"entities": []}], ["This effect vanished upon a second appraisal with a different batch of LPS.", {"entities": []}], ["The effect of LPS in airway smooth muscle is thus, at present, equivocal.", {"entities": []}], ["Ganoderma lucidum (G. lucidum) polysaccharides (GLPs) have been used as traditional Chinese medicine for cancer prevention for many years.", {"entities": [[105, 111, "DISEASE"]]}], ["However, the mechanism by which GLP exerts its chemopreventive activities remains elusive.", {"entities": []}], ["In addition, it is unclear whether sporoderm-broken spores of G. lucidum water extract (BSGLWE), which contains mainly GLPs, has anticancer effects on colorectal cancer.", {"entities": [[151, 168, "DISEASE"], [162, 168, "DISEASE"]]}], ["The present study investigated the anticancer effects and potential mechanisms of BSGLWE on colorectal cancer in vivo and in vitro .", {"entities": [[92, 109, "DISEASE"], [103, 109, "DISEASE"]]}], ["Our results showed that BSGLWE significantly inhibited colorectal cancer HCT116 cell viability in a time- and dose-dependent manner.", {"entities": [[55, 72, "DISEASE"], [66, 72, "DISEASE"]]}], ["Flow cytometry analysis indicated that BSGLWE disrupted cell cycle progression at G2/M phase via downregulation of cyclin B1 and cyclin A2, and upregulation of P21 at mRNA levels.", {"entities": []}], ["Moreover, BSGLWE induced apoptosis by decreasing Bcl-2 and survivin at mRNA levels, and reduced Bcl-2, PARP, pro-caspase-3 and pro-caspase-9 at protein levels.", {"entities": []}], ["Furthermore, BSGLWE suppressed tumor growth in vivo by regulating the expression of genes and proteins associated with cell cycle and apoptosis, which was further confirmed by a reduction of Ki67, PCNA, and Bcl-2 expression as determined by immunohistochemistry staining.", {"entities": [[197, 201, "GENE"]]}], ["NSAID activated gene-1 (NAG-1), a pro-apoptotic gene, was significantly upregulated in vivo and in vitro upon BSGLWE treatment at both mRNA and protein levels.", {"entities": []}], ["In addition, the relative amounts of secreted NAG-1 in cell culture medium or serum of nude mice were all upregulated upon BSGLWE treatments, suggesting a role of NAG-1 in BSGLWE-induced anticolorectal cancer activity.", {"entities": [[202, 208, "DISEASE"]]}], ["This is the first study to show that BSGLWE inhibits colorectal cancer carcinogenesis through regulating genes responsible for cell proliferation, cell cycle and apoptosis cascades.", {"entities": [[53, 70, "DISEASE"], [64, 70, "DISEASE"]]}], ["These findings indicate that BSGLWE possesses chemopreventive potential in colorectal cancer which may serve as a promising anticancer agent for clinical applications.", {"entities": [[75, 92, "DISEASE"], [86, 92, "DISEASE"]]}], ["Mast cells (MCs) arise in situ from circulating stem cell factor (SCF)-dependent committed progenitors (PrMCs) and accumulate at sites of allergic mucosal inflammation.", {"entities": []}], ["We hypothesized that human (h)PrMCs and their mature counterparts might share overlapping patterns of chemokine and cytokine receptor utilization with eosinophils, basophils, and T helper type 2 (Th2) lymphocytes for their homing and allergy-associated hyperplasia.", {"entities": []}], ["We have characterized committed hPrMCs and fully mature hMCs derived in vitro from cord blood for their functional responses to chemokine and cytokine agonists germane to allergic inflammation and for their maturation-related expression of the corresponding receptors.", {"entities": []}], ["After 4 wk of culture in the presence of recombinant stem cell factor (SCF), interleukin (IL)-6, and IL-10, the cells were characterized as hPrMCs based upon their uniform surface expression of c- kit and CD13, low-level expression of Fc\u2208RI\u03b1, absence of CD14 and CD16 expression, and immunoreactivity for MC chymase in >80%, and about half were immunoreactive for tryptase and metachromatic with toluidine blue.", {"entities": [[254, 258, "GENE"]]}], ["By week 9, the cells had matured into hMCs, identified by higher levels of c- kit , continued expression of CD13 and low-level Fc\u2208RI\u03b1, uniform toluidine blue metachromasia, and uniform immunoreactivity for both tryptase and chymase.", {"entities": []}], ["The 4-wk-old hPrMCs expressed four chemokine receptors (CXCR2, CCR3, CXCR4, and CCR5).", {"entities": [[56, 61, "GENE"], [63, 67, "GENE"], [69, 74, "GENE"], [80, 84, "GENE"]]}], ["Each receptor mediated transient rapid calcium fluxes in response to its respective ligand.", {"entities": []}], ["Both recombinant human eotaxin and stromal cell\u2013derived factor 1\u03b1 elicited chemotaxis of hPrMCs.", {"entities": []}], ["Only CCR3 was retained on the mature 9-wk-old hMCs from among these chemokine receptors, and hMCs responded to eotaxin with a sustained calcium flux but without chemotaxis.", {"entities": [[5, 9, "GENE"]]}], ["The Th2 cytokines IL-3, IL-5, IL-6, IL-9, and granulocyte/macrophage colony-stimulating factor each augmented the SCF-dependent proliferation of hPrMCs and hMCs.", {"entities": []}], ["In contrast, the prototypical Th1 cytokine, interferon \u03b3, suppressed SCF-driven proliferation of both hPrMCs and hMCs.", {"entities": []}], ["Thus, throughout their development in vitro, hMCs obey SCF-dependent, cytokine-driven mitogenic responses that reflect a Th2-type polarization characteristic of allergy and asthma.", {"entities": [[173, 179, "DISEASE"]]}], ["Furthermore, committed hPrMCs have a unique profile of chemokine receptor expression from among reported hematopoietic cells, including CCR3, which is shared with the other cells central to allergic inflammation (eosinophils, basophils, and Th2 lymphocytes).", {"entities": [[136, 140, "GENE"]]}], ["Particulate matter with diameter less than 10 micrometers (PM 10 ) that originates from anthropogenic activities and natural sources may settle in the bronchi and cause adverse effects possibly via oxidative stress in susceptible individuals, such as asthmatic children.", {"entities": []}], ["This study aimed to investigate the effect of outdoor PM 10 concentrations on childhood asthma admissions (CAA) in Athens, Greece.", {"entities": [[88, 94, "DISEASE"]]}], ["Daily counts of CAA from the three Children's Hospitals within the greater Athens' area were obtained from the hospital records during a four-year period (2001-2004, n = 3602 children).", {"entities": []}], ["Mean daily PM 10 concentrations recorded by the air pollution-monitoring network of the greater Athens area were also collected.", {"entities": []}], ["The relationship between CAA and PM 10 concentrations was investigated using the Generalized Linear Models with Poisson distribution and logistic analysis.", {"entities": []}], ["There was a statistically significant (95% CL) relationship between CAA and mean daily PM 10 concentrations on the day of exposure (+3.8% for 10 \u03bcg/m 10 concentrations), while a 1-day lag (+3.4% for 10 \u03bcg/m 10 concentrations) and a 4-day lag (+4.3% for 10 \u03bcg/m 10 concentrations) were observed for older asthmatic children (5-14 year-old).", {"entities": []}], ["High mean daily PM 10 concentration (the highest 10%; >65.69 \u03bcg/m Our results provide evidence of the adverse effect of PM 10 on the rates of paediatric asthma exacerbations and hospital admissions.", {"entities": [[153, 159, "DISEASE"]]}], ["A four-day lag effect between PM 10 peak exposure and asthma admissions was also observed in the older age group.", {"entities": [[54, 60, "DISEASE"]]}], ["Asthma is a complex genetic disease caused by a combination of genetic and environmental risk factors.", {"entities": [[0, 6, "DISEASE"], [20, 35, "DISEASE"]]}], ["We sought to test classes of genetic variants largely missed by genome-wide association studies (GWAS), including copy number variants (CNVs) and low-frequency variants, by performing whole-genome sequencing (WGS) on 16 individuals from asthma-enriched and asthma-depleted families.", {"entities": [[237, 243, "DISEASE"], [257, 263, "DISEASE"]]}], ["The samples were obtained from an extended 13-generation Hutterite pedigree with reduced genetic heterogeneity due to a small founding gene pool and reduced environmental heterogeneity as a result of a communal lifestyle.", {"entities": []}], ["We sequenced each individual to an average depth of 13-fold, generated a comprehensive catalog of genetic variants, and tested the most severe mutations for association with asthma.", {"entities": [[174, 180, "DISEASE"]]}], ["We identified and validated 1960 CNVs, 19 nonsense or splice-site single nucleotide variants (SNVs), and 18 insertions or deletions that were out of frame.", {"entities": []}], ["As follow-up, we performed targeted sequencing of 16 genes in 837 cases and 540 controls of Puerto Rican ancestry and found that controls carry a significantly higher burden of mutations in IL27RA (2.0% of controls; 0.23% of cases; nominal p\u200a=\u200a0.004; Bonferroni p\u200a=\u200a0.21).", {"entities": [[190, 196, "GENE"]]}], ["We also genotyped 593 CNVs in 1199 Hutterite individuals.", {"entities": []}], ["We identified a nominally significant association (p\u200a=\u200a0.03; Odds ratio (OR)\u200a=\u200a3.13) between a 6 kbp deletion in an intron of NEDD4L and increased risk of asthma.", {"entities": [[155, 161, "DISEASE"], [126, 132, "GENE"]]}], ["We genotyped this deletion in an additional 4787 non-Hutterite individuals (nominal p\u200a=\u200a0.056; OR\u200a=\u200a1.69).", {"entities": []}], ["NEDD4L is expressed in bronchial epithelial cells, and conditional knockout of this gene in the lung in mice leads to severe inflammation and mucus accumulation.", {"entities": [[0, 6, "GENE"]]}], ["Our study represents one of the early instances of applying WGS to complex disease with a large environmental component and demonstrates how WGS can identify risk variants, including CNVs and low-frequency variants, largely untested in GWAS.", {"entities": []}], ["A novel method to ultra-purify unstimulated neutrophils by flow sorting and subsequent demonstration of the neutrophils' ability to release IL-1\u03b2 following inflammatory stimulus.", {"entities": []}], ["The technical limitations of isolating neutrophils without contaminating leukocytes, while concurrently minimizing neutrophil activation, is a barrier to determining specific neutrophil functions.", {"entities": []}], ["We aimed to assess the use of FACS for generating highly pure quiescent neutrophil populations in an antibody-free environment.", {"entities": []}], ["Peripheral blood human granulocytes and murine bone marrow-derived neutrophils were isolated by discontinuous Percoll gradient and flow-sorted using FSC/SSC profiles and differences in autofluorescence.", {"entities": []}], ["Postsort purity was assessed by morphological analysis and flow cytometry.", {"entities": []}], ["Neutrophil activation was measured in unstimulated-unsorted and sorted cells and in response to fMLF, LTB 4 , and PAF by measuring shape change, CD62L, and CD11b expression; intracellular calcium flux; and chemotaxis.", {"entities": [[102, 105, "GENE"]]}], ["Cytokine production by human neutrophils was also determined.", {"entities": []}], ["Postsort human neutrophil purity was 99.95% ( sem =0.03; n =11; morphological analysis), and 99.68% were CD16 sem =0.06; n =11), with similar results achieved for murine neutrophils.", {"entities": []}], ["Flow sorting did not alter neutrophil activation or chemotaxis, relative to presorted cells, and no differences in response to agonists were observed.", {"entities": []}], ["Stimulated neutrophils produced IL-1\u03b2, although to a lesser degree than CXCL8/IL-8.", {"entities": []}], ["The exploitation of the difference in autofluorescence between neutrophils and eosinophils by FACS is a quick and effective method for generating highly purified populations for subsequent in vitro study.", {"entities": []}], ["Notwithstanding previous studies supporting independent associations between obstructive sleep apnea (OSA) and prevalence of diabetes, the underlying pathogenesis of impaired glucose regulation in OSA remains unclear.", {"entities": []}], ["We explored mechanisms linking OSA with prediabetes/diabetes and associated biomarker profiles.", {"entities": []}], ["We hypothesized that OSA is associated with distinct alterations in glucose homeostasis and biomarker profiles in subjects with normal (NGM) and impaired glucose metabolism (IGM).", {"entities": []}], ["Forty-five severely obese adults (36 women) without certain comorbidities/medications underwent anthropometric measurements, polysomnography, and blood tests.", {"entities": []}], ["We measured fasting serum glucose, insulin, selected cytokines, and calculated homeostasis model assessment estimates of insulin sensitivity (HOMA-IS) and pancreatic beta-cell function (HOMA-B).", {"entities": []}], ["Both increases in apnea-hypopnea index (AHI) and the presence of prediabetes/diabetes were associated with reductions in HOMA-IS in the entire cohort even after adjustment for sex, race, age, and BMI ( P = 0.003).", {"entities": []}], ["In subjects with NGM (n = 30), OSA severity was associated with significantly increased HOMA-B (a trend towards decreased HOMA-IS) independent of sex and adiposity.", {"entities": []}], ["OSA-related oxyhemoglobin desaturations correlated with TNF-\u03b1 (r=-0.76; P = 0.001) in women with NGM and with IL-6 (rho=-0.55; P = 0.035) in women with IGM (n = 15) matched individually for age, adiposity, and AHI.", {"entities": []}], ["OSA is independently associated with altered glucose homeostasis and increased basal beta-cell function in severely obese adults with NGM.", {"entities": []}], ["The findings suggest that moderate to severe OSA imposes an excessive functional demand on pancreatic beta-cells, which may lead to their exhaustion and impaired secretory capacity over time.", {"entities": []}], ["The two distinct biomarker profiles linking sleep apnea with NGM and IGM via TNF-\u03b1 and IL-6 have been discerned in our study to suggest that sleep apnea and particularly nocturnal oxyhemoglobin desaturations are associated with chronic metabolic fluxes and specific cytokine stressors that reflect links between sleep apnea and glucose metabolism.", {"entities": []}], ["The study may help illuminate potential mechanisms for glucose dysregulation in OSA, and resolve some controversy over the associations of OSA with TNF-\u03b1 and IL-6 in previous studies.", {"entities": []}], ["Not all patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) benefit from treatment with systemic corticosteroids and antibiotics.", {"entities": [[45, 82, "DISEASE"]]}], ["The aim of the study was to identify criteria recommended in current COPD guidelines for treating acute exacerbations with systemic corticosteroids and antibiotics and to assess the underlying evidence.", {"entities": []}], ["Current COPD guidelines were identified by a systematic literature search.", {"entities": []}], ["The most recent guidelines as per country/organisation containing recommendations about treating acute exacerbations of COPD were included.", {"entities": []}], ["Guideline development and criteria for treating acute exacerbations with systemic corticosteroids and antibiotics were appraised.", {"entities": []}], ["Randomised controlled trials directly referred to in context with the recommendations were evaluated in terms of study design, setting, and study population.", {"entities": []}], ["A total of 19 COPD guidelines were included.", {"entities": []}], ["Systemic corticosteroids were often universally recommended to all patients with acute exacerbations.", {"entities": []}], ["Criteria for treatment with antibiotics were mainly an increase in respiratory symptoms.", {"entities": []}], ["Objective diagnostic tests or clinical examination were only rarely recommended.", {"entities": []}], ["Only few criteria were directly linked to underlying evidence, and the trial patients represented a highly specific group of COPD patients.", {"entities": []}], ["Current COPD guidelines are of little help in primary care to identify patients with acute exacerbations probably benefitting from treatment with systemic corticosteroids and antibiotics in primary care, and might contribute to overuse or inappropriate use of either treatment.", {"entities": []}], ["Type 2 diabetes mellitus (DM) has been associated with lung dysfunction, but this association has not been explored in Hispanics/Latinos.", {"entities": [[7, 24, "DISEASE"]]}], ["The relation between diabetic nephropathy and lung function and symptoms has not been explored.", {"entities": []}], ["The Hispanic Community Health Study/Study of Latinos (HCHS/SOL), a large, multicenter, observational study, recruited 16,415 participants aged 18\u201374 years (14,455 with complete data on variables of interest), between 2008 and 2011 from four U.S. communities through a two-stage area household probability design.", {"entities": []}], ["Baseline measurements were used for analyses.", {"entities": []}], ["Forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC), and dyspnea score were compared between individuals with and without DM, overall, and stratified by albuminuria.", {"entities": [[33, 36, "GENE"]]}], ["The analyses were performed separately for those with and without preexisting lung disease (chronic bronchitis, emphysema, asthma).", {"entities": [[123, 129, "DISEASE"], [78, 90, "DISEASE"], [100, 110, "DISEASE"]]}], ["Linear regression with sampling weights was used for all analyses.", {"entities": []}], ["Among Hispanics/Latinos without lung disease, those with DM had lower mean FEV 1 and FVC values and a higher mean dyspnea score than those without DM (mean [95% CI] FEV 1 3.00 [2.96\u20133.04] vs. 3.10 [3.09\u20133.11] L, P < 0.01; FVC 3.62 [3.59\u20133.66] vs. 3.81 [3.79\u20133.83] L, P < 0.001; dyspnea score 0.60 [0.49\u20130.71] vs. 0.41 [0.34\u20130.49], P < 0.001).", {"entities": [[32, 44, "DISEASE"], [75, 78, "GENE"], [165, 168, "GENE"], [75, 78, "GENE"], [165, 168, "GENE"]]}], ["Hispanics/Latinos with DM and macroalbuminuria showed 10% lower FVC ( P < 0.001), 6% lower FEV 1 ( P < 0.001), and 2.5-fold higher dyspnea score ( P = 0.04) than those without DM and with normoalbuminuria.", {"entities": [[91, 94, "GENE"]]}], ["Similar findings but with higher impairment in FVC were found in Hispanics/Latinos with lung disease.", {"entities": [[88, 100, "DISEASE"]]}], ["Hispanics/Latinos with DM have functional and symptomatic pulmonary impairment that mirror kidney microangiopathy.", {"entities": []}], ["The progression of pulmonary impairment in adults with DM needs to be investigated further.", {"entities": []}], ["Assisting smoking parents to quit smoking and eliminating the secondhand smoke (SHS) exposure of their children is a global health priority.", {"entities": []}], ["Engaging healthcare workers in developing countries to address this priority has been a challenge.", {"entities": []}], ["This study intends to explore issues around current practice related to SHS exposure assessment and counseling and identify barriers to SHS exposure reduction counseling in the Chinese pediatric setting.", {"entities": []}], ["We conducted qualitative interviews (11 focus groups discussions (FGDs) with pediatricians, 6 FGDs with pediatric nurses and 11 in-depth interviews (IDIs) with hospital administrators) among 101 health-care professionals (HCP) from 5 hospitals in four major cities of Guangxi Province, China.", {"entities": []}], ["All FGDs/ IDIs were audio recorded and analysed thematically.", {"entities": []}], ["The findings suggest that few Chinese pediatricians routinely address the SHS exposure of children in their usual practice.", {"entities": []}], ["All HCPs felt the need for clinical interventions to promote SHS exposure reduction for children.", {"entities": []}], ["Primary barriers to SHS exposure reduction counseling in the Chinese pediatric setting included: lack of skills and training in tobacco use reduction and cessation counseling; time constraints and heavy workloads, uncertainty about the usefulness of smoking cessation interventions and lack of hospital-wide systems requiring pediatricians to record tobacco use or SHS exposure information.", {"entities": []}], ["Ideas for overcoming these barriers were building capacity of pediatricians, collaboration with international organization to initiate training, engaging top level leaders in the effort and ensuring financial resources to support the program.", {"entities": []}], ["This study among hospital administrators and service providers in China demonstrated a high level of interest in delivering SHS exposure reduction interventions in the pediatric setting.", {"entities": []}], ["The findings can inform the creation and delivery of clinical interventions in China to promote SHS exposure reduction to children in the pediatric setting.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2431-14-266) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Lead is neurotoxic at very low dose and there is a need to better characterize the impact of domestic sources of lead on the biological exposure of young children.", {"entities": []}], ["A cross-sectional survey evaluated the contribution of drinking water, house dust and paint to blood lead levels (BLLs) of young children living in old boroughs of Montr\u00e9al (Canada).", {"entities": []}], ["Three hundred and six children aged 1 to 5 years and currently drinking tap water participated in the study.", {"entities": []}], ["For each participant, residential lead was measured in kitchen tap water, floor dust, windowsill dust and house paint and a venous blood sample was analyzed.", {"entities": []}], ["Multivariate logistic regression was used to evaluate the association between elevated BLL in the children (\u2265 75th percentile) and indoor lead contamination by means of odds ratios (OR) using 95% confidence intervals (CI).", {"entities": []}], ["There was an association between BLL \u226575th percentile (1.78\u2009 \u03bc g/dL) and water lead when the mean water concentration was >3.3\u2009 \u03bc g/L: adjusted OR=4.7 (95% CI: 2.1\u201310.2).", {"entities": []}], ["Windowsill dust loading >14.1\u2009 \u03bc g/ft \u03bc g/dL: adjusted OR=3.2 (95% CI: 1.3\u20137.8).", {"entities": []}], ["Despite relatively low BLLs, tap water and house dust lead contribute to an increase of BLLs in exposed young children.", {"entities": []}], ["A single-item measure of self-rated mental health (SRMH) is being used increasingly in health research and population health surveys.", {"entities": []}], ["The item asks respondents to rate their mental health on a five-point scale from excellent to poor.", {"entities": []}], ["This scoping study presents the first known review of the SRMH literature.", {"entities": []}], ["Electronic databases of Medline, CINAHL, PsycINFO, EMBASE and Cochrane Reviews were searched using keywords.", {"entities": []}], ["The databases were also searched using the titles of surveys known to include the SRMH single item.", {"entities": []}], ["The search was supplemented by manually searching the bibliographic sections of the included studies.", {"entities": []}], ["Two independent reviewers coded articles for inclusion or exclusion based on whether articles included SRMH.", {"entities": []}], ["Each study was coded by theme and data were extracted about study design, sample, variables, and results.", {"entities": []}], ["Fifty-seven studies included SRMH.", {"entities": []}], ["SRMH correlated moderately with the following mental health scales: Kessler Psychological Distress Scale, Patient Health Questionnaire, mental health subscales of the Short-Form Health Status Survey, Behaviour and Symptom Identification Scale, and World Mental Health Clinical Diagnostic Interview Schedule.", {"entities": []}], ["However, responses to this item may differ across racial and ethnic groups.", {"entities": []}], ["Poor SRMH was associated with poor self-rated health, physical health problems, increased health service utilization and less likelihood of being satisfied with mental health services.", {"entities": []}], ["Poor or fair SRMH was also associated with social determinants of health, such as low socioeconomic position, weak social connections and neighbourhood stressors.", {"entities": []}], ["Synthesis of this literature provides important information about the relationships SRMH has with other variables.", {"entities": []}], ["SRMH is associated with multi-item measures of mental health, self-rated health, health problems, service utilization, and service satisfaction.", {"entities": []}], ["Given these relationships and its use in epidemiologic surveys, SRMH should continue to be assessed as a population health measure.", {"entities": []}], ["More studies need to examine relationships between SRMH and clinical mental illnesses.", {"entities": []}], ["Longitudinal analyses should look at whether SRMH is predictive of future mental health problems.", {"entities": []}], ["The online version of this article (doi:10.1186/1472-6963-14-398) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Many people are unable to withstand the set point for usual vicissitudes of life and are overwhelmed by depression, especially when there is a potential stressor like a disease.", {"entities": []}], ["Gender is very important in defining susceptibility and exposure to a number of mental health risks.", {"entities": []}], ["The objective of this review is to systematically identify, appraise and synthesize the best available evidence on gender disparity in prevalence of depression among patient populations.", {"entities": []}], ["Observational analytical studies done on patients of 18 years old were included.", {"entities": []}], ["The JBI-MAStARI tool for extraction was used to pool quantitative data.", {"entities": []}], ["Review Manager Software was used for meta-analysis and Odds ratios and their 95% confidence intervals were calculated.", {"entities": []}], ["On Meta-analysis, a total of 19639 patients were involved, with male to female ratio of 1.14:1.", {"entities": []}], ["The finding of the Meta analysis showed that male sex is 63% less likely to develop depression than female sex (Odds ratio=0.63, 95% Confidence Interval= 0.59, 0.68).", {"entities": []}], ["The studies included were homogenous; Heterogeneity test: Chi Depression is more common among females than male patients.", {"entities": []}], ["To probe seroepidemiology of the 2009 pandemic influenza A (H1N1) among health care workers (HCWs) in a children's hospital.", {"entities": [[47, 56, "DISEASE"]]}], ["From August 2009 to March 2010, serum samples were drawn from 150 HCWs in a children's hospital in Taipei before the 2009 influenza A (H1N1) pandemic, before H1N1 vaccination, and after the pandemic.", {"entities": [[122, 131, "DISEASE"]]}], ["HCWs who had come into direct contact with 2009 influenza A (H1N1) patients or their clinical respiratory samples during their daily work were designated as a high-risk group.", {"entities": [[48, 57, "DISEASE"]]}], ["Antibody levels were determined by hemagglutination inhibition (HAI) assay.", {"entities": []}], ["A four-fold or greater increase in HAI titers between any successive paired sera was defined as seroconversion, and factors associated with seroconversion were analyzed.", {"entities": []}], ["Among the 150 HCWs, 18 (12.0%) showed either virological or serological evidence of 2009 pandemic influenza A (H1N1) infection.", {"entities": [[98, 107, "DISEASE"]]}], ["Of the 90 unvaccinated HCWs, baseline and post-pandemic seroprotective rates were 5.6% and 20.0%.", {"entities": []}], ["Seroconversion rates among unvaccinated HCWs were 14.4% (13/90), 22.5% (9/40), and 8.0% (4/50) for total, high-risk group, and low-risk group, respectively.", {"entities": []}], ["Multivariate analysis revealed being in the high-risk group is an independent risk factor associated with seroconversion.", {"entities": []}], ["The infection rate of 2009 pandemic influenza A (H1N1) in HCWs was moderate and not higher than that for the general population.", {"entities": [[36, 45, "DISEASE"]]}], ["The majority of unvaccinated HCWs remained susceptible.", {"entities": []}], ["Direct contact of influenza patients and their respiratory samples increased the risk of infection.", {"entities": [[18, 27, "DISEASE"]]}], ["Background: Autoantibodies may be present in a variety of underlying cancers several years before tumours can be detected and testing for their presence may allow earlier diagnosis.", {"entities": []}], ["We report the clinical validation of an autoantibody panel in newly diagnosed patients with lung cancer (LC).", {"entities": [[92, 103, "DISEASE"], [97, 103, "DISEASE"]]}], ["Patients and methods: Three cohorts of patients with newly diagnosed LC were identified: group 1 ( n = 145), group 2 ( n = 241) and group 3 ( n = 269).", {"entities": []}], ["Patients were individually matched by gender, age and smoking history to a control individual with no history of malignant disease.", {"entities": []}], ["Serum samples were obtained after diagnosis but before any anticancer treatment.", {"entities": []}], ["Autoantibody levels were measured against a panel of six tumour-related antigens (p53, NY-ESO-1, CAGE, GBU4-5, Annexin 1 and SOX2).", {"entities": [[125, 129, "GENE"]]}], ["Assay sensitivity was tested in relation to demographic variables and cancer type/stage.", {"entities": [[70, 76, "DISEASE"]]}], ["Results: The autoantibody panel demonstrated a sensitivity/specificity of 36%/91%, 39%/89% and 37%/90% in groups 1, 2 and 3, respectively, with good reproducibility.", {"entities": []}], ["There was no significant difference between different LC stages, indicating that the antigens included covered the different types of LC well.", {"entities": []}], ["Conclusion: This assay confirms the value of an autoantibody panel as a diagnostic tool and offers a potential system for monitoring patients at high risk of LC.", {"entities": []}], ["The Nrf2/anti-oxidant response element (ARE) pathway plays an important role in regulating cellular anti-oxidants, including haem oxygenase-1 (HO-1).", {"entities": []}], ["Various kinases have been implicated in the pathways leading to Nrf2 activation.", {"entities": []}], ["Here, we investigated the effect of epigallocatechin (EGC) on ARE-mediated gene expression in human monocytic cells.", {"entities": []}], ["EGC time and dose dependently increased HO-1 mRNA and protein expression but had minimal effect on expression of other ARE-regulated genes, including NAD(P)H:quinone oxidoreductase 1, glutathione cysteine ligase and ferritin.", {"entities": []}], ["siRNA knock down of Nrf2 significantly inhibited EGC-induced HO-1 expression.", {"entities": []}], ["Furthermore, inhibition of PKC by Ro-31-8220 dose dependently decreased EGC-induced HO-1 mRNA expression, whereas MAP kinase and phosphatidylinositol-3-kinase pathway inhibitors had no significant effect.", {"entities": []}], ["EGC stimulated phosphorylation of PKC\u03b1\u03b2 and \u03b4 in THP-1 cells.", {"entities": []}], ["PKC\u03b4 inhibition significantly decreased EGC-induced HO-1 mRNA expression, whereas PKC\u03b1- and \u03b2-specific inhibitors had no significant effect.", {"entities": []}], ["These results demonstrate for the first time that EGC-induced HO-1 expression occurs via PKC\u03b4 and Nrf2.", {"entities": []}], ["The pollen coat is the first structure of the pollen to encounter the mucosal immune system upon inhalation.", {"entities": []}], ["Prior characterizations of pollen allergens have focused on water-soluble, cytoplasmic proteins, but have overlooked much of the extracellular pollen coat.", {"entities": []}], ["Due to washing with organic solvents when prepared, these pollen coat proteins are typically absent from commercial standardized allergenic extracts (i.e., \u201cde-fatted\u201d), and, as a result, their involvement in allergy has not been explored.", {"entities": []}], ["Using a unique approach to search for pollen allergenic proteins residing in the pollen coat, we employed transmission electron microscopy (TEM) to assess the impact of organic solvents on the structural integrity of the pollen coat.", {"entities": []}], ["TEM results indicated that de-fatting of Cynodon dactylon (Bermuda grass) pollen (BGP) by use of organic solvents altered the structural integrity of the pollen coat.", {"entities": []}], ["The novel IgE-binding proteins of the BGP coat include a cysteine protease (CP) and endoxylanase (EXY).", {"entities": [[76, 78, "GENE"]]}], ["The full-length cDNA that encodes the novel IgE-reactive CP was cloned from floral RNA.", {"entities": [[57, 59, "GENE"]]}], ["The EXY and CP were purified to homogeneity and tested for IgE reactivity.", {"entities": [[12, 14, "GENE"]]}], ["The CP from the BGP coat increased the permeability of human airway epithelial cells, caused a clear concentration-dependent detachment of cells, and damaged their barrier integrity.", {"entities": [[4, 6, "GENE"]]}], ["Using an immunoproteomics approach, novel allergenic proteins of the BGP coat were identified.", {"entities": []}], ["These proteins represent a class of novel dual-function proteins residing on the coat of the pollen grain that have IgE-binding capacity and proteolytic activity, which disrupts the integrity of the airway epithelial barrier.", {"entities": []}], ["The identification of pollen coat allergens might explain the IgE-negative response to available skin-prick-testing proteins in patients who have positive symptoms.", {"entities": []}], ["Further study of the role of these pollen coat proteins in allergic responses is warranted and could potentially lead to the development of improved diagnostic and therapeutic tools.", {"entities": []}], ["Theories, models, and frameworks used by implementation science, including Diffusion of Innovations, tend to focus on the adoption of one innovation, when often organizations may be facing multiple simultaneous adoption decisions.", {"entities": []}], ["For instance, despite evidence that care management practices (CMPs) are helpful in managing chronic illness, there is still uneven adoption by physician organizations.", {"entities": []}], ["This exploratory paper leverages this natural variation in uptake to describe inter-organizational patterns in adoption of CMPs and to better understand how adoption choices may be related to one another.", {"entities": []}], ["We assessed a cross section of national survey data from physician organizations reporting on the use of 20 CMPs (5 each for asthma, congestive heart failure, depression, and diabetes).", {"entities": [[133, 157, "DISEASE"], [125, 131, "DISEASE"]]}], ["Item response theory was used to explore patterns in adoption, first considering all 20 CMPs together and then by subsets according to disease focus or CMP type (e.g., registries, patient reminders).", {"entities": []}], ["Mokken scale analysis explored whether adoption choices were linked by disease focus or CMP type and whether a consistent ordering of adoption choices was present.", {"entities": []}], ["The Mokken scale for all 20 CMPs demonstrated medium scalability ( H \u00a0=\u00a00.43), but no consistent ordering.", {"entities": []}], ["Scales for subsets of CMPs sharing a disease focus had medium scalability (0.4\u00a0<\u00a0 H \u00a0<\u00a00.5), while subsets sharing a CMP type had strong scalability ( H \u00a0>\u00a00.5).", {"entities": []}], ["Scales for CMP type consistently ranked diabetes CMPs as most adoptable and depression CMPs as least adoptable.", {"entities": []}], ["Within disease focus scales, patient reminders were ranked as the most adoptable CMP, while clinician feedback and patient education were ranked the least adoptable.", {"entities": []}], ["Patterns of adoption indicate that innovation characteristics may influence adoption.", {"entities": []}], ["CMP dissemination efforts may be strengthened by encouraging traditionally non-adopting organizations to focus on more adoptable practices first and then describing a pathway for the adoption of subsequent CMPs.", {"entities": []}], ["Clarifying why certain CMPs are \u201cless adoptable\u201d may also provide insights into how to overcome CMP adoption constraints.", {"entities": []}], ["The online version of this article (doi:10.1186/s13012-017-0639-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Periodontitis is a chronic inflammatory disease of tooth supporting tissues resulting in periodontal tissue destruction, which may ultimately lead to tooth loss.", {"entities": [[0, 13, "DISEASE"]]}], ["The disease is characterized by continuous leukocyte infiltration, likely mediated by local chemokine production but the pathogenic mechanisms are not fully elucidated.", {"entities": []}], ["There are no reliable serologic biomarkers for the diagnosis of periodontitis, which is today based solely on the degree of local tissue destruction, and there is no available biological treatment tool.", {"entities": [[64, 77, "DISEASE"]]}], ["Prompted by the increasing interest in periodontitis and systemic inflammatory mediators we mapped serum cytokine and chemokine levels from periodontitis subjects and healthy controls.", {"entities": [[39, 52, "DISEASE"], [140, 153, "DISEASE"]]}], ["We used multivariate partial least squares (PLS) modeling and identified monocyte chemoattractant protein-1 (MCP-1) and eotaxin as clearly associated with periodontitis along with C-reactive protein (CRP), years of smoking and age, whereas the number of remaining teeth was associated with being healthy.", {"entities": [[155, 168, "DISEASE"], [200, 203, "GENE"]]}], ["Moreover, body mass index correlated significantly with serum MCP-1 and CRP, but not with eotaxin.", {"entities": [[72, 75, "GENE"]]}], ["We detected higher MCP-1 protein levels in inflamed gingival connective tissue compared to healthy but the eotaxin levels were undetectable.", {"entities": []}], ["Primary human gingival fibroblasts displayed strongly increased expression of MCP-1 and eotaxin mRNA and protein when challenged with tumor necrosis factor-\u03b1 (TNF-\u03b1 and interleukin-1\u03b2 (IL-1\u03b2), key mediators of periodontal inflammation.", {"entities": []}], ["We also demonstrated that the upregulated chemokine expression was dependent on the NF-\u03ba\u0392 pathway.", {"entities": []}], ["In summary, we identify higher levels of CRP, eotaxin and MCP-1 in serum of periodontitis patients.", {"entities": [[76, 89, "DISEASE"], [41, 44, "GENE"]]}], ["This, together with our finding that both CRP and MCP-1 correlates with BMI points towards an increased systemic inflammatory load in patients with periodontitis and high BMI.", {"entities": [[148, 161, "DISEASE"], [42, 45, "GENE"]]}], ["Targeting eotaxin and MCP-1 in periodontitis may result in reduced leukocyte infiltration and inflammation in periodontitis and maybe prevent tooth loss.", {"entities": [[31, 44, "DISEASE"], [110, 123, "DISEASE"]]}], ["The population is aging and multimorbidity is becoming a common problem in the elderly.", {"entities": []}], ["To explore the effect of multimorbidity patterns on mortality for all causes at 3- and 5-year follow-up periods.", {"entities": []}], ["A prospective community-based cohort (2009\u20132014) embedded within a randomized clinical trial was conducted in seven primary health care centers, including 328 subjects aged 85 years at baseline.", {"entities": []}], ["Sociodemographic variables, sensory status, cardiovascular risk factors, comorbidity, and geriatric tests were analyzed.", {"entities": []}], ["Multimorbidity patterns were defined as combinations of two or three of 16 specific chronic conditions in the same individual.", {"entities": []}], ["Of the total sample, the median and interquartile range value of conditions was 4 (3\u20135).", {"entities": []}], ["The individual morbidities significantly associated with death were chronic obstructive pulmonary disease (COPD; hazard ratio [HR]: 2.47; 95% confidence interval [CI]: 1.3; 4.7), atrial fibrillation (AF; HR: 2.41; 95% CI: 1.3; 4.3), and malignancy (HR: 1.9; 95% CI: 1.0; 3.6) at 3-year follow-up; whereas dementia (HR: 2.04; 95% CI: 1.3; 3.2), malignancy (HR: 1.84; 95% CI: 1.2; 2.8), and COPD (HR: 1.77; 95% CI: 1.1; 2.8) were the most associated with mortality at 5-year follow-up, after adjusting using Barthel functional index (BI).", {"entities": [[305, 313, "DISEASE"], [68, 105, "DISEASE"], [127, 129, "GENE"], [204, 206, "GENE"], [249, 251, "GENE"], [315, 317, "GENE"], [356, 358, "GENE"], [395, 397, "GENE"], [127, 129, "GENE"], [204, 206, "GENE"], [249, 251, "GENE"], [315, 317, "GENE"], [356, 358, "GENE"], [395, 397, "GENE"], [127, 129, "GENE"], [204, 206, "GENE"], [249, 251, "GENE"], [315, 317, "GENE"], [356, 358, "GENE"], [395, 397, "GENE"], [127, 129, "GENE"], [204, 206, "GENE"], [249, 251, "GENE"], [315, 317, "GENE"], [356, 358, "GENE"], [395, 397, "GENE"], [127, 129, "GENE"], [204, 206, "GENE"], [249, 251, "GENE"], [315, 317, "GENE"], [356, 358, "GENE"], [395, 397, "GENE"], [127, 129, "GENE"], [204, 206, "GENE"], [249, 251, "GENE"], [315, 317, "GENE"], [356, 358, "GENE"], [395, 397, "GENE"]]}], ["The two multimorbidity patterns most associated with death were AF, chronic kidney disease (CKD), and visual impairment (HR: 4.19; 95% CI: 2.2; 8.2) at 3-year follow-up as well as hypertension, CKD, and malignancy (HR: 3.24; 95% CI: 1.8; 5.8) at 5 years, after adjusting using BI.", {"entities": [[180, 192, "DISEASE"], [76, 90, "DISEASE"], [121, 123, "GENE"], [215, 217, "GENE"], [121, 123, "GENE"], [215, 217, "GENE"]]}], ["Multimorbidity as specific combinations of chronic conditions showed an effect on mortality, which would be higher than the risk attributable to individual morbidities.", {"entities": []}], ["The most important predicting pattern for mortality was the combination of AF, CKD, and visual impairment after 3 years.", {"entities": []}], ["These findings suggest that a new approach is required to target multimorbidity in octogenarians.", {"entities": []}], ["Ethnographic studies from East Africa suggest that cerebral malaria and anaemia are not classified in local knowledge as malaria complications, but as illnesses in their own right.", {"entities": [[51, 67, "DISEASE"], [60, 67, "DISEASE"], [121, 128, "DISEASE"]]}], ["Cerebral malaria ' degedege' has been most researched, in spite of anaemia being a much more frequent complication in infants, and not much is known on how this is interpreted by caretakers.", {"entities": [[0, 16, "DISEASE"], [9, 16, "DISEASE"]]}], ["Anaemia is difficult to recognize clinically, even by health workers.", {"entities": []}], ["Ethnographic longitudinal cohort field study for 14 months, with monthly home-visits in families of 63 newborn babies, identified by community census, followed throughout April \u2013 November 2003 and during follow-up in April-May 2004.", {"entities": []}], ["Interviews with care-takers (mostly mothers) and observational studies of infants and social environment were combined with three haemoglobin (Hb) screenings, supplemented with reports from mothers after health facility use.", {"entities": []}], ["General danger signs, reported by mothers, e.g.", {"entities": []}], ["infant unable to breast-feed or sit, too weak to be carried on back \u2013 besides of more alarming signs such as sleeping all time, loosing consciousness or convulsing \u2013 were well associated with actual or evolving moderate to severe anaemia (Hb \u2264 5\u20138 g/dl).", {"entities": []}], ["By integrating the local descriptions of danger symptoms and signs, and comparing with actual or evolving low Hb, an algorithm to detect anaemia was developed, with significant sensitivity and specificity.", {"entities": []}], ["For most danger signs, mothers twice as often took young children to traditional healers for herbal treatment, rather than having their children admitted to hospital.", {"entities": []}], ["As expected, pallor was more rarely recognized by mothers, or primary reason for treatment seeking.", {"entities": []}], ["Mothers do recognize and respond to symptoms and danger signs related to development of anaemia, the most frequent complication of malaria in young children in malaria endemic areas.", {"entities": [[131, 138, "DISEASE"], [160, 167, "DISEASE"]]}], ["Mothers' observations and actions should be reconsidered and integrated in management of childhood illness programmes.", {"entities": []}], ["Inflammation and metabolism have been shown to be evolutionary linked and increasing evidence exists that pro-inflammatory factors are involved in the pathogenesis of obesity and type 2 diabetes.", {"entities": [[167, 174, "DISEASE"]]}], ["Until now, most data suggest that within adipose tissue these factors are secreted by cells of the innate immune system, e. g. macrophages.", {"entities": []}], ["In the present study we demonstrate that B lymphocyte stimulator (BLyS) is increased in human obesity.", {"entities": [[94, 101, "DISEASE"]]}], ["In contrast to several pro-inflammatory factors, we found the source of BLyS in human adipose tissue to be the adipocytes rather than immune cells.", {"entities": []}], ["In grade 3 obese human subjects, expression of BLyS in vivo in adipose tissue is significantly increased (p<0.001).", {"entities": []}], ["Furthermore, BLyS serum levels are elevated in grade 3 human obesity (862.5+222.0 pg/ml vs. 543.7+60.7 pg/ml in lean controls, p<0.001) and are positively correlated to the BMI ( r \u200a=\u200a0.43, p<0.0002).", {"entities": [[61, 68, "DISEASE"]]}], ["In the present study, bariatric surgery significantly altered serum BLyS concentrations.", {"entities": []}], ["In contrast, weight loss due to a very-low-calorie-formula-diet (800 kcal/d) had no such effect.", {"entities": []}], ["To examine metabolic activity of BLyS, in a translational research approach, insulin sensitivity was measured in human subjects in vivo before and after treatment with the human recombinant anti-BLyS antibody belimumab.", {"entities": []}], ["Since BLyS is known to promote B-cell proliferation and immunoglobulin secretion, the present data suggest that adipocytes of grade 3 obese human subjects are able to activate the adaptive immune system, suggesting that in metabolic inflammation in humans both, innate and adaptive immunity, are of pathophysiological relevance.", {"entities": []}], ["C ystic F ibrosis (CF) is an inherited pleiotropic disease that results from abnormalities in the gene codes of a chloride channel.", {"entities": []}], ["The lungs of CF patients are chronically infected by several pathogens but bacteraemia have rarely been reported in this pathology.", {"entities": []}], ["Besides that, circulating monocytes in CF patients exhibit a patent E ndotoxin T olerance (ET) state since they show a significant reduction of the inflammatory response to bacterial stimulus.", {"entities": []}], ["Despite a previous description of this phenomenon, the direct cause of ET in CF patients remains unknown.", {"entities": []}], ["In this study we have researched the possible role of microbial/endotoxin translocation from a localized infection to the bloodstream as a potential cause of ET induction in CF patients.", {"entities": []}], ["Plasma analysis of fourteen CF patients revealed high levels of LPS compared to healthy volunteers and patients who suffer from Chronic Obstructive Pulmonary Disease.", {"entities": []}], ["Experiments in vitro showed that endotoxin concentrations found in plasma of CF patients were enough to induce an ET phenotype in monocytes from healthy controls.", {"entities": []}], ["In agreement with clinical data, we failed to detect bacterial DNA in CF plasma.", {"entities": []}], ["Our results suggest that soluble endotoxin present in bloodstream of CF patients causes endotoxin tolerance in their circulating monocytes.", {"entities": []}], ["Several studies have confirmed the crucial roles of microRNAs (miRNAs) in cancer occurrence.", {"entities": [[74, 80, "DISEASE"]]}], ["In addition, single nucleotide polymorphisms (SNPs) in miRNA genes have been associated with various cancers.", {"entities": []}], ["The aim of the present study was to investigate the association of SNPs in miRNA genes with cervical intraepithelial neoplasia (CIN) and cervical cancer in a Chinese Han population.", {"entities": [[146, 152, "DISEASE"], [137, 152, "DISEASE"]]}], ["We searched SNPs in nineteen miRNAs by sequencing healthy individuals (n=50).", {"entities": []}], ["Then, a total of 400 patients with CIN, 609 patients with cervical cancer and 583 healthy individuals were recruited to genotype the SNPs using a Taqman assay.", {"entities": [[67, 73, "DISEASE"], [58, 73, "DISEASE"]]}], ["The results showed that only five of the nineteen miRNAs had SNPs (rs11134527 in pri-miR-218-2; rs74693964 in pri-miR-145; rs6062251 in pri-miR-133a2; rs531564 in pri-miR-124-1; and rs1834306 in pri-miR-100) in this Chinese Han population.", {"entities": []}], ["The frequency of the rs11134527A allele was significantly higher in the control group than in CIN and cervical cancer groups ( P =0.011 and 0.035, respectively).", {"entities": [[111, 117, "DISEASE"], [102, 117, "DISEASE"]]}], ["The frequency of the rs531564G allele was higher in the CIN and control groups than in the cervical cancer group ( P =0.019 and 0.017, respectively).", {"entities": [[100, 106, "DISEASE"], [91, 106, "DISEASE"]]}], ["These results indicated that rs11134527 in pri-miR-218-2 and rs531564 in pri-miR-124-1 could be associated with CIN and cervical cancer in the Chinese Han population.", {"entities": [[129, 135, "DISEASE"], [120, 135, "DISEASE"]]}], ["Neutrophils have the shortest lifespan among leukocytes and usually die via apoptosis, limiting their deleterious potential.", {"entities": []}], ["However, this tightly regulated cell death program can be modulated by pathogen-associated molecular patterns (PAMPs), danger-associated molecular pattern (DAMPs), and inflammatory cytokines.", {"entities": []}], ["We have previously reported that low pH, a hallmark of inflammatory processes and solid tumors, moderately delays neutrophil apoptosis.", {"entities": []}], ["Here we show that fever-range hyperthermia accelerates the rate of neutrophil apoptosis at neutral pH but markedly increases neutrophil survival induced by low pH.", {"entities": []}], ["Interestingly, an opposite effect was observed in lymphocytes; hyperthermia plus low pH prevents lymphocyte activation and promotes the death of lymphocytes and lymphoid cell lines.", {"entities": []}], ["Analysis of the mechanisms through which hyperthermia plus low pH increased neutrophil survival revealed that hyperthermia further decreases cytosolic pH induced by extracellular acidosis.", {"entities": []}], ["The fact that two Na", {"entities": []}], ["Airborne microorganisms have significant effects on human health, and children are more vulnerable to pathogens and allergens than adults.", {"entities": []}], ["However, little is known about the microbial communities in the air of childcare facilities.", {"entities": []}], ["Here, we analyzed the bacterial and fungal communities in 50 air samples collected from five daycare centers and five elementary schools located in Seoul, Korea using culture-independent high-throughput pyrosequencing.", {"entities": []}], ["The microbial communities contained a wide variety of taxa not previously identified in child daycare centers and schools.", {"entities": []}], ["Moreover, the dominant species differed from those reported in previous studies using culture-dependent methods.", {"entities": []}], ["The well-known fungi detected in previous culture-based studies ( Alternaria , Aspergillus , Penicillium , and Cladosporium ) represented less than 12% of the total sequence reads.", {"entities": []}], ["The composition of the fungal and bacterial communities in the indoor air differed greatly with regard to the source of the microorganisms.", {"entities": []}], ["The bacterial community in the indoor air appeared to contain diverse bacteria associated with both humans and the outside environment.", {"entities": []}], ["In contrast, the fungal community was largely derived from the surrounding outdoor environment and not from human activity.", {"entities": []}], ["The profile of the microorganisms in bioaerosols identified in this study provides the fundamental knowledge needed to develop public health policies regarding the monitoring and management of indoor air quality.", {"entities": []}], ["A genetic component in early childhood caries ( ECC ) is theorized, but no genome\u2010wide investigations of ECC have been conducted.", {"entities": []}], ["This pilot study is part of a long\u2010term research program aimed to: (1) determine the proportion of ECC variance attributable to the human genome and (2) identify ECC \u2010associated genetic loci.", {"entities": []}], ["The study's community\u2010based sample comprised 212 children (mean age=39\u00a0months; range\u00a0=\u00a030\u201352\u00a0months; males\u00a0=\u00a055%; Hispanic/Latino\u00a0=\u00a035%, African\u2010American\u00a0=\u00a032%; American Academy of Pediatric Dentistry definition of ECC prevalence\u00a0=\u00a038%).", {"entities": []}], ["Approximately 2.4 million single nucleotide polymorphisms ( SNP s) were genotyped using DNA purified from saliva.", {"entities": []}], ["A P\u00a0 < \u00a0 5\u00a0\u00d7\u00a010 SNP s with P\u00a0 < \u00a0 5\u00a0\u00d7\u00a010 ECC prevalence.", {"entities": []}], ["SNP s with minor allele frequency \u22655% explained 52% (standard error\u00a0=\u00a054%) of ECC variance (one\u2010sided P\u00a0 = \u00a0 0.03).", {"entities": []}], ["Unsurprisingly, given the pilot's small sample size, no genome\u2010wide significant associations were found.", {"entities": []}], ["An intergenic locus on 4q32 (rs4690994) displayed the strongest association with ECC [ P\u00a0 = \u00a0 2.3\u00a0\u00d7\u00a010 OR )\u00a0=\u00a03.5; 95% confidence interval ( CI )\u00a0=\u00a02.1\u20135.9].", {"entities": []}], ["Thirteen loci with suggestive associations were followed\u2010up \u2013 none showed evidence of association in the replication samples.", {"entities": []}], ["This study's findings support a heritable component of ECC and demonstrate the feasibility of conducting genomics studies among preschool\u2010age children.", {"entities": []}], ["Anemia is a major public health problem in young children.", {"entities": [[0, 6, "DISEASE"]]}], ["Reports on the role of anemia on infectious diseases remained controversial.", {"entities": [[23, 29, "DISEASE"]]}], ["We aim to investigate the effect of anemia on innate immunity, nasopharyngeal bacterial colonization, and subsequent infectious outcome.", {"entities": [[36, 42, "DISEASE"]]}], ["Blood tests were examined at the age of 12 months.", {"entities": []}], ["TLR-induced cytokine production was assessed by ELISA.", {"entities": []}], ["Bacteria from nasopharyngeal specimens were identified with traditional culture.", {"entities": []}], ["Clinical infectious diseases were followed yearly until 3 years of age.", {"entities": []}], ["Result showed that of the 423 infants, 72 had hemoglobin level\u2009\u2264\u200911\u2009g/dL, among which 55% had normal iron level.", {"entities": []}], ["There was significant association between hemoglobin level and TLR1\u20132, and 4 induced IL-6 (p\u2009=\u20090.04, 0.02) and that of TLR4 stimulated TNF-\u03b1 response (p\u2009=\u20090.04).", {"entities": [[119, 123, "GENE"]]}], ["Children with anemia had higher nasopharyngeal colonization with Moxarella catarrhalis .", {"entities": [[14, 20, "DISEASE"]]}], ["Clinical analysis did not show anemia to be associated with infectious morbidity.", {"entities": [[31, 37, "DISEASE"]]}], ["However, children who developed LRTIs had mean lower ferritin levels.", {"entities": []}], ["We speculated that iron might be the key factor related to infectious morbidity.", {"entities": []}], ["Thus, to investigate the role of anemia in infectious diseases, it is important to first consider the prevalence of iron deficit, since the incidence of iron deficiency-induced anemia may vary among different regions.", {"entities": [[33, 39, "DISEASE"], [177, 183, "DISEASE"]]}], ["Children and adolescents with inflammatory bowel disease (IBD) are at increased risk of vaccine preventable diseases (VPD).", {"entities": [[30, 56, "DISEASE"]]}], ["This includes invasive pneumococcal disease and influenza.", {"entities": [[48, 57, "DISEASE"]]}], ["The primary aim of this study was to describe compliance with current Australian guidelines for vaccination of children and adolescents diagnosed with IBD.", {"entities": []}], ["A secondary aim was to review the serological screening for VPD.", {"entities": []}], ["A random sample of patients (0-18 years at diagnosis), were selected from the Victoria Australia state based Pediatric Inflammatory Bowel Disease Register.", {"entities": [[119, 145, "DISEASE"]]}], ["A multi-faceted retrospective review of immunization status was undertaken, with hospital records audited, a telephone interview survey conducted with consenting parents and the vaccination history was checked against the primary care physician and Australian Childhood Immunization Register (ACIR) records.", {"entities": []}], ["The routine primary childhood vaccinations and administration of the recommended additional influenza and pneumococcal vaccines was clarified.", {"entities": [[92, 101, "DISEASE"]]}], ["This 2007 audit reviewed the immunization status of 101individuals on the Victorian Pediatric IBD database.", {"entities": []}], ["Median age at diagnosis was 12.1 years, 50% were on active immunosuppressive therapy.", {"entities": []}], ["90% (38/42) [95% confidence intervals (CI) 77%; 97%] with complete immunization information were up-to-date with routine primary immunizations.", {"entities": []}], ["Only 5% (5/101) [95% CI 2%; 11%] received a recommended pneumococcal vaccine booster and 10% (10/101) [95% CI 5%; 17%] had evidence of having ever received a seasonal influenza vaccine.", {"entities": [[167, 176, "DISEASE"]]}], ["Those living in rural Victoria (p = 0.005) and younger at the age of diagnosis (p = 0.002) were more likely to have ever received an influenza vaccine Serological testing, reviewing historical protection from VPD, identified 18% (17/94) with evidence of at least one serology sample.", {"entities": [[133, 142, "DISEASE"]]}], ["This study highlights poor compliance in IBD patients for additional recommended vaccines.", {"entities": []}], ["A multi-faceted approach is required to maximize protection from VPD in this vulnerable special risk population.", {"entities": []}], ["The anaesthetic conserving device (AnaConDa pat ) and ventilator side of the reflector (C loss ) to describe its technical performance.", {"entities": []}], ["A Puritan Bennett 840 ICU ventilator (Pleasanton, US), AnaConDa T , 0.3, 0.5, and 1.0 l) were varied.", {"entities": []}], ["C pat was measured via a thin catheter in the middle of the 3 l-bag in steady state (online data storage and averaging over >10 min).", {"entities": []}], ["C loss was calculated from IR (to yield the volume of vapour per unit of time), and expired minute volume (in which the vapour is diluted) on the assumption that, in the steady state, input by liquid infusion equals output through the reflector.", {"entities": []}], ["At lower concentrations ( C pat < 1 vol%) the ratio C loss /C pat was constant ( R C = 0.096\u200a\u00b1\u00b10.012) for all combinations of IR, RR and V T , both for isoflurane and sevoflurane.", {"entities": []}], ["The device could efficiently reflect up to 10 ml vapour per breath (e.g.", {"entities": []}], ["2 vol% in 0.5 l).", {"entities": []}], ["When exceeding this capacity, surplus vapour \u201cspilled over\u201d and R C markedly increased indicating decreased performance.", {"entities": []}], ["The triple product minute volume times R C times C pat describes anaesthetic losses through the reflector.", {"entities": []}], ["It can easily be calculated as long as the 10 ml reflection capacity is not exceeded and thus R C is constant.", {"entities": []}], ["Increased minute ventilation necessitates increasing the IR to keep C pat constant.", {"entities": []}], ["When using large V T and high C pat \u201cspill over\u201d occurs.", {"entities": []}], ["This effect offers some protection against an inadvertent overdose.", {"entities": []}], ["Little is known about the prevalence of dietary supplement (DS) use in American adolescents.", {"entities": []}], ["We conducted this study to analyze the prevalence of DS use and factors associated with this use in a national population-based sample.", {"entities": []}], ["We used data from the 1999 \u2013 2002 National Health and Nutrition Examination Surveys (NHANES) for adolescents age 11 to 19.", {"entities": []}], ["Using weighted logistic regression, we identified demographic and clinical factors associated with the use of any DS, vitamins or minerals, herbs and other DS.", {"entities": []}], ["Among the 5,306 responses representing approximately 36 million Americans 11\u201319 years old, 27% reported use of one or more DS in the prior month.", {"entities": []}], ["The most commonly used DS were: multivitamins (16%) and vitamin C (6%).", {"entities": []}], ["In the multivariable analysis, African American [adjusted odds ratio 0.40 (0.31\u20130.50) 95% CI] and Mexican American [0.55 (0.44\u20130.69)] adolescents were less likely to use DS compared with non-Hispanic whites.", {"entities": []}], ["DS use was more common in those who used prescription medications [1.37 (1.10\u20131.72)] and among those who had a diagnosis of chronic headaches [1.25 (1.04\u20131.50)].", {"entities": []}], ["DS use was less common among those reporting fair or poor health status [0.59 (0.40\u20130.88)].", {"entities": []}], ["Twenty seven percent of American adolescents use DS.", {"entities": []}], ["DS use is higher among teens that use prescription medications; physicians and pharmacists should be aware of this, ask patients, and check for potential interactions.", {"entities": []}], ["Classical randomized controlled trials are the gold standard in medical evidence because of their high internal validity.", {"entities": []}], ["However, their necessarily strict design can limit their external validity and the ability to extrapolate these data to real world patients.", {"entities": []}], ["Therefore, alternatively designed studies may play a complementary role in evaluating the comparative effectiveness of therapies in nonidealized patients in more naturalistic, real world settings.", {"entities": []}], ["Observational studies have high external validity and can evaluate real world outcomes.", {"entities": []}], ["Their strength lies in hypothesis generation and testing and in identifying areas in which further clinical trials may be required.", {"entities": []}], ["Pragmatic trials are designed to maximize applicability of trial results to usual care settings by relying on clinically important outcomes and enrolling a wide range of participants.", {"entities": []}], ["A combination of these approaches is preferable and necessary.", {"entities": []}], ["This study examined: (a) differences in lung function between current and non current smokers who had sedentary lifestyles and non sedentary lifestyles and (b) the mediating effect of sedentary lifestyle on the association between smoking and lung function in African Americans.", {"entities": []}], ["Sedentary lifestyle was defined as the lowest quartile of the total physical activity score.", {"entities": []}], ["The results of linear and logistic regression analyses revealed that non smokers with non sedentary lifestyles had the highest level of lung function, and smokers with sedentary lifestyles had the lowest level.", {"entities": []}], ["The female non-smokers with sedentary lifestyles had a significantly higher FEV1% predicted and FVC% predicted than smokers with non sedentary lifestyles (93.3% vs. 88.6%; p = 0.0102 and 92.1% vs. 86.9%; p = 0.0055 respectively).", {"entities": []}], ["FEV1/FVC ratio for men was higher in non smokers with sedentary lifestyles than in smokers with non sedentary lifestyles (80.9 vs. 78.1; p = 0.0048).", {"entities": []}], ["Though smoking is inversely associated with lung function, it seems to have a more deleterious effect than sedentary lifestyle on lung function.", {"entities": []}], ["Physically active smokers had higher lung function than their non physically active counterparts.", {"entities": []}], ["There are a number of different manifestations of pulmonary aspergillosis.", {"entities": [[60, 73, "DISEASE"]]}], ["This study aims to review the radiology, presentation, and histological features of lung nodules caused by Aspergillus spp .", {"entities": []}], ["Patients were identified from a cohort attending our specialist Chronic Pulmonary Aspergillosis clinic.", {"entities": [[82, 95, "DISEASE"]]}], ["Patients with cavitating lung lesions, with or without fibrosis and those with aspergillomas or a diagnosis of invasive aspergillosis were excluded.", {"entities": [[120, 133, "DISEASE"], [111, 133, "DISEASE"]]}], ["Demographic, laboratory, and clinical data and radiologic findings were recorded.", {"entities": []}], ["Thirty-three patients with pulmonary nodules and diagnostic features of aspergillosis (histology and/or laboratory findings) were identified.", {"entities": [[72, 85, "DISEASE"]]}], ["Eighteen (54.5\u00a0%) were male, mean age 58\u00a0years (range 27\u201380 years).", {"entities": []}], ["19 (57.6\u00a0%) were former or current smokers.", {"entities": []}], ["The median Charleston co-morbidity index was 3 (range 0\u20137).", {"entities": []}], ["All complained of a least one of; dyspnoea, cough, haemoptysis, or weight loss.", {"entities": []}], ["None reported fever.", {"entities": []}], ["Ten patients (31\u00a0%) did not have an elevated Aspergillus IgG, and only 4 patients had elevated Aspergillus precipitins.", {"entities": []}], ["Twelve patients (36\u00a0%) had a single nodule, six patients (18\u00a0%) had between 2 and 5 nodules, 2 (6\u00a0%) between 6 and 10 nodules and 13 (39\u00a0%) had more than 10 nodules.", {"entities": []}], ["The mean size of the nodules was 21\u00a0mm, with a maximum size ranging between 5\u201350\u00a0mm.", {"entities": []}], ["No nodules had cavitation radiographically.", {"entities": []}], ["The upper lobes were most commonly involved.", {"entities": []}], ["Histology was available for 18 patients and showed evidence of granulation tissue, fibrosis, and visualisation of fungal hyphae.", {"entities": []}], ["Pulmonary nodules are a less common manifestation of aspergillosis in immunocompetent patients.", {"entities": [[53, 66, "DISEASE"]]}], ["Distinguishing these nodules from other lung pathology may be difficult on CT findings alone.", {"entities": []}], ["Heparanase is an endo-\u03b2-glucuronidase that specifically cleaves heparan sulfate proteoglycans in the extracellular matrix.", {"entities": []}], ["Expression of this enzyme is increased in several pathological conditions including inflammation.", {"entities": []}], ["We have investigated the role of heparanase in pulmonary inflammation in the context of allergic and non-allergic pulmonary cell recruitment using heparanase knockout (Hpa", {"entities": []}], ["Chelation therapy is the preferred medical treatment for reducing the toxic effects of metals.", {"entities": []}], ["Chelating agents are capable of binding to toxic metal ions to form complex structures which are easily excreted from the body removing them from intracellular or extracellular spaces.", {"entities": []}], ["2,3-Dimercaprol has long been the mainstay of chelation therapy for lead or arsenic poisoning, however its serious side effects have led researchers to develop less toxic analogues.", {"entities": []}], ["Hydrophilic chelators like meso -2,3-dimercaptosuccinic acid effectively promote renal metal excretion, but their ability to access intracellular metals is weak.", {"entities": []}], ["Newer strategies to address these drawbacks like combination therapy (use of structurally different chelating agents) or co-administration of antioxidants have been reported recently.", {"entities": []}], ["In this review we provide an update of the existing chelating agents and the various strategies available for the treatment of heavy metals and metalloid intoxications.", {"entities": []}], ["Despite recent advances in methods for culturing Mycobacterium tuberculosis (MTB), the diagnostic yield of tuberculous pleural effusion (TBPE) remains unsatisfactory.", {"entities": [[63, 75, "DISEASE"]]}], ["However, unlike repeated sputum cultures of pulmonary tuberculosis, little is known about the role of repeated pleural cultures.", {"entities": [[54, 66, "DISEASE"], [44, 66, "DISEASE"]]}], ["We examined whether repeated pleural cultures are associated with increased MTB yield from TBPE.", {"entities": []}], ["A multicenter, retrospective cohort study was performed from January 2012 to December 2015 in South Korea.", {"entities": []}], ["Patients were categorized into two groups: single- or repeated-culture groups.", {"entities": []}], ["The diagnostic yield of MTB and clinical, radiological, and pleural fluid characteristics were evaluated.", {"entities": []}], ["Among the 329 patients with TBPE, 77 (23.4%) had repeated cultures and 252 (76.5%) had a single culture.", {"entities": []}], ["Pleural culture was performed twice in all 77 patients in the repeated-culture group at a 1-day interval (inter-quartile range, 1.0\u20132.0).", {"entities": []}], ["In the repeated-culture group, the yield of MTB from the first culture was 31.2%, which was similar to that in the single-culture group (31.2% vs. 29.8%, P = 0.887).", {"entities": []}], ["However, the yield of MTB from the second culture (10/77, 13.0%) was more than that from the first.", {"entities": []}], ["These results may be attributable to the insufficient immune clearance for MTB invasion into the pleural space between the first and second cultures.", {"entities": []}], ["Over time, the yield of the second cultures decreased from 17.4% to 6.7% and then 6.3%.", {"entities": []}], ["Finally, the overall yield of MTB in the repeated- and single-culture groups was 44.2% and 29.8% respectively (P < 0.001).", {"entities": []}], ["The results showed that repeated pleural cultures increased MTB yield from TBPE in human immunodeficiency virus-negative individuals.", {"entities": []}], ["Furthermore, repeated cultures may increase yield when carried out for two consecutive days.", {"entities": []}], ["\u201cInfluenzanet\u201d is a network of Internet-based platforms aimed at collecting real-time data for influenza surveillance in several European countries.", {"entities": [[95, 104, "DISEASE"]]}], ["More than 30,000 European volunteers participate every year in the study, representing one of the largest existing Internet-based multicenter cohorts.", {"entities": []}], ["Each week during the influenza season, participants are asked to report their symptoms (if any) along with a set of additional questions.", {"entities": [[21, 30, "DISEASE"]]}], ["Focusing on the first influenza season of 2011-12, when the Influenzanet system was completely harmonized within a common framework in Sweden, the United Kingdom, the Netherlands, Belgium, France, Italy, and Portugal, we investigated the propensity of users to regularly come back to the platform to provide information about their health status.", {"entities": [[22, 31, "DISEASE"]]}], ["Our purpose was to investigate demographic and behavioral factors associated with participation in follow-up.", {"entities": []}], ["By means of a multilevel analysis, we evaluated the association between regular participation during the season and sociodemographic and behavioral characteristics as measured by a background questionnaire completed by participants on registration.", {"entities": []}], ["We found that lower participation in follow-up was associated with lower educational status (odds ratio [OR] 0.80, 95% CI 0.75-0.85), smoking (OR 0.64, 95% CI 0.59-0.70), younger age (OR ranging from 0.30, 95% CI 0.26-0.33 to 0.70, 95% CI 0.64-0.77), not being vaccinated against seasonal influenza (OR 0.77, 95% CI 0.72-0.84), and living in a household with children (OR 0.69, 95% CI 0.65-0.74).", {"entities": [[289, 298, "DISEASE"]]}], ["Most of these results hold when single countries are analyzed separately.", {"entities": []}], ["Given the opportunistic enrollment of self-selected volunteers in the Influenzanet study, we have investigated how sociodemographic and behavioral characteristics may be associated with follow-up participation in the Influenzanet cohort.", {"entities": []}], ["The study described in this paper shows that, overall, the most important determinants of participation are related to education and lifestyle: smoking, lower education level, younger age, people living with children, and people who have not been vaccinated against seasonal influenza tend to have a lower participation in follow-up.", {"entities": [[275, 284, "DISEASE"]]}], ["Despite the cross-country variation, the main findings are similar in the different national cohorts, and indeed the results are found to be valid also when performing a single-country analysis.", {"entities": []}], ["Differences between countries do not seem to play a crucial role in determining the factors associated with participation in follow-up.", {"entities": []}], ["Laboratory testing results are often used to monitor influenza illness in populations, but results may not be representative of illness burden and distribution, especially in populations that are geographically, socioeconomically, and racially/ethnically diverse.", {"entities": [[53, 62, "DISEASE"]]}], ["Descriptive epidemiology and chi\u2010square analyses using demographic, geographic, and medical condition prevalence comparisons were employed to assess whether a group of individuals with outpatient laboratory\u2010confirmed influenza illness during S eptember\u2013 N ovember 2009 represented the burden and distribution of influenza illness in N ew M exico ( NM ).", {"entities": [[217, 226, "DISEASE"], [312, 321, "DISEASE"]]}], ["The outpatient group was identified via random selection from those with positive influenza tests at NM laboratories.", {"entities": [[82, 91, "DISEASE"]]}], ["Comparison groups included those with laboratory\u2010confirmed H1N 1\u2010related influenza hospitalization and death identified via prospective active statewide surveillance, those with self\u2010reported influenza\u2010like illness ( ILI ) identified through random digit dialing, and the NM population.", {"entities": [[73, 82, "DISEASE"], [192, 201, "DISEASE"]]}], ["This analysis included 334 individuals with outpatient laboratory\u2010confirmed influenza, 888 individuals with laboratory\u2010confirmed H1N 1\u2010related hospitalization, 39 individuals with laboratory\u2010confirmed H1N 1\u2010related death, 334 individuals with ILI , and NM population data ( N \u00a0=\u00a02\u00a0036\u00a0112).", {"entities": [[76, 85, "DISEASE"]]}], ["The outpatient laboratory\u2010confirmed group had a different distribution of demographic and geographic factors, as well as prevalence of certain medical conditions as compared to the groups of laboratory\u2010confirmed H1N 1\u2010related hospitalization and death, the ILI group, and the NM population.", {"entities": []}], ["The outpatient laboratory\u2010confirmed group may reflect provider testing practices and potentially healthcare\u2010seeking behavior and access to care, rather than influenza burden and distribution in NM during the H1N 1 pandemic.", {"entities": [[157, 166, "DISEASE"]]}], ["Stroke is a major cause of dysphagia, but little is known about when and how dysphagic patients should be fed and treated after an acute stroke.", {"entities": []}], ["The purpose of this study is to establish the feasibility, risks and clinical outcomes of early intensive oral care and a new speech and language therapist/nurse led structured policy for oral feeding in patients with an acute intracerebral hemorrhage (ICH).", {"entities": []}], ["A total of 219 patients with spontaneous ICH who were admitted to our institution from 2004 to 2007 were retrospectively analyzed.", {"entities": []}], ["An early intervention program for oral feeding, which consisted of intensive oral care and early behavioral interventions, was introduced from April 2005 and fully operational by January 2006.", {"entities": []}], ["Outcomes were compared between an early intervention group of 129 patients recruited after January 2006 and a historical control group of 90 patients recruited between January 2004 and March 2005.", {"entities": []}], ["A logistic regression technique was used to adjust for baseline differences between the groups.", {"entities": []}], ["To analyze time to attain oral feeding, the Kaplan-Meier method and Cox proportional hazard model were used.", {"entities": []}], ["The proportion of patients who could tolerate oral feeding was significantly higher in the early intervention group compared with the control group (112/129 (86.8%) vs. 61/90 (67.8%); odds ratio 3.13, 95% CI, 1.59-6.15; P < 0.001).", {"entities": []}], ["After adjusting for baseline imbalances, the odds ratio was 4.42 (95% CI, 1.81-10.8; P = 0.001).", {"entities": []}], ["The incidence of chest infection was lower in the early intervention group compared with the control group (27/129 (20.9%) vs. 32/90 (35.6%); odds ratio 0.48, 95% CI, 0.26-0.88; P = 0.016).", {"entities": []}], ["A log-rank test found a significant difference in nutritional supplementation-free survival between the two groups (hazard ratio 1.94, 95% CI, 1.46-2.71; P < 0.001).", {"entities": []}], ["Our data suggest that the techniques can be used safely and possibly with enough benefit to justify a randomized controlled trial.", {"entities": []}], ["Further investigation is needed to solve the eating problems that are associated with patients recovering from a severe stroke.", {"entities": []}], ["This prospective cohort study is to verify the hypothesis that the balance of Th17 and Treg cells frequencies in the peripheral circulation is disturbed in patients with varying degrees of connective tissue diseases-associated pulmonary arterial hypertension (CTD-aPAH) and to prove the influence of Th17/Treg imbalance on prognosis.", {"entities": [[246, 258, "DISEASE"]]}], ["We detected the frequencies and absolute counts of Th17 and Treg cells and related serum cytokines secretion and expressions of key transcription factors in 117 patients with connective tissue diseases (CTD), 53 patients with CTD-aPAH, and 48 healthy volunteers.", {"entities": []}], ["Moreover, the median value according to levels of Th17/Treg ratios in patients with CTD-aPAH was chosen as basis of group division for survival analysis.", {"entities": []}], ["CTD-aPAH patients revealed significant increase in peripheral Th17 cells, Th17-related cytokines, and ROR \u03b3 t mRNA levels.", {"entities": []}], ["They also presented a significant decrease in Treg cells, Treg-related cytokines, and Foxp3 mRNA levels as compared with CTD patients and healthy controls.", {"entities": [[86, 91, "GENE"]]}], ["More importantly, the Th17/Treg ratio was significantly related to the severity and prognosis of CTD-aPAH.", {"entities": []}], ["This study indicated that the Th17/Treg axis disorder plays a critical role in CTD-aPAH.", {"entities": []}], ["Furthermore, the dynamic balance between Th17 and Treg cells was likely to influence prognosis of patients with CTD-aPAH.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is a chronic disease with repeated exacerbations resulting in gradual debilitation.", {"entities": [[0, 37, "DISEASE"]]}], ["The quality of life has been shown to be poor in patients with COPD despite efforts to improve self-management.", {"entities": []}], ["However, the evidence on the benefit of self-management in COPD is conflicting.", {"entities": []}], ["Whether this could be due to other unmet needs of patients have not been investigated.", {"entities": []}], ["Therefore, we aimed to explore unmet needs of patients from both patients and doctors managing COPD.", {"entities": []}], ["We conducted a qualitative study with doctors and patients in Malaysia.", {"entities": []}], ["We used convenience sampling to recruit patients until data saturation.", {"entities": []}], ["Eighteen patients and eighteen doctors consented and were interviewed using a semi-structured interview guide.", {"entities": []}], ["The interviews were audio-recorded, transcribed verbatim and checked by the interviewers.", {"entities": []}], ["Data were analysed using a thematic approach.", {"entities": []}], ["The themes were similar for both the patients and doctors.", {"entities": []}], ["Three main themes emerged: knowledge and awareness of COPD, psychosocial and physical impact of COPD and the utility of self-management.", {"entities": []}], ["Knowledge about COPD was generally poor.", {"entities": []}], ["Patients were not familiar with the term chronic obstructive pulmonary disease or COPD.", {"entities": [[41, 78, "DISEASE"]]}], ["The word \u2018asthma\u2019 was used synonymously with COPD by both patients and doctors.", {"entities": [[10, 16, "DISEASE"]]}], ["Most patients experienced difficulties in their psychosocial and physical functions such as breathlessness, fear and helplessness.", {"entities": []}], ["Most patients were not confident in self-managing their illness and prefer a more passive role with doctors directing their care.", {"entities": []}], ["In conclusion, our study showed that knowledge of COPD is generally poor.", {"entities": []}], ["There was mislabelling of COPD as asthma by both patients and physicians.", {"entities": [[34, 40, "DISEASE"]]}], ["This could have resulted in the lack of understanding of treatment options, outcomes, and prognosis of COPD.", {"entities": []}], ["The misconception that cough due to COPD was contagious, and breathlessness that resulted from COPD, had important physical and psychosocial impact, and could lead to social isolation.", {"entities": []}], ["Most patients and physicians did not favour self-management approaches, suggesting innovations based on self-management may be of limited benefit.", {"entities": []}], ["Various epidemiologic investigations have shown that ambient air pollution levels are associated with acute increases in hospital admissions and mortality in the United States and abroad.", {"entities": []}], ["The objectives of this investigation were a) to determine if racial minorities are more adversely affected by ambient air pollution than their white counterparts and b) to assess the contribution of socioeconomic status to any observed racial differences in pollution effect.", {"entities": []}], ["Time-series regression methods were conducted to investigate these hypotheses for daily respiratory hospital admissions in New York City, New York.", {"entities": []}], ["Pollutants considered included mean daily levels of particulate matter with a mass median aerodynamic diameter less than 10 microm (PM(10), ozone (O3), strong aerosol acidity (H+), and sulfates (SO4(2).", {"entities": []}], ["The relative risk for respiratory hospital admission was calculated for each pollutant for a maximum minus mean increment in mean daily pollutant concentration.", {"entities": []}], ["The greatest difference between the white and nonwhite subgroups was observed for O(3), where the white relative risk (RR) was 1.032 [95% confidence interval (CI): 0.977-1.089] and the nonwhite RR was 1.122 (95%CI: 1.074-1.172).", {"entities": []}], ["Although not statistically different from each other, the various pollutants' RR estimates for the Hispanic nonwhite category in New York City were generally larger in magnitude than those for the non-Hispanic white group.", {"entities": []}], ["When these analyses incorporated differences in the underlying respiratory hospitalization rates across races (that for nonwhites, was roughly twice that for whites), the disparities in attributable risks from pollution (in terms of excess admissions per day per million persons) were even larger for nonwhites versus whites.", {"entities": []}], ["However, when insurance status was used as an indicator of socioeconomic/health coverage status, higher RRs were indicated for the poor/working poor (i.e., those on Medicaid and the uninsured) than for those who were economically better off (i.e., the privately insured), even among non-Hispanic whites.", {"entities": []}], ["Thus, although potential racial differences in pollution exposures could not be explored as a factor, within-race analyses suggested that most of the apparent differences in air pollutant effects found across races were explained by socioeconomic and/or health care disparities.", {"entities": []}], ["Personal health records (PHRs) have emerged as an important tool with which patients can electronically communicate with their doctors and doctor\u2019s offices.", {"entities": []}], ["However, there is a lack of theoretical and empirical research on how patients perceive the PHR and the differences in perceptions between users and non-users of the PHR.", {"entities": []}], ["To apply a theoretical model, the diffusion of innovation model, to the study of PHRs and conduct an exploratory empirical study on the applicability of the model to the study of perceptions of PHRs.", {"entities": []}], ["A secondary objective was to assess whether perceptions of PHRs predict the perceived value of the PHR for communicating with the doctor\u2019s office.", {"entities": []}], ["We first developed a survey capturing perceptions of PHR use and other factors such as sociodemographic characteristics, access and use of technology, perceived innovativeness in the domain of information technology, and perceptions of privacy and security.", {"entities": []}], ["We then conducted a cross-sectional survey (N = 1500).", {"entities": []}], ["Patients were grouped into five groups of 300: PHR users (innovators, other users, and laggards), rejecters, and non-adopters.", {"entities": []}], ["We applied univariate statistical analysis (Pearson chi-square and one-way ANOVA) to assess differences among groups and used multivariate statistical techniques (factor analysis and multiple regression analysis) to assess the presence of factors identified by the diffusion of innovation model and the predictors of our dependent variable (value of PHR for communicating with the doctor\u2019s office).", {"entities": []}], ["Of the 1500 surveys, 760 surveys were returned for an overall response rate of 51%.", {"entities": []}], ["Computer use among non-adopters (75%) was lower than that among PHR users (99%) and rejecters (92%) ( P < .001).", {"entities": []}], ["Non-adopters also reported a lower score on personal innovativeness in information technology (mean = 2.8) compared to 3.6 and 3.1, respectively, for users and rejecters ( P < .001).", {"entities": []}], ["Four factors identified by the diffusion of innovation model emerged in the factor analysis: ease of use, relative advantage, observability, and trialability.", {"entities": []}], ["PHR users perceived greater ease of use and relative advantage of the PHR than rejecters and non-adopters ( P <.001).", {"entities": []}], ["Multiple regression analysis showed the following factors as significant positive predictors of the value of PHR for communicating with the doctor\u2019s office: relative advantage, ease of use, trialability, perceptions of privacy and security, age, and computer use.", {"entities": []}], ["Our study found that the diffusion of innovation model fits the study of perceptions of the PHR and provides a suitable theoretical and empirical framework to identify the factors that distinguish PHR users from non-users.", {"entities": []}], ["The ease of use and relative advantage offered by the PHR emerged as the most important domains among perceptions of PHR use and in predicting the value of the PHR.", {"entities": []}], ["Efforts to improve uptake and use of PHRs should focus on strategies that enhance the ease of use of PHRs and that highlight the relative advantages of PHRs.", {"entities": []}], ["Administrative data is often used to identify patients with chronic obstructive pulmonary disease (COPD), yet the validity of this approach is unclear.", {"entities": [[60, 97, "DISEASE"]]}], ["We sought to develop a predictive model utilizing administrative data to accurately identify patients with COPD.", {"entities": []}], ["Sequential logistic regression models were constructed using 9573 patients with postbronchodilator spirometry at two Veterans Affairs medical centers (2003-2007).", {"entities": []}], ["COPD was defined as: 1) FEV1/FVC <0.70, and 2) FEV1/FVC < lower limits of normal.", {"entities": []}], ["Model inputs included age, outpatient or inpatient COPD-related ICD-9 codes, and the number of metered does inhalers (MDI) prescribed over the one year prior to and one year post spirometry.", {"entities": []}], ["Model performance was assessed using standard criteria.", {"entities": []}], ["4564 of 9573 patients (47.7%) had an FEV1/FVC < 0.70.", {"entities": []}], ["The presence of \u22651 outpatient COPD visit had a sensitivity of 76% and specificity of 67%; the AUC was 0.75 (95% CI 0.74-0.76).", {"entities": []}], ["Adding the use of albuterol MDI increased the AUC of this model to 0.76 (95% CI 0.75-0.77) while the addition of ipratropium bromide MDI increased the AUC to 0.77 (95% CI 0.76-0.78).", {"entities": []}], ["The best performing model included: \u22656 albuterol MDI, \u22653 ipratropium MDI, \u22651 outpatient ICD-9 code, \u22651 inpatient ICD-9 code, and age, achieving an AUC of 0.79 (95% CI 0.78-0.80).", {"entities": []}], ["Commonly used definitions of COPD in observational studies misclassify the majority of patients as having COPD.", {"entities": []}], ["Using multiple diagnostic codes in combination with pharmacy data improves the ability to accurately identify patients with COPD.", {"entities": []}], ["The PHARMACOP-intervention significantly improved medication adherence and inhalation technique for patients with COPD compared with usual care.", {"entities": []}], ["This study aimed to evaluate its cost-effectiveness.", {"entities": []}], ["An economic analysis was performed from the Belgian healthcare payer\u2019s perspective.", {"entities": []}], ["A Markov model was constructed in which a representative group of patients with COPD (mean age of 70\u00a0years, 66% male, 43% current smokers and mean Forced Expiratory Volume in 1\u00a0second of % predicted of 50), was followed for either receiving the 3-month PHARMACOP-intervention or usual care.", {"entities": []}], ["Three types of costs were calculated: intervention costs, medication costs and exacerbation costs.", {"entities": []}], ["Outcome measures included the number of hospital-treated exacerbations, cost per prevented hospital-treated exacerbation and cost per Quality Adjusted Life-Year.", {"entities": []}], ["Follow-up was 1\u00a0year in the basecase analysis.", {"entities": []}], ["Sensitivity and scenario analyses (including long-term follow-up) were performed to assess uncertainty.", {"entities": []}], ["In the basecase analysis, the average overall costs per patient for the PHARMACOP-intervention and usual care were \u20ac2,221 and \u20ac2,448, respectively within the 1-year time horizon.", {"entities": []}], ["This reflects cost savings of \u20ac227 for the PHARMACOP-intervention.", {"entities": []}], ["The PHARMACOP-intervention resulted in the prevention of 0.07 hospital-treated exacerbations per patient (0.177 for PHARMACOP versus 0.244 for usual care).", {"entities": []}], ["Results showed robust cost-savings in various sensitivity analyses.", {"entities": []}], ["Optimization of current pharmacotherapy (e.g.", {"entities": []}], ["close monitoring of inhalation technique and medication adherence) has been shown to be cost-saving and should be considered before adding new therapies.", {"entities": []}], ["Neuroleptic malignant syndrome (NMS) is a life threatening neurologic emergency associated with neuroleptic or antipsychotic agent use.", {"entities": [[22, 30, "DISEASE"], [32, 35, "GENE"]]}], ["NMS is rarely related to thyroid disease.", {"entities": [[0, 3, "GENE"]]}], ["We report a case of NMS in a 66-year-old male with past medical history of paranoid schizophrenia on chlorpromazine, diabetes, hypertension and asthma, who presented with a humeral fracture after a fall.", {"entities": [[127, 139, "DISEASE"], [84, 97, "DISEASE"], [75, 97, "DISEASE"], [144, 150, "DISEASE"], [20, 23, "GENE"]]}], ["Patient developed hyperpyrexia, altered consciousness, autonomic instability, elevated serum creatine kinase (CK) without rigidity.", {"entities": []}], ["CT head and workup for infection were negative.", {"entities": []}], ["Electroencephalogram (EEG) showed generalized slow wave activity.", {"entities": []}], ["Ultrasound revealed a large goiter with nodules.", {"entities": [[28, 34, "DISEASE"]]}], ["Chlorpromazine was stopped due to concern of NMS.", {"entities": [[45, 48, "GENE"]]}], ["Patient was treated with cooling, fluid and electrolyte maintenance.", {"entities": []}], ["Patient slowly improved and CK level normalized.", {"entities": []}], ["Thyroid-stimulating hormone (TSH) level trended down from 10.2\u200amIU/L to 0.02\u200amIU/L.", {"entities": []}], ["Patient was discharged with aripiprazole.", {"entities": []}], ["Hypothyroidism predisposes patients to NMS by altering central dopaminergic systems.", {"entities": [[0, 14, "DISEASE"], [39, 42, "GENE"]]}], ["The typical symptoms may be masked by hypothyroidism.", {"entities": [[38, 52, "DISEASE"]]}], ["Thyroid dysfunction should be excluded in all patients with NMS.", {"entities": [[60, 63, "GENE"]]}], ["Discontinuing antipsychotic agents decreases TSH levels which maybe due to the negative feedback of dopaminergic activity.", {"entities": []}], ["This is the first case report describing dramatic changes in TSH after discontinuing chlorpromazine in NMS.", {"entities": [[103, 106, "GENE"]]}], ["Rhinosporiodiosis is a cosmopolitan disease of man and animals, endemic in India and Sri Lanka with main focus of infection in Southern Tamil Nadu.", {"entities": []}], ["Uttar Pradesh (UP) is not known to be an endemic zone for this disease .We present here the first case of nasal Rhinosporiodiosis from this non-endemic zone.", {"entities": []}], ["Transcription factors (TFs) often trigger developmental decisions, yet, their transcripts are often only moderately regulated and thus not easily detected by conventional statistics on expression data.", {"entities": []}], ["Here we present a method that allows to determine such genes based on trajectory analysis of time-resolved transcriptome data.", {"entities": []}], ["As a proof of principle, we have analysed apical stem cells of filamentous moss ( P. patens ) protonemata that develop from leaflets upon their detachment from the plant.", {"entities": []}], ["By our novel correlation analysis of the post detachment transcriptome kinetics we predict five out of 1,058 TFs to be involved in the signaling leading to the establishment of pluripotency.", {"entities": []}], ["Among the predicted regulators is the basic helix loop helix TF PpRSL1, which we show to be involved in the establishment of apical stem cells in P. patens .", {"entities": [[61, 63, "GENE"]]}], ["Our methodology is expected to aid analysis of key players of developmental decisions in complex plant and animal systems.", {"entities": []}], ["To provide the types, frequency and clinical information on common cranial nerve palsies seen at the Eye Clinic at the University of Port Harcourt Teaching Hospital.", {"entities": []}], ["A chart review was performed of patients who presented with cranial nerve palsy at the Eye Clinic over a 3-year period (January 2009-December 2011).", {"entities": [[60, 79, "DISEASE"]]}], ["Data were collected on age, sex, type of cranial nerve palsy, a history of systemic disease such as diabetes mellitus (DM), hypertension and cerebrovascular disease.", {"entities": [[124, 136, "DISEASE"], [141, 164, "DISEASE"], [41, 60, "DISEASE"], [100, 117, "DISEASE"]]}], ["Exclusion criteria included medical charts with incomplete data.", {"entities": []}], ["Data was analyzed using Epi-info Version 6.04D.", {"entities": []}], ["Statistical significance was indicated by P < 0.05.", {"entities": []}], ["Twenty-four patients had cranial nerve palsies.", {"entities": []}], ["There were 11 males and 13 females with a mean age of 34.50 \u00b1 18.41 years.", {"entities": []}], ["Four patients (26.6%) had exotropia while three patients (20%) had esotropia.", {"entities": [[67, 76, "DISEASE"], [26, 35, "DISEASE"]]}], ["Complete ophthalmoplegia was noted in two patients (13.3%).", {"entities": [[9, 24, "DISEASE"]]}], ["The 3 P < 0.01).", {"entities": []}], ["This is the first study in the literature on ocular cranial nerve palsies in Southern Nigeria.", {"entities": []}], ["Third and sixth cranial nerve palsies were the most common cases to present to the University of Port Harcourt Teaching Hospital Eye Clinic.", {"entities": []}], ["There was a statistically significant association to systemic disorders such as hypertension and DM and majority of cases with 6", {"entities": [[80, 92, "DISEASE"]]}], ["Exercise therapy is generally recommended in osteoarthritis (OA) of the hip or knee.", {"entities": [[45, 59, "DISEASE"]]}], ["However, coexisting disorders may bring additional impairments, which may necessitate adaptations to exercise for OA of the hip or knee.", {"entities": []}], ["For the purpose of developing an adapted protocol for exercise therapy in OA patients with coexisting disorders, information is needed on which specific coexisting disorders in OA are associated with activity limitations and pain.", {"entities": []}], ["To describe the relationship between specific coexisting disorders, activity limitations, and pain in patients with OA of the hip or knee, a cross-sectional cohort study among 288 older adults (50\u201385\u00a0years of age) with OA of hip or knee was conducted.", {"entities": []}], ["Subjects were recruited from three rehabilitation centers and two hospitals.", {"entities": []}], ["Demographic data, clinical data, information about coexisting disorders (i.e., comorbidity and other disorders), activity limitations (WOMAC: physical functioning domain), and pain (visual analogue scale (VAS)) were collected by questionnaire.", {"entities": []}], ["Statistical analysis included descriptive statistics and multivariate regression analysis.", {"entities": []}], ["Coexisting disorders associated with activity limitations were chronic back pain or hernia, arthritis of the hand or feet, and other chronic rheumatic diseases (all musculoskeletal disorders); diabetes and chronic cystitis (non-musculoskeletal disorders); hearing impairments in a face-to-face conversation, vision impairments in long distances, and dizziness in combination with falling (all sensory impairments); and overweight and obesity.", {"entities": [[206, 222, "DISEASE"], [434, 441, "DISEASE"], [214, 222, "DISEASE"], [92, 101, "DISEASE"]]}], ["Coexistent disorders associated with pain were arthritis of the hand or feet, other chronic rheumatic diseases (musculoskeletal disorders), and diabetes (non-musculoskeletal disorder).", {"entities": [[47, 56, "DISEASE"]]}], ["Specific disorders coexisting next to OA and associated with additional activity limitations and pain were identified.", {"entities": []}], ["These coexisting disorders need to be addressed in exercise therapy and rehabilitation for patients with OA of the hip or knee.", {"entities": []}], ["A long-term cohort study of working men in Israel found that smokers who reduced their cigarette consumption had lower subsequent mortality rates than those who did not.", {"entities": []}], ["We conducted comparable analyses in 2 populations of smokers in Scotland.", {"entities": []}], ["The Collaborative Study included 1,524 men and women aged 40\u201365 years in a working population who were screened twice, in 1970\u20131973 and 1977.", {"entities": []}], ["The Renfrew/Paisley Study included 3,730 men and women aged 45\u201364 years in a general population who were screened twice, in 1972\u20131976 and 1977\u20131979.", {"entities": []}], ["Both groups were followed up through 2010.", {"entities": []}], ["Subjects were categorized by smoking intensity at each screening as smoking 0, 1\u201310, 11\u201320, or \u226521 cigarettes per day.", {"entities": []}], ["At the second screening, subjects were categorized as having increased, maintained, or reduced their smoking intensity or as having quit smoking between the first and second screenings.", {"entities": []}], ["There was no evidence of lower mortality in all reducers compared with maintainers.", {"entities": []}], ["Multivariate adjusted hazard ratios of mortality were 0.91 (95% confidence interval (CI): 0.75, 1.10) in the Collaborative Study and 1.08 (95% CI: 0.97, 1.20) in the Renfrew/Paisley Study.", {"entities": []}], ["There was clear evidence of lower mortality among quitters in both the Collaborative Study (hazard ratio = 0.66, 95% CI: 0.56, 0.78) and the Renfrew/Paisley Study (hazard ratio = 0.75, 95% CI: 0.67, 0.84).", {"entities": []}], ["In the Collaborative Study only, we observed lower mortality similar to that of quitters among heavy smokers (\u226521 cigarettes/day) who reduced their smoking intensity.", {"entities": []}], ["These inconclusive results support the view that reducing cigarette consumption should not be promoted as a means of reducing mortality, although it may have a valuable role as a step toward smoking cessation.", {"entities": []}], ["The study of Hospitalizations for ambulatory care sensitive conditions (ACSH) has been proposed as an indirect measure of access to and receipt of care by older persons at the entryway to the Spanish public health system.", {"entities": []}], ["The aim of this work is to identify the rates of ACSH in persons 65 years or older living in different small-areas of the Community of Madrid (CM) and to detect possible differences in ACSH.", {"entities": []}], ["Cross-sectional, ecologic study, which covered all 34 health districts of the CM.", {"entities": []}], ["The study population consisted of all individuals aged 65 years or older residing in the CM between 2001 and 2003, inclusive.", {"entities": []}], ["Using hospital discharge data, avoidable ACSH were selected from the list of conditions validated for Spain.", {"entities": []}], ["Age- and sex-adjusted ACSH rates were calculated for the population of each health district and the statistics describing the data variability.", {"entities": []}], ["Point graphs and maps were designed to represent the ACSH rates in the different health districts.", {"entities": []}], ["Of all the hospitalizations, 16.5% (64,409) were ACSH.", {"entities": []}], ["Globally, the rate was higher among men: 33.15 per 1,000 populations vs. 22.10 in women and these differences were statistically significant (p < 0.05) in each district.", {"entities": []}], ["For men the range was 70.82 and the coefficient of variation (CV) was 0.47, while for women the range was 43.69 and the CV was 0.48.", {"entities": []}], ["In 93.1% of cases, the ACSH were caused by hypertensive cardiovascular disease, heart failure or pneumonia.", {"entities": [[97, 106, "DISEASE"]]}], ["A centripetal pattern can be observed, with lower rates in the districts in the center of the CM.", {"entities": []}], ["This geographic distribution is maintained after grouping by sex.", {"entities": []}], ["A significant variation is demonstrated in \"preventable\" hospitalizations between the different districts.", {"entities": []}], ["In all the districts the men present rates significantly higher than women.", {"entities": []}], ["Important variations in the access are observed the Primary Attention in spite of existing a universal sanitary cover.", {"entities": []}], ["HLA-G molecule has well-recognized tolerogenic properties, and the encoding gene shows lower frequency of polymorphism at the coding region but higher variability at regulatory 5\u2019 and 3\u2019 untranslated (3\u2019UTR) regions.", {"entities": [[0, 5, "GENE"]]}], ["At least three 3\u2019UTR polymorphic sites have been associated with HLA-G mRNA regulation, including the 14 base pair (14bp) Insertion/Deletion, +3142C-G and +3187A-G. We studied the association of polymorphic sites at 3\u2019UTR (sequencing analysis, encompassing the 14bp Ins-Del/+3003T-C/+3010C-G/+3027C-A/+3035C-T/+3142C-G/+3187A-G/+3196C-G polymorphic sites) with plasma soluble HLA-G levels (sHLA-G, detected by ELISA) in\u00a0187 French and 153 Brazilian healthy individuals.", {"entities": [[65, 70, "GENE"], [376, 381, "GENE"], [65, 70, "GENE"], [376, 381, "GENE"]]}], ["Allele and genotype frequencies were closely similar in both populations; however, Brazilians showed a higher HLA-G 3\u2019UTR haplotype diversity.", {"entities": [[110, 115, "GENE"]]}], ["Considering sHLA-G levels in both populations altogether, individuals presenting 14bp Del/Del showed higher levels compared to 14bpIns/Ins genotype ( P <0.05); those presenting +3010C/G showed higher levels compared to the +3010C-C genotype ( P < 0.05); those presenting +3027C-C showed higher levels than the +3027A-A genotype ( P < 0.05); and those bearing +3035C-C showed higher levels compared to the +3035C-T (P < 0.01) and +3035T-T ( P < 0.05) genotypes.", {"entities": []}], ["The analyses of 3\u2019UTR haplotypes showed that UTR-1 (DelTGCCCGC) was associated with higher expression of sHLA-G, whereas UTR-5 (InsTCCTGAC) and UTR-7 (InsTCATGAC) with lower expression and other UTRs (UTR-2/3/4/6) exhibited intermediate levels.", {"entities": []}], ["Since the differential expression of HLA-G may be beneficial or harmful depending on the underlying condition, the identification of individuals genetically programmed to differentially express HLA-G may help on defining novel strategies to control the immune response against the underlying disorder.", {"entities": [[37, 42, "GENE"], [194, 199, "GENE"], [37, 42, "GENE"], [194, 199, "GENE"]]}], ["Developing siRNA therapeutics poses technical challenges including appropriate molecular design and testing in suitable pre-clinical models.", {"entities": []}], ["We previously detailed sequence-selection and modification strategies for siRNA candidates targeting STAT6.", {"entities": [[101, 106, "GENE"]]}], ["Here, we describe methodology that evaluates the suitability of candidate siRNA for respiratory administration.", {"entities": []}], ["Chemically-modified siRNA exhibited similar inhibitory activity (IC 50 ) against STAT6 in vitro compared to unmodified siRNA and apical exposure testing with Caco-2 cell monolayers showed modification was not associated with cellular toxicity.", {"entities": [[81, 86, "GENE"]]}], ["Use of a modified RNA extraction protocol improved the sensitivity of a PCR-based bio-analytical assay (lower limit of siRNA strand quantification \u200a=\u200a 0.01 pg/\u00b5l) which was used to demonstrate that lung distribution profiles for both siRNAs were similar following intra-tracheal administration.", {"entities": []}], ["However, after 6 hours, modified siRNA was detected in lung tissue at concentrations >1000-fold higher than unmodified siRNA.", {"entities": []}], ["Evaluation in a rat model of allergic inflammation confirmed the persistence of modified siRNA in vivo , which was detectable in broncho-alveolar lavage (BAL) fluid, BAL cells and lung tissue samples, 72 hours after dosing.", {"entities": []}], ["Based upon the concept of respiratory allergy as a single airway disease, we considered nasal delivery as a route for respiratory targeting, evaluating an intra-nasal exposure model that involved simple dosing followed by fine dissection of the nasal cavity.", {"entities": []}], ["Notably, endogenous STAT6 expression was invariant throughout the nasal cavities and modified siRNA persisted for at least 3 days after administration.", {"entities": [[20, 25, "GENE"]]}], ["Coupled with our previous findings showing upregulated expression of inflammatory markers in nasal samples from asthmatics, these findings support the potential of intranasal siRNA delivery.", {"entities": []}], ["In summary, we demonstrate the successful chemical modification of STAT6 targeting siRNA, which enhanced bio-availability without cellular toxicity or reduced efficacy.", {"entities": [[67, 72, "GENE"]]}], ["We have established a robust, sensitive method for determining siRNA bio-distribution in vivo , and developed a nasal model to aid evaluation.", {"entities": []}], ["Further work is warranted.", {"entities": []}], ["Inhibition of chymase is likely to divulge therapeutic ways for the treatment of cardiovascular diseases, and fibrotic disorders.", {"entities": []}], ["To find novel and potent chymase inhibitors and to provide a new idea for drug design, we used both ligand-based and structure-based methods to perform the virtual screening(VS) of commercially available databases.", {"entities": []}], ["Different pharmacophore models generated from various crystal structures of enzyme may depict diverse inhibitor binding modes.", {"entities": []}], ["Therefore, multiple pharmacophore-based approach is applied in this study.", {"entities": []}], ["X-ray crystallographic data of chymase in complex with different inhibitors were used to generate four structure\u2013based pharmacophore models.", {"entities": []}], ["One ligand\u2013based pharmacophore model was also developed from experimentally known inhibitors.", {"entities": []}], ["After successful validation, all pharmacophore models were employed in database screening to retrieve hits with novel chemical scaffolds.", {"entities": []}], ["Drug-like hit compounds were subjected to molecular docking using GOLD and AutoDock.", {"entities": []}], ["Finally four structurally diverse compounds with high GOLD score and binding affinity for several crystal structures of chymase were selected as final hits.", {"entities": []}], ["Identification of final hits by three different pharmacophore models necessitates the use of multiple pharmacophore-based approach in VS process.", {"entities": []}], ["Quantum mechanical calculation is also conducted for analysis of electrostatic characteristics of compounds which illustrates their significant role in driving the inhibitor to adopt a suitable bioactive conformation oriented in the active site of enzyme.", {"entities": []}], ["In general, this study is used as example to illustrate how multiple pharmacophore approach can be useful in identifying structurally diverse hits which may bind to all possible bioactive conformations available in the active site of enzyme.", {"entities": []}], ["The strategy used in the current study could be appropriate to design drugs for other enzymes as well.", {"entities": []}], ["Recent pandemics of influenza A H1N1pdm09 virus have caused severe illness, especially in young people.", {"entities": [[20, 29, "DISEASE"]]}], ["Very few studies on influenza A H1N1pdm09 in post-pandemic periods exist, and there is no information on the severity of both seasonal influenza A(H1N1) and A(H3N2) from the same season, adjusting for potential confounders, including vaccine.", {"entities": [[20, 29, "DISEASE"], [135, 144, "DISEASE"]]}], ["We performed a retrospective observational study of adults hospitalized during the 2014 season with influenza A(H1N1) or A(H3N2).", {"entities": [[100, 109, "DISEASE"]]}], ["All patients underwent the same diagnostic and therapeutic protocol in a single hospital, including early Oseltamivir therapy.", {"entities": []}], ["We included 234 patients: 146 (62.4%) influenza A(H1N1) and 88 (37.6%) A(H3N2).", {"entities": [[38, 47, "DISEASE"]]}], ["A(H1N1) patients were younger (p<0.01), developed more pneumonia (p<0.01), respiratory complications (p = 0.015), ARDS (p = 0.047), and septic shock (p = 0.049), were more frequently admitted to the ICU (p = 0.022), required IMV (p = 0.049), and were less frequently vaccinated (p = 0.008).", {"entities": [[55, 64, "DISEASE"]]}], ["After adjusting for age, comorbidities, time from onset of illness, and vaccine status, influenza A(H1N1) (OR, 2.525), coinfection (OR, 2.821), and no vaccination (OR, 3.086) were independent risk factors for severe disease.", {"entities": [[88, 97, "DISEASE"]]}], ["Hospitalized patients with influenza A(H1N1) were more than twice as likely to have severe influenza.", {"entities": [[27, 36, "DISEASE"], [91, 100, "DISEASE"]]}], ["They were younger and most had not received the vaccine.", {"entities": []}], ["Our findings suggest that seasonal influenza A(H1N1) maintains some features of pandemic viruses, and recommend wider use of vaccination in younger adult high-risk patients.", {"entities": [[35, 44, "DISEASE"]]}], ["Treatment of non-small-cell lung cancer (NSCLC) might take into account comorbidities as an important variable.", {"entities": [[28, 39, "DISEASE"], [33, 39, "DISEASE"]]}], ["The aim of this study was to generate a new simplified comorbidity score (SCS) and to determine whether or not it improves the possibility of predicting prognosis of NSCLC patients.", {"entities": []}], ["A two-step methodology was used.", {"entities": []}], ["Step 1: An SCS was developed and its prognostic value was compared with classical prognostic determinants in the outcome of 735 previously untreated NSCLC patients.", {"entities": []}], ["Step 2: the SCS reliability as a prognostic determinant was tested in a different population of 136 prospectively accrued NSCLC patients with a formal comparison between SCS and the classical Charlson comorbidity index (CCI).", {"entities": []}], ["Prognosis was analysed using both univariate and multivariate (Cox model) statistics.", {"entities": []}], ["The SCS summarised the following variables: tobacco consumption, diabetes mellitus and renal insufficiency (respective weightings 7, 5 and 4), respiratory, neoplastic and cardiovascular comorbidities and alcoholism (weighting=1 for each item).", {"entities": [[65, 82, "DISEASE"]]}], ["In step 1, aside from classical variables such as age, stage of the disease and performance status, SCS was a statistically significant prognostic variable in univariate analyses.", {"entities": []}], ["In the Cox model weight loss, stage grouping, performance status and SCS were independent determinants of a poor outcome.", {"entities": []}], ["There was a trend towards statistical significance for age ( P =0.08) and leucocytes count ( P =0.06).", {"entities": []}], ["In Step 2, both SCS and well-known prognostic variables were found as significant determinants in univariate analyses.", {"entities": []}], ["There was a trend towards a negative prognostic effect for CCI.", {"entities": []}], ["In multivariate analysis, stage grouping, performance status, histology, leucocytes, lymphocytes, lactate dehydrogenase, CYFRA 21-1 and SCS were independent determinants of a poor prognosis.", {"entities": []}], ["CCI was removed from the Cox model.", {"entities": []}], ["In conclusion, the SCS, constructed as an independent prognostic factor in a large NSCLC patient population, is validated in another prospective population and appears more informative than the CCI in predicting NSCLC patient outcome.", {"entities": []}], ["Studies have identified that environmental tobacco smoke exposure is associated with sociodemographic factors such as age, sex, and socioeconomic status, but few studies have been conducted in South Korea.", {"entities": []}], ["In this study, the authors investigated the extent of environmental tobacco smoke exposure and factors related in a nationally representative sample of Korean adults.", {"entities": []}], ["The data of 7,801 adults aged 19 years and over collected during the 2005 Korea National Health and Nutrition Examination Survey were analyzed.", {"entities": []}], ["Information on smoking habits and exposure to environmental tobacco smoke was obtained by self-reports using a standardized questionnaire.", {"entities": []}], ["Risks of environmental tobacco smoke exposure conferred by sociodemographic variables and behavioral risk factors were evaluated using logistic regression methods.", {"entities": []}], ["Overall, 36.1% of nonsmokers (defined as those not currently smoking) and 50.1% of current smokers were found to be exposed to environmental tobacco smoke either at work or at home.", {"entities": []}], ["Among the nonsmokers, women were more likely to be exposed to environmental tobacco smoke at home (OR = 5.22, 95%CI, 4.08-6.67).", {"entities": []}], ["Furthermore, an inverse relationship was found between education level and the risk of environmental tobacco smoke exposure at home (OR = 1.73, 95%CI, 1.38-2.17 for those with a high school education; OR = 2.30, 95%CI, 1.68-3.16 for those with a middle school education; and OR = 2.58, 95%CI, 1.85-3.59 for those with less than an elementary school education vs. those with a college education or more).", {"entities": []}], ["In addition, those with office, sales service, or manual labor jobs were found to be at significantly higher risk of environmental tobacco smoke exposure at work than those with professional, administrative, or managerial jobs.", {"entities": []}], ["Also, the risk of environmental tobacco smoke exposure in the workplace was significantly higher for alcohol drinkers than non-drinkers (OR = 1.23, 95%CI, 1.07-1.47).", {"entities": []}], ["After adjusting for age, sex and education, it was found that those exposed to environmental tobacco smoke at home were more likely to have been admitted to hospital during the previous year (OR 1.29, 95%CI, 1.002-1.66).", {"entities": []}], ["In this study of Korean adults, exposure to environmental tobacco smoke at home or work was found to be affected by sex, age, marital status, educational level, and type of occupation.", {"entities": []}], ["Accordingly, these factors should be given appropriate consideration by those developing policies or interventions designed to control exposure to environmental tobacco smoke.", {"entities": []}], ["To assess whether being employed in a smoke-free workplace is associated with living in a smoke-free home in 15 low and middle income countries (LMICs).", {"entities": []}], ["Country-specific individual level analyses of cross-sectional Global Adult Tobacco Survey data (2008\u20132011) from 15 LMICs was conducted using multiple logistic regression.", {"entities": []}], ["The dependent variable was living in a smoke-free home ; the independent variable was being employed in a smoke-free workplace .", {"entities": []}], ["Analyses were adjusted for age, gender, residence, region, education, occupation, current smoking, current smokeless tobacco use and number of household members.", {"entities": []}], ["Individual country results were combined in a random effects meta-analysis.", {"entities": []}], ["In each country, the percentage of participants employed in a smoke-free workplace who reported living in a smoke-free home was higher than those employed in a workplace not smoke-free.", {"entities": []}], ["The adjusted odds ratios (AORs) of living in a smoke-free home among participants employed in a smoke-free workplace (vs. those employed where smoking occurred) were statistically significant in 13 of the 15 countries, ranging from 1.12 [95% CI 0.79\u20131.58] in Uruguay to 2.29 [1.37\u20133.83] in China.", {"entities": []}], ["The pooled AOR was 1.61 [1.46\u20131.79].", {"entities": []}], ["In LMICs, employment in a smoke-free workplace is associated with living in a smoke-free home.", {"entities": []}], ["Accelerated implementation of comprehensive smoke-free policies is likely to result in substantial population health benefits in these settings.", {"entities": []}], ["\u2022 Individual level Global Adult Tobacco Survey data analyzed for 15 LMICs (2008\u20132010) \u2022 Studied association of smoke-free workplace policy with living in smoke-free home \u2022 Implementation of smoke-free workplace policy varies greatly across LMICs.", {"entities": []}], ["\u2022 Smoke-free homes 60% more likely with employment in smoke-free workplaces in LMICs \u2022 100% smoke-free policy in LMICs changes social norms around exposing others to SHS.", {"entities": []}], ["Individual level Global Adult Tobacco Survey data analyzed for 15 LMICs (2008\u20132010) Studied association of smoke-free workplace policy with living in smoke-free home Implementation of smoke-free workplace policy varies greatly across LMICs.", {"entities": []}], ["Smoke-free homes 60% more likely with employment in smoke-free workplaces in LMICs 100% smoke-free policy in LMICs changes social norms around exposing others to SHS.", {"entities": []}], ["Background\u2002 Patients with underlying disease represent a high\u2010risk group for influenza\u2010associated complications and hospitalization.", {"entities": [[77, 86, "DISEASE"]]}], ["However, few studies investigated the immunogenicity of influenza vaccine in patients with liver disease.", {"entities": [[56, 65, "DISEASE"], [91, 104, "DISEASE"]]}], ["Objective\u2002 To examine immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with liver disease and to explore the associated factors on lowered immune response.", {"entities": [[40, 49, "DISEASE"], [88, 101, "DISEASE"]]}], ["Patients/Methods\u2002 A single subcutaneous dose of monovalent inactivated unadjuvanted split\u2010virus influenza A(H1N1)pdm09 vaccination was performed in 80 patients with chronic hepatitis C virus infection at Osaka City University Hospital in Japan.", {"entities": [[96, 105, "DISEASE"], [173, 182, "DISEASE"]]}], ["To measure the hemagglutination inhibition antibody titer, serum samples were collected before and 3\u2003weeks after vaccination.", {"entities": []}], ["Results\u2002 No serious adverse events were observed.", {"entities": []}], ["After vaccination, antibody titers \u22651:40 were observed in 56 patients (71%).", {"entities": []}], ["The corresponding seroconversion proportion was 72%, and the mean fold rise was 10\u00b73.", {"entities": []}], ["Immune responses were robust regardless of severity of liver disease or existence of probable cirrhosis.", {"entities": [[55, 68, "DISEASE"]]}], ["However, patients with older age, lower body mass index, or receiving Stronger Neo\u2010Minophagen C tended to show lower antibody responses to A(H1N1)pdm09 vaccine.", {"entities": []}], ["In addition, reduced immune responses were observed in patients who had received the 2009/10 seasonal vaccination prior to A(H1N1)pdm09 vaccination.", {"entities": []}], ["Conclusions\u2002 Single dose of A(H1N1)pdm09 vaccine achieved a sufficient level of immunity among patients with chronic hepatitis C. Antibody response may be affected by age, body mass index, Stronger Neo\u2010Minophagen C administration, and recent seasonal influenza vaccination.", {"entities": [[251, 260, "DISEASE"], [117, 126, "DISEASE"]]}], ["A genome-wide association study identified single nucleotide polymorphisms (SNPs) rs3077 and rs9277535 located in the 3\u2032 untranslated regions of human leukocyte antigen (HLA) class II genes HLA-DPA1 and HLA-DPB1 , respectively, as the independent variants most strongly associated with chronic hepatitis B.", {"entities": [[294, 303, "DISEASE"], [170, 173, "GENE"], [190, 193, "GENE"], [203, 206, "GENE"], [190, 198, "GENE"], [203, 211, "GENE"]]}], ["We examined whether these SNPs are associated with mRNA expression of HLA-DPA1 and HLA-DPB1 .", {"entities": [[70, 78, "GENE"], [83, 91, "GENE"]]}], ["We identified gene expression-associated SNPs (eSNPs) in normal liver samples obtained from 651 individuals of European ancestry by integrating genotype (\u223c650\u2009000 SNPs) and gene expression (>39\u2009000 transcripts) data from each sample.", {"entities": []}], ["We used the Kruskal\u2013Wallis test to determine associations between gene expression and genotype.", {"entities": []}], ["To confirm findings, we measured allelic expression imbalance (AEI) of complementary DNA compared with DNA in liver specimens from subjects who were heterozygous for rs3077 and rs9277535.", {"entities": []}], ["On a genome-wide basis, rs3077 was the SNP most strongly associated with HLA-DPA1 expression ( p =10 HLA-DPB1 expression ( p =10 p =3.0 \u00d7 10 p =0.001; 17 samples).", {"entities": [[73, 81, "GENE"], [101, 109, "GENE"]]}], ["We conclude that the variants previously associated with chronic hepatitis B are also strongly associated with mRNA expression of HLA-DPA1 and HLA-DPB1 , suggesting that expression of these genes is important in control of HBV.", {"entities": [[65, 74, "DISEASE"], [130, 138, "GENE"], [143, 151, "GENE"]]}], ["Activin A, a member of the TGF-\u03b2 superfamily of cytokines, was originally identified as an inducer of follicle stimulating hormone release, but has since been ascribed roles in normal physiological processes, as an immunoregulatory cytokine and as a driver of fibrosis.", {"entities": []}], ["In the last 10\u201315 years, it has also become abundantly clear that activin A plays an important role in the regulation of asthmatic inflammation and airway remodelling.", {"entities": []}], ["This review provides a brief introduction to the activin A/TGF-\u03b2 superfamily, focussing on the regulation of receptors and signalling pathways.", {"entities": []}], ["We examine the contradictory evidence for generalized pro- vs. anti-inflammatory effects of activin A in inflammation, before appraising its role in asthmatic inflammation and airway remodelling specifically by evaluating data from both murine models and clinical studies.", {"entities": []}], ["We identify key issues to be addressed, paving the way for safe exploitation of modulation of activin A function for treatment of allergic asthma and other inflammatory lung diseases.", {"entities": [[130, 145, "DISEASE"], [139, 145, "DISEASE"]]}], ["COPD is a frequent and significant cause of respiratory morbidity in HIV-infected patients despite the control of HIV.", {"entities": []}], ["We aimed to analyze the factors correlated with COPD in this population to evaluate the existence of specific indicators of vulnerability in this population.", {"entities": []}], ["623 HIV-infected outpatients were enrolled during one year.", {"entities": []}], ["This population was characterised by a dedicated questionnaire and electronic patient records.", {"entities": []}], ["COPD screening was performed according to recommended spirometric criteria.", {"entities": []}], ["The prevalence of COPD was 9.0%.", {"entities": []}], ["Age and smoking were independently correlated with COPD (OR, 1.61 per 10 years increase, P = 0.007; OR, 1.28 per 10 pack-year increase, P = 0.003, respectively).", {"entities": []}], ["Body mass index (BMI) and CD4 cell-count were independently and negatively correlated with COPD (OR, 0.78, P < 0.001; 0R, 0.77 per 100 cell/mm P < 0.001, respectively).", {"entities": [[26, 29, "GENE"]]}], ["Among COPD patients, 77% did not know their diagnosis.", {"entities": []}], ["Five COPD-patients never smoked and 44.2% did not have any respiratory symptoms and so were not eligible to perform a spirometry according to the guidelines.", {"entities": []}], ["In addition to known risk factors, immune defect through CD4 cell count was independently and strongly correlated with COPD.", {"entities": [[57, 60, "GENE"]]}], ["COPD is largely underdiagnosed and thus unmanaged.", {"entities": []}], ["However, early management and urgent smoking cessation are essential to improve prognosis.", {"entities": []}], ["Clinicians\u2019 awareness on the particular vulnerability for COPD in HIV-infected patients is crucial.", {"entities": []}], ["Moreover, indications to perform conventional spirometry to diagnose COPD may include more parameters than tobacco-smoking and respiratory complaints with a particular concern toward patients with a profound CD4 cell count defect.", {"entities": [[208, 211, "GENE"]]}], ["Currently, the genetic variants identified by genome wide association study (GWAS) generally only account for a small proportion of the total heritability for complex disease.", {"entities": []}], ["One crucial reason is the underutilization of gene-gene joint effects commonly encountered in GWAS, which includes their main effects and co-association.", {"entities": []}], ["However, gene-gene co-association is often customarily put into the framework of gene-gene interaction vaguely.", {"entities": []}], ["From the causal graph perspective, we elucidate in detail the concept and rationality of gene-gene co-association as well as its relationship with traditional gene-gene interaction, and propose two Fisher r-to-z transformation-based simple statistics to detect it.", {"entities": []}], ["Three series of simulations further highlight that gene-gene co-association refers to the extent to which the joint effects of two genes differs from the main effects, not only due to the traditional interaction under the nearly independent condition but the correlation between two genes.", {"entities": []}], ["The proposed statistics are more powerful than logistic regression under various situations, cannot be affected by linkage disequilibrium and can have acceptable false positive rate as long as strictly following the reasonable GWAS data analysis roadmap.", {"entities": []}], ["Furthermore, an application to gene pathway analysis associated with leprosy confirms in practice that our proposed gene-gene co-association concepts as well as the correspondingly proposed statistics are strongly in line with reality.", {"entities": [[69, 76, "DISEASE"]]}], ["Annexin A1 (AnxA1) is an endogenous protein that modulates anti-inflammatory processes, and its therapeutic potential has been reported in a range of inflammatory diseases.", {"entities": [[12, 17, "GENE"]]}], ["The effect of AnxA1 on ischemia-reperfusion (IR)-induced lung injury has not been examined.", {"entities": [[23, 31, "DISEASE"], [14, 19, "GENE"]]}], ["In this study, isolated, perfused rat lungs were subjected to IR lung injury induced by ischemia for 40 min, followed by reperfusion for 60 min.", {"entities": [[88, 96, "DISEASE"]]}], ["The rat lungs were randomly treated with vehicle (phosphate-buffered saline), and Ac2-26 (an active N-terminal peptide of AnxA1) with or without an N -formyl peptide receptor (FPR) antagonist N-Boc-Phe-Leu-Phe-Leu-Phe (Boc2).", {"entities": [[122, 127, "GENE"]]}], ["An in vitro study of the effects of Ac2-26 on human alveolar epithelial cells subjected to hypoxia-reoxygenation was also investigated.", {"entities": []}], ["Administration of Ac2-26 in IR lung injury produced a significant attenuation of lung edema, pro-inflammatory cytokine production recovered in bronchoalveolar lavage fluid, oxidative stress, apoptosis, neutrophil infiltration, and lung tissue injury.", {"entities": []}], ["Ac2-26 also decreased AnxA1 protein expression, inhibited the activation of nuclear factor-\u03baB and mitogen-activated protein kinase pathways in the injured lung tissue.", {"entities": [[22, 27, "GENE"]]}], ["Finally, treatment with Boc2 abolished the protective action of Ac2-26.", {"entities": []}], ["The results indicated that Ac2-26 had a protective effect against acute lung injury induced by IR, which may be via the activation of the FPR.", {"entities": []}], ["Heart failure is a common cause of unplanned hospital admissions but there is little evidence on why, despite evidence-based interventions, admissions occur.", {"entities": []}], ["This study aimed to identify critical points on patient pathways where risk of admission is increased and identify barriers to the implementation of evidence-based interventions.", {"entities": []}], ["Multicentre, longitudinal, patient-led ethnography.", {"entities": []}], ["National Health Service settings across primary, community and secondary care in three geographical locations in England, UK.", {"entities": []}], ["31 patients with severe or difficult to manage heart failure followed for up to 11\u2005months; 9 carers; 55 healthcare professionals.", {"entities": []}], ["Fragmentation of healthcare, inequitable provision of services and poor continuity of care presented barriers to interventions for heart failure.", {"entities": []}], ["Critical points where a reduction in the risk of current or future admission occurred throughout the pathway.", {"entities": []}], ["At the beginning some patients did not receive a formal clinical diagnosis, in addition patients lacked information about heart failure, self-care and knowing when to seek help.", {"entities": []}], ["Some clinicians lacked knowledge about diagnosis and management.", {"entities": []}], ["Misdiagnoses of symptoms and discontinuity of care resulted in unplanned admissions.", {"entities": []}], ["Approaching end of life, patients were admitted to hospital when other options including palliative care could have been appropriate.", {"entities": []}], ["Findings illustrate the complexity involved in caring for people with heart failure.", {"entities": []}], ["Fragmented healthcare and discontinuity of care added complexity and increased the likelihood of suboptimal management and unplanned admissions.", {"entities": []}], ["Diagnosis and disclosure is a vital first step for the patient in a journey of acceptance and learning to self-care/monitor.", {"entities": []}], ["The need for clinician education about heart failure and specialist services was acknowledged.", {"entities": []}], ["Patient education should be seen as an ongoing \u2018conversation\u2019 with trusted clinicians and end-of-life planning should be broached within this context.", {"entities": []}], ["The role of the chemokine CCL2 in breast cancer is controversial.", {"entities": [[34, 47, "DISEASE"], [41, 47, "DISEASE"], [26, 30, "GENE"]]}], ["While CCL2 recruits and activates pro-tumor macrophages, it is also reported to enhance neutrophil-mediated anti-tumor activity.", {"entities": [[6, 10, "GENE"]]}], ["Moreover, loss of CCL2 in early development enhances breast cancer progression.", {"entities": [[53, 66, "DISEASE"], [60, 66, "DISEASE"], [18, 22, "GENE"]]}], ["To clarify these conflicting findings, we examined the ability of CCL2 to alter na\u00efve and tumor entrained neutrophil production of ROS, release of granzyme-B, and killing of tumor cells in multiple mouse models of breast cancer.", {"entities": [[214, 227, "DISEASE"], [221, 227, "DISEASE"], [66, 70, "GENE"]]}], ["CCL2 was delivered intranasally in mice to elevate CCL2 levels in the lung and effects on seeding and growth of breast tumor cells were evaluated.", {"entities": [[0, 4, "GENE"], [51, 55, "GENE"], [0, 4, "GENE"], [51, 55, "GENE"]]}], ["The TCGA data base was queried for relationship between CCL2 expression and relapse free survival of breast cancer patients and compared to subsets of breast cancer patients.", {"entities": [[101, 114, "DISEASE"], [151, 164, "DISEASE"], [108, 114, "DISEASE"], [158, 164, "DISEASE"], [56, 60, "GENE"]]}], ["Even though each of the tumor cell lines studied produced approximately equal amounts of CCL2, exogenous delivery of CCL2 to co-cultures of breast tumor cells and neutrophils enhanced the ability of tumor-entrained neutrophils (TEN) to kill the less aggressive 67NR variant of 4T1 breast cancer cells.", {"entities": [[281, 294, "DISEASE"], [288, 294, "DISEASE"], [89, 93, "GENE"], [117, 121, "GENE"], [89, 93, "GENE"], [117, 121, "GENE"]]}], ["However, exogenous CCL2 did not enhance na\u00efve or TEN neutrophil killing of more aggressive 4T1 or PyMT breast tumor cells.", {"entities": [[19, 23, "GENE"]]}], ["Moreover, this anti-tumor activity was not observed in vivo.", {"entities": []}], ["Intranasal delivery of CCL2 to BALB/c mice markedly enhanced seeding and outgrowth of 67NR cells in the lung and increased the recruitment of CD4+ T cells and CD8+ central memory T cells into lungs of tumor bearing mice.", {"entities": [[23, 27, "GENE"]]}], ["There was no significant increase in the recruitment of CD19+ B cells, or F4/80+, Ly6G+ and CD11c\u2009+\u2009myeloid cells.", {"entities": []}], ["CCL2 had an equal effect on CD206+ and MHCII+ populations of macrophages, thus balancing the pro- and anti-tumor macrophage cell population.", {"entities": [[0, 4, "GENE"]]}], ["Analysis of the relationship between CCL2 levels and relapse free survival in humans revealed that overall survival is not significantly different between high CCL2 expressing and low CCL2 expressing breast cancer patients grouped together.", {"entities": [[200, 213, "DISEASE"], [207, 213, "DISEASE"], [37, 41, "GENE"], [160, 164, "GENE"], [184, 188, "GENE"], [37, 41, "GENE"], [160, 164, "GENE"], [184, 188, "GENE"], [37, 41, "GENE"], [160, 164, "GENE"], [184, 188, "GENE"]]}], ["However, examination of the relationship between high CCL2 expressing basal-like, HER2+ and luminal B breast cancer patients revealed that higher CCL2 expressing tumors in these subgroups have a significantly higher probability of surviving longer than those expressing low CCL2.", {"entities": [[102, 115, "DISEASE"], [109, 115, "DISEASE"], [54, 58, "GENE"], [146, 150, "GENE"], [274, 278, "GENE"], [54, 58, "GENE"], [146, 150, "GENE"], [274, 278, "GENE"], [54, 58, "GENE"], [146, 150, "GENE"], [274, 278, "GENE"]]}], ["While our in vitro data support a potential anti-tumor role for CCL2 in TEN neutrophil- mediated tumor killing in poorly aggressive tumors, intranasal delivery of CCL2 increased CD4+ T cell recruitment to the pre-metastatic niche of the lung and this correlated with enhanced seeding and growth of tumor cells.", {"entities": [[64, 68, "GENE"], [163, 167, "GENE"], [64, 68, "GENE"], [163, 167, "GENE"]]}], ["These data indicate that effects of CCL2/CCR2 antagonists on the intratumoral leukocyte content should be monitored in ongoing clinical trials using these agents.", {"entities": []}], ["The online version of this article (doi:10.1186/s12885-017-3074-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We developed a Dutch outpatient multidisciplinary group treatment (Go4it) for obese adolescents, including cognitive behavioural therapy and education on healthy dietary and physical activity behaviour.", {"entities": []}], ["This study examined the effect of Go4it on Health Related Quality of Life (HRQoL).", {"entities": []}], ["At our outpatient paediatric obesity clinic, obese adolescents (n\u2009=\u2009122, 11\u201318\u00a0years) were randomly assigned to 1) Go4it, 7 sessions with an interval of 2\u00a0weeks or 2) current regular care consisting of referral to a dietician in the home care setting (controls).", {"entities": [[29, 36, "DISEASE"]]}], ["Linear mixed model analysis was performed to evaluate the intervention effects on HRQoL at 6 and 18-month follow-ups.", {"entities": []}], ["HRQoL indicators included the Child Health Questionnaire, the Paediatric Quality of Life Inventory\u2122 Version 4.0 (PedsQL\u21224.0), and the Body Esteem Scale (BES).", {"entities": []}], ["In total, 95 adolescents (Go4it 57, controls 38) were included in the current analysis with a mean age of 14.5\u2009\u00b1\u20091.7 and mean BMI-SDS of 2.9\u2009\u00b1\u20090.5.", {"entities": []}], ["At baseline, all participants experienced lower levels of physical and psychosocial well-being compared to a normal weight reference group.", {"entities": []}], ["At the 18\u00a0month follow-up, we found small but beneficial intervention effects on all subscales of the PedsQL\u21224.0 and BES questionnaires.", {"entities": []}], ["Two subscales improved significantly; i.e., physical health ( between group difference 5.4; 95%CI: 0.3; 10.6), and school functioning ( between group difference 7.4; 95%CI: 1.6; 13.2).", {"entities": []}], ["Obese adolescents experienced lower HRQoL than their healthy peers.", {"entities": []}], ["The Go4it intervention had small beneficial effects on HRQoL compared to the current regular care practices for obese adolescents.", {"entities": []}], ["Netherlands Trial Register: ISRCTN27626398 , METC number: 05.134 (WMO, monocenter).", {"entities": []}], ["Remarkable interest has risen in the idea that oxidative/nitrosative stress is mediated in the etiology of numerous human diseases.", {"entities": []}], ["Oxidative/Nitrosative stress is the result of an disequilibrium in oxidant/antioxidant which reveals from continuous increase of Reactive Oxygen and Reactive Nitrogen Species production.", {"entities": []}], ["The aim of this review is to emphasize with current information the importance of antioxidants which play the role in cellular responce against oxidative/nitrosative stress, which would be helpful in enhancing the knowledge of any biochemist, pathophysiologist, or medical personnel regarding this important issue.", {"entities": []}], ["Products of lipid peroxidation have commonly been used as biomarkers of oxidative/nitrosative stress damage.", {"entities": []}], ["Lipid peroxidation generates a variety of relatively stable decomposition end products, mainly \u03b1, \u03b2-unsaturated reactive aldehydes, such as malondialdehyde, 4-hydroxy-2-nonenal, 2-propenal (acrolein) and isoprostanes, which can be measured in plasma and urine as an indirect index of oxidative/nitrosative stress.", {"entities": []}], ["Antioxidants are exogenous or endogenous molecules that mitigate any form of oxidative/nitrosative stress or its consequences.", {"entities": []}], ["They may act from directly scavenging free radicals to increasing antioxidative defences.", {"entities": []}], ["Antioxidant deficiencies can develop as a result of decreased antioxidant intake, synthesis of endogenous enzymes or increased antioxidant utilization.", {"entities": []}], ["Antioxidant supplementation has become an increasingly popular practice to maintain optimal body function.", {"entities": []}], ["However, antoxidants exhibit pro-oxidant activity depending on the specific set of conditions.", {"entities": []}], ["Of particular importance are their dosage and redox conditions in the cell.", {"entities": []}], ["Affect and emotion are defined as \u201can essential part of the process of an organism's interaction with stimuli.\u201d Similar to affect, the immune response is the \u201ctool\u201d the body uses to interact with the external environment.", {"entities": []}], ["Thanks to the emotional and immunological response, we learn to distinguish between what we like and what we do not like, to counteract a broad range of challenges, and to adjust to the environment we are living in.", {"entities": []}], ["Recent compelling evidence has shown that the emotional and immunological systems share more than a similarity of functions.", {"entities": []}], ["This review article will discuss the crosstalk between these two systems and the need for a new scientific area of research called affective immunology.", {"entities": []}], ["Research in this field will allow a better understanding and appreciation of the immunological basis of mental disorders and the emotional side of immune diseases.", {"entities": []}], ["We aimed to explore the role of IL-10 -592 A/C SNP in the susceptibility to gastric cancer through a systematic review and meta-analysis.", {"entities": [[84, 90, "DISEASE"]]}], ["Each initially included article was scored for quality appraisal.", {"entities": []}], ["17 studies were eligible for the meta-analysis.", {"entities": []}], ["We adopted the most probably appropriate genetic model (recessive model).", {"entities": []}], ["Potential sources of heterogeneity were sought out via subgroup and sensitivity analyses, and publication biases were estimated.", {"entities": []}], ["IL-10-592 AA genotype is associated with the reduced risk of developing gastric cancer among Asians and even apparently observed among Asians high quality subgroup, suggesting IL-10-592 AA genotype may seem to be more protective from overall gastric cancer in Asian populations.", {"entities": [[80, 86, "DISEASE"], [250, 256, "DISEASE"]]}], ["IL-10-592 AA genotype is also associated with the overall reduced gastric cancer susceptibility in persons with H. pylori infection compared with controls without H. pylori infection, suggesting IL-10-592 AA genotype may seem to be more protective from overall gastric cancer susceptibility in persons infected with H. pylori .", {"entities": [[74, 80, "DISEASE"], [269, 275, "DISEASE"]]}], ["IL-10-592 AA genotype is not associated with either pathologic subtypes (intestinal or diffuse) or anatomic subtypes (non-cardia or cardia) of gastric cancer susceptibility.", {"entities": [[151, 157, "DISEASE"]]}], ["Genotyping methods like direct sequencing should be highly advocated to be conducted in future well-designed high quality studies among different ethnicities or populations.", {"entities": []}], ["In order to determine differences in cardiovascular cell response during nutrient stress to different cardiovascular protective drugs, we investigated cell responses of serum starved mouse cardiomyocyte HL-1 cells and primary cultures of human coronary artery vascular smooth muscles (hCAVSMCs) to treatment with \u03b2-blockers (atenolol, metoprolol, carvedilol, nebivolol, 3\u03bcM each), AT1R blocker losartan (1\u03bcM) and AT2R agonists (CGP42112A and novel agonist NP-6A4, 300nM each).", {"entities": []}], ["Treatment with nebivolol, carvedilol, metoprolol and atenolol suppressed Cell Index (CI) of serum-starved HL-1 cells (\u226417%, \u22648%, \u226415% and \u226415% respectively) as measured by the Xcelligence Real-Time Cell Analyzer (RTCA).", {"entities": []}], ["Conversely, CI was increased by Ang II (\u22659.6%), CGP42112A (\u226514%), and NP-6A4 (\u226525%) respectively and this effect was blocked by AT2R antagonist PD123319, but not by AT1R antagonist losartan.", {"entities": [[32, 35, "GENE"]]}], ["Thus, the CI signature for each drug could be unique.", {"entities": []}], ["MTS cell proliferation assay showed that NP-6A4, but not other drugs, increased viability (\u226520%) of HL-1 and hCAVSMCs.", {"entities": []}], ["Wheat Germ Agglutinin (WGA) staining showed that nebivolol was most effective in reducing cell sizes of HL-1 and hCAVSMCs.", {"entities": []}], ["Myeloid Cell Leukemia 1 (MCL-1) is a protein critical for cardiovascular cell survival and implicated in cell adhesion.", {"entities": []}], ["\u03b2-blockers significantly suppressed and NP-6A4 increased MCL-1 expression in HL-1 and hCAVSMCs as determined by immunofluorescence.", {"entities": []}], ["Thus, reduction in cell size and/or MCL-1 expression might underlie \u03b2-blocker-induced reduction in CI of HL-1.", {"entities": []}], ["Conversely, increase in cell viability and MCL-1 expression by NP-6A4 through AT2R could have resulted in NP-6A4 mediated increase in CI of HL-1.", {"entities": []}], ["These data show for the first time that activation of the AT2R-MCL-1 axis by NP-6A4 in nutrient-stressed mouse and human cardiovascular cells (mouse HL-1 cells and primary cultures of hCAVSMCs) might underlie improved survival of cells treated by NP-6A4 compared to other drugs tested in this study.", {"entities": []}], ["Acetazolamide is commonly given to chronic obstructive pulmonary disease (COPD) patients with metabolic alkalosis.", {"entities": [[35, 72, "DISEASE"]]}], ["Little is known of the pharmacodynamics of acetazolamide in the critically ill. We undertook the pharmacodynamic modeling of bicarbonate response to acetazolamide in COPD patients under mechanical ventilation.", {"entities": []}], ["This observational, retrospective study included 68 invasively ventilated COPD patients who received one or multiple doses of 250 or 500 mg of acetazolamide during the weaning period.", {"entities": []}], ["Among the 68 investigated patients, 207 time-serum bicarbonate observations were available for analysis.", {"entities": []}], ["Population pharmacodynamics was modeled using a nonlinear mixedeffect model.", {"entities": []}], ["The main covariates of interest were baseline demographic data, Simplified Acute Physiology Score II (SAPS II) at ICU admission, cause of respiratory failure, co-prescription of drugs interfering with the acid-base equilibrium, and serum concentrations of protein, creatinin, potassium and chloride.", {"entities": [[138, 157, "DISEASE"]]}], ["The effect of acetazolamide on serum bicarbonate levels at different doses and in different clinical conditions was subsequently simulated in silico .", {"entities": []}], ["The main covariates interacting with acetazolamide pharmacodynamics were SAPS II at ICU admission ( P = 0.01), serum chloride ( P < 0.001) and concomitant administration of corticosteroids ( P = 0.02).", {"entities": []}], ["Co-administration of furosemide significantly decreased bicarbonate elimination.", {"entities": []}], ["Acetazolamide induced a decrease in serum bicarbonate with a dose-response relationship.", {"entities": []}], ["The amount of acetazolamide inducing 50% of the putative maximum effect was 117 \u00b1 21 mg.", {"entities": []}], ["According to our model, an acetazolamide dosage > 500 mg twice daily is required to reduce serum bicarbonate concentrations > 5 mmol/L in the presence of high serum chloride levels or coadministration of systemic corticosteroids or furosemide.", {"entities": []}], ["This study identified several covariates that influenced acetazolamide pharmacodynamics and could allow a better individualization of acetazolamide dosing when treating COPD patients with metabolic alkalosis.", {"entities": []}], ["We systematically reviewed epidemiologic studies on ambient air pollution and congenital anomalies and conducted meta-analyses for a number of air pollutant\u2013anomaly combinations.", {"entities": []}], ["From bibliographic searches we extracted 10 original epidemiologic studies that examined the association between congenital anomaly risk and concentrations of air pollutants.", {"entities": []}], ["Meta-analyses were conducted if at least four studies published risk estimates for the same pollutant and anomaly group.", {"entities": []}], ["Summary risk estimates were calculated for a ) risk at high versus low exposure level in each study and b ) risk per unit increase in continuous pollutant concentration.", {"entities": []}], ["Each individual study reported statistically significantly increased risks for some combinations of air pollutants and congenital anomalies, among many combinations tested.", {"entities": []}], ["In meta-analyses, nitrogen dioxide (NO 2 ) and sulfur dioxide (SO 2 ) exposures were related to increases in risk of coarctation of the aorta [odds ratio (OR) per 10 ppb NO 2 = 1.17; 95% confidence interval (CI), 1.00\u20131.36; OR per 1 ppb SO 2 = 1.07; 95% CI, 1.01\u20131.13] and tetralogy of Fallot (OR per 10 ppb NO 2 = 1.20; 95% CI, 1.02\u20131.42; OR per 1 ppb SO 2 = 1.03; 95% CI, 1.01\u20131.05), and PM 10 (particulate matter \u2264 10 \u03bcm) exposure was related to an increased risk of atrial septal defects (OR per 10 \u03bcg/m We found some evidence for an effect of ambient air pollutants on congenital cardiac anomaly risk.", {"entities": []}], ["Improvements in the areas of exposure assessment, outcome harmonization, assessment of other congenital anomalies, and mechanistic knowledge are needed to advance this field.", {"entities": []}], ["Human metapneumovirus (HMPV) is a leading cause of respiratory infection that causes upper airway and severe lower respiratory tract infections.", {"entities": []}], ["HMPV infection is initiated by viral surface glycoproteins that attach to cellular receptors and mediate virus membrane fusion with cellular membranes.", {"entities": []}], ["Most paramyxoviruses use two viral glycoproteins to facilitate virus entry\u2014an attachment protein and a fusion (F) protein.", {"entities": []}], ["However, membrane fusion for the human paramyxoviruses in the Pneumovirus subfamily, HMPV and respiratory syncytial virus (hRSV), is unique in that the F protein drives fusion in the absence of a separate viral attachment protein.", {"entities": []}], ["Thus, pneumovirus F proteins can perform the necessary functions for virus entry, i.e.", {"entities": []}], [", attachment and fusion.", {"entities": []}], ["In this review, we discuss recent advances in the understanding of how HMPV F mediates both attachment and fusion.", {"entities": []}], ["We review the requirements for HMPV viral surface glycoproteins during entry and infection, and review the identification of cellular receptors for HMPV F. We also review our current understanding of how HMPV F mediates fusion, concentrating on structural regions of the protein that appear to be critical for membrane fusion activity.", {"entities": []}], ["Finally, we illuminate key unanswered questions and suggest how further studies can elucidate how this clinically important paramyxovirus fusion protein may have evolved to initiate infection by a unique mechanism.", {"entities": []}], ["Gastroesophageal reflux is considered to cause sleep disturbance, whereas proton pump inhibitor (PPI) administration is reported to improve insomnia associated with gastroesophageal reflux disease (GERD).", {"entities": [[165, 196, "DISEASE"]]}], ["The majority of patients with gastroesophageal reflux are asymptomatic and a significant number with erosive esophagitis are also reported to be asymptomatic.", {"entities": [[109, 120, "DISEASE"]]}], ["We examined whether PPI administration has a therapeutic effect for improving insomnia in patients without reflux symptoms in the same manner as patients with reflux symptoms.", {"entities": []}], ["We performed a randomized multicenter double-blind placebo-controlled trial using 176 patients with insomnia regardless of the presence of reflux symptoms.", {"entities": []}], ["The patients were divided into those administered omeprazole (20\u2009mg) or a placebo for 14 days.", {"entities": []}], ["Four self-reporting questionnaires, QOLRAD-J (Japanese translation of Quality of Life in Reflux and Dyspepsia), Pittsburg Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and a sleep diary, were used for evaluating GERD-related quality of life (QOL) and sleep disturbance.", {"entities": []}], ["We evaluated 171 patients with insomnia, of whom 69 had typical reflux symptoms.", {"entities": []}], ["Omeprazole statistically significantly improved GERD-related QOL from 30.8\u00b10.7 to 33.0\u00b10.5 ( P <0.01) (QOLRAD-J, total) and from 6.0\u00b10.2 to 6.6\u00b10.1 ( P <0.01) (QOLRAD-J, sleep-related) when administrated to patients with reflux symptoms.", {"entities": []}], ["Omeprazole also improved insomnia significantly better than the placebo in patients with reflux symptoms; PSQI, from 9.3\u00b10.5 to 7.9\u00b10.5 ( P <0.01) and sleep diary, from 2.1\u00b10.1 to 1.8\u00b10.1 ( P <0.01).", {"entities": []}], ["On the other hand, the therapeutic effects of omeprazole and the placebo were not different in patients without reflux symptoms.", {"entities": []}], ["Our results showed that PPI administration is effective only for insomnia in patients with reflux symptoms.", {"entities": []}], ["One of the central physiological functions of the lungs is to transfer inhaled gases from the alveoli to pulmonary capillary blood.", {"entities": []}], ["However, current measures of alveolar gas uptake provide only global information and thus lack the sensitivity and specificity needed to account for regional variations in gas exchange.", {"entities": []}], ["Here we exploit the solubility, high magnetic resonance (MR) signal intensity, and large chemical shift of hyperpolarized (HP) The features observed in dissolved-phase", {"entities": [[123, 125, "GENE"]]}], ["T-helper 2 (Th2) cell responses defend against parasites.", {"entities": []}], ["Although dendritic cells (DCs) are vital for the induction of T-cell responses, the DC subpopulations that induce Th2 cells in the intestine are unidentified.", {"entities": []}], ["Here we show that intestinal Th2 responses against Trichuris muris worms and Schistosoma mansoni eggs do not develop in mice with IRF-4-deficient DCs (IRF-4 S. mansoni -specific Th2 responses.", {"entities": []}], ["Surprisingly, transferred IRF-4-deficient DCs also effectively prime S. mansoni -specific Th2 responses.", {"entities": []}], ["Egg antigens do not induce the expression of IRF-4-related genes.", {"entities": []}], ["Instead, IRF-4 T helper 2 (Th2) cell responses are essential for immunity against parasites, but how Th2 response is modulated in the gut is still unclear.", {"entities": []}], ["Here the authors show that distinct dendritic cell subsets distinguishable by CD11b, CD103 and IRF4 function in the small intestine or colon to promote Th2 responses.", {"entities": [[95, 99, "GENE"]]}], ["To investigate the association of clinical outcomes with platelet function-guided modification in antiplatelet therapy in patients with ischemic stroke.", {"entities": []}], ["Among 812 patients, 223 patients had aspirin nonresponse, 204 patients was modified in antiplatelet therapy after platelet function testing.", {"entities": []}], ["Mean follow-up period was 4.8 \u00b1 1.7 years (ranged from 1 to 6.4 years).", {"entities": []}], ["The incidence rates of ischemic events, death, or bleeding events were not significantly different between the patients with and without antiplatelet therapy modification.", {"entities": []}], ["However, in patients with aspirin nonresponse, antiplatelet therapy modification was associated with decreased ischemic events (hazard ratio, 0.67; 95% confidence interval [CI], 0.62\u20130.97; P = 0.01) and ischemic stroke (hazard ratio, 0.70; 95% CI, 0.63\u20130.98; P = 0.03) compared with no modification in antiplatelet therapy.", {"entities": []}], ["In patients with aspirin nonresponse, platelet function-guided modification in antiplatelet therapy after an ischemic stroke was associated with significantly lower rate of ischemic events.", {"entities": []}], ["The platelet function testing may be useful to guide antiplatelet therapy modification.", {"entities": []}], ["This is a retrospective, multicentre study.", {"entities": []}], ["From August 2010 to December 2014, 812 patients with ischemic stroke underwent platelet function testing using platelet aggregation.", {"entities": []}], ["Antiplatelet therapy modification was defined as any change in antiplatelet therapy after testing, including increasing aspirin dosage, adding an additional antiplatelet agent to aspirin, or switching to a more potent antiplatelet agent.", {"entities": []}], ["The primary outcome was ischemic events.", {"entities": []}], ["Secondary outcomes included death and bleeding events.", {"entities": []}], ["Clinical outcomes were compared between patients with and without antiplatelet therapy modification using univariate and propensity score-adjusted analyses.", {"entities": []}], ["This paper reports the findings of a South Australian qualitative, exploratory study of children and young people living with a chronic disease, and their perceptions and experiences of physical activity.", {"entities": []}], ["The perceptions and experiences of their parents were also explored.", {"entities": []}], ["The chronic diseases were type 1 diabetes, asthma and cystic fibrosis.", {"entities": [[54, 69, "DISEASE"], [43, 49, "DISEASE"]]}], ["Multiple qualitative data collection techniques were used to elicit the children and young people's perspectives and experiences of physical activity, including focus groups, maps, photos and 'traffic light posters'.", {"entities": []}], ["The children's parents were interviewed separately to ascertain their views of their child's participation in physical activities.", {"entities": []}], ["Children and young people described their active participation in a wide variety of physical activities including organised sports and play, but made very little mention of any negative influence or impact due to their disease.", {"entities": []}], ["Their parents' stories described the diligent background planning and management undertaken to enable their child to participate in a wide range of physical activities.", {"entities": []}], ["The results of this study suggest that for these children and young people, having a chronic disease was not perceived as a barrier to participation in organised sport and recreational activities.", {"entities": []}], ["They were physically active and perceived themselves to be no different from their peers.", {"entities": []}], ["Their positive beliefs were shared by their parents and the level of participation described was enabled by the high level of parental support and background planning involved in managing their child's health care needs.", {"entities": []}], ["Recent genome-wide association studies (GWAS) have identified a number of novel genetic associations with complex human diseases.", {"entities": []}], ["In spite of these successes, results from GWAS generally explain only a small proportion of disease heritability, an observation termed the \u2018missing heritability problem\u2019.", {"entities": []}], ["Several sources for the missing heritability have been proposed, including the contribution of many common variants with small individual effect sizes, which cannot be reliably found using the standard GWAS approach.", {"entities": []}], ["The goal of our study was to explore a complimentary approach, which combines GWAS results with functional data in order to identify novel genetic associations with small effect sizes.", {"entities": []}], ["To do so, we conducted a GWAS for lymphocyte count, a physiologic quantitative trait associated with asthma, in 462 Hutterites.", {"entities": [[101, 107, "DISEASE"]]}], ["In parallel, we performed a genome-wide gene expression study in lymphoblastoid cell lines from 96 Hutterites.", {"entities": []}], ["We found significant support for genetic associations using the GWAS data when we considered variants near the 193 genes whose expression levels across individuals were most correlated with lymphocyte counts.", {"entities": []}], ["Interestingly, these variants are also enriched with signatures of an association with asthma susceptibility, an observation we were able to replicate.", {"entities": [[87, 93, "DISEASE"]]}], ["The associated loci include genes previously implicated in asthma susceptibility as well as novel candidate genes enriched for functions related to T cell receptor signaling and adenosine triphosphate synthesis.", {"entities": [[59, 65, "DISEASE"]]}], ["Our results, therefore, establish a new set of asthma susceptibility candidate genes.", {"entities": [[47, 53, "DISEASE"]]}], ["More generally, our observations support the notion that many loci of small effects influence variation in lymphocyte count and asthma susceptibility.", {"entities": [[128, 134, "DISEASE"]]}], ["Concerns persist about adverse reactions to intravenous (IV) iron.", {"entities": []}], ["We aimed to determine the relative safety of ferumoxytol compared to other IV iron compounds.", {"entities": []}], ["This retrospective cohort study with propensity-score matching for patients and drug doses used the Medicare 20% random sample to identify patients (1) without chronic kidney disease (non-CKD) and (2) with non-dialysis-dependent chronic kidney disease (NDD-CKD) who received a first dose of IV iron in 2010\u20132012.", {"entities": [[168, 182, "DISEASE"], [237, 251, "DISEASE"]]}], ["Exposures were ferumoxytol, iron sucrose, sodium ferric gluconate, or iron dextran.", {"entities": []}], ["Outcomes were hypersensitivity symptoms, anaphylaxis, emergency department (ED) encounters, hospitalizations, and death after acute IV iron exposure.", {"entities": []}], ["In the primary analysis for reactions on the day of or following exposure, there was no difference in hypersensitivity symptoms (hazard ratio 1.04, 95% confidence interval 0.94\u20131.16) or hypotension (0.83, 0.52\u20131.34) between 4289 non-CKD ferumoxytol users and an equal number of users of other compounds; results were similar for 7358 NDD-CKD patients and an equal number of controls.", {"entities": []}], ["All-cause ED encounters or hospitalizations were less common in both the non-CKD (0.56, 0.45\u20130.70) and NDD-CKD ferumoxytol-treated patients (0.83, 0.71\u20130.95).", {"entities": []}], ["Fewer than 10 deaths occurred in both the non-CKD and NDD-CKD ferumoxytol users and in matched controls; the hazard for death did not differ significantly between ferumoxytol users and controls in the non-CKD patients (2.00, 0.33\u201311.97) or in the NDD-CKD patients (0.25, 0.04\u20131.52).", {"entities": []}], ["Multiple sensitivity analyses showed similar results.", {"entities": []}], ["Ferumoxytol did not appear to be associated with more adverse reactions than other compounds for the treatment of iron-deficiency anemia in both non-CKD and NDD-CKD patients.", {"entities": [[119, 136, "DISEASE"], [130, 136, "DISEASE"]]}], ["Obesity may cause adverse effects on the respiratory system.", {"entities": [[0, 7, "DISEASE"]]}], ["The main purpose of this study was to investigate how various measures of obesity are related to arterial blood gases and pulmonary function.", {"entities": [[74, 81, "DISEASE"]]}], ["This is a cross-sectional study of consecutive morbidly obese patients with normal lung function.", {"entities": []}], ["Blood gas samples were taken from the radial artery after 5\u00a0min of rest with subjects sitting upright.", {"entities": []}], ["Lung function measurements included dynamic spirometry, static lung volumes, and gas diffusing capacity.", {"entities": []}], ["The 149 patients (77% women) had a mean (SD) age of 43\u00a0years (11\u00a0years) and BMI of 45.0\u00a0kg/m P values\u2009<\u20090.05).", {"entities": []}], ["BMI, neck circumference (NC), and waist circumference (WC) were negatively correlated with ERV ( r \u2009=\u2009\u22120.25, \u22120.19, \u22120.21, respectively, all P values\u2009<\u20090.05).", {"entities": []}], ["Multiple linear regression showed that BMI, WC, and NC were significantly associated with pO2 after adjustments for age, gender, and pack-years (all P values\u2009<\u20090.001).", {"entities": []}], ["The models explained 34\u201336% of the variations in pO2.", {"entities": []}], ["BMI, NC, and WC were also significantly associated with pCO2 (all P values\u2009<\u20090.05).There was no significant association between waist-to-hip ratio and blood gases (both P values\u2009>\u20090.27).", {"entities": []}], ["Both central and overall obesity were associated with unfavorable blood gases and low ERV.", {"entities": [[25, 32, "DISEASE"]]}], ["Patients with atopic dermatitis have genetically determined risk factors that affect the barrier function of the skin and immune responses that interact with environmental factors.", {"entities": [[14, 31, "DISEASE"], [21, 31, "DISEASE"]]}], ["Clinically, this results in an intensely pruriginous and inflamed skin that allows the penetration of irritants and allergens and predisposes patients to colonization and infection by microorganisms.", {"entities": []}], ["Among the various etiological factors responsible for the increased prevalence of atopic diseases over the past few decades, the role of vitamin D has been emphasized.", {"entities": []}], ["As the pathogenesis of AD involves a complex interplay of epidermal barrier dysfunction and dysregulated immune response, and vitamin D is involved in both processes, it is reasonable to expect that vitamin D's status could be associated with atopic dermatitis' risk or severity.", {"entities": [[243, 260, "DISEASE"], [250, 260, "DISEASE"]]}], ["Such association is suggested by epidemiological and experimental data.", {"entities": []}], ["In this review, we will discuss the evidence for and against this controversial relationship, emphasizing the possible etiopathogenic mechanisms involved.", {"entities": []}], ["Studies have suggested that demographic and lifestyle factors could shape the composition of fecal microbiota in early life.", {"entities": []}], ["This study evaluated infant stool microbiota signatures in two Asian populations, Singapore (n = 42) and Indonesia (n = 32) with contrasting socioeconomic development, and examined the putative influences of demographic factors on these human fecal associated bacterial signatures.", {"entities": []}], ["Longitudinal analysis showed associations of geographical origin with Clostridium leptum, Atopobium and Bifidobacterium groups.", {"entities": []}], ["Mode of delivery had the largest effect on stool microbiota signatures influencing the abundance of four bacterial groups.", {"entities": []}], ["Significantly higher abundance of bacterial members belonging to the Bacteroides-Prevotella, Bifidobacterium and Atopobium groups, but lower abundance of Lactobacilli-Enterococci group members, were observed in vaginal delivered compared to caesarean delivered infants.", {"entities": []}], ["Demographic factors influencing the structure of infants stool microbiota during the first year of life included breastfeeding, age of weaning, sibship size and exposure to antibiotics.", {"entities": []}], ["Differences in stool microbiota signatures were observed in relation to various demographic factors.", {"entities": []}], ["These features may confound studies relating to the association of the structure of fecal microbiota and the predisposition to human modern disease.", {"entities": []}], ["Connective tissue growth factor (CTGF) contributes to airway smooth muscle (ASM) cell hyperplasia in asthma.", {"entities": [[101, 107, "DISEASE"], [33, 37, "GENE"]]}], ["Humanized single-chain variable fragment antibody (scFv) was well characterized as a CTGF antagonist in the differentiation of fibroblast into myofibroblast and pulmonary fibrosis in our previous studies.", {"entities": [[161, 179, "DISEASE"], [85, 89, "GENE"]]}], ["To further improve the bioactivity of scFv, we constructed a plasmid to express scFv-linker-matrilin-6\u00d7His fusion proteins that could self-assemble into the scFv dimers by disulfide bonds in matrilin under non-reducing conditions.", {"entities": []}], ["An immunoreactivity assay demonstrated that the scFv dimer could highly bind to CTGF in a concentration-dependent manner.", {"entities": [[80, 84, "GENE"]]}], ["The MTT and EdU assay results revealed that CTGF (\u226510 ng/mL) promoted the proliferation of ASM cells, and this effect was inhibited when the cells were treated with anti-CTGF scFv dimer.", {"entities": [[44, 48, "GENE"], [170, 174, "GENE"]]}], ["The western blot analysis results showed that increased phosphorylation of Akt and mTOR induced by CTGF could be suppressed by this scFv dimer.", {"entities": [[83, 87, "GENE"], [99, 103, "GENE"]]}], ["Based on these findings, anti-CTGF scFv dimer may be a potential agent for the prevention of airway remodeling in asthma.", {"entities": [[114, 120, "DISEASE"]]}], ["Mucopolysaccharidosis VI (MPS VI) is an autosomal recessive progressive multiorgan disorder due to mutation in the gene encoding the enzyme Arylsulfatase B (ARSB).", {"entities": [[157, 161, "GENE"]]}], ["Dysfunctional ARSB causes lysosomal accumulation of glycosaminoglycans (GAG).", {"entities": [[14, 18, "GENE"]]}], ["Currently, enzyme replacement therapy (ERT) is preferred to hematopoietic stem cell transplantation (SCT) due to the treatment-related risks of the latter.", {"entities": []}], ["However, ERT constitutes an expensive life-long treatment.", {"entities": []}], ["Increased experience and safety of SCT-procedures in recent years suggest that SCT should be further explored as a treatment option.", {"entities": []}], ["This is the first report on haploidentical SCT in patients with MPS VI.", {"entities": []}], ["The primary objective was to assess the treatment safety and clinical and biochemical outcome.", {"entities": []}], ["Two siblings diagnosed with MPS VI at 10\u00a0months of age and at birth with genotype p.C192R, reported as mild to intermediate phenotype, underwent unrelated umbilical cord blood transplantation pre-symptomatic.", {"entities": []}], ["Due to graft failure, both patients were urgently re-transplantated with haploidentical SCT with the father as donor.", {"entities": []}], ["Continuous clinical and biochemical status was monitored and concluded 3.8 and 4.6\u00a0years after the haploidentical SCT.", {"entities": []}], ["Haploidentical SCT resulted in prompt and sustained engraftment.", {"entities": []}], ["Complete donor chimerism was achieved in both patients, apart from mixed B cells chimerism in patient 2.", {"entities": []}], ["ARSB activity in leukocytes post transplant increased from 0.0 to 19.0 \u03bckat/kg protein (patient 1) and from 3.6 to 17.9 \u03bckat/kg protein (patient 2) (ref.", {"entities": [[0, 4, "GENE"]]}], ["Total urinary GAG normalized in both patients, although patient 2\u2019s values slightly exceed normal range since 6\u00a0months.", {"entities": []}], ["However, dermatan sulfaturia was substantially normalized since 16\u00a0months and 12\u00a0months post-SCT, respectively.", {"entities": []}], ["Height was -1.85 SD and -1.27 SD at follow-up.", {"entities": []}], ["Patient 1 had impaired visual acuity and discrete hepatomegaly.", {"entities": []}], ["Patient 2 had elevated intraocular pressure and X-ray revealed steep acetabular angles and slightly flattened lumbar vertebrae.", {"entities": []}], ["This study demonstrates that young children with MPS VI tolerate haploidentical SCT.", {"entities": []}], ["Normalization of enzyme production and dermatan sulfaturia indicates correction of the inborn error of metabolism and coincide with no obvious symptoms of progressive MPS VI up to 4.6\u00a0years post-SCT.", {"entities": []}], ["The incorporation of sex and gender-specific analysis in medical research is increasing due to pressure from public agencies, funding bodies, and the clinical and research community.", {"entities": []}], ["However, generations of knowledge and publication trends in this discipline are currently spread over distinct specialties and are difficult to analyze comparatively.", {"entities": []}], ["Using a text-mining approach, we have analysed sex and gender aspects in research within nine clinical subspecialties - Cardiology, Pulmonology, Nephrology, Endocrinology, Gastroenterology, Haematology, Oncology, Rheumatology, Neurology - using six paradigmatic diseases in each one.", {"entities": []}], ["Articles have been classified into five pre-determined research categories - Epidemiology, Pathophysiology, Clinical research, Management and Outcomes.", {"entities": []}], ["Additional information has been collected on the type of study (human/animal) and the number of subjects included.", {"entities": []}], ["Of the 8,836 articles initially retrieved, 3,466 (39%) included sex and gender-specific research and have been further analysed.", {"entities": []}], ["Literature incorporating sex/gender analysis increased over time and displays a stronger trend if compared to overall publication increase.", {"entities": []}], ["All disciplines, but cardiology (22%), demonstrated an underrepresentation of research about gender differences in management, which ranges from 3 to 14%.", {"entities": []}], ["While the use of animal models for identification of sex differences in basic research varies greatly among disciplines, studies involving human subjects are frequently conducted in large cohorts with more than 1,000 patients (24% of all human studies).", {"entities": []}], ["Heterogeneity characterizes sex and gender-specific research.", {"entities": []}], ["Although large cohorts are often analysed, sex and gender differences in clinical management are insufficiently investigated leading to potential inequalities in health provision and outcomes.", {"entities": []}], ["Recent advances in research concerning the public health value of natural environments have been remarkable.", {"entities": []}], ["The growing interest in this topic (often housed under terms such as green and/or blue space) has been occurring in parallel with the microbiome revolution and an increased use of remote sensing technology in public health.", {"entities": []}], ["In the context of biodiversity loss, rapid urbanization, and alarming rates of global non-communicable diseases (many associated with chronic, low-grade inflammation), discussions of natural vis-a-vis built environments are not merely fodder for intellectual curiosity.", {"entities": []}], ["Here, we argue for increased interdisciplinary collaboration with the aim of better understanding the mechanisms\u2014including aerobiological and epigenetic\u2014that might help explain some of the noted positive health outcomes.", {"entities": []}], ["It is our contention that some of these mechanisms are related to ecodiversity (i.e., the sum of biodiversity and geodiversity, including biotic and abiotic constituents).", {"entities": []}], ["We also encourage researchers to more closely examine individual nature relatedness and how it might influence many outcomes that are at the interface of lifestyle habits and contact with ecodiversity.", {"entities": []}], ["We present a high-level framework to show the process by which an investment in primary prevention produces value.", {"entities": []}], ["We define primary prevention broadly to include investments in any of the determinants of health.", {"entities": []}], ["Although it builds on previously developed frameworks, ours incorporates several additional features.", {"entities": []}], ["It distinguishes direct and upstream determinants of health, a distinction that can help identify, describe, and track the impact of a policy or program on health and health care costs.", {"entities": []}], ["It recognizes multiple dimensions of value, including the need to establish the nonhealth value of investments whose objectives are not limited to improvements in health (and whose costs should not be attributed solely to the health benefits).", {"entities": []}], ["Finally, it emphasizes the need to describe value from the perspectives of the multiple stakeholders that can influence such investments.", {"entities": []}], ["Reticular basement membrane (RBM) thickening has been variably associated with asthma and chronic obstructive pulmonary disease (COPD).", {"entities": [[90, 127, "DISEASE"], [79, 85, "DISEASE"], [29, 32, "GENE"]]}], ["Even if RBM thickness is similar in both diseases, its composition might still differ.", {"entities": [[8, 11, "GENE"]]}], ["To assess whether RBM thickness and composition differ between asthma and COPD.", {"entities": [[63, 69, "DISEASE"], [18, 21, "GENE"]]}], ["We investigated 24 allergic asthmatics (forced expiratory volume in one second [FEV 1 ] 92% predicted), and 17 nonallergic COPD patients (FEV 1 60% predicted), and for each group a control group of similar age and smoking habits (12 and 10 persons, respectively).", {"entities": [[80, 83, "GENE"], [138, 141, "GENE"], [80, 83, "GENE"], [138, 141, "GENE"]]}], ["Snap-frozen sections of bronchial biopsies were stained with hematoxylin/eosin and for collagen I, III, IV, V, laminin and tenascin.", {"entities": []}], ["RBM thickening was assessed by digital image analysis.", {"entities": [[0, 3, "GENE"]]}], ["Relative staining intensity of each matrix component was determined.", {"entities": []}], ["Mean (SD) RBM thickness was not significantly different between asthma and COPD 5.5 (1.3) vs 6.0 (1.8) \u03bcm, but significantly larger than in their healthy counterparts, ie, 4.7 (0.9) and 4.8 (1.2) \u03bcm, respectively.", {"entities": [[64, 70, "DISEASE"], [10, 13, "GENE"]]}], ["Collagen I and laminin stained significantly stronger in asthma than in COPD.", {"entities": [[57, 63, "DISEASE"]]}], ["Tenascin stained stronger in asthma than in healthy controls of similar age, and stronger in COPD controls than in asthma controls (p < 0.05).", {"entities": [[29, 35, "DISEASE"], [115, 121, "DISEASE"]]}], ["RBM thickening occurs both in asthma and COPD.", {"entities": [[30, 36, "DISEASE"], [0, 3, "GENE"]]}], ["We provide supportive evidence that its composition differs in asthma and COPD.", {"entities": [[63, 69, "DISEASE"]]}], ["Background .", {"entities": []}], ["A cross-sectional survey was designed to provide a baseline data on the prevalence and distribution of overweight and obesity and their associations among adults in Palestine.", {"entities": [[118, 125, "DISEASE"]]}], ["A random representative sample of 3617 adults aged 18\u201364 years was collected between October 1999 and October 2000.", {"entities": []}], ["The prevalence of overweight was 35.5% in women and 40.3% in men, obesity was 31.5% in women and 17.5% in men.", {"entities": [[66, 73, "DISEASE"]]}], ["Adults aged 45\u201354 years old were significantly more likely to be obese (29.2% in men and 50.2% in women) or overweight (48.1% in men and 37.2% in women).", {"entities": []}], ["When compared with women, men showed significantly more normal BMI level (40.5% versus 31.6%; P < 0.05).", {"entities": []}], ["Cut-off points for a high waist circumference and high waist-to-hip ratio identified 57.8% and 47.2% of the population, respectively, to be at an increased and high risk for cardiovascular disease.", {"entities": []}], ["Sociodemographic factors (age, sex, educational level, and marital status) were also found to be significantly related to BMI.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Obesity and overweight are enormous public health problems in Palestine.", {"entities": [[0, 7, "DISEASE"]]}], ["Population-based research at the national level to investigate the social and cultural factors associated with high prevalence of overweight and obesity among Palestinian adults should be implemented.", {"entities": [[145, 152, "DISEASE"]]}], ["People with osteoarthritis (OA) frequently report that their joint pain is influenced by weather conditions.", {"entities": [[12, 26, "DISEASE"]]}], ["This study aimed to examine whether there are differences in perceived joint pain between older people with OA who reported to be weather-sensitive versus those who did not in six European countries with different climates and to identify characteristics of older persons with OA that are most predictive of perceived weather sensitivity.", {"entities": []}], ["Baseline data from the European Project on OSteoArthritis (EPOSA) were used.", {"entities": [[43, 57, "DISEASE"]]}], ["ACR classification criteria were used to determine OA.", {"entities": [[0, 3, "GENE"]]}], ["Participants with OA were asked about their perception of weather as influencing their pain.", {"entities": []}], ["Using a two-week follow-up pain calendar, average self-reported joint pain was assessed (range: 0 (no pain)-10 (greatest pain intensity)).", {"entities": []}], ["Linear regression analyses, logistic regression analyses and an independent t-test were used.", {"entities": []}], ["Analyses were adjusted for several confounders.", {"entities": []}], ["The majority of participants with OA (67.2%) perceived the weather as affecting their pain.", {"entities": []}], ["Weather-sensitive participants reported more pain than non-weather-sensitive participants (M\u2009=\u20094.1, SD\u2009=\u20092.4 versus M\u2009=\u20093.1, SD\u2009=\u20092.4; p\u2009<\u20090.001).", {"entities": []}], ["After adjusting for several confounding factors, the association between self-perceived weather sensitivity and joint pain remained present (B\u2009=\u20090.37, p\u2009=\u20090.03).", {"entities": []}], ["Logistic regression analyses revealed that women and more anxious people were more likely to report weather sensitivity.", {"entities": []}], ["Older people with OA from Southern Europe were more likely to indicate themselves as weather-sensitive persons than those from Northern Europe.", {"entities": []}], ["Weather (in)stability may have a greater impact on joint structures and pain perception in people from Southern Europe.", {"entities": []}], ["The results emphasize the importance of considering weather sensitivity in daily life of older people with OA and may help to identify weather-sensitive older people with OA.", {"entities": []}], ["Some COPD patients are more susceptible to exacerbations than others.", {"entities": []}], ["Mechanisms underlying these differences in susceptibility are not well understood.", {"entities": []}], ["We hypothesized that altered cell mediated immune responses may underlie a propensity to suffer from frequent exacerbations in COPD.", {"entities": []}], ["Peripheral blood mononuclear cells (PBMCs) were obtained from 24 stable COPD patients, eight frequent exacerbators (\u22653 diary-card exacerbations/year) and 16 infrequent exacerbators (< 3 diary-card exacerbations/year).", {"entities": []}], ["Detailed multi-parameter flow cytometry was used to study differences in innate and adaptive systemic immune function between frequent and infrequently exacerbating COPD patients.", {"entities": []}], ["The 24 COPD patients had a mean (SD) age of 76.3 (9.4) years and FEV 1 1.43 (0.60)L, 53.3 (18.3)% predicted.", {"entities": [[65, 68, "GENE"]]}], ["PBMCs of frequent exacerbators (FE) contained lower frequencies of CD4+ T central memory cells (CD4+ Tcm) compared to infrequent exacerbators (IE) (FE\u2009=\u200918.7\u00a0%; IE\u2009=\u200923.9\u00a0%; p \u2009=\u20090.035).", {"entities": []}], ["This observation was also apparent in absolute numbers of CD4+ Tcm cells (FE\u2009=\u20090.17\u2009\u00d7\u200910^6/mL; IE\u2009=\u20090.25\u2009\u00d7\u200910^6/mL; p \u2009=\u20090.035).", {"entities": []}], ["PBMCs of FE contained a lower frequency of CD8+ T effector memory cells expressing HLA-DR (Human Leukocyte Antigen - D Related) compared to IE COPD patients (FE\u2009=\u200922.7\u00a0%; IE\u2009=\u200931.5\u00a0%; p \u2009=\u20090.007).", {"entities": []}], ["Differences in the adaptive systemic immune system might associate with exacerbation susceptibility in the \u2018frequent exacerbator\u2019 COPD phenotype.", {"entities": []}], ["These differences include fewer CD4+ T central memory cells and CD8+ T effector memory cells.", {"entities": []}], ["Not applicable.", {"entities": []}], ["Motivation: Underrepresentation of racial groups represents an important challenge and major gap in phenomics research.", {"entities": []}], ["Most of the current human phenomics research is based primarily on European populations; hence it is an important challenge to expand it to consider other population groups.", {"entities": []}], ["One approach is to utilize data from EMR databases that contain patient data from diverse demographics and ancestries.", {"entities": []}], ["The implications of this racial underrepresentation of data can be profound regarding effects on the healthcare delivery and actionability.", {"entities": []}], ["To the best of our knowledge, our work is the first attempt to perform comparative, population-scale analyses of disease networks across three different populations, namely Caucasian (EA), African American (AA) and Hispanic/Latino (HL).", {"entities": []}], ["Results: We compared susceptibility profiles and temporal connectivity patterns for 1988 diseases and 37 282 disease pairs represented in a clinical population of 1 025 573 patients.", {"entities": []}], ["Accordingly, we revealed appreciable differences in disease susceptibility, temporal patterns, network structure and underlying disease connections between EA, AA and HL populations.", {"entities": []}], ["We found 2158 significantly comorbid diseases for the EA cohort, 3265 for AA and 672 for HL.", {"entities": []}], ["We further outlined key disease pair associations unique to each population as well as categorical enrichments of these pairs.", {"entities": []}], ["Finally, we identified 51\u2009key \u2018hub\u2019 diseases that are the focal points in the race-centric networks and of particular clinical importance.", {"entities": []}], ["Incorporating race-specific disease comorbidity patterns will produce a more accurate and complete picture of the disease landscape overall and could support more precise understanding of disease relationships and patient management towards improved clinical outcomes.", {"entities": []}], ["Contacts : rong.chen@mssm.edu or joel.dudley@mssm.edu Supplementary information: Supplementary data are available at Bioinformatics online.", {"entities": []}], ["Mutations in the bone morphogenetic protein receptor 2 ( BMPR2 ) gene can lead to idiopathic pulmonary arterial hypertension (IPAH).", {"entities": [[112, 124, "DISEASE"], [57, 62, "GENE"]]}], ["This study prospectively screened for BMPR2 mutations in a large cohort of PAH-patients and compared clinical features between BMPR2 mutation carriers and non-carriers.", {"entities": [[38, 43, "GENE"], [127, 132, "GENE"], [38, 43, "GENE"], [127, 132, "GENE"]]}], ["Patients have been assessed by right heart catheterization and genetic testing.", {"entities": []}], ["In all patients a detailed family history and pedigree analysis have been obtained.", {"entities": []}], ["We compared age at diagnosis and hemodynamic parameters between carriers and non-carriers of BMPR2 mutations.", {"entities": [[93, 98, "GENE"]]}], ["In non-carriers with familial aggregation of PAH further genes/gene regions as the BMPR2 promoter region, the ACVRL1 , Endoglin , and SMAD8 genes have been analysed.", {"entities": [[83, 88, "GENE"], [110, 116, "GENE"]]}], ["Of the 231 index patients 22 revealed a confirmed familial aggregation of the disease (HPAH), 209 patients had sporadic IPAH.", {"entities": []}], ["In 49 patients (86.3% of patients with familial aggregation and 14.3% of sporadic IPAH) mutations of the BMPR2 gene have been identified.", {"entities": [[105, 110, "GENE"]]}], ["Twelve BMPR2 mutations and 3 unclassified sequence variants have not yet been described before.", {"entities": [[7, 12, "GENE"]]}], ["Mutation carriers were significantly younger at diagnosis than non-carriers (38.53 \u00b1 12.38 vs. 45.78 \u00b1 11.32 years, p < 0.001) and had a more severe hemodynamic compromise.", {"entities": []}], ["No gene defects have been detected in 3 patients with HPAH.", {"entities": []}], ["This study identified in a large prospectively assessed cohort of PAH- patients new BMPR2 mutations, which have not been described before and confirmed previous findings that mutation carriers are younger at diagnosis with a more severe hemodynamic compromise.", {"entities": [[84, 89, "GENE"]]}], ["Thus, screening for BMPR2 mutations may be clinically useful.", {"entities": [[20, 25, "GENE"]]}], ["Association of the neurotransmitter serotonin (5-HT) with the pathogenesis of allergic asthma is well recognized and its role as a chemoattractant for eosinophils (Eos) in vitro and in vivo has been previously demonstrated.", {"entities": [[78, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["Here we have examined the regulation of 5-HT-induced human and murine Eos trafficking and migration at a cellular and molecular level.", {"entities": []}], ["Eos from allergic donors and bone marrow-derived murine Eos (BM-Eos) were found to predominantly express the 5-HT2A receptor.", {"entities": []}], ["Exposure to 5-HT or 2,5-dimethoxy-4-iodoamphetamine (DOI), a 5-HT2A/C selective agonist, induced rolling of human Eos and AML14.3D10 human Eos-like cells on vascular cell adhesion molecule (VCAM)-1 under conditions of flow in vitro coupled with distinct cytoskeletal and cell shape changes as well as phosphorylation of MAPK.", {"entities": []}], ["Blockade of 5-HT2A or of ROCK MAPK, PI3K, PKC and calmodulin, but not G \u03b1i -proteins, with specific inhibitors inhibited DOI-induced rolling, actin polymerization and changes in morphology of VCAM-1-adherent AML14.3D10 cells.", {"entities": []}], ["More extensive studies with murine BM-Eos demonstrated the role of 5-HT in promoting rolling in vivo within inflamed post-capillary venules of the mouse cremaster microcirculation and confirmed that down-stream signaling of 5-HT2A activation involves ROCK, MAPK, PI3K, PKC and calmodulin similar to AML14.3D10 cells.", {"entities": []}], ["DOI-induced migration of BM-Eos is also dependent on these signaling molecules and requires Ca", {"entities": []}], ["Low grade chronic inflammation is observed in patients with type 2 diabetes mellitus (T2DM).", {"entities": [[67, 84, "DISEASE"], [60, 84, "DISEASE"]]}], ["Endotoxin derived from gut bacteria may act as a potent inflammatory stimulant.", {"entities": []}], ["Probiotics, which are believed to contain health promoting live microorganisms, may influence circulating endotoxin levels.", {"entities": []}], ["Ingestion of live probiotic cultures may alter gut microbiota in a beneficial manner to reduce inflammation; no information is available whether or not they do so in patients with T2DM.", {"entities": []}], ["Therefore, the aim of this study is to characterize the beneficial effects of probiotics on circulating endotoxin levels and other biomarkers related to systemic low-grade inflammation in patients with T2DM.", {"entities": []}], ["One hundred and twenty consenting adult Saudi T2DM patients (na\u00efve or newly diagnosed and without co-morbidities) will be enrolled in this clinical trial and randomized to receive daily placebo or probiotics (Ecologic\u00aeBarrier) for 26 weeks in a double-blind manner.", {"entities": []}], ["Inflammatory and metabolic markers will be measured and fecal samples analyzed.", {"entities": []}], ["Measurements/samples will be obtained at baseline and after 4, 8, 12/13 and 26 weeks of treatment.", {"entities": []}], ["It is expected that the probiotic product will induce beneficial changes in gut microbiota, reduce the systemic inflammatory state through altering systemic endotoxin levels and, as such, reduce the systemic inflammatory response observed in T2DM subjects.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT01765517", {"entities": []}], ["Several aquaporin-type water channels are expressed in mammalian airways and lung: AQP1 in microvascular endothelia, AQP3 in upper airway epithelia, AQP4 in upper and lower airway epithelia, and AQP5 in alveolar epithelia.", {"entities": [[83, 87, "GENE"], [117, 121, "GENE"], [149, 153, "GENE"], [195, 199, "GENE"]]}], ["Novel quantitative methods were developed to compare airway fluid transport\u2013related functions in wild-type mice and knockout mice deficient in these aquaporins.", {"entities": []}], ["Lower airway humidification, measured from the moisture content of expired air during mechanical ventilation with dry air through a tracheotomy, was 54\u201356% efficient in wild-type mice, and reduced by only 3\u20134% in AQP1/AQP5 or AQP3/AQP4 double knockout mice.", {"entities": []}], ["Upper airway humidification, measured from the moisture gained by dry air passed through the upper airways in mice breathing through a tracheotomy, decreased from 91 to 50% with increasing ventilation from 20 to 220 ml/min, and reduced by 3\u20135% in AQP3/AQP4 knockout mice.", {"entities": []}], ["The depth and salt concentration of the airway surface liquid in trachea was measured in vivo using fluorescent probes and confocal and ratio imaging microscopy.", {"entities": []}], ["Airway surface liquid depth was 45 \u00b1 5 \u03bcm and [Na", {"entities": []}], ["Elective knee surgery is performed to reduce chronic pain and improve function in degenerate knees.", {"entities": []}], ["Treatment of acute post-operative pain is suboptimal in 75% of patients despite multimodal analgesic approaches resulting in higher post-operative opiate consumption.", {"entities": []}], ["The effect of corticosteroids as an adjunct for post-operative pain control remains undefined.", {"entities": []}], ["The databases MEDLINE, EMBASE and CENTRAL (Cochrane library) will be searched from their inception to present using broad search criteria for eligible randomised/quasi-randomised controlled trials investigating perioperative corticosteroid adjunctive use in elective knee surgery.", {"entities": []}], ["Meta-analyses will be conducted according to the recommendations from the Cochrane Handbook for Systematic Reviews of Interventions.", {"entities": []}], ["This systematic review of the perioperative adjunctive use of corticosteroids will assess the analgesic effects, post-operative nausea and vomiting, opiate consumption, infection rates and time till discharge and assess whether adjunctive corticosteroids should be encouraged in elective knee surgery.", {"entities": []}], ["PROPSERO CRD42016049336 The online version of this article (doi:10.1186/s13643-017-0485-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Obesity is generally believed to be a risk factor for the development of postoperative complications.", {"entities": [[0, 7, "DISEASE"]]}], ["Although being obese is associated with medical hazards, recent literature shows no convincing data to support this assumption.", {"entities": []}], ["Moreover a paradox between body mass index and survival is described.", {"entities": []}], ["This study was designed to determine influence of body mass index on postoperative complications and long-term survival after surgery.", {"entities": []}], ["A single-centre prospective analysis of postoperative complications in 4293 patients undergoing general surgery was conducted, with a median follow-up time of 6.3\u00a0years.", {"entities": []}], ["We analyzed the impact of bodyweight on postoperative morbidity and mortality, using univariate and multivariate regression models.", {"entities": []}], ["The obese had more concomitant diseases, increased risk of wound infection, greater intraoperative blood loss and a longer operation time.", {"entities": []}], ["Being underweight was associated with a higher risk of complications, although not significant in adjusted analysis.", {"entities": []}], ["Multivariate regression analysis demonstrated that underweight patients had worse outcome (HR 2.1; 95\u00a0% CI 1.4-3.0), whereas being overweight (HR 0.6; 95\u00a0% CI 0.5\u20130.8) or obese (HR 0.7; 95\u00a0% CI 0.6\u20130.9) was associated with improved survival.", {"entities": [[91, 93, "GENE"], [143, 145, "GENE"], [178, 180, "GENE"], [91, 93, "GENE"], [143, 145, "GENE"], [178, 180, "GENE"], [91, 93, "GENE"], [143, 145, "GENE"], [178, 180, "GENE"]]}], ["Obesity alone is a significant risk factor for wound infection, more surgical blood loss and a longer operation time.", {"entities": [[0, 7, "DISEASE"]]}], ["Being obese is associated with improved long-term survival, validating the obesity paradox.", {"entities": [[75, 82, "DISEASE"]]}], ["We also found that complication and mortality rates are significantly worse for underweight patients.", {"entities": []}], ["Our findings suggest that a tendency to regard obesity as a major risk factor in general surgery is not justified.", {"entities": [[47, 54, "DISEASE"]]}], ["It is the underweight patient who is most at risk of major postoperative complications, including long-term mortality.", {"entities": []}], ["The online version of this article (doi:10.1186/s12871-015-0096-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We aimed to determine whether a 5-day intensive inpatient spa and exercise therapy and educational program is more effective than usual care in improving the rate of returning to work at 1 year for patients with subacute and chronic low back pain (LBP) on sick leave for 4 to 24 weeks.", {"entities": [[248, 251, "GENE"]]}], ["We conducted a 12-month randomized controlled trial.", {"entities": []}], ["LBP patients were assigned to 5-day spa (2 hr/day), exercise (30\u2009min/day) and education (45\u2009min/day) or to usual care.", {"entities": [[0, 3, "GENE"]]}], ["The primary outcome was the percentage of patients returning to work at 1 year after randomization.", {"entities": []}], ["Secondary outcomes were pain, disability and health-related quality of life at 1 year and number of sick leave days from 6 to 12 months.", {"entities": []}], ["The projected recruitment was not achieved.", {"entities": []}], ["Only 88/700 (12.6%) patients planned were enrolled: 45 in the spa therapy group and 43 in the usual care group.", {"entities": []}], ["At 1 year, returning to work was 56.3% versus 41.9% (OR 1.69 [95% CI 0.60\u20134.73], p\u2009=\u20090.32) respectively.", {"entities": []}], ["There was no significant difference for any of the secondary outcomes.", {"entities": []}], ["However, our study lacked power.", {"entities": []}], ["Deep inspirations (DI) have bronchodilatory and bronchoprotective effects in healthy human subjects, but these effects appear to be absent in asthmatic lungs.", {"entities": []}], ["We have characterized the effects of DI on lung mechanics during mechanical ventilation in healthy mice and in a murine model of acute and chronic airway inflammation.", {"entities": []}], ["Balb/c mice were sensitized to ovalbumin (OVA) and exposed to nebulized OVA for 1 week or 12 weeks.", {"entities": []}], ["Control mice were challenged with PBS.", {"entities": []}], ["Mice were randomly selected to receive DI, which were given twice during the minute before assessment of lung mechanics.", {"entities": []}], ["DI protected against bronchoconstriction of central airways in healthy mice and in mice with acute airway inflammation, but not when OVA-induced chronic inflammation was present.", {"entities": []}], ["DI reduced lung resistance induced by methacholine from 3.8 \u00b1 0.3 to 2.8 \u00b1 0.1 cmH 2 O\u00b7s\u00b7mL 2 O\u00b7s\u00b7mL P < 0.001).", {"entities": []}], ["In healthy mice, DI reduced the maximum decrease in lung compliance from 15.9 \u00b1 1.5% to 5.6 \u00b1 0.6% ( P < 0.0001).", {"entities": []}], ["This protective effect was even more pronounced in mice with chronic inflammation where DI attenuated maximum decrease in compliance from 44.1 \u00b1 6.6% to 14.3 \u00b1 1.3% ( P < 0.001).", {"entities": []}], ["DI largely prevented increased peripheral tissue damping (G) and tissue elastance (H) in both healthy (G and H both P < 0.0001) and chronic allergen-treated animals (G and H both P < 0.0001).", {"entities": []}], ["We have tested a mouse model of potential value for defining mechanisms and sites of action of DI in healthy and asthmatic human subjects.", {"entities": []}], ["Our current results point to potent protective effects of DI on peripheral parts of chronically inflamed murine lungs and that the presence of DI may blunt airway hyperreactivity.", {"entities": []}], ["The pleiotrophic cytokine interleukin (IL)-13 features prominently in allergic and inflammatory diseases.", {"entities": []}], ["In allergic asthma, IL-13 is well established as an inducer of airway inflammation and tissue remodeling.", {"entities": [[3, 18, "DISEASE"], [12, 18, "DISEASE"]]}], ["We demonstrated previously that IL-13 induces release of transforming growth factor-\u03b1 (TGF\u03b1) from human bronchial epithelial cells, with proliferation of these cells mediated by the autocrine/paracrine action of this growth factor.", {"entities": []}], ["TGF\u03b1 exists as an integral membrane protein and requires proteolytic processing to its mature form, with a disintegrin and metalloproteinase (ADAM)17 responsible for this processing in a variety of tissues.", {"entities": []}], ["In this study, normal human bronchial epithelial (NHBE) cells grown in air/liquid interface (ALI) culture were used to examine the mechanisms whereby IL-13 induces release of TGF\u03b1 and cellular proliferation.", {"entities": []}], ["Inhibitors and antisense RNA were used to examine the role of ADAM17 in these processes, while IL-13-induced changes in the intracellular expression of TGF\u03b1 and ADAM17 were visualized by confocal microscopy.", {"entities": [[62, 68, "GENE"], [161, 167, "GENE"], [62, 68, "GENE"], [161, 167, "GENE"]]}], ["IL-13 was found to induce proliferation of NHBE cells, and release of TGF\u03b1, in an ADAM17-dependent manner; however, this IL-13-induced proliferation did not appear to result solely from ADAM17 activation.", {"entities": [[82, 88, "GENE"], [186, 192, "GENE"]]}], ["Rather, IL-13 induced a change in the location of TGF\u03b1 expression from intracellular to apical regions of the NHBE cells.", {"entities": []}], ["The apical region was also found to be a site of significant ADAM17 expression, even prior to IL-13 stimulation.", {"entities": [[61, 67, "GENE"]]}], ["Results from this study indicate that ADAM17 mediates IL-13-induced proliferation and TGF\u03b1 shedding in NHBE cells.", {"entities": [[38, 44, "GENE"]]}], ["Furthermore, they provide the first example wherein a cytokine (IL-13) induces a change in the intracellular expression pattern of a growth factor, apparently inducing redistribution of intracellular stores of TGF\u03b1 to the apical region of NHBE cells where expression of ADAM17 is prominent.", {"entities": [[270, 276, "GENE"]]}], ["Thus, IL-13-induced, ADAM17-mediated release of TGF\u03b1, and subsequent epithelial cell proliferation, could contribute to the epithelial hypertrophy, as well as other features, associated with airway remodeling in allergic asthma.", {"entities": [[212, 227, "DISEASE"], [221, 227, "DISEASE"]]}], ["Long-term studies of smokers who switch to lower nicotine yield cigarettes have been identified by the World Health Organization Study Group TobReg and the US Food and Drug Administration as one key area where new knowledge is required to guide science based regulation.", {"entities": []}], ["The limited number of long-term switching studies have concluded that smokers who switch to lower nicotine yield cigarettes show evidence of partial compensation.", {"entities": []}], ["Since the European Union tobacco product directive of 2001 introduced tar and nicotine yield ceilings, there has been no long-term observational switching study.", {"entities": []}], ["To address the limitations of previous studies where smokers were forced switched for relatively short durations, we plan to undertake a long-term study of spontaneous switching which is appropriately powered and includes non-switchers as a control group.", {"entities": []}], ["Healthy adult smokers aged 21\u201364 years will be enrolled into this 5-year non-residential, multicentre study across 10 cities in Germany.", {"entities": []}], ["They will be assessed at 10 timepoints with 6 month intervals during which inclusion criteria will be reassessed and spent cigarette filter tips, saliva and 24 h urine samples will be collected.", {"entities": []}], ["These samples will be used to determine average daily cigarette consumption, estimate mouth-level exposure to tar and nicotine and measure selected biomarkers of exposure, respectively.", {"entities": []}], ["Spontaneous changes in subjects\u2019 preferred cigarette products and any consequent change in tar or nicotine yield will be monitored.", {"entities": []}], ["Subjects will be required to complete questionnaires on quality of life, smoking behaviours, smoking-related sensory attributes and recent life changes.", {"entities": []}], ["The planned study is anticipated to contribute to understanding smokers\u2019 behaviours and their consequent exposure to smoke constituents.", {"entities": []}], ["It will also allow assessment of compensatory changes in their behaviour following spontaneous switching of cigarette product smoked.", {"entities": []}], ["Data from this study are expected to provide insights into study design and conduct for non-clinical assessment of smokers\u2019 exposure as part of post marketing surveillance programmes.", {"entities": []}], ["Current Controlled Trials Database reference ISRCTN95019245 .", {"entities": []}], ["The complication of asthma during pregnancy is associated with a number of poor outcomes for the mother and fetus.", {"entities": [[20, 26, "DISEASE"]]}], ["This may be partially driven by increased oxidative stress induced by the combination of asthma and pregnancy.", {"entities": [[89, 95, "DISEASE"]]}], ["Asthma is a chronic inflammatory disease of the airways associated with systemic inflammation and oxidative stress, which contributes to worsening asthma symptoms.", {"entities": [[0, 6, "DISEASE"], [147, 153, "DISEASE"]]}], ["Pregnancy alone also intensifies oxidative stress through the systemic generation of excess reactive oxidative species (ROS).", {"entities": []}], ["Antioxidants combat the damaging effects of ROS; yet antioxidant defenses are reduced in asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["Diet and nutrition have been postulated as potential factors to combat the damaging effects of asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["In particular, dietary antioxidants may play a role in alleviating the heightened oxidative stress in asthma.", {"entities": [[102, 108, "DISEASE"]]}], ["Although there are some observational and interventional studies that have shown protective effects of antioxidants in asthma, assessment of antioxidants in pregnancy are limited and there are no antioxidant intervention studies in asthmatic pregnancies on asthma outcomes.", {"entities": [[119, 125, "DISEASE"], [257, 263, "DISEASE"]]}], ["The aims of this paper are to (i) review the relationships between oxidative stress and dietary antioxidants in adults with asthma and asthma during pregnancy, and (ii) provide the rationale for which dietary management strategies, specifically increased dietary antioxidants, might positively impact maternal asthma outcomes.", {"entities": [[124, 130, "DISEASE"], [135, 141, "DISEASE"], [310, 316, "DISEASE"]]}], ["Improving asthma control through a holistic antioxidant dietary approach might be valuable in reducing asthma exacerbations and improving asthma management during pregnancy, subsequently impacting perinatal health.", {"entities": [[10, 16, "DISEASE"], [103, 109, "DISEASE"], [138, 144, "DISEASE"]]}], ["Climate-related health indicators are potentially useful for tracking and predicting the adverse public health effects of climate change, identifying vulnerable populations, and monitoring interventions.", {"entities": []}], ["However, there is a need to understand stakeholders\u2019 perspectives on the identification, development, and utility of such indicators.", {"entities": []}], ["A qualitative approach was used, comprising semi-structured interviews with key informants and service providers from government and non-government stakeholder organizations in South Australia.", {"entities": []}], ["Stakeholders saw a need for indicators that could enable the monitoring of health impacts and time trends, vulnerability to climate change, and those which could also be used as communication tools.", {"entities": []}], ["Four key criteria for utility were identified, namely robust and credible indicators, specificity, data availability, and being able to be spatially represented.", {"entities": []}], ["The variability of risk factors in different regions, lack of resources, and data and methodological issues were identified as the main barriers to indicator development.", {"entities": []}], ["This study demonstrates a high level of stakeholder awareness of the health impacts of climate change, and the need for indicators that can inform policy makers regarding interventions.", {"entities": []}], ["Concentrations of ambient PM2.5 (particulate matter <2.5 microm in aerodynamic diameter) were associated with increased mortality in two prospective cohort studies.", {"entities": []}], ["In this paper, I assess whether the weight of the evidence supports a causal association.", {"entities": []}], ["I assumed the study population in each city to have the same exposure; therefore, these are ecologic studies because exposure is at the group level.", {"entities": []}], ["Health outcome and confounding data are at the individual level.", {"entities": []}], ["Ambient PM concentrations are inadequate surrogates for personal exposure because they are at the group level and comprise only a small proportion of personal exposure, they change over time, and they constitute only a small proportion of a life span.", {"entities": []}], ["The strength of association and exposure-response relationships cannot be determined because the ecologic group-level risks of PM2.5 are overestimated 150- to 300-fold based on an analogy with individual-level exposure to inhaled cigarette smoke.", {"entities": []}], ["Risk estimates may also be high because of confounding from factors such as physical activity and lung function.", {"entities": []}], ["The evidence is not coherent because the stronger associations are expected to be with morbidity, but instead are with mortality.", {"entities": []}], ["For example, PM2.5 was associated with mortality but not with measurable reductions in lung function.", {"entities": []}], ["Biological plausibility is lacking because lifetime exposure of rats to combustion products at concentrations two to three orders of magnitude higher than air pollution levels cause lung overloading but no consistent reduction in survival.", {"entities": []}], ["Criteria for quantitative risk assessment are not met so the data are not useful for setting air quality standards.", {"entities": []}], ["The weight of evidence suggests there is no substantive basis for concluding that a cause-effect relationship exists between long-term ambient PM2.5 and increased mortality.", {"entities": []}], ["Relatively few studies have been conducted of the association between air pollution and emergency department (ED) visits, and most of these have been based on a small number of visits, for a limited number of health conditions and pollutants, and only daily measures of exposure and response.", {"entities": []}], ["A time-series analysis was conducted on nearly 400,000 ED visits to 14 hospitals in seven Canadian cities during the 1990s and early 2000s.", {"entities": []}], ["Associations were examined between carbon monoxide (CO), nitrogen dioxide (NO 2 ), ozone (O 3 ), sulfur dioxide (SO 2 ), and particulate matter (PM 10 and PM 2.5 ), and visits for angina/myocardial infarction, heart failure, dysrhythmia/conduction disturbance, asthma, chronic obstructive pulmonary disease (COPD), and respiratory infections.", {"entities": [[269, 306, "DISEASE"], [187, 208, "DISEASE"], [261, 267, "DISEASE"]]}], ["Daily and 3-hourly visit counts were modeled as quasi-Poisson and analyses controlled for effects of temporal cycles, weather, day of week and holidays.", {"entities": []}], ["24-hour average concentrations of CO and NO 2 lag 0 days exhibited the most consistent associations with cardiac conditions (2.1% (95% CI, 0.0\u20134.2%) and 2.6% (95% CI, 0.2\u20135.0%) increase in visits for myocardial infarction/angina per 0.7 ppm CO and 18.4 ppb NO 2 respectively; 3.8% (95% CI, 0.7\u20136.9%) and 4.7% (95% CI, 1.2\u20138.4%) increase in visits for heart failure).", {"entities": [[200, 221, "DISEASE"]]}], ["Ozone (lag 2 days) was most consistently associated with respiratory visits (3.2% (95% CI, 0.3\u20136.2%), and 3.7% (95% CI, -0.5\u20137.9%) increases in asthma and COPD visits respectively per 18.4 ppb).", {"entities": [[144, 150, "DISEASE"]]}], ["Associations tended to be of greater magnitude during the warm season (April \u2013 September).", {"entities": []}], ["In particular, the associations of PM 10 and PM 2.5 with asthma visits were respectively nearly three- and over fourfold larger vs. all year analyses (14.4% increase in visits, 95% CI, 0.2\u201330.7, per 20.6 \u03bcg/m 10 and 7.6% increase in visits, 95% CI, 5.1\u201310.1, per 8.2 \u03bcg/m 2.5 ).", {"entities": [[57, 63, "DISEASE"]]}], ["No consistent associations were observed between three hour average pollutant concentrations and same-day three hour averages of ED visits.", {"entities": []}], ["In this large multicenter analysis, daily average concentrations of CO and NO 2 exhibited the most consistent associations with ED visits for cardiac conditions, while ozone exhibited the most consistent associations with visits for respiratory conditions.", {"entities": []}], ["PM 10 and PM 2.5 were strongly associated with asthma visits during the warm season.", {"entities": [[47, 53, "DISEASE"]]}], ["Introduction : Smoke-free homes can help protect children from tobacco smoke exposure (TSE).", {"entities": []}], ["The objective of this study was to conduct a meta-analysis to quantify effects of interventions on changes in tobacco smoke pollution in the home, as measured by air nicotine and particulate matter (PM).", {"entities": []}], ["Methods : We searched MEDLINE, PubMed, Web of Science, PsycINFO, and Embase.", {"entities": []}], ["We included controlled trials of interventions which aimed to help parents protect children from tobacco smoke exposure.", {"entities": []}], ["Two reviewers identified relevant studies, and three reviewers extracted data.", {"entities": []}], ["Results : Seven studies were identified.", {"entities": []}], ["Interventions improved tobacco smoke air pollution in homes as assessed by nicotine or PM.", {"entities": []}], ["(6 studies, N = 681, p = 0.02).", {"entities": []}], ["Analyses of air nicotine and PM separately also showed some benefit (Air nicotine: 4 studies, N = 421, p = 0.08; PM: 3 studies, N = 340, p = 0.02).", {"entities": []}], ["Despite improvements, tobacco smoke pollution was present in homes in all studies at follow-up.", {"entities": []}], ["Conclusions : Interventions designed to protect children from tobacco smoke are effective in reducing tobacco smoke pollution (as assessed by air nicotine or PM) in homes, but contamination remains.", {"entities": []}], ["The persistence of significant pollution levels in homes after individual level intervention may signal the need for other population and regulatory measures to help reduce and eliminate childhood tobacco smoke exposure.", {"entities": []}], ["Early neurological deterioration (END) is associated with increased risk of functional disability and mortality.", {"entities": []}], ["However, data are limited regarding the long-term risk of poor functional outcomes.", {"entities": []}], ["Thus we explored the association between END and long-term outcomes in patients with acute ischemic stroke.", {"entities": []}], ["A total of 1064 patients were enrolled with acute ischemic stroke who were consecutively admitted to the 3 stroke units of Huai-He Hospital, Kaifeng, China.", {"entities": []}], ["END was defined as an increment change of at least one point in motor power or total National Institute of Health Stroke Scale (NIHSS) score deterioration \u22652 points within the first week after admission.", {"entities": []}], ["We retrospectively assessed the risk factors of END and prospectively explored the relationship between END and the long-term outcomes by multivariable regression models after adjusting the potential confounding factors.", {"entities": []}], ["Outcomes were evaluated at 18 months based on modified Rankin scale (MRS) scores.", {"entities": []}], ["Approximately 32% of first-ever ischemic stroke patients experienced END during the acute phase.", {"entities": []}], ["END was associated with diabetes (odds ratio [OR], 2.218; 95% confidence interval [CI] 1.619\u20133.037), NIHSS score at admission (OR, 1.052; 95% CI 1.023\u20131.082), C-reactive protein (CRP) levels (OR, 1.224; 95% CI 1.066\u20131.406]), and homocysteine (HCY) levels (OR, 1.203; 95% CI 1.061\u20131.365) after adjusting related factors, such as hypertension, diabetes, NIHSS at admission, and some blood laboratory values, including direct bilirubin, total cholesterol, low-density lipoprotein, glucose, CRP, HCY, and D-dimer levels.", {"entities": [[328, 340, "DISEASE"], [179, 182, "GENE"], [487, 490, "GENE"], [179, 182, "GENE"], [487, 490, "GENE"]]}], ["During the follow-up period, 52 (4.9%) patients died, 160 (15.0%) recrudesced, and 317 (29.8%) suffered poor outcomes.", {"entities": []}], ["Multivariate logistic regression analyses revealed that poor outcome was associated with END (OR, 3.366; 95% CI 2.495\u20134.542), age (OR, 1.028; 95% CI 1.015\u20131.041), body mass index (OR, 1.096; 95% CI 1.051\u20131.144), coronary heart disease (OR, 1.637; 95% CI 1.108\u20132.416), and CRP (OR, 2.474; 95% CI 1.840\u20133.326).", {"entities": [[221, 234, "DISEASE"], [212, 234, "DISEASE"], [272, 275, "GENE"]]}], ["The risk factors of END are multifaceted.", {"entities": []}], ["Diabetes, NIHSS score at admission, CRP, and HCY are independent predictors of END.", {"entities": [[36, 39, "GENE"]]}], ["In addition, the results of this study indicate that END is an important predictor of poor functional outcome.", {"entities": []}], ["Radiotherapy can result in lung diseases pneumonitis or fibrosis dependent on patient susceptibility.", {"entities": []}], ["Herein we used inbred and genetically altered mice to investigate whether the tissue adaptive immune response to radiation injury influences the development of radiation-induced lung disease.", {"entities": [[178, 190, "DISEASE"]]}], ["Six inbred mouse strains were exposed to 18\u2009Gy whole thorax irradiation and upon respiratory distress strains prone to pneumonitis with fibrosis presented an increased pulmonary frequency of Thelper (Th)17 cells which was not evident in strains prone solely to pneumonitis.", {"entities": []}], ["The contribution of Th17 cells to fibrosis development was supported as the known enhanced fibrosis of toll-like receptor 2&4 deficient mice, compared to C57BL/6J mice, occurred with earlier onset neutrophilia, and with increased levels of pulmonary Th17, but not Th1, cells following irradiation.", {"entities": []}], ["Irradiated Il17\u2212/\u2212 mice lacked Th17 cells, and were spared both fibrosis and pneumonitis, as they survived to the end of the experiment with a significantly increased pulmonary Th1 cell frequency, only.", {"entities": []}], ["Interferon-\u03b3\u2212/\u2212 mice, deficient in Th1 cells, developed a significantly enhanced fibrosis response compared to that of C57BL/6J mice.", {"entities": []}], ["The tissue adaptive immune response influences the pulmonary disease response to radiotherapy, as an increased Th17 cell frequency enhanced and a Th1 response spared, fibrosis in mice.", {"entities": []}], ["Airway wall remodelling is a key pathology of asthma.", {"entities": [[46, 52, "DISEASE"]]}], ["It includes thickening of the airway wall, hypertrophy and hyperplasia of bronchial smooth muscle cells (BSMC), as well as an increased vascularity of the sub-epithelial cell layer.", {"entities": []}], ["BSMC are known to be the effector cells of bronchoconstriction, but they are increasingly recognized as an important source of inflammatory mediators and angiogenic factors.", {"entities": []}], ["To compare the angiogenic potential of BSMC of asthmatic and non-asthmatic patients and to identify asthma-specific angiogenic factors.", {"entities": [[100, 106, "DISEASE"]]}], ["Primary BSMC were isolated from human airway tissue of asthmatic and non-asthmatic patients.", {"entities": []}], ["Conditioned medium (CM) collected from BSMC isolates was tested for angiogenic capacity using the endothelial cell (EC)-spheroid in vitro angiogenesis assay.", {"entities": []}], ["Angiogenic factors in CM were quantified using a human angiogenesis antibody array and enzyme linked immunosorbent assay.", {"entities": []}], ["Induction of sprout outgrowth from EC-spheroids by CM of BSMC obtained from asthma patients was increased compared with CM of control BSMC (twofold, p < 0.001).", {"entities": [[76, 82, "DISEASE"]]}], ["Levels of ENA-78, GRO-\u03b1 and IL-8 were significantly elevated in CM of BSMC from asthma patients (p < 0.05 vs. non-asthmatic patients).", {"entities": [[80, 86, "DISEASE"]]}], ["SB 265610, a competitive antagonist of chemokine (CXC-motif) receptor 2 (CXCR2), attenuated the increased sprout outgrowth induced by CM of asthma patient-derived BSMC.", {"entities": [[140, 146, "DISEASE"], [73, 78, "GENE"]]}], ["BSMC isolated from asthma patients exhibit increased angiogenic potential.", {"entities": [[19, 25, "DISEASE"]]}], ["This effect is mediated through the CXCR2 ligands (ENA78, GRO-\u03b1 and IL-8) produced by BSMC.", {"entities": [[36, 41, "GENE"]]}], ["CXCR2 ligands may play a decisive role in directing the neovascularization in the sub-epithelial cell layers of the lungs of asthma patients.", {"entities": [[125, 131, "DISEASE"], [0, 5, "GENE"]]}], ["Counteracting the CXCR2-mediated neovascularization by pharmaceutical compounds may represent a novel strategy to reduce airway remodelling in asthma.", {"entities": [[143, 149, "DISEASE"]]}], ["Early-life exposure to household pets has the capacity to reduce risk for overweight and allergic disease, especially following caesarean delivery.", {"entities": []}], ["Since there is some evidence that pets also alter the gut microbial composition of infants, changes to the gut microbiome are putative pathways by which pet exposure can reduce these risks to health.", {"entities": []}], ["To investigate the impact of pre- and postnatal pet exposure on infant gut microbiota following various birth scenarios, this study employed a large subsample of 746 infants from the Canadian Healthy Infant Longitudinal Development Study (CHILD) cohort, whose mothers were enrolled during pregnancy between 2009 and 2012.", {"entities": []}], ["Participating mothers were asked to report on household pet ownership at recruitment during the second or third trimester and 3\u00a0months postpartum.", {"entities": []}], ["Infant gut microbiota were profiled with 16S rRNA sequencing from faecal samples collected at the mean age of 3.3\u00a0months.", {"entities": []}], ["Two categories of pet exposure (i) only during pregnancy and (ii) pre- and postnatally were compared to no pet exposure under different birth scenarios.", {"entities": []}], ["Over half of studied infants were exposed to at least one furry pet in the prenatal and/or postnatal periods, of which 8% were exposed in pregnancy alone and 46.8% had exposure during both time periods.", {"entities": []}], ["As a common effect in all birth scenarios, pre- and postnatal pet exposure enriched the abundance of Oscillospira and/or Ruminococcus ( P \u2009<\u20090.05) with more than a twofold greater likelihood of high abundance.", {"entities": []}], ["Among vaginally born infants with maternal intrapartum antibiotic prophylaxis exposure, Streptococcaceae were substantially and significantly reduced by pet exposure ( P \u2009<\u20090.001, FDRp\u2009=\u20090.03), reflecting an 80% decreased likelihood of high abundance (OR 0.20, 95%CI, 0.06\u20130.70) for pet exposure during pregnancy alone and a 69% reduced likelihood (OR 0.31, 95%CI, 0.16\u20130.58) for exposure in the pre- and postnatal time periods.", {"entities": []}], ["All of these associations were independent of maternal asthma/allergy status, siblingship, breastfeeding exclusivity and other home characteristics.", {"entities": [[55, 61, "DISEASE"]]}], ["The impact of pet ownership varies under different birth scenarios; however, in common, exposure to pets increased the abundance of two bacteria, Ruminococcus and Oscillospira , which have been negatively associated with childhood atopy and obesity.", {"entities": [[241, 248, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s40168-017-0254-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Early school success is clearly related to later health.", {"entities": []}], ["A prediction index that uses parent report to assess children's risk for poor academic achievement could potentially direct targeted service delivery to improve child outcomes.", {"entities": []}], ["We obtained risk factors through literature review and used the National Longitudinal Survey of Youth 1979 Child Files to examine the predictive associations of these factors with academic achievement scores.", {"entities": []}], ["Twenty predictors were identified including four strong predictors (maternal education, child gender, family income, and low birth weight).", {"entities": []}], ["Significantly, 12 predictors explained 17-24% of score variance.", {"entities": []}], ["Parent-reported factors provide predictive accuracy for academic achievement.", {"entities": []}], ["Although several studies have demonstrated that mesenchymal stem cells derived from adipose tissue (ASCs) can ameliorate allergic airway inflammation, the immunomodulatory mechanism of ASCs remains unclear.", {"entities": []}], ["In this study, we investigated whether regulatory T cells (Tregs) induction is a potential mechanism in immunomodulatory effects of ASCs on allergic airway disease and how these induced Tregs orchestrate allergic inflammation.", {"entities": []}], ["Intravenous administration of ASCs significantly reduced allergic symptoms and inhibited eosinophilic inflammation.", {"entities": []}], ["Airway hyperresponsiveness, total immune cell and eosinophils in the bronchoalveolar lavage fluid, mucus production, and serum allergen-specific IgE and IgG1 were significantly reduced after ASCs administration.", {"entities": []}], ["ASCs significantly inhibited Th2 cytokines (IL-4, IL-5, and IL-13) and enhanced Th1 cytokine (IFN- \u03b3 ) and regulatory cytokines (IL-10 and TGF- \u03b2 ) in the bronchoalveolar lavage fluid and lung draining lymph nodes.", {"entities": []}], ["Furthermore, levels of IDO, TGF- \u03b2 , and PGE 2 were significantly increased after ASCs administration.", {"entities": []}], ["Interestingly, this upregulation was accompanied by increased Treg populations.", {"entities": []}], ["In conclusion, ASCs ameliorated allergic airway inflammation and improved lung function through the induction of Treg expansion.", {"entities": []}], ["The induction of Treg by ASCs involves the secretion of soluble factors such as IDO, TGF- \u03b2 , and PGE 2 and Treg might be involved in the downregulation of Th2 cytokines and upregulation of Th1 cytokines production.", {"entities": []}], ["Prediction equations for the carbon monoxide diffusing capacity of the lung (DLCO) and diffusing capacity per liter of lung volume (DLCO/VA) were derived from 90 normal nonsmoking subjects (40 men and 50 women), using a standardized single-breath technique for determining carbon monoxide diffusing capacity.", {"entities": []}], ["The results obtained are as follows: The mean values for DLCO and DLCO/VA were 28.05\u00b15.07 ml/min/mmHg, 4.569\u00b10.694 ml/min/mmHg/L for men and 20.79\u00b14.03 ml/min/mmHg, 4.695\u00b10.743 ml/min/mmHg/L for women, respectively.", {"entities": []}], ["The values for DLCO and DLCO/VA disclosed significantly negative correlation with advancing age and positive correlation with height.", {"entities": []}], ["Normal prediction formulas were obtained for diffusing capacity, using age and height.", {"entities": []}], ["Men : DLCO = 0.3504 \u2009 H \u2212 0.2156 \u2009 A \u2212 23.168 DLCO / VA = \u2212 0.0205 \u2009 H \u2212 0.0283 A + 9.0919 Women : DLCO = 0.2491 \u2009 H \u2212 0.1533 \u2009 A \u2212 11.662 DLCO / VA \u2009 = 0.0140 \u2009 H \u2212 \u2009 0.0216 \u2009 A + 3.413 The mean values for DLCO and DLCO/VA were 28.05\u00b15.07 ml/min/mmHg, 4.569\u00b10.694 ml/min/mmHg/L for men and 20.79\u00b14.03 ml/min/mmHg, 4.695\u00b10.743 ml/min/mmHg/L for women, respectively.", {"entities": []}], ["The values for DLCO and DLCO/VA disclosed significantly negative correlation with advancing age and positive correlation with height.", {"entities": []}], ["Normal prediction formulas were obtained for diffusing capacity, using age and height.", {"entities": []}], ["Effects of air pollution on morbidity and mortality may be mediated by alterations in immune competence.", {"entities": []}], ["In this study we examined short-term associations of air pollution exposures with lymphocyte immunophenotypes in cord blood among 1,397 deliveries in two districts of the Czech Republic.", {"entities": []}], ["We measured fine particulate matter < 2.5 \u03bcm in diameter (PM 2.5 ) and 12 polycyclic aromatic hydrocarbons (PAHs) in 24-hr samples collected by versatile air pollution samplers.", {"entities": []}], ["Cord blood samples were analyzed using a FACSort flow cytometer to determine phenotypes of CD3 2.5 was 24.8 \u03bcg/m 2.5 levels during the 14 days before birth were associated with decreases in T-lymphocyte phenotype fractions (i.e., CD3 2.5 .", {"entities": []}], ["Ambient air pollution may influence the relative distribution of lymphocyte immunophenotypes of the fetus.", {"entities": []}], ["The presence of a mass in the nose and paranasal sinuses may seem to be a simple problem; however it raises many questions about the differential diagnosis.", {"entities": []}], ["The aim of this study is to evaluate the clinico-pathological profile of sinonasal masses in our environment This is a retrospective analytical review of all the patients with sinonasal masses that presented to the national ear care center, Kaduna over a six year (2003-2008) period.", {"entities": []}], ["Their biodata, clinical profile and histological diagnoses were analyzed.", {"entities": []}], ["A total of 76 patients were analyzed, age range 5 to 64 yrs with a mean age of 33.3 yr median and modal age of 35.00 (SD = 13.1 \u00b1 1.5).", {"entities": []}], ["Majority of the patients were in the age groups 21-50 yrs.", {"entities": []}], ["There were 34 male and 42 female with M: F ratio of 1:1.2.", {"entities": []}], ["The main presenting symptoms are nasal blockage 97.4% and rhinorrhea 94.7%.", {"entities": []}], ["It was bilateral in 34 (44.7%), left side in 24(31.6%) and right side in 18(23.7%) patients.", {"entities": []}], ["The commonest clinical diagnoses were simple nasal polyp 47(61.8%) and antrochoanal polyp 10(13.2%).", {"entities": []}], ["About 59 (77.6%) were benign, 2 (2.6%) were malignant and 15 (19.7%) were lost to follow up.", {"entities": []}], ["The commonest histological diagnosis is simple inflammatory nasal polyp in 28 (36.8%) patients and the least was nasal capillary hemangioma 2 (2.6%).", {"entities": [[119, 139, "DISEASE"], [129, 139, "DISEASE"]]}], ["About 55(72.4%) patients had surgical treatment.", {"entities": []}], ["Nasal obstruction and rhinorrhea are the commonest symptoms of presentation, simple inflammatory nasal polyp is still the commonest histological pattern seen in our environment, and surgery is still the best modality of treatment for benign tumor thus the need for advocacy for early recognition and referral to the ENT surgeon.", {"entities": []}], ["Tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) has been frequently detected in environmental media and has adverse health effect on wildlife and humans.", {"entities": []}], ["It has been implicated to have hepatotoxicity, but its molecular mechanisms remain unclear.", {"entities": []}], ["In the present study, adult male zebrafish were exposed to TDCIPP and global hepatic gene expression was examined by RNA-Seq and RT-qPCR in order to understand the molecular mechanisms of TDCIPP-induced hepatotoxicity.", {"entities": []}], ["Our results indicated that TDCIPP exposure significantly up-regulated the expression of genes involved in endoplasmic reticulum stress and Toll-like receptor (TLR) pathway, implying an inflammatory response, which was supported by up-regulation of inflammation-related biomaker genes.", {"entities": []}], ["Hepatic inflammation was further confirmed by histological observation of increase of infiltrated neutrophils and direct observation of liver recruitment of neutrophils labeled with Ds-Red fluorescent protein of Tg ( lysC:DsRed ) zebrafish upon TDCIPP exposure.", {"entities": [[212, 214, "GENE"]]}], ["To further characterize the hepatotoxicity of TDCIPP, the expression of hepatotoxicity biomarker genes, liver histopathology and morphology were examined.", {"entities": []}], ["The exposure to TDCIPP significantly up-regulated the expression of several biomarker genes for hepatotoxicity ( gck , gsr and nqo1 ) and caused hepatic vacuolization and apoptosis as well as increase of the liver size.", {"entities": [[113, 116, "GENE"], [119, 122, "GENE"], [127, 131, "GENE"]]}], ["Collectively, our results suggest that exposure to TDCIPP induces hepatic inflammation and leads to hepatotoxicity in zebrafish.", {"entities": []}], ["ST2 (suppression of tumorigenity) has been described as a receptor for the interleukin-33, a member of the IL-1 family of cytokines.", {"entities": []}], ["It is associated to coronary artery disease, all-causes mortality and cardiovascular mortality.", {"entities": []}], ["The present study was designed to assess the immunohistochemical expression of the ST2 receptor (ST2L/Il-1R) in atherosclerotic plaques of formalin fixed paraffin-embedded internal carotid arteries of patients with and without cerebro-vascular symptoms.", {"entities": []}], ["The study involved 41 cases (23 asymptomatic and 18 symptomatic).", {"entities": []}], ["All the clinical and morphological parameters examined were uniformly distributed between the two groups, with a mild predominance of degree of calcification in asymptomatic cases (p = 0.01).", {"entities": []}], ["ST2L expression was found to be more evident as a membrane pattern in macrophages when observing carotid atherosclerotic plaques of symptomatic patients, rather than in asymptomatic patients\u2019 plaques (77.7% vs 39.1%; p = 0.015), and its expression was particularly remarkable in VI type plaque (AHA).", {"entities": []}], ["Significantly, ST2L was marked by the endothelium of neoangiogenetic vessels on the shoulder region of the plaque, but not (apart from a few cases) in the endothelium covering the residual lumen of the vessel.", {"entities": []}], ["The ST2L immunohistochemical expression was for the first time investigated in a large number of human carotid atherosclerotic plaques, as for its pattern of distribution in the different plaque cell populations.", {"entities": []}], ["Furthermore, ST2L was particularly remarkable on macrophages, as a membrane pattern, of symptomatic patients\u2019 plaque.", {"entities": []}], ["Considering our data, we hypothesize that ST2L/IL33 axis could drive the mechanism of plaque development and eventually rupture.", {"entities": []}], ["Controlled trials have found therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) infusion therapy to be equally efficacious in treating Guillain-Barr\u00e9 syndrome (GBS).", {"entities": [[171, 179, "DISEASE"]]}], ["Due to increases in the price of IVIg compared to human serum albumin (HSA), used as a replacement fluid in TPE, we examined direct hospital-level expenditures for TPE and IVIg for meaningful cost-differences between these treatments.", {"entities": []}], ["Using financial data from our two institutions, hospital cost profiles for IVIg and 5% albumin were established.", {"entities": []}], ["Reimbursement amounts were obtained from publicly available Medicare data resources to determine payment rates for TPE, non-tunneled central catheter line placement, and drug infusion therapy.", {"entities": []}], ["A model was developed which allows hospitals to input cost and reimbursement amounts for both IVIg and TPE with HSA that results in real-time valuations of these interventions.", {"entities": []}], ["The direct cost of five IVIg infusion sessions totaling 2.0 grams per kilogram (g/kg) body weight was $10,329.85 compared to a series of five TPE procedures, which had direct costs of $4,638.16.", {"entities": []}], ["In GBS patients, direct costs of IVIg therapy are more than twice that of TPE.", {"entities": []}], ["Given equivalent efficacy and similar severity and frequencies of adverse events, TPE appears to be a less expensive first-line therapy option for treatment of patients with GBS.", {"entities": []}], ["Hereditary Inclusion Body Myopathy (HIBM) is an autosomal recessive, adult onset, non-inflammatory neuromuscular disorder with no effective treatment.", {"entities": []}], ["The causative gene, GNE , codes for UDP- N -acetylglucosamine 2-epimerase/ N -acetylmannosamine kinase, which catalyzes the first two reactions in the synthesis of sialic acid.", {"entities": [[20, 23, "GENE"]]}], ["Reduced sialylation of muscle glycoproteins, such as \u03b1-dystroglycan and neural cell adhesion molecule (NCAM), has been reported in HIBM.", {"entities": []}], ["We treated 4 HIBM patients with intravenous immune globulin (IVIG), in order to provide sialic acid, because IgG contains 8 \u03bcmol of sialic acid/g.", {"entities": []}], ["IVIG was infused as a loading dose of 1 g/kg on two consecutive days followed by 3 doses of 400 mg/kg at weekly intervals.", {"entities": []}], ["For all four patients, mean quadriceps strength improved from 19.0 kg at baseline to 23.2 kg (+22%) directly after IVIG loading to 25.6 kg (+35%) at the end of the study.", {"entities": []}], ["Mean shoulder strength improved from 4.1 kg at baseline to 5.9 kg (+44%) directly after IVIG loading to 6.0 kg (+46%) at the end of the study.", {"entities": []}], ["The composite improvement for 8 other muscle groups was 5% after the initial loading and 19% by the end of the study.", {"entities": []}], ["Esophageal motility and lingual strength improved in the patients with abnormal barium swallows.", {"entities": []}], ["Objective measures of functional improvement gave variable results, but the patients experienced improvements in daily activities that they considered clinically significant.", {"entities": []}], ["Immunohistochemical staining and immunoblotting of muscle biopsies for \u03b1-dystroglycan and NCAM did not provide consistent evidence for increased sialylation after IVIG treatment.", {"entities": []}], ["Side effects were limited to transient headaches and vomiting.", {"entities": []}], ["The mild benefits in muscle strength experienced by HIBM patients after IVIG treatment may be related to the provision of sialic acid supplied by IVIG.", {"entities": []}], ["Other sources of sialic acid are being explored as treatment options for HIBM.", {"entities": []}], ["There is increasing evidence to suggest that extracellular matrix (ECM) components play an active role in tumor progression and are an important determinant for the growth and progression of solid tumors.", {"entities": []}], ["Tumor cells interfere with the normal programming of ECM biosynthesis and can extensively modify the structure and composition of the matrix.", {"entities": []}], ["In ovarian cancer alterations in the extracellular environment are critical for tumor initiation and progression and intra-peritoneal dissemination.", {"entities": [[3, 17, "DISEASE"], [11, 17, "DISEASE"]]}], ["ECM molecules including versican and hyaluronan (HA) which interacts with the HA receptor, CD44, have been shown to play critical roles in ovarian cancer metastasis.", {"entities": [[139, 153, "DISEASE"], [147, 153, "DISEASE"], [91, 95, "GENE"]]}], ["This review focuses on versican, HA, and CD44 and their potential as therapeutic targets for ovarian cancer.", {"entities": [[93, 107, "DISEASE"], [101, 107, "DISEASE"], [41, 45, "GENE"]]}], ["Polycyclic aromatic hydrocarbons (PAHs), including benzo[ a ]pyrene (BaP), are air pollutants released by the World Trade Center (WTC) fires and urban combustion sources.", {"entities": []}], ["BaP\u2013DNA adducts provide a measure of PAH-specific genetic damage, which has been associated with increased risk of adverse birth outcomes and cancer.", {"entities": [[142, 148, "DISEASE"]]}], ["We previously reported that levels of BaP\u2013DNA adducts in maternal and umbilical cord blood obtained at delivery were elevated among subjects who had resided within 1 mile of the WTC site during the month after 9/11; and that elevated blood adducts in combination with in utero exposure to environmental tobacco smoke (ETS) were significantly associated with decreased fetal growth.", {"entities": []}], ["Our aim was to assess possible effects of prenatal exposure to WTC pollutants on child development.", {"entities": []}], ["After 11 September 2001, we enrolled a cohort of nonsmoking pregnant women who delivered at three lower Manhattan hospitals.", {"entities": []}], ["We have followed a subset of children through their third birthdays and measured cognitive and motor development using the Bayley-II Scales of Child Development (BSID-II).", {"entities": []}], ["In multivariate analyses, we found a significant interaction between cord blood adducts and in utero exposure to ETS on mental development index score at 3 years of age ( p = 0.02, n = 98) whereas neither adducts nor ETS alone was a significant predictor of (BSID-II) cognitive development.", {"entities": []}], ["Although limited by small numbers, these results suggest that exposure to elevated levels of PAHs in conjunction with prenatal ETS exposure may have contributed to a modest reduction in cognitive development among cohort children.", {"entities": []}], ["The impact of asthma and chronic obstructive pulmonary disease (COPD) on individuals\u2019 lives may be substantial, yet clinical practice often focuses only on symptoms.", {"entities": [[25, 62, "DISEASE"], [14, 20, "DISEASE"]]}], ["We aimed to better understand the perspective of asthma or COPD patients and to identify condition-related burden, life impact, priorities, unmet needs, and treatment goals.", {"entities": [[49, 55, "DISEASE"]]}], ["Individuals aged at least 18\u00a0years with asthma or COPD were identified by a recruitment panel via clinical referrals, support groups, consumer networks, and a patient database.", {"entities": [[40, 46, "DISEASE"]]}], ["Interviews were carried out individually (by telephone) or in focus groups (with no more than five participants per group).", {"entities": []}], ["A semi-structured interview guide was used with prespecified topics, informed by a literature review, that were considered impactful in asthma or COPD (symptoms and daily-life impact, satisfaction with current treatment, important aspects of treatment, adherence, and ideal treatment).", {"entities": [[136, 142, "DISEASE"]]}], ["Overall, 72 people participated in focus groups/individual interviews (asthma n \u00a0=\u00a018/ n \u00a0=\u00a021; COPD n \u00a0=\u00a015/ n \u00a0=\u00a018).", {"entities": [[71, 77, "DISEASE"]]}], ["\u201cShortness of breath\u201d was the most frequently reported symptom; however, participants discussed the life impact of their condition more than symptoms alone.", {"entities": []}], ["Reported physical impacts included the inability to sleep and socialize, while emotional impacts included \u201cembarrassment, stigma, and/or self-consciousness\u201d, \u201cfear and/or panic\u201d, and \u201csadness, anxiety, and/or depression\u201d.", {"entities": []}], ["Coping mechanisms for normal activities included continuing at reduced pace and avoidance.", {"entities": []}], ["Treatment preferences centered on resolving impacts; improved sleep, \u201cspeed of action\u201d, and \u201clength of relief\u201d were the most frequently reported ideal treatment factors.", {"entities": []}], ["Patients with asthma or COPD experience substantial quality of life limitations and tend to focus on these in their expressions of concern, rather than symptoms per se.", {"entities": [[14, 20, "DISEASE"]]}], ["Life impacts of these conditions may have implications beyond those commonly appreciated in routine practice; these considerations will be applied to a future discrete choice experiment survey.", {"entities": []}], ["GSK funded study (H0-15-15502/204821).", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-017-0557-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The immune system has previously been demonstrated to be associated with the pathophysiological development of metabolic abnormalities.", {"entities": []}], ["However, the mechanisms linking immunity to metabolic disease remain to be fully elucidated.", {"entities": []}], ["It has previously been suggested that innate lymphoid cells (ILCs) may be involved in the progression of numerous types of metabolic diseases as these cells act as suppressors and promoters for obesity and associated conditions, and are particularly involved in adipose tissue inflammation, which is a major feature of metabolic imbalance.", {"entities": [[194, 201, "DISEASE"]]}], ["Group 2 ILCs (ILC2s) have been revealed as anti-obese immune regulators by secreting anti-inflammatory cytokines and promoting the polarization of M2 macrophages, whereas group 1 ILCs (ILC1s), including natural killer cells, may promote adipose tissue inflammation via production of interferon-\u03b3, which in turn polarizes macrophages toward the M1 type.", {"entities": []}], ["The majority of studies to date have demonstrated the pathological association between ILCs and obesity in the context of adipose tissue inflammation, whereas the roles of ILCs in other organs which participate in obesity development have not been fully characterized.", {"entities": [[96, 103, "DISEASE"], [214, 221, "DISEASE"]]}], ["Therefore, identifying the roles of all types of ILCs as central components mediating obesity-associated inflammation, is of primary concern, and may lead to the discovery of novel preventative and therapeutic interventions.", {"entities": [[86, 93, "DISEASE"]]}], ["Common complex diseases are influenced by both genetic and environmental factors.", {"entities": []}], ["Many genetic factors overlap between various autoimmune diseases.", {"entities": []}], ["The aim of the present study is to determine whether four genetic variants known to be risk variants for several autoimmune diseases could be associated with an increased susceptibility to type 1 diabetes mellitus.", {"entities": [[189, 213, "DISEASE"], [196, 213, "DISEASE"]]}], ["We genotyped four genetic variants (rs2358817, rs1049550, rs6679356, rs9865818) within VTCN1, ANXA11, IL12RB2 and LPP genes respectively, in 265 T1DM family trios in Croatian population.", {"entities": [[87, 92, "GENE"], [94, 100, "GENE"], [102, 109, "GENE"], [114, 117, "GENE"]]}], ["We did not detect association of these polymorphisms with T1DM.", {"entities": []}], ["However, quantitative transmission disequilibrium test (QTDT, orthogonal model) revealed a significant association between the age of onset of T1DM and IL12RB2 rs6679356 variant.", {"entities": [[152, 159, "GENE"]]}], ["An earlier onset of T1DM was associated with the rs6679356 minor dominant allele C (p\u200a=\u200a0.005).", {"entities": []}], ["The association remained significant even after the Bonferroni correction for multiple testing and permutation.", {"entities": []}], ["Variants originally associated with juvenile idiopathic arthritis ( VTCN1 gene), sarcoidosis ( ANXA11 gene), primary biliary cirrhosis ( IL12RB2 gene) and celiac disease ( LPP gene) were not associated with type 1 diabetes in our dataset.", {"entities": [[109, 134, "DISEASE"], [155, 169, "DISEASE"], [81, 92, "DISEASE"], [56, 65, "DISEASE"], [68, 73, "GENE"], [95, 101, "GENE"], [137, 144, "GENE"], [172, 175, "GENE"]]}], ["Nevertheless, association of IL12RB2 rs6679356 polymorphism with the age of T1DM onset suggests that this gene plays a role in defining the time of disease onset.", {"entities": [[29, 36, "GENE"]]}], ["Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a variable course.", {"entities": [[11, 29, "DISEASE"]]}], ["Not uncommonly, IPF patients are hospitalized for respiratory-related causes, including disease worsening.", {"entities": []}], ["This study aimed to characterize the prevalence, and economic and health care burden of IPF.", {"entities": []}], ["Retrospective insurance claims data collected yearly between January 1, 2009 and December 31, 2011, were used to determine prevalence and calculate all-cause and respiratory-related resource utilization and costs.", {"entities": []}], ["Patients had at least one inpatient claim or two outpatient claims for IPF (ICD-9-CM code 516.3).", {"entities": []}], ["Results for health care burden are reported for the 2011 cohort (similar findings in 2009\u20132010).", {"entities": []}], ["Costs are reported in 2011 US dollars ($).", {"entities": []}], ["Patients with IPF had a mean age of 69.8\u201371.3\u00a0years.", {"entities": []}], ["Overall prevalence for IPF was 28.8, 28.1 and 19.8 per 100,000 insured persons in 2009, 2010 and 2011.", {"entities": []}], ["In each year, prevalence increased with age.", {"entities": []}], ["In 2011, 37.7\u00a0% of patients were hospitalized at least once for any cause; 19.5\u00a0% for respiratory-related reasons.", {"entities": []}], ["Also in 2011, the mean number of all-cause outpatient visits and respiratory-related office visits was 18.5 and 5.7 per patient, respectively.", {"entities": []}], ["All-cause health care costs in 2011 were $59,379 per patient; 36.6\u00a0% of costs ($21,732) were respiratory related.", {"entities": []}], ["The prevalence of IPF in this claims database increased with age, with a notable increase in those over 65\u00a0years.", {"entities": []}], ["IPF is associated with a large economic and health care burden.", {"entities": []}], ["Additional research is needed to determine how such burden might be reduced.", {"entities": []}], ["OBJECTIVE\u2014 Genetic and environmental factors modulate the susceptibility to diabetic nephropathy, as initiating and/or progression factors.", {"entities": []}], ["The objective of the European Rational Approach for the Genetics of Diabetic Complications (EURAGEDIC) study is to identify nephropathy susceptibility genes.", {"entities": []}], ["We report molecular genetic studies for 127 candidate genes for nephropathy.", {"entities": []}], ["RESEARCH DESIGN AND METHODS\u2014 Polymorphisms were identified through sequencing of promoter, exon, and flanking intron gene regions and a database search.", {"entities": []}], ["A total of 344 nonredundant SNPs and nonsynonymous variants were tested for association with diabetic nephropathy (persistent albuminuria \u2265300 mg/24 h) in a large type 1 diabetes case/control (1,176/1,323) study from three European populations.", {"entities": []}], ["RESULTS\u2014 Only one SNP, rs2281999, located in the UNC13B gene, was significantly associated with nephropathy after correction for multiple testing.", {"entities": [[49, 55, "GENE"]]}], ["Analyses of 21 additional markers fully characterizing the haplotypic variability of the UNC13B gene showed consistent association of SNP rs13293564 (G/T) located in intron 1 of the gene with nephropathy in the three populations.", {"entities": [[89, 95, "GENE"]]}], ["The odds ratio (OR) for nephropathy associated with the TT genotype was 1.68 (95% CI 1.29\u20132.19) ( P = 1.0 \u00d7 10 P = 2.3 \u00d7 10 CONCLUSIONS\u2014 We identified a polymorphism in the UNC13B gene associated with nephropathy.", {"entities": [[173, 179, "GENE"]]}], ["UNC13B mediates apopotosis in glomerular cells in the presence of hyperglycemia, an event occurring early in the development of nephropathy.", {"entities": [[66, 79, "DISEASE"], [0, 6, "GENE"]]}], ["We propose that this polymorphism could be a marker for the initiation of nephropathy.", {"entities": []}], ["However, further studies are needed to clarify the role of UNC13B in nephropathy.", {"entities": [[59, 65, "GENE"]]}], ["Children are prone to get infections, especially in the respiratory system and the gut mainly because their immune system is immature.", {"entities": []}], ["T cells significantly contribute to the prevention of infections, and different helper T cell (Th) subsets play different anti-pathogen roles.", {"entities": []}], ["Interleukin (IL)-22 producing by T-helper 22 cells (Th22) play an important role in host defense against Gram-negative bacterial organisms in gut and lung.", {"entities": []}], ["T-helper 17 cells (Th17) protect against extracelluar bacteria and fungi especially at the epithelial surface.", {"entities": []}], ["However, there is no report comparing IL-22 producing T cells and Th17 cells in healthy young children to adults.", {"entities": []}], ["Flow cytometry (FCM) was used to observe whether Th22 subset existed in the peripheral blood of healthy young children.", {"entities": []}], ["Meanwhile, we determined the frequencies of Th subsets including Th17, Th1 and Th2, cytotoxic T (Tc)1 subset, CD4+ and CD8+ memory T cells in the peripheral blood of both young children and adults.", {"entities": []}], ["In the present study, we demonstrated that Th22 subset existed in peripheral blood of children, with IL-22 mainly secreted by CD4\u2009+\u2009CD45RO+ memory T cells.", {"entities": [[126, 129, "GENE"]]}], ["Moreover, we observed that IL-22\u2009+\u2009CD4\u2009+\u2009T cells and Th subsets including Th17, Th1, and Th2 frequencies of young children (1\u20136 years old) were significantly lower than adults.", {"entities": [[35, 38, "GENE"]]}], ["While the Th1 frequency from Group A (1\u20133 years old) was markedly lower than that from Group B (4\u20136 years old).", {"entities": []}], ["No significant differences of Th17 or IL-22\u2009+\u2009CD4\u2009+\u2009T cells frequencies were observed between these two groups.", {"entities": [[46, 49, "GENE"]]}], ["In addition, Tc1 subset frequencies were also remarkably lower in young children than in adults.", {"entities": []}], ["Furthermore, lower frequencies of CD45RO+ memory CD4+ and CD8+ T cells in young children than in adults, and significant correlation between CD45RO+ memory CD4\u2009+\u2009T cells and IL-22\u2009+\u2009CD4\u2009+\u2009T cells, Th1, Th17 were observed.", {"entities": [[49, 52, "GENE"], [156, 159, "GENE"], [182, 185, "GENE"], [49, 52, "GENE"], [156, 159, "GENE"], [182, 185, "GENE"]]}], ["Th22 subset exists in the peripheral blood of young children.", {"entities": []}], ["Compared with adults, there are lower frequencies of IL-22\u2009+\u2009CD4\u2009+\u2009T cells, as well as Th1, Th17, Th2 and Tc1 subsets in the peripheral blood of young children.", {"entities": [[61, 64, "GENE"]]}], ["The comparative analysis of genome sequences emerging for several avian species with the fully sequenced chicken genome enables the genome-wide investigation of selective processes in functionally important chicken genes.", {"entities": []}], ["In particular, because of pathogenic challenges it is expected that genes involved in the chicken immune system are subject to particularly strong adaptive pressure.", {"entities": []}], ["Signatures of selection detected by inter-species comparison may then be investigated at the population level in global chicken populations to highlight potentially relevant functional polymorphisms.", {"entities": []}], ["Comparative evolutionary analysis of chicken ( Gallus gallus ) and zebra finch ( Taeniopygia guttata ) genes identified interleukin 4 receptor alpha-chain (IL-4R\u03b1), a key cytokine receptor as a candidate with a significant excess of substitutions at nonsynonymous sites, suggestive of adaptive evolution.", {"entities": []}], ["Resequencing and detailed population genetic analysis of this gene in diverse village chickens from Asia and Africa, commercial broilers, and in outgroup species red jungle fowl (JF), grey JF, Ceylon JF, green JF, grey francolin and bamboo partridge, suggested elevated and balanced diversity across all populations at this gene, acting to preserve different high-frequency alleles at two nonsynonymous sites.", {"entities": []}], ["Haplotype networks indicate that red JF is the primary contributor of diversity at chicken IL-4R\u03b1: the signature of variation observed here may be due to the effects of domestication, admixture and introgression, which produce high diversity.", {"entities": []}], ["However, this gene is a key cytokine-binding receptor in the immune system, so balancing selection related to the host response to pathogens cannot be excluded.", {"entities": []}], ["Vaccination is an important strategy in the prevention of influenza, but immunologic response to vaccination can vary widely.", {"entities": [[58, 67, "DISEASE"]]}], ["Recent studies have shown an association between serum 25-hydroxyvitamin D (25[OH]D) levels and immune function.", {"entities": []}], ["The purpose of this study was to determine if serum 25(OH)D level correlates with influenza vaccine immunogenicity in children and adolescents.", {"entities": [[82, 91, "DISEASE"]]}], ["We conducted a prospective cohort study of children age 3 to 15 years of age vaccinated with trivalent influenza vaccine (A/Brisbane/59/2007[H1N1]-like virus, A/Brisbane/10/2007 [H3N2]-like virus and B/Florida/4/2006-like virus) in Hutterite communities in Alberta, Saskatchewan and Manitoba.", {"entities": [[103, 112, "DISEASE"]]}], ["Serum 25(OH)D levels were measured at baseline and immunogenicity was assessed using hemagluttination inhibition (HAI) titers done at baseline and 3\u20135 weeks post vaccination.", {"entities": []}], ["Logistic regression was used to assess the relationship between serum 25(OH)D level as both a continuous and dichotomous variable and seroprotection, seroconversion, fold increase in geometric mean titer (GMT) and post vaccination titer.", {"entities": []}], ["A total of 391 children and adolescents were included in the study and 221 (57% had post-vaccination HAI titers.", {"entities": []}], ["The median serum 25(OH)D level was 61.0 nmol/L (Interquartile range [IQR] 50.0, 71.0).", {"entities": []}], ["No relationship was found between serum 25(OH)D level and seroprotection (post-vaccination titer \u226540 and \u2265320) or seroconversion (post-vaccination titer \u226540 for participants with pre-vaccine titer <10 or four-fold rise in post-vaccination titer for those with a pre-vaccine titer \u226510).", {"entities": []}], ["Serum 25(OH)D level was not associated with influenza vaccine immunogenicity in otherwise healthy children and adolescents.", {"entities": [[44, 53, "DISEASE"]]}], ["Other strategies to enhance influenza vaccine response should continue to be evaluated in this population.", {"entities": [[28, 37, "DISEASE"]]}], ["The role of serum 25(OH)D level in vaccine responsiveness in other populations, especially those hyporesponsive to influenza vaccination, requires further study.", {"entities": [[115, 124, "DISEASE"]]}], ["The International Classification of Diseases (ICD) has been grouping the allergic and hypersensitivity disorders involving the respiratory tract under topographic distribution, regardless of the underlying mechanisms, triggers or concepts currently in use for allergic and hypersensitivity conditions.", {"entities": []}], ["In order to strengthen awareness and deliberate the creation of the new \u201cAllergic or hypersensitivity disorders involving the respiratory tract\u201d section of the ICD-11, we here propose make the building process public.", {"entities": []}], ["The new frame has been constructed to cover the gaps previously identified and was based on consensus academic reports and ICD-11 principles.", {"entities": []}], ["Constant and bilateral discussion was kept with relevant groups representing specialties and resulted in proposals submission into the ICD-11 online platform.", {"entities": []}], ["The \u201cAllergic or hypersensitivity disorders involving the respiratory tract\u201d section covers 64 entities distributed across five main categories.", {"entities": []}], ["All the 79 proposals submitted resulted from an intensive collaboration of the Allergy working group, relevant Expert working groups and the WHO ICD governance.", {"entities": []}], ["The establishment of the ICD-11 \u201cAllergic or hypersensitivity disorders involving the respiratory tract\u201d section will allow the dissemination of the updated concepts to be used in clinical practice by many different specialties and health professionals.", {"entities": []}], ["The etiology of post-inflammatory gastrointestinal (GI) motility dysfunction, after resolution of acute symptoms of inflammatory bowel diseases (IBD) and intestinal infection, is largely unknown, however, a possible involvement of T cells is suggested.", {"entities": []}], ["Using the mouse model of T cell activation-induced enteritis, we investigated whether enhancement of smooth muscle cell (SMC) contraction by interleukin (IL)-17A is involved in postinflammatory GI hypermotility.", {"entities": []}], ["Activation of CD3 induces temporal enteritis with GI hypomotility in the midst of, and hypermotility after resolution of, intestinal inflammation.", {"entities": []}], ["Prolonged upregulation of IL-17A was prominent and IL-17A injection directly enhanced GI transit and contractility of intestinal strips.", {"entities": []}], ["Postinflammatory hypermotility was not observed in IL-17A-deficient mice.", {"entities": []}], ["Incubation of a muscle strip and SMCs with IL-17A in vitro resulted in enhanced contractility with increased phosphorylation of Ser19 in myosin light chain 2 (p-MLC), a surrogate marker as well as a critical mechanistic factor of SMC contractility.", {"entities": []}], ["Using primary cultured murine and human intestinal SMCs, I\u03baB\u03b6- and p38 mitogen-activated protein kinase (p38MAPK)-mediated downregulation of the regulator of G protein signaling 4 (RGS4), which suppresses muscarinic signaling of contraction by promoting inactivation/desensitization of G\u03b1 q/11 protein, has been suggested to be involved in IL-17A-induced hypercontractility.", {"entities": [[181, 185, "GENE"]]}], ["The opposite effect of L-1\u03b2 was mediated by I\u03baB\u03b6 and c-jun N-terminal kinase (JNK) activation.", {"entities": []}], ["We propose and discuss the possible involvement of IL-17A and its downstream signaling cascade in SMCs in diarrheal hypermotility in various GI disorders.", {"entities": []}], ["Dietary n -3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are associated with reduction of inflammation, although the mechanisms are poorly understood, especially how the spleen, as a secondary lymphoid organ, is involved.", {"entities": []}], ["To investigate the effects of EPA and DHA on spleen gene expression, male C57BL/6J mice were fed high fat diets (HFD) differing in fatty acid composition, either based on corn oil (HFD-CO), or CO enriched with 2 g/100 g EPA and DHA (HFD-ED), for eight weeks.", {"entities": []}], ["Spleen tissue was analyzed using transcriptomics and for fatty acids profiling.", {"entities": []}], ["Biological processes (BPs) related to the immune response, including T-cell receptor signaling pathway, T-cell differentiation and co-stimulation, myeloid dendritic cell differentiation, antigen presentation and processing, and the toll like receptor pathway were downregulated by HFD-ED compared with control and HFD-CO.", {"entities": []}], ["These findings were supported by the down-regulation of NF-\u03baB in HFD-ED compared with HFD-CO fed mice.", {"entities": []}], ["Lower phospholipid arachidonic acid levels in HFD-ED compared with HFD-CO, and control mice suggest attenuation of pathways via prostaglandins and leukotrienes.", {"entities": []}], ["The HFD-ED also upregulated BPs related to erythropoiesis and hematopoiesis compared with control and HFD-CO fed mice.", {"entities": []}], ["Our findings suggest that EPA and DHA down-regulate the splenic immune response induced by HFD-CO, supporting earlier work that the spleen is a target organ for the anti-inflammatory effects of these n -3 fatty acids.", {"entities": []}], ["Mice and humans produce chitinase-like proteins (CLPs), which are highly homologous to chitinases but lack chitinolytic activity.", {"entities": [[49, 53, "GENE"]]}], ["Mice express primarily three CLPs, including breast regression protein-39 (BRP-39) [chitinase 3-like-1 (Chi3l1) or 38-kDa glycoprotein (gp38k)], Ym1 (Chi3l3) and Ym2 (Chi3l4).", {"entities": [[29, 33, "GENE"], [104, 110, "GENE"]]}], ["Recently, CLPs have attracted considerable attention due to their increased expression in a number of pathological conditions, including asthma, allergies, rheumatoid arthritis and malignant tumors.", {"entities": [[156, 176, "DISEASE"], [167, 176, "DISEASE"], [137, 143, "DISEASE"], [10, 14, "GENE"]]}], ["Although the exact functions of CLPs are largely unknown, the significance of their increased expression levels during pathophysiological states needs to be determined.", {"entities": [[32, 36, "GENE"]]}], ["The quantification of BRP-39, Ym1 and Ym2 is an important step in gaining insight into the in vivo regulation of the CLPs.", {"entities": [[117, 121, "GENE"]]}], ["We constructed a standard DNA for quantitative real-time PCR (qPCR) by containing three CLPs target fragments and five reference genes cDNA in a one-to-one ratio.", {"entities": [[88, 92, "GENE"]]}], ["We evaluated this system by analyzing the eight target cDNA sequences.", {"entities": []}], ["Tissue cDNAs obtained by reverse transcription from total RNA from four embryonic stages and eight adult tissues were analyzed using the qPCR system with the standard DNA.", {"entities": []}], ["We established a qPCR system detecting CLPs and comparing their expression levels with those of five reference genes using the same scale in mouse tissues.", {"entities": [[39, 43, "GENE"]]}], ["We found that BRP-39 and Ym1 were abundant in the mouse lung, whereas Ym2 mRNA was abundant in the stomach, followed by lung.", {"entities": []}], ["The expression levels of BRP-39 and Ym1 in the mouse lung were higher than those of two active chitinases and were comparable to glyceraldehyde-3-phosphate dehydrogenase, a housekeeping gene which is constitutively expressed in all tissues.", {"entities": []}], ["Our results indicate that catalytically inactive BRP-39 and Ym1 are constitutive genes in normal mouse lung.", {"entities": []}], ["There is an urgent need for new tools for the rapid diagnosis of tuberculosis disease.", {"entities": [[65, 77, "DISEASE"]]}], ["We evaluated the potentials of 74 host markers as biomarkers for the immunological diagnosis of tuberculosis and monitoring of treatment response.", {"entities": [[96, 108, "DISEASE"]]}], ["Fifty-five individuals that presented with signs and symptoms requiring investigation for tuberculosis disease were prospectively recruited prior to clinical diagnosis, at a health centre in Cape Town, South Africa.", {"entities": [[90, 102, "DISEASE"]]}], ["Patients were later classified as having tuberculosis disease or other respiratory diseases (ORD) using a combination of clinical, radiological and laboratory findings.", {"entities": [[41, 53, "DISEASE"]]}], ["Out of 74 host markers that were evaluated in plasma samples from study participants using a multiplex platform, 18 showed potential as tuberculosis diagnostic candidates with the most promising being NCAM, CRP, SAP, IP-10, ferritin, TPA, I-309, and MIG, which diagnosed tuberculosis disease individually, with area under the ROC curve \u22650.80.", {"entities": [[136, 148, "DISEASE"], [271, 283, "DISEASE"], [207, 210, "GENE"]]}], ["Six-marker biosignatures containing NCAM diagnosed tuberculosis disease with a sensitivity of 100% (95%CI, 86.3-100%) and specificity of 89.3% (95%CI, 67.6-97.3%) irrespective of HIV status, and 100% accuracy in the absence of HIV infection.", {"entities": [[51, 63, "DISEASE"]]}], ["Furthermore, the concentrations of 11 of these proteins changed with treatment, thereby indicating that they may be useful in monitoring of the response to tuberculosis treatment.", {"entities": [[156, 168, "DISEASE"]]}], ["Our findings have potential to be translated into a point-of-care screening test for tuberculosis, after future validation studies.", {"entities": [[85, 97, "DISEASE"]]}], ["Macrophage secretion of proinflammatory cytokines contributes to the pathogenesis of obesity-related insulin resistance.", {"entities": [[85, 92, "DISEASE"]]}], ["An important regulator of inflammation is the suppressor of cytokine signaling-1 (SOCS1), which inhibits the JAK-STAT and toll-like receptor-4 (TLR4) pathways.", {"entities": [[82, 87, "GENE"], [144, 148, "GENE"]]}], ["Despite the reported role of SOCS1 in inhibiting insulin signaling, it is surprising that a SOCS1 polymorphism that increases SOCS1 promoter activity is associated with enhanced insulin sensitivity despite obesity.", {"entities": [[206, 213, "DISEASE"], [29, 34, "GENE"], [92, 97, "GENE"], [126, 131, "GENE"], [29, 34, "GENE"], [92, 97, "GENE"], [126, 131, "GENE"], [29, 34, "GENE"], [92, 97, "GENE"], [126, 131, "GENE"]]}], ["In the current study, we investigated the physiological role of myeloid and lymphoid cell SOCS1 in regulating inflammation and insulin sensitivity.", {"entities": [[90, 95, "GENE"]]}], ["We used mice generated by crossing SOCS1 floxed mice with mice expressing Cre recombinase under the control of the LysM-Cre promoter (SOCS1 LysM-Cre ).", {"entities": [[35, 40, "GENE"], [134, 139, "GENE"], [35, 40, "GENE"], [134, 139, "GENE"]]}], ["These mice have deletion of SOCS1 in macrophages and lymphocytes.", {"entities": [[28, 33, "GENE"]]}], ["We assessed macrophage inflammation using flow cytometry and serum cytokine levels using Bioplex assays.", {"entities": []}], ["We then measured insulin sensitivity using glucose tolerance tests and the euglycemic-hyperinsulinemic clamp.", {"entities": []}], ["Using bone marrow\u2013derived macrophages, we tested the effects of SOCS1 deletion in regulating responses to the TLR4 ligands: lipopolysaccharide (LPS) and palmitic acid.", {"entities": [[64, 69, "GENE"], [110, 114, "GENE"]]}], ["SOCS1 LysM-Cre mice had increased macrophage expression of CD11c, enhanced sensitivity to LPS, and palmitic acid and increased serum concentrations of tumor necrosis factor-\u03b1, interleukin-6, and monocyte chemoattractant protein.", {"entities": [[0, 5, "GENE"]]}], ["Increased inflammation was associated with impaired glucose tolerance and hyperinsulinemia as a result of reduced hepatic but not skeletal muscle insulin sensitivity.", {"entities": []}], ["The expression of SOCS1 in hematopoietic cells protects mice against systemic inflammation and hepatic insulin resistance potentially by inhibiting LPS and palmitate-induced TLR4 signaling in macrophages.", {"entities": [[18, 23, "GENE"], [174, 178, "GENE"]]}], ["Spinal manipulative therapy (SMT) is a widely used manual treatment, but many reviews exist with conflicting conclusions about the safety of SMT.", {"entities": []}], ["We performed an overview of reviews to elucidate and quantify the risk of serious adverse events (SAEs) associated with SMT.", {"entities": []}], ["We searched five electronic databases from inception to December 8, 2015.", {"entities": []}], ["We included reviews on any type of studies, patients, and SMT technique.", {"entities": []}], ["Our primary outcome was SAEs.", {"entities": []}], ["Quality of the included reviews was assessed using a measurement tool to assess systematic reviews (AMSTAR).", {"entities": []}], ["Since there were insufficient data for calculating incidence rates of SAEs, we used an alternative approach; the conclusions regarding safety of SMT were extracted for each review, and the communicated opinion were judged by two reviewers independently as safe, harmful, or neutral/unclear.", {"entities": []}], ["Risk ratios (RRs) of a review communicating that SMT is safe and meeting the requirements for each AMSTAR item, were calculated.", {"entities": []}], ["We identified 283 eligible reviews, but only 118 provided data for synthesis.", {"entities": []}], ["The most frequently described adverse events (AEs) were stroke, headache, and vertebral artery dissection.", {"entities": []}], ["Fifty-four reviews (46%) expressed that SMT is safe, 15 (13%) expressed that SMT is harmful, and 49 reviews (42%) were neutral or unclear.", {"entities": []}], ["Thirteen reviews reported incidence estimates for SAEs, roughly ranging from 1 in 20,000 to 1 in 250,000,000 manipulations.", {"entities": []}], ["Low methodological quality was present, with a median of 4 of 11 AMSTAR items met (interquartile range, 3 to 6).", {"entities": []}], ["Reviews meeting the requirements for each of the AMSTAR items (i.e.", {"entities": []}], ["good internal validity) had a higher chance of expressing that SMT is safe.", {"entities": []}], ["It is currently not possible to provide an overall conclusion about the safety of SMT; however, the types of SAEs reported can indeed be significant, sustaining that some risk is present.", {"entities": []}], ["High quality research and consistent reporting of AEs and SAEs are needed.", {"entities": []}], ["PROSPERO CRD42015030068 .", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-017-0458-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objectives : To understand the key characteristics of Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome (ACOS) and to identify evidence gaps relating to the identification, treatment and management of ACOS patients.", {"entities": [[54, 60, "DISEASE"]]}], ["Methods : A structured literature review and 1-hour telephone interviews with specialist respiratory physicians were conducted (n=10; China, France, Germany, Japan and the USA).", {"entities": []}], ["Results : All 10 physicians used the term ACOS in clinical practice.", {"entities": []}], ["ACOS was not clearly defined in the literature.", {"entities": []}], ["Prevalence of ACOS among adult patients with COPD or asthma ranged from 12\u201355%.", {"entities": [[53, 59, "DISEASE"]]}], ["ACOS patients had severe disease, with increased exacerbations and hospitalisations compared to some asthma and COPD patients.", {"entities": [[101, 107, "DISEASE"]]}], ["ACOS represented a clinical challenge due to a lack of evidence-based guidelines distinguishing between asthma, COPD and ACOS.", {"entities": [[104, 110, "DISEASE"]]}], ["Published data quantifying ACOS costs were limited.", {"entities": []}], ["Conclusions : There is a need for consensus evidence-based guidance to facilitate earlier diagnosis and to optimise the management of ACOS patients.", {"entities": []}], ["Inflammatory cytokines within the tumor microenvironment are linked to progression in breast cancer.", {"entities": [[86, 99, "DISEASE"], [93, 99, "DISEASE"]]}], ["Interleukin- (IL-) 19, part of the IL-10 family, contributes to a range of diseases and disorders, such as asthma, endotoxic shock, uremia, psoriasis, and rheumatoid arthritis.", {"entities": [[155, 175, "DISEASE"], [140, 149, "DISEASE"], [132, 138, "DISEASE"], [166, 175, "DISEASE"], [107, 113, "DISEASE"]]}], ["IL-19 is expressed in several types of tumor cells, especially in squamous cell carcinoma of the skin, tongue, esophagus, and lung and invasive duct carcinoma of the breast.", {"entities": [[80, 89, "DISEASE"], [149, 158, "DISEASE"], [66, 89, "DISEASE"]]}], ["In breast cancer, IL-19 expression is correlated with increased mitotic figures, advanced tumor stage, higher metastasis, and poor survival.", {"entities": [[3, 16, "DISEASE"], [10, 16, "DISEASE"]]}], ["The mechanisms of IL-19 in breast cancer have recently been explored both in vitro and in vivo .", {"entities": [[27, 40, "DISEASE"], [34, 40, "DISEASE"]]}], ["IL-19 has an autocrine effect in breast cancer cells.", {"entities": [[33, 46, "DISEASE"], [40, 46, "DISEASE"]]}], ["It directly promotes proliferation and migration and indirectly provides a microenvironment for tumor progression, which suggests that IL-19 is a prognostic marker in breast cancer and that antagonizing IL-19 may have therapeutic potential.", {"entities": [[167, 180, "DISEASE"], [174, 180, "DISEASE"]]}], ["15-deoxy-\u0394 2 (15d-PGJ 2 ) is one of factors contributed to the neurotoxicity of amyloid \u03b2 (A\u03b2), a causative protein of Alzheimer's disease.", {"entities": []}], ["Type 2 receptor for prostaglandin D 2 (DP2) and peroxysome-proliferator activated receptor\u03b3 (PPAR\u03b3) are identified as the membrane receptor and the nuclear receptor for 15d-PGJ 2 , respectively.", {"entities": []}], ["Previously, we reported that the cytotoxicity of 15d-PGJ 2 was independent of DP2 and PPAR\u03b3, and suggested that 15d-PGJ 2 induced apoptosis through the novel specific binding sites of 15d-PGJ 2 different from DP2 and PPAR\u03b3.", {"entities": []}], ["To relate the cytotoxicity of 15d-PGJ 2 to amyloidoses, we performed binding assay [ 2 and specified targets for 15d-PGJ 2 associated with cytotoxicity.", {"entities": []}], ["In the various cell lines, there was a close correlation between the susceptibilities to 15d-PGJ 2 and fibrillar A\u03b2.", {"entities": []}], ["Specific binding sites of [ 2 were detected in rat cortical neurons and human bronchial smooth muscle cells.", {"entities": []}], ["When the binding assay was performed in subcellular fractions of neurons, the specific binding sites of [ 2 were detected in plasma membrane, nuclear and cytosol, but not in microsome.", {"entities": []}], ["A proteomic approach was used to identify protein targets for 15d-PGJ 2 in the plasma membrane.", {"entities": []}], ["By using biotinylated 15d-PGJ 2 , eleven proteins were identified as biotin-positive spots and classified into three different functional proteins: glycolytic enzymes (Enolase2, pyruvate kinase M1 (PKM1) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH)), molecular chaperones (heat shock protein 8 and T-complex protein 1 subunit \u03b1), cytoskeletal proteins (Actin \u03b2, F-actin-capping protein, Tubulin \u03b2 and Internexin \u03b1).", {"entities": [[250, 255, "GENE"]]}], ["GAPDH, PKM1 and Tubulin \u03b2 are A\u03b2-interacting proteins.", {"entities": [[0, 5, "GENE"]]}], ["Thus, the present study suggested that 15d-PGJ 2 plays an important role in amyloidoses not only in the central nervous system but also in the peripheral tissues.", {"entities": []}], ["Previous cross-sectional and prevalent case-control studies have suggested increased risk of asthma in adults related to dampness problems and molds in homes.", {"entities": [[93, 99, "DISEASE"]]}], ["We conducted a population-based incident case-control study to assess the effects of indoor dampness problems and molds at work and at home on development of asthma in adults.", {"entities": [[158, 164, "DISEASE"]]}], ["We recruited systematically all new cases of asthma during a 2.5-year study period (1997-2000) and randomly selected controls from a source population consisting of adults 21-63 years old living in the Pirkanmaa Hospital district, South Finland.", {"entities": [[45, 51, "DISEASE"]]}], ["The clinically diagnosed case series consisted of 521 adults with newly diagnosed asthma and the control series of 932 controls, after we excluded 76 (7.5%) controls with a history of asthma.", {"entities": [[82, 88, "DISEASE"], [184, 190, "DISEASE"]]}], ["In logistic regression analysis adjusting for confounders, the risk of asthma was related to the presence of visible mold and/or mold odor in the workplace (odds ratio, 1.54; 95% confidence interval, 1.01-2.32) but not to water damage or damp stains alone.", {"entities": [[71, 77, "DISEASE"]]}], ["We estimated the fraction of asthma attributable to workplace mold exposure to be 35.1% (95% confidence interval, 1.0-56.9%) among the exposed.", {"entities": [[29, 35, "DISEASE"]]}], ["Present results provide new evidence of the relation between workplace exposure to indoor molds and adult-onset asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["Background: Previously we showed that the release properties of a liposomal ciprofloxacin (CFI) formulation could be attenuated by incorporation of drug nanocrystals within the vesicles.", {"entities": [[91, 94, "GENE"]]}], ["Rather than forming these drug nanocrystals during drug loading, they were created post manufacture simply by freezing and thawing the formulation.", {"entities": []}], ["The addition of surfactant to CFI, either polysorbate 20 or Brij 30, provided an additional means to modify the release profile or incorporate an immediate-release or \u2018burst\u2019 component as well.", {"entities": [[30, 33, "GENE"]]}], ["The goal of this study was to develop a CFI formulation that retained its nanocrystalline morphology and attenuated release profile after delivery as an inhaled aerosol.", {"entities": [[40, 43, "GENE"]]}], ["Methods: Preparations of 12.5\u2009mg/mL CFI containing 90\u2009mg/mL sucrose and 0.1% polysorbate 20 were formulated between pH 4.6 to 5.9, stored frozen, and thawed prior to use.", {"entities": [[36, 39, "GENE"]]}], ["These thawed formulations, before and after mesh nebulization, and after subsequent refrigerated storage for up to 6 weeks, were characterized in terms of liposome structure by cryogenic transmission electron microscopy (cryo-TEM) imaging, vesicle size by dynamic light scattering, pH, drug encapsulation by centrifugation-filtration, and in vitro release (IVR) performance.", {"entities": []}], ["Results: Within the narrower pH range of 4.9 to 5.3, these 12.5\u2009mg/mL liposomal ciprofloxacin formulations containing 90\u2009mg/mL sucrose and 0.1% polysorbate 20 retained their physicochemical stability for an additional 3 months refrigerated storage post freeze-thaw, were robust to mesh nebulization maintaining their vesicular form containing nanocrystalline drug and an associated slower release profile, and formed respirable aerosols with a mass median aerodynamic diameter (MMAD) of \u223c3.9\u2009\u03bcm and a geometric standard deviation (GSD) of \u223c1.5.", {"entities": []}], ["Conclusions: This study demonstrates that an attenuated release liposomal ciprofloxacin formulation can be created through incorporation of drug nanocrystals in response to freeze-thaw, and the formulation retains its physicochemical properties after aerosolization by mesh nebulizer.", {"entities": []}], ["Charles Darwin\u2019s long-term illness has been the subject of much speculation.", {"entities": []}], ["His numerous symptoms have led to conclusions that his illness was essentially psychogenic in nature.", {"entities": []}], ["These diagnoses have never been fully convincing, however, particularly in regard to the proposed underlying psychological background causes of the illness.", {"entities": []}], ["Similarly, two proposed somatic causes of illness, Chagas disease and arsenic poisoning, lack credibility and appear inconsistent with the lifetime history of the illness.", {"entities": []}], ["Other physical explanations are simply too incomplete to explain the range of symptoms.", {"entities": []}], ["Here, a very different sort of explanation will be offered.", {"entities": []}], ["We now know that mitochondrial mutations producing impaired mitochondrial function may result in a wide range of differing symptoms, including symptoms thought to be primarily psychological.", {"entities": []}], ["Examination of Darwin\u2019s maternal family history supports the contention that his illness was mitochondrial in nature; his mother and one maternal uncle had strange illnesses and the youngest maternal sibling died of an infirmity with symptoms characteristic of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS syndrome), a condition rooted in mitochondrial dysfunction.", {"entities": [[261, 292, "DISEASE"], [343, 351, "DISEASE"], [294, 309, "DISEASE"]]}], ["Darwin\u2019s own symptoms are described here and are in accord with the hypothesis that he had the mtDNA mutation commonly associated with the MELAS syndrome.", {"entities": [[145, 153, "DISEASE"]]}], ["An inverse relation between Helicobacter pylori infection and allergic disease has been reported by a range of independent epidemiological studies, but evidence from longitudinal studies is scarce.", {"entities": []}], ["We have investigated the effects of H. pylori infection on the incidence and prevalence of allergic diseases and sensitization in a low-income birth cohort.", {"entities": []}], ["In 2005/2006, a population-based birth cohort was established in Butajira, Ethiopia, and the 1006 singleton babies born were followed up at ages 1, 3, and 5.", {"entities": []}], ["Symptoms of allergic disease were collected using the ISAAC questionnaire, allergen skin tests performed, and stool samples analysed for H. pylori antigen and geohelminths.", {"entities": []}], ["Multiple logistic regression was used to determine the independent effects of H. pylori measured at age 3 on the incidence of each outcome between ages 3 and 5 years (in those without the outcome at age 3), controlling for potential confounders, and to additionally assess cross-sectional associations.", {"entities": []}], ["A total of 863 children were followed up to age 5.", {"entities": []}], ["H. pylori infection was found in 25% of the children at both ages 3 and 5, in 21% at age 5 but not 3, and in 17% at age 3 but not at age 5.", {"entities": []}], ["H. pylori infection at age 3 was significantly associated with a decreased risk of incident eczema between ages 3 and 5 (adjusted OR, 95% CI, 0.31; 0.10\u20130.94, P = 0.02).", {"entities": []}], ["Cross-sectionally at age 5, H. pylori infection was inversely associated with skin sensitization (adjusted OR, 95% CI, 0.26; 0.07\u20130.92, P = 0.02).", {"entities": []}], ["These findings provide further evidence to suggest that early-life exposure to H. pylori may play a protective role in the development of allergy.", {"entities": []}], ["Aspergillus fumigatusis a saprophytic fungus that is ubiquitous in the environment and commonly associated with allergic sensitization and severe asthma in humans.", {"entities": [[146, 152, "DISEASE"]]}], ["Although A. fumigatus is recognized by multiple microbial pattern recognition receptors, we identified and synthesized an A. fumigatus glycosphingolipid, asperamide B, that directly activated invariant natural killer T ( i NKT) cells in vitro in a CD1d-restricted, MyD88- and dectin-1-independent fashion.", {"entities": []}], ["Moreover, asperamide B, when loaded into CD1d, directly stained, and was sufficient to activate, i NKT cells.", {"entities": [[41, 45, "GENE"]]}], ["In vivo , asperamide B rapidly induced airway hyperreactivity, a cardinal feature of asthma, by activating pulmonary i NKT cells in an IL-33-ST2-dependent fashion.", {"entities": [[85, 91, "DISEASE"]]}], ["Asperamide B is thus the first fungal glycolipid found to directly activate i NKT cells.", {"entities": []}], ["These results extend the range of microorganisms that can be directly detected by i NKT cells to the Kingdom of Fungi, and may explain the effectiveness of A. fumigatus in causing severe chronic respiratory diseases in humans.", {"entities": []}], ["To examine the process and outcomes of care of COPD patients by Advanced Practice Providers (APPs) and primary care physicians.", {"entities": []}], ["We conducted a cross sectional retrospective cohort study of Medicare beneficiaries with COPD who had at least one hospitalization in 2010.", {"entities": []}], ["We examined the process measures of receipt of spirometry evaluation, influenza and pneumococcal vaccine, use of COPD medications, and referral to a pulmonary specialist visit.", {"entities": [[70, 79, "DISEASE"]]}], ["Outcome measures were emergency department (ER) visit, number of hospitalizations and 30-day readmission in 2010.", {"entities": []}], ["A total of 7,257 Medicare beneficiaries with COPD were included.", {"entities": []}], ["Of these, 1,999 and 5,258 received primary care from APPs and primary care physicians, respectively.", {"entities": []}], ["Patients in the APP group were more likely to be white, younger, male, residing in non-metropolitan areas and have fewer comorbidities.", {"entities": [[16, 19, "GENE"]]}], ["In terms of process of care measures, APPs were more likely to prescribe short acting bronchodilators (adjusted odds ratio [aOR] = 1.18, 95%Confidence Interval [CI] 1.05\u20131.32), oxygen therapy (aOR = 1.25, 95% CI 1.12\u20131.40) and consult a pulmonary specialist (aOR = 1.39, 95% CI 1.23\u20131.56), but less likely to give influenza and pneumococcal vaccinations.", {"entities": [[314, 323, "DISEASE"]]}], ["Patients receiving care from APPs had lower rates of ER visits for COPD (aOR = 0.84, 95%CI 0.71\u20130.98) and had a higher follow-up rate with pulmonary specialist within 30 days of hospitalization for COPD (aOR = 1.25, 95%CI 1.07\u20131.48) than those cared for by physicians.", {"entities": []}], ["Compared to patients cared for by physicians, patients cared for by APPs were more likely to receive short acting bronchodilator, oxygen therapy and been referred to pulmonologist, however they had lower rates of vaccination probably due to lower age group.", {"entities": []}], ["Patients cared for by APPs were less like to visit an ER for COPD compared to patients care for by physicians, conversely there was no differences in hospitalization or readmission for COPD between MDs and APPs.", {"entities": []}], ["MicroRNAs are short non-coding single stranded RNAs that regulate gene expression.", {"entities": []}], ["While much is known about the effects of individual microRNAs, there is now growing evidence that they can work in co-operative networks.", {"entities": []}], ["MicroRNAs are known to be dysregulated in many diseases and affect pathways involved in the pathology.", {"entities": []}], ["We investigated dysregulation of microRNA networks using asthma as the disease model.", {"entities": [[57, 63, "DISEASE"]]}], ["Asthma is a chronic inflammatory disease of the airways characterized by bronchial hyperresponsiveness and airway remodelling.", {"entities": [[0, 6, "DISEASE"]]}], ["The airway epithelium is a major contributor to asthma pathology and has been shown to produce an excess of inflammatory and pro-remodelling cytokines such as TGF-\u03b2, IL-6 and IL-8 as well as deficient amounts of anti-viral interferons.", {"entities": [[48, 54, "DISEASE"]]}], ["After performing microRNA arrays, we found that microRNAs -18a, -27a, -128 and -155 are down-regulated in asthmatic bronchial epithelial cells, compared to cells from healthy donors.", {"entities": []}], ["Interestingly, these microRNAs are predicted in silico to target several components of the TGF-\u03b2, IL-6, IL-8 and interferons pathways.", {"entities": []}], ["Manipulation of the levels of individual microRNAs in bronchial epithelial cells did not have an effect on any of these pathways.", {"entities": []}], ["Importantly, knock-down of the network of microRNAs miR-18a, -27a, -128 and -155 led to a significant increase of IL-8 and IL-6 expression.", {"entities": [[52, 59, "GENE"]]}], ["Interestingly, despite strong in silico predictions, down-regulation of the pool of microRNAs did not have an effect on the TGF-\u03b2 and Interferon pathways.", {"entities": []}], ["In conclusion, using both bioinformatics and experimental tools we found a highly relevant potential role for microRNA dysregulation in the control of IL-6 and IL-8 expression in asthma.", {"entities": [[179, 185, "DISEASE"]]}], ["Our results suggest that microRNAs may have different roles depending on the presence of other microRNAs.", {"entities": []}], ["Thus, interpretation of in silico analysis of microRNA function should be confirmed experimentally in the relevant cellular context taking into account interactions with other microRNAs when studying disease.", {"entities": []}], ["Introduction Discriminating acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) from cardiogenic pulmonary edema (CPE) using the plasma level of brain natriuretic peptide (BNP) alone remains controversial.", {"entities": [[82, 90, "DISEASE"], [115, 130, "DISEASE"], [132, 135, "GENE"]]}], ["The aim of this study was to determine the diagnostic utility of combination measurements of BNP and C-reactive protein (CRP) in critically ill patients with pulmonary edema.", {"entities": [[158, 173, "DISEASE"], [121, 124, "GENE"]]}], ["This was a cross-sectional study.", {"entities": []}], ["BNP and CRP data from 147 patients who presented to the emergency department due to acute respiratory failure with bilateral pulmonary infiltrates were analyzed.", {"entities": [[90, 109, "DISEASE"], [8, 11, "GENE"]]}], ["There were 53 patients with ALI/ARDS, 71 with CPE, and 23 with mixed edema.", {"entities": [[46, 49, "GENE"]]}], ["Median BNP and CRP levels were 202 (interquartile range 95-439) pg/mL and 119 (62-165) mg/L in ALI/ARDS, and 691 (416-1,194) pg/mL (p < 0.001) and 8 (2-42) mg/L (p < 0.001) in CPE.", {"entities": [[15, 18, "GENE"], [176, 179, "GENE"]]}], ["BNP or CRP alone offered good discriminatory performance (C-statistics 0.831 and 0.887), but the combination offered greater one [C-statistics 0.931 (p < 0.001 versus BNP) (p = 0.030 versus CRP)].", {"entities": [[7, 10, "GENE"], [190, 193, "GENE"], [7, 10, "GENE"], [190, 193, "GENE"]]}], ["In multiple logistic-regression, BNP and CRP were independent predictors for the diagnosis after adjusting for other variables.", {"entities": [[41, 44, "GENE"]]}], ["Measurement of CRP is useful as well as that of BNP for distinguishing ALI/ARDS from CPE.", {"entities": [[15, 18, "GENE"], [85, 88, "GENE"]]}], ["Furthermore, a combination of BNP and CRP can provide higher accuracy for the diagnosis.", {"entities": [[38, 41, "GENE"]]}], ["This study aimed to evaluate the correlation between associating factors of moderate to severe asthma with obstructive sleep apnea (OSA).", {"entities": [[95, 101, "DISEASE"]]}], ["One hundred and sixty-seven patients who visited the pulmonary and sleep clinic in Severance Hospital presenting with symptoms of sleep-disordered breathing were evaluated.", {"entities": []}], ["All subjects were screened with ApneaLink.", {"entities": []}], ["Thirty-two subjects with a high likelihood of having OSA were assessed with full polysomnography (PSG).", {"entities": []}], ["The mean age was 58.8\u00b112.0 years and 58.7% of subjects were male.", {"entities": []}], ["The mean ApneaLink apnea-hypopnea index (AHI) was 12.7\u00b113.0/hr.", {"entities": []}], ["The mean ApneaLink AHI for the 32 selected high risk patients of OSA was 22.3\u00b113.2/hr, which was lower than the sleep laboratory-based PSG AHI of 39.1\u00b120.5/hr.", {"entities": []}], ["When OSA was defined at an ApneaLink AHI \u22655/hr, the positive correlating factors for OSA were age, male gender, and moderate to severe asthma.", {"entities": [[135, 141, "DISEASE"]]}], ["Moderate to severe asthma showed strong correlation with OSA when defined at an ApneaLink AHI \u22655/hr.", {"entities": [[19, 25, "DISEASE"]]}], ["Genome-wide gene expression profiling has been extensively used to generate biological hypotheses based on differential expression.", {"entities": []}], ["Recently, many studies have used microarrays to measure gene expression levels across genetic mapping populations.", {"entities": []}], ["These gene expression phenotypes have been used for genome-wide association analyses, an analysis referred to as expression QTL (eQTL) mapping.", {"entities": []}], ["Here, eQTL analysis was performed in adipose tissue from 28 inbred strains of mice.", {"entities": []}], ["We focused our analysis on \u201ctrans-eQTL bands\u201d, defined as instances in which the expression patterns of many genes were all associated to a common genetic locus.", {"entities": []}], ["Genes comprising trans-eQTL bands were screened for enrichments in functional gene sets representing known biological pathways, and genes located at associated trans-eQTL band loci were considered candidate transcriptional modulators.", {"entities": []}], ["We demonstrate that these patterns were enriched for previously characterized relationships between known upstream transcriptional regulators and their downstream target genes.", {"entities": []}], ["Moreover, we used this strategy to identify both novel regulators and novel members of known pathways.", {"entities": []}], ["Finally, based on a putative regulatory relationship identified in our analysis, we identified and validated a previously uncharacterized role for cyclin H in the regulation of oxidative phosphorylation.", {"entities": []}], ["We believe that the specific molecular hypotheses generated in this study will reveal many additional pathway members and regulators, and that the analysis approaches described herein will be broadly applicable to other eQTL data sets.", {"entities": []}], ["Genome-wide association (GWA) analyses seek to relate variation of phenotype to underlying (and presumably causative) variation in genotype.", {"entities": []}], ["Recently, many GWA studies have identified candidate genes underlying disease phenotypes such as diabetes, heart disease, and cancer risk.", {"entities": [[107, 120, "DISEASE"], [126, 132, "DISEASE"]]}], ["Many groups have also performed GWA using variation in gene expression levels as the input phenotype.", {"entities": []}], ["These expression QTL (eQTL) studies have provided important clues as to the genetic basis of gene expression regulation.", {"entities": []}], ["Here, we perform an eQTL study in mouse adipose tissue.", {"entities": []}], ["We then developed a systematic analysis method to relate these patterns of eQTL associations to biological pathways.", {"entities": []}], ["Based on this approach, we identified putative roles for thousands of candidate upstream regulators and candidate pathway members in relation to specific biological pathways.", {"entities": []}], ["Statistical analysis showed that these predictions were highly enriched for true genetic modulators of these pathways.", {"entities": []}], ["Based on these predictions, we also experimentally validated a role for one particular gene, cyclin H, in the regulation of oxidative phosphorylation.", {"entities": []}], ["These findings illustrate a new analysis method for relating eQTL studies to biological pathways and identify cyclin H as a novel key regulator of cellular energy metabolism.", {"entities": []}], ["Interleukin-6 is a pleiotropic, pro-inflammatory cytokine that can promote both innate and adaptive immune responses.", {"entities": []}], ["In humans with respiratory virus infections, such as Respiratory Syncytial Virus (RSV), elevated concentrations of IL-6 are associated with more severe disease.", {"entities": []}], ["In contrast the polymorphisms in the Il6 promoter which favour lower IL-6 production are associated with increased risk of both RSV and Rhinovirus infections.", {"entities": [[37, 40, "GENE"]]}], ["To determine the precise contribution of IL-6 to protection and pathology we used murine models of respiratory virus infection.", {"entities": []}], ["RSV infection resulted in increased IL-6 production both in the airways and systemically which remained heightened for at least 2 weeks.", {"entities": []}], ["IL-6 depletion early, but not late, during RSV or Influenza A virus infection resulted in significantly increased disease associated with an influx of virus specific T H 1 and cytotoxic CD8 H 1 responses in the lungs, and sufficient to limit RSV induced disease.", {"entities": []}], ["Overall we found that during respiratory virus infection the prototypic inflammatory cytokine IL-6 is a critical anti-inflammatory regulator of viral induced immunopathology in the respiratory tract through its induction of IL-27.", {"entities": []}], ["In clearing a respiratory virus, the host must strike a careful balance between the need to clear the infection and the potential of the immune response to damage the delicate structure of the lungs.", {"entities": []}], ["Here we show that Interleukin-6, a soluble mediator commonly associated with inflammation and seen in humans with severe respiratory infection, is actually critical in promoting the resolution of the host response to respiratory virus infection and limiting disease.", {"entities": []}], ["We have found that the early production of IL-6 after infection promotes the production of the regulatory mediator Interleukin-27 by lung resident immune cells, which in turn drives suppression of otherwise damaging inflammation.", {"entities": []}], ["Removal of either IL-6 or IL-27 enhances disease during viral infection, while restoration of IL-27 is sufficient to allow faster recovery.", {"entities": []}], ["Thus we have identified a novel immunological network within the respiratory tract which accelerates recovery after respiratory virus infection.", {"entities": []}], ["Although culture-independent techniques have shown that the lungs are not sterile, little is known about the lung microbiome in chronic obstructive pulmonary disease (COPD).", {"entities": [[128, 165, "DISEASE"]]}], ["We used pyrosequencing of 16S amplicons to analyze the lung microbiome in two ways: first, using bronchoalveolar lavage (BAL) to sample the distal bronchi and air-spaces; and second, by examining multiple discrete tissue sites in the lungs of six subjects removed at the time of transplantation.", {"entities": []}], ["We performed BAL on three never-smokers (NS) with normal spirometry, seven smokers with normal spirometry (\u201cheathy smokers\u201d, HS), and four subjects with COPD (CS).", {"entities": [[159, 161, "GENE"]]}], ["Bacterial 16 s sequences were found in all subjects, without significant quantitative differences between groups.", {"entities": []}], ["Both taxonomy-based and taxonomy-independent approaches disclosed heterogeneity in the bacterial communities between HS subjects that was similar to that seen in healthy NS and two mild COPD patients.", {"entities": []}], ["The moderate and severe COPD patients had very limited community diversity, which was also noted in 28% of the healthy subjects.", {"entities": []}], ["Both approaches revealed extensive membership overlap between the bacterial communities of the three study groups.", {"entities": []}], ["No genera were common within a group but unique across groups.", {"entities": []}], ["Our data suggests the existence of a core pulmonary bacterial microbiome that includes Pseudomonas, Streptococcus, Prevotella, Fusobacterium, Haemophilus, Veillonella, and Porphyromonas .", {"entities": []}], ["Most strikingly, there were significant micro-anatomic differences in bacterial communities within the same lung of subjects with advanced COPD.", {"entities": []}], ["These studies are further demonstration of the pulmonary microbiome and highlight global and micro-anatomic changes in these bacterial communities in severe COPD patients.", {"entities": []}], ["Despite the low prevalence of daily smokers in Sweden, children are still being exposed to environmental tobacco smoke (ETS), primarily by their smoking parents.", {"entities": []}], ["A prospective intervention study using methods from Quality Improvement was performed in Child Health Care (CHC).", {"entities": []}], ["The aim was to provide nurses with new methods for motivating and supporting parents in their efforts to protect children from ETS exposure.", {"entities": []}], ["Collaborative learning was used to implement and test an intervention bundle.", {"entities": []}], ["Twenty-two CHC nurses recruited 86 families with small children which had at least one smoking parent.", {"entities": []}], ["Using a bundle of interventions, nurses met and had dialogues with the parents over a one-year period.", {"entities": []}], ["A detailed questionnaire on cigarette consumption and smoking policies in the home was answered by the parents at the beginning and at the end of the intervention, when children also took urine tests to determine cotinine levels.", {"entities": []}], ["Seventy-two families completed the study.", {"entities": []}], ["Ten parents (11%) quit smoking.", {"entities": []}], ["Thirty-two families (44%) decreased their cigarette consumption.", {"entities": []}], ["Forty-five families (63%) were outdoor smokers at follow up.", {"entities": []}], ["The proportion of children with urinary cotinine values of >6\u00a0ng/ml had decreased.", {"entities": []}], ["The intensified tobacco prevention in CHC improved smoking parents\u2019 ability to protect their children from ETS exposure.", {"entities": []}], ["Total knee arthroplasty (TKA) has been regarded as a most painful orthopaedic surgery.", {"entities": []}], ["Although many surgeons sequentially use parecoxib and celecoxib as a routine strategy for postoperative pain control after TKA, high quality evidence is still lacking to prove the effect of this sequential regimen, especially at the medium-term follow-up.", {"entities": []}], ["The purpose of this study, therefore, is to evaluate efficacy and safety of postoperative intravenous parecoxib sodium followed by oral celecoxib in patients with osteoarthritis (OA) undergoing TKA.", {"entities": [[163, 177, "DISEASE"]]}], ["The hypothesis is that compared to placebo with opioids as rescue treatment, sequential use of parecoxib and celecoxib can achieve less morphine consumption over the postoperative 2\u2005weeks, as well as better pain control, quicker functional recovery in the postoperative 6\u2005weeks and less opioid-related adverse events during the 12-week recovery phase.", {"entities": []}], ["This study is designed as a multicentre, randomised, double-blind, parallel-group and placebo-controlled trial.", {"entities": []}], ["The target sample size is 246.", {"entities": []}], ["All participants who meet the study inclusion and exclusion criteria will be randomly assigned in a 1:1 ratio to either the parecoxib/celecoxib group or placebo group.", {"entities": []}], ["The randomisation and allocation will be study site based.", {"entities": []}], ["The study will consist of three phases: an initial screening phase; a 6-week double-blind treatment phase; and a 6-week follow-up phase.", {"entities": []}], ["The primary end point is cumulative opioid consumption during 2\u2005weeks postoperation.", {"entities": []}], ["Secondary end points consist of the postoperative visual analogue scale score, knee joint function, quality of life, local skin temperature, erythrocyte sedimentation rate, C reactive protein, cytokines and blood coagulation parameters.", {"entities": []}], ["Safety end points will be monitored too.", {"entities": []}], ["Ethics approval for this study has been obtained from the Ethics Committee, Peking Union Medical College Hospital, China (Protocol number: S-572) Study results will be available as published manuscripts and presentations at national and international meetings.", {"entities": []}], ["NCT02198924 .", {"entities": []}], ["Spherical monodisperse ferromagnetic iron oxide particles of 1.9 \u03bcm geometric and 4.2 \u03bcm aerodynamic diameter were inhaled by seven patients with primary ciliary dyskinesia (PCD) using the shallow bolus technique, and compared to 13 healthy non-smokers (NS) from a previous study.", {"entities": [[146, 172, "DISEASE"]]}], ["The bolus penetration front depth was limiting to the phase1 dead space volume.", {"entities": []}], ["In PCD patients deposition was 58+/-8 % after 8 s breath holding time.", {"entities": []}], ["Particle retention was measured by the magnetopneumographic method over a period of nine months.", {"entities": []}], ["Particle clearance from the airways showed a fast and a slow phase.", {"entities": []}], ["In PCD patients airway clearance was retarded and prolonged, 42+/-12 % followed the fast phase with a mean half time of 16.8+/-8.6 hours.", {"entities": []}], ["The remaining fraction was cleared slowly with a half time of 121+/-25 days.", {"entities": []}], ["In healthy NS 49+/-9 % of particles were cleared in the fast phase with a mean half time of 3.0+/-1.6 hours, characteristic of an intact mucociliary clearance.", {"entities": []}], ["There was no difference in the slow clearance phase between PCD patients and healthy NS.", {"entities": []}], ["Despite non-functioning cilia the effectiveness of airway clearance in PCD patients is comparable to healthy NS, with a prolonged kinetics of one week, which may primarily reflect the effectiveness of cough clearance.", {"entities": []}], ["This prolonged airway clearance allows longer residence times of bacteria and viruses in the airways and may be one reason for increased frequency of infections in PCD patients.", {"entities": []}], ["Only 29 cases of constitutional 9q22 deletions have been published and all have been sporadic.", {"entities": []}], ["Most associate with Gorlin syndrome or nevoid basal cell carcinoma syndrome (NBCCS, MIM #109400) due to haploinsufficiency of the PTCH1 gene (MIM *601309).", {"entities": [[57, 66, "DISEASE"], [46, 66, "DISEASE"], [27, 35, "DISEASE"], [67, 75, "DISEASE"], [39, 75, "DISEASE"], [130, 135, "GENE"]]}], ["We report two mentally retarded female siblings and their cognitively normal father, all carrying a similar 5.3 Mb microdeletion at 9q22.2q22.32, detected by array CGH (244 K).", {"entities": [[112, 114, "GENE"]]}], ["The deletion does not involve the PTCH1 gene, but instead 30 other gene,s including the ROR2 gene (MIM *602337) which causing both brachydactyly type 1 (MIM #113000) and Robinow syndrome (MIM #268310), and the immunologically active SYK gene (MIM *600085).", {"entities": [[131, 144, "DISEASE"], [178, 186, "DISEASE"], [34, 39, "GENE"], [88, 92, "GENE"], [233, 236, "GENE"]]}], ["The deletion in the father was de novo and FISH analysis of blood lymphocytes did not suggest mosaicism.", {"entities": []}], ["All three patients share similar mild dysmorphic features with downslanting palpebral fissures, narrow, high bridged nose with small nares, long, deeply grooved philtrum, ears with broad helix and uplifted lobuli, and small toenails.", {"entities": []}], ["All have significant dysarthria and suffer from continuous middle ear and upper respiratory infections.", {"entities": []}], ["The father also has a funnel chest and unilateral hypoplastic kidney but the daughters have no malformations.", {"entities": []}], ["This is the first report of a familial constitutional 9q22 deletion and the first deletion studied by array-CGH which does not involve the PTCH1 gene.", {"entities": [[139, 144, "GENE"]]}], ["The phenotype and penetrance are variable and the deletion found in the cognitively normal normal father poses a challenge in genetic counseling.", {"entities": []}], ["Macrophages (M\u03c6s) are involved in a variety of physiological and pathological events including wound healing and tissue regeneration, in which they play both positive and negative roles depending on their polarization state.", {"entities": []}], ["In this study, we investigated the cellular behaviours of bone marrow mesenchymal stem cells ( BMMSC s) after incubation in different conditioned media ( CM s) generated by unpolarized M\u03c6s (M0) or polarized M\u03c6s (M1 and M2).", {"entities": []}], ["M\u03c6 polarization was induced by stimulation with various cytokines, and CM s were obtained from in vitro M\u03c6 cultures termed CM 0, CM 1 and CM 2 based on each M\u03c6 phenotype.", {"entities": []}], ["We found that CM 1 supported the proliferation and adipogenic differentiation of BMMSC s, whereas CM 0 had a remarkable effect on cell osteogenic differentiation.", {"entities": []}], ["To a certain degree, CM 2 also facilitated BMMSC osteogenesis; in particular, cells incubated with CM 2 exhibited an enhanced capacity to form robust stem cell sheets.", {"entities": []}], ["Although incubation with CM 1 also increased production of extracellular matrix components, such as fibronectin, COL \u20101 and integrin \u03b21during sheet induction, the sheets generated by CM 2\u2010incubated cells were thicker than those generated by CM 1\u2010incubated cells ( P < 0.001).", {"entities": []}], ["Our data suggest that each M\u03c6 phenotype has a unique effect on BMMSC s. Fine\u2010tuning M\u03c6 polarization following transplantation may serve as an effective method to modulate the therapeutic potential of BMMSC s.", {"entities": []}], ["We created Asthma e-Lab, a secure web-based research environment to support consistent recording, description and sharing of data, computational/statistical methods and emerging findings across the five UK birth cohorts.", {"entities": []}], ["The e-Lab serves as a data repository for our unified dataset and provides the computational resources and a scientific social network to support collaborative research.", {"entities": []}], ["All activities are transparent, and emerging findings are shared via the e-Lab, linked to explanations of analytical methods, thus enabling knowledge transfer.", {"entities": []}], ["eLab facilitates the iterative interdisciplinary dialogue between clinicians, statisticians, computer scientists, mathematicians, geneticists and basic scientists, capturing collective thought behind the interpretations of findings.", {"entities": []}], ["Aseptic loosening (AL) is the main problem of total joints replacement (TJR) by the implantation of permanently prosthetic components.", {"entities": []}], ["In vitro and in vivo studies have clearly demonstrated that wear debris and its byproducts could trigger inflammation in the peri-implant tissue.", {"entities": []}], ["Lipoxins (LXs) are endogenous eicosanoids synthesized locally from arachidonate acid (AA) at sites of inflammation and mediate pro-resolving activity.", {"entities": []}], ["A number of studies have demonstrated the effect of LXA 4 to counteract inflammation in different cell and animal models, but till now, no relative report about the role of LXs in progress or prevention of AL.", {"entities": []}], ["Murine RAW264.7 macrophage cell line and MC3T3-E1 osteoblasts (OB) cell line were purchased.", {"entities": []}], ["Co-cultured model of these two cell lines was established.", {"entities": []}], ["To explore the effect of exogenous Lipoxin A 4 (LXA 4 ) on polymethylmethacrylate (PMMA) induced inflammation, pro-inflammatory cytokines including TNF-\u03b1, IL-1\u03b2, PGE 2 and GM-CSF were measured by ELISA kits and bone resorption was quantified by measuring calcium release from 5-day-old mice calvaria in vitro.", {"entities": []}], ["To determine further the endogenous effect of LXA 4 , cells were co-cultured and with or without 15-lipoxygease (15-LO) blocking by 15-LO siRNA.", {"entities": []}], ["Both real-time PCR and western blotting were applied to confirm the inhibitory efficiency of 15-LO by siRNA.", {"entities": []}], ["0.1 mg/ml, 0.5 mg/ml and 1.0 mg/ml PMMA showed a time-dependent manner to trigger production of all the pro-inflammatory cytokines studied.", {"entities": []}], ["Exogenous 0\u2013100 nM LXA 4 presented an inhibitory effect on both generation of above cytokines and PMMA stimulated calvarial bone resorption with a dose-dependent manner.", {"entities": []}], ["LXA 4 in supernatant from neither rest macrophages nor macrophages cultured alone exposing to PMMA was detectable.", {"entities": []}], ["In co-cultured cells challenged by PMMA, LXA 4 was increased significantly, while, this enhance could be partly inhibited by 15-LO siRNA.", {"entities": []}], ["When LXA 4 generation was blocked with 15-LO siRNA, the PMMA induced pro-inflammatory cytokines were elevated and bone resorption was accelerated.", {"entities": []}], ["In the present study, we demonstrated that LXA 4 had a favorable inhibitory effect on PMMA-induced inflammation in a macrophage and OB co-culture system.", {"entities": []}], ["The safety of vaccines is a critical factor in maintaining public trust in national vaccination programs.", {"entities": []}], ["Vaccines are recommended for children, adults and elderly subjects and have to meet higher safety standards, since they are administered to healthy subjects, mainly healthy children.", {"entities": []}], ["Although vaccines are strictly monitored before authorization, the possibility of adverse events and/or rare adverse events cannot be totally eliminated.", {"entities": []}], ["Two main types of influenza vaccines are currently available: parenteral inactivated influenza vaccines and intranasal live attenuated vaccines.", {"entities": [[18, 27, "DISEASE"], [85, 94, "DISEASE"]]}], ["Both display a good safety profile in adults and children.", {"entities": []}], ["However, they can cause adverse events and/or rare adverse events, some of which are more prevalent in children, while others with a higher prevalence in adults.", {"entities": []}], ["The aim of this review is to provide an overview of influenza vaccine safety according to target groups, vaccine types and production methods.", {"entities": [[52, 61, "DISEASE"]]}], ["Though life expectancy sex differences are decreasing in many Western countries, men experience higher mortality rates at all ages.", {"entities": []}], ["Men are often reluctant to seek medical care because health help-seeking is strongly linked to femininity, male weakness, and vulnerability.", {"entities": []}], ["Many men are also more likely to access emergency care services in response to injury and/or severe pain instead of engaging primary health care (PHC) services.", {"entities": []}], ["Nurse practitioners are well positioned to increase men\u2019s engagement with PHC to waylay the pressure on emergency services and advance the well-being of men.", {"entities": []}], ["This article demonstrates how nurse practitioners can work with men in PHC settings to optimize men\u2019s self-health and illness prevention and management.", {"entities": []}], ["Four recommendations are discussed: (1) leveling the hierarchies, (2) talking it through, (3) seeing diversity within patterns, and (4) augmenting face-to-face PHC services.", {"entities": []}], ["In terms of leveling the hierarchies nurse practitioners can engage men in effectual health decision making.", {"entities": []}], ["Within the interactions detailed in the talking it through section are strategies for connecting with male patients and mapping their progress.", {"entities": []}], ["In terms of seeing diversity with in patterns and drawing on the plurality of masculinities, nurse practitioners are encouraged to adapt a variety of age sensitive assessment tools to better intervene and guide men\u2019s self-health efforts.", {"entities": []}], ["Examples of community and web based men\u2019s health resources are shared in the augmenting face-to-face PHC services section to guide the work of nurse practitioners.", {"entities": []}], ["Overall, the information and recommendations shared in this article can proactively direct the efforts of nurse practitioners working with men.", {"entities": []}], ["Tracheobronchial amyloidosis is an uncommon localized form of amyloidosis that can simulate a tracheal tumor.", {"entities": [[17, 28, "DISEASE"], [62, 73, "DISEASE"]]}], ["Clinical signs are not specific and the diagnosis is rarely given before performing a bronchoscopy with multiples biopsies.", {"entities": []}], ["We report the case of a 60-year-old Moroccan woman, complaining of dyspnea and wheezing for three years, who was treated at our institution for management of severe asthma.", {"entities": [[165, 171, "DISEASE"]]}], ["A bronchoscopy revealed a tumor formation of her trachea; multiples biopsies were performed and a diagnosis made of amyloid light-chain amyloidosis.", {"entities": [[136, 147, "DISEASE"]]}], ["She successfully received an endoscopic resection.", {"entities": []}], ["This case highlights the importance of routinely carrying out an endoscopy in any patient complaining of atypical bronchial symptoms or with uncontrolled asthma.", {"entities": [[154, 160, "DISEASE"]]}], ["Tracheal amyloidosis is a rare disease, confirmed by histological examination of bronchial biopsies, and the treatment of choice is based on the bronchoscopic resection.", {"entities": [[9, 20, "DISEASE"]]}], ["Vaccination likely prevented 700,000\u20131,500,000 clinical cases, 4,000\u201310,000 hospitalizations, and 200\u2013500 deaths.", {"entities": []}], ["In April 2009, the United States began a response to the emergence of a pandemic influenza virus strain: A(H1N1)pdm09.", {"entities": [[81, 90, "DISEASE"]]}], ["Vaccination began in October 2009.", {"entities": []}], ["By using US surveillance data (April 12, 2009\u2013April 10, 2010) and vaccine coverage estimates (October 3, 2009\u2013April 18, 2010), we estimated that the A(H1N1)pdm09 virus vaccination program prevented 700,000\u20131,500,000 clinical cases, 4,000\u201310,000 hospitalizations, and 200\u2013500 deaths.", {"entities": []}], ["We found that the national health effects were greatly influenced by the timing of vaccine administration and the effectiveness of the vaccine.", {"entities": []}], ["We estimated that recommendations for priority vaccination of targeted priority groups were not inferior to other vaccination prioritization strategies.", {"entities": []}], ["These results emphasize the need for relevant surveillance data to facilitate a rapid evaluation of vaccine recommendations and effects.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a public health problem.", {"entities": []}], ["Interprofessional collaboration and health promotion interventions such as exercise training, education, and behaviour change are cost effective, have a good effect on health status, and are recommended in COPD treatment guidelines.", {"entities": []}], ["There is a gap between the guidelines and the healthcare available to people with COPD.", {"entities": []}], ["The aim of this study was to increase the understanding of what shapes the provision of primary care services to people with COPD and what healthcare is offered to them from the perspective of healthcare professionals and managers.", {"entities": []}], ["The study was conducted in primary care in a Swedish county council during January to June 2015.", {"entities": []}], ["A qualitatively driven mixed methods design was applied.", {"entities": []}], ["Qualitative and quantitative findings were merged into a joint analysis.", {"entities": []}], ["Interviews for the qualitative component were performed with healthcare professionals ( n \u00a0=\u00a014) from two primary care centres and analysed with qualitative content analysis.", {"entities": []}], ["Two questionnaires were used for the quantitative component; one was answered by senior managers or COPD nurses at primary care centres ( n \u00a0=\u00a026) in the county council and the other was answered by healthcare professionals ( n \u00a0=\u00a018) at two primary care centres.", {"entities": []}], ["The questionnaire data were analysed with descriptive statistics.", {"entities": []}], ["The analysis gave rise to the overarching theme building COPD care on shaky ground .", {"entities": []}], ["This represents professionals driven to build a supportive COPD care on \u2018shaky\u2019 organisational ground in a fragmented and non-compliant healthcare organisation.", {"entities": []}], ["The shaky ground is further represented by uninformed patients with a complex disease, which is surrounded with shame.", {"entities": []}], ["The professionals are autonomous and pragmatic, used to taking responsibility for their work, and with limited involvement of the management.", {"entities": []}], ["They wish to provide high quality COPD care with interprofessional collaboration, but they lack competence and are hindered by inadequate routines and lack of resources.", {"entities": []}], ["There is a gap between COPD treatment guidelines and the healthcare that is provided in primary care.", {"entities": []}], ["To facilitate implementation of the guidelines several actions are needed, such as further training for professionals, additional resources, and improved organisational structure for interprofessional collaboration and patient education.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-017-2393-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Nowadays, there is a considerable gap in knowledge concerning the mechanism(s) by which long-acting \u03b2 2 -agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) interact to induce bronchodilation.", {"entities": []}], ["This study aimed to characterise the pharmacological interaction between glycopyrronium bromide and indacaterol fumarate and to identify the mechanism(s) leading to the bronchorelaxant effect of this interaction.", {"entities": []}], ["The effects of glycopyrronium plus indacaterol on the contractile tone of medium and small human isolated bronchi were evaluated, and acetylcholine and cAMP concentrations were quantified.", {"entities": []}], ["The interaction was assessed by Bliss Independence approach.", {"entities": []}], ["Glycopyrronium plus indacaterol synergistically inhibited the bronchial tone (medium bronchi, +32.51\u00a0%\u2009\u00b1\u20097.86\u00a0%; small bronchi, +28.46\u00a0%\u2009\u00b1\u20095.35\u00a0%; P \u2009<\u20090.05 vs. additive effect).", {"entities": []}], ["The maximal effect was reached 140\u00a0min post-administration.", {"entities": []}], ["A significant ( P \u2009<\u20090.05) synergistic effect was observed during 9\u00a0h post-administration on the cholinergic tone, but not on the histaminergic contractility.", {"entities": []}], ["Co-administration of glycopyrronium and indacaterol reduced the release of acetylcholine from the epithelium but not from bronchi, and enhanced cAMP levels in bronchi and epithelial cells ( P \u2009<\u20090.05 vs. control), an effect that was inhibited by the selective KCa P \u2009<\u20090.05 vs. additive effect), but not on indacaterol ( P \u2009>\u20090.05 vs. additive effect), with regard of the bronchial relaxant response and cAMP increase.", {"entities": []}], ["Glycopyrronium/indacaterol co-administration leads to a synergistic improvement of bronchodilation by increasing cAMP concentrations in both airway smooth muscle and bronchial epithelium, and by decreasing acetylcholine release from the epithelium.", {"entities": []}], ["The goal of asthma treatment is to obtain and maintain a good control of symptoms.", {"entities": [[12, 18, "DISEASE"]]}], ["Investigating factors associated with inadequately control asthma could help in strategies to improve asthma control.", {"entities": [[59, 65, "DISEASE"], [102, 108, "DISEASE"]]}], ["This study aimed to determine the prevalence and factors associated with inadequately controlled asthma in asthma patients under chest specialist care.", {"entities": [[97, 103, "DISEASE"], [107, 113, "DISEASE"]]}], ["A cross-sectional study was conducted from November 2012 to May 2013.", {"entities": []}], ["Physician-diagnosed asthma patients aged 12 years and above were included.", {"entities": [[20, 26, "DISEASE"]]}], ["A questionnaire was used to collect demographic data, comorbidities, and medical history of asthma.", {"entities": [[92, 98, "DISEASE"]]}], ["Asthma control was assessed using the Asthma Control Test (ACT), with a score less than 20 for inadequately controlled asthma and a score greater or equal to 20 for controlled asthma.", {"entities": [[0, 6, "DISEASE"], [38, 44, "DISEASE"], [119, 125, "DISEASE"], [176, 182, "DISEASE"]]}], ["A multivariate analysis was used to identify factors associated with inadequately controlled asthma.", {"entities": [[93, 99, "DISEASE"]]}], ["Overall, 243 patients were included in this study.", {"entities": []}], ["Asthma was controlled in 141 patients (58%) and inadequately controlled in 102 (42%).", {"entities": [[0, 6, "DISEASE"]]}], ["The mean duration of asthma was 8 years with an interquartile range of 4 and 18 years.", {"entities": [[21, 27, "DISEASE"]]}], ["Forty-three participants (17.7%) were not under any controller medication while the mean ACT score was 19.3 \u00b1 4.6.", {"entities": []}], ["Independent associations were found between inadequately controlled asthma and female gender (OR 1.91; 95% CI 1.06-3.47) and obesity (OR 1.81; 1.01-3.27).", {"entities": [[125, 132, "DISEASE"], [68, 74, "DISEASE"]]}], ["Asthma remains poorly controlled in a large proportion of asthma patients under specialist care in Cameroon.", {"entities": [[0, 6, "DISEASE"], [58, 64, "DISEASE"]]}], ["Educational programs for asthma patients targeting women and based on weight loss for obese patients may help in improving the control of asthma.", {"entities": [[25, 31, "DISEASE"], [138, 144, "DISEASE"]]}], ["Birch trees produce large amounts of highly allergenic pollen grains that are distributed by wind and impact human health by causing seasonal hay fever, pollen-related asthma, and other allergic diseases.", {"entities": [[168, 174, "DISEASE"]]}], ["Traditionally, pollen forecasts are based on conventional microscopic counting techniques that are labor-intensive and limited in the reliable identification of species.", {"entities": []}], ["Molecular biological techniques provide an alternative approach that is less labor-intensive and enables identification of any species by its genetic fingerprint.", {"entities": []}], ["A particularly promising method is quantitative Real-Time polymerase chain reaction (qPCR), which can be used to determine the number of DNA copies and thus pollen grains in air filter samples.", {"entities": []}], ["During the birch pollination season in 2010 in Mainz, Germany, we collected air filter samples of fine (<3 \u03bcm) and coarse air particulate matter.", {"entities": []}], ["These were analyzed by qPCR using two different primer pairs: one for a single-copy gene ( BP8 ) and the other for a multi-copy gene (ITS).", {"entities": []}], ["The BP8 gene was better suitable for reliable qPCR results, and the qPCR results obtained for coarse particulate matter were well correlated with the birch pollen forecasting results of the regional air quality model COSMO-ART.", {"entities": []}], ["As expected due to the size of birch pollen grains (~23 \u03bcm), the concentration of DNA in fine particulate matter was lower than in the coarse particle fraction.", {"entities": []}], ["For the ITS region the factor was 64, while for the single-copy gene BP8 only 51.", {"entities": []}], ["The possible presence of so-called sub-pollen particles in the fine particle fraction is, however, interesting even in low concentrations.", {"entities": []}], ["These particles are known to be highly allergenic, reach deep into airways and cause often severe health problems.", {"entities": []}], ["In conclusion, the results of this exploratory study open up the possibility of predicting and quantifying the pollen concentration in the atmosphere more precisely in the future.", {"entities": []}], ["Diagnostic tests are performed in a subset of the population who are at higher risk, resulting in undiagnosed cases among those who do not receive the test.", {"entities": []}], ["This poses a challenge for estimating the prevalence of the disease in the study population, and also for studying the risk factors for the disease.", {"entities": []}], ["We formulate this problem as a missing data problem because the disease status is unknown for those who do not receive the test.", {"entities": []}], ["We propose a Bayesian selection model which models the joint distribution of the disease outcome and whether testing was received.", {"entities": []}], ["The sensitivity analysis allows us to assess how the association of the risk factors with the disease outcome as well as the disease prevalence change with the sensitivity parameter.", {"entities": []}], ["We illustrated our model using a retrospective cohort study of children with asthma exacerbation that were evaluated for pneumonia in the emergency department.", {"entities": [[121, 130, "DISEASE"], [77, 83, "DISEASE"]]}], ["Our model found that female gender, having fever during ED or at triage, and having severe hypoxia are significantly associated with having radiographic pneumonia.", {"entities": [[153, 162, "DISEASE"]]}], ["In addition, simulation studies demonstrate that the Bayesian selection model works well even under circumstances when both the disease prevalence and the screening proportion is low.", {"entities": []}], ["The Bayesian selection model is a viable tool to consider for estimating the disease prevalence and in studying risk factors of the disease, when only a subset of the target population receive the test.", {"entities": []}], ["Sugar\u2010sweetened beverage ( SSB ) consumption is associated with adverse health outcomes.", {"entities": [[27, 30, "GENE"]]}], ["Improved understanding of the determinants will inform effective interventions to reduce SSB consumption.", {"entities": [[89, 92, "GENE"]]}], ["A total of 46,876 papers were identified through searching eight electronic databases.", {"entities": []}], ["Evidence from intervention ( n \u2009=\u200913), prospective ( n \u2009=\u20096) and cross\u2010sectional ( n \u2009=\u200925) studies on correlates/determinants of SSB consumption was quality assessed and synthesized.", {"entities": [[130, 133, "GENE"]]}], ["Twelve correlates/determinants were associated with higher SSB consumption (child's preference for SSBs , TV viewing/screen time and snack consumption; parents' lower socioeconomic status, lower age, SSB consumption, formula milk feeding, early introduction of solids, using food as rewards, parental\u2010perceived barriers, attending out\u2010of\u2010home care and living near a fast food/convenience store).", {"entities": [[59, 62, "GENE"], [200, 203, "GENE"], [59, 62, "GENE"], [200, 203, "GENE"]]}], ["Five correlates/determinants were associated with lower SSB consumption (parental positive modelling, parents' married/co\u2010habiting, school nutrition policy, staff skills and supermarket nearby).", {"entities": [[56, 59, "GENE"]]}], ["There was equivocal evidence for child's age and knowledge, parental knowledge, skills, rules/restrictions and home SSB availability.", {"entities": [[116, 119, "GENE"]]}], ["Eight intervention studies targeted multi\u2010level (child, parents, childcare/preschool setting) determinants; four were effective.", {"entities": []}], ["Four intervention studies targeted parental determinants; two were effective.", {"entities": []}], ["One (effective) intervention targeted the preschool environment.", {"entities": []}], ["There is consistent evidence to support potentially modifiable correlates/determinants of SSB consumption in young children acting at parental (modelling), child ( TV viewing) and environmental (school policy) levels.", {"entities": [[90, 93, "GENE"]]}], ["Psoriasis is considered a systemic inflammatory disorder.", {"entities": [[0, 9, "DISEASE"]]}], ["Previous studies have reported conflicting positive or negative correlations between psoriasis and chronic obstructive pulmonary disease.", {"entities": [[85, 94, "DISEASE"], [99, 136, "DISEASE"]]}], ["We performed a meta-analysis to determine whether there is an associated risk between psoriasis and chronic obstructive pulmonary disease.", {"entities": [[86, 95, "DISEASE"], [100, 137, "DISEASE"]]}], ["We performed a complete 30-year literature search of MEDLINE, Embase, and Cochrane Central Register databases on this topic.", {"entities": []}], ["Four observational studies with a total of 13,418 subjects were identified.", {"entities": []}], ["The odds ratios of chronic obstructive pulmonary disease in subjects with psoriasis/mild-to-moderate psoriasis were analyzed using the random-effects model, while the odds ratios of chronic obstructive pulmonary disease in subjects with severe psoriasis and current smoking in subjects with psoriasis were analyzed using the fixed-effect model.", {"entities": [[74, 83, "DISEASE"], [101, 110, "DISEASE"], [244, 253, "DISEASE"], [291, 300, "DISEASE"], [19, 56, "DISEASE"], [182, 219, "DISEASE"]]}], ["We found that psoriasis patients were at a greater risk of developing chronic obstructive pulmonary disease than the general population (odds ratio, 1.90; 95% confidence interval, 1.36\u20132.65) and that the association between of psoriasis and with chronic obstructive pulmonary disease was stronger among patients with severe psoriasis (odds ratio, 2.15; 95% confidence interval, 1.26\u20133.67).", {"entities": [[14, 23, "DISEASE"], [227, 236, "DISEASE"], [324, 333, "DISEASE"], [70, 107, "DISEASE"], [246, 283, "DISEASE"]]}], ["Psoriasis patients should be advised to cease smoking to reduce their risk of COPD.", {"entities": [[0, 9, "DISEASE"]]}], ["Moreover, identification of this potential risk may enable earlier implementation of preventive measures for reduction comorbidity and mortality rates.", {"entities": []}], ["Identifying different patterns of allergens and understanding their predictive ability in relation to asthma and other allergic diseases is crucial for the design of personalized diagnostic tools.", {"entities": [[102, 108, "DISEASE"]]}], ["Allergen-IgE screening using ImmunoCAP ISAC\u00ae assay was performed at age 11\u00a0yrs in children participating a population-based birth cohort.", {"entities": []}], ["Logistic regression (LR) and nonlinear statistical learning models, including random forests (RF) and Bayesian networks (BN), coupled with feature selection approaches, were used to identify patterns of allergen responses associated with asthma, rhino-conjunctivitis, wheeze, eczema and airway hyper-reactivity (AHR, positive methacholine challenge).", {"entities": [[252, 266, "DISEASE"], [238, 244, "DISEASE"], [312, 315, "GENE"]]}], ["Sensitivity/specificity and area under the receiver operating characteristic (AUROC) were used to assess model performance via repeated validation.", {"entities": []}], ["Serum sample for IgE measurement was obtained from 461 of 822 (56.1%) participants.", {"entities": []}], ["Two hundred and thirty-eight of 461 (51.6%) children had at least one of 112 allergen components IgE\u00a0>\u00a00\u00a0ISU.", {"entities": []}], ["The binary threshold >0.3\u00a0ISU performed less well than using continuous IgE values, discretizing data or using other data transformations, but not significantly (p\u00a0=\u00a00.1).", {"entities": []}], ["With the exception of eczema (AUROC\u223c0.5), LR, RF and BN achieved comparable AUROC, ranging from 0.76 to 0.82.", {"entities": []}], ["Dust mite, pollens and pet allergens were highly associated with asthma, whilst pollens and dust mite with rhino-conjunctivitis.", {"entities": [[113, 127, "DISEASE"], [65, 71, "DISEASE"]]}], ["Egg/bovine allergens were associated with eczema.", {"entities": []}], ["After validation, LR, RF and BN demonstrated reasonable discrimination ability for asthma, rhino-conjunctivitis, wheeze and AHR, but not for eczema.", {"entities": [[97, 111, "DISEASE"], [83, 89, "DISEASE"], [124, 127, "GENE"]]}], ["However, further improvements in threshold ascertainment and/or value transformation for different components, and better interpretation algorithms are needed to fully capitalize on the potential of the technology.", {"entities": []}], ["In the United Kingdom, licensed nicotine-containing products can be recommended to reduce the harm associated with smoking.", {"entities": []}], ["Many smokers find currently available nicotine replacement products unsatisfactory.", {"entities": []}], ["The arterial and venous pharmacokinetics (PK) of nicotine delivered via a novel inhaler device were determined.", {"entities": []}], ["Results are reported for Parts A ( N = 18) and C ( N = 18) of a 4-part (A\u2013D) Phase I study.", {"entities": []}], ["Participants (18\u201355 years, \u226510 cigarettes/day, smoking within 1hr of waking, expired carbon monoxide >10 ppm on screening) orally inhaled 2 single doses of nicotine (2 of 3 dose levels [0.22, 0.45, and 0.67 mg]) (Part A) and repeated hourly doses of 0.67mg nicotine for 12hr (Part C), via the novel device.", {"entities": []}], ["Arterial and venous PK and tolerability were assessed.", {"entities": []}], ["In Part A, mean arterial plasma nicotine concentrations at 2min after the start of inhalation were 1.10, 2.06, and 2.59ng/mL for the 0.22, 0.45, and 0.67mg doses, respectively.", {"entities": []}], ["Mean maximum arterial plasma nicotine concentrations ( C max ) were 2.11, 3.73, and 4.38ng/mL and mean times to C max were 10.2, 7.3, and 6.5min after the start of inhalation for the 0.22, 0.45, and 0.67mg doses, respectively.", {"entities": [[57, 60, "GENE"], [114, 117, "GENE"], [57, 60, "GENE"], [114, 117, "GENE"]]}], ["In Part C, the mean pre- and postdose venous plasma nicotine concentration increased steadily and fluctuated in the range 8\u201310mg/mL after 9hr.", {"entities": []}], ["The novel device was well tolerated; most adverse events were mild.", {"entities": []}], ["The novel inhaler device delivers nicotine rapidly into the systemic circulation and offers a viable alternative to cigarettes for those finding it difficult to quit the behavioral and sensorial aspects of smoking.", {"entities": []}], ["Seasonal influenza vaccination (SIV) is recommended for people with diabetes, but its effectiveness has not been demonstrated.", {"entities": [[9, 18, "DISEASE"]]}], ["All of the available studies are observational and marred with the healthy vaccine bias, that is, bias resulting from the generally better health behaviours practised by people who choose to be vaccinated against influenza, compared with those who do not.", {"entities": [[213, 222, "DISEASE"]]}], ["This protocol is intended to study the effectiveness of SIV in people with treated diabetes and simultaneously to control for bias.", {"entities": []}], ["This case-control study is nested in a historical cohort and is designed to study vaccine effectiveness (VE) assessed by morbidity, mortality and anti-infective drug use.", {"entities": []}], ["The cohort will comprise a representative sample of health insurance beneficiaries in France and will cover 10 consecutive epidemic seasons.", {"entities": []}], ["It will include all patients reimbursed three separate times for drugs to treat diabetes.", {"entities": []}], ["The first study of VE will use reasons for hospitalisation as the primary end point, and the second with the use of neuraminidase inhibitors and of antibiotics as the end points.", {"entities": []}], ["A case will be defined as any person in the cohort reaching any end point at a given date.", {"entities": []}], ["The case patient will be matched with the largest possible number of controls (individuals not reaching the end point by this date) according to the propensity score method with an optimal calliper width.", {"entities": []}], ["A conditional logistic model will be used to estimate ORs to take into account both the matching and the repetition of measurements.", {"entities": []}], ["The model will be applied separately during and outside of epidemic periods to estimate the residual confounding.", {"entities": []}], ["The study has been approved by the French Commission on Individual Data Protection and Public Liberties (ref: AT/CPZ/SVT/JB/DP/CR05222O).", {"entities": []}], ["The study's findings will be published in peer-reviewed journals and disseminated at international conferences and through social media.", {"entities": []}], ["Pneumococcal pneumonia causes high morbidity and mortality among adults.", {"entities": [[13, 22, "DISEASE"]]}], ["This study aimed to identify risk factors for bacteremic pneumococcal pneumonia, and to construct a prediction model for the development of bacteremia in patients with community-acquired pneumococcal pneumonia.", {"entities": [[70, 79, "DISEASE"], [200, 209, "DISEASE"]]}], ["We retrospectively analyzed data from patients hospitalized with community-acquired pneumococcal pneumonia between April 2007 and August 2015.", {"entities": [[97, 106, "DISEASE"]]}], ["Logistic regression models were applied to detect risk factors for pneumococcal bacteremia, and a receiver operating characteristic curve was used to devise a prediction model.", {"entities": []}], ["Based on the results of sputum cultures, urine antigen tests, and/or blood cultures, 389 patients were diagnosed with pneumococcal pneumonia, 46 of whom had bacteremia.", {"entities": [[131, 140, "DISEASE"]]}], ["In the multivariate analysis, age\u2009<\u200965\u00a0years, serum albumin level\u2009<\u20093.0\u00a0g/dL, need for intensive respiratory or vasopressor support (IRVS), and C-reactive protein level\u2009>\u200920\u00a0mg/dL were identified as independent risk factors for the development of pneumococcal bacteremia.", {"entities": []}], ["The bacteremia prediction score based on receiver operating characteristic curve analysis had a sensitivity of 0.74 and a specificity of 0.78 in patients with two risk factors.", {"entities": []}], ["The area under the receiver operating characteristic curve was 0.77 (95% confidence interval (CI), 0.70\u20130.85).", {"entities": []}], ["Age\u2009<\u200965\u00a0years, hypoalbuminemia, IRVS, and high C-reactive protein level on admission are independent risk factors for the development of bacteremia in patients with community-acquired pneumococcal pneumonia.", {"entities": [[198, 207, "DISEASE"]]}], ["A prediction model based on these four risk factors could help to identify patients with community-acquired pneumococcal pneumonia at high risk of developing bacteremia; this can be used to guide antibiotic choices.", {"entities": [[121, 130, "DISEASE"]]}], ["UMIN-CTR UMIN 000004353 .", {"entities": []}], ["Registered 7 October 2010.", {"entities": []}], ["Retrospectively registered.", {"entities": []}], ["Accumulating evidence has demonstrated that hydrogen sulphide (H 2 S) is involved in the pathogenesis of various respiratory diseases.", {"entities": []}], ["In the present study, we established a rat model of passive smoking and investigated whether or not H 2 S has protective effects against pulmonary fibrosis induced by chronic cigarette smoke exposure.", {"entities": [[137, 155, "DISEASE"]]}], ["Rat lung tissues were stained with haematoxylin-eosin and Masson's trichrome.", {"entities": []}], ["The expression of type I collagen was detected by immunohistochemistry.", {"entities": []}], ["Oxidative stress was evaluated by detecting serum levels of malondialdehyde, superoxide dismutase and glutathione peroxidase and measuring reactive oxygen species generation in lung tissue.", {"entities": []}], ["Inflammation was assessed by measuring serum levels of inflammatory cytokines, including high-sensitivity C-reactive protein, tumour necrosis factor-\u03b1, interleukin (IL)-1\u03b2 and IL-6.", {"entities": []}], ["The protein expression of Nrf2, NF-\u03baB and phosphorylated mitogen-activated protein kinases (MAPKs) in the pulmonary tissue was determined by Western blotting.", {"entities": []}], ["Our findings indicated that administration of NaHS (a donor of H 2 S) could protect against pulmonary fibrosis in the smoking rats.", {"entities": [[92, 110, "DISEASE"]]}], ["H 2 S was found to induce the nuclear accumulation of Nrf2 in lung tissue and consequently up-regulate the expression of antioxidant genes HO-1 and Trx-1 in the smoking rats.", {"entities": []}], ["Moreover, H 2 S could also reduce cigarette smoking-induced inflammation by inhibiting the phosphorylation of ERK 1/2, JNK and p38 MAPKs and negatively regulating NF-\u03baB activation.", {"entities": []}], ["In conclusion, our study suggests that H 2 S has protective effects against pulmonary fibrosis in the smoking rats by attenuating oxidative stress and inflammation.", {"entities": [[76, 94, "DISEASE"]]}], ["Presenting to primary care with potential cancer symptoms is contingent on one\u2019s ability to recognize potentially serious symptoms.", {"entities": [[42, 48, "DISEASE"]]}], ["We investigated differences between smokers and non-smokers in symptoms experienced, awareness and consulting of potential respiratory, head and neck cancer symptoms.", {"entities": [[150, 156, "DISEASE"]]}], ["Smokers and non-smokers aged over 50 from Yorkshire general practice lists were sent a postal questionnaire asking about symptoms, consulting and awareness of cancer symptoms.", {"entities": [[159, 165, "DISEASE"]]}], ["Data were analysed using STATA14.", {"entities": []}], ["Response rate after one reminder was 30.5% (1205/3954).", {"entities": []}], ["Smoking status was associated with experience of cough (p<0.001), breathlessness (p = 0.002) and tiredness (p = 0.004) with smokers (25.8% of population) more likely than never-smokers (53.6% of population) to experience all three symptoms (cough OR = 2.56;95%CI[1.75\u20133.75], breathlessness OR = 2.39;95%CI[1.43\u20134.00], tiredness OR = 1.57;95%CI[1.12\u20132.19]).", {"entities": []}], ["Smoking status was associated with awareness of breathlessness as a potential cancer symptom (p = 0.035) and consulting for cough (p = 0.011) with smokers less likely to consult than never-smokers (OR = 0.37;95% CI[0.17\u20130.80]).", {"entities": [[78, 84, "DISEASE"]]}], ["Our findings suggest that current smokers are more likely to experience cough, breathlessness and tiredness, but are less likely to consult for cough than never-smokers.", {"entities": []}], ["To increase cancer awareness and promote consulting among smokers, innovative interventions improving symptom recognition and empowering smokers to seek help are required.", {"entities": [[12, 18, "DISEASE"]]}], ["Vascular endothelial growth factor (VEGF) is supposed to contribute to the pathogenesis of allergic airway disease.", {"entities": []}], ["VEGF expression is regulated by a variety of stimuli such as nitric oxide, growth factors, and hypoxia-inducible factor-1 alpha (HIF-1\u03b1).", {"entities": []}], ["Recently, inhibition of the mammalian target of rapamycin (mTOR) has been shown to alleviate cardinal asthmatic features, including airway hyperresponsiveness, eosinophilic inflammation, and increased vascular permeability in asthma models.", {"entities": [[226, 232, "DISEASE"], [59, 63, "GENE"]]}], ["Based on these observations, we have investigated whether mTOR is associated with HIF-1\u03b1-mediated VEGF expression in allergic asthma.", {"entities": [[117, 132, "DISEASE"], [126, 132, "DISEASE"], [58, 62, "GENE"]]}], ["In studies with the mTOR inhibitor rapamycin, we have elucidated the stimulatory role of a mTOR-HIF-1\u03b1-VEGF axis in allergic response.", {"entities": [[20, 24, "GENE"], [91, 95, "GENE"]]}], ["Next, the mechanisms by which mTOR is activated to modulate this response have been evaluated.", {"entities": [[30, 34, "GENE"]]}], ["mTOR is known to be regulated by phosphoinositide 3-kinase (PI3K)/Akt or protein kinase C-delta (PKC \u03b4) in various cell types.", {"entities": [[0, 4, "GENE"]]}], ["Consistent with these, our results have revealed that suppression of PKC \u03b4 by rottlerin leads to the inhibition of PI3K/Akt activity and the subsequent blockade of a mTOR-HIF-1\u03b1-VEGF module, thereby attenuating typical asthmatic attack in a murine model.", {"entities": []}], ["Thus, the present data indicate that PKC \u03b4 is necessary for the modulation of the PI3K/Akt/mTOR signaling cascade, resulting in a tight regulation of HIF-1\u03b1 activity and VEGF expression.", {"entities": []}], ["In conclusion, PKC \u03b4 may represent a valuable target for innovative therapeutic treatment of allergic airway disease.", {"entities": []}], ["Among children earlier having been identified with a hospital or primary care diagnosis of asthma at least once between 0-7 years of age, almost 40 % of their parents reported in the ISAAC-questionnaire as never having had asthma ( NA ).", {"entities": [[91, 97, "DISEASE"], [223, 229, "DISEASE"]]}], ["These are further analysed and compared with the persisting asthma cases ( A ) in this study.", {"entities": [[60, 66, "DISEASE"]]}], ["All these children's medical records were scrutinized concerning their asthma diagnose retrospectively.", {"entities": [[71, 77, "DISEASE"]]}], ["The aim of this study was to analyse possible factors related to the outcome in an Asthma diagnosis reassessment by parental questionnaire at the age of ten of the children earlier having been identified with a hospital or primary health care diagnosis of asthma at least once between 0-7 years of age in a total birth-year cohort in a defined Swedish geographical area.", {"entities": [[83, 89, "DISEASE"], [256, 262, "DISEASE"]]}], ["A multiple logistic analysis revealed four significant and independent factors associated to the improvement/non-report of asthma at the age of ten.", {"entities": [[123, 129, "DISEASE"]]}], ["These factors were; not having any past experiences of allergic symptoms (p<0.0001), only having one or two visits at the hospital for asthma diagnosis in the 0-7 interval (p=0.001), not living in a flat but a villa at the age of ten (p=0.029) and no previous perception of mist or mould damage in the house (p=0.052).", {"entities": [[135, 141, "DISEASE"]]}], ["In the early postnatal stage, obstructive and bronchospastic symptoms typical of asthma may be unspecific, and those cases not continuing to persisting disease tend to have identifiable salutogenetic factors of constitutional rather than environmental nature, namely, an overall reduced allergic predisposition.", {"entities": [[81, 87, "DISEASE"]]}], ["Data on influenza epidemiology in HIV-infected persons are limited, particularly for sub-Saharan Africa, where HIV infection is widespread.", {"entities": [[8, 17, "DISEASE"]]}], ["We tested respiratory and blood samples from patients with acute lower respiratory tract infections hospitalized in South Africa during 2009\u20132011 for viral and pneumococcal infections.", {"entities": []}], ["Influenza was identified in 9% (1,056/11,925) of patients enrolled; among influenza case-patients, 358 (44%) of the 819 who were tested were infected with HIV.", {"entities": [[0, 9, "DISEASE"], [74, 83, "DISEASE"]]}], ["Influenza-associated acute lower respiratory tract infection incidence was 4\u20138 times greater for HIV-infected (186\u2013228/100,000) than for HIV-uninfected persons (26\u201354/100,000).", {"entities": [[0, 9, "DISEASE"]]}], ["Furthermore, multivariable analysis showed HIV-infected patients were more likely to have pneumococcal co-infection; to be infected with influenza type B compared with type A; to be hospitalized for 2\u20137 days or >7 days; and to die from their illness.", {"entities": [[137, 146, "DISEASE"]]}], ["These findings indicate that HIV-infected persons are at greater risk for severe illnesses related to influenza and thus should be prioritized for influenza vaccination.", {"entities": [[102, 111, "DISEASE"], [147, 156, "DISEASE"]]}], ["Air pollution is among the leading global risks for mortality and responsible for increasing risk for chronic diseases.", {"entities": []}], ["Community perceptions on exposure are critical in determining people\u2019s response and acceptance of related policies.", {"entities": []}], ["Therefore, understanding people\u2019 perception is critical in informing the design of appropriate intervention measures.", {"entities": []}], ["The aim of this paper was to establish levels and associations between perceived pollution and health risk perception among slum residents.", {"entities": []}], ["A cross-sectional study of 5,317 individuals aged 35+ years was conducted in two slums of Nairobi.", {"entities": []}], ["Association of perceived score and individual characteristics was assessed using linear regression.", {"entities": []}], ["Spatial variation in the perceived levels was determined through hot spot analysis using ArcGIS.", {"entities": []}], ["The average perceived air pollution level was higher among residents in Viwandani compared to those in Korogocho.", {"entities": []}], ["Perceived air pollution level was positively associated with perceived health risks.", {"entities": []}], ["The majority of respondents were exposed to air pollution in their place of work with 66% exposed to at least two sources of air pollution.", {"entities": []}], ["Less than 20% of the respondents in both areas mentioned sources related to indoor pollution.", {"entities": []}], ["The perceived air pollution level and related health risks in the study community were lowamong the residents indicating the need for promoting awareness on air pollution sources and related health risks.", {"entities": []}], ["Please cite this paper as: Larcombe et\u00a0al.", {"entities": []}], ["(2012) Acute diesel exhaust particle exposure increases viral titre and inflammation associated with existing influenza infection, but does not exacerbate deficits in lung function.", {"entities": [[110, 119, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses DOI:10.1111/irv.12012.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Exposure to diesel exhaust particles (DEP) is thought to exacerbate many pre\u2010existing respiratory diseases, including asthma, bronchitis and chronic obstructive pulmonary disease, however, there is a paucity of data on whether DEP exacerbates illness due to respiratory viral infection.", {"entities": [[153, 190, "DISEASE"], [130, 136, "DISEASE"], [138, 148, "DISEASE"]]}], ["Objectives\u2002 To assess the physiological consequences of an acute DEP exposure during the peak of influenza\u2010induced illness.", {"entities": [[97, 106, "DISEASE"]]}], ["Methods\u2002 We exposed adult female BALB/c mice to 100\u2003\u03bcg DEP (or control) 3\u00b775\u2003days after infection with 10 Results\u2002 Influenza infection resulted in significantly increased inflammation, cytokine influx and impairment to lung function.", {"entities": [[115, 124, "DISEASE"]]}], ["DEP exposure alone resulted in less inflammation and cytokine influx, and no impairment to lung function.", {"entities": []}], ["Mice infected with influenza and exposed to DEP had higher viral titres and neutrophilia compared with infected mice, yet they did not have more impaired lung mechanics than mice infected with influenza alone.", {"entities": [[19, 28, "DISEASE"], [193, 202, "DISEASE"]]}], ["Conclusions\u2002 A single dose of DEP is not sufficient to physiologically exacerbate pre\u2010existing respiratory disease caused by influenza infection in mice.", {"entities": [[125, 134, "DISEASE"]]}], ["The interaction between airway epithelial progenitor cells and their microenvironment is critical for maintaining lung homeostasis.", {"entities": []}], ["This microenvironment includes fibroblast cells, which support the growth of airway progenitor cells.", {"entities": []}], ["However, the mechanism of this support is not fully understood.", {"entities": []}], ["In the present study, the authors observed that inhibition of transforming growth factor (TGF)-\u03b2 signal with SB431542 promotes the expression of hepatocyte growth factor (HGF) in fibroblast cells.", {"entities": [[171, 174, "GENE"]]}], ["The HGF receptor, c-Met, is expressed on airway progenitor cells; HGF promotes the colony-forming ability of airway progenitor cells.", {"entities": [[4, 7, "GENE"], [66, 69, "GENE"], [4, 7, "GENE"], [66, 69, "GENE"]]}], ["The deletion of Smad4 in airway progenitor cells increases the colony-forming ability, suggesting that Smad4 plays a negative role in the regulating the proliferation of airway progenitor cells.", {"entities": [[16, 21, "GENE"], [103, 108, "GENE"], [16, 21, "GENE"], [103, 108, "GENE"]]}], ["These data demonstrated that the regulation of airway progenitor cells by TGF-\u03b2 depends on TGF-\u03b2R1/2 on stromal cells, rather than on epithelial progenitor cells.", {"entities": []}], ["These data suggested a role for the TGF-\u03b2-TGF-\u03b2R1/2-HGF-Smad4 axis in airway epithelial homeostasis and sheds new light on the interaction between airway progenitor cells and their microenvironment.", {"entities": []}], ["Breastfeeding provides a protective effect against infectious diseases in infancy.", {"entities": []}], ["Still, immunological evidence for enhanced adaptive immunity in breastfed children remains inconclusive.", {"entities": []}], ["To determine whether breastfeeding affects B- and T-cell memory in the first years of life.", {"entities": []}], ["We performed immunophenotypic analysis on blood samples within a population-based prospective cohort study.", {"entities": []}], ["Participants included children at 6 months (n=258), 14 months (n=166), 25 months (n=112) and 6 years of age (n=332) with both data on breastfeeding and blood lymphocytes.", {"entities": []}], ["Total B- and T-cell numbers and their memory subsets were determined with 6-color flow cytometry.", {"entities": []}], ["Mothers completed questionnaires on breastfeeding when their children were aged 2, 6, and 12 months.", {"entities": []}], ["Multiple linear regression models with adjustments for potential confounders were performed.", {"entities": []}], ["Per month continuation of breastfeeding, a 3% (95% CI -6, -1) decrease in CD27+IgM+, a 2% (95 CI % -5, -1) decrease in CD27+IgA+ and a 2% (95% CI -4, -1) decrease in CD27-IgG+ memory B cell numbers were observed at 6 months of age.", {"entities": []}], ["CD8 T-cell numbers at 6 months of age were 20% (95% CI 3, 37) higher in breastfed than in non-breastfed infants.", {"entities": []}], ["This was mainly found for central memory CD8 T cells and associated with exposure to breast milk, rather than duration.", {"entities": []}], ["The same trend was observed at 14 months, but associations disappeared at older ages.", {"entities": []}], ["Longer breastfeeding is associated with increased CD8 T-cell memory, but not B-cell memory numbers in the first 6 months of life.", {"entities": []}], ["This transient skewing towards T cell memory might contribute to the protective effect against infectious diseases in infancy.", {"entities": []}], ["Health surveys (HS) are a well-established methodology for measuring the health status of a population.", {"entities": []}], ["The relative merit of using information based on HS versus electronic health records (EHR) to measure multimorbidity has not been established.", {"entities": []}], ["Our study had two objectives: 1) to measure and compare the prevalence and distribution of multimorbidity in HS and EHR data, and 2) to test specific hypotheses about potential differences between HS and EHR reporting of diseases with a symptoms-based diagnosis and those requiring diagnostic testing.", {"entities": []}], ["Cross-sectional study using data from a periodic HS conducted by the Catalan government and from EHR covering 80% of the Catalan population aged 15\u2009years and older.", {"entities": []}], ["We determined the prevalence of 27 selected health conditions in both data sources, calculated the prevalence and distribution of multimorbidity (defined as the presence of \u22652 of the selected conditions), and determined multimorbidity patterns.", {"entities": []}], ["We tested two hypotheses: a) health conditions requiring diagnostic tests for their diagnosis and management would be more prevalent in the EHR; and b) symptoms-based health problems would be more prevalent in the HS data.", {"entities": []}], ["We analysed 15,926 HS interviews and 1,597,258 EHRs.", {"entities": []}], ["The profile of the EHR sample was 52% women, average age 47\u2009years (standard deviation: 18.8), and 68% having at least one of the selected health conditions, the 3 most prevalent being hypertension (20%), depression or anxiety (16%) and mental disorders (15%).", {"entities": [[184, 196, "DISEASE"]]}], ["Multimorbidity was higher in HS than in EHR data (60% vs. 43%, respectively, for ages 15-75+, P <0.001, and 91% vs. 83% in participants aged \u226565\u2009years, P <0.001).", {"entities": []}], ["The most prevalent multimorbidity cluster was cardiovascular.", {"entities": []}], ["Circulation disorders (other than varicose veins), chronic allergies, neck pain, haemorrhoids, migraine or frequent headaches and chronic constipation were more prevalent in the HS.", {"entities": [[138, 150, "DISEASE"], [95, 103, "DISEASE"], [34, 48, "DISEASE"]]}], ["Most symptomatic conditions (71%) had a higher prevalence in the HS, while less than a third of conditions requiring diagnostic tests were more prevalent in EHR.", {"entities": []}], ["Prevalence of multimorbidity varies depending on age and the source of information.", {"entities": []}], ["The prevalence of self-reported multimorbidity was significantly higher in HS data among younger patients; prevalence was similar in both data sources for elderly patients.", {"entities": []}], ["Self-report appears to be more sensitive to identifying symptoms-based conditions.", {"entities": []}], ["A comprehensive approach to the study of multimorbidity should take into account the patient perspective.", {"entities": []}], ["Autoantibodies against CD28 have been found in patients with autoimmune and atopic diseases.", {"entities": [[23, 27, "GENE"]]}], ["These antibodies may act as superagonists and activate T cells but may also be antagonistic or induce immunosuppressive effects by activating regulatory T cells.", {"entities": []}], ["Autoimmunity in melanoma patients has been discussed controversially.", {"entities": [[16, 24, "DISEASE"]]}], ["We investigated 230 melanoma patients for the occurrence of CD28 antibodies and the effect of the latter on overall and progress-free survival.", {"entities": [[20, 28, "DISEASE"], [60, 64, "GENE"]]}], ["We constructed an ELISA assay to measure CD28 serum antibodies.", {"entities": [[41, 45, "GENE"]]}], ["230 patients with melanoma and a control-group of 625 patients consistent of 212 patients with virus hepatitis b or c, 149 patients with allergies, 78 patients with psoriasis, 46 patients with plasmocytoma and 140 healthy blood donors were investigated for the occurrence of CD28 antibodies.", {"entities": [[165, 174, "DISEASE"], [101, 112, "DISEASE"], [101, 110, "DISEASE"], [18, 26, "DISEASE"], [275, 279, "GENE"]]}], ["CD28 abs occur at a higher percentage in patients with melanoma and in patients with viral hepatitis than in other groups investigated (p<0.001).", {"entities": [[91, 100, "DISEASE"], [55, 63, "DISEASE"], [85, 100, "DISEASE"], [0, 4, "GENE"]]}], ["Occurrence of CD28 abs is significantly higher in patients receiving interferons independent from the underlying disease (p<0.001).", {"entities": [[14, 18, "GENE"]]}], ["In vitro CD28 serum antibodies have an inhibitory effect on the CD28 receptor as they lead to reduced stimulation of Jurkat cells.", {"entities": [[9, 13, "GENE"], [64, 68, "GENE"], [9, 13, "GENE"], [64, 68, "GENE"]]}], ["Presence of CD28 was correlated with a higher risk of dying from melanoma (p\u200a=\u200a0.043), but not with a significantly shortened overall survival or progression-free survival.", {"entities": [[65, 73, "DISEASE"], [12, 16, "GENE"]]}], ["Interferon therapy appears to induce the production of CD28 abs.", {"entities": [[55, 59, "GENE"]]}], ["In light of reports that these CD28 abs induce immunosuppressive Tregs and \u2013 as our data show \u2013 that they are inhibitors of CD28 receptor mediated stimulation, the continuation of therapies with interferons in melanoma patients developing CD28 antibodies should be critically reconsidered, since our data indicate a worse outcome of patients with CD28 abs.", {"entities": [[210, 218, "DISEASE"], [31, 35, "GENE"], [124, 128, "GENE"], [239, 243, "GENE"], [347, 351, "GENE"], [31, 35, "GENE"], [124, 128, "GENE"], [239, 243, "GENE"], [347, 351, "GENE"], [31, 35, "GENE"], [124, 128, "GENE"], [239, 243, "GENE"], [347, 351, "GENE"], [31, 35, "GENE"], [124, 128, "GENE"], [239, 243, "GENE"], [347, 351, "GENE"]]}], ["This report describes the epidemiology, burden, and treatment of osteoporosis in the 27 countries of the European Union (EU27).", {"entities": [[65, 77, "DISEASE"]]}], ["Osteoporosis is characterized by reduced bone mass and disruption of bone architecture, resulting in increased risk of fragility fractures which represent the main clinical consequence of the disease.", {"entities": [[0, 12, "DISEASE"]]}], ["Fragility fractures are associated with substantial pain and suffering, disability and even death for affected patients and substantial costs to society.", {"entities": []}], ["The aim of this report was to characterize the burden of osteoporosis in the EU27 in 2010 and beyond.", {"entities": [[57, 69, "DISEASE"]]}], ["The literature on fracture incidence and costs of fractures in the EU27 was reviewed and incorporated into a model estimating the clinical and economic burden of osteoporotic fractures in 2010.", {"entities": []}], ["Twenty-two million women and 5.5 million men were estimated to have osteoporosis; and 3.5 million new fragility fractures were sustained, comprising 610,000 hip fractures, 520,000 vertebral fractures, 560,000 forearm fractures and 1,800,000 other fractures (i.e.", {"entities": [[68, 80, "DISEASE"]]}], ["fractures of the pelvis, rib, humerus, tibia, fibula, clavicle, scapula, sternum and other femoral fractures).", {"entities": []}], ["The economic burden of incident and prior fragility fractures was estimated at \u20ac 37 billion.", {"entities": []}], ["Incident fractures represented 66\u00a0% of this cost, long-term fracture care 29\u00a0% and pharmacological prevention 5\u00a0%.", {"entities": []}], ["Previous and incident fractures also accounted for 1,180,000 quality-adjusted life years lost during 2010.", {"entities": []}], ["The costs are expected to increase by 25\u00a0% in 2025.", {"entities": []}], ["The majority of individuals who have sustained an osteoporosis-related fracture or who are at high risk of fracture are untreated and the number of patients on treatment is declining.", {"entities": [[50, 62, "DISEASE"]]}], ["In spite of the high social and economic cost of osteoporosis, a substantial treatment gap and projected increase of the economic burden driven by the aging populations, the use of pharmacological interventions to prevent fractures has decreased in recent years, suggesting that a change in healthcare policy is warranted.", {"entities": [[49, 61, "DISEASE"]]}], ["Leishmaniasis is a virulent parasitic infection that causes a worldwide disease burden.", {"entities": []}], ["Most treatments have toxic side-effects and efficacy has decreased due to the emergence of resistant strains.", {"entities": []}], ["The outlook is worsened by the absence of promising drug targets for this disease.", {"entities": []}], ["We have taken a computational approach to the detection of new drug targets, which may become an effective strategy for the discovery of new drugs for this tropical disease.", {"entities": []}], ["We have predicted the protein interaction network of Leishmania major by using three validated methods: PSIMAP, PEIMAP, and iPfam.", {"entities": []}], ["Combining the results from these methods, we calculated a high confidence network (confidence score > 0.70) with 1,366 nodes and 33,861 interactions.", {"entities": []}], ["We were able to predict the biological process for 263 interacting proteins by doing enrichment analysis of the clusters detected.", {"entities": []}], ["Analyzing the topology of the network with metrics such as connectivity and betweenness centrality, we detected 142 potential drug targets after homology filtering with the human proteome.", {"entities": []}], ["Further experiments can be done to validate these targets.", {"entities": []}], ["We have constructed the first protein interaction network of the Leishmania major parasite by using a computational approach.", {"entities": []}], ["The topological analysis of the protein network enabled us to identify a set of candidate proteins that may be both (1) essential for parasite survival and (2) without human orthologs.", {"entities": []}], ["These potential targets are promising for further experimental validation.", {"entities": []}], ["This strategy, if validated, may augment established drug discovery methodologies, for this and possibly other tropical diseases, with a relatively low additional investment of time and resources.", {"entities": []}], ["Although fungi have been implicated as initiating/deteriorating factors for allergic asthma, their contributing components have not been fully elucidated.", {"entities": [[76, 91, "DISEASE"], [85, 91, "DISEASE"]]}], ["We previously isolated soluble \u03b2-glucan from Candida albicans (CSBG) (Ohno et al., 2007).", {"entities": []}], ["In the present study, the effects of CSBG exposure on airway immunopathology in the presence or absence of other immunogenic allergen was investigated in vivo , and their cellular mechanisms were analyzed both in vivo and in vitro .", {"entities": []}], ["In vivo , ICR mice were divided into 4 experimental groups: vehicle, CSBG (25 \u03bcg/animal), ovalbumin (OVA: 2 \u03bcg/animal), and CSBG + OVA were repeatedly administered intratracheally.", {"entities": []}], ["The bronchoalveolar lavage cellular profile, lung histology, levels of cytokines and chemokines in the lung homogenates, the expression pattern of antigen-presenting cell (APC)-related molecules in the lung digests, and serum immunoglobulin values were studied.", {"entities": [[172, 175, "GENE"]]}], ["In vitro , the impacts of CSBG (0\u201312.5 \u03bcg/ml) on the phenotype and function of immune cells such as splenocytes and bone marrow-derived dendritic cells (BMDCs) were evaluated in terms of cell proliferation, the surface expression of APC-related molecules, and OVA-mediated T-cell proliferating activity.", {"entities": []}], ["In vivo , repeated pulmonary exposure to CSBG induced neutrophilic airway inflammation in the absence of OVA, and markedly exacerbated OVA-related eosinophilic airway inflammation with mucus metaplasia in mice, which was concomitant with the amplified lung expression of Th2 cytokines and IL-17A and chemokines related to allergic response.", {"entities": []}], ["Exposure to CSBG plus OVA increased the number of cells bearing MHC class II with or without CD80 in the lung compared to that of others.", {"entities": [[93, 97, "GENE"]]}], ["In vitro , CSBG significantly augmented splenocyte proliferation in the presence or absence of OVA.", {"entities": []}], ["Further, CSBG increased the expression of APC-related molecules such as CD80, CD86, and DEC205 on BMDCs and amplified OVA-mediated T-cell proliferation through BMDCs.", {"entities": [[72, 76, "GENE"], [78, 82, "GENE"]]}], ["CSBG potentiates allergic airway inflammation with maladaptive Th immunity, and this potentiation was associated with the enhanced activation of APCs including DC.", {"entities": [[145, 149, "GENE"]]}], ["Selected circulating microRNAs (miRNAs) have been suggested for non-invasive screening of non-small cell lung cancer (NSCLC), however the numerous proposed miRNA signatures are inconsistent.", {"entities": [[105, 116, "DISEASE"], [110, 116, "DISEASE"]]}], ["Aiming to identify miRNAs suitable specifically for stage I-II NSCLC screening in serum/plasma samples, we searched the databases \u201cPubmed\u201d, \u201cMedline\u201d, \u201cScopus\u201d, \u201cEmbase\u201d and \u201cWOS\u201d and systematically reviewed the publications reporting quantitative data on the efficacy [sensitivity, specificity and/or area under the curve (AUC)] of circulating miRNAs as biomarkers of NSCLC stage I and/or II.", {"entities": []}], ["The 20 studies fulfilling the search criteria included 1110 NSCLC patients and 1009 controls, and were of medium quality according to Quality Assessment of Diagnostic Accuracy Studies checklist.", {"entities": []}], ["In these studies, the patient cohorts as well as the control groups were heterogeneous for demographics and clinicopathological characteristics; moreover, numerous pre-analytical and analytical variables likely influenced miRNA determinations, and potential bias of hemolysis was often underestimated.", {"entities": []}], ["We identified four circulating miRNAs scarcely influenced by hemolysis, each featuring high sensitivity (> 80%) and AUC (> 0.80) as biomarkers of stage I-II NSCLC: miR-223, miR-20a, miR-448 and miR-145; four other miRNAs showed high specificity (> 90%): miR-628-3p, miR-29c, miR-210 and miR-1244.", {"entities": [[164, 171, "GENE"], [173, 180, "GENE"], [182, 189, "GENE"], [194, 201, "GENE"], [254, 264, "GENE"], [266, 273, "GENE"], [275, 282, "GENE"]]}], ["In a model of two-step screening for stage I-II NSCLC using first the above panel of serum miRNAs with high sensitivity and high AUC, and subsequently the panel with high specificity, the estimated overall sensitivity is 91.6% and overall specificity is 93.4%.", {"entities": []}], ["These and other circulating miRNAs suggested for stage I-II NSCLC screening require validation in multiple independent studies before they can be proposed for clinical application.", {"entities": []}], ["The effects of epicutaneous allergen administration on systemic immune responses in allergic and non-allergic individuals has not been investigated with defined allergen molecules.", {"entities": []}], ["We studied the effects of epicutaneous administration of rBet v 1 and rBet v 1 fragments on systemic immune responses in allergic and non-allergic subjects.", {"entities": []}], ["We conducted a clinical trial in which rBet v 1 and two hypoallergenic rBet v 1 fragments were applied epicutaneously by atopy patch testing (APT) to 15 birch pollen (bp) allergic patients suffering from atopic dermatitis, 5 bp-allergic patients suffering from rhinoconjunctivitis only, 5 patients with respiratory allergy without bp allergy and 5 non-allergic individuals.", {"entities": [[204, 221, "DISEASE"], [211, 221, "DISEASE"]]}], ["Epicutaneous administration of rBet v 1 and rBet v 1 fragments led to strong and significant increases of allergen-specific T cell proliferation (CLA+ and CCR4+T cell responses) only in bp-allergic patients with a positive APT reaction.", {"entities": []}], ["There were no relevant changes of Bet v 1-specific IgE and IgG responses.", {"entities": []}], ["No changes were noted in allergic subjects without bp allergy and in non-allergic subjects.", {"entities": []}], ["Epicutaneous allergen application boosts specific T cell but not antibody responses mainly in allergic, APT-positive patients suggesting IgE-facilitated allergen presentation as mechanism for its effects on systemic allergen-specific immune responses.", {"entities": []}], ["Numerous studies have reported weak but statistically significant acute health effects of particulate air pollution.", {"entities": []}], ["The associations are observed at levels below the current U.S. standard of 150 micrograms/m3 (24 hr).", {"entities": [[97, 99, "GENE"]]}], ["Health effects include acute increased mortality from cardiopulmonary conditions and acute morbidity such as hospital admissions for related diseases.", {"entities": []}], ["We reviewed recent epidemiology studies to evaluate whether criteria for causality are met, and we conclude that they are not.", {"entities": []}], ["The weak associations are as likely to be due to confounding by weather, copollutants, or exposure misclassification as by ambient particulate matter (PM).", {"entities": []}], ["The results from the same metropolitan areas are inconsistent, and PM explains such a small amount of the variability in mortality/morbidity that the association has little practical significance.", {"entities": []}], ["Finally, experimental chamber studies of susceptible individuals exposed to PM concentrations well above 150 micrograms/m3 provide no evidence to support the morbidity/mortality findings.", {"entities": []}], ["None of the criteria for establishing causality of the PM/mortality hypothesis are clearly met at ambient concentrations common in many U.S. cities.", {"entities": []}], ["In terms of scientific activities generally and ethnobiological pursuits in particular, North Korea, officially known as the Democratic People\u2019s Republic of Korea, is an almost blank entity on the quilt of global research.", {"entities": []}], ["During a sabbatical semester at Pyongyang University of Science and Technology the author used this opportunity to gather some information on the uses of insect and other terrestrial arthropods as human food and components of traditional healing methods in that country.", {"entities": []}], ["Despite the widely publicised shortcomings in the supply of food stuffs to the population of North Korea, insects are not generally seen as a source of food worthy of exploitation.", {"entities": []}], ["However, the therapeutic use of insects, centipedes and scorpions to treat illnesses as diverse as the common cold, skin rashes, constipation, dysentery, nervous prostration, whooping cough, osteomyelitis, tetanus, and various forms of cancer is apparently still popular.", {"entities": [[129, 141, "DISEASE"], [206, 213, "DISEASE"], [191, 204, "DISEASE"], [103, 114, "DISEASE"], [143, 152, "DISEASE"], [236, 242, "DISEASE"]]}], ["The arthropods used therapeutically are credited with anti-inflammatory, immunological and other health-promoting effects, because they are said to contain hormones, steroids, lipids and plant-derived alkaloids, all of which capable of exerting their effects on the human body.", {"entities": []}], ["The harmful effects of secondhand smoke are convincing more and more communities across the United States and the world to prohibit smoking in public places, especially in eating and drinking establishments.", {"entities": []}], ["A 1993 Missouri state law allows smoking in designated areas in indoor public places such as restaurants and bars.", {"entities": []}], ["Consequently, some Missouri communities have adopted local ordinances that prohibit smoking in all indoor workplaces, including restaurants and bars.", {"entities": []}], ["We used an objective measure of economic activity, the taxable sales revenues of eating and drinking establishments, to empirically examine the economic effect of smoke-free ordinances.", {"entities": []}], ["We studied the economic effect of smoke-free ordinances in 11 Missouri cities using multivariate log-linear regression models with log-transformed taxable sales revenues of eating and drinking establishments as the dependent variable and the smoke-free ordinance as the independent variable, while controlling for seasonality, economic condition and unemployment.", {"entities": []}], ["We used data from 20 quarters before the smoke-free ordinances and at least 10 quarters after the smoke-free ordinances for all cities.", {"entities": []}], ["The null hypothesis of no effect of smoke-free ordinance on taxable sales of the eating and drinking establishments was tested.", {"entities": []}], ["Eight of the 11 cities had increased taxable sales for eating and drinking establishments postordinance.", {"entities": []}], ["The remaining 3 experienced no change.", {"entities": []}], ["The findings of our study are consistent with findings from most published economic studies that a smoke-free ordinance does not harm a local economy.", {"entities": []}], ["Breathlessness is a debilitating and distressing symptom in a wide variety of diseases and still a difficult symptom to manage.", {"entities": []}], ["An integrative review of systematic reviews of non-pharmacological and pharmacological interventions for breathlessness in non-malignant disease was undertaken to identify the current state of clinical understanding of the management of breathlessness and highlight promising interventions that merit further investigation.", {"entities": []}], ["Systematic reviews were identified via electronic databases between July 2007 and September 2009.", {"entities": []}], ["Reviews were included within the study if they reported research on adult participants using either a measure of breathlessness or some other measure of respiratory symptoms.", {"entities": []}], ["In total 219 systematic reviews were identified and 153 included within the final review, of these 59 addressed non-pharmacological interventions and 94 addressed pharmacological interventions.", {"entities": []}], ["The reviews covered in excess of 2000 trials.", {"entities": []}], ["The majority of systematic reviews were conducted on interventions for asthma and COPD, and mainly focussed upon a small number of pharmacological interventions such as corticosteroids and bronchodilators, including beta-agonists.", {"entities": [[71, 77, "DISEASE"]]}], ["In contrast, other conditions involving breathlessness have received little or no attention and studies continue to focus upon pharmacological approaches.", {"entities": []}], ["Moreover, although there are a number of non-pharmacological studies that have shown some promise, particularly for COPD, their conclusions are limited by a lack of good quality evidence from RCTs, small sample sizes and limited replication.", {"entities": []}], ["More research should focus in the future on the management of breathlessness in respiratory diseases other than asthma and COPD.", {"entities": [[112, 118, "DISEASE"]]}], ["In addition, pharmacological treatments do not completely manage breathlessness and have an added burden of side effects.", {"entities": []}], ["It is therefore important to focus more research on promising non-pharmacological interventions.", {"entities": []}], ["Acute minor ischemic stroke (AMIS) or transient ischemic attack (TIA) is a common cerebrovascular event with a considerable high recurrence.", {"entities": []}], ["Prior research demonstrated the effectiveness of regular long-term remote ischemic conditioning (RIC) in secondary stroke prevention in patients with intracranial stenosis.", {"entities": []}], ["We hypothesized that RIC can serve as an effective adjunctive therapy to pharmacotherapy in preventing ischemic events in patients with AMIS/TIA.", {"entities": []}], ["This study aimed to investigate the feasibility, safety, and preliminary efficacy of daily RIC in inhibiting cerebrovascular/cardiovascular events after AMIS/TIA.", {"entities": []}], ["This is a single-arm, open-label, multicenter Phase IIa futility study with a sample size of 165.", {"entities": []}], ["Patients with AMIS/TIA receive RIC as an additional therapy to secondary stroke prevention regimen.", {"entities": []}], ["RIC consists of five cycles of 5-min inflation (200 mmHg) and 5-min deflation of cuffs on bilateral upper limbs twice a day for 90 days.", {"entities": []}], ["The antiplatelet strategy is based on individual physician's best practice: aspirin alone, clopidogrel alone, or combination of aspirin and clopidogrel.", {"entities": []}], ["We will assess the recurrence rate of ischemic stroke/TIA within 3 months as the primary outcomes.", {"entities": []}], ["The data gathered from the study will be used to determine whether a further large-scale, multicenter randomized controlled Phase II trial is warranted in patients with AMIS/TIA.", {"entities": []}], ["ClinicalTrials.gov, NCT03004820; https://www.clinicaltrials.gov/ct2/show/NCT03004820 .", {"entities": []}], ["Proximity to a park does not necessarily imply access or use, and the social environment may positively or negatively influence the positive intentions of the built environment.", {"entities": []}], ["To investigate parks, park use and physical activity, and their associations with exposure to community violence, we interviewed residents ( n = 354) of a densely populated urban community.", {"entities": []}], ["Our findings indicate that proximity to any park is not associated with physical activity.", {"entities": []}], ["However, proximity to the preferred park reported by residents to be conducive for physical activity (with walking paths, large fields, playgrounds for children and tennis courts) was associated with physical activity.", {"entities": []}], ["Conversely, knowledge of sexual assault or rape in the neighborhood is inversely associated with every type of physical activity (park-based, outdoor, and indoor).", {"entities": []}], ["Our findings suggest that improvements to the built environment (parks, green spaces) may be hindered by adverse social environments and both are necessary for consideration in the design of public health interventions.", {"entities": []}], ["Diet has been speculated to be a factor in the pathogenesis of inflammatory bowel disease and may be an important factor in managing disease symptoms.", {"entities": [[63, 89, "DISEASE"]]}], ["Patients manipulate their diet in attempt to control symptoms, often leading to the adoption of inappropriately restrictive diets, which places them at risk for nutritional complications.", {"entities": []}], ["Health professionals struggle to provide evidence-based nutrition guidance to patients due to an overall lack of uniformity or clarity amongst research studies.", {"entities": []}], ["Well-designed diet studies are urgently needed to create an enhanced understanding of the role diet plays in the management of inflammatory bowel disease.", {"entities": [[127, 153, "DISEASE"]]}], ["The aim of this review is to summarize the current data available on dietary management of inflammatory bowel disease and to demonstrate that dietary modulation may be an important consideration in managing disease.", {"entities": [[91, 117, "DISEASE"]]}], ["By addressing the relevance of diet in inflammatory bowel disease, health professionals are able to better support patients and collaborate with dietitians to improve nutrition therapy.", {"entities": [[39, 65, "DISEASE"]]}], ["Nesfatin-1 is involved in cardiovascular regulation, stress-related responses.", {"entities": []}], ["The objective of this study is to investigate the impact of volatile anesthetics on Nesfatin-1 levels.", {"entities": []}], ["Fourty-two patients aged 30\u201365\u00a0years with the American Society Anesthesiology (ASA) Class I-II who were scheduled for laparoscopic cholecystectomy were included in the study Patients were randomized into two group; desflurane administered group (Group I, n \u00a0=\u200921) and sevoflurane administered group (Group II, n\u2009=\u200921).", {"entities": []}], ["For anesthesia maintenance, the patients received 6% desflurane or 2% sevoflurane in 40% O2 and 60% air.", {"entities": []}], ["The patient\u2019s heart rate (HR), mean, systolic and diastolic arterial pressures (MAP, SAP, DAP), peripheral O2 saturation (SpO2) were monitored and recorded before induction, after induction, after intubation, and during extubation.", {"entities": [[26, 28, "GENE"]]}], ["Blood samples were collected before induction (T1), and after extubation when aldrete score was 10 (T2).", {"entities": []}], ["Demographic data were similar between the groups.", {"entities": []}], ["The preoperative levels of nesfatin were similar in the two groups ( p \u2009=\u20090.715).", {"entities": []}], ["In desflurane group, post-operative nesfatin levels were similar compared to preoperative levels ( p \u2009=\u20090.073).", {"entities": []}], ["In sevoflurane group, post-operative nesfatin levels were similar ( p \u2009=\u20090.131).", {"entities": []}], ["The nesfatin levels (postoperative vs preoperative) were similar between the groups ( p \u2009=\u20090.900).", {"entities": []}], ["In conclusion, this study results suggest that nesfatin-1 levels are not affected by the use of sevoflurane or desflurane in patients undergoing laparoscopic cholecystectomy.", {"entities": []}], ["Australian New Zealand Clinical Trials Registry, ACTRN12617001023347 , retrospectively registered on 17 July 2017.", {"entities": []}], ["Infections have been and remain the major cause of morbidity and mortality after lung transplantation.", {"entities": []}], ["Because mucociliary clearance plays an important role in human defense mechanisms, the influence of drugs on the mucociliary epithelium of patients undergoing lung transplantation must be examined.", {"entities": []}], ["Prednisone is the most important corticosteroid used after lung transplantation.", {"entities": []}], ["The aim of this study was to evaluate the effects of bronchial transection and prednisone therapy on mucociliary clearance.", {"entities": []}], ["A total of 120 rats were assigned to 4 groups according to surgical procedure or drug therapy: prednisone therapy (1.25 mg/kg/day); bronchial section and anastomosis + prednisone therapy (1.25 mg/kg/day); bronchial section + saline solution (2 ml/day); and saline solution (2 ml/day).", {"entities": []}], ["After 7, 15, or 30 days, the animals were sacrificed, and the lungs were removed from the thoracic cavity.", {"entities": []}], ["The in situ mucociliary transport velocity, ciliary beat frequency and in vitro mucus transportability were evaluated.", {"entities": []}], ["Animals undergoing bronchial section surgery and anastomosis had a significant decrease in the ciliary beat frequency and mucociliary transport velocity 7 and 15 days after surgery ( p <0.001).", {"entities": []}], ["These parameters were normalized 30 days after the surgical procedure.", {"entities": []}], ["Prednisone improved mucous transportability in the animals undergoing bronchial section and anastomosis at 15 and 30 days ( p <0.05).", {"entities": []}], ["Bronchial section and anastomosis decrease mucociliary clearance in the early postoperative period.", {"entities": []}], ["Prednisone therapy improves mucus transportability in animals undergoing bronchial section and anastomosis.", {"entities": []}], ["The association between hygiene and prevalence of autoimmune disease has been attributed in part to enteric helminth infection.", {"entities": []}], ["A pilot study of experimental infection with the hookworm Necator americanus was undertaken among a group of otherwise healthy people with celiac disease to test the potential of the helminth to suppress the immunopathology induced by gluten.", {"entities": [[139, 153, "DISEASE"]]}], ["In a 21-week, double-blinded, placebo-controlled study, we explored the effects of N. americanus infection in 20 healthy, helminth-na\u00efve adults with celiac disease well controlled by diet.", {"entities": [[149, 163, "DISEASE"]]}], ["Staged cutaneous inoculations with 10 and 5 infective 3 Enteric colonisation with hookworm established in all 10 cases, resulting in transiently painful enteritis in 5.", {"entities": []}], ["Chronic infection was asymptomatic, with no effect on hemoglobin levels.", {"entities": []}], ["Although some duodenal eosinophilia was apparent, hookworm-infected mucosa retained a healthy appearance.", {"entities": [[23, 35, "DISEASE"]]}], ["In both groups, wheat challenge caused deterioration in both primary and several secondary outcomes.", {"entities": []}], ["Experimental N. americanus infection proved to be safe and enabled testing its effect on a range of measures of the human autoimmune response.", {"entities": []}], ["Infection imposed no obvious benefit on pathology.", {"entities": []}], ["ClinicalTrials.gov NCT00671138", {"entities": []}], ["In everyday clinical practice, almost all physicians come across many instances of suspected adverse cutaneous drug reactions (ACDR) in different forms.", {"entities": []}], ["Although such cutaneous reactions are common, comprehensive information regarding their incidence, severity and ultimate health effects are often not available as many cases go unreported.", {"entities": []}], ["It is also a fact that in the present world, almost everyday a new drug enters market; therefore, a chance of a new drug reaction manifesting somewhere in some form in any corner of world is unknown or unreported.", {"entities": []}], ["Although many a times, presentation is too trivial and benign, the early identification of the condition and identifying the culprit drug and omit it at earliest holds the keystone in management and prevention of a more severe drug rash.", {"entities": []}], ["Therefore, not only the dermatologists, but all practicing physicians should be familiar with these conditions to diagnose them early and to be prepared to handle them adequately.", {"entities": []}], ["However, we all know it is most challenging and practically difficult when patient is on multiple medicines because of myriad clinical symptoms, poorly understood multiple mechanisms of drug-host interaction, relative paucity of laboratory testing that is available for any definitive and confirmatory drug-specific testing.", {"entities": []}], ["Therefore, in practice, the diagnosis of ACDR is purely based on clinical judgment.", {"entities": []}], ["In this discussion, we will be primarily focusing on pathomechanism and approach to reach a diagnosis, which is the vital pillar to manage any case of ACDR.", {"entities": []}], ["Recently, we have highlighted the immunomodulatory activity of the standardized extracts of Phyllanthus amarus and P. urinaria.", {"entities": []}], ["The present study was carried out to correlate between the prevalent constituents of the herbs and their inhibitory effects on phagocytic activity of human neutrophils.", {"entities": []}], ["The compounds, gallic acid, ellagic acid, corilagin, geraniin, phyllanthin and hypophyllanthin were identified and quantitatively analyzed in the extracts of Phyllanthus amarus and P. urinaria obtained from Malaysia and Indonesia by using a validated reversed phase high performance liquid chromatography (RP-HPLC) method.", {"entities": []}], ["The standardized extracts and the pure compounds were evaluated for their effects on chemotaxis, \u03b22 integrin (CD18) expression, phagocytosis and chemiluminescence of human phagocytes.", {"entities": []}], ["Chemotactic activity was assessed using the Boyden chamber technique, inhibition of CD18 expression and phagocytic ability were tested with the aid of flow cytometry, while effect on the respiratory burst was investigated using a luminol-based chemiluminescence assay.", {"entities": []}], ["All plant extracts strongly inhibited migration of the phagocytes with the Malaysian P. amarus depicting the highest inhibitory activity.", {"entities": []}], ["Amongst the compounds tested, geraniin demonstrated the strongest inhibitory activity on chemotaxis of polymorphonuclear leukocytes (PMNs) and monocytes with IC 50 values of 1.09 and 1.69\u00a0\u03bcM, respectively, which were lower than that of ibuprofen.", {"entities": []}], ["All plant extracts and pure compounds exhibited high inhibitory activity on the oxidative burst of zymosan and PMA stimulated leukocytes.", {"entities": []}], ["Geraniin and corilagin exhibited exceptionally strong inhibition on the reactive oxygen species (ROS) activity with IC 50 values lower than aspirin.", {"entities": []}], ["The plant extracts exhibited moderate inhibition of E. coli uptake by monocytes but weak effect on PMNs.", {"entities": []}], ["Of all the compounds, phyllanthin at 50\u00a0\u03bcg/mL exhibited the highest engulfment inhibitory activity with percentage of phagocytizing cells of 14.2 and 27.1% for PMNs and monocytes, respectively.", {"entities": []}], ["All plants and compounds tested possessed weak effect on CD18 expression on leukocytes except for hypophyllanthin and phyllanthin which exhibited significant inhibitory effect.", {"entities": []}], ["The strong inhibition of the extracts on the phagocytic activity of neutrophils was due to the presence of their major constituents especially geraniin, corilagin, phyllanthin and hypophllanthin which were able to modulate the innate response of phagocytes at different steps.", {"entities": []}], ["Korematsu S, Yamamoto K, Nagakura T, Miyahara H, Okazaki N, Akiyoshi K, Maeda T, Suenobu S-i, Izumi T. The indication and effectiveness of low-dose erythromycin therapy in pediatric patients with bronchial asthma.", {"entities": [[206, 212, "DISEASE"]]}], ["Pediatr Allergy Immunol 2010: 21: 489\u2013492.", {"entities": []}], ["\u00a9 2010 John Wiley & Sons A/S To elucidate the mechanisms of intractable pediatric bronchial asthma and the indication of low-dose erythromycin (EM) therapy, the serum chemokine levels of and the angiogenic factor were evaluated in 55 pediatric patients with bronchial asthma; 7.4 \u00b1 3.5 yr old, who had been treated with inhaled steroid, leukotriene receptor antagonist, theophylline and others for more than a year.", {"entities": [[92, 98, "DISEASE"], [268, 274, "DISEASE"]]}], ["Both the levels of interleukin (IL) 8 (p = 0.036) and vascular endothelial growth factor (VEGF) (p = 0.005) were higher in patients with severe type than those of patients with the milder type, while other chemokine levels such as serum eotaxin and MCP1 did not show the correlation with the severity of bronchial asthma.", {"entities": [[314, 320, "DISEASE"]]}], ["Induction of therapy with low-dose EM induced improvement of the clinical symptoms in patients with severe type and decrease of their serum chemokine levels: IL8; from 736 \u00b1 88 to 75 \u00b1 85 pg/ml (p < 0.0005), and VEGF; from 352.0 \u00b1 160.5 to 132.2 \u00b1 59.9 pg/ml (p = 0.021) within the next 6 months.", {"entities": [[158, 161, "GENE"]]}], ["Moreover, low-dose EM resulted in a decreased daily peak-trough fluctuation rate of the serum theophylline concentration; ( C max \u2212 C min )/ C min , from 1.3 \u00b1 0.5 to 0.5 \u00b1 0.3, which led to the maintenance of effective serum levels.", {"entities": [[126, 129, "GENE"]]}], ["These results indicated that IL8 and VEGF affect the severity of standard therapies resistance intractable bronchial asthma.", {"entities": [[117, 123, "DISEASE"], [29, 32, "GENE"]]}], ["Through the suppression of these chemokines and maintenance of effective theophylline levels, low-dose EM therapy improves the symptoms of bronchial asthma.", {"entities": [[149, 155, "DISEASE"]]}], ["Chair based exercise (CBE) is suggested to engage older people with compromised health and mobility in an accessible form of exercise.", {"entities": []}], ["A systematic review looking at the benefits of CBE for older people identified a lack of clarity regarding a definition, delivery, purpose and benefits.", {"entities": []}], ["This study aimed to utilise expert consensus to define CBE for older people and develop a core set of principles to guide practice and future research.", {"entities": []}], ["The framework for consensus was constructed through a team workshop identifying 42 statements within 7 domains.", {"entities": []}], ["A four round electronic Delphi study with multi-disciplinary health care experts was undertaken.", {"entities": []}], ["Statements were rated using a 5 point Likert scale of agreement and free text responses.", {"entities": []}], ["A threshold of 70% agreement was used to determine consensus.", {"entities": []}], ["Free text responses were analysed thematically.", {"entities": []}], ["Between rounds a number of strategies (e.g., amended wording of statements, generation and removal of statements) were used to move towards consensus.", {"entities": []}], ["16 experts agreed on 46 statements over four rounds of consultation (Round 1: 22 accepted, 3 removed, 5 new and 17 modified; Round 2: 16 accepted, 0 removed, 4 new and 6 modified; Round 3: 4 accepted, 2 removed, 0 new and 4 modified; Round 4: 4 accepted, 0 removed, 0 new, 0 modified).", {"entities": []}], ["Statements were accepted in all seven domains: the definition of CBE (5), intended users (3), potential benefits (8), structure (12), format (8), risk management (7) and evaluation (3).", {"entities": []}], ["The agreed definition of CBE had five components: 1.", {"entities": []}], ["CBE is primarily a seated exercise programme; 2.", {"entities": []}], ["The purpose of using a chair is to promote stability in both sitting and standing; 3.", {"entities": []}], ["CBE should be considered as part of a continuum of exercise for frail older people where progression is encouraged; 4.", {"entities": []}], ["CBE should be used flexibly to respond to the changing needs of frail older people; and 5.", {"entities": []}], ["Where possible CBE should be used as a starting point to progress to standing programmes.", {"entities": []}], ["Consensus has been reached on a definition and a set of principles governing CBE for older people; this provides clarity for implementation and future research about CBE.", {"entities": []}], ["Worldwide, lung cancer kills more people than breast, colon and prostate cancer combined.", {"entities": [[11, 22, "DISEASE"], [16, 22, "DISEASE"], [73, 79, "DISEASE"], [64, 79, "DISEASE"]]}], ["Alterations in macrophage number and function during lung tumorigenesis suggest that these immune effector cells stimulate lung cancer growth.", {"entities": [[123, 134, "DISEASE"], [128, 134, "DISEASE"]]}], ["Evidence from cancer models in other tissues suggests that cancer cells actively recruit growth factor-producing macrophages through a reciprocal signaling pathway.", {"entities": [[14, 20, "DISEASE"], [59, 65, "DISEASE"]]}], ["While the levels of lung macrophages increase during tumor progression in mouse models of lung cancer, and high pulmonary macrophage content correlates with a poor prognosis in human non-small cell lung cancer, the specific role of alveolar macrophages in lung tumorigenesis is not clear.", {"entities": [[90, 101, "DISEASE"], [198, 209, "DISEASE"], [95, 101, "DISEASE"], [203, 209, "DISEASE"]]}], ["After culturing either an immortalized lung macrophage cell line or primary murine alveolar macrophages from na\u00efve and lung-tumor bearing mice with primary tumor isolates and immortalized cell lines, the effects on epithelial proliferation and cellular kinase activation were determined.", {"entities": []}], ["Insulin-like growth factor-1 (IGF-1) was quantified by ELISA, and macrophage conditioned media IGF-1 levels manipulated by IL-4 treatment, immuno-depletion and siRNA transfection.", {"entities": []}], ["Primary macrophages from both na\u00efve and lung-tumor bearing mice stimulated epithelial cell proliferation.", {"entities": []}], ["The lungs of tumor-bearing mice contained 3.5-times more IGF-1 than na\u00efve littermates, and media conditioned by freshly isolated tumor-educated macrophages contained more IGF-1 than media conditioned by na\u00efve macrophages; IL-4 stimulated IGF-1 production by both macrophage subsets.", {"entities": []}], ["The ability of macrophage conditioned media to stimulate neoplastic proliferation correlated with media IGF-1 levels, and recombinant IGF-1 alone was sufficient to induce epithelial proliferation in all cell lines evaluated.", {"entities": []}], ["Macrophage-conditioned media and IGF-1 stimulated lung tumor cell growth in an additive manner, while EGF had no effect.", {"entities": [[102, 105, "GENE"]]}], ["Macrophage-derived factors increased p-Erk1/2, p-Akt and cyclin D1 levels in neoplastic cells, and the combined inhibition of both MEK and PI3K ablated macrophage-mediated increases in epithelial growth.", {"entities": []}], ["Macrophages produce IGF-1 which directly stimulates neoplastic proliferation through Erk and Akt activation.", {"entities": []}], ["This observation suggests that combining macrophage ablation therapy with IGF-1R, MEK and/or PI3K inhibition could improve therapeutic response in human lung cancer.", {"entities": [[153, 164, "DISEASE"], [158, 164, "DISEASE"]]}], ["Exploring macrophage-based intervention could be a fruitful avenue for future research.", {"entities": []}], ["To investigate the efficacy and safety of emergency endoscopic retrograde cholangiopancreatography (ERCP) in elderly patients with acute cholangitis.", {"entities": [[137, 148, "DISEASE"], [131, 148, "DISEASE"]]}], ["From June 2008 to May 2016, emergency ERCPs were performed in 207 cases of acute cholangitis at our institution.", {"entities": [[81, 92, "DISEASE"], [75, 92, "DISEASE"]]}], ["Patients were classified as elderly if they were aged 80 years and older ( n = 102); controls were under the age of 80 years ( n = 105).", {"entities": []}], ["The patients\u2019 medical records were retrospectively reviewed for comorbidities, laboratory data, etiology of cholangitis (presence of biliary stones, biliary stricture and malignancy), details of the ERCP (therapeutic approaches, technical success rates, procedure duration), ERCP-related complications and mortality.", {"entities": [[108, 119, "DISEASE"]]}], ["The frequency of comorbidities was higher in the elderly group than the control group (91.2% vs 67.6%).", {"entities": []}], ["Periampullary diverticulum was observed in the elderly group at a higher frequency than the control group (24.5% vs 13.3%).", {"entities": []}], ["Between the groups, there was no significant difference in the technical success rates (95.1% vs 95.2%) or endoscopic procedure durations.", {"entities": []}], ["With regard to the frequency of ERCP-related complications, there was no significant difference between the two groups (6.9% vs 6.7%), except for a lower rate of post-ERCP pancreatitis in the elderly group than in the control group (1.0% vs 3.8%).", {"entities": [[172, 184, "DISEASE"]]}], ["Neither angiographic nor surgical intervention was required in any of the cases with ERCP-related complications.", {"entities": []}], ["There was no mortality during the observational periods.", {"entities": []}], ["Emergency ERCP for acute cholangitis can be performed safely even in elderly patients aged 80 years and older.", {"entities": [[25, 36, "DISEASE"], [19, 36, "DISEASE"]]}], ["Genome-wide association studies are useful for discovering genotype\u2013phenotype associations but are limited because they require large cohorts to identify a signal, which can be population-specific.", {"entities": []}], ["Mapping genetic variation to genes improves power and allows the effects of both protein-coding variation as well as variation in expression to be combined into \u201cgene level\u201d effects.", {"entities": []}], ["Previous work has shown that warfarin dose can be predicted using information from genetic variation that affects protein-coding regions.", {"entities": []}], ["Here, we introduce a method that improves dose prediction by integrating tissue-specific gene expression.", {"entities": []}], ["In particular, we use drug pathways and expression quantitative trait loci knowledge to impute gene expression\u2014on the assumption that differential expression of key pathway genes may impact dose requirement.", {"entities": []}], ["We focus on 116 genes from the pharmacokinetic and pharmacodynamic pathways of warfarin within training and validation sets comprising both European and African-descent individuals.", {"entities": []}], ["We build gene-tissue signatures associated with warfarin dose in a cohort-specific manner and identify a signature of 11 gene-tissue pairs that significantly augments the International Warfarin Pharmacogenetics Consortium dosage-prediction algorithm in both populations.", {"entities": []}], ["Our results demonstrate that imputed expression can improve dose prediction and bridge population-specific compositions.", {"entities": []}], ["MATLAB code is available at https://github.com/assafgo/warfarin-cohort The online version of this article (doi:10.1186/s13073-017-0495-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Children with sleep-disordered breathing (SDB) are at risk of developing post-operative respiratory complications following adenotonsillectomy (T&A).", {"entities": []}], ["Our goal was to describe and quantify these complications following T&A in children with clinical SDB but with a pre-operative overnight home oximetry score of \u201cnormal/inconclusive\u201d (McGill Oximetry Score (MOS) of 1), and to determine whether these children could safely undergo surgery in peripheral hospitals or outpatient surgical centers.", {"entities": []}], ["We performed a retrospective chart review of patients 3 years and older who had T&A between 2003 and 2010 at 2 of our institution\u2019s hospitals.", {"entities": []}], ["To be included in the study, in addition to not having severe comorbidities, children had to have undergone an overnight home oximetry within 12 months of surgery that was normal or inconclusive (MOS of 1).", {"entities": []}], ["This was defined as fewer than 3 episodes of oxygen desaturation below 90% and stable baseline saturation over 95%.", {"entities": []}], ["Medical charts were reviewed for major and minor postoperative respiratory complications.", {"entities": []}], ["The main outcome measure was post-T&A respiratory complications.", {"entities": []}], ["Out of 2708 T&A patients, 231 met the inclusion criteria.", {"entities": []}], ["No patient had a major postoperative respiratory complication requiring re-intubation or admission to the intensive care unit.", {"entities": []}], ["Five patients (2.16%) had minor respiratory complications but only one required admission to the ward.", {"entities": []}], ["An overnight home oximetry that is \u201cnormal/inconclusive\u201d (MOS of 1) can be used as a screening tool to identify patients with sleep-disordered breathing who can be safely sent to peripheral hospitals or outpatient surgical centers for T&A.", {"entities": []}], ["Generalized anxiety disorder (GAD) is a chronic and highly prevalent disorder associated with increased disability and mortality in the elderly.", {"entities": [[12, 28, "DISEASE"]]}], ["Treatment is difficult with low rate of full remission, thus highlighting the need to identify early predictors for prevention in elderly people.", {"entities": []}], ["The aim of this study is to identify and characterize incident GAD predictors in elderly people.", {"entities": []}], ["A total of 1711 individuals aged 65 years and above and free of GAD at baseline were randomly recruited from electoral rolls between 1999 and 2001 (the prospective ESPRIT study).", {"entities": []}], ["The participants were examined at baseline and five times over 12 years.", {"entities": []}], ["GAD and psychiatric comorbidity were diagnosed with a standardized psychiatric examination, the Mini-International Neuropsychiatry Interview on the basis of DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, fourth edition) criteria and validated by a clinical panel.", {"entities": []}], ["During the follow-up, 8.4% (95% confidence interval=7.1\u20139.7%) of the participants experienced incident GAD, 80% being first episodes; the incident rate being 10 per 1000 person-years.", {"entities": []}], ["The principal predictors of late-onset incident GAD over 12 years derived from a multivariate Cox model were being female, recent adverse life events, having chronic physical (respiratory disorders, arrhythmia and heart failure, dyslipidemia, cognitive impairment) and mental (depression, phobia and past GAD) health disorders.", {"entities": []}], ["Poverty, parental loss or separation and low affective support during childhood, as well as history of mental problems in parents were also significantly and independently associated with incident GAD.", {"entities": []}], ["GAD appears as a multifactorial stress-related affective disorder resulting from both proximal and distal risk factors, some of them being potentially modifiable by health care intervention.", {"entities": []}], ["Clinical guidelines recommend long-acting bronchodilators as first maintenance therapy for chronic obstructive pulmonary disease (COPD), with inhaled corticosteroids (ICS) reserved for patients with more severe disease and exacerbations.", {"entities": [[91, 128, "DISEASE"]]}], ["The aim of this analysis was to examine real-life prescribing of first maintenance therapy for COPD in the UK.", {"entities": []}], ["Data were extracted from the UK Optimum Patient Care Research Database for patients with a first prescription for COPD maintenance therapy between 2009 and 2012 and a diagnosis of COPD at or before the date of the first prescription for COPD maintenance therapy.", {"entities": []}], ["Routine clinical data including demographics, disease history and symptoms, comorbidities, therapy, hospitalisation rate and exacerbation rate were collected and used to characterise patients stratified by disease severity and Global Initiative for Chronic Obstructive Lung Disease (GOLD) group (A\u2013D).", {"entities": []}], ["The analysis population included 2,217 individuals (55.4% male, 45.2% smokers).", {"entities": []}], ["Long-acting muscarinic antagonists (LAMA) as monotherapy were prescribed as first maintenance therapy for 40.2% of patients.", {"entities": []}], ["ICS were prescribed as ICS/long-acting beta-agonists combination for 29.1% of patients or as monotherapy for 15.5%.", {"entities": []}], ["ICS (alone or in combination) were prescribed to >40% of patients in each GOLD group.", {"entities": []}], ["ICS-containing regimens were prescribed to patients with a history of pneumonia and comorbid conditions for whom the risks of ICS therapy may outweigh the benefits.", {"entities": [[70, 79, "DISEASE"]]}], ["The clinical reality of prescribing indicates that ICS are often prescribed outside current guideline recommendations for many patients newly diagnosed with COPD in the UK.", {"entities": []}], ["Encouragingly, LAMAs are increasingly being prescribed as first maintenance therapy for these patients.", {"entities": []}], ["Diabetes is one of the most common diseases in the nation.", {"entities": []}], ["Students with diabetes face the daily task of balancing food, physical activity, and medication to survive.", {"entities": []}], ["Teachers and school personnel often lack the knowledge needed to assist them.", {"entities": []}], ["An estimated 2647 schoolchildren in Wisconsin have diabetes.", {"entities": []}], ["The Wisconsin Diabetes Prevention and Control Program frequently receives anecdotal reports from parents and diabetes educators on the care of children with diabetes in the schools; the program also manages requests for information on new diabetes-related equipment from school personnel.", {"entities": []}], ["A statewide workgroup convened to develop Children with Diabetes: A Resource Guide for Wisconsin Schools and Families, aimed at improving the school staff's knowledge of diabetes and its management and their awareness of the benefits of maintaining glucose control.", {"entities": []}], ["Training sessions for school professionals were developed and conducted around the state.", {"entities": []}], ["All attendees were asked to complete an evaluation of the training.", {"entities": []}], ["In addition, the workgroup included an evaluation form with each guide distributed and conducted a follow-up survey on the impact of the guide and changes to school policies.", {"entities": []}], ["Of the 762 people who attended training sessions, 631 (83%) completed the evaluation form.", {"entities": []}], ["On questions about the training session's content, quality, organization, and appropriateness, responses averaged 4.42 points on a scale of 1 (poor) to 5 (excellent).", {"entities": []}], ["More than 9713 resource guides were distributed to more than 1359 individuals; 58 recipients responded to the evaluation form included with the resource guide, with 57 (98%) of these indicating that they would recommend the guide to others.", {"entities": []}], ["Preliminary results of the follow-up impact survey show that many positive changes have been implemented to improve the school environment for children with diabetes since the resource guide was implemented.", {"entities": []}], ["This model of working with school professionals, health care practitioners, parents, and community organizations to create a resource guide with accompanying training sessions can be used in other states to accomplish similar goals of increasing knowledge about diabetes and improving social and policy environments.", {"entities": []}], ["To examine impressions of public healthcare providers/professionals (PHCPs) who are working closely with family medicine specialists (FMSs) at public health clinics.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["This study is part of a larger national study on the perception of Malaysian public healthcare professionals on FMSs (PERMFAMS).", {"entities": []}], ["PHCPs from three categories of health facility: hospitals, health clinics and health offices.", {"entities": []}], ["Qualitative analyses of written comments of respondents\u2019 general impression of FMSs.", {"entities": []}], ["The participants\u2019 response rate was 58.0% (780/1345), with almost equal proportions from each public healthcare facility.", {"entities": []}], ["A total of 23 categories for each of the 648 impression comments were identified.", {"entities": []}], ["The six emerging themes were: (1) importance of FMSs; (2) roles of FMSs; (3) clinical performance of FMSs; (4) attributes of FMSs; (5) FMS practice challenges; (6) misconception of FMS roles.", {"entities": []}], ["Overall, FMS practice was perceived to be safe and able to provide effective treatments in a challenging medical discipline that was in line with the current standards of medical care and ethical and professional values.", {"entities": []}], ["The areas of concern were in clinical performance expressed by PHCPs from some hospitals and the lack of personal attributes and professionalism among FMSs mentioned by PHCPs from health clinics and offices.", {"entities": []}], ["FMSs were perceived to be capable of providing effective treatment and were considered to be important primary care physicians.", {"entities": []}], ["There were a few negative impressions in some areas of FMS practice, which demanded attention by the FMSs themselves and the relevant authorities in order to improve efficiency and safeguard the fraternity's reputation.", {"entities": []}], ["This study was conducted to evaluate the prophylactic effect of ginger extract on ethanol-induced reproductive toxicity in male rats.", {"entities": []}], ["Twenty-eight adult male Sprague-Dawley rats were randomly divided into 4 groups and treated daily for 28 days as follows: control, control-ginger (1 g/kg of body weight [BW]/day by gavage), ethanol group (ethanol 4 g/kg of BW/day by gavage), and ginger-ethanol group.", {"entities": []}], ["At the end of the experiment, all the rats were sacrificed and their testes were removed and used for measurement of the total homocysteine (tHcy), trace elements, antioxidant enzymes activity, and malondialdehyde (MDA).", {"entities": []}], ["The results in the ethanol group indicate that ethanol decreased antioxidant enzymes activity and increased MDA and tHcy compared with the control groups ( P < .05).", {"entities": []}], ["In ginger-ethanol group, ginger improved antioxidant enzymes activity and reduced tHcy and MDA compared to ethanol group ( P < .05).", {"entities": []}], ["It can be concluded that ginger protects the ethanol-induced testicular damage and improves the hormonal levels, trace elements, antioxidant enzymes activity, and decreases tHcy and MDA.", {"entities": []}], ["Objective .", {"entities": []}], ["Limited information exists on features of pediatric Selective IgM immunodeficiency (SIgMID).", {"entities": []}], ["Previously published pediatric cases and 2 new cases are reviewed.", {"entities": []}], ["English literature from PubMed and references from relevant articles were reviewed.", {"entities": []}], ["Previously reported cases and 2 new cases from an allergy/immunology practice were analyzed.", {"entities": []}], ["Forty-nine reported cases of SIgMID presented with respiratory infections (77.6%), gastrointestinal disease (16.3%), skin disease (12.2%), and meningitis (8.2%).", {"entities": [[143, 153, "DISEASE"], [117, 129, "DISEASE"]]}], ["Mean serum IgM level was 16.5 \u00b1 13.8 mg/dL.", {"entities": []}], ["Two patients were identified with SIgMID among 6300 active pediatric patients (0.03%) presenting with asthma, vasomotor rhinitis, and recurrent respiratory infections.", {"entities": [[110, 128, "DISEASE"], [120, 128, "DISEASE"], [102, 108, "DISEASE"]]}], ["In the 51 cases reported, none developed lymphoproliferative disease nor evolved into panhypogammaglobulinemia; four fatalities were reported.", {"entities": []}], ["Conclusions .", {"entities": []}], ["The prevalence of SIgMID in our pediatric population was 0.03%.", {"entities": []}], ["In general, respiratory infections are the common comorbid conditions.", {"entities": []}], ["Death and autoimmune disease are uncommon complications of pediatric SIgMID.", {"entities": []}], ["Cord blood IgE has previously been studied as a possible predictor of asthma and allergic diseases.", {"entities": [[70, 76, "DISEASE"]]}], ["Results from different studies have been contradictory, and most have focused on high-risk infants and early infancy.", {"entities": []}], ["Few studies have followed their study population into adulthood.", {"entities": []}], ["This study assessed whether cord blood IgE levels and a family history of asthma were associated with, and could predict, asthma medication and allergy-related respiratory symptoms in adults.", {"entities": [[74, 80, "DISEASE"], [122, 128, "DISEASE"]]}], ["A follow-up was carried out in a Swedish birth cohort comprising 1,701 consecutively born children.", {"entities": []}], ["In all, 1,661 individuals could be linked to the Swedish Prescribed Drug Register and the Medical Birth Register, and 1,227 responded to a postal questionnaire.", {"entities": []}], ["Cord blood IgE and family history of asthma were correlated with reported respiratory symptoms and dispensed asthma medication at 32\u201334 years.", {"entities": [[37, 43, "DISEASE"], [109, 115, "DISEASE"]]}], ["Elevated cord blood IgE was associated with a two- to threefold increased risk of pollen-induced respiratory symptoms and dispensed anti-inflammatory asthma medication.", {"entities": [[150, 156, "DISEASE"]]}], ["Similarly, a family history of asthma was associated with an increased risk of pollen-induced respiratory symptoms and anti-inflammatory medication.", {"entities": [[31, 37, "DISEASE"]]}], ["However, only 8% of the individuals with elevated cord blood IgE or a family history of asthma in infancy could be linked to current dispensation of anti-inflammatory asthma medication at follow-up.", {"entities": [[88, 94, "DISEASE"], [167, 173, "DISEASE"]]}], ["In all, 49 out of 60 individuals with dispensed anti-inflammatory asthma medication at 32\u201334 years of age had not been reported having asthma at previous check-ups of the cohort during childhood.", {"entities": [[66, 72, "DISEASE"], [135, 141, "DISEASE"]]}], ["Among those, only 5% with elevated cord blood IgE and 6% with a family history of asthma in infancy could be linked to current dispensation of anti-inflammatory asthma medication as adults.", {"entities": [[82, 88, "DISEASE"], [161, 167, "DISEASE"]]}], ["Elevated cord blood IgE and a positive family history of asthma were associated with reported respiratory symptoms and dispensed asthma medication in adulthood, but their predictive power was poor in this long-time follow-up.", {"entities": [[57, 63, "DISEASE"], [129, 135, "DISEASE"]]}], ["Non-communicable diseases are a threat to human health and economic development of low-income countries.", {"entities": []}], ["Hypertension (HT) and chronic obstructive pulmonary disease (COPD) are two major causes of deaths, worldwide.", {"entities": [[0, 12, "DISEASE"], [22, 59, "DISEASE"]]}], ["This study assesses the health status, health-care seeking, and health provider responses among patients with these conditions.", {"entities": []}], ["The study carried out population-based cross-sectional survey in a rural and an urban surveillance area in Bangladesh.", {"entities": []}], ["It interviewed all patients identified with HT and COPD at home using a structured questionnaire on the health consequences, healthcare-seeking behaviours, and coping strategies.", {"entities": []}], ["Qualitative techniques identified key factors relating to the behaviours of patients and providers.", {"entities": []}], ["COPD and HT correlate with lower activities of daily living (ADL) scores.", {"entities": []}], ["The odds ratio (OR) for ADL scores in the combied conditions are high (OR: 3.04, p\u2009<\u20090.05) as compared to hypertension.", {"entities": [[106, 118, "DISEASE"]]}], ["Financial crises occur significantly more frequently among COPD patients in the urban site as compared to those in rural ares (12.5% vs. 2.4%, p\u2009<\u20090.01).", {"entities": []}], ["Self-treatment at the onset is common.", {"entities": []}], ["Seeking care from trained providers is higher in urban settings and is higher for HT.", {"entities": []}], ["Referral for both COPD and hypertension was inadequate until the disease severity increased.", {"entities": [[27, 39, "DISEASE"]]}], ["COPD and HT significantly are associated with lower ADL scores and financial problems.", {"entities": []}], ["Public-sector primary healthcare facilities should be better organised to address both conditions with the aim to reduce household poverty.", {"entities": []}], ["According to international guidelines, the goal of asthma management is to achieve and maintain control of the disease, which can be assessed using composite measures.", {"entities": [[51, 57, "DISEASE"]]}], ["Prospective studies are required to determine how these measures are associated with asthma outcomes and/or future risk.", {"entities": [[85, 91, "DISEASE"]]}], ["The \u2018 InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol (LIAISON) \u2019 observational study has been designed to evaluate asthma control and its determinants, including components of asthma management.", {"entities": [[67, 73, "DISEASE"], [144, 150, "DISEASE"], [205, 211, "DISEASE"]]}], ["The LIAISON study will be conducted in 12 European countries and comprises a cross-sectional phase and a 12-month prospective phase.", {"entities": []}], ["Both phases will aim at assessing asthma control (six-item Asthma Control Questionnaire, ACQ), asthma-related quality of life (Mini Asthma Quality of Life Questionnaire, Mini-AQLQ), risk of non-adherence to treatment (four-item Morisky Medication Adherence Scale, MMAS-4), potential reasons for poor control, treatment strategies and associated healthcare costs.", {"entities": [[34, 40, "DISEASE"], [59, 65, "DISEASE"], [95, 101, "DISEASE"], [132, 138, "DISEASE"]]}], ["The cross-sectional phase will recruit\u2009>\u20098,000 adult patients diagnosed with asthma for at least 6\u2009months and receiving the same asthma treatment in the 4\u2009weeks before enrolment.", {"entities": [[77, 83, "DISEASE"], [129, 135, "DISEASE"]]}], ["The prospective phase will include all patients with uncontrolled/poorly controlled asthma at the initial visit to assess the proportion reaching control during follow-up and to examine predictors of future risk.", {"entities": [[84, 90, "DISEASE"]]}], ["Visits will take place after 3, 6 and 12\u2009months.", {"entities": []}], ["The LIAISON study will provide important information on the prevalence of asthma control and on the quality of life in a broad spectrum of real-life patient populations from different European countries and will also contribute to evaluate differences in management strategies and their impact on healthcare costs over 12\u2009months of observation.", {"entities": [[74, 80, "DISEASE"]]}], ["ClinicalTrials.gov identifier, NCT01567280 .", {"entities": []}], ["Multidrug resistance (MDR) is the main cause of failed chemotherapy treatments.", {"entities": []}], ["Therefore, preventing MDR is pivotal in treating colorectal cancer (CRC).", {"entities": [[49, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["In a previous study miR-133b was shown to be a tumor suppressor.", {"entities": [[20, 28, "GENE"]]}], ["Additionally, in CRC cells transfected with miR-133b, ATP-binding cassette (ABC) subfamily C member 1(ABCC1) was shown to be significantly down regulated.", {"entities": [[44, 52, "GENE"], [102, 107, "GENE"]]}], ["Whether miR-133b also enhances the chemosensitivity of drugs used to treat CRC by targeting ABCC1 is still unclear.", {"entities": [[8, 16, "GENE"], [92, 97, "GENE"]]}], ["Here, we utilized flow cytometry and high-performance liquid chromatography (HPLC) analysis to identify the ability of miR-133b to reserve MDR in CRC.", {"entities": [[119, 127, "GENE"]]}], ["We then used a dual-luciferase reporter assay to validate that miR-133b targets ABCC1.", {"entities": [[63, 71, "GENE"], [80, 85, "GENE"]]}], ["Further in vivo experiments were designed to validate the method in which miR-133b reversed MDR in CRC cells.", {"entities": [[74, 82, "GENE"]]}], ["The results demonstrated that the level of miR-133b was down-regulated and the expression of ABCC1 was up-regulated in drug-resistant CRC cells compared to non-drug-resistant CRC cells.", {"entities": [[43, 51, "GENE"], [93, 98, "GENE"]]}], ["The restoration of miR-133b expression in CRC drug-resistant cells in vitro resulted in reduced IC50s to chemotherapeutic drugs, significantly induced G1 accumulation, inhibited growth and promoted necrosis in combination with either 5-fluorouracil (5-FU) or vincristine (VCR), and decreased the expression of ABCC1.", {"entities": [[19, 27, "GENE"], [310, 315, "GENE"]]}], ["The dual-luciferase assay demonstrated that miR-133b directly targets ABCC1.", {"entities": [[44, 52, "GENE"], [70, 75, "GENE"]]}], ["The combination of agomiRNA-133b with chemotherapeutic drugs in vivo inhibited tumor growth induced by CRC drug-resistant cells.", {"entities": []}], ["A xenograft from the in vivo model resulted in up-regulated levels of miR-133b and down-regulated levels of ABCC1.", {"entities": [[70, 78, "GENE"], [108, 113, "GENE"]]}], ["Therefore, miR-133b enhances the chemosensitivity of CRC cells to anti-tumor drugs by directly down-regulating ABCC1.", {"entities": [[11, 19, "GENE"], [111, 116, "GENE"]]}], ["This discovery provides a therapeutic strategy in which miR-133b is used as a potential sensitizer for drug-resistant CRC.", {"entities": [[56, 64, "GENE"]]}], ["This review highlights recent advances towards non-invasive and continuous glucose monitoring devices, with a particular focus placed on monitoring glucose concentrations in alternative physiological fluids to blood.", {"entities": []}], ["The innate immune system is the first line of defense against viruses by inducing expression of cytokines and chemokines.", {"entities": []}], ["Many pandemic influenza H1N1 virus [P(H1N1)] infected severe cases occur in young adults under 18 years old who were rarely seriously affected by seasonal influenza.", {"entities": [[14, 23, "DISEASE"], [155, 164, "DISEASE"]]}], ["Results regarding host cytokine profiles of P(H1N1) are ambivalent.", {"entities": []}], ["In the present study we investigated host cytokine profiles in P(H1N1) patients and identified cytokines related to disease severity.", {"entities": []}], ["We retrieved 77, 59, 26 and 26 sera samples from P(H1N1) and non-flu influenza like illness (non-ILIs) cases with mild symptoms (mild patients), P(H1N1) vaccinees and healthy individuals, respectively.", {"entities": [[69, 78, "DISEASE"]]}], ["Nine and 16 sera were from hospitalized P(H1N1) and non-ILIs patients with severe symptoms (severe patients).", {"entities": []}], ["Cytokines of IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IFN-\u03b3 and TNF-\u03b1 were assayed by cytokine bead array, IL-17 and IL-23 measured with ELISA.", {"entities": []}], ["Mild P(H1N1) patients produced significantly elevated IL-2, IL-12, IFN-\u03b3, IL-6, TNF-\u03b1, IL-5, IL-10, IL-17 and IL-23 versus to healthy controls.", {"entities": []}], ["While an overwhelming IL-6 and IL-10 production were observed in severe P(H1N1) patients.", {"entities": []}], ["Higher IL-10 secretion in P(H1N1) vaccinees confirmed our observation that highly increased level of sera IL-6 and IL-10 in P(H1N1) patients may lead to disease progression.", {"entities": []}], ["A comprehensive innate immune response was activated at the early stage of P(H1N1) infection with a combine Th1/Th2/Th3 cytokines production.", {"entities": []}], ["As disease progression, a systemic production of IL-6 and IL-10 were observed in severe P(H1N1) patients.", {"entities": []}], ["Further analysis found a strong correlation between IL-6 and IL-10 production in the severe P(H1N1) patients.", {"entities": []}], ["IL-6 may be served as a mediator to induce IL-10 production.", {"entities": []}], ["Highly elevated level of sera IL-6 and IL-10 in P(H1N1) patients may lead to disease progression, but the underlying mechanism awaits further detailed investigations.", {"entities": []}], ["Alpha-1-Antitrypsin Deficiency (AATD) is an economically unexplored genetic disease.", {"entities": [[68, 83, "DISEASE"]]}], ["Direct and indirect costs (based on self-reported information on healthcare utilization) and health-related quality of life (HRQL, as assessed by SGRQ, CAT, and EQ-5D-3\u00a0L) were compared between 131 AATD patients (106 with, 25 without augmentation therapy (AT)) and 2,049 COPD patients without AATD participating in the COSYCONET COPD cohort.", {"entities": []}], ["The medication costs of AT were excluded from all analyses to reveal differences associated with morbidity profiles.", {"entities": []}], ["The association of AATD (with/without AT) with costs or HRQL was examined using generalized linear regression modelling (GLM) adjusting for age, sex, GOLD grade, BMI, smoking status, education and comorbidities.", {"entities": []}], ["Adjusted mean direct annual costs were \u20ac6,099 in AATD patients without AT, \u20ac7,117 in AATD patients with AT (excluding costs for AT), and \u20ac7,460 in COPD patients without AATD.", {"entities": []}], ["AATD with AT was significantly associated with higher outpatient (+273%) but lower inpatient (\u221235%) and medication costs (\u221210%, disregarding AT) compared with COPD patients without AATD.", {"entities": []}], ["There were no significant differences between groups regarding indirect costs and HRQL.", {"entities": []}], ["Apart from AT costs, AATD patients tended to have lower, though not significant, overall costs and similar HRQL compared to COPD patients without AATD.", {"entities": []}], ["AT was not associated with lower costs or higher HRQL.", {"entities": []}], ["NCT01245933 The online version of this article (doi:10.1186/s12931-017-0543-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Alcohol intake increases the risk of acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) and is associated with poor outcomes in patients who develop these syndromes.", {"entities": [[96, 104, "DISEASE"]]}], ["No specific therapies are currently available to treat or decrease the risk of ARDS in patients with alcoholism.", {"entities": []}], ["We have recently shown increased levels of lung adenosine inhibit alveolar fluid clearance, an important predictor of outcome in patients with ARDS.", {"entities": []}], ["We hypothesized that alcohol might worsen lung injury by increasing lung adenosine levels, resulting in impaired active Na We treated wild-type mice with alcohol administered i.p.", {"entities": []}], ["to achieve blood alcohol levels associated with moderate to severe intoxication and measured the rate of alveolar fluid clearance and Na,K-ATPase expression in peripheral lung tissue and assessed the effect of alcohol on survival during exposure to hyperoxia.", {"entities": []}], ["We used primary rat alveolar type II cells to investigate the mechanisms by which alcohol regulates alveolar Na Exposure to alcohol reduced alveolar fluid clearance, downregulated Na,K-ATPase in the lung tissue and worsened hyperoxia-induced lung injury.", {"entities": []}], ["Alcohol caused an increase in BAL fluid adenosine levels.", {"entities": []}], ["A similar increase in lung adenosine levels was observed after exposure to hyperoxia.", {"entities": []}], ["In primary rat alveolar type II cells alcohol and adenosine decreased the abundance of the Na,K-ATPase at the basolateral membrane via a mechanism that required activation of the AMPK.", {"entities": []}], ["Alcohol decreases alveolar fluid clearance and impairs survival from acute lung injury.", {"entities": []}], ["Alcohol induced increases in lung adenosine levels may be responsible for reduction in alveolar fluid clearance and associated worsening of lung injury.", {"entities": []}], ["With high-quality community-based primary care, hospitalizations for ambulatory care sensitive conditions (ACSC) are considered avoidable.", {"entities": []}], ["The purpose of this study was to test the inter-physician reliability of judgments of avoidable hospitalizations for one ACSC, uncomplicated hypertension, derived from medical chart review.", {"entities": [[141, 153, "DISEASE"]]}], ["We applied the Canadian Institute for Health Information\u2019s case definition to obtain a random sample of patients who had an ACSC hospitalization for uncomplicated hypertension in Calgary, Alberta.", {"entities": [[163, 175, "DISEASE"]]}], ["Medical chart review was conducted by three experienced internal medicine specialists.", {"entities": []}], ["Implicit methods were used to judge avoidability of hospitalization using a validated 5-point scale.", {"entities": []}], ["There was poor agreement among three physicians raters when judging the avoidability of 82 ACSC hospitalizations for uncomplicated hypertension ( \u03ba \u2009=\u20090.092).", {"entities": [[131, 143, "DISEASE"]]}], ["The \u03ba also remained low when assessing agreement between raters 1 and 3 ( \u03ba \u2009=\u20090.092), but the \u03ba was lower (less than chance agreement) for raters 1 and 2 ( \u03ba \u2009=\u2009-0.119) and raters 2 and 3 ( \u03ba \u2009=\u2009-0.008).", {"entities": []}], ["When the 5-point scale was dichotomized, there was fair agreement among three raters ( \u03ba \u2009=\u20090.217).", {"entities": []}], ["The proportion of ACSC hospitalizations for uncomplicated hypertension that were rated as avoidable was 32.9%, 6.1% and 26.8% for raters 1, 2, and 3, respectively.", {"entities": [[58, 70, "DISEASE"]]}], ["This study found a low proportion of ACSC hospitalization were rated as avoidable, with poor to fair agreement of judgment between physician raters.", {"entities": []}], ["This suggests that the validity and utility of this health indicator is questionable.", {"entities": []}], ["It points to a need to abandon the use of ACSC entirely; or alternatively to work on the development of explicit criteria for judging avoidability of hospitalization for ACSC such as hypertension.", {"entities": [[183, 195, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12911-017-0487-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Accurate methods of assessing food intake in infants are needed to assess the relationship between infant feeding practices and risk of childhood obesity.", {"entities": [[146, 153, "DISEASE"]]}], ["Current methods are either subjective or have limited ability for use beyond clinical research settings.", {"entities": []}], ["To assess the accuracy of the RFPM to evaluate simulated milk intake including energy, macronutrient, and micronutrient intake compared to direct weighing within a controlled study.", {"entities": []}], ["Individuals were recruited to prepare three 2 fl oz, 4 fl oz, 6 fl oz, and 8 fl oz servings of infant formula and to capture photographs at different stages of preparation (dry powdered formula, prepared formula, and liquid waste) using the SmartIntake Intake of formula prepared from powder measured by the RFPM was equivalent to weighed intake within 7.5% equivalence bounds among all servings and each serving size.", {"entities": []}], ["The mean difference between methods varied among servings sizes with the RFPM underestimating intake by 1.6 \u00b1 0.4 kcals in 2 fl oz servings, 4.8 \u00b1 0.6 kcals in 4 fl oz servings, and 6.2 \u00b1 1.0 kcals in 6 fl oz servings, and overestimating intake by 0.1 \u00b1 1.2 kcals in 8 fl oz servings.", {"entities": []}], ["Bland-Altman analysis showed that the RFPM overestimated intake at lower levels food intake and underestimated intake at higher levels.", {"entities": []}], ["Considering photographs of only the prepared formula bottle and the bottle with formula waste to simulate ready-to-feed formula and human breast milk, intake estimated by the RFPM was equivalent to the directly weighed intake within 7.5% for all servings.", {"entities": []}], ["The RFPM has higher accuracy than subjective methods and similar accuracy as compared to the objective methods in estimating simulated intake of milk and formula with lower burden to caregivers.", {"entities": []}], ["The RFPM is a viable method for measuring intake in exclusively milk fed infants by caregivers in a controlled environment with potential for widespread use in research and clinical practice.", {"entities": []}], ["Drugs for inhalation are the cornerstone of therapy in obstructive lung disease.", {"entities": [[55, 79, "DISEASE"], [67, 79, "DISEASE"]]}], ["We have observed that up to 75\u2009% of patients do not perform a correct inhalation technique.", {"entities": []}], ["The inability of patients to correctly use their inhaler device may be a direct consequence of insufficient or poor inhaler technique instruction.", {"entities": []}], ["The objective of this study is to test the efficacy of two educational interventions to improve the inhalation techniques in patients with Chronic Obstructive Pulmonary Disease (COPD).", {"entities": []}], ["This study uses both a multicenter patients\u00b4 preference trial and a comprehensive cohort design with 495 COPD-diagnosed patients selected by a non-probabilistic method of sampling from seven Primary Care Centers.", {"entities": []}], ["The participants will be divided into two groups and five arms.", {"entities": []}], ["The two groups are: 1) the patients\u00b4 preference group with two arms and 2) the randomized group with three arms.", {"entities": []}], ["In the preference group, the two arms correspond to the two educational interventions (Intervention A and Intervention B) designed for this study.", {"entities": []}], ["In the randomized group the three arms comprise: intervention A, intervention B and a control arm.", {"entities": []}], ["Intervention A is written information (a leaflet describing the correct inhalation techniques).", {"entities": []}], ["Intervention B is written information about inhalation techniques\u2009plus\u2009training by an instructor.", {"entities": []}], ["Every patient in each group will be visited six times during the year of the study at health care center.", {"entities": []}], ["Our hypothesis is that the application of two educational interventions in patients with COPD who are treated with inhaled therapy will increase the number of patients who perform a correct inhalation technique by at least 25\u2009%.", {"entities": []}], ["We will evaluate the effectiveness of these interventions on patient inhalation technique improvement, considering that it will be adequate and feasible within the context of clinical practice.", {"entities": []}], ["Current Controlled Trials ISRTCTN15106246", {"entities": []}], ["Few children with drug-resistant (DR) tuberculosis (TB) are identified, diagnosed, and given an appropriate treatment.", {"entities": [[38, 50, "DISEASE"]]}], ["The few studies that have described this vulnerable population have used inconsistent definitions.", {"entities": []}], ["The World Health Organization (WHO) definitions used for adults with DR-TB and for children with drug-susceptible TB are not always appropriate for children with DR-TB.", {"entities": []}], ["The Sentinel Project on Pediatric Drug-Resistant Tuberculosis was formed in 2011 as a network of experts and stakeholders in childhood DR-TB.", {"entities": [[49, 61, "DISEASE"]]}], ["An early priority was to establish standardized definitions for key parameters in order to facilitate study comparisons and the development of an evidence base to guide future clinical management.", {"entities": []}], ["This consensus statement proposes standardized definitions to be used in research.", {"entities": []}], ["In particular, it suggests consistent terminology, as well as definitions for measures of exposure, drug resistance testing, previous episodes and treatment, certainty of diagnosis, site and severity of disease, adverse events, and treatment outcome.", {"entities": []}], ["Background: several studies suggest that a decreased thyroid activity might be favourable in oldest-old subjects and that subclinical thyroid hyperfunction may be detrimental.", {"entities": []}], ["Objectives: to verify whether declining levels of circulating thyroid hormones may contribute to longevity.", {"entities": []}], ["Design: cross-sectional observational study.", {"entities": []}], ["Setting: all subjects were born in Calabria (southern Italy) and their ancestry in the region was ascertained up to the grandparents.", {"entities": []}], ["Subjects: six hundred and four home-dwelling subjects (301 females, 303 males), divided into three groups: 278 individuals 60\u201385\u00a0years old; 179 children or nieces/nephews of centenarians who are 60\u201385 years old; 147 individuals older than 85 years.", {"entities": []}], ["Methods: thyroid function parameters were measured in the frame of a comprehensive geriatric assessment.", {"entities": []}], ["Results: FT3 and FT4 levels were negatively associated with age.", {"entities": []}], ["Lower levels of FT3, FT4 and TSH were found in centenarians\u2019 children and nieces/nephews with respect to age-matched controls.", {"entities": []}], ["Indeed, being a relative of centenarians qualified as an independent correlate of thyroid parameters.", {"entities": []}], ["Conclusions: age-related subtle thyroid hypofunction (either due to a familial component or due to a reset of the thyroid function occurring between the sixth and the eighth decade of life) appears to be related to longevity.", {"entities": []}], ["Acute chorioamnionitis contributes to premature birth, and is associated with post-birth complications.", {"entities": [[6, 22, "DISEASE"]]}], ["How chorioamnionitis impacts neonate\u2019s developing immune system has not been well defined.", {"entities": [[4, 20, "DISEASE"]]}], ["Blood from extremely preterm infants (\u226428 weeks gestation) was drawn at the 1 At 1 week of life, exposure to funisitis, but not maternal chorioamnionitis was associated with an increased expression of RORC and RORC/FOXP3 ratio.", {"entities": [[109, 118, "DISEASE"], [137, 153, "DISEASE"], [201, 205, "GENE"], [210, 214, "GENE"]]}], ["These increases in RORC and RORC/FOXP3 ration were sustained over the 4 weeks of follow-up.", {"entities": [[19, 23, "GENE"], [28, 32, "GENE"]]}], ["Leukocytes from infants who developed BPD had increased stimulated and unstimulated IL-4 at the 1 Chorioamnionitis exposure, in particular to funisitis, lead to enhanced Th17-like responses that persist for 4 weeks after birth.", {"entities": [[142, 151, "DISEASE"], [98, 114, "DISEASE"]]}], ["Infants who later developed BPD did not exhibit a strikingly distinct immune profile.", {"entities": []}], ["Mutually exclusive expression of T-bet and Eomes drives the development of distinct NK cell lineages with complementary functions.", {"entities": [[43, 48, "GENE"]]}], ["Nijmegen breakage syndrome (NBS) is a rare autosomal recessive syndrome of chromosomal instability mainly characterized by microcephaly at birth, combined immunodeficiency and predisposition to malignancies.", {"entities": [[18, 26, "DISEASE"], [63, 71, "DISEASE"], [123, 135, "DISEASE"]]}], ["Due to a founder mutation in the underlying NBN gene (c.657_661del5) the disease is encountered most frequently among Slavic populations.", {"entities": [[44, 47, "GENE"]]}], ["The principal clinical manifestations of the syndrome are: microcephaly, present at birth and progressive with age, dysmorphic facial features, mild growth retardation, mild-to-moderate intellectual disability, and, in females, hypergonadotropic hypogonadism.", {"entities": [[186, 209, "DISEASE"], [45, 53, "DISEASE"], [59, 71, "DISEASE"], [246, 258, "DISEASE"]]}], ["Combined cellular and humoral immunodeficiency with recurrent sinopulmonary infections, a strong predisposition to develop malignancies (predominantly of lymphoid origin) and radiosensitivity are other integral manifestations of the syndrome.", {"entities": [[233, 241, "DISEASE"]]}], ["The NBN gene codes for nibrin which, as part of a DNA repair complex, plays a critical nuclear role wherever double-stranded DNA ends occur, either physiologically or as a result of mutagenic exposure.", {"entities": [[4, 7, "GENE"]]}], ["Laboratory findings include: (1) spontaneous chromosomal breakage in peripheral T lymphocytes with rearrangements preferentially involving chromosomes 7 and 14, (2) sensitivity to ionizing radiation or radiomimetics as demonstrated in vitro by cytogenetic methods or by colony survival assay, (3) radioresistant DNA synthesis, (4) biallelic hypomorphic mutations in the NBN gene, and (5) absence of full-length nibrin protein.", {"entities": [[370, 373, "GENE"]]}], ["Microcephaly and immunodeficiency are common to DNA ligase IV deficiency (LIG4 syndrome) and severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation due to NHEJ1 deficiency (NHEJ1 syndrome).", {"entities": [[79, 87, "DISEASE"], [234, 242, "DISEASE"], [93, 125, "DISEASE"], [0, 12, "DISEASE"], [131, 143, "DISEASE"], [74, 78, "GENE"], [210, 215, "GENE"], [228, 233, "GENE"], [210, 215, "GENE"], [228, 233, "GENE"]]}], ["In fact, NBS was most commonly confused with Fanconi anaemia and LIG4 syndrome.", {"entities": [[70, 78, "DISEASE"], [65, 69, "GENE"]]}], ["Genetic counselling should inform parents of an affected child of the 25% risk for further children to be affected.", {"entities": []}], ["Prenatal molecular genetic diagnosis is possible if disease-causing mutations in both alleles of the NBN gene are known.", {"entities": [[101, 104, "GENE"]]}], ["No specific therapy is available for NBS, however, hematopoietic stem cell transplantation may be one option for some patients.", {"entities": []}], ["Prognosis is generally poor due to the extremely high rate of malignancies.", {"entities": []}], ["Zesp\u00f3\u0142 Nijmegen ( Nijmegen breakage syndrome ; NBS) jest rzadkim schorzeniem z wrodzon\u0105 niestabilno\u015bci\u0105 chromosomow\u0105 dziedzicz\u0105cym si\u0119 w spos\u00f3b autosomalny recesywny, charakteryzuj\u0105cym si\u0119 przede wszystkim wrodzonym ma\u0142og\u0142owiem, z\u0142o\u017conymi niedoborami odporno\u015bci i predyspozycj\u0105 do rozwoju nowotwor\u00f3w.", {"entities": [[36, 44, "DISEASE"]]}], ["Choroba wyst\u0119puje najcz\u0119\u015bciej w populacjach s\u0142owia\u0144skich, w kt\u00f3rych uwarunkowana jest mutacj\u0105 za\u0142o\u017cycielsk\u0105 w genie NBN (c.657_661del5).", {"entities": [[116, 119, "GENE"]]}], ["Do najwa\u017cniejszych objaw\u00f3w zespo\u0142u zalicza si\u0119: ma\u0142og\u0142owie obecne od urodzenia i post\u0119puj\u0105ce z wiekiem, charakterystyczne cechy dysmorfii twarzy, op\u00f3\u017anienie wzrastania, niepe\u0142nosprawno\u015b\u0107 intelektualn\u0105 w stopniu lekkim do umiarkowanego oraz hipogonadyzm hipogonadotropowy u dziewcz\u0105t.", {"entities": []}], ["Na obraz choroby sk\u0142adaj\u0105 si\u0119 tak\u017ce: niedob\u00f3r odporno\u015bci kom\u00f3rkowej i humoralnej, kt\u00f3ry jest przyczyn\u0105 nawracaj\u0105cych infekcji, znaczna predyspozycja do rozwoju nowotwor\u00f3w z\u0142o\u015bliwych (zw\u0142aszcza uk\u0142adu ch\u0142onnego), a tak\u017ce zwi\u0119kszona wra\u017cliwo\u015b\u0107 na promieniowanie jonizuj\u0105ce.", {"entities": []}], ["Wyniki bada\u0144 laboratoryjnych wykazuj\u0105: (1) spontaniczn\u0105 \u0142amliwo\u015b\u0107 chromosom\u00f3w w limfocytach T krwi obwodowej, z preferencj\u0105 do rearan\u017cacji chromosom\u00f3w 7 i 14, (2) nadwra\u017cliwo\u015b\u0107 na promieniowanie jonizuj\u0105ce lub radiomimetyki, co mo\u017cna wykaza\u0107 metodami in vitro , (3) radiooporno\u015b\u0107 syntezy DNA, (4) hipomorficzne mutacje na obu allelach genu NBN , oraz (5) brak w kom\u00f3rkach pe\u0142nej cz\u0105steczki bia\u0142ka, nibryny.", {"entities": [[340, 343, "GENE"]]}], ["Ma\u0142og\u0142owie i niedob\u00f3r odporno\u015bci wyst\u0119puj\u0105 tak\u017ce w zespole niedoboru ligazy IV (LIG4) oraz w zespole niedoboru NHEJ1.", {"entities": [[80, 84, "GENE"], [111, 116, "GENE"]]}], ["Rodzice powinni otrzyma\u0107 porad\u0119 genetyczn\u0105 ze wzgl\u0119du na wysokie ryzyko (25%) powt\u00f3rzenia si\u0119 choroby u kolejnego potomstwa.", {"entities": []}], ["Mo\u017cliwe jest zaproponowanie molekularnej diagnostyki prenatalnej je\u017celi znane s\u0105 obie mutacje b\u0119d\u0105ce przyczyn\u0105 choroby.", {"entities": []}], ["Nie ma mo\u017cliwo\u015bci zaproponowania specyficznej terapii, ale przeszczep szpiku mo\u017ce by\u0107 alternatyw\u0105 dla niekt\u00f3rych pacjent\u00f3w.", {"entities": []}], ["Generalnie prognoza nie jest pomy\u015blna z uwagi na wysokie ryzyko rozwoju nowotworu.", {"entities": []}], ["The industrial agriculture system consumes fossil fuel, water, and topsoil at unsustainable rates.", {"entities": []}], ["It contributes to numerous forms of environmental degradation, including air and water pollution, soil depletion, diminishing biodiversity, and fish die-offs.", {"entities": []}], ["Meat production contributes disproportionately to these problems, in part because feeding grain to livestock to produce meat--instead of feeding it directly to humans--involves a large energy loss, making animal agriculture more resource intensive than other forms of food production.", {"entities": []}], ["The proliferation of factory-style animal agriculture creates environmental and public health concerns, including pollution from the high concentration of animal wastes and the extensive use of antibiotics, which may compromise their effectiveness in medical use.", {"entities": []}], ["At the consumption end, animal fat is implicated in many of the chronic degenerative diseases that afflict industrial and newly industrializing societies, particularly cardiovascular disease and some cancers.", {"entities": []}], ["In terms of human health, both affluent and poor countries could benefit from policies that more equitably distribute high-protein foods.", {"entities": []}], ["The pesticides used heavily in industrial agriculture are associated with elevated cancer risks for workers and consumers and are coming under greater scrutiny for their links to endocrine disruption and reproductive dysfunction.", {"entities": [[83, 89, "DISEASE"]]}], ["In this article we outline the environmental and human health problems associated with current food production practices and discuss how these systems could be made more sustainable.", {"entities": []}], ["Progressive, chronic bacterial infection of the airways is a leading cause of death in cystic fibrosis (CF).", {"entities": [[87, 102, "DISEASE"]]}], ["Culture-independent methods based on sequencing of the bacterial 16S rRNA gene describe a distinct microbial community that decreases in richness and diversity with disease progression.", {"entities": []}], ["Understanding the functional characteristics of the microbial community may aid in identifying potential therapies and may assist in management, but current methods are cumbersome.", {"entities": []}], ["Here, we demonstrate the use of an oxidative metabolic assay as a complement to sequencing methods to describe the microbiome in the airways of patients with CF.", {"entities": []}], ["Expectorated sputum was collected from 16 CF subjects and 8 control subjects.", {"entities": []}], ["The Biolog Gen III Microplate was used in a community-level physiological profiling (CLPP)-based assay to examine oxidative metabolic activity.", {"entities": [[85, 89, "GENE"]]}], ["16S rRNA V4 amplicon sequencing was used to characterize the taxonomy and diversity of the samples.", {"entities": []}], ["Correlations were then identified among the oxidative activity and taxonomy data.", {"entities": []}], ["In an additional paired analysis, sputum from seven CF subjects were collected at two separate clinic visits and compared for oxidative activity, taxonomy, and diversity.", {"entities": []}], ["Significant differences in oxidative metabolic activity, microbial taxonomy, and diversity were found between the CF and control sputum samples.", {"entities": []}], ["Oxidative activity correlated positively with total genera but not with other measures of diversity or taxonomy, demonstrating that the metabolic assay complements the structural aspects of the microbiome.", {"entities": []}], ["As expected, Pseudomonas was significantly enriched in CF samples, while Streptococcus and Prevotella were similarly abundant in both CF and control samples.", {"entities": []}], ["Paired analysis of CF samples at separate clinic visits revealed comparable oxidative activity that correlated with similar stability in taxonomy and diversity.", {"entities": []}], ["The CLPP assay used in this study complements existing sequencing methods to delineate the oxidative metabolic footprint of the CF airway bacterial community.", {"entities": [[4, 8, "GENE"]]}], ["This method may be useful to study the CF microbial community over time and with changes in disease state.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-017-0289-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Traditional medicine has been practised in Ghana for centuries with the majority of Ghanaians still patronising the services of traditional healers.", {"entities": []}], ["Throughout Africa a large number of people use pangolins as a source of traditional medicine, however, there is a dearth of information on the use of animals in folk medicine in Ghana, in particular the use of pangolins.", {"entities": []}], ["The aim of this study was to determine the prevalent use of pangolins and the level of knowledge of pangolin use among traditional healers in Ghana for the treatment of human ailments.", {"entities": []}], ["Data was gathered from 48 traditional healers using semi-structured interviews on the traditional medicinal use of pangolin body parts in the Kumasi metropolis of Ghana.", {"entities": []}], ["The cultural importance index, relative frequency of citation, informant agreement ratio and use agreement values were calculated to ascertain the most culturally important pangolin body part as well as the level of knowledge dissemination among traditional healers with regards pangolin body parts.", {"entities": []}], ["Our study revealed that 13 body parts of pangolins are used to treat various medicinal ailments.", {"entities": []}], ["Pangolin scales and bones were the most prevalent prescribed body parts and indicated the highest cultural significance among traditional healing practices primarily for the treatment of spiritual protection, rheumatism, financial rituals and convulsions.", {"entities": []}], ["Despite being classified under Schedule 1 of Ghana\u2019s Wildlife Conservation Act of 1971 (LI 685), that prohibits anyone from hunting or being in possession of a pangolin, our results indicated that the use of pangolins for traditional medicinal purposes is widespread among traditional healers in Ghana.", {"entities": []}], ["A study on the population status and ecology of the three species of African pangolins occurring in Ghana is urgently required in order to determine the impact this harvest for traditional medical purposes has on their respective populations as current levels appear to be unmonitored and unsustainable.", {"entities": []}], ["To assess asthma patients in Brazil in terms of the level of asthma control, compliance with maintenance treatment, and the use of rescue medication.", {"entities": [[10, 16, "DISEASE"], [61, 67, "DISEASE"]]}], ["We used data from a Latin American survey of a total of 400 asthma patients in four Brazilian state capitals, all of whom completed a questionnaire regarding asthma control and treatment.", {"entities": [[60, 66, "DISEASE"], [158, 164, "DISEASE"]]}], ["In that sample, the prevalence of asthma was 8.8%.", {"entities": [[34, 40, "DISEASE"]]}], ["Among the 400 patients studied, asthma was classified, in accordance with the Global Initiative for Asthma criteria, as controlled, partially controlled, and uncontrolled in 37 (9.3%), 226 (56.5%), and 137 (34.3%), respectively.", {"entities": [[32, 38, "DISEASE"], [100, 106, "DISEASE"]]}], ["In those three groups, the proportion of patients on maintenance therapy in the past four weeks was 5.4%, 19.9%, and 41.6%, respectively.", {"entities": []}], ["The use of rescue medication was significantly more common in the uncontrolled asthma group (86.9%; p < 0.001).", {"entities": [[79, 85, "DISEASE"]]}], ["Our findings suggest that, in accordance with the established international criteria, asthma is uncontrolled in the vast majority of asthma patients in Brazil.", {"entities": [[86, 92, "DISEASE"], [133, 139, "DISEASE"]]}], ["Maintenance medications are still underutilized in Brazil, and patients with partially controlled or uncontrolled asthma are more likely to use rescue medications and oral corticosteroids.", {"entities": [[114, 120, "DISEASE"]]}], ["Barrier epithelia that are persistently exposed to microbes have evolved potent immune tools to eliminate such pathogens.", {"entities": []}], ["If mechanisms that control Drosophila systemic responses are well-characterized, the epithelial immune responses remain poorly understood.", {"entities": []}], ["Here, we performed a genetic dissection of the cascades activated during the immune response of the Drosophila airway epithelium i.e.", {"entities": []}], ["We present evidence that bacteria induced-antimicrobial peptide (AMP) production in the trachea is controlled by two signalling cascades.", {"entities": []}], ["AMP gene transcription is activated by the inducible IMD pathway that acts non-cell autonomously in trachea.", {"entities": []}], ["This IMD-dependent AMP activation is antagonized by a constitutively active signalling module involving the receptor Toll-8/Tollo, the ligand Sp\u00e4tzle2/DNT1 and Ect-4, the Drosophila ortholog of the human Sterile alpha and HEAT/ARMadillo motif (SARM).", {"entities": []}], ["Our data show that, in addition to Toll-1 whose function is essential during the systemic immune response, Drosophila relies on another Toll family member to control the immune response in the respiratory epithelium.", {"entities": []}], ["Invertebrates solely rely on innate immune responses for defense against microbial infections.", {"entities": []}], ["Taking advantage of its powerful genetics, the fly Drosophila melanogaster has been extensively used as a model system to dissect the molecular mechanisms that control innate immunity.", {"entities": []}], ["This work led to the discovery of the essential role of the Toll-1 receptor in triggering the systemic immune response in flies, and paved the way for the discovery of the function of members of the Toll-like receptor (TLR) family in mammalian immunity.", {"entities": []}], ["Whereas all TLRs are implicated in the mammalian immune response, Toll-1 was, so far, the only Drosophila Toll family member to be involved in the regulation of the immune response.", {"entities": []}], ["In the present study, we show that another Toll family member, Toll-8 (Tollo), plays an important role in controlling the respiratory epithelium immune response.", {"entities": []}], ["Our data indicate that, by antagonizing the IMD pathway, Tollo is preventing over-activation of the antibacterial response in the airway epithelium.", {"entities": []}], ["Despite the burden of acute respiratory illnesses (ARI) among Aboriginal and Torres Strait Islander children being a substantial cause of childhood morbidity and associated costs to families, communities and the health system, data on disease burden in urban children are lacking.", {"entities": []}], ["Consequently evidence-based decision-making, data management guidelines, health resourcing for primary health care services and prevention strategies are lacking.", {"entities": []}], ["This study aims to comprehensively describe the epidemiology, impact and outcomes of ARI in urban Aboriginal and Torres Strait Islander children (hereafter referred to as Indigenous) in the greater Brisbane area.", {"entities": []}], ["An ongoing prospective cohort study of Indigenous children aged less than five years registered with a primary health care service in Northern Brisbane, Queensland, Australia.", {"entities": []}], ["Children are recruited at time of presentation to the service for any reason.", {"entities": []}], ["Demographic, epidemiological, risk factor, microbiological, economic and clinical data are collected at enrolment.", {"entities": []}], ["Enrolled children are followed for 12\u00a0months during which time ARI events, changes in child characteristics over time and monthly nasal swabs are collected.", {"entities": []}], ["Children who develop an ARI with cough as a symptom during the study period are more intensely followed-up for 28 (\u00b13) days including weekly nasal swabs and parent completed cough diary cards.", {"entities": []}], ["Children with persistent cough at day 28 post-ARI are reviewed by a paediatrician.", {"entities": []}], ["Our study will be one of the first to comprehensively evaluate the natural history, epidemiology, aetiology, economic impact and outcomes of ARIs in this population.", {"entities": []}], ["The results will inform studies for the development of evidence-based guidelines to improve the early detection, prevention and management of chronic cough and setting of priorities in children during and after ARI.", {"entities": []}], ["Australia New Zealand Clinical Trial Registry Registration Number: 12614001214628 .", {"entities": []}], ["Registered 18 November 2014", {"entities": []}], ["Dehydroandrographolide (DA) is one of major active components in the well-known oriental herbal medicine Andrographis paniculata (Burm.f) Nees which belongs to the Acanthaceae family.", {"entities": []}], ["DA is used for the treatment of infections in China.", {"entities": []}], ["However, DA has not been found to significantly inhibit bacterial and viral growth directly.", {"entities": []}], ["The current study investigates the effect of DA on the expression of human \u03b2 \u2013defensin-2 (hBD-2) in human intestinal epithelial cells and the possible signaling pathways.", {"entities": []}], ["Human intestinal epithelial HCT-116 cells were incubated with 1\u2013100\u00a0\u03bcM DA for 2\u201324\u00a0h. RT\u2013PCR and Western blot were used to assess the expression of hBD-2.", {"entities": []}], ["The specific inhibitors were used and the levels of phosphorylation of signaling molecules were detected for dissecting the signaling pathways leading to the induction of hBD-2.", {"entities": []}], ["MTT assay showed there was no obvious cytotoxicity for HCT-116 cells by 1\u2013100\u00a0\u03bcM DA treatment.", {"entities": []}], ["RT-PCR and Western blot assays showed that DA (1\u2013100\u00a0\u03bcM) could up-regulate the expression of hBD-2, and the effect lasted longer than 24\u00a0h. By using SB203580 and SB202190 (inhibitors of p38), the enhancement of hBD-2 expression were significantly attenuated.", {"entities": []}], ["However, inhibitor of ERK and inhibitor of JNK could not block the effect of DA.", {"entities": []}], ["Furthermore, Western blot found activation of p38 but not ERK and JNK in DA-treated HCT-116 cells.", {"entities": []}], ["The results suggested that DA enhanced innate immunity of intestinal tract by up-regulating the expression of hBD-2 through the p38 MAPK pathways.", {"entities": []}], ["Airborne-contact dermatitis (ABCD) represents a unique type of contact dermatitis originating from dust, sprays, pollens or volatile chemicals by airborne fumes or particles without directly touching the allergen.", {"entities": [[9, 27, "DISEASE"], [63, 81, "DISEASE"], [17, 27, "DISEASE"], [71, 81, "DISEASE"]]}], ["ABCD in Indian patients has been attributed exclusively by pollens of the plants like Parthenium hysterophorus , etc., but in recent years the above scenario has been changing rapidly in urban and semiurban perspective especially in developing countries.", {"entities": []}], ["ABCD has been reported worldwide due to various type of nonplant allergens and their clinical feature are sometimes distinctive.", {"entities": []}], ["Preventive aspect has been attempted by introduction of different chemicals of less allergic potential.", {"entities": []}], ["Spontaneous pneumomediastinum (SPM) is a rare entity, with only a few cases reported, especially in adolescents.", {"entities": []}], ["We aimed to analyze the clinical characteristics of SPM in adolescents and the diagnostic implications of computed tomography (CT) and esophagography therein.", {"entities": []}], ["This retrospective descriptive study was conducted as a review of medical records of 416 adolescents (10-18 years of age) with chest pain from March 2005 to June 2013.", {"entities": []}], ["Information on clinical presentation, methods of diagnosis, hospital stay, and outcomes were collected and analyzed.", {"entities": []}], ["Among adolescents complaining of chest pain, 11 patients had SPM (11/416, 2.64%).", {"entities": []}], ["All patients presented with pleuritic chest pain, and 54.5% reported neck pain as the most common associated complaint.", {"entities": []}], ["Clinical findings were nonspecific, and initial chest X-ray assessment was diagnostic only in three of 11 patients.", {"entities": []}], ["However, reassessment of chest X-ray revealed diagnostic findings of SPM in five of the remaining eight patients.", {"entities": []}], ["CT was diagnostic in all patients, while esophagography and echocardiogram were uninformative.", {"entities": []}], ["Symptomatic improvement was noted within 2.45\u00b11.2 hours (range, 0.5 to 4) after supportive care; mean hospital stay was 4.54\u00b10.99 days (range, 2 to 6).", {"entities": []}], ["No recurrence was observed.", {"entities": []}], ["SPM is a rare disease that should be considered in adolescent patients with pleuritic chest pain.", {"entities": []}], ["Careful reading of initial chest X-rays is important to avoiding further unnecessary investigations.", {"entities": []}], ["SPM is self-limited and treatment is supportive; nevertheless, if there are no indications of esophageal rupture, urgent esophagography is not recommended.", {"entities": []}], ["The incidence of tuberculosis (TB) remains high among Chinese Uygurs (a long-dwelling ethnic minority in Xinjiang) in China and the variants in IL-23R likely contribute to individual\u2019s diversity in host response during infection.", {"entities": [[17, 29, "DISEASE"]]}], ["A hospital based one to one matched case\u2013control study was performed to assess the role of single nucleotide polymorphisms (SNPs) and copy number variation (CNV) of IL-23R in susceptibility and clinical features of pulmonary TB in Chinese Uygurs.", {"entities": []}], ["Thirteen SNPs in IL-23R were genotyped by multiplex SNaPshot and a CNV was analyzed using Taqman real-time PCR in 250 pairs of pulmonary TB patients and controls.", {"entities": []}], ["The SNP rs7518660 (OR\u2009=\u20094.78, 95\u00a0% CI 3.14\u20138.52) and the CNV in IL23R (OR\u2009=\u20092.75, 95\u00a0% CI 1.51\u20134.98) were significantly associated with susceptibility to pulmonary TB.", {"entities": [[64, 69, "GENE"]]}], ["The SNP rs11465802 (OR\u2009=\u20093.23, 95\u00a0% CI 1.85\u20135.62) was significantly associated with drug-resistance and the SNP rs1884444 (OR\u2009=\u20093.61, 95\u00a0% CI 1.90\u20136.85) was significantly related to cavitary lesion in Chinese Uygurs.", {"entities": []}], ["Our study shows for the first time that SNP and CNV in IL23R were associated with susceptibility, drug resistance and cavity formation of pulmonary TB.", {"entities": [[55, 60, "GENE"]]}], ["Our findings indicate that these IL-23R polymorphisms may be considered as risk factors for active pulmonary TB and its severe clinical forms.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-015-1284-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The increasing incidence of new diseases as well as changing features of known diseases has partly been attributed to the impact of environmental changes.", {"entities": []}], ["As a result, there have been calls from health experts for proper surveillance and monitoring of these changes.", {"entities": []}], ["This is a report of mopane worm allergy in a 36 year old female from the Tswana tribe in Botswana.", {"entities": []}], ["Mopane worm, the caterpillar stage of Gonimbrasia belina moths, is a seasonal delicacy to people in many communities in southern Africa.", {"entities": []}], ["As a result, by adulthood, many residents of these communities have had substantial exposure to the worm.", {"entities": []}], ["Gonimbrasia belina moths belong to the Lepidoptera order of insects.", {"entities": []}], ["Though some members of this order are known to induce contact allergy, there is no reported incidence of ingestion allergy from mopane worm.", {"entities": []}], ["Therefore, it is important to track this case for its epidemiological significance and to alert both clinicians and the vulnerable public on the incidence of mopane worm allergy in this region.", {"entities": []}], ["This is a case of a 36 year old woman from the Tswana ethnic group in Botswana, who was diagnosed with food allergy.", {"entities": [[103, 115, "DISEASE"]]}], ["She presented with itchy skin rash, facial swelling, and mild hypotension after eating mopane worm.", {"entities": []}], ["She had no previous history of allergic reaction following contact or ingestion of mopane worm and had no atopic illness in the past.", {"entities": []}], ["She was treated and her symptoms resolved after 4 days.", {"entities": []}], ["The proper management of allergy involves patients' avoidance and clinicians' predictability.", {"entities": []}], ["Though hypothetical, this report is expected to sensitize clinicians to anticipate and properly manage subsequent occurrence, as well as educate the public in these communities.", {"entities": []}], ["In addition, tracking new disease patterns, with relationship to environmental changes, will compliment existing evidence in validating the importance of proper environmental surveillance and management.", {"entities": []}], ["Objective To assess the effects of major multi-sport events on health and socioeconomic determinants of health in the population of the city hosting the event.", {"entities": []}], ["Design Systematic review.", {"entities": []}], ["Data sources We searched the following sources without language restrictions for papers published between 1978 and 2008: Applied Social Science Index and Abstracts (ASSIA), British Humanities Index (BHI), Cochrane database of systematic reviews, Econlit database, Embase, Education Resources Information Center (ERIC) database, Health Management Information Consortium (HMIC) database, International Bibliography of the Social Sciences (IBSS), Medline, PreMedline, PsycINFO, Sociological Abstracts, Sportdiscus, Web of Knowledge, Worldwide Political Science Abstracts, and the grey literature.", {"entities": []}], ["Review methods Studies of any design that assessed the health and socioeconomic impacts of major multi-sport events on the host population were included.", {"entities": []}], ["We excluded studies that used exclusively estimated data rather than actual data, that investigated host population support for an event or media portrayals of host cities, or that described new physical infrastructure.", {"entities": []}], ["Studies were selected and critically appraised by two independent reviewers.", {"entities": []}], ["Results Fifty four studies were included.", {"entities": []}], ["Study quality was poor, with 69% of studies using a repeat cross-sectional design and 85% of quantitative studies assessed as being below 2+ on the Health Development Agency appraisal scale, often because of a lack of comparison group.", {"entities": []}], ["Five studies, each with a high risk of bias, reported health related outcomes, which were suicide, paediatric health service demand, presentations for asthma in children (two studies), and problems related to illicit drug use.", {"entities": [[151, 157, "DISEASE"]]}], ["Overall, the data did not indicate clear negative or positive health impacts of major multi-sport events on host populations.", {"entities": []}], ["The most frequently reported outcomes were economic outcomes (18 studies).", {"entities": []}], ["The outcomes used were similar enough to allow us to perform a narrative synthesis, but the overall impact of major multi-sport events on economic growth and employment was unclear.", {"entities": []}], ["Two thirds of the economic studies reported increased economic growth or employment immediately after the event, but all these studies used some estimated data in their models, failed to account for opportunity costs, or examined only short term effects.", {"entities": []}], ["Outcomes for transport were also similar enough to allow synthesis of six of the eight studies, which showed that event related interventions\u2014including restricted car use and public transport promotion\u2014were associated with significant short term reductions in traffic volume, congestion, or pollution in four out of five cities.", {"entities": []}], ["Conclusions The available evidence is not sufficient to confirm or refute expectations about the health or socioeconomic benefits for the host population of previous major multi-sport events.", {"entities": []}], ["Future events such as the 2012 Olympic Games and Paralympic Games, or the 2014 Commonwealth Games, cannot be expected to automatically provide benefits.", {"entities": []}], ["Until decision makers include robust, long term evaluations as part of their design and implementation of events, it is unclear how the costs of major multi-sport events can be justified in terms of benefits to the host population.", {"entities": []}], ["The burden of morbidity represented by patients with long term conditions (LTCs) varies substantially between general practices.", {"entities": []}], ["This study aimed to determine the characteristics of general practices with high morbidity burden.", {"entities": []}], ["Retrospective cross-sectional study; general practices in England, 2014/15.", {"entities": []}], ["Three composite morbidity measures (MMs) were constructed to quantify LTC morbidity at practice level: a count of LTCs derived from the 20 LTCs included in the UK Quality and Outcomes Framework (QOF) disease registers, expressed as \u2018number of QOF LTCs per 100 registered patients\u2019; the % of patients with one or more QOF LTCs; the % of patients with one or more of 15 broadly defined LTCs included in the GP Patient Survey (GPPS).", {"entities": []}], ["Determinants of MM scores were analysed using multi-level regression models.", {"entities": []}], ["Analysis was based on a national dataset of English general practices ( n \u2009=\u20097779 practices); GPPS responses ( n \u2009=\u2009903,357); general practice characteristics (e.g.", {"entities": []}], ["list size, list size per full time GP); patient demographic characteristics (age, deprivation status); secondary care utilisation (out-patient, emergency department, emergency admission rates).", {"entities": []}], ["Mean MM scores (95% CIs) were: 57.7 (\u00b122.3) QOF LTCs per 100 registered patients; 22.8% (\u00b18.2) patients with a QOF LTC; 63.5% (\u00b111.7) patients with a GPPS LTC.", {"entities": []}], ["The proportion of elderly patients and social deprivation scores were the strongest predictors of each MM score; scores were largely independent of practice characteristics.", {"entities": []}], ["MM scores were positive predictors of secondary care utilization and negative predictors\u2019 access, continuity of care and overall satisfaction.", {"entities": []}], ["Wide variation in LTC morbidity burden was observed across English general practice.", {"entities": []}], ["Variation was determined by demographic factors rather than practice characteristics.", {"entities": []}], ["Higher rates of secondary care utilisation in practices with higher morbidity burden have implications for resource allocation and commissioning budgets; lower reported satisfaction in these practices suggests that practices may struggle with increased workload.", {"entities": []}], ["There is a need for a readily available metric to define the burden of morbidity and multimorbidity in general practice.", {"entities": []}], ["Patients with non-affective psychotic disorders (NAPD) face higher risk of somatic problems and early natural death compared to the general population.", {"entities": []}], ["Therefore, treatment guidelines for schizophrenia and psychosis stress the importance of monitoring somatic risk factors.", {"entities": [[36, 49, "DISEASE"]]}], ["This study examined somatic Health Care utilization (HCu) of patients with NAPD compared to non-psychiatric controls and patients with depression, anxiety or bipolar disorders using a large Health Insurance database.", {"entities": []}], ["Results show lower specialist somatic HCu of patients with NAPD compared to matched controls and also lower percentages for prescribed somatic medication and general practitioner consultations for patients aged \u226560\u00a0years and after longer illness duration.", {"entities": []}], ["Protein-rich nutrition is necessary for wound healing after surgery.", {"entities": []}], ["In this study, the benefit of preoperative nutritional support was investigated for non-small cell lung cancer patients who underwent anatomic resection.", {"entities": [[99, 110, "DISEASE"], [104, 110, "DISEASE"]]}], ["A prospective study was planned with the approval of our institutional review board.", {"entities": []}], ["Fifty-eight patients who underwent anatomic resection in our department between January 2014 and December 2014 were randomized.", {"entities": []}], ["Thirty-one patients were applied a preoperative nutrition program with immune modulating formulae (enriched with arginine, omega-3 fatty acids and nucleotides) for ten days.", {"entities": []}], ["There were 27 patients in the control group who were fed with only normal diet.", {"entities": []}], ["Patients who were malnourished, diabetic or who had undergone bronchoplastic procedures or neoadjuvant therapy were excluded from the study.", {"entities": []}], ["Patients\u2019 baseline serum albumin levels, defined as the serum albumin level before any nutrition program, and the serum albumin levels on the postoperative third day were calculated and recorded with the other data.", {"entities": []}], ["Anatomic resection was performed by thoracotomy in 20 patients, and 11 patients were operated by videothoracoscopy in the nutrition program group.", {"entities": []}], ["On the other hand 16 patients were operated by thoracotomy and 11 patients were operated by videothoracoscopy in the control group.", {"entities": []}], ["In the control group, the patients\u2019 albumin levels decreased to 25.71\u00a0% of the baseline on the postoperative third day, but this reduction was only 14.69\u00a0% for nutrition program group patients and the difference was statistically significant ( p \u2009<\u20090.001).", {"entities": []}], ["Complications developed in 12 patients (44.4\u00a0%) in the control group compared to 6 patients in the nutrition group ( p \u2009=\u20090.049).", {"entities": []}], ["The mean chest tube drainage time was 6 (1\u201342) days in the control group against 4 (2\u201315) days for the nutrition program group ( p \u2009=\u20090.019).", {"entities": []}], ["Our study showed that preoperative nutrition is beneficial in decreasing the complications and chest tube removal time in non-small cell lung cancer patients that were applied anatomic resection with a reduction of 25\u00a0% in the postoperative albumin levels of non-malnourished patients who underwent resection.", {"entities": [[137, 148, "DISEASE"], [142, 148, "DISEASE"]]}], ["Lead exposure has been associated with higher blood pressure, hypertension, electrocardiogram abnormalities, and increased mortality from circulatory causes.", {"entities": [[62, 74, "DISEASE"]]}], ["We assessed the association between bone lead\u2014a more accurate biomarker of chronic lead exposure than blood lead\u2014and risk for future ischemic heart disease (IHD).", {"entities": [[133, 155, "DISEASE"], [142, 155, "DISEASE"]]}], ["In a prospective cohort study (VA Normative Aging Study), 837 men who underwent blood or bone lead measurements at baseline were followed-up for an ischemic heart disease event between 1 September 1991 and 31 December 2001.", {"entities": [[148, 170, "DISEASE"], [157, 170, "DISEASE"]]}], ["IHD was defined as either a diagnosis of myocardial infarction or angina pectoris that was confirmed by a cardiologist.", {"entities": [[41, 62, "DISEASE"]]}], ["Events of fatal myocardial infarction were assessed from death certificates.", {"entities": [[16, 37, "DISEASE"]]}], ["An IHD event occurred in 83 cases (70 nonfatal and 13 fatal).", {"entities": []}], ["The mean blood, tibia, and patella lead levels were higher in IHD cases than in noncases.", {"entities": []}], ["In multivariate Cox-proportional hazards models, one standard deviation increase in blood lead level was associated with a 1.27 (95% confidence interval, 1.01\u20131.59) fold greater risk for ischemic heart disease.", {"entities": [[187, 209, "DISEASE"], [196, 209, "DISEASE"]]}], ["Similarly, a one standard deviation increase in patella and tibia lead levels was associated with greater risk for IHD (hazard ratio for patella lead = 1.29; 95% confidence interval, 1.02\u20131.62).", {"entities": []}], ["Men with increased blood and bone lead levels were at increased risk for future IHD.", {"entities": []}], ["Although the pathogenesis of IHD is multifactorial, lead exposure may be one of the risk factors.", {"entities": []}], ["To develop quality indicators for the diagnosis and antibiotic treatment of acute respiratory tract infections, tailored to the Danish general practice setting.", {"entities": []}], ["A RAND/UCLA Appropriateness Method was used.", {"entities": []}], ["General practice.", {"entities": []}], ["A panel of nine experts, mainly general practitioners, was asked to rate the relevance of 64 quality indicators for the diagnosis and antibiotic treatment of acute respiratory tract infections based on guidelines.", {"entities": []}], ["Subsequently, a face-to-face meeting was held to resolve misinterpretations and to achieve consensus.", {"entities": []}], ["The experts were asked to rate the indicators on a nine-point Likert scale.", {"entities": []}], ["Consensus of appropriateness for a quality indicator was reached if the overall panel median rating was 7\u20139 with agreement.", {"entities": []}], ["A total of 50 of the 64 proposed quality indicators attained consensus.", {"entities": []}], ["Consensus was achieved for 12 indicators focusing on the diagnostic process and 19 indicators focusing on the decision about antibiotic treatment and choice of antibiotics, respectively.", {"entities": []}], ["These newly developed quality indicators may be used to strengthen Danish general practitioners\u2019 focus on their management of patients with acute respiratory tract infections and to identify where there is a need for future quality improvements.", {"entities": []}], ["Aims: To quantify the reduction potential of asthma in Finland achievable by adjusting exposures to selected environmental factors.", {"entities": [[45, 51, "DISEASE"]]}], ["Methods: A life table model for the Finnish population for 1986\u20132040 was developed and Years Lived with Disability caused by asthma and attributable to the following selected exposures were estimated: tobacco smoke (smoking and second hand tobacco smoke), ambient fine particles, indoor dampness and mould, and pets.", {"entities": [[125, 131, "DISEASE"]]}], ["Results: At baseline (2011) about 25% of the total asthma burden was attributable to the selected exposures.", {"entities": [[51, 57, "DISEASE"]]}], ["Banning tobacco was the most efficient mitigation action, leading to 6% reduction of the asthma burden.", {"entities": [[89, 95, "DISEASE"]]}], ["A 50% reduction in exposure to dampness and mould as well as a doubling in exposure to pets lead each to a 2% reduction.", {"entities": []}], ["Ban of urban small scale wood combustion, chosen as a mitigation action to reduce exposure to fine particles, leads to a reduction of less than 1% of the total asthma burden.", {"entities": [[160, 166, "DISEASE"]]}], ["Combination of the most efficient mitigation actions reduces the total asthma burden by 10%.", {"entities": [[71, 77, "DISEASE"]]}], ["A more feasible combination of mitigation actions leads to 6% reduction of the asthma burden.", {"entities": [[79, 85, "DISEASE"]]}], ["Conclusions: The adjustment of environmental exposures can reduce the asthma burden in Finland by up to 10%.", {"entities": [[70, 76, "DISEASE"]]}], ["\u201cAirwave\u201d is the new communication system currently being rolled out across the United Kingdom for the police and emergency services, based on the Terrestrial Trunked Radio Telecommunications System (TETRA).", {"entities": []}], ["Some police officers have complained about skin rashes, nausea, headaches, and depression as a consequence of using their Airwave handsets.", {"entities": []}], ["In addition, a small subgroup in the population self-report being sensitive to electromagnetic fields (EMFs) in general.", {"entities": []}], ["We conducted a randomized double-blind provocation study to establish whether short-term exposure to a TETRA base station signal has an impact on the health and well-being of individuals with self-reported \u201celectrosensitivity\u201d and of participants who served as controls.", {"entities": []}], ["Fifty-one individuals with self-reported electrosensitivity and 132 age- and sex-matched controls participated in an open provocation test; 48 sensitive and 132 control participants went on to complete double-blind tests in a fully screened semianechoic chamber.", {"entities": []}], ["Heart rate, skin conductance, and blood pressure readings provided objective indices of short-term physiological response.", {"entities": []}], ["Visual analog scales and symptom scales provided subjective indices of well-being.", {"entities": []}], ["We found no differences on any measure between TETRA and sham (no signal) under double-blind conditions for either controls or electrosensitive participants, and neither group could detect the presence of a TETRA signal at rates greater than chance (50%).", {"entities": []}], ["When conditions were not double blind, however, the self-reported electrosensitive individuals did report feeling worse and experienced more severe symptoms during TETRA compared with sham.", {"entities": []}], ["Our findings suggest that the adverse symptoms experienced by electrosensitive individuals are due to the belief of harm from TETRA base stations rather than to the low-level EMF exposure itself.", {"entities": []}], ["To determine whether IL4R single-nucleotide polymorphisms (SNPs) rs1805010 (I50V) and rs1801275 (Q551R), which have been associated with disease severity in rheumatoid arthritis (RA) patients of European ancestry, relate to the presence of rheumatoid nodules and radiographic erosions in African Americans.", {"entities": [[157, 177, "DISEASE"], [168, 177, "DISEASE"], [21, 25, "GENE"]]}], ["Two IL4R SNPs, rs1805010 and rs1801275, were genotyped in 749 patients from the Consortium for Longitudinal Evaluation of African-Americans with Early Rheumatoid Arthritis (CLEAR) registries.", {"entities": [[151, 171, "DISEASE"], [162, 171, "DISEASE"], [4, 8, "GENE"]]}], ["End points were rheumatoid nodules defined as present either by physical examination or by chest radiography and radiographic erosions (radiographs of hands/wrists and feet were scored using the modified Sharp/van der Heijde system).", {"entities": []}], ["Statistical analyses were performed by using logistic regression modeling adjusted for confounding factors.", {"entities": []}], ["Of the 749 patients with RA, 156 (20.8%) had rheumatoid nodules, with a mean age of 47.0 years, 84.6% female gender, and median disease duration of 1.9 years.", {"entities": []}], ["Of the 461 patients with available radiographic data, 185 (40.1%) had erosions (score >0); their mean age was 46.7 years; 83.3% were women; and median disease duration was 1.5 years.", {"entities": []}], ["Patients positive for HLA-DRB1 shared epitope (SE) and autoantibodies (rheumatoid factor (RF) or anti-cyclic citrullinated peptide (CCP)) had a higher risk of developing rheumatoid nodules in the presence of the AA and AG alleles of rs1801275 (odds ratio (OR) adj = 8.08 (95% confidence interval (CI): 1.60-40.89), P = 0.01 and OR adj = 2.97 (95% CI, 1.08 to 8.17), P = 0.04, respectively).", {"entities": [[22, 30, "GENE"]]}], ["Likewise, patients positive for the HLA-DRB1 SE and RF alone had a higher risk of developing rheumatoid nodules in presence of the AA and AG alleles of rs1801275 (OR adj = 8.45 (95% CI, 1.57 to 45.44), P = 0.01, and OR adj = 3.57 (95% CI, 1.18 to 10.76), P = 0.02, respectively) and in the presence of AA allele of rs1805010 (OR adj = 4.52 (95% CI, 1.20 to 17.03), P = 0.03).", {"entities": [[36, 44, "GENE"]]}], ["No significant association was found between IL4 R and radiographic erosions or disease susceptibility, although our statistical power was limited by relatively small numbers of cases and controls.", {"entities": [[45, 48, "GENE"]]}], ["We found that IL4R SNPs, rs1801275 and rs1805010, are associated with rheumatoid nodules in autoantibody-positive African-American RA patients with at least one HLA-DRB1 allele encoding the SE.", {"entities": [[14, 18, "GENE"], [161, 169, "GENE"]]}], ["These findings highlight the need for analysis of genetic factors associated with clinical RA phenotypes in different racial/ethnic populations.", {"entities": []}], ["Carbon nanotubes (CNTs) are engineered graphene cylinders with numerous applications in engineering, electronics and medicine.", {"entities": []}], ["However, CNTs cause inflammation and fibrosis in the rodent lung, suggesting a potential human health risk.", {"entities": []}], ["We hypothesized that multi-walled CNTs (MWCNTs) induce two key inflammatory enzymes in macrophages, cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), through activation of extracellular signal-regulated kinases (ERK1,2).", {"entities": []}], ["RAW264.7 macrophages were exposed to MWCNTs or carbon black nanoparticles (CBNPs) over a range of doses and time course.", {"entities": []}], ["Uptake and subcellular localization of MWCNTs was visualized by transmission electron microscopy (TEM).", {"entities": []}], ["Protein levels of COX-2, iNOS, and ERK1,2 (total ERK and phosphorylated ERK) were measured by Western blot analysis.", {"entities": []}], ["Prostaglandin-E 2 (PGE 2 ) and nitric oxide (NO) levels in cell supernatants were measured by ELISA and Greiss assay, respectively.", {"entities": []}], ["MWCNTs, but not CBNPs, induced COX-2 and iNOS in a time- and dose-dependent manner.", {"entities": []}], ["COX-2 and iNOS induction by MWCNTs correlated with increased PGE 2 and NO production, respectively.", {"entities": []}], ["MWCNTs caused ERK1,2 activation and inhibition of ERK1,2 (U0126) blocked MWCNT induction of COX-2 and PGE 2 production, but did not reduce the induction of iNOS.", {"entities": []}], ["Inhibition of iNOS (L-NAME) did not affect ERK1,2 activation, nor did L-NAME significantly decrease COX-2 induction by MWCNT.", {"entities": []}], ["Nickel nanoparticles (NiNPs), which are present in MWCNTs as a residual catalyst, also induced COX-2 via ERK-1,2.", {"entities": []}], ["However, a comparison of COX-2 induction by MWCNTs containing 4.5 and 1.8% Ni did not show a significant difference in ability to induce COX-2, indicating that characteristics of MWCNTs in addition to Ni content contribute to COX-2 induction.", {"entities": []}], ["This study identifies COX-2 and subsequent PGE 2 production, along with iNOS induction and NO production, as inflammatory mediators involved in the macrophage response to MWCNTs.", {"entities": []}], ["Furthermore, our work demonstrates that COX-2 induction by MWCNTs in RAW264.7 macrophages is ERK1,2-dependent, while iNOS induction by MWCNTs is ERK1,2-independent.", {"entities": []}], ["Our data also suggest contributory physicochemical factors other than residual Ni catalyst play a role in COX-2 induction to MWCNT.", {"entities": []}], ["Therapeutic human papillomavirus (HPV) vaccines are currently being developed.", {"entities": []}], ["However, no therapeutic efficacy has been achieved in clinical trials for the treatment of cervical intraepithelial neoplasia or cancer.", {"entities": [[129, 135, "DISEASE"]]}], ["One of the important issues in increasing vaccine efficacy is determining the best way to enhance tumor antigen-specific cellular immune responses.", {"entities": []}], ["This study aimed to explore the virus-like particles (VLPs) of hepatitis B core antigen (HBcAg) as potential therapeutic vaccine carriers and to assess its immunological characteristics.", {"entities": [[63, 72, "DISEASE"]]}], ["Chimeric VLPs presenting a HPV 16 cytotoxic T lymphocytes epitope E7 49\u201357 (amino acid 49\u201357 of the E7 protein) were prepared using recombinant genes.", {"entities": []}], ["C57BL/6 mice were immunized with VLPs and grafted with tumor cells TC-1 which is an E7-expressing tumorigenic cell line.", {"entities": []}], ["The dynamic tumor growth was monitored and anti-tumor immune responses were investigated.", {"entities": []}], ["Using a preventive strategy, immunization with VLPs resulted in nearly complete suppression of tumor growth.", {"entities": []}], ["In treatment studies, VLP immunization significantly suppressed the tumor progression in mice carrying 2\u20133 mm tumors and in those bearing even larger tumors with diameters up to 8\u20139 mm.", {"entities": []}], ["The VLP structure was shown to be important to induce vigorous antitumor immunity and effects.", {"entities": []}], ["In immunized mice, enhanced E7 49\u201357 -specific cellular immune responses were evidenced by increased interferon (IFN)-\u03b3 expression and decreased interleukin (IL)-4 expression in splenic lymphocytes, as well as an elevated number of effector cells expressing IFN-\u03b3 in response to the in vitro stimulation of the specific peptide E7 49\u201357 .", {"entities": []}], ["In addition, effective immune memory after VLP immunization was maintained for at least 16 weeks, preventing significant tumor growth after subsequent TC-1 challenge.", {"entities": []}], ["While VLPs were highly immunogenic in stimulating humoral immunity, our results strongly indicated that VLPs, such as HBcAg particles, might also be potent therapeutic vaccine carriers to elicit robust cellular immune responses, even in the immunosuppressive microenvironment of a tumor.", {"entities": []}], ["The involvement of \u03b2 2 -adrenergic receptor (ADRB2) and \u03b2 3 -adrenergic receptor (ADRB3) in both adipocyte lipolysis and thermogenic activity suggests that polymorphisms in the encoding genes might be linked with interindividual variation in obesity, an important risk factor for postmenopausal breast cancer.", {"entities": [[295, 308, "DISEASE"], [242, 249, "DISEASE"], [302, 308, "DISEASE"], [45, 50, "GENE"], [82, 87, "GENE"]]}], ["In order to examine the hypothesis that genetic variations in ADRB2 and ADRB3 represent interindividual susceptibility factors for obesity and breast cancer, we conducted a hospital-based, case-control study in the Aichi Cancer Center, Japan.", {"entities": [[143, 156, "DISEASE"], [131, 138, "DISEASE"], [150, 156, "DISEASE"], [221, 227, "DISEASE"], [62, 67, "GENE"], [72, 77, "GENE"]]}], ["A self-administered questionnaire was given to 200 breast cancer patients and 182 control individuals, and pertinent information on lifestyle, family history and reproduction was collected.", {"entities": [[51, 64, "DISEASE"], [58, 64, "DISEASE"]]}], ["ADRB2 and ADRB3 genotypes were determined by polymerase chain reaction (PCR) restriction fragment length polymorphism assessment.", {"entities": [[0, 5, "GENE"], [10, 15, "GENE"]]}], ["Twenty-five (12.4%) breast cancer patients and 32 (17.6%) control individuals were found to bear a glutamic acid (Glu) allele for the ADRB2 gene (odds ratio [OR] 0.67, 95% confidence interval [CI] 0.38-1.18), and 60 (30.0%) breast cancer patients and 61 (33.5%) control individuals were found to bear an Arg allele for the ADRB3 gene (OR 0.85, 95% CI 0.55-1.31).", {"entities": [[20, 33, "DISEASE"], [224, 237, "DISEASE"], [27, 33, "DISEASE"], [231, 237, "DISEASE"], [134, 139, "GENE"], [323, 328, "GENE"]]}], ["A significantly lower risk was observed in those who carried the Glu ADRB2 allele and who reported first childbirth when they were younger than 25 years (OR 0.35; 95% CI 0.13-0.99).", {"entities": [[69, 74, "GENE"]]}], ["A potential association may exist between risk of breast cancer and polymorphisms in the ADRB2 and ADRB3 genes; further studies in larger samples and/or in different ethnic groups are warranted to investigate this potential association.", {"entities": [[50, 63, "DISEASE"], [57, 63, "DISEASE"], [89, 94, "GENE"], [99, 104, "GENE"]]}], ["The Geospatial Determinants of Health Outcomes Consortium (GeoDHOC) study investigated ambient air quality across the international border between Detroit, Michigan, USA and Windsor, Ontario, Canada and its association with acute asthma events in 5- to 89-year-old residents of these cities.", {"entities": [[230, 236, "DISEASE"]]}], ["NO 2 , SO 2 , and volatile organic compounds (VOCs) were measured at 100 sites, and particulate matter (PM) and polycyclic aromatic hydrocarbons (PAHs) at 50 sites during two 2-week sampling periods in 2008 and 2009.", {"entities": []}], ["Acute asthma event rates across neighborhoods in each city were calculated using emergency room visits and hospitalizations and standardized to the overall age and gender distribution of the population in the two cities combined.", {"entities": [[6, 12, "DISEASE"]]}], ["Results demonstrate that intra-urban air quality variations are related to adverse respiratory events in both cities.", {"entities": []}], ["Annual 2008 asthma rates exhibited statistically significant positive correlations with total VOCs and total benzene, toluene, ethylbenzene and xylene (BTEX) at 5-digit zip code scale spatial resolution in Detroit.", {"entities": [[12, 18, "DISEASE"]]}], ["In Windsor, NO 2 , VOCs, and PM 10 concentrations correlated positively with 2008 asthma rates at a similar 3-digit postal forward sortation area scale.", {"entities": [[82, 88, "DISEASE"]]}], ["The study is limited by its coarse temporal resolution (comparing relatively short term air quality measurements to annual asthma health data) and interpretation of findings is complicated by contrasts in population demographics and health-care delivery systems in Detroit and Windsor.", {"entities": [[123, 129, "DISEASE"]]}], ["Inhalation of antigen in immunized mice induces an infiltration of eosinophils into the airways and increased bronchial hyperreactivity as are observed in human asthma.", {"entities": [[161, 167, "DISEASE"]]}], ["We employed a model of late-phase allergic pulmonary inflammation in mice to address the role of leukotrienes (LT) in mediating airway eosinophilia and hyperreactivity to methacholine.", {"entities": [[135, 147, "DISEASE"], [111, 113, "GENE"]]}], ["Allergen intranasal challenge in OVA-sensitized mice induced LTB4 and LTC4 release into the airspace, widespread mucus occlusion of the airways, leukocytic infiltration of the airway tissue and broncho-alveolar lavage fluid that was predominantly eosinophils, and bronchial hyperreactivity to methacholine.", {"entities": []}], ["Specific inhibitors of 5- lipoxygenase and 5-lipoxygenase-activating protein (FLAP) blocked airway mucus release and infiltration by eosinophils indicating a key role for leukotrienes in these features of allergic pulmonary inflammation.", {"entities": []}], ["The role of leukotrienes or eosinophils in mediating airway hyperresponsiveness to aeroallergen could not be established, however, in this murine model.", {"entities": []}], ["The effects of air cleaners on the removal of airborne indoor allergens, especially house dust mites (HDM), are still controversial.", {"entities": []}], ["The objective of this study is to evaluate the effect of an air cleaner with an electrostatic filter on the removal of airborne mite allergens.", {"entities": []}], ["A dried HDM culture medium that contained mite body particles and excretions was dispersed in a chamber equipped with an electrostatic air cleaner.", {"entities": []}], ["The number of airborne particles was recorded continuously by a dust spectrometer for 60 minutes.", {"entities": []}], ["Airborne particles in the chamber were collected on a sampling filter at a flow rate of 10 L/min and the Der f 1 concentration in the filter extracts was measured by two-site ELISA.", {"entities": []}], ["The air cleaner efficiently removed airborne HDM particles.", {"entities": []}], ["The air cleaner removed airborne HDM particles (size 2-12.5 \u00b5m) 11.4 \u00b1 2.9 fold (cleaner operating for 15 minutes), 5.4 \u00b1 0.7 fold (cleaner operating for 30 minutes), and 2.4 \u00b1 0.2 fold (cleaner operating for 60 minutes) more than the removal of HDM particles by natural settle down.", {"entities": []}], ["Removal kinetics differed according to the particle size of the airborne particles.", {"entities": []}], ["The air cleaner decreased the concentration of Der f 1 in the extraction of airborne particles collected on the air sampling filter by 60.3%.", {"entities": []}], ["The electrostatic air cleaner can remove airborne HDM allergens and may be useful as a supplementary environmental control tool for HDM sensitized respiratory allergic patients.", {"entities": []}], ["Prostaglandins (PGs) can enhance or suppress inflammation by acting on different receptors expressed by hematopoietic and nonhematopoietic cells.", {"entities": []}], ["Prostaglandin D 2 binds to the D prostanoid (DP)1 and DP2 receptor and is seen as a critical mediator of asthma causing vasodilation, bronchoconstriction, and inflammatory cell influx.", {"entities": [[105, 111, "DISEASE"]]}], ["Here we show that inhalation of a selective DP1 agonist suppresses the cardinal features of asthma by targeting the function of lung dendritic cells (DCs).", {"entities": [[92, 98, "DISEASE"]]}], ["In mice treated with DP1 agonist or receiving DP1 agonist-treated DCs, there was an increase in Foxp3", {"entities": [[96, 101, "GENE"]]}], ["Overweight and obesity affect ~1.5 billion people worldwide, and are major risk factors for type-2 diabetes (T2D), cardiovascular disease and related metabolic and inflammatory disturbances.", {"entities": [[15, 22, "DISEASE"]]}], ["Finally, we show that the disturbances in DNA methylation predict future type-2 diabetes (relative risk per 1SD increase in Methylation Risk Score: 2.3 [2.07-2.56]; P=1.1x10", {"entities": []}], ["The Adverse Outcome Pathway (AOP) framework represents a valuable conceptual tool to systematically integrate existing toxicological knowledge from a mechanistic perspective to facilitate predictions of chemical-induced effects across species.", {"entities": []}], ["However, its application for decision-making requires the transition from qualitative to quantitative AOP (qAOP).", {"entities": []}], ["Here we used a fish model and the synthetic glucocorticoid beclomethasone dipropionate (BDP) to investigate the role of chemical-specific properties, pharmacokinetics, and internal exposure dynamics in the development of qAOPs.", {"entities": []}], ["We generated a qAOP network based on drug plasma concentrations and focused on immunodepression, skin androgenisation, disruption of gluconeogenesis and reproductive performance.", {"entities": []}], ["We showed that internal exposure dynamics and chemical-specific properties influence the development of qAOPs and their predictive power.", {"entities": []}], ["Comparing the effects of two different glucocorticoids, we highlight how relatively similar in vitro hazard-based indicators can lead to different in vivo risk.", {"entities": []}], ["This discrepancy can be predicted by their different uptake potential, pharmacokinetic (PK) and pharmacodynamic (PD) profiles.", {"entities": []}], ["We recommend that the development phase of qAOPs should include the application of species-species uptake and physiologically-based PK/PD models.", {"entities": []}], ["This integration will significantly enhance the predictive power, enabling a more accurate assessment of the risk and the reliable transferability of qAOPs across chemicals.", {"entities": []}], ["To investigate whether eosinophilic bronchitis without airway hyperresponsiveness will develop bronchial asthma in allergic mice.", {"entities": [[105, 111, "DISEASE"], [36, 46, "DISEASE"]]}], ["Mice were sensitized with OVA on days 0, 7, and 14, challenged on days 21 to 23 (1 L ) was assessed 24 h after each challenge and on day 45 followed by analysis of leukocyte distribution in the bronchoalveolar lavage (BAL) fluid and histological examination.", {"entities": []}], ["Twenty-four hours after the 1 L in all groups.", {"entities": []}], ["At doses \u22651.56 mg/mL, R L in the AS group was significantly higher than that of the NS-1 group ( P <0.01 or 0.05) and at doses \u226512.5 mg/mL, R L was markedly higher in the AS group than that of the EB group ( P <0.01).", {"entities": []}], ["The percentage of eosinophils in both the EB group and the AS group was markedly higher than that of the control group.", {"entities": []}], ["Twenty-four hours after the 2 L among all groups ( P >0.05).", {"entities": []}], ["At doses \u226512.5 mg/mL, R L in the AS group was significantly higher than that of the control group and EB group ( P <0.01 or 0.05).", {"entities": []}], ["The percentage of eosinophils in the AS group was noticeably higher than that of the EB group( P <0.05).", {"entities": []}], ["Furthermore, there was apparent infiltration by inflammatory cells, predominantly eosinophils, into the sub-epithelial region of the bronchus and the bronchioles and around the vessels in the EB and AS group.", {"entities": []}], ["Re-challenge with low doses of ovalbumin did not increase airway reactivity and failed to induce bronchial asthma in mice with ovalbumin-induced EB.", {"entities": [[107, 113, "DISEASE"]]}], ["There is a lack of evidence to inform policy development on the reasons why health professionals migrate.", {"entities": []}], ["Few studies have sought to empirically determine factors influencing the intention to migrate and none have explored the relationship between factors.", {"entities": []}], ["This paper reports on the first international attempt to investigate the migration intentions of pharmacy students and identify migration factors and their relationships.", {"entities": []}], ["Responses were gathered from 791 final-year pharmacy students from nine countries: Australia, Bangladesh, Croatia, Egypt, Portugal, Nepal, Singapore, Slovenia and Zimbabwe.", {"entities": []}], ["Data were analysed by means of Principal Components Analysis (PCA) and two-step cluster analysis to determine the relationships between factors influencing migration and the characteristics of subpopulations most likely and least likely to migrate.", {"entities": []}], ["Results showed a significant difference in attitudes towards the professional and sociopolitical environment of the home country and perceptions of opportunities abroad between those who have no intention of migrating and those who intend to migrate on a long-term basis.", {"entities": []}], ["Attitudes of students planning short-term migration were not significantly different from those of students who did not intend to migrate.", {"entities": []}], ["These attitudes, together with gender, knowledge of other migrant pharmacists and past experiences abroad, are associated with an increased propensity for migration.", {"entities": []}], ["Given the influence of the country context and environment on migration intentions, research and policy should frame the issue of migration in the context of the wider human resource agenda, thus viewing migration as one form of attrition and a symptom of other root causes.", {"entities": []}], ["Remuneration is not an independent stand-alone factor influencing migration intentions and cannot be decoupled from professional development factors.", {"entities": []}], ["Comprehensive human resource policy development that takes into account the issues of both remuneration and professional development are necessary to encourage retention.", {"entities": []}], ["The Hypogonadism in Males study estimated the prevalence of hypogonadism [total testosterone (TT) <300 ng/dl] in men aged \u226545 years visiting primary care practices in the United States.", {"entities": [[4, 16, "DISEASE"], [60, 72, "DISEASE"]]}], ["A blood sample was obtained between 8 am and noon and assayed for TT, free testosterone (FT) and bioavailable testosterone (BAT).", {"entities": []}], ["Common symptoms of hypogonadism, comorbid conditions, demographics and reason for visit were recorded.", {"entities": [[19, 31, "DISEASE"]]}], ["Of 2162 patients, 836 were hypogonadal, with 80 receiving testosterone.", {"entities": []}], ["Crude prevalence rate of hypogonadism was 38.7%.", {"entities": [[25, 37, "DISEASE"]]}], ["Similar trends were observed for FT and BAT.", {"entities": []}], ["Among men not receiving testosterone, 756 (36.3%) were hypogonadal; odds ratios for having hypogonadism were significantly higher in men with hypertension (1.84), hyperlipidaemia (1.47), diabetes (2.09), obesity (2.38), prostate disease (1.29) and asthma or chronic obstructive pulmonary disease (1.40) than in men without these conditions.", {"entities": [[142, 154, "DISEASE"], [258, 295, "DISEASE"], [204, 211, "DISEASE"], [220, 236, "DISEASE"], [91, 103, "DISEASE"], [248, 254, "DISEASE"]]}], ["The prevalence of hypogonadism was 38.7% in men aged \u226545 years presenting to primary care offices.", {"entities": [[18, 30, "DISEASE"]]}], ["To examine whether in utero exposure to local and systemic corticosteroids is associated with asthma development in offspring.", {"entities": [[94, 100, "DISEASE"]]}], ["Cohort study.", {"entities": []}], ["We included all singletons born alive in Denmark between 1996 and 2009.", {"entities": []}], ["Data on maternal corticosteroid use, asthma in offspring and covariates were obtained from medical registries.", {"entities": [[37, 43, "DISEASE"]]}], ["We compared asthma risks of children prenatally exposed to corticosteroids and of children of former corticosteroid users with that of unexposed children.", {"entities": [[12, 18, "DISEASE"]]}], ["We computed absolute risks and used proportional-hazards regression to compute adjusted HRs (aHRs).", {"entities": []}], ["Using logistic regression we compared exposed children with unexposed siblings in a \u2018within-mother-between-pregnancy\u2019 analysis.", {"entities": []}], ["Adjustment addressed varying length of follow-up.", {"entities": []}], ["We identified 877\u2005778 children, 3.6% of whom were prenatally exposed to systemic (n=5327) or local (n=24\u2005436) corticosteroids.", {"entities": []}], ["A total of 105\u2005677 children developed asthma during follow-up with a 10-year risk of 18.4% among the exposed and 13.5% among the unexposed.", {"entities": [[38, 44, "DISEASE"]]}], ["The aHR was 1.54 (95% CI 1.45 to 1.65) for systemic use, 1.45 (95% CI 1.40 to 1.50) for local use and 1.32 (95% CI 1.30 to 1.34) for former use.", {"entities": [[4, 7, "GENE"]]}], ["The adjusted OR of the \u2018within-mother-between-pregnancy\u2019 analysis was 1.11 (95% CI 0.98 to 1.25).", {"entities": []}], ["These population-based data do not support a strong causal association between maternal corticosteroid use during pregnancy and increased asthma risk in offspring.", {"entities": [[138, 144, "DISEASE"]]}], ["To evaluate the risks of medical conditions, evaluate gastric sleeve narrowing, and assess hydrostatic balloon dilatation to treat dysphagia after vertical sleeve gastrectomy (VSG).", {"entities": []}], ["VSG is being performed more frequently worldwide as a treatment for medically-complicated obesity, and dysphagia is common post-operatively.", {"entities": [[90, 97, "DISEASE"]]}], ["We hypothesize that post-operative dysphagia is related to underlying medical conditions or narrowing of the gastric sleeve.", {"entities": []}], ["This is a retrospective, single institution study of consecutive patients who underwent sleeve gastrectomy from 2013 to 2015.", {"entities": []}], ["Patients with previous bariatric procedures were excluded.", {"entities": []}], ["Narrowing of a gastric sleeve includes: inability to pass a 9.6 mm gastroscope due to stenosis or sharp angulation or spiral hindering its passage.", {"entities": []}], ["Of 400 consecutive patients, 352 are included; the prevalence of dysphagia is 22.7%; 33 patients (9.3%) have narrowing of the sleeve with 25 (7.1%) having sharp angulation or a spiral while 8 (2.3%) have a stenosis.", {"entities": []}], ["All 33 patients underwent balloon dilatation of the gastric sleeve and dysphagia resolved in 13 patients (39%); 10 patients (30%) noted resolution of dysphagia after two additional dilatations.", {"entities": []}], ["In a multivariate model, medical conditions associated with post-operative dysphagia include diabetes mellitus, symptoms of esophageal reflux, a low whole blood thiamine level, hypothyroidism, use of non-steroidal anti-inflammatory drugs, and use of opioids.", {"entities": [[177, 191, "DISEASE"], [93, 110, "DISEASE"]]}], ["Narrowing of the gastric sleeve and gastric sleeve stenosis are common after VSG.", {"entities": []}], ["Endoscopic balloon dilatations of the gastric sleeve resolves dysphagia in 69% of patients.", {"entities": []}], ["Global trade has increased nearly 100-fold since 1950, according to the World Trade Organization.", {"entities": []}], ["Today, major changes in trade are occurring with the advent of mega-ships that can transport thousands more containers than cargo ships now in use.", {"entities": []}], ["Because global trade is expected to increase dramatically, the railroad industry\u2014in the U.S. alone\u2014has invested more than $5 billion a year over the past decade to expand rail yards and enhance rail routes to transport goods from ports to retail destinations.", {"entities": []}], ["This article describes cancer risks for residents living in close proximity to rail yards with emissions of diesel particulate matter pollution from locomotives, trucks and yard equipment.", {"entities": [[23, 29, "DISEASE"]]}], ["The article examines the demographics (income, race/ethnicity) of populations living in the highest estimated cancer risk zones near 18 major rail yards in California, concluding that the majority are over-represented by either lower-income or minority residents (or both).", {"entities": [[110, 116, "DISEASE"]]}], ["The authors also describe a review of the news media and environmental impact reports to determine if rail yards are still being constructed or expanded in close proximity to homes and schools or in working class/working poor communities of color.", {"entities": []}], ["The paper suggests policy efforts that might provide more public health protection and result in more \u201cenvironmentally just\u201d siting of rail yards.", {"entities": []}], ["The authors conclude that diesel pollution from rail yards, which creates significant diesel cancer risks for those living near the facilities, is an often overlooked public health, health disparities and environmental justice issue in the U.S.", {"entities": [[93, 99, "DISEASE"]]}], ["The conclusions are relevant to other countries where international trade is increasing and large new intermodal rail facilities are being considered.", {"entities": []}], ["To compare the prevalences of and risk factors for asthma, wheeze, hay fever and eczema in primary schoolchildren in Aberdeen in 2014.", {"entities": [[51, 57, "DISEASE"]]}], ["Cross-sectional survey.", {"entities": []}], ["Primary schools in Aberdeen, North-East Scotland.", {"entities": []}], ["Children in Scottish school years primary 1\u20137 were handed a questionnaire by their class teacher to be completed by their parents and returned to the researchers by post or online.", {"entities": []}], ["Lifetime history of asthma, eczema and hay fever, and recent history of wheeze.", {"entities": [[20, 26, "DISEASE"]]}], ["41 schools agreed to participate (87%).", {"entities": []}], ["11\u2005249 questionnaires were distributed and 3935 returned (35%).", {"entities": []}], ["A parent-reported lifetime history of asthma, eczema and hay fever was present in 14%, 30% and 24% of children, respectively.", {"entities": [[38, 44, "DISEASE"]]}], ["The odds of lifetime asthma increased with age (OR 1.1 per year, 95% CI 1.1 to 1.2), male sex (OR 1.89, 95% CI 1.4 to 2.3), parental smoking (OR 1.7, 95% CI 1.2 to 2.3) and eczema (OR 6.6, 95% CI 5.2 to 8.4).", {"entities": [[21, 27, "DISEASE"]]}], ["Prevalence of recent wheeze was also reported to be 14% and was positively associated with male sex, parental smoking and eczema.", {"entities": []}], ["In contrast, parental eczema was the only identified predictor of childhood eczema risk.", {"entities": []}], ["The lifetime prevalence of asthma in primary schoolchildren was 14% in this survey, approximately half the prevalence of eczema.", {"entities": [[27, 33, "DISEASE"]]}], ["We report diverging prevalences in relation to previous studies in our locality, and different risk factors for asthma and eczema.", {"entities": [[112, 118, "DISEASE"]]}], ["These findings suggest that asthma and eczema are unlikely to have a common origin.", {"entities": [[28, 34, "DISEASE"]]}], ["\u2022 Small molecule analogues (SMAs) of the immunomodulator, ES-62, have been produced.", {"entities": []}], ["\u2022 Two SMAs protect against oxazolone-induced skin inflammation in mouse ears.", {"entities": []}], ["\u2022 Protection is associated with reduced cellular infiltration and collagen deposition.", {"entities": []}], ["\u2022 Protection is associated with decreased IFN\u03b3 mRNA in the ears.", {"entities": []}], ["Small molecule analogues (SMAs) of the immunomodulator, ES-62, have been produced.", {"entities": []}], ["Two SMAs protect against oxazolone-induced skin inflammation in mouse ears.", {"entities": []}], ["Protection is associated with reduced cellular infiltration and collagen deposition.", {"entities": []}], ["Protection is associated with decreased IFN\u03b3 mRNA in the ears.", {"entities": []}], ["ES-62 is the major secreted protein of the rodent filarial nematode Acanthocheilonema viteae .", {"entities": []}], ["The molecule contains covalently attached phosphorylcholine (PC) residues, which confer anti-inflammatory properties on ES-62, underpinning the idea that drugs based on this active moiety may have therapeutic potential in human diseases associated with aberrant inflammation.", {"entities": [[61, 63, "GENE"]]}], ["Here we demonstrate that two synthetic small molecule analogues (SMAs) of ES-62 termed SMA 11a and SMA 12b are protective in the oxazolone-induced acute allergic contact dermatitis mouse model of skin inflammation, as measured by a significant reduction in ear inflammation following their administration before oxazolone sensitisation and before oxazolone challenge.", {"entities": [[162, 180, "DISEASE"], [153, 180, "DISEASE"], [170, 180, "DISEASE"]]}], ["Furthermore, it was found that when tested, 12b was effective at reducing ear swelling even when first administered before challenge.", {"entities": []}], ["Histological analysis of the ears showed elevated cellular infiltration and collagen deposition in oxazolone-treated mice both of which were reduced by treatment with the two SMAs.", {"entities": []}], ["Likewise, the oxazolone-induced increase in IFN\u03b3 mRNA in the ears was reduced but no effect on other cytokines investigated was observed.", {"entities": []}], ["Finally, no influence on the mast cell populations in the ear was observed.", {"entities": []}], ["Previous studies have investigated the relationship between GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and bladder cancer (BCa) susceptibility, respectively, but the results remain inconsistent.", {"entities": [[117, 123, "DISEASE"], [60, 65, "GENE"], [67, 72, "GENE"], [74, 79, "GENE"], [85, 90, "GENE"]]}], ["So, we conducted this meta-analysis including 79 case\u2013control studies to explore such relationships.", {"entities": []}], ["We searched PubMed, EMBASE, Cochrane library, Web of Science, and CNKI for relevant available studies.", {"entities": []}], ["The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were implemented to evaluate the intensity of associations.", {"entities": []}], ["Publication bias was estimated using Begg funnel plots and Egger regression test.", {"entities": []}], ["To assess the stability of the results, we used sensitivity analysis with the method of calculating the results again by omitting 1 single study each time.", {"entities": []}], ["Between-study heterogeneity was tested using the I No significant association between GSTA1 polymorphism and BCa susceptibility (OR\u200a=\u200a1.05, 95% CI 0.83\u20131.33) was noted.", {"entities": [[86, 91, "GENE"]]}], ["Besides, meaningful association between individuals who carried the GSTM1 null genotype and increased BCa risk was detected (OR\u200a=\u200a1.39, 95%CI 1.28\u20131.51).", {"entities": [[68, 73, "GENE"]]}], ["When stratified by ethnicity, significant difference was found in both Caucasian (OR\u200a=\u200a1.39, 95% CI 1.23\u20131.58) and Asian populations (OR\u200a=\u200a1.45, 95% CI 1.31\u20131.61).", {"entities": []}], ["Moreover, in the subgroup analysis by source of controls (SOC), the results were significant in both hospital-based control groups (OR\u200a=\u200a1.49, 95% CI 1.35\u20131.64) and population-based control groups (OR\u200a=\u200a1.21, 95% CI\u200a=\u200a1.07\u20131.37).", {"entities": []}], ["Additionally, the analysis revealed no significant association between GSTP1 polymorphism and BCa risk (OR\u200a=\u200a1.07, 95% CI 0.96\u20131.20).", {"entities": [[71, 76, "GENE"]]}], ["What is more, significant associations between GSTT1 polymorphism and BCa susceptibility were discovered (OR\u200a=\u200a1.11, 95% CI 1.00\u20131.22).", {"entities": [[47, 52, "GENE"]]}], ["In the subgroup analysis by ethnicity, significant associations between GSTT1 null genotype and BCa risk were observed only in Caucasians (OR\u200a=\u200a1.25, 95% CI 1.09\u20131.44).", {"entities": [[72, 77, "GENE"]]}], ["Furthermore, when stratified by SOC, no obvious relationship was found between the GSTT1 null genotype polymorphism with hospital-based population (OR\u200a=\u200a1.11, 95% CI 0.97\u20131.28) or population-based population (OR\u200a=\u200a1.10, 95% CI 0.96\u20131.27).", {"entities": [[83, 88, "GENE"]]}], ["This study suggested that GSTM1 null genotype and GSTT1 null genotype might be related to higher BCa risk, respectively.", {"entities": [[26, 31, "GENE"], [50, 55, "GENE"]]}], ["However, no associations were observed between GSTA1 or GSTP1 polymorphisms and BCa susceptibility.", {"entities": [[47, 52, "GENE"], [56, 61, "GENE"]]}], ["Three tesla (3T) coronary magnetic resonance angiography (MRA) may be optimized using gadolinium-based contrast agents (GBCA) such as gadofosveset trisodium.", {"entities": []}], ["The goal of this study was to evaluate if there is a qualitative or quantitative improvement in the coronary arteries with variation in contrast dose.", {"entities": []}], ["Twenty-eight healthy volunteers were prospectively recruited for coronary MRA at 3T using a steady state injection technique for 3D radial whole-heart image acquisition with retrospective respiratory self-gating (ClinicalTrials.gov identifier: NCT01853592).", {"entities": []}], ["Nineteen volunteers completed both single- and double-dose imaging instances (0.03 and 0.06 mmol/kg, respectively).", {"entities": []}], ["Intra-individual comparison of image quality was assessed by measurement of apparent signal/contrast-to-noise ratio (aSNR/aCNR) and subjective evaluation of image quality by 2 independent reviewers.", {"entities": []}], ["The average duration of coronary MRA acquisition was 7.2 \u00b1 1.2 min.", {"entities": []}], ["There was significantly higher (60 %, p < 0.001) aSNR of the aorta and right/left ventricle for the double dose compared to single dose injection scheme and aSNR of the coronary arteries increased by 70 % ( p < 0.001) for the double dose injection.", {"entities": []}], ["aCNR increased by +55 % and +60 % in the ventricles and coronary arteries, respectively ( p < 0.001).", {"entities": []}], ["Overall segmental artery visualization for single dose was possible 47 % of the time, which improved to 60 % with double dose ( p = 0.019), predominantly driven by improvements in more distal segment visualization (+40 % improvement in mid arterial segments, p = 0.013).", {"entities": []}], ["Gadofosveset trisodium dose of 0.06 mmol/kg significantly quantitatively and qualitatively improves the coronary artery image quality compared to 0.03 mmol/kg at 3T for moderate duration (6\u20138 min) steady state contrast enhanced coronary MRA.", {"entities": []}], ["Recently the vagal output of the central nervous system has been shown to suppress the innate immune defense to pathogens.", {"entities": []}], ["Here we investigated by anatomical and physiological techniques the communication of the brain with the spleen and provided evidence that the brain has the capacity to stimulate the production of antigen specific antibodies by its parasympathetic autonomic output.", {"entities": []}], ["This conclusion was reached by successively demonstrating that: 1.", {"entities": []}], ["The spleen receives not only sympathetic input but also parasympathetic input.", {"entities": []}], ["Intravenous trinitrophenyl-ovalbumin (TNP-OVA) does not activate the brain and does not induce an immune response.", {"entities": []}], ["Intravenous TNP-OVA with an inducer of inflammation; lipopolysaccharide (LPS), activates the brain and induces TNP-specific IgM.", {"entities": []}], ["LPS activated neurons are in the same areas of the brain as those that provide parasympathetic autonomic information to the spleen, suggesting a feed back circuit between brain and immune system.", {"entities": []}], ["Consequently we investigated the interaction of the brain with the spleen and observed that specific parasympathetic denervation but not sympathetic denervation of the spleen eliminates the LPS-induced antibody response to TNP-OVA.", {"entities": []}], ["These findings not only show that the brain can stimulate antibody production by its autonomic output, it also suggests that the power of LPS as adjuvant to stimulate antibody production may also depend on its capacity to activate the brain.", {"entities": []}], ["The role of the autonomic nervous system in the stimulation of the adaptive immune response may explain why mood and sleep have an influence on antibody production.", {"entities": []}], ["With the rapid progress in nanotechnology and microengineering, point-of-care and personalised healthcare, based on wearable and implantable diagnostics, is becoming a reality.", {"entities": []}], ["Enzymatic fuel cells (EFCs) hold great potential as a sustainable means to power such devices by using physiological fluids as the fuel.", {"entities": []}], ["This review summarises the fundamental operation of EFCs and discusses the most recent advances for their use as implantable and wearable self-powered sensors.", {"entities": []}], ["Air pollution is a suspected developmental neurotoxicant.", {"entities": []}], ["Many schools are located in close proximity to busy roads, and traffic air pollution peaks when children are at school.", {"entities": []}], ["We aimed to assess whether exposure of children in primary school to traffic-related air pollutants is associated with impaired cognitive development.", {"entities": []}], ["We conducted a prospective study of children ( n = 2,715, aged 7 to 10 y) from 39 schools in Barcelona (Catalonia, Spain) exposed to high and low traffic-related air pollution, paired by school socioeconomic index; children were tested four times (i.e., to assess the 12-mo developmental trajectories) via computerized tests ( n = 10,112).", {"entities": []}], ["Chronic traffic air pollution (elemental carbon [EC], nitrogen dioxide [NO2], and ultrafine particle number [UFP; 10\u2013700 nm]) was measured twice during 1-wk campaigns both in the courtyard (outdoor) and inside the classroom (indoor) simultaneously in each school pair.", {"entities": []}], ["Cognitive development was assessed with the n -back and the attentional network tests, in particular, working memory (two-back detectability), superior working memory (three-back detectability), and inattentiveness (hit reaction time standard error).", {"entities": []}], ["Linear mixed effects models were adjusted for age, sex, maternal education, socioeconomic status, and air pollution exposure at home.", {"entities": []}], ["Children from highly polluted schools had a smaller growth in cognitive development than children from the paired lowly polluted schools, both in crude and adjusted models (e.g., 7.4% [95% CI 5.6%\u20138.8%] versus 11.5% [95% CI 8.9%\u201312.5%] improvement in working memory, p = 0.0024).", {"entities": []}], ["Cogently, children attending schools with higher levels of EC, NO2, and UFP both indoors and outdoors experienced substantially smaller growth in all the cognitive measurements; for example, a change from the first to the fourth quartile in indoor EC reduced the gain in working memory by 13.0% (95% CI 4.2%\u201323.1%).", {"entities": []}], ["Residual confounding for social class could not be discarded completely; however, the associations remained in stratified analyses (e.g., for type of school or high-/low-polluted area) and after additional adjustments (e.g., for commuting, educational quality, or smoking at home), contradicting a potential residual confounding explanation.", {"entities": []}], ["Children attending schools with higher traffic-related air pollution had a smaller improvement in cognitive development.", {"entities": []}], ["In a prospective cohort study, Jordi Sunyer and colleagues examine the association between traffic-related air pollution and 12 month cognitive development trajectories in primary school children in Barcelona.", {"entities": []}], ["Human brain development is a complex and lengthy process.", {"entities": []}], ["During pregnancy, the basic structures of the brain are formed, and the neural circuits that will eventually control movement, speech, memory, and other cognitive (thinking) functions, as well as the function of many organs, begin to be established.", {"entities": []}], ["By the time of birth, the brain is about a quarter of its adult size, and the neural circuits that control vital bodily functions such as breathing are well developed.", {"entities": []}], ["By contrast, the cerebral cortex\u2014the brain region that is involved in thought and action\u2014is poorly developed.", {"entities": []}], ["Much of the development of the cerebral cortex happens during the first two years of life.", {"entities": []}], ["For example, babies usually learn to crawl at about nine months.", {"entities": []}], ["Other aspects of brain function take longer to develop.", {"entities": []}], ["Thus, the cognitive functions that are essential for learning undergo considerable development between the ages of 6 and 10 years, and further brain changes occur during adolescence.", {"entities": []}], ["Exposure to the air pollutants produced by the combustion of fossil fuels by vehicles during pregnancy or infancy has been associated with delays in cognitive development.", {"entities": []}], ["Moreover, experiments in animals suggest that traffic-related air pollution is a developmental neurotoxicant\u2014a factor that disrupts brain development.", {"entities": []}], ["However, although many schools are located next to busy roads and although traffic-related air pollution levels peak during school hours, it is not known whether exposure of school-age children to traffic-related air pollutants impairs their cognitive development and thus their ability to learn.", {"entities": []}], ["Here, in a prospective cohort study (the BREATHE study), the researchers assess whether exposure of children aged 7\u201310 years to traffic-related air pollutants in schools in Barcelona, Spain, is associated with impaired cognitive development.", {"entities": []}], ["A prospective cohort study is an observational investigation that studies groups (cohorts) of individuals who differ with respect to a specific factor to determine how exposure to this factor affects specific outcomes.", {"entities": []}], ["The researchers used computerized tests to measure the development of working memory (the system that holds multiple pieces of transitory information in the mind where they can be manipulated), superior working memory (working memory that involves continuous updating of the working memory buffer), and attentiveness every three months over a 12-month period in 2,715 primary school children attending 39 schools exposed to high or low levels of traffic-related air pollution and paired by socioeconomic index.", {"entities": []}], ["That is, the researchers compared three cognitive development outcomes in the children attending each school where exposure to air pollution was high with the same outcomes in children attending a school with a similar socioeconomic index where exposure to pollution was low; school pairing was undertaken to avoid \u201cconfounding\u201d by social class, a factor that is known to affect cognitive development.", {"entities": []}], ["Statistical analyses of these data indicated that the increase in cognitive development over time among children attending highly polluted schools was less than that among children attending paired lowly polluted schools, even after adjusting for additional factors that affect cognitive development.", {"entities": []}], ["Thus, for example, there was an 11.5% 12-month increase in working memory at the lowly polluted schools but only a 7.4% 12-month increase in working memory at the highly polluted schools.", {"entities": []}], ["Other analyses indicated that children attending schools with higher levels of traffic-related air pollutants in either the courtyard or in the classroom experienced a substantially smaller increase over the 12-month study in all three cognitive measurements than those attending schools with lower levels of pollutants.", {"entities": []}], ["These findings suggest that, compared with attendance at schools exposed to low levels of traffic-related air pollution, attendance at schools exposed to high levels of traffic-related air pollution is associated with a smaller increase in cognitive development over a 12-month period among 7- to 10-year-old children in Barcelona.", {"entities": []}], ["The accuracy of these findings may be limited by residual confounding.", {"entities": []}], ["That is, the children attending schools where traffic-related pollution is high might have shared other unknown characteristics that affected their cognitive development.", {"entities": []}], ["Importantly, these findings do not prove that traffic-related air pollution causes impairment of cognitive development.", {"entities": []}], ["Rather, they suggest that the developing brain may be vulnerable to traffic-related air pollution well into middle childhood, a conclusion that has implications for the design of air pollution regulations and for the location of new schools.", {"entities": []}], ["Please access these websites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001792 .", {"entities": []}], ["The US Centers for Disease Control and Prevention provides information about child development , including information about middle childhood (in English and Spanish) Tox Town is an interactive site that provides information about toxic chemicals and environmental health risks, including air pollution The US Environmental Protection Agency provides information about air pollution near roadways and health Wikipedia has pages on cognitive development and on air pollution (note that Wikipedia is a free online encyclopedia that anyone can edit; available in several languages) MedlinePlus provides links to additional resources about air pollution (in English and Spanish) The Centre for Research in Environmental Epidemiology website provides more information about the BREATHE study", {"entities": []}], ["To enable rationale vaccine design, studies of molecular and cellular mechanisms of immune recognition need to be linked with clinical studies in humans.", {"entities": []}], ["A major challenge in conducting such translational research studies lies in the management and integration of large amounts and various types of data collected from multiple sources.", {"entities": []}], ["For this purpose, we have established \u201cIMMUNOCAT\u201d, an interactive data management system for the epitope discovery research projects conducted by our group.", {"entities": []}], ["The system provides functions to store, query, and analyze clinical and experimental data, enabling efficient, systematic, and integrative data management.", {"entities": []}], ["We demonstrate how IMMUNOCAT is utilized in a large-scale research contract that aims to identify epitopes in common allergens recognized by T cells from human donors, in order to facilitate the rational design of allergy vaccines.", {"entities": []}], ["At clinical sites, demographic information and disease history of each enrolled donor are captured, followed by results of an allergen skin test and blood draw.", {"entities": []}], ["At the laboratory site, T cells derived from blood samples are tested for reactivity against a panel of peptides derived from common human allergens.", {"entities": []}], ["IMMUNOCAT stores results from these T cell assays along with MHC:peptide binding data, results from RAST tests for antibody titers in donor serum, and the respective donor HLA typing results.", {"entities": [[172, 175, "GENE"]]}], ["Through this system, we are able to perform queries and integrated analyses of the various types of data.", {"entities": []}], ["This provides a case study for the use of bioinformatics and information management techniques to track and analyze data produced in a translational research study aimed at epitope identification.", {"entities": []}], ["The mass spectrometric analysis of the impact of sulfur dioxide and dust emission on carbon and oxygen stable isotopic compositions of glucose hydrolysed from \u03b1-cellulose samples extracted from Scots pine growing in the vicinity of \u201cHuta Katowice\u201d steelworks was the main aim of this study.", {"entities": []}], ["The annual rings covered the time span from 1975 to 2012 AD.", {"entities": []}], ["The relationships between climatic conditions, sulfur dioxide, and industrial dust emission and oxygen and carbon isotopic compositions were analyzed using correlation function methods.", {"entities": []}], ["This study shows the first analysis of carbon and oxygen stable isotopes in glucose as the bio-indicators of CO 2 , sulfur dioxide, and industrial dust emission.", {"entities": []}], ["The anticoincidence trend of \u03b4", {"entities": []}], ["Small island states are likely the countries most vulnerable to climate variability and long-term climate change.", {"entities": []}], ["Climate models suggest that small island states will experience warmer temperatures and changes in rainfall, soil moisture budgets, prevailing winds (speed and direction), and patterns of wave action.", {"entities": []}], ["El Ni\u00f1o events likely will strengthen short-term and interannual climate variations.", {"entities": []}], ["In addition, global mean sea level is projected to increase by 0.09\u20130.88 m by 2100, with variable effects on regional and local sea level.", {"entities": []}], ["To better understand the potential human health consequences of these projected changes, a series of workshops and a conference organized by the World Health Organization, in partnership with the World Meteorological Organization and the United Nations Environment Programme, addressed the following issues: the current distribution and burden of climate-sensitive diseases in small island states, the potential future health impacts of climate variability and change, the interventions currently used to reduce the burden of climate-sensitive diseases, additional interventions that are needed to adapt to current and future health impacts, and the health implications of climate variability and change in other sectors.", {"entities": []}], ["Information on these issues is synthesized and key recommendations are identified for improving the capacity of the health sector to anticipate and prepare for climate variability and change in small island states.", {"entities": []}], ["Asthma is a rapidly growing chronic disease in the general population of the world, mostly in children.", {"entities": [[0, 6, "DISEASE"]]}], ["Puerto Ricans have the highest prevalence of children with asthma among the Hispanic community in the US and its territories.", {"entities": [[59, 65, "DISEASE"]]}], ["Asthma and air quality are becoming a significant and potentially costly public health issue in Puerto Rico.", {"entities": [[0, 6, "DISEASE"]]}], ["The CDC has reported that in Puerto Rico, 320,350 adults have asthma and this number represents 11.5% of the island adult population.", {"entities": [[62, 68, "DISEASE"]]}], ["The north east municipality of Carolina, Puerto Rico, has the highest asthma prevalence in the 0 to 17 year old range (2001 data).", {"entities": [[70, 76, "DISEASE"]]}], ["In this study, we address the potential relationship between anthropogenic and naturally occurring environmental factors, and asthma prevalence in an urban elementary public school in Carolina in an effort to empower and engage communities to work on their environmental health issues.", {"entities": [[126, 132, "DISEASE"]]}], ["We integrated geographic information systems (GIS) data of anthropogenic activities near the school as well as the natural resources and geomorphology of the region.", {"entities": []}], ["We found that as Carolina is close by to Caribbean National Forest (El Yunque), this together with the temperature and precipitation cycles in the zone creates the ideal environmental conditions for increased humidity and pollen, mold and fungi development through out the year.", {"entities": []}], ["We also collected health and socio economic data to generate an asthma profile of the students, employees and parents from the school community, and through a survey we identified perceptions on environmental asthma triggers, and indoor air quality in the school and homes of the students and employees.", {"entities": [[64, 70, "DISEASE"], [209, 215, "DISEASE"]]}], ["Finally, we implemented a workshop on indoor air quality designed to engage the school community in managing asthma triggers and the school environment.", {"entities": [[109, 115, "DISEASE"]]}], ["Our results showed that nearly 30 % of its student\u2019s population has asthma, and from this group 58% are males and 42% are female students.", {"entities": [[68, 74, "DISEASE"]]}], ["Of all asthmatic children, only 43% receive treatment for the disease.", {"entities": []}], ["The study also showed that most asthmatic children are between 7 and 9 year old, and live in households with an annual income below $10,000.", {"entities": []}], ["It also showed that 25 % of the student\u2019s parents have the condition, and that 25% of the employees are also affected by this chronic condition.", {"entities": []}], ["All these numbers are significantly higher than those reported by the CDC for Puerto Rico.", {"entities": []}], ["The perception component had a response of 83% of school employees, and a 39% response from parents.", {"entities": []}], ["It showed that people know asthma as a disease but many can\u2019t identify most environmental asthma triggers.", {"entities": [[27, 33, "DISEASE"], [90, 96, "DISEASE"]]}], ["Pre and post tests of the workshop protocol showed that before the activity only 21% of participants can identify asthma triggers.", {"entities": [[114, 120, "DISEASE"]]}], ["At the end of the workshop nearly 80% were able to identify and manage environmental asthma triggers.", {"entities": [[85, 91, "DISEASE"]]}], ["This work validates the fact that Puerto Rico continues to have a significant number of people with asthma, particularly children asthma, and that schools are an important settings to create community based action plans to manage environmental asthma triggers through outreach and training.", {"entities": [[100, 106, "DISEASE"], [130, 136, "DISEASE"], [244, 250, "DISEASE"]]}], ["The number of leishmaniasis cases associated with immunosuppression has increased regularly over the past 20 years.", {"entities": [[14, 27, "DISEASE"]]}], ["Immunosuppression related to HIV infection, immunosuppressive treatment, organ transplantation, and neoplastic diseases increases the risk for Leishmania -infected people to develop visceral illness.", {"entities": []}], ["Three cases of Leishmania infantum leishmaniasis in corticosteroid (CS)-treated patients are reported: an isolated lingual leishmaniasis in a farmer treated with CS for asthma, a severe visceral leishmaniasis associated with cutaneous lesions in a woman with myasthenia gravis , and a visceral involvement after cutaneous leishmaniasis in a man receiving CS.", {"entities": [[186, 208, "DISEASE"], [259, 276, "DISEASE"], [35, 48, "DISEASE"], [123, 136, "DISEASE"], [195, 208, "DISEASE"], [322, 335, "DISEASE"], [312, 335, "DISEASE"], [169, 175, "DISEASE"], [68, 70, "GENE"], [162, 164, "GENE"], [355, 357, "GENE"], [68, 70, "GENE"], [162, 164, "GENE"], [355, 357, "GENE"], [68, 70, "GENE"], [162, 164, "GENE"], [355, 357, "GENE"]]}], ["Physicians should recognise CS-treated patients as a population likely to be immunesuppressed.", {"entities": []}], ["In immunodeficiency conditions, unusual forms of leishmaniasis can develop and foster the risk of a diagnostic delay and of poor response to therapy.", {"entities": [[49, 62, "DISEASE"]]}], ["Medical Cyber-Physical Systems (MCPS) are context-aware, life-critical systems with patient safety as the main concern, demanding rigorous processes for validation to guarantee user requirement compliance and specification-oriented correctness.", {"entities": []}], ["In this article, we propose a model-based approach for early validation of MCPS, focusing on promoting reusability and productivity.", {"entities": []}], ["It enables system developers to build MCPS formal models based on a library of patient and medical device models, and simulate the MCPS to identify undesirable behaviors at design time.", {"entities": []}], ["Our approach has been applied to three different clinical scenarios to evaluate its reusability potential for different contexts.", {"entities": []}], ["We have also validated our approach through an empirical evaluation with developers to assess productivity and reusability.", {"entities": []}], ["Finally, our models have been formally verified considering functional and safety requirements and model coverage.", {"entities": []}], ["Providers and patients are most likely to use and benefit from guidelines accompanied by implementation support.", {"entities": []}], ["Guidelines published in 2007 and earlier assessed with the Appraisal of Guidelines, Research and Evaluation (AGREE) instrument scored poorly for applicability, which reflects the inclusion of implementation instructions or tools.", {"entities": []}], ["The purpose of this study was to examine the applicability of guidelines published in 2008 or later and identify factors associated with applicability.", {"entities": []}], ["Systematic review of studies that used AGREE to assess guidelines published in 2008 or later.", {"entities": []}], ["MEDLINE and EMBASE were searched from 2008 to July 2014, and the reference lists of eligible items.", {"entities": []}], ["Two individuals independently screened results for English language studies that reviewed guidelines using AGREE and reported all domain scores, and extracted data.", {"entities": []}], ["Descriptive statistics were calculated across all domains.", {"entities": []}], ["Multilevel regression analysis with a mixed effects model identified factors associated with applicability.", {"entities": []}], ["Of 245 search results, 53 were retrieved as potentially relevant and 20 studies were eligible for review.", {"entities": []}], ["The mean and median domain scores for applicability across 137 guidelines published in 2008 or later were 43.6% and 42.0% (IQR 21.8\u201363.0%), respectively.", {"entities": []}], ["Applicability scored lower than all other domains, and did not markedly improve compared with guidelines published in 2007 or earlier.", {"entities": []}], ["Country (UK) and type of developer (disease-specific foundation, non-profit healthcare system) appeared to be associated with applicability when assessed with AGREE II (not original AGREE).", {"entities": []}], ["Despite increasing recognition of the need for implementation tools, guidelines continue to lack such resources.", {"entities": []}], ["To improve healthcare delivery and associated outcomes, further research is needed to establish the type of implementation tools needed and desired by healthcare providers and consumers, and methods for developing high-quality tools.", {"entities": []}], ["Innovative approaches are needed to support patients' adherence to drug therapy.", {"entities": []}], ["The Real Time Medication Monitoring (RTMM) system offers real time monitoring of patients' medication use combined with short message service (SMS) reminders if patients forget to take their medication.", {"entities": [[143, 146, "GENE"]]}], ["This combination of monitoring and tailored reminders provides opportunities to improve adherence.", {"entities": []}], ["This article describes the design of an intervention study aimed at evaluating the effect of RTMM on adherence to oral antidiabetics.", {"entities": []}], ["Randomised Controlled Trial (RCT) with two intervention arms and one control arm involving diabetes type 2 patients with suboptimal levels of adherence to oral antidiabetics (less than 80% based on pharmacy refill data).", {"entities": []}], ["Patients in the first intervention arm use RTMM including SMS reminders and a personal webpage where they can monitor their medication use.", {"entities": [[58, 61, "GENE"]]}], ["Patients in the second intervention arm use RTMM without SMS reminders or webpage access.", {"entities": [[57, 60, "GENE"]]}], ["Patients in the control arm are not exposed to any intervention.", {"entities": []}], ["Patients are randomly assigned to one of the three arms.", {"entities": []}], ["The intervention lasts for six months.", {"entities": []}], ["Pharmacy refill data of all patients are available from 11 months before, until 11 months after the start of the intervention.", {"entities": []}], ["Primary outcome measure is adherence to oral antidiabetics calculated from: 1) data collected with RTMM, as a percentage of medication taken as prescribed, and as percentage of medication taken within the correct time interval, 2) refill data, taking the number of days for which oral antidiabetics are dispensed during the study period divided by the total number of days of the study period.", {"entities": []}], ["Differences in adherence between the intervention groups and control group are studied using refill data.", {"entities": []}], ["Differences in adherence between the two intervention groups are studied using RTMM data.", {"entities": []}], ["The intervention described in this article consists of providing RTMM to patients with suboptimal adherence levels.", {"entities": []}], ["This system combines real time monitoring of medication use with SMS reminders if medication is forgotten.", {"entities": [[65, 68, "GENE"]]}], ["If RTMM proves to be effective, it can be considered for use in various patient populations to support patients with their medication use and improve their adherence.", {"entities": []}], ["Netherlands Trial Register NTR1882", {"entities": []}], ["Gastroschisis research is limited in quality by the presence of significant heterogeneity in outcome measure reporting (PloS One 10(1):e0116908, 2015).", {"entities": [[0, 13, "DISEASE"]]}], ["Using core outcome sets in research is one proposed method for addressing this problem (Trials 13:103, 2012; Clin Rheumatol 33(9):1313-1322, 2014; Health Serv Res Policy 17(1):1-2, 2012).", {"entities": []}], ["Ultimately, standardising outcome measure reporting will improve research quality and translate into improvements in patient care.", {"entities": []}], ["Candidate outcome measures have been identified through systematic reviews.", {"entities": []}], ["These outcome measures will form the starting point for an online, three-phase Delphi process that will be carried out in parallel by three panels of experts.", {"entities": []}], ["Panel 1 is a neonatal panel, panel 2 is a non-neonatal panel and panel 3 is a lay panel.", {"entities": []}], ["In round 1, experts will be asked to score the previously identified outcome measures from 1\u20139 based on how important they think the measures are in determining the overall success of their/their child\u2019s/their patient\u2019s gastroschisis treatment.", {"entities": [[220, 233, "DISEASE"]]}], ["In round 2, experts will be presented with the same list of outcome measures and with graphical representations of how their panel scored that outcome in round 1.", {"entities": []}], ["They will be asked to re-score the outcome measure taking into account how important other members of their panel felt it to be.", {"entities": []}], ["In round 3, experts will again be asked to re-score each outcome measure, but this time they will receive a graphical representation of the distribution of scores from all three panels which they should take into account when re-scoring.", {"entities": []}], ["Following round 3 of the Delphi process, 40 experts will be invited to attend a face-to-face consensus meeting.", {"entities": []}], ["Participants will be invited in a purposive manner to obtain balance between the different panels.", {"entities": []}], ["The results of the Delphi process will be discussed, and outcomes re-scored.", {"entities": []}], ["Outcome measures where\u2009>\u200970\u00a0% of the participants at the meeting scored them as 7\u20139 and\u2009<\u200915\u00a0% scored them as 1\u20133 will form the core outcome set.", {"entities": []}], ["Development of a core outcome set will help to reduce the heterogeneity of the outcome measure reporting in gastroschisis.", {"entities": [[108, 121, "DISEASE"]]}], ["This will increase the quality of research taking place and ultimately improve care provided to infants with gastroschisis.", {"entities": [[109, 122, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s13063-016-1453-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The present study investigates the association between single nucleotide polymorphisms (SNPs) in the chitinase 3-like 1 ( CHI3L1) gene and serum concentrations of YKL-40 in Danish patients with rheumatoid arthritis (RA) and healthy controls as well as the association with RA in the Danish population.", {"entities": [[194, 214, "DISEASE"], [205, 214, "DISEASE"], [122, 128, "GENE"]]}], ["The CHI3L1 gene is located on chromosome 1q32.1 and encodes the YKL-40 glycoprotein.", {"entities": [[4, 10, "GENE"]]}], ["YKL-40 concentrations are elevated in the serum of patients with RA compared to healthy subjects, and YKL-40 has been suggested to be an auto-antigen and may play a role in development of RA and in inflammation.", {"entities": []}], ["Eight SNPs in the CHI3L1 gene and promotor were genotyped in 308 patients with RA and 605 controls (healthy blood donors) using TaqMan allele discrimination assays.", {"entities": [[18, 24, "GENE"]]}], ["Serum concentrations of YKL-40 were determined by an enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["We found significant association between the serum concentrations of YKL-40 and polymorphism in the CHI3L1 gene among both patients with RA and controls.", {"entities": [[100, 106, "GENE"]]}], ["The g.-131(C > G) polymorphism (rs4950928) was most strongly associated with age adjusted serum concentrations of YKL-40 in patients with RA ( P < 2.4e-8) and controls ( P < 2.2e-16).", {"entities": []}], ["No significant allelic- or genotypic association with RA was found in this Danish cohort.", {"entities": []}], ["We suggest that the g.-131(C > G) promoter polymorphism has a substantial impact on serum concentrations of YKL-40 in patients with RA and healthy subjects.", {"entities": []}], ["However, the polymorphism does not seem to confer risk to RA itself.", {"entities": []}], ["The effect of CHI3L1 polymorphism on clinical outcome or the response to treatment in patients with RA remains to be investigated.", {"entities": [[14, 20, "GENE"]]}], ["Respiratory syncytial virus (RSV) is the principal cause of bronchiolitis in infants and a significant healthcare problem.", {"entities": [[60, 73, "DISEASE"]]}], ["The RSV Glycoprotein (G) mediates attachment of the virus to the cell membrane, which facilitates interaction of the RSV Fusion (F) protein with nucleolin, thereby triggering fusion of the viral and cellular membranes.", {"entities": []}], ["However, a host protein ligand for G has not yet been identified.", {"entities": []}], ["Here we show that CX3CR1 is expressed in the motile cilia of differentiated human airway epithelial (HAE) cells, and that CX3CR1 co-localizes with RSV particles.", {"entities": [[18, 24, "GENE"], [122, 128, "GENE"], [18, 24, "GENE"], [122, 128, "GENE"]]}], ["Upon infection, the distribution of CX3CR1 in these cells is significantly altered.", {"entities": [[36, 42, "GENE"]]}], ["Complete or partial deletion of RSV G results in viruses binding at least 72-fold less efficiently to cells, and reduces virus replication.", {"entities": []}], ["Moreover, an antibody targeting an epitope near the G protein\u2019s CX3CR1-binding motif significantly inhibits binding of the virus to airway cells.", {"entities": []}], ["Given previously published evidence of the interaction of G with CX3CR1 in human lymphocytes, these findings suggest a role for G in the interaction of RSV with ciliated lung cells.", {"entities": [[65, 71, "GENE"]]}], ["This interpretation is consistent with past studies showing a protective benefit in immunizing against G in animal models of RSV infection, and would support targeting the CX3CR1-G protein interaction for prophylaxis or therapy.", {"entities": []}], ["CX3CR1 expression in lung epithelial cells may also have implications for other respiratory diseases such as asthma.", {"entities": [[109, 115, "DISEASE"], [0, 6, "GENE"]]}], ["Colorectal adenomatous polyps are precancerous lesions of colorectal cancer.", {"entities": [[58, 75, "DISEASE"], [69, 75, "DISEASE"]]}], ["The aim of this study was to assess the prevalence of colorectal adenomatous polyps in chronic obstructive pulmonary disease (COPD) patients and determine whether COPD is associated with colorectal malignant potential.", {"entities": [[87, 124, "DISEASE"]]}], ["Subjects who had undergone post-bronchodilator spirometry and colonoscopy and were 40 years or older were selected from the hospital database.", {"entities": []}], ["COPD was defined as a spirometry in which the ratio of forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC) is <0.7 in post-bronchodilator spirometry.", {"entities": [[93, 96, "GENE"]]}], ["The non-COPD group was matched for both age and sex, and were defined as having an FEV 1 , FVC, and FEV 1 /FVC \u22650.7 in spirometry.", {"entities": [[83, 86, "GENE"], [100, 103, "GENE"], [83, 86, "GENE"], [100, 103, "GENE"]]}], ["Finally, 333 patients were retrospectively reviewed; of this group, 82 patients had COPD.", {"entities": []}], ["Among the subjects, 201 patients (60%) were nonsmokers, while 78 (23%) were current smokers.", {"entities": []}], ["The prevalence of colorectal adenomatous polyps was 39% (98/251) in the non-COPD group and 66% (54/82) in the COPD group.", {"entities": []}], ["Among 54 patients with adenomatous polyps in the COPD group, 47 had tubular adenoma and seven had villous adenoma.", {"entities": [[76, 83, "DISEASE"], [106, 113, "DISEASE"]]}], ["Multiple logistic regression analyses revealed that only COPD patients whom matched to the criteria of COPD by pulmonary function test (odds ratio 2.1, 95% confidence interval: 1.1\u20133.8; P =0.019) were independently associated with colorectal malignant potential.", {"entities": []}], ["The risk of colorectal malignant potential in the COPD group was higher than in the non-COPD group.", {"entities": []}], ["We may suggest that COPD patients should consider regular colonoscopic evaluation to screen for premalignant colon polyps regardless of smoking.", {"entities": []}], ["Extensive experimental information supports the formation of ligand-specific conformations of G protein-coupled receptors (GPCRs) as a possible molecular basis for their functional selectivity for signaling pathways.", {"entities": []}], ["Taking advantage of the recently published inactive and active crystal structures of GPCRs, we have implemented an all-atom computational strategy that combines different adaptive biasing techniques to identify ligand-specific conformations along pre-determined activation pathways.", {"entities": []}], ["Using the prototypic GPCR \u03b22-adrenergic receptor as a suitable test case for validation, we show that ligands with different efficacies (either inverse agonists, neutral antagonists, or agonists) modulate the free-energy landscape of the receptor by shifting the conformational equilibrium towards active or inactive conformations depending on their elicited physiological response.", {"entities": []}], ["Notably, we provide for the first time a quantitative description of the thermodynamics of the receptor in an explicit atomistic environment, which accounts for the receptor basal activity and the stabilization of different active-like states by differently potent agonists.", {"entities": []}], ["Structural inspection of these metastable states reveals unique conformations of the receptor that may have been difficult to retrieve experimentally.", {"entities": []}], ["G protein-coupled receptors (GPCRs) constitute one of the most important classes of cellular targets owing to their known response to a host of extracellular stimuli, and consequent involvement in numerous vital biological processes.", {"entities": []}], ["Compelling evidence herein referred to as \u2018functional selectivity\u2019 shows that ligands with varied efficacies can stabilize different GPCR conformations that may selectively interact with different intracellular proteins, and therefore induce different biological responses.", {"entities": []}], ["Understanding how this selectivity is achieved may lead to the discovery of drugs with improved therapeutic properties.", {"entities": []}], ["We propose here a computational strategy that enables identification of the specific conformations assumed by a GPCR when interacting with ligands that elicit different physiological responses.", {"entities": []}], ["Not only can these computational models help bridge the information gap in structural biology of GPCRs, but they can be used for virtual screening, and possibly lead to the structure-based rational discovery of novel \u2018biased\u2019 ligands that are capable of selectively activating one cellular signaling pathway over another.", {"entities": []}], ["To evaluate the diagnostic accuracy of clinical signs and symptoms, C-reactive protein (CRP) and spirometric parameters and determine their interrelation in patients suspected to have an obstructive airway disease (OAD) in primary care.", {"entities": [[88, 91, "GENE"]]}], ["In a cross sectional diagnostic study, 60 adult patients coming to the general practitioner (GP) for the first-time with complaints suspicious for obstructive airway disease (OAD) underwent spirometry.", {"entities": []}], ["Peak expiratory flow (PEF)-variability within two weeks was determined in patients with inconspicuous spirometry.", {"entities": []}], ["Structured medical histories were documented and CRP was measured.", {"entities": [[49, 52, "GENE"]]}], ["The reference standard was the Tiffeneau ratio (FEV 1 /VC) in spirometry and the PEF-variability.", {"entities": [[48, 51, "GENE"]]}], ["OAD was diagnosed when FEV 1 /VC \u2264 70% or PEF-variability > 20%.", {"entities": [[23, 26, "GENE"]]}], ["37 (62%) patients had OAD.", {"entities": []}], ["The best cut-off value for CRP was found at 2 mg/l with a diagnostic odds ratio (OR) of 4.4 (95% CI 1.4\u201313.8).", {"entities": [[27, 30, "GENE"]]}], ["Self-reported wheezing was significantly related with OAD (OR 3.4; CI 1.1\u201310.3), whereas coughing was inversely related (OR 0.2; CI 0.1\u20130.7).", {"entities": []}], ["The diagnostic OR of CRP increased when combined with dyspnea (OR 8.5; 95% CI 1.7\u201342.3) or smoking history (OR 8.4; 95% CI 1.5\u201348.9).", {"entities": [[21, 24, "GENE"]]}], ["CRP (p = 0.004), FEV 1 (p = 0.001) and FIV 1 (p = 0.023) were related with the severity of dyspnea.", {"entities": [[0, 3, "GENE"], [17, 20, "GENE"]]}], ["CRP increased with the number of cigarettes, expressed in pack years (p = 0.001).", {"entities": [[0, 3, "GENE"]]}], ["The diagnostic accuracy of clinical signs and symptoms was low.", {"entities": []}], ["The diagnostic accuracy of CRP improved in combination with dyspnea and smoking history.", {"entities": [[27, 30, "GENE"]]}], ["Due to their coherence with the severity of dyspnea and number of cigarettes respectively, CRP and spirometry might allow risk stratification of patients with OAD in primary care.", {"entities": [[91, 94, "GENE"]]}], ["Further studies need to be done to confirm these findings.", {"entities": []}], ["Women living with HIV may present with high levels of body fat that are associated with altered bioenergetic function.", {"entities": []}], ["Excess body fat may therefore exacerbate the bioenergetic dysfunction observed with HIV infection.", {"entities": []}], ["To determine if body fat is associated with bioenergetic function in HIV, we conducted a cross-sectional study of 42 women with HIV who were virologically suppressed on antiretroviral therapy.", {"entities": []}], ["Body composition was determined via dual-energy x-ray absorptiometry.", {"entities": []}], ["Oxygen consumption rate (OCR) of monocytes was sorted from peripheral blood mononuclear cells obtained from participants in the fasting state.", {"entities": []}], ["Differences in bioenergetic function, as measured by OCR, was assessed using Kruskal-Wallis tests and Spearman correlations adjusted for age, race, and smoking status.", {"entities": []}], ["Participants were 86% Black, 45.5 years old, 48% current smokers, and 57% were obese (body mass index \u226530).", {"entities": []}], ["Nearly all women (93%) had >30% total fat mass, while 12% had >50% total fat mass.", {"entities": []}], ["Elevated levels of total fat mass, trunk fat, and leg fat were inversely correlated with measures of bioenergetic health as evidenced by lower maximal and reserve capacity OCR, and Bioenergetic Health Index.", {"entities": []}], ["Measures of extracellular acidification (ECAR) in the absence (basal) or maximal (with oligomycin) were positively correlated with measures of bioenergetics, except proton leak, and were negatively correlated with fat mass.", {"entities": []}], ["Despite virological suppression, women with HIV present with extremely high levels of adiposity that correlate with impaired bioenergetic health.", {"entities": []}], ["Without effective interventions, this syndemic of HIV infection and obesity will likely have devastating consequences for our patients, potentially mediated through altered mitochondrial and glycolytic function.", {"entities": [[68, 75, "DISEASE"]]}], ["fx1 \u2022 Women with HIV have high levels of total, central, and leg body fat.", {"entities": []}], ["\u2022 High body fat levels are inversely correlated to bioenergetic function in monocytes.", {"entities": []}], ["\u2022 Excess body fat may exacerbate bioenergetics dysfunction observed in people living with HIV.", {"entities": []}], ["Women with HIV have high levels of total, central, and leg body fat.", {"entities": []}], ["High body fat levels are inversely correlated to bioenergetic function in monocytes.", {"entities": []}], ["Excess body fat may exacerbate bioenergetics dysfunction observed in people living with HIV.", {"entities": []}], ["One of the major challenges health care systems face in modern time is treating chronic disorders.", {"entities": []}], ["In recent years, the increasing occurrence of multiple chronic disorders (MCC) in single individuals has compounded the complexity of health care.", {"entities": [[74, 77, "GENE"]]}], ["In 2008, it was estimated that worldwide as many as one quarter of the population between the ages of sixty five to sixty nine suffered from two or more chronic conditions and this prevalence rose with age.", {"entities": []}], ["Clinical guidelines provide guidance for management of single disorders, but not for MCC.", {"entities": [[85, 88, "GENE"]]}], ["The aim of the present study was the study of the prevalence, distribution and impact of MCC in a large Israeli health system.", {"entities": [[89, 92, "GENE"]]}], ["We performed a cross-sectional study of MCC in the Maccabi Healthcare System (MHS), Israel\u2019s second largest healthcare service, providing care for approximately two million people.", {"entities": [[40, 43, "GENE"]]}], ["Data regarding chronic conditions was collected through electronic medical records and organizational records, as was demographic and socioeconomic data.", {"entities": []}], ["Age and sex specific data were compared with previously published data from Scotland.", {"entities": []}], ["Two thirds of the population had two or more chronic disorders.", {"entities": []}], ["This is significantly higher than previously published rates.", {"entities": []}], ["A correlation between patient age and number of chronic disorders was found, as was a correlation between number of chronic disorders and low socioeconomic status, with the exception of children due to a high prevalence of learning disabilities, asthma, and visual disturbances.", {"entities": [[246, 252, "DISEASE"]]}], ["MCC is very prevalent in the MHS population, increases with age, and except for children is more prevalent in lower socioeconomic classes, possibly due to the a combination of the structure of the Israeli universal insurance and requirements of the ministry of education for exemptions and benefits.", {"entities": [[0, 3, "GENE"]]}], ["A higher than previously reported prevalence of MCC may be due to the longtime use of use of integrated electronic medical records.", {"entities": [[48, 51, "GENE"]]}], ["To effectively deal with MCC health care systems must devise strategies, including but not limited to, information technologies that enable shared teamwork based on clinical guidelines which address the problem of multiple, as opposed to single chronic disorders in patients.", {"entities": [[25, 28, "GENE"]]}], ["Methotrexate (MTX) is a folate antagonist widely used both as an anticancer drug and as an immunosupressant.", {"entities": []}], ["Administration of an 8-day methotrexate and folinic acid regime may be associated with pleuritic chest pain and pneumonitis.", {"entities": []}], ["We have reviewed the toxicity seen in 168 consecutive patients treated with low-dose MTX for persistent trophoblastic disease.", {"entities": []}], ["Twenty-five per cent of patients developed serosal symptoms, pleurisy was the commonest complaint.", {"entities": [[61, 69, "DISEASE"]]}], ["The majority of patients had mild to moderate symptoms which were controlled with simple analgesia and did not necessitate a change in treatment; 11.9% had severe symptoms which necessitated a change in treatment.", {"entities": []}], ["One patient developed a pericardial effusion and a second patient developed severe reversible peritoneal irritation.", {"entities": [[24, 44, "DISEASE"]]}], ["The possible aetiology and pathophysiology of methotrexate-induced serosal toxicity is discussed.", {"entities": []}], ["\u00a9 1999 Cancer Research Campaign", {"entities": [[7, 13, "DISEASE"]]}], ["To address the problem of specificity in G-protein coupled receptor (GPCR) drug discovery, there has been tremendous recent interest in allosteric drugs that bind at sites topographically distinct from the orthosteric site.", {"entities": []}], ["Unfortunately, structure-based drug design of allosteric GPCR ligands has been frustrated by the paucity of structural data for allosteric binding sites, making a strong case for predictive computational methods.", {"entities": []}], ["In this work, we map the surfaces of the \u03b2 1 (\u03b2 1 AR) and \u03b2 2 (\u03b2 2 AR) adrenergic receptor structures to detect a series of five potentially druggable allosteric sites.", {"entities": []}], ["We employ the FTMAP algorithm to identify \u2018hot spots\u2019 with affinity for a variety of organic probe molecules corresponding to drug fragments.", {"entities": []}], ["Our work is distinguished by an ensemble-based approach, whereby we map diverse receptor conformations taken from molecular dynamics (MD) simulations totaling approximately 0.5 \u03bcs.", {"entities": []}], ["Our results reveal distinct pockets formed at both solvent-exposed and lipid-exposed cavities, which we interpret in light of experimental data and which may constitute novel targets for GPCR drug discovery.", {"entities": []}], ["This mapping data can now serve to drive a combination of fragment-based and virtual screening approaches for the discovery of small molecules that bind at these sites and which may offer highly selective therapies.", {"entities": []}], ["Inappropriate cross talk between mammals and their gut microbiota may trigger intestinal inflammation and drive extra-intestinal immune-mediated diseases.", {"entities": []}], ["Epithelial cells constitute the interface between gut microbiota and host tissue, and may regulate host responses to commensal enteric bacteria.", {"entities": []}], ["Gnotobiotic animals represent a powerful approach to study bacterial-host interaction but are not readily accessible to the wide scientific community.", {"entities": []}], ["We aimed at refining a protocol that in a robust manner would deplete the cultivable intestinal microbiota of conventionally raised mice and that would prove to have significant biologic validity.", {"entities": []}], ["Previously published protocols for depleting mice of their intestinal microbiota by administering broad-spectrum antibiotics in drinking water were difficult to reproduce.", {"entities": []}], ["We show that twice daily delivery of antibiotics by gavage depleted mice of their cultivable fecal microbiota and reduced the fecal bacterial DNA load by 400 fold while ensuring the animals' health.", {"entities": []}], ["Mice subjected to the protocol for 17 days displayed enlarged ceca, reduced Peyer's patches and small spleens.", {"entities": []}], ["Antibiotic treatment significantly reduced the expression of antimicrobial factors to a level similar to that of germ-free mice and altered the expression of 517 genes in total in the colonic epithelium.", {"entities": []}], ["Genes involved in cell cycle were significantly altered concomitant with reduced epithelial proliferative activity in situ assessed by Ki-67 expression, suggesting that commensal microbiota drives cellular proliferation in colonic epithelium.", {"entities": []}], ["We present a robust protocol for depleting conventionally raised mice of their cultivatable intestinal microbiota with antibiotics by gavage and show that the biological effect of this depletion phenocopies physiological characteristics of germ-free mice.", {"entities": []}], ["Avoidable hospitalizations (AH) are hospital admissions for diseases and conditions that could have been prevented by appropriate ambulatory care.", {"entities": []}], ["We examine regional variation of AH in Switzerland and the factors that determine AH.", {"entities": []}], ["We used hospital service areas, and data from 2008\u20132010 hospital discharges in Switzerland to examine regional variation in AH.", {"entities": []}], ["Age and sex standardized AH were the outcome variable, and year of admission, primary care physician density, medical specialist density, rurality, hospital bed density and type of hospital reimbursement system were explanatory variables in our multilevel poisson regression.", {"entities": []}], ["Regional differences in AH were as high as 12-fold.", {"entities": []}], ["Poisson regression showed significant increase of all AH over time.", {"entities": []}], ["There was a significantly lower rate of all AH in areas with more primary care physicians.", {"entities": []}], ["Rates increased in areas with more specialists.", {"entities": []}], ["Rates of all AH also increased where the proportion of residences in rural communities increased.", {"entities": []}], ["Regional hospital capacity and type of hospital reimbursement did not have significant associations.", {"entities": []}], ["Inconsistent patterns of significant determinants were found for disease specific analyses.", {"entities": []}], ["The identification of regions with high and low AH rates is a starting point for future studies on unwarranted medical procedures, and may help to reduce their incidence.", {"entities": []}], ["AH have complex multifactorial origins and this study demonstrates that rurality and physician density are relevant determinants.", {"entities": []}], ["The results are helpful to improve the performance of the outpatient sector with emphasis on local context.", {"entities": []}], ["Rural and urban differences in health care delivery remain a cause of concern in Switzerland.", {"entities": []}], ["Previous studies have demonstrated that \u03b2 2 -adrenergic receptors (\u03b2 2 ARs) can be phosphorylated by G protein-coupled receptor kinases (GRKs) and protein kinase A (PKA), affecting \u03b2 2 AR internalization and desensitization.", {"entities": []}], ["However, the exact physiological function of \u03b2 2 ARs in cardiomyocytes is unknown.", {"entities": []}], ["In this study, we showed that neonatal mouse cardiomyocytes had different contraction and internalization responses to sustained or repeated, transient agonist stimulation.", {"entities": []}], ["Specifically, short-time stimulation (10 min) with epinephrine or norepinephrine increased the cardiomyocyte contraction rate, reaching a maximum at 5 min, followed by a slow decline.", {"entities": []}], ["When the agonist was re-added after a 60-min wash-out period, the increase in the cardiomyocyte contraction rate was similar to the initial response.", {"entities": []}], ["In contrast, when cardiomyocytes were exposed continuously to epinephrine or norepinephrine for 60 min, the second agonist stimulation did not increase the contraction response.", {"entities": []}], ["These results indicated that continuous \u03b2 2 AR stimulation caused functional desensitization.", {"entities": []}], ["Phosphorylation of \u03b2 2 ARs at serine (Ser) 2 AR internalization increased.", {"entities": []}], ["Interestingly, \u03b2 2 AR internalization was blocked by mutations at the GRK phosphorylation sites, but not by mutations at the PKA phosphorylation sites.", {"entities": []}], ["Furthermore, inhibition of \u03b2 2 AR dephosphorylation by okadaic acid, a phosphatase 2A inhibitor, impaired the recovery of internalized \u03b2 2 ARs and reduced the cardiomyocyte contraction rate in response to epinephrine.", {"entities": []}], ["Finally, epinephrine treatment induced the physical interaction of \u03b2-arrestin with internalized \u03b2 2 ARs in cardiomyocytes.", {"entities": []}], ["Together, these data revealed the essential role of the Ser 2 ARs in regulating receptor internalization and physiological resensitization in neonatal cardiomyocytes to contraction functions.", {"entities": []}], ["Chronic cough is common and is associated with significant economic and human costs.", {"entities": []}], ["While cough can be a problematic symptom without serious consequences, it could also reflect a serious underlying illness.", {"entities": []}], ["Evidence shows that the management of chronic cough in children needs to be improved.", {"entities": []}], ["Our study tests the hypothesis that the management of chronic cough in children with an evidence-based management pathway is feasible and reliable, and improves clinical outcomes.", {"entities": []}], ["We are conducting a multicentre randomised controlled trial based in respiratory clinics in 5 major Australian cities.", {"entities": []}], ["Children (n = 250) fulfilling inclusion criteria (new patients with chronic cough) are randomised (allocation concealed) to the standardised clinical management pathway (specialist starts clinical pathway within 2 weeks) or usual care (existing care until review by specialist at 6 weeks).", {"entities": []}], ["Cough diary, cough-specific quality of life (QOL) and generic QOL are collected at baseline and at 6, 10, 14, 26, and 52 weeks.", {"entities": []}], ["Children are followed-up for 6 months after diagnosis and cough resolution (with at least monthly contact from study nurses).", {"entities": []}], ["A random sample from each site will be independently examined to determine adherence to the pathway.", {"entities": []}], ["Primary outcomes are group differences in QOL and proportion of children that are cough free at week 6.", {"entities": []}], ["The clinical management pathway is based on data from Cochrane Reviews combined with collective clinical experience (250 doctor years).", {"entities": []}], ["This study will provide additional evidence on the optimal management of chronic cough in children.", {"entities": []}], ["ACTRN12607000526471", {"entities": []}], ["[ Patients received [ Fifteen centers contributed 154 melanoma patients who were injected with both agents and were intraoperatively evaluated.", {"entities": [[54, 62, "DISEASE"]]}], ["Intraoperatively, 232 of 235 blue nodes were detected by [ p \u00a0<\u00a00.001).", {"entities": []}], ["[ n \u00a0=\u00a0150) than blue dye ( n \u00a0=\u00a0138, p \u00a0=\u00a00.002).", {"entities": []}], ["In 135 of 138 patients with at least one blue node, all blue nodes were radioactive.", {"entities": []}], ["Melanoma was identified in the SLNs of 22.1\u00a0% of patients; all 45 melanoma-positive SLNs were detected by [ p \u00a0=\u00a00.004).", {"entities": [[0, 8, "DISEASE"], [66, 74, "DISEASE"]]}], ["No positive SLNs were detected exclusively by blue dye.", {"entities": []}], ["Four of 34 node-positive patients were identified only by [ [", {"entities": []}], ["Clear recognition of the damaging effects of poverty on early childhood development has fueled an interest in interventions aimed at mitigating these harmful consequences.", {"entities": []}], ["Psychosocial interventions aimed at alleviating the negative impacts of poverty on children are frequently shown to be of benefit, but effect sizes are typically small to moderate.", {"entities": []}], ["However, averaging outcomes over an entire sample, as is typically done, could underestimate efficacy because weaker effects on less susceptible individuals would dilute estimation of effects on those more disposed to respond.", {"entities": []}], ["This study investigates whether a genetic polymorphism of the serotonin transporter gene moderates susceptibility to a psychosocial intervention.", {"entities": []}], ["We reanalyzed data from a randomized controlled trial of a home-visiting program delivered by community health workers in a black, isiXhosa-speaking population in Khayelitsha, South Africa.", {"entities": []}], ["The intervention, designed to enhance maternal-infant attachment, began in the third trimester and continued until 6 mo postpartum.", {"entities": []}], ["Implemented between April 1999 and February 2003, the intervention comprised 16 home visits delivered to 220 mother\u2013infant dyads by specially trained community health workers.", {"entities": []}], ["A control group of 229 mother\u2013infant dyads did not receive the intervention.", {"entities": []}], ["Security of maternal-infant attachment was the main outcome measured at infant age 18 mo.", {"entities": []}], ["Compared to controls, infants in the intervention group were significantly more likely to be securely attached to their primary caregiver (odds ratio [OR] = 1.7, p = 0.029, 95% CI [1.06, 2.76], d = 0.29).", {"entities": []}], ["After the trial, 162 intervention and 172 control group children were reenrolled in a follow-up study at 13 y of age (December 2012\u2013June 2014).", {"entities": []}], ["At this time, DNA collected from 279 children (134 intervention and 145 control) was genotyped for a common serotonin transporter polymorphism.", {"entities": []}], ["There were both genetic data and attachment security data for 220 children (110 intervention and 110 control), of whom 40% (44 intervention and 45 control) carried at least one short allele of the serotonin transporter gene.", {"entities": []}], ["For these 220 individuals, carrying at least one short allele of the serotonin transporter gene was associated with a 26% higher rate of attachment security relative to controls (OR = 3.86, p = 0.008, 95% CI [1.42, 10.51], d = 0.75), whereas there was a negligible (1%) difference in security between intervention and control group individuals carrying only the long allele (OR = 0.95, p = 0.89, 95% CI [0.45, 2.01], d = 0.03).", {"entities": []}], ["Expressed in terms of absolute risk, for those with the short allele, the probability of secure attachment being observed in the intervention group was 84% (95% CI [73%, 95%]), compared to 58% (95% CI [43%, 72%]) in the control group.", {"entities": []}], ["For those with two copies of the long allele, 70% (95% CI [59%, 81%]) were secure in the intervention group, compared to 71% (95% CI [60%, 82%]) of infants in the control group.", {"entities": []}], ["Controlling for sex, maternal genotype, and indices of socioeconomic adversity (housing, employment, education, electricity, water) did not change these results.", {"entities": []}], ["A limitation of this study is that we were only able to reenroll 49% of the original sample randomized to the intervention and control conditions.", {"entities": []}], ["Attribution of the primary outcome to causal effects of intervention in the present subsample should therefore be treated with caution.", {"entities": []}], ["When infant genotype for serotonin transporter polymorphism was taken into account, the effect size of a maternal-infant attachment intervention targeting impoverished pregnant women increased more than 2.5-fold when only short allele carriers were considered (from d = 0.29 for all individuals irrespective of genotype to d = 0.75) and decreased 10-fold when only those carrying two copies of the long allele were considered (from d = 0.29 for all individuals to d = 0.03).", {"entities": []}], ["Genetic differential susceptibility means that averaging across all participants is a misleading index of efficacy.", {"entities": []}], ["The study raises questions about how policy-makers deal with the challenge of balancing equity (equal treatment for all) and efficacy (treating only those whose genes render them likely to benefit) when implementing psychosocial interventions.", {"entities": []}], ["Current Controlled Trials ISRCTN25664149 In light of genetic information Barak Morgan and colleagues re-analyze data from a randomized controlled trial to explore the genetic susceptibility to a psychosocial intervention.", {"entities": []}], ["It has been shown that individuals with the short form of a gene involved in nerve signaling in the brain are generally sensitive, or \u201csusceptible,\u201d to psychosocial interventions (i.e., they benefit), whereas individuals with the long form of the gene are insensitive, or \u201cnonsusceptible,\u201d deriving little benefit from the same intervention.", {"entities": []}], ["This study was conducted to investigate whether such a gene \u00d7 intervention interaction was present in a previously conducted randomized controlled home-visiting intervention trial designed to increase levels of secure maternal-infant attachment at 18 mo of age in a population in South Africa.", {"entities": []}], ["Genotyping revealed that 40% of the study sample ( n = 89) carried at least one short allele of the serotonin transporter gene, while 60% of the sample ( n = 131) carried two long alleles of this gene.", {"entities": []}], ["We reanalyzed the original maternal-infant attachment results and found that the increase in secure attachment found for the intervention in the original trial (odds ratio = 1.7, effect size d = 0.29) was almost entirely attributable to children with the short form of the gene (odds ratio = 3.86, effect size d = 0.75).", {"entities": []}], ["For children not carrying the short allele, there was no significant increase in secure attachment with the intervention (odds ratio = 0.95, effect size d = 0.03).", {"entities": []}], ["Children carrying the short form of the gene whose mothers received the intervention were 3.86 times more likely to be securely attached at 18 mo (84% were secure) than children carrying the short form whose mothers did not receive the intervention (58% were secure).", {"entities": []}], ["Among children without the short form, the number who were securely attached did not differ based on whether their mothers received the intervention (71% were secure) or not (70% were secure).", {"entities": []}], ["These results indicate the importance of genetic differences when considering the efficacy of psychosocial interventions aimed at improving developmental outcomes in children living in the context of socioeconomic adversity.", {"entities": []}], ["The findings also raise complex questions regarding spending limited resources implementing costly interventions on individuals who may not benefit because of their genetic makeup and who may comprise the majority of the population (60% in this case), but where these same interventions may nevertheless confer large benefit for a subgroup of genetically susceptible individuals (40% in this case).", {"entities": []}], ["Diesel exhaust is a mixture of combustion gases and ultrafine particles coated with organic compounds.", {"entities": []}], ["There is concern whether exposure can result in or worsen obstructive airway diseases, but there is only limited information to assess this risk.", {"entities": []}], ["U.S. railroad workers have been exposed to diesel exhaust since diesel locomotives were introduced after World War II, and by 1959, 95% of the locomotives were diesel.", {"entities": []}], ["We conducted a case\u2013control study of railroad worker deaths between 1981 and 1982 using U.S. Railroad Retirement Board job records and next-of-kin smoking, residential, and vitamin use histories.", {"entities": []}], ["There were 536 cases with chronic obstructive pulmonary disease (COPD) and 1,525 controls with causes of death not related to diesel exhaust or fine particle exposure.", {"entities": [[26, 63, "DISEASE"]]}], ["After adjustment for age, race, smoking, U.S. Census region of death, vitamin use, and total years off work, engineers and conductors with diesel-exhaust exposure from operating trains had an increased risk of COPD mortality.", {"entities": []}], ["The odds of COPD mortality increased with years of work in these jobs, and those who had worked \u2265 16 years as an engineer or conductor after 1959 had an odds ratio of 1.61 (95% confidence interval, 1.12\u20132.30).", {"entities": []}], ["These results suggest that diesel-exhaust exposure contributed to COPD mortality in these workers.", {"entities": []}], ["Further study is needed to assess whether this risk is observed after exposure to exhaust from later-generation diesel engines with modern emission controls.", {"entities": []}], ["Pharmaceutical safety testing requires a cheap, fast and highly efficient platform for real-time evaluation of drug toxicity and secondary effects.", {"entities": []}], ["In this study, we have developed a microfluidic system for phenotype-based evaluation of toxic and teratogenic effects of drugs using zebrafish ( Danio rerio ) embryos and larvae as the model organism.", {"entities": []}], ["The microfluidic chip is composed of two independent functional units, enabling the assessment of zebrafish embryos and larvae.", {"entities": []}], ["Each unit consists of a fluidic concentration gradient generator and a row of seven culture chambers to accommodate zebrafish.", {"entities": []}], ["To test the accuracy of this new chip platform, we examined the toxicity and teratogenicity of an anti-asthmatic agent-aminophylline (Apl) on 210 embryos and 210 larvae (10 individuals per chamber).", {"entities": []}], ["The effect of Apl on zebrafish embryonic development was quantitatively assessed by recording a series of physiological indicators such as heart rate, survival rate, body length and hatch rate.", {"entities": []}], ["Most importantly, a new index called clonic convulsion rate, combined with mortality was used to evaluate the toxicities of Apl on zebrafish larvae.", {"entities": []}], ["We found that Apl can induce deformity and cardiovascular toxicity in both zebrafish embryos and larvae.", {"entities": []}], ["This microdevice is a multiplexed testing apparatus that allows for the examination of indexes beyond toxicity and teratogenicity at the sub-organ and cellular levels and provides a potentially cost-effective and rapid pharmaceutical safety assessment tool.", {"entities": []}], ["Asthma is a multifactorial pathology influenced by environmental and genetic factors.", {"entities": [[0, 6, "DISEASE"]]}], ["Glucocorticoid treatment decreases symptoms by regulating genes involved in the inflammatory process through binding to specific DNA sequences.", {"entities": []}], ["Polymorphisms located in the promoter region of the Prostaglandin D Receptor ( PTGDR ) gene have been related to asthma.", {"entities": [[113, 119, "DISEASE"], [79, 84, "GENE"]]}], ["We aimed to analyze the effect of PTGDR promoter haplotypes on gene expression and response to corticosteroid therapy.", {"entities": [[34, 39, "GENE"]]}], ["A549 lung epithelial cells were transfected with vectors carrying four different PTGDR haplotypes (CTCT, CCCC, CCCT and TCCT), and treated with dexamethasone.", {"entities": [[81, 86, "GENE"]]}], ["Different approaches to study the promoter activity (Dual Luciferase Reporter System), gene expression levels (qPCR) and cytokine secretion (Multiplexed Bead-based Flow Cytometric) were used.", {"entities": []}], ["In addition, in silico analysis was also performed.", {"entities": []}], ["Cells carrying the TCCT haplotype showed the lowest promoter activity (p-value<0.05) and mRNA expression levels in basal conditions.", {"entities": []}], ["After dexamethasone treatment, cells carrying the wild-type variant CTCT showed the highest response, and those carrying the TCCT variant the lowest (p-value<0.05) in luciferase assays.", {"entities": []}], ["Different transcription factor binding patterns were identified in silico .", {"entities": []}], ["Moreover, differences in cytokine secretion were also found among different promoter haplotypes.", {"entities": []}], ["Polymorphisms of PTGDR gene influence basal promoter activity and gene expression, as well as the cytokine secretory pattern.", {"entities": [[17, 22, "GENE"]]}], ["Furthermore, an association between these positions and response to corticoid treatment was observed.", {"entities": []}], ["A rise in obesity, poor-quality diets, and low physical activity has led to a dramatic increase in the number of Americans with metabolic syndrome and diabetes.", {"entities": [[10, 17, "DISEASE"], [138, 146, "DISEASE"]]}], ["Our objective was to determine the effect of a short-term, multifaceted wellness program carried out in a church setting on weight, metabolic syndrome, and self-reported wellness.", {"entities": [[142, 150, "DISEASE"]]}], ["Forty-one overweight or obese adults in a church congregation provided fasting blood samples and answered a wellness questionnaire before and after completing an 8-week diet and exercise program.", {"entities": []}], ["We also measured weight, body fat, body mass index, and waist and hip circumference.", {"entities": []}], ["The intervention decreased weight, body fat, and central adiposity; improved indexes of metabolic syndrome; and increased self-reported wellness.", {"entities": [[98, 106, "DISEASE"]]}], ["A multifaceted wellness intervention that emphasizes diet and exercise can rapidly influence weight, insulin resistance, metabolic syndrome, and self-reported wellness.", {"entities": [[131, 139, "DISEASE"]]}], ["We describe, for the first time, the use of a mobile device platform for remote direct observation of inhaler use and technique.", {"entities": []}], ["The research programme commenced with a rapid systematic review of mobile device (or videophone) use for direct observation of therapy (MDOT).", {"entities": []}], ["Ten studies (mainly pilots) were identified involving patients with tuberculosis, sickle cell disease and Alzheimer's disease.", {"entities": [[68, 80, "DISEASE"]]}], ["New studies are ongoing (ClinicalTrials.gov website) in TB, stroke, sickle cell disease, HIV and opioid dependence.", {"entities": []}], ["Having identified no prior use of MDOT in inhaler monitoring, we implemented a feasibility study in 12 healthy volunteer children (2\u201312 years; 8 females and 4 males) over a period of 14 days, with twice daily video upload of their 'dummy' inhaler use.", {"entities": []}], ["Two children uploaded 100% of the requested videos, with only one child having an inhaler upload rate of <75%.", {"entities": []}], ["The quality of uploaded videos was generally good (only 1.7% of unacceptable quality for evaluation).", {"entities": []}], ["The final aspect of the research was a pilot study using MDOT (6 weeks) in 22 children with difficult to treat asthma.", {"entities": [[111, 117, "DISEASE"]]}], ["Healthcare professionals evaluated inhaler technique using uploaded videos and provided telephone instruction on improving inhaler use.", {"entities": []}], ["The main outcomes were assessed at week 12 post initiation of MDOT.", {"entities": []}], ["By week 5, all children still engaging in MDOT (n = 18) were judged to have effective inhaler technique.", {"entities": []}], ["Spirometry values did not vary to a significantly significant degree between baseline and 12 weeks (P>0.05), however, mean fraction of exhaled nitric oxide (FeNO) values normalised (mean 38.7 to 19.3ppm) and mean Asthma Control Test values improved (13.1 to mean 17.8).", {"entities": [[213, 219, "DISEASE"]]}], ["Feedback from participants was positive.", {"entities": []}], ["Overall the findings open up a new paradigm in device independent (can be used for any type of inhaler device) monitoring, providing a platform for evaluating / improving inhaler use at home.", {"entities": []}], ["Adherence to treatment is often reported to be low in children with cystic fibrosis.", {"entities": [[68, 83, "DISEASE"]]}], ["Adherence in cystic fibrosis is an important research area and more research is needed to better understand family barriers to adherence in order for clinicians to provide appropriate intervention.", {"entities": [[13, 28, "DISEASE"]]}], ["The aim of this study was to evaluate adherence to enzyme supplements, vitamins and chest physiotherapy in children with cystic fibrosis and to determine if any modifiable risk factors are associated with adherence.", {"entities": [[121, 136, "DISEASE"]]}], ["A sample of 100 children (\u226418\u00a0years) with cystic fibrosis (44 male; median [range] 10.1 [0.2-18.6] years) and their parents were recruited to the study from the Northern Ireland Paediatric Cystic Fibrosis Centre.", {"entities": [[42, 57, "DISEASE"], [189, 204, "DISEASE"]]}], ["Adherence to enzyme supplements, vitamins and chest physiotherapy was assessed using a multi-method approach including; Medication Adherence Report Scale, pharmacy prescription refill data and general practitioner prescription issue data.", {"entities": []}], ["Beliefs about treatments were assessed using refined versions of the Beliefs about Medicines Questionnaire-specific.", {"entities": []}], ["Parental depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale.", {"entities": []}], ["Using the multi-method approach 72% of children were classified as low-adherers to enzyme supplements, 59% low-adherers to vitamins and 49% low-adherers to chest physiotherapy.", {"entities": []}], ["Variations in adherence were observed between measurement methods, treatments and respondents.", {"entities": []}], ["Parental necessity beliefs and child age were significant independent predictors of child adherence to enzyme supplements and chest physiotherapy, but parental depressive symptoms were not found to be predictive of adherence.", {"entities": []}], ["Child age and parental beliefs about treatments should be taken into account by clinicians when addressing adherence at routine clinic appointments.", {"entities": []}], ["Low adherence is more likely to occur in older children, whereas, better adherence to cystic fibrosis therapies is more likely in children whose parents strongly believe the treatments are necessary.", {"entities": [[86, 101, "DISEASE"]]}], ["The necessity of treatments should be reinforced regularly to both parents and children.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-015-0038-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Sea cucumbers have been valued for many centuries as a tonic and functional food, dietary delicacies and important ingredients of traditional medicine in many Asian countries.", {"entities": []}], ["An assortment of bioactive compounds has been described in sea cucumbers.", {"entities": []}], ["The most important and abundant secondary metabolites from sea cucumbers are triterpene glycosides (saponins).", {"entities": []}], ["Due to the wide range of their potential biological activities, these natural compounds have gained attention and this has led to their emergence as high value compounds with extended application in nutraceutical, cosmeceutical, medicinal and pharmaceutical products.", {"entities": []}], ["They are characterized by bearing a wide spectrum of structures, such as sulfated, non-sulfated and acetylated glycosides.", {"entities": []}], ["Over 700 triterpene glycosides have been reported from the Holothuroidea in which more than 145 are decorated with an acetoxy group having 38 different aglycones.", {"entities": []}], ["The majority of sea cucumber triterpene glycosides are of the holostane type containing a C18 (20) lactone group and either \u0394", {"entities": []}], ["Studies have shown that a proportion of children as young as two years are already overweight.", {"entities": []}], ["This indicates that obesity prevention programs that commence as early as possible and are family-focused are needed.", {"entities": [[20, 27, "DISEASE"]]}], ["This Healthy Beginnings Trial aims to determine the efficacy of a community-based randomized controlled trial (RCT) of a home visiting intervention in preventing the early onset of childhood overweight and obesity.", {"entities": [[206, 213, "DISEASE"]]}], ["The intervention will be conducted over the first two years of life to increase healthy feeding behaviours and physical activity, decrease physical inactivity, enhance parent-child interaction, and hence reduce overweight and obesity among children at 2 and 5 years of age in the most socially and economically disadvantaged areas of Sydney, Australia.", {"entities": [[226, 233, "DISEASE"]]}], ["This RCT will be conducted with a consecutive sample of 782 first time mothers with their newborn children.", {"entities": []}], ["Pregnant women who are expecting their first child, and who are between weeks 24 and 34 of their pregnancy, will be invited to participate in the trial at the antenatal clinic.", {"entities": []}], ["Informed consent will be obtained and participants will then be randomly allocated to the intervention or the control group.", {"entities": []}], ["The allocation will be concealed by sequentially numbered, sealed opaque envelopes containing a computer generated random number.", {"entities": []}], ["The intervention comprises eight home visits from a specially trained community nurse over two years and pro-active telephone support between the visits.", {"entities": []}], ["Main outcomes include a) duration of breastfeeding measured at 6 and 12 months, b) introduction of solids measured at 4 and 6 months, c) nutrition, physical activity and television viewing measured at 24 months, and d) overweight/obesity status at age 2 and 5 years.", {"entities": [[230, 237, "DISEASE"]]}], ["The results of this trial will ascertain whether the home based early intervention is effective in preventing the early onset of childhood overweight and obesity.", {"entities": [[154, 161, "DISEASE"]]}], ["If proved to be effective, it will result in a series of recommendations for policy and practical methods for promoting healthy feeding and physical activity of children in the first two years of life with particular application to families who are socially and economically disadvantaged.", {"entities": []}], ["Dexamethasone (Dex) is an effective glucocorticoid in treating inflammation and preventing rejection reaction.", {"entities": []}], ["However, the side effects limit its clinical application.", {"entities": []}], ["To improve its druggable profile, the conjugates of RGD-peptide-modified Dex were presented and their enhanced anti-inflammation activity, minimized osteoporotic action, and nanoscaled assembly were explored.", {"entities": []}], ["(RGD stands for Arg-Gly-Asp.", {"entities": []}], ["Standard single letter biochemical abbreviations for amino acids have been used throughout this paper.)", {"entities": []}], ["In respect of the rejection reaction, the survival time of the implanted myocardium of the mice treated with 1.43 \u00b5mol/kg/d of the conjugates for 15 consecutive days was significantly longer than that of the mice treated with 2.5 \u00b5mol/kg/d of Dex, and the conjugates, but not Dex, exhibited no toxic action.", {"entities": []}], ["At a single dose of 14.3 \u00b5mol/kg (100 times minimal effective dose, 0.143 \u00b5mol/kg), the conjugates induced no liver, kidney, or systemic toxicity.", {"entities": []}], ["At the dose of 1.43 \u00b5mol/kg, the conjugates, but not Dex, prolonged the bleeding time of the mice, and inhibited the thrombosis of the rats.", {"entities": []}], ["In water and rat plasma, the conjugates formed nanoparticles of 14\u2013250 and 101\u2013166 nm in diameter, respectively.", {"entities": []}], ["Since the nanoparticles of ~100 nm in size cannot be entrapped by macrophages in the circulation, RGDF-Dex would particularly be worthy of development, since its nanoparticle diameter is 101 nm.", {"entities": []}], ["Risk factors for psychiatric comorbidity in multiple sclerosis (MS) are poorly understood.", {"entities": [[44, 62, "DISEASE"]]}], ["We evaluated the association between physical comorbidity and incident depression, anxiety disorder, and bipolar disorder in a MS population relative to a matched general population cohort.", {"entities": [[83, 99, "DISEASE"], [105, 121, "DISEASE"]]}], ["Using population\u2010based administrative data from Alberta, Canada we identified 9624 persons with MS , and 41,194 matches.", {"entities": []}], ["Using validated case definitions, we estimated the incidence of depression, anxiety disorder, and bipolar disorder, and their association with physical comorbidities using Cox regression, adjusting for age, sex, socioeconomic status, and index year.", {"entities": [[76, 92, "DISEASE"], [98, 114, "DISEASE"]]}], ["In both populations, men had a lower risk of depression and anxiety disorders than women, as did individuals who were \u226545\u00a0years versus <45\u00a0years at the index date.", {"entities": []}], ["The risk of bipolar disorder declined with increasing age.", {"entities": [[12, 28, "DISEASE"]]}], ["The risks of incident depression ( HR 1.92; 1.82\u20132.04), anxiety disorders ( HR 1.52; 1.42\u20131.63), and bipolar disorder ( HR 2.67; 2.29\u20133.11) were higher in the MS population than the matched population.", {"entities": [[101, 117, "DISEASE"], [35, 37, "GENE"], [76, 78, "GENE"], [120, 122, "GENE"], [35, 37, "GENE"], [76, 78, "GENE"], [120, 122, "GENE"], [35, 37, "GENE"], [76, 78, "GENE"], [120, 122, "GENE"]]}], ["These associations persisted essentially unchanged after adjustment for covariates including physical comorbidities.", {"entities": []}], ["Multiple physical comorbidities were associated with psychiatric disorders in both populations.", {"entities": []}], ["Persons with MS are at increased risk of psychiatric comorbidity generally, and some physical comorbidities are associated with additional risk.", {"entities": []}], ["Previously, we showed that treatment with the Rho-kinase inhibitor Y-27632 was able to control airway responsiveness, inflammation, remodeling, and oxidative stress in an animal model of asthma, suggesting that this drug is beneficial in asthma.", {"entities": [[187, 193, "DISEASE"], [238, 244, "DISEASE"]]}], ["However, studies evaluating the effects of these inhibitors in conjunction with corticosteroids on chronic pulmonary inflammation have not been conducted.", {"entities": []}], ["Therefore, we evaluated the effects of treatment with the Rho-kinase inhibitor Y-27632, with or without concurrent dexamethasone treatment, on airway and lung tissue mechanical responses, inflammation, extracellular matrix remodeling, and oxidative stress in guinea pigs with chronic allergic inflammation.", {"entities": []}], ["The guinea pigs were subjected to seven ovalbumin or saline inhalation exposures.", {"entities": []}], ["Treatment with Y-27632 (1\u00a0mM) and dexamethasone (2\u00a0mg/kg) started at the fifth inhalation.", {"entities": []}], ["Seventy-two hours after the seventh inhalation, the pulmonary mechanics were evaluated and exhaled nitric oxide (E NO ) levels were determined.", {"entities": []}], ["The lungs were removed and histological analysis was performed using morphometry.", {"entities": []}], ["The treatment of guinea pigs with the Rho-kinase inhibitor and dexamethasone (ORC group) decreased E NO , the maximal mechanical responses after antigen challenge, inflammation, extracellular matrix remodeling and oxidative stress in the lungs.", {"entities": []}], ["This therapeutic strategy reduced the levels of collagen and IFN-\u03b3 in the airway walls, as well as IL-2, IFN-\u03b3, 8-iso-PGF2\u03b1 and NF-\u03baB in the distal parenchyma, when compared to isolated treatment with corticosteroid or Rho-kinase inhibitor (P\u2009<\u20090.05) and reduced the number of TIMP-1-positive cells and eosinophils in the alveolar septa compared to corticosteroid-treated animals (P\u2009<\u20090.05).", {"entities": []}], ["The combined treatment with the Rho-kinase inhibitor and the corticosteroid provided maximal control over the remodeling response and inflammation in the airways and parenchyma.", {"entities": []}], ["Rho-kinase inhibition, alone or in combination with corticosteroids, can be considered a future pharmacological tool for the control of asthma.", {"entities": [[136, 142, "DISEASE"]]}], ["Bronchospasm induced in non-asthmatic human subjects can be easily reversed by a deep inspiration (DI) whereas bronchospasm that occurs spontaneously in asthmatic subjects cannot.", {"entities": []}], ["This physiological effect of a DI has been attributed to the manner in which a DI causes airway smooth muscle (ASM) cells to stretch, but underlying molecular mechanisms\u2013and their failure in asthma\u2013remain obscure.", {"entities": [[191, 197, "DISEASE"]]}], ["Using cells and tissues from wild type and zyxin", {"entities": []}], ["\u2022 We studied the age-specific RSV neutralising antibody response.", {"entities": []}], ["\u2022 These responses were used to infer the optimal age for vaccination.", {"entities": []}], ["\u2022 Significant responses were observed only beyond 4 months of age.", {"entities": []}], ["\u2022 Live-virus vaccines are unlikely to optimally protect before 4 months of age.", {"entities": []}], ["\u2022 Maternal vaccination to boost trans-placental antibodies should be considered.", {"entities": []}], ["We studied the age-specific RSV neutralising antibody response.", {"entities": []}], ["These responses were used to infer the optimal age for vaccination.", {"entities": []}], ["Significant responses were observed only beyond 4 months of age.", {"entities": []}], ["Live-virus vaccines are unlikely to optimally protect before 4 months of age.", {"entities": []}], ["Maternal vaccination to boost trans-placental antibodies should be considered.", {"entities": []}], ["To determine the age at which infants mount significant neutralising antibody responses to both natural RSV infection and live vaccines that mimic natural infection, RSV-specific neutralising antibodies in the acute and convalescent phase sera of infants with RSV infection were assayed.", {"entities": []}], ["Age-specific incidence estimates for hospitalisation with severe RSV disease were determined and compared to age-specific neutralising antibody response patterns.", {"entities": []}], ["Disease incidence peaked at between 2 and 3.9 months of life.", {"entities": []}], ["Following natural infection, relative to the mean acute phase antibody titre, the mean convalescent titre was lower in the 0\u20131.9 month age class, no different in the 2\u20133.9 month age class and greater in all age classes greater than 4 months.", {"entities": []}], ["These data suggest effective vaccination with live vaccines that mimic natural infection may not be achieved before the age of 4 months.", {"entities": []}], ["Maternal vaccination may be an alternative to direct infant vaccination in order to protect very young babies.", {"entities": []}], ["Recent case reports describe multidrug-resistant influenza A pandemic (H1N1) 2009 virus infection in immunocompromised patients exposed to neuraminidase inhibitors because of an I223R neuraminidase mutation.", {"entities": [[49, 58, "DISEASE"]]}], ["We report a case of multidrug-resistant pandemic (H1N1) 2009 bearing the I223R mutation in an ambulatory child with no previous exposure to neuraminidase inhibitors.", {"entities": []}], ["Despite advances in prostate cancer (PC) treatment and outcomes, it remains one of the most commonly diagnosed cancers and the second leading cause of cancer mortality in men.", {"entities": [[29, 35, "DISEASE"], [151, 157, "DISEASE"], [20, 35, "DISEASE"], [37, 39, "GENE"]]}], ["Furthermore, there exist little data about patient awareness of PC and the frequency of screening.", {"entities": [[64, 66, "GENE"]]}], ["Adult men (470) presenting to the emergency department at a tertiary care center (Stony Brook University) between 2014 and 2015 were surveyed orally for their perceived risk of PC, awareness of PC and screening modalities, and screening history.", {"entities": [[177, 179, "GENE"], [194, 196, "GENE"], [177, 179, "GENE"], [194, 196, "GENE"]]}], ["In a population that mirrors the racial demographics of the United States, it was observed that significant disparities in awareness of PC exist among several populations including those at greatest risk.", {"entities": [[136, 138, "GENE"]]}], ["This study revealed an important opportunity for education on PC and screening modalities among the population of men at risk.", {"entities": [[62, 64, "GENE"]]}], ["Conventional cigarette smoking is known to result in significant COPD morbidity and mortality.", {"entities": []}], ["Strategies to reduce and/or stop smoking in this highly vulnerable patient group are key public health priorities to reduce COPD morbidity and mortality.", {"entities": []}], ["Unfortunately, smoking cessation efforts in patients with COPD are poor and there is a compelling need for more efficient approaches to cessation for patients with COPD.", {"entities": []}], ["Electronic cigarettes (ECs) are devices that use batteries to vaporize nicotine.", {"entities": []}], ["They may facilitate quit attempts and cessation in many smokers.", {"entities": []}], ["Although they are not risk free, ECs are much less harmful than tobacco smoking.", {"entities": []}], ["Hence, the use of ECs in vulnerable groups and in patients with challenges to abstain or multiple relapses to this habit may be promising.", {"entities": []}], ["To date, little is known about health consequences of EC use among COPD smokers and whether their regular use has any effects on subjective and objective COPD outcomes.", {"entities": []}], ["In the current review, we discuss the current perspectives and literature on the role of ECs in abstaining from conventional smoking and the effects of ECs on the respiratory tract in patients with COPD.", {"entities": []}], ["Skin-derived dendritic cells (DCs) play a crucial role in the maintenance of immune homeostasis due to their role in antigen trafficking from the skin to the draining lymph nodes (dLNs).", {"entities": []}], ["To quantify the spatiotemporal regulation of skin-derived DCs in vivo , we generated knock-in mice expressing the photoconvertible fluorescent protein KikGR.", {"entities": []}], ["By exposing the skin or dLN of these mice to violet light, we were able to label and track the migration and turnover of endogenous skin-derived DCs.", {"entities": []}], ["Langerhans cells and CD103", {"entities": []}], ["The fixed-dose, long-acting bronchodilator combination of umeclidinium/vilanterol (UMEC/VI) has not previously been compared with a combination of a long-acting muscarinic antagonist and long-acting \u03b2 2 -agonist in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[229, 266, "DISEASE"]]}], ["This 12-week, randomized, blinded, triple-dummy, parallel-group, non-inferiority study compared once-daily UMEC/VI 62.5/25\u00a0mcg with once-daily tiotropium (TIO) 18\u00a0mcg\u00a0+\u00a0indacaterol (IND) 150\u00a0mcg in patients with moderate-to-very-severe COPD.", {"entities": []}], ["The primary endpoint was the trough forced expiratory volume in 1\u00a0s (FEV 1 ) on day\u00a085 (predefined non-inferiority margin \u221250\u00a0mL), and the secondary endpoint was the 0- to 6-h weighted mean (WM) FEV 1 on day 84.", {"entities": [[69, 72, "GENE"], [195, 198, "GENE"], [69, 72, "GENE"], [195, 198, "GENE"]]}], ["Other efficacy endpoints [including rescue medication use, the Transition Dyspnea Index (TDI) focal score, and the St.\u00a0George\u2019s Respiratory Questionnaire (SGRQ) score] and safety endpoints [adverse events (AEs), vital signs, and COPD exacerbations] were also assessed.", {"entities": []}], ["Trough FEV 1 improvements were comparable between treatment groups [least squares (LS) mean changes from baseline to day\u00a085: UMEC/VI 172\u00a0mL; TIO\u00a0+\u00a0IND 171\u00a0mL; treatment difference 1\u00a0mL; 95\u00a0% confidence interval (CI) \u221229 to 30\u00a0mL], demonstrating non-inferiority between UMEC/VI and TIO\u00a0+\u00a0IND.", {"entities": [[7, 10, "GENE"]]}], ["The treatments produced similar improvements in the trough FEV 1 at other study visits and the 0- to 6-h WM FEV 1 (LS mean changes at day\u00a084: UMEC/VI 235\u00a0mL; TIO\u00a0+\u00a0IND 258\u00a0mL; treatment difference \u221223\u00a0mL; 95\u00a0%\u00a0CI \u221254 to 8\u00a0mL).", {"entities": [[59, 62, "GENE"], [108, 111, "GENE"], [59, 62, "GENE"], [108, 111, "GENE"]]}], ["The results for patient-reported measures (rescue medication use, TDI focal score, and SGRQ score) were comparable; both treatments produced clinically meaningful improvements in TDI and SGRQ scores.", {"entities": []}], ["The incidence of AEs and COPD exacerbations, and changes in vital signs were similar for the two treatments.", {"entities": []}], ["UMEC/VI and TIO\u00a0+\u00a0IND, given once daily, provided similar improvements in lung function and patient-reported outcomes over 12\u00a0weeks in patients with COPD, with comparable tolerability and safety profiles.", {"entities": []}], ["ClinicalTrials.gov study\u00a0ID NCT02257385; GSK study no.", {"entities": []}], ["The online version of this article (doi:10.1007/s40268-016-0131-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Patterns of inhaled \u03b2 2 -agonist therapy use during severe asthma exacerbations before hospital attendance are poorly understood.", {"entities": [[59, 65, "DISEASE"]]}], ["To assess \u03b2 2 -agonist use prior to hospital attendance.", {"entities": []}], ["We undertook an exploratory post hoc analysis of data from a 6-month clinical trial of 303 patients randomised to combination budesonide/formoterol inhaler according to a Single combination inhaler as Maintenance And Reliever Therapy regimen (\u2018SMART\u2019) or fixed-dose budesonide/formoterol with salbutamol as reliever (\u2018Standard\u2019).", {"entities": []}], ["Patterns of \u03b2 2 -agonist use for 14 days before hospital attendance with a severe asthma exacerbation were determined by electronic monitoring of inhaler use.", {"entities": [[82, 88, "DISEASE"]]}], ["There were 22 hospital attendances in 16 patients during the study.", {"entities": []}], ["Seven and nine hospital attendances were eligible for analysis in the SMART and Standard groups, respectively.", {"entities": []}], ["In both regimens, \u03b2 2 -agonist use increased before hospital attendance, with a median (range) maximum daily number of actuations of 14 (9 to 63) budesonide/formoterol in SMART and 46 (6 to 95) salbutamol in Standard with 4 (0 to 10) budesonide/formoterol actuations on the day of maximal salbutamol use.", {"entities": []}], ["There was delay in obtaining medical review despite high \u03b2 2 -agonist use, in 9/16 patients.", {"entities": []}], ["Different patterns of use were observed, including repeated days of no inhaled corticosteroid despite marked salbutamol use, which occurred in 3/9 patients in the Standard group.", {"entities": []}], ["Delay in obtaining medical review in association with high \u03b2 2 -agonist use is common in patients before hospital presentation with severe exacerbations of asthma.", {"entities": [[156, 162, "DISEASE"]]}], ["The SMART regimen reduced nonadherence with inhaled corticosteroid therapy during severe exacerbations.", {"entities": []}], ["The prevalence of gastroesophagel reflux disease (GERD) has steadily increased.", {"entities": []}], ["However, the association between GERD itself and the risk of pneumonia remains unclear.", {"entities": [[61, 70, "DISEASE"]]}], ["This study aimed to investigate the association between GERD and long-term risk of pneumonia and to identify the major risk factors for pneumonia in GERD patients.", {"entities": [[83, 92, "DISEASE"], [136, 145, "DISEASE"]]}], ["Using the Taiwan National Health Insurance Research Database, we identified patients who were newly diagnosed with GERD and treated with proton pump inhibitors (PPIs) from January 1, 2004 through December 31, 2010.", {"entities": []}], ["Two groups comprising 15,715 GERD cases and 15,715 non-GERD matched controls were generated using propensity score matching, thereby making the differences in basic demographics, concomitant medication use, and comorbidities between the two groups inconsiderable.", {"entities": []}], ["Cumulative incidence of pneumonia was significantly higher in the patients with GERD than that in the non-GERD matched controls, with an adjusted HR of 1.48 (95% confidence interval [CI] = 1.31\u20131.67; P < 0.001) within 6-year follow-ups.", {"entities": [[24, 33, "DISEASE"], [146, 148, "GENE"]]}], ["Multivariate stratified analyses revealed similar results in many subgroups, with a highest risk in individuals younger than 40 years of age (HR = 2.17, 95% CI = 1.48\u20133.19).", {"entities": [[142, 144, "GENE"]]}], ["Crucially, patients with GERD using PPIs longer than 4 months were at a significantly increased risk of pneumonia than those who did not use PPIs or took PPIs less than 4 months.", {"entities": [[104, 113, "DISEASE"]]}], ["GERD was significantly associated with long-term risk of pneumonia, especially in GERD with PPI use longer than 4 months or in the young population.", {"entities": [[57, 66, "DISEASE"]]}], ["Further prospective longitudinal studies should be conducted for validation and implementing clinical practice guidelines.", {"entities": []}], ["This study demonstrated that the vitamin D 3 decomposition product VDP1 exerts an antibacterial action against Helicobacter pylori but not against other bacteria.", {"entities": []}], ["Treatment with VDP1 induced a collapse of cell membrane structures of H. pylori and ultimately lysed the bacterial cells.", {"entities": []}], ["A unique dimyristoyl phosphatidylethanolamine in the membrane lipid compositions contributed to the interaction of VDP1 with H. pylori cells.", {"entities": []}], ["In separate experiments, VDP1 had no influence on the viability of the human cancer cell lines MKN45 and T47D and lacked any vitamin D 3 -like hormonal action against the latter.", {"entities": [[77, 83, "DISEASE"]]}], ["In both H. pylori .", {"entities": []}], ["Pneumococcal disease causes significant morbidity and mortality in at-risk individuals, and is complicated by emerging antibiotic resistance.", {"entities": []}], ["An effective, safe and cost-effective vaccine is available, but despite this many patients who would benefit from pneumococcal vaccination remain unvaccinated.", {"entities": []}], ["The purpose of this study was to determine the rates of missed opportunities to provide pneumococcal vaccination to patients being discharged from a tertiary center medical teaching unit and to determine if a nurse coordinator-based intervention would increase rates of pneumococcal vaccination prior to discharge home.", {"entities": []}], ["We conducted a prospective, controlled study in the setting of a Medical Teaching Unit at a tertiary care centre to assess the impact of a nurse coordinator based intervention on the rates of vaccination of eligible patients on discharge home.", {"entities": []}], ["The rates of vaccination during an eight-week usual-care period (February 20 to April 16, 2002) and an eight-week intervention period (April 22 to June 16, 2002) were compared.", {"entities": []}], ["Prior to the intervention none of thirty-eight eligible patients were vaccinated prior to discharge home from the Medical Teaching Unit.", {"entities": []}], ["After the intervention 27 (54%) of fifty eligible patients were vaccinated prior to discharge.", {"entities": []}], ["There are significant missed opportunities to provide pneumococcal vaccination to inpatients who are discharged home from a medical unit.", {"entities": []}], ["Using a patient care coordinator we were able to significantly improve the rates of vaccination on discharge.", {"entities": []}], ["In order to accurately distinguish gaps of varying length in drug treatment for chronic conditions from discontinuation without resuming therapy, short-term observation does not suffice.", {"entities": []}], ["Thus, the use of inhalation corticosteroids (ICS) in the long-term, during a ten-year period is investigated.", {"entities": []}], ["To describe medication use as a continuum, taking into account the timeliness and consistency of refilling, a Markov model is proposed.", {"entities": []}], ["Patients, that filled at least one prescription in 1993, were selected from the PHARMO medical record linkage system (RLS) containing >95% prescription dispensings per patient originating from community pharmacy records of 6 medium-sized cities in the Netherlands.", {"entities": []}], ["The probabilities of continuous use, the refilling of at least one ICS prescription in each year of follow-up, and medication free periods were assessed by Markov analysis.", {"entities": []}], ["Stratified analysis according to new use was performed.", {"entities": []}], ["The transition probabilities of the refilling of at least one ICS prescription in the subsequent year of follow-up, were assessed for each year of follow-up and for the total study period.", {"entities": []}], ["The change of transition probabilities in time was evaluated, e.g.", {"entities": []}], ["the probability of continuing ICS use of starters in the first two years (51%) of follow-up increased to more than 70% in the following years.", {"entities": []}], ["The probabilities of different patterns of medication use were assessed: continuous use (7.7%), cumulative medication gaps (1\u20138 years 69.1%) and discontinuing (23.2%) during ten-year follow-up for new users.", {"entities": []}], ["New users had lower probability of continuous use (7.7%) and more variability in ICS refill patterns than previous users (56%).", {"entities": []}], ["In addition to well-established methods in epidemiology to ascertain compliance and persistence, a Markov model could be useful to further specify the variety of possible patterns of medication use within the continuum of adherence.", {"entities": []}], ["This Markov model describes variation in behaviour and patterns of ICS use and could also be useful to investigate continuous use of other drugs applied in chronic diseases.", {"entities": []}], ["Antenatal preparation programmes are recommended worldwide to promote a healthy pregnancy and greater autonomy during labor and delivery, prevent physical discomfort and high levels of anxiety.", {"entities": []}], ["The objective of this study was to evaluate effectiveness and safety of a birth preparation programme to minimize lumbopelvic pain, urinary incontinence, anxiety, and increase physical activity during pregnancy as well as to compare its effects on perinatal outcomes comparing two groups of nulliparous women.", {"entities": []}], ["A randomized controlled trial was conducted with 197 low risk nulliparous women aged 16 to 40 years, with gestational age \u2265 18 weeks.", {"entities": []}], ["Participants were randomly allocated to participate in a birth preparation programme (BPP; n=97) or a control group (CG; n=100).", {"entities": []}], ["The intervention was performed on the days of prenatal visits, and consisted of physical exercises, educational activities and instructions on exercises to be performed at home.", {"entities": []}], ["The control group followed a routine of prenatal care.", {"entities": []}], ["Primary outcomes were urinary incontinence, lumbopelvic pain, physical activity, and anxiety.", {"entities": []}], ["Secondary outcomes were perinatal variables.", {"entities": []}], ["The risk of urinary incontinence in BPP participants was significantly lower at 30 weeks of pregnancy (BPP 42.7%, CG 62.2%; relative risk [RR] 0.69; 95% confidence interval [CI] 0.51-0.93) and at 36 weeks of pregnancy (BPP 41.2%, CG 68.4%; RR 0.60; 95%CI 0.45-0.81).", {"entities": []}], ["Participation in the BPP encouraged women to exercise during pregnancy (p=0.009).", {"entities": []}], ["No difference was found between the groups regarding to anxiety level, lumbopelvic pain, type or duration of delivery and weight or vitality of the newborn infant.", {"entities": []}], ["The BPP was effective in controlling urinary incontinence and to encourage the women to exercise during pregnancy with no adverse effects to pregnant women or the fetuses.", {"entities": []}], ["Clinicaltrials.gov, ( NCT01155804 )", {"entities": []}], ["Science, technology and innovation have long played a role in Ghana\u2019s vision for development, including in improving its health outcomes.", {"entities": []}], ["However, so far little research has been conducted on Ghana\u2019s capacity for health innovation to address local diseases.", {"entities": []}], ["This research aims to fill that gap, mapping out the key actors involved, highlighting examples of indigenous innovation, setting out the challenges ahead and outlining recommendations for strengthening Ghana\u2019s health innovation system.", {"entities": []}], ["Case study research methodology was used.", {"entities": []}], ["Data were collected through reviews of academic literature and policy documents and through open-ended, face-to-face interviews with 48 people from across the science-based health innovation system.", {"entities": []}], ["Data was collected over three visits to Ghana from February 2007 to August 2008, and stakeholders engaged subsequently.", {"entities": []}], ["Ghana has strengths which could underpin science-based health innovation in the future, including health and biosciences research institutions with strong foreign linkages and donor support; a relatively strong regulatory system which is building capacity in other West African countries; the beginnings of new funding forms such as venture capital; and the return of professionals from the diaspora, bringing expertise and contacts.", {"entities": []}], ["Some health products and services are already being developed in Ghana by individual entrepreneurs, which are innovative in the sense of being new to the country and, in some cases, the continent.", {"entities": []}], ["They include essential medicines, raw pharmaceutical materials, new formulations for pediatric use and plant medicines at various stages of development.", {"entities": []}], ["While Ghana has many institutions concerned with health research and its commercialization, their ability to work together to address clear health goals is low.", {"entities": []}], ["If Ghana is to capitalize on its assets, including political and macroeconomic stability which underpin investment in health enterprises, it needs to improve the health innovation environment through increasing support for its small firms; coordinating policies; and beginning a dialogue with donors on how health research can create locally-owned knowledge and be more demand-driven.", {"entities": []}], ["Mobilizing stakeholders around health product development areas, such as traditional medicines and diagnostics, would help to create trust between groups and build a stronger health innovation system.", {"entities": []}], ["The burden of oxidative stress is increased in chronic obstructive pulmonary disease (COPD).", {"entities": [[47, 84, "DISEASE"]]}], ["However, whether the intra-cellular mechanisms controlling the oxidant/anti-oxidant balance in structural airway cells such as airway smooth muscle in COPD is altered is unclear.", {"entities": []}], ["We sought to determine whether the expression of the NADPH oxidase (NOX)-4 is increased in airway smooth muscle in COPD both in vivo and primary cells in vitro and its role in hydrogen peroxide-induced reactive oxygen species generation.", {"entities": []}], ["We found that in vivo NOX4 expression was up-regulated in the airway smooth muscle bundle in COPD ( n \u2009=\u20099) and healthy controls with >20 pack year history ( n \u2009=\u20094) compared to control subjects without a significant smoking history ( n \u2009=\u20096).", {"entities": [[22, 26, "GENE"]]}], ["In vitro NOX4 expression was increased in airway smooth muscle cells from subjects with COPD ( n \u2009=\u20095) compared to asthma ( n \u2009=\u20097) and upregulated following TNF-\u03b1 stimulation.", {"entities": [[115, 121, "DISEASE"], [9, 13, "GENE"]]}], ["Hydrogen peroxide-induced reactive oxygen species generation by airway smooth muscle cells in COPD ( n \u2009=\u20095) was comparable to healthy controls ( n \u2009=\u20099) but lower than asthma ( n \u2009=\u20095); and was markedly attenuated by NOX4 inhibition.", {"entities": [[169, 175, "DISEASE"], [218, 222, "GENE"]]}], ["Our findings demonstrate that NOX4 expression is increased in vivo and in vitro in COPD and although we did not observe an intrinsic increase in oxidant-induced reactive oxygen species generation in COPD, it was reduced markedly by NOX4 inhibition supporting a potential therapeutic role for NOX4 in COPD.", {"entities": [[30, 34, "GENE"], [232, 236, "GENE"], [292, 296, "GENE"], [30, 34, "GENE"], [232, 236, "GENE"], [292, 296, "GENE"], [30, 34, "GENE"], [232, 236, "GENE"], [292, 296, "GENE"]]}], ["Hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) is an important regulator of immune and inflammatory responses.", {"entities": []}], ["We hypothesized that nasal allergic inflammation is attenuated by HIF-1\u03b1 inhibition and strengthened by HIF-1\u03b1 stabilization.", {"entities": []}], ["To elucidate the role of HIF-1\u03b1 in a murine model of allergic rhinitis (AR).", {"entities": [[53, 70, "DISEASE"], [62, 70, "DISEASE"]]}], ["Mice were pretreated with the HIF-1\u03b1 inhibitor 2-methoxyestradiol (2ME2) or the HIF-1\u03b1 inducer cobalt chloride (CoCl 2 ) in an established AR murine model using ovalbumin (OVA)-sensitized BALB/c mice.", {"entities": []}], ["HIF-1\u03b1 and vascular endothelial growth factor (VEGF) expression in nasal mucosa was measured and multiple parameters of allergic responses were evaluated.", {"entities": []}], ["HIF-1\u03b1 and VEGF levels were locally up-regulated in nasal mucosa during AR.", {"entities": []}], ["Inflammatory responses to OVA challenge, including nasal symptoms, inflammatory cell infiltration, eosinophil recruitment, up-regulation of T-helper type 2 cytokines in nasal lavage fluid, and serum OVA-specific IgE levels were present in the OVA-challenged mice.", {"entities": []}], ["2ME2 effectively inhibited HIF-1\u03b1 and VEGF expression and attenuated the inflammatory responses.", {"entities": []}], ["Stabilization of HIF-1\u03b1 by CoCl 2 facilitated nasal allergic inflammation.", {"entities": []}], ["HIF-1\u03b1 protein levels in nasal airways correlated with the severity of AR in mice.", {"entities": []}], ["HIF-1\u03b1 is intimately involved in the pathogenesis of nasal allergies, and the inhibition of HIF-1\u03b1 may be useful as a novel therapeutic approach for AR.", {"entities": []}], ["Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects.", {"entities": [[164, 166, "GENE"]]}], ["We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs).", {"entities": []}], ["PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS).", {"entities": []}], ["Experiments were repeated using cigarette smoke extract (CSE) for comparison.", {"entities": []}], ["IL-8 was measured by ELISA, activation of NF-\u03baB by ELISA and Western blotting, and caspase-3 activity by Western blotting.", {"entities": []}], ["Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method.", {"entities": []}], ["CSE was pro-inflammatory after a 24\u00a0h exposure and 42% of cells were apoptotic or necrotic after this exposure time.", {"entities": []}], ["Acrolein was pro-inflammatory for the PNEC cultures (30\u2009 \u03bc M exposure for 4\u00a0h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS.", {"entities": []}], ["In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50\u2009 \u03bc M exposure to nicotine for 24\u00a0h), and acetylaldehyde was without effect.", {"entities": []}], ["Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-\u03baB activation.", {"entities": []}], ["Both chemicals increased levels of cleaved caspase 3 and induced cell death.", {"entities": []}], ["Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures.", {"entities": []}], ["CSE induces cell death predominantly by apoptotic mechanisms.", {"entities": []}], ["Reversible airway hyperreactivity underlies the pathophysiology of asthma, yet the precise mediators of the response remain unclear.", {"entities": [[67, 73, "DISEASE"]]}], ["Human studies have correlated aberrant activation of T helper (Th) 2-like effector systems in the airways with disease.", {"entities": []}], ["A murine model of airway hyperreactivity in response to acetylcholine was established using mice immunized with ovalbumin and challenged with aerosolized antigen.", {"entities": []}], ["No airway hyperractivity occurred in severe combined immunodeficient mice.", {"entities": []}], ["Identically immunized BALB/c mice developed an influx of cells, with a predominance of eosinophils and CD4+ T cells, into the lungs and bronchoalveolar lavage fluid at the time that substantial changes in airway pressure and resistance were quantitated.", {"entities": []}], ["Challenged animals developed marked increases in Th2 cytokine production, eosinophil influx, and serum immunoglobulin E levels.", {"entities": []}], ["Neutralization of interleukin (IL) 4 using monoclonal antibodies administered during the period of systemic immunization abrogated airway hyperractivity but had little effect on the influx of eosinophils.", {"entities": []}], ["Administration of anti-IL-4 only during the period of the aerosol challenge did not affect the subsequent response to acetylcholine.", {"entities": []}], ["Finally, administration of anti- IL-5 antibodies at levels that suppressed eosinophils to < 1% of recruited cells had no effect on the subsequent airway responses.", {"entities": []}], ["BALB/c mice had significantly greater airway responses than C57BL/6 mice, consistent with enhanced IL-4 responses to antigen in BALB/c mice.", {"entities": []}], ["Taken together, these data implicate IL-4 generated during the period of lymphocyte priming with antigen in establishing the cascade of responses required to generate airway hyperractivity to inhaled antigen.", {"entities": []}], ["No role for IL-5 or eosinophils could be demonstrated.", {"entities": []}], ["Non-cystic fibrosis bronchiectasis is a chronic structural lung condition that courses with recurrent infectious exacerbations that lead to frequent antibiotic treatment making this population more susceptible to acquire pathogens with antibiotic resistance.", {"entities": [[20, 34, "DISEASE"], [4, 19, "DISEASE"]]}], ["We aimed to investigate risk factors associated with isolation of multidrug-resistant pathogens in bronchiectasis exacerbations.", {"entities": [[99, 113, "DISEASE"]]}], ["A prospective observational study was conducted in two tertiary-care hospitals, enrolling patients when first exacerbation appeared.", {"entities": []}], ["Multidrug-resistance was determined according to European Centre of Diseases Prevention and Control classification.", {"entities": []}], ["Two hundred thirty three exacerbations were included and microorganisms were isolated in 159 episodes.", {"entities": []}], ["Multidrug-resistant pathogens were found in 20.1% episodes: Pseudomonas aeruginosa (48.5%), methicillin-resistant Staphylococcus aureus (18.2%) and Extended spectrum betalactamase\u00a0+\u00a0Enterobacteriaceae (6.1%), and they were more frequent in exacerbations requiring hospitalization (24.5% vs. 10.2%, p : 0.016).", {"entities": []}], ["Three independent multidrug-resistant risk factors were found: chronic renal disease (Odds ratio (OR), 7.60, 95% CI 1.92\u201330.09), hospitalization in the previous year (OR, 3.88 95% CI 1.37\u201311.02) and prior multidrug-resistant isolation (OR, 5.58, 95% CI 2.02\u201315.46).", {"entities": []}], ["The proportion of multidrug-resistant in the 233 exacerbations was as follows: 3.9% in patients without risk factors, 12.6% in those with 1 factor and 53.6% if \u22652 risk factors.", {"entities": []}], ["Hospitalization in the previous year, chronic renal disease, and prior multidrug-resistant isolation are risk factors for identification multidrug-resistant pathogens in exacerbations.", {"entities": []}], ["This information may assist clinicians in choosing empirical antibiotics in daily clinical practice.", {"entities": []}], ["Reintubation is associated with high mortality.", {"entities": []}], ["Identification of methods to avoid reintubation is needed.", {"entities": []}], ["The aim of this study was to assess whether prophylactic noninvasive ventilation (NIV) would benefit patients with various cough strengths.", {"entities": []}], ["We prospectively enrolled 356 patients who successfully passed a spontaneous breathing trial in a respiratory intensive care unit.", {"entities": []}], ["Before extubation, cough peak flow was measured.", {"entities": []}], ["After extubation, attending physicians determined whether the patients would receive prophylactic NIV or conventional oxygen treatment (control group).", {"entities": []}], ["Patients were followed up to 90\u00a0days postextubation or death, whichever came first.", {"entities": []}], ["The median value of cough peak flow was 70\u00a0L/minute.", {"entities": []}], ["Among the patients with cough peak flow \u226470\u00a0L/minute, 108 received NIV and 72 received conventional oxygen treatment.", {"entities": []}], ["In this cohort, NIV reduced reintubation (9\u00a0% vs. 35\u00a0% at postextubation 72\u00a0h, p \u2009<\u20090.01; and 24\u00a0% vs. 49\u00a0% at postextubation 7\u00a0days, p \u2009<\u20090.01) and postextubation 90-day mortality (43\u00a0% vs. 61\u00a0%, p \u2009=\u20090.02) compared with the control group.", {"entities": []}], ["Further, use of NIV was an independent protective factor for reintubation (OR\u2009=\u20090.19, p \u2009<\u20090.01 at 72\u00a0h postextubation; and OR\u2009=\u20090.33, p \u2009<\u20090.01 at 7\u00a0days postextubation) and for death at 90\u00a0days postextubation (OR\u2009=\u20090.40, p \u2009=\u20090.02).", {"entities": []}], ["Among patients with cough peak flow >70\u00a0L/minute, 71 received NIV and 105 received conventional oxygen treatment.", {"entities": []}], ["In this cohort, NIV did not reduce reintubation (6\u00a0% vs. 6\u00a0% at 72\u00a0h postextubation, p \u2009>\u20090.99; and 9\u00a0% vs. 9\u00a0% at 7\u00a0days postextubation, p \u2009>\u20090.99) or postextubation 90-day mortality (21\u00a0% vs. 15\u00a0%, p \u2009=\u20090.32) compared with the control group.", {"entities": []}], ["Further, use of NIV was not associated with reintubation or postextubation 90-day mortality.", {"entities": []}], ["In a planned extubated population, prophylactic NIV benefited patients with weak cough but possibly not in patients with strong cough.", {"entities": []}], ["To evaluate the association between post-inhaled corticosteroid (ICS) pulmonary tuberculosis (TB), pneumonia and lung cancer in patients with asthma.", {"entities": [[113, 124, "DISEASE"], [99, 108, "DISEASE"], [80, 92, "DISEASE"], [142, 148, "DISEASE"], [70, 92, "DISEASE"], [118, 124, "DISEASE"]]}], ["The study samples were collected from the National Health Insurance Database.", {"entities": []}], ["Asthmatic patients who were first-time users of ICS between 2003 and 2005 were identified as cases.", {"entities": []}], ["For each case, 4 control individuals were randomly matched for sex, age and date of ICS use.", {"entities": []}], ["Cases and matched controls were followed up until the end of 2010.", {"entities": []}], ["Cox proportional hazard regression was used to determine the hazard ratio for pulmonary infections and lung cancer risk in the ICS users and non-users.", {"entities": [[103, 114, "DISEASE"], [108, 114, "DISEASE"]]}], ["A total of 10,904 first-time users of ICS were matched with 43,616 controls.", {"entities": []}], ["The hazard ratios for lung cancer were: 2.52 (95% confidence interval [CI], 1.22\u20135.22; p = 0.012) for individuals with post-ICS TB, 1.28 (95%CI, 0.73\u20132.26; p = 0.389) for post-ICS pneumonia, 2.31(95%CI, 0.84\u20136.38; p = 0.105) for post-ICS pneumonia+TB, 1.08 (95%CI, 0.57\u20132.03; p = 0.815) for TB, 0.99 (95%CI, 0.63\u20131.55; p = 0.970) for pneumonia, and 0.32 (95%CI, 0.05\u20132.32; p = 0.261) for pneumonia+ TB, respectively.", {"entities": [[22, 33, "DISEASE"], [180, 189, "DISEASE"], [238, 247, "DISEASE"], [334, 343, "DISEASE"], [388, 397, "DISEASE"], [27, 33, "DISEASE"]]}], ["Post-ICS TB increased lung cancer risk in patients with asthma.", {"entities": [[22, 33, "DISEASE"], [56, 62, "DISEASE"], [27, 33, "DISEASE"]]}], ["Because of the high mortality associated with lung cancer, screening tests are recommended for patients with post-ICS TB.", {"entities": [[46, 57, "DISEASE"], [51, 57, "DISEASE"]]}], ["To test the performance of new variants of models to identify people at risk of an emergency hospital admission.", {"entities": []}], ["We compared (1) the impact of using alternative data sources (hospital inpatient, A&E, outpatient and general practitioner (GP) electronic medical records) (2) the effects of local calibration on the performance of the models and (3) the choice of population denominators.", {"entities": []}], ["Multivariate logistic regressions using person-level data adding each data set sequentially to test value of additional variables and denominators.", {"entities": []}], ["5 Primary Care Trusts within England.", {"entities": []}], ["1\u2005836\u2005099 people aged 18\u201395 registered with GPs on 31 July 2009.", {"entities": []}], ["Models to predict hospital admission and readmission were compared in terms of the positive predictive value and sensitivity for various risk strata and with the receiver operating curve C statistic.", {"entities": []}], ["The addition of each data set showed moderate improvement in the number of patients identified with little or no loss of positive predictive value.", {"entities": []}], ["However, even with inclusion of GP electronic medical record information, the algorithms identified only a small number of patients with no emergency hospital admissions in the previous 2\u2005years.", {"entities": []}], ["The model pooled across all sites performed almost as well as the models calibrated to local data from just one site.", {"entities": []}], ["Using population denominators from GP registers led to better case finding.", {"entities": []}], ["These models provide a basis for wider application in the National Health Service.", {"entities": []}], ["Each of the models examined produces reasonably robust performance and offers some predictive value.", {"entities": []}], ["The addition of more complex data adds some value, but we were unable to conclude that pooled models performed less well than those in individual sites.", {"entities": []}], ["Choices about model should be linked to the intervention design.", {"entities": []}], ["Characteristics of patients identified by the algorithms provide useful information in the design/costing of intervention strategies to improve care coordination/outcomes for these patients.", {"entities": []}], ["All near-equilibrium systems under linear regime evolve to stationary states in which there is constant entropy production rate.", {"entities": []}], ["In an open chemical system that exchanges matter and energy with the exterior, we can identify both the energy and entropy flows associated with the exchange of matter and energy.", {"entities": []}], ["This can be achieved by applying statistical mechanics (SM), which links the microscopic properties of a system to its bulk properties.", {"entities": []}], ["In the case of contractile tissues such as human placenta, Huxley\u2019s equations offer a phenomenological formalism for applying SM.", {"entities": []}], ["SM was investigated in human placental stem villi (PSV) (n = 40).", {"entities": []}], ["PSV were stimulated by means of KCl exposure (n = 20) and tetanic electrical stimulation (n = 20).", {"entities": []}], ["This made it possible to determine statistical entropy (S), internal energy (E), affinity (A), thermodynamic force (A / T) (T: temperature), thermodynamic flow (v) and entropy production rate (A / T x v).", {"entities": []}], ["We found that PSV operated near equilibrium, i.e., A \u227a\u227a 2500 J/mol and in a stationary linear regime, i.e., (A / T) varied linearly with v. As v was dramatically low, entropy production rate which quantified irreversibility of chemical processes appeared to be the lowest ever observed in any contractile system.", {"entities": []}], ["The nature and development of cardiorespiratory impairments associated with sickle cell disease are poorly understood.", {"entities": []}], ["Given that the mechanisms of these impairments cannot be addressed adequately in clinical studies, we characterized cardiorespiratory pathophysiology from birth to maturity in the sickle cell disease SAD mouse model.", {"entities": []}], ["We identified two critical phases of respiratory dysfunction in SAD mice; the first prior to weaning and the second in adulthood.", {"entities": []}], ["At postnatal day 3, 43% of SAD mice showed marked apneas, anemia, and pulmonary vascular congestion typical of acute chest syndrome; none of these mice survived to maturity.", {"entities": [[111, 131, "DISEASE"], [123, 131, "DISEASE"], [58, 64, "DISEASE"]]}], ["The remaining SAD mice had mild lung histological changes in room air with an altered respiratory pattern, seizures, and a high rate of death in response to hypoxia.", {"entities": []}], ["Approximately half the SAD mice that survived to adulthood had an identifiable respiratory phenotype including baseline tachypnea at 7\u20138 months of age, restrictive lung disease, pulmonary hypertension, cardiac enlargement, lower total lung capacity, and pulmonary vascular congestion.", {"entities": [[188, 200, "DISEASE"], [178, 200, "DISEASE"], [164, 176, "DISEASE"]]}], ["All adult SAD mice demonstrated impairments in exercise capacity and response to hypoxia, with a more severe phenotype in the tachypneic mice.", {"entities": []}], ["The model revealed distinguishable subgroups of SAD mice with cardiorespiratory pathophysiology mimicking the complications of human sickle cell disease.", {"entities": []}], ["Some health behaviours are liable to affect the incidence of allergies and/or common infections in young people; however, the extent and ways in which these might occur are mostly unknown.", {"entities": []}], ["This study examines the association of health behaviours related to physical activity, sedentariness, diet and sleep with allergy and infection symptoms in adolescents, and also with biological markers that might mediate disease incidence.", {"entities": []}], ["The study comprised a total of 2054 adolescents (50.7% girls) from the Madrid region of Spain.", {"entities": []}], ["The incidence of infection and allergy symptoms three months prior to the study was obtained from a self-administered questionnaire.", {"entities": []}], ["Physical and sedentary activities, height and weight, food habits and sleep duration were also self-reported and their influence on infection and allergy incidence was assessed by logistic regression analysis.", {"entities": []}], ["Blood biomarkers (IgE, eosinophil percentage, leptin, interleukin (IL)-2, IL-4, IL-5 and IL-10) were evaluated in a subsample of 198 subjects.", {"entities": []}], ["Adequate sleep duration (OR\u2009=\u20090.79, 95%CI: 0.64 to 0.97) and unhealthy weight status (overweight/obesity) (OR\u2009=\u20091.35, 95%CI: 1.04-1.74) were independently associated with decreased and increased allergy incidence, respectively.", {"entities": [[97, 104, "DISEASE"]]}], ["No significant association was observed with infection incidence.", {"entities": []}], ["IgE and leptin differed between adolescents with and without allergy symptoms.", {"entities": []}], ["In regression models IgE was significantly associated with inadequate sleep duration and leptin with weight status.", {"entities": []}], ["Excess weight and inadequate sleep duration are independently associated with the incidence of allergy symptoms in adolescents.", {"entities": []}], ["Adequate sleep duration and weight during adolescence might be relevant for a decreased risk of suffering allergy symptoms.", {"entities": []}], ["To investigate whether normal variation of adult height is associated with clinical characteristics in rheumatoid arthritis (RA), including disease activity (DAS28), impairment of joint function (mechanical joint score, MJS) and overall disability (health assessment questionnaire, HAQ).", {"entities": [[103, 123, "DISEASE"], [114, 123, "DISEASE"]]}], ["A cohort (134 males, 287 females) of consecutively recruited RA patients of Northern European origin was studied.", {"entities": []}], ["Height, weight and demographic information were obtained.", {"entities": []}], ["A core set of disease measurements, including DAS28, MJS and HAQ, were recorded at baseline, 12 and 24 months.", {"entities": []}], ["Other clinical variables (e.g.", {"entities": []}], ["disease duration, IgM rheumatoid factor, antibodies to cyclic citrullinated peptide, C-reactive protein, erythrocyte sedimentation rate) were recorded at baseline.", {"entities": []}], ["Socioeconomic status, smoking status, comorbid condition, other autoimmune conditions and drug therapy were also recorded.", {"entities": []}], ["Associations were analyzed using univariate statistics and multivariate linear regression models.", {"entities": []}], ["Mediation tests were also carried out for evaluating the relationship between gender, height and disease measures.", {"entities": []}], ["In males, height was inversely associated with DAS28, MJS and HAQ (at baseline and over 24 months) independent of other factors (e.g.", {"entities": []}], ["weight, body mass index, age, disease duration, osteoporosis, autoantibodies, erosive disease, joint replacement, steroid use, smoking status, socioeconomic status and comorbid disease).", {"entities": [[48, 60, "DISEASE"]]}], ["In females, a similar trend was seen but the relationships were non significant.", {"entities": []}], ["In the whole population, the association of female gender with more active disease and poor function disappeared after adjustment for height.", {"entities": []}], ["Mediation analysis indicated that height served as a full mediator in the relationship of gender with disease activity and overall disability.", {"entities": []}], ["Confirmation of these findings was demonstrated in a second RA population (n\u200a=\u200a288).", {"entities": []}], ["Adult height is inversely associated with disease activity, impairment of joint function and overall disability in RA, particularly in males.", {"entities": []}], ["The association of female sex with more severe disease activity and disability appears to be mediated by smaller stature.", {"entities": []}], ["Multi-marker approaches have received a lot of attention recently in genome wide association studies and can enhance power to detect new associations under certain conditions.", {"entities": []}], ["Gene-, gene-set- and pathway-based association tests are increasingly being viewed as useful supplements to the more widely used single marker association analysis which have successfully uncovered numerous disease variants.", {"entities": []}], ["A major drawback of single-marker based methods is that they do not look at the joint effects of multiple genetic variants which individually may have weak or moderate signals.", {"entities": []}], ["Here, we describe novel tests for multi-marker association analyses that are based on phenotype predictions obtained from machine learning algorithms.", {"entities": []}], ["Instead of assuming a linear or logistic regression model, we propose the use of ensembles of diverse machine learning algorithms for prediction.", {"entities": []}], ["We show that phenotype predictions obtained from ensemble learning algorithms provide a new framework for multi-marker association analysis.", {"entities": []}], ["They can be used for constructing tests for the joint association of multiple variants, adjusting for covariates and testing for the presence of interactions.", {"entities": []}], ["To demonstrate the power and utility of this new approach, we first apply our method to simulated SNP datasets.", {"entities": []}], ["We show that the proposed method has the correct Type-1 error rates and can be considerably more powerful than alternative approaches in some situations.", {"entities": []}], ["Then, we apply our method to previously studied asthma-related genes in 2 independent asthma cohorts to conduct association tests.", {"entities": [[48, 54, "DISEASE"], [86, 92, "DISEASE"]]}], ["MicroRNAs (miRNAs) negatively regulate the gene expression and act as tumor suppressors or oncogenes in oncogenesis.", {"entities": []}], ["The association between single nucleotide polymorphism (SNP) in miR-196a2 rs11614913 and the susceptibility of digestive system cancers was inconsistent in previous studies.", {"entities": []}], ["An updated meta-analysis based on 15 independent case-control studies consisting of 4999 cancer patients and 7606 controls was performed to address this association.", {"entities": [[89, 95, "DISEASE"]]}], ["It was found that miR-196a2 polymorphism significantly elevated the risks of digestive system cancers (CT vs. TT, OR\u200a=\u200a1.25, 95% CI\u200a=\u200a1.07\u20131.45; CC vs. TT, OR\u200a=\u200a1.38, 95% CI\u200a=\u200a1.13\u20131.67; CC/CT vs. TT, OR\u200a=\u200a1.29, 95% CI\u200a=\u200a1.10\u20131.50; CC vs. CT/TT, OR\u200a=\u200a1.14, 95% CI\u200a=\u200a1.01\u20131.30; C vs. T, OR\u200a=\u200a1.15, 95% CI\u200a=\u200a1.05\u20131.26).", {"entities": []}], ["We also found that variant in miR-196a2 increased the susceptibility of colorectal cancer (CRC) (CT vs. TT, OR\u200a=\u200a1.23, 95% CI\u200a=\u200a1.04\u20131.44; CC vs. TT, OR\u200a=\u200a1.32, 95% CI\u200a=\u200a1.08\u20131.61; CC/CT vs. TT, OR\u200a=\u200a1.25, 95% CI\u200a=\u200a1.07\u20131.46; C vs. T, OR\u200a=\u200a1.15, 95% CI\u200a=\u200a1.05\u20131.28), while the association in recessive model (CC vs. CT/TT, OR\u200a=\u200a1.16, 95% CI\u200a=\u200a0.98\u20131.38) showed a marginal significance.", {"entities": [[72, 89, "DISEASE"], [83, 89, "DISEASE"]]}], ["Additionally, significant association between miR-196a2 polymorphism and increased risk of hepatocellular cancer (HCC) was detected.", {"entities": [[106, 112, "DISEASE"]]}], ["By stratifying tumors on the basis of site of origin, source of controls, ethnicity and allele frequency in controls, elevated cancer risks were observed.", {"entities": [[127, 133, "DISEASE"]]}], ["Our findings suggest the significant association between miR-196a2 polymorphism and increased susceptibility of digestive system cancers, especially of CRC, HCC and Asians.", {"entities": []}], ["Besides, C allele may contribute to increased digestive cancer risks.", {"entities": [[56, 62, "DISEASE"]]}], ["Adenoid cystic carcinoma (ACC) of the trachea is rare, it represents 1% of all respiratory tract cancers.", {"entities": [[15, 24, "DISEASE"]]}], ["It's generally considered as a slow-growing, with pronlonged clinical course.", {"entities": []}], ["Most patients present with dyspnea, and the symptoms often mimic those of asthma or chronic bronchitis Surgical resection is the mainstay of treatment often combined to radiotherapy because of close surgical margins.", {"entities": [[74, 80, "DISEASE"], [92, 102, "DISEASE"]]}], ["When surgery isn't possible, most tumors respond to radiotherapy alone wich often results in long periods of remission We report two cases of primary ACC of trachea: a 49 year old male presented a distal unresectable tracheal ACC treated with chemo-radiotherapy who developed a recurrence and died 7 years after the diagnosis.", {"entities": []}], ["And a 50 years old female with a proximal tracheal tumor treated by surgical resection and end- to- end anastomosis followed by adjuvant radiotherapy.", {"entities": []}], ["At 10 months follow-up, our patient shows no evidence of disease with negative histological findings.", {"entities": []}], ["Dry powder inhalers (DPIs) are commonly used for the delivery of inhaled medications, and should provide consistent, efficient dosing, be easy to use correctly, and be liked by patients; these attributes can all affect patient compliance and therefore treatment efficacy.", {"entities": []}], ["The ELLIPTA in vitro dose-delivery characteristics of the ELLIPTA inhaler, and describes the results of human factors validation tests, designed to assess the performance of critical tasks required to use the inhaler.", {"entities": []}], ["Results from the in vitro studies indicate that the ELLIPTA inhaler performs consistently with respect to in vitro dose delivery characteristics at a range of flow rates that can be achieved by the target population (\u226530\u2009L/min) and over its 30-day in-use life.", {"entities": []}], ["Data from the human factors validation tests demonstrated that almost all participants (\u226597%) were able to complete each of the steps required to prepare a dose for inhalation without error.", {"entities": []}], ["Overall, the ELLIPTA inhaler has a versatile single- or two-strip design that allows it to be used for the delivery of a range of treatment options.", {"entities": []}], ["It also improves patient ease-of-use when compared with the DISKUS", {"entities": []}], ["Unlike most other effector cells of the innate, as well as the adaptive immune systems, the neutrophil is a relatively undiscerning aggressor with scant regard for damage limitation.", {"entities": []}], ["Although this highly combative, professional phagocyte has become increasingly implicated in the immunopathogenesis of many acute and chronic inflammatory disorders, of both infective and noninfective origin, effective pharmacological strategies to counter neutrophilaggression have remained elusive.", {"entities": []}], ["Activation of neutrophils results in rapid mobilization of both stored and extracellular Ca", {"entities": []}], ["In Sweden, chiropractic is not included in mainstream health care.", {"entities": []}], ["In Norway chiropractic is a recognized health care profession.", {"entities": []}], ["The aim of this study was to explore the perceptions of chiropractic among Swedish and Norwegian General Practitioners (GPs).", {"entities": []}], ["Eight hundred surveys in each country were distributed randomly by post to Swedish and Norwegian GPs offices.", {"entities": []}], ["The survey contained two main sections: Experiences and opinions about chiropractic and referral patterns.", {"entities": []}], ["The data were then described and compared between the countries.", {"entities": []}], ["In Sweden the response rate was 44.8% and in Norway 45.3%.", {"entities": []}], ["More than half of the Swedish GPs participating in this study stated that they had poor knowledge about chiropractic, while just a tenth of Norwegian GPs stated the same.", {"entities": []}], ["Nearly all Norwegian GPs had some experience of chiropractic treatment whilst a fairly large number of the Swedish GPs said that they had no experience at all of chiropractic.", {"entities": []}], ["It was twice as common for GPs in Norway to refer patients to a chiropractor as compared to Sweden.", {"entities": []}], ["However, Swedish and Norwegian GPs agreed that chiropractors were competent to treat musculo-skeletal conditions with an adequate education to be part of mainstream medicine.", {"entities": []}], ["Swedish and Norwegian GPs agree that chiropractors are competent to treat musculoskeletal conditions.", {"entities": []}], ["However, there are many differences in GPs perceptions of chiropractic between the two countries and the overall picture indicates that chiropractic is more accepted and recognised as a health care profession in Norway.", {"entities": []}], ["The study aimed to investigate the role of Tanshinone IIA (Tan IIA) in lipopolysaccharide (LPS)\u2010induced acute lung injury (ALI) in its regulation of TRPM7.", {"entities": [[149, 154, "GENE"]]}], ["Wistar male rats were randomly divided into the normal saline (NS), LPS, knockout (KO) + LPS, low\u2010dose Tan IIA (Tan\u2010L), middle\u2010dose Tan IIA (Tan\u2010M), high\u2010dose Tan IIA (Tan\u2010H) and KO + high\u2010dose Tan IIA (KO + Tan\u2010H) groups.", {"entities": []}], ["The level of tumour necrosis factor\u2010\u03b1 (TNF\u2010\u03b1), interleukin (IL)\u20101\u03b2, IL\u20106, TRPM7 protein expression, current density\u2010voltage curve and Ca", {"entities": [[74, 79, "GENE"]]}], ["The airway epithelium is responsible for the production of a number of arachidonic acid and non-prostanoid inhibitory factors.", {"entities": []}], ["Epithelium synthesises nitric oxide (NO) which may be important in regulating the function of airways smooth muscles.", {"entities": []}], ["We studied in vitro the effect of histamine (100 nM-100 microM) which increases the NO release on rabbit airway smooth muscles induced by 80 mM KC1 in the presence or not of 10(-5) Methylene blue (MB) (inactivator of guanylate cyclase) or N(G)-monomethyl L-arginine (L-NMMA), a NOS inhibitor.", {"entities": [[197, 199, "GENE"]]}], ["All experiments were done in tracheal muscle strips from 28 rabbits with epithelium and after epithelium removal.", {"entities": []}], ["The additional use of histamine (1 microM) on KC1 contraction induced a relaxation of 10% of the initial contraction.", {"entities": []}], ["The additional use of L-NMMA decreased the relaxation to 5% of initial contraction.", {"entities": []}], ["MB rather than L-NMMA increased the contraction significantly (p<0.01).", {"entities": [[0, 2, "GENE"]]}], ["Epithelium removal increased the contraction induced by KC1 (80 mM) and histamine (1 microM) by about 30% (p<0.001).", {"entities": []}], ["NO release especially from epithelium regulates the airways smooth muscle functions.", {"entities": []}], ["Damage to the epithelium may contribute to an increase in airways sensitivity, observed in asthma.", {"entities": [[91, 97, "DISEASE"]]}], ["Computerized clinical decision support systems (CCDSSs) are claimed to improve processes and outcomes of primary preventive care (PPC), but their effects, safety, and acceptance must be confirmed.", {"entities": []}], ["We updated our previous systematic reviews of CCDSSs and integrated a knowledge translation approach in the process.", {"entities": []}], ["The objective was to review randomized controlled trials (RCTs) assessing the effects of CCDSSs for PPC on process of care, patient outcomes, harms, and costs.", {"entities": []}], ["We conducted a decision-maker-researcher partnership systematic review.", {"entities": []}], ["We searched MEDLINE, EMBASE, Ovid's EBM Reviews Database, Inspec, and other databases, as well as reference lists through January 2010.", {"entities": []}], ["We contacted authors to confirm data or provide additional information.", {"entities": []}], ["We included RCTs that assessed the effect of a CCDSS for PPC on process of care and patient outcomes compared to care provided without a CCDSS.", {"entities": []}], ["A study was considered to have a positive effect ( i.e ., CCDSS showed improvement) if at least 50% of the relevant study outcomes were statistically significantly positive.", {"entities": []}], ["We added 17 new RCTs to our 2005 review for a total of 41 studies.", {"entities": []}], ["RCT quality improved over time.", {"entities": []}], ["CCDSSs improved process of care in 25 of 40 (63%) RCTs.", {"entities": []}], ["Cumulative scientifically strong evidence supports the effectiveness of CCDSSs for screening and management of dyslipidaemia in primary care.", {"entities": []}], ["There is mixed evidence for effectiveness in screening for cancer and mental health conditions, multiple preventive care activities, vaccination, and other preventive care interventions.", {"entities": [[59, 65, "DISEASE"]]}], ["Fourteen (34%) trials assessed patient outcomes, and four (29%) reported improvements with the CCDSS.", {"entities": []}], ["Most trials were not powered to evaluate patient-important outcomes.", {"entities": []}], ["CCDSS costs and adverse events were reported in only six (15%) and two (5%) trials, respectively.", {"entities": []}], ["Information on study duration was often missing, limiting our ability to assess sustainability of CCDSS effects.", {"entities": []}], ["Evidence supports the effectiveness of CCDSSs for screening and treatment of dyslipidaemia in primary care with less consistent evidence for CCDSSs used in screening for cancer and mental health-related conditions, vaccinations, and other preventive care.", {"entities": [[170, 176, "DISEASE"]]}], ["CCDSS effects on patient outcomes, safety, costs of care, and provider satisfaction remain poorly supported.", {"entities": []}], ["Several studies have estimated the burden of coronary heart disease (CHD) mortality from ambient regional particulate matter \u2264 2.5 \u03bcm (PM 2.5 ).", {"entities": [[54, 67, "DISEASE"], [45, 67, "DISEASE"]]}], ["The burden of near-roadway air pollution (NRAP) generally has not been examined, despite evidence of a causal link with CHD.", {"entities": [[42, 46, "GENE"]]}], ["We investigated the CHD burden from NRAP and compared it with the PM 2.5 burden in the California South Coast Air Basin for 2008 and under a compact urban growth greenhouse gas reduction scenario for 2035.", {"entities": [[36, 40, "GENE"]]}], ["We estimated the population attributable fraction and number of CHD events attributable to residential traffic density, proximity to a major road, elemental carbon (EC), and PM 2.5 compared with the expected disease burden if the population were exposed to background levels of air pollution.", {"entities": []}], ["In 2008, an estimated 1,300 CHD deaths (6.8% of the total) were attributable to traffic density, 430 deaths (2.4%) to residential proximity to a major road, and 690 (3.7%) to EC.", {"entities": []}], ["There were 1,900 deaths (10.4%) attributable to PM 2.5 .", {"entities": []}], ["Although reduced exposures in 2035 should result in smaller fractions of CHD attributable to traffic density, EC, and PM 2.5 , the numbers of estimated deaths attributable to each of these exposures are anticipated to increase to 2,500, 900, and 2,900, respectively, due to population aging.", {"entities": []}], ["A similar pattern of increasing NRAP-attributable CHD hospitalizations was estimated to occur between 2008 and 2035.", {"entities": []}], ["These results suggest that a large burden of preventable CHD mortality is attributable to NRAP and is likely to increase even with decreasing exposure by 2035 due to vulnerability of an aging population.", {"entities": [[90, 94, "GENE"]]}], ["Greenhouse gas reduction strategies developed to mitigate climate change offer unexploited opportunities for air pollution health co-benefits.", {"entities": []}], ["Ghosh R, Lurmann F, Perez L, Penfold B, Brandt S, Wilson J, Milet M, K\u00fcnzli N, McConnell R. 2016.", {"entities": []}], ["Near-roadway air pollution and coronary heart disease: burden of disease and potential impact of a greenhouse gas reduction strategy in Southern California.", {"entities": [[40, 53, "DISEASE"], [31, 53, "DISEASE"]]}], ["Environ Health Perspect 124:193\u2013200;\u2002 http://dx.doi.org/10.1289/ehp.1408865", {"entities": []}], ["MicroRNAs (miRNAs), a class of small non-coding RNAs of 18\u201324 nucleotides in length, function to posttranscriptionally regulate protein expression.", {"entities": []}], ["miR-155 was one of the first identified and, to date, the most studied miRNA, and has been linked to various cellular processes such as modulation of immune responses and oncogenesis.", {"entities": [[0, 7, "GENE"]]}], ["Previous studies have identified miR-155 as a crucial positive regulator of Th1 immune response in autoimmune diseases, but as a suppressor of Th2 immunity in allergic disorders.", {"entities": [[33, 40, "GENE"]]}], ["However, recent studies have found new evidence that miR-155 plays an indispensible role in allergic asthma.", {"entities": [[92, 107, "DISEASE"], [101, 107, "DISEASE"], [53, 60, "GENE"]]}], ["This review summarizes the recent findings with respect to miR-155 in immune responses and the underlying mechanisms responsible for miR-155-related allergic diseases, as well as the similarities between miR-155 and glucocorticoids in immunity.", {"entities": [[59, 66, "GENE"], [133, 140, "GENE"], [204, 211, "GENE"], [59, 66, "GENE"], [133, 140, "GENE"], [204, 211, "GENE"]]}], ["Keratoconus is the most common corneal ectatic disorder, the cause of which is largely unknown.", {"entities": [[0, 11, "DISEASE"]]}], ["Many factors have been implicated, and the ocular allergy is being one of them.", {"entities": []}], ["The commonly proposed pathogenesis includes the release of inflammatory mediators due to eye rubbing which may alter the corneal collagen and lead to corneal ectasias.", {"entities": []}], ["The onset of keratoconus is often early in cases associated with allergy and routine corneal topography may detect subtle forms of keratoconus.", {"entities": [[13, 24, "DISEASE"], [131, 142, "DISEASE"]]}], ["These cases may require early keratoplasty and are at an increased risk of having acute corneal hydrops.", {"entities": []}], ["Surgical outcomes are similar to primary keratoconus cases.", {"entities": [[41, 52, "DISEASE"]]}], ["However, post-operative epithelial breakdown may be a problem in these cases.", {"entities": []}], ["Control of allergy and eye rubbing is the best measure to prevent corneal ectasias in cases of ocular allergy.", {"entities": []}], ["Ulaanbaatar, Mongolia, is known as severely air-polluted city in the world due to increased coal consumption in the cold season.", {"entities": []}], ["The health effects of air pollution in Mongolia such as mortality, morbidity and symptoms have been previously reported.", {"entities": []}], ["However, the concept of health-related quality of life (HR-QoL), which refers to the individual\u2019s perception of well-being, should also be included as an adverse health outcome of air pollution.", {"entities": []}], ["Surveys on the Mongolian people living in Ulaanbaatar were performed in the warm and cold seasons.", {"entities": []}], ["Self-completed questionnaires on the subjects\u2019 HR-QoL, data from health checkups and pulmonary function tests by respiratory specialists were collected for Mongolian adults aged 40\u201379\u00a0years ( n \u00a0=\u00a0666).", {"entities": []}], ["Ambient PM2.5 and PM10 were concurrently sampled and the components were analyzed to estimate the source of air pollution.", {"entities": []}], ["In logistic regression analyses, respiratory symptoms and smoke-rich fuels were associated with reduced HR-QoL (> 50th percentile vs. \u2264 50th percentile).", {"entities": []}], ["PM 2.5 levels were much higher in the cold season (median 86.4\u00a0\u03bcg/m Our study showed that air pollution in Ulaanbaatar worsened in the cold season and was estimated to be contributed by solid fuel combustion.", {"entities": []}], ["Various aspects of HR-QoL in subjects with ventilatory impairment using smoke-rich fuels deteriorated only in the cold season while those with normal lung function did not.", {"entities": []}], ["These results suggest that countermeasures or interventions by the policymakers to reduce coal usage would improve HR-QoL of the residents of Ulaanbaatar, especially for those with ventilatory impairment in the winter months.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-017-4507-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Acute lower respiratory tract infections (ALRI) are the major cause of morbidity and mortality in young children worldwide.", {"entities": []}], ["Information on viral etiology in ALRI from India is limited.", {"entities": []}], ["The aim of the present study was to develop a simple, sensitive, specific and cost effective multiplex PCR (mPCR) assay without post PCR hybridization or nested PCR steps for the detection of respiratory syncytial virus (RSV), influenza viruses, parainfluenza viruses (PIV1\u20133) and human metapneumovirus (hMPV).", {"entities": [[227, 236, "DISEASE"]]}], ["Nasopharyngeal aspirates (NPAs) were collected from children with ALRI \u2264 5 years of age.", {"entities": []}], ["The sensitivity and specificity of mPCR was compared to virus isolation by centrifugation enhanced culture (CEC) followed by indirect immunofluorescence (IIF).", {"entities": []}], ["From April 2005\u2013March 2007, 301 NPAs were collected from children attending the outpatient department or admitted to the ward of All India Institute of Medical Sciences hospital at New Delhi, India.", {"entities": []}], ["Multiplex PCR detected respiratory viruses in 106 (35.2%) of 301 samples with 130 viruses of which RSV was detected in 61, PIV3 in 22, PIV2 in 17, hMPV in 11, PIV1 in 10 and influenza A in 9 children.", {"entities": [[174, 183, "DISEASE"]]}], ["CEC-IIF detected 79 viruses only.", {"entities": []}], ["The sensitivity of mPCR was 0.1TCID 50 for RSV and influenza A and 1TCID 50 for hMPV, PIV1, PIV2, PIV3 and Influenza B.", {"entities": [[51, 60, "DISEASE"], [107, 116, "DISEASE"]]}], ["Mixed infections were detected in 18.8% of the children with viral infections, none detected by CEC-IIF.", {"entities": []}], ["Bronchiolitis was significantly associated with both total viral infections and RSV infection (p < 0.05).", {"entities": []}], ["History of ARI in family predisposed children to acquire viral infection (p > 0.05).", {"entities": []}], ["Multiplex PCR offers a rapid, sensitive and reasonably priced diagnostic method for common respiratory viruses.", {"entities": []}], ["The increasing protein sequences from the genome project require theoretical methods to predict transmembrane helical segments (TMHs).", {"entities": []}], ["So far, several prediction methods have been reported, but there are some deficiencies in prediction accuracy and adaptability in these methods.", {"entities": []}], ["In this paper, a method based on discrete wavelet transform (DWT) has been developed to predict the number and location of TMHs in membrane proteins.", {"entities": []}], ["PDB coded as 1KQG is chosen as an example to describe the prediction process by this method.", {"entities": []}], ["80 proteins with known 3D structure from Mptopo database are chosen at random as data sets (including 325 TMHs) and 80 sequences are divided into 13 groups according to their function and type.", {"entities": []}], ["TMHs prediction is carried out for each group of membrane protein sequences and obtain satisfactory result.", {"entities": []}], ["To verify the feasibility of this method, 80 membrane protein sequences are treated as test sets, 308 TMHs can be predicted and the prediction accuracy is 96.3%.", {"entities": []}], ["Compared with the main prediction results of seven popular prediction methods, the obtained results indicate that the proposed method in this paper has higher prediction accuracy.", {"entities": []}], ["The poultry abattoir industry continues to grow and contribute significantly to the gross domestic product in many countries.", {"entities": []}], ["The industry expects working shifts of eight to eleven hours, during which workers are exposed to occupational hazards which include physical hazards ranging from noise, vibration, exposure to cold and ergonomic stress from manual, repetitive tasks that require force.", {"entities": []}], ["A PubMed, Medline and Science Direct online database search, using specific keywords was conducted and the results confirmed that physical and ergonomic hazards impact on abattoir processing workers health, with harm not only to workers\u2019 health but also as an economic burden due to the loss of their livelihoods and the need for treatment and compensation in the industry.", {"entities": []}], ["This review endeavours to highlight the contribution poultry processing plays in the development of physical agents and ergonomic stress related occupational diseases in poultry abattoir processing workers.", {"entities": []}], ["The impact includes noise-induced hearing loss, increased blood pressure, menstrual and work related upper limb disorders.", {"entities": []}], ["These are summarised as a quick reference guide for poultry abattoir owners, abattoir workers, poultry associations, occupational hygienists and medical practitioners to assist in the safer management of occupational health in poultry abattoirs.", {"entities": []}], ["Ozone therapy is a modestly invasive procedure based on the regeneration capabilities of low ozone concentrations and used in medicine as an alternative/adjuvant treatment for different diseases.", {"entities": []}], ["However, the cellular mechanisms accounting for the positive effects of mild ozonization are still largely unexplored.", {"entities": []}], ["To this aim, in the present study the effects of low ozone concentrations (1 to 20 \u00b5g O 3 /mL O 2 ) on structural and functional cell features have been investigated in vitro by using morphological, morphometrical, cytochemical and immunocytochemical techniques at bright field, fluorescence and transmission electron microscopy.", {"entities": []}], ["Cells exposed to pure O 2 or air served as controls.", {"entities": []}], ["The results demonstrated that the effects of ozone administration are dependent on gas concentration, and the cytoskeletal organization, mitochondrial activity and nuclear transcription may be differently affected.", {"entities": []}], ["This suggests that, to ensure effective and permanent metabolic cell activation, ozone treatments should take into account the cytological and cytokinetic features of the different tissues.", {"entities": []}], ["N-chlorotaurine, a long-lived oxidant produced by human leukocytes, can be applied in human medicine as an endogenous antiseptic.", {"entities": []}], ["Its antimicrobial activity can be enhanced by ammonium chloride.", {"entities": []}], ["This study was designed to evaluate the tolerability of inhaled N-chlorotaurine (NCT) in the pig model.", {"entities": []}], ["Anesthetized pigs inhaled test solutions of 1% (55 mM) NCT (n = 7), 5% NCT (n = 6), or 1% NCT plus 1% ammonium chloride (NH 4 Cl) (n = 6), and 0.9% saline solution as a control (n = 7), respectively.", {"entities": []}], ["Applications with 5 ml each were performed hourly within four hours.", {"entities": []}], ["Lung function, haemodynamics, and pharmacokinetics were monitored.", {"entities": []}], ["Bronchial lavage samples for captive bubble surfactometry and lung samples for histology and electron microscopy were removed.", {"entities": []}], ["Arterial pressure of oxygen (PaO 2 ) decreased significantly over the observation period of 4 hours in all animals.", {"entities": []}], ["Compared to saline, 1% NCT + 1% NH 4 Cl led to significantly lower PaO 2 values at the endpoint after 4 hours (62 \u00b1 9.6 mmHg vs. 76 \u00b1 9.2 mmHg, p = 0.014) with a corresponding increase in alveolo-arterial difference of oxygen partial pressure (AaDO 2 ) (p = 0.004).", {"entities": []}], ["Interestingly, AaDO 2 was lowest with 1% NCT, even lower than with saline (p = 0.016).", {"entities": []}], ["The increase of pulmonary artery pressure (PAP) over the observation period was smallest with 1% NCT without difference to controls (p = 0.91), and higher with 5% NCT (p = 0.02), and NCT + NH 4 Cl (p = 0.05).", {"entities": []}], ["Histological and ultrastructural investigations revealed no differences between the test and control groups.", {"entities": []}], ["The surfactant function remained intact.", {"entities": []}], ["There was no systemic resorption of NCT detectable, and its local inactivation took place within 30 min.", {"entities": []}], ["The concentration of NCT tolerated by A549 lung epithelial cells in vitro was similar to that known from other body cells (0.25\u20130.5 mM).", {"entities": []}], ["The endogenous antiseptic NCT was well tolerated at a concentration of 1% upon inhalation in the pig model.", {"entities": []}], ["Addition of ammonium chloride in high concentration provokes a statistically significant impact on blood oxygenation.", {"entities": []}], ["Introduction .", {"entities": []}], ["Charcot foot is a rare and devastating complication of diabetes.", {"entities": []}], ["While some risk factors are known, debate continues regarding etiology.", {"entities": []}], ["Elucidating other associated disorders and their temporal occurrence could lead to a better understanding of its pathogenesis.", {"entities": []}], ["We applied a large data mining approach to Charcot foot for elucidating novel associations.", {"entities": []}], ["We conducted an association analysis using ICD-9 diagnosis codes for every patient in our health system ( n = 1.6 million with 41.2 million time-stamped ICD-9 codes).", {"entities": []}], ["For the current analysis, we focused on the 388 patients with Charcot foot (ICD-9 713.5).", {"entities": []}], ["We found 710 associations, 676 (95.2%) of which had a P value for the association less than 1.0 \u00d7 10 P < 1.0 \u00d7 10 Conclusion .", {"entities": []}], ["We identified novel associations with Charcot foot in the context of pathogenesis models that include neurotrophic, neurovascular, and microtraumatic factors mediated through inflammatory cytokines.", {"entities": []}], ["Future work should focus on confirmatory analyses.", {"entities": []}], ["These novel areas of investigation could lead to prevention or earlier diagnosis.", {"entities": []}], ["The living conditions and the health of Manx mothers continued to improve from 1881 to 1961.", {"entities": []}], ["Against this background they were at first delivered conservatively and mostly by midwives.", {"entities": []}], ["During this conservative phase the proportion of mothers surviving childbirth increased as their health improved: by the quinquennium 1907-1911 the maternal mortality rate on the Island was half what it had been twenty years earlier.", {"entities": []}], ["Between 1912 and 1927 maternal mortality rose and during the quinquennium 1922-1926 the MD/BR was again at the level it had been thirty years before.", {"entities": []}], ["Some of the maternal deaths during the quinquennium were among women who were subjected to intervention during childbirth by doctors in the unfavourable surroundings of their homes; conditions more suited to delivery by the conservative methods of kindly and patient handywomen.", {"entities": []}], ["Following the opening of a small maternity home on 6 May 1927 the family doctors began to send their difficult deliveries into the Home where they were looked after by skilled staff and delivered in a well-equipped labour room.", {"entities": []}], ["Throughout the subsequent decade the MD/BR remained at a level below that in 1907-1911.", {"entities": []}], ["T-cell-mediated inflammatory cytokines, such as interleukin (IL)-4, IL-5, IL-13 and tumor necrosis factor-alpha (TNF-\u03b1), play an important role in the initiation and progression of inflammatory airways diseases.", {"entities": []}], ["Low-molecular-weight heparins (LMWHs), widely used anticoagulants, possess anti-inflammatory properties making them potential treatment options for inflammatory diseases, including asthma.", {"entities": [[181, 187, "DISEASE"]]}], ["In the current study, we investigated the modulating effects of two LMWHs (enoxaparin and dalteparin) on the release of cytokines from stimulated peripheral blood mononuclear cells (PBMCs) of asthmatic subjects to identify the specific components responsible for the effects.", {"entities": []}], ["PBMCs from asthmatic subjects (consist of ~75% of T-cells) were isolated from blood taken from ten asthmatic subjects.", {"entities": []}], ["The PBMCs were pre-treated in the presence or absence of different concentrations of LMWHs, and were then stimulated by phytohaemagglutinin for the release of IL-4, IL-5, IL-13 and TNF-\u03b1.", {"entities": []}], ["LMWHs were completely or selectively desulfated and their anticoagulant effect, as well as the ability to modulate cytokine release, was determined.", {"entities": []}], ["LMWHs were chromatographically fractionated and each fraction was tested for molecular weight determination along with an assessment of anticoagulant potency and effect on cytokine release.", {"entities": []}], ["Enoxaparin inhibited cytokine release by more than 48%, whereas dalteparin increased their release by more than 25%.", {"entities": []}], ["The observed anti-inflammatory effects of enoxaparin were independent of their anticoagulant activities.", {"entities": []}], ["Smaller fractions, in particular dp4 (four saccharide units), were responsible for the inhibitory effect of enoxaparin.", {"entities": []}], ["Whereas, the larger fractions, in particular dp22 (twenty two saccharide units), were associated with the stimulatory effect of dalteparin.", {"entities": []}], ["Enoxaparin and dalteparin demonstrated opposing effects on inflammatory markers.", {"entities": []}], ["These observed effects could be due to the presence of structurally different components in the two LMWHs arising from different methods of depolymerisation.", {"entities": []}], ["This study provides a platform for further studies investigating the usefulness of enoxaparin in various inflammatory diseases.", {"entities": []}], ["Numerous studies have demonstrated the antioxidant effects of grape seed proanthocyanidin extract (GSPE).", {"entities": []}], ["The generation of free radicals and the ensuing apoptosis may contribute to the pathogenesis of epilepsy; therefore, in the present study, we examined the effects of GSPE on cognitive impairment and neuronal damage induced by chronic seizures in rats.", {"entities": []}], ["Seizures were induced by a daily intraperitoneal (i.p.)", {"entities": []}], ["injection of pentylenetetrazole (PTZ; 35 mg/kg/day, 36 days).", {"entities": []}], ["Two other groups were treated with GSPE (100 or 200 mg/kg/day, orally) for 24 days and then for 36 days prior to each PTZ injection.", {"entities": []}], ["After the final PTZ injection, hippocampus-dependent spatial learning was assessed using the Morris water maze (MWM).", {"entities": []}], ["The rats were then sacrificed for the measurement of hippocampal malondialdehyde (MDA, a measure of lipid peroxidation) and glutathione (GSH, a measure of endogenous antioxidant capacity) levels, and for the expression of pro-apoptotic factors [cytochrome c (Cyt c ), caspase-9 and caspase-3].", {"entities": []}], ["The mitochondrial generation of reactive oxygen species (ROS), degree of mitochondrial swelling, neuronal damage and mitochondrial ultrastructure were also examined.", {"entities": []}], ["Performance in the MWM was markedly impaired by PTZ-induced seizures, as evidenced by longer escape latencies during training and fewer platform crossings during the probe trial.", {"entities": []}], ["This cognitive decline was accompanied by oxidative stress (MDA accumulation, ROS generation, reduced GSH activity), an increased expression of pro-apoptotic proteins, as well as damage to CA1 pyramidal neurons and the mitochondria.", {"entities": [[189, 192, "GENE"]]}], ["Pre-treatment with GSPE dose-dependently reversed PTZ-induced impaired performance in the MWM, oxidative stress, mitochondrial ROS generation, the expression of pro-apoptotic proteins and neuronal and mitochondrial damage.", {"entities": []}], ["Thus, GSPE may reverse the hippocampal dysfunction induced by chronic seizures, by reducing oxidative stress and preserving mitochondrial function.", {"entities": []}], ["NF- \u03ba B activation is a critical signaling event in the inflammatory response and has been implicated in a number of pathological lung diseases.", {"entities": []}], ["To enable the assessment of NF- \u03ba B activity in the lungs, we transfected a luciferase based NF- \u03ba B reporter into the lungs of mice or into Raw264.7 cells in culture.", {"entities": []}], ["The transfected mice showed specific luciferase expression in the pulmonary tissues.", {"entities": []}], ["Using these mouse models, we studied the kinetics of NF- \u03ba B activation following exposure to lipopolysaccharide (LPS).", {"entities": []}], ["The Raw264.7 cells expressed a dose-dependent increase in luciferase following exposure to LPS and the NF- \u03ba B reporter mice expressed luciferase in the lungs following LPS challenge, establishing that bioluminescence imaging provides adequate sensitivity for tracking the NF- \u03ba B activation pathway.", {"entities": []}], ["Interventions affecting the NF- \u03ba B pathway are promising clinical therapeutics, thus we further examined the effect of IKK-2 inhibition by MLN120B and glycogen synthase kinase 3 beta inhibition by TDZD-8 on NF- \u03ba B activation.", {"entities": []}], ["Pre-treatment with either MLN120B or TDZD-8 attenuated NF- \u03ba B activation in the pulmonary tissues, which was accompanied with suppression of pro-inflammatory chemokine MIP-1\u00df and induction of anti-inflammatory cytokine IL-10.", {"entities": []}], ["In summary, we have established an imaging based approach for non-invasive and longitudinal assessment of NF- \u03ba B activation and regulation during acute lung injury.", {"entities": []}], ["This approach will potentiate further studies on NF- \u03ba B regulation under various inflammatory conditions.", {"entities": []}], ["Respiratory conditions remain a source of morbidity globally.", {"entities": []}], ["As such, this study aimed to explore factors associated with the development of airflow obstruction (AFO) in a rural Indian setting and, using spirometry, study whether underweight is linked to AFO.", {"entities": []}], ["Patients > 35 years old attending a rural clinic in West Bengal, India, took a structured questionnaire, had their body mass index (BMI) measured, and had spirometry performed by an ancillary health care worker.", {"entities": []}], ["In total, 416 patients completed the study; spirometry was acceptable for analysis of forced expiratory volume in 1 second in 286 cases (69%); 16% were noted to exhibit AFO.", {"entities": []}], ["Factors associated with AFO were: increasing age (95% confidence interval (CI) 0.004\u20130.011; P = 0.005), smoking history (95% CI 0.07\u20130.174; P = 0.006), male gender (95% CI 0.19\u20130.47; P = 0.012), reduced BMI (95% CI 0.19\u20130.65; P = 0.02), and occupation (95% CI 0.12\u20130.84; P = 0.08).", {"entities": []}], ["The mean BMI in males who currently smoked (n = 60; 19.29 kg/m P < 0.001).", {"entities": []}], ["AFO was observed in 27% of subjects with a BMI <18.5 kg/m P = 0.013).", {"entities": []}], ["AFO was observed in 11% of housewives, 22% of farm laborers, and 31% of cotton/jute workers ( P = 0.035).", {"entities": []}], ["In a rural Indian setting, AFO was related to advancing age, current or previous smoking, male gender, reduced BMI, and occupation.", {"entities": []}], ["The data also suggest that being under-weight is linked with AFO and that a mechanistic relationship exists between low body weight, smoking tobacco, and development of AFO.", {"entities": []}], ["Synoptic circulation patterns (large-scale tropospheric motion systems) affect air pollution and, potentially, air-pollution-morbidity associations.", {"entities": []}], ["We evaluated the effect of synoptic circulation patterns (air masses) on the association between ozone and hospital admissions for asthma and myocardial infarction (MI) among adults in North Carolina.", {"entities": [[142, 163, "DISEASE"], [131, 137, "DISEASE"]]}], ["Daily surface meteorology data (including precipitation, wind speed, and dew point) for five selected cities in North Carolina were obtained from the U.S. EPA Air Quality System (AQS), which were in turn based on data from the National Climatic Data Center of the National Oceanic and Atmospheric Administration.", {"entities": []}], ["We used the Spatial Synoptic Classification system to classify each day of the 9-year period from 1996 through 2004 into one of seven different air mass types: dry polar, dry moderate, dry tropical, moist polar, moist moderate, moist tropical, or transitional.", {"entities": []}], ["Daily 24-hour maximum 1-hour ambient concentrations of ozone were obtained from the AQS.", {"entities": []}], ["Asthma and MI hospital admissions data for the 9-year period were obtained from the North Carolina Department of Health and Human Services.", {"entities": [[0, 6, "DISEASE"]]}], ["Generalized linear models were used to assess the association of the hospitalizations with ozone concentrations and specific air mass types, using pollutant lags of 0 to 5 days.", {"entities": []}], ["We examined the effect across cities on days with the same air mass type.", {"entities": []}], ["In all models we adjusted for dew point and day-of-the-week effects related to hospital admissions.", {"entities": []}], ["Ozone was associated with asthma under dry tropical (1- to 5-day lags), transitional (3- and 4-day lags), and extreme moist tropical (0-day lag) air masses.", {"entities": [[26, 32, "DISEASE"]]}], ["Ozone was associated with MI only under the extreme moist tropical (5-day lag) air masses.", {"entities": []}], ["Elevated ozone levels are associated with dry tropical, dry moderate, and moist tropical air masses, with the highest ozone levels being associated with the dry tropical air mass.", {"entities": []}], ["Certain synoptic circulation patterns/air masses in conjunction with ambient ozone levels were associated with increased asthma and MI hospitalizations.", {"entities": [[121, 127, "DISEASE"]]}], ["Individual exposure to ultraviolet radiation (UVR) is challenging to measure, particularly for diseases with substantial latency periods between first exposure and diagnosis of outcome, such as cancer.", {"entities": [[194, 200, "DISEASE"]]}], ["To guide the choice of surrogates for long-term UVR exposure in epidemiologic studies, we assessed how well stable sun-related individual characteristics and environmental/meteorological factors predicted daily personal UVR exposure measurements.", {"entities": []}], ["We evaluated 123 United States Radiologic Technologists subjects who wore personal UVR dosimeters for 8 hours daily for up to 7 days (N\u200a=\u200a837 days).", {"entities": []}], ["Potential predictors of personal UVR derived from a self-administered questionnaire, and public databases that provided daily estimates of ambient UVR and weather conditions.", {"entities": []}], ["Factors potentially related to personal UVR exposure were tested individually and in a model including all significant variables.", {"entities": []}], ["The strongest predictors of daily personal UVR exposure in the full model were ambient UVR, latitude, daily rainfall, and skin reaction to prolonged sunlight (R In the absence of feasible measures of individual longitudinal sun exposure history, stable personal characteristics, ambient UVR, and weather parameters may help estimate long-term personal UVR exposure.", {"entities": []}], ["Structured care for people with chronic obstructive pulmonary disease (COPD) can improve outcomes.", {"entities": [[32, 69, "DISEASE"]]}], ["Delivering care in a deprived ethnically diverse area can prove challenging.", {"entities": []}], ["Evaluation of a system change to enhance COPD care delivery in a primary care setting between 2010 and 2013 using observational data.", {"entities": []}], ["All 36 practices in one inner London primary care trust were grouped geographically into eight networks of 4\u20135 practices, each supported by a network manager, clerical staff and an educational budget.", {"entities": []}], ["A multidisciplinary group, including a respiratory specialist and the community respiratory team, developed a \u2018care package\u2019 for COPD management, with financial incentives based on network achievements of clinical targets and supported case management and education.", {"entities": []}], ["Monthly electronic dashboards enabled networks to track and improve performance.", {"entities": []}], ["The size of network COPD registers increased by 10% in the first year.", {"entities": []}], ["Between 2010 and 2013 completed care plans increased from 53 to 86.5%, pulmonary rehabilitation referrals rose from 45 to 70% and rates of flu immunisation from 81 to 83%, exceeding London and England figures.", {"entities": []}], ["Hospital admissions decreased in Tower Hamlets from a historic high base.", {"entities": []}], ["Investment of financial, organisational and educational resource into general practice networks was associated with clinically important improvements in COPD care in socially deprived, ethnically diverse communities.", {"entities": []}], ["Key behaviour change included the following: collaborative working between practices driven by high-quality information to support performance review; shared financial incentives; and engagement between primary and secondary care clinicians.", {"entities": []}], ["Many epidemiological studies examining long-term health effects of exposure to air pollutants have characterized exposure by the outdoor air concentrations at sites that may be distant to subjects\u2019 residences at different points in time.", {"entities": []}], ["The temporal and spatial mobility of subjects and the spatial scale of exposure assessment could thus lead to misclassification in the cumulative exposure estimation.", {"entities": []}], ["This paper attempts to fill the gap regarding cumulative exposure assessment to air pollution at a fine spatial scale in epidemiological studies investigating long-term health effects.", {"entities": []}], ["We propose a conceptual framework showing how major difficulties in cumulative long-term exposure assessment could be surmounted.", {"entities": []}], ["We then illustrate this conceptual model on the case of exposure to NO 2 following two steps: (i) retrospective reconstitution of NO 2 concentrations at a fine spatial scale; and (ii) a novel approach to assigning the time-relevant exposure estimates at the census block level, using all available data on residential mobility throughout a 10- to 20-year period prior to that for which the health events are to be detected.", {"entities": []}], ["Our conceptual framework is both flexible and convenient for the needs of different epidemiological study designs.", {"entities": []}], ["Alpha-1 antitrypsin (AAT) deficiency is an inherited genetic disorder currently diagnosed in approximately 5,000 people in the United States.", {"entities": [[53, 69, "DISEASE"]]}], ["Although some individuals with AAT deficiency are asymptomatic, the condition often leads to deterioration of lung function in adults and is associated with emphysema, asthma, chronic obstructive pulmonary disease, and other respiratory diseases.", {"entities": [[176, 213, "DISEASE"], [168, 174, "DISEASE"]]}], ["In children, AAT deficiency can result in severe liver disease, including fatal cirrhosis in newborn infants.", {"entities": [[49, 62, "DISEASE"]]}], ["Although much is known about the clinical pathology of AAT deficiency, researchers are just beginning to characterize environmental, occupational, and genetic modifiers affecting the onset and progression of diseases related to AAT deficiency.", {"entities": []}], ["On 19 August 2002, a group of basic scientists, clinicians, environmental health researchers, and public interest groups gathered at the National Institute of Environmental Health Sciences in Research Triangle Park, North Carolina, to discuss ongoing research on these topics.", {"entities": []}], ["The goals of this workshop were to a) assess the present state of knowledge regarding environmental and occupational risk factors contributing to AAT deficiency morbidity and mortality, b) define future research needs in this area, and c) explore collaborative opportunities to advance understanding of risk factors affecting the progression of AAT deficiency-related disease.", {"entities": []}], ["Participants agreed that new research initiatives in these areas represent an opportunity to benefit both basic science, through enhanced understanding of gene-environment interaction, and the AAT deficiency patient community, through innovative new approaches to disease management and treatment.", {"entities": []}], ["Rivaroxaban is established for the treatment and secondary prevention of venous thromboembolism, but whether it is useful in patients with antiphospholipid syndrome is uncertain.", {"entities": [[139, 164, "DISEASE"], [156, 164, "DISEASE"]]}], ["This randomised, controlled, open-label, phase 2/3, non-inferiority trial, done in two UK hospitals, included patients with antiphospholipid syndrome who were taking warfarin for previous venous thromboembolism, with a target international normalised ratio of 2\u00b75.", {"entities": [[124, 149, "DISEASE"], [141, 149, "DISEASE"]]}], ["Patients were randomly assigned 1:1 to continue with warfarin or receive 20 mg oral rivaroxaban daily.", {"entities": []}], ["Randomisation was done centrally, stratified by centre and patient type (with vs without systemic lupus erythematosus).", {"entities": [[98, 117, "DISEASE"], [89, 117, "DISEASE"]]}], ["The primary outcome was percentage change in endogenous thrombin potential (ETP) from randomisation to day 42, with non-inferiority set at less than 20% difference from warfarin in mean percentage change.", {"entities": []}], ["Analysis was by modified intention to treat.", {"entities": []}], ["Other thrombin generation parameters, thrombosis, and bleeding were also assessed.", {"entities": []}], ["Treatment effect was measured as the ratio of rivaroxaban to warfarin for thrombin generation.", {"entities": []}], ["This trial is registered with the ISRCTN registry, number ISRCTN68222801.", {"entities": []}], ["Of 116 patients randomised between June 5, 2013, and Nov 11, 2014, 54 who received rivaroxaban and 56 who received warfarin were assessed.", {"entities": [[53, 56, "GENE"]]}], ["At day 42, ETP was higher in the rivaroxaban than in the warfarin group (geometric mean 1086 nmol/L per min, 95% CI 957\u20131233 vs 548, 484\u2013621, treatment effect 2\u00b70, 95% CI 1\u00b77\u20132\u00b74, p<0\u00b70001).", {"entities": []}], ["Peak thrombin generation was lower in the rivaroxaban group (56 nmol/L, 95% CI 47\u201366 vs 86 nmol/L, 72\u2013102, treatment effect 0\u00b76, 95% CI 0\u00b75\u20130\u00b78, p=0\u00b70006).", {"entities": []}], ["No thrombosis or major bleeding were seen.", {"entities": []}], ["Serious adverse events occurred in four patients in each group.", {"entities": []}], ["ETP for rivaroxaban did not reach the non-inferiority threshold, but as there was no increase in thrombotic risk compared with standard-intensity warfarin, this drug could be an effective and safe alternative in patients with antiphospholipid syndrome and previous venous thromboembolism.", {"entities": [[226, 251, "DISEASE"], [243, 251, "DISEASE"]]}], ["Arthritis Research UK, Comprehensive Clinical Trials Unit at UCL, LUPUS UK, Bayer, National Institute for Health Research Biomedical Research Centre.", {"entities": []}], ["Therapeutic intervention in the pathophysiology of airway mucus hypersecretion is clinically important.", {"entities": []}], ["Several types of drugs are available with different possible modes of action.", {"entities": []}], ["We examined the effects of guaifenesin (GGE), N -acetylcysteine (NAC) and ambroxol (Amb) on differentiated human airway epithelial cells stimulated with IL-13 to produce additional MUC5AC.", {"entities": []}], ["After IL-13 pre-treatment (3 days), the cultures were treated with GGE, NAC or Amb (10\u2013300 \u03bcM) in the continued presence of IL-13.", {"entities": []}], ["Cellular and secreted MUC5AC, mucociliary transport rates (MTR), mucus rheology at several time points, and the antioxidant capacity of the drugs were assessed.", {"entities": [[59, 62, "GENE"]]}], ["IL-13 increased MUC5AC content (~25%) and secretion (~2-fold) and decreased MTR, but only slightly affected the G\u2019 (elastic) or G\u201d (viscous) moduli of the secretions.", {"entities": [[76, 79, "GENE"]]}], ["GGE significantly inhibited MUC5AC secretion and content in the IL-13-treated cells in a concentration-dependent manner (IC 50 s at 24 hr ~100 and 150 \u03bcM, respectively).", {"entities": [[135, 137, "GENE"]]}], ["NAC or Amb were less effective.", {"entities": []}], ["All drugs increased MTR and decreased G\u2019 and G\u201d relative to IL-13 alone.", {"entities": [[20, 23, "GENE"]]}], ["Cell viability was not affected and only NAC exhibited antioxidant capacity.", {"entities": []}], ["Thus, GGE effectively reduces cellular content and secretion of MUC5AC, increases MTR, and alters mucus rheology, and may therefore be useful in treating airway mucus hypersecretion and mucostasis in airway diseases.", {"entities": [[82, 85, "GENE"]]}], ["IL-33 is a new member of the IL-1 family cytokines, which is expressed by different types of immune cells and non-immune cells.", {"entities": []}], ["IL-33 is constitutively expressed in the nucleus, where it can act as a transcriptional regulator.", {"entities": []}], ["So far, no direct target for nuclear IL-33 has been identified, and the regulation of IL-33 nuclear function remains largely unclear.", {"entities": []}], ["Here, we report that the transcription of type 2 inflammatory cytokine IL-13 is positively regulated by nuclear IL-33.", {"entities": []}], ["IL-33 can directly bind to the conserved non-coding sequence (CNS) before the translation initiation site in the IL13 gene locus.", {"entities": [[113, 117, "GENE"]]}], ["Moreover, IL-33 nuclear function and stability are regulated by the enzyme ubiquitin-specific protease 17 (USP17) through deubiquitination of IL-33 both at the K48 and at the K63 sites.", {"entities": [[107, 112, "GENE"]]}], ["Our data suggest that IL13 gene transcription can be directly activated by nuclear IL-33, which is negatively regulated by the deubiquitinase USP17.", {"entities": [[22, 26, "GENE"], [142, 147, "GENE"]]}], ["Elucidation of human disease similarities has emerged as an active research area, which is highly relevant to etiology, disease classification, and drug repositioning.", {"entities": []}], ["In pioneer studies, disease similarity was commonly estimated according to clinical manifestation.", {"entities": []}], ["Subsequently, scientists started to investigate disease similarity based on gene-phenotype knowledge, which were inevitably biased to well-studied diseases.", {"entities": []}], ["In recent years, estimating disease similarity according to transcriptomic behavior significantly enhances the probability of finding novel disease relationships, while the currently available studies usually mine expression data through differential expression analysis that has been considered to have little chance of unraveling dysfunctional regulatory relationships, the causal pathogenesis of diseases.", {"entities": []}], ["We developed a computational approach to measure human disease similarity based on expression data.", {"entities": []}], ["Differential coexpression analysis, instead of differential expression analysis, was employed to calculate differential coexpression level of every gene for each disease, which was then summarized to the pathway level.", {"entities": []}], ["Disease similarity was eventually calculated as the partial correlation coefficients of pathways\u2019 differential coexpression values between any two diseases.", {"entities": []}], ["The significance of disease relationships were evaluated by permutation test.", {"entities": []}], ["Based on mRNA expression data and a differential coexpression analysis based method, we built a human disease network involving 1326 significant Disease-Disease links among 108 diseases.", {"entities": []}], ["Compared with disease relationships captured by differential expression analysis based method, our disease links shared known disease genes and drugs more significantly.", {"entities": []}], ["Some novel disease relationships were discovered, for example, Obesity and cancer, Obesity and Psoriasis, lung adenocarcinoma and S. pneumonia , which had been commonly regarded as unrelated to each other, but recently found to share similar molecular mechanisms.", {"entities": [[111, 125, "DISEASE"], [106, 125, "DISEASE"], [133, 142, "DISEASE"], [75, 81, "DISEASE"]]}], ["Additionally, it was found that both the type of disease and the type of affected tissue influenced the degree of disease similarity.", {"entities": []}], ["A sub-network including Allergic asthma, Type 2 diabetes and Chronic kidney disease was extracted to demonstrate the exploration of their common pathogenesis.", {"entities": [[69, 83, "DISEASE"], [33, 39, "DISEASE"]]}], ["The present study produces a global view of human diseasome for the first time from the viewpoint of regulation mechanisms, which therefore could provide insightful clues to etiology and pathogenesis, and help to perform drug repositioning and design novel therapeutic interventions.", {"entities": []}], ["This article was reviewed by Limsoon Wong, Rui Wang-Sattler, and Andrey Rzhetsky.", {"entities": []}], ["The online version of this article (doi:10.1186/s13062-015-0088-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The prevalence of asthma has increased over the past two decades; if this trend persists over the next two decades, the number of individuals with asthma in the United States will double by 2020, affecting 29 million Americans.", {"entities": [[18, 24, "DISEASE"], [147, 153, "DISEASE"]]}], ["Many of these individuals will be adults.", {"entities": []}], ["Recent community-based participatory research in Harlem has focused on children with asthma, but little is known about the prevalence and burden of asthma among adults.", {"entities": [[85, 91, "DISEASE"], [148, 154, "DISEASE"]]}], ["We conducted a population-based probability sample of Central Harlem adults 18-65 years of age from 1992 to 1994.", {"entities": []}], ["Asthma was one of three ambulatory care-sensitive conditions surveyed.", {"entities": [[0, 6, "DISEASE"]]}], ["We used an additional set of questions regarding asthma management and burden for those respondents who reported they had asthma.", {"entities": [[49, 55, "DISEASE"], [122, 128, "DISEASE"]]}], ["The prevalence of self-reported asthma was 14% in this population-based sample of Central Harlem adults.", {"entities": [[32, 38, "DISEASE"]]}], ["Respondents with asthma reported remarkably high rates of emergency department (ED) visits for asthma, but women were more likely than men to report two or more ED visits in the year prior to interview (38% vs. 18%).", {"entities": [[17, 23, "DISEASE"], [95, 101, "DISEASE"]]}], ["Women with asthma were also more likely than men with asthma to report activity restrictions because of asthma (61% vs. 26%).", {"entities": [[11, 17, "DISEASE"], [54, 60, "DISEASE"], [104, 110, "DISEASE"]]}], ["The burden of asthma among adults in Central Harlem is considerable.", {"entities": [[14, 20, "DISEASE"]]}], ["We urgently need comprehensive health approaches to address the high prevalence of health risks related to multiple chronic diseases, notably smoking and obesity.", {"entities": [[154, 161, "DISEASE"]]}], ["Key priorities are to determine which community education, prevention, and promotion programs are most effective and will best serve Harlem adults.", {"entities": []}], ["Many asthmatic patients exhibit uncontrolled asthma despite high-dose inhaled corticosteroids (ICS).", {"entities": [[45, 51, "DISEASE"]]}], ["Airway epithelial cells (AEC) have distinct activation profiles that can influence ICS response.", {"entities": []}], ["A pilot study to identify gene expression markers of AEC dysfunction and markers of corticosteroid sensitivity in asthmatic and non-asthmatic control children, for comparison with published reports in adults.", {"entities": []}], ["AEC were obtained by nasal brushings and primary submerged cultures, and incubated in control conditions or in the presence of 10 ng/ml TNFalpha, 10 6 patients without asthma (median age 11yr; min-max: 7\u201313), 8 with controlled asthma (11yr, 7\u201313; median daily fluticasone dose = 100 \u03bcg), and 4 with uncontrolled asthma (12yr, 7\u201314; 1000 \u03bcg fluticasone daily) were included.", {"entities": [[168, 174, "DISEASE"], [227, 233, "DISEASE"], [312, 318, "DISEASE"]]}], ["Baseline expression of LIF mRNA was significantly increased in uncontrolled vs controlled asthmatic children.", {"entities": [[23, 26, "GENE"]]}], ["TNFalpha significantly increased LIF expression in uncontrolled asthma.", {"entities": [[64, 70, "DISEASE"], [33, 36, "GENE"]]}], ["A similar trend was observed regarding IL-6.", {"entities": []}], ["Dexamethasone significantly upregulated FKBP51 expression in all groups but the response was blunted in asthmatic children.", {"entities": []}], ["No significant upregulation was identified regarding NF-kB, serpinB2 and porin.", {"entities": [[60, 68, "GENE"]]}], ["LIF and FKBP51 expression in epithelial cells were the most interesting markers of AEC dysfunction/response to corticosteroid treatment.", {"entities": [[0, 3, "GENE"]]}], ["There is growing evidence that vitamin D plays a role in the pathogenesis of asthma but it is unclear whether supplementation during childhood may improve asthma outcomes.", {"entities": [[77, 83, "DISEASE"], [155, 161, "DISEASE"]]}], ["The objective of this systematic review and meta-analysis was to evaluate the efficacy and safety of vitamin D supplementation as a treatment or adjunct treatment for asthma.", {"entities": [[167, 173, "DISEASE"]]}], ["We searched MEDLINE, Embase, CENTRAL, and CINAHL through July 2014.", {"entities": []}], ["We included RCTs that evaluated vitamin D supplementation in children versus active control or placebo for asthma.", {"entities": [[107, 113, "DISEASE"]]}], ["One reviewer extracted data and one reviewer verified data accuracy.", {"entities": []}], ["We qualitatively summarized the main results of efficacy and safety and meta-analyzed data on comparable outcomes across studies.", {"entities": []}], ["We used GRADE for strength of evidence.", {"entities": []}], ["Main planned outcomes measures were ED visits and hospitalizations.", {"entities": []}], ["As secondary outcomes, we examined measures of asthma control, including frequency of asthma exacerbations, asthma symptom scores, measures of lung function, \u03b2 2 -agonist use and daily steroid use, adverse events and 25-hydroxyvitamin D levels.", {"entities": [[47, 53, "DISEASE"], [86, 92, "DISEASE"], [108, 114, "DISEASE"]]}], ["Eight RCTs (one parallel, one crossover design) comprising 573 children aged 3 to 18 years were included.", {"entities": []}], ["One study (moderate-quality, n = 100) reported significantly less ED visits for children treated with vitamin D. No other studies examined the primary outcome (ED visits and hospitalizations).", {"entities": []}], ["There was a reduced risk of asthma exacerbations in children receiving vitamin D (low-quality; RR 0.41, 95% CI 0.27 to 0.63, 3 studies, n = 378).", {"entities": [[28, 34, "DISEASE"]]}], ["There was no significant effect for asthma symptom scores and lung function.", {"entities": [[36, 42, "DISEASE"]]}], ["The serum 25(OH)D level was higher in the vitamin D group at the end of the intervention (low-quality; MD 19.66 nmol/L, 95% CI 5.96 nmol/L to 33.37 nmol/L, 5 studies, n = 167).", {"entities": []}], ["We identified a high degree of clinical diversity (interventions and outcomes) and methodological heterogeneity (sample size and risk of bias) in included trials.", {"entities": []}], ["Randomized controlled trials provide some low-quality evidence to support vitamin D supplementation for the reduction of asthma exacerbations.", {"entities": [[121, 127, "DISEASE"]]}], ["Evidence on the benefits of vitamin D supplementation for other asthma-related outcomes in children is either limited or inconclusive.", {"entities": [[64, 70, "DISEASE"]]}], ["We recommend that future trials focus on patient-relevant outcomes that are comparable across studies, including standardized definitions of asthma exacerbations.", {"entities": [[141, 147, "DISEASE"]]}], ["Percutaneous cholecystostomy is currently indicated for patients with cholecystitis who might be poor candidates for operative cholecystectomy.", {"entities": [[70, 83, "DISEASE"]]}], ["We performed a study to evaluate the long-term outcome of patients undergoing emergent tube cholecystostomy.", {"entities": []}], ["This study was a retrospective chart review of patients who underwent tube cholecystostomy from July 1, 2005, to July 1, 2012.", {"entities": []}], ["During the study period, 82 patients underwent 125 cholecystostomy tube placements.", {"entities": []}], ["Four patients (5%) died during the year after tube placement.", {"entities": []}], ["The mean hospital length of stay for survivors was 8.8 days (range, 1\u201359 days).", {"entities": []}], ["Twenty-eight patients (34%) required at least 1 additional percutaneous procedure (range, 1\u20136) for gallbladder drainage.", {"entities": []}], ["Twenty-nine patients (34%) ultimately underwent cholecystectomy.", {"entities": []}], ["Surgery was performed a mean of 7 weeks after cholecystostomy tube placement.", {"entities": []}], ["Laparoscopic cholecystectomy was attempted in 25 operative patients but required conversion to an open approach in 8 cases (32%).", {"entities": []}], ["In another 4 cases, planned open cholecystectomy was performed.", {"entities": []}], ["Major postoperative complications were limited to 2 patients with postoperative common bile duct obstruction requiring endoscopic retrograde cholangiopancreatography, 1 patient requiring a return to the operating room for hemoperitoneum, and 2 patients with bile leak from the cystic duct stump.", {"entities": []}], ["In high-risk patients receiving cholecystostomy tubes for acute cholecystitis, only about one third will undergo surgical cholecystectomy.", {"entities": [[64, 77, "DISEASE"]]}], ["Laparoscopic cholecystectomy performed in this circumstance has a higher rate of conversion to open surgery and higher hepatobiliary morbidity rate.", {"entities": []}], ["Acute myocardial infarction is a major cause of hospitalization and death in patients with chronic obstructive pulmonary disease ( COPD ); however, temporal trends in the management and clinical outcomes of these patients remain unclear.", {"entities": [[91, 128, "DISEASE"], [6, 27, "DISEASE"], [0, 27, "DISEASE"]]}], ["We conducted an observational study by using a representative sample of 1\u00a0million beneficiaries from the Taiwan National Health Insurance Research Database.", {"entities": []}], ["Comorbidities, in\u2010hospital treatment, and outcomes were compared for patients with acute myocardial infarction with and without COPD between 2004 and 2013.", {"entities": [[89, 110, "DISEASE"], [83, 110, "DISEASE"]]}], ["Temporal trends in treatment and outcomes were analyzed.", {"entities": []}], ["We included 6770 patients admitted to hospitals with acute myocardial infarction diagnoses, of whom 1921 (28.3%) had COPD .", {"entities": [[59, 80, "DISEASE"], [53, 80, "DISEASE"]]}], ["Fewer patients with COPD received \u03b2\u2010blockers (adjusted odds ratio 0.66, 95% CI 0.59\u20130.74), angiotensin\u2010converting enzyme inhibitors/angiotensin II receptor blockers (adjusted odds ratio 0.83, 95% CI 0.73\u20130.93), statins, anticoagulants, dual antiplatelets, and coronary interventions.", {"entities": []}], ["These patients had higher mortality (in hospital: adjusted hazard ratio 1.25 [95% CI 1.11\u20131.41]; 1 year: adjusted hazard ratio 1.20 [95% CI 1.09\u20131.32]) and respiratory failure risk during admission.", {"entities": [[156, 175, "DISEASE"]]}], ["Temporal trends showed little improvement in mortality in patients with COPD over 10\u00a0years.", {"entities": []}], ["Multivariable logistic regression indicated that dual antiplatelets, \u03b2\u2010blockers, angiotensin\u2010converting enzyme inhibitors/angiotensin II receptor blockers, statins, coronary angiography, and coronary artery bypass grafting surgery were significantly correlated with improved mortality in patients with COPD.", {"entities": []}], ["In Taiwan, a lower proportion of patients with COPD received evidence\u2010based therapies for acute myocardial infarction than did patients without COPD , and their clinical outcomes were inferior.", {"entities": [[96, 117, "DISEASE"], [90, 117, "DISEASE"]]}], ["Limited improvement in mortality was observed over the preceding 10\u00a0years and is attributable to the underuse of evidence\u2010based treatments.", {"entities": []}], ["Since the discovery of the endocannabinoid system consisting of cannabinoid receptors, endogenous ligands, and biosynthetic and metabolizing enzymes, interest has been renewed in investigating the promise of cannabinoids as therapeutic agents.", {"entities": []}], ["Abundant evidence indicates that cannabinoids modulate immune responses.", {"entities": []}], ["An inflammatory response is triggered when innate immune cells receive a danger signal provided by pathogen- or damage-associated molecular patterns engaging pattern-recognition receptors.", {"entities": []}], ["Toll-like receptor family members are prominent pattern-recognition receptors expressed on innate immune cells.", {"entities": []}], ["Cannabinoids suppress Toll-like receptor-mediated inflammatory responses.", {"entities": []}], ["However, the relationship between the endocannabinoid system and innate immune system may not be one-sided.", {"entities": []}], ["Innate immune cells express cannabinoid receptors and produce endogenous cannabinoids.", {"entities": []}], ["Hence, innate immune cells may play a role in regulating endocannabinoid homeostasis, and, in turn, the endocannabinoid system modulates local inflammatory responses.", {"entities": []}], ["Studies designed to probe the interaction between the innate immune system and the endocannabinoid system may identify new potential molecular targets in developing therapeutic strategies for chronic inflammatory diseases.", {"entities": []}], ["This review discusses the endocannabinoid system and Toll-like receptor family and evaluates the interaction between them.", {"entities": []}], ["A very simple, selective, and fast flow injection spectrophotometeric method is developed for determination of nickel using furildioxime as complexing agent.", {"entities": []}], ["Micellar solution of brij-35 is employed to solubilize the sparingly soluble complex of Ni-furildioxime in buffered aqueous system (pH-9.00).", {"entities": []}], ["Under optimized conditions, absorbance is linear from 0.02 to 10\u2009 \u03bc g\u2009mL \u03bc L sample volume and from 10 to 30\u2009 \u03bc g\u2009mL \u03bc L sample volume of nickel at 480\u2009nm, with R \u03bc g\u2009mL n = 5), indicating that the method is highly precise and reproducible.", {"entities": []}], ["Interference from cobalt is removed by Nitroso R-salt-modified XAD-16.", {"entities": []}], ["The developed method is validated by analysing certified reference materials and is applied to assess nickel content of commercially available cigarettes.", {"entities": []}], ["Studies conducted in Western countries have shown that bone loss associated with pregnancy and breast-feeding is recovered after weaning.", {"entities": []}], ["However, it is not clear whether recovery takes place after repeated pregnancies followed by prolonged periods of breast-feeding; especially in developing countries where nutritional intake is comparatively low.", {"entities": []}], ["This study was designed to examine the effects of multiparity and prolonged breast-feeding on maternal bone mineral density (BMD) in a community-based sample of 210 Sri Lankan women, aged between 46 and 98 years.", {"entities": []}], ["BMD of the lumbar spine (L 2 \u2013L 4 ) and femoral neck were measured by dual-energy X-ray absorptiometry.", {"entities": []}], ["Reproductive history was recorded by using a questionnaire.", {"entities": []}], ["Women were, first, divided into groups according to parity (nulliparous, 1\u20132, 3\u20134, and 5 or more children), and BMDs in different groups were compared, initially unadjusted and then adjusted for age.", {"entities": []}], ["Same subjects were subdivided, again, according to the total duration of breast-feeding (0, 1\u201348, 49\u201396, and 97 months or more) and similar analysis was carried out.", {"entities": []}], ["Women who had 5 or more children and women who had breast-fed for 97 months or more were older than the other women (p < 0.01) but no differences in height, weight or BMI were observed among the groups.", {"entities": []}], ["Age adjusted BMD at lumbar spine and femoral neck BMDs of women grouped according to parity were not significantly different.", {"entities": []}], ["Neither was there any difference between lumbar spine or femoral neck BMD in groups based on duration of breast-feeding.", {"entities": []}], ["From this population-based study conducted in a developing country, we infer that history of multiparity or prolonged breast-feeding has no detrimental effects on maternal BMD in post-menopausal age.", {"entities": []}], ["Bronchopulmonary dysplasia (BPD) is characterized by lifelong obstructive lung disease and profound, refractory bronchospasm.", {"entities": [[62, 86, "DISEASE"], [74, 86, "DISEASE"]]}], ["It is observed among survivors of premature birth who have been treated with prolonged supplemental oxygen.", {"entities": []}], ["Therapeutic options are limited.", {"entities": []}], ["Using a neonatal mouse model of BPD, we show that hyperoxia increases activity and expression of a mediator of endogenous bronchoconstriction, S-nitrosoglutathione (GSNO) reductase.", {"entities": []}], ["MicroRNA-342-3p, predicted in silico and shown in this study in vitro to suppress expression of GSNO reductase, was decreased in hyperoxia-exposed pups.", {"entities": []}], ["Both pretreatment with aerosolized GSNO and inhibition of GSNO reductase attenuated airway hyperresponsiveness in vivo among juvenile and adult mice exposed to neonatal hyperoxia.", {"entities": []}], ["Our data suggest that neonatal hyperoxia exposure causes detrimental effects on airway hyperreactivity through microRNA-342-3p\u2013mediated upregulation of GSNO reductase expression.", {"entities": []}], ["Furthermore, our data demonstrate that this adverse effect can be overcome by supplementing its substrate, GSNO, or by inhibiting the enzyme itself.", {"entities": []}], ["Rates of BPD have not improved over the past two decades; nor have new therapies been developed.", {"entities": []}], ["GSNO-based therapies are a novel treatment of the respiratory problems that patients with BPD experience.", {"entities": []}], ["Coronary heart disease (CHD) is one of the leading causes of death worldwide.", {"entities": [[9, 22, "DISEASE"]]}], ["Scientific literature shows that prevention of CHD is inadequate.", {"entities": []}], ["The clinical pharmacist\u2019s role in patient-centred care has been shown favourable in a large amount of studies, also in relation to reduction of risk factors related to CHD.", {"entities": []}], ["We developed and piloted a pharmacist-led follow-up program for patients with established CHD after hospital discharge from a hospital in North Norway.", {"entities": []}], ["The aim of the present study was to explore how participants in the follow-up program experienced the program with regard to four main topics; medication knowledge, feeling of safety and comfort with medications, the functionality of the program and the clinical pharmacist\u2019s role in the interdisciplinary team.", {"entities": []}], ["We performed semi-structured thematic interviews with four patients included in the program.", {"entities": []}], ["After verbatim transcribing, we analysed the interviews using \u201cqualitative content analyses\u201d by Graneheim and Lundman.", {"entities": []}], ["Trial registration http://www.clinicaltrials.gov : NCT01131715.", {"entities": []}], ["All participants appreciated the follow-up program because their medication knowledge had increased, participation had made them feel safe, they were reassured about the appropriateness of their medications, and they had become more involved in their own medication.", {"entities": []}], ["The participants reported that the program was well structured and the clinical pharmacist was said to be an important caretaker in the health-care system.", {"entities": []}], ["The importance of collaboration between pharmacists and physicians, both in hospital and primary care, was emphasized.", {"entities": []}], ["Our results indicate that the follow-up program was highly appreciated among the four participants included in this study.", {"entities": []}], ["The results must be interpreted in the context of the health care system in Norway today.", {"entities": []}], ["Here, few pharmacists are working in hospitals or in close relation to the general practitioners.", {"entities": []}], ["In addition, physicians are short of time in order to supply appropriate medication information, both in hospital and primary care.", {"entities": []}], ["Involving pharmacists in follow-up of patients with CHD seems to be highly appreciated among patients and may be a step towards improving patient care.", {"entities": []}], ["The study is limited by the low number of participants.", {"entities": []}], ["The peripheral circadian clock in mice is entrained not only by light-dark cycles but also by daily restricted feeding schedules.", {"entities": []}], ["Behavioral and cell culture experiments suggest an increase in glucose level as a factor in such feeding-induced entrainment.", {"entities": []}], ["For application of feeding-induced entrainment in humans, nutrient content and dietary variations should be considered.", {"entities": []}], ["To elucidate the food composition necessary for dietary entrainment, we examined whether complete or partial substitution of dietary nutrients affected phase shifts in liver clocks of mice.", {"entities": []}], ["Compared with fasting mice or ad libitum fed mice, the liver bioluminescence rhythm advanced by 3\u20134 h on the middle day in Per2 ::luciferase knock-in mice that were administered a standard mouse diet, i.e.", {"entities": [[123, 127, "GENE"]]}], ["AIN-93M formula [0.6\u20130.85 g/10 g mouse BW] (composition: 14% casein, 47% cornstarch, 15% gelatinized cornstarch, 10% sugar, 4% soybean oil, and 10% other [fiber, vitamins, minerals, etc.", {"entities": []}], ["]), for 2 days.", {"entities": []}], ["When each nutrient was tested alone (100% nutrient), an insignificant weak phase advance was found to be induced by cornstarch and soybean oil, but almost no phase advance was induced by gelatinized cornstarch, high-amylose cornstarch, glucose, sucrose, or casein.", {"entities": []}], ["A combination of glucose and casein without oil, vitamin, or fiber caused a significant phase advance.", {"entities": []}], ["When cornstarch in AIN-93M was substituted with glucose, sucrose, fructose, polydextrose, high-amylose cornstarch, or gelatinized cornstarch, the amplitude of phase advance paralleled the increase in blood glucose concentration.", {"entities": []}], ["Our results strongly suggest the following: (1) balanced diets containing carbohydrates/sugars and proteins are good for restricted feeding-induced entrainment of the peripheral circadian clock and (2) a balanced diet that increases blood glucose, but not by sugar alone, is suitable for entrainment.", {"entities": []}], ["These findings may assist in the development of dietary recommendations for on-board meals served to air travelers and shift workers to reduce jet lag-like symptoms.", {"entities": []}], ["Background : Number of deaths increases during periods of elevated heat.", {"entities": []}], ["Objectives : To examine whether differences in heat-related deaths between 2003 and 2015 occurred in Slovenia.", {"entities": []}], ["Materials and Methods : We estimated relative risks for deaths for the observed diagnoses, sex, age, and area, as well as 95% confidence intervals and excess deaths associated with heat waves occurring in 2015 and 2003.", {"entities": []}], ["For comparison between 2015 and 2003, we calculated relative risks ratio and 95% confidence intervals.", {"entities": []}], ["Results : Statistically significant in 2015 were the following: age group 75+, all causes of deaths (RR = 1.10, 95% CI 1.00\u20131.22); all population, circulatory system diseases (RR = 1.14, 95% CI 1.01\u20131.30) and age group 75+, diseases of circulatory system (RR = 1.17, 95% CI 1.01\u20131.34).", {"entities": []}], ["Statistically significant in 2003 were the following: female, age group 5\u201374, circulatory system diseases (RR = 1.69, 95% CI 1.08\u20132.62).", {"entities": []}], ["Discussion : Comparison between 2015 and 2003, all, circulatory system diseases (RRR = 1.25, 95% CI 1.01\u20131.55); male, circulatory system diseases (RRR = 1.85, 95% CI 1.41\u20132.43); all, age group 75+ circulatory system diseases (RRR = 1.34, 95% CI 1.07\u20131.69); male, age group 75+, circulatory system diseases (RRR = 1.52, 95% CI 1.03\u20132.25) and female, age group 75+, circulatory system diseases (RRR = 1.43, 95% CI 1.08\u20131.89).", {"entities": []}], ["Conclusions : Public health efforts are urgent and should address circulatory system causes and old age groups.", {"entities": []}], ["Some intervention trials have reported a reduction in systemic inflammation with the Mediterranean diet (MedDiet) while others have observed no effect.", {"entities": []}], ["Despite the fact that sex differences have been highlighted in the inflammatory regulation, it is still not known whether MedDiet exerts similar effects on systemic inflammation in men and women.", {"entities": []}], ["The aim of this study was therefore to investigate sex differences in the effects of the MedDiet on high-sensitivity C-reactive protein (hs-CRP).", {"entities": []}], ["Participants were 35 men and 27 premenopausal women (24\u201353\u00a0years) presenting a slightly deteriorated lipid profile.", {"entities": []}], ["All foods were provided to participants during a 4-week isocaloric MedDiet.", {"entities": []}], ["At baseline, women had higher hs-CRP concentrations than men (P\u2009=\u20090.03).", {"entities": []}], ["No sex difference was observed in hs-CRP response to the MedDiet (P for sex-by-time interaction\u2009=\u20090.36), with both men and women experiencing no change (respectively P\u2009=\u20090.62 and P\u2009>\u20090.99).", {"entities": []}], ["When subgroups were formed according to hs-CRP concentration before the MedDiet phase, men with elevated baseline values (\u22652\u00a0mg/l) experienced a reduction in hs-CRP over time with the MedDiet (\u221226.5\u00a0%) while an increase was observed in men with lower baseline values (+96.6\u00a0%; P for group-by-time interaction\u2009=\u20090.02).", {"entities": []}], ["This pattern of change was not observed in women.", {"entities": []}], ["Results from this controlled feeding study suggest that men and women have similar effects from the MedDiet on systemic inflammation.", {"entities": []}], ["The individual\u2019s overall inflammatory status seems to influence these effects, but only in men.", {"entities": []}], ["This clinical trial was registered at www.clinicaltrials.gov as NCT01293344 .", {"entities": []}], ["Administrative health databases are a valuable research tool to assess health care utilization at the population level.", {"entities": []}], ["However, their use in obesity research limited due to the lack of data on body weight.", {"entities": [[22, 29, "DISEASE"]]}], ["A potential workaround is to use the ICD code of obesity to identify obese individuals.", {"entities": [[49, 56, "DISEASE"]]}], ["The objective of the current study was to investigate the sensitivity and specificity of an ICD code-based diagnosis of obesity from administrative health data relative to the gold standard measured BMI.", {"entities": [[120, 127, "DISEASE"]]}], ["Linkage of a population-based survey with anthropometric measures in elementary school children in 2003 with longitudinal administrative health data (physician visits and hospital discharges 1992-2006) from the Canadian province of Nova Scotia.", {"entities": []}], ["Measured obesity was defined based on the CDC cut-offs applied to the measured BMI.", {"entities": [[9, 16, "DISEASE"]]}], ["An ICD code-based diagnosis obesity was defined as one or more ICD-9 (278) or ICD-10 code (E66-E68) of obesity from a physician visit or a hospital stay.", {"entities": [[28, 35, "DISEASE"], [103, 110, "DISEASE"]]}], ["Sensitivity and specificity were calculated and health care cost estimates based on measured obesity and ICD-based obesity were compared.", {"entities": [[93, 100, "DISEASE"], [115, 122, "DISEASE"]]}], ["The sensitivity of an ICD code-based obesity diagnosis was 7.4% using ICD codes between 2002 and 2004.", {"entities": [[37, 44, "DISEASE"]]}], ["Those correctly identified had a higher BMI and had higher health care utilization and costs.", {"entities": []}], ["An ICD diagnosis of obesity in Canadian administrative health data grossly underestimates the true prevalence of childhood obesity and overestimates the health care cost differential between obese and non-obese children.", {"entities": [[20, 27, "DISEASE"], [123, 130, "DISEASE"]]}], ["Pulmonary fibrosis affects millions worldwide and, even though there has been a significant investment in understanding the processes involved in wound healing and maladaptive repair, a complete understanding of the mechanisms responsible for lung fibrogenesis eludes us, and interventions capable of reversing or halting disease progression are not available.", {"entities": [[0, 18, "DISEASE"]]}], ["Pulmonary fibrosis is characterized by the excessive expression and uncontrolled deposition of extracellular matrix (ECM) proteins resulting in erosion of the tissue structure.", {"entities": [[0, 18, "DISEASE"]]}], ["Initially considered an \u2018end-stage\u2019 process elicited after injury, these events are now considered pathogenic and are believed to contribute to the course of the disease.", {"entities": []}], ["By interacting with integrins capable of signal transduction and by influencing tissue mechanics, ECM proteins modulate processes ranging from cell adhesion and migration to differentiation and growth factor expression.", {"entities": []}], ["In doing so, ECM proteins help orchestrate complex developmental processes and maintain tissue homeostasis.", {"entities": []}], ["However, poorly controlled deposition of ECM proteins promotes inflammation, fibroproliferation, and aberrant differentiation of cells, and has been implicated in the pathogenesis of pulmonary fibrosis, atherosclerosis and cancer.", {"entities": [[203, 218, "DISEASE"], [183, 201, "DISEASE"], [223, 229, "DISEASE"]]}], ["Considering their vital functions, ECM proteins are the target of investigation, and oxidation\u2013reduction (redox) reactions have emerged as important regulators of the ECM.", {"entities": []}], ["Oxidative stress invariably accompanies lung disease and promotes ECM expression directly or through the overproduction of pro-fibrotic growth factors, while affecting integrin binding and activation.", {"entities": [[40, 52, "DISEASE"]]}], ["In vitro and in vivo investigations point to redox reactions as targets for intervention in pulmonary fibrosis and related disorders, but studies in humans have been disappointing probably due to the narrow impact of the interventions tested, and our poor understanding of the factors that regulate these complex reactions.", {"entities": [[92, 110, "DISEASE"]]}], ["This review is not meant to provide a comprehensive review of this field, but rather to highlight what has been learned and to raise interest in this area in need of much attention.", {"entities": []}], ["Refractory breathlessness is a highly prevalent and distressing symptom in advanced chronic respiratory disease.", {"entities": []}], ["Its intensity is not reliably predicted by the severity of lung pathology, with unhelpful emotions and behaviours inadvertently exacerbating and perpetuating the problem.", {"entities": []}], ["Improved symptom management is possible if clinicians choose appropriate non-pharmacological approaches, but these require engagement and commitment from both patients and clinicians.", {"entities": []}], ["The Breathing Thinking Functioning clinical model is a proposal, developed from current evidence, that has the potential to facilitate effective symptom control, by providing a rationale and focus for treatment.", {"entities": []}], ["The identification of patients at highest risk for adverse outcome who are presenting with acute dyspnea to the emergency department remains a challenge.", {"entities": []}], ["This study investigates the prognostic value of Copeptin, the C-terminal part of the vasopressin prohormone alone and combined to N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with acute dyspnea.", {"entities": []}], ["We conducted a prospective, observational cohort study in the emergency department of a university hospital and enrolled 287 patients with acute dyspnea.", {"entities": []}], ["Copeptin levels were elevated in non-survivors (n = 29) compared to survivors at 30 days (108 pmol/l, interquartile range (IQR) 37 to 197 pmol/l) vs. 18 pmol/l, IQR 7 to 43 pmol/l; P < 0.0001).", {"entities": []}], ["The areas under the receiver operating characteristic curve (AUC) to predict 30-day mortality were 0.83 (95% confidence interval (CI) 0.76 to 0.90), 0.76 (95% CI 0.67 to 0.84) and 0.63 (95% CI 0.53 to 0.74) for Copeptin, NT-proBNP and BNP, respectively (Copeptin vs. NTproBNP P = 0.21; Copeptin vs. BNP P = 0.002).", {"entities": []}], ["When adjusted for common cardiovascular risk factors and NT-proBNP, Copeptin was the strongest independent predictor for short-term mortality in all patients (HR 3.88 (1.94 to 7.77); P < 0.001) and especially in patients with acute decompensated heart failure (ADHF) (HR 5.99 (2.55 to 14.07); P < 0.0001).", {"entities": [[159, 161, "GENE"], [268, 270, "GENE"], [159, 161, "GENE"], [268, 270, "GENE"]]}], ["With the inclusion of Copeptin to the adjusted model including NTproBNP, the net reclassification improvement (NRI) was 0.37 ( P < 0.001).", {"entities": []}], ["An additional 30% of those who experienced events were reclassified as high risk, and an additional 26% without events were reclassified as low risk.", {"entities": []}], ["Copeptin is a new promising prognostic marker for short-term mortality independently and additive to natriuretic peptide levels in patients with acute dyspnea.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) have increased cardiovascular risk.", {"entities": [[14, 51, "DISEASE"]]}], ["Natriuretic peptides (NP) in other populations are useful in identifying cardiovascular disease, stratifying risk, and guiding therapy.", {"entities": []}], ["We performed a systematic literature review to examine NP in COPD, utilising Medline, EMBASE, and the Cochrane Library.", {"entities": []}], ["Fifty one studies were identified.", {"entities": []}], ["NP levels were lower in stable compared to exacerbation of COPD, and significantly increased with concomitant left ventricular systolic dysfunction or cor pulmonale.", {"entities": [[151, 164, "DISEASE"]]}], ["Elevation occurred in 16\u00a0to 60% of exacerbations and persisted in approximately one half of patients at discharge.", {"entities": []}], ["Cardiovascular comorbidities were associated with increased levels.", {"entities": []}], ["Levels consistently correlated with pulmonary artery pressure and left ventricular ejection fraction, but not pulmonary function or oxygen saturation.", {"entities": []}], ["NP demonstrated high negative predictive values (0.80 to 0.98) to exclude left ventricular dysfunction in both stable and exacerbation of COPD, but relatively low positive predictive values.", {"entities": []}], ["NP elevation predicted early adverse outcomes, but the association with long term mortality was inconsistent.", {"entities": []}], ["NP reflect diverse aspects of the cardiopulmonary continuum which limits utility when applied in isolation.", {"entities": []}], ["Strategies integrating NP with additional variables, biomarkers and imaging require further investigation.", {"entities": []}], ["The choice of primary hip hemiarthroplasty or total hip arthroplasty for displaced femoral neck fracture is still controversial.", {"entities": []}], ["Revision hip arthroplasty not only increases risk and cost but also could result in worse outcome.", {"entities": []}], ["Determining the risk factors for revision can help inform medical decision-making and aid in risk stratification of publicly reported outcomes.", {"entities": []}], ["Therefore, we conducted a nationwide population-based study to identify the disease-related risk factors and construct a risk score nomogram to predict revision surgery.", {"entities": []}], ["Records of all 68,030 femoral neck fracture patients receiving partial hemiarthroplasty (HA) in 2000\u20132010, with no total hip arthroplasty (THA) or revision HA history, were collected from the National Health Insurance Research Database.", {"entities": []}], ["Cox proportional hazard regression was used to estimate the risk of revision hip replacement (RHA).", {"entities": []}], ["The score of each risk factor was the quotient of the regression coefficient of the variable by the regression coefficient for a 10-year increase in age.", {"entities": []}], ["The predictive accuracy was tested using the area under the receiver operating characteristic curve (AUROC).", {"entities": []}], ["The revision risk for hemiarthroplasty increased in male, those with schizophrenia and end-stage renal disease patients had 1.58-, 1.88-, and 1.74-fold revision HA risk (95\u00a0% confidence interval (CI)\u2009=\u20091.40\u20131.78, 1.26\u20132.79, and 1.29\u20132.34, respectively).", {"entities": [[69, 82, "DISEASE"]]}], ["In a predictive model, the cumulative risk score ranged from 0 to 13 with a 5.08 to 91.82\u00a0% 10-year predicted RHA risk.", {"entities": []}], ["The percentage of AUROC for 10-year RHA risk in nomogram was 61.9 (95\u00a0% CI\u2009=\u200960.0\u201363.4).", {"entities": []}], ["Males, schizophrenia and end-stage renal disease patients have higher risk of revision surgery after hemiarthroplasty for femoral neck fracture.", {"entities": [[7, 20, "DISEASE"]]}], ["To evaluate the impact of avoidable mortality on the changes in life expectancy at birth in Spain.", {"entities": []}], ["Standard life table techniques and the Arriaga method were used to calculate and to decompose life expectancy (LE) changes by age, effects and groups of causes of avoidable mortality among three periods (1987\u201391, 1992\u20136 and 1997\u20132001).", {"entities": []}], ["A list of causes of avoidable mortality reached by consensus and previously published in Spain was used.", {"entities": []}], ["Life expectancy increased in all ages and both sexes.", {"entities": []}], ["The main contribution to the increase of LE at birth was due to people over 50.", {"entities": []}], ["Mortality in young adults produced a reduction in LE between the first two periods, but there was an important increase in LE between the last two periods; in both cases, this was the result of factors amenable to health policy interventions.", {"entities": []}], ["The highest improvement in LE was due to non-avoidable causes, but avoidable mortality through health service interventions showed improvements in LE in those younger than 1 year and in those aged 45\u201375 years.", {"entities": []}], ["Making a distinction between several groups of causes of avoidable mortality and using decomposition by causes, ages and effects allowed us to better explain the impact of avoidable mortality on the LE of the whole population and gave a new dimension to this indicator that could be very useful in public health.", {"entities": []}], ["Prisoners are associated with high health care needs compared with the general population.", {"entities": []}], ["This study aims to investigate prisoners' use of health service.", {"entities": []}], ["A cross-sectional study of 29 prisons in central and southern parts of Norway.", {"entities": []}], ["A questionnaire was distributed to 1, 454 prisoners (90% response rate).", {"entities": []}], ["Multilevel analyses were employed to analyse help seeking behaviour among the prisoners.", {"entities": []}], ["Help seeking was substantially associated with sleep problems and drug problems.", {"entities": []}], ["There was also a tendency for closed prisons as well as high staffing levels of healthcare professionals to be associated with elevated health care use.", {"entities": []}], ["This study suggests that sleep problems and drug use are most frequently associated with health service use.", {"entities": []}], ["The differences in health care use between prisons suggest that the implementation of prison health care standards should be addressed.", {"entities": []}], ["Japanese encephalitis (JE) is the most important form of viral encephalitis in Asia.", {"entities": [[57, 75, "DISEASE"], [9, 21, "DISEASE"], [63, 75, "DISEASE"]]}], ["The critical factors determining mortality and severity of JE virus (JEV) infection remain unclear.", {"entities": []}], ["We identified brain-infiltrating T cells associated with a fatal outcome of JEV infection in mice.", {"entities": []}], ["Dying mice were defined as those that lost more than 25\u00a0% of their body weight by day 13 and died by day 21, while surviving mice were defined as those that lost less than 10\u00a0% by day 13, based on the result of the survival time course study.", {"entities": []}], ["Two groups of five mice that demonstrated brain virus titers of >1\u00a0\u00d7\u00a010", {"entities": []}], ["Salmeterol and fluticasone combination (SFC) has anti-inflammatory effects and improves clinical symptoms in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[123, 160, "DISEASE"]]}], ["However, the anti-inflammatory mechanism of SFC remains unclear.", {"entities": []}], ["In this study, we investigated the inflammatory responses of COPD, as well as the relationship of the inflammatory factors with the levels of CD4 Twenty-one patients with moderate or severe COPD received treatment with 50/500 \u03bcg of SFC twice a day for 12 weeks.", {"entities": [[142, 145, "GENE"]]}], ["Before and after treatment, the patients were evaluated using the Modified Medical Research Council (MMRC) dyspnea scale and by conducting a 6-min walk test.", {"entities": []}], ["The number of neutrophils, monocytes and lymphocytes in induced sputum were counted.", {"entities": []}], ["Levels of cytokines, including pre-inflammatory IL-8, TNF-\u03b1, IL-17A and cytokine IL-10, in the sputum supernatant and peripheral blood were measured by ELISA.", {"entities": []}], ["The proportion of Foxp3 After treatment with SFC, the forced expiratory volume in 1 s as a percentage of predicted values (FEV1%) and the 6-min walk distance in the COPD patients significantly increased, while dyspnea scores decreased.", {"entities": [[18, 23, "GENE"]]}], ["The total number of cells, neutrophils, and the percentage of neutrophils in induced sputum reduced notably, while the proportion of monocytes was significantly increased.", {"entities": []}], ["Levels of the inflammatory cytokines IL-8, TNF-\u03b1, and IL-17A in the sputum supernatant and in the blood were markedly lowered, while IL-10 levels were unchanged.", {"entities": []}], ["The proportion of Foxp3 SFC can reduce the levels of inflammatory factors and improve symptoms of COPD.", {"entities": [[18, 23, "GENE"]]}], ["The levels of inflammatory factors are associated with the variation of Foxp3 This study was registered with http://www.chictr.org (Chinese Clinical Trial Register) as follows: ChiCTR-TNC-10001270", {"entities": [[72, 77, "GENE"]]}], ["Aboriginal people in Australia experience significant health burden from chronic disease.", {"entities": []}], ["There has been limited research to identify effective healthy lifestyle programs to address risk factors for chronic disease among Aboriginal people.", {"entities": []}], ["The Knockout Health Challenge is a community-led healthy lifestyle program for Aboriginal communities across New South Wales, Australia.", {"entities": []}], ["An evaluation of the 2013 Knockout Health Challenge was undertaken.", {"entities": []}], ["Participants\u2019 self-reported physical activity and diet were measured at four time points - at the start and end of the Challenge (via paper form), and 5 and 9 months after the Challenge (via telephone survey).", {"entities": []}], ["Participants\u2019 weight was measured objectively at the start and end of the Challenge, and self-reported (via telephone survey) 5 and 9 months after the Challenge.", {"entities": []}], ["Changes in body composition, physical activity and diet between time points were analysed using linear mixed models.", {"entities": []}], ["As part of the telephone survey participants were also asked to identify other impacts of the Challenge; these were analysed descriptively (quantitative items) and thematically (qualitative items).", {"entities": []}], ["A total of 586 people registered in 22 teams to participate in the Challenge.", {"entities": []}], ["The mean weight at the start was 98.54kg (SD 22.4), and 94% of participants were overweight or obese.", {"entities": []}], ["Among participants who provided data at all four time points ( n =122), the mean weight loss from the start to the end of the Challenge was 2.3kg (95%CI -3.0 to -1.9, p <0.001), and from the start to 9 months after the Challenge was 2.3kg (95%CI -3.3 to -1.3, p <0.001).", {"entities": []}], ["Body mass index decreased by an average of 0.9kg/m p <0.001) from the start to the end of the Challenge, and 0.8kg/m p <0.001) 9 months after.", {"entities": []}], ["At the end of the Challenge, participants reported they were more physically active and had increased fruit and vegetable consumption compared with the start of the Challenge, and identified a range of other positive impacts.", {"entities": []}], ["The Challenge was effective in reducing weight and promoting healthy lifestyles among Aboriginal people across New South Wales, and has potential to contribute to closing the health gap between Aboriginal and non-Aboriginal people.", {"entities": []}], ["Body weight is of physical and psychological importance to Canadian women; it is associated with health status, physical activity, body image, and self-esteem.", {"entities": []}], ["Although the problems associated with overweight and obesity are indeed serious, there are also problems connected to being underweight.", {"entities": [[53, 60, "DISEASE"]]}], ["Weight prejudice and the dieting industry intensify body image concerns for Canadian women and can have a major negative impact on self-esteem.", {"entities": []}], ["Women have lower BMIs than men, a lower incidence of being overweight and a higher incidence of being underweight.", {"entities": []}], ["However, women across all weight categories are more dissatisfied with their bodies.", {"entities": []}], ["Sixty percent of women are inactive, and women with a BMI of 27 or higher are more likely to be inactive than women with lower BMIs.", {"entities": []}], ["The data show that women are aware of the health benefits of exercise, but there is a gap between knowledge and practice.", {"entities": []}], ["When asked about barriers to health improvement, 39.7% of women cited lack of time and 39.2% lack of willpower.", {"entities": []}], ["Weight prejudice must be made unacceptable and positive body image should be encouraged and diversity valued.", {"entities": []}], ["Health policies should encourage healthy eating and healthy activity.", {"entities": []}], ["Health curricula for young students should include information about healthy eating, active lifestyle, and self-esteem.", {"entities": []}], ["Physical activities that mothers can participate in with their families should be encouraged.", {"entities": []}], ["Research should be funded to elucidate the most effective methods of getting women to become and remain physically active without focusing on appearance.", {"entities": []}], ["Founder populations and large pedigrees offer many well-known advantages for genetic mapping studies, including cost-efficient study designs.", {"entities": []}], ["Here, we describe PRIMAL ( P edig R ee IM putation AL gorithm), a fast and accurate pedigree-based phasing and imputation algorithm for founder populations.", {"entities": []}], ["PRIMAL incorporates both existing and original ideas, such as a novel indexing strategy of Identity-By-Descent (IBD) segments based on clique graphs.", {"entities": []}], ["We were able to impute the genomes of 1,317 South Dakota Hutterites, who had genome-wide genotypes for ~300,000 common single nucleotide variants (SNVs), from 98 whole genome sequences.", {"entities": []}], ["Using a combination of pedigree-based and LD-based imputation, we were able to assign 87% of genotypes with >99% accuracy over the full range of allele frequencies.", {"entities": []}], ["Using the IBD cliques we were also able to infer the parental origin of 83% of alleles, and genotypes of deceased recent ancestors for whom no genotype information was available.", {"entities": []}], ["This imputed data set will enable us to better study the relative contribution of rare and common variants on human phenotypes, as well as parental origin effect of disease risk alleles in >1,000 individuals at minimal cost.", {"entities": []}], ["The recent availability of whole genome and whole exome sequencing allows genetic studies of human diseases and traits at an unprecedented resolution, although their cost limits the size of the studied sample.", {"entities": []}], ["To overcome this limitation and design cost-efficient studies, we developed a two step method: sequencing of relatively few members of a well-characterized founder population followed by pedigree-based whole genome imputation of many other individuals with genome-wide genotype data.", {"entities": []}], ["We show that by sequencing only 98 Hutterites, we can impute 7 million variants in an additional 1,317 Hutterites with >99% accuracy and an average call rate of 87%.", {"entities": []}], ["Furthermore, parental origin was assigned to 83% of the alleles.", {"entities": []}], ["Such studies in the Hutterites and other founder populations should yield new insights into the genetic architecture of common diseases, gene expression traits, and clinically relevant biomarkers of disease, and ultimately provide outstanding opportunities for personalized medicine in these well-characterized populations.", {"entities": []}], ["Objective To assess the association between obstetricians\u2019 years of experience after training and the maternal complications of their patients during their first 40 years of post-residency practice.", {"entities": []}], ["Design Retrospective cohort analysis.", {"entities": []}], ["Setting Obstetrical discharges from acute care hospitals in Florida and New York between academic years 1992 and 2009.", {"entities": []}], ["Population 6\u2009704\u2009311 deliveries performed by 5175 obstetricians.", {"entities": []}], ["Main outcome measure Three composite measures of maternal complication rates per physician year from vaginal and cesarean births separately and combined, adjusted for secular trends.", {"entities": []}], ["Results Obstetricians\u2019 maternal complication rates declined during the first three decades after completion of residency.", {"entities": []}], ["The improvement was largest in the first decade and diminished thereafter.", {"entities": []}], ["For all deliveries, the change was \u22120.21 (95% confidence interval \u22120.23 to \u22120.19) percentage points per year in the first decade, \u22120.11 (\u22120.13 to \u22120.09) percentage points per year in the second decade, and \u22120.05 (\u22120.08 to \u22120.01) percentage points in the third decade (P<0.001 for second to first decade comparison; P=0.001 for third to second decade comparison).", {"entities": []}], ["The patterns were comparable for cesarean deliveries and vaginal deliveries and across several sensitivity checks.", {"entities": []}], ["Conclusions Among obstetricians practicing in Florida and New York, those with more years of experience had fewer maternal complications.", {"entities": []}], ["This association persisted over the first three decades of practice but diminished in magnitude.", {"entities": []}], ["Nasal polyps can make nasoendotracheal intubation difficult.", {"entities": []}], ["We present a case of complete obstruction of a nasoendotracheal tube by a nasal polyp during a blind nasoendotracheal intubation in emergency oral surgery.", {"entities": []}], ["Aggressiveness in humans is a hereditary behavioral trait that mobilizes all systems of the body\u2014first of all, the nervous and endocrine systems, and then the respiratory, vascular, muscular, and others\u2014e.g., for the defense of oneself, children, family, shelter, territory, and other possessions as well as personal interests.", {"entities": []}], ["The level of aggressiveness of a person determines many other characteristics of quality of life and lifespan, acting as a stress factor.", {"entities": []}], ["Aggressive behavior depends on many parameters such as age, gender, diseases and treatment, diet, and environmental conditions.", {"entities": []}], ["Among them, genetic factors are believed to be the main parameters that are well-studied at the factual level, but in actuality, genome-wide studies of aggressive behavior appeared relatively recently.", {"entities": []}], ["One of the biggest projects of the modern science\u20141000 Genomes\u2014involves identification of single nucleotide polymorphisms (SNPs), i.e., differences of individual genomes from the reference genome.", {"entities": []}], ["SNPs can be associated with hereditary diseases, their complications, comorbidities, and responses to stress or a drug.", {"entities": []}], ["Clinical comparisons between cohorts of patients and healthy volunteers (as a control) allow for identifying SNPs whose allele frequencies significantly separate them from one another as markers of the above conditions.", {"entities": []}], ["Computer-based preliminary analysis of millions of SNPs detected by the 1000 Genomes project can accelerate clinical search for SNP markers due to preliminary whole-genome search for the most meaningful candidate SNP markers and discarding of neutral and poorly substantiated SNPs.", {"entities": []}], ["Here, we combine two computer-based search methods for SNPs (that alter gene expression) {i} Web service SNP_TATA_Comparator (DNA sequence analysis) and {ii} PubMed-based manual search for articles on aggressiveness using heuristic keywords.", {"entities": []}], ["Near the known binding sites for TATA-binding protein (TBP) in human gene promoters, we found aggressiveness-related candidate SNP markers, including rs1143627 (associated with higher aggressiveness in patients undergoing cytokine immunotherapy), rs544850971 (higher aggressiveness in old women taking lipid-lowering medication), and rs10895068 (childhood aggressiveness-related obesity in adolescence with cardiovascular complications in adulthood).", {"entities": [[379, 386, "DISEASE"], [55, 58, "GENE"]]}], ["After validation of these candidate markers by clinical protocols, these SNPs may become useful for physicians (may help to improve treatment of patients) and for the general population (a lifestyle choice preventing aggressiveness-related complications).", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-016-3353-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Circulating pro-inflammatory cytokines were associated with increased relative mortality risk, while immune parameters reflecting improved T-cell function were predictors of survival in hemodialysis (HD) patients.", {"entities": []}], ["We evaluated in the prospective study whether variants in T helper cell cytokine-associated genes are determinants of mortality in HD patients.", {"entities": []}], ["The study was carried out in 532 prevalent HD subjects who were followed-up for 7\u00a0years.", {"entities": []}], ["HRM analysis was used for IFNL3 , IL12A , IL13 , and IL4R genotyping.", {"entities": [[34, 39, "GENE"], [42, 46, "GENE"], [53, 57, "GENE"]]}], ["CCL2 , IL12B , and IL18 were genotyped using PCR\u2013RFLP analysis.", {"entities": [[0, 4, "GENE"], [7, 12, "GENE"], [19, 23, "GENE"]]}], ["Survival analyses were conducted using the Kaplan-Meier method and the Cox proportional hazard model.", {"entities": []}], ["In univariate analyses, IFNL3 rs8099917 was associated with all-cause mortality in recessive model of inheritance (log-rank test P \u00a0=\u00a00.044), IL12A rs568408 - in dominant model (log-rank test P \u00a0=\u00a00.029).", {"entities": [[142, 147, "GENE"]]}], ["Minor homozygotes (the genotype GG) in IFNL3 rs8099917 showed shorter survival during the study (3.6, 1.0\u20137.0\u00a0years vs 4.7, 0.1\u20137.0\u00a0years, P \u00a0=\u00a00.009) than the major allele (T) bearers.", {"entities": []}], ["The rs8099917 GG patients demonstrated higher risk of death than the remaining patients (GT\u00a0+\u00a0TT) (OR 1.94, 95%CI 1.11\u20133.40, P \u00a0=\u00a00.020).", {"entities": []}], ["Major homozygosity (the genotype GG) in IL12A rs568408 was associated with higher mortality than that shown in bearers of the minor allele (AA\u00a0+\u00a0AG) (HR 1.31, 95%CI 1.02\u20131.69, P \u00a0=\u00a00.035).", {"entities": [[40, 45, "GENE"], [150, 152, "GENE"]]}], ["In multivariate analyses, however, the mentioned polymorphisms were not independent predictors of survival.", {"entities": []}], ["Polymorphisms of IFNL3 rs8099917 and IL12A rs568408 contribute to survival of HD patients, but not as independent factors.", {"entities": [[37, 42, "GENE"]]}], ["The online version of this article (doi:10.1186/s12882-017-0582-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Health Related Quality of Life (HRQoL) studies on children with chronic illness such as thalassaemia are limited.", {"entities": []}], ["We conducted the first study to investigate if children with thalassaemia have a lower quality of life in the four dimensions as measured using the PedsQL 4.0 generic Scale Score: physical, emotional, social and role (school) functioning compared to the healthy controls allowing for age, gender, ethnicity and household income.", {"entities": []}], ["The PedsQL 4.0 was administered to children receiving blood transfusions and treatments at Hospital Kuala Lumpur, Malaysia using PedsQL 4.0 generic Scale Score.", {"entities": []}], ["Accordingly, the questionnaire was also administered to a control group of healthy school children.", {"entities": []}], ["Socio-demographic data were also collected from patients and controls using an interview schedule designed for the study.", {"entities": []}], ["Of the 96 thalassaemia patients approached, 78 gave consent to be interviewed giving a response rate of 81.3%.", {"entities": []}], ["Out of 235 healthy controls approached, all agreed to participate giving a response rate of 100%.", {"entities": []}], ["The mean age for the patients and schoolchildren is 11.9 and 13.2 years respectively.", {"entities": []}], ["The age range for the patients and the schoolchildren is between 5 to 18 years and 7 to 18 years respectively.", {"entities": []}], ["After controlling for age and demographic background, the thalassaemia patients reported having significantly lower quality of life than the healthy controls.", {"entities": []}], ["Thalassaemia has a negative impact on perceived physical, emotional, social and school functioning in thalassaemia patients which was also found to be worse than the children's healthy counterparts.", {"entities": []}], ["Continuing support of free desferal from the Ministry of Health should be given to these patients.", {"entities": []}], ["More understanding and support especially from health authorities, school authorities and the society is essential to enhance their quality of life.", {"entities": []}], ["Increasing child vaccination coverage to 85% or more in rural India from the current level of 50% holds great promise for reducing infant and child mortality and improving health of children.", {"entities": []}], ["We have tested a novel strategy called Rural Effective Affordable Comprehensive Health Care (REACH) in a rural population of more than 300 000 in Rajasthan and succeeded in achieving full immunization coverage of 88.7% among children aged 12 to 23 months in a short span of less than 2 years.", {"entities": []}], ["The REACH strategy was first developed and successfully implemented in a demonstration project by SHARE INDIA in Medchal region of Andhra Pradesh, and was then replicated in Rajgarh block of Rajasthan in cooperation with Bhoruka Charitable Trust (private partners of Integrated Child Development Services and National Rural Health Mission health workers in Rajgarh).", {"entities": []}], ["The success of the REACH strategy in both Andhra Pradesh and Rajasthan suggests that it could be successfully adopted as a model to enhance vaccination coverage dramatically in other areas of rural India.", {"entities": []}], ["Sparassis crispa , also known as cauliflower mushroom, is an edible mushroom with medicinal properties.", {"entities": []}], ["Its cultivation became popular in Japan about 10 years ago, a phenomenon that has been attributed not only to the quality of its taste, but also to its potential for therapeutic applications.", {"entities": []}], ["Herein, I present a comprehensive summary of the pharmacological activities and mechanisms of action of its bioactive components, such as beta-glucan, and other physiologically active substances.", {"entities": []}], ["In particular, the immunomodulatory mechanisms of the beta-glucan components are presented herein in detail.", {"entities": []}], ["In the present study, we aimed to determine whether ethanol extracts of Fructus Schisandrae (FS), the dried fruit of Schizandra chinensis Baillon, mitigates the development of dexamethasone-induced muscle atrophy.", {"entities": []}], ["Adult SPF/VAT outbred CrljOri:CD1 (ICR) mice were either treated with dexamethasone to induce muscle atrophy.", {"entities": []}], ["Some mice were treated with various concentrations of FS or oxymetholone, a 17\u03b1-alkylated anabolic-androgenic steroid.", {"entities": []}], ["Muscle thickness and weight, calf muscle strength, and serum creatine and creatine kinase (CK) levels were then measured.", {"entities": []}], ["The administration of FS attenuated the decrease in calf thickness, gastrocnemius muscle thickness, muscle strength and weight, fiber diameter and serum lactate dehydrogenase levels in the gastrocnemius muscle bundles which was induced by dexamethasone in a dose-dependent manner.", {"entities": []}], ["Treatment with FS also prevented the dexamethasone-induced increase in serum creatine and creatine kinase levels, histopathological muscle fiber microvacuolation and fibrosis, and the immunoreactivity of muscle fibers for nitrotyrosine, 4-hydroxynonenal, inducible nitric oxide synthase and myostatin.", {"entities": []}], ["In addition, the destruction of the gastrocnemius antioxidant defense system was also inhibited by the administration of FS in a dose-dependent manner.", {"entities": []}], ["FS downregulated the mRNA expression of atrogin-1 and muscle RING-finger protein-1 (involved in muscle protein degradation), myostatin (a potent negative regulator of muscle growth) and sirtuin 1 (a representative inhibitor of muscle regeneration), but upregulated the mRNA expression of phosphatidylinositol 3-kinase, Akt1, adenosine A1 receptor and transient receptor potential cation channel subfamily V member 4, involved in muscle growth and the activation of protein synthesis.", {"entities": [[319, 323, "GENE"]]}], ["The overall effects of treatment with 500 mg/kg FS were comparable to those observed following treatment with 50 mg/kg oxymetholone.", {"entities": []}], ["The results from the present study support the hypothesis that FS has a favorable ameliorating effect on muscle atrophy induced by dexamethasone, by exerting anti-inflammatory and antioxidant effects on muscle fibers, which may be due to an increase in protein synthesis and a decrease in protein degradation.", {"entities": []}], ["Dietary gammalinolenic acid (GLA), a potent inhibitor of 5-lipoxygenase (5-LOX) and suppressor of leukotriene B 4 (LTB 4 ), can attenuate the clinical course of rheumatoid arthritics, with negligible side effects.", {"entities": [[29, 32, "GENE"], [115, 118, "GENE"]]}], ["Since Zileuton, also an inhibitor of 5-LOX, attenuates asthma but with an undesirable side effect, we investigated whether dietary GLA would suppress biosynthesis of PMN-LTB 4 isolated from asthma patients and attenuate asthma.", {"entities": [[55, 61, "DISEASE"], [190, 196, "DISEASE"], [220, 226, "DISEASE"], [131, 134, "GENE"]]}], ["Twenty-four mild-moderate asthma patients (16\u201375 years) were randomized to receive either 2.0 g daily GLA (borage oil) or corn oil (placebo) for 12 months.", {"entities": [[26, 32, "DISEASE"], [102, 105, "GENE"]]}], ["Blood drawn at 3 months intervals was used to prepare sera for fatty acid analysis, PMNs for determining phospholipid fatty acids and for LTB4 generation.", {"entities": []}], ["Patients were monitored by daily asthma scores, pulmonary function, and exhaled NO.", {"entities": [[33, 39, "DISEASE"]]}], ["Ingestion of daily GLA (i) increased DGLA (GLA metabolite) in PMN-phospholipids; (ii) increased generation of PMN-15-HETrE (5-LOX metabolite of DGLA).", {"entities": [[19, 22, "GENE"], [43, 46, "GENE"], [19, 22, "GENE"], [43, 46, "GENE"]]}], ["Increased PMN-DGLA/15-HETrE paralleled the decreased PMN generation of proinflammatory LTB 4 .", {"entities": [[87, 90, "GENE"]]}], ["However, the suppression of PMN-LTB4 did not reveal statistically significant suppression of the asthma scores evaluated.", {"entities": [[97, 103, "DISEASE"]]}], ["Nonetheless, the study demonstrated dietary fatty acid modulation of endogenous inflammatory mediators without side effects and thus warrant further explorations into the roles of GLA at higher doses, leukotrienes and asthma.", {"entities": [[218, 224, "DISEASE"], [180, 183, "GENE"]]}], ["The aim of study was to evaluate the scientific basis for the traditional use of Elephantopus scaber leaves.", {"entities": []}], ["In the present study, ethanol extract of Elephantopus scaber leaves was evaluated for preliminary phytochemical screening and antiasthmatic activity using histamine and acetylcholine-induced bronchospasm, mast cell degranulation and histamine induced constriction on isolated guinea pig tracheal chain at different dose levels.", {"entities": []}], ["Student's t -Test and Dunett's test were used for statistical analysis.", {"entities": []}], ["The result of present investigation showed that the ethanolic extract of E. scaber significantly ( P <0.001) decreased the bronchospasm induced by histamine, acetylcholine and protected mast cell degranulation as compared to control groups.", {"entities": []}], ["It also decreased the histamine induce constriction on isolated guinea pig trachea in dose-dependent manner.", {"entities": []}], ["Phytochemical studies revealed the presence of steroids, saponin, flavonoids, and phenolic compounds in the extract.", {"entities": []}], ["The present study concludes that the antiasthmatic activity of ethanolic extract of E. scaber leaves may be due to the presence of flavonoids or steroids.", {"entities": []}], ["Antiasthmatic action of the E. scaber could be due to its antihistaminic, anticholinergic and mast-cell-stabilizing property.", {"entities": []}], ["Mortality amongst COPD patients treated on the ICU is high.", {"entities": []}], ["Health-related quality of life (HRQL) after intensive care is a relevant concern for COPD patients, their families and providers of health care.", {"entities": []}], ["Still, there are few HRQL studies after intensive care of this patient group.", {"entities": []}], ["Our hypothesis was that HRQL of COPD patients treated on the ICU declines rapidly with time.", {"entities": []}], ["Fifty-one COPD patients (COPD-ICU group) with an ICU stay longer than 24 hours received a questionnaire at 6, 12 and 24 months after discharge from ICU.", {"entities": []}], ["HRQL was measured using two generic instruments: the EuroQoL instrument (EQ-5D and EQ-VAS) and the Short Form 36 Health Survey (SF-36).", {"entities": []}], ["The results were compared to HRQL of two reference groups from the general population; an age- and sex-adjusted reference population (Non-COPD reference) and a reference group with COPD (COPD reference).", {"entities": []}], ["HRQL of the COPD-ICU group at 6 months after discharge from ICU was lower compared to the COPD reference group: Median EQ-5D was 0.66 vs. 0.73, P = 0.08 and median EQ-VAS was 50 vs.55, P < 0.05.", {"entities": []}], ["There were no significant differences in the SF-36 dimensions between the COPD-ICU and COPD-reference groups, although the difference in physical functioning (PF) approached statistical significance (P = 0.059).", {"entities": []}], ["Patients in the COPD-ICU group who were lost to follow-up after 6 months had low HRQL scores at 6 months.", {"entities": []}], ["Scores for patients who died were generally lower compared to patients who failed to respond to the questionnaire.", {"entities": []}], ["The PF and social functioning (SF) scores in those who died were significantly lower compared to patients with a complete follow up.", {"entities": []}], ["HRQL of patients in the COPD-ICU group that survived a complete 24 months follow up was low but stable with no statistically significant decline from 6 to 24 months after ICU discharge.", {"entities": []}], ["Their HRQL at 24 months was not significantly different from HRQL in the COPD reference group.", {"entities": []}], ["HRQL in COPD survivors after intensive care was low but did not decline from 6 to 24 months after discharge from ICU.", {"entities": []}], ["Furthermore, HRQL at 24 months was similar to patients with COPD who had not received ICU treatment.", {"entities": []}], ["Primary aluminum production is an industrial process with high potential health risk for workers.", {"entities": []}], ["We consider in this article how to assess community health risks associated with primary aluminum smelter emissions.", {"entities": []}], ["We reviewed the literature on health effects, community exposure data, and dose\u2013response relationships of the principal hazardous agents emitted.", {"entities": []}], ["On the basis of representative measured community exposure levels, we were able to make rough estimates on health risks associated with specific agents and categorize these as none, low, medium, or high.", {"entities": []}], ["It is possible to undertake a rough-estimate community Health Risk Assessment for individual smelters on the basis of information available in the epidemiological literature and local community exposure data.", {"entities": []}], ["It is increasingly being appreciated that multiple autoimmune diseases share common susceptibility genes.", {"entities": []}], ["The tumour necrosis factor ligand superfamily member 4 gene ( TNFSF4 , OX40L ), which encodes for the T cell costimulatory molecule OX40 ligand, has been identified as a susceptibility gene for the development of systemic lupus erythematosus (SLE).", {"entities": [[222, 241, "DISEASE"], [213, 241, "DISEASE"], [62, 68, "GENE"]]}], ["Accordingly, the aim of the current study was to investigate the possible association of the TNFSF4 gene region with systemic sclerosis (SSc), an autoimmune disease that leads to the development of cutaneous and visceral fibrosis.", {"entities": [[93, 99, "GENE"]]}], ["A total of 9 single nucleotide polymorphisms (SNPs) in the TNFSF4 gene region, previously associated with susceptibility to SLE, were tested for association with SSc in a collection of 1059 patients with SSc and 698 controls.", {"entities": [[59, 65, "GENE"]]}], ["Case-control comparisons revealed a significant association between susceptibility to SSc and the minor alleles at SNPs rs1234314 (OR 1.20, 95% CI 1.04 to 1.4, p FDR =0.019), rs2205960 (OR 1.24, 95% CI 1.10 to 1.50, p FDR =0.019) and rs844648 (OR 1.16, 95% CI 1.01 to 1.30, p FDR =0.032).", {"entities": []}], ["The minor allele at rs844644 was protective (OR 0.84, 95% CI 0.70 to 0.97, p FDR =0.038).", {"entities": []}], ["Analysis of subsets of patients with SSc demonstrated significant associations of the TNFSF4 SNPs with limited and diffuse SSc as well as specific SNPs that were associated with SSc-associated autoantibodies.", {"entities": [[86, 92, "GENE"]]}], ["Finally, the analyses suggest a potential interaction between two TNFSF4 SNPs, rs2205960 and rs844648, with regards to SSc susceptibility.", {"entities": [[66, 72, "GENE"]]}], ["Polymorphisms in the TNFSF4 gene region are associated with susceptibility to SSc and its clinical and autoantibody subsets.", {"entities": [[21, 27, "GENE"]]}], ["TNFSF4 may be another gene that confers risk to multiple autoimmune diseases.", {"entities": [[0, 6, "GENE"]]}], ["The contribution of hereditary factors in basal cell carcinoma of the skin has not been well defined at the population level.", {"entities": [[53, 62, "DISEASE"], [42, 62, "DISEASE"]]}], ["We aimed to assess the hereditary component in basal cell carcinoma by comparing its occurrence in monozygotic and dizygotic twin pairs.", {"entities": [[58, 67, "DISEASE"], [47, 67, "DISEASE"]]}], ["The Finnish Twin Cohort, comprising 12,941 adult, like-sex twin pairs with established zygosity and resident in Finland in 1975, was linked with the Finnish Cancer Registry.", {"entities": []}], ["We identified 335 twin pairs in which at least one twin had basal cell carcinoma diagnosed between 1953 and 1996.", {"entities": [[71, 80, "DISEASE"], [60, 80, "DISEASE"]]}], ["Standardized incidence ratios, concordances, tetrachoric correlations and pairwise relative risks were computed by standard methods.", {"entities": []}], ["Components of variance in liability were estimated by structural equation modelling.", {"entities": []}], ["There was an elevated risk of basal cell carcinoma for the co-twin of a diseased twin, but no difference in risk by zygosity.", {"entities": [[41, 50, "DISEASE"], [30, 50, "DISEASE"]]}], ["During the prospective follow-up in 1976-96, the probandwise concordance was 7.7% in monozygotic and 7.0% in dizygotic pairs.", {"entities": []}], ["Model fitting indicated that genetic factors were not needed to account for the distribution of basal cell carcinoma in twin pairs.", {"entities": [[107, 116, "DISEASE"], [96, 116, "DISEASE"]]}], ["These results confirm the major role of environmental factors in the aetiology of basal cell carcinoma.", {"entities": [[93, 102, "DISEASE"], [82, 102, "DISEASE"]]}], ["A change in the perception of respiratory symptoms after treatment with inhaled beta2 agonists is often used to aid diagnosis of exercise-induced bronchoconstriction (EIB).", {"entities": []}], ["Our aim was to test the association between subjective ratings of respiratory symptoms and changes in airway caliber after induced and inhibited bronchoconstriction in athletes with EIB.", {"entities": []}], ["Eighty-five athletes with diagnosed or suspected EIB performed a eucapnic voluntary hyperpnea (EVH) challenge with dry air.", {"entities": []}], ["Of the 45 athletes with hyperpnea-induced bronchoconstriction [i.e., post-EVH fall in forced expiratory volume in 1 s (FEV 1 ) \u226510%, EVH 1 ) was performed before and after EVH, and respiratory symptoms were recorded 15 min after EVH on visual analog scales.", {"entities": [[119, 122, "GENE"]]}], ["Terbutaline inhibited bronchoconstriction (i.e., maximal fall in FEV 1 <10% after EVH) in 83% of the EVH-positive athletes, with an average degree of bronchoprotection of 53% (95% confidence interval [CI], 45% to 62%).", {"entities": [[65, 68, "GENE"]]}], ["Terbutaline reduced group mean symptom scores ( P < 0.01), but the degree of bronchoprotection did not correlate with individual differences in symptom scores between terbutaline and placebo.", {"entities": []}], ["Of the 29 athletes who had less than 10% FEV 1 fall after EVH in the terbutaline condition, almost half (48%) rated at least one respiratory symptom higher under terbutaline, and more than one quarter (28%) had a higher total symptom score under terbutaline.", {"entities": [[41, 44, "GENE"]]}], ["Self-reports of respiratory symptoms in conditions of induced and inhibited bronchoconstriction do not correlate with changes in airway caliber in athletes with EIB.", {"entities": []}], ["Therefore, subjective ratings of respiratory symptoms after treatment with inhaled beta2 agonists should not be used as the sole diagnostic tool for EIB in athletes.", {"entities": []}], ["Cancer is predicted to be an increasingly important cause of morbidity and mortality in Bangladesh in the next few decades.", {"entities": [[0, 6, "DISEASE"]]}], ["The estimated incidence of 12.7 million new cancer cases will rise to 21.4 million by 2030.", {"entities": [[44, 50, "DISEASE"]]}], ["More than two-thirds of the total expenditure on health is through out-of-pocket payments.", {"entities": []}], ["According to the Bangladesh Bureau of Statistics, cancer is the sixth leading cause of death.", {"entities": [[50, 56, "DISEASE"]]}], ["International Agency for Research on Cancer has estimated cancer-related death rates in Bangladesh to be 7.5% in 2005 and 13% in 2030.", {"entities": [[37, 43, "DISEASE"], [58, 64, "DISEASE"]]}], ["The two leading causes are in males are lung and oral cancer and in females are breast cancer and cervical cancer.", {"entities": [[80, 93, "DISEASE"], [54, 60, "DISEASE"], [87, 93, "DISEASE"], [107, 113, "DISEASE"], [98, 113, "DISEASE"]]}], ["Bangladesh is now in severe shortage of radiation therapy machines, hospital bed, trained oncologists, medical radiation physicists and technologists.", {"entities": []}], ["Bangladesh having different cancers associated with smoking and smokeless tobacco use, Human papilloma virus infection, Hepatitis B and C infection, Helicobacter Pylori infection, arsenic contaminated groundwater, availability of chemical carcinogens mainly formalin treated fruits, fish and vegetables at open market, tannery waste contaminated with chromium (which is used for poultry feed and fish feed preparation).", {"entities": [[93, 102, "DISEASE"]]}], ["A World Health Organization study revealed the annual cost of illnesses in Bangladesh attributable to tobacco usage is US$ 500 million and the total annual benefit from the tobacco sector is US$ 305 million as tax revenue.", {"entities": []}], ["Bangladesh has developed a National Cancer Control Strategy and Action Plan with the aim of delivering a universal, quality-based and timely service.", {"entities": [[36, 42, "DISEASE"]]}], ["Cancer prevention through tobacco control, health promotion and vaccination program, cancer early detection program for oral cavity, breast and cervix has initiated.", {"entities": [[0, 6, "DISEASE"], [85, 91, "DISEASE"]]}], ["Cancer detection and diagnostic facilities will be made available at medical colleges and district- hospitals and establish a referral chain.", {"entities": [[0, 6, "DISEASE"]]}], ["National capacity development, more cancer research will allow Bangladesh to deal effectively and efficiently with the cancer problems through evidence-based decision making.", {"entities": [[36, 42, "DISEASE"], [119, 125, "DISEASE"]]}], ["Corticosteroids are extensively used in pediatrics, yet the burden of side effects is significant.", {"entities": []}], ["Availability of a simple, fast, and reliable biochemical read out of steroidal drug pharmacodynamics could enable a rapid and objective assessment of safety and efficacy of corticosteroids and aid development of corticosteroid replacement drugs.", {"entities": []}], ["To identify potential corticosteroid responsive biomarkers we performed proteome profiling of serum samples from DMD and IBD patients with and without corticosteroid treatment using SOMAscan aptamer panel testing 1,129 proteins in <0.1 cc of sera.", {"entities": [[113, 116, "GENE"]]}], ["Ten pro-inflammatory proteins were elevated in untreated patients and suppressed by corticosteroids (MMP12, IL22RA2, CCL22, IGFBP2, FCER2, LY9, ITGa1/b1, LTa1/b2, ANGPT2 and FGG).", {"entities": [[101, 106, "GENE"], [108, 115, "GENE"], [117, 122, "GENE"], [124, 130, "GENE"], [132, 137, "GENE"], [139, 142, "GENE"], [163, 169, "GENE"], [174, 177, "GENE"]]}], ["These are candidate biomarkers for anti-inflammatory efficacy of corticosteroids.", {"entities": []}], ["Known safety concerns were validated, including elevated non-fasting insulin (insulin resistance), and elevated angiotensinogen (salt retention).", {"entities": []}], ["These were extended by new candidates for metabolism disturbances (leptin, afamin), stunting of growth (growth hormone binding protein), and connective tissue remodeling (MMP3).", {"entities": [[171, 175, "GENE"]]}], ["Significant suppression of multiple adrenal steroid hormones was also seen in treated children (reductions of 17-hydroxyprogesterone, corticosterone, 11-deoxycortisol and testosterone).", {"entities": []}], ["A panel of new pharmacodynamic biomarkers for corticosteroids in children was defined.", {"entities": []}], ["Future studies will need to bridge specific biomarkers to mechanism of drug action, and specific clinical outcomes.", {"entities": []}], ["In developed countries, giardiasis is considered a travel related disease.", {"entities": [[24, 34, "DISEASE"]]}], ["However, routine surveillance data from Germany indicate that >50% of infections were acquired indigenously.", {"entities": []}], ["We studied the epidemiological characteristics of symptomatic Giardia infections acquired in Germany and abroad, and verified the proportion of cases acquired in Germany in order to investigate risk factors for sporadic autochthonous Giardia infections.", {"entities": []}], ["We identified Giardia cases notified by 41 local health authorities between February 2007 and January 2008 and interviewed them on their clinical symptoms, underlying morbidities, travel abroad and potential risk factors for the disease.", {"entities": []}], ["We conducted a case-control-study including laboratory-confirmed (microscopy or antigen-test) autochthonous Giardia cases with clinical manifestations (diarrhoea, cramps, bloating) and randomly selected controls from the local population registry matched by county of residence and age-group (0-5, 6-19, \u226520 years).", {"entities": []}], ["Secondary cases, controls with diarrhoea and persons who had travelled outside Germany in the three weeks prior to disease onset (exposure period) were excluded.", {"entities": []}], ["We calculated adjusted odds ratios (aOR) with 95% confidence intervals (CI) using conditional logistic regression.", {"entities": []}], ["Of 273 interviewed cases, 131 (48%) had not travelled abroad during the defined exposure period.", {"entities": []}], ["Of these 131, 85 (65%) were male, 68 (54%) were living in communities with >100,000 inhabitants and 107 (83%) were aged 20 years or older.", {"entities": []}], ["We included 120 cases and 240 controls in the case-control study.", {"entities": []}], ["Cases were more likely to be male (aOR 2.5 CI 1.4-4.4), immunocompromised (aOR 15.3 CI 1.8-127) and daily consumers of green salad (aOR 2.9 CI 1.2-7.2).", {"entities": []}], ["Contact with animals (pets/farm animals) and exposure to surface water (swimming/water sports) were not associated with symptomatic disease.", {"entities": []}], ["A substantial proportion of Giardia lamblia cases in Germany are indigenously acquired.", {"entities": []}], ["Symptomatic cases are significantly more likely to be immunocompromised than control persons from the general population.", {"entities": []}], ["Physicians should consider Giardia infections among patients with no recent history of travel abroad, particularly if they have immune deficiencies.", {"entities": []}], ["Green salads may be an important vehicle of infection.", {"entities": []}], ["Information campaigns highlighting this food-borne risk should emphasise the risk to persons with immune deficiencies.", {"entities": []}], ["Low therapeutic adherence to medication is very common.", {"entities": []}], ["Clinical effectiveness is related to dose rate and route of administration and so poor therapeutic adherence can reduce the clinical benefit of treatment.", {"entities": []}], ["The therapeutic adherence of patients with chronic obstructive pulmonary disease (COPD) is extremely poor according to most studies.", {"entities": [[43, 80, "DISEASE"]]}], ["The research about COPD adherence has mainly focussed on quantifying its effect, and few studies have researched factors that affect non-adherence.", {"entities": []}], ["Our study will evaluate the effectiveness of a multifactor intervention to improve the therapeutic adherence of COPD patients.", {"entities": []}], ["A randomized controlled clinical trial with 140 COPD diagnosed patients selected by a non-probabilistic method of sampling.", {"entities": []}], ["Subjects will be randomly allocated into two groups, using the block randomization technique.", {"entities": []}], ["Every patient in each group will be visited four times during the year of the study.", {"entities": []}], ["Intervention: Motivational aspects related to adherence (beliefs and behaviour): group and individual interviews; cognitive aspects : information about illness; skills : inhaled technique training.", {"entities": []}], ["Reinforcement of the cognitive-emotional aspects and inhaled technique training will be carried out in all visits of the intervention group.", {"entities": []}], ["Adherence to a prescribed treatment involves a behavioural change.", {"entities": []}], ["Cognitive, emotional and motivational aspects influence this change and so we consider the best intervention procedure to improve adherence would be a cognitive and emotional strategy which could be applied in daily clinical practice.", {"entities": []}], ["Our hypothesis is that the application of a multifactor intervention (COPD information, dose reminders and reinforcing audiovisual material, motivational aspects and inhalation technique training) to COPD patients taking inhaled treatment will give a 25% increase in the number of patients showing therapeutic adherence in this group compared to the control group.", {"entities": []}], ["We will evaluate the effectiveness of this multifactor intervention on patient adherence to inhaled drugs considering that it will be right and feasible to the clinical practice context.", {"entities": []}], ["Current Controlled Trials ISCTN18841601", {"entities": []}], ["Using RefSeq annotations, most disease/trait-associated genetic variants identified by genome-wide association studies (GWAS) appear to be located within intronic or intergenic regions, which makes it difficult to interpret their functions.", {"entities": []}], ["We reassessed GWAS-Associated single-nucleotide polymorphisms (herein termed as GASs) for their potential functionalities using integrative approaches.", {"entities": []}], ["8834 of 9184 RefSeq \u201cnoncoding\u201d GASs were reassessed to have potential regulatory functionalities.", {"entities": []}], ["As examples, 3 variants (rs3130320, rs3806932 and rs6890853) were shown to have regulatory properties in HepG2, A549 and 293T cells.", {"entities": []}], ["Except rs3130320 as a known expression quantitative trait loci (eQTL), rs3806932 and rs6890853 were not reported as eQTLs in previous reports.", {"entities": []}], ["1999 of 9184 \u201cnoncoding\u201d GASs were re-annotated to the promoters or intragenic regions using Ensembl, UCSC and AceView gene annotations but they were not annotated into corresponding regions in RefSeq database.", {"entities": []}], ["Moreover, these GAS-harboring genes were broadly expressed across different tissues and a portion of them was expressed in a tissue-specific manner, suggesting that they could be functional.", {"entities": []}], ["Collectively, our study demonstrates the benefits of using integrative analyses to interpret genetic variants and may help to predict or explain disease susceptibility more accurately and comprehensively.", {"entities": []}], ["Pseudomyxoma peritonei (PMP) is a rare neoplasm of mainly appendiceal origin, characterised by excess intra-abdominal mucin production leading to high morbidity and mortality.", {"entities": []}], ["While histological features are frequently indolent, this tumour disseminates aggressively throughout the abdominal cavity, yet seldom metastasises.", {"entities": []}], ["This study determined the expression of several markers of colorectal differentiation (carcinoembryonic antigen (CEA), cytokeratins (CK20 and CK7), epithelial membrane antigen), mucin production (MUC-2, interleukin-9 (IL-9), IL-9 receptor (IL-9R \u03b1 )), and cell adhesion (N- and E-cadherin, vimentin) in PMP tissue ( n =26) compared with expressions in normal colonic mucosa ( n =19) and colorectal adenocarcinoma ( n =26).", {"entities": [[398, 412, "DISEASE"]]}], ["Expressions of CEA and cytokeratins were similar for PMP as those in colorectal adenocarcinomas with the exception that the CK20\u2212/CK7\u2212 pattern was rare in PMP (Fisher's exact test: P =0.001).", {"entities": []}], ["Similarly, expressions of mucin-related proteins were comparable for adenocarcinoma and PMP, with the exception that IL-9 expression was uncommon in adenocarcinoma ( P =0.009).", {"entities": [[69, 83, "DISEASE"], [149, 163, "DISEASE"]]}], ["Pseudomyxoma peritonei demonstrated a specific pattern of adhesion-related protein expressions of increased N-cadherin, reduced E-cadherin, and increased vimentin ( P =0.004), a phenotype suggesting a possible epithelial\u2013mesenchymal transition state.", {"entities": []}], ["Primary PMP cell cultures were successfully maintained and demonstrated marker expressions similar to those seen in in vivo tissues.", {"entities": []}], ["These early characterisation studies demonstrate similarities between PMP and colorectal adenocarcinoma, but also reveal a specific cadherin phenotype that may characterise the distinct non-metastasising behaviour of PMP, and form the basis for future mechanistic and therapy-targeting research.", {"entities": [[89, 103, "DISEASE"]]}], ["Racemic albuterol is an equimolar mixture of two isomers, (R) and (S).", {"entities": []}], ["Whether (R) and (S) isomers and the combination of both exert different effects in immune activation is not well defined.", {"entities": []}], ["We analyzed the effects of (R+S)-albuterol, (R)-albuterol and (S)-albuterol in a murine model of allergic pulmonary inflammation and in activated T cells.", {"entities": []}], ["Mice (C57BL/6) sensitized and aerosol challenged with the allergen ovalbumin (OVA) or phosphate buffered saline (PBS) were treated with (R)-albuterol, (S)-albuterol or (R+S)-albuterol.", {"entities": []}], ["Following administration of (R)-albuterol, allergen induced bronchoalveolar lavage eosinophils and IgE showed a decrease, albeit not significantly by ANOVA.", {"entities": []}], ["As T cells are important in allergic inflammation, we asked whether (R+S), (R) or (S)-albuterol might differ in effects on T cells and on the activity of the inflammatory transcription factor NF-\u03baB.", {"entities": []}], ["In activated T cells, (R)-albuterol administration decreased levels of inflammatory cytokines and NF-\u03baB activity.", {"entities": []}], ["These studies suggest that (R)-albuterol decreases cytokine secretion and NF-\u03baB activity in T cells.", {"entities": []}], ["Increasing numbers of emergency calls, shortages of Emergency Medical Service (EMS), physicians, prolonged emergency response times and regionally different quality of treatment by EMS physicians require improvement of this system.", {"entities": []}], ["Telemedical solutions have been shown to be beneficial in different emergency projects, focused on specific disease patterns.", {"entities": []}], ["Our previous pilot studies have shown that the implementation of a holistic prehospital EMS teleconsultation system, between paramedics and experienced tele-EMS physicians, is safe and feasible in different emergency situations.", {"entities": []}], ["We aim to extend the clinical indications for this teleconsultation system.", {"entities": []}], ["We hypothesize that the use of a tele-EMS physician is noninferior regarding the occurrence of system-induced patient adverse events and superior regarding secondary outcome parameters, such as the quality of guideline-conforming treatment and documentation, when compared to conventional EMS-physician treatment.", {"entities": []}], ["Three thousand and ten patients will be included in this single-center, open-label, randomized controlled, noninferiority trial with two parallel arms.", {"entities": []}], ["According to the inclusion criteria, all emergency cases involving adult patients who require EMS-physician treatment, excluding life-threatening cases, will be randomly assigned by the EMS dispatching center into two groups.", {"entities": []}], ["One thousand five hundred and five patients in the control group will be treated by a conventional EMS physician on scene, and 1505 patients in the intervention group will be treated by paramedics who are concurrently instructed by the tele-EMS physicians at the teleconsultation center.", {"entities": []}], ["The primary outcome measure will include the rate of treatment-specific adverse events in relation to the kind of EMS physician used.", {"entities": []}], ["The secondary outcome measures will record the specific treatment-associated quality indicators.", {"entities": []}], ["The evidence underlines the better quality of service using telemedicine networks between medical personnel and medical experts in prehospital emergency care, as well as in other medical areas.", {"entities": []}], ["The worldwide unique EMS teleconsultation system in Aachen has been optimized and evaluated in pilot studies and subsequently integrated into routine use for a broad spectrum of indications.", {"entities": []}], ["It has enabled prompt, safe and efficient patient treatment with optimized use of the \u201cresource\u201d EMS physician.", {"entities": []}], ["There is, however, a lack of evidence as to whether the advantages of the teleconsultation system can be replicated in wider-ranging EMS-physician indications (excluding life-threatening emergency calls).", {"entities": []}], ["ClinicalTrials.gov, identifier: NCT02617875 .", {"entities": []}], ["Registered on 24 November 2015.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-1781-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although adverse health effects of particulate matter with a diameter of < 100 nm (nanoparticles) have been proposed, molecular and/or experimental evidence for their facilitation of lung inflammation in vivo is not fully defined.", {"entities": []}], ["In the present study we investigated the effects of nanoparticles on lung inflammation related to bacterial endotoxin [lipopolysaccharide (LPS)] in mice.", {"entities": []}], ["We intratracheally administered vehicle, two sizes (14 nm, 56 nm) of carbon black nanoparticles (4 mg/kg), LPS (2.5 mg/kg), or LPS plus nanoparticles and evaluated parameters for lung inflammation and coagulation.", {"entities": []}], ["Nanoparticles alone induced slight lung inflammation and significant pulmonary edema compared with vehicle.", {"entities": [[69, 84, "DISEASE"]]}], ["Fourteen-nanometer nanoparticles intensively aggravated LPS-elicited lung inflammation and pulmonary edema that was concomitant with the enhanced lung expression of interleukin-1\u03b2 (IL-1\u03b2), macrophage inflammatory protein-1\u03b1 (MIP-1\u03b1), macrophage chemoattractant protein-1, MIP-2, and keratinocyte chemoattractant in overall trend, whereas 56-nm nanoparticles did not show apparent effects.", {"entities": [[91, 106, "DISEASE"]]}], ["Immunoreactivity for 8-hydroxyguanosine, a marker for oxidative stress, was more intense in the lungs from the LPS + 14-nm nanoparticle group than in those from the LPS group.", {"entities": []}], ["Circulatory fibrinogen levels were higher in the LPS + plus 14-nm nanoparticle group than in the LPS group.", {"entities": []}], ["Taken together, evidence indicates that nanoparticles can aggravate lung inflammation related to bacterial endotoxin, which is more prominent with smaller particles.", {"entities": []}], ["The enhancement may be mediated, at least partly, via the increased local expression of proinflammatory cytokines and via the oxidative stress.", {"entities": []}], ["Furthermore, nanoparticles can promote coagulatory disturbance accompanied by lung inflammation.", {"entities": []}], ["Assessing asthma control using standardised questionnaires is recommended as good clinical practice but there is little evidence validating their use within primary care.", {"entities": [[10, 16, "DISEASE"]]}], ["There is however, strong empirical evidence to indicate that age, weight, gender, smoking, symptom pattern, medication use, health service resource use, geographical location, deprivation, and organisational issues, are factors strongly associated with asthma control.", {"entities": [[253, 259, "DISEASE"]]}], ["A good control measure is therefore one whose variation is most explained by these factors.", {"entities": []}], ["Eight binary (Yes = poor control, No = good control) models of asthma control were constructed from a large UK primary care dataset: the Royal College of Physicians 3-Questions (RCP-3Qs); the Jones Morbidity Index; three composite measures; three single component models.", {"entities": [[63, 69, "DISEASE"]]}], ["Accounting for practice clustering of patients, we investigated the effects of each model for assessing control.", {"entities": []}], ["The binary models were assessed for goodness-of-fit statistics using Pseudo R-squared and Akaikes Information Criteria (AIC), and for performance using Area Under the Receiver Operator Characteristic (AUROC).", {"entities": []}], ["In addition, an expanded RCP-3Q control scale (0-9) was derived and assessed with linear modelling.", {"entities": []}], ["The analysis identified which model was best explained by the independent variables and thus could be considered a good model of control assessment.", {"entities": []}], ["1,205 practices provided information on 64,929 patients aged 13+ years.", {"entities": []}], ["The RCP-3Q model provided the best fit statistically, with a Pseudo R-squared of 18%, and an AUROC of 0.79.", {"entities": []}], ["By contrast, the composite model based on the GINA definition of controlled asthma had a higher AIC, an AUROC of 0.72, and only 10% variability explained.", {"entities": [[76, 82, "DISEASE"]]}], ["In addition, although the Peak Expiratory Flow Rate (PEFR) model had the lowest AIC, it had an AUROC of 71% and only 6% of variability explained.", {"entities": []}], ["However, compared with the RCP-3Qs binary model, the linear RCP-3Q Total Score Model (Scale 0-9), was found to be a more robust 'tool' for assessing asthma control with a lower AIC (28,6163) and an R-squared of 33%.", {"entities": [[149, 155, "DISEASE"]]}], ["In the absence of a gold standard for assessing asthma control in primary care, the results indicate that the RCP-3Qs is an effective control assessment tool but, for maximum effect, the expanded scoring model should be used.", {"entities": [[48, 54, "DISEASE"]]}], ["An ethnobotanical survey was carried out to collect information on the use of medicinal plants in Southern Western Ghats of India (Madurai district, Tamil Nadu).", {"entities": []}], ["Information presented in this paper was gathered from the paliyar tribes using an integrated approach of botanical collections, group discussions and interviews with questionnaires in the years 1998 \u2013 1999.", {"entities": []}], ["The informants interviewed were 12 among whom 4 were tribal practitioners.", {"entities": []}], ["A total of 60 ethnomedicinal plant species distributed in 32 families are documented in this study.", {"entities": []}], ["The medicinal plants used by paliyars are listed with Latin name, family, local name, parts used, mode of preparation and medicinal uses.", {"entities": []}], ["Generally, fresh part of the plant was used for the preparation of medicine.", {"entities": []}], ["We observed that the documented ethnomedicinal plants were mostly used to cure skin diseases, poison bites, stomachache and nervous disorders.", {"entities": []}], ["The results of this study showed that these tribal people still depend on medicinal plants in Madurai district forest areas.", {"entities": []}], ["With the functional demonstration of a role in erythrocyte invasion by Plasmodium falciparum parasites, implications in the aetiology of common conditions that prevail in individuals of African origin, and a wealth of pharmacological knowledge, the stimulatory G protein (Gs) signal transduction pathway presents an exciting target for anti-malarial drug intervention.", {"entities": []}], ["Having previously demonstrated a role for the G-alpha-s gene, GNAS , in severe malaria disease, we sought to identify other important components of the Gs pathway.", {"entities": [[79, 86, "DISEASE"], [62, 66, "GENE"]]}], ["Using meta-analysis across case-control and family trio (affected child and parental controls) studies of severe malaria from The Gambia and Malawi, we sought evidence of association in six Gs pathway candidate genes: adenosine receptor 2A ( ADORA2A ) and 2B ( ADORA2B ), beta-adrenergic receptor kinase 1 ( ADRBK1 ), adenylyl cyclase 9 ( ADCY9 ), G protein beta subunit 3 ( GNB3 ), and regulator of G protein signalling 2 ( RGS2 ).", {"entities": [[113, 120, "DISEASE"], [242, 249, "GENE"], [261, 268, "GENE"], [308, 314, "GENE"], [339, 344, "GENE"], [375, 379, "GENE"], [425, 429, "GENE"]]}], ["Our study amassed a total of 2278 cases and 2364 controls.", {"entities": []}], ["Allele-based models of association were investigated in all genes, and genotype and haplotype-based models were investigated where significant allelic associations were identified.", {"entities": []}], ["Although no significant associations were observed in the other genes, several were identified in ADORA2A .", {"entities": [[98, 105, "GENE"]]}], ["The most significant association was observed at the rs9624472 locus, where the G allele (\u223c20% frequency) appeared to confer enhanced risk to severe malaria [OR\u200a=\u200a1.22 (1.09\u20131.37); P \u200a=\u200a0.001].", {"entities": [[149, 156, "DISEASE"]]}], ["Further investigation of the ADORA2A gene region is required to validate the associations identified here, and to identify and functionally characterize the responsible causal variant(s).", {"entities": [[29, 36, "GENE"]]}], ["Our results provide further evidence supporting a role of the Gs signal transduction pathway in the regulation of severe malaria, and request further exploration of this pathway in future studies.", {"entities": [[121, 128, "DISEASE"]]}], ["We conducted a 1-year epidemiologic study in Boston, Massachusetts, beginning May 1997, to examine the associations between environmental factors and office workers' health.", {"entities": []}], ["We recruited 98 subjects (81 females and 17 males) in 21 offices in four office buildings.", {"entities": []}], ["We conducted environmental sampling every 6 weeks and concurrently administered detailed questionnaires to collect information on work-related symptoms, psychosocial factors, and perceptions of the office environments.", {"entities": []}], ["In multivariate analyses, eye irritation was positively correlated with floor dust [odds ratio (OR) = 1.46; 95% confidence intervals (CI), 1.14-1.86] and reported lack of office cleanliness (OR = 1.52; 95% CI, 1.11-2.08).", {"entities": []}], ["Nonspecific symptoms were positively associated with unidentified chair fungi (OR = 1.87; 95% CI, 1.11-3.15) and several self-reported conditions, including a history of asthma (OR = 3.15; 95% CI, 1.26-7.87), more people in offices (OR = 1.71; 95% CI, 1.16-2.51), lack of office cleanliness (OR = 2.85; 95% CI, 1.72-4.73), and low job satisfaction (OR = 1.72; 95% CI, 1.06-2.81).", {"entities": [[170, 176, "DISEASE"]]}], ["Upper respiratory symptoms were positively associated with total fungal concentrations recovered from chair dust (OR = 1.35; 95% CI, 1.07-1.70) and the following self-reported conditions: more people in offices (OR = 1.45; 95% CI, 1.01-2.08), lack of office cleanliness (OR = 1.62; 95% CI, 1.15-2.30), and jobs frequently requiring hard work (OR = 1.43; 95% CI, 1.05-1.95).", {"entities": []}], ["This study emphasizes the importance of maintaining a clean, uncrowded workspace and the importance of chair fungi as a correlate for health effects.", {"entities": []}], ["Acute pulmonary inflammation is characterized by migration of polymorphonuclear neutrophils (PMNs) into the different compartments of the lung, passing an endothelial and epithelial barrier.", {"entities": []}], ["Recent studies showed evidence that phosphodiesterase (PDE)4-inhibitors stabilized endothelial cells.", {"entities": []}], ["PDE4B and PDE4D subtypes play a pivotal role in inflammation, whereas blocking PDE4D is suspected to cause gastrointestinal side effects.", {"entities": [[0, 5, "GENE"], [10, 15, "GENE"], [79, 84, "GENE"], [10, 15, "GENE"], [79, 84, "GENE"]]}], ["We thought to investigate the particular role of the PDE4-inhibitors roflumilast and rolipram on lung epithelium.", {"entities": []}], ["Acute pulmonary inflammation was induced by inhalation of LPS.", {"entities": []}], ["PDE4-inhibitors were administered i.p.", {"entities": []}], ["or nebulized after inflammation.", {"entities": []}], ["The impact of PDE4-inhibitors on PMN migration was evaluated in vivo and in vitro.", {"entities": []}], ["Microvascular permeability, cytokine levels, and PDE4B and PDE4D expression were analyzed.", {"entities": [[49, 54, "GENE"], [59, 64, "GENE"]]}], ["In vivo, both PDE4-inhibitors decreased transendothelial and transepithelial migration even when administered after inflammation, whereas roflumilast showed a superior effect compared to rolipram on the epithelium.", {"entities": []}], ["Both inhibitors decreased TNF\u03b1, IL6, and CXCL2/3.", {"entities": [[32, 35, "GENE"]]}], ["CXCL1, the strong PMN chemoattractant secreted by the epithelium, was significantly more reduced by roflumilast.", {"entities": [[0, 5, "GENE"]]}], ["In vitro assays with human epithelium also emphasized the pivotal role of roflumilast on the epithelium.", {"entities": []}], ["Additionally, LPS-induced stress fibers, an essential requirement for a direct migration of PMNs into the alveolar space, were predominantly reduced by roflumilast.", {"entities": []}], ["Expression of PDE4B and PDE4D were both increased in the lungs by LPS, PDE4-inhibitors decreased mainly PDE4B.", {"entities": [[14, 19, "GENE"], [104, 109, "GENE"], [24, 29, "GENE"], [14, 19, "GENE"], [104, 109, "GENE"]]}], ["The topical administration of PDE4-inhibitors was also effective in curbing down PMN migration, further highlighting the clinical potential of these compounds.", {"entities": []}], ["In pulmonary epithelial cells, both subtypes were found coexistent around the nucleus and the cytoplasm.", {"entities": []}], ["In these epithelial cells, LPS increased PDE4B and, to a lesser extend, PDE4D, whereas the effect of the inhibitors was prominent on the PDE4B subtype.", {"entities": [[41, 46, "GENE"], [137, 142, "GENE"], [72, 77, "GENE"], [41, 46, "GENE"], [137, 142, "GENE"]]}], ["In conclusion, we determined the pivotal role of the PDE4-inhibitor roflumilast on lung epithelium and emphasized its main effect on PDE4B in hyperinflammation.", {"entities": [[133, 138, "GENE"]]}], ["Pro-inflammatory/cytotoxic T cells (IFN\u03b3, TNF\u03b1, granzyme B+) are increased in the peripheral circulation in COPD.", {"entities": []}], ["NKT-like and NK cells are effector lymphocytes that we have also shown to be major sources of pro-inflammatory cytokines and granzymes.", {"entities": []}], ["P-glycoprotein 1 (Pgp1) is a transmembrane efflux pump well characterised in drug resistant cancer cells.", {"entities": [[92, 98, "DISEASE"]]}], ["We hypothesized that Pgp1 would be increased in peripheral blood T, NKT-like and NK cells in patients with COPD, and that this would be accompanied by increased expression of IFN\u03b3, TNF\u03b1 and granzyme B.", {"entities": []}], ["We further hypothesized that treatment with cyclosporine A, a Pgp1 inhibitor, would render cells more sensitive to treatment with corticosteroids.", {"entities": []}], ["Pgp1, granzyme B, IFN\u03b3 and TNF\u03b1 expression were measured in peripheral blood T, NK and NKT-like cells from COPD patients and control subjects (\u00b1 cyclosporine A and prednisolone) following in vitro stimulation and results correlated with uptake of efflux dye Calcein-AM using flow cytometry.", {"entities": []}], ["There was increased Pgp1 expression by peripheral blood T, NKT-like and NK cells co-expressing IFN\u03b3, TNF\u03b1 and granzyme B in COPD patients compared with controls (e.g.", {"entities": []}], ["%IFN\u03b3/Pgp1 T, NKT-like, NK for COPD (Control): 25(6), 54(27), 39(23)).", {"entities": []}], ["There was an inverse correlation between Pgp1 expression and Calcein-AM uptake.", {"entities": []}], ["Treatment with 2.5\u00a0ng/ml cylosporin A and10 Treatment strategies that target Pgp1 in T, NKT-like and NK cells may reduce systemic inflammatory mediators in COPD and improve patient morbidity.", {"entities": []}], ["Probiotic products that may modify the intestinal microbiota are becoming increasingly available and known to consumers due to their potential to prevent or treat many pediatric health conditions.", {"entities": []}], ["As scientific knowledge of the health benefits of probiotics increases, it is important to identify factors that may prevent their successful integration into patient care as well as to ensure effective translation of research findings.", {"entities": []}], ["The aim of this study was to describe maternal perspectives on probiotics and their use in infants.", {"entities": []}], ["Mothers with a child aged two years or younger enrolled in the Alberta Pregnancy Outcomes and Nutrition (APrON) study were invited by email to complete a 29 item self-administered web-based questionnaire.", {"entities": []}], ["A total of 413 mothers of the 1327 contacted completed the questionnaire.", {"entities": []}], ["The majority (99.3%) of respondents had heard of probiotics and were aware that they contained live bacteria (87.0%); 89.3% had used a product containing probiotics themselves but only 50.8% had given one to their infant.", {"entities": []}], ["Most mothers indicated they believed that probiotics were beneficial (73.1%) and none thought they were harmful.", {"entities": []}], ["Over a third of mothers did not feel informed enough to make a decision on whether probiotics were safe to use in infants (36.6%).", {"entities": []}], ["The study demonstrates that awareness and understanding of probiotics is high among mothers in Alberta, Canada.", {"entities": []}], ["However, there is still uncertainty regarding the benefit of probiotics as well as safety in infants which could be important factors determining therapeutic use in the future.", {"entities": []}], ["Further studies that demonstrate beneficial effects and safety of probiotics in healthy infants as well as targeted knowledge translation should help to address these potential concerns.", {"entities": []}], ["Since July 2015, Lebanon has been experiencing a waste management crisis.", {"entities": []}], ["Dumpsites in inhabited areas and waste burning have emerged due to the waste accumulation, further adding to the gravity of the situation.", {"entities": []}], ["However, the association between the crisis and health of the population has not been scientifically reported.", {"entities": []}], ["A comparative cross-sectional study was conducted to assess whether exposure to open dumpsites and waste burning is associated with acute health symptoms.", {"entities": []}], ["The study sample included 221 male workers between the ages of 18\u201360 years selected from two areas chosen based on their proximity to a garbage dumpsite and waste burning.", {"entities": []}], ["110 workers were exposed to a garbage dumpsite and waste burning, and 111 workers were not.", {"entities": []}], ["Data were collected via a face-to-face interview using a newly developed validated structured questionnaire.", {"entities": []}], ["Chi-square tests were used to check for statistically significant differences between exposure and covariates.", {"entities": []}], ["Multivariable analyses using multiple logistic regression were used to compare health symptoms between exposed and unexposed workers adjusting for potential confounders.", {"entities": []}], ["The prevalence of acute health symptoms was greater among the exposed workers than the non-exposed workers, including gastrointestinal, respiratory, dermatological and constitutional symptoms.", {"entities": []}], ["Controlling for confounding variables, such as age, insurance, family support, residence near dumpsite, work site, and smoking, a minimum odds ratio (OR) of 4.30 was obtained when comparing the exposed population to those non-exposed.", {"entities": []}], ["The strong association between improper waste management and physical health calls for immediate attention by the government, stakeholders and community members to find optimal solutions for this waste management crisis and set immediate priority interventions such as regular waste collection, volume reduction and recycling performance improvement.", {"entities": []}], ["However, the long recall period may have underestimated our results.", {"entities": []}], ["During the development of selective peptides against highly homologous targets, a reliable tool is sought that can predict information on both mechanisms of binding and relative af\ufb01nities.", {"entities": []}], ["These tools must \ufb01rst be tested on known pro\ufb01les before application on novel therapeutic candidates.", {"entities": []}], ["We therefore present a comparative docking protocol in HADDOCK using critical motifs, and use it to \u201cpredict\u201d the various selectivity pro\ufb01les of several major \u03b1KTX scorpion toxin families versus K v 1.1, K v 1.2 and K v 1.3.", {"entities": []}], ["By correlating results across toxins of similar pro\ufb01les, a comprehensive set of functional residues can be identi\ufb01ed.", {"entities": []}], ["Reasonable models of channel-toxin interactions can be then drawn that are consistent with known af\ufb01nity and mutagenesis.", {"entities": []}], ["Without biological information on the interaction, HADDOCK reproduces mechanisms underlying the universal binding of \u03b1KTX-2 toxins, and K v 1.3 selectivity of \u03b1KTX-3 toxins.", {"entities": []}], ["The addition of constraints encouraging the critical lysine insertion con\ufb01rms these \ufb01ndings, and gives analogous explanations for other families, including models of partial pore-block in \u03b1KTX-6.", {"entities": []}], ["While qualitatively informative, the HADDOCK scoring function is not yet suf\ufb01cient for accurate af\ufb01nity-ranking.", {"entities": []}], ["False minima in low-af\ufb01nity complexes often resemble true binding in high-af\ufb01nity complexes, despite steric/conformational penalties apparent from visual inspection.", {"entities": []}], ["This contamination signi\ufb01cantly complicates energetic analysis, although it is usually possible to obtain correct ranking via careful interpretation of binding-well characteristics and elimination of false positives.", {"entities": []}], ["Aside from adaptations to the broader potassium channel family, we suggest that this strategy of comparative docking can be extended to other channels of interest with known structure, especially in cases where a critical motif exists to improve docking effectiveness.", {"entities": []}], ["Despite the availability of effective therapies, asthma remains a source of significant morbidity and use of health care resources.", {"entities": [[49, 55, "DISEASE"]]}], ["The central research question of the ACCURATE trial is whether maximal doses of (combination) therapy should be used for long periods in an attempt to achieve complete control of all features of asthma.", {"entities": [[195, 201, "DISEASE"]]}], ["An additional question is whether patients and society value the potential incremental benefit, if any, sufficiently to concur with such a treatment approach.", {"entities": []}], ["We assessed patient preferences and cost-effectiveness of three treatment strategies aimed at achieving different levels of clinical control: 1. sufficiently controlled asthma 2. strictly controlled asthma 3. strictly controlled asthma based on exhaled nitric oxide as an additional disease marker 720 Patients with mild to moderate persistent asthma from general practices with a practice nurse, age 18-50 yr, daily treatment with inhaled corticosteroids (more then 3 months usage of inhaled corticosteroids in the previous year), will be identified via patient registries of general practices in the Leiden, Nijmegen, and Amsterdam areas in The Netherlands.", {"entities": [[169, 175, "DISEASE"], [199, 205, "DISEASE"], [229, 235, "DISEASE"], [344, 350, "DISEASE"]]}], ["The design is a 12-month cluster-randomised parallel trial with 40 general practices in each of the three arms.", {"entities": []}], ["The patients will visit the general practice at baseline, 3, 6, 9, and 12 months.", {"entities": []}], ["At each planned and unplanned visit to the general practice treatment will be adjusted with support of an internet-based asthma monitoring system supervised by a central coordinating specialist nurse.", {"entities": [[121, 127, "DISEASE"]]}], ["Patient preferences and utilities will be assessed by questionnaire and interview.", {"entities": []}], ["Data on asthma control, treatment step, adherence to treatment, utilities and costs will be obtained every 3 months and at each unplanned visit.", {"entities": [[8, 14, "DISEASE"]]}], ["Differences in societal costs (medication, other (health) care and productivity) will be compared to differences in the number of limited activity days and in quality adjusted life years (Dutch EQ5D, SF6D, e-TTO, VAS).", {"entities": []}], ["This is the first study to assess patient preferences and cost-effectiveness of asthma treatment strategies driven by different target levels of asthma control.", {"entities": [[80, 86, "DISEASE"], [145, 151, "DISEASE"]]}], ["Netherlands Trial Register (NTR): NTR1756", {"entities": []}], ["Secondhand tobacco smoke (SHS) is associated with increased risk of respiratory illness, cancer, and cardiovascular disease.", {"entities": [[89, 95, "DISEASE"]]}], ["Prior to smoking bans on airlines in the late 1980s, flight attendants were exposed to a significant amount of SHS.", {"entities": []}], ["In the present study, we examine associations between flight attendant SHS exposure and development of respiratory illnesses and cardiovascular disease.", {"entities": []}], ["Between December 2006 and October 2010, three hundred sixty-two flight attendants completed an online questionnaire with information regarding experience as a flight attendant, medical history, smoking history, and SHS exposure.", {"entities": []}], ["Rates of illnesses in flight attendants were compared with an age and smoking history matched population sample from NHANES 2005-2006.", {"entities": []}], ["Logistic regression analysis was used to examine the association of reported medical conditions and pre-ban years of exposure.", {"entities": []}], ["Compared with the sample from NHANES 2005-2006, flight attendants had increased prevalence of chronic bronchitis (11.7% vs. 7.2%, p < 0.05), emphysema/COPD (3.2% vs. 0.9%, p < 0.03), and sinus problems (31.5% vs. 20.9%, p < 0.002), despite a lower prevalence of medical illnesses including high blood pressure, diabetes, high cholesterol, heart failure, cancer, and thyroid disease.", {"entities": [[354, 360, "DISEASE"], [102, 112, "DISEASE"]]}], ["Amongst flight attendants who reported never smoking over their lifetimes, there was not a significant association between years of service as a flight attendant in the pre-smoking ban era and illnesses.", {"entities": []}], ["However, in this same group, there was a significantly increased risk of daily symptoms (vs. no symptoms) of nasal congestion, throat, or eye irritation per 10-year increase of years of service as a flight attendant prior to the smoking ban (OR 2.14, 95% CI 1.41 - 3.24).", {"entities": []}], ["Flight attendants experience increased rates of respiratory illnesses compared to a population sample.", {"entities": []}], ["The frequency of symptoms of nasal congestion, throat or eye irritation is associated with occupational SHS exposure in the pre-smoking ban era.", {"entities": []}], ["The aim of this study was to investigate changes in plasma fatty acids proportions and estimated desaturase activities for variable grading of liver steatosis in children.", {"entities": []}], ["In total, 111 schoolchildren (aged 8\u201318 years) were included in the analysis from March 2015 to August 2016.", {"entities": []}], ["Anthropometric evaluation, liver ultrasound examination and scoring for nonalcoholic fatty liver disease (NAFLD score = 0\u20136), and biochemical and plasma fatty acids analysis were performed.", {"entities": [[85, 104, "DISEASE"], [91, 104, "DISEASE"]]}], ["We compared the composition ratio of fatty acids between children with high-grade liver steatosis (NAFLD score = 4\u20136), low-grade liver steatosis (NAFLD score = 1\u20133), and healthy controls (NAFLD score = 0).", {"entities": []}], ["In addition, correlation coefficients (r) between NAFLD score, metabolic variables, and estimated activity of desaturase indices (stearoyl-coenzyme A desaturase-1 (SCD1), delta-5 and delta-6 desaturase) were calculated.", {"entities": []}], ["Compared with healthy controls, children with liver steatosis showed a higher proportion of monounsaturated fatty acids (21.16 \u00b1 2.81% vs. 19.68 \u00b1 2.71%, p = 0.024).", {"entities": []}], ["In addition, children with high- grade liver steatosis exhibited higher proportions of palmitic acid (C16:0), palmitoleic acid (C16:1n-7), dihomo-\u03b3-linolenic acid (C20:3n-6), adrenic acid (C22:4n-6), and docosapentaenoic acid (C22:5n-6); and lower proportions of eicosapentaenoic acid (C20:5n-3) ( P < 0.05).", {"entities": []}], ["In all subjects, the NAFLD score was positively correlated with body mass index (BMI) (kg/m (16) (r = 0.273), and the delta-6 index (r = 0.494); and inversely associated with the delta-5 index (r = -0.443).", {"entities": []}], ["Our current data suggested that children with liver steatosis was highly associated with obesity, and insulin resistance.", {"entities": [[89, 96, "DISEASE"]]}], ["In addition, increased endogenous lipogenesis through altered desaturase activity may contribute to the progression of liver steatosis in children.", {"entities": []}], ["Otitis media (OM) is a major cause of morbidity in pediatric and adult patients.", {"entities": [[0, 12, "DISEASE"]]}], ["This inflammatory condition is characterized by mucous cell hyperplasia that is thought to produce mucins from the middle ear mucosa.", {"entities": []}], ["We are interested in the role of Notch signalling pathway in this inflammatory process.", {"entities": []}], ["Using an acute otitis media (AOM) mouse model through injection of Streptococcus Pneumoniae into the middle ear, histopathologic examination and quantitative RT-PCR, acute inflammation with the thickness of mucosa, Goblet cell hyperplasia, and cilia loss were determined and gene expression related to the Notch signaling pathway were evaluated.", {"entities": [[15, 27, "DISEASE"]]}], ["Upregulation of the mucous cell markers, Argr2 and Muc5AC, and downregulation of the cilia cell marker, Foxj1 and Dnai2, were observed in AOM.", {"entities": [[104, 109, "GENE"], [114, 119, "GENE"]]}], ["In addition, genes encoding Notch receptors and ligands (Notch1, Notch2, Notch3, Notch4 and Dll1) and the Notch target genes (Hes1, Hes5, Hey1, NRARP) in AOM decreased significantly.", {"entities": [[57, 63, "GENE"], [65, 71, "GENE"], [73, 79, "GENE"], [81, 87, "GENE"], [92, 96, "GENE"], [126, 130, "GENE"], [132, 136, "GENE"], [138, 142, "GENE"], [144, 149, "GENE"]]}], ["The expression of the Notch1 and Jagged1 also showed down-regulation throughout the mouse middle ear epithelium.", {"entities": [[22, 28, "GENE"]]}], ["Taken together, this study suggests that downregulation of the Notch signaling pathway is involved in the mucosa hyperplasia during AOM.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) may be an autoimmune disease.", {"entities": []}], ["Smoking causes an imbalance of proteases and antiproteases in the lung resulting in the generation of elastin peptides that can potentially act as autoantigens.", {"entities": []}], ["Similar to COPD, Z alpha-1 antitrypsin deficiency (Z-A1ATD) and cystic fibrosis (CF) are associated with impaired pulmonary antiprotease defences leading to unopposed protease activity.", {"entities": [[64, 79, "DISEASE"]]}], ["Here, we show that there is a trend towards higher bronchoalveolar lavage fluid (BALF) antielastin antibody levels in COPD and Z-A1ATD and significantly lower levels in CF compared to control BALF; the lower levels in CF are due to the degradation of these antibodies by neutrophil elastase.", {"entities": []}], ["We also provide evidence that these autoantibodies have the potential to induce T cell proliferation in the emphysematous lung.", {"entities": []}], ["This study highlights that antielastin antibodies are tissue specific, can be detected at elevated levels in COPD and Z-A1ATD BALF despite their being no differences in their levels in plasma compared to controls, and suggests a therapeutic role for agents targeting these autoantibodies in the lungs.", {"entities": []}], ["Limited studies have prospectively examined the role of body mass index (BMI) as a major risk factor for asthma during adolescence.", {"entities": [[105, 111, "DISEASE"]]}], ["This study investigates whether BMI is associated with increased risk of developing physician-diagnosed asthma during 12-month follow-up among adolescents with undiagnosed asthma-like symptoms at baseline.", {"entities": [[104, 110, "DISEASE"], [172, 178, "DISEASE"]]}], ["A total of 4,052 adolescents with undiagnosed asthma-like symptoms at baseline were re-examined after a 12-month follow-up.", {"entities": [[46, 52, "DISEASE"]]}], ["Asthma cases were considered confirmed only after diagnosis by a physician based on the New England core and International Study of Asthma and Allergies in Childhood (ISAAC) criteria video questionnaires, and accompanying pulmonary function tests.", {"entities": [[0, 6, "DISEASE"], [132, 138, "DISEASE"]]}], ["Logistic regression analyses were used to evaluate the relationship of BMI and the risk of acquiring asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["The results indicated that girls with higher BMI were at an increased risk of developing asthma during the 12-month follow-up.", {"entities": [[89, 95, "DISEASE"]]}], ["The odds ratios for girls developing physician-diagnosed asthma were 1.75 (95% CI = 1.18-2.61) and 1.12 (95% CI = 0.76-1.67), respectively, for overweight and obesity as compared to the normal weight reference group after adjustment for other covariates.", {"entities": [[159, 166, "DISEASE"], [57, 63, "DISEASE"]]}], ["A similar relationship was not observed for overweight and obese boys who were also significantly more active than their female counterparts.", {"entities": []}], ["Increased BMI exaggerates the risk of acquiring asthma in symptomatic adolescent females but not in adolescent males.", {"entities": [[48, 54, "DISEASE"]]}], ["Thus, gender is an important modifier of BMI-related asthma risk.", {"entities": [[53, 59, "DISEASE"]]}], ["Additional research will be required to determine whether the increased asthma risk results from genetic, physiological or behavioural differences.", {"entities": [[72, 78, "DISEASE"]]}], ["Sleep disturbance is a common complaint in patients with chronic obstructive lung disease (COPD).", {"entities": [[65, 89, "DISEASE"], [77, 89, "DISEASE"]]}], ["However, the factors resulting in sleep disturbance remain unclear.", {"entities": []}], ["This retrospective, observational, multicenter study aimed to identify the factors associated with sleep disturbance in patients with COPD.", {"entities": []}], ["The study was a retrospective, observational, and multicenter research.", {"entities": []}], ["Data including age, sex, body mass index, smoking status, COPD inhaler prescribed, clinical symptoms, pulmonary function tests, medical history of comorbidities, and questionnaires were collected.", {"entities": []}], ["Parameters including demographics, symptoms, medication, severity, functional classification, and comorbidities were correlated with sleep quality scores.", {"entities": []}], ["Among 377 patients with COPD, 200 (53\u00a0%) patients experienced poor sleep quality (Pittsburg Sleep Quality Index scores\u2009>\u20095).", {"entities": []}], ["A significant difference in sleep quality, as measured by PSQI scores, was noted between groups based on the 2011 Global Initiatives for Chronic Obstructive Lung Disease (GOLD) classification system.", {"entities": [[145, 169, "DISEASE"], [157, 169, "DISEASE"]]}], ["The most common sleep disturbances included \u201cgetting up to use the bathroom\u201d (70.3\u00a0%), \u201cwake up at night or early morning\u201d (40.3\u00a0%), and \u201ccough and snore loudly at night\u201d (15.9\u00a0%).", {"entities": []}], ["The use of inhaled corticosteroids, the presence of wheezing, COPD Assessment Test (CAT) scores, and Modified Medical Research Council (mMRC) dyspnea scale scores positively correlated with poor sleep quality (odds ratio: 1.51, 1.66, 1.09, and 1.30, respectively).", {"entities": []}], ["Upon multivariate analysis, the CAT score was an independent factor for poor sleep quality in these patients.", {"entities": []}], ["With the exception of sleep problem items, based on the CAT questionnaire, phlegm was significantly higher in COPD patients with poor sleep quality.", {"entities": []}], ["Poor sleep quality is common among patients with COPD and symptoms including wheeze, phlegm, and inhaled corticosteroid use may contribute to poor sleep quality.", {"entities": []}], ["The CAT score is a good indicator of poor sleep quality in patients with COPD.", {"entities": []}], ["Five antioxidant and two oxidative stress assays were applied to serum samples of 43 healthy males.", {"entities": []}], ["The antioxidant tests showed different inter-assay correlations.", {"entities": []}], ["A very good correlation of 0.807 was observed between the ferric reducing ability of plasma (FRAP) and total antioxidant status (TAS) assay and also a fair correlation of 0.501 between the biological antioxidant potential (BAP) and TAS assay.", {"entities": []}], ["There was no statistically significant correlation between the BAP and FRAP assay.", {"entities": []}], ["The anti-oxidant assays have a high correlation with uric acid, especially the TAS (0.922) and FRAP assay (0.869).", {"entities": []}], ["The BAP assay has a much lower and no statistically significant correlation with uric acid (0.302), which makes BAP more suitable for the antioxidant status.", {"entities": []}], ["The total thiol assay showed no statistically significant correlation with uric acid (0.114).", {"entities": []}], ["The total thiol assay, which is based on a completely different principle, showed a good and statistically significant correlation with the BAP assay (0.510) and also to the TAS assay, but to a lower and not significant extent (0.279) and not with the FRAP assay (\u22120.008).", {"entities": []}], ["The oxy-adsorbent test (OXY) assay has no correlation with any of the other assays tested.", {"entities": []}], ["The oxidative stress assays, reactive oxygen metabolites (ROM) and total oxidant status (TOS), based on a different principle, do not show a statistically significant correlation with the serum samples in this study.", {"entities": []}], ["Both assays showed a negative, but not significant, correlation with the antioxidant assays.", {"entities": []}], ["In conclusion, the ROM, TOS, BAP and TTP assays are based on different principles and will have an additional value when a combination of these assays will be applied in large-scale population studies.", {"entities": []}], ["Non-smokers are exposed to tobacco smoke from the burning cigarette and the exhaled smoke from smokers.", {"entities": []}], ["In spite of decades of development of approaches to assess secondhand smoke exposure (SHSe), there are still unresolved methodological issues.", {"entities": []}], ["This manuscript summarises the scientific evidence on the use of SHSe reported measures and their methods, objectives, strengths and limitations; and discusses best practices for assessing behaviour leading to SHSe for lifetime and immediate or current SHSe.", {"entities": []}], ["Recommendations for advancing measurement science of SHSe are provided.", {"entities": []}], ["Behavioural measures of SHSe commonly rely on self-reports from children and adults.", {"entities": []}], ["Most commonly, the methodology includes self, proxy and interview-based reporting styles using retrospective recall or diary-style reporting formats.", {"entities": []}], ["The reporting method used will vary based upon the subject of interest, assessment objectives and cultural context.", {"entities": []}], ["Appropriately implemented, reported measures of SHSe provide an accurate, timely and cost-effective method for assessing exposure time, location and quantity in a wide variety of populations.", {"entities": []}], ["Group B Streptococcus (GBS) is a common commensal capable of causing severe invasive infections.", {"entities": []}], ["Most GBS infections occur in neonates (often as pneumonia).", {"entities": [[48, 57, "DISEASE"]]}], ["GBS can also cause infection in adults with diabetes and other immunological impairments but rarely leads to pneumonia in adults.", {"entities": [[109, 118, "DISEASE"]]}], ["GBS has occasionally been found in the sputum of Cystic Fibrosis (CF) patients, an inherited condition known for progressive lung disease.", {"entities": [[125, 137, "DISEASE"]]}], ["However, the epidemiology and clinical significance of GBS in CF are not understood.", {"entities": []}], ["We retrospectively reviewed a large single-centre adult CF population with an associated comprehensive, prospectively collected bacterial biobank beginning in 1978.", {"entities": []}], ["We identified all individuals with GBS isolated from their sputum on at least one occasion.", {"entities": []}], ["The primary outcome was risk of pulmonary exacerbation (PEx) at the time of the first GBS isolate compared to the preceding visit.", {"entities": []}], ["Secondary outcomes included determining: prevalence of GBS infection in a CF population, whether GBS infections where transient or persistent, whether GBS strains were shared among patients, change in % predicted FEV 1 at the time of GBS isolate compared to the preceding visit, PEx frequency after the first GBS isolate, change in % predicted FEV 1 after the first GBS isolate, and complications of GBS infection.", {"entities": [[213, 216, "GENE"], [344, 347, "GENE"], [213, 216, "GENE"], [344, 347, "GENE"]]}], ["GBS was uncommon, infecting 3.5% (11/318) adults within our cohort.", {"entities": []}], ["Only three individuals developed persistent GBS infection, all lasting > 12 months.", {"entities": []}], ["There were no shared GBS strains among patients.", {"entities": []}], ["PEx risk was not increased at initial GBS isolation (RR 5.0, CI 0.69\u201336.1, p=0.10).", {"entities": []}], ["In the two years preceding initial GBS isolation compared to the two following years, there was no difference in PEx frequency (median 2, range 0\u20134 vs 1, range 0 to 5, respectively, p=0.42) or lung function decline, as measured by % predicted FEV 1 , (median \u22121.0%, range \u221219 to 7% vs median \u22126.0%, range \u221218 to 22%, p=0.86).", {"entities": [[243, 246, "GENE"]]}], ["There were no invasive GBS infections.", {"entities": []}], ["In adults with CF, GBS is uncommon and is generally a transient colonizer of the lower airways.", {"entities": []}], ["Despite the presence of structural lung disease and impaired innate immunity in CF, incident GBS infection did not increase PEx risk, PEx frequency, rate of lung function decline, or other adverse clinical outcomes.", {"entities": [[35, 47, "DISEASE"]]}], ["The online version of this article (10.1186/s12879-017-2729-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Expression of plasminogen activator inhibitor ( PAI )\u20101, the major physiological inhibitor of fibrinolysis, is increased in the lung following inhalation of ozone (O 3 ), a gaseous air pollutant.", {"entities": []}], ["PAI \u20101 regulates expression of interleukin ( IL )\u20106, keratinocyte chemoattractant ( KC ), and macrophage inflammatory protein ( MIP )\u20102, which are cytokines that promote lung injury, pulmonary inflammation, and/or airway hyperresponsiveness following acute exposure to O 3 .", {"entities": [[128, 131, "GENE"]]}], ["Given these observations, we hypothesized that PAI \u20101 contributes to the severity of the aforementioned sequelae by regulating expression of IL \u20106, KC , and MIP \u20102 following acute exposure to O 3 .", {"entities": [[157, 160, "GENE"]]}], ["To test our hypothesis, wild\u2010type mice and mice genetically deficient in PAI \u20101 ( PAI \u20101\u2010deficient mice) were acutely exposed to either filtered room air or O 3 (2\u00a0ppm) for 3\u00a0h. Four and/or twenty\u2010four hours following cessation of exposure, indices of lung injury [bronchoalveolar lavage fluid ( BALF ) protein and epithelial cells], pulmonary inflammation ( BALF IL \u20106, KC , MIP \u20102, macrophages, and neutrophils), and airway responsiveness to aerosolized acetyl\u2010 \u03b2 \u2010methylcholine chloride (respiratory system resistance) were measured in wild\u2010type and PAI \u20101\u2010deficient mice.", {"entities": [[376, 379, "GENE"]]}], ["O 3 significantly increased indices of lung injury, pulmonary inflammation, and airway responsiveness in wild\u2010type and PAI \u20101\u2010deficient mice.", {"entities": []}], ["With the exception of MIP \u20102, which was significantly lower in PAI \u20101\u2010deficient as compared to wild\u2010type mice 24\u00a0h following cessation of exposure to O 3 , no other genotype\u2010related differences occurred subsequent to O 3 exposure.", {"entities": [[22, 25, "GENE"]]}], ["Thus, following acute exposure to O 3 , PAI \u20101 neither regulates pulmonary expression of IL \u20106 and KC nor functionally contributes to any of the pulmonary pathological sequelae that arise from the noxious effects of inhaled O 3 .", {"entities": []}], ["Climate justice is a local, national, and global movement to protect at-risk populations who are disproportionately affected by climate change.", {"entities": []}], ["The social context for this review is the Southeastern region of the United States, which is particularly susceptible to climate change because of the geography of the area and the vulnerabilities of the inhabiting populations.", {"entities": []}], ["Negative human health effects on variable and vulnerable populations within the Southeast region due to changing climate are concerning, as health threats are not expected to produce parallel effects among all individuals.", {"entities": []}], ["Vulnerable communities, such as communities of color, indigenous people, the geographically isolated, and those who are socioeconomically disadvantaged and already experiencing poor environmental quality, are least able to respond and adapt to climate change.", {"entities": []}], ["Focusing on vulnerable populations in the Southeastern United States, this review is a synthesis of the recent (2010 to 2015) literature-base on the health effects connected to climate change.", {"entities": []}], ["This review also addresses local and regional mitigation and adaptation strategies for citizens and leaders to combat direct and indirect human health effects related to a changing climate.", {"entities": []}], ["Growing evidence points toward a critical role for early (prenatal) atypical neurodevelopmental processes in the aetiology of autism spectrum condition (ASC).", {"entities": []}], ["One such process that could impact early neural development is inflammation.", {"entities": []}], ["We review the evidence for atypical expression of molecular markers in the amniotic fluid, serum, cerebrospinal fluid (CSF), and the brain parenchyma that suggest a role for inflammation in the emergence of ASC.", {"entities": []}], ["This is complemented with a number of neuroimaging and neuropathological studies describing microglial activation.", {"entities": []}], ["Implications for treatment are discussed.", {"entities": []}], ["People who live in cities with dirty air have blacker lungs than people who live in rural areas with less air pollution.", {"entities": []}], ["This is because, although particulates larger than 10 microm are filtered out when inhaled air passes through the nose, smaller particulates reach the lower airways.", {"entities": []}], ["The particulates that reach the alveoli (the terminal air pockets of the lungs) stay there permanently.", {"entities": []}], ["This accounts for the fact that a person who has lived in a polluted city for many years has blacker lungs than one who has lived in a polluted city for a shorter time.", {"entities": []}], ["Background: In animals, some phthalates impair male reproductive development and function.", {"entities": []}], ["Epidemiological studies have reported inconsistent evidence of associations between phthalates and markers of human testicular function.", {"entities": []}], ["Objectives: We aimed to provide estimates of the effects of phthalate exposure on reproductive hormone levels and semen quality in healthy men.", {"entities": []}], ["Methods: A total of 881 men gave urine, serum, and semen samples.", {"entities": []}], ["Serum levels of testosterone, estradiol (E 2 ), sex hormone-binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), and inhibin-B; semen quality; and urinary concentrations of 14 phthalate metabolites, including metabolites of di(2-ethylhexyl) phthalate (DEHP) and diisononyl phthalate (DiNP), were assessed.", {"entities": [[78, 82, "GENE"]]}], ["The proportions of DEHP and DiNP excreted as their respective primary metabolites [mono(2-ethylhexyl) phthalate (MEHP) and mono-isononyl phthalate (MiNP)] were calculated and expressed as percentages (%MEHP and %MiNP, respectively).", {"entities": []}], ["Results: The free androgen index was 15% lower [95% confidence interval (CI): \u201323, \u20138%] for men in the highest %MiNP quartile compared to the lowest quartile ( p < 0.001) after adjusting for confounders, and 9% lower (95% CI: \u201316, \u20131%) in the highest %MEHP quartile ( p = 0.02).", {"entities": []}], ["%MEHP and %MiNP were negatively associated with the ratio of testosterone/LH and testosterone/FSH.", {"entities": []}], ["%MEHP was negatively associated with total testosterone, free testosterone, and ratio of testosterone/E 2 .", {"entities": []}], ["%MiNP was positively associated with SHBG.", {"entities": [[37, 41, "GENE"]]}], ["There was little evidence of associations between urinary phthalate metabolites or sums of phthalates with reproductive hormones or semen quality Conclusion: Our data suggest that both testosterone production and pituitary\u2013hypothalamic feedback may be compromised in individuals excreting a high proportion of primary metabolites of long-chained phthalates relative to the proportion of secondary metabolites.", {"entities": []}], ["Phenotypic plasticity, i.e.", {"entities": []}], ["the capacity to change the phenotype in response to changes in the environment without alteration of the genotype, is important for coping with unstable environments.", {"entities": []}], ["In spite of the ample evidence that microorganisms are a major environmental component playing a significant role in eukaryotic organisms health and disease, there is not much information about the effect of microorganism-induced developmental phenotypic plasticity on adult animals\u2019 stress resistance and longevity.", {"entities": []}], ["We examined the consequences of development of Caenorhabditis elegans larvae fed with different bacterial strains on stress resistance and lifespan of adult nematodes.", {"entities": []}], ["Bacterial strains used in this study were either pathogenic or innocuous to nematodes.", {"entities": []}], ["Exposure to the pathogen during development did not affect larval survival.", {"entities": []}], ["However, the development of nematodes on the pathogenic bacterial strains increased lifespan of adult nematodes exposed to the same or a different pathogen.", {"entities": []}], ["A longer nematode lifespan, developed on pathogens and exposed to pathogens as adults, did not result from an enhanced capacity to kill bacteria, but is likely due to an increased tolerance to the damage inflicted by the pathogenic bacteria.", {"entities": []}], ["We observed that adult nematodes developed on a pathogen induce higher level of expression of the hsp-16.2 gene and have higher resistance to heat shock than nematodes developed on an innocuous strain.", {"entities": []}], ["Therefore, the increased resistance to pathogens could be, at least partially, due to the early induction of the heat shock response in nematodes developed on pathogens.", {"entities": []}], ["The lifespan increase is controlled by the DBL-1 transforming growth factor beta-like, DAF-2/DAF-16 insulin-like, and p38 MAP kinase pathways.", {"entities": []}], ["Therefore, the observed modulation of adult nematode lifespans by developmental exposure to a pathogen is likely a genetically controlled response.", {"entities": []}], ["Our study shows that development on pathogens has a hormetic effect on adult nematodes, as it results in increased resistance to different pathogens and to heat shock.", {"entities": []}], ["Such developmental plasticity of C. elegans nematodes, which are self-fertilizing homozygous animals producing offspring with negligible genetic variation, could increase the probability of survival in changing environments.", {"entities": []}], ["Main risk factor for the development of chronic obstructive pulmonary disease (COPD) is smoking, although only less than 1/3 of smokers develop clinically manifest COPD.", {"entities": [[40, 77, "DISEASE"]]}], ["COPD\u2019s progressive nature with high disability and mortality makes it plausible to detect it as early as possible thus allowing for an early intervention.", {"entities": []}], ["The only tool for an early diagnosis that could be used on the global scale is spirometry, even though symptoms and deprivation of health related quality of life (HRQoL) precede relevant spirometric changes.", {"entities": []}], ["Existing HRQoL questionnaires are too complicated or not developed for an early detection of COPD.", {"entities": []}], ["The aim of our study was to develop a new simple HRQoL tool that will allow (alone or in combination with other markers) early detection of patients with COPD.", {"entities": []}], ["A multicenter prospective cohort study recruiting 500 subjects at risk for COPD (smokers/ex-smokers \u226520 pack-years, 40\u201365 years, both sexes, with no prior diagnosis of COPD) will be carried out in two phases: (1) cross-sectional - development and validation of a new questionnaire; and (2) prospective - follow-up of a cohort of patients at risk for COPD.", {"entities": []}], ["Subjects were recruited by 25 GPs and assessed for COPD by dedicated pulmonologists in 7 hospital centers using a predefined protocol: HRQoL, history, physical, blood sampling, exhaled breath temperature (EBT), lung function, 6-min walk test (6MWT).", {"entities": []}], ["Patients without COPD and those in GOLD stage 1 at initial assessment will be reassessed for disease progression by the same pulmonologist after 2 and 5\u00a0years.", {"entities": []}], ["This is one of the first cohort studies attempting to establish the incidence of COPD in the pre-symptomatic stage before significant end organ damage.", {"entities": []}], ["We intend to assess the validity, predictability and discriminative power (\u2018healthy\u2019 smokers vs. pre-symptomatic phase in newly developed COPD) of newly developed HRQoL tool alone or in combination with other markers; EBT, lung function, 6MWT, genomics, transcriptomics, proteomics).", {"entities": []}], ["We expect that the results of this study can improve our understanding of the development of COPD, identify some new underlying pathophysiological pathways, and offer to sensitive smokers/ex-smokers new preventive and early intervention measures thus improving the management of COPD.", {"entities": []}], ["Clinicaltrial.gov NCT01550679 retrospectively registered February 28, 2012.", {"entities": []}], ["There is evidence of higher prevalence of asthma in populations of lower socio-economic status in affluent societies, and the prevalence of asthma is also very high in some Latin American countries, where societies are characterized by a marked inequality in wealth.", {"entities": [[42, 48, "DISEASE"], [140, 146, "DISEASE"]]}], ["This study aimed to examine the relationship between estimates of asthma prevalence based on surveys conducted in children in Brazilian cities and health and socioeconomic indicators measured at the population level in the same cities.", {"entities": [[66, 72, "DISEASE"]]}], ["We searched the literature in the medical databases and in the annals of scientific meeting, retrieving population-based surveys of asthma that were conducted in Brazil using the methodology defined by the International Study of Asthma and Allergies in Childhood.", {"entities": [[132, 138, "DISEASE"], [229, 235, "DISEASE"]]}], ["We performed separate analyses for the age groups 6\u20137 years and 13\u201314 years.", {"entities": []}], ["We examined the association between asthma prevalence rates and eleven health and socio-economic indicators by visual inspection and using linear regression models weighed by the inverse of the variance of each survey.", {"entities": [[36, 42, "DISEASE"]]}], ["Six health and socioeconomic variables showed a clear pattern of association with asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["The prevalence of asthma increased with poorer sanitation and with higher infant mortality at birth and at survey year, GINI index and external mortality.", {"entities": [[18, 24, "DISEASE"]]}], ["In contrast, asthma prevalence decreased with higher illiteracy rates.", {"entities": [[13, 19, "DISEASE"]]}], ["The prevalence of asthma in urban areas of Brazil, a middle income country, appears to be higher in cities with more marked poverty or inequality.", {"entities": [[18, 24, "DISEASE"]]}], ["Back pain is one of the most common complaints that patients report to physicians and two-thirds of the population has an elevated body mass index (BMI), indicating they are either overweight or obese.", {"entities": []}], ["It was once assumed that extra body weight would stress the low back and lead to pain, however, researchers have reported inconsistencies association between body weight and back pain.", {"entities": []}], ["In contrast, more recent studies do indicate that an elevated BMI is associated with back pain and other musculoskeletal pain syndromes due to the presence of a chronic systemic inflammatory state, suggesting that the relationship between BMI and musculoskeletal pains be considered in more detail.", {"entities": []}], ["To describe how an elevated BMI can be associated with chronic systemic inflammation and pain expression.", {"entities": []}], ["To outline measurable risk factors for chronic inflammation that can be used in clinical practice and discuss basic treatment considerations.", {"entities": []}], ["Adiposopathy, or \u201csick fat\u201d syndrome, is a term that refers to an elevated BMI that is associated with a chronic systemic inflammatory state most commonly referred to as the metabolic syndrome.", {"entities": [[28, 36, "DISEASE"], [184, 192, "DISEASE"]]}], ["The best available evidence suggests that the presence of adiposopathy determines if an elevated BMI will contribute to musculoskeletal pain expression.", {"entities": []}], ["It is not uncommon for physicians to fail to identify the presence of adiposopathy/metabolic syndrome.", {"entities": [[93, 101, "DISEASE"]]}], ["Patients with an elevated BMI should be further examined to identify inflammatory factors associated with adiposopathy, such as the metabolic syndrome, which may be promoting back pain and other musculoskeletal pain syndromes.", {"entities": [[142, 150, "DISEASE"]]}], ["To study metabolic/inflammatory biomarker risk profiles in women with PCOS and PCOS offspring.", {"entities": []}], ["Cross-sectional comparison of serum biomarkers.", {"entities": []}], ["University Medical Center Utrecht.", {"entities": []}], ["Hyperandrogenic PCOS women (HA-PCOS, n = 34), normoandrogenic PCOS women (NA-PCOS, n = 34), non-PCOS reference population (n = 32), PCOS offspring (n = 14, age 6\u20138 years), and a paedriatic reference population (n = 30).", {"entities": []}], ["Clustering profile of adipocytokines ( IL-1b, IL-6, IL-13, IL-17, IL-18, TNF-\u03b1, adiponectin, adipsin, leptin, chemerin, resistin, RBP4, DPP-IV/sCD26, CCL2/MCP-1), growth factors ( PIGF, VEGF, sVEGF-R1), soluble cell adhesion molecules ( sICAM-1/sCD54, sVCAM-1/sCD106), and other inflammatory related proteases (MMP-9, S100A8, Cathepsin S).", {"entities": [[130, 134, "GENE"], [180, 184, "GENE"], [318, 324, "GENE"]]}], ["Differences in median biomarker concentrations between groups, and associations with the free androgen index (FAI; Testosterone/SHBG x100).", {"entities": []}], ["The cluster analysis identified leptin, RBP-4, DPP-IV and adiponectin as potential discriminative markers for HA-PCOS with a specifically strong correlation in cases with increased BMI.", {"entities": []}], ["Leptin (R In this preliminary investigation we observed significant differences in adipocytokines between women with or without hyperandrogenic PCOS and non-PCOS controls, mostly influenced by BMI.", {"entities": []}], ["Leptin and adiponectin showed the strongest correlation with the FAI in adult women with PCOS.", {"entities": []}], ["In PCOS offspring other inflammatory biomarkers (MMP-9, S100A8) were increased, suggesting that these children may exhibit increased chronic low-grade inflammation.", {"entities": [[56, 62, "GENE"]]}], ["Additional research is required to confirm results of the current exploratory investigation.", {"entities": []}], ["Asthma has a high burden of morbidity if not controlled and may frequently complicate pregnancy, posing a risk for pregnancy outcomes.", {"entities": [[0, 6, "DISEASE"]]}], ["Elevated plasma level of the inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is related to a worse prognosis in many conditions such as infectious, autoimmune, or pregnancy-related diseases; however the value of suPAR in asthma and asthmatic pregnancy is unknown.", {"entities": [[253, 259, "DISEASE"]]}], ["The present study aimed to investigate the suPAR, CRP and IL-6 levels in asthma (asthmatic non-pregnant, ANP; N\u200a=\u200a38; female N\u200a=\u200a27) and asthmatic pregnancy (AP; N\u200a=\u200a15), compared to healthy non-pregnant controls (HNP; N\u200a=\u200a29; female N\u200a=\u200a19) and to healthy pregnant women (HP; N\u200a=\u200a58).", {"entities": [[73, 79, "DISEASE"], [50, 53, "GENE"], [273, 275, "GENE"]]}], ["The relationship between suPAR levels and asthma control was also evaluated.", {"entities": [[42, 48, "DISEASE"]]}], ["The diagnostic efficacy of suPAR in asthma control was analyzed using ROC analysis.", {"entities": [[36, 42, "DISEASE"]]}], ["IL-6 and CRP levels were comparable in all study groups.", {"entities": [[9, 12, "GENE"]]}], ["Circulating suPAR levels were lower in HP and AP than in HNP and ANP subjects, respectively (2.01 [1.81\u20132.38] and 2.39 [2.07\u20132.69] vs. 2.60 [1.82\u20133.49] and 2.84 [2.33\u20133.72] ng/mL, respectively, p\u200a=\u200a0.0001).", {"entities": [[39, 41, "GENE"]]}], ["suPAR and airway resistance correlated in ANP (r\u200a=\u200a0.47, p\u200a=\u200a0.004).", {"entities": []}], ["ROC analysis of suPAR values in ANP patients with PEF above and below 80% yielded an AUC of 0.75 (95% CI: 0.57\u20130.92, p\u200a=\u200a0.023) and with ACT total score above and below 20 an AUC of 0.80 (95% CI: 0.64\u20130.95, p\u200a=\u200a0.006).", {"entities": []}], ["The cut-off value of suPAR to discriminate between controlled and not controlled AP and ANP was 4.04 ng/mL.", {"entities": []}], ["In conclusion, suPAR may help the objective assessment of asthma control, since it correlates with airway resistance and has good sensitivity in the detection of impaired asthma control.", {"entities": [[58, 64, "DISEASE"], [171, 177, "DISEASE"]]}], ["Decrease in circulating suPAR levels detected both in healthy and asthmatic pregnant women presumably represents pregnancy induced immune tolerance.", {"entities": []}], ["Eosinophils (EOs) participate in a variety of inflammatory states characterized by endothelial cell damage, such as vasculitis, pneumonitis, and endocarditis.", {"entities": [[145, 157, "DISEASE"], [116, 126, "DISEASE"]]}], ["We find that 100 U/ml TNF- alpha/cachectin (TNF), a concentration attainable in the blood of humans with parasitic infestations, stimulates highly purified populations of EOs to damage human umbilical vein endothelial cells (HUVEC), a model of human endothelium.", {"entities": [[22, 25, "GENE"], [44, 47, "GENE"]]}], ["This TNF-dependent EO cytotoxicity is strongly inhibited by heparin and methyprednisolone but unaffected by the platelet-activating factor antagonist BN52012 or scavengers of superoxide anion and H2O2, superoxide dismutase and catalase.", {"entities": []}], ["However, addition of a physiologically relevant concentration of Br- (100 microM) enhances EO/TNF damage to HUVEC, implicating the possible participation of EO peroxidase (EPO) in the killing mechanism.", {"entities": [[172, 175, "GENE"]]}], ["EOs adherent to FCS-coated plastic wells more than double their production of superoxide anion and the cytotoxic EPO-derived oxidant HOBr when exposed to TNF, showing that TNF activates the respiratory burst of EOs attached to a \"physiologic\" surface.", {"entities": [[154, 157, "GENE"], [172, 175, "GENE"], [154, 157, "GENE"], [172, 175, "GENE"]]}], ["Unlike PMNs, EOs were not irreversibly activated to kill unopsonized endothelium by previous exposure to TNF, and did not degranulate or upregulate CR3 expression as detected by Mo1 in the presence of 100 U/ml TNF.", {"entities": [[105, 108, "GENE"], [210, 213, "GENE"], [105, 108, "GENE"], [210, 213, "GENE"]]}], ["HUVEC exposed 18 h to TNF were considerably more susceptible to lysis by PMA-activated EOs and reagent H2O2, demonstrating a direct effect of TNF upon endothelium, perhaps through inhibition of antioxidant defenses.", {"entities": [[22, 25, "GENE"], [142, 145, "GENE"], [22, 25, "GENE"], [142, 145, "GENE"]]}], ["These findings suggest that abnormally elevated serum levels of TNF may provoke EOs to damage endothelial cells and thereby play a role in the pathogenesis of tissue damage in hypereosinophilic states.", {"entities": [[64, 67, "GENE"]]}], ["Rabbits immunized intravenously with living culture or nucleoproteins of non-hemolytic streptococci react to subsequent intracutaneous inoculations with homologous streptococci with smaller and harder lesions than are shown by normal animals similarly inoculated; and they do not develop the general manifestations of hypersensitiveness such as are shown by animals previously inoculated into the tissues with the same cultures.", {"entities": []}], ["A rabbit may react to intracutaneous inoculation with non-hemolytic streptococci in one of four ways, depending on whether it is normal, hypersensitive, immune or cachectic.", {"entities": []}], ["Most normal animals show a secondary reaction about 10 days after inoculation with suitable strains of non-hemolytic streptococci; hypersensitive, allergic, or hyperergic animals show much larger lesions than do normals with the corresponding doses of the same streptococci, and practically never show secondary reactions; immune animals show smaller and harder early lesions and usually do not have secondary reactions if they are fairly well immunized.", {"entities": []}], ["Cachectic animals show very soft and rapidly fading primary reactions and no secondary reactions.", {"entities": []}], ["Early detection of and intervention in childhood adversity has powerful potential to improve the health and well-being of children.", {"entities": []}], ["A systematic review was conducted to better understand the pediatric health outcomes associated with childhood adversity.", {"entities": []}], ["PubMed, PsycArticles, and CINAHL were searched for relevant articles.", {"entities": []}], ["Longitudinal studies examining various adverse childhood experiences and biological health outcomes occurring prior to age 20 were selected.", {"entities": []}], ["Mental and behavioral health outcomes were excluded, as were physical health outcomes that were a direct result of adversity (i.e.", {"entities": []}], ["abusive head trauma).", {"entities": []}], ["Data were extracted and risk of bias was assessed by 2 independent reviewers.", {"entities": []}], ["After identifying 15940 records, 35 studies were included in this review.", {"entities": []}], ["Selected studies indicated that exposure to childhood adversity was associated with delays in cognitive development, asthma, infection, somatic complaints, and sleep disruption.", {"entities": [[117, 123, "DISEASE"]]}], ["Studies on household dysfunction reported an effect on weight during early childhood, and studies on maltreatment reported an effect on weight during adolescence.", {"entities": []}], ["Maternal mental health issues were associated with elevated cortisol levels, and maltreatment was associated with blunted cortisol levels in childhood.", {"entities": []}], ["Furthermore, exposure to childhood adversity was associated with alterations of immune and inflammatory response and stress-related accelerated telomere erosion.", {"entities": []}], ["Childhood adversity affects brain development and multiple body systems, and the physiologic manifestations can be detectable in childhood.", {"entities": []}], ["A history of childhood adversity should be considered in the differential diagnosis of developmental delay, asthma, recurrent infections requiring hospitalization, somatic complaints, and sleep disruption.", {"entities": [[108, 114, "DISEASE"]]}], ["The variability in children\u2019s response to adversity suggests complex underlying mechanisms and poses a challenge in the development of uniform diagnostic guidelines.", {"entities": []}], ["More large longitudinal studies are needed to better understand how adversity, its timing and severity, and the presence of individual genetic, epigenetic, and protective factors affects children\u2019s health and development.", {"entities": []}], ["Lung function measures are heritable, predict mortality and are relevant in diagnosis of chronic obstructive pulmonary disease (COPD).", {"entities": [[89, 126, "DISEASE"]]}], ["COPD and asthma are diseases of the airways with major public health impacts and each have a heritable component.", {"entities": [[9, 15, "DISEASE"]]}], ["Genome-wide association studies of SNPs have revealed novel genetic associations with both diseases but only account for a small proportion of the heritability.", {"entities": []}], ["Complex copy number variation may account for some of the missing heritability.", {"entities": []}], ["A well-characterised genomic region of complex copy number variation contains beta-defensin genes ( DEFB103 , DEFB104 and DEFB4 ), which have a role in the innate immune response.", {"entities": []}], ["Previous studies have implicated these and related genes as being associated with asthma or COPD.", {"entities": [[82, 88, "DISEASE"]]}], ["We hypothesised that copy number variation of these genes may play a role in lung function in the general population and in COPD and asthma risk.", {"entities": [[133, 139, "DISEASE"]]}], ["We undertook copy number typing of this locus in 1149 adult and 689 children using a paralogue ratio test and investigated association with COPD, asthma and lung function.", {"entities": [[146, 152, "DISEASE"]]}], ["Replication of findings was assessed in a larger independent sample of COPD cases and smoking controls.", {"entities": []}], ["We found evidence for an association of beta-defensin copy number with COPD in the adult cohort (OR\u200a=\u200a1.4, 95%CI:1.02\u20131.92, P\u200a=\u200a0.039) but this finding, and findings from a previous study, were not replicated in a larger follow-up sample(OR\u200a=\u200a0.89, 95%CI:0.72\u20131.07, P\u200a=\u200a0.217).", {"entities": []}], ["No robust evidence of association with asthma in children was observed.", {"entities": [[39, 45, "DISEASE"]]}], ["We found no evidence for association between beta-defensin copy number and lung function in the general populations.", {"entities": []}], ["Our findings suggest that previous reports of association of beta-defensin copy number with COPD should be viewed with caution.", {"entities": []}], ["Suboptimal measurement of copy number can lead to spurious associations.", {"entities": []}], ["Further beta-defensin copy number measurement in larger sample sizes of COPD cases and children with asthma are needed.", {"entities": [[101, 107, "DISEASE"]]}], ["The vaccinia virus (VACV) N1 protein is an intracellular virulence factor that has a Bcl-2-like structure and inhibits both apoptosis and signalling from the interleukin 1 receptor, leading to nuclear factor kappa B activation.", {"entities": [[4, 12, "DISEASE"]]}], ["Here, we investigated the immune response to intranasal infection with a virus lacking the N1L gene (v\u0394N1L) compared with control viruses expressing N1L .", {"entities": []}], ["Data presented show that deletion of N1L did not affect the proportion of CD4", {"entities": [[74, 77, "GENE"]]}], ["Background: Biological pathway-based chemical testing approaches are central to the National Research Council\u2019s vision for 21st century toxicity testing.", {"entities": []}], ["Approaches such as high-throughput in vitro screening offer the potential to evaluate thousands of chemicals faster and cheaper than ever before and to reduce testing on laboratory animals.", {"entities": []}], ["Collaborative scientific engagement is important in addressing scientific issues arising in new federal chemical testing programs and for achieving stakeholder support of their use.", {"entities": []}], ["Objectives: We present two recommendations specifically focused on increasing scientific engagement in the U.S. Environmental Protection Agency (EPA) ToxCast\u2122 initiative.", {"entities": []}], ["Through these recommendations we seek to bolster the scientific foundation of federal chemical testing efforts such as ToxCast\u2122 and the public health decisions that rely upon them.", {"entities": []}], ["Discussion: Environmental Defense Fund works across disciplines and with diverse groups to improve the science underlying environmental health decisions.", {"entities": []}], ["We propose that the U.S. EPA can strengthen the scientific foundation of its new chemical testing efforts and increase support for them in the scientific research community by a ) expanding and diversifying scientific input into the development and application of new chemical testing methods through collaborative workshops, and b ) seeking out mutually beneficial research partnerships.", {"entities": []}], ["Conclusions: Our recommendations provide concrete actions for the U.S. EPA to increase and diversify engagement with the scientific research community in its ToxCast\u2122 initiative.", {"entities": []}], ["We believe that such engagement will help ensure that new chemical testing data are scientifically robust and that the U.S. EPA gains the support and acceptance needed to sustain new testing efforts to protect public health.", {"entities": []}], ["Citation: McPartland J, Dantzker HC, Portier CJ.", {"entities": []}], ["Building a robust 21st century chemical testing program at the U.S. Environmental Protection Agency: recommendations for strengthening scientific engagement.", {"entities": []}], ["Environ Health Perspect 123:1\u20135;\u2002 http://dx.doi.org/10.1289/ehp.1408601", {"entities": []}], ["Although thrombocytopenia is common in typhoid fever, its course, response to treatment, and need for specific therapies such as platelet transfusion are not well characterized.", {"entities": [[9, 25, "DISEASE"], [39, 52, "DISEASE"]]}], ["We report a case of typhoid fever in a 4-year-old Asian male returned traveler, admitted with prolonged fever and found to have severe thrombocytopenia (platelets 16 \u00d7 10 There is no consensus in the medical literature guiding the optimal management of severe thrombocytopenia in typhoid fever, but it may improve with conservative management, as in our case.", {"entities": [[135, 151, "DISEASE"], [260, 276, "DISEASE"], [20, 33, "DISEASE"], [280, 293, "DISEASE"]]}], ["The epidemiology and management of this condition merits further research to guide clinical practice.", {"entities": []}], ["Fever and neutropenia (FN) is a common complication of pediatric cancer treatment, but hospital utilization patterns for this condition are not well described.", {"entities": [[10, 21, "DISEASE"], [65, 71, "DISEASE"]]}], ["Data were analyzed from the Kids\u2019 Inpatient Database (KID), an all-payer US hospital database, for 2009.", {"entities": []}], ["Pediatric FN patients were identified using: age \u226419\u00a0years, urgent or emergent admit type, non-transferred, and a combination of ICD-9-CM codes for fever and neutropenia.", {"entities": [[158, 169, "DISEASE"]]}], ["Sampling weights were used to permit national inferences.", {"entities": []}], ["Pediatric cancer patients accounted for 1.5 % of pediatric hospital discharges in 2009 (n\u2009=\u2009110,967), with 10.1 % of cancer-related discharges meeting FN criteria (n\u2009=\u200911,261).", {"entities": [[10, 16, "DISEASE"], [117, 123, "DISEASE"]]}], ["Two-fifths of FN discharges had a \u201cshort length of stay\u201d (SLOS) of \u22643\u00a0days, which accounted for approximately $65.5 million in hospital charges.", {"entities": []}], ["Upper respiratory infection (6.0 %) and acute otitis media (AOM) (3.7 %) were the most common infections associated with SLOS.", {"entities": [[46, 58, "DISEASE"]]}], ["Factors significantly associated with SLOS included living in the Midwest region (OR\u2009=\u20091.65, 1.22\u20132.24) or West region (OR 1.54, 1.11\u20132.14) versus Northeast, having a diagnosis of AOM (OR\u2009=\u20091.39, 1.03\u20131.87) or viral infection (OR\u2009=\u20091.63, 1.18\u20132.25) versus those without those comorbidities, and having a soft tissue sarcoma (OR\u2009=\u20091.47, 1.05\u20132.04), Hodgkin lymphoma (OR\u2009=\u20092.33, 1.62\u20133.35), or an ovarian/testicular tumor (OR\u2009=\u20091.76, 1.05\u20132.95) compared with patients without these diagnoses.", {"entities": [[316, 323, "DISEASE"], [356, 364, "DISEASE"]]}], ["FN represents a common precipitant for hospitalizations among pediatric cancer patients.", {"entities": [[72, 78, "DISEASE"]]}], ["SLOS admissions are rarely associated with serious infections, but contribute substantially to the burden of hospitalization for pediatric FN.", {"entities": []}], ["Previous research has observed large inequalities in the distribution of welfare benefits.", {"entities": []}], ["The Norwegian welfare state includes several schemes that give households with children the opportunity to apply for public income support to compensate for expenses related to chronic disease.", {"entities": []}], ["The aims of this study were to examine the geographic distribution of children receiving compensatory cash benefits because of a chronic asthma condition and to determine whether social or geographic factors account for area variations in uptake independent of the associations with need.", {"entities": [[137, 143, "DISEASE"]]}], ["Considerable variation between counties was evident, with rates of benefit uptake ranging from 10.5 recipients per 1,000 children younger than nine years in the highest-ranking county, to 1.5 per 1,000 in the lowest.", {"entities": []}], ["It is argued that the observed area-level inequalities reflect more than variations in morbidity.", {"entities": []}], ["In particular, the chance of receiving benefits reflects variations in the ability of street-level bureaucrats to inform families about their rights.", {"entities": []}], ["Spatial variations also reflect, in part, the fact that families with different socio-economic standing inhabit different locations and that the threshold for receiving benefits is systematically lower for families with an academic background.", {"entities": []}], ["To be able to refine the implementation of a welfare policy, a better understanding of the processes that generate the outcomes of the various welfare schemes and services is required.", {"entities": []}], ["This can be achieved by adopting an approach to the study of outcomes of welfare policy that integrates both the social and geographic perspective, and that focuses on specific diagnoses or distributional procedures.", {"entities": []}], ["Objective To review the beneficial and harmful effects of laughter.", {"entities": []}], ["Design Narrative synthesis.", {"entities": []}], ["Data sources and review methods We searched Medline (1946 to June 2013) and Embase (1974 to June 2013) for reports of benefits or harms from laughter in humans, and counted the number of papers in each category.", {"entities": []}], ["Results Benefits of laughter include reduced anger, anxiety, depression, and stress; reduced tension (psychological and cardiovascular); increased pain threshold; reduced risk of myocardial infarction (presumably requiring hearty laughter); improved lung function; increased energy expenditure; and reduced blood glucose concentration.", {"entities": [[179, 200, "DISEASE"]]}], ["However, laughter is no joke\u2014dangers include syncope, cardiac and oesophageal rupture, and protrusion of abdominal hernias (from side splitting laughter or laughing fit to burst), asthma attacks, interlobular emphysema, cataplexy, headaches, jaw dislocation, and stress incontinence (from laughing like a drain).", {"entities": [[180, 186, "DISEASE"]]}], ["Infectious laughter can disseminate real infection, which is potentially preventable by laughing up your sleeve.", {"entities": []}], ["As a side effect of our search for side effects, we also list pathological causes of laughter, among them epilepsy (gelastic seizures), cerebral tumours, Angelman\u2019s syndrome, strokes, multiple sclerosis, and amyotrophic lateral sclerosis or motor neuron disease.", {"entities": [[208, 237, "DISEASE"], [241, 261, "DISEASE"], [184, 202, "DISEASE"], [165, 173, "DISEASE"], [220, 237, "DISEASE"]]}], ["Conclusions Laughter is not purely beneficial.", {"entities": []}], ["The harms it can cause are immediate and dose related, the risks being highest for Homeric (uncontrollable) laughter.", {"entities": []}], ["The benefit-harm balance is probably favourable.", {"entities": []}], ["It remains to be seen whether sick jokes make you ill or jokes in bad taste cause dysgeusia, and whether our views on comedians stand up to further scrutiny.", {"entities": []}], ["The inequality in health outcomes between Indigenous (Throughout the paper, the term Indigenous will be used to represent both Aboriginal Australians and Torres Strait Islander Australians.)", {"entities": []}], ["and non-Indigenous Australians continues to be a major public health issue.", {"entities": []}], ["Chronic conditions are responsible for the majority of the gap in life expectancy for this population.", {"entities": []}], ["Evidence suggests that chronic condition management models focusing on self-management have led to improved health outcomes in Indigenous populations.", {"entities": []}], ["The Flinders Closing the Gap Program (FCTGP) is a chronic condition care planning tool which aims to engage Indigenous people in self-managing their chronic conditions.", {"entities": []}], ["Indigenous health workers (IHWs) can provide culturally appropriate self-management support; however there is paucity in current literature describing specific barriers and facilitators that they may experience when attempting to deliver this support.", {"entities": []}], ["This study aimed to explore IHWs\u2019 perceptions of the effectiveness and appropriateness of the FCTGP, as an evidence-based example of self-management support, and to explore the barriers and facilitators that IHWs experience in their workplace and communities in providing self-management support.", {"entities": []}], ["In-depth interviews were undertaken with five IHWs, drawn from five different states in Australia.", {"entities": []}], ["Their selection was aided by key informants from the FCTGP training unit.", {"entities": []}], ["Interviews were recorded and transcribed verbatim, and were analysed using thematic analysis.", {"entities": []}], ["The following themes were identified.", {"entities": []}], ["IHWs reported that the FCTGP was appropriate, flexible and acceptable in their communities.", {"entities": []}], ["Facilitators included factors improving client and worker empowerment, and activities around sharing knowledge.", {"entities": []}], ["Barriers included competing priorities that clients experience relating to social determinants of health, and negative experiences within mainstream health services.", {"entities": []}], ["IHW burnout from time pressures, lack of support, and high staff turnover were also considered important barriers.", {"entities": []}], ["This study contributes an insight into the experiences of IHWs who are considered important stakeholders in implementation and sustainability of chronic condition management programs, including the FCTGP.", {"entities": []}], ["Recommendations focus on supporting and supplementing the role of IHWs and identify the FCTGP as a facilitator in providing self-management support to a population with complex needs.", {"entities": []}], ["Self-management interventions improve different outcome variables in various chronic diseases.", {"entities": []}], ["Their role in COPD has not been clearly established.", {"entities": []}], ["We assessed the efficacy of an intervention called the self-management program on the need for hospital care due to disease exacerbation in patients with advanced COPD.", {"entities": []}], ["Multicenter, randomized study in two hospitals with follow-up of 1 year.", {"entities": []}], ["All the patients had severe or very severe COPD, and had gone to either an accident and emergency (A&E) department or had been admitted to a hospital at least once in the previous year due to exacerbation of COPD.", {"entities": []}], ["The intervention consisted of a group education session on the main characteristics of the disease, an individual training session on inhalation techniques, at the start and during the 3rd month, and a written action plan containing instructions for physical activity and treatment for stable phases and exacerbations.", {"entities": []}], ["We determined the combined number of COPD-related hospitalizations and emergency visits per patient per year.", {"entities": []}], ["Secondary endpoints were number of patients with visits to A&E and the number of patients hospitalized because of exacerbations, use of antibiotics and corticosteroids, length of hospital stay, and all-cause mortality.", {"entities": []}], ["After 1 year, the rate of COPD exacerbations with visits to A&E or hospitalization had decreased from 1.37 to 0.89 ( P =0.04) and the number of exacerbations dropped from 52 to 42 in the group of patients who received the intervention.", {"entities": []}], ["The numbers of patients hospitalized, at 19 (40.4%) versus 20 (52.6%) ( P =0.26), and those who went to A&E, at 9 (19.1%) versus 14 (36.8%) ( P =0.06), due to exacerbation of COPD were also lower in this group.", {"entities": []}], ["Intake of antibiotics was higher in the intervention group, whereas use of glucocorticoids was slightly lower, though there were no significant differences ( P =0.30).", {"entities": []}], ["There were also no differences between groups in the length of hospital stay ( P =0.154) or overall mortality ( P =0.191).", {"entities": []}], ["The implementation of a self-management program for patients with advanced COPD reduced exacerbations that required hospital care.", {"entities": []}], ["RNA-sequencing (RNA-seq) is an essential technique for transcriptome studies, hundreds of analysis tools have been developed since it was debuted.", {"entities": []}], ["Although recent efforts have attempted to assess the latest available tools, they have not evaluated the analysis workflows comprehensively to unleash the power within RNA-seq.", {"entities": []}], ["Here we conduct an extensive study analysing a broad spectrum of RNA-seq workflows.", {"entities": []}], ["Surpassing the expression analysis scope, our work also includes assessment of RNA variant-calling, RNA editing and RNA fusion detection techniques.", {"entities": []}], ["Specifically, we examine both short- and long-read RNA-seq technologies, 39 analysis tools resulting in ~120 combinations, and ~490 analyses involving 15 samples with a variety of germline, cancer and stem cell data sets.", {"entities": [[190, 196, "DISEASE"]]}], ["We report the performance and propose a comprehensive RNA-seq analysis protocol, named RNACocktail, along with a computational pipeline achieving high accuracy.", {"entities": []}], ["Validation on different samples reveals that our proposed protocol could help researchers extract more biologically relevant predictions by broad analysis of the transcriptome.", {"entities": []}], ["RNA-seq is widely used for transcriptome analysis.", {"entities": []}], ["Here, the authors analyse a wide spectrum of RNA-seq workflows and present a comprehensive analysis protocol named RNACocktail as well as a computational pipeline leveraging the widely used tools for accurate RNA-seq analysis.", {"entities": []}], ["Small airway fibrosis is the main contributor to physiological airway dysfunction in COPD.", {"entities": []}], ["One potential mechanism contributing to small airway fibrosis is epithelial mesenchymal transition (EMT).", {"entities": []}], ["When associated with angiogenesis (so called EMT-Type-3) it may well also be the link with the development of cancer, which is closely associated with COPD and predominantly in large airways.", {"entities": [[110, 116, "DISEASE"]]}], ["In a recent study published in Respiratory Research, Qin Wang and colleagues investigated the role of urokinase plasminogen activator receptor (uPAR) in EMT in small airway epithelium of COPD patients.", {"entities": []}], ["However, there are some issues with the paper which we wish to comment on.", {"entities": []}], ["Background .", {"entities": []}], ["Elastase mediates important oxidative actions during the development of chronic obstructive pulmonary disease (COPD).", {"entities": [[72, 109, "DISEASE"]]}], ["However, few resources for the inhibition of elastase have been investigated.", {"entities": []}], ["Our study evaluated the ability of the recombinant plant derived Bauhinia bauhinioides Kallikrein proteinase Inhibitor (rBbKI) to modulate elastase-induced pulmonary inflammation.", {"entities": []}], ["C57Bl/6 mice were given intratracheal elastase (ELA group) or saline (SAL group) and were treated intraperitoneally with rBbKI (ELA-rBbKI and SAL-rBbKI groups).", {"entities": []}], ["At day 28, the following analyses were performed: (I) lung mechanics, (II) exhaled nitric oxide (ENO), (III) bronchoalveolar lavage fluid (BALF), and (IV) lung immunohistochemical staining.", {"entities": []}], ["In addition to decreasing mechanical alterations and alveolar septum disruption, rBbKI reduced the number of cells in the BALF and decreased the cellular expression of TNF- \u03b1 , MMP-9, MMP-12, TIMP-1, eNOS, and iNOS in airways and alveolar walls compared with the ELA group.", {"entities": []}], ["rBbKI decreased the volume proportion of 8-iso-PGF2 \u03b1 , collagen, and elastic fibers in the airways and alveolar walls compared with the ELA group.", {"entities": []}], ["A reduction in the number of MUC-5-positive cells in the airway walls was also observed.", {"entities": []}], ["Conclusion .", {"entities": []}], ["rBbKI reduced elastase-induced pulmonary inflammation and extracellular matrix remodeling.", {"entities": []}], ["rBbKI may be a potential pharmacological tool for COPD treatment.", {"entities": []}], ["The Diabetes Manual is a type 2 diabetes self-management programme based upon the clinically effective 'Heart Manual'.", {"entities": []}], ["The 12 week programme is a complex intervention theoretically underpinned by self-efficacy theory.", {"entities": []}], ["It is a one to one intervention meeting United Kingdom requirements for structured diabetes-education and is delivered within routine primary care.", {"entities": []}], ["In a two-group cluster randomized controlled trial, GP practices are allocated by computer minimisation to an intervention group or a six-month deferred intervention group.", {"entities": []}], ["We aim to recruit 250 participants from 50 practices across central England.", {"entities": []}], ["Eligibility criteria are adults able to undertake the programme with type 2 diabetes, not taking insulin, with HbA1c over 8% (first 12 months) and following an agreed protocol change over 7% (months 13 to 18).", {"entities": []}], ["Following randomisation, intervention nurses receive two-day training and delivered the Diabetes Manual programme to participants.", {"entities": []}], ["Deferred intervention nurses receive the training following six-month follow-up.", {"entities": []}], ["Primary outcome is HbA1c with total and HDL cholesterol; blood pressure, body mass index; self-efficacy and quality of life as additional outcomes.", {"entities": []}], ["Primary analysis is between-group HbA1c differences at 6 months powered to give 80% power to detect a difference in HbA1c of 0.6%.", {"entities": []}], ["A 12 month cohort analysis will assess maintenance of effect and assess relationship between self-efficacy and outcomes, and a qualitative study is running alongside.", {"entities": []}], ["This trial incorporates educational and psychological diabetes interventions into a single programme and assesses both clinical and psychosocial outcomes.", {"entities": []}], ["The trial will increase our understanding of intervention transferability between conditions, those diabetes related health behaviours that are more or less susceptible to change through efficacy enhancing mechanisms and how this impacts on clinical outcomes.", {"entities": []}], ["Phosphoinositides bind to a selective site in the proximal C-terminal region to regulate TRPV1.", {"entities": [[89, 94, "GENE"]]}], ["Although PI(4,5)P 2 is believed to play an essential role in regulating the activity of numerous ion channels and transporters, the mechanisms by which it does so are unknown.", {"entities": []}], ["Here, we used the ability of the TRPV1 ion channel to discriminate between PI(4,5)P 2 and PI(4)P to localize the region of TRPV1 sequence that interacts directly with the phosphoinositide.", {"entities": [[33, 38, "GENE"], [123, 128, "GENE"], [33, 38, "GENE"], [123, 128, "GENE"]]}], ["We identified a point mutation in the proximal C-terminal region after the TRP box, R721A, that inverted the selectivity of TRPV1.", {"entities": [[124, 129, "GENE"]]}], ["Although the R721A mutation produced only a 30% increase in the EC 50 for activation by PI(4,5)P 2 , it decreased the EC 50 for activation by PI(4)P by more than two orders of magnitude.", {"entities": []}], ["We used chemically induced and voltage-activated phosphatases to determine that PI(4)P continued to support TRPV1 activity even after depletion of PI(4,5)P 2 from the plasma membrane.", {"entities": [[108, 113, "GENE"]]}], ["Our data cannot be explained by a purely electrostatic mechanism for interaction between the phosphoinositide and the protein, similar to that of the MARCKS (myristoylated alanine-rich C kinase substrate) effector domain or the EGF receptor.", {"entities": [[150, 156, "GENE"], [228, 231, "GENE"]]}], ["Rather, conversion of a PI(4,5)P 2 -selective channel to a PI(4)P-selective channel indicates that a structured phosphoinositide-binding site mediates the regulation of TRPV1 activity and that the amino acid at position 721 likely interacts directly with the moiety at the 5\u2032 position of the phosphoinositide.", {"entities": [[169, 174, "GENE"]]}], ["Tests of pulmonary mechanical function may be used in determining the prominent site of pulmonary reaction to intervention.", {"entities": []}], ["Responses may be localized from a knowledge of changes in lung resistance and compliance.", {"entities": []}], ["A peripheral airway or parenchymal response is characterized by a decrease in lung compliance.", {"entities": []}], ["A central airway reaction is characterized by an increase in pulmonary resistance.", {"entities": []}], ["In mixed reactions both parameters may change.", {"entities": []}], ["In this communication some of the physiologic determinants of pulmonary resistance and compliance are discussed and examples of localized responses given.", {"entities": []}], ["Medication errors are an important source of potentially preventable morbidity and mortality.", {"entities": []}], ["The PINCER study, a cluster randomised controlled trial, is one of the world\u2019s first experimental studies aiming to reduce the risk of such medication related potential for harm in general practice.", {"entities": []}], ["Bayesian analyses can improve the clinical interpretability of trial findings.", {"entities": []}], ["Experts were asked to complete a questionnaire to elicit opinions of the likely effectiveness of the intervention for the key outcomes of interest - three important primary care medication errors.", {"entities": []}], ["These were averaged to generate collective prior distributions, which were then combined with trial data to generate Bayesian posterior distributions.", {"entities": []}], ["The trial data were analysed in two ways: firstly replicating the trial reported cohort analysis acknowledging pairing of observations, but excluding non-paired observations; and secondly as cross-sectional data, with no exclusions, but without acknowledgement of the pairing.", {"entities": []}], ["Frequentist and Bayesian analyses were compared.", {"entities": []}], ["Bayesian evaluations suggest that the intervention is able to reduce the likelihood of one of the medication errors by about 50 (estimated to be between 20% and 70%).", {"entities": []}], ["However, for the other two main outcomes considered, the evidence that the intervention is able to reduce the likelihood of prescription errors is less conclusive.", {"entities": []}], ["Clinicians are interested in what trial results mean to them, as opposed to what trial results suggest for future experiments.", {"entities": []}], ["This analysis suggests that the PINCER intervention is strongly effective in reducing the likelihood of one of the important errors; not necessarily effective in reducing the other errors.", {"entities": []}], ["Depending on the clinical importance of the respective errors, careful consideration should be given before implementation, and refinement targeted at the other errors may be something to consider.", {"entities": []}], ["Helicobacter pylori (H. pylori), a pathogen inducing peptic disease, is recently found to be binding to the progress of periodontitis.", {"entities": [[120, 133, "DISEASE"]]}], ["Most previous studies are case-controlled, and they investigate the risk of H. pylori infection in disease the development of while few studies evaluate the correlation between H. pylori and periodontal pathogens.", {"entities": []}], ["Therefore, we investigated the correlation between H. pylori infection with periodontal parameters, periodontal pathogens and inflammation.", {"entities": []}], ["The results indicated that patients with H. pylori showed significantly higher probing depth and attachment loss than those without ( p < 0.05).", {"entities": []}], ["Among 28 subgingival plaque samples from 14 patients, the frequencies of Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium nucleatum and Treponema denticola were significantly higher with H. pylori infection than those without H. pylori infection ( p < 0.05).", {"entities": []}], ["However, the frequency of Aggregatibacter actinomycetemcomitans was lower ( p < 0.05).", {"entities": []}], ["Furthermore, after human acute monocytic leukemia cell line (THP-1) was stimulated with cagA -positive standard strains ( cagA 26695), the expression of periodontitis-related molecules Wnt5a, interleukin 8 (IL-8), interleukin 6 (IL-6) and interferon gamma (IFN-\u03b3) significantly increased ( p < 0.05).", {"entities": [[25, 49, "DISEASE"], [153, 166, "DISEASE"], [41, 49, "DISEASE"], [31, 49, "DISEASE"], [185, 190, "GENE"]]}], ["Conversely, the expression of tumor necrosis factor alpha (TNF-\u03b1) was almost stable.", {"entities": []}], ["Meanwhile, cagA promoted significantly higher expression of IL-8 and Wnt5a than isogenic cagA mutants strains ( cagA 26695) did.", {"entities": [[69, 74, "GENE"]]}], ["Taken together, our data suggested that H. pylori might promote the growth of some periodontal pathogens and aggravate the progress of chronic periodontitis.", {"entities": [[143, 156, "DISEASE"]]}], ["Traditional knowledge about the use of medicinal plants for herbal drinks (HDs) is not well documented in the Azad Kashmir region despite their widespread use.", {"entities": []}], ["This study highlights the taxonomic diversity and traditional knowledge on medicinal plants used for HDs while examining the diversity of diseases treated with HDs in the study area.", {"entities": []}], ["Individual discussions were conducted with 255 informants (84 women and 171 men).", {"entities": []}], ["Data gathered included (i) informant age and gender, (ii) HD species and respective plant parts used, (iii) health disorders treated, and (iv) mode of preparation and utilizations.", {"entities": []}], ["Quantitative ethnobotanical indices including relative frequency of citation (RFC), informant consensus factor (ICF), and use value (UV) were used for data analyses.", {"entities": []}], ["Altogether, 73 medicinal plants belonging to 40 families and 66 genera were reported to be used in HD preparations, with Asteraceae being the richest family.", {"entities": []}], ["The average number of HD species cited was 9.09\u2009\u00b1\u20090.17 per informant and did not vary either by age or gender.", {"entities": []}], ["In addition, men and women, and adults and the young used the same pool of species (dissimilarity nearly zero).", {"entities": []}], ["The most used plant parts were leaves (20.00%), roots (17.25%), and fruits (16.47%).", {"entities": []}], ["Based on UV, the top five most used species were Valeriana jatamansi , Isodon rugosus , Onopordum acanthium , Acacia nilotica , and Viola canescens ; and the UV was similar among gender and age categories too.", {"entities": []}], ["The most utilized herbal preparation forms included decoctions, infusions, and tea.", {"entities": []}], ["One hundred and eleven diseases grouped into 13 ailment categories were reported to be cured using HDs.", {"entities": []}], ["The main category of disease treated with HDs was gastrointestinal (GIT) disorders (RFC\u2009=\u200917.43%).", {"entities": []}], ["Relatively few species were used by a large proportion of informants for each category of ailment (ICF\u2009\u2265\u20090.60).", {"entities": []}], ["Only one species was used for \u201cglandular disorders\u201d and \u201ceye diseases\u201d (ICF\u2009=\u20091).", {"entities": []}], ["A novelty of about 22% (16 species) was recorded for HD species in the present work.", {"entities": []}], ["The diversity of medicinal plant species used as HDs and the associated traditional knowledge are of considerable value to the indigenous communities of the Azad Kashmir region.", {"entities": []}], ["Therefore, there is a need for conservation and preservation of medicinal HD species as well as the wealth of indigenous knowledge.", {"entities": []}], ["The conservation effort should be high for species in the ailments categories glandular disorders and eye diseases.", {"entities": []}], ["The therapeutic uses of HDs have provided basic data for further research focused on phytochemical and pharmacological studies and conservation of the most important species.", {"entities": []}], ["Questionnaires can be used to assess perceived indoor air quality and symptoms in schools.", {"entities": []}], ["Questionnaires for primary school aged children have traditionally been parent-administered, but self-administered questionnaires would be easier to administer and may yield as good, if not better, information.", {"entities": []}], ["Our aim was to compare the repeatability of self- and parent-administered indoor air questionnaires designed for primary school aged pupils.", {"entities": []}], ["Indoor air questionnaire with questions on child\u2019s symptoms and perceived indoor air quality in schools was sent to parents of pupils aged 7\u201312\u00a0years in two schools and again after two weeks.", {"entities": []}], ["Slightly modified version of the questionnaire was administered to pupils aged 9\u201312\u00a0years in another two schools and repeated after a week.", {"entities": []}], ["351 (52%) parents and 319 pupils (86%) answered both the first and the second questionnaire.", {"entities": []}], ["Test-retest repeatability was assessed with intra-class correlation (ICC) and Cohen\u2019s kappa coefficients (k).", {"entities": []}], ["Test-retest repeatability was generally between 0.4\u20130.7 (ICC; k) in both self- and parent-administered questionnaire.", {"entities": []}], ["In majority of the questions on symptoms and perceived indoor air quality test-retest repeatability was at the same level or slightly better in self-administered compared to parent-administered questionnaire.", {"entities": []}], ["Agreement of self- and parent administered questionnaires was generally <\u20090.4 (ICC; k) in reported symptoms and 0.4\u20130.6 (ICC; k) in perceived indoor air quality.", {"entities": []}], ["Children aged 9\u201312\u00a0years can give as, or even more, repeatable information about their respiratory symptoms and perceived indoor air quality than their parents.", {"entities": []}], ["Therefore, it may be possible to use self-administered questionnaires in future studies also with children.", {"entities": []}], ["The online version of this article (10.1186/s12890-018-0584-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["BATF plays important roles in the function of the immune system.", {"entities": [[0, 4, "GENE"]]}], ["Batf null mice are deficient in both CD4 Batf null mice to investigate how altering levels of BATF expression in T cells impacts the development and function of a recently characterized population of iNKT cells expressing IL-17 (iNKT-17).", {"entities": [[0, 4, "GENE"], [41, 45, "GENE"], [94, 98, "GENE"], [37, 40, "GENE"], [0, 4, "GENE"], [41, 45, "GENE"], [94, 98, "GENE"], [0, 4, "GENE"], [41, 45, "GENE"], [94, 98, "GENE"]]}], ["BATF has a direct impact on IL-17 expression by iNKT cells.", {"entities": [[0, 4, "GENE"]]}], ["However, in contrast to the Th17 lineage where BATF activates IL-17 expression and leads to the expansion of the lineage, BATF overexpression restricts overall iNKT cell numbers while skewing the compartment in vivo and in vitro toward an iNKT-17 phenotype.", {"entities": [[47, 51, "GENE"], [122, 126, "GENE"], [47, 51, "GENE"], [122, 126, "GENE"]]}], ["This work is the first to demonstrate that BATF joins ROR\u03b3t as the molecular signature for all IL-17 producing cells in vivo and identifies BATF as a component of the nuclear protein network that could be targeted to regulate IL-17-mediated disease.", {"entities": [[43, 47, "GENE"], [140, 144, "GENE"], [43, 47, "GENE"], [140, 144, "GENE"]]}], ["Interestingly, these studies also reveal that while the Il17a gene is a common target for BATF regulation in Th17 and iNKT-17 cells, this regulation is accompanied by opposite effects on the growth and expansion of these two cell lineages.", {"entities": [[56, 61, "GENE"], [90, 94, "GENE"]]}], ["Controlling thrombin-driven microglial activation may serve as a therapeutic target for intracerebral hemorrhage (ICH).", {"entities": []}], ["Here, we investigated microRNA (miRNA)-based regulation of thrombin-driven microglial activation using an in vitro thrombin toxicity model applied to primary human microglia.", {"entities": []}], ["A miRNA array identified 22 differential miRNA candidates.", {"entities": []}], ["Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) identified miR-181c as the most significantly downregulated miRNA.", {"entities": [[92, 100, "GENE"]]}], ["TargetScan analysis identified mixed lineage leukemia-1 (MLL1) as a putative gene target for miR-181c.", {"entities": [[45, 53, "DISEASE"], [93, 101, "GENE"]]}], ["qRT-PCR was applied to assess tumor necrosis factor-alpha (TNF-\u03b1), miR-181c, and MLL1 levels following thrombin or proteinase-activated receptor-4-specific activating peptide (PAR4AP) exposure.", {"entities": [[67, 75, "GENE"]]}], ["Anti-TNF-\u03b1 antibodies and tumor necrosis factor receptor (TNFR) silencing were employed to test TNF-\u03b1/TNFR dependence.", {"entities": []}], ["A dual-luciferase reporter system and miR-181c mimic transfection assessed whether mir-181c directly binds to and negatively regulates MLL1.", {"entities": [[38, 46, "GENE"], [83, 91, "GENE"], [38, 46, "GENE"], [83, 91, "GENE"]]}], ["Nuclear factor kappa-B (NF-\u03baB)-dependent luciferase reporter assays and NF-\u03baB target gene expression were assessed in wild-type (MLL1+) and MLL1-silenced cells.", {"entities": []}], ["Thrombin or PAR4AP-induced miR-181c downregulation ( p \u2009<\u20090.05) and MLL1 upregulation ( p \u2009<\u20090.05) that were dependent upon TNF-\u03b1/TNFR.", {"entities": [[27, 35, "GENE"]]}], ["miR-181c decreased wild-type MLL1 3\u2032-UTR luciferase reporter activity ( p \u2009<\u20090.05), and a miR-181c mimic suppressed MLL1 expression ( p \u2009<\u20090.05).", {"entities": [[0, 8, "GENE"], [90, 98, "GENE"], [0, 8, "GENE"], [90, 98, "GENE"]]}], ["Thrombin treatment increased, while miR-181c reduced, NF-\u03baB activity and NF-\u03baB target gene expression in both wild-type (MLL1+) and MLL1-silenced cells ( p \u2009<\u20090.05).", {"entities": [[36, 44, "GENE"]]}], ["Thrombin-induced, TNF-\u03b1/TNFR-dependent miR-181c downregulation promotes MLL1 expression, increases NF-\u03baB activity, and upregulates NF-\u03baB target gene expression.", {"entities": [[39, 47, "GENE"]]}], ["As miR-181c opposes thrombin\u2019s stimulation of pro-inflammatory NF-\u03baB activity, miR-181c mimic therapy may show promise in controlling thrombin-driven microglial activation following ICH.", {"entities": [[3, 11, "GENE"], [79, 87, "GENE"], [3, 11, "GENE"], [79, 87, "GENE"]]}], ["The online version of this article (doi:10.1186/s12974-017-0887-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Please cite this paper as: Toovey S et\u00a0al.", {"entities": []}], ["(2011) Parkinson\u2019s disease or Parkinson symptoms following seasonal influenza.", {"entities": [[68, 77, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 5(5), 328\u2013333.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Influenza may cause neurological sequelae and has been associated with encephalitis lethargica, an entity displaying Parkinson\u2019s disease (PD) signs and symptoms that followed the 1918 influenza pandemic.", {"entities": [[12, 21, "DISEASE"], [196, 205, "DISEASE"], [83, 95, "DISEASE"]]}], ["We studied the association between diagnosed influenza and idiopathic PD or Parkinson symptoms (PS) not followed by a firm PD diagnosis.", {"entities": [[45, 54, "DISEASE"]]}], ["Methods\u2002 We used the UK\u2010based General Practice Research Database to perform a case\u2013control analysis.", {"entities": []}], ["We identified cases who developed an incident diagnosis of PD or PS between 1994 and March 2007, and we matched four controls on age, gender, general practice, calendar time, and history in the database to each case.", {"entities": []}], ["We calculated odds ratios (OR) with 95% confidence intervals (CI) using conditional logistic regression to assess the relative risk of developing PD or PS in association with previous influenza diagnoses.", {"entities": [[184, 193, "DISEASE"]]}], ["Results\u2002 We identified 3976 PD cases and 18\u2003336 PS cases.", {"entities": []}], ["The risk of developing PD was not associated with previous influenza infections.", {"entities": [[59, 68, "DISEASE"]]}], ["However, PS was associated with recent influenza (last infection 0\u201329\u2003days: OR 3\u00b703, 95% CI 1\u00b794\u20134\u00b774; 30\u2013364\u2003days: OR 1\u00b736, 95% CI 1\u00b714\u20131\u00b763), number of influenza episodes (1 attack: OR 1\u00b720, 95% CI 1\u00b712\u20131\u00b728; 2 attacks: OR 1\u00b752, 95% CI 1\u00b728\u20131\u00b781; \u22653 attacks: OR 2\u00b700, 95% CI 1\u00b745\u20132\u00b775), and severity of preceding influenza infections (\u22651 severe attack: OR 1\u00b745, 95% CI 1\u00b725\u20131\u00b768).", {"entities": [[39, 48, "DISEASE"], [154, 163, "DISEASE"], [315, 324, "DISEASE"]]}], ["Conclusions\u2002 Influenza is associated with PD\u2010like symptoms such as tremor, particularly in the month after an infection, but not with an increased risk of developing idiopathic PD.", {"entities": [[13, 22, "DISEASE"]]}], ["TP53 gene mutations can lead to the expression of a dysfunctional protein that in turn may enable genetically unstable cells to survive and change into malignant cells.", {"entities": [[0, 4, "GENE"]]}], ["Mutant p53 accumulates early in cells and can precociously induce circulating anti-p53 antibodies (p53Abs); in fact, p53 overexpression has been observed in pre-neoplastic lesions, such as bronchial dysplasia, and p53Abs have been found in patients with Chronic Obstructive Pulmonary Disease, before the diagnosis of lung and other tobacco-related tumors.", {"entities": []}], ["A large prospective study was carried out, enrolling non-smokers, ex-smokers and smokers with or without the impairment of lung function, to analyze the incidence of serum p53Abs and the correlation with clinicopathologic features, in particular smoking habits and impairment of lung function, in order to investigate their possible role as early markers of the onset of lung cancer or other cancers.", {"entities": [[371, 382, "DISEASE"], [376, 382, "DISEASE"]]}], ["The p53Ab levels were evaluated by a specific ELISA in 675 subjects.", {"entities": []}], ["Data showed that significant levels of serum p53Abs were present in 35 subjects (5.2%); no difference was observed in the presence of p53Abs with regard to age and gender, while p53Abs correlated with the number of cigarettes smoked per day and packs-year.", {"entities": []}], ["Furthermore, serum p53Abs were associated with the worst lung function impairment.", {"entities": []}], ["The median p53Ab level in positive subjects was 3.5 units/ml (range 1.2 to 65.3 units/ml).", {"entities": []}], ["Only fifteen positive subjects participated in the follow-up, again resulting positive for serum p53Abs, and no evidence of cancer was found in these patients.", {"entities": [[124, 130, "DISEASE"]]}], ["The presence of serum p53Abs was found to be associated with smoking level and lung function impairment, both risk factors of cancer development.", {"entities": [[126, 132, "DISEASE"]]}], ["However, in our study we have not observed the occurrence of lung cancer or other cancers in the follow-up of positive subjects, therefore we cannot directly correlate the presence of serum p53Abs with cancer risk.", {"entities": [[61, 72, "DISEASE"], [66, 72, "DISEASE"], [202, 208, "DISEASE"]]}], ["A previously healthy man working as a machine operator in an automotive factory developed respiratory symptoms.", {"entities": []}], ["Medical evaluation showed abnormal pulmonary function tests, a lung biopsy showed hypersensitivity pneumonitis, and his illness was traced to his work environment.", {"entities": []}], ["His physician asked the employer to remove him from exposure to metalworking fluids.", {"entities": []}], ["Symptoms reoccurred when he was later reexposed to metalworking fluids, and further permanent decrement in his lung function occurred.", {"entities": []}], ["Investigation of his workplace showed that five of six large reservoirs of metalworking fluids (cutting oils) grew Mycobacterium chelonae (or Mycobacterium immunogenum ), an organism previously associated with outbreaks of hypersensitivity pneumonitis in automaking factories.", {"entities": []}], ["His lung function remained stable after complete removal from exposure.", {"entities": []}], ["The employer, metalworking fluid supplier, union, and the National Institute for Occupational Safety and Health were notified of this sentinel health event.", {"entities": []}], ["No further cases have been documented in this workplace.", {"entities": []}], ["The objectives of this study were to estimate the impact of recruitment source and outcome definition on the incidence of acute exacerbations of COPD (AECOPD) and explore possible predictors of AECOPD.", {"entities": []}], ["During a 1-year follow-up, we performed a baseline visit and four telephone interviews of 81 COPD patients and 132 controls recruited from a population-based survey and 205 hospital-recruited COPD patients.", {"entities": []}], ["Both a definition based on health care utilization and a symptom-based definition of AECOPD were applied.", {"entities": []}], ["For multivariate analyses, we chose a negative binomial regression model.", {"entities": []}], ["COPD patients from the population- and hospital-based samples experienced on average 0.4 utilization-defined and 2.9 symptom-defined versus 1.0 and 5.9 annual exacerbations, respectively.", {"entities": []}], ["The incidence rate ratios for utilization-defined AECOPD were 2.45 (95% CI 1.22\u20134.95), 3.43 (95% CI 1.59\u20137.38), and 5.67 (95% CI 2.58\u201312.48) with Global Initiative on Obstructive Lung Disease spirometric stages II, III, and IV, respectively.", {"entities": []}], ["The corresponding incidence rate ratios for the symptom-based definition were 3.08 (95% CI 1.96\u20134.84), 3.45 (95% CI 1.92\u20136.18), and 4.00 (95% CI 2.09\u20137.66).", {"entities": []}], ["Maintenance therapy (regular long-acting muscarinic antagonists, long-acting beta-2 agonists, inhaled corticosteroids, or theophylline) also increased the risk of AECOPD with both exacerbation definitions (incidence rate ratios 1.65 and 1.73, respectively).", {"entities": []}], ["The risk of AECOPD was 59%\u201378% higher in the hospital sample than in the population sample.", {"entities": []}], ["If externally valid conclusions are to be made regarding incidence and predictors of AECOPD, studies should be based on general population samples or adjustments should be made on account of a likely higher incidence in other samples.", {"entities": []}], ["Likewise, the effect of different AECOPD definitions should be taken into consideration.", {"entities": []}], ["A constellation of related genetic diseases are caused by defects in the telomere maintenance machinery.", {"entities": []}], ["These disorders, often referred to as telomeropathies, share symptoms and molecular mechanisms, and mounting evidence indicates they are points along a spectrum of disease.", {"entities": []}], ["Several new causes of these disorders have been recently discovered, and a number of related syndromes may be unrecognized telomeropathies.", {"entities": []}], ["Progress in the clinical understanding of telomeropathies has in turn driven progress in the basic science of telomere biology.", {"entities": []}], ["In addition, the pattern of genetic anticipation in some telomeropathies generates thought-provoking questions about the way telomere length impacts the course of these diseases.", {"entities": []}], ["The purpose of this study was to test the hypothesis that particulate matter < or = 10 microns in aerodynamic diameter (PM10) particles have the ability to generate free radical activity at their surface.", {"entities": []}], ["We collected PM10 filters from the Edinburgh, United Kingdom, Enhanced Urban Network sampling site, removed particles from the filter, and tested their ability to cause free radical damage to supercoiled plasmid DNA.", {"entities": []}], ["We found that the PM10 particles did cause damage to the DNA that was mediated by hydroxyl radicals, as shown by inhibition of the injury with mannitol.", {"entities": []}], ["The PM10-associated hydroxyl radical activity was confirmed using a high-performance liquid chromatography-based assay to measure the hydroxyl radical adduct of salicylic acid.", {"entities": []}], ["Desferrioxamine abolished the hydroxyl radical-mediated injury, which suggests that iron was involved.", {"entities": []}], ["Analysis of PM10 filters confirmed the presence of large amounts of iron and leaching studies confirmed that the PM10 samples could release substantial amounts of Fe(III) and lesser amounts of Fe(II).", {"entities": []}], ["To investigate the size of the particles involved in the hydroxyl radical injury, we centrifuged the suspension of PM10 to clarity, tested the clear supernatant, and found that it had all of the suspension activity.", {"entities": []}], ["We conclude, therefore, that the free radical activity is derived either from a fraction that is not centrifugeable on a bench centrifuge, or that the radical generating system is released into solution.", {"entities": []}], ["Inflammatory myopathy is a rare autoimmune muscle disorder.", {"entities": [[13, 21, "DISEASE"]]}], ["Treatment typically focuses on skeletal muscle weakness or inflammation within muscle, as well as complications of respiratory failure secondary to respiratory muscle weakness.", {"entities": [[115, 134, "DISEASE"]]}], ["Impaired respiratory muscle function contributes to increased dyspnea and reduced exercise capacity in pulmonary hypertension (PH), a debilitating condition that has few treatment options.", {"entities": [[113, 125, "DISEASE"], [103, 125, "DISEASE"]]}], ["The initiation and progression of PH is associated with inflammation and inflammatory cell recruitment and it is established that hypoxia-induced mitogenic factor (HIMF, also known as resistin-like molecule \u03b1), activates macrophages in PH.", {"entities": []}], ["However, the relationship between HIMF and inflammatory myoblasts remains unclear.", {"entities": []}], ["This study investigated the signaling pathway involved in interleukin-18 (IL-18) expression and its relationship with HIMF in cultured myoblasts.", {"entities": []}], ["We found that HIMF increased IL-18 production in myoblasts and that secreted IL-18 promoted tube formation of the endothelial progenitor cells.", {"entities": []}], ["We used the mouse xenograft model and the chick chorioallantoic membrane assay to further explore the role of HIMF in inflammatory myoblasts and angiogenesis in vivo .", {"entities": []}], ["Thus, our study focused on the mechanism by which HIMF mediates IL-18 expression in myoblasts through angiogenesis in vitro and in vivo .", {"entities": []}], ["Our findings provide an insight into HIMF functioning in inflammatory myoblasts.", {"entities": []}], ["MALDI-TOF MS recently emerged as a valuable identification tool for bacteria and yeasts and revolutionized the daily clinical laboratory routine.", {"entities": []}], ["But it has not been established for routine mould identification.", {"entities": []}], ["This study aimed to validate a standardized procedure for MALDI-TOF MS-based mould identification in clinical laboratory.", {"entities": []}], ["First, pre-extraction and extraction procedures were optimized.", {"entities": []}], ["With this standardized procedure, a 143 mould strains reference spectra library was built.", {"entities": []}], ["Then, the mould isolates cultured from sequential clinical samples were prospectively subjected to this MALDI-TOF MS based-identification assay.", {"entities": []}], ["MALDI-TOF MS-based identification was considered correct if it was concordant with the phenotypic identification; otherwise, the gold standard was DNA sequence comparison-based identification.", {"entities": []}], ["The optimized procedure comprised a culture on sabouraud-gentamicin-chloramphenicol agar followed by a chemical extraction of the fungal colonies with formic acid and acetonitril.", {"entities": []}], ["The identification was done using a reference database built with references from at least four culture replicates.", {"entities": []}], ["For five months, 197 clinical isolates were analyzed; 20 were excluded because they were not identified at the species level.", {"entities": []}], ["MALDI-TOF MS-based approach correctly identified 87% (154/177) of the isolates analyzed in a routine clinical laboratory activity.", {"entities": []}], ["It failed in 12% (21/177), whose species were not represented in the reference library.", {"entities": []}], ["MALDI-TOF MS-based identification was correct in 154 out of the remaining 156 isolates.", {"entities": []}], ["One Beauveria bassiana was not identified and one Rhizopus oryzae was misidentified as Mucor circinelloides .", {"entities": []}], ["This work's seminal finding is that a standardized procedure can also be used for MALDI-TOF MS-based identification of a wide array of clinically relevant mould species.", {"entities": []}], ["It thus makes it possible to identify moulds in the routine clinical laboratory setting and opens new avenues for the development of an integrated MALDI-TOF MS-based solution for the identification of any clinically relevant microorganism.", {"entities": []}], ["To optimally leverage the scalability and unique features of the electronic health records (EHR) for research that would ultimately improve patient care, we need to accurately identify patients and extract clinically meaningful measures.", {"entities": []}], ["Using multiple sclerosis (MS) as a proof of principle, we showcased how to leverage routinely collected EHR data to identify patients with a complex neurological disorder and derive an important surrogate measure of disease severity heretofore only available in research settings.", {"entities": [[6, 24, "DISEASE"]]}], ["In a cross-sectional observational study, 5,495 MS patients were identified from the EHR systems of two major referral hospitals using an algorithm that includes codified and narrative information extracted using natural language processing.", {"entities": []}], ["In the subset of patients who receive neurological care at a MS Center where disease measures have been collected, we used routinely collected EHR data to extract two aggregate indicators of MS severity of clinical relevance multiple sclerosis severity score (MSSS) and brain parenchymal fraction (BPF, a measure of whole brain volume).", {"entities": [[225, 243, "DISEASE"]]}], ["The EHR algorithm that identifies MS patients has an area under the curve of 0.958, 83% sensitivity, 92% positive predictive value, and 89% negative predictive value when a 95% specificity threshold is used.", {"entities": []}], ["The correlation between EHR-derived and true MSSS has a mean R Incorporation of sophisticated codified and narrative EHR data accurately identifies MS patients and provides estimation of a well-accepted indicator of MS severity that is widely used in research settings but not part of the routine medical records.", {"entities": []}], ["Similar approaches could be applied to other complex neurological disorders.", {"entities": []}], ["Rates of readmission to hospital within 30\u00a0days are highest amongst those with chronic diseases.", {"entities": []}], ["Effective interventions to reduce unplanned readmissions are needed.", {"entities": []}], ["Providing support to patients with chronic disease via telephone may help prevent unnecessary readmission.", {"entities": []}], ["This systematic review aimed to determine the methodological quality and effectiveness of interventions utilising telephone follow up (TFU) alone or in combination with other components in reducing readmission within 30\u00a0days amongst patients with cardiovascular disease, chronic respiratory disease and diabetes.", {"entities": []}], ["A systematic search of MEDLINE, the Cochrane Library and EMBASE were conducted for articles published from database inception to 19 Ten studies were identified, of which five were effective in reducing readmissions within 30\u00a0days.", {"entities": []}], ["Overall, the methodological quality of included studies was poor.", {"entities": []}], ["All identified studies combined TFU with other intervention components.", {"entities": []}], ["Interventions that were effective included three studies which provided TFU in addition to pre-discharge support; and two studies which provided TFU with both pre- and post-discharge support which included education, discharge planning, physical therapy and dietary consults, medication assessment, home visits and a resident curriculum.", {"entities": []}], ["There was no evidence that TFU and telemedicine or TFU and post-discharge interventions was effective, however, only one to two studies examined each of these types of interventions.", {"entities": []}], ["Evidence is inconclusive for the effectiveness of interventions utilising TFU alone or in combination with other components in reducing readmissions within 30\u00a0days in patients with chronic disease.", {"entities": []}], ["High methodological quality studies examining the effectiveness of TFU in a standardised way are needed.", {"entities": []}], ["There is also potential importance in focusing interventions on enhancing provider skills in patient education, transitional care and conducting TFU.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-016-1650-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To prove a causal link between an epigenetic change and an environmental or behavioural risk factor for a given disease, it is first necessary to show that the onset of exposure precedes the first detection of that epigenetic change in subjects who are still free of disease.", {"entities": []}], ["Towards this end, a cohort of women aged 15\u201319 years, recruited soon after they first had sexual intercourse, were used to provide sequential observations on the relationship between cigarette smoking and the detection in cervical cytological samples of methylated forms of CDKN2A (p16) using nested methylation-specific polymerase chain reaction.", {"entities": [[274, 280, "GENE"]]}], ["Among women who remained cytologically normal and who tested negative for human papillomavirus DNA in cervical smears during follow-up, those who first started to smoke during follow-up had an increased risk of acquiring CDKN2A methylation compared with never-smokers (odds ratio=3.67; 95% confidence interval 1.09\u201312.33; P =0.04).", {"entities": [[221, 227, "GENE"]]}], ["Smoking initiation is associated with the appearance of methylated forms of CDKN2A.", {"entities": [[76, 82, "GENE"]]}], ["There is a marked socioeconomic gradient in the prevalence of chronic obstructive pulmonary disease (COPD) and asthma, but a large proportion of patients remain undiagnosed.", {"entities": [[62, 99, "DISEASE"], [111, 117, "DISEASE"]]}], ["It is a challenge for general practitioners (GPs) to both identify patients and contribute to equity and high quality in services delivered.", {"entities": []}], ["The aim of this study was to identify patients with COPD and asthma diagnoses recorded by GPs and explore their utilisation of GP services by education level.", {"entities": [[61, 67, "DISEASE"]]}], ["This was a cross-sectional, national, register-based study from Norwegian general practice in the period 2009\u20132011.", {"entities": []}], ["Based on claims from GPs, the number of patients aged \u2a7e40 years with a diagnosis of COPD or asthma and their GP services utilisation were estimated and linked to the national education database.", {"entities": [[92, 98, "DISEASE"]]}], ["Multivariate Poisson and logistic regression models were used to explore the variations in GP utilisation.", {"entities": []}], ["In the population aged \u2a7e40 years, 2.8% had COPD and 3.8% had asthma according to GPs\u2019 diagnoses.", {"entities": [[61, 67, "DISEASE"]]}], ["COPD was four times more prevalent in patients with basic education than higher education; this increase was \u2a7d80% for asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["Consultation rates were 12% higher ( P <0.001) for COPD and 25% higher ( P <0.001) for asthma in patients with low versus high education in the age group of 40\u201359 years after adjusting for comorbidity, and patient and GP characteristics.", {"entities": [[87, 93, "DISEASE"]]}], ["Approximately 25% of COPD patients and 20% of asthma patients had \u2a7e1 spirometry test in general practice in 2011, with no significant education differences in adjusted models.", {"entities": [[46, 52, "DISEASE"]]}], ["The higher consultation rate in lower-education groups indicates that GPs contribute to fair distribution of healthcare.", {"entities": []}], ["Current research focuses on cancer therapy, diagnostics and imaging, although many challenges still need to be solved.", {"entities": [[28, 34, "DISEASE"]]}], ["However, for the application of gold nanoparticles (GNPs) in therapy and diagnostics it is necessary to know the bioaccumulation and local or systemic toxicity associated to them.", {"entities": []}], ["The aim of the present study was to investigate the effects of intraperitoneal administration of GNPs on the histological alterations of the heart tissue of rats in an attempt to cover and understand the toxicity and the potential role of GNPs in the therapeutic and diagnostic applications.", {"entities": []}], ["Animals were randomly divided into 3 GNPs-treated rats groups and one control group (CG).", {"entities": []}], ["The 10, 20 and 50 nm GNPs were administered intraperitonealy at the rate of 3 or 7 days as follows: Group 1: received infusion of 100 \u03bcl GNPs of size 10 nm for 3 or 7 days; Group 2: received infusion of 100 \u03bcl GNPs of size 20 nm for 3 or 7 days; Group 3: received infusion of 100 \u03bcl GNPs of size 50 nm for 3 or 7 days.", {"entities": []}], ["Control group: received no GNPs.", {"entities": []}], ["In comparison with the respective control rats, GNPs-treated rat received 100 \u03bcl of 10 and 20 nm particles for 3 days or 7 days demonstrating congested heart muscle with prominent dilated blood vessels, scattered and extravasations of red blood cells, focus of muscle hyalinosis, disturbed muscle fascicles, dense prominent focus of inflammatory cells infiltrate by small lymphocytes and few plasma cells while GNPs-treated rat received 100 \u03bcl of 50 nm particles for 3 or 7 days demonstrating benign normal looking heart muscle with normal muscle direction and fascicles, and very few scattered small lymphocytes.", {"entities": []}], ["The histological alterations induced by intraperitoneal administration of GNPs were size-dependent with smaller ones induced more affects and related with time exposure of GNPs.", {"entities": []}], ["This study suggests that interaction of GNPs with proteins and various cell types might be evaluated as part of the toxicological assessment in addition to further experiments related to tissues antioxidant enzymes, oxidative parameters, lipid peroxidation, production of free radicals and/or ROS and cytokine, histomorphologcal and ultrastrucural will be performed to cover and understand the toxicity and the potential use of GNPs as therapeutic and diagnostic tool.", {"entities": []}], ["Asthma is a disease of airway inflammation and hyperreactivity that is associated with a lymphocytic infiltrate in the bronchial submucosa.", {"entities": [[0, 6, "DISEASE"]]}], ["The interactions between infiltrating T lymphocytes with cellular and extracellular matrix components of the airway and the consequences of these interactions have not been defined.", {"entities": []}], ["We demonstrate the constitutive expression of CD44 on human airway smooth muscle (ASM) cells in culture as well as in human bronchial tissue transplanted into severe combined immunodeficient mice.", {"entities": [[46, 50, "GENE"]]}], ["In contrast, basal levels of intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) expression are minimal but are induced on ASM by inflammatory mediators such as tumor necrosis factor alpha (TNF-alpha).", {"entities": []}], ["Activated, but not resting T cells, adhere to cultured ASM; stimulation of the ASM with TNF-alpha enhanced this adhesion.", {"entities": []}], ["Adhesion was partially blocked by monoclonal antibodies (mAb) specific for lymphocyte function-associated antigen 1 (LFA-1) and very late antigen 4 (VLA-4) on T cells and ICAM-1 and VCAM-1 on ASM cells.", {"entities": []}], ["The observed integrin-independent adhesion was mediated by CD44/hyaluronate interactions as it was inhibited by anti-CD44 mAb 5F12 and by hyaluronidase.", {"entities": []}], ["Furthermore, the adhesion of activated T lymphocytes induced DNA synthesis in growth-arrested ASM cells.", {"entities": []}], ["Thus, the interaction between T cells and ASM may provide insight into the mechanisms that induce bronchial inflammation and possibly ASM cell hyperplasia seen in asthma.", {"entities": [[163, 169, "DISEASE"]]}], ["Non-adherence to corticosteroid treatment has been shown to reduce treatment efficacy, thus compromising asthma control.", {"entities": [[105, 111, "DISEASE"]]}], ["To examine the experiences of treatment side effects, treatment concerns and adherence to inhaled (ICS) and oral corticosteroids (OCS) among people with asthma and to identify the degree of concordance between clinician estimates of side effects and the prevalence reported by patients.", {"entities": [[153, 159, "DISEASE"]]}], ["Asthma UK members were sent validated questionnaires assessing treatment concerns, experiences of side effects and adherence.", {"entities": [[0, 6, "DISEASE"]]}], ["Questionnaires measuring clinicians\u2019 estimates of the prevalence of corticosteroid side effects were completed online.", {"entities": []}], ["Completed questionnaires were returned by 1,524 people taking ICS, 233 taking OCS and 244 clinicians (67% of clinicians were primary care nurses).", {"entities": []}], ["Among people with asthma, 64% of those taking ICS and 88% of those taking OCS reported \u2a7e1 side effect.", {"entities": [[18, 24, "DISEASE"]]}], ["People reporting high adherence to ICS ( t =\u22123.09, P <0.005) and those reporting low adherence to OCS ( t =1.86, P <0.05; one-tailed test) reported more side effects.", {"entities": []}], ["There was a disparity between clinicians\u2019 estimates of the frequency of side effects and the frequency reported by people with asthma: e.g., although 46% of people taking ICS reported sore throat, clinicians estimated that this figure would be 10%.", {"entities": [[127, 133, "DISEASE"]]}], ["Patients who reported side effects had stronger concerns about both ICS ( r =0.46, P <0.0001) and OCS ( r =0.50, P <0.0001).", {"entities": []}], ["Concerns about corticosteroids were associated with low adherence to ICS ( t =6.90, P <0.0001) and OCS ( t =1.71; P <0.05; one-tailed test).", {"entities": []}], ["An unexpectedly large proportion of people with asthma experienced side effects and had strong concerns about their treatment, which compromised adherence.", {"entities": [[48, 54, "DISEASE"]]}], ["These findings have implications for the design of interventions to optimise asthma control through improved adherence.", {"entities": [[77, 83, "DISEASE"]]}], ["Dendritic cells (DCs) control the balance between protection against pathogens and tolerance to innocuous or self-antigens.", {"entities": []}], ["Here, we demonstrate for the first time that mouse plasmacytoid DCs (pDCs) can be segregated into three distinct populations, exhibiting phenotypic and functional differences, according to their surface expression of CD8\u03b1 or CD8\u03b2 as CD8\u03b1", {"entities": []}], ["Article first published online 17 April 2015.", {"entities": []}], ["Supplemental Digital Content is Available in the Text.", {"entities": []}], ["Pediatric Inflammatory Bowel Disease (PIBD) is a chronic condition seen in genetically predisposed individuals.", {"entities": []}], ["Genome-wide association studies have implicated >160 genomic loci in IBD with many genes coding for proteins in key immune pathways.", {"entities": []}], ["This study looks at autoimmune disease burden in patients diagnosed with PIBD and interrogates exome data of a subset of patients.", {"entities": []}], ["Patients were recruited from the Southampton Genetics of PIBD cohort.", {"entities": []}], ["Clinical diagnosis of autoimmune disease in these individuals was ascertained from medical records.", {"entities": []}], ["For a subset of patients with PIBD and concurrent asthma, exome data was interrogated to ascertain the burden of pathogenic variants within genes implicated in asthma.", {"entities": [[50, 56, "DISEASE"], [160, 166, "DISEASE"]]}], ["Association testing was conducted between cases and population controls using the SKAT-O test.", {"entities": []}], ["Forty-nine (28.3%) PIBD children (18.49% CD, 8.6% UC, and 21.15% IBDU patients) had a concurrent clinical diagnosis of at least one other autoimmune disorder; asthma was the most prevalent, affecting 16.2% of the PIBD cohort.", {"entities": [[159, 165, "DISEASE"]]}], ["Rare and common variant association testing revealed 6 significant genes ( P < 0.05) before Bonferroni adjustment.", {"entities": []}], ["Three of these genes were previously implicated in both asthma and IBD ( ZPBP2 IL1R1 , and IL18R1 ) and 3 in asthma only ( PYHIN1, IL2RB , and GSTP1 ).", {"entities": [[56, 62, "DISEASE"], [109, 115, "DISEASE"], [73, 78, "GENE"], [79, 84, "GENE"], [91, 97, "GENE"], [123, 129, "GENE"], [131, 136, "GENE"], [143, 148, "GENE"]]}], ["One-third of our cohort had a concurrent autoimmune condition.", {"entities": []}], ["We observed higher incidence of asthma compared with the overall pediatric prevalence.", {"entities": [[32, 38, "DISEASE"]]}], ["Despite a small sample size, SKAT-O evaluated a significant burden of rare and common mutations in 6 genes.", {"entities": []}], ["Variant burden suggests that a systemic immune dysregulation rather than organ-specific could underpin immune dysfunction for a subset of patients.", {"entities": []}], ["Prenatal exposure to air pollution is considered to be associated with adverse effects on child health.", {"entities": []}], ["This may partly be mediated by mechanisms related to DNA methylation.", {"entities": []}], ["We investigated associations between exposure to air pollution, using nitrogen dioxide (NO2) as marker, and epigenome-wide cord blood DNA methylation.", {"entities": []}], ["We meta-analyzed the associations between NO2 exposure at residential addresses during pregnancy and cord blood DNA methylation (Illumina 450K) in four European and North American studies (n = 1,508) with subsequent look-up analyses in children ages 4 (n = 733) and 8 (n = 786) years.", {"entities": []}], ["Additionally, we applied a literature-based candidate approach for antioxidant and anti-inflammatory genes.", {"entities": []}], ["To assess influence of exposure at the transcriptomics level, we related mRNA expression in blood cells to NO2 exposure in 4- (n = 111) and 16-year-olds (n = 239).", {"entities": []}], ["We found epigenome-wide significant associations [false discovery rate (FDR) p < 0.05] between maternal NO2 exposure during pregnancy and DNA methylation in newborns for 3 CpG sites in mitochondria-related genes: cg12283362 (LONP1), cg24172570 (3.8 kbp upstream of HIBADH), and cg08973675 (SLC25A28).", {"entities": [[225, 230, "GENE"], [265, 271, "GENE"], [290, 298, "GENE"]]}], ["The associations with cg08973675 methylation were also significant in the older children.", {"entities": []}], ["Further analysis of antioxidant and anti-inflammatory genes revealed differentially methylated CpGs in CAT and TPO in newborns (FDR p < 0.05).", {"entities": [[111, 114, "GENE"]]}], ["NO2 exposure at the time of biosampling in childhood had a significant impact on CAT and TPO expression.", {"entities": [[89, 92, "GENE"]]}], ["NO2 exposure during pregnancy was associated with differential offspring DNA methylation in mitochondria-related genes.", {"entities": []}], ["Exposure to NO2 was also linked to differential methylation as well as expression of genes involved in antioxidant defense pathways.", {"entities": []}], ["Gruzieva O, Xu CJ, Breton CV, Annesi-Maesano I, Ant\u00f3 JM, Auffray C, Ballereau S, Bellander T, Bousquet J, Bustamante M, Charles MA, de Kluizenaar Y, den Dekker HT, Duijts L, Felix JF, Gehring U, Guxens M, Jaddoe VV, Jankipersadsing SA, Merid SK, Kere J, Kumar A, Lemonnier N, Lepeule J, Nystad W, Page CM, Panasevich S, Postma D, Slama R, Sunyer J, S\u00f6derh\u00e4ll C, Yao J, London SJ, Pershagen G, Koppelman GH, Mel\u00e9n E. 2017.", {"entities": []}], ["Epigenome-wide meta-analysis of methylation in children related to prenatal NO2 air pollution exposure.", {"entities": []}], ["Environ Health Perspect 125:104\u2013110;\u2002http://dx.doi.org/10.1289/EHP36", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a major and an increasingly prevalent health problem worldwide.", {"entities": []}], ["It has been reported that genetic variation may play a role in the development and severity of COPD.", {"entities": []}], ["The purpose of this study was to investigate whether single nucleotide polymorphisms in multiple genetic variants were associated with COPD in a Chinese population from Hainan province.", {"entities": []}], ["In this case-control study, including 200 COPD patients and 401 controls, we genotyped 14 tag single nucleotide polymorphisms and evaluated their association with COPD using the \u03c7 The polymorphism, rs10007052, in the RNF150 gene was significantly associated with COPD risk at a 5% level (odds ratio =1.43, 95% confidence interval, 1.06\u20131.95, P =0.020).", {"entities": []}], ["In the log-additive model, the minor allele (C) of rs10007052 in the RNF150 gene ( P =0.026) and the minor allele (C) of rs3733829 in the EGLN2 gene ( P =0.037) were associated with COPD risk after adjustment for age, sex, and smoking status.", {"entities": [[138, 143, "GENE"]]}], ["Further haplotype analysis revealed that the \u201cCT\u201d haplotype composed of the mutant allele (C) of rs7937, rs3733829 in the EGLN2 gene, was associated with increased COPD risk (odds ratio =1.55; 95% confidence interval, 1.05\u20132.31; P =0.029).", {"entities": [[122, 127, "GENE"]]}], ["Our findings indicated that rs10007052 in the RNF150 and rs3733829 in the EGLN2 gene were significantly associated with the risk of COPD in Chinese populations of Hainan province.", {"entities": [[74, 79, "GENE"]]}], ["These data may provide novel insights into the pathogenesis of COPD, although further studies with larger numbers of participants worldwide are needed for validation of our conclusions.", {"entities": []}], ["Hypersecretion of cytokines and serine proteinases has been observed in asthma.", {"entities": [[72, 78, "DISEASE"]]}], ["Since protease-activated receptors (PARs) are receptors of several serine proteinases and airway epithelial cells are a major source of cytokines, the influence of serine proteinases and PARs on interleukin (IL)-8 secretion and gene expression in cultured A549 cells was examined.", {"entities": []}], ["A549 cells express all four PARs at both protein and mRNA levels as assessed by flow cytometry, immunofluorescence microscopy and reverse transcription polymerase chain reaction (PCR).", {"entities": []}], ["Thrombin, tryptase, elastase and trypsin induce a up to 8, 4.3, 4.4 and 5.1 fold increase in IL-8 release from A549 cells, respectively following 16 h incubation period.", {"entities": []}], ["The thrombin, elastase and trypsin induced secretion of IL-8 can be abolished by their specific inhibitors.", {"entities": []}], ["Agonist peptides of PAR-1, PAR-2 and PAR-4 stimulate up to 15.6, 6.6 and 3.5 fold increase in IL-8 secretion, respectively.", {"entities": []}], ["Real time PCR shows that IL-8 mRNA is up-regulated by the serine proteinases tested and by agonist peptides of PAR-1 and PAR-2.", {"entities": []}], ["The proteinases, possibly through activation of PARs can stimulate IL-8 release from A549 cells, suggesting that they are likely to contribute to IL-8 related airway inflammatory disorders in man.", {"entities": []}], ["Skeletal muscle is able to restore contractile functionality after injury thanks to its ability to regenerate.", {"entities": []}], ["Following muscle necrosis, debris is removed by macrophages, and muscle satellite cells (MuSCs), the muscle stem cells, are activated and subsequently proliferate, migrate, and form muscle fibers restoring muscle functionality.", {"entities": []}], ["In most muscle dystrophies (MDs), MuSCs fail to properly proliferate, differentiate, or replenish the stem cell compartment, leading to fibrotic deposition.", {"entities": []}], ["However, besides MuSCs, interstitial nonmyogenic cells and inflammatory cells also play a key role in orchestrating muscle repair.", {"entities": []}], ["A complete understanding of the complexity of these mechanisms should allow the design of interventions to attenuate MDs pathology without disrupting regenerative processes.", {"entities": []}], ["In this review we will focus on the contribution of immune cells in the onset and progression of MDs, with particular emphasis on Duchenne muscular dystrophy (DMD).", {"entities": [[139, 157, "DISEASE"], [159, 162, "GENE"]]}], ["We will briefly summarize the current knowledge and recent advances made in our understanding of the involvement of different innate immune cells in MDs and will move on to critically evaluate the possible role of cell populations within the acquired immune response.", {"entities": []}], ["Revisiting previous observations in the light of recent evidence will likely change our current view of the onset and progression of the disease.", {"entities": []}], ["Smoke-free legislation is associated with improved early-life outcomes; however its impact on perinatal survival is unclear.", {"entities": []}], ["We linked individual-level data with death certificates for all registered singletons births in England (1995\u20132011).", {"entities": []}], ["We used interrupted time series logistic regression analysis to study changes in key adverse perinatal events following the July 2007 national, comprehensive smoke-free legislation.", {"entities": []}], ["We studied 52,163 stillbirths and 10,238,950 live-births.", {"entities": []}], ["Smoke-free legislation was associated with an immediate 7.8% (95%CI 3.5\u201311.8; p\u2009<\u20090.001) reduction in stillbirth, a 3.9% (95%CI 2.6\u20135.1; p\u2009<\u20090.001) reduction in low birth weight, and a 7.6% (95%CI 3.4\u201311.7; p\u2009=\u20090.001) reduction in neonatal mortality.", {"entities": []}], ["No significant impact on SIDS was observed.", {"entities": []}], ["Using a counterfactual scenario, we estimated that in the first four years following smoke-free legislation, 991 stillbirths, 5,470 cases of low birth weight, and 430 neonatal deaths were prevented.", {"entities": []}], ["In conclusion, smoke-free legislation in England was associated with clinically important reductions in severe adverse perinatal outcomes.", {"entities": []}], ["Exposing children to secondhand tobacco smoke (SHS) causes significant harm and occurs predominantly through smoking by caregivers in the family home.", {"entities": []}], ["We report a trial of a complex intervention designed to reduce secondhand smoke exposure of children whose primary caregiver feels unable or unwilling to quit smoking.", {"entities": []}], ["An open-label, parallel, randomised controlled trial.", {"entities": []}], ["Deprived communities in Nottingham City and County, England Caregivers resident in Nottingham City and County in England who were at least 18 years old, the main caregiver of a child aged under 5 years living in their household, and reported that they were smoking tobacco inside their home.", {"entities": []}], ["We compared a complex intervention combining personalised feedback on home air quality, behavioural support and nicotine replacement therapy for temporary abstinence with usual care.", {"entities": []}], ["The primary outcome was change in air quality in the home, measured as average 16\u201324 \u2009hours levels of particulate matter of\u2009 < 2.5 \u2009\u00b5m diameter (PM 2.5 ), between baseline and 12 weeks.", {"entities": []}], ["Secondary outcomes included changes in maximum PM 2.5 , proportion of time PM 2.5 exceeded WHO recommended levels of maximum exposure of 25 \u2009\u00b5g/mg Arithmetic mean PM 2.5 decreased significantly more (by 35.2 %; 95% \u2009CI 12.7% to 51.9 %) in intervention than in usual care households, as did the proportion of time PM 2.5 exceeded 25 \u2009\u00b5g/mg By reducing exposure to SHS in the homes of children who live with smokers unable or unwilling to quit, this intervention offers huge potential to reduce children\u2019s\u2019 tobacco-related harm.", {"entities": []}], ["ISRCTN81701383.", {"entities": []}], ["This trial was funded by the UK National Institute for Health Research (NIHR): RP-PG-0608-10020", {"entities": []}], ["Genome-wide association studies in human populations have facilitated the creation of genomic profiles which combine the effects of many associated genetic variants to predict risk of disease.", {"entities": []}], ["The area under the receiver operator characteristic (ROC) curve is a well established measure for determining the efficacy of tests in correctly classifying diseased and non-diseased individuals.", {"entities": []}], ["We use quantitative genetics theory to provide insight into the genetic interpretation of the area under the ROC curve (AUC) when the test classifier is a predictor of genetic risk.", {"entities": []}], ["Even when the proportion of genetic variance explained by the test is 100%, there is a maximum value for AUC that depends on the genetic epidemiology of the disease, i.e.", {"entities": []}], ["either the sibling recurrence risk or heritability and disease prevalence.", {"entities": []}], ["We derive an equation relating maximum AUC to heritability and disease prevalence.", {"entities": []}], ["The expression can be reversed to calculate the proportion of genetic variance explained given AUC, disease prevalence, and heritability.", {"entities": []}], ["We use published estimates of disease prevalence and sibling recurrence risk for 17 complex genetic diseases to calculate the proportion of genetic variance that a test must explain to achieve AUC\u200a=\u200a0.75; this varied from 0.10 to 0.74.", {"entities": []}], ["We provide a genetic interpretation of AUC for use with predictors of genetic risk based on genomic profiles.", {"entities": []}], ["We provide a strategy to estimate proportion of genetic variance explained on the liability scale from estimates of AUC, disease prevalence, and heritability (or sibling recurrence risk) available as an online calculator.", {"entities": []}], ["Genome-wide association studies in human populations have facilitated the creation of genomic profiles that combine the effects of many associated genetic variants to predict risk of disease.", {"entities": []}], ["However, genomic profiles are inherently constrained in their ability to classify diseased from non-diseased individuals dictated by the genetic epidemiology of the disease.", {"entities": []}], ["In this paper, we use a genetic interpretation to provide insight into the constraints on genomic profiles for risk prediction.", {"entities": []}], ["We provide a strategy to estimate proportion of genetic variance explained on the liability scale from estimates of AUC, disease prevalence, and heritability available as an online calculator.", {"entities": []}], ["In this review we describe and discuss several approaches to selecting higher plants as candidates for drug development with the greatest possibility of success.", {"entities": []}], ["We emphasize the role of information derived from various systems of traditional medicine (ethnomedicine) and its utility for drug discovery purposes.", {"entities": []}], ["We have identified 122 compounds of defined structure, obtained from only 94 species of plants, that are used globally as drugs and demonstrate that 80% of these have had an ethnomedical use identical or related to the current use of the active elements of the plant.", {"entities": []}], ["We identify and discuss advantages and disadvantages of using plants as starting points for drug development, specifically those used in traditional medicine.", {"entities": []}], ["Interleukin-8 ( IL-8 ) gene polymorphisms have been considered as susceptibility factors in periodontal disease.", {"entities": [[92, 111, "DISEASE"]]}], ["However, the functional roles of IL-8 gene haplotypes have not been investigated.", {"entities": []}], ["Here, we demonstrate for the first time the use of the CRISPR/Cas9 system to engineer the IL-8 gene, and tested the functionality of different haplotypes.", {"entities": []}], ["Two sgRNAs vectors targeting the IL-8 gene and the naked homologous repair DNA carrying different haplotypes were used to successfully generate HEK293T cells carrying the AT genotype at the first SNP - rs4073 (alias -251), TT genotype at the second SNP - rs2227307 (alias +396), TC or CC genotypes at the third SNP - rs2227306 (alias +781) at the IL-8 locus.", {"entities": []}], ["When stimulated with Poly I:C, ATC/TTC haplotype, cells significantly up-regulated the IL-8 at both transcriptional and translational levels.", {"entities": []}], ["To test whether ATC/TTC haplotype is functional, we used a trans-well assay to measure the transmigration of primary neutrophils incubated with supernatants from the Poly I:C stimulation experiment.", {"entities": []}], ["ATC/TTC haplotype cells significantly increased transmigration of neutrophils confirming the functional role for this IL-8 haplotype.", {"entities": []}], ["Taken together, our data provides evidence that carriage of the ATC/TTC haplotype in itself may increase the influx of neutrophils in inflammatory lesions and influence disease susceptibility.", {"entities": []}], ["In general, assessment tools for stigma in mental disorders such as attention deficit hyperactivity disorder (ADHD) are lacking.", {"entities": [[68, 108, "DISEASE"]]}], ["Moreover, misbeliefs and misconceptions about ADHD are common, in particular with regard to the adult form of ADHD.", {"entities": []}], ["The aim of the present study was to develop a questionnaire measuring stigma in adults with ADHD and to demonstrate its sensitivity.", {"entities": []}], ["A questionnaire initially containing 64 items associated with stigma in adults with ADHD was developed.", {"entities": []}], ["A total number of 1261 respondents were included in the analyses.", {"entities": []}], ["The psychometric properties were investigated on a sample of 1033 participants.", {"entities": []}], ["The sensitivity of the questionnaire was explored on 228 participants consisting of teachers, physicians and control participants.", {"entities": []}], ["Thirty-seven items were extracted due to exploratory factor analysis (EFA) and the internal consistency of items.", {"entities": []}], ["Confirmatory factor analysis (CFA) revealed good psychometric properties of a 6-factor structure.", {"entities": []}], ["Teachers and physicians differed significantly in their stigmatizing attitudes from control participants.", {"entities": []}], ["The present data shed light on various dimensions of stigma in adult ADHD.", {"entities": []}], ["Reliability and Social Functioning, Malingering and Misuse of Medication, Ability to Take Responsibility, Norm-violating and Externalizing Behavior, Consequences of Diagnostic Disclosure and Etiology represent critical aspects associated with stigmatization.", {"entities": []}], ["Supplemental Digital Content is available in the text Exhaled nitric oxide (eNO) has been proposed as a noninvasive measure of airway inflammation.", {"entities": []}], ["However, its value in patients with obstructive sleep apnea (OSA) is still controversial.", {"entities": []}], ["The authors aim to assess the difference in eNO levels between patients with OSA and controls by a meta-analysis.", {"entities": []}], ["A systematic search was performed in the PubMed, EMBASE, the Cochrane Library, and MEDLINE databases to collect relevant studies published from 1996 to 2016.", {"entities": []}], ["Eligible studies that reported eNO levels in patients with OSA were included.", {"entities": []}], ["STATA (version 12.0) was used for data analysis.", {"entities": []}], ["Two hundred eighty-four studies were reviewed for inclusion, with 16 studies pooled for analysis (16 studies for fractional exhaled nitric oxide [FENO], 5 for alveolar nitric oxide [CANO], and 4 for the maximum airway wall flux of nitric oxide [J\u2032awNO]).", {"entities": []}], ["The FENO levels were significantly higher in patients with OSA compared with that in the control groups (6.32 ppb, 95% confidence interval [CI] 4.46\u20138.33, P \u200a<\u200a0.001).", {"entities": []}], ["Furthermore, FENO was significantly increased (4.00 ppb, 95% CI 1.74\u20136.27, P \u200a=\u200a0.001) after overnight sleep in patients with OSA, but not in healthy controls.", {"entities": []}], ["Additionally, long-term continuous positive airway pressure (CPAP) therapy reduced FENO levels (\u22125.82 ppb, 95% CI \u22129.6 to \u22122.01, P \u200a<\u200a0.001).", {"entities": []}], ["However, the CANO (\u22120.01 ppb, 95% CI \u22121.66 to 1.64, P \u200a=\u200a0.989) and J\u2019awNO levels (220.32\u200apl/s, 95% CI \u221249.31 to 489.94, P \u200a=\u200a0.109) were not significantly different between the OSA groups and non-OSA groups.", {"entities": []}], ["The results of the meta-analysis suggest that OSA is significantly associated with airway inflammation and elevated FENO levels can be modified by long-term CPAP therapy.", {"entities": []}], ["J\u2019awNO and CANO levels were not significantly different between the OSA groups and control groups.", {"entities": []}], ["Four hundred specimens were collected from pediatric patients hospitalized in Singapore; 21 of these specimens tested positive for human metapneumovirus (HMPV), with the A2 genotype predominating.", {"entities": []}], ["A 5% infection rate was estimated, suggesting that HMPV is a significant cause of morbidity among the pediatric population of Singapore.", {"entities": []}], ["Various sources of variation in observed response in clinical trials and clinical practice are considered, and ways in which the corresponding components of variation might be estimated are discussed.", {"entities": []}], ["Although the issues have been generally well\u2010covered in the statistical literature, they seem to be poorly understood in the medical literature and even the statistical literature occasionally shows some confusion.", {"entities": []}], ["To increase understanding and communication, some simple graphical approaches to illustrating issues are proposed.", {"entities": []}], ["It is also suggested that reducing variation in medical practice might make as big a contribution to improving health outcome as personalising its delivery according to the patient.", {"entities": []}], ["It is concluded that the common belief that there is a strong personal element in response to treatment is not based on sound statistical evidence.", {"entities": []}], ["\u00a9 2015 The Authors.", {"entities": []}], ["Statistics in Medicine published by John Wiley & Sons Ltd.", {"entities": []}], ["The purposes of this study were: firstly, to estimate time trends in the prevalence of prescription antibiotic consumption between 2003 and 2014; secondly, to identify the factors associated with the probability of consuming antibiotics during this period in elderly persons in Spain.", {"entities": []}], ["We analyzed data collected from the Spanish National Health Survey in 2003 (n = 21,650), 2006 (n = 29,478), and 2012 (n = 20,007) and from the European Health Interview Survey for Spain in 2009 (n = 22,188) and 2014 (n = 22,842).", {"entities": []}], ["Antibiotic consumption was the dependent variable.", {"entities": []}], ["We also analyzed sociodemographic features, self-perceived health status, lifestyle habits, comorbid diseases, and disabilities using logistic regression models.", {"entities": []}], ["The prevalence of antibiotic consumption increased from 2003 to 2014 in both sexes.", {"entities": []}], ["The variables that predicted antibiotic consumption (men; women) were secondary education (OR 1.38; OR 1.31), visits to a general practitioner (OR 2.05; OR 2.15), hospitalization (OR 1.91; OR 1.83), therapy with > 4 non-antibiotic drugs (OR 3.36; OR 5.84), instrumental activities of daily living (OR 1.50; OR 1.24), and activities of daily living (OR 1.39; OR 1.35).", {"entities": []}], ["In contrast, age > 85 years was associated with low antibiotic consumption in both men (OR 0.81) and women (OR 0.88).", {"entities": []}], ["The prevalence of antibiotic prescription has increased in Spain in the last decade.", {"entities": []}], ["Our study identified several factors that appear to affect antibiotic consumption in elderly persons, with potential implications for healthcare providers.", {"entities": []}], ["Responsiveness, or sensitivity to clinical change, is an important consideration in selection of a health-related quality of life (HRQL) measure for trials or clinical applications.", {"entities": []}], ["Many approaches can be used to assess responsiveness, which may affect the interpretation of study results.", {"entities": []}], ["We compared the relative responsiveness of generic and heart failure specific HRQL instruments, as measured both by common psychometric indices and by external clinical criteria.", {"entities": []}], ["We analyzed data collected at baseline and 6-weeks in 298 subjects with heart failure on the following HRQL measures: EQ-5D (US, UK, and VAS Scoring), Kansas City Cardiomyopathy Questionnaire (KCCQ) (Clinical and Overall Summary Score), and RAND12 (Physical and Mental Component Summaries).", {"entities": []}], ["Three external indicators of clinical change were used to classify subjects as improved, deteriorated, or unchanged: 6-minute walk test, New York Heart Association (NYHA) class, and physician global rating of change.", {"entities": []}], ["Four responsiveness statistics (T-test, effect size, Guyatt's responsiveness statistic, and standardized response mean) were used to evaluate the responsiveness of the select measures.", {"entities": []}], ["The median rank of each HRQL measure across responsiveness indices and clinical criteria was then determined.", {"entities": []}], ["Average age of subjects was 60 years, 75 percent were male, and had moderate to severe heart failure symptoms.", {"entities": []}], ["Overall, the KCCQ Summary Scores had the highest relative ranking, irrespective of the responsiveness index or external criterion used.", {"entities": []}], ["Importantly, we observed that the relative ranking of responsiveness of the generic measures (i.e.", {"entities": []}], ["EQ-5D, RAND12) was influenced by both the responsive indices and external criterion used.", {"entities": []}], ["The disease specific KCCQ was the most responsive HRQL measure assessing change over a 6-week period, although generic measures provide information for which the KCCQ is not suitable.", {"entities": []}], ["The responsiveness of generic HRQL measures may be affected by the index used, as well as the external criterion to classify patients who have clinically change or remained stable.", {"entities": []}], ["Adenylate kinase and downstream AMP signaling is an integrated metabolic monitoring system which reads the cellular energy state in order to tune and report signals to metabolic sensors.", {"entities": []}], ["A network of adenylate kinase isoforms (AK1-AK7) are distributed throughout intracellular compartments, interstitial space and body fluids to regulate energetic and metabolic signaling circuits, securing efficient cell energy economy, signal communication and stress response.", {"entities": []}], ["The dynamics of adenylate kinase-catalyzed phosphotransfer regulates multiple intracellular and extracellular energy-dependent and nucleotide signaling processes, including excitation-contraction coupling, hormone secretion, cell and ciliary motility, nuclear transport, energetics of cell cycle, DNA synthesis and repair, and developmental programming.", {"entities": []}], ["Metabolomic analyses indicate that cellular, interstitial and blood AMP levels are potential metabolic signals associated with vital functions including body energy sensing, sleep, hibernation and food intake.", {"entities": []}], ["Either low or excess AMP signaling has been linked to human disease such as diabetes, obesity and hypertrophic cardiomyopathy.", {"entities": [[111, 125, "DISEASE"], [98, 125, "DISEASE"], [86, 93, "DISEASE"]]}], ["Recent studies indicate that derangements in adenylate kinase-mediated energetic signaling due to mutations in AK1, AK2 or AK7 isoforms are associated with hemolytic anemia, reticular dysgenesis and ciliary dyskinesia.", {"entities": [[156, 172, "DISEASE"], [174, 194, "DISEASE"], [166, 172, "DISEASE"], [111, 114, "GENE"], [116, 119, "GENE"], [123, 126, "GENE"]]}], ["Moreover, hormonal, food and antidiabetic drug actions are frequently coupled to alterations of cellular AMP levels and associated signaling.", {"entities": []}], ["Thus, by monitoring energy state and generating and distributing AMP metabolic signals adenylate kinase represents a unique hub within the cellular homeostatic network.", {"entities": []}], ["Allergy immunotherapy (AIT) with the SQ In a non-interventional, open-label study, patients treated with the SLIT-tablet were observed for about 12\u00a0months compared with patients only symptomatically treated.", {"entities": []}], ["Patients assessed their HRQoL with the 12-Item Short Form Health Survey (SF-12) and the Rhinitis Quality of Life Questionnaire (RQLQ) in the grass pollen seasons (GPS) at baseline (GPS1, HRQoL1 ), after GPS1 ( HRQoL2 ) and in the following GPS (GPS2, HRQoL3 ).", {"entities": [[181, 185, "GENE"], [203, 207, "GENE"], [181, 185, "GENE"], [203, 207, "GENE"], [245, 249, "GENE"]]}], ["Tolerability, compliance, symptoms and medication use were assessed in the SLIT-tablet group by the physician.", {"entities": []}], ["Overall, data were analysed in 576 patients.", {"entities": []}], ["Mean differences (\u00b1SD) in overall scores for HRQoL3 versus HRQoL1 (186 patients) of SF-12 were +11.4\u00a0\u00b1\u00a016.8 (SLIT-tablet) and \u22123.4\u00a0\u00b1\u00a015.7 (symptomatic medication), ( p \u00a0<\u00a00.0001), and of RQLQ \u22121.31\u00a0\u00b1\u00a01.07 and +0.10\u00a0\u00b1\u00a00.74 ( p \u00a0<\u00a00.001), and for HRQoL3 versus HRQoL2 (238 patients) of SF-12 \u22121.6\u00a0\u00b1\u00a015.3 and \u221210.0\u00a0\u00b1\u00a014.1 ( p \u00a0=\u00a00.0003), and of RQLQ +0.22\u00a0\u00b1\u00a01.29 and +1.24\u00a0\u00b1\u00a01.30 ( p \u00a0<\u00a00.0001).", {"entities": []}], ["Tolerability and adherence for the SLIT-tablet were comparable with data of other non-interventional studies.", {"entities": []}], ["Routine treatment with the SQ", {"entities": []}], ["Gastric cancer is the second leading cause of cancer-related death worldwide.", {"entities": [[8, 14, "DISEASE"], [46, 52, "DISEASE"]]}], ["The correlation of Helicobacter pylori and the etiology of gastric cancer was substantially certain.", {"entities": [[67, 73, "DISEASE"]]}], ["Cholesterol-rich microdomains (also called lipid rafts), which provide platforms for signaling, are associated with H .", {"entities": []}], ["pylori -induced pathogenesis leading to gastric cancer.", {"entities": [[48, 54, "DISEASE"]]}], ["Patients who have been prescribed statins, inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase, have exhibited a reduced risk of several types of cancer.", {"entities": [[167, 173, "DISEASE"]]}], ["However, no studies have addressed the effect of statins on H .", {"entities": []}], ["pylori -associated gastric cancer from the antineoplastic perspective.", {"entities": [[27, 33, "DISEASE"]]}], ["In this study, we showed that treatment of gastric epithelial cells with simvastatin reduced the level of cellular cholesterol and led to attenuation of translocation and phosphorylation of H .", {"entities": []}], ["pylori cytotoxin-associated gene A (CagA), which is recognized as a major determinant of gastric cancer development.", {"entities": [[97, 103, "DISEASE"]]}], ["Additionally, a nationwide case-control study based on data from the Taiwanese National Health Insurance Research Database (NHIRD) was conducted.", {"entities": []}], ["A population-based case-control study revealed that patients who used simvastatin exhibited a significantly reduced risk of gastric cancer (adjusted odds ratio (OR) = 0.76, 95% confidence interval (CI) = 0.70\u20130.83).", {"entities": [[132, 138, "DISEASE"]]}], ["In patients exhibiting H .", {"entities": []}], ["pylori infection who were prescribed simvastatin, the adjusted OR for gastric cancer was 0.25 (95% CI = 0.12\u20130.50).", {"entities": [[78, 84, "DISEASE"]]}], ["Our results combined an in vitro study with a nationwide population analysis reveal that statin use might be a feasible approach to prevent H .", {"entities": []}], ["pylori -associated gastric cancer.", {"entities": [[27, 33, "DISEASE"]]}], ["Transglutaminase 2 (TG2) is a post-translational protein-modifying enzyme that catalyzes the transamidation reaction, producing crosslinked or polyaminated proteins.", {"entities": []}], ["Increased TG2 expression and activity have been reported in various inflammatory conditions, such as rheumatoid arthritis, inflammation-associated pulmonary fibrosis, and autoimmune encephalitis.", {"entities": [[101, 121, "DISEASE"], [182, 194, "DISEASE"], [112, 121, "DISEASE"], [147, 165, "DISEASE"]]}], ["In particular, TG2 from epithelial cells is important during the initial inflammatory response in the lung.", {"entities": []}], ["In this study, we evaluated the role of TG2 in the pathogenesis of allergic asthma, particularly whether TG2 affects initial activation signaling leading to Th2 differentiation against antigens.", {"entities": [[67, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["We induced allergic asthma by ovalbumin sensitization and intranasal challenge in wild-type (WT) BALB/c and TG2-deficient mice.", {"entities": [[11, 26, "DISEASE"], [20, 26, "DISEASE"]]}], ["Broncheoalveolar lavage fluid cells and intracellular cytokine production were analyzed by flow cytometry.", {"entities": []}], ["Interleukin (IL)-33 and TG2 expression in lung epithelial cells was detected by confocal microscopy.", {"entities": []}], ["Airway responsiveness was attenuated in TG2-deficient mice compared to that in the WT control.", {"entities": []}], ["In addition, recruitment of eosinophils and Th2 and Th17 differentiation decreased in TG2-deficient mice.", {"entities": []}], ["Treatment with cysteamine, a transglutaminase inhibitor, also reduced airway hypersensitivity, inflammatory cell recruitment, and T helper cell differentiation.", {"entities": []}], ["TG2-deficient mice showed reduced IL-33 expression following induction of allergic asthma compared to those in the WT control.", {"entities": [[74, 89, "DISEASE"], [83, 89, "DISEASE"]]}], ["We found that pulmonary epithelial cells damaged by allergens triggered TG2-mediated IL-33 expression leading to type 2 responses by recruiting both innate and adaptive arms of the immune system.", {"entities": []}], ["Heart failure prevalence is increasing in older adults, and polypharmacy is a major problem in this population.", {"entities": []}], ["We compared medication regimen complexity using the validated patient-level Medication Regimen Complexity Index (pMRCI) tool in \u201cyoung-old\u201d (60\u201374 years) versus \u201cold-old\u201d (75\u201389 years) patients with heart failure.", {"entities": []}], ["We also compared pMRCI between patients with ischemic cardiomyopathy (ISCM) versus nonischemic cardiomyopathy (NISCM).", {"entities": [[54, 68, "DISEASE"], [95, 109, "DISEASE"]]}], ["Medication lists were retrospectively abstracted from the electronic medical records of ambulatory patients aged 60\u201389 years with heart failure.", {"entities": []}], ["Medications were categorized into three types \u2013 heart failure prescription medications, other prescription medications, and over-the-counter (OTC) medications \u2013 and scored using the pMRCI tool.", {"entities": [[142, 145, "GENE"]]}], ["The study evaluated 145 patients (n=80 young-old, n=65 old-old, n=85 ISCM, n=60 NISCM, mean age 73\u00b17 years, 64% men, 81% Caucasian).", {"entities": []}], ["Mean total pMRCI scores (32.1\u00b114.4, range 3\u201384) and total medication counts (13.3\u00b14.8, range 2\u201330) were high for the entire cohort, of which 72% of patients were taking eleven or more total medications.", {"entities": []}], ["Total and subtype pMRCI scores and medication counts did not differ significantly between the young-old and old-old groups, with the exception of OTC medication pMRCI score (6.2\u00b14 young-old versus 7.8\u00b15.8 old-old, P =0.04).", {"entities": [[146, 149, "GENE"]]}], ["With regard to heart failure etiology, total pMRCI scores and medication counts were significantly higher in patients with ISCM versus NISCM (pMRCI score 34.5\u00b115.2 versus 28.8\u00b112.7, P =0.009; medication count 14.1\u00b14.9 versus 12.2\u00b14.5, P =0.008), which was largely driven by other prescription medications.", {"entities": []}], ["Medication regimen complexity is high in older adults with heart failure, and differs based on heart failure etiology.", {"entities": []}], ["Additional work is needed to address polypharmacy and to determine if medication regimen complexity influences adherence and clinical outcomes in this population.", {"entities": []}], ["Hyperlipidemia and oxidative stress are major risk factors for atherosclerosis, and all three are among the most important risk factors for cardiovascular diseases.", {"entities": [[63, 78, "DISEASE"]]}], ["Cassia occidentalis aqueous extract has been used in African traditional medicine for the treatment of hypertension and associated cardiovascular diseases.", {"entities": [[103, 115, "DISEASE"]]}], ["This study was undertaken to evaluate the hypolipidemic and anti-atherosclerotic properties of the aqueous extract of the leaves of C. occidentalis in rats with hypercholesterolemia (HC).", {"entities": []}], ["Sixty Normocholesterolemic (NC) male rats were divided into six groups ( n \u2009=\u200910) and fed a high-cholesterol (HC) diet for 30\u00a0days (5 groups), or normal rat chow (normal control group).", {"entities": []}], ["The plant extract was administered to animals at the increasing dose of 240, 320 and 400\u00a0mg/kg.", {"entities": []}], ["After 4\u00a0weeks of treatment 5 rats out of 10 were sacrificed, blood samples, aorta, liver, and fresh faecal were collected and processed for biochemical tests.", {"entities": []}], ["The experiments were conducted under the same conditions with a group of rat treated with Atorvastatin (1\u00a0mg/kg), used positive control.", {"entities": []}], ["The effects of C. occidentalis on weight gain, water and food consumptions, levels of serum lipids and lipoprotein lipid oxidation and stress markers in blood and liver were also examined.", {"entities": []}], ["A significant body weight gain was observed in general in all the group of animals without any treatment after 4\u00a0weeks.", {"entities": []}], ["During the treatment period, the C. occidentalis extract induced a significant increase ( P \u2009<\u20090.01) in water consumption and food intakes.", {"entities": []}], ["After 4\u00a0weeks of treatment with hypercholesterolemia, the body temperature and organ weights including the liver, kidney, heart and the testis did not present any significant change.", {"entities": []}], ["The administration of C. occidentalis extract significantly ( p \u2009<\u20090.05) prevented the elevation in TC, LDL-C, VLDL-C, hepatic and aortic TG and TC.", {"entities": [[138, 140, "GENE"]]}], ["The atherogenic, triglycerides, and lipid peroxidation (TBARS) index were also decreased in the rats treated with the plant extract.", {"entities": []}], ["C. occidentalis favoured the performance of faecal cholesterol.", {"entities": []}], ["It also significantly inhibited the changes and the formation of aortic atherosclerotic plaques.", {"entities": []}], ["This study provides evidence of hypolipidemic and antiatherosclerotic effects of C. occidentalis extract.", {"entities": []}], ["C. occidenntalis aqueous extract reduced bad cholesterols, triglycerides and increasing good cholesterols in rats subjected to a feeding regime enriched with cholesterol.", {"entities": []}], ["The results support the traditional use of the extract of this plant in the treatment of hypertension and diabetes.", {"entities": [[89, 101, "DISEASE"]]}], ["S1 Using computerized adaptive testing Tim Croudace S2 Well-being: what is it, how does it compare to health and what are the implications of using it to inform health policy John Brazier O1 \u201cAm I going to get better?\u201d\u2014Using PROMs to inform patients about the likely benefit of surgery Nils Gutacker, Andrew Street O2 Identifying Patient Reported Outcome Measures for an electronic Personal Health Record Dan Robotham, Samantha Waterman, Diana Rose, Safarina Satkunanathan, Til Wykes O3 Examining the change process over time qualitatively: transformative learning and response shift Nasrin Nasr, Pamela Enderby O4 Developing a PROM to evaluate self-management in diabetes (HASMID): giving patients a voice Jill Carlton, Donna Rowen, Jackie Elliott, John Brazier, Katherine Stevens, Hasan Basarir, Alex Labeit O5 Development of the Primary Care Outcomes Questionnaire (PCOQ) Mairead Murphy, Sandra Hollinghurst, Chris Salisbury O6 Developing the PKEX score- a multimodal assessment tool for patients with shoulder problems Dominic Marley, James Wilson, Amy Barrat, Bibhas Roy O7 Applying multiple imputation to multi-item patient reported outcome measures: advantages and disadvantages of imputing at the item, sub-scale or score level Ines Rombach, \u00d3rlaith Burke, Crispin Jenkinson, Alastair Gray, Oliver Rivero-Arias O8 Integrating Patient Reported Outcome Measures (PROMs) into routine primary care for patients with multimorbidity: a feasibility study Ian Porter, Jaheeda Gangannagaripalli, Charlotte Bramwell, Jose M. Valderas O9 eRAPID: electronic self-report and management of adverse-events for pelvic radiotherapy (RT) patients Patricia Holch, Susan Davidson, Jacki Routledge, Ann Henry, Kevin Franks, Alex Gilbert, Kate Absolom & Galina Velikova O10 Patient reported outcomes (PROMs) based recommendation in clinical guidance for the management of chronic conditions in the United Kingdom Ian Porter, Jose M.Valderas O11 Cross-sectional and longitudinal parameter shifts in epidemiological data: measurement invariance and response shifts in cohort and survey data describing the UK\u2019s Quality of Life Jan R. Boehnke O12 Patient-reported outcomes within health technology decision making: current status and implications for future policy Andrew Trigg, Ruth Howells O13 Can social care needs and well-being be explained by the EQ-5D?", {"entities": []}], ["Analysis of Health Survey for England dataset Jeshika Singh, Subhash Pokhrel, Louise Longworth O14 Where patients and policy meet: exploring individual-level use of the Long-Term Conditions Questionnaire (LTCQ) Caroline Potter, Cheryl Hunter, Laura Kelly, Elizabeth Gibbons, Julian Forder, Angela Coulter, Ray Fitzpatrick, Michele Peters", {"entities": []}], ["Objective .", {"entities": []}], ["To describe selected biochemical and hematological parameters (blood picture, liver enzymes, and kidney functions) in petrol station attendants in Mansoura city.", {"entities": []}], ["This is a comparative cross-sectional study.", {"entities": []}], ["The exposed group included 102 petrol station attendants.", {"entities": []}], ["They were compared to a matched group of healthy 102 male service and office workers at the Faculty of Medicine, Mansoura University.", {"entities": []}], ["The results of blood picture, liver enzymes, and kidney functions were compared between both groups.", {"entities": []}], ["Mean Red Blood Cells (RBCs) count, hemoglobin level, and Hematocrit (HCT) level were significantly lower in petrol station attendants than the comparison group.", {"entities": []}], ["All other blood picture parameters showed nonsignificant difference between both groups.", {"entities": []}], ["Liver enzymes, renal functions, serum albumin, and total protein showed statistically nonsignificant difference between both groups except for alanine aminotransferase (ALT) which was significantly higher in petrol station attendants.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Some laboratory parameters among petrol station attendants showed changes that could be attributed to workplace exposure and should be given attention at preemployment and periodic medical examination.", {"entities": []}], ["Cumulative lead exposure is associated with a widened pulse pressure (PP; the difference between systolic and diastolic blood pressure), a marker of arterial stiffness and a predictor of cardiovascular disease.", {"entities": []}], ["Polymorphisms in the hemochromatosis gene ( HFE ) have been shown to modify the impact of cumulative lead exposure on measures of adult cognition and cardiac function.", {"entities": [[21, 36, "DISEASE"], [44, 47, "GENE"]]}], ["We examined whether the HFE mutations modify the impact of lead on PP in community-dwelling older men.", {"entities": [[24, 27, "GENE"]]}], ["We examined 619 participants with a total of 1,148 observations of PP from a substudy of bone lead levels (a measure of cumulative exposure, measured by in vivo K-shell X-ray fluorescence) and health in the Normative Aging Study between 1991 and 2001.", {"entities": []}], ["Linear mixed-effects regression models with random intercepts were constructed.", {"entities": []}], ["Of the 619 subjects, 138 and 72 carried the HFE H63D and C282Y variants, respectively.", {"entities": [[44, 47, "GENE"]]}], ["After adjusting for age; education; alcohol intake; smoking; daily intakes of calcium, sodium, and potassium; total calories; family history of hypertension; diabetes; height; heart rate; high-density lipoprotein (HDL); total cholesterol:HDL ratio; and waist circumference, baseline bone lead levels were associated with steeper increases in PP in men with at least one H63D allele ( p -interaction = 0.03 for tibia and 0.02 for patella) compared with men with only the wild types or C282Y variant.", {"entities": [[144, 156, "DISEASE"]]}], ["The HFE H63D polymorphism, but not the C282Y mutation, appears to enhance susceptibility to the deleterious impact of cumulative lead on PP, possibly via prooxidative or pro-inflammatory mechanisms.", {"entities": [[4, 7, "GENE"]]}], ["Approximately 7% of children and young people aged 5\u201315 years in the UK have obesity at a level likely to be associated with comorbidities.", {"entities": [[77, 84, "DISEASE"]]}], ["The majority of multicomponent lifestyle programmes have limited applicability and generalisability for British adolescents.", {"entities": []}], ["The Healthy Eating and Lifestyle Programme (HELP) was a specific adolescent-focused intervention, designed for obese 12 to 18-year-olds seeking help to manage their weight.", {"entities": []}], ["Participants were randomised to the 12-session HELP intervention or standard care.", {"entities": []}], ["The primary outcome was difference in mean body mass index (BMI) (kg/m 174 subjects were randomised (87 in each arm), of whom 145 (83%) provided primary outcome data at week 26.", {"entities": []}], ["At week 26 there were no significant effects of the intervention on BMI (mean change in BMI 0.18\u2009kg/m At minimum this study reinforces the need for higher level, structured interventions to tackle the growing public health burden of obesity in the UK and internationally.", {"entities": [[233, 240, "DISEASE"]]}], ["The HELP intervention was no more effective than a single educational session for reducing BMI in a community sample of obese adolescents.", {"entities": []}], ["Further work is needed to understand how weight management programmes can be delivered effectively to young people from diverse and deprived backgrounds in which childhood obesity is common.", {"entities": [[172, 179, "DISEASE"]]}], ["The study has significant implications in terms of informing public health interventions to tackle childhood obesity.", {"entities": [[109, 116, "DISEASE"]]}], ["ISRCTN: ISRCTN99840111.", {"entities": []}], ["Microbubble-mediated sonoporation has shown its great potential in facilitating intracellular uptake of gene/drugs and other therapeutic agents that are otherwise difficult to enter cells.", {"entities": []}], ["However, the biophysical mechanisms underlying microbubble-cell interactions remain unclear.", {"entities": []}], ["Particularly, it is still a major challenge to get a comprehensive understanding of the impact of cell cycle phase on the cellular responses simultaneously occurring in cell membrane and cytoskeleton induced by microbubble sonoporation.", {"entities": []}], ["Methods: Here, efficient synchronizations were performed to arrest human cervical epithelial carcinoma (HeLa) cells in individual cycle phases.", {"entities": [[93, 102, "DISEASE"]]}], ["The, topography and stiffness of synchronized cells were examined using atomic force microscopy.", {"entities": []}], ["The variations in cell membrane permeabilization and cytoskeleton arrangement induced by sonoporation were analyzed simultaneously by a real-time fluorescence imaging system.", {"entities": []}], ["Results: The results showed that G1-phase cells typically had the largest height and elastic modulus, while S-phase cells were generally the flattest and softest ones.", {"entities": []}], ["Consequently, the S-Phase was found to be the preferred cycle for instantaneous sonoporation treatment, due to the greatest enhancement of membrane permeability and the fastest cytoskeleton disassembly at the early stage after sonoporation.", {"entities": []}], ["Conclusion: The current findings may benefit ongoing efforts aiming to pursue rational utilization of microbubble-mediated sonoporation in cell cycle-targeted gene/drug delivery for cancer therapy.", {"entities": [[182, 188, "DISEASE"]]}], ["Multi-walled carbon nanotubes (MWCNTs) are engineered nanomaterials used for a variety of industrial and consumer products.", {"entities": []}], ["Their high tensile strength, hydrophobicity, and semi-conductive properties have enabled many novel applications, increasing the possibility of accidental nanotube inhalation by either consumers or factory workers.", {"entities": []}], ["While MWCNT inhalation has been previously shown to cause inflammation and pulmonary fibrosis at high doses, the susceptibility of differentiating bronchial epithelia to MWCNT exposure remains unexplored.", {"entities": [[75, 93, "DISEASE"]]}], ["In this study, we investigate the effect of MWCNT exposure on cilia development in a differentiating air-liquid interface (ALI) model.", {"entities": []}], ["Primary bronchial epithelial cells (BECs) were isolated from human donors via bronchoscopy and treated with non-cytotoxic doses of MWCNTs in submerged culture for 24\u00a0h. Cultures were then allowed to differentiate in ALI for 28\u00a0days in the absence of further MWCNT exposure.", {"entities": []}], ["At 28\u00a0days, mucociliary differentiation endpoints were assessed, including whole-mount immunofluorescent staining, histological, immunohistochemical and ultrastructural analysis, gene expression, and cilia beating analysis.", {"entities": []}], ["We found a reduction in the prevalence and beating of ciliated cells in MWCNT-treated cultures, which appeared to be caused by a disruption of cellular microtubules and cytoskeleton during ciliogenesis and basal body docking.", {"entities": []}], ["Expression of gene markers of mucociliary differentiation, such as FOXJ1 and MUC5AC/B, were not affected by treatment.", {"entities": [[67, 72, "GENE"]]}], ["Colocalization of basal body marker CEP164 with \u03b3-tubulin during days 1\u20133 of ciliogenesis, as well as abundance of basal bodies up to day 14, were attenuated by treatment with MWCNTs.", {"entities": [[36, 42, "GENE"]]}], ["Our results suggest that a single exposure of bronchial cells to MWCNT during a vulnerable period before differentiation may impair their ability to develop into fully functional ciliated cells.", {"entities": []}], ["The online version of this article (10.1186/s12989-017-0225-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Pulmonary hypertension (PH) is a devastating, progressive disease with increasingly debilitating symptoms and usually shortened overall life expectancy due to a narrowing of the pulmonary vasculature and consecutive right heart failure.", {"entities": [[10, 22, "DISEASE"]]}], ["Little is known about PH in Africa, but limited reports suggest that PH is more prevalent in Africa compared with developed countries due to the high prevalence of risk factors in the region.", {"entities": []}], ["A multinational multicentre registry-type cohort study was established and tailored to resource-constraint settings to describe disease presentation, disease severity and aetiologies of PH, comorbidities, diagnostic and therapeutic management, and the natural course of PH in Africa.", {"entities": []}], ["PH will be diagnosed by specialist cardiologists using echocardiography (right ventricular systolic pressure >35\u2005mm\u2005Hg, absence of pulmonary stenosis and acute right heart failure), usually accompanied by shortness of breath, fatigue, peripheral oedema and other cardiovascular symptoms, ECG and chest X-ray changes in keeping with PH as per guidelines (European Society of Cardiology and European Respiratory Society (ESC/ERS) guidelines).", {"entities": []}], ["Additional investigations such as a CT scan, a ventilation/perfusion scan or right heart catheterisation will be performed at the discretion of the treating physician.", {"entities": []}], ["Functional tests include a 6\u2005min walk test and the Karnofsky Performance Score.", {"entities": []}], ["The WHO classification system for PH will be applied to describe the different aetiologies of PH.", {"entities": []}], ["Several substudies have been implemented within the registry to investigate specific types of PH and their outcome at up to 24\u2005months.", {"entities": []}], ["Data will be analysed by an independent institution following a data analyse plan.", {"entities": []}], ["All local ethics committees of the participating centres approved the protocol.", {"entities": []}], ["The data will be disseminated through peer-reviewed journals at national and international conferences and public events at local care providers.", {"entities": []}], ["IFN-\u03b3 induces the interaction of HDAC1 and p53, leading to p53 deacetylation, which facilitates autophagy via Bmf suppression.", {"entities": [[33, 38, "GENE"], [110, 113, "GENE"]]}], ["Interferon \u03b3 (IFN-\u03b3)\u2013induced cell death is mediated by the BH3-only domain protein, Bik, in a p53-independent manner.", {"entities": [[84, 87, "GENE"]]}], ["However, the effect of IFN-\u03b3 on p53 and how this affects autophagy have not been reported.", {"entities": []}], ["The present study demonstrates that IFN-\u03b3 down-regulated expression of the BH3 domain-only protein, Bmf, in human and mouse airway epithelial cells in a p53-dependent manner.", {"entities": [[100, 103, "GENE"]]}], ["p53 also suppressed Bmf expression in response to other cell death\u2013stimulating agents, including ultraviolet radiation and histone deacetylase inhibitors.", {"entities": [[20, 23, "GENE"]]}], ["IFN-\u03b3 did not affect Bmf messenger RNA half-life but increased nuclear p53 levels and the interaction of p53 with the Bmf promoter.", {"entities": [[21, 24, "GENE"], [118, 121, "GENE"], [21, 24, "GENE"], [118, 121, "GENE"]]}], ["IFN-\u03b3\u2013induced interaction of HDAC1 and p53 resulted in the deacetylation of p53 and suppression of Bmf expression independent of p53\u2019s proline-rich domain.", {"entities": [[29, 34, "GENE"], [99, 102, "GENE"]]}], ["Suppression of Bmf facilitated IFN-\u03b3\u2013induced autophagy by reducing the interaction of Beclin-1 and Bcl-2.", {"entities": [[15, 18, "GENE"]]}], ["Furthermore, autophagy was prominent in cultured bmf but not in bmf cells.", {"entities": [[49, 52, "GENE"], [64, 67, "GENE"], [49, 52, "GENE"], [64, 67, "GENE"]]}], ["Collectively, these observations show that deacetylation of p53 suppresses Bmf expression and facilitates autophagy.", {"entities": [[75, 78, "GENE"]]}], ["Athletes frequently experience gastrointestinal (GI) symptoms during training and competition.", {"entities": []}], ["Although the prevalence of exercise-induced GI symptoms is high, the mechanisms leading to GI distress during exercise are not fully understood.", {"entities": []}], ["The aim of this study was to identify running-induced changes in intestinal permeability and markers of GI function and investigate their association with gastrointestinal symptoms.", {"entities": []}], ["We recruited 17 active runners who we allocated as either asymptomatic or symptomatic based on their history of experiencing GI symptoms during running.", {"entities": []}], ["The participants took part in a running test where they were asked to run for 90\u00a0min at 80% of their best 10\u00a0km race speed.", {"entities": []}], ["Intestinal permeability was measured at baseline and after the running test.", {"entities": []}], ["Levels of serum intestinal fatty acid-binding protein (I-FABP), zonulin, bacterial lipopolysaccharide (LPS), and fecal calprotectin were also measured at baseline and after the running test.", {"entities": []}], ["Running induced a significant increase in intestinal permeability and serum I-FABP concentration but there were no differences between asymptomatic and symptomatic runners.", {"entities": []}], ["Serum LPS activity did not change from baseline following the running test but the symptomatic group exhibited higher LPS activity at baseline compared to the asymptomatic runners.", {"entities": []}], ["Running for 90\u00a0min at a challenging pace causes small intestinal damage and increases intestinal permeability.", {"entities": []}], ["However, these alterations in GI function do not appear to correlate with the development of GI symptoms during running.", {"entities": []}], ["The city of Zarghan is located 25\u2009km northeast of Shiraz, southern Iran.", {"entities": []}], ["Zarghan is affected by numerous pollution sources such as oil refinery, an industrial park, and Shiraz-Tehran highway.", {"entities": []}], ["The numerous contaminating sources around Zarghan can cause serious local air pollution.", {"entities": []}], ["Sulfur dioxide gas is an important index of air pollution in cities.", {"entities": []}], ["Therefore, in order to control and manage Zarghan air quality, it is important to monitor sulfur dioxide concentration in the surrounding area.", {"entities": []}], ["It is also essential to know about the contribution level of other sources of pollution as well as dispersion radius of pollutants in the area.", {"entities": []}], ["In this study, the concentration of sulfur dioxide was measured by passive sampling at 10 different stations.", {"entities": []}], ["These values were interpolated in other parts of the city using ArcGIS software.", {"entities": []}], ["The results of sampling showed that the concentration of the gas was 60\u2009 \u00b5 gm \u00b5 gm", {"entities": []}], ["Acute COPD exacerbations account for much of the rising disability and costs associated with COPD, but data on predictive risk factors are limited.", {"entities": []}], ["The goal of the current study was to develop a robust, clinically based model to predict frequent exacerbation risk.", {"entities": []}], ["Patients identified from the Optimum Patient Care Research Database (OPCRD) with a diagnostic code for COPD and a forced expiratory volume in 1 second/forced vital capacity ratio <0.7 were included in this historical follow-up study if they were \u226540 years old and had data encompassing the year before (predictor year) and year after (outcome year) study index date.", {"entities": []}], ["The data set contained potential risk factors including demographic, clinical, and comorbid variables.", {"entities": []}], ["Following univariable analysis, predictors of two or more exacerbations were fed into a stepwise multivariable logistic regression.", {"entities": []}], ["Sensitivity analyses were conducted for subpopulations of patients without any asthma diagnosis ever and those with questionnaire data on symptoms and smoking pack-years.", {"entities": [[79, 85, "DISEASE"]]}], ["The full predictive model was validated against 1 year of prospective OPCRD data.", {"entities": []}], ["The full data set contained 16,565 patients (53% male, median age 70 years), including 9,393 patients without any recorded asthma and 3,713 patients with questionnaire data.", {"entities": [[123, 129, "DISEASE"]]}], ["The full model retained eleven variables that significantly predicted two or more exacerbations, of which the number of exacerbations in the preceding year had the strongest association; others included height, age, forced expiratory volume in 1 second, and several comorbid conditions.", {"entities": []}], ["Significant predictors not previously identified included eosinophilia and COPD Assessment Test score.", {"entities": [[58, 70, "DISEASE"]]}], ["The predictive ability of the full model ( C statistic 0.751) changed little when applied to the validation data set (n=2,713; C statistic 0.735).", {"entities": []}], ["Results of the sensitivity analyses supported the main findings.", {"entities": []}], ["Patients at risk of exacerbation can be identified from routinely available, computerized primary care data.", {"entities": []}], ["Further study is needed to validate the model in other patient populations.", {"entities": []}], ["The stiffness sensing ability is required to respond to the stiffness of the matrix.", {"entities": []}], ["Here we determined whether normal cells and cancer cells display distinct mechanical phenotypes.", {"entities": [[44, 50, "DISEASE"]]}], ["Cancer cells were softer than their normal counterparts, regardless of the type of cancer (breast, bladder, cervix, pancreas, or Ha-Ras", {"entities": [[0, 6, "DISEASE"], [83, 89, "DISEASE"]]}], ["In contrast with the frequency distribution of chronic obstructive pulmonary disease (COPD) stages in the population, in which the majority of the patients is classified as GOLD 2, much less information is available on the prevalence and implications of systemic manifestations in less severe patients relative to GOLD 3 and 4.", {"entities": [[47, 84, "DISEASE"]]}], ["To characterize local and systemic impairment in relation to disease burden in a group of GOLD 2 COPD patients (n = 127, forced expiratory volume in one second (SD): 67 (11)% pred) that were eligible for the Interdisciplinary Community-based COPD management (INTERCOM) trial.", {"entities": []}], ["Patients were included for this lifestyle program based on a peak exercise capacity (Wmax) <70% of predicted.", {"entities": []}], ["Metabolic and ventilatory response to incremental cycle ergometry, 6 minute walking distance (6MWD), constant work rate test (CWR), lung function, maximal inspiratory pressure (Pimax), quadriceps force (QF), quadriceps average power (QP) (isokinetic dynamometry), handgrip force (HGF) and body composition were measured.", {"entities": [[280, 283, "GENE"]]}], ["Quality of life (QoL) was assessed by the St. George\u2019s Respiratory Questionnaire (SGRQ) and dyspnea by the modified Medical Research Council (MRC) dyspnea scale.", {"entities": []}], ["Exacerbations and COPD-associated hospital admissions in 12 months prior to the start of the study were recorded.", {"entities": []}], ["Burden of disease was defined in terms of exercise capacity, QoL, hospitalization, and exacerbation frequency.", {"entities": []}], ["GOLD 2 patients were compared with reference values and with GOLD 3 patients who were also included in the trial.", {"entities": []}], ["HGF (77.7 (18.8) % pred) and Pimax (67.1 (22.5)% pred) were impaired in GOLD 2, while QF (93.5 (22.5)% pred) was only modestly decreased.", {"entities": [[0, 3, "GENE"]]}], ["Depletion of FFM was present in 15% of weight stable GOLD 2 patients while only 2% had experienced recent involuntary weight loss.", {"entities": []}], ["In contrast to Wmax, submaximal exercise capacity, muscle function, and body composition were not significantly different between GOLD 2 and 3 subgroups.", {"entities": []}], ["Body mass index and fat-free mass index were significantly lower in smokers compared to ex-smokers.", {"entities": []}], ["In multivariate analysis, QF and diffusing capacity (DLco) were independently associated with Wmax and 6 MWD in GOLD 2 while only 6 MWD was identified as an independent determinant of health-related QoL.", {"entities": []}], ["HGF was an independent predictor of hospitalization.", {"entities": [[0, 3, "GENE"]]}], ["This study shows that also in patients with moderate COPD, eligible for a lifestyle program based on a decreased exercise capacity, systemic impairment is an important determinant of disease burden and that smoking affects body composition.", {"entities": []}], ["Inhaler technique can be corrected with training, but skills drop off quickly without repeated training.", {"entities": []}], ["The aim of our study was to explore the effect of novel inhaler technique labels on the retention of correct inhaler technique.", {"entities": []}], ["In this single-blind randomized parallel-group active-controlled study, clinical pharmacists enrolled asthma patients using controller medication by Accuhaler [Diskus] or Turbuhaler.", {"entities": [[102, 108, "DISEASE"]]}], ["Inhaler technique was assessed using published checklists (score 0\u20139).", {"entities": []}], ["Symptom control was assessed by asthma control test.", {"entities": [[32, 38, "DISEASE"]]}], ["Patients were randomized into active (ACCa; THa) and control (ACCc; THc) groups.", {"entities": []}], ["All patients received a \u201cShow-and-Tell\u201d inhaler technique counseling service.", {"entities": []}], ["Active patients also received inhaler labels highlighting their initial errors.", {"entities": []}], ["Baseline data were available for 95 patients, 68% females, mean age 44.9 (SD 15.2) years.", {"entities": []}], ["Mean inhaler scores were ACCa:5.3\u2009\u00b1\u20091.0; THa:4.7\u2009\u00b1\u20090.9, ACCc:5.5\u2009\u00b1\u20091.1; THc:4.2\u2009\u00b1\u20091.0.", {"entities": []}], ["Asthma was poorly controlled (mean ACT scores ACCa:13.9\u2009\u00b1\u20094.3; THa:12.1\u2009\u00b1\u20093.9; ACCc:12.7\u2009\u00b1\u20093.3; THc:14.3\u2009\u00b1\u20093.7).", {"entities": [[0, 6, "DISEASE"]]}], ["After training, all patients had correct technique (score 9/9).", {"entities": []}], ["After 3 months, there was significantly less decline in inhaler technique scores for active than control groups (mean difference: Accuhaler \u22121.04 (95% confidence interval \u22121.92, \u22120.16, P \u2009=\u20090.022); Turbuhaler \u22121.61 (\u22122.63, \u22120.59, P \u2009=\u20090.003).", {"entities": []}], ["Symptom control improved significantly, with no significant difference between active and control patients, but active patients used less reliever medication (active 2.19 (SD 1.78) vs. control 3.42 (1.83) puffs/day, P \u2009=\u20090.002).", {"entities": []}], ["After inhaler training, novel inhaler technique labels improve retention of correct inhaler technique skills with dry powder inhalers.", {"entities": []}], ["Inhaler technique labels represent a simple, scalable intervention that has the potential to extend the benefit of inhaler training on asthma outcomes.", {"entities": [[135, 141, "DISEASE"]]}], ["Personalized labels on asthma inhalers remind patients of correct technique and help improve symptoms over time.", {"entities": [[23, 29, "DISEASE"]]}], ["Iman Basheti at the Applied Science Private University in Jordan and co-workers trialed the approach of placing patient-specific reminder labels on dry-powder asthma inhalers to improve long-term technique.", {"entities": [[159, 165, "DISEASE"]]}], ["Poor asthma control is often exacerbated by patients making mistakes when using their inhalers.", {"entities": [[5, 11, "DISEASE"]]}], ["During the trial, 95 patients received inhaler training before being split into two groups: the control group received no further help, while the other group received individualized labels on their inhalers reminding them of their initial errors.", {"entities": []}], ["After three months, 67% of patients with reminder labels retained correct technique compared to only 12% of controls.", {"entities": []}], ["They also required less reliever medication and reported improved symptoms.", {"entities": []}], ["This represents a simple, cheap way of tackling inhaler technique errors.", {"entities": []}], ["This prospective study focuses on risk factors for arterial damage in children with type 1 diabetes (T1D).", {"entities": []}], ["Eighty children and adolescents with T1D were investigated twice, approximately 2\u00a0years apart, for carotid artery intima-media thickness (cIMT) and compliance (CAC), flow-mediated dilatation (FMD) of the brachial artery, and plasma levels of matrix metalloproteinase (MMP)-8.", {"entities": []}], ["All subjects were genotyped for HLA.", {"entities": [[32, 35, "GENE"]]}], ["The number of respiratory tract infections (RTI) during the past year was obtained by a questionnaire in 56 patients.", {"entities": []}], ["cIMT progression, defined as percentage (%) change of cIMT from baseline, correlated inversely with the % changes of both CAC ( p \u00a0=\u00a00.04, r \u00a0=\u00a0\u2212\u00a00.3; n \u00a0=\u00a062) and FMD ( p \u00a0=\u00a00.03, r \u00a0=\u00a0\u2212\u00a00.3; n \u00a0=\u00a047).", {"entities": []}], ["In multivariate analysis, RTI frequency correlated significantly with cIMT progression irrespective of age, diabetes duration, BMI, and HbA1c ( p \u00a0=\u00a00.03, r \u00a0=\u00a00.3).", {"entities": []}], ["When patients were divided in relation to RTI, the association of DQ2/8 with cIMT progression remained significant in patients with over three infections/year ( p \u00a0=\u00a00.04, r \u00a0=\u00a00.3).", {"entities": []}], ["During follow-up, the group of DQ2/8 patients with hsCRP\u00a0>\u00a01\u00a0mg/l showed significantly higher levels of plasma MMP-8 than the non-DQ2/8 group.", {"entities": []}], ["The diabetes-risk genotype DQ2/8 and systemic inflammation contribute to pro-atherosclerotic vascular changes in children and adolescents with T1D.", {"entities": []}], ["To determine the influence of polymorphisms of the beta-2 adrenergic receptor (ADRB2) in triggering exercise-induced bronchospasm (EIB) in adolescents.", {"entities": [[79, 84, "GENE"]]}], ["The subjects were divided into two groups: present EIB (EIB+) (n=45) and absent EIB (EIB\u2212) (n=115).", {"entities": []}], ["The bronchial provocation test with exercise was performed with a protocol that consisted of walking/running for at least eight minutes at high intensity, i.e., >85% of maximum heart rate, considering EIB+ as a 10% decrease in forced expiratory volume in one second (FEV 1 ).", {"entities": [[267, 270, "GENE"]]}], ["The genotyping of the ADRB2 gene was performed by the Taqman method, using the Step One Plus system.", {"entities": [[22, 27, "GENE"]]}], ["Independent t -test, Mann\u2013Whitney and Chi-square tests, as well as Spearman's correlation coefficient were used for the statistical analysis.", {"entities": []}], ["Age, body weight, height, FEV 1 , FVC and FEV 1 /FVC ratio were lower in the EIB+ group when compared to EIB\u2212 ( p <0.05).", {"entities": [[26, 29, "GENE"], [42, 45, "GENE"], [26, 29, "GENE"], [42, 45, "GENE"]]}], ["There were no significant differences in the proportion of the allele at position 27 and Arg16Gly and Gln27Glu genotypes between the EIB+ and EIB\u2212 groups ( p =0.26; p =0.97 and p =0.43, respectively).", {"entities": []}], ["However, there was a trend toward statistical significance regarding the greater proportion of the Gly16 allele for the EIB+ when compared to the EIB\u2212 group ( p =0.08).", {"entities": []}], ["The presence of polymorphisms associated with the Glu27 allele and Arg16Gly and Gln27Glu genotypes had no influence on EIB.", {"entities": []}], ["However, the statistical trend toward greater frequency of the Gly16 allele in individuals with EIB+ can be considered evidence of the influence of polymorphisms of the ADBR2 gene on EIB in adolescents.", {"entities": []}], ["Determinar a influ\u00eancia dos polimorfismos dos receptores adren\u00e9rgicos beta 2 ( ADRB2 ) no desencadeamento de broncoespasmo induzido pelo exerc\u00edcio (BIE) em adolescentes.", {"entities": [[79, 84, "GENE"], [132, 136, "GENE"]]}], ["Os sujeitos foram divididos em dois grupos: BIE presente (BIE+) (n=45) e BIE ausente (BIE\u2212) (n=115).", {"entities": []}], ["O teste de broncoprovoca\u00e7\u00e3o com exerc\u00edcio foi feito com protocolo que consistiu em caminhar/correr durante no m\u00ednimo oito minutos em intensidade superior a 85% da frequ\u00eancia card\u00edaca m\u00e1xima, considerando como BIE presente uma queda de 10% do volume expirat\u00f3rio for\u00e7ado no primeiro segundo (VEF 1 ).", {"entities": []}], ["A genotipagem do gene ADRB2 foi feita pelo m\u00e9todo Taqman por meio do aparelho Step One Plus.", {"entities": [[22, 27, "GENE"], [38, 42, "GENE"], [57, 60, "GENE"]]}], ["Para an\u00e1lise estat\u00edstica usaram-se os testes t independente, U de Mann-Whitney, qui-quadrado e coeficiente de correla\u00e7\u00e3o de Spearman.", {"entities": []}], ["Idade, massa corporal, estatura, VEF 1 , CVF e rela\u00e7\u00e3o VEF 1 /CVF foram menores no grupo BIE+ em compara\u00e7\u00e3o com o BIE\u2212 ( p <0,05).", {"entities": []}], ["N\u00e3o houve diferen\u00e7as significativas na propor\u00e7\u00e3o do alelo na posi\u00e7\u00e3o 27 e dos gen\u00f3tipos Arg16Gly e Gln27Glu entre os grupos BIE+ e BIE\u2212 ( p =0,26; p =0,97 e p =0,43, respectivamente).", {"entities": []}], ["Entretanto, verificou-se uma tend\u00eancia \u00e0 signific\u00e2ncia estat\u00edstica na maior propor\u00e7\u00e3o do alelo Gly16 para o grupo BIE+ comparado com o BIE\u2212 ( p =0,08).", {"entities": []}], ["A presen\u00e7a de polimorfismos associados ao alelo Glu27 e os gen\u00f3tipos Arg16Gly e Gln27Glu n\u00e3o influenciam no BIE.", {"entities": []}], ["Por\u00e9m, a tend\u00eancia estat\u00edstica observada para uma maior frequ\u00eancia do alelo Gly16 nos indiv\u00edduos com a presen\u00e7a de BIE pode ser considerado ind\u00edcio da influ\u00eancia de polimorfismos no gene ADBR2 no BIE em adolescentes.", {"entities": []}], ["Alpha 1 antitrypsin deficiency is a hereditary condition characterized by low alpha 1 proteinase inhibitor (also known as alpha 1 antitrypsin [AAT]) serum levels.", {"entities": []}], ["Reduced levels of AAT allow abnormal degradation of lung tissue, which may ultimately lead to the development of early-onset emphysema.", {"entities": []}], ["Intravenous infusion of AAT is the only therapeutic option that can be used to maintain levels above the protective threshold.", {"entities": []}], ["Based on its biochemical efficacy, AAT replacement therapy was approved by the US Food and Drug administration in 1987.", {"entities": []}], ["However, there remained considerable interest in selecting appropriate outcome measures that could confirm clinical efficacy in a randomized controlled trial setting.", {"entities": []}], ["Using computed tomography as the primary measure of decline in lung density, the capacity for intravenously administered AAT replacement therapy to slow and modify the course of disease progression was demonstrated for the first time in the Randomized, Placebo-controlled Trial of Augmentation Therapy in Alpha-1 Proteinase Inhibitor Deficiency (RAPID) trial.", {"entities": []}], ["Following these results, an expert review forum was held at the European Respiratory Society to discuss the findings of the RAPID trial program and how they may change the landscape of alpha 1 antitrypsin emphysema treatment.", {"entities": []}], ["This review summarizes the results of the RAPID program and the implications for clinical considerations with respect to diagnosis, treatment and management of emphysema due to alpha 1 antitrypsin deficiency.", {"entities": []}], ["Genome-wide association studies (GWAS) have generated sufficient data to assess the role of selection in shaping allelic diversity of disease-associated SNPs.", {"entities": []}], ["Negative selection against disease risk variants is expected to reduce their frequencies making them overrepresented in the group of minor (<50%) alleles.", {"entities": []}], ["Indeed, we found that the overall proportion of risk alleles was higher among alleles with frequency <50% (minor alleles) compared to that in the group of major alleles.", {"entities": []}], ["We hypothesized that negative selection may have different effects on environment (or lifestyle)-dependent versus environment (or lifestyle)-independent diseases.", {"entities": []}], ["We used an environment/lifestyle index (ELI) to assess influence of environmental/lifestyle factors on disease etiology.", {"entities": []}], ["ELI was defined as the number of publications mentioning \u201cenvironment\u201d or \u201clifestyle\u201d AND disease per 1,000 disease-mentioning publications.", {"entities": []}], ["We found that the frequency distributions of the risk alleles for the diseases with strong environmental/lifestyle components follow the distribution expected under a selectively neutral model, while frequency distributions of the risk alleles for the diseases with weak environmental/lifestyle influences is shifted to the lower values indicating effects of negative selection.", {"entities": []}], ["We hypothesized that previously selectively neutral variants become risk alleles when environment changes.", {"entities": []}], ["The hypothesis of ancestrally neutral, currently disadvantageous risk-associated alleles predicts that the distribution of risk alleles for the environment/lifestyle dependent diseases will follow a neutral model since natural selection has not had enough time to influence allele frequencies.", {"entities": []}], ["The results of our analysis suggest that prediction of SNP functionality based on the level of evolutionary conservation may not be useful for SNPs associated with environment/lifestyle dependent diseases.", {"entities": []}], ["We reviewed several thousand genome wide association studies that were conducted to identify genetic variants influencing risk of human diseases.", {"entities": []}], ["We tested the hypothesis that single nucleotide polymorphisms (SNPs) that influence disease risk undergo positive or negative selection more frequently than an average SNP in the human genome.", {"entities": []}], ["We found no evidence for excess of positive selection on disease-associated SNPs.", {"entities": []}], ["At the same time we found that alleles associated with a higher disease risk undergo negative selection.", {"entities": []}], ["We also demonstrated that risk alleles for diseases with strong influence of environment/lifestyle factors (e.g.", {"entities": []}], ["Type II diabetes) show little evidence of negative selection, while risk alleles for diseases with weak influence of environment/lifestyle factors (e.g.", {"entities": []}], ["Pathological myopia) show clear signs of negative selection.", {"entities": [[13, 19, "DISEASE"]]}], ["The approach used in this study can be used to estimate the number of genetic variants in the human genome influencing risk of human diseases.", {"entities": []}], ["Despite rapid growth in biofuel production worldwide, it is uncertain whether decision-makers possess sufficient information to fully evaluate the impacts of the industry and avoid unintended consequences.", {"entities": []}], ["Doing so requires rigorous peer-reviewed data and analyses across the entire range of direct and indirect effects.", {"entities": []}], ["To assess the coverage of scientific research, we analyzed over 1600 peer-reviewed articles published between 2000 and 2009 that addressed 23 biofuels-related topics within four thematic areas: environment and human well-being, economics, technology, and geography.", {"entities": []}], ["Greenhouse gases, fuel production, and feedstock production were well-represented in the literature, while trade, biodiversity, and human health were not.", {"entities": []}], ["Gaps were especially striking across topics in the Southern Hemisphere, where the greatest potential socio-economic benefits, as well as environmental damages, may co-occur.", {"entities": []}], ["There was strong asymmetry in the connectedness of research topics; greenhouse gases articles were twice as often connected to other topics as biodiversity articles.", {"entities": []}], ["This could undermine the ability of scientific and economic analyses to adequately evaluate impacts and avoid significant unintended consequences.", {"entities": []}], ["At the least, our review suggests caution in this developing industry and the need to pursue more interdisciplinary research to assess complex trade-offs and feedbacks inherent to an industry with wide-reaching potential impacts.", {"entities": []}], ["The aim of this study was to evaluate the 30-year progress of research on exhaled breath condensate in a disease-based approach.", {"entities": []}], ["We searched PubMed/Medline, ScienceDirect, and Google Scholar using the following keywords: exhaled breath condensate (EBC), biomarkers, pH, asthma, gastroesophageal reflux (GERD), smoking, COPD, lung cancer, NSCLC, mechanical ventilation, cystic fibrosis, pulmonary arterial hypertension (PAH), idiopathic pulmonary fibrosis, interstitial lung diseases, obstructive sleep apnea (OSA), and drugs.", {"entities": [[276, 288, "DISEASE"], [196, 207, "DISEASE"], [240, 255, "DISEASE"], [307, 325, "DISEASE"], [141, 147, "DISEASE"], [296, 325, "DISEASE"], [201, 207, "DISEASE"]]}], ["We found 12600 related articles in total in Google Scholar, 1807 in ScienceDirect, and 1081 in PubMed/Medline, published from 1980 to October 2014.", {"entities": []}], ["228 original investigation and review articles were eligible.", {"entities": []}], ["Conclusions .", {"entities": []}], ["There is rapidly increasing number of innovative articles, covering all the areas of modern respiratory medicine and expanding EBC potential clinical applications to other fields of internal medicine.", {"entities": []}], ["However, the majority of published papers represent the results of small-scale studies and thus current knowledge must be further evaluated in large cohorts.", {"entities": []}], ["In regard to the potential clinical use of EBC-analysis, several limitations must be pointed out, including poor reproducibility of biomarkers and absence of large surveys towards determination of reference-normal values.", {"entities": []}], ["In conclusion, contemporary EBC-analysis is an intriguing achievement, but still in early stage when it comes to its application in clinical practice.", {"entities": []}], ["While chronic glucocorticoid (GC) therapy leads to ocular hypertension in about one third of individuals, almost all primary open-angle glaucoma (POAG) patients show this response and are called \u201csteroid responders.\u201d Two differentially spliced isoforms of the glucocorticoid receptor (GR), GR\u03b1 and GR\u03b2, regulate GC responsiveness in trabecular meshwork (TM) cells.", {"entities": [[58, 70, "DISEASE"], [51, 70, "DISEASE"], [136, 144, "DISEASE"], [125, 144, "DISEASE"], [30, 32, "GENE"], [312, 314, "GENE"], [30, 32, "GENE"], [312, 314, "GENE"]]}], ["GR\u03b2 acts as a dominant negative regulator of GC activity and is expressed at lower levels in glaucomatous TM cells, making them more sensitive to GCs.", {"entities": [[45, 47, "GENE"]]}], ["Several arginine/serine-rich splicing factor (SR) proteins have been implicated in alternative splicing of the GR.", {"entities": []}], ["We have previously demonstrated that immunophilins FKBP5 and FKBP4 are required for GR\u03b1 and GR\u03b2 translocation into the nucleus, which is essential for their biologic activity.", {"entities": [[51, 56, "GENE"], [61, 66, "GENE"]]}], ["The purpose of the present study was to use single nucleotide polymorphism (SNP) genotyping to determine whether there are any allele frequency differences in GR , FKBP4/5 , or SR genes between normal control, POAG, and steroid responder populations.", {"entities": []}], ["Clinically characterized individuals (400 normal controls, 197 POAG, and 107 steroid responders) were recruited from the U. Iowa Ophthalmology Clinics after IRB approved consent.", {"entities": []}], ["Genotyping of DNA samples for 48 SNPs in SFRS3 , SFRS5 , SFRS9 , FKBP4 , FKBP5 , and NR3C1 was done at GeneSeek using a mass spectroscopy based system.", {"entities": [[65, 70, "GENE"], [73, 78, "GENE"], [85, 90, "GENE"]]}], ["All 48 SNPs displayed high call rates (99%).", {"entities": []}], ["There were no significant differences in allele frequencies or genotypes in SNPs for SFRS5 , SFRS9 , FKBP4 , FKBP5 , and NR3C1 between the 3 groups.", {"entities": [[101, 106, "GENE"], [109, 114, "GENE"], [121, 126, "GENE"]]}], ["Up to three SNPs in SFRS3 had p-values <0.05 when comparing controls to POAG or steroid responders, but this statistical significance was lost when the p values were adjusted for multiple measures.", {"entities": []}], ["Although these 6 genes may be involved in the pathogenesis of GC-induced ocular hypertension, it does not appear that major heritable risk alleles in these genes are responsible for the development of GC-induced ocular hypertension or POAG.", {"entities": [[80, 92, "DISEASE"], [219, 231, "DISEASE"], [73, 92, "DISEASE"], [212, 231, "DISEASE"]]}], ["We previously reported a progressive decline in absolute responses of FEV 1 and FVC to a near-maximal dose of 2 different short-acting bronchodilators over 4\u00a0years.", {"entities": [[70, 73, "GENE"]]}], ["Since varying host factors and the method of expressing the response may impact the time trend of acute bronchodilator responses, we now examined the potential influence of salient host characteristics on changes in bronchodilator responses over time expressed in different ways.", {"entities": []}], ["As part of the 4-year, placebo-controlled Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT) trial, pre- and post-bronchodilator spirometry was performed at baseline and 1\u00a0month and every 6\u00a0months thereafter.", {"entities": []}], ["Post-bronchodilator values for FEV 1 and FVC were analyzed for subjects completing at least the 1\u00a0year visit (Placebo \u2013 N\u2009=\u20092463; Tiotropium \u2013 N\u2009=\u20092579), stratified by GOLD stage, age, gender and smoking status and expressed as absolute, relative (%) and % predicted changes from pre-bronchodilator values.", {"entities": [[31, 34, "GENE"]]}], ["Annual changes in bronchodilator response were estimated using linear mixed effects models.", {"entities": []}], ["For all subjects analyzed, FEV 1 and FVC bronchodilator responses showed progressive and highly significant (p\u2009<\u20090.0001) declines over 4\u00a0years.", {"entities": [[27, 30, "GENE"]]}], ["Declines were generally larger in patients with severe/very severe than mild/moderate airflow obstruction, in older patients (\u226565 yrs) and in former than continuing smokers.", {"entities": []}], ["Acute FEV 1 and FVC responses to bronchodilators decline significantly over time in COPD patients, whether expressed as absolute, relative or % predicted changes, potentially impacting on the clinical responses to bronchodilator therapy as well as on the annual rate of decline in post-bronchodilator lung function.", {"entities": [[6, 9, "GENE"]]}], ["NCT00144339 The online version of this article (doi:10.1186/s12931-014-0102-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Overweight and obesity are serious threats to health and increase healthcare utilization and costs.", {"entities": [[15, 22, "DISEASE"]]}], ["The Obesity Prevention Tailored for Health (OPT) study was designed to test the effectiveness of a family-based intervention targeting diet and physical activity.", {"entities": [[4, 11, "DISEASE"]]}], ["We describe the results of efforts to recruit parents and children enrolled in a large managed-care organization into the OPT study.", {"entities": []}], ["Parents with 10- to 12-year-old children were randomly selected from the membership of Kaiser Permanente Southern California, a large integrated health plan, and contacted between June 2010 and November 2011.", {"entities": []}], ["We describe recruitment outcomes and compare characteristics of parents and children who did and did not participate.", {"entities": []}], ["Information was collected from calls with parents and through the administrative and electronic medical records of the health plan.", {"entities": []}], ["Of the 4,730 parents contacted, 16.1% expressed interest in participation (acceptors), 28.8% declined participation (refusers), 4.7% were ineligible, and, even after multiple attempts, we were unable to reach 50.4%.", {"entities": []}], ["Slightly less than half of the acceptors (n\u2009=\u2009361) were ultimately randomized to receive either the OPT program plus usual care or usual care alone (7.6% of all parents initially contacted).", {"entities": []}], ["There were not any significant differences between acceptors who were or were not randomized.", {"entities": []}], ["Overall, we found that acceptors were more likely to be female parents, have overweight/obese children, and higher utilization of outpatient visits by parents and children compared with refusers and those we were unable to reach.", {"entities": []}], ["We found no differences in recruitment outcomes by body mass index or comorbidity score of the parents, level of physical activity of the parents and children, education of the parents, or household income.", {"entities": []}], ["Recruiting parents and children into an obesity prevention program in a healthcare setting proved to be challenging and resource-intensive.", {"entities": [[40, 47, "DISEASE"]]}], ["Barriers and incentives for participation in obesity prevention programs need to be identified and addressed.", {"entities": [[45, 52, "DISEASE"]]}], ["Concern for the weight of their children may motivate parents to participate in family-based lifestyle interventions; however, the healthcare setting may be more relevant to weight-related treatment than to primary prevention.", {"entities": []}], ["Trial Registration Number: ISRCTN06248443 , 30 January 2014.", {"entities": []}], ["Psoriasis is an inflammatory disease characterized by the abnormal proliferation of skin cells, including dermal microvascular endothelial cells.", {"entities": [[0, 9, "DISEASE"]]}], ["Recently, chemokine-like factor 1 (CKLF1) was found to participate in the local inflammation and cell proliferation.", {"entities": []}], ["To explore its role in the pathogenesis of psoriasis, the expression of both CKLF1 and its receptor (CCR4) was determined in the psoriatic lesions.", {"entities": [[43, 52, "DISEASE"], [101, 105, "GENE"]]}], ["Also, the effect of the C-terminal peptides (C19 and C27) of CKLF1 on the proliferation of human umbilical vein endothelial cells was studied in vitro.", {"entities": []}], ["By immunohistochemistry and immunofluorescence, the expression of both CKLF1 and CCR4 was determined in the psoriatic lesions.", {"entities": [[81, 85, "GENE"]]}], ["The effect of C-terminal peptides on human umbilical vein endothelial cells (HUVECs) was studied in vitro by the evaluation of cell proliferation and apoptosis.", {"entities": []}], ["The in vivo assessment was performed accordingly through the subcutaneous injection peptides on BALB/c mice.", {"entities": []}], ["The results showed that, by immunohistochemistry, both CKLF1 and CCR4 were increasingly expressed in psoriatic lesions as compared to normal skins.", {"entities": [[65, 69, "GENE"]]}], ["Moreover, the primary umbilical vein endothelial cells exhibited higher proliferation ratio under the C19 or C27 stimulation, which was even enhanced by the addition of psoriatic sera or TNF-\u03b1.", {"entities": []}], ["Furthermore, the enhancement of peptide simulation was accompanied with the activation of ERK1/2-MAPKs pathway.", {"entities": []}], ["In addition, such effect of C19 and C27 was mirrored by the hyperproliferation of cutaneous microvessels in BALB/c mice that were subcutaneously injected with the two peptides.", {"entities": []}], ["Therefore, we concluded that CKLF1 plays a role in the pathogenesis of psoriasis by promoting the proliferation of microvascular endothelial cells that possibly correlates with ERK1/2-MAPKs activation.", {"entities": [[71, 80, "DISEASE"]]}], ["Chlamydia trachomatis is a very common sexually transmissible infection in both developing and developed countries.", {"entities": []}], ["A hallmark of C. trachomatis infection is the induction of severe inflammatory responses which play critical roles in its pathogenesis.", {"entities": []}], ["Antibiotics are the only treatment option currently available for controlling C. trachomatis infection; however, they are efficacious only when administered early after an infection.", {"entities": []}], ["The objectives of this study are to explore alternative strategies in the control and regulation of inflammatory responses triggered by a C. trachomatis infection.", {"entities": []}], ["We employed silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles, which have been shown to possess anti-inflammatory properties, as our target and the in vitro mouse J774 macrophage model of C. trachomatis infection.", {"entities": []}], ["Our hypothesis is that small sizes of Ag-PVP nanoparticles will control inflammatory mediators triggered by a C. trachomatis infection.", {"entities": []}], ["Cytotoxicity studies using Ag-PVP nanoparticles of 10, 20, and 80 nm sizes revealed >80% macrophage viability up to a concentration of 6.25 \u03bcg/mL, with the 10 nm size being the least toxic.", {"entities": []}], ["All sizes of Ag-PVP nanoparticles, especially the 10 nm size, reduced the levels of the prototypic cytokines, tumor necrosis factor (TNF) and interleukin (IL)-6, as elicited from C. trachomatis infected macrophages.", {"entities": [[133, 136, "GENE"]]}], ["Additionally, Ag-PVP nanoparticles (10 nm) selectively inhibited a broad spectrum of other cytokines and chemokines produced by infected macrophages.", {"entities": []}], ["Of significance, Ag-PVP nanoparticles (10 nm) caused perturbations in a variety of upstream (toll like receptor 2 [TLR2], nucleotide-binding oligomerization-protein 2 [NOD2], cluster of differentiation [CD]40, CD80, and CD86) and downstream (IL-1 receptor-associated kinase 3 [IRAK3] and matrix metallopeptidase 9 [MMP9]) inflammatory signaling pathways by downregulating their messenger ribonucleic acid (mRNA) gene transcript expressions as induced by C. trachomatis in macrophages.", {"entities": [[115, 119, "GENE"], [168, 172, "GENE"], [210, 214, "GENE"], [220, 224, "GENE"], [277, 282, "GENE"], [315, 319, "GENE"]]}], ["Collectively, our data provides further evidence for the anti-inflammatory properties of Ag-PVP nanoparticles, and opens new possibilities for smaller sizes of Ag-PVP nanoparticles to be employed as regulators of inflammatory responses induced by C. trachomatis .", {"entities": []}], ["The mechanisms by which increased mortality and morbidity occur in individuals with preexistent cardiopulmonary disease following acute episodes of air pollution are unknown.", {"entities": []}], ["Studies involving air pollution effects on animal models of human cardiopulmonary diseases are both infrequent and difficult to interpret.", {"entities": []}], ["Such models are, however, extensively used in studies of disease pathogenesis.", {"entities": []}], ["Primarily they comprise those developed by genetic, pharmacologic, or surgical manipulations of the cardiopulmonary system.", {"entities": []}], ["This review attempts a comprehensive description of rodent cardiopulmonary disease models in the context of their potential application to susceptibility studies of air pollutants regardless of whether the models have been previously used for such studies.", {"entities": []}], ["The pulmonary disease models include bronchitis, emphysema, asthma/allergy, chronic obstructive pulmonary disease, interstitial fibrosis, and infection.", {"entities": [[76, 113, "DISEASE"], [60, 66, "DISEASE"], [37, 47, "DISEASE"]]}], ["The models of systemic hypertension and congestive heart failure include: those derived by genetics (spontaneously hypertensive, Dahl S. renin transgenic, and other rodent models); congestive heart failure models derived by surgical manipulations; viral myocarditis; and cardiomyopathy induced by adriamycin.", {"entities": [[40, 64, "DISEASE"], [181, 205, "DISEASE"], [23, 35, "DISEASE"], [271, 285, "DISEASE"], [254, 265, "DISEASE"]]}], ["The characteristic pathogenic features critical to understanding the susceptibility to inhaled toxicants are described.", {"entities": []}], ["It is anticipated that this review will provide a ready reference for the selection of appropriate rodent models of cardiopulmonary diseases and identify not only their pathobiologic similarities and/or differences to humans but also their potential usefulness in susceptibility studies.", {"entities": []}], ["Meta-analyses offer a rigorous and transparent systematic framework for synthesizing data that can be used for a wide range of research areas, study designs, and data types.", {"entities": []}], ["Both the outcome of meta-analyses and the meta-analysis process itself can yield useful insights for answering scientific questions and making policy decisions.", {"entities": []}], ["Development of the National Ambient Air Quality Standards illustrates many potential applications of meta-analysis.", {"entities": []}], ["These applications demonstrate the strengths and limitations of meta-analysis, issues that arise in various data realms, how meta-analysis design choices can influence interpretation of results, and how meta-analysis can be used to address bias and heterogeneity.", {"entities": []}], ["Reviewing available data from a meta-analysis perspective can provide a useful framework and impetus for identifying and refining strategies for future research.", {"entities": []}], ["Moreover, increased pervasiveness of a meta-analysis mindset\u2014focusing on how the pieces of the research puzzle fit together\u2014would benefit scientific research and data syntheses regardless of whether or not a quantitative meta-analysis is undertaken.", {"entities": []}], ["While an individual meta-analysis can only synthesize studies addressing the same research question, the results of separate meta-analyses can be combined to address a question encompassing multiple data types.", {"entities": []}], ["This observation applies to any scientific or policy area where information from a variety of disciplines must be considered to address a broader research question.", {"entities": []}], ["Genetics of gene expression (eQTLs or expression QTLs) has proved an indispensable tool for understanding biological pathways and pathomechanisms of trait-associated SNPs.", {"entities": []}], ["However, power of most genome-wide eQTL studies is still limited.", {"entities": []}], ["We performed a large eQTL study in peripheral blood mononuclear cells of 2112 individuals increasing the power to detect trans -effects genome-wide.", {"entities": []}], ["Going beyond univariate SNP-transcript associations, we analyse relations of eQTLs to biological pathways, polygenetic effects of expression regulation, trans -clusters and enrichment of co-localized functional elements.", {"entities": []}], ["We found eQTLs for about 85% of analysed genes, and 18% of genes were trans -regulated.", {"entities": []}], ["Local eSNPs were enriched up to a distance of 5 Mb to the transcript challenging typically implemented ranges of cis -regulations.", {"entities": [[48, 50, "GENE"]]}], ["Pathway enrichment within regulated genes of GWAS-related eSNPs supported functional relevance of identified eQTLs.", {"entities": []}], ["We demonstrate that nearest genes of GWAS-SNPs might frequently be misleading functional candidates.", {"entities": []}], ["We identified novel trans -clusters of potential functional relevance for GWAS-SNPs of several phenotypes including obesity-related traits, HDL-cholesterol levels and haematological phenotypes.", {"entities": [[116, 123, "DISEASE"]]}], ["We used chromatin immunoprecipitation data for demonstrating biological effects.", {"entities": []}], ["Yet, we show for strongly heritable transcripts that still little trans -chromosomal heritability is explained by all identified trans -eSNPs; however, our data suggest that most cis -heritability of these transcripts seems explained.", {"entities": []}], ["Dissection of co-localized functional elements indicated a prominent role of SNPs in loci of pseudogenes and non-coding RNAs for the regulation of coding genes.", {"entities": []}], ["In summary, our study substantially increases the catalogue of human eQTLs and improves our understanding of the complex genetic regulation of gene expression, pathways and disease-related processes.", {"entities": []}], ["Patients face increasing insurance restrictions on prescription drugs, including generic-only coverage.", {"entities": []}], ["There are no generic inhaled corticosteroids (ICS), which are a mainstay of asthma therapy, and patients pay the full price for these drugs under generic-only policies.", {"entities": [[76, 82, "DISEASE"]]}], ["We examined changes in ICS use following the introduction of generic-only coverage in a Medicare Advantage population from 2003\u20132004.", {"entities": []}], ["Subjects were age 65+, with asthma, prior ICS use, and no chronic obstructive pulmonary disorder (n = 1,802).", {"entities": [[28, 34, "DISEASE"]]}], ["In 2004, 74.0% switched from having a $30 brand-copayment plan to a generic-only coverage plan (restricted coverage); 26% had $15\u201325 brand copayments in 2003\u20132004 (unrestricted coverage).", {"entities": []}], ["Using linear difference-in-difference models, we examined annual changes in ICS use (measured by days-of-supply dispensed).", {"entities": []}], ["There was a lower-cost ICS available within the study setting and we also examined changes in drug choice (higher- vs. lower-cost ICS).", {"entities": []}], ["In multivariable models we adjusted for socio-demographic, clinical, and asthma characteristics.", {"entities": [[73, 79, "DISEASE"]]}], ["In 2003 subjects had an average of 188 days of ICS supply.", {"entities": []}], ["Restricted compared with unrestricted coverage was associated with reductions in ICS use from 2003\u20132004 (-15.5 days-of-supply, 95% confidence interval (CI): -25.0 to -6.0).", {"entities": []}], ["Among patients using higher-cost ICS drugs in 2003 (n = 662), more restricted versus unrestricted coverage subjects switched to the lower-cost ICS in 2004 (39.8% vs. 10.3%).", {"entities": []}], ["Restricted coverage was not associated with decreased ICS use (2003\u20132004) among patients who switched to the lower-cost ICS (18.7 days-of-supply, CI: -27.5 to 65.0), but was among patients who did not switch (-38.6 days-of-supply, CI: -57.0 to -20.3).", {"entities": []}], ["In addition, restricted coverage was associated with decreases in ICS use among patients with both higher- and lower-risk asthma (-15.0 days-of-supply, CI: -41.4 to 11.44; and -15.6 days-of-supply, CI: -25.8 to -5.3, respectively).", {"entities": [[122, 128, "DISEASE"]]}], ["In this elderly population, patients reduced their already low ICS use in response to losing drug coverage.", {"entities": []}], ["Switching to the lower-cost ICS mitigated reductions in use among patients who previously used higher-cost drugs.", {"entities": []}], ["Additional work is needed to assess barriers to switching ICS drugs and the clinical effects of these drug use changes.", {"entities": []}], ["We conducted a cohort study to clarify this relationship between asthma\u2013chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) and pulmonary embolism (PE).", {"entities": [[72, 109, "DISEASE"], [125, 133, "DISEASE"], [145, 163, "DISEASE"], [65, 71, "DISEASE"]]}], ["From the National Health Insurance Research Database of Taiwan, we identified patients who had a diagnosis of asthma and a diagnosis of COPD (defined as ACOS) and concurrent treatment between January 1999 and December 2009 (ACOS cohort: n = 14,150; non-ACOS cohort: n = 55,876).", {"entities": [[110, 116, "DISEASE"]]}], ["Cox proportional hazards regression analysis was performed to determine the adjusted hazard ratios (aHRs) for PE of the ACOS cohort compared with the non-ACOS cohort.", {"entities": []}], ["Comparing the ACOS cohort with the non-ACOS cohort, the aHR of PE was 2.08 (95% confidence intervals [CIs]: 1.56\u20132.76).", {"entities": [[56, 59, "GENE"]]}], ["The risk of PE was higher in ACOS cohort than non-ACOS cohort, regardless of age, sex, comorbidity, inhaled corticosteroids (ICSs) and oral steroids (OSs) used.", {"entities": []}], ["For ages ranging from 20 to 65 years, the aHR of PE was 2.53 (95% CI: 1.44\u20134.44) in the ACOS cohort.", {"entities": [[42, 45, "GENE"]]}], ["ACOS patients using ICSs (aHR: 1.97, 95% CI: 1.29\u20133.01) or OSs (aHR: 1.97, 95% CI: 1.46\u20132.65), the risk of PE was higher than in the non-ACOS cohort.", {"entities": [[26, 29, "GENE"], [64, 67, "GENE"], [26, 29, "GENE"], [64, 67, "GENE"]]}], ["The risk of PE increased with the number of outpatient visits and hospitalizations necessitated, ranging from 2.32 (95% CI: 1.54\u20133.52) in patients having 3\u20139 visits to 4.20 (95% CI: 2.74\u20136.44) for those having >9 visits.", {"entities": []}], ["ACOS is associated with increased risk of PE, particularly patients with a high frequency of AE\u2014even in young adults or people without comorbidities.", {"entities": []}], ["Acute respiratory infections (ARIs) are a great public health challenge globally.", {"entities": []}], ["The prevalence of respiratory viruses in patients with ARIs attending at different hospital settings is fully undetermined.", {"entities": []}], ["Laboratory-based surveillance for ARIs was conducted at inpatient and outpatient settings of 11 hospitals in North China.", {"entities": []}], ["The first 2\u20135 patients with ARIs were recruited in each hospital weekly from 2012 through 2015.", {"entities": []}], ["The presence of respiratory viruses was screened by PCR assays.", {"entities": []}], ["The prevalence of respiratory viruses was determined and compared between patients at different hospital settings.", {"entities": []}], ["A total of 3487 hospitalized cases and 6437 outpatients/Emergency Department (ED) patients were enrolled.", {"entities": []}], ["The most commonly detected viruses in the hospitalized cases were respiratory syncytial virus (RSV, 33.3%) in children less than two years old, adenoviruses (13.0%) in patients 15\u201334\u00a0years old, and influenza viruses (IFVs, 9.6%) in patients \u226565\u00a0years.", {"entities": [[198, 207, "DISEASE"]]}], ["IFVs were the most common virus in outpatient/ED patients across all age groups (22.7%).", {"entities": []}], ["After controlling for the confounders caused by other viruses and covariates, adenoviruses (adjusted odds ratio [aOR]: 3.97, 99% confidence interval [99% CI]: 2.19\u20137.20) and RSV (aOR: 2.04, 99% CI: 1.34\u20133.11) were independently associated with increased hospitalization in children, as well as adenoviruses in adults (aOR: 2.14, 99% CI: 1.19\u20133.85).", {"entities": []}], ["Additionally, co-infection of RSV with IFVs was associated with increased hospitalization in children (aOR: 12.20, 99% CI: 2.65\u201356.18).", {"entities": []}], ["A substantial proportion of ARIs was associated with respiratory viruses in North China.", {"entities": []}], ["RSV, adenoviruses, and co-infection of RSV and IFVs were more frequent in hospitalized children (or adenoviruses in adults), which might predict the severity of ARIs.", {"entities": []}], ["Attending clinicians should be more vigilant of these infections.", {"entities": []}], ["The online version of this article (10.1186/s12879-018-2982-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study investigated the effects of particulate matter (PM) on human skin diseases by conducting a systematic review of existing literature and performing a meta-analysis.", {"entities": []}], ["It considered articles reporting an original effect of PM on human skin.", {"entities": []}], ["From among 918 articles identified, 13 articles were included for further consideration after manual screening of the articles resulted in the exclusion of articles that did not contain data, review articles, editorials, and also articles in languages other than English.", {"entities": []}], ["Random-effects models and forest plots were used to estimate the effect of PM on the skin by Meta-Disc analysis.", {"entities": []}], ["According to people\u2019s reports of exposure and negative skin effects (atopic dermatitis (AD), eczema, and skin aging, etc.)", {"entities": [[69, 86, "DISEASE"], [76, 86, "DISEASE"]]}], ["due to air pollution, the summary relative risk (odds ratio) of PM 10 was determined to be 0.99 (95% confidence interval (CI) 0.89\u20131.11) whereas PM 2.5 was determined to be 1.04 (95% CI 0.96\u20131.12).", {"entities": []}], ["Simultaneously, there was a different extent of impact between PM 10 and PM 2.5 on atopic dermatitis (AD) for those of young age: the odds ratio of PM 10 and PM 2.5 were 0.96 (95% CI 0.83\u20131.11; I 10 and 1.60% (0.45\u20132.82) due to PM 2.5 .", {"entities": [[83, 100, "DISEASE"], [90, 100, "DISEASE"]]}], ["Following the results, PM 10 and PM 2.5 are associated with increased risks of human skin diseases, especially AD, whose risk is higher in infants and school children.", {"entities": []}], ["With its smaller size and a high concentration of metals, PM 2.5 is more closely related to AD in younger people, compared to PM 10 .", {"entities": []}], ["Polysaccharide responsiveness is tested by measuring antibody responses to polysaccharide vaccines to diagnose for humoral immunodeficiency.", {"entities": []}], ["A common assumption is that this responsiveness is biased by any previous exposure to the polysaccharides in the form of protein-coupled polysaccharide vaccines, such as those used in many childhood vaccination programmes.", {"entities": []}], ["To examine this assumption, we investigated the effect of protein-coupled polysaccharide vaccination on subsequent polysaccharide responsiveness.", {"entities": []}], ["HIV-infected adults (n\u200a=\u200a47) were vaccinated twice with protein-coupled polysaccharides and six months later with pure polysaccharides.", {"entities": []}], ["We measured immunoglobulin G responses against three polysaccharides present in only the polysaccharide vaccine (non-memory polysaccharides) and seven recurring polysaccharides (memory polysaccharides).", {"entities": []}], ["Responsiveness was evaluated according to the consensus guidelines published by the American immunology societies.", {"entities": []}], ["Impaired responsiveness to non-memory polysaccharides was more frequent than to memory polysaccharides (51% versus 28%, P\u200a=\u200a0.015), but the individual polysaccharides did not differ in triggering sufficient responses (74% versus 77%, P\u200a=\u200a0.53).", {"entities": []}], ["Closer analysis revealed important shortcomings of the current evaluation guidelines.", {"entities": []}], ["The interpreted response\u015b number and their specificities influenced the likelihood of impaired responsiveness in a complex manor.", {"entities": []}], ["This influence was propelled by the dichotomous approaches inherent to the American guidelines.", {"entities": []}], ["We therefore define a novel more robust polysaccharide responsiveness measure, the Z-score, which condenses multiple, uniformly weighted responses into one continuous variable.", {"entities": []}], ["Using the Z-score, responsiveness to non-memory polysaccharides and memory-polysaccharides were found to correlate (R We found that polysaccharide responsiveness was not biased by prior protein-coupled polysaccharide vaccination in HIV-infected adults.", {"entities": []}], ["Studies in additional populations are warranted.", {"entities": []}], ["Biomarkers enable early diagnosis, guide molecularly targeted therapy and monitor the activity and therapeutic responses across a variety of diseases.", {"entities": []}], ["Despite intensified interest and research, however, the overall rate of development of novel biomarkers has been falling.", {"entities": []}], ["Moreover, no solution is yet available that efficiently retrieves and processes biomarker information pertaining to infectious diseases.", {"entities": []}], ["Infectious Disease Biomarker Database (IDBD) is one of the first efforts to build an easily accessible and comprehensive literature-derived database covering known infectious disease biomarkers.", {"entities": []}], ["IDBD is a community annotation database, utilizing collaborative Web 2.0 features, providing a convenient user interface to input and revise data online.", {"entities": []}], ["It allows users to link infectious diseases or pathogens to protein, gene or carbohydrate biomarkers through the use of search tools.", {"entities": []}], ["It supports various types of data searches and application tools to analyze sequence and structure features of potential and validated biomarkers.", {"entities": []}], ["Currently, IDBD integrates 611 biomarkers for 66 infectious diseases and 70 pathogens.", {"entities": []}], ["It is publicly accessible at http://biomarker.cdc.go.kr and http://biomarker.korea.ac.kr .", {"entities": []}], ["Low back pain (LBP) is a common cause of disability and is ranked as the most burdensome health condition globally.", {"entities": [[15, 18, "GENE"]]}], ["Self-management, including components on increased knowledge, monitoring of symptoms, and physical activity, are consistently recommended in clinical guidelines as cost-effective strategies for LBP management and there is increasing interest in the potential role of digital health.", {"entities": [[194, 197, "GENE"]]}], ["The study aimed to synthesize and critically appraise published evidence concerning the use of interactive digital interventions to support self-management of LBP.", {"entities": [[159, 162, "GENE"]]}], ["The following specific questions were examined: (1) What are the key components of digital self-management interventions for LBP, including theoretical underpinnings?", {"entities": [[125, 128, "GENE"]]}], ["(2) What outcome measures have been used in randomized trials of digital self-management interventions in LBP and what effect, if any, did the intervention have on these?", {"entities": [[106, 109, "GENE"]]}], ["and (3) What specific characteristics or components, if any, of interventions appear to be associated with beneficial outcomes?", {"entities": []}], ["Bibliographic databases searched from 2000 to March 2016 included Medline, Embase, CINAHL, PsycINFO, Cochrane Library, DoPHER and TRoPHI, Social Science Citation Index, and Science Citation Index.", {"entities": []}], ["Reference and citation searching was also undertaken.", {"entities": []}], ["Search strategy combined the following concepts: (1) back pain, (2) digital intervention, and (3) self-management.", {"entities": []}], ["Only randomized controlled trial (RCT) protocols or completed RCTs involving adults with LBP published in peer-reviewed journals were included.", {"entities": [[89, 92, "GENE"]]}], ["Two reviewers independently screened titles and abstracts, full-text articles, extracted data, and assessed risk of bias using Cochrane risk of bias tool.", {"entities": []}], ["An independent third reviewer adjudicated on disagreements.", {"entities": []}], ["Data were synthesized narratively.", {"entities": []}], ["Of the total 7014 references identified, 11 were included, describing 9 studies: 6 completed RCTs and 3 protocols for future RCTs.", {"entities": []}], ["The completed RCTs included a total of 2706 participants (range of 114-1343 participants per study) and varied considerably in the nature and delivery of the interventions, the duration/definition of LBP, the outcomes measured, and the effectiveness of the interventions.", {"entities": [[200, 203, "GENE"]]}], ["Participants were generally white, middle aged, and in 5 of 6 RCT reports, the majority were female and most reported educational level as time at college or higher.", {"entities": []}], ["Only one study reported between-group differences in favor of the digital intervention.", {"entities": []}], ["There was considerable variation in the extent of reporting the characteristics, components, and theories underpinning each intervention.", {"entities": []}], ["None of the studies showed evidence of harm.", {"entities": []}], ["The literature is extremely heterogeneous, making it difficult to understand what might work best, for whom, and in what circumstances.", {"entities": []}], ["Participants were predominantly female, white, well educated, and middle aged, and thus the wider applicability of digital self-management interventions remains uncertain.", {"entities": []}], ["No information on cost-effectiveness was reported.", {"entities": []}], ["The evidence base for interactive digital interventions to support patient self-management of LBP remains weak.", {"entities": [[94, 97, "GENE"]]}], ["Garcinia parvifolia belongs to the same family as mangosteen ( Garcinia mangostana ), which is known locally in Sabah as \u201casam kandis\u201d or cherry mangosteen.", {"entities": []}], ["The present study was conducted to determine the phytochemicals content (total phenolic, flavonoid, anthocyanin, and carotenoid content) and antioxidant and acetylcholinesterase inhibition activity of the flesh and peel of G. parvifolia .", {"entities": []}], ["All samples were freeze-dried and extracted using 80% methanol and distilled water.", {"entities": []}], ["For the 80% methanol extract, the flesh of G. parvifolia displayed higher phenolic and flavonoid contents than the peel, with values of 7.2 \u00b1 0.3\u2009mg gallic acid equivalent (GAE)/g and 5.9 \u00b1 0.1\u2009mg rutin equivalent (RU)/g, respectively.", {"entities": []}], ["Anthocyanins were detected in the peel part of G. parvifolia but absent in the flesh.", {"entities": []}], ["The peel of G. parvifolia displayed higher total carotenoid content as compared to the flesh part with the values of 17.0 \u00b1 0.3 and 3.0 \u00b1 0.0\u2009mg \u03b2 -carotene equivalents (BC)/100\u2009g, respectively.", {"entities": []}], ["The free-radical scavenging, ferric reducing, and acetylcholinesterase inhibition effect of the flesh were higher as compared to the peel in both extracts.", {"entities": []}], ["These findings suggested that the edible part of G. parvifolia fruit has a potential as a natural source of antioxidant and anti-Alzheimer's agents.", {"entities": []}], ["Background: Our previous work demonstrated that the extracellular matrix protein mindin contributes to allergic airways disease.", {"entities": []}], ["However, the role of mindin in nonallergic airways disease has not previously been explored.", {"entities": []}], ["Objectives: We hypothesized that mindin would contribute to airways disease after inhalation of either lipopolysaccharide (LPS) or ozone.", {"entities": []}], ["Methods: We exposed C57BL/6J and mindin-deficient ( ex vivo bronchial ring studies.", {"entities": []}], ["Results: After inhalation of LPS, mindin Conclusions: These data demonstrate that the extracellular matrix protein mindin modifies the airway response to both LPS and ozone.", {"entities": []}], ["Our data support a conserved role of mindin in production of proinflammatory cytokines and the development of AHR in two divergent models of reactive airways disease, as well as a role of mindin in airway smooth muscle contractility after exposure to ozone.", {"entities": [[110, 113, "GENE"]]}], ["Acute viral respiratory infections are an important cause of morbidity and mortality in humans worldwide.", {"entities": []}], ["The etiological backgrounds of these infections remain unconfirmed in most clinical cases.", {"entities": []}], ["The aim of this study was to estimate the prevalence of human coronavirus infections in a series of children hospitalized with symptoms of acute respiratory tract disease in a one-year period in Slovenia.", {"entities": []}], ["The 664 specimens from 592 children under six years of age hospitalized at the University Children\u2019s Hospital in Ljubljana were sent for the routine laboratory detection of respiratory viruses.", {"entities": []}], ["Respiratory viruses were detected with a direct immunofluorescence assay and human coronaviruses were detected with a modified real-time RT\u2013PCR.", {"entities": []}], ["HCoV RNA was detected in 40 (6%, 95% CI: 4.3%\u20138.1%) of 664 samples.", {"entities": []}], ["Of these specimens, 21/40 (52.5%) were identified as species HKU1, 7/40 (17.5%) as OC43, 6/40 (15%) as 229E, and 6/40 (15%) as NL63.", {"entities": []}], ["Infection with HCoV occurred as a coinfection with one or more other viruses in most samples (70%).", {"entities": []}], ["Of the HCoV-positive children, 70.3% had lower respiratory tract infections.", {"entities": []}], ["The results of our study show that HCoV are frequently detected human pathogens, often associated with other respiratory viruses and acute respiratory tract infections in hospitalized children.", {"entities": []}], ["An association between age and the viral load was found.", {"entities": []}], ["The highest viral load was detected in children approximately 10 months of age.", {"entities": []}], ["Genome-wide association studies have identified the ORM (yeast)-like protein isoform 3 ( ORMDL3 ) gene locus on human chromosome 17q to be a highly significant risk factor for childhood-onset asthma.", {"entities": [[192, 198, "DISEASE"], [89, 95, "GENE"]]}], ["We sought to investigate in\u00a0vivo the functional role of ORMDL3 in disease inception.", {"entities": [[56, 62, "GENE"]]}], ["An Ormdl3 -deficient mouse was generated and the role of ORMDL3 in the generation of allergic airways disease to the fungal aeroallergen Alternaria alternata was determined.", {"entities": [[3, 9, "GENE"], [57, 63, "GENE"], [3, 9, "GENE"], [57, 63, "GENE"]]}], ["An adeno-associated viral vector was also used to reconstitute ORMDL3 expression in airway epithelial cells of Ormdl3 knockout mice.", {"entities": [[63, 69, "GENE"], [111, 117, "GENE"], [63, 69, "GENE"], [111, 117, "GENE"]]}], ["Ormdl3 knockout mice were found to be protected from developing allergic airways disease and showed a marked decrease in pathophysiology, including lung function and airway eosinophilia induced by Alternaria.", {"entities": [[173, 185, "DISEASE"], [0, 6, "GENE"]]}], ["Alternaria is a potent inducer of cellular stress and the unfolded protein response, and ORMDL3 was found to play a critical role in driving the activating transcription factor 6\u2013mediated arm of this response through Xbp1 and downstream activation of the endoplasmic reticulum\u2013associated degradation pathway.", {"entities": [[89, 95, "GENE"], [217, 221, "GENE"]]}], ["In addition, ORMDL3 mediated uric acid release, another marker of cellular stress.", {"entities": [[13, 19, "GENE"]]}], ["In the knockout mice, reconstitution of Ormdl3 transcript levels specifically in the bronchial epithelium resulted in reinstatement of susceptibility to fungal allergen\u2013induced allergic airways disease.", {"entities": [[40, 46, "GENE"]]}], ["This study demonstrates that ORMDL3 , an asthma susceptibility gene identified by genome-wide association studies, contributes to key pathways that promote changes in airway physiology during allergic immune responses.", {"entities": [[41, 47, "DISEASE"], [29, 35, "GENE"]]}], ["Overweight has increased in many countries over the past 20 years and excessive body weight is an established risk factor for adverse health outcomes and chronic diseases.", {"entities": []}], ["This study aimed to determine comorbidity associated with overweight and obesity in a nationally representative sample of German adults.", {"entities": [[73, 80, "DISEASE"]]}], ["In the German National Health Interview and Examination Survey 1998 standardized measures of body weight, height and waist circumference (WC) were obtained for 7,124 men and women 18 to 79 years of age.", {"entities": []}], ["Information on pre-existing health conditions, health-related behaviors, and sociodemographic characteristics was collected using physician-administered computer-assisted interviews and self-administered questionnaires.", {"entities": []}], ["World Health Organization (WHO) cut-off criteria were applied to define overweight (BMI 25.0-29.9 kg/m The crude prevalence of persons with cardiometabolic risk factors, diabetes mellitus, cardiovascular disease (CVD), gall bladder disease, and osteoarthritis showed a significant stepwise increase from the lowest to the highest BMI category in both sexes.", {"entities": [[224, 239, "DISEASE"], [245, 259, "DISEASE"], [170, 187, "DISEASE"]]}], ["In multiple logistic regression models adjusting for age, social status, and smoking, significant associations with overweight and obesity persisted for cardiometabolic risk factors and osteoarthritis.", {"entities": [[131, 138, "DISEASE"], [186, 200, "DISEASE"]]}], ["For example, obese persons had a three- to fourfold higher chance of having any cardiometabolic risk factor compared to normal weight persons (odds ratio (OR)\u2009=\u20094.07, 95% CI: 3.16-5.25 for men; OR\u2009=\u20093.40 (2.60-4.46) for women).", {"entities": []}], ["Only in women, overweight and obesity as well as abdominal obesity, independent of BMI category, were significantly and consistently associated with diabetes (overweight: OR\u2009=\u20091.85 (1.03-3.30); obesity: OR\u2009=\u20092.94 (1.63-5.31); abdominal obesity: OR\u2009=\u20091.44 (1.08-1.92) and gall bladder disease (overweight: OR\u2009=\u20091.65 (1.22-2.25); obesity: OR\u2009=\u20093.06 (2.26-4.14); abdominal obesity: OR\u2009=\u20091.73 (1.25-2.39)).", {"entities": [[276, 291, "DISEASE"], [30, 37, "DISEASE"], [59, 66, "DISEASE"], [194, 201, "DISEASE"], [236, 243, "DISEASE"], [328, 335, "DISEASE"], [370, 377, "DISEASE"]]}], ["Current estimates of disease burden underline the public health importance and clinical relevance related to overweight and obesity and needs to take into account comorbidity aspects.", {"entities": [[124, 131, "DISEASE"]]}], ["Background : Plasma glutathione peroxidase (eGPx) is an important selenium containing antioxidant in human defense against oxidative stress.", {"entities": []}], ["While crevicular fluid (GCF) eGPx levels and its association with periodontal disease is well documented, there is no data on correlation of GCF and serum eGPx levels in chronic periodontitis.", {"entities": [[178, 191, "DISEASE"], [66, 85, "DISEASE"]]}], ["Hence this study was undertaken to further probe into the role of oxidative stress in periodontal diseases and effect of nonsurgical periodontal therapy (NSPT) by correlating GCF and serum levels of eGPx.", {"entities": []}], ["Materials and methods : Thirty subjects (16-Males and 14-Females; age: 30\u201338 years) participated in the study.", {"entities": []}], ["The subjects were divided, based on gingival index, probing pocket depth and clinical attachment level into: Healthy (group-1, n =10), Gingivitis (group-2, n =10) and Periodontitis (group-3, n =10).", {"entities": [[167, 180, "DISEASE"], [135, 145, "DISEASE"]]}], ["Chronic periodontitis patients after NSPT constituted group 4.", {"entities": [[8, 21, "DISEASE"]]}], ["GCF and serum samples collected from each subject were quantified for eGPx levels using Enzyme linked Immunosorbent Assay.", {"entities": []}], ["Results : The mean eGPx concentrations increased from health (14.01 ng/\u03bcl and 78.26 ng/ml) to gingivitis (22.86 ng/\u03bcl and 90.44 ng/ml) and then to periodontitis (29.89 ng/\u03bcl and 103.43 ng/ml), in GCF and serum respectively.", {"entities": [[147, 160, "DISEASE"], [94, 104, "DISEASE"]]}], ["After NSPT, there was statistically significant reduction in eGPx concentration in GCF and serum (19.41 ng/\u03bcl and 85.21 ng/ml).", {"entities": []}], ["Further, all the GCF eGPx values showed a positive correlation to that of serum eGPx level.", {"entities": []}], ["Conclusion : Thus, increased eGPx concentration in GCF can be considered as an indicator of local increase in oxidative stress.", {"entities": []}], ["While, increase in serum eGPx levels indicates that periodontal disease can also lead to increased oxidative stress at the systemic level.", {"entities": [[52, 71, "DISEASE"]]}], ["Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible fibrotic lung disease that requires long-term treatment.", {"entities": [[11, 29, "DISEASE"], [89, 101, "DISEASE"]]}], ["Given the importance of adherence to treatment and management of adverse events (AEs), patients with IPF need long-term, high-quality support in living with their condition, and adhering to therapy so they can derive maximum benefit.", {"entities": []}], ["The IPF Care Patient Support Program (IPF Care) provides support, education, and empowerment to patients receiving pirfenidone for the treatment of IPF in Europe, through the provision of frequent, patient-managed discussions with specialist IPF nurses.", {"entities": []}], ["In this review, we describe the structure of IPF Care in the United Kingdom (UK) and Austria, two of the longest-running IPF Care programs to date, and describe the benefits that these programs provide to patients with IPF.", {"entities": []}], ["Analysis of results demonstrates a low rate of discontinuation from the program, and provides insight into the questions and concerns that patients express, not only with respect to pirfenidone (the only approved treatment for IPF at the time of analysis), but also in relation to other aspects of living with IPF.", {"entities": []}], ["Pirfenidone dose modifications are common in patients in IPF Care and AEs most commonly occur early in treatment, with the majority of affected patients continuing on a stable maintenance dose.", {"entities": []}], ["This highlights the value of the advice and support that patients receive in IPF Care regarding management of AEs and staying on treatment.", {"entities": []}], ["Patient satisfaction was high in a survey of the UK program, with patients reporting high scores regarding \u2018feeling in control of their condition\u2019, \u2018knowing what to expect from treatment\u2019, and \u2018feeling confident about how their disease is managed\u2019.", {"entities": []}], ["IPF Care in Europe will continue to evolve over time, striving to provide individually tailored support and patient-friendly information to improve treatment outcomes and quality of life for patients living with IPF.", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-015-0183-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Acute, inflammatory conditions associated with dysregulated complement activation are characterized by significant increases in blood concentration of reactive oxygen species (ROS) and ATP.", {"entities": []}], ["The mechanisms by which these molecules arise are not fully understood.", {"entities": []}], ["In this study, using luminometric- and fluorescence-based methods, we show that ligation of glycophorin A (GPA) on human red blood cells (RBCs) results in a 2.1-fold, NADPH-oxidase-dependent increase in intracellular ROS that, in turn, trigger multiple downstream cascades leading to caspase-3 activation, ATP release, and increased band 3 phosphorylation.", {"entities": []}], ["Functionally, using 2D microchannels to assess membrane deformability, GPS-ligated RBCs travel 33% slower than control RBCs, and lipid mobility was hindered by 10% using fluorescence recovery after photobleaching (FRAP).", {"entities": []}], ["These outcomes were preventable by pretreating RBCs with cell-permeable ROS scavenger glutathione monoethyl ester (GSH-ME).", {"entities": []}], ["Our results obtained in vitro using anti-GPA antibodies were validated using complement-altered RBCs isolated from control and septic patients.", {"entities": []}], ["Our results suggest that during inflammatory conditions, circulating RBCs significantly contribute to capillary flow dysfunctions, and constitute an important but overlooked source of intravascular ROS and ATP, both critical mediators responsible for endothelial cell activation, microcirculation impairment, platelet activation, as well as long-term dysregulated adaptive and innate immune responses.", {"entities": []}], ["Background: Exposure to chemicals that cause rodent mammary gland tumors is common, but few studies have evaluated potential breast cancer risks of these chemicals in humans.", {"entities": [[125, 138, "DISEASE"], [132, 138, "DISEASE"]]}], ["Objective: The goal of this review was to identify and bring together the needed tools to facilitate the measurement of biomarkers of exposure to potential breast carcinogens in breast cancer studies and biomonitoring.", {"entities": [[178, 191, "DISEASE"], [185, 191, "DISEASE"]]}], ["Methods: We conducted a structured literature search to identify measurement methods for exposure biomarkers for 102 chemicals that cause rodent mammary tumors.", {"entities": []}], ["To evaluate concordance, we compared human and animal evidence for agents identified as plausibly linked to breast cancer in major reviews.", {"entities": [[108, 121, "DISEASE"], [115, 121, "DISEASE"]]}], ["To facilitate future application of exposure biomarkers, we compiled information about relevant cohort studies.", {"entities": []}], ["Results: Exposure biomarkers have been developed for nearly three-quarters of these rodent mammary carcinogens.", {"entities": []}], ["Analytical methods have been published for 73 of the chemicals.", {"entities": []}], ["Some of the remaining chemicals could be measured using modified versions of existing methods for related chemicals.", {"entities": []}], ["In humans, biomarkers of exposure have been measured for 62 chemicals, and for 45 in a nonoccupationally exposed population.", {"entities": []}], ["The Centers for Disease Control and Prevention has measured 23 in the U.S. population.", {"entities": []}], ["Seventy-five of the rodent mammary carcinogens fall into 17 groups, based on exposure potential, carcinogenicity, and structural similarity.", {"entities": []}], ["Carcinogenicity in humans and rodents is generally consistent, although comparisons are limited because few agents have been studied in humans.", {"entities": []}], ["We identified 44 cohort studies, with a total of > 3.5 million women enrolled, that have recorded breast cancer incidence and stored biological samples.", {"entities": [[98, 111, "DISEASE"], [105, 111, "DISEASE"]]}], ["Conclusions: Exposure measurement methods and cohort study resources are available to expand biomonitoring and epidemiology related to breast cancer etiology and prevention.", {"entities": [[135, 148, "DISEASE"], [142, 148, "DISEASE"]]}], ["Citation: Rudel RA, Ackerman JM, Attfield KR, Brody JG.", {"entities": []}], ["New exposure biomarkers as tools for breast cancer epidemiology, biomonitoring, and prevention: a systematic approach based on animal evidence.", {"entities": [[37, 50, "DISEASE"], [44, 50, "DISEASE"]]}], ["Environ Health Perspect 122:881\u2013895;\u2002 http://dx.doi.org/10.1289/ehp.1307455", {"entities": []}], ["Preterm birth is the main reason for neonatal deaths worldwide.", {"entities": []}], ["We investigate whether maternal gut microbiota may play a previously overlooked role.", {"entities": []}], ["The Norwegian Microbiota Study (NoMIC) is a case control study on preterm birth (<259 days of gestation, calculated primarily based on the last menstrual period), including two consecutively born term infants per infant born prematurely.", {"entities": []}], ["Eligible mothers were fluent in Norwegian and recruited from the maternity ward at a county hospital in Eastern Norway in the period 2002\u20132005.", {"entities": []}], ["Fecal samples were collected at day 4 postpartum, and analyzed using 16S ribosomal RNA gene sequencing.", {"entities": []}], ["We used samples from 121 mothers giving birth vaginally.", {"entities": []}], ["Measures of alpha diversity (Shannon, Phylogenetic Diversity and Observed Operational Taxonomic Units) and microbiome composition were combined with information from the Medical Birth Registry, pregnancy journals, and questionnaires.", {"entities": []}], ["The association between maternal gut diversity and preterm delivery was examined using logistic regression.", {"entities": []}], ["One IQR increase in Shannon diversity was significantly associated with 38% lower odds of spontaneous preterm birth, (95% confident interval (CI): 1%, 61%), and the association was stronger when adjusting for maternal age, marital status, ethnicity, parity, BMI, education, antibiotic use, pets in the household, income and smoking (48% lower odds, 95% CI: 4.2%, 72%).", {"entities": []}], ["Mothers delivering prematurely also had lower abundance of OTUs belonging to Bifidobacterium and Streptococcus , and of the Clostridiales order.", {"entities": []}], ["Analysis of maternal gut microbiota using next-generation sequencing shows that low gut diversity, with a distinct microbial composition, is associated with spontaneous preterm delivery.", {"entities": []}], ["Sunitinib is the currently standard treatment for metastatic renal cell carcinoma (mRCC).", {"entities": [[72, 81, "DISEASE"], [61, 81, "DISEASE"]]}], ["Multiple candidate predictive biomarkers for sunitinib response have been evaluated but none of them has been implemented in the clinic yet.", {"entities": []}], ["The aim of this study was to analyze single nucleotide polymorphisms (SNPs) in genes linked to mode of action of sunitinib and immune response as biomarkers for mRCC.", {"entities": []}], ["This is a multicenter, prospective and observational study involving 20 hospitals.", {"entities": []}], ["Seventy-five mRCC patients treated with sunitinib as first line were used to assess the impact of 63 SNPs in 31 candidate genes on clinical outcome.", {"entities": []}], ["rs2243250 (IL4) and rs5275 ( PTGS2 ) were found to be significantly associated with shorter cancer-specific survival (CSS).", {"entities": [[92, 98, "DISEASE"], [11, 14, "GENE"], [29, 34, "GENE"]]}], ["Moreover, allele C (rs5275) was associated with higher PTGS2 expression level confirming its functional role.", {"entities": [[55, 60, "GENE"]]}], ["Combination of rs5275 and rs7651265 or rs2243250 for progression free survival (PFS) or CSS, respectively, was a more valuable predictive biomarker remaining significant after correction for multiple testing.", {"entities": []}], ["It is the first time that association of rs5275 with survival in mRCC patients is described.", {"entities": []}], ["Two-SNP models containing this functional variant may serve as more predictive biomarkers for sunitinib and could suppose a clinically relevant tool to improve the mRCC patient management.", {"entities": []}], ["To date, clinico-physiologic indices have not been compared with quantitative CT imaging indices in determining the risk of chronic obstructive pulmonary disease (COPD) exacerbation.", {"entities": [[124, 161, "DISEASE"]]}], ["We therefore compared clinico-physiologic and CT imaging indices as risk factors for COPD exacerbation in patients with COPD.", {"entities": []}], ["We retrospectively analyzed 260 COPD patients from pulmonary clinics at 11 hospitals in Korea from June 2005 to November 2009 and followed-up for at least one year.", {"entities": []}], ["At the time of enrollment, none of these patients had COPD exacerbations for at least 2 months.", {"entities": []}], ["All underwent clinico-physiologic and radiological evaluation for risk factors of COPD exacerbation.", {"entities": []}], ["After 1 yr, 106 of the 260 patients had at least one exacerbation of COPD.", {"entities": []}], ["Multiple logistic regression analysis showed that old age, high Charlson Index, and low FEV 1 were significant in a clinico-physiologic model, with C-statistics of 0.69, and that increased age and emphysema index were significant in a radiologic model, with C-statistics of 0.64.", {"entities": [[88, 91, "GENE"]]}], ["The difference between the two models was statistically significant ( P = 0.04 by bootstrap analysis).", {"entities": []}], ["Combinations of clinico-physiologic risk factors may be better than those of imaging risk factors in predicting COPD exacerbation.", {"entities": []}], ["Health professionals and organizations in developed countries adapt slowly to the increase of ethnically diverse populations attending health care centres.", {"entities": []}], ["Several studies report that attention to immigrant mental health comes up with barriers in access, diagnosis and therapeutics, threatening equity.", {"entities": []}], ["This study analyzes differences in exposure to antidepressant drugs between the immigrant and the native population of a Spanish health region.", {"entities": []}], ["Cross-sectional study of the dispensation of antidepressant drugs to the population aged 15 years or older attending the public primary health centres of a health region, 232,717 autochthonous and 33,361 immigrants, during 2008.", {"entities": []}], ["Data were obtained from computerized medical records and pharmaceutical records of medications dispensed in pharmacies.", {"entities": []}], ["Age, sex, country of origin, visits, date of entry in the regional health system, generic drugs and active ingredients were considered.", {"entities": []}], ["Statistical analysis expressed the percentage of persons exposed to antidepressants stratified by age, gender, and country of origin and prevalence ratios of antidepressant exposition were calculated.", {"entities": []}], ["Antidepressants were dispensed to 11% of native population and 2.6% of immigrants.", {"entities": []}], ["Depending on age, native women were prescribed antidepressants between 1.9 and 2.7 times more than immigrant women, and native men 2.5 and 3.1 times more than their immigrant counterparts.", {"entities": []}], ["Among immigrant females, the highest rate was found in the Latin Americans (6.6%) and the lowest in the sub-Saharans (1.4%).", {"entities": []}], ["Among males, the highest use was also found in the Latin Americans (1.6%) and the lowest in the sub-Saharans (0.7%).", {"entities": []}], ["The percentage of immigrants prescribed antidepressants increased significantly in relation to the number of years registered with the local health system.", {"entities": []}], ["Significant differences were found for the new antidepressants, prescribed 8% more in the native population than in immigrants, both in men and in women.", {"entities": []}], ["All the immigrants, regardless of the country of origin, had lower antidepressant consumption than the native population of the same age and sex.", {"entities": []}], ["Latin American women presented the highest levels of consumption, and the sub-Saharan men the lowest.", {"entities": []}], ["The prescription profiles also differed, since immigrants consumed more generics and fewer recently commercialized active ingredients.", {"entities": []}], ["Postoperative analgesia after primary total hip arthroplasty (THA) using opioids is associated with troublesome side effects such as nausea and dizziness, and epidural analgesic means delayed mobilization.", {"entities": []}], ["Thus, local infiltration analgesia (LIA) during surgery prolonged with local infusion analgesia (LINFA) into the soft tissue in the hip region through a catheter in the first postoperative days has gained major interest in THA fast-track settings within a short period of time.", {"entities": []}], ["LIA at the time of surgery is a validated treatment.", {"entities": []}], ["We investigated the additional effect of giving postoperative LINFA after THA in patients already having LIA during surgery.", {"entities": []}], ["60 consecutive patients undergoing non-cemented THA were randomized into two groups in a double-blind and controlled study.", {"entities": []}], ["During surgery, all patients received standardized pain treatment with LIA.", {"entities": []}], ["Postoperatively, they were treated either with a solution of Ropivacain, Ketorolac, and Adrenaline (LINFA group) or placebo (placebo group) administered through a catheter to the hip 10 and 22 h after surgery.", {"entities": []}], ["Pain score, opioid consumption, and length of stay (LOS) were evaluated.", {"entities": []}], ["After adjustment for multiple testing, there was no statistically significant postoperative difference between the LINFA group and the placebo group regarding pain and tiredness.", {"entities": []}], ["We found some evidence of a short-term effect on nausea and vomiting.", {"entities": []}], ["Opioid consumption and length of stay were similar in the two groups.", {"entities": []}], ["We found some evidence of a short-term effect of LINFA on nausea and vomiting, but no evidence of an effect on postoperative pain and tiredness.", {"entities": []}], ["Thus, LINFA cannot be recommended as a standard pain treatment in patients with THA.", {"entities": []}], ["Insertion of T4 lysozyme (T4L) into the GPCR successfully enhanced GPCR protein stability and solubilization.", {"entities": []}], ["However, the biological functions of the recombinant GPCR protein have not been analyzed.", {"entities": []}], ["We engineered the CCR5-T4L mutant and expressed and purified the soluble recombinant protein using an E .", {"entities": []}], ["coli expression system.", {"entities": []}], ["The antiviral effects of this recombinant protein in THP-1 cell lines, primary human macrophages, and PBMCs from different donors were investigated.", {"entities": []}], ["We also explored the possible mechanisms underlying the observed antiviral effects.", {"entities": []}], ["Our data showed the biphasic inhibitory and promotion effects of different concentrations of soluble recombinant CCR5-T4L protein on R5 tropic human immunodeficiency virus-1 (HIV-1) infection in THP-1 cell lines, human macrophages, and PBMCs from clinical isolates.", {"entities": []}], ["We demonstrated that soluble recombinant CCR5-T4L acts as a HIV-1 co-receptor, interacts with wild type CCR5, down-regulates the surface CCR5 expression in human macrophages, and interacts with CCL5 to inhibit macrophage migration.", {"entities": [[41, 45, "GENE"], [104, 108, "GENE"], [137, 141, "GENE"], [41, 45, "GENE"], [104, 108, "GENE"], [137, 141, "GENE"], [194, 198, "GENE"]]}], ["Using binding assays, we further determined that recombinant CCR5-T4L and [ Our results suggest that recombinant CCR5-T4L protein marginally promotes HIV-1 infection at low concentrations and markedly inhibits infection at higher concentrations.", {"entities": []}], ["This recombinant protein may be helpful in the future development of anti-HIV-1 therapeutic agents.", {"entities": []}], ["Acute lung injury (ALI) is a common disease in critically ill patients with a high morbidity and mortality.", {"entities": []}], ["12/15-lipoxygenase (12/15-LO) is an enzyme generating 12-hydroxy-eicosatetraenoic acid (12-HETE) and 15-HETE from arachidonic acid.", {"entities": []}], ["It has been shown that 12/15-LO is involved in the regulation of vascular permeability during ALI.", {"entities": []}], ["To test whether 12/15-LO participates in leukocyte recruitment into the lung, we investigated the role of 12/15-LO in mouse models of lipopolysaccharide (LPS)-induced pulmonary inflammation and acid-induced ALI, a clinically relevant model of acute lung injury.", {"entities": []}], ["The increase in neutrophil recruitment following LPS inhalation was reduced in 12/15-LO-deficient ( Alox15 ) mice and in wild-type (WT) mice after the blocking of 12/15-LO with a pharmacological inhibitor.", {"entities": [[100, 106, "GENE"]]}], ["Bone marrow chimeras revealed that 12/15-LO in hematopoietic cells regulates neutrophil accumulation in the interstitial and alveolar compartments, whereas the accumulation of neutrophils in the intravascular compartment is regulated by 12/15-LO in non-hematopoietic and hematopoietic cells.", {"entities": []}], ["Mechanistically, the increased plasma levels of the chemokine CXCL1 in Alox15 mice led to a reduced response of the neutrophil chemokine receptor CXCR2 to stimulation with CXCL1, which in turn abrogated neutrophil recruitment.", {"entities": [[62, 67, "GENE"], [172, 177, "GENE"], [71, 77, "GENE"], [146, 151, "GENE"], [62, 67, "GENE"], [172, 177, "GENE"]]}], ["Alox15 mice also showed decreased edema formation, reduced neutrophil recruitment and improved gas exchange in an acid-induced ALI model.", {"entities": [[0, 6, "GENE"]]}], ["Our findings suggest that 12/15-LO modulates neutrophil recruitment into the lung by regulating chemokine/chemokine receptor homeostasis.", {"entities": []}], ["Wnt signaling pathways are tightly controlled under a physiological condition, under which they play key roles in many biological functions, including cell fate specification and tissue regeneration.", {"entities": []}], ["Increasing lines of evidence recently demonstrated that a dysregulated activation of Wnt signaling, particularly the Wnt/ \u03b2 -catenin signaling, was involved in the pathogenesis of chronic pulmonary diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).", {"entities": [[216, 253, "DISEASE"], [276, 294, "DISEASE"], [265, 294, "DISEASE"]]}], ["In this respect, Wnt signaling interacts with other cellular signaling pathways to regulate the initiation and pathogenic procedures of airway inflammation and remodeling, pulmonary myofibroblast proliferation, epithelial-to-mesenchymal transition (EMT), and development of emphysema.", {"entities": []}], ["Intriguingly, Wnt/ \u03b2 -catenin signaling is activated in IPF; an inhibition of this signaling leads to an alleviation of pulmonary inflammation and fibrosis in experimental models.", {"entities": []}], ["Conversely, Wnt/ \u03b2 -catenin signaling is inactivated in COPD tissues, and its reactivation results in an amelioration of airspace enlargement with a restored alveolar epithelial structure and function in emphysema models.", {"entities": []}], ["These studies thus imply distinct mechanisms of Wnt/ \u03b2 -catenin signaling in the pathogenesis of these two chronic pulmonary diseases, indicating potential targets for COPD and IPF treatments.", {"entities": []}], ["This review article aims to summarize the involvement and pathogenic roles of Wnt signaling pathways in the COPD and IPF, with a focus on the implication of Wnt/ \u03b2 -catenin signaling as underlying mechanisms and therapeutic targets in these two incurable diseases.", {"entities": []}], ["Few studies of atopic dermatitis (AD) in adult patients have evaluated differences in clinical features of AD according to onset age.", {"entities": [[15, 32, "DISEASE"], [22, 32, "DISEASE"]]}], ["We aimed to characterize the clinical features of AD in adult patients according to age of onset.", {"entities": []}], ["Subjects with AD outpatient visiting the Department of Dermatology at Kangnam Sacred Heart Hospital were recruited for this study.", {"entities": []}], ["A dermatologist conducted clinical evaluation, a survey of demographics, and onset of AD-associated signs and symptoms for each participant.", {"entities": []}], ["Total immunoglobulin E (IgE) was also tested.", {"entities": []}], ["A total of 280 adult AD patients were enrolled, among which 232 patients (82.86%) showed pre-adult-onset (age < 18 years) and 48 patients (17.14%) had adult-onset (age \u2265 18 years) of AD.", {"entities": []}], ["There were significant differences between the 2 groups in the area of initial involvement ( P = 0.017) and in treatment history ( P = 0.010).", {"entities": []}], ["Interestingly, patients with body mass index (BMI) \u2265 25 showed significantly higher Eczema Area and Severity Index (EASI) scores than did patients with BMI < 25 in the pre-adult-onset adult AD group ( P = 0.048).", {"entities": []}], ["On the other hand, there were no significant differences in sex, family history, BMI, EASI, and total IgE between patients with pre-adult-onset AD and patients with adult-onset AD.", {"entities": []}], ["Our findings suggest that, even though many common features exist, there are significant differences between the clinical characteristics of pre-adult-onset and adult-onset AD subgroups, in adult patients with AD.", {"entities": []}], ["During October 2013\u2013May 2014, there were 102 cases of pneumonia diagnosed in US Air Force Academy cadets.", {"entities": [[54, 63, "DISEASE"]]}], ["A total of 73% of tested nasal washes contained Chlamydophila pneumoniae .", {"entities": []}], ["This agent can be considered to be present on campus settings during outbreaks with numerous, seemingly disconnected cases of relatively mild pneumonia.", {"entities": [[142, 151, "DISEASE"]]}], ["Taenia crassiceps , like other helminths, can exert regulatory effects on the immune system of its host.", {"entities": []}], ["This study investigates the effect of chronic T. crassiceps infection on the outcome of Multiple Low Dose Streptozotocin-Induced Diabetes (MLDS).", {"entities": []}], ["Healthy or previously T. crassiceps -infected mice received MLDS and type 1 diabetes (T1D) symptoms were evaluated for 6 weeks following the induction of MLDS.", {"entities": []}], ["T. crassiceps -infected mice displayed lower blood glucose levels throughout the study.", {"entities": []}], ["A significantly lower percentage of T. crassiceps -infected mice (40%) developed T1D compared to the uninfected group (100%).", {"entities": []}], ["Insulitis was remarkably absent in T. crassiceps -infected mice, which had normal pancreatic insulin content, whereas uninfected mice showed a dramatic reduction in pancreatic insulin.", {"entities": []}], ["Infected mice that received MLDS did not show an increase in their regulatory T cell population, however, they had a greater number of alternatively activated macrophages, higher levels of the cytokine IL-4, and lower levels of TNF- \u03b1 .", {"entities": []}], ["Therefore, infection with T. crassiceps causes an immunomodulation that modifies the incidence and development of MLDS-induced autoimmune diabetes.", {"entities": []}], ["Sekiya et al.", {"entities": []}], ["demonstrate that deletion of the nuclear orphan receptor Nr4a in T reg cells results in a fatal systemic immunopathology due to abrogated suppressive capability in limiting Th2 and Tfh conversion.", {"entities": []}], ["Regulatory T (T reg) cells are central mediators of immune suppression.", {"entities": []}], ["As such, T reg cells are characterized by a distinct pattern of gene expression, which includes up-regulation of immunosuppressive genes and silencing of inflammatory cytokine genes.", {"entities": []}], ["Although an increasing number of transcription factors that regulate T reg cells have been identified, the mechanisms by which the T reg cell\u2013specific transcriptional program is maintained and executed remain largely unknown.", {"entities": []}], ["The Nr4a family of nuclear orphan receptors, which we recently identified as essential for the development of T reg cells, is highly expressed in mature T reg cells as well, suggesting that Nr4a factors play important roles even beyond T reg cell development.", {"entities": []}], ["Here, we showed that deletion of Nr4a genes specifically in T reg cells caused fatal systemic immunopathology.", {"entities": []}], ["Nr4a-deficient T reg cells exhibited global alteration of the expression of genes which specify the T reg cell lineage, including reduction of Foxp3 and Ikzf4 .", {"entities": [[143, 148, "GENE"], [153, 158, "GENE"]]}], ["Furthermore, Nr4a deficiency abrogated T reg cell suppressive activities and accelerated conversion to cells with Th2 and follicular helper T (Tfh) effector-like characteristics, with heightened expression of Th2 and Tfh cytokine genes.", {"entities": []}], ["These findings demonstrate that Nr4a factors play crucial roles in mature T reg cells by directly controlling a genetic program indispensable for T reg cell maintenance and function.", {"entities": []}], ["COPD is a leading cause of morbidity and mortality, characterized by a chronic abnormal inflammatory response to noxious agents.", {"entities": []}], ["Apoptosis is a physiologic process, critical to cellular homeostasis, in which cell death follows a programmed sequence of events.", {"entities": []}], ["Apoptosis has been recognized to play an important role in clinical and experimental models of lung diseases.", {"entities": []}], ["Abnormal apoptotic events in smokers\u2019 and in emphysematous lungs have been shown in epithelial and endothelial lung cells, neutrophils, lymphocytes, and myocytes.", {"entities": []}], ["Many factors associated with COPD, including cigarette smoke, have the potential to cause apoptosis of alveolar epithelial cells, the main sites of vascular endothelial growth factor (VEGF) production.", {"entities": []}], ["The decreased expression of VEGF, a known survival factor for endothelial cells, and its receptor, results in lung septal endothelial cell death, leading perhaps to the emphysema observed in COPD.", {"entities": []}], ["In smokers who develop COPD there is an activation of adaptive immunity, with an infiltration of CD4+ and, especially, CD8 + cells.", {"entities": []}], ["CD8 + cells are cytotoxic to epithelial cells through the release of granzymes and perforin, which can further induce apoptosis of alveolar cells.", {"entities": []}], ["Moreover, any reduction in neutrophil apoptosis or dysregulation of macrophage uptake of apoptotic neutrophils could lead to chronic inflammation and tissue injury.", {"entities": []}], ["Increased rates of T-cell apoptosis may lead to a defective immune response to infective organisms, contributing to the high frequency of infections seen in COPD.", {"entities": []}], ["Increased apoptosis of skeletal muscle could be responsible for the skeletal muscle atrophy, the main cause of unexplained weight loss in patients with COPD.", {"entities": []}], ["This paper is a review of the current knowledge on the apoptotic pathways involved in COPD pathogenesis and their interaction with other known contributing factors.", {"entities": []}], ["Bronchiectasis revealed by high-resolution computed tomography (HRCT) is common in chronic obstructive pulmonary disease (COPD), but the causes and risk factors remain to be determined.", {"entities": [[83, 120, "DISEASE"], [0, 14, "DISEASE"]]}], ["Chronic rhinosinusitis (CRS) is closely associated with bronchiectasis or COPD, but whether it is associated with comorbid bronchiectasis in COPD (COPD-Bx) is unknown.", {"entities": [[56, 70, "DISEASE"], [123, 137, "DISEASE"]]}], ["Patients with stable COPD were enrolled consecutively and evaluated for the presence of CRS by questionnaire and paranasal sinus computed tomography.", {"entities": []}], ["The presence and severity of bronchiectasis on lung HRCT were evaluated by the Smith and severity scores.", {"entities": [[29, 43, "DISEASE"]]}], ["COPD symptoms were evaluated by COPD Assessment Test (CAT) and Modified British Medical Research Council Questionnaire.", {"entities": []}], ["The sputum cell differentials and concentrations of interleukin (IL)-6, IL-8, IL-5, matrix metalloproteinases-9 (MMP-9), and tissue inhibitor of matrix metalloproteinases-1 were measured.", {"entities": []}], ["We enrolled 136 patients with stable COPD, of which 66 (48.5%) were diagnosed with CRS according to the European Position Paper on Rhinosinusitis and Nasal Polyps (EP P =0.017).", {"entities": []}], ["COPD-Bx patients with CRS showed a significantly higher severity score of bronchiectasis than those without CRS ( P =0.034).", {"entities": [[74, 88, "DISEASE"]]}], ["COPD patients with CRS had a higher percentage of eosinophils, higher levels of IL-8, IL-6, and MMP-9 in sputum as compared to those without CRS.", {"entities": []}], ["In COPD-Bx patients with CRS, the percentage of eosinophils and the levels of IL-6 and MMP-9 in sputum were increased as compared to those without CRS.", {"entities": []}], ["In all the subjects, Sino-Nasal Outcome Test-20 correlated with CAT score ( r =0.315, P <0.01) and in COPD patients with CRS, Lund\u2013MacKay scores correlated with forced expiratory volume in 1 s (% pred) ( r =\u22120.251, P <0.05).", {"entities": []}], ["CRS was associated with COPD-Bx and this was probably due to increased airway inflammation.", {"entities": []}], ["Ultrasound examination of the chest has advanced in recent decades.", {"entities": []}], ["This imaging modality is currently used to diagnose several pathological conditions and provides qualitative and quantitative information.", {"entities": []}], ["Acoustic barriers represented by the aerated lungs and the bony framework of the chest generate well-described sonographic artifacts that can be used as diagnostic aids.", {"entities": []}], ["The normal pleural line and A, B, C, E and Z lines (also known as false B lines) are artifacts with specific characteristics.", {"entities": []}], ["Lung consolidation and pneumothorax sonographic patterns are also well established.", {"entities": [[23, 35, "DISEASE"]]}], ["Some scanning protocols have been used in patient management.", {"entities": []}], ["The Blue, FALLS and C.A.U.S.E.", {"entities": []}], ["protocols are examples of algorithms using artifact combinations to achieve accurate diagnoses.", {"entities": []}], ["Combined chest ultrasonography and radiography are often sufficient to diagnose and manage lung and chest wall conditions.", {"entities": []}], ["Chest ultrasonography is a highly valuable diagnostic tool for radiologists, emergency and intensive care physicians.", {"entities": []}], ["Besides nicotine replacement therapies, a realistic alternative for smoking cessation or for smoking substitution may come from electronic cigarettes (ECs), whose popularity has been steadily growing.", {"entities": []}], ["As for any emerging behaviour associated with exposure to inhalational agents, there is legitimate cause for concern and many health organizations and policy makers have pushed for restrictive policy measures ranging from complete bans to tight regulations of these products.", {"entities": []}], ["Nonetheless, it is important to reframe these concerns in context of the well-known harm caused by cigarette smoking.", {"entities": []}], ["In this article, we discuss key public health principles that should be considered when regulating ECs.", {"entities": []}], ["These include the concept of tobacco harm reduction, importance of relative risk and risk continuum, renormalization of smoking, availability of low-risk product, proportionate taxation, and reassessment of the role of non-tobacco flavours.", {"entities": []}], ["These public health principles may be systematically scrutinized using a risk assessment matrix that allows: (1) to determine the measure of certainty that a risk will occur; and (2) to estimate the impact of such a risk on public health.", {"entities": []}], ["Consequently, the ultimate goal of responsible ECs regulation should be that of maximizing the favourable impact of these reduced-risk products whilst minimizing further any potential risks.", {"entities": []}], ["Consumer perspectives, sound EC research, continuous post-marketing surveillance and reasonable safety and quality product standards should be at the very heart of future regulatory schemes that will address concerns while minimizing unintended consequences of ill-informed regulation.", {"entities": []}], ["Objective The capability to share data, and harness its potential to generate knowledge rapidly and inform decisions, can have transformative effects that improve health.", {"entities": []}], ["The infrastructure to achieve this goal at scale\u2014marrying technology, process, and policy\u2014is commonly referred to as the Learning Health System (LHS).", {"entities": []}], ["Achieving an LHS raises numerous scientific challenges.", {"entities": []}], ["Materials and methods The National Science Foundation convened an invitational workshop to identify the fundamental scientific and engineering research challenges to achieving a national-scale LHS.", {"entities": []}], ["The workshop was planned by a 12-member committee and ultimately engaged 45 prominent researchers spanning multiple disciplines over 2\u2005days in Washington, DC on 11\u201312 April 2013.", {"entities": []}], ["Results The workshop participants collectively identified 106 research questions organized around four system-level requirements that a high-functioning LHS must satisfy.", {"entities": []}], ["The workshop participants also identified a new cross-disciplinary integrative science of cyber-social ecosystems that will be required to address these challenges.", {"entities": []}], ["Conclusions The intellectual merit and potential broad impacts of the innovations that will be driven by investments in an LHS are of great potential significance.", {"entities": []}], ["The specific research questions that emerged from the workshop, alongside the potential for diverse communities to assemble to address them through a \u2018new science of learning systems\u2019, create an important agenda for informatics and related disciplines.", {"entities": []}], ["An increasing body of evidence suggests that the long-acting muscarinic antagonist (LAMA)/long-acting \u03b2 2 -agonist (LABA) combination appears to play an important role in maximizing bronchodilation, with studies to date indicating that combining different classes of bronchodilators may result in significantly greater improvements in lung function compared to the use of a single drug, and that these combinations are well tolerated in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD).", {"entities": [[470, 507, "DISEASE"]]}], ["An inhaled, fixed-dose combination of two 24-hour bronchodilators, the LAMA umeclidinium and the LABA vilanterol, is under development as a once-daily treatment for COPD.", {"entities": []}], ["The efficacy of both mono-components has already been demonstrated.", {"entities": []}], ["The information currently available suggests that umeclidinium/vilanterol is an effective once-daily dual bronchodilator fixed-dose combination in the treatment of COPD.", {"entities": []}], ["However, it remains to be seen if it compares favorably with current therapies.", {"entities": []}], ["Moreover, the question remains whether umeclidinium/vilanterol fixed-dose combination, which significantly improves FEV 1 , is also associated with improvements in other outcome measures that are important to COPD patients.", {"entities": [[116, 119, "GENE"]]}], ["Horizontal drilling, hydraulic fracturing, and other drilling and well stimulation technologies are now used widely in the United States and increasingly in other countries.", {"entities": []}], ["They enable increases in oil and gas production, but there has been inadequate attention to human health impacts.", {"entities": []}], ["Air quality near oil and gas operations is an underexplored human health concern for five reasons: (1) prior focus on threats to water quality; (2) an evolving understanding of contributions of certain oil and gas production processes to air quality; (3) limited state air quality monitoring networks; (4) significant variability in air emissions and concentrations; and (5) air quality research that misses impacts important to residents.", {"entities": []}], ["Preliminary research suggests that volatile compounds, including hazardous air pollutants, are of potential concern.", {"entities": []}], ["This study differs from prior research in its use of a community-based process to identify sampling locations.", {"entities": []}], ["Through this approach, we determine concentrations of volatile compounds in air near operations that reflect community concerns and point to the need for more fine-grained and frequent monitoring at points along the production life cycle.", {"entities": []}], ["Grab and passive air samples were collected by trained volunteers at locations identified through systematic observation of industrial operations and air impacts over the course of resident daily routines.", {"entities": []}], ["A total of 75 volatile organics were measured using EPA Method TO-15 or TO-3 by gas chromatography/mass spectrometry.", {"entities": []}], ["Formaldehyde levels were determined using UMEx 100 Passive Samplers.", {"entities": []}], ["Levels of eight volatile chemicals exceeded federal guidelines under several operational circumstances.", {"entities": []}], ["Benzene, formaldehyde, and hydrogen sulfide were the most common compounds to exceed acute and other health-based risk levels.", {"entities": []}], ["Air concentrations of potentially dangerous compounds and chemical mixtures are frequently present near oil and gas production sites.", {"entities": []}], ["Community-based research can provide an important supplement to state air quality monitoring programs.", {"entities": []}], ["The online version of this article (doi:10.1186/1476-069X-13-82) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The U.S. Centers for Medicare and Medicaid Services established the Electronic Health Record (EHR) Incentive Program in 2009 to stimulate the adoption of EHRs.", {"entities": []}], ["One component of the program requires eligible providers to implement clinical decision support (CDS) interventions that can improve performance on one or more quality measures pre-selected for each specialty.", {"entities": []}], ["Because the unique decision-making challenges and existing HIT capabilities vary widely across specialties, the development of meaningful objectives for CDS within such programs must be supported by deliberative analysis.", {"entities": []}], ["We developed a conceptual framework and protocol that combines evidence review with expert opinion to elicit clinically meaningful objectives for CDS directly from specialists.", {"entities": []}], ["The framework links objectives for CDS to specialty-specific performance gaps while ensuring that a workable set of CDS opportunities are available to providers to address each performance gap.", {"entities": []}], ["Performance gaps may include those with well-established quality measures but also priorities identified by specialists based on their clinical experience.", {"entities": []}], ["Moreover, objectives are not constrained to performance gaps with existing CDS technologies, but rather may include those for which CDS tools might reasonably be expected to be developed in the near term, for example, by the beginning of Stage 3 of the EHR Incentive program.", {"entities": []}], ["The protocol uses a modified Delphi expert panel process to elicit and prioritize CDS meaningful use objectives.", {"entities": []}], ["Experts first rate the importance of performance gaps, beginning with a candidate list generated through an environmental scan and supplemented through nominations by panelists.", {"entities": []}], ["For the highest priority performance gaps, panelists then rate the extent to which existing or future CDS interventions, characterized jointly as \u201cCDS opportunities,\u201d might impact each performance gap and the extent to which each CDS opportunity is compatible with specialists\u2019 clinical workflows.", {"entities": []}], ["The protocol was tested by expert panels representing four clinical specialties: oncology, orthopedic surgery, interventional cardiology, and pediatrics.", {"entities": []}], ["Accreditation of healthcare organizations is a widely used method to assess and improve quality of healthcare.", {"entities": []}], ["Our aim was to determine the effectiveness of improvement plans in practice accreditation of primary care practices, focusing on cardiovascular risk management (CVRM).", {"entities": []}], ["A two-arm cluster randomized controlled trial with a block design was conducted with measurements at baseline and follow-up.", {"entities": []}], ["Primary care practices allocated to the intervention group (n\u200a=\u200a22) were instructed to focus improvement plans during the intervention period on CVRM, while practices in the control group (n\u200a=\u200a23) could focus on any domain except on CVRM and diabetes mellitus.", {"entities": [[242, 259, "DISEASE"]]}], ["Primary outcomes were systolic blood pressure <140 mmHg, LDL cholesterol <2.5 mmol/l and prescription of antiplatelet drugs.", {"entities": []}], ["Secondary outcomes were 17 indicators of CVRM and physician's perceived goal attainment for the chosen improvement project.", {"entities": []}], ["No effect was found on the primary outcomes.", {"entities": []}], ["Blood pressure targets were reached in 39.8% of patients in the intervention and 38.7% of patients in the control group; cholesterol target levels were reached in 44.5% and 49.0% respectively; antiplatelet drugs were prescribed in 82.7% in both groups.", {"entities": []}], ["Six secondary outcomes improved: smoking status, exercise control, diet control, registration of alcohol intake, measurement of waist circumference, and fasting glucose.", {"entities": []}], ["Participants' perceived goal attainment was high in both arms: mean scores of 7.9 and 8.2 on the 10-point scale.", {"entities": []}], ["The focus of improvement plans on CVRM in the practice accreditation program led to some improvements of CVRM, but not on the primary outcomes.", {"entities": []}], ["ClinicalTrials.gov NCT00791362", {"entities": []}], ["The ability of neutrophils and other leucocyte members of the innate immune system to expel their DNA into the extracellular environment in a controlled manner in order to trap and kill pathogenic microorganisms lead to a paradigm shift in our understanding of host microbe interactions.", {"entities": []}], ["Surprisingly, the neutrophil extracellular trap (NET) cast by neutrophils is very wide and extends to the entrapment of viruses as well as multicellular eukaryotic parasites.", {"entities": []}], ["Not unexpectedly, it has emerged that pathogenic microorganisms can employ a wide array of strategies to avoid ensnarement, including expression of DNAse enzymes that destroy the lattice backbone of NETs.", {"entities": []}], ["Alternatively, they may use molecular mimicry to avoid detection or trigger events leading to the expression of immune modulatory cytokines such as IL-10, which dampen the NETotic response of neutrophils.", {"entities": []}], ["In addition, the host microenvironment may contribute to the innate immune response by the production of lectin-like molecules that bind to bacteria and promote their entrapment on NETs.", {"entities": []}], ["An example of this is the production of surfactant protein D by the lung epithelium.", {"entities": []}], ["In addition, pregnancy provides a different challenge, as the mother needs to mount an effective response against pathogens, without harming her unborn child.", {"entities": []}], ["An examination of these decoy and host response mechanisms may open the path for new therapies to treat pathologies mediated by overt NETosis.", {"entities": []}], ["We used the Third National Health and Nutrition Examination Survey (NHANES III), conducted from 1988 to 1994, to investigate the relationship between environmental tobacco smoke (ETS) exposure and cognitive abilities among U.S. children and adolescents 6\u201316 years of age.", {"entities": []}], ["Serum cotinine was used as a biomarker of ETS exposure.", {"entities": []}], ["Children were included in the sample if their serum cotinine levels were \u226415 ng/mL, a level consistent with ETS exposure, and if they denied using any tobacco products in the previous 5 days.", {"entities": []}], ["Cognitive and academic abilities were assessed using the reading and math subtests of the Wide Range Achievement Test\u2013Revised and the block design and digit span subtests of the Wechsler Intelligence Scale for Children\u2013III.", {"entities": []}], ["Analyses were conducted using SUDAAN software.", {"entities": []}], ["Of the 5,365 6- to 16-year-olds included in NHANES III, 4,399 (82%) were included in this analysis.", {"entities": []}], ["The geometric mean serum cotinine level was 0.23 ng/mL (range, 0.035\u201315 ng/mL); 80% of subjects had levels < 1 ng/mL.", {"entities": []}], ["After adjustment for sex, race, region, poverty, parent education and marital status, ferritin, and blood lead concentration, there was a significant inverse relationship between serum cotinine and scores on reading (\u03b2= \u22122.69, p = 0.001), math (\u03b2= \u22121.93, p = 0.01), and block design (\u03b2= \u22120.55, p < 0.001) but not digit span (\u03b2= \u22120.08, p = 0.52).", {"entities": []}], ["The estimated ETS-associated decrement in cognitive test scores was greater at lower cotinine levels.", {"entities": []}], ["A log-linear analysis was selected as the best fit to characterize the increased slope in cognitive deficits at lower levels of exposure.", {"entities": []}], ["These data, which indicate an inverse association between ETS exposure and cognitive deficits among children even at extremely low levels of exposure, support policy to further restrict children\u2019s exposure.", {"entities": []}], ["The cell state splitter is a membraneless organelle at the apical end of each epithelial cell in a developing embryo.", {"entities": []}], ["It consists of a microfilament ring and an intermediate filament ring subtending a microtubule mat.", {"entities": []}], ["The microtubules and microfilament ring are in mechanical opposition as in a tensegrity structure.", {"entities": []}], ["The cell state splitter is bistable, perturbations causing it to contract or expand radially.", {"entities": []}], ["The intermediate filament ring provides metastability against small perturbations.", {"entities": []}], ["Once this snap-through organelle is triggered, it initiates signal transduction to the nucleus, which changes gene expression in one of two readied manners, causing its cell to undergo a step of determination and subsequent differentiation.", {"entities": []}], ["The cell state splitter also triggers the cell state splitters of adjacent cells to respond, resulting in a differentiation wave.", {"entities": []}], ["Embryogenesis may be represented then as a bifurcating differentiation tree, each edge representing one cell type.", {"entities": []}], ["In combination with the differentiation waves they propagate, cell state splitters explain the spatiotemporal course of differentiation in the developing embryo.", {"entities": []}], ["This review is excerpted from and elaborates on \u201c Embryogenesis Explained\u201d (World Scientific Publishing, Singapore, 2016).", {"entities": []}], ["To investigate secondhand smoke (SHS) exposure at home from neighbours in Hong Kong adolescents and its association with respiratory symptoms in never-smokers.", {"entities": []}], ["A cross-sectional study.", {"entities": []}], ["79 randomly selected secondary schools in Hong Kong.", {"entities": []}], ["61\u2005810 secondary 1 (USA grade 7) to 7 students, in which 50\u2005762 never-smokers were identified and included in the analysis of the association between SHS exposure at home from neighbours and respiratory symptoms.", {"entities": []}], ["Smoking status, family smoking status, SHS exposure at home from inside the home and from neighbours in the past 7\u2005days, respiratory symptoms and sociodemographic characteristics were reported.", {"entities": []}], ["Adjusted ORs (AORs) of respiratory symptoms for SHS exposure from the 2 sources in never-smokers were calculated using logistic regression.", {"entities": []}], ["In all students, 33.2% were exposed to SHS at home, including 16.2% from inside the home only, 10.0% from neighbours only and 7.0% from both.", {"entities": []}], ["The prevalence of SHS exposure from neighbours was 17.1%, including 13.5% for 1\u20134\u2005days/week and 3.6% for 5\u20137\u2005days/week.", {"entities": []}], ["In never-smokers (n=50\u2005762), respiratory symptoms were significantly associated with SHS exposure from neighbours with AORs (95% CI) of 1.29 (1.20 to 1.39) for any exposure (p<0.001), 1.21 (1.12 to 1.31) for 1\u20134\u2005days/week (p<0.001) and 1.63 (1.44 to 1.86) for 5\u20137\u2005days/week (p<0.001) (P for trend <0.001).", {"entities": []}], ["Compared with no SHS exposure at home from any source, the AORs were 1.16 (1.07 to 1.25) for SHS from inside the home only (p<0.001), 1.20 (1.11 to 1.31) from neighbours only (p<0.001), and 1.74 (1.56 to 1.94) from both (p<0.001).", {"entities": []}], ["SHS exposure at home from neighbours was prevalent in Hong Kong adolescents, and was associated with respiratory symptoms in never-smokers.", {"entities": []}], ["SHS exposure at home may be underestimated by ignoring the neighbouring source.", {"entities": []}], ["Smoke-free housing policy is needed to protect children and adolescents from harms of SHS.", {"entities": []}], ["High sodium intake is associated with the development of chronic diseases such as obesity.", {"entities": [[82, 89, "DISEASE"]]}], ["Although its role in obesity remains controversial, there may be a correlation between salt sensitivity and the early onset of chronic diseases in obese children.", {"entities": [[21, 28, "DISEASE"]]}], ["In all, 2,163 Korean children (1,106 boys and 1,057 girls) aged 8\u20139 years were recruited from seven elementary schools in Seoul.", {"entities": []}], ["To evaluate whether obesity risk was modulated by the salt sensitivity, 11 SNPs related to salt sensitive genes (SSG) became the target of sodium intakes in obese children.", {"entities": [[20, 27, "DISEASE"]]}], ["BP, HOMA-IR, LDLc, TG, and the girls\u2019 sodium intake significantly increased, but HDLc significantly decreased with increase in BMI.", {"entities": [[19, 21, "GENE"]]}], ["Regardless of sex, the obesity risk was 5.27-fold (CI; 1.320\u201327.560) higher in the Q2 to Q5 of sodium intake adjusted by energy (4044.9\u20135058.9 mg/day) than in the lowest Q1 level (2287.6 mg/day) in obese children.", {"entities": [[23, 30, "DISEASE"]]}], ["BP was sensitively dependent on insulin resistance and lipid accumulation in all subjects; however, sodium intake may be an independent risk factor of obesity without increasing BP in girls.", {"entities": [[151, 158, "DISEASE"]]}], ["GRK4 A486V mutant homozygote was highly distributed in the obese group, but other SNPs had no impact.", {"entities": [[0, 4, "GENE"]]}], ["The obesity risk increased 7.06, 16.8, and 46.09-fold more in boys with GRK4 A486V , ACE , and SLC12A3 mutants as sodium intake increased.", {"entities": [[4, 11, "DISEASE"], [72, 76, "GENE"], [95, 102, "GENE"]]}], ["Among girls, the obesity risk increased in GRK4 A486V heterozygote and CYP11\u03b2-2 mutant homozygote although sodium intake was relatively lower, implying that ACE , SLC12A , CYP11\u03b2-2 , and GRK4 A486V polymorphisms showed gender-based differences with regard to interaction between sodium intake and obesity.", {"entities": [[17, 24, "DISEASE"], [297, 304, "DISEASE"], [43, 47, "GENE"], [187, 191, "GENE"], [43, 47, "GENE"], [187, 191, "GENE"]]}], ["A high sodium intake markedly increased the obesity risk in variants of GRK4 A486V regardless of sex.", {"entities": [[44, 51, "DISEASE"], [72, 76, "GENE"]]}], ["The obesity risk increased with GRK4 A486V , ACE , and SLC12A3 variants in boys, whereas it increased with GRK4 A486V and CYP11B2 variants in girls as sodium intake increased.", {"entities": [[4, 11, "DISEASE"], [32, 36, "GENE"], [107, 111, "GENE"], [55, 62, "GENE"], [32, 36, "GENE"], [107, 111, "GENE"], [122, 129, "GENE"]]}], ["Obese children with the specific gene variants are recommended to reduce their sodium intake.", {"entities": []}], ["Antigen peptides are actively transported across the endoplasmic reticulum by the transporters associated with antigen presentation (TAP).", {"entities": []}], ["TAP genes polymorphism could influence the selection process that determines which antigen peptides play a role in the pathogenesis of allergic rhinitis.", {"entities": [[135, 152, "DISEASE"], [144, 152, "DISEASE"]]}], ["The aim of this study was to investigate the association of TAP genes polymorphism with allergic rhinitis.", {"entities": [[88, 105, "DISEASE"], [97, 105, "DISEASE"]]}], ["TAP1 and TAP2 genotyping were performed on 110 allergic rhinitis patients and 107 healthy controls.", {"entities": [[47, 64, "DISEASE"], [56, 64, "DISEASE"], [0, 4, "GENE"], [9, 13, "GENE"]]}], ["TAP1 polymorphic residues at codons 333 and 637, and TAP2 polymorphic residues at codons 379, 565, 651, and 665 were analyzed by the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR).", {"entities": [[0, 4, "GENE"], [53, 57, "GENE"]]}], ["Analysis of TAP1 gene polymorphism demonstrated decreased frequencies of Ile/Val genotype at codon 333, Asp/Gly genotype at codon 637, and haplotype A and B in allergic rhinitis patients when compared to controls ( p <0.05).", {"entities": [[160, 177, "DISEASE"], [169, 177, "DISEASE"], [12, 16, "GENE"]]}], ["However, there was no significant difference in the genotype, phenotype, or allele frequencies at four TAP2 codons between controls and allergic rhinitis patients.", {"entities": [[136, 153, "DISEASE"], [145, 153, "DISEASE"], [103, 107, "GENE"]]}], ["In conclusion, TAP1 gene polymorphism may be an important factor contributing to the genetic susceptibility in the development of allergic rhinitis in the Korean population.", {"entities": [[130, 147, "DISEASE"], [139, 147, "DISEASE"], [15, 19, "GENE"]]}], ["This study aimed to establish and evaluate a bovine respiratory model of experimentally induced acute C. psittaci infection.", {"entities": []}], ["Calves are natural hosts and pathogenesis may resemble the situation in humans.", {"entities": []}], ["Intrabronchial inoculation of C. psittaci strain DC15 was performed in calves aged 2\u20133 months via bronchoscope at four different challenge doses from 10 C. psittaci or cell culture medium.", {"entities": []}], ["While 10 C. psittaci , the respiratory disease was accompanied by severe systemic illness (apathy, tremor, markedly reduced appetite).", {"entities": []}], ["At the time point of most pronounced clinical signs (3 dpi) the extent of lung lesions was below 10% of pulmonary tissue in calves inoculated with 10 C. psittaci .", {"entities": []}], ["Beside clinical signs and pathologic lesions, the bacterial load of lung tissue and markers of pulmonary inflammation (i.e., cell counts, concentration of proteins and eicosanoids in broncho-alveolar lavage fluid) were positively associated with ifu of viable C. psittaci .", {"entities": []}], ["While any effect of endotoxin has been ruled out, all effects could be attributed to infection by the replicating bacteria.", {"entities": []}], ["In conclusion, the calf represents a suitable model of respiratory chlamydial infection.", {"entities": []}], ["Dose titration revealed that both clinically latent and clinically manifest infection can be reproduced experimentally by either 10 C. psittaci DC15 while doses above 10 C. psittaci cannot be recommended for further studies for ethical reasons.", {"entities": []}], ["This defined model of different clinical expressions of chlamydial infection allows studying host-pathogen interactions.", {"entities": []}], ["Presence of chronic obstructive pulmonary disease (COPD) in heart failure (HF) has prognostic and therapeutic implications.", {"entities": [[12, 49, "DISEASE"]]}], ["Exact prevalence estimates are lacking because most previous studies estimated the prevalence of COPD among HF patients while unstable and in the presence of pulmonary congestion.", {"entities": []}], ["Community-dwelling patients with an established diagnosis of HF and in a stable phase of their disease were invited for spirometry.", {"entities": []}], ["COPD was defined according to the Global initiative for chronic Obstructive Lung Disease (GOLD) classification and considered present if the ratio of the post-bronchodilator forced expiratory volume in 1 second and forced vital capacity was below 0.7.", {"entities": []}], ["Thirty of the 106 patients with HF (mean age 76 [standard deviation] 11.9 years, 57% male) had COPD (prevalence 28.3% [95% confidence interval (CI) 19.7%\u201336.9%]), with similar rates among those with HF and a reduced ejection fraction (18 individuals; prevalence 28.6% [95% CI 20.0%\u201337.2%]) and HF with preserved ejection fraction (12 individuals; prevalence 27.9% [95% CI 19.4\u201336.4]).", {"entities": []}], ["Twenty-one (70%) of the 30 participants were newly detected cases of COPD.", {"entities": []}], ["More than a quarter of the patients with HF concomitantly have COPD, with the large majority being previously unrecognized.", {"entities": []}], ["Coexistence of COPD should be considered more often in these patients.", {"entities": []}], ["Increased life expectancy due to recent medical advances has increased the need to understand more fully the quality of life (QoL) in patients with sickle cell disease (SCD) and factors predicting disease adaptation .The objectives of this study were to assess the impairment of health related quality of life (HRQoL) domains in a sample of Saudi Arabian adolescents with SCD.", {"entities": [[169, 172, "GENE"], [372, 375, "GENE"], [169, 172, "GENE"], [372, 375, "GENE"]]}], ["A non-probability sample composed of Saudi adolescents with SCD (n=180) aged 14-18 years and comparable age and gender matched healthy controls (n=202).", {"entities": [[60, 63, "GENE"]]}], ["Socio-demographics and disease related data were obtained through personal interview with parents/legal guardians and reviewing patients\u2032 medical records.", {"entities": []}], ["Selfadministered \u2018Short Form-36\u2019 questionnaire was used to assess HRQoL of the included groups.", {"entities": []}], ["HRQoL showed significant deterioration in adolescents with SCD especially in role physical, general health, and bodily pain domains irrespective of the gender, while female adolescents with SCD demonstrated significant deterioration in emotional wellbeing.", {"entities": [[59, 62, "GENE"], [190, 193, "GENE"], [59, 62, "GENE"], [190, 193, "GENE"]]}], ["Those with SCD-complications showed worse scores along the physical, general health, and emotional wellbeing domains.", {"entities": []}], ["HRQol scores were negatively associated with increasing age, female gender, rural residence, low family income, presence of disease-related complications and frequent hospital admissions as revealed by multivariate regression analysis.", {"entities": []}], ["Saudi adolescents with SCD experience deterioration along all domains of HRQoL especially the physical.", {"entities": [[23, 26, "GENE"]]}], ["Disease related complications and sociodemographic correlates are significant determinants to worse HRQoL among the included adolescents with SCD.", {"entities": [[142, 145, "GENE"]]}], ["When expiratory flow is maximal during tidal breathing and cannot be increased unless operative lung volumes move towards total lung capacity, tidal expiratory flow limitation (EFL) is said to occur.", {"entities": []}], ["EFL represents a severe mechanical constraint caused by different mechanisms and observed in different conditions, but it is more relevant in terms of prevalence and negative consequences in obstructive lung diseases and particularly in chronic obstructive pulmonary disease (COPD).", {"entities": [[237, 274, "DISEASE"]]}], ["Although in COPD patients EFL more commonly develops during exercise, in more advanced disorder it can be present at rest, before in supine position, and then in seated-sitting position.", {"entities": []}], ["In any circumstances EFL predisposes to pulmonary dynamic hyperinflation and its unfavorable effects such as increased elastic work of breathing, inspiratory muscles dysfunction, and progressive neuroventilatory dissociation, leading to reduced exercise tolerance, marked breathlessness during effort, and severe chronic dyspnea.", {"entities": []}], ["We and others have extensively investigated the role of PARP-1 in cell growth and demise in response to pathophysiological cues.", {"entities": []}], ["Most of the clinical trials on PARP inhibitors are targeting primarily estrogen receptor (ER) negative cancers with BRCA-deficiency.", {"entities": []}], ["It is surprising that the role of the enzyme has yet to be investigated in ER-mediated cell growth.", {"entities": []}], ["It is noteworthy that ER is expressed in the majority of breast cancers.", {"entities": []}], ["We recently showed that the scaffolding protein PDZK1 is critical for 17\u03b2-estradiol (E 2 )-induced growth of breast cancer cells.", {"entities": [[109, 122, "DISEASE"], [116, 122, "DISEASE"], [48, 53, "GENE"]]}], ["We demonstrated that E 2 -induced PDZK1 expression is indirectly regulated by ER and requires IGF-1 receptor (IGF-1R).", {"entities": [[34, 39, "GENE"]]}], ["The breast cancer cell lines MCF-7 and BT474 were used as ER(+) cell culture models.", {"entities": [[4, 17, "DISEASE"], [11, 17, "DISEASE"]]}], ["Thieno[2,3-c]isoquinolin-5-one (TIQ-A) and olaparib (AZD2281) were used as potent inhibitors of PARP.", {"entities": []}], ["PARP-1 knockdown by shRNA was used to show specificity of the effects to PARP-1.", {"entities": []}], ["In this study, we aimed to determine the effect of PARP inhibition on estrogen-induced growth of breast cancer cells and examine whether the potential effect is linked to PDZK1 and IGF-1R expression.", {"entities": [[97, 110, "DISEASE"], [104, 110, "DISEASE"], [171, 176, "GENE"]]}], ["Our results show that PARP inhibition pharmacologically by TIQ-A or olaparib or by PARP-1 knockdown blocked E 2 -dependent growth of MCF-7 cells.", {"entities": []}], ["Such inhibitory effect was also observed in olaparib-treated BT474 cells.", {"entities": []}], ["The effect of PARP inhibition on cell growth coincided with an efficient reduction in E 2 -induced PDZK1 expression.", {"entities": [[99, 104, "GENE"]]}], ["This effect was accompanied by a similar decrease in the cell cycle protein cyclin D1.", {"entities": []}], ["PARP appeared to regulate E 2 -induced PDZK1 at the mRNA level.", {"entities": [[39, 44, "GENE"]]}], ["Such regulation may be linked to a modulation of IGF-1R as PARP inhibition pharmacologically or by PARP-1 knockdown efficiently reduced E 2 -induced expression of the receptor at the protein and mRNA levels.", {"entities": []}], ["Overall, our results show for the first time that PARP regulates E 2 -mediated cell growth by controlling the ER/IGF-1R/PDZK1 axis.", {"entities": []}], ["These findings suggest that the relationship between ER, PDZK1, and IGF-1R may be perturbed by blocking PARP function and that PARP inhibitors may be considered in clinical trials on ER(+) cancers.", {"entities": [[57, 62, "GENE"]]}], ["Based on own translational research of the biochemical and hormonal effects of cow\u2019s milk consumption in humans, this review presents milk as a signaling system of mammalian evolution that activates the nutrient-sensitive kinase mechanistic target of rapamycin complex 1 (mTORC1), the pivotal regulator of translation.", {"entities": []}], ["Milk, a mammary gland-derived secretory product, is required for species-specific gene-nutrient interactions that promote appropriate growth and development of the newborn mammal.", {"entities": []}], ["This signaling system is highly conserved and tightly controlled by the lactation genome.", {"entities": []}], ["Milk is sufficient to activate mTORC1, the crucial regulator of protein, lipid, and nucleotide synthesis orchestrating anabolism, cell growth and proliferation.", {"entities": []}], ["To fulfill its mTORC1-activating function, milk delivers four key metabolic messengers: (1) essential branched-chain amino acids (BCAAs); (2) glutamine; (3) palmitic acid; and (4) bioactive exosomal microRNAs, which in a synergistical fashion promote mTORC1-dependent translation.", {"entities": []}], ["In all mammals except Neolithic humans, postnatal activation of mTORC1 by milk intake is restricted to the postnatal lactation period.", {"entities": []}], ["It is of critical concern that persistent hyperactivation of mTORC1 is associated with aging and the development of age-related disorders such as obesity, type 2 diabetes mellitus, cancer, and neurodegenerative diseases.", {"entities": [[146, 153, "DISEASE"], [181, 187, "DISEASE"], [162, 179, "DISEASE"], [155, 179, "DISEASE"]]}], ["Persistent mTORC1 activation promotes endoplasmic reticulum (ER) stress and drives an aimless quasi-program, which promotes aging and age-related diseases.", {"entities": []}], ["Abundant literature supports the beneficial effects of physical activity for improving health of people with chronic diseases.", {"entities": []}], ["The relationship between multimorbidity and physical activity levels, however, has been little evaluated.", {"entities": []}], ["The purpose of the current exploratory study was to examine the relationship between a) multimorbidity and physical activity levels, and b) long-term limitations on activity, self-rated general health, psychological distress, and physical activity levels for each sex in adults, after age, education, income, and employment factors were controlled for.", {"entities": []}], ["Data from the Quebec Health Survey 1998 were used.", {"entities": []}], ["The sample included 16,782 adults 18\u201369 yr of age.", {"entities": []}], ["Independent variables were multimorbidity, long-term limitations on activity, self-rated general health, and psychological distress.", {"entities": []}], ["The dependent variable was physical activity levels.", {"entities": []}], ["Links between the independent and dependent variables were assessed separately for men and women with multinomial regressions while accounting for the survey sampling design and household clustering.", {"entities": []}], ["About 46% of the participants were men.", {"entities": []}], ["Multimorbidity was not associated with physical activity levels for either men or women.", {"entities": []}], ["Men and women with long-term limitations on activity and with poor-to-average self-rated general health were less likely to be physically active.", {"entities": []}], ["No relationship between psychological distress and physical activity was found for men.", {"entities": []}], ["Women with high levels of psychological distress were less likely to be physically active.", {"entities": []}], ["Multimorbidity was not associated with physical activity levels in either sex, when age, education, income, and employment factors were controlled for.", {"entities": []}], ["Long-term limitations on activity and poor-to-average self-rated general health seem related to a reduction in physical activity levels for both sexes, whereas psychological distress was associated with a reduction in physical activity levels only among women.", {"entities": []}], ["Longitudinal studies using a comorbidity or multimorbidity index to account for severity of the chronic diseases are needed to replicate the results of this exploratory study.", {"entities": []}], ["COPD is a major cause of death and morbidity worldwide, and is characterized by persistent airflow obstruction.", {"entities": []}], ["The evaluation of obstruction is critically dependent on sensitive methods for lung-function testing.", {"entities": []}], ["A wide body of knowledge has been accumulated in recent years showing that these methods have been significantly refined and seems promising for detection of early disease.", {"entities": []}], ["This review focuses on research on pulmonary function analysis in COPD performed in Brazil during this century.", {"entities": []}], ["The literature was searched using a systematic search strategy limited to English language studies that were carried out in Brazil from the year 2000 onward, with study objectives that included a focus on lung function.", {"entities": []}], ["After we applied our inclusion and exclusion criteria, 94 articles addressed our stated objectives.", {"entities": []}], ["Among the new methods reviewed are the forced-oscillation technique and the nitrogen-washout test, which may provide information on small-airway abnormalities.", {"entities": []}], ["Studies investigating the respiratory muscles and thoracoabdominal motion are also discussed, as well as studies on automatic clinical decision-support systems and complexity measurements.", {"entities": []}], ["We also examined important gaps in the present knowledge and suggested future directions for the cited research fields.", {"entities": []}], ["There is clear evidence that improvements in lung-function methods allowed us to obtain new pathophysiological information, contributing to improvement in our understanding of COPD.", {"entities": []}], ["In addition, they may also assist in the diagnosis and prevention of COPD.", {"entities": []}], ["Further investigations using prospective and longitudinal design may be of interest to elucidate the use of these new methods in the diagnosis and prevention of COPD.", {"entities": []}], ["Physical activity and sedentary behaviour are associated with metabolic and mental health during childhood and adolescence.", {"entities": []}], ["Understanding the inter-relationships between these behaviours will help to inform intervention design.", {"entities": []}], ["This systematic review and meta-analysis synthesized evidence from observational studies describing the association between sedentary behaviour and physical activity in young people (<18\u2009years).", {"entities": []}], ["English-language publications up to August 2013 were located through electronic and manual searches.", {"entities": []}], ["Included studies presented statistical associations between at least one measure of sedentary behaviour and one measure of physical activity.", {"entities": []}], ["One hundred sixty-three papers were included in the meta-analysis, from which data on 254 independent samples was extracted.", {"entities": []}], ["In the summary meta-analytic model ( k \u2009=\u2009230), a small, but significant, negative association between sedentary behaviour and physical activity was observed ( r \u2009=\u2009\u22120.108, 95% confidence interval [CI]\u2009=\u2009\u22120.128, \u22120.087).", {"entities": []}], ["In moderator analyses, studies that recruited smaller samples ( n \u2009<\u2009100, r \u2009=\u2009\u22120.193, 95% CI\u2009=\u2009\u22120.276, \u22120.109) employed objective methods of measurement (objectively measured physical activity; r \u2009=\u2009\u22120.233, 95% CI\u2009=\u2009\u22120.330, \u22120.137) or were assessed to be of higher methodological quality ( r \u2009=\u2009\u22120.176, 95% CI\u2009=\u2009\u22120.215, \u22120.138) reported stronger associations, although effect sizes remained small.", {"entities": []}], ["The association between sedentary behaviour and physical activity in young people is negative, but small, suggesting that these behaviours do not directly displace one another.", {"entities": []}], ["Obesity affects quality of life and life expectancy and is associated with cardiovascular disorders, cancer, diabetes, reproductive disorders in women, prostate diseases in men, and congenital anomalies in children.", {"entities": [[0, 7, "DISEASE"], [101, 107, "DISEASE"]]}], ["The use of single nucleotide polymorphism (SNP) markers of diseases and drug responses (i.e., significant differences of personal genomes of patients from the reference human genome) can help physicians to improve treatment.", {"entities": []}], ["Clinical research can validate SNP markers via genotyping of patients and demonstration that SNP alleles are significantly more frequent in patients than in healthy people.", {"entities": []}], ["The search for biomedical SNP markers of interest can be accelerated by computer-based analysis of hundreds of millions of SNPs in the 1000 Genomes project because of selection of the most meaningful candidate SNP markers and elimination of neutral SNPs.", {"entities": []}], ["We cross-validated the output of two computer-based methods: DNA sequence analysis using Web service SNP_TATA_Comparator and keyword search for articles on comorbidities of obesity.", {"entities": [[173, 180, "DISEASE"]]}], ["Near the sites binding to TATA-binding protein (TBP) in human gene promoters, we found 22 obesity-related candidate SNP markers, including rs10895068 (male breast cancer in obesity); rs35036378 (reduced risk of obesity after ovariectomy); rs201739205 (reduced risk of obesity-related cancers due to weight loss by diet/exercise in obese postmenopausal women); rs183433761 (obesity resistance during a high-fat diet); rs367732974 and rs549591993 (both: cardiovascular complications in obese patients with type 2 diabetes mellitus); rs200487063 and rs34104384 (both: obesity-caused hypertension); rs35518301, rs72661131, and rs562962093 (all: obesity); and rs397509430, rs33980857, rs34598529, rs33931746, rs33981098, rs34500389, rs63750953, rs281864525, rs35518301, and rs34166473 (all: chronic inflammation in comorbidities of obesity).", {"entities": [[580, 592, "DISEASE"], [156, 169, "DISEASE"], [90, 97, "DISEASE"], [173, 180, "DISEASE"], [211, 218, "DISEASE"], [268, 275, "DISEASE"], [373, 380, "DISEASE"], [565, 572, "DISEASE"], [641, 648, "DISEASE"], [827, 834, "DISEASE"], [151, 169, "DISEASE"], [163, 169, "DISEASE"], [511, 528, "DISEASE"], [504, 528, "DISEASE"], [48, 51, "GENE"]]}], ["Using an electrophoretic mobility shift assay under nonequilibrium conditions, we empirically validated the statistical significance (\u03b1 < 0.00025) of the differences in TBP affinity values between the minor and ancestral alleles of 4 out of the 22 SNPs: rs200487063, rs201381696, rs34104384, and rs183433761.", {"entities": [[169, 172, "GENE"]]}], ["We also measured half-life (t 1/2 ), Gibbs free energy change (\u0394G), and the association and dissociation rate constants, k a and k d , of the TBP-DNA complex for these SNPs.", {"entities": []}], ["Validation of the 22 candidate SNP markers by proper clinical protocols appears to have a strong rationale and may advance postgenomic predictive preventive personalized medicine.", {"entities": []}], ["Cystic fibrosis (CF) lungs harbor a complex community of interacting microbes, including pathogens like Pseudomonas aeruginosa .", {"entities": []}], ["Meta-taxogenomic analysis based on V5-V6 rrs PCR products of 52 P. aeruginosa-positive (Pp) and 52 P. aeruginosa-negative (Pn) pooled DNA extracts from CF sputa suggested positive associations between P .", {"entities": []}], ["aeruginosa and Stenotrophomonas and Prevotella , but negative ones with Haemophilus , Neisseria and Burkholderia .", {"entities": []}], ["Internal Transcribed Spacer analyses (RISA) from individual DNA extracts identified three significant genetic structures within the CF cohorts, and indicated an impact of P .", {"entities": []}], ["aeruginosa .", {"entities": []}], ["RISA clusters Ip and IIIp contained CF sputa with a P .", {"entities": []}], ["aeruginosa prevalence above 93%, and of 24.2% in cluster IIp.", {"entities": []}], ["Clusters Ip and IIIp showed lower RISA genetic diversity and richness than IIp.", {"entities": []}], ["Highly similar cluster IIp RISA profiles were obtained from two patients harboring isolates of a same P .", {"entities": []}], ["aeruginosa clone, suggesting convergent evolution in the structure of their microbiota.", {"entities": []}], ["CF patients of cluster IIp had received significantly less antibiotics than patients of clusters Ip and IIIp but harbored the most resistant P .", {"entities": []}], ["aeruginosa strains.", {"entities": []}], ["Patients of cluster IIIp were older than those of Ip.", {"entities": []}], ["The effects of P .", {"entities": []}], ["aeruginosa on the RISA structures could not be fully dissociated from the above two confounding factors but several trends in these datasets support the conclusion of a strong incidence of P .", {"entities": []}], ["aeruginosa on the genetic structure of CF lung microbiota.", {"entities": []}], ["Asthma is a serious and hereditary respiratory disorder affecting all age groups.", {"entities": [[0, 6, "DISEASE"]]}], ["Interleukin-13 (IL-13) is a central regulator of allergic inflammation.", {"entities": []}], ["The purpose of the present study was to estimate the relationship between IL-13 +1923C/T polymorphism and asthma susceptibility.", {"entities": [[106, 112, "DISEASE"]]}], ["Relevant case-control studies published between January 2000 and July 2016 were searched in the online databases.", {"entities": []}], ["Review Manage (RevMan) 5.3 was used to conduct the statistical analysis.", {"entities": []}], ["The pooled odds ratio (OR) with its 95% confidence interval (CI) was employed to calculate the strength of association.", {"entities": []}], ["A total of 26 articles were retrieved, including 17642 asthma patients and 42402 controls.", {"entities": [[55, 61, "DISEASE"]]}], ["Overall, our results found that IL-13 +1923C/T polymorphism was significantly associated with increased risk of asthma under each genetic model ( P <0.00001).", {"entities": [[112, 118, "DISEASE"]]}], ["Subgroup analysis by ethnicity showed that alleles and genotypes of this variant correlated with asthma among Asians and Caucasians, but only TT genotype under the homozygote model in Africans.", {"entities": [[97, 103, "DISEASE"]]}], ["When stratified by age group, this variant highly correlated with asthma in children and moderately in adults.", {"entities": [[66, 72, "DISEASE"]]}], ["Furthermore, the TT, CT and CC genotypes in asthma group were all significantly associated with increased IgE levels in sera of asthma patients when compared with controls.", {"entities": [[44, 50, "DISEASE"], [128, 134, "DISEASE"]]}], ["Our results suggested that IL-13 +1923C/T polymorphism contributed to the development of asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["Further case-control studies with more ethnicities are still needed.", {"entities": []}], ["Concerns have been raised about how the transmission of emerging infectious diseases from patients to healthcare workers (HCWs) and vice versa could be recognized and prevented in a timely manner.", {"entities": []}], ["An effective strategy to block transmission of pandemic H1N1 (2009) influenza in HCWs is important.", {"entities": [[68, 77, "DISEASE"]]}], ["An infection control program was implemented to survey and prevent nosocomial outbreaks of H1N1 (2009) influenza at a 2,600-bed, tertiary-care academic hospital.", {"entities": [[103, 112, "DISEASE"]]}], ["In total, 4,963 employees at Kaohsiung Chang Gung Memorial Hospital recorded their temperature and received online education on control practices for influenza infections.", {"entities": [[150, 159, "DISEASE"]]}], ["Administration records provided vaccination records and occupational characteristics of all HCWs.", {"entities": []}], ["Early recognition of a pandemic H1N1 (2009) influenza case was followed by a semi-structured questionnaire to analyze possible routes of patient contact, household contact, or unspecified contact.", {"entities": [[44, 53, "DISEASE"]]}], ["Surveillance spanned August 1, 2009 to January 31, 2010; 51 HCWs were confirmed to have novel H1N1 (2009) influenza by quantitative real-time reverse transcription polymerase chain reaction.", {"entities": [[106, 115, "DISEASE"]]}], ["Prevalence of patient contact, household contact, or unspecified contact infection was 13.7% (7/51), 13.7% (7/51), and 72.5% (37/51), respectively.", {"entities": []}], ["The prevalence of the novel H1N1 infection was significantly lower among vaccinated HCWs than among unvaccinated HCWs (p<0.001).", {"entities": []}], ["Higher viral loads in throat swabs were found in HCWs with patient and household contact infection than in those with unspecified contact infection (4.15 vs. 3.53 copies/mL, log 10 , p\u200a=\u200a0.035).", {"entities": []}], ["A surveillance system with daily temperature recordings and online education for HCWs is important for a low attack rate of H1N1 (2009) influenza transmission before H1N1 (2009) influenza vaccination is available, and the attack rate is further decreased after mass vaccination.", {"entities": [[136, 145, "DISEASE"], [178, 187, "DISEASE"]]}], ["Unspecified contact infection rates were significantly higher than that of patient contact and household contact infection, highlighting the need for public education of influenza transmission in addition to hospital infection control.", {"entities": [[170, 179, "DISEASE"]]}], ["Degenerative fibrotic diseases encompass numerous systemic and organ-specific disorders.", {"entities": []}], ["Despite their associated significant morbidity and mortality, there is currently no effective antifibrotic treatment.", {"entities": []}], ["Fibrosis is characterized by the development and persistence of myofibroblasts, whose unregulated deposition of extracellular matrix components disrupts signaling cascades and normal tissue architecture leading to organ failure and death.", {"entities": []}], ["The profibrotic cytokine transforming growth factor beta (TGF \u03b2 ) is considered the foremost inducer of fibrosis, driving myofibroblast differentiation in diverse tissues.", {"entities": []}], ["This review summarizes recent in vitro and in vivo data demonstrating that TGF \u03b2 -induced myofibroblast differentiation is driven by a prooxidant shift in redox homeostasis.", {"entities": []}], ["Elevated NADPH oxidase 4 (NOX4)-derived hydrogen peroxide (H 2 O 2 ) supported by concomitant decreases in nitric oxide (NO) signaling and reactive oxygen species scavengers are central factors in the molecular pathogenesis of fibrosis in numerous tissues and organs.", {"entities": [[26, 30, "GENE"]]}], ["Moreover, complex interplay between NOX4-derived H 2 O 2 and NO signaling regulates myofibroblast differentiation.", {"entities": []}], ["Restoring redox homeostasis via antioxidants or NOX4 inactivation as well as by enhancing NO signaling via activation of soluble guanylyl cyclases or inhibition of phosphodiesterases can inhibit and reverse myofibroblast differentiation.", {"entities": [[48, 52, "GENE"]]}], ["Thus, dysregulated redox signaling represents a potential therapeutic target for the treatment of wide variety of different degenerative fibrotic disorders.", {"entities": []}], ["Transcription factors in disease-relevant pathways represent potential drug targets, by impacting a distinct set of pathways that may be modulated through gene regulation.", {"entities": []}], ["The influence of transcription factors is typically studied on a per disease basis, and no current resources provide a global overview of the relations between transcription factors and disease.", {"entities": []}], ["Furthermore, existing pipelines for related large-scale analysis are tailored for particular sources of input data, and there is a need for generic methodology for integrating complementary sources of genomic information.", {"entities": []}], ["We here present a large-scale analysis of multiple diseases versus multiple transcription factors, with a global map of over-and under-representation of 446 transcription factors in 1010 diseases.", {"entities": []}], ["This map, referred to as the differential disease regulome, provides a first global statistical overview of the complex interrelationships between diseases, genes and controlling elements.", {"entities": []}], ["The map is visualized using the Google map engine, due to its very large size, and provides a range of detailed information in a dynamic presentation format.", {"entities": []}], ["The analysis is achieved through a novel methodology that performs a pairwise, genome-wide comparison on the cartesian product of two distinct sets of annotation tracks, e.g.", {"entities": []}], ["all combinations of one disease and one TF.", {"entities": [[40, 42, "GENE"]]}], ["The methodology was also used to extend with maps using alternative data sets related to transcription and disease, as well as data sets related to Gene Ontology classification and histone modifications.", {"entities": []}], ["We provide a web-based interface that allows users to generate other custom maps, which could be based on precisely specified subsets of transcription factors and diseases, or, in general, on any categorical genome annotation tracks as they are improved or become available.", {"entities": []}], ["We have created a first resource that provides a global overview of the complex relations between transcription factors and disease.", {"entities": []}], ["As the accuracy of the disease regulome depends mainly on the quality of the input data, forthcoming ChIP-seq based binding data for many TFs will provide improved maps.", {"entities": []}], ["We further believe our approach to genome analysis could allow an advance from the current typical situation of one-time integrative efforts to reproducible and upgradable integrative analysis.", {"entities": []}], ["The differential disease regulome and its associated methodology is available at http://hyperbrowser.uio.no .", {"entities": []}], ["The induction of peripheral tolerance may constitute a disease-modifying treatment for allergic patients.", {"entities": []}], ["We studied how oral immunotherapy (OIT) with milk proteins controlled allergy in sensitized mice (cholera toxin plus milk proteins) upon exposure to the allergen.", {"entities": [[98, 105, "DISEASE"]]}], ["Symptoms were alleviated, skin test was negativized, serum specific IgE and IgG1 were abrogated, a substantial reduction in the secretion of IL-5 and IL-13 by antigen-stimulated spleen cells was observed, while IL-13 gene expression in jejunum was down-regulated, and IL-10 and TGF-\u03b2 were increased.", {"entities": []}], ["In addition, we observed an induction of CD4", {"entities": [[41, 44, "GENE"]]}], ["Respiratory syncytial viruses encode a nonstructural protein (NS1) that interferes with type I and III interferon and other antiviral responses.", {"entities": []}], ["Proteomic studies were conducted on human A549 type II alveolar epithelial cells and type I interferon-deficient Vero cells (African green monkey kidney cells) infected with wild-type and NS1-deficient clones of human respiratory syncytial virus to identify other potential pathway and molecular targets of NS1 interference.", {"entities": []}], ["These analyses included two-dimensional differential gel electrophoresis and quantitative Western blotting.", {"entities": []}], ["Surprisingly, NS1 was found to suppress the induction of manganese superoxide dismutase (SOD2) expression in A549 cells and to a much lesser degree Vero cells in response to infection.", {"entities": [[89, 93, "GENE"]]}], ["Because SOD2 is not directly inducible by type I interferons, it served as a marker to probe the impact of NS1 on signaling of other cytokines known to induce SOD2 expression and/or indirect effects of type I interferon signaling.", {"entities": [[8, 12, "GENE"], [159, 163, "GENE"], [8, 12, "GENE"], [159, 163, "GENE"]]}], ["Deductive analysis of results obtained from cell infection and cytokine stimulation studies indicated that interferon-\u03b3 signaling was a potential target of NS1, possibly as a result of modulation of STAT1 levels.", {"entities": [[199, 204, "GENE"]]}], ["However, this was not sufficient to explain the magnitude of the impact of NS1 on SOD2 induction in A549 cells.", {"entities": [[82, 86, "GENE"]]}], ["Vero cell infection experiments indicated that NS1 targeted a component of the type I interferon response that does not directly induce SOD2 expression but is required to induce another initiator of SOD2 expression.", {"entities": [[136, 140, "GENE"], [199, 203, "GENE"], [136, 140, "GENE"], [199, 203, "GENE"]]}], ["STAT2 was ruled out as a target of NS1 interference using quantitative Western blot analysis of infected A549 cells, but data were obtained to indicate that STAT1 was one of a number of potential targets of NS1.", {"entities": [[0, 5, "GENE"], [157, 162, "GENE"]]}], ["A label-free mass spectrometry-based quantitative approach is proposed as a means of more definitive identification of NS1 targets.", {"entities": []}], ["The adenosine A 3 receptor (A3R) is involved in cardiovascular, neurological and tumour-related pathologies and serves as an exceptional pharmaceutical target in the clinical setting.", {"entities": []}], ["A3R antagonists are considered antiinflammatory, antiallergic and anticancer agents, and to have potential for the treatment of asthma, COPD, glaucoma and stroke.", {"entities": [[142, 150, "DISEASE"], [128, 134, "DISEASE"]]}], ["Hence, an appropriate A3R PET tracer would be highly beneficial for the diagnosis and therapy monitoring of these diseases.", {"entities": []}], ["Therefore, in this preclinical in vivo study we evaluated the potential as a PET tracer of the A3R antagonist [ Rats were injected with [ [ p \u2009=\u20090.03), and pretreatment with the P-gp inhibitor tariquidar led to a 1.24-fold increase in [ p \u2009=\u20090.09) in rat brain.", {"entities": []}], ["There was no significant difference in metabolites in plasma and brain in the treatment groups.", {"entities": []}], ["However, plasma concentrations of [ p \u2009=\u20090.12), the xenograft model showed significantly increased uptake of [ p \u2009=\u20090.03).", {"entities": []}], ["[ Selective and significant tracer uptake of [", {"entities": []}], ["Guidelines and performance measures recommend avoiding antibiotics for acute cough/acute bronchitis and presume visits are straightforward with simple diagnostic decision-making.", {"entities": [[89, 99, "DISEASE"]]}], ["We evaluated clinician-assigned diagnoses, diagnostic uncertainty, and antibiotic prescribing for acute cough visits in primary care.", {"entities": []}], ["We conducted a retrospective analysis of acute cough visits \u2013 cough lasting \u226421\u00a0days in adults 18\u201364\u00a0years old without chronic lung disease \u2013 in a primary care practice from March 2011 through June 2012.", {"entities": [[127, 139, "DISEASE"]]}], ["Of 56,301 visits, 962 (2%) were for acute cough.", {"entities": []}], ["Clinicians diagnosed patients with 1, 2, or\u2009\u2265\u20093 cough-related diagnoses in 54%, 35%, and 11% of visits, respectively.", {"entities": []}], ["The most common principal diagnoses were upper respiratory infection (46%), sinusitis (10%), acute bronchitis (9%), and pneumonia (8%).", {"entities": [[120, 129, "DISEASE"], [76, 85, "DISEASE"], [99, 109, "DISEASE"]]}], ["Clinicians prescribed antibiotics in 22% of all visits: 65% of visits with antibiotic-appropriate diagnoses and 4% of visits with non-antibiotic-appropriate diagnoses.", {"entities": []}], ["Clinicians expressed diagnostic uncertainty in 16% of all visits: 43% of visits with antibiotic-appropriate diagnoses and 5% of visits with non-antibiotic-appropriate diagnoses.", {"entities": []}], ["Clinicians expressed uncertainty more often when prescribing antibiotics than when not prescribing antibiotics (30% vs. 12%; p\u2009<\u20090.001).", {"entities": []}], ["As the number of visit diagnoses increased from 1 to 2 to\u2009\u2265\u20093, clinicians were more likely to express diagnostic uncertainty (5%, 25%, 40%, respectively; p\u2009<\u20090.001) and prescribe antibiotics (16%, 25%, 41%, respectively; p\u2009<\u20090.001).", {"entities": []}], ["Acute cough may be more complex and have more diagnostic uncertainty than guidelines and performance measures presume.", {"entities": []}], ["Efforts to reduce antibiotic prescribing for acute cough should address diagnostic complexity and uncertainty that clinicians face.", {"entities": []}], ["There has been increased interest in discovering combinations of single-nucleotide polymorphisms (SNPs) that are strongly associated with a phenotype even if each SNP has little individual effect.", {"entities": []}], ["Efficient approaches have been proposed for searching two-locus combinations from genome-wide datasets.", {"entities": []}], ["However, for high-order combinations, existing methods either adopt a brute-force search which only handles a small number of SNPs (up to few hundreds), or use heuristic search that may miss informative combinations.", {"entities": []}], ["In addition, existing approaches lack statistical power because of the use of statistics with high degrees-of-freedom and the huge number of hypotheses tested during combinatorial search.", {"entities": []}], ["Due to these challenges, functional interactions in high-order combinations have not been systematically explored.", {"entities": []}], ["We leverage discriminative-pattern-mining algorithms from the data-mining community to search for high-order combinations in case-control datasets.", {"entities": []}], ["The substantially improved efficiency and scalability demonstrated on synthetic and real datasets with several thousands of SNPs allows the study of several important mathematical and statistical properties of SNP combinations with order as high as eleven.", {"entities": []}], ["We further explore functional interactions in high-order combinations and reveal a general connection between the increase in discriminative power of a combination over its subsets and the functional coherence among the genes comprising the combination, supported by multiple datasets.", {"entities": []}], ["Finally, we study several significant high-order combinations discovered from a lung-cancer dataset and a kidney-transplant-rejection dataset in detail to provide novel insights on the complex diseases.", {"entities": [[85, 91, "DISEASE"]]}], ["Interestingly, many of these associations involve combinations of common variations that occur in small fractions of population.", {"entities": []}], ["Thus, our approach is an alternative methodology for exploring the genetics of rare diseases for which the current focus is on individually rare variations.", {"entities": []}], ["Many patients at high risk of cardiovascular diseases are managed and monitored in general practice.", {"entities": []}], ["Recommendations for cardiovascular risk management, including lifestyle change, are clearly described in the Dutch national guideline.", {"entities": []}], ["Although lifestyle interventions, such as advice on diet, physical exercise, smoking and alcohol, have moderate, but potentially relevant effects in these patients, adherence to lifestyle advice in general practice is not optimal.", {"entities": []}], ["The IMPALA study intends to improve adherence to lifestyle advice by involving patients in decision making on cardiovascular prevention by nurse-led clinics.", {"entities": []}], ["The aim of this paper is to describe the design and methods of a study to evaluate an intervention aimed at involving patients in cardiovascular risk management.", {"entities": []}], ["A cluster-randomised controlled trial in 20 general practices, 10 practices in the intervention arm and 10 in the control arm, starting on October 2005.", {"entities": []}], ["A total of 720 patients without existing cardiovascular diseases but eligible for cardiovascular risk assessment will be recruited.", {"entities": []}], ["In both arms, the general practitioners and nurses will be trained to apply the national guideline for cardiovascular risk management.", {"entities": []}], ["Nurses in the intervention arm will receive an extended training in risk assessment, risk communication, the use of a decision aid and adapted motivational interviewing.", {"entities": []}], ["This communication technique will be used to support the shared decision-making process about risk reduction.", {"entities": []}], ["The intervention comprises 2 consultations and 1 follow-up telephone call.", {"entities": []}], ["The nurses in the control arm will give usual care after the risk estimation, according to the national guideline.", {"entities": []}], ["Primary outcome measures are self-reported adherence to lifestyle advice and drug treatment.", {"entities": []}], ["Secondary outcome measures are the patients' perception of risk and their motivation to change their behaviour.", {"entities": []}], ["The measurements will take place at baseline and after 12 and 52 weeks.", {"entities": []}], ["Clinical endpoints will not be measured, but the absolute 10-year risk of cardiovascular events will be estimated for each patient from medical records at baseline and after 1 year.", {"entities": []}], ["The combined use of risk communication, a decision aid and motivational interviewing to enhance patient involvement in decision making is an innovative aspect of the intervention.", {"entities": []}], ["Current Controlled Trials ISRCTN51556722", {"entities": []}], ["The World Health Organization warns that chronic, noncommunicable diseases are rapidly becoming epidemic worldwide.", {"entities": []}], ["Escalating rates of neurocognitive, metabolic, autoimmune and cardiovascular diseases cannot be ascribed only to genetics, lifestyle, and nutrition; early life and ongoing exposures, and bioaccumulated toxicants may also cause chronic disease.", {"entities": []}], ["Contributors to ill health are summarized from multiple perspectives\u2014biological effects of classes of toxicants, mechanisms of toxicity, and a synthesis of toxic contributors to major diseases.", {"entities": []}], ["Healthcare practitioners have wide-ranging roles in addressing environmental factors in policy and public health and clinical practice.", {"entities": []}], ["Public health initiatives include risk recognition and chemical assessment then exposure reduction, remediation, monitoring, and avoidance.", {"entities": []}], ["The complex web of disease and environmental contributors is amenable to some straightforward clinical approaches addressing multiple toxicants.", {"entities": []}], ["Widely applicable strategies include nutrition and supplements to counter toxic effects and to support metabolism; as well as exercise and sweating, and possibly medication to enhance excretion.", {"entities": []}], ["Addressing environmental health and contributors to chronic disease has broad implications for society, with large potential benefits from improved health and productivity.", {"entities": []}], ["Background: Dissecting complex disease has become more feasible because of the availability of large-scale DNA resources and advances in high-throughput genomic technology.", {"entities": []}], ["Although these tools help scientists identify potential susceptibility loci, subjects with relevant genotypes are needed for clinical phenotyping and toxicity studies.", {"entities": []}], ["Objective: We have developed a resource of subjects and their DNA to use for translational research of environmental disease.", {"entities": []}], ["Methods: More than 15,000 individuals of diverse sex, age, race, and ethnicity were recruited from North Carolina.", {"entities": []}], ["DNA was isolated from their blood and coded with personal identification numbers linked to their identities.", {"entities": []}], ["This linked resource of subjects and their DNA\u2014the Environmental Polymorphism Registry (EPR)\u2014allows scientists to screen for individuals with genotypes of interest and invite them to participate in follow-up studies.", {"entities": []}], ["Discussion: The EPR is a phenotype-by-genotype resource designed to facilitate translational studies of environmental disease.", {"entities": []}], ["Based on their genotypes, subjects are invited to participate at all levels of research, from basic laboratory ex vivo cell phenotyping experiments that require viable tissue to in vivo observational studies and clinical trials.", {"entities": []}], ["Here we report on progress of the EPR since 2008.", {"entities": []}], ["We also describe a major effort at the National Institute of Environmental Health Sciences (NIEHS) to investigate susceptibility loci in 87 environmental response genes and gene \u00d7 environment interactions using EPR resources.", {"entities": []}], ["Conclusion: The EPR is a unique and novel resource and is ideal for genotype-driven translational research of environmental disease.", {"entities": []}], ["We expect that it will serve as a model for future resources.", {"entities": []}], ["Such tools help scientists attain their ultimate goals: to identify at-risk populations and develop strategies for preventing and treating human disease.", {"entities": []}], ["We have recently shown that the CXCL5 chemokine is secreted by adipose tissue in the obese state.", {"entities": [[32, 37, "GENE"]]}], ["We demonstrated that adipose tissue-derived CXCL5 mediates insulin resistance in muscle.", {"entities": [[44, 49, "GENE"]]}], ["We speculate in this paper that CXCL5 could also mediate other obesity, and diabetes-derived pathologies, such as cardiovascular disease, retinopathy, or inflammatory bowel disease.", {"entities": [[154, 180, "DISEASE"], [63, 70, "DISEASE"], [32, 37, "GENE"]]}], ["In this scenario CXCL5 targeted therapy would prevent not only the development of type II diabetes in obese subjects, but also several other obesity-related co morbidities.", {"entities": [[141, 148, "DISEASE"], [17, 22, "GENE"]]}], ["Finally we propose to analyze the CXCL5 gene to find particular polymorphisms that could predict the development of type II diabetes in obese subjects.", {"entities": [[34, 39, "GENE"]]}], ["Single-nucleotide polymorphisms (SNPs) in GSDMB (Gasdermin B) and ORMDL3 (ORMDL sphingolipid biosynthesis regulator 3) are strongly associated with childhood asthma, but the molecular alterations contributing to disease remain unknown.", {"entities": [[158, 164, "DISEASE"], [42, 47, "GENE"], [66, 72, "GENE"]]}], ["We investigated the effects of asthma-associated SNPs on DNA methylation and mRNA levels of GSDMB and ORMDL3 .", {"entities": [[31, 37, "DISEASE"], [92, 97, "GENE"], [102, 108, "GENE"]]}], ["Genetic association between GSDMB / ORMDL3 and physician-diagnosed childhood asthma was confirmed in the Swedish birth-cohort BAMSE.", {"entities": [[77, 83, "DISEASE"], [28, 33, "GENE"], [36, 42, "GENE"]]}], ["CpG-site SNPs (rs7216389 and rs4065275) showed differences in DNA methylation depending on carrier status of the risk alleles, and were significantly associated with methylation levels in two CpG sites in the 5\u2032 UTR (untranslated region) of ORMDL3 .", {"entities": [[241, 247, "GENE"]]}], ["In the Swedish Search study, we found significant differences in DNA methylation between asthmatics and controls in five CpG sites; after adjusting for lymphocyte and neutrophil cell counts, three remained significant: one in IKZF3 [IKAROS family zinc finger 3 (Aiolos); cg16293631] and two in the CpG island (CGI) of ORMDL3 (cg02305874 and cg16638648).", {"entities": [[226, 231, "GENE"], [318, 324, "GENE"]]}], ["Also, cg16293631 and cg02305874 correlated with mRNA levels of ORMDL3 .", {"entities": [[63, 69, "GENE"]]}], ["The association between methylation and asthma was independent of the genotype in rs7216389, rs4065275 and rs12603332.", {"entities": [[40, 46, "DISEASE"]]}], ["Both SNPs and CpG sites showed significant associations with ORMDL3 mRNA levels.", {"entities": [[61, 67, "GENE"]]}], ["SNPs influenced expression independently of methylation, and the residual association between methylation and expression was not mediated by these SNPs.", {"entities": []}], ["We found a differentially methylated region in the CGI shore of ORMDL3 with six CpG sites less methylated in CD8 ORMDL3 expression.", {"entities": [[64, 70, "GENE"], [113, 119, "GENE"], [64, 70, "GENE"], [113, 119, "GENE"]]}], ["Asthma is the most common chronic childhood disease in developed nations and its prevalence has increased in the world over the last 25 years.", {"entities": [[0, 6, "DISEASE"]]}], ["It is a complex disease with both genetic and environmental risk factors.", {"entities": []}], ["Asthma is caused by multiple interacting genes, some having a protective effect and others contributing to the disease pathogenesis, with each gene having its own tendency to be influenced by the environment.", {"entities": [[0, 6, "DISEASE"]]}], ["This article reviews the current state of the genetics of asthma in six categories, viz .", {"entities": [[58, 64, "DISEASE"]]}], ["epidemiology, management, aetiology, family and twin studies, segregation and linkage studies, and candidate genes and single nucleotide polymorphisms (SNPs).", {"entities": []}], ["Bronchiolitis guidelines suggest that neither bronchodilators nor corticosteroids, antiviral and antibacterial agents should be routinely used.", {"entities": [[0, 13, "DISEASE"]]}], ["Although recommendations, many clinicians persistently prescribe drugs for bronchiolitis.", {"entities": [[75, 88, "DISEASE"]]}], ["To unravel main reasons of pediatricians in prescribing drugs to infants with bronchiolitis, and to possibly correlate therapeutic choices to the severity of clinical presentation.", {"entities": [[78, 91, "DISEASE"]]}], ["Also possible influence of socially deprived condition on therapeutic choices is analyzed.", {"entities": []}], ["Patients admitted to Pediatric Division of 2 main Hospitals of Naples because of bronchiolitis in winter season 2008-2009 were prospectively analyzed.", {"entities": [[81, 94, "DISEASE"]]}], ["An RDAI (Respiratory Distress Assessment Instrument) score was assessed at different times from admission.", {"entities": []}], ["Enrolment criteria were: age 1-12 months; 1 Eighty-four children were enrolled in the study.", {"entities": []}], ["Mean age was 3.5 months.", {"entities": []}], ["Forty-four per cent of patients presented with increased respiratory rate, 70.2% with chest retractions, and 7.1% with low SaO2.", {"entities": []}], ["Mean starting RDAI score was 8.", {"entities": []}], ["Lung consolidation was found in 3.5% on chest roentgenogram.", {"entities": []}], ["Data analysis also unraveled that 64.2% matched clinical admission criteria.", {"entities": []}], ["Social deprivation status analysis revealed that 72.6% of patients were from areas \"at social risk\".", {"entities": []}], ["Evaluation of length of stay vs. social deprivation status evidenced no difference between \"at social risk\" and \"not at social risk\" patients.", {"entities": []}], ["Following therapeutic interventions were prescribed: nasal suction (64.2%), oxygen administration (7.1%), antibiotics (50%), corticosteroids (85.7%), bronchodilators (91.6%).", {"entities": []}], ["Statistically significant association was not found for any used drug with neither RDAI score nor social deprivation status.", {"entities": []}], ["The reasons of hospital pediatricians to prescribe drugs were mainly the perception of clinical severity of the disease, the clinical findings at chest examination, and the detection of some improvement after drug administration.", {"entities": []}], ["We strongly confirm the large use of drugs in bronchiolitis management by hospital pediatricians.", {"entities": [[46, 59, "DISEASE"]]}], ["Main reason of this wrong practice appears to be the fact that pediatricians recognize bronchiolitis as a severe condition, with consequent anxiety in curing so acutely ill children without drugs, and that sometimes they feel forced to prescribe drugs because of personal reassurance or parental pressure.", {"entities": [[87, 100, "DISEASE"]]}], ["We also found that social \"at risk\" condition represents a main reason for hospitalization, not correlated to clinical severity of the disease neither to drug prescription.", {"entities": []}], ["Eventually, we suggest a \"step-by-step\" strategy to rich a more evidence based approach to bronchiolitis therapy, by adopting specific and shared resident guidelines.", {"entities": [[91, 104, "DISEASE"]]}], ["Allergen-specific immunotherapy (AIT) induces tolerance and shifts the Th2 response towards a regulatory T-cell profile.", {"entities": []}], ["The underlying mechanisms are not fully understood, but dendritic cells (DC) play a vital role as key regulators of T-cell responses.", {"entities": []}], ["DCs interact with allergens via Fc receptors (FcRs) and via certain C-type lectin receptors (CLRs), including CD209/DC-SIGN, CD206/MR and Dectin-2/CLEC6A.", {"entities": []}], ["In this study, the effect of AIT on the frequencies as well as the FcR and CLR expression profiles of human DC subsets was assessed.", {"entities": []}], ["PBMC was isolated from peripheral blood from seven allergic donors before and after 8 weeks and 1 year of subcutaneous AIT, as well as from six non-allergic individuals.", {"entities": []}], ["Cells were stained with antibodies against DC subset-specific markers and a panel of FcRs and CLRs and analyzed by flow cytometry.", {"entities": []}], ["After 1 year of AIT, the frequency of CD123", {"entities": []}], ["Propolis, an ancient herbal medicine, has been reported the beneficial effect both in asthma patients and murine model of asthma, but the mechanism was not clearly understood.", {"entities": [[86, 92, "DISEASE"], [122, 128, "DISEASE"]]}], ["In this study, the effect of caffeic acid phenethyl ester (CAPE), the most extensively studied components in propolis, on the functions of human monocyte-derived dendritic cells (MoDCs) was investigated.", {"entities": []}], ["CAPE significantly inhibited IL-12 p40, IL-12 p70, IL-10 protein expression in mature healthy human MoDCs stimulated by lipopolysaccharides (LPS) and IL-12 p40, IL-10, IP-10 stimulated by crude mite extract.", {"entities": []}], ["CAPE significantly inhibited IL-10 and IP-10 but not IL-12 expression in allergic patients' MoDCs stimulated by crude mite extract.", {"entities": []}], ["In contrast, the upregulation of costimulatory molecules in mature MoDCs was not suppressed by CAPE.", {"entities": []}], ["Further, the antigen presenting ability of DCs was not inhibited by CAPE.", {"entities": []}], ["CAPE inhibited I\u03baB\u03b1 phosphorylation and NF-\u03baB activation but not mitogen-activated protein kinase (MAPK) family phosphorylation in human MoDCs.", {"entities": []}], ["These results indicated that CAPE inhibited cytokine and chemokine production by MoDCs which might be related to the NF-\u03baB signaling pathway.", {"entities": []}], ["This study provided a new insight into the mechanism of CAPE in immune response and the rationale for propolis in the treatment of asthma and other allergic disorders.", {"entities": [[131, 137, "DISEASE"]]}], ["Eosinophils are abundantly present in most phenotypes of asthma and they contribute to the maintenance and exacerbations of the disease.", {"entities": [[57, 63, "DISEASE"]]}], ["Regulators of eosinophil longevity play critical roles in determining whether eosinophils accumulate into the airways of asthmatics.", {"entities": []}], ["Several cytokines enhance eosinophil survival promoting eosinophilic airway inflammation while for example glucocorticoids, the most important anti-inflammatory drugs used to treat asthma, promote the intrinsic pathway of eosinophil apoptosis and by this mechanism contribute to the resolution of eosinophilic airway inflammation.", {"entities": [[181, 187, "DISEASE"]]}], ["Mitochondria seem to play central roles in both intrinsic mitochondrion-centered and extrinsic receptor-mediated pathways of apoptosis in eosinophils.", {"entities": []}], ["Mitochondria may also be important for survival signalling.", {"entities": []}], ["In addition to glucocorticoids, another important agent that regulates human eosinophil longevity via mitochondrial route is nitric oxide, which is present in increased amounts in the airways of asthmatics.", {"entities": []}], ["Nitric oxide seems to be able to trigger both survival and apoptosis in eosinophils.", {"entities": []}], ["This review discusses the current evidence of the mechanisms of induced eosinophil apoptosis and survival focusing on the role of mitochondria and clinically relevant stimulants, such as glucocorticoids and nitric oxide.", {"entities": []}], ["Community acquired pneumonia is a major cause of morbidity and mortality.", {"entities": [[19, 28, "DISEASE"]]}], ["The association between serum phosphorus levels on admission and the outcome of patients with community acquired pneumonia has not been widely examined.", {"entities": [[113, 122, "DISEASE"]]}], ["We aimed to investigate the prognostic value of serum phosphorus levels on admission on the 30- day mortality.", {"entities": []}], ["The cohort included patients of 18\u00a0years old or older who were diagnosed with community acquired pneumonia between 2006 and 2012.", {"entities": [[97, 106, "DISEASE"]]}], ["Patients were retrospectively analyzed to identify risk factors for a primary endpoint of 30-day mortality.", {"entities": []}], ["Binary logistic regression analysis was used for the calculation of the odds ratios (OR) and p values in bivariate and multivariate analysis to identify association between patients\u2019 characteristic and 30-day mortality.", {"entities": []}], ["The cohort included 3894 patients.", {"entities": []}], ["In multivariate regression analysis, variables associated with increased risk of 30-day mortality included: age >80\u00a0years, increased CURB-65 score, RDW >15, hypernatremia >150\u00a0mmol/l, hypoalbuminemia <2 gr/dl and abnormal levels of phosphorus.", {"entities": []}], ["Levels of <1.5\u00a0mg/dl and >4.5\u00a0mg/dl were significantly associated with excess 30-day mortality, 38\u00a0% (OR 2.9, CI 1.8-4.9, P\u2009=\u20090.001) and 39\u00a0% (OR 3.4, CI 2.7-4.2, P\u2009=\u20090.001), respectively.", {"entities": []}], ["Phosphorus levels within the upper normal limits (4-4.5\u00a0mg/dl) were associated with higher mortality rates compared to levels between 1.5-3.5\u00a0mg/dl, the reference group, 24\u00a0% (OR 1.9, CI 1.5-2.4, P\u2009=\u20090.001).", {"entities": []}], ["Abnormal phosphorus levels on admission are associated with increased mortality rates among patients hospitalized with Community acquired pneumonia.", {"entities": [[138, 147, "DISEASE"]]}], ["Antidepressants are heavily prescribed drugs and have been shown to affect inflammatory signals.", {"entities": []}], ["We examined whether these have anti-inflammatory properties in animal models of septic shock and allergic asthma.", {"entities": [[97, 112, "DISEASE"], [106, 112, "DISEASE"]]}], ["We also analysed whether antidepressants act directly on peripheral cell types that participate in the inflammatory response in these diseases.", {"entities": []}], ["The antidepressants desipramine and fluoxetine were compared in vivo to the glucocorticoid prednisolone, an anti-inflammatory drug of reference.", {"entities": []}], ["In a murine model of lipopolysaccharides (LPS)-induced septic shock, animals received the drugs either before or after injection of LPS.", {"entities": []}], ["Circulating levels of tumour necrosis factor (TNF)-\u03b1 and mortality rate were measured.", {"entities": [[46, 49, "GENE"]]}], ["In ovalbumin-sensitized rats, the effect of drug treatment on lung inflammation was assessed by counting leukocytes in bronchoalveolar lavages.", {"entities": []}], ["Bronchial hyperreactivity was measured using barometric plethysmography.", {"entities": []}], ["In vitro production of TNF-\u03b1 and Regulated upon Activation, Normal T cell Expressed and presumably Secreted (RANTES) from activated monocytes and lung epithelial cells, respectively, was analysed by immunoassays.", {"entities": []}], ["Reporter gene assays were used to measure the effect of antidepressants on the activity of nuclear factor-\u03baB and activator protein-1 which are involved in the control of TNF-\u03b1 and RANTES expression.", {"entities": []}], ["In the septic shock model, all three drugs given preventively markedly decreased circulating levels of TNF-\u03b1 and mortality (50% mortality in fluoxetine treated group, 30% in desipramine and prednisolone treated groups versus 90% in controls).", {"entities": []}], ["In the curative trial, antidepressants had no statistically significant effect, while prednisolone still decreased mortality (60% mortality versus 95% in controls).", {"entities": []}], ["In ovalbumin-sensitized rats, the three drugs decreased lung inflammation, albeit to different degrees.", {"entities": []}], ["Prednisolone and fluoxetine reduced the number of macrophages, lymphocytes, neutrophils and eosinophils, while desipramine diminished only the number of macrophages and lymphocytes.", {"entities": []}], ["However, antidepressants as opposed to prednisolone did not attenuate bronchial hyperreactivity.", {"entities": []}], ["In vitro, desipramine and fluoxetine dose-dependently inhibited the release of TNF-\u03b1 from LPS-treated monocytes.", {"entities": []}], ["In lung epithelial cells, these compounds decreased TNF-\u03b1-induced RANTES expression as well as the activity of nuclear factor-\u03baB and activator protein-1.", {"entities": []}], ["Desipramine and fluoxetine reduce the inflammatory reaction in two animal models of human diseases.", {"entities": []}], ["These antidepressants act directly on relevant peripheral cell types to decrease expression of inflammatory mediators probably by affecting their gene transcription.", {"entities": []}], ["Clinical implications of these observations are discussed.", {"entities": []}], ["Sarcoidosis is an inflammatory granulomatous disease with unknown etiology driven by cytokines and chemokines.", {"entities": [[0, 11, "DISEASE"]]}], ["There is limited information regarding the regulation of cytokine/chemokine-receptor network in bronchoalveolar lavage (BAL) cells in pulmonary sarcoidosis, suggesting contribution of miRNAs and transcription factors.", {"entities": [[144, 155, "DISEASE"], [134, 155, "DISEASE"]]}], ["We therefore investigated gene expression of 25 inflammation-related miRNAs, 27 cytokines/chemokines/receptors, and a Th1-transcription factor T-bet in unseparated BAL cells obtained from 48 sarcoidosis patients and 14 control subjects using quantitative RT-PCR.", {"entities": [[191, 202, "DISEASE"]]}], ["We then examined both miRNA-mRNA expressions to enrich relevant relationships.", {"entities": []}], ["This first study on miRNAs in sarcoid BAL cells detected deregulation of miR-146a , miR-150 , miR-202 , miR-204 , and miR-222 expression comparing to controls.", {"entities": [[73, 81, "GENE"], [84, 91, "GENE"], [94, 101, "GENE"], [104, 111, "GENE"], [118, 125, "GENE"]]}], ["Subanalysis revealed higher number of miR-155 , let-7c transcripts in progressing ( n = 20) comparing to regressing ( n = 28) disease as assessed by 2-year follow-up.", {"entities": [[38, 45, "GENE"], [48, 54, "GENE"]]}], ["Correlation network analysis revealed relationships between microRNAs, transcription factor T-bet , and deregulated cytokine/chemokine-receptor network in sarcoid BAL cells.", {"entities": []}], ["Furthermore, T-bet showed more pronounced regulatory capability to sarcoidosis-associated cytokines/chemokines/receptors than miRNAs, which may function rather as \u201cfine-tuners\u201d of cytokine/chemokine expression.", {"entities": [[67, 78, "DISEASE"]]}], ["Our correlation network study implies contribution of both microRNAs and Th1-transcription factor T-bet to the regulation of cytokine/chemokine-receptor network in BAL cells in sarcoidosis.", {"entities": [[177, 188, "DISEASE"]]}], ["Functional studies are needed to confirm biological relevance of the obtained relationships.", {"entities": []}], ["The optimal dose (300IR) of a five-grass pollen sublingual immunotherapy tablet in terms of efficacy was previously demonstrated from the first pollen season.", {"entities": []}], ["Here, we aim to confirm whether this dose remained optimal during the peak of the pollen season by assessing the efficacy and quality of life data.", {"entities": []}], ["A total of 628 subjects with grass pollen rhinoconjunctivitis were randomized in a double-blind, placebo-controlled, multi-centre, pan-European trial.", {"entities": []}], ["Subjects received once-daily tablets (Stallergenes, Antony, France) of 100IR, 300IR, 500IR or placebo, starting 4 months before and throughout the 2005 grass pollen season.", {"entities": []}], ["The pollen season was defined as the first day of 3 consecutive days with a grass pollen count above 30 grains/m The grass pollen season lasted an average of 30 days, with a peak of 12 days.", {"entities": []}], ["The mean treatment duration before the grass pollen season was similar in the four treatment groups (121.4\u00b131.1 to 128.6\u00b115.4 days in the safety population).", {"entities": []}], ["Both the 300IR and 500IR groups had highly significant improvements in Rhinoconjunctivitis Total Symptom Score (RTSS) vs. placebo at the peak pollen season ( P =0.0005 and 0.0014, respectively), which agreed with improvements in RTSS in the primary evaluations.", {"entities": []}], ["The average RTSS scores were slightly elevated during the peak pollen season in all treatment groups.", {"entities": []}], ["The overall Rhinoconjunctivitis Quality of Life Questionnaire score confirmed the optimal dosage 300IR at peak ( P <0.0001) and at the end ( P \u2a7d0.0031) of the pollen season.", {"entities": []}], ["All doses were well tolerated.", {"entities": []}], ["At the peak pollen season, the efficacy and quality of life data for both 300IR and 500IR groups was significantly improved vs. the placebo group.", {"entities": []}], ["These results confirm the conclusions of the primary evaluations and validate the use of 300IR tablets for clinical practice.", {"entities": []}], ["Modern toxicology has embraced in vitro methods, and major hopes are based on the Omics technologies and systems biology approaches they bring along (Hartung and McBride in ALTEX 28(2):83\u201393,", {"entities": []}], ["Mast cells (MCs) have long been suspected as important players for implantation based on the fact that their degranulation causes the release of pivotal factors, e.g., histamine, MMPs, tryptase and VEGF, which are known to be involved in the attachment and posterior invasion of the embryo into the uterus.", {"entities": []}], ["Moreover, MC degranulation correlates with angiogenesis during pregnancy.", {"entities": []}], ["The number of MCs in the uterus has been shown to fluctuate during menstrual cycle in human and estrus cycle in rat and mouse indicating a hormonal influence on their recruitment from the periphery to the uterus.", {"entities": []}], ["However, the mechanisms behind MC migration to the uterus are still unknown.", {"entities": []}], ["We first utilized migration assays to show that MCs are able to migrate to the uterus and to the fetal-maternal interface upon up-regulation of the expression of chemokine receptors by hormonal changes.", {"entities": []}], ["By using a model of ovariectomized animals, we provide clear evidences that also in vivo , estradiol and progesterone attract MC to the uterus and further provoke their maturation and degranulation.", {"entities": []}], ["We propose that estradiol and progesterone modulate the migration of MCs from the periphery to the uterus and their degranulation, which may prepare the uterus for implantation.", {"entities": []}], ["A validated instrument to assess the effects of chronic cough on health status in patients with chronic obstructive pulmonary disease (COPD) is currently not available.", {"entities": [[96, 133, "DISEASE"]]}], ["The Leicester Cough Questionnaire (LCQ) is a cough-specific health status questionnaire which is originally validated for a population of general patients presenting with chronic cough.", {"entities": []}], ["We examined the psychometric performance of the LCQ in patients with COPD and chronic productive cough.", {"entities": []}], ["Concurrent validity, internal consistency, reproducibility and responsiveness were determined.", {"entities": []}], ["The St. George's Respiratory Questionnaire (SGRQ) and the Short Form-36 (SF-36) were used as external criteria.", {"entities": []}], ["Questionnaires were completed at the start of the study.", {"entities": []}], ["After 2 and 12 weeks the LCQ was repeated, together with a global rating of change.", {"entities": []}], ["In total 54 patients were included.", {"entities": []}], ["Concurrent validity analysis showed significant correlations between corresponding domains of the LCQ and the SGRQ (r s -0.31 to -0.60).", {"entities": []}], ["Corresponding domains of the LCQ and the SF-36 showed weaker correlations (r s 0.04 to 0.41).", {"entities": []}], ["Internal consistency was adequate for two of the three domains (Cronbach's \u03b1 0.74 - 0.86).", {"entities": []}], ["Test-retest reliability in stable patients was high (intraclass correlation coefficients 0.79 - 0.93).", {"entities": []}], ["The mean difference after two weeks was 0.73 (\u00b1 1.75).", {"entities": []}], ["Responsiveness analysis indicated that the LCQ was able to detect changes after 12 weeks.", {"entities": []}], ["The LCQ is a valid, reliable, responsive instrument to measure health status in COPD patients with chronic productive cough.", {"entities": []}], ["ClinicalTrials.gov: NCT01071161", {"entities": []}], ["The 2009 flu pandemic and the appearance of oseltamivir-resistant H1N1 influenza strains highlight the need for treatment alternatives.", {"entities": [[71, 80, "DISEASE"]]}], ["One such option is the creation of a protective physical barrier in the nasal cavity.", {"entities": []}], ["In vitro tests demonstrated that iota-carrageenan is a potent inhibitor of influenza A virus infection, most importantly also of pandemic H1N1/2009 in vitro.", {"entities": [[75, 84, "DISEASE"]]}], ["Consequently, we tested a commercially available nasal spray containing iota-carrageenan in an influenza A mouse infection model.", {"entities": [[95, 104, "DISEASE"]]}], ["Treatment of mice infected with a lethal dose of influenza A PR8/34 H1N1 virus with iota-carrageenan starting up to 48 hours post infection resulted in a strong protection of mice similar to mice treated with oseltamivir.", {"entities": [[49, 58, "DISEASE"]]}], ["Since alternative treatment options for influenza are rare, we conclude that the nasal spray containing iota-carrageenan is an alternative to neuraminidase inhibitors and should be tested for prevention and treatment of influenza A in clinical trials in humans.", {"entities": [[40, 49, "DISEASE"], [220, 229, "DISEASE"]]}], ["The production of reactive oxygen species (ROS) from the inner mitochondrial membrane is one of many fundamental processes governing the balance between health and disease.", {"entities": []}], ["It is well known that ROS are necessary signaling molecules in gene expression, yet when expressed at high levels, ROS may cause oxidative stress and cell damage.", {"entities": []}], ["Both hypoxia and hyperoxia may alter ROS production by changing mitochondrial Po 2 ( ).", {"entities": []}], ["Because depends on the balance between O 2 transport and utilization, we formulated an integrative mathematical model of O 2 transport and utilization in skeletal muscle to predict conditions to cause abnormally high ROS generation.", {"entities": []}], ["Simulations using data from healthy subjects during maximal exercise at sea level reveal little mitochondrial ROS production.", {"entities": []}], ["However, altitude triggers high mitochondrial ROS production in muscle regions with high metabolic capacity but limited O 2 delivery.", {"entities": []}], ["This altitude roughly coincides with the highest location of permanent human habitation.", {"entities": []}], ["Above 25,000 ft., more than 90% of exercising muscle is predicted to produce abnormally high levels of ROS, corresponding to the \u201cdeath zone\u201d in mountaineering.", {"entities": []}], ["Oral lichen planus (OLP) is a chronic inflammatory disease characterized by subepithelial T-cell infiltration.", {"entities": [[5, 18, "DISEASE"]]}], ["Recent studies reported that specific T helper (Th) subsets, especially Th2 cells, are involved in the pathogenesis of OLP.", {"entities": []}], ["Thymic stromal lymphopoietin (TSLP) is mainly secreted by epithelial cells and potently activates myeloid dendritic cells (mDCs) to induce Th2-mediated inflammation.", {"entities": [[30, 34, "GENE"]]}], ["Here, we investigated the expression of TSLP and related molecules in OLP.", {"entities": [[40, 44, "GENE"]]}], ["Buccal mucosa specimens from patients with OLP, hyperkeratosis, and ulcer were analyzed by immunohistochemistry for expression of TSLP, its receptor (TSLPR), and inflammatory cells.", {"entities": [[130, 134, "GENE"]]}], ["TSLP was detected in/around the epithelium of patients with OLP and hyperkeratosis, whereas TSLPR, CD11c (mDC), and GATA3 (Th2) were strongly expressed in the subepithelial layer only in OLP patients.", {"entities": [[0, 4, "GENE"], [116, 121, "GENE"]]}], ["Double immunofluorescence staining showed that TSLPR expression mainly co-localized with CD11c.", {"entities": []}], ["Moreover, the number of CD11c- and GATA-3 positive cells was correlated in OLP patients.", {"entities": []}], ["In lesions selectively extracted by laser microdissection, the mRNA expression of Th2 (IL-4, MDC, TARC, GATA3)- and Th17 (IL-17, ROR\u03b3t)-related molecules in OLP patients was significantly higher than in other groups.", {"entities": [[104, 109, "GENE"]]}], ["These results suggest that CD11c", {"entities": []}], ["A new approach to the treatment of COPD includes controlling inflammation because of its important role in exacerbation of the disease.", {"entities": []}], ["Recently, roflumilast has been added as a therapeutic option for COPD.", {"entities": []}], ["Roflumilast is an oral phosphodiesterase-4 inhibitor that targets inflammatory cells involved in triggering exacerbations of COPD.", {"entities": []}], ["The objective of the current study was to evaluate roflumilast for its contribution to phagocytic activity in COPD patients.", {"entities": []}], ["Twenty-one patients diagnosed with COPD received roflumilast once daily for 6 months in combination with fluticasone (an inhaled corticosteroid), salmeterol (a long-acting \u03b22-agonist), and tiotropium (a long-acting muscarinic antagonist) or combinations of these agents.", {"entities": []}], ["The main inclusion criterion was stable disease for at least the previous 30 days.", {"entities": []}], ["Neutrophils and spirometric changes, ie, forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC), were measured in the COPD patients at indicated time points.", {"entities": [[79, 82, "GENE"]]}], ["The first sample was taken before receiving roflumilast, the second 3 months later, and the third after 6 months.", {"entities": []}], ["Examination of defective phagocytosis was done by flow cytometry using a FagoFlowEx Our results indicate that phagocytic activity was increased after 3 and 6 months of treatment when compared with baseline ( P <0.001).", {"entities": []}], ["Similarly, FVC and FEV 1 were also increased during the 6-month period, but only FVC differed significantly from baseline ( P <0.001).", {"entities": [[19, 22, "GENE"]]}], ["Although the number of patients in this study was limited, our results indicate that roflumilast induces phagocytic activity, which improves lung function.", {"entities": []}], ["Studies of human polyomavirus (HPyV) infection and lung cancer are limited and those regarding the association of human papillomavirus (HPV) infection and lung cancer have produced inconsistent results.", {"entities": [[51, 62, "DISEASE"], [155, 166, "DISEASE"], [56, 62, "DISEASE"], [160, 166, "DISEASE"]]}], ["We conducted a nested case\u2013control study to assess the association between incident lung cancer of various histologies and evidence of prior infection with HPyVs and HPVs.", {"entities": [[84, 95, "DISEASE"], [89, 95, "DISEASE"]]}], ["We selected serum from 183 cases and 217 frequency matched controls from the Yunnan Tin Miner\u2019s Cohort study, which was designed to identify biomarkers for early detection of lung cancer.", {"entities": [[175, 186, "DISEASE"], [180, 186, "DISEASE"]]}], ["Using multiplex liquid bead microarray (LBMA) antibody assays, we tested for antibodies to the VP1 structural protein and small T antigen (ST-Ag) of Merkel cell, KI, and WU HPyVs.", {"entities": []}], ["We also tested for antibodies against HPV L1 structural proteins (high-risk types 16, 18, 31, 33, 52, and 58 and low-risk types 6 and 11) and E6 and E7 oncoproteins (high risk types 16 and 18).", {"entities": []}], ["Measures of antibody reactivity were log transformed and analyzed using logistic regression.", {"entities": []}], ["We found no association between KIV, WUV, and MCV antibody levels and incident lung cancer (P-corrected for multiple comparisons >0.10 for all trend tests).", {"entities": [[79, 90, "DISEASE"], [84, 90, "DISEASE"]]}], ["We also found no association with HPV-16, 18, 31, 33, 52, and 58 seropositivity (P-corrected for multiple comparisons >0.05 for all).", {"entities": []}], ["Future studies of infectious etiologies of lung cancer should look beyond HPyVs and HPVs as candidate infectious agents.", {"entities": [[43, 54, "DISEASE"], [48, 54, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12885-016-2381-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Anecdotal reports of children experiencing eczema flares during winter and summer months along with global variation in eczema prevalence has fueled speculation that climate may modulate disease activity.", {"entities": []}], ["The aim of this study was to determine if long-term weather patterns affect the severity and persistence of eczema symptoms in children.", {"entities": []}], ["We performed a prospective cohort study of U.S. children (N=5,595) enrolled in PEER (Pediatric Eczema Elective Registry) between 2004 and 2012 to evaluate the effect of climate (daily temperature, daily sun exposure, daily humidity) on the severity of eczema symptoms.", {"entities": []}], ["Odds ratios were calculated for the patient evaluated outcome of disease control.", {"entities": []}], ["Multivariate logistic regression modeling adjusting for gender, race, income, and topical medication use demonstrated that higher temperature (OR=0\u00b790, 95% CI: 0\u00b787\u20130\u00b793, p<0\u00b7001) and increased sun exposure (OR=0\u00b793, 95% CI: 0\u00b789\u20130\u00b798, p=0\u00b7009) were associated with poorly controlled eczema.", {"entities": []}], ["Higher humidity (OR=0\u00b790, 95% CI: 0\u00b7812\u20130.997, p=0\u00b704) was also associated with poorly controlled disease, but the statistical significance of this association was lost in our multivariate analysis (p=0.44).", {"entities": []}], ["Retrospective audit.", {"entities": []}], ["Secondary paediatric outpatient clinic, Troms\u00f8, Norway.", {"entities": []}], ["The participants were 80 (62.5% boys and 37.5% girls) children and adolescents with a diagnosed egg allergy who had to be on an egg-free diet and be unable to eat any food containing any amount of egg, including egg-containing baked goods, without an allergic reaction to egg protein.", {"entities": [[96, 107, "DISEASE"]]}], ["We also included patients who were sensitised to egg but had never been exposed to egg or egg-containing baked goods and were on an egg-free diet.", {"entities": []}], ["Other atopic diseases among the study participants were also registered.", {"entities": []}], ["The vaccination took place from November to December 2009.", {"entities": []}], ["The patients were vaccinated with a monovalent influenza A (H1N1) vaccine that had an ovalbumin content <0.33\u2005\u03bcg/ml.", {"entities": [[47, 56, "DISEASE"]]}], ["They were divided into two groups, receiving the vaccine either as a single dose or as a fractionated dose.", {"entities": []}], ["Patients were selected for the fractionated dose because of their prior reaction to egg or because they never had been exposed to egg.", {"entities": []}], ["There were no serious adverse reactions to the vaccine; only one mild adverse reaction and two possible adverse reactions.", {"entities": []}], ["Patients ranged in age from 10\u2005months to 16.5\u2005years.", {"entities": []}], ["Thirty-eight (48%) patients received a fractionated dose.", {"entities": []}], ["Sixty-three (79%) had one or more atopic disease apart from egg allergy.", {"entities": [[60, 71, "DISEASE"]]}], ["With regard to atopy, serum specific IgE levels or skin prick test, there were no significant differences between the groups receiving the vaccine as a fractionated or as a single dose.", {"entities": []}], ["The study confirmed that patients allergic to egg can be safely vaccinated with a regular influenza vaccine containing <0.333\u2005\u03bcg/ml ovalbumin, even if these patients had displayed previous anaphylactic reactions to egg and had been diagnosed with concurrent atopic diseases.", {"entities": [[90, 99, "DISEASE"]]}], ["We wanted to vaccinate the children severely affected by egg allergy with the same vaccine that the rest of the Norwegian population was receiving at the time and that vaccine contained egg residue.", {"entities": [[57, 68, "DISEASE"]]}], ["It is safe to vaccinate children with severe egg allergy with a vaccine containing a low level of egg residue, even if these children suffer from concurrent atopic diseases.", {"entities": [[45, 56, "DISEASE"]]}], ["The level of serum-specific IgE to egg does not predict a reaction to the vaccine.", {"entities": []}], ["Children with a positive serum-specific IgE test to egg allergy, who had never been exposed to egg, should be treated as if they are allergic to egg.", {"entities": [[52, 63, "DISEASE"]]}], ["The strength of this study is that it is the same doctor who thoroughly evaluated all the patients before vaccination also evaluated the patients with suspected reactions to the vaccine.", {"entities": []}], ["A weakness is that the number of participants in the study is quite small.", {"entities": []}], ["We propose that a C-type lectin receptor, SIGNR-1, plays a role in conditioning gastrointestinal lamina propria (LP) DC subset for the induction of oral tolerance in a model of food-induced anaphylaxis.", {"entities": []}], ["Oral delivery of bovine serum albumin (BSA) bearing 51 mols of mannosides (Man 51 -BSA) significantly reduced the levels of BSA-induced anaphylactic response.", {"entities": []}], ["Man 51 -BSA was found to, selectively, target the LPDC subset expressing a member of the CLRs, SIGNR1, and induce the expression of IL-10, but not IL-6 and IL-12p70.", {"entities": []}], ["This was noted also in Man 51 -BSA-treated IL-10-GFP knockin (tiger) mice.", {"entities": []}], ["The Man 51 -BSA\u2013SIGNR1 axis in LPDCs, both in vitro and in vivo , promoted the generation of CD4 in vivo -generated Tr1-like cells were capable of transferring tolerance.", {"entities": [[93, 96, "GENE"]]}], ["These results suggest the potential utility of sugar-modified antigen in oral tolerance through targeting of SIGNR1 and LPDCs.", {"entities": []}], ["Eosinophilic mucin rhinosinusitis is an inflammatory pathological condition of the nose and paranasal sinuses.", {"entities": []}], ["It is rare, occurs in immunocompetent patients and is characterised by peripheral eosinophilia and extensive bilateral sinus disease.", {"entities": [[82, 94, "DISEASE"]]}], ["To the best of our knowledge, visual loss with this condition has not been previously reported.", {"entities": []}], ["We present the case of a 26-year-old Asian woman with a background history of chronic sinusitis who presented with acute left-sided visual loss.", {"entities": [[86, 95, "DISEASE"]]}], ["Imaging showed significant opacification in the frontal, ethmoidal and sphenoidal sinuses as well as evidence of a unilateral optic neuritis.", {"entities": [[132, 140, "DISEASE"], [126, 140, "DISEASE"]]}], ["Histological analysis of sinus mucin revealed dense eosinophilic infiltrate and, despite medical and surgical intervention, vision was not restored in her left eye.", {"entities": []}], ["We introduce visual loss as a complication of eosinophilic mucin rhinosinusitis.", {"entities": []}], ["This adds further evidence to previous reports in the literature that optic neuropathy in sinusitis can occur secondary to non-compressive mechanisms.", {"entities": [[76, 86, "DISEASE"], [90, 99, "DISEASE"]]}], ["We also describe a rare finding: the vision in this patient did not improve following steroid therapy, antifungal therapy or surgical intervention.", {"entities": []}], ["There are very few such cases described in the literature.", {"entities": []}], ["We conclude that chronic sinusitis is an indolent inflammatory process which can cause visual loss and we reiterate the importance of recognizing and considering sinusitis as a cause of visual loss in patients in order that prompt medical and surgical treatment of the underlying disease can be initiated.", {"entities": [[25, 34, "DISEASE"], [162, 171, "DISEASE"]]}], ["Interleukin (IL)-17 is recognized to play a critical role in numerous immune and inflammatory responses by regulating the expression of various inflammatory mediators, which include cytokines, chemokines, and adhesion molecules.", {"entities": []}], ["There is growing evidence that IL-17 is involved in the pathogenesis of asthma.", {"entities": [[72, 78, "DISEASE"]]}], ["IL-17 orchestrates the neutrophilic influx into the airways and also enhances T-helper 2 (Th2) cell-mediated eosinophilic airway inflammation in asthma.", {"entities": [[145, 151, "DISEASE"]]}], ["Recent studies have demonstrated that not only inhibitor of IL-17 per se but also diverse regulators of IL-17 expression reduce antigen-induced airway inflammation, bronchial hyperresponsiveness, and Th2 cytokine levels in animal models of asthma.", {"entities": [[240, 246, "DISEASE"]]}], ["This review will summarize the role of IL-17 in the context of allergic airway inflammation and discuss the therapeutic potential of various strategies targeting IL-17 for asthma.", {"entities": [[172, 178, "DISEASE"]]}], ["Recurrent pneumonia (RP), i.e., at least two episodes of pneumonia in one year or three episodes ever with intercritical radiographic clearing of densities, occurs in 7.7%\u20139% of children with community-acquired pneumonia.", {"entities": [[10, 19, "DISEASE"], [57, 66, "DISEASE"], [211, 220, "DISEASE"]]}], ["In RP, the challenge is to discriminate between children with self-limiting or minor problems, that do not require a diagnostic work-up, and those with an underlying disease.", {"entities": []}], ["The aim of the current review is to discuss a reasoned diagnostic approach to RP in childhood.", {"entities": []}], ["Particular emphasis has been placed on which children should undergo a diagnostic work-up and which tests should be performed.", {"entities": []}], ["A pediatric case series is also presented, in order to document a single centre experience of RP.", {"entities": []}], ["A management algorithm for the approach to children with RP, based on the evidence from a literature review, is proposed.", {"entities": []}], ["Like all algorithms, it is not meant to replace clinical judgment, but it should drive physicians to adopt a systematic approach to pediatric RP and provide a useful guide to the clinician.", {"entities": []}], ["Pulmonary thromboembolism (PTE) is part of a larger clinicopathological entity, venous thromboembolism.", {"entities": []}], ["It is also a complex, multifactorial disorder divided into four major disease processes including venous thrombosis, thrombus in transit, acute pulmonary embolism, and pulmonary circulation reconstruction.", {"entities": [[144, 162, "DISEASE"]]}], ["Even when treated, some patients develop chronic thromboembolic pulmonary hypertension.", {"entities": [[74, 86, "DISEASE"], [64, 86, "DISEASE"]]}], ["PTE is also a common fatal type of pulmonary vascular disease worldwide, but earlier studies primarily focused on the pathological changes in the blood component of the disease.", {"entities": [[45, 61, "DISEASE"]]}], ["With contemporary advances in molecular and cellular biology, people are becoming increasingly aware of coagulation pathways, the function of vascular smooth muscle cells, microparticles, and the inflammatory pathways that play key roles in PTE.", {"entities": []}], ["Combined hypoxia and immune research has revealed that PTE should be regarded as a class of complex diseases caused by multiple factors involving the vascular microenvironment and vascular cell dysfunction.", {"entities": []}], ["Prostate cancer is worldwide the sixth leading cause of cancer related death in men thus early detection and successful treatment are still of major interest.", {"entities": [[9, 15, "DISEASE"], [56, 62, "DISEASE"], [0, 15, "DISEASE"]]}], ["The commonly performed screening of the prostate-specific antigen (PSA) is controversially discussed, as in many patients the prostate-specific antigen levels are chronically elevated in the absence of cancer.", {"entities": [[202, 208, "DISEASE"]]}], ["Due to the unsatisfying efficiency of available prostate cancer screening markers and the current treatment outcome of the aggressive hormone refractory prostate cancer, the evaluation of novel molecular markers and targets is considered an issue of high importance.", {"entities": [[57, 63, "DISEASE"], [162, 168, "DISEASE"], [48, 63, "DISEASE"], [153, 168, "DISEASE"]]}], ["MicroRNAs are relatively stable in body fluids orchestrating simultaneously the expression of many genes.", {"entities": []}], ["These molecules are currently discussed to bear a greater diagnostic potential than protein-coding genes, being additionally promising therapeutic drugs and/or targets.", {"entities": []}], ["Herein we review the potential impact of the microRNA let-7 family on prostate cancer and show how deregulation of several of its target genes could influence the cellular equilibrium in the prostate gland, promoting cancer development as they do in a variety of other human malignant neoplasias.", {"entities": [[79, 85, "DISEASE"], [217, 223, "DISEASE"], [70, 85, "DISEASE"]]}], ["Eosinophils are produced in the bone marrow from CD34", {"entities": [[49, 53, "GENE"]]}], ["Toll-like receptor 4 (TLR4) is a key modulator in many inflammation-related diseases.", {"entities": [[22, 26, "GENE"]]}], ["Polymorphisms in the TLR4 gene may alter TLR4 expression and affect the extent and severity of coronary artery disease (CAD).", {"entities": [[21, 25, "GENE"], [41, 45, "GENE"], [21, 25, "GENE"], [41, 45, "GENE"]]}], ["We analyzed 3 polymorphisms of TLR4 in 607 Chinese subjects who underwent coronary arteriography.", {"entities": [[31, 35, "GENE"]]}], ["Blood samples were collected to identify the polymorphisms.", {"entities": []}], ["We evaluated the relationships between the polymorphisms and the number of vessels involved in coronary stenosis, Gensini scores, and Duke prognostic scores.", {"entities": [[95, 112, "DISEASE"]]}], ["We found that rs11536889 was associated with an increased risk of 3-vessel disease.", {"entities": []}], ["When subjects with 3-vessel disease were compared to subjects with nonsignificant CAD, rs11536889 variant genotypes were associated with an increased risk of 3-vessel disease (GC/CC vs .", {"entities": []}], ["GG: OR=2.06, 95%CI=1.21-3.51).", {"entities": []}], ["When subjects with 3-vessel disease were compared to subjects with 1-vessel disease, rs11536889 variant genotypes were associated with an increased risk of 3-vessel disease (GC vs .", {"entities": [[174, 176, "GENE"]]}], ["GG: OR=2.14, 95%CI=1.20-3.79; GC/CC vs .", {"entities": []}], ["GG: OR=2.06, 95%CI=1.20-3.54).", {"entities": []}], ["When subjects with 3-vessel disease were compared to subjects with non-3-vessel disease, rs11536889 variant genotypes were associated with an increased risk of 3-vessel disease (GC vs .", {"entities": [[178, 180, "GENE"]]}], ["GG: OR=1.76, 95%CI=1.12-2.75; GC/CC vs .", {"entities": []}], ["GG: OR=1.83, 95%CI=1.19-2.82).", {"entities": []}], ["The TLR4 rs11536889 polymorphism was also related to Gensini score ( P =0.02).", {"entities": [[4, 8, "GENE"]]}], ["The Gensini score was higher in subjects with the variant CC and GC/CC genotype than in subjects with the wild GG genotype (61.28 1.84 and 57.6434.82 vs .", {"entities": []}], ["51.2734.57).", {"entities": []}], ["Our results demonstrate that TLR4 rs11536889 polymorphism is a novel genetic factor in the development of CAD, influencing the extent and severity of CAD.", {"entities": [[29, 33, "GENE"]]}], ["Inflammatory bowel disease (IBD) is hypothesized to result from stimulation of immune responses against resident intestinal bacteria within a genetically susceptible host.", {"entities": []}], ["Mast cells may play a critical role in IBD pathogenesis, since they are typically located just beneath the intestinal mucosal barrier and can be activated by bacterial antigens.", {"entities": []}], ["This study investigated effects of mast cells on inflammation and associated neoplasia in IBD-susceptible interleukin (IL)-10-deficient mice with and without mast cells.", {"entities": []}], ["IL-10-deficient mast cells produced more pro-inflammatory cytokines in vitro both constitutively and when triggered, compared with wild type mast cells.", {"entities": []}], ["However despite this enhanced in vitro response, mast cell-sufficient Il10 in vivo .", {"entities": [[70, 74, "GENE"]]}], ["Mast cell deficiency predisposed Il10 in vivo that preceded the development of colon inflammation.", {"entities": [[33, 37, "GENE"]]}], ["However, mast cell deficiency did not affect the severity of IBD triggered by non-steroidal anti-inflammatory agents (NSAID) exposure or helicobacter infection that also affect intestinal permeability.", {"entities": []}], ["Mast cells thus appear to have a primarily protective role within the colonic microenvironment by enhancing the efficacy of the mucosal barrier.", {"entities": []}], ["In addition, although mast cells were previously implicated in progression of sporadic colon cancers, mast cells did not affect the incidence or severity of colonic neoplasia in this inflammation-associated model.", {"entities": []}], ["Background: With an increase in indoor smoking bans, many smokers smoke outside establishments and near their entrances, which has become a public health concern.", {"entities": []}], ["Objectives: We characterized the exposure of nonsmokers to secondhand smoke (SHS) outside a restaurant and bar in Athens, Georgia, where indoor smoking is banned, using salivary cotinine and urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).", {"entities": []}], ["Methods: In a crossover study, we assigned 28 participants to outdoor patios of a restaurant and a bar and an open-air site with no smokers on three weekend days; participants visited each site once and stayed for 3 hr.", {"entities": [[216, 218, "GENE"]]}], ["We collected saliva and urine samples immediately before and after the visits (postexposure) and on the following morning and analyzed samples for cotinine and total NNAL, respectively.", {"entities": []}], ["Regression models were fitted and changes in biomarkers were contrasted between locations.", {"entities": []}], ["Results: Postexposure and preexposure geometric mean salivary cotinine concentrations differed by 0.115 ng/mL [95% confidence interval (CI): 0.105, 0.126)] and by 0.030 ng/mL (95% CI: 0.028, 0.031) for bar and restaurant visits, respectively.", {"entities": []}], ["There were no significant post- and preexposure differences in cotinine levels after control site visits, and changes after bar and restaurant site visits were significantly different from changes after control site visits ( p < 0.001).", {"entities": []}], ["Results comparing next-day and preexposure salivary cotinine levels were similar.", {"entities": []}], ["Next-day creatinine-corrected urinary NNAL concentrations also were higher than preexposure levels following bar and restaurant visits [1.858 pg/mg creatinine higher (95% CI: 0.897, 3.758) and 0.615 pg/mg creatinine higher (95% CI: 0.210, 1.761), respectively], and were significantly different from changes after the control visits ( p = 0.005).", {"entities": []}], ["Conclusion: Salivary cotinine and urinary NNAL increased significantly in nonsmokers after outdoor SHS exposure.", {"entities": []}], ["Our findings indicate that such exposures may increase risks of health effects associated with tobacco carcinogens.", {"entities": []}], ["The aim of this research was to evaluate long-term pulmonary sequelae on paired inspiration-expiration thin-section computed tomography (CT) scans 3 years after influenza A (H1N1) virus-associated pneumonia, and to analyze the affecting factors on pulmonary fibrosis.", {"entities": [[161, 170, "DISEASE"], [197, 206, "DISEASE"], [248, 266, "DISEASE"]]}], ["Twenty-four patients hospitalized with H1N1 virus-associated pneumonia at our hospital between September 2009 and January 2010 were included.", {"entities": [[61, 70, "DISEASE"]]}], ["The patients underwent thin-section CT 3 years after recovery.", {"entities": []}], ["Abnormal pulmonary lesion patterns (ground-glass opacity, consolidation, parenchymal bands, air trapping, and reticulation) and evidence of fibrosis (architectural distortion, traction bronchiectasis, or honeycombing) were evaluated on follow-up thin-section CT.", {"entities": [[185, 199, "DISEASE"]]}], ["Patients were assigned to Group 1 (with CT evidence of fibrosis) and Group 2 (without CT evidence of fibrosis).", {"entities": []}], ["Demographics, rate of mechanical ventilation therapy, rate of intensive care unit admission, cumulative prednisolone-equivalent dose, laboratory tests results (maximum levels of alanine aminotransferase, aspartate transaminase [AST], lactate dehydrogenase [LDH], and creatine kinase [CK]), and peak radiographic opacification of 24 patients during the course of their illness in the hospital were compared between two groups.", {"entities": []}], ["Parenchymal abnormality was present in 17 of 24 (70.8%) patients and fibrosis occurred in 10 of 24 (41.7%) patients.", {"entities": []}], ["Patients in Group 1 (10/24; 41.7%) had a higher rate of mechanical ventilation therapy ( Z = \u22122.340, P = 0.019), higher number of doses of cumulative prednisolone-equivalent ( Z = \u22122.579, P = 0.010), higher maximum level of laboratory tests results (AST [ Z = \u22122.140, P = 0.032], LDH [ Z = \u22123.227, P = 0.001], and CK [ Z = \u22123.345, P = 0.019]), and higher peak opacification on chest radiographs ( Z = \u22122.743, P = 0.006) than patients in group 2 (14/24; 58.3%).", {"entities": []}], ["H1N1 virus-associated pneumonia frequently is followed by long-term pulmonary sequelae, including fibrotic changes, in lung parenchyma.", {"entities": [[22, 31, "DISEASE"]]}], ["Patients who need more steroid therapy, need more mechanical ventilation therapy, had higher laboratory tests results (maximum levels of AST, LDH, and CK), and had higher peak opacification on chest radiographs during treatment are more likely to develop lung fibrosis.", {"entities": []}], ["Glucocorticoid-induced leucine zipper (GILZ) is a mediator of the anti-inflammatory activities of glucocorticoids.", {"entities": []}], ["However, GILZ deletion does not impair the anti-inflammatory activities of exogenous glucocorticoids in mice arthritis models and GILZ could also mediate some glucocorticoid-related adverse events.", {"entities": [[109, 118, "DISEASE"]]}], ["Osteoarthritis (OA) is a metabolic disorder that is partly attributed to adipokines such as leptin, and we previously observed that glucocorticoids induced leptin secretion in OA synovial fibroblasts.", {"entities": []}], ["The purpose of this study was to position GILZ in OA through its involvement in the anti-inflammatory activities of glucocorticoids and/or in the metabolic pathway of leptin induction.", {"entities": []}], ["The influences of mineralocorticoids on GILZ and leptin expression were also investigated.", {"entities": []}], ["Human synovial fibroblasts were isolated from OA patients during knee replacement surgery.", {"entities": []}], ["Then, the cells were treated with a glucocorticoid (prednisolone), a mineralocorticoid (aldosterone), a glucocorticoid receptor (GR) antagonist (mifepristone), a selective glucocorticoid receptor agonist (Compound A), mineralocorticoid receptor (MR) antagonists (eplerenone and spironolactone), TNF-\u03b1 or transforming growth factor (TGF)-\u03b2.", {"entities": []}], ["Cells were transfected with shRNA lentiviruses for the silencing of GILZ and GR.", {"entities": []}], ["The leptin, IL-6, IL-8 and matrix metalloproteinase (MMP)-1 levels were measured by ELISA.", {"entities": []}], ["Leptin, the leptin receptor (Ob-R), GR and GILZ expression levels were analyzed by western blotting and/or RT-qPCR.", {"entities": []}], ["(1) The glucocorticoid prednisolone and the mineralocorticoid aldosterone induced GILZ expression dose-dependently in OA synovial fibroblasts, through GR but not MR.", {"entities": []}], ["Similar effects on leptin and Ob-R were observed: leptin secretion and Ob-R expression were also induced by prednisolone and aldosterone through GR; (2) GILZ silencing experiments demonstrated that GILZ was involved in the glucocorticoid-induced and mineralocorticoid-induced leptin secretion and Ob-R expression in OA synovial fibroblasts; and (3) GILZ inhibition did not alter the production of pro-inflammatory cytokines by OA synovial fibroblast or the anti-inflammatory properties of glucocorticoids.", {"entities": []}], ["The absence of GILZ prevents corticoid-induced leptin and Ob-R expression without affecting the anti-inflammatory properties of glucocorticoids in OA synovial fibroblasts.", {"entities": []}], ["Mineralocorticoids also induce leptin and Ob-R expression through GILZ.", {"entities": []}], ["Co-morbidity is a common phenomenon in the elderly and is considered to be a major threat to quality of life (QOL).", {"entities": []}], ["Knowledge of co-existing conditions or patient characteristics that lead to an increased QOL decline is important for individual care, and for public health purposes.", {"entities": []}], ["In visually impaired older adults, it remains unclear which co-existing conditions or other characteristics influence their health-related QOL.", {"entities": []}], ["Our aim was to present a risk profile of characteristics and conditions which predict deterioration of QOL in visually impaired older patients.", {"entities": []}], ["Analyses were performed on data from an observational study among 296 visually impaired older patients from four Dutch hospitals.", {"entities": []}], ["QOL was measured with the EuroQol-5D (EQ-5D) at baseline and at five-month follow-up.", {"entities": []}], ["Nine co-existing condition categories (musculoskeletal; diabetes; heart; hypertension; chronic obstructive pulmonary disease (COPD) or asthma; hearing impairment; stroke; cancer; gastrointestinal conditions) and six patient characteristics (age; gender; visual acuity; social status; independent living; rehabilitation type) were tested in a linear regression model to determine the risk profile.", {"entities": [[73, 85, "DISEASE"], [87, 124, "DISEASE"], [135, 141, "DISEASE"], [171, 177, "DISEASE"]]}], ["The model was corrected for baseline EQ-5D scores.", {"entities": []}], ["In addition, baseline EQ-5D scores were compared with reference scores from a younger visually impaired population and from elderly in the general population.", {"entities": []}], ["From the 296 patients, 50 (16.9%) were lost to follow-up.", {"entities": []}], ["Patients who reported diabetes, COPD or asthma, consequences of stroke, musculoskeletal conditions, cancer, gastrointestinal conditions or higher logMAR Visual Acuity values, experienced a lower QOL.", {"entities": [[40, 46, "DISEASE"], [100, 106, "DISEASE"]]}], ["After five months, visual acuity, musculoskeletal conditions, COPD/asthma and stroke predicted a decline in QOL (R In visually impaired older patients, visual acuity, musculoskeletal conditions, COPD/asthma and stroke predicted a relatively rapid decline in health-related QOL.", {"entities": [[67, 73, "DISEASE"], [200, 206, "DISEASE"]]}], ["With this risk profile, a specific referral by the ophthalmologist to another sub-specialty may have a beneficial effect on the patient's health-related QOL.", {"entities": []}], ["A referral by the ophthalmologist or optometrist to a multidisciplinary rehabilitation service seems appropriate for some patients with co-morbidity.", {"entities": []}], ["The current results need to be confirmed in studies using pre-structured questionnaires to assess co-morbidity.", {"entities": []}], ["A high amount of sedentary time has been proposed as a risk factor for various health outcomes in adults.", {"entities": []}], ["While the evidence is less clear in children and adolescents, monitoring sedentary time is important to understand the prevalence rates and how this behaviour varies over time and by place.", {"entities": []}], ["This systematic literature review aims to provide an overview of existing cross-European studies on sedentary time in children (0-12y) and adolescents (13-18y), to describe the variation in population levels of sedentary time, and to discuss the impact of assessment methods.", {"entities": []}], ["Six literature databases were searched (PubMed, EMBASE, CINAHL, PsycINFO, SportDiscus and OpenGrey), followed by backward- and forward tracking and searching authors\u2019 and experts\u2019 literature databases.", {"entities": []}], ["Included articles were observational studies reporting on levels of sedentary time in the general population of children and/or adolescents in at least two European countries.", {"entities": []}], ["Population levels were reported separately for children and adolescents.", {"entities": []}], ["Data were reviewed, extracted and assessed by two researchers, with disagreements being resolved by a third researcher.", {"entities": []}], ["The review protocol is published under registration number CRD42014013379 in the PROSPERO database.", {"entities": []}], ["Forty-two eligible articles were identified, most were cross-sectional ( n \u2009=\u200938).", {"entities": []}], ["The number of included European countries per article ranged from 2 to 36.", {"entities": []}], ["Levels of sedentary time were observed to be higher in East-European countries compared to the rest of Europe.", {"entities": []}], ["There was a large variation in assessment methods and reported outcome variables.", {"entities": []}], ["The majority of articles used a child-specific questionnaire (60\u00a0%).", {"entities": []}], ["Other methods included accelerometers, parental questionnaires or interviews and ecological momentary assessment tools.", {"entities": []}], ["Television time was reported as outcome variable in 57\u00a0% of included articles (ranging from a mean value of 1\u00a0h to 2.7\u00a0h in children and 1.3\u00a0h to 4.4\u00a0h in adolescents), total sedentary time in 24\u00a0% (ranging from a mean value of 192\u00a0min to 552\u00a0min in children and from 268\u00a0min to 506\u00a0min in adolescents).", {"entities": []}], ["A substantial number of published studies report on levels of sedentary time in children and adolescents across European countries, but there was a large variation in assessment methods.", {"entities": []}], ["Questionnaires (child specific) were used most often, but they mostly measured specific screen-based activities and did not assess total sedentary time.", {"entities": []}], ["There is a need for harmonisation and standardisation of objective and subjective methods to assess sedentary time in children and adolescents to enable comparison across countries.", {"entities": []}], ["The online version of this article (doi:10.1186/s12966-016-0395-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In April 2009, the World Health Organization (WHO) declared pandemic influenza A (H1N1) \u201cpublic health emergency of international concern\u201d.", {"entities": [[69, 78, "DISEASE"]]}], ["On June 11, 2009, WHO raised the pandemic alert level to phase 6, indicating a global pandemic.", {"entities": []}], ["By December 2009, more than 208 countries and territories had reported swine flu cases.", {"entities": []}], ["The descriptive epidemiology of the first reported 100 cases of this virus in Saudi Arabia are summarized in this report.", {"entities": []}], ["Data were collected from 1 June to 3 July, 2009 using a predesigned questionnaire.", {"entities": []}], ["Questionnaires were filled by Field Epidemiology Training Program residents.", {"entities": []}], ["Data for the first 100 complete cases of confirmed pandemic influenza A (H1N1) were compiled and analyzed.", {"entities": [[60, 69, "DISEASE"]]}], ["The age of reported cases was in the range of 1 to 56 years.", {"entities": []}], ["The highest percentage of cases was in the age group of 20 to 30 years followed by the age group of 1 to 10 years.", {"entities": []}], ["Females represented 55% of the cases; imported cases represented 47%, 58% of whom had come via the King Khaled Airport.", {"entities": []}], ["The most common nationalities most were from Saudi Arabia and the Philippines.", {"entities": []}], ["The main symptoms were fever (56%), cough (54%), and sore throat and the number of cases was seen to peak from the 27 to 29 June.", {"entities": []}], ["Pandemic influenza A (H1N1) is still a threat to Saudi Arabia.", {"entities": [[9, 18, "DISEASE"]]}], ["Thus, comprehensive and effective measures for surveillance and prevention of the disease are needed to control its spread.", {"entities": []}], ["Whereas structural abnormalities in the cerebellum have been associated with essential tremor (ET), the contribution of vascular disease via white matter hyperintensities (WMHs) and strokes has not been examined.", {"entities": [[120, 136, "DISEASE"], [77, 93, "DISEASE"]]}], ["In this study, we have explored these potential associations and hypothesized that ET would be associated with greater overall WMH volume, greater cerebellar WMH volume, and greater infarct presence.", {"entities": []}], ["In a cross-sectional magnetic resonance imaging (MRI) study of 540 community-dwelling elderly persons in northern Manhattan, New York, brain measures of total WMH volume and regional WMH volume were derived from T 2 -weighted fluid attenuated inverse recovery-weighted MR images.", {"entities": []}], ["The presence of cerebral infarcts on MRI was determined as well.", {"entities": []}], ["Total WMH volume was greater among 33 ET cases than 507 controls in both univariate (OR\u200a=\u200a1.41, p\u200a=\u200a0.038) and fully adjusted analyses (OR\u200a=\u200a1.44, p\u200a=\u200a0.03).", {"entities": []}], ["Cerebellar WMH volume was associated with marginally increased odds of ET in a univariate model (OR\u200a=\u200a1.52, p\u200a=\u200a0.11) and significantly increased odds in a fully adjusted multivariate model (OR\u200a=\u200a1.74, p\u200a=\u200a0.049).", {"entities": []}], ["Temporal lobe WMH volume was associated with significantly increased odds of ET in both univariate (OR\u200a=\u200a3.36, p<0.001) and fully adjusted models (OR\u200a=\u200a3.73, p<0.001).", {"entities": []}], ["Large strokes were significantly more common in cases than in controls in unadjusted analyses (OR\u200a=\u200a3.04, p\u200a=\u200a0.02) and marginally in adjusted analyses (OR\u200a=\u200a2.56\u20132.57, p\u200a=\u200a0.045 \u2013 0.056).", {"entities": []}], ["The distribution of strokes did not differ by diagnosis.", {"entities": []}], ["MRI data in this study indicated that ET was associated with greater total WMH volume, greater cerebellar WMH volume and possibly more strokes.", {"entities": []}], ["Cerebrovascular disease could play a role in the development of ET.", {"entities": []}], ["Although it has been shown that acute beta-blocker administration may reduce the presence or severity of myocardial perfusion defects with dipyridamole stress, little information is available about the potential effect of chronic beta-blocker treatment on the sensitivity of dipyridamole myocardial perfusion imaging (DMPI).", {"entities": []}], ["As a randomized clinical trial, one hundred twenty patients (103 male and 17 female) with angiographically confirmed CAD who were on long-term beta blocker therapy (\u22653 months) enrolled in a randomized clinical trial study.", {"entities": []}], ["The patients were allocated into two groups: Group A (n=60) in whom the beta-blocker agent was discontinued for 72h before DMPI and Group B (n=60) without discontinuation of beta-blockers prior to DMPI.", {"entities": []}], ["No significant difference was noted between the groups concerning age, sex, type of the injected radiotracer and number of involved coronary vessels.", {"entities": []}], ["The mean rank of total perfusion scores for whole myocardium (irrespective of reversibility or irreversibility) in group B was not significantly different from that of group A, (65.75 vs. 55.25, P=0.096).", {"entities": []}], ["Regarding the only irreversible perfusion defects, the mean rank of perfusion score in group B was higher than that of group A for whole myocardium (72 vs. 49, P=0.0001); however, no difference was noted between two groups for only reversible perfusion defects (61.0 vs. 60.0, P=0.898).", {"entities": []}], ["The overall sensitivity of DMPI for the diagnosis of CAD in group A (91.7%) was not statistically different from group B (90%).", {"entities": []}], ["Beta-blocker withholding before DMPI did not generally affect the sensitivity of the test for the diagnostic purposes in our study.", {"entities": []}], ["Thus, beta-blocker withdrawal for just the purpose of diagnostic imaging is not mandatory particularly when medication discontinuation may cause the patients to face increased risk of heart events.", {"entities": []}], ["CD4 T cells acquire functional properties including cytokine production upon antigenic stimulation through the T cell receptor (TCR) and differentiate into T helper (Th) cells.", {"entities": [[0, 3, "GENE"]]}], ["Th1 cells produce interferon (IFN)-\u03b3 and Th2 cells produce interleukin (IL)-4.", {"entities": []}], ["Th1 and 2 cells utilize IFN-\u03b3 and IL-4 for further maturation and maintenance, respectively.", {"entities": []}], ["Promyelocytic leukemia zinc finger (PLZF)-expressing invariant natural killer T (iNKT) cells develop in the thymus and acquire functional ability to produce IL-4 and IFN-\u03b3 in the thymus in the absence of antigenic stimulation.", {"entities": [[14, 22, "DISEASE"]]}], ["In response to antigenic stimulation, iNKT cells rapidly produce IFN-\u03b3 and IL-4.", {"entities": []}], ["However, it is still unknown as to whether iNKT cells require these cytokines for maturation or survival in vivo.", {"entities": []}], ["In this study, using IL-4- and IL-4 receptor- (IL-4R) deficient mice, we demonstrate that IL-4 as well as IL-4R expression is dispensable for the development, function and maintenance of iNKT cells.", {"entities": []}], ["Speleotherapy \u2013 a special form of climatotherapy \u2013 uses certain conditions specific to caves and salt-mines to treat several medical conditions, especially respiratory and skin-related.", {"entities": []}], ["This reduces all types of irritations and therefore disease symptoms are mitigated or fully suppressed while the patient is accommodated into the salt-mine.", {"entities": []}], ["Objective: Influence of microclimate in salt-mines of Turda, Dej and Cacica on morphology and electrophoretic expression of in vitro lung and skin fibroblasts acquired from the lung and hypodermic tissues of Wistar rats, in normal conditions and after ovalbumin-induced asthma, respectively after experimental injuries and burns.", {"entities": [[270, 276, "DISEASE"]]}], ["Materials and methods: skin fibroblast cultures acquired from lung and hypodermic tissue sampled from Wistar rats.", {"entities": []}], ["Cultures acquired are developed in fibroblast monolayer attached to the culture dish.", {"entities": []}], ["Wistar rats with weight between 75 -100 g were divided in three groups: one control group, one group with experimental asthma, one group with injuries and burns.", {"entities": [[119, 125, "DISEASE"]]}], ["10 animals from each group were sent to salt-mines in Turda, Dej and Cacica for 14 days and kept in a saline environment, similar to speleotherapy.", {"entities": []}], ["Results: Speleotherapy applied to Wistar rats determined significant differences in cellular morphology and in electrophoretic expression of lung and skin fibroblasts from primary cultures.", {"entities": []}], ["Conclusions: Results of this survey indicates that speleotherapy induces changes in morphology and protein expression of in vitro lung and skin fibroblasts, and these changes support the therapeutic effects of speleotherapy.", {"entities": []}], ["Cellular damage caused by reactive oxygen species (ROS) has been implicated in several diseases, and hence natural antioxidants have significant importance in human health.", {"entities": []}], ["The present study was carried out to evaluate the in vitro antioxidant and reactive oxygen species scavenging activities of Terminalia chebula , Terminalia belerica and Emblica officinalis fruit extracts.", {"entities": []}], ["The 70% methanol extracts were studied for in vitro total antioxidant activity along with phenolic and flavonoid contents and reducing power.", {"entities": []}], ["Scavenging ability of the extracts for radicals like DPPH, hydroxyl, superoxide, nitric oxide, hydrogen peroxide, peroxynitrite, singlet oxygen, hypochlorous acid were also performed to determine the potential of the extracts.", {"entities": []}], ["The ability of the extracts of the fruits in exhibiting their antioxative properties follow the order T. chebula > E. officinalis > T. belerica .", {"entities": []}], ["The same order is followed in their flavonoid content, whereas in case of phenolic content it becomes E. officinalis > T. belerica > T. chebula .", {"entities": []}], ["In the studies of free radicals' scavenging, where the activities of the plant extracts were inversely proportional to their IC 50 values, T. chebula and E. officinalis were found to be taking leading role with the orders of T. chebula > E. officinalis > T. belerica for superoxide and nitric oxide, and E. officinalis > T. belerica > T. chebula for DPPH and peroxynitrite radicals.", {"entities": []}], ["Miscellaneous results were observed in the scavenging of other radicals by the plant extracts, viz., T. chebula > T. belerica > E. officinalis for hydroxyl, T. belerica > T. chebula > E. officinalis for singlet oxygen and T. belerica > E. officinalis > T. chebula for hypochlorous acid.", {"entities": []}], ["In a whole, the studied fruit extracts showed quite good efficacy in their antioxidant and radical scavenging abilities, compared to the standards.", {"entities": []}], ["The evidences as can be concluded from the study of the 70% methanol extract of the fruits of Terminalia chebula , Terminalia belerica and Emblica officinalis , imposes the fact that they might be useful as potent sources of natural antioxidant.", {"entities": []}], ["We previously demonstrated that chronic pulmonary infection with Cryptococcus neoformans results in enhanced allergic inflammation and airway hyperreactivity in a rat model.", {"entities": []}], ["Because the cell wall of C. neoformans consists of chitin, and since acidic mammalian chitinase (AMCase) has recently been implicated as a novel mediator of asthma, we sought to determine whether such infection induces chitinase activity and expression of AMCase in the rat.", {"entities": [[157, 163, "DISEASE"]]}], ["We utilized a previously-established model of chronic C. neoformans pulmonary infection in the rat to analyze the activity, expression and localization of AMCase.", {"entities": []}], ["Our studies indicate that intratracheal inoculation of C. neoformans induces chitinase activity within the lung and bronchoalveolar lavage fluid of infected rats.", {"entities": []}], ["Chitinase activity is also elicited by pulmonary infection with other fungi (e.g.", {"entities": []}], ["C. albicans ), but not by the inoculation of dead organisms.", {"entities": []}], ["Enhanced chitinase activity reflects increased AMCase expression by airway epithelial cells and alveolar macrophages.", {"entities": []}], ["Systemic cryptococcosis is not associated with increased pulmonary chitinase activity or AMCase expression.", {"entities": [[9, 23, "DISEASE"]]}], ["Our findings indicate a possible link between respiratory fungal infections, including C. neoformans , and asthma through the induction of AMCase.", {"entities": [[107, 113, "DISEASE"]]}], ["The Schistosoma mansoni V enom- A llergen- L ike proteins (SmVALs) are members of the SCP/TAPS ( S perm- c oating p rotein/ T px-1/ A g5/ P R-1/ S c7) protein superfamily, which may be important in the host-pathogen interaction.", {"entities": [[147, 149, "GENE"]]}], ["Some of these molecules were suggested by us and others as potential immunomodulators and vaccine candidates, due to their functional classification, expression profile and predicted localization.", {"entities": []}], ["From a vaccine perspective, one of the concerns is the potential allergic effect of these molecules.", {"entities": []}], ["Herein, we characterized the putative secreted proteins SmVAL4 and SmVAL26 and explored the mouse model of airway inflammation to investigate their potential allergenic properties.", {"entities": []}], ["The respective recombinant proteins were obtained in the Pichia pastoris system and the purified proteins used to produce specific antibodies.", {"entities": []}], ["SmVAL4 protein was revealed to be present only in the cercarial stage, increasing from 0\u20136 h in the secretions of newly transformed schistosomulum.", {"entities": []}], ["SmVAL26 was identified only in the egg stage, mainly in the hatched eggs' fluid and also in the secretions of cultured eggs.", {"entities": []}], ["Concerning the investigation of the allergic properties of these proteins in the mouse model of airway inflammation, SmVAL4 induced a significant increase in total cells in the bronchoalveolar lavage fluid, mostly due to an increase in eosinophils and macrophages, which correlated with increases in IgG1, IgE and IL-5, characterizing a typical allergic airway inflammation response.", {"entities": []}], ["High titers of anaphylactic IgG1 were revealed by the P assive C utaneous A naphylactic (PCA) hypersensitivity assay.", {"entities": []}], ["Additionally, in a more conventional protocol of immunization for vaccine trials, rSmVAL4 still induced high levels of IgG1 and IgE.", {"entities": []}], ["Our results suggest that members of the SmVAL family do present allergic properties; however, this varies significantly and therefore should be considered in the design of a schistosomiasis vaccine.", {"entities": [[174, 189, "DISEASE"]]}], ["Additionally, the murine model of airway inflammation proved to be useful in the investigation of allergic properties of potential vaccine candidates.", {"entities": []}], ["The Schistosoma mansoni Venom Allergen Like proteins (SmVALs) have been identified in the Transcriptome and Post-Genomic studies as targets for immune interventions.", {"entities": []}], ["Two secreted members of the family were obtained as recombinant proteins in the native conformation.", {"entities": []}], ["Antibodies produced against them showed that SmVAL4 was present mostly in cercarial secretions and SmVAL26 in egg secretions and that only the native SmVAL4 contained carbohydrate moieties.", {"entities": []}], ["Due to concerns with potential allergic characteristics of this class of molecules, we have explored the mouse model of airway inflammation in order to investigate these properties in a more confined system.", {"entities": []}], ["Sensitization and challenge with rSmVAL4, but not rSmVAL26, induced extensive migration of cells to the lungs, mostly eosinophils and macrophages; moreover, immunological parameters were also characteristic of an allergic inflammatory response.", {"entities": []}], ["Our results showed that the allergic potential of this class of proteins can be variable and that the vaccine candidates should be characterized; the mouse model of airway inflammation can be useful to evaluate these properties.", {"entities": []}], ["This paper summarizes the themes and recommendations that emerge from the papers presented by the Working Group on Tropospheric Ozone.", {"entities": []}], ["In terms of current knowledge, the following are considered of particular importance: a) lack of clear evidence for a human analogue of the terminal bronchiolar and proximal acinar changes observed in the lungs of ozone-exposed animals; b) lack of evidence for a connection between the acute respiratory effects of O3 and possible chronic respiratory effects; c) need to better define the characteristics of O3-susceptible individuals; d) the lack of adequate exposure assessment tools for reconstruction of lifetime O3 exposure; and e) incomplete information on the role of other ambient environmental pollutants in the facilitation of O3 effects or as a cause of effects attributed to O3 in human populations.", {"entities": []}], ["Based on the above, several recommendations for epidemiologic research on health effects of O3 are offered.", {"entities": []}], ["a) Studies to investigate the existence of chronic health effects of O3 are essential, particularly those that include autopsied human lung tissue and biologic and physiologic response markers.", {"entities": []}], ["b) Studies are needed to link acute responses with chronic effects and should include joint epidemiologic and controlled-exposure assessments.", {"entities": []}], ["c) Studies are needed to identify susceptible subgroups.", {"entities": []}], ["Such studies should include newly emerging biologic markers of O3 exposure.", {"entities": []}], ["d) Accurate and precise tools for chronic O3 exposure assessment need to be developed for use in retrospective and prospective studies.", {"entities": []}], ["e) Collaborative studies between epidemiologists and laboratory investigators are needed to develop and evaluate markers of O3 exposure and to test O3 exposure models.", {"entities": []}], ["Protein tyrosine phosphatase 1B (PTP1B) is an established therapeutic target for type 2 diabetes mellitus (T2DM) and obesity.", {"entities": [[117, 124, "DISEASE"], [88, 105, "DISEASE"], [81, 105, "DISEASE"]]}], ["The aim of this study was to investigate the inhibitory activity of Magnolia officinalis extract (ME) on PTP1B and its anti-T2DM effects.", {"entities": []}], ["Inhibition assays and inhibition kinetics of ME were performed in vitro .", {"entities": []}], ["3T3-L1 adipocytes and C2C12 myotubes were stimulated with ME to explore its bioavailability in cell level.", {"entities": []}], ["The in vivo studies were performed on db/db mice to probe its anti-T2DM effects.", {"entities": []}], ["In the present study, ME inhibited PTP1B in a reversible competitive manner and displayed good selectivity against PTPs in vitro .", {"entities": []}], ["Furthermore, ME enhanced tyrosine phosphorylation levels of cellular proteins, especially the insulin-induced tyrosine phosphorylations of insulin receptor \u03b2 -subunit (IR \u03b2 ) and ERK1/2 in a dose-dependent manner in stimulated 3T3-L1 adipocytes and C2C12 myotubes.", {"entities": []}], ["Meanwhile, ME enhanced insulin-stimulated GLUT4 translocation.", {"entities": []}], ["More importantly, there was a significant decrease in fasting plasma glucose level of db/db diabetic mice treated orally with 0.5\u2009g/kg ME for 4 weeks.", {"entities": []}], ["These findings indicated that improvement of insulin sensitivity and hypoglycemic effects of ME may be attributed to the inhibition of PTP1B.", {"entities": []}], ["Thereby, we pioneered the inhibitory potential of ME targeted on PTP1B as anti-T2DM drug discovery.", {"entities": []}], ["Gut-homing of donor T cells is causative for the development of intestinal GvHD in recipients of allogeneic hematopoietic stem cell transplantation (HSCT).", {"entities": []}], ["Expression of the gut-specific homing receptors integrin-\u03b14\u03b27 and chemokine receptor CCR9 on T cells is imprinted in gut-associated lymphoid tissues (GALT) under the influence of the vitamin A metabolite retinoic acid.", {"entities": [[85, 89, "GENE"]]}], ["Here we addressed the role of vitamin A deficiency in HSCT-recipients for donor T cell migration in the course of experimental GvHD.", {"entities": []}], ["Vitamin A-deficient (VAD) mice were prepared by feeding them a vitamin A-depleted diet.", {"entities": []}], ["Experiments were performed in a C57BL/6 into BALB/c model of acute GvHD.", {"entities": []}], ["We found that expression of integrin-\u03b14\u03b27 and CCR9 in GALT was reduced in VAD recipients after HSCT.", {"entities": [[46, 50, "GENE"]]}], ["Competitive in vivo homing assays showed that allogeneic T cells primed in VAD mice did not home as efficiently to the intestine as T cells primed in mice fed with standard diet (STD).", {"entities": []}], ["The course of GvHD was ameliorated in VAD HSCT-recipients and, consequently, their survival was prolonged compared to recipients receiving STD.", {"entities": []}], ["However, VAD-recipients were not protected and died of clinical GvHD.", {"entities": []}], ["We found reduced numbers of donor T cells in the intestine but increased cell counts and tissue damage in other organs of VAD-recipients.", {"entities": []}], ["Furthermore, we observed high IFN-\u03b3", {"entities": []}], ["The alarmin cytokines IL-25 and IL-33 are key promoters of type 2 inflammation.", {"entities": []}], ["Basophils respond to alarmin cytokines, however the relationship of these cytokines with basophil activation and recruitment in human studies of allergic asthma has not been well characterized.", {"entities": [[145, 160, "DISEASE"], [154, 160, "DISEASE"]]}], ["This study investigated the effect of IL-25 and IL-33 on basophils in a model of allergic asthma.", {"entities": [[81, 96, "DISEASE"], [90, 96, "DISEASE"]]}], ["10 mild allergic asthmatics underwent allergen and diluent inhalation challenges.", {"entities": []}], ["Bone marrow aspirates were collected at pre-challenge and 24\u00a0h (h) post challenge.", {"entities": []}], ["Peripheral blood and sputum samples were collected at pre-challenge, 7\u00a0h, and 24\u00a0h post-challenge to measure basophil expression of IL-17RB, ST2, and intracellular IL-25.", {"entities": []}], ["Freshly isolated peripheral blood basophils from allergic donors were incubated overnight with IL-25 and IL-33, or sputum supernatant collected post-allergen to assess pro-inflammatory effects of mediators released in the airways.", {"entities": []}], ["There were increased percentage of basophils expressing IL-17RB, ST2, and intracellular IL-25 collected from bone marrow, peripheral blood, and sputum after allergen inhalation challenge.", {"entities": []}], ["In vitro stimulation with IL-25 and IL-33 increased the percentage of basophils expressing intracellular type 2 cytokines and surface activation markers, and primed eotaxin-induced migratory potential of basophils, which was mediated directly through IL-17RB and ST2, respectively.", {"entities": []}], ["Stimulation of basophils with sputum supernatants collected post-allergen challenge up-regulated the percentage of basophils expressing markers of activation and intracellular type 2 cytokines, which was reversed following blockade of the common \u03b2 chain (\u03b2c).", {"entities": []}], ["Our findings indicate that the alarmin cytokines IL-33 and IL-25 increase basophil activation and migratory potential, and may pose as a novel therapeutic targets for the treatment of allergic asthma.", {"entities": [[184, 199, "DISEASE"], [193, 199, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12931-016-0321-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The snake venom MT-III is a group IIA secreted phospholipase A 2 (sPLA 2 ) enzyme with functional and structural similarities with mammalian pro-inflammatory sPLA 2 s of the same group.", {"entities": []}], ["Previously, we demonstrated that MT-III directly activates the innate inflammatory response of macrophages, including release of inflammatory mediators and formation of lipid droplets (LDs).", {"entities": []}], ["However, the mechanisms coordinating these processes remain unclear.", {"entities": []}], ["In the present study, by using TLR2 2 , PGD 2 , PGJ 2 , IL-1\u03b2 and IL-10 and increased the number of LDs in WT macrophages.", {"entities": [[31, 35, "GENE"], [40, 43, "GENE"]]}], ["In MT-III-stimulated TLR2 2 , IL-1\u03b2 and IL-10 was abrogated, but release of PGD 2 and PGJ 2 was maintained.", {"entities": [[21, 25, "GENE"], [76, 79, "GENE"]]}], ["In addition, COX-2 protein expression seen in MT-III-stimulated WT macrophages was abolished in both TLR2 2 -induced inflammatory response in macrophages.", {"entities": [[101, 105, "GENE"]]}], ["Patients resuscitated after cardiac arrest are reportedly at high risk for infection and sepsis, especially those treated with targeted temperature management (TTM).", {"entities": []}], ["There is, however, limited evidence suggesting that early antibiotic use improves patient outcomes.", {"entities": []}], ["We examined the hypothesis that early treatment with antibiotics reduces mortality in patients with cardiac arrest receiving TTM.", {"entities": []}], ["We identified 2803 patients with cardiogenic out-of-hospital cardiac arrest (OHCA) that were treated with TTM and were admitted to 371 hospitals that contribute to the Japanese Diagnosis Procedure Combination inpatient database between July 2007 and March 2013.", {"entities": []}], ["Of these, 1272 received antibiotics within the first 2\u00a0days (antibiotics) and 1531 did not (control).", {"entities": []}], ["We generated 802 propensity score-matched pairs.", {"entities": []}], ["There was no significant difference in 30-day mortality between the groups (control vs. antibiotics; 33.0\u00a0% vs. 29.9\u00a0%; difference, 3.1\u00a0%; 95\u00a0% confidence interval [CI], \u22121.4 to 7.7\u00a0%, p \u2009=\u20090.18).", {"entities": []}], ["Analysis using the hospital antibiotics prescribing rate as an instrumental variable showed that antibiotic use was not significantly associated with a reduction in 30-day mortality (6.6\u00a0%, CI 95\u00a0%, \u22120.5 to 13.7\u00a0%, p \u2009=\u20090.28).", {"entities": []}], ["A subgroup analysis of patients who required extracorporeal membrane oxygenation (ECMO) indicated a significant difference in 30-day mortality between the 2 groups (62.9\u00a0% vs. 43.5\u00a0%; difference 19.3\u00a0%, CI 95\u00a0%, 5.9 to 32.7\u00a0%, p \u2009=\u20090.005).", {"entities": []}], ["In the instrumental variable model, the estimated reduction in 30-day mortality associated with antibiotics was 18.2\u00a0% (CI 95\u00a0%, 21.3 to 34.4\u00a0%, p \u2009=\u20090.03) in ECMO patients.", {"entities": []}], ["Although there was no significant association between the use of antibiotics and mortality after overall cardiogenic OHCA treated with TTM, antibiotics may be beneficial in patients who require ECMO.", {"entities": []}], ["Background: Cuba is a unique country, and despite limited economic development, has an excellent health system.", {"entities": []}], ["However, the prevalence of asthma symptoms in children in Havana, Cuba, is unusually high.", {"entities": [[27, 33, "DISEASE"]]}], ["Aim: As early life exposures are critical to the aetiology of asthma, we have studied environmental influences on the risk of wheezing in Cuban infants.", {"entities": [[62, 68, "DISEASE"]]}], ["Design: Cross-sectional study.", {"entities": []}], ["Methods: A random sample of 2032 children aged 12\u201315 months living in Havana was selected for inclusion in the cohort.", {"entities": []}], ["Data were collected using questionnaires administered by researchers.", {"entities": []}], ["Results: Of 2032 infants invited to participate, 1956 (96%) infants provided data.", {"entities": []}], ["The prevalence of any wheeze was 45%, severe wheeze requiring use of emergency services was 30% and recurrent wheeze on three or more occasions was 20%.", {"entities": []}], ["The largest adjusted risk factors for any wheeze were presence of eczema [odds ratio (OR) 2.09; 95% confidence interval (CI) 1.48\u20132.94], family history of asthma (OR 2.05; 95% CI 1.60\u20132.62), poor ventilation in the house (OR 1.99; 95% CI 1.48\u20132.67), attendance at nursery (OR 1.78; 95% CI 1.24\u20132.57), male sex (OR1.52; 95% CI 1.19\u20131.96) and the number of smokers in the house ( P < 0.03 for trend), OR 1.64 (95% CI 1.17\u20132.31) for three or more smokers in the house compared to no smokers in the household.", {"entities": [[155, 161, "DISEASE"]]}], ["Conclusion: We have identified several risk factors for any wheeze in young infants living in modern day Cuba.", {"entities": []}], ["As the prevalence of smoking in the house is high (51%), intervention studies are required to determine effective strategies to improve infant health.", {"entities": []}], ["The liver-X-receptors have shown anti-inflammatory ability in several animal models of respiratory disease.", {"entities": []}], ["Our purpose is to investigate the effect of LXR ligand in allergen-induced airway remodeling in mice.", {"entities": []}], ["Ovalbumin-sensitized mice were chronically challenged with aerosolized ovalbumin for 8 weeks.", {"entities": []}], ["Some mice were administered a LXR agonist, T0901317 (12.5, 25, 50 mg/kg bodyweight) before challenge.", {"entities": []}], ["Then mice were evaluated for airway inflammation, airway hyperresponsiveness and airway remodeling.", {"entities": []}], ["T0901317 failed to attenuate the inflammatory cells and Th2 cytokines in bronchoalveolar lavage fluid.", {"entities": []}], ["But the application of T0901317 reduced the thickness of airway smooth muscle and the collagen deposition.", {"entities": []}], ["Meanwhile, T0901317 treatment evidently abolished the high level of OVA-specific IgE, TGF-\u03b21 and MMP-9 in lung.", {"entities": []}], ["So LXRs may attenuate the progressing of airway remodeling, providing a potential treatment of asthma.", {"entities": [[95, 101, "DISEASE"]]}], ["Genotyping chips for rare and low-frequent variants have recently gained popularity with the introduction of exome chips, but the utility of these chips remains unclear.", {"entities": []}], ["These chips were designed using exome sequencing data from mainly American-European individuals, enriched for a narrow set of common diseases.", {"entities": []}], ["In addition, it is well-known that the statistical power of detecting associations with rare and low-frequent variants is much lower compared to studies exclusively involving common variants.", {"entities": []}], ["We developed a simulation program adaptable to any exome chip design to empirically evaluate the power of the exome chips.", {"entities": []}], ["We implemented the main properties of the Illumina HumanExome BeadChip array.", {"entities": []}], ["The simulated data sets were used to assess the power of exome chip based studies for varying effect sizes and causal variant scenarios.", {"entities": []}], ["We applied two widely-used statistical approaches for rare and low-frequency variants, which collapse the variants into genetic regions or genes.", {"entities": []}], ["Under optimal conditions, we found that a sample size between 20,000 to 30,000 individuals were needed in order to detect modest effect sizes (0.5% < PAR > 1%) with 80% power.", {"entities": []}], ["For small effect sizes (PAR <0.5%), 60,000\u2013100,000 individuals were needed in the presence of non-causal variants.", {"entities": []}], ["In conclusion, we found that at least tens of thousands of individuals are necessary to detect modest effects under optimal conditions.", {"entities": []}], ["In addition, when using rare variant chips on cohorts or diseases they were not originally designed for, the identification of associated variants or genes will be even more challenging.", {"entities": []}], ["The aim of the study was to evaluate the microbiological and chemical contamination in settled dust at poultry farms.", {"entities": []}], ["The scope of research included evaluating the contributions of the various granulometric fractions in settled dust samples, assessing microbial contamination using culture methods, concentrations of secondary metabolites in dust and their cytotoxicity against hepatocyte chicken cells by means of MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide) tests.", {"entities": []}], ["In addition, we also evaluated the concentration of selected volatile odorous compounds (VOCs) using gas chromatographic and spectrophotometric methods and airborne dust concentration in the air with DustTrak\u2122 DRX Aerosol Monitor.", {"entities": []}], ["Studies were carried out on chicken broilers and laying hens at 13 poultry farms, with numbers of birds ranging from 8000 to 42,000.", {"entities": []}], ["The airborne total dust concentration at poultry farms averaged 1.44 mg/m 10 fraction (particulate matter with a diameter less than 10 \u03bcm).", {"entities": []}], ["Microorganism concentrations in the settled dust were: 3.2 \u00d7 10 Enterococcus spp., Escherichia coli , Salmonella spp., Aspergillus fumigatus , Paecilomyces variotii ) were also found.", {"entities": []}], ["Secondary metabolites included aurofusarin, deoxynivalenol, 15-hydroxyculmorin zearalenone, zearalenone-sulfate, infectopyron, and neochinulin A.", {"entities": []}], ["However, the dust samples showed weak cytotoxicity towards chicken hepatocyte cells, which ranged between 9.2% and 29.7%.", {"entities": []}], ["Among volatile odorous compounds ammonia, acrolein, methyloamine, acetic acid, acetoaldehyde and formaldehyde were detected in the air.", {"entities": []}], ["In conclusion, settled dust can be a carrier of microorganisms, odours and secondary metabolites in poultry farms, which can be harmful to workers\u2019 health.", {"entities": []}], ["Objectives To describe the potential benefits and harms of zanamivir.", {"entities": []}], ["Design Systematic review of clinical study reports of randomised placebo controlled trials and regulatory information Data sources Clinical study reports, trial registries, electronic databases, regulatory archives, and correspondence with manufacturers.", {"entities": []}], ["Eligibility criteria for selecting studies Randomised placebo controlled trials in adults and children who had confirmed or suspected exposure to natural influenza.", {"entities": [[154, 163, "DISEASE"]]}], ["Main outcome measures Time to first alleviation of symptoms, influenza outcomes and complications, admissions to hospital, and adverse events in the intention to treat (ITT) population.", {"entities": [[61, 70, "DISEASE"]]}], ["Results We included 28 trials in stage 1 (judgment of appropriate study design) and 26 in stage 2 (formal analysis).", {"entities": []}], ["For treatment of adults, zanamivir reduced the time to first alleviation of symptoms of influenza-like illness by 0.60 days (95% confidence interval 0.39 to 0.81, P<0.001, I Conclusions Based on a full assessment of all trials conducted, zanamivir reduces the time to symptomatic improvement in adults (but not in children) with influenza-like illness by just over half a day, although this effect might be attenuated by symptom relief medication.", {"entities": [[88, 97, "DISEASE"], [329, 338, "DISEASE"]]}], ["Zanamivir also reduces the proportion of patients with laboratory confirmed symptomatic influenza.", {"entities": [[88, 97, "DISEASE"]]}], ["We found no evidence that zanamivir reduces the risk of complications of influenza, particularly pneumonia, or the risk of hospital admission or death.", {"entities": [[73, 82, "DISEASE"], [97, 106, "DISEASE"]]}], ["Its harmful effects were minor (except for bronchospasm), perhaps because of low bioavailability.", {"entities": []}], ["When a complex dynamical system is externally disturbed, the statistical moments of signals associated to it can be affected in ways that depend on the nature and amplitude of the perturbation.", {"entities": []}], ["In systems that exhibit phase transitions, the statistical moments can be used as Early Warnings (EW) of the transition.", {"entities": []}], ["A natural question is thus to wonder what effect external disturbances have on the EWs of system.", {"entities": []}], ["In this work we study the impact of external noise added to the system on the EWs, with particular focus on understanding the importance of the amplitude and complexity of the noise.", {"entities": []}], ["We do this by analyzing the EWs of two computational models related to biology: the Kuramoto model, which is a paradigm of synchronization for biological systems, and a cellular automaton model of cardiac dynamics which has been used as a model for atrial fibrillation.", {"entities": []}], ["For each model we first characterize the EWs.", {"entities": []}], ["Then, we introduce external noise of varying intensity and nature to observe what effect this has on the EWs.", {"entities": []}], ["In both cases we find that the introduction of noise amplified the EWs, with more complex noise having a greater effect.", {"entities": []}], ["This both offers a way to improve the chance of detection of EWs in real systems and suggests that natural variability in the real world does not have a detrimental effect on EWs, but the opposite.", {"entities": []}], ["There is conflicting evidence of the effectiveness of montelukast in preschool wheeze.", {"entities": []}], ["A recent Cochrane review focused on its use in viral-induced wheeze; however, such subgroups are unlikely to exist in real life and change with time, recently highlighted in an international consensus report.", {"entities": []}], ["We have therefore sought to investigate the effectiveness of montelukast in all children with preschool wheeze (viral-induced and multiple-trigger wheeze).", {"entities": []}], ["The PubMed, Cochrane Library, Ovid Medline and Ovid EMBASE were screened for randomised controlled trials (RCTs), examining the efficacy of montelukast compared with placebo in children with the recurrent preschool wheeze.", {"entities": []}], ["The primary endpoint examined was frequency of wheezing episodes.", {"entities": []}], ["Five trials containing 3960 patients with a preschool wheezing disorder were analysed.", {"entities": []}], ["Meta-analyses of studies of intermittent montelukast showed no benefit in preventing episodes of wheeze (mean difference (MD) 0.07, 95% confidence interval (CI) \u22120.14 to 0.29; mean for montelukast 2.68 vs placebo 2.54 ( p \u00a0=\u00a00.5)), reducing unscheduled medical attendances (MD \u22120.13, 95% CI \u22120.33 to 0.07; mean for montelukast 1.62 vs placebo 1.78 ( p \u00a0=\u00a00.21)) and reducing oral corticosteroids (MD \u22120.06, 95% CI \u22120.16 to 0.02; mean for montelukast 0.35 vs placebo 0.36 ( p \u00a0=\u00a00.25)).", {"entities": []}], ["The pooled results of the continuous regimen showed no significant difference in the number of wheezing episodes between the montelukast and placebo groups (MD \u22120.40, 95% CI \u22121.00 to 0.19; mean for montelukast 2.05 vs placebo 2.37 ( p \u00a0=\u00a00.18)).", {"entities": []}], ["Conclusions : This review highlights that the currently available evidence does not support the use of montelukast in preschool children with recurrent wheeze.", {"entities": []}], ["We recommend further studies to investigate if a \u2018montelukast responder\u2019 phenotype exists, and how these can be easily identified in the clinical setting.", {"entities": []}], ["Recent studies have shown that influenza is associated with significant disease burden in many countries in the tropics, but until recently national surveillance for influenza was not conducted in most countries in Africa.", {"entities": [[31, 40, "DISEASE"], [166, 175, "DISEASE"]]}], ["In 2007, the Kenyan Ministry of Health with technical support from the CDC-Kenya established a national sentinel surveillance system for influenza.", {"entities": [[137, 146, "DISEASE"]]}], ["At 11 hospitals, for every hospitalized patient with severe acute respiratory illness (SARI), and for the first three outpatients with influenza-like illness (ILI) per day, we collected both nasopharyngeal and oropharyngeal swabs.", {"entities": [[135, 144, "DISEASE"]]}], ["Beginning in 2008, we conducted in-hospital follow-up for SARI patients to determine outcome.", {"entities": []}], ["Specimens were tested by real time RT-PCR for influenza A and B.", {"entities": [[46, 55, "DISEASE"]]}], ["Influenza A-positive specimens were subtyped for H1, H3, H5, and (beginning in May 2009) A(H1N1)pdm09.", {"entities": [[0, 9, "DISEASE"]]}], ["From July 1, 2007 through June 30, 2013, we collected specimens from 24,762 SARI and 14,013 ILI patients.", {"entities": []}], ["For SARI and ILI case-patients, the median ages were 12 months and 16 months, respectively, and 44% and 47% were female.", {"entities": []}], ["In all, 2,378 (9.6%) SARI cases and 2,041 (14.6%) ILI cases were positive for influenza viruses.", {"entities": [[78, 87, "DISEASE"]]}], ["Most influenza-associated SARI cases (58.6%) were in children <2 years old.", {"entities": [[5, 14, "DISEASE"]]}], ["Of all influenza-positive specimens, 78% were influenza A, 21% were influenza B, and 1% were influenza A/B coinfections.", {"entities": [[7, 16, "DISEASE"], [46, 55, "DISEASE"], [68, 77, "DISEASE"], [93, 102, "DISEASE"]]}], ["Influenza circulated in every month.", {"entities": [[0, 9, "DISEASE"]]}], ["In four of the six years influenza activity peaked during July\u2013November.", {"entities": [[25, 34, "DISEASE"]]}], ["Of 9,419 SARI patients, 2.7% died; the median length of hospitalization was 4 days.", {"entities": []}], ["During six years of surveillance in Kenya, influenza was associated with nearly 10 percent of hospitalized SARI cases and one-sixth of outpatient ILI cases.", {"entities": [[43, 52, "DISEASE"]]}], ["Most influenza-associated SARI and ILI cases were in children <2 years old; interventions to reduce the burden of influenza, such as vaccine, could consider young children as a priority group.", {"entities": [[5, 14, "DISEASE"], [114, 123, "DISEASE"]]}], ["This paper summarizes information about breast MRI to be provided to women and referring physicians.", {"entities": []}], ["After listing contraindications, procedure details are described, stressing the need for correct scheduling and not moving during the examination.", {"entities": []}], ["The structured report including BI-RADS\u00ae categories and further actions after a breast MRI examination are discussed.", {"entities": []}], ["Breast MRI is a very sensitive modality, significantly improving screening in high-risk women.", {"entities": []}], ["It also has a role in clinical diagnosis, problem solving, and staging, impacting on patient management.", {"entities": []}], ["However, it is not a perfect test, and occasionally breast cancers can be missed.", {"entities": []}], ["Therefore, clinical and other imaging findings (from mammography/ultrasound) should also be considered.", {"entities": []}], ["Conversely, MRI may detect lesions not visible on other imaging modalities turning out to be benign (false positives).", {"entities": []}], ["These risks should be discussed with women before a breast MRI is requested/performed.", {"entities": []}], ["Because breast MRI drawbacks depend upon the indication for the examination, basic information for the most important breast MRI indications is presented.", {"entities": []}], ["Seventeen notes and five frequently asked questions formulated for use as direct communication to women are provided.", {"entities": []}], ["The text was reviewed by Europa Donna\u2013The European Breast Cancer Coalition to ensure that it can be easily understood by women undergoing MRI.", {"entities": [[51, 64, "DISEASE"], [58, 64, "DISEASE"]]}], ["\u2022 Information on breast MRI concerns advantages/disadvantages and preparation to the examination \u2022 Claustrophobia, implantable devices, allergic predisposition, and renal function should be checked \u2022 Before menopause, scheduling on day 7\u201314 of the cycle is preferred \u2022 During the examination, it is highly important that the patient keeps still \u2022 Availability of prior examinations improves accuracy of breast MRI interpretation The online version of this article (doi:10.1007/s00330-015-3807-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease that dramatically affects patients\u2019 quality of life (QoL) and dignity of life (DoL).", {"entities": [[52, 77, "DISEASE"], [12, 29, "DISEASE"]]}], ["We aimed to study the impact of ALS on QoL and DoL and how these evolve throughout the duration of the disease.", {"entities": []}], ["First, we performed an observational, descriptive study of 43 patients with ALS recruited from the ALS unit at our center and compared them with 20 healthy age- and sex-matched controls.", {"entities": []}], ["Second, we performed a prospective cohort study, following up 23 patients with ALS over 3\u00a0months.", {"entities": []}], ["All participants completed questionnaires about their functional status, QoL, and DoL.", {"entities": []}], ["QoL and DoL were significantly worse in the ALS group than in controls (both p \u2009<\u20090.001).", {"entities": []}], ["During the three-month follow-up in the ALS cohort, statistically significant declines were observed in clinical status and QoL.", {"entities": []}], ["For clinical status, median scores on the ALS Functional Rating scale changed from 30.95 points at baseline to 27.24 points after 3\u00a0months ( p \u2009=\u20090.0003).", {"entities": []}], ["For QoL, median scores on the ALS Assessment Questionnaire changed from 124.19 points at baseline to 131.81 at 3\u00a0months ( p \u2009=\u20090.0062).", {"entities": []}], ["However, no significant differences were found between the DoL scores at baseline (48.14 points) and 3\u00a0months (45 points) ( p -value\u2009=\u20090.12).", {"entities": []}], ["ALS is a neurodegenerative disease that affects QoL and DoL alike.", {"entities": [[9, 34, "DISEASE"]]}], ["We found that clinical status and QoL both deteriorated in patients with ALS as the disease progressed, but that DoL was preserved.", {"entities": []}], ["However, our findings are limited by small sample sizes.", {"entities": []}], ["The preservation of DoL may be due to multiple factors, including the therapies provided by the ALS unit.", {"entities": []}], ["These findings suggest that alongside QoL, DoL may be an important target in the management and care of ALS patients.", {"entities": []}], ["Compelling evidence suggests that the early interaction between porcine circovirus 2 (PCV-2) and the innate immune system is the key event in the pathogenesis of Post-Weaning Multisystemic Wasting Syndrome (PMWS).", {"entities": []}], ["Furthermore, PCV2 has been detected in bone-marrow samples, potentially enabling an easy spread and reservoir for the virus.", {"entities": []}], ["To assess the gene-expression differences induced by an in-vitro PCV2b infection in different three different myeloid innate immune cell subsets generated from the same animal, we used the Agilent Porcine Gene Expression Microarray (V2).", {"entities": []}], ["Alveolar macrophages (AM\u00d8s), monocyte-derived dendritic cells (MoDCs) and bone-marrow cells (BMCs) were generated from each animal, and challenged with a UK-isolate of a PCV2 genotype b-strain at a MOI of 0.5.", {"entities": []}], ["Remarkably, analysis showed a highly distinct and cell-type dependent response to PCV2b challenge.", {"entities": []}], ["Overall, MoDCs showed the most marked response to PCV2b challenge in vitro and revealed a key role for TNF in the interaction with PCV2b, whereas only few genes were affected in BMCs and AM\u00d8s.", {"entities": [[103, 106, "GENE"]]}], ["These observations were further supported by an enrichment of genes in the downstream NF-\u03baB Signalling pathway as well as an up regulation of genes with pro-apoptotic functions post-challenge.", {"entities": []}], ["PCV2b challenge increases the expression of a large number of immune-related and pro-apoptotic genes mainly in MoDC, which possibly explain the increased inflammation, granulomatous inflammation and lymphocyte depletion seen in PMWS-affected pigs.", {"entities": []}], ["Objective: To examine cognitive outcome in children and adolescents with acute lymphoblastic leukaemia (ALL) in remission, treated with central nervous system prophylactic chemotherapy only.", {"entities": []}], ["Method: Thirty-five children and adolescents, age 8.4\u201315.3 years in long-term remission from ALL, 4.2\u201312.4 years post diagnosis, without relapse and no prediagnosis history of neurodevelopmental disorder were compared with 35 healthy controls matched for gender and age, on measures of intellectual functioning Wechsler Intelligence Scale for Children-Third Edition (WISC-III).", {"entities": []}], ["Results: All but two of the ALL survivors treated by chemotherapy only obtained WISC-III Total Intelligence Quotient (IQ) scores in the normal range (M = 95.3), but their scores were significantly below levels for their matched controls and below normative standards for WISC-III.", {"entities": []}], ["The difference between patients and controls was significant at the p < 0.001 level for the following measures: Total IQ, Verbal IQ, Verbal Comprehension Index, Freedom from Distraction Index and three verbal subtest scores.", {"entities": []}], ["Conclusion: The results indicate long-term sequelae in global cognitive functions, and indicate that verbal function, processing speed, attention and complex visual-spatial problem solving may be affected in the chemotherapy only group.", {"entities": []}], ["Despite the increasing demand for acupuncture and homoeopathy in Germany, little is known about the effects of these treatments in routine care.", {"entities": []}], ["We set up a pragmatic documentation study in general practice funded within the scope of project launched by a German health insurer.", {"entities": []}], ["Patients were followed-up for up to four years.", {"entities": []}], ["The aim of the project was to study the effects and benefits of acupuncture and/or homoeopathy, and to assess patient satisfaction within a prospective documentation of over 5000 acupuncture and over 900 homoeopathy patients.", {"entities": []}], ["As data sources, we used the documentation made available by therapists on every individual visit and a standardised quality-of-life questionnaire (MOS SF-36); these were complemented by questions concerning the patient's medical history and by questions on patient satisfaction.", {"entities": []}], ["The health insurer provided us with data on work absenteeism.", {"entities": []}], ["Descriptive analyses of the main outcomes showed benefit of treatment with middle to large-sized effects for the quality of life questionnaire SF-36 and about 1 point improvement on a rating scale of effects, given by doctors.", {"entities": []}], ["Data on the treatment and the patients' and physicians' background suggests chronically ill patients treated by fairly regular schemes.", {"entities": []}], ["Since the results showed evidence of a subjective benefit for patients from acupuncture and homoeopathy, this may account for the increase in demand for these treatments especially when patients are chronically ill and unsatisfied with the conventional treatment given previously.", {"entities": []}], ["Owing to the high and increasing morbidity and mortality, chronic obstructive pulmonary disease (COPD) has become a major public health problem worldwide.", {"entities": [[58, 95, "DISEASE"]]}], ["Although the majority of patients with COPD are in the early stages, little attention has been paid to them, in particular regarding to early intervention.", {"entities": []}], ["Tiotropium bromide can significantly relieve symptoms and reduce the incidence of acute exacerbations of COPD.", {"entities": []}], ["Therefore, we hypothesise that therapy with tiotropium bromide will benefit patients with COPD with early-stage disease.", {"entities": []}], ["A randomised, double-blinded, placebo-controlled, parallel-group, multicentre clinical trial (Tiotropium In Early COPD study, Tie-COPD study) is being conducted to evaluate the efficacy and safety of long-term intervention with tiotropium in patients with COPD with early-stage disease.", {"entities": []}], ["A total of 839 patients with COPD who satisfied the eligibility criteria were randomly assigned (1:1) to receive a once daily inhaled capsule of either tiotropium bromide (18\u2005\u03bcg) or matching placebo for 2\u2005years.", {"entities": []}], ["Measurements will include forced expiratory volume in 1\u2005s, health-related quality of life, grade degree of breathlessness related to activities, COPD exacerbations and pharmacoeconomic analysis.", {"entities": []}], ["This study was approved by the Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University.", {"entities": []}], ["Recruitment started in November 2011 and ended in October 2013, with 839 patients randomised.", {"entities": []}], ["The treatment follow-up of participants with Tie-COPD is currently ongoing and is due to finish in November 2015.", {"entities": []}], ["The authors will disseminate the findings in peer-reviewed publications, conferences and seminar presentations.", {"entities": []}], ["ClinicalTrials.gov (NCT01455129).", {"entities": []}], ["Venom allergy is significantly underestimated in China.", {"entities": []}], ["Venom-specific IgE may not provide accurate clinical reactions.", {"entities": []}], ["Our conducted retrospective analysis observes alternative diagnostic considerations in assessing confirmation and severity of honeybee venom allergy.", {"entities": []}], ["Retrospective review of honeybee venom allergy versus nonallergy patients presented with positive honeybee venom (i1) sIgE results.", {"entities": []}], ["According to clinically observed reactions caused by a honeybee sting, patients were divided into three groups.", {"entities": []}], ["Patient residence and exposure types were analyzed.", {"entities": []}], ["The sIgE/T-IgE among allergy and control groups was compared.", {"entities": []}], ["Gender ratio male:female was 32:22; median age was 39 years (31, 50).", {"entities": []}], ["48% (26/54) of patients live in urban areas, 52% (28/54) in rural areas.", {"entities": []}], ["Based on bee sting reactions, patients were divided into common localized reactions (32/54), large localized reactions (7/54), and systemic reactions (15/54).", {"entities": []}], ["In the systemic reaction group, patients presented as Type II (6/15), Type III (6/15).", {"entities": []}], ["There is significant difference ( P < 0.001) between the three groups in regards to exposure types.", {"entities": []}], ["In the systemic reaction group, 8.7% (13/15) of patients are beekeepers.", {"entities": []}], ["A significant difference ( P < 0.001) was observed between allergic and control groups based on sIgE/T-IgE results.", {"entities": []}], ["As well as significant difference observed between the systemic reaction group to the other two reaction groups in regards to sIgE/T-IgE results.", {"entities": []}], ["Six systemic reaction patients presented with large localized reactions before onset of system symptoms 1 month to 1 year of being stung.", {"entities": []}], ["Occupational exposure is the most common cause in honeybee venom allergy induced systemic reactions.", {"entities": []}], ["The use of sIgE/T-IgE results is a useful diagnostic parameter in determining honeybee venom allergy.", {"entities": []}], ["Gymnema sylvestre is an ethno-pharmacologically important medicinal plant used in many polyherbal formulations for its potential health benefits.", {"entities": []}], ["Silver nanoparticles (SNPs) were biofunctionalized using aqueous leaf extracts of G. sylvestre .", {"entities": []}], ["The anticancer properties of the bioactive compounds and the biofunctionalized SNPs were compared using the HT29 human adenoma colon cancer cell line.", {"entities": [[119, 126, "DISEASE"], [127, 139, "DISEASE"], [133, 139, "DISEASE"]]}], ["The preliminary phytochemical screening for bioactive compounds from aqueous extracts revealed the presence of alkaloids, triterpenes, flavonoids, steroids, and saponins.", {"entities": []}], ["Biofunctionalized SNPs were synthesized using silver nitrate and characterized by ultraviolet\u2013visible spectroscopy, scanning electron microscopy, energy-dispersive X-ray analysis, Fourier transform infrared spectroscopy, and X-ray diffraction for size and shape.", {"entities": []}], ["The characterized biofunctionalized G. sylvestre were tested for its in vitro anticancer activity against HT29 human colon adenocarcinoma cells.", {"entities": [[123, 137, "DISEASE"], [117, 137, "DISEASE"]]}], ["The biofunctionlized G. sylvestre SNPs showed the surface plasmon resonance band at 430 nm.", {"entities": []}], ["The scanning electron microscopy images showed the presence of spherical nanoparticles of various sizes, which were further determined using the Scherrer equation.", {"entities": []}], ["In vitro cytotoxic activity of the biofunctionalized green-synthesized SNPs (GSNPs) indicated that the sensitivity of HT29 human colon adenocarcinoma cells for cytotoxic drugs is higher than that of Vero cell line for the same cytotoxic agents and also higher than the bioactive compound of the aqueous extract.", {"entities": [[135, 149, "DISEASE"], [129, 149, "DISEASE"]]}], ["Our results show that the anticancer properties of the bioactive compounds of G. sylvestre can be enhanced through biofunctionalizing the SNPs using the bioactive compounds present in the plant extract without compromising their medicinal properties.", {"entities": []}], ["Close postdischarge follow-up could help prevent future severe respiratory disease.", {"entities": []}], ["Severe lower respiratory tract infection (LRTI) in infants caused by respiratory syncytial virus (RSV) has been associated with later pneumonia hospitalization among children.", {"entities": [[134, 143, "DISEASE"]]}], ["To determine risk for pneumonia after RSV hospitalization in infancy, we conducted a retrospective cohort analysis of 2,813 infants admitted to a hospital in Kenya and identified readmissions for pneumonia among this group during early childhood ( < 60 months of age).", {"entities": [[22, 31, "DISEASE"], [196, 205, "DISEASE"]]}], ["Incidence of readmission for pneumonia was higher for children whose first admission as infants was for LRTI and who were < 3 months of age than for children who were first admitted as infants for non-LRTI, irrespective of RSV status.", {"entities": [[29, 38, "DISEASE"]]}], ["Incidence of readmission for pneumonia with wheeze was higher for children whose first admission involved RSV compared with those who had non-RSV LRTI.", {"entities": [[29, 38, "DISEASE"]]}], ["Excess pneumonia risk persisted for 2 years after the initial hospitalization.", {"entities": [[7, 16, "DISEASE"]]}], ["Close postdischarge follow-up of infants with LRTI, with or without RSV, could help prevent severe pneumonia later in childhood.", {"entities": [[99, 108, "DISEASE"]]}], ["Influenza epidemics have a substantial impact on human health, by increasing the mortality from pneumonia and influenza, respiratory and circulatory diseases, and all causes.", {"entities": [[0, 9, "DISEASE"], [110, 119, "DISEASE"], [96, 105, "DISEASE"]]}], ["This paper provides estimates of excess mortality rates associated with influenza virus circulation for 7 causes of death and 8 age groups in Portugal during the period of 1980\u20132004.", {"entities": [[72, 81, "DISEASE"]]}], ["We compiled monthly mortality time series data by age for all-cause mortality, cerebrovascular diseases, ischemic heart diseases, diseases of the respiratory system, chronic respiratory diseases, pneumonia and influenza.", {"entities": [[210, 219, "DISEASE"], [196, 205, "DISEASE"]]}], ["We also used a control outcome, deaths from injuries.", {"entities": []}], ["Age- and cause-specific baseline mortality was modelled by the ARIMA approach; excess deaths attributable to influenza were calculated by subtracting expected deaths from observed deaths during influenza epidemic periods.", {"entities": [[109, 118, "DISEASE"], [194, 203, "DISEASE"]]}], ["Influenza was associated with a seasonal average of 24.7 all-cause excess deaths per 100,000 inhabitants, approximately 90% of which were among seniors over 65 yrs.", {"entities": [[0, 9, "DISEASE"]]}], ["Excess mortality was 3\u20136 fold higher during seasons dominated by the A(H3N2) subtype than seasons dominated by A(H1N1)/B.", {"entities": []}], ["High excess mortality impact was also seen in children under the age of four years.", {"entities": []}], ["Seasonal excess mortality rates from all the studied causes of death were highly correlated with each other (Pearson correlation range, 0.65 to 0.95, P<0.001) and with seasonal rates of influenza-like-illness (ILI) among seniors over 65 years (Pearson correlation rho>0.64, P<0.05).", {"entities": [[186, 195, "DISEASE"]]}], ["By contrast, there was no correlation with excess mortality from injuries.", {"entities": []}], ["Our excess mortality approach is specific to influenza virus activity and produces influenza-related mortality rates for Portugal that are similar to those published for other countries.", {"entities": [[45, 54, "DISEASE"], [83, 92, "DISEASE"]]}], ["Our results indicate that all-cause excess mortality is a robust indicator of influenza burden in Portugal, and could be used to monitor the impact of influenza epidemics in this country.", {"entities": [[78, 87, "DISEASE"], [151, 160, "DISEASE"]]}], ["Additional studies are warranted to confirm these findings in other settings.", {"entities": []}], ["Airway remodeling is generally quite broadly defined as any change in composition, distribution, thickness, mass or volume and/or number of structural components observed in the airway wall of patients relative to healthy individuals.", {"entities": []}], ["However, two types of airway remodeling should be distinguished more clearly: (1) physiological airway remodeling, which encompasses structural changes that occur regularly during normal lung development and growth leading to a normal mature airway wall or as an acute and transient response to injury and/or inflammation, which ultimately results in restoration of a normal airway structures; and (2) pathological airway remodeling, which comprises those structural alterations that occur as a result of either disturbed lung development or as a response to chronic injury and/or inflammation leading to persistently altered airway wall structures and function.", {"entities": []}], ["This review will address a few major aspects: (1) what are reliable quantitative approaches to assess airway remodeling?", {"entities": []}], ["(2) Are there any indications supporting the notion that airway remodeling can occur as a primary event, i.e., before any inflammatory process was initiated?", {"entities": []}], ["(3) What is known about airway remodeling being a secondary event to inflammation?", {"entities": []}], ["And (4), what can we learn from the different animal models ranging from invertebrate to primate models in the study of airway remodeling?", {"entities": []}], ["Future studies are required addressing particularly pheno-/endotype-specific aspects of airway remodeling using both endotype-specific animal models and \u201cendotyped\u201d human asthmatics.", {"entities": []}], ["Hopefully, novel in vivo imaging techniques will be further advanced to allow monitoring development, growth and inflammation of the airways already at a very early stage in life.", {"entities": []}], ["This study aimed to investigate the clinicopathological changes induced by corticosteroid therapy in immunoglobulin (Ig)G4-related tubulointerstitial nephritis (TIN).", {"entities": [[150, 159, "DISEASE"]]}], ["We studied six IgG4-related TIN patients receiving renal biopsies before and after corticosteroid therapy.", {"entities": []}], ["Their clinical data and histological findings were evaluated before and after therapy.", {"entities": []}], ["Elevated serum creatinine levels rapidly improved after corticosteroid therapy except for two patients, in whom it persisted.", {"entities": []}], ["Abnormal radiological findings improved in all patients, although focal cortical atrophy persisted in three.", {"entities": []}], ["Histologically, TIN-like dense lymphoplasmacytic infiltration, interstitial fibrosis, IgG4-positive plasma cell, CD4+CD25+ T cell, and Foxp3+ cell infiltration were characteristic before therapy.", {"entities": []}], ["After therapy, the area with cell infiltration decreased and regional fibrosis became evident in the renal interstitium.", {"entities": []}], ["The number of IgG4-positive plasma cells and Foxp3+ cells significantly diminished even in the early stage of therapy, whereas low to moderate numbers of CD4+ and CD8+ T cells still infiltrated where inflammation persisted in the later stage.", {"entities": []}], ["Our study shows that persistent renal insufficiency associated with macroscopic atrophy and microscopic fibrosis is not so rare in IgG4-related TIN.", {"entities": []}], ["Pathologically, the behavior of regulatory T cells during the clinical course is quite similar to that of IgG4-positive plasma cells, and the behavior pattern of those cells is distinctive.", {"entities": []}], ["Accurate immunosuppression is of critical importance in preventing rejection, while avoiding toxicity following lung transplantation.", {"entities": []}], ["The mainstay immunosuppressants are calcineurin inhibitors, which require regular monitoring due to interactions with other medications and diet.", {"entities": []}], ["Adherence to immunosuppression and patient knowledge is vital and can be improved through patient education.", {"entities": []}], ["Education using tablet-computers was investigated.", {"entities": []}], ["To compare tablet-PC education and conventional education in improving immunosuppression trough levels in target range 6 months after a single education.", {"entities": []}], ["Secondary parameters were ratio of immunosuppression level measurements divided by per protocol recommended measurements, time and patient satisfaction regarding education.", {"entities": []}], ["Single-centre, open labelled randomised controlled trial.", {"entities": []}], ["Patients >6 months after lung-transplantation with <50% of calcineurin inhibitor trough levels in target range.", {"entities": []}], ["Tablet-pc education versus personal, nurse-led education.", {"entities": []}], ["Calcineurin inhibitor levels in target range 6 months after education, level variability, interval adherence, knowledge and adherence was studied.", {"entities": []}], ["As outcome parameter, renal function was measured and adverse events registered.", {"entities": []}], ["Sixty-four patients were 1:1 randomised for either intervention.", {"entities": []}], ["Levels of immunosuppression 6 months after education were equal (tablet-PC 58% vs. conventional 48%, p\u200a=\u200a0.27), both groups improved in achieving a CNI trough level within target range by either education method (delta tablet-PC 29% vs. conventional 20%).", {"entities": []}], ["In all patients, level variability decreased (\u221220.4%), whereas interval adherence remained unchanged.", {"entities": []}], ["Knowledge about immunosuppression improved by 7% and compliance tests demonstrated universal improvements with no significant difference between groups.", {"entities": []}], ["Education is a simple, effective tool in improving adherence to immunosuppression.", {"entities": []}], ["Tablet-PC education was non-inferior to conventional education.", {"entities": []}], ["ClinicalTrials.gov NCT01398488 http://clinicaltrials.gov/ct2/show/NCT01398488?term=gottlieb+tablet+pc+education&rank=1 .", {"entities": []}], ["The current study was conducted to evaluate the effects of overweight, hyperglycemia symptoms, Hispanic ethnicity, and language barriers on health-related quality of life (HRQoL) among children and adolescents.", {"entities": [[71, 84, "DISEASE"]]}], ["Parents'/guardians of a population based sample of 5530 children between ages 3 and 18 were administered the parents' version of the KINDL The mean age of children was 10.6 (SD = 4.3).", {"entities": []}], ["The mean KINDL p < 0.001).", {"entities": []}], ["Overweight children had lower overall HRQoL ( p = 0.008).", {"entities": []}], ["However, the association was not significant for the four of the six subscales including the physical health domain.", {"entities": []}], ["Children with hyperglycemia symptoms and a family history of diabetes also had significantly lower overall and physical health HRQoL ( p < 0.05).", {"entities": [[14, 27, "DISEASE"]]}], ["Children diagnosed with diabetes and in lower income strata also had significantly lower overall HRQoL ( p < 0.05).", {"entities": []}], ["No significant association between the Hispanic ethnicity and HRQoL was observed.", {"entities": []}], ["However, those who reported mostly speaking Spanish exhibited significantly lower overall HRQoL ( p = 0.001).", {"entities": []}], ["Results suggest that overweight may reduce overall quality of life among children, though it does not directly influence physical functioning.", {"entities": []}], ["However, hyperglycemia symptoms may affect both overall health and physical functioning.", {"entities": [[9, 22, "DISEASE"]]}], ["Findings also suggest the need for developing programs directed at overcoming language barriers that may face Spanish-speaking children or their parents.", {"entities": []}], ["Furthermore, targeting children who have hyperglycemia symptoms with public information campaigns may be more appropriate than targeting overweight children.", {"entities": [[41, 54, "DISEASE"]]}], ["Pollen of common ragweed ( Ambrosia artemisiifolia ) is a main cause of allergic diseases in Northern America.", {"entities": []}], ["The weed has recently become spreading as a neophyte in Europe, while climate change may also affect the growth of the plant and additionally may also influence pollen allergenicity.", {"entities": []}], ["To gain better insight in the molecular mechanisms in the development of ragweed pollen and its allergenic proteins under global change scenarios, we generated SuperSAGE libraries to identify differentially expressed transcripts.", {"entities": []}], ["Ragweed plants were grown in a greenhouse under 380\u00a0ppm CO 2 and under elevated level of CO 2 (700\u00a0ppm).", {"entities": []}], ["In addition, drought experiments under both CO 2 concentrations were performed.", {"entities": []}], ["The pollen viability was not altered under elevated CO 2 , whereas drought stress decreased its viability.", {"entities": []}], ["Increased levels of individual flavonoid metabolites were found under elevated CO 2 and/or drought.", {"entities": []}], ["Total RNA was isolated from ragweed pollen, exposed to the four mentioned scenarios and four SuperSAGE libraries were constructed.", {"entities": []}], ["The library dataset included 236,942 unique sequences, showing overlapping as well as clear differently expressed sequence tags (ESTs).", {"entities": []}], ["The analysis targeted ESTs known in Ambrosia , as well as in pollen of other plants.", {"entities": []}], ["Among the identified ESTs, those encoding allergenic ragweed proteins (Amb a) increased under elevated CO 2 and drought stress.", {"entities": []}], ["In addition, ESTs encoding allergenic proteins in other plants were also identified.", {"entities": []}], ["The analysis of changes in the transcriptome of ragweed pollen upon CO 2 and drought stress using SuperSAGE indicates that under global change scenarios the pollen transcriptome was altered, and impacts the allergenic potential of ragweed pollen.", {"entities": []}], ["The Netherlands does not have a national haemoglobinopathy (HbP)-carrier screening programme aimed at facilitating informed reproductive choice.", {"entities": []}], ["HbP-carrier testing for those at risk is at best offered on the basis of anaemia.", {"entities": []}], ["Registration of ethnicity has proved controversial and may complicate the introduction of a screening programme if based on ethnicity.", {"entities": []}], ["However, other factors may also play a role.", {"entities": []}], ["To explore perceived barriers and attitudes among GPs and midwives regarding the registration of ethnicity and ethnicity-based HbP-carrier screening.", {"entities": []}], ["Six focus groups in Dutch primary care, with a total of 37 GPs ( n = 9) and midwives ( n = 28) were conducted, transcribed and content analysed using Atlas-ti.", {"entities": []}], ["Both GPs and midwives struggled with correctly identifying ethnicities at risk for HbP.", {"entities": []}], ["Ethical concerns regarding privacy seemed to originate from World War II experiences, when ethnic and religious registration facilitated deportation of Jewish citizens, coupled with the political climate at the time focus groups were held.", {"entities": []}], ["Some respondents thought the ethnicity question might undermine the relationship with their clients.", {"entities": []}], ["Software programmes prevented GPs from registering ethnicity of patients at risk.", {"entities": []}], ["Financial implications for patients were also a concern.", {"entities": []}], ["Despite this, respondents seemed positive about screening and were familiar with identifying ethnicity and used this for individual patient care.", {"entities": []}], ["Although health professionals are generally positive about screening, ethical, financial and practical issues surrounding ethnicity-based HbP-carrier screening need to be clarified before introducing such a programme.", {"entities": []}], ["Primary care professionals can be targeted through professional organizations but they need national policy support.", {"entities": []}], ["Regulatory T-cells (Tregs) play a pivotal role in maintaining peripheral tolerance.", {"entities": []}], ["Increasing Treg numbers/functions has been shown to ameliorate autoimmune diseases.", {"entities": []}], ["However, common Treg expansion approaches use T-Cell Receptor (TCR)-mediated stimulation which also causes proliferation of effector T-cells (Teff).", {"entities": []}], ["To overcome this limitation, purified patient-specific Tregs are expanded ex vivo and transfused.", {"entities": []}], ["Although promising, this approach is not suitable for routine clinical use.", {"entities": []}], ["Therefore, an alternative approach to selectively expand functional Tregs in vivo is highly desired.", {"entities": []}], ["We report a novel TCR-independent strategy for the selective proliferation of Foxp3+Tregs (without Teff proliferation), by co-culturing CD4+ T-cells with OX40\u2009L+Jagged(JAG)-1+ bone marrow-derived DCs differentiated with GM-CSF or treating them with soluble OX40\u2009L and JAG1 in the presence of exogenous IL-2.", {"entities": [[268, 272, "GENE"]]}], ["Tregs expanded using soluble OX40\u2009L and JAG1 were of suppressive phenotype and delayed the onset of diabetes in NOD mice.", {"entities": [[40, 44, "GENE"]]}], ["Ligation of OX40\u2009L and JAG1 with their cognate-receptors OX40 and Notch3, preferentially expressed on Tregs but not on Teff cells, was required for selective Treg proliferation.", {"entities": [[23, 27, "GENE"], [66, 72, "GENE"]]}], ["Soluble OX40L-JAG1-induced NF-\u03baB activation as well as IL-2-induced STAT5 activation were essential for the proliferation of Tregs with sustained Foxp3 expression.", {"entities": [[146, 151, "GENE"]]}], ["Altogether, these findings demonstrate the utility of soluble OX40\u2009L and JAG1 to induce TCR-independent Treg proliferation.", {"entities": [[73, 77, "GENE"]]}], ["Chronic pain is defined as pain lasting beyond normal tissue healing time, generally taken to be 12 weeks.", {"entities": []}], ["It contributes to disability, anxiety, depression, sleep disturbances, poor quality of life, and healthcare costs.", {"entities": []}], ["Chronic pain has a weighted mean prevalence in adults of 20%.", {"entities": []}], ["For many years, the treatment choice for chronic pain included recommendations for rest and inactivity.", {"entities": []}], ["However, exercise may have specific benefits in reducing the severity of chronic pain, as well as more general benefits associated with improved overall physical and mental health, and physical functioning.", {"entities": []}], ["Physical activity and exercise programmes are increasingly being promoted and offered in various healthcare systems, and for a variety of chronic pain conditions.", {"entities": []}], ["It is therefore important at this stage to establish the efficacy and safety of these programmes, and furthermore to address the critical factors that determine their success or failure.", {"entities": []}], ["To provide an overview of Cochrane Reviews of adults with chronic pain to determine (1) the effectiveness of different physical activity and exercise interventions in reducing pain severity and its impact on function, quality of life, and healthcare use; and (2) the evidence for any adverse effects or harm associated with physical activity and exercise interventions.", {"entities": []}], ["We searched the Cochrane Database of Systematic Reviews (CDSR) on the Cochrane Library (CDSR 2016, Issue 1) for systematic reviews of randomised controlled trials (RCTs), after which we tracked any included reviews for updates, and tracked protocols in case of full review publication until an arbitrary cut-off date of 21 March 2016 (CDSR 2016, Issue 3).", {"entities": []}], ["We assessed the methodological quality of the reviews using the AMSTAR tool, and also planned to analyse data for each painful condition based on quality of the evidence.", {"entities": []}], ["We extracted data for (1) self-reported pain severity, (2) physical function (objectively or subjectively measured), (3) psychological function, (4) quality of life, (5) adherence to the prescribed intervention, (6) healthcare use/attendance, (7) adverse events, and (8) death.", {"entities": []}], ["Due to the limited data available, we were unable to directly compare and analyse interventions, and have instead reported the evidence qualitatively.", {"entities": []}], ["We included 21 reviews with 381 included studies and 37,143 participants.", {"entities": []}], ["Of these, 264 studies (19,642 participants) examined exercise versus no exercise/minimal intervention in adults with chronic pain and were used in the qualitative analysis.", {"entities": []}], ["Pain conditions included rheumatoid arthritis, osteoarthritis, fibromyalgia, low back pain, intermittent claudication, dysmenorrhoea, mechanical neck disorder, spinal cord injury, postpolio syndrome, and patellofemoral pain.", {"entities": [[25, 45, "DISEASE"], [190, 198, "DISEASE"], [36, 45, "DISEASE"], [47, 61, "DISEASE"], [63, 75, "DISEASE"], [92, 117, "DISEASE"]]}], ["None of the reviews assessed 'chronic pain' or 'chronic widespread pain' as a general term or specific condition.", {"entities": []}], ["Interventions included aerobic, strength, flexibility, range of motion, and core or balance training programmes, as well as yoga, Pilates, and tai chi.", {"entities": []}], ["Reviews were well performed and reported (based on AMSTAR), and included studies had acceptable risk of bias (with inadequate reporting of attrition and reporting biases).", {"entities": []}], ["However the quality of evidence was low due to participant numbers (most included studies had fewer than 50 participants in total), length of intervention and follow-up (rarely assessed beyond three to six months).", {"entities": []}], ["We pooled the results from relevant reviews where appropriate, though results should be interpreted with caution due to the low quality evidence.", {"entities": []}], ["Pain severity: several reviews noted favourable results from exercise: only three reviews that reported pain severity found no statistically significant changes in usual or mean pain from any intervention.", {"entities": []}], ["However, results were inconsistent across interventions and follow-up, as exercise did not consistently bring about a change (positive or negative) in self-reported pain scores at any single point.", {"entities": []}], ["Physical function: was the most commonly reported outcome measure.", {"entities": []}], ["Physical function was significantly improved as a result of the intervention in 14 reviews, though even these statistically significant results had only small-to-moderate effect sizes (only one review reported large effect sizes).", {"entities": []}], ["Psychological function and quality of life: had variable results: results were either favourable to exercise (generally small and moderate effect size, with two reviews reporting significant, large effect sizes for quality of life), or showed no difference between groups.", {"entities": []}], ["There were no negative effects.", {"entities": []}], ["Adherence to the prescribed intervention: could not be assessed in any review.", {"entities": []}], ["However, risk of withdrawal/dropout was slightly higher in the exercising group (82.8/1000 participants versus 81/1000 participants), though the group difference was non-significant.", {"entities": []}], ["Healthcare use/attendance: was not reported in any review.", {"entities": []}], ["Adverse events, potential harm, and death: only 25% of included studies (across 18 reviews) actively reported adverse events.", {"entities": []}], ["Based on the available evidence, most adverse events were increased soreness or muscle pain, which reportedly subsided after a few weeks of the intervention.", {"entities": []}], ["Only one review reported death separately to other adverse events: the intervention was protective against death (based on the available evidence), though did not reach statistical significance.", {"entities": []}], ["The quality of the evidence examining physical activity and exercise for chronic pain is low.", {"entities": []}], ["This is largely due to small sample sizes and potentially underpowered studies.", {"entities": []}], ["A number of studies had adequately long interventions, but planned follow-up was limited to less than one year in all but six reviews.", {"entities": []}], ["There were some favourable effects in reduction in pain severity and improved physical function, though these were mostly of small-to-moderate effect, and were not consistent across the reviews.", {"entities": []}], ["There were variable effects for psychological function and quality of life.", {"entities": []}], ["The available evidence suggests physical activity and exercise is an intervention with few adverse events that may improve pain severity and physical function, and consequent quality of life.", {"entities": []}], ["However, further research is required and should focus on increasing participant numbers, including participants with a broader spectrum of pain severity, and lengthening both the intervention itself, and the follow-up period.", {"entities": []}], ["Background Chronic (long-term) pain is pain that has lasted beyond the body's usual healing time.", {"entities": []}], ["It is often described as pain that has lasted for at least three months.", {"entities": []}], ["Chronic pain causes many problems, beyond the pain itself, including fatigue, anxiety, depression, and a poor quality of life.", {"entities": []}], ["In the past, people with chronic pain were told to rest.", {"entities": []}], ["However, general advice now is to keep active - whether to affect the pain directly or to combat the other problems associated with it.", {"entities": []}], ["Therefore, research studies have attempted to examine the effect of physical activity in people with chronic pain.", {"entities": []}], ["This overview aimed to bring together and analyse any reviews published by Cochrane that looked at physical activity and exercise studies in any chronic pain condition, including arthritis, back and neck pain, and menstrual (period) pain.", {"entities": [[179, 188, "DISEASE"]]}], ["Key results and quality of the evidence In January 2016, we identified 21 Cochrane Reviews which covered 10 different diagnoses (osteoarthritis (a joint disease), rheumatoid arthritis (joint pain and swelling), fibromyalgia (widespread pain condition), low back pain, intermittent claudication (cramping pain in the legs), dysmenorrhoea (period pain), mechanical neck disorders (neck pain), spinal cord injury, postpolio syndrome (a condition occurring in people who have had polio), patellofemoral pain (pain at the front of the knee)).", {"entities": [[163, 183, "DISEASE"], [421, 429, "DISEASE"], [174, 183, "DISEASE"], [129, 143, "DISEASE"], [211, 223, "DISEASE"], [268, 293, "DISEASE"]]}], ["The physical activity or exercise programme used in the trials ranged in frequency, intensity, and type, including land- and water-based activities, those focusing on building strength, endurance, flexibility and range of motion, and muscle activation exercises.", {"entities": []}], ["The quality of the evidence was low.", {"entities": []}], ["This was mostly due to the small numbers of people with chronic pain who participated in each reviewed study.", {"entities": []}], ["Ideally, a study should have hundreds of people assigned to each group, whereas most of the studies included in the review process here had fewer than 50 people in total.", {"entities": []}], ["There was evidence that physical activity reduced the severity of pain, improved physical function, and had a variable effect on both psychological function and quality of life.", {"entities": []}], ["However, these results were not found in all studies.", {"entities": []}], ["The inconsistency could be due to the quality of the studies or because of the mix of different types of physical activity tested in the studies.", {"entities": []}], ["Additionally, participants had predominantly mild-to-moderate pain, not moderate-to-severe pain.", {"entities": []}], ["Conclusions According to the available evidence (only 25% of included studies reported on possible harm or injury from the intervention), physical activity did not cause harm.", {"entities": []}], ["Muscle soreness that sometimes occurs with starting a new exercise subsided as the participants adapted to the new activities.", {"entities": []}], ["This is important as it shows physical activity in general is acceptable and unlikely to cause harm in people with chronic pain, many of whom may have previously feared it would increase their pain further.", {"entities": []}], ["Future studies should focus on increasing participant numbers, including a wider range of severity of pain (more people with more severe pain), and lengthening both the intervention (exercise programme) itself, and the follow-up period.", {"entities": []}], ["This pain is chronic in nature, and so a long-term intervention, with longer periods of recovery or follow-up, may be more effective.", {"entities": []}], ["Current iterations of the hygiene hypothesis suggest an adaptive role for helminth parasites in shaping the proper maturation of the immune system.", {"entities": []}], ["However, aspects of this hypothesis are based on assumptions that may not fully account for realities about human helminth infections.", {"entities": []}], ["Such realities include evidence of causal associations between helminth infections and asthma or inflammatory bowel disease as well as the fact that helminth infections remain widespread in the United States, especially among populations at greatest risk for inflammatory and autoimmune diseases.", {"entities": [[97, 123, "DISEASE"], [87, 93, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory airway disease associated with various systemic comorbidities including osteoporosis.", {"entities": [[143, 155, "DISEASE"]]}], ["Osteoporosis and its related fractures are common and have significant impacts on quality of life and even respiratory function in patients with COPD.", {"entities": [[0, 12, "DISEASE"]]}], ["COPD-associated osteoporosis is however extremely undertreated.", {"entities": [[16, 28, "DISEASE"]]}], ["Recent studies have suggested that both decreased bone mineral density (BMD) and impaired bone quality contribute to bone fragility, causing fractures in COPD patients.", {"entities": []}], ["Various clinical risk factors of osteoporosis in COPD patients, including older age, emaciation, physical inactivity, and vitamin D deficiency, have also been described.", {"entities": [[33, 45, "DISEASE"]]}], ["It is critically important for pulmonologists to be aware of the high prevalence of osteoporosis in COPD patients and evaluate them for such fracture risks.", {"entities": [[84, 96, "DISEASE"]]}], ["Routine screening for osteoporosis will enable physicians to diagnose COPD patients with comorbid osteoporosis at an early stage and give them appropriate treatment to prevent fracture, which may lead to improved quality of life as well as better long-term prognosis.", {"entities": [[22, 34, "DISEASE"], [98, 110, "DISEASE"]]}], ["Acute cough is a common reason to prescribe antibiotics in primary care.", {"entities": []}], ["This study aimed to explore help-seeking and antibiotic prescribing for acute cough in Chinese primary care population.", {"entities": []}], ["This is a prospective multicentre observational study that included adults presenting with acute cough.", {"entities": []}], ["Clinicians recorded patients\u2019 presenting symptoms, examination findings and medication prescription.", {"entities": []}], ["Patients completed symptom diaries for up to 28 days by charting their symptom severity and recovery.", {"entities": []}], ["Adjusted binary logistic regression models identified factors independently associated with antibiotic prescription.", {"entities": []}], ["Primary care clinicians ( n =19) recruited 455 patients.", {"entities": []}], ["A total of 321 patients (70.5%) returned their completed symptom diaries.", {"entities": []}], ["Concern about illness severity (41.6%) and obtaining a prescription for symptomatic medications (45.9%), rather than obtaining a prescription for antibiotics, were the main reasons for consulting.", {"entities": []}], ["Antibiotics were prescribed for 6.8% (n=31) of patients, of which amoxicillin was the most common antimicrobial prescribed (61.3%), as it was associated with clinicians\u2019 perception of benefit from antibiotic treatment (odds ratio (OR): 25.9, 95% confidence interval (CI): 6.7\u2013101.1), patients\u2019 expectation for antibiotics (OR: 5.1, 95% CI: 1.7\u201311.6), anticipation (OR: 5.1, 95% CI: 1.6\u201315.0) and request for antibiotics (OR 15.7, 95% CI: 5.0\u201349.4), as well as the severity of respiratory symptoms (cough, sputum, short of breath and wheeze OR: 2.7\u20133.7, all P<0.05).", {"entities": []}], ["There was a significant difference in antibiotic prescription rates between private primary care clinicians and public primary care clinicians (17.4 vs 1.6%, P=0.00).", {"entities": []}], ["Symptomatic medication was prescribed in 98.0% of patients.", {"entities": []}], ["Mean recovery was 9 days for cough and 10 days for all symptoms, which was not significantly associated with antibiotic treatment.", {"entities": []}], ["Although overall antibiotic-prescribing rates were low, there was a higher rate of antibiotic prescribing among private primary care clinicians, which warrants further exploration and scope for education and intervention.", {"entities": []}], ["Depression is a common mental disorder associated with substantial disability.", {"entities": []}], ["It is inadequately recognised and managed, and clinicians\u2019 attitudes to this condition and its treatment may play a part in this.", {"entities": []}], ["Most research in this area has used the Depression Attitude Questionnaire (DAQ), but analyses have shown this measure to exhibit problems in psychometric properties and suitability for the health professionals and settings where depression recognition may occur.", {"entities": []}], ["We revised the DAQ using a pooled review of findings from studies using this measure, together with a Delphi study which sought the opinions of a panel of relevant experts based in the UK, USA, Australia, and European countries (n\u2009=\u200924) using 3 rounds of questioning to consider attitude dimensions, content, and item wording.", {"entities": []}], ["After item generation, revision and consensus (agreement >70%) using the Delphi panel, the revised DAQ (R-DAQ) was tested with 1193 health care providers to determine its psychometric properties.", {"entities": []}], ["Finally the test-retest reliability of the R-DAQ was examined with 38 participants.", {"entities": []}], ["The 22-item R-DAQ scale showed good internal consistency: Cronbach\u2019s alpha coefficient was 0.84; and satisfactory test-retest reliability: intraclass correlation coefficient was 0.62 (95% C.I.", {"entities": []}], ["0.37 to 0.78).", {"entities": []}], ["Exploratory factor analysis favoured a three-factor structure (professional confidence, therapeutic optimism/pessimism, and a generalist perspective), which accounted for 45.3% of the variance.", {"entities": []}], ["The R-DAQ provides a revised tool for examining clinicians\u2019 views and understanding of depression.", {"entities": []}], ["It addresses important weaknesses in the original measure whilst retaining items and dimensions that appeared valid.", {"entities": []}], ["This revised scale is likely to be useful in examining attitudes across the health professional workforce and beyond the confines of the UK, and may be valuable for the purpose of evaluating training that aims to address clinicians\u2019 attitudes to depression.", {"entities": []}], ["It incorporates key dimensions of attitudes with a modest number of items making it applicable to use in busy clinical settings.", {"entities": []}], ["The online version of this article (doi:10.1186/s12888-014-0381-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The purpose of this study was to determine the mitochondrial content, and the oxidative and nitrosative stress of the placenta in women with gestational diabetes mellitus (GDM).", {"entities": [[141, 161, "DISEASE"], [153, 170, "DISEASE"]]}], ["Full-term placentas from GDM and healthy pregnancies were collected following informed consent.", {"entities": []}], ["The lipid peroxidation (TBARS) and oxidized protein (carbonyls) levels were determined by spectrophotometry, and 3-nitrotyrosine (3-NT), subunit IV of cytochrome oxidase (COX4), adenosine 5\u2032-monophosphate (AMP)\u2013activated protein kinase (AMPK) and actin were determined by western blot, whereas ATPase activity was performed by determining the adenosine triphosphate (ATP) consumption using a High-performance liquid chromatography (HPLC) system.", {"entities": []}], ["TBARS and carbonyls levels were lower in the placentas of women with GDM compared with the normal placentas ( p \u2009<\u20090.001 and p \u2009<\u20090.05, respectively).", {"entities": []}], ["Also, 3-NT/actin and AMPK/actin ratios were higher in GDM placentas than in the normal placentas ( p \u2009=\u20090.03 and p \u2009=\u20090.012, respectively).", {"entities": []}], ["Whereas COX4/actin ratio and ATPase activity were similar between GDM placentas and those controls.", {"entities": []}], ["These data suggest that placentas with GDM are more protected against oxidative damage, but are more susceptible to nitrosative damage as compared to normal placentas.", {"entities": []}], ["Moreover, the increased expression levels of AMPK in GDM placentas suggest that AMPK might have a role in maintaining the mitochondrial biogenesis at normal levels.", {"entities": []}], ["HGRL28072011 .", {"entities": []}], ["Registered 28 July 2011.", {"entities": []}], ["Chronic neuropathic pain (CNP) is one of the most significant unmet clinical needs in modern medicine.", {"entities": [[26, 29, "GENE"]]}], ["Alongside the lack of effective treatments, there is a great deficit in the availability of objective diagnostic methods to reliably facilitate an accurate diagnosis.", {"entities": []}], ["We therefore aimed to determine the feasibility of a simple diagnostic test by analysing differentially expressed genes in the blood of patients diagnosed with CNP of the lower back and compared to healthy human controls.", {"entities": [[160, 163, "GENE"]]}], ["Refinement of microarray expression data was performed using correlation analysis with 3900 human 2-colour microarray experiments.", {"entities": []}], ["Selected genes were analysed in the dorsal horn of Sprague\u2013Dawley rats after L5 spinal nerve ligation (SNL), using qRT-PCR and ddPCR, to determine possible associations with pathophysiological mechanisms underpinning CNP and whether they represent translational biomarkers of CNP.", {"entities": [[217, 220, "GENE"], [276, 279, "GENE"], [217, 220, "GENE"], [276, 279, "GENE"]]}], ["We found that of the 15 potential biomarkers identified, tissue inhibitor of matrix metalloproteinase-1 ( TIMP1 ) gene expression was upregulated in chronic neuropathic lower back pain (CNBP) ( p \u00a0=\u00a00.0049) which positively correlated ( R \u00a0=\u00a00.68, p \u00a0=\u00a0\u22640.05) with increased plasma TIMP1 levels in this group ( p \u00a0=\u00a00.0433).", {"entities": [[106, 111, "GENE"], [282, 287, "GENE"], [186, 190, "GENE"], [106, 111, "GENE"], [282, 287, "GENE"]]}], ["Moreover, plasma TIMP1 was also significantly upregulated in CNBP than chronic inflammatory lower back pain ( p \u00a0=\u00a00.0272).", {"entities": [[17, 22, "GENE"], [61, 65, "GENE"]]}], ["In the SNL model, upregulation of the Timp1 gene was also observed ( p \u00a0=\u00a00.0058) alongside a strong trend for the upregulation of melanocortin 1 receptor ( p \u00a0=\u00a00.0847).", {"entities": [[38, 43, "GENE"]]}], ["Our data therefore highlights several genes that warrant further investigation, and of these, TIMP1 shows the greatest potential as an accessible and translational CNP biomarker.", {"entities": [[94, 99, "GENE"], [164, 167, "GENE"]]}], ["The online version of this article (doi:10.1007/s12035-017-0492-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Once considered primarily a pediatric concern, respiratory syncytial virus (RSV) infection is gaining recognition as a cause of significant morbidity and mortality in adults.", {"entities": []}], ["A better understanding of RSV epidemiology and disease in adults is needed to guide patient management and to assess the need for prophylaxis, vaccines, and treatments.", {"entities": []}], ["We conducted a retrospective cohort study of adults admitted to four hospitals in Toronto, Canada, between September 2012 and June 2013 with RSV identified by a qualitative real-time reverse-transcriptase polymerase chain reaction assay in nasopharyngeal swab or bronchoscopy specimens.", {"entities": []}], ["Main outcomes were hospital length of stay, need for intensive care unit (ICU) or mechanical ventilation, and all-cause mortality.", {"entities": []}], ["Eighty-six patients were identified as requiring hospitalization for RSV infection (56% female).", {"entities": []}], ["Median age was 74 (range 19\u2013102) years; 29 (34%) were\u2009<\u200965\u00a0years.", {"entities": []}], ["Eighty-three (97%) had underlying chronic medical conditions; 27 (31%) were immunosuppressed, and 10 (12%) known smokers.", {"entities": []}], ["The most common symptoms and signs were cough in 73 (85%), shortness of breath in 68 (79%), sputum production in 54 (63%), weakness in 43 (50%), fever in 41 (48%), and wheezing in 33 (38%).", {"entities": []}], ["Lower respiratory tract complications occurred in 45 (52%), cardiovascular complications occurred in 19 (22%), and possible co-pathogens were identified in 11 (13%).", {"entities": []}], ["Sixty-seven (78%) were treated with antibiotics and 31 (36%) with anti-influenza therapy.", {"entities": [[71, 80, "DISEASE"]]}], ["Thirteen (15%) required ICU care and 8 (9%) required mechanical ventilation.", {"entities": []}], ["Five (6%) died during hospitalization.", {"entities": []}], ["Need for ICU and mechanical ventilation were associated with mortality (P\u2009\u2264\u20090.02).", {"entities": []}], ["Median hospital length of stay was 6\u00a0days (mean 10.8\u00a0days).", {"entities": []}], ["RSV infection is associated with the need for extended hospital stay, ICU care and mortality in adults of all ages with chronic underlying conditions.", {"entities": []}], ["Presenting signs and symptoms are nonspecific, co-infections occur, and patients often receive antibiotics and anti-influenza therapy.", {"entities": [[116, 125, "DISEASE"]]}], ["There is need for ongoing research and development of RSV prophylaxis, vaccines and treatments for adults.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-014-0665-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The public health benefits expected by reducing known hazardous emissions from mobile sources should not be compromised by increasing levels of other potentially hazardous unregulated emissions.", {"entities": []}], ["Catalytic converters are going to be used to meet the statutory requirements on carbon monoxide and hydrocarbon emissions from light duty motor vehicles.", {"entities": []}], ["Platinum and palladium metals are the catalytic materials to be used in these emission control devices.", {"entities": []}], ["Preliminary experimental evidence and analysis of the impact of these control devices on the future use and demand for platinum indicates that this metal may appear at detectable levels in the environment by the end of this decade.", {"entities": []}], ["At the present time, platinum and palladium are not present in the public environment and represent potentially new environmental contaminants as a consequence of use of this new abatement control technology.", {"entities": []}], ["There is relatively little information available to adequately assess the potential health hazards that may be associated with exposure to these metals and their compounds.", {"entities": []}], ["Analysis of the environmental problems and concerns associated with possible new environmental contaminants are discussed.", {"entities": []}], ["Limited estimates are made on community exposure by use of a meteorological dispersion model.", {"entities": []}], ["Biodegradation potential and attention is also given to the limited toxicological information available.", {"entities": []}], ["Food allergy affects approximately 5% of children and is the leading cause of hospitalization for anaphylactic reactions in westernized countries.", {"entities": [[0, 12, "DISEASE"]]}], ["However, the pathways of anaphylaxis in food allergy are still relatively unknown.", {"entities": [[40, 52, "DISEASE"]]}], ["We investigated the effector pathways of allergic and anaphylactic responses of different strains of mice in a clinical relevant model of peanut allergy.", {"entities": []}], ["C3H/HeOuJ, C57BL/6 and BALB/c mice were sensitized by intragastric peanut extract and challenged by intragastric or intraperitoneal injection of peanut.", {"entities": []}], ["Peanut-specific T cell responses, IgE, IgG1 and IgG2a and mucosal mast cell degranulation were induced to different extent in C3H/HeOuJ, C57BL/6 and BALB/c mice.", {"entities": []}], ["Interestingly, anaphylactic symptoms after systemic challenge were highest in C3H/HeOuJ followed by C57BL/6 but were absent in BALB/c mice.", {"entities": []}], ["Mechanistic studies showed that the food allergic systemic anaphylaxis was dependent on platelets, FcR\u03b3 and mast cells, and partially dependent on platelet activating factor and monocytes/macrophages, depending on mouse strain.", {"entities": []}], ["These data demonstrate that in three mouse strains, components of the classic and alternative anaphylactic cascade are differently expressed, leading to differential outcomes in parameters of allergic disease and food induced systemic anaphylaxis.", {"entities": []}], ["We report that the DNA methylation profile of a child\u2019s neonatal whole blood can be significantly influenced by his or her mother\u2019s neonatal blood lead levels (BLL).", {"entities": []}], ["We recruited 35 mother-infant pairs in Detroit and measured the whole blood lead (Pb) levels and DNA methylation levels at over 450,000 loci from current blood and neonatal blood from both the mother and the child.", {"entities": []}], ["We found that mothers with high neonatal BLL correlate with altered DNA methylation at 564 loci in their children\u2019s neonatal blood.", {"entities": []}], ["Our results suggest that Pb exposure during pregnancy affects the DNA methylation status of the fetal germ cells, which leads to altered DNA methylation in grandchildren\u2019s neonatal dried blood spots.", {"entities": []}], ["This is the first demonstration that an environmental exposure in pregnant mothers can have an epigenetic effect on the DNA methylation pattern in the grandchildren.", {"entities": []}], ["Spindle cell carcinoma of the breast is a rare subtype of metaplastic carcinoma, and no effective chemotherapy special for metaplastic carcinoma exists until now.", {"entities": [[13, 22, "DISEASE"], [70, 79, "DISEASE"], [135, 144, "DISEASE"], [0, 22, "DISEASE"]]}], ["As spindle cell carcinomas of the breast are typically \u201cTriple Negative\u201d, endocrine therapy and molecular therapy targeted to Her2 might not be favorable, resulting in poor prognosis.", {"entities": []}], ["Apatinib is currently being tested in patients with breast or lung cancers.", {"entities": []}], ["Here we report a successful case using Apatinib to treat spindle cell carcinoma of breast.", {"entities": [[70, 79, "DISEASE"], [57, 79, "DISEASE"]]}], ["A 52- year- old woman presented with a gradually enlarged lump in left breast, which was revealed to be a triple-negative spindle cell carcinoma, underwent a modified radical mastectomy.", {"entities": [[135, 144, "DISEASE"], [122, 144, "DISEASE"]]}], ["After the first line chemotherapy with Cyclophosphamide and Epirubicin, multiple metastases in bilateral lung and left anterior thoracic wall appeared.", {"entities": []}], ["After disease progressed with therapy of Bevacizumab combined with Albumin-bound Paclitaxel and Cisplatin, we treated the patient with Apatinib according to her VEGFR expression, which showed nearly complete response and controllable and tolerated side effects.", {"entities": []}], ["Next-generation sequencing analysis of the tumor specimen and real time ctDNA was performed to observe the mutated gene numbers matched with therapeutic effect.", {"entities": []}], ["The present case can help to provide a new and effective therapy strategy to treat advanced spindle cell carcinoma.", {"entities": [[105, 114, "DISEASE"], [92, 114, "DISEASE"]]}], ["Protein 3-nitrotyrosine is a post-translational modification that commonly arises from the nitration of tyrosine residues.", {"entities": []}], ["This modification has been detected under a wide range of pathological conditions and has been shown to alter protein function.", {"entities": []}], ["Whether 3-nitrotyrosine is important in normal cellular processes or is likely to affect specific biological pathways remains unclear.", {"entities": []}], ["Using GPS-YNO2, a recently described 3-nitrotyrosine prediction algorithm, a set of predictions for nitrated residues in the human proteome was generated.", {"entities": []}], ["In total, 9.27 per cent of the proteome was predicted to be nitratable (27 922/301 091).", {"entities": []}], ["By matching the predictions against a set of curated and experimentally validated 3-nitrotyrosine sites in human proteins, it was found that GPS-YNO2 is able to predict 73.1 per cent (404/553) of these sites.", {"entities": []}], ["Furthermore, of these sites, 42 have been shown to be nitrated endogenously, with 85.7 per cent (36/42) of these predicted to be nitrated.", {"entities": []}], ["This demonstrates the feasibility of using the predicted dataset for a whole proteome analysis.", {"entities": []}], ["A comprehensive bioinformatics analysis was subsequently performed on predicted and all experimentally validated nitrated tyrosine.", {"entities": []}], ["This found mild but specific biophysical constraints that affect the susceptibility of tyrosine to nitration, and these may play a role in increasing the likelihood of 3-nitrotyrosine to affect processes, including phosphorylation and DNA binding.", {"entities": []}], ["Furthermore, examining the evolutionary conservation of predicted 3-nitrotyrosine showed that, relative to non-nitrated tyrosine residues, 3-nitrotyrosine residues are generally less conserved.", {"entities": []}], ["This suggests that, at least in the majority of cases, 3-nitrotyrosine is likely to have a deleterious effect on protein function and less likely to be important in normal cellular function.", {"entities": []}], ["To assess the cost effectiveness of palivizumab for prevention of severe respiratory syncytial virus (RSV) disease in high-risk infants in Spain, incorporating country-specific observational hospitalisation data.", {"entities": []}], ["An existing decision tree model, designed using data from a large international clinical trial of palivizumab versus no prophylaxis, was updated to include Spanish observational hospitalisation data.", {"entities": []}], ["The analysis was performed for preterm children born at or before 32\u00a0weeks gestational age, who are at high risk of developing severe RSV disease requiring hospitalisation.", {"entities": []}], ["Data sources included published literature, official price/tariff lists and national population statistics.", {"entities": []}], ["The primary perspective of the study was that of the Spanish National Health Service in 2006.", {"entities": []}], ["The base-case analysis included the direct medical costs associated with palivizumab prophylaxis and hospital care for RSV infections.", {"entities": []}], ["Use of palivizumab produces an undiscounted incremental cost-effectiveness ratio (ICER) of \u20ac6,142 per quality-adjusted life-year (QALY), and a discounted ICER of \u20ac12,814/QALY.", {"entities": []}], ["Palivizumab provides a cost-effective method of prophylaxis against severe RSV disease requiring hospitalisation among preterm infants in Spain.", {"entities": []}], ["The management system of occupational diseases in Korea can be assessed from the perspective of a surveillance system.", {"entities": []}], ["Workers' compensation insurance reports are used to produce official statistics on occupational diseases in Korea.", {"entities": []}], ["National working conditions surveys are used to monitor the magnitude of work-related symptoms and signs in the labor force.", {"entities": []}], ["A health examination program was introduced to detect occupational diseases through both selective and mass screening programs.", {"entities": []}], ["The Working Environment Measurement Institution assesses workers' exposure to hazards in the workplace.", {"entities": []}], ["Government regulates that the employer should do health examinations and working conditions measurement through contracted private agencies and following the Occupational Safety and Health Act.", {"entities": []}], ["It is hoped that these institutions may be able to effectively detect and monitor occupational diseases and hazards in the workplace.", {"entities": []}], ["In view of this, the occupational management system in Korea is well designed, except for the national survey system.", {"entities": []}], ["In the future, national surveys for detection of hazards and ill-health outcomes in workers should be developed.", {"entities": []}], ["The existing surveillance system for occupational disease can be improved by providing more refined information through statistical analysis of surveillance data.", {"entities": []}], ["Neutrophil influx into the airways is an important mechanism in the pathophysiology of the inflammatory process in the airways of patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[144, 181, "DISEASE"]]}], ["Previously it was shown that anticholinergic drugs reduce the release of non-neuronal paracrine mediators, which modulate inflammation in the airways.", {"entities": []}], ["On this basis, we investigated the ability of the long-acting anticholinergic tiotropium bromide to inhibit a) alveolar macrophage (AM)-mediated chemotaxis of neutrophils, and b) cellular release of reactive oxygen species (ROS).", {"entities": []}], ["AM and neutrophils were collected from 71 COPD patients.", {"entities": []}], ["Nanomolar concentrations of tiotropium bromide were tested in AM cultured up to 20 h with LPS (1 \u03bcg/ml).", {"entities": []}], ["AM supernatant was tested for TNF\u03b1, IL8, IL6, LTB4, GM-CSF, MIP\u03b1/\u03b2 and ROS.", {"entities": [[36, 39, "GENE"], [41, 44, "GENE"]]}], ["It was further used in a 96-well chemotaxis chamber to stimulate the migration of fluorescence labelled neutrophils.", {"entities": []}], ["Control stimulants consisted of acetylcholine (ACh), carbachol, muscarine or oxotremorine and in part PMA (phorbol myristate acetate, 0.1 \u03bcg/ml).", {"entities": []}], ["Potential contribution of M 1-3 -receptors was ascertained by a) analysis of mRNA transcription by RT-PCR, and b) co-incubation with selective M-receptor inhibitors.", {"entities": []}], ["Supernatant from AM stimulated with LPS induced neutrophilic migration which could be reduced by tiotropium in a dose dependent manner: 22.1 \u00b1 10.2 (3 nM), 26.5 \u00b1 18,4 (30 nM), and 37.8 \u00b1 24.0 (300 nM, p < 0.001 compared to non-LPS activated AM).", {"entities": []}], ["Concomitantly TNF\u03b1 release of stimulated AM dropped by 19.2 \u00b1 7.2% of control (p = 0.001).", {"entities": []}], ["Tiotropium bromide did not affect cellular IL8, IL6, LTB4, GM-CSF and MIP\u03b1/\u03b2 release in this setting.", {"entities": [[43, 46, "GENE"], [48, 51, "GENE"]]}], ["Tiotropium (30 nM) reduced ROS release of LPS stimulated AM by 36.1 \u00b1 15.2% (p = 0.002) and in carbachol stimulated AM by 46.2 \u00b1 30.2 (p < 0.001).", {"entities": []}], ["M3R gene expression dominated over M2R and M1R.", {"entities": []}], ["Chemotaxis inhibitory effect of tiotropium bromide was mainly driven by M3R inhibition.", {"entities": []}], ["Our data confirm that inhibiting muscarinic cholinergic receptors with tiotropium bromide reduces TNF\u03b1 mediated chemotactic properties and ROS release of human AM, and thus may contribute to lessen cellular inflammation.", {"entities": []}], ["Increasing use of electronic health records offers the potential to incorporate computer decision support systems (CDSSs) to prompt evidence-based actions within routine consultations.", {"entities": []}], ["To synthesise the evidence for the use of CDSSs by professionals managing people with asthma.", {"entities": [[86, 92, "DISEASE"]]}], ["We systematically searched Medline, Embase, Health Technology Assessment, Cochrane and Inspec databases (1990 to April 2012, no language restrictions) for trials, and four online repositories for unpublished studies.", {"entities": []}], ["We also wrote to authors.", {"entities": []}], ["Eligible studies were randomised controlled trials of CDSSs supporting professional management of asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["Studies were appraised (Cochrane Risk of Bias Tool) and findings synthesised narratively.", {"entities": []}], ["A total of 5787 articles were screened, and eight trials were found eligible, with six at high risk of bias.", {"entities": []}], ["Overall, CDSSs for professionals were ineffective.", {"entities": []}], ["Usage of the systems was generally low: in the only trial at low risk of bias the CDSS was not used at all.", {"entities": []}], ["When a CDSS was used, compliance with the advice offered was also low.", {"entities": []}], ["However, if actually used, CDSSs could result in closer guideline adherence (improve investigating, prescribing and issuing of action plans) and could improve some clinical outcomes.", {"entities": []}], ["The study at moderate risk of bias showed increased prescribing of inhaled steroids.", {"entities": []}], ["The current generation of CDSSs is unlikely to result in improvements in outcomes for patients with asthma because they are rarely used and the advice is not followed.", {"entities": [[100, 106, "DISEASE"]]}], ["Future decision support systems need to align better with professional workflows so that pertinent and timely advice is easily accessible within the consultation.", {"entities": []}], ["The role of patient engagement as an important risk factor for healthcare outcomes has not been well established.", {"entities": []}], ["The objective of this article was to systematically review the relationship between patient engagement and health outcomes in chronic disease to determine whether patient engagement should be quantified as an important risk factor in health risk appraisals to enhance the practice of personalized medicine.", {"entities": []}], ["A systematic review of prospective clinical trials conducted between January 1993 and December 2012 was performed.", {"entities": []}], ["Articles were identified through a medical librarian-conducted multi-term search of Medline, Embase, and Cochrane databases.", {"entities": []}], ["Additional studies were obtained from the references of meta-analyses and systematic reviews on hypertension, diabetes, and chronic care.", {"entities": [[96, 108, "DISEASE"]]}], ["Search terms included variations of the following: self-care, self-management, self-monitoring, (shared) decision-making, patient education, patient motivation, patient engagement, chronic disease, chronically ill, and randomized controlled trial.", {"entities": []}], ["Studies were included only if they: (1) compared patient engagement interventions to an appropriate control among adults with chronic disease aged 18\u00a0years and older; (2) had minimum 3\u00a0months between pre- and post-intervention measurements; and (3) defined patient engagement as: (a) understanding the importance of taking an active role in one\u2019s health and health care; (b) having the knowledge, skills, and confidence to manage health; and (c) using knowledge, skills and confidence to perform health-promoting behaviors.", {"entities": []}], ["Three authors and two research assistants independently extracted data using predefined fields including quality metrics.", {"entities": []}], ["We reviewed 543 abstracts to identify 10 trials that met full inclusion criteria, four of which had \u2018high\u2019 methodological quality (Jadad score\u2009\u2265\u20093).", {"entities": []}], ["Diverse measurement of patient engagement prevented robust statistical analyses, so data were qualitatively described.", {"entities": []}], ["Nine studies documented improvements in patient engagement.", {"entities": []}], ["Five studies reported reduction in clinical markers of disease (for example HbA1C).", {"entities": []}], ["All studies reported improvements in self-reported health status.", {"entities": []}], ["This review suggests patient engagement should be quantified as part of a comprehensive health risk appraisal given its apparent value in helping individuals to effectively self-manage chronic disease.", {"entities": []}], ["Patient engagement measures should include assessment of the knowledge, confidence and skills to prevent and manage chronic disease, plus the behaviors to do so.", {"entities": []}], ["The human rhinoviruses (HRV) are one of the most common and diverse respiratory pathogens of humans.", {"entities": []}], ["Over 100 distinct HRV serotypes are known, yet only 6 genomes are available.", {"entities": []}], ["Due to the paucity of HRV genome sequence, little is known about the genetic diversity within HRV or the forces driving this diversity.", {"entities": []}], ["Previous comparative genome sequence analyses indicate that recombination drives diversification in multiple genera of the picornavirus family, yet it remains unclear if this holds for HRV.", {"entities": []}], ["To resolve this and gain insight into the forces driving diversification in HRV, we generated a representative set of 34 fully sequenced HRVs.", {"entities": []}], ["Analysis of these genomes shows consistent phylogenies across the genome, conserved non-coding elements, and only limited recombination.", {"entities": []}], ["However, spikes of genetic diversity at both the nucleotide and amino acid level are detectable within every locus of the genome.", {"entities": []}], ["Despite this, the HRV genome as a whole is under purifying selective pressure, with islands of diversifying pressure in the VP1, VP2, and VP3 structural genes and two non-structural genes, the 3C protease and 3D polymerase.", {"entities": []}], ["Mapping diversifying residues in these factors onto available 3-dimensional structures revealed the diversifying capsid residues partition to the external surface of the viral particle in statistically significant proximity to antigenic sites.", {"entities": []}], ["Diversifying pressure in the pleconaril binding site is confined to a single residue known to confer drug resistance (VP1 191).", {"entities": []}], ["In contrast, diversifying pressure in the non-structural genes is less clear, mapping both nearby and beyond characterized functional domains of these factors.", {"entities": []}], ["This work provides a foundation for understanding HRV genetic diversity and insight into the underlying biology driving evolution in HRV.", {"entities": []}], ["It expands our knowledge of the genome sequence space that HRV reference serotypes occupy and how the pattern of genetic diversity across HRV genomes differs from other picornaviruses.", {"entities": []}], ["It also reveals evidence of diversifying selective pressure in both structural genes known to interact with the host immune system and in domains of unassigned function in the non-structural 3C and 3D genes, raising the possibility that diversification of undiscovered functions in these essential factors may influence HRV fitness and evolution.", {"entities": []}], ["Excess body weight is a major risk factor for cardiometabolic diseases.", {"entities": []}], ["The complex molecular mechanisms of body weight change-induced metabolic perturbations are not fully understood.", {"entities": []}], ["Specifically, in-depth molecular characterization of long-term body weight change in the general population is lacking.", {"entities": []}], ["Here, we pursued a multi-omic approach to comprehensively study metabolic consequences of body weight change during a seven-year follow-up in a large prospective study.", {"entities": []}], ["We used data from the population-based Cooperative Health Research in the Region of Augsburg (KORA) S4/F4 cohort.", {"entities": []}], ["At follow-up (F4), two-platform serum metabolomics and whole blood gene expression measurements were obtained for 1,631 and 689 participants, respectively.", {"entities": []}], ["Using weighted correlation network analysis, omics data were clustered into modules of closely connected molecules, followed by the formation of a partial correlation network from the modules.", {"entities": []}], ["Association of the omics modules with previous annual percentage weight change was then determined using linear models.", {"entities": []}], ["In addition, we performed pathway enrichment analyses, stability analyses, and assessed the relation of the omics modules with clinical traits.", {"entities": []}], ["Four metabolite and two gene expression modules were significantly and stably associated with body weight change ( P- values ranging from 1.9\u2009\u00d7\u200910 Long-term weight change in the general population globally associates with serum metabolite concentrations.", {"entities": []}], ["An integrated metabolomics and transcriptomics approach improved the understanding of molecular mechanisms underlying the association of weight gain with changes in lipid and amino acid metabolism, insulin sensitivity, mitochondrial function as well as blood cell development and function.", {"entities": []}], ["The online version of this article (doi:10.1186/s12916-015-0282-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The regulatory architecture of gene expression remains an area of active research.", {"entities": []}], ["Here, we studied how the interplay of genetic and environmental variation affects gene expression by exposing Drosophila melanogaster strains to four different developmental temperatures.", {"entities": []}], ["At 18\u00b0C we observed almost complete canalization with only very few allelic effects on gene expression.", {"entities": []}], ["In contrast, at the two temperature extremes, 13\u00b0C and 29\u00b0C a large number of allelic differences in gene expression were detected due to both cis - and trans -regulatory effects.", {"entities": []}], ["Allelic differences in gene expression were mainly dominant, but for up to 62% of the genes the dominance swapped between 13 and 29\u00b0C.", {"entities": []}], ["Our results are consistent with stabilizing selection causing buffering of allelic expression variation in non-stressful environments.", {"entities": []}], ["We propose that decanalization of gene expression in stressful environments is not only central to adaptation, but may also contribute to genetic disorders in human populations.", {"entities": []}], ["Gene expression is the most direct link between the genetically encoded information and the phenotype.", {"entities": []}], ["We analyzed the patterns of gene expression in two different D. melanogaster genotypes and their offspring at four different temperatures to determine if gene expression regulation is modulated by temperature.", {"entities": []}], ["Interestingly, we find that at the intermediate temperature (18\u00b0C) alleles from both genotypes have very similar gene expression, suggesting a strong canalization of gene expression despite substantial genetic differences.", {"entities": []}], ["More extreme temperatures break this canalization and result in many differently expressed genes, caused mainly by trans -acting factors.", {"entities": []}], ["Most of the expression differences are non-additive, with a swap in dominance between the two extreme temperatures.", {"entities": []}], ["Multiple excitatory neurotransmitters have been identified in the mammalian taste transduction, with few studies focused on inhibitory neurotransmitters.", {"entities": []}], ["Since the synthetic enzyme glutamate decarboxylase (GAD) for gamma-aminobutyric acid (GABA) is expressed in a subset of mouse taste cells, we hypothesized that other components of the GABA signaling pathway are likely expressed in this system.", {"entities": []}], ["GABA signaling is initiated by the activation of either ionotropic receptors (GABA A and GABA C ) or metabotropic receptors (GABA B ) while it is terminated by the re-uptake of GABA through transporters (GATs).", {"entities": []}], ["Using reverse transcriptase-PCR (RT-PCR) analysis, we investigated the expression of different GABA signaling molecules in the mouse taste system.", {"entities": []}], ["Taste receptor cells (TRCs) in the circumvallate papillae express multiple subunits of the GABA A and GABA B receptors as well as multiple GATs.", {"entities": []}], ["Immunocytochemical analyses examined the distribution of the GABA machinery in the circumvallate papillae.", {"entities": []}], ["Both GABA A -and GABA B - immunoreactivity were detected in the peripheral taste receptor cells.", {"entities": []}], ["We also used transgenic mice that express green fluorescent protein (GFP) in either the Type II taste cells, which can respond to bitter, sweet or umami taste stimuli, or in the Type III GAD67 expressing taste cells.", {"entities": []}], ["Thus, we were able to identify that GABAergic receptors are expressed in some Type II and Type III taste cells.", {"entities": []}], ["Mouse GAT4 labeling was concentrated in the cells surrounding the taste buds with a few positively labeled TRCs at the margins of the taste buds.", {"entities": []}], ["The presence of GABAergic receptors localized on Type II and Type III taste cells suggests that GABA is likely modulating evoked taste responses in the mouse taste bud.", {"entities": []}], ["We conducted a prospective study to examine whether in-utero exposure to magnetic fields (MFs) increases the risk of childhood obesity.", {"entities": [[127, 134, "DISEASE"]]}], ["Participating women carried a meter measuring MF levels during pregnancy and 733 of their children were followed up to 13 years to collect clinically recorded information on growth patterns with 33 weight measurements per child on average.", {"entities": []}], ["Prenatal exposure to high MF level was associated with increased risk of being obese in offspring than those with lower MF level (odds ratio = 1.69, 95% confidence interval: 1.01\u20132.84).", {"entities": []}], ["The association demonstrated a dose-response relationship and was stronger (more than 2.3 fold increased risk) among children who were followed up to the end of the study.", {"entities": []}], ["The association existed only for persistent obesity, but not for transitory (unlikely) obesity.", {"entities": [[44, 51, "DISEASE"], [87, 94, "DISEASE"]]}], ["Maternal exposure to high MF during pregnancy may be a new and previously unknown factor contributing to the world-wide epidemic of childhood obesity/overweight.", {"entities": [[142, 149, "DISEASE"]]}], ["Frictional lichenoid dermatitis.", {"entities": [[21, 31, "DISEASE"]]}], ["Frictional lichenoid dermatitis (FLE) is an entity that is probably under diagnosed and has been variably associated with either friction and/or atopy with a distinctive seasonal variation.", {"entities": [[21, 31, "DISEASE"]]}], ["To study correlation of FLE with UV index and to assess its association with atopic dermatitis.", {"entities": [[77, 94, "DISEASE"], [84, 94, "DISEASE"]]}], ["A cross sectional analysis of children with FLE was done, over a period of 6 years in two tertiary hospitals.", {"entities": []}], ["A detailed history and examination was done to assess the features of atopic dermatitis.", {"entities": [[70, 87, "DISEASE"], [77, 87, "DISEASE"]]}], ["The number of cases seen per month was compared with the mean monthly UV index.", {"entities": []}], ["Two-tailed significance tests using Pearson's coefficient of correlation and T-test were used to interpret the data.", {"entities": []}], ["( P < 0.05).", {"entities": []}], ["One hundred seventy-four patients were studied using the UKC criterion 17.2% of the patients had AD while xerosis (40.3%) was the predominant cutaneous finding.", {"entities": []}], ["The number of patients seen in summer was more than in winter ( P < 0.05) but there was no statistical difference between the cases in winter and spring.", {"entities": []}], ["There was a significant correlation of the number of cases per month with UV index ( P = 0.019).", {"entities": []}], ["Almost 42% of patients gave a history of recurrence.", {"entities": []}], ["FLE is probably not associated with atopic dermatitis and is likely to be related to the ambient UV index though a larger cohort with meticulous follow up may be needed to draw a final conclusion.", {"entities": [[36, 53, "DISEASE"], [43, 53, "DISEASE"]]}], ["The Pearson's coefficient of correlation was used for comparing the cases per month with the UV index.", {"entities": []}], ["The tests of hypothesis used included the paired T-tests.", {"entities": []}], ["F-test of variance, Welch test, Wilcoxon rank sum test and the Kolmogorov-Smirnov Test.", {"entities": []}], ["P < 0.05 was considered significant.", {"entities": []}], ["Oxidative stress is involved in neuronal cell death and mitochondrial dysfunction in neurodegenerative diseases.", {"entities": []}], ["Liriope platyphylla (LP) has been suggested to have anti-inflammation, anti-bacterial, and anti-cancer effects.", {"entities": [[96, 102, "DISEASE"]]}], ["However, whether LP exerts neuroprotective effects on neuronal cells is unknown.", {"entities": []}], ["The present study was performed to investigate the neuroprotective effects of LP extract (LPE) against hydrogen peroxide (H 2 O 2 )-induced injury in human neuroblastoma cells SH-SY5Y.", {"entities": [[156, 169, "DISEASE"]]}], ["To test neuroprotective effects of LPE, we performed cell viability assay, flow cytometry analysis and western blot analysis.", {"entities": []}], ["In addition, mitochondrial membrane potential (MMP) and oxidative stress were performed to evaluate the anti-apoptotic and anti-oxidant effects.", {"entities": []}], ["LPE pretreatment conferred significant protection against the H 2 O 2 -induced decrease of SH-SY5Y cell viability.", {"entities": []}], ["H 2 O 2 -induced increases of intracellular oxidative stress and mitochondrial dysfunction were attenuated by LPE pretreatment.", {"entities": []}], ["Therefore, LPE pretreatment prevented SH-SY5Y cell injury.", {"entities": []}], ["Treatment with H 2 O 2 significantly induced poly(ADP ribose) polymerase (PARP) and caspase-3 cleavage, which was blocked by LPE.", {"entities": []}], ["We found that p38 activation was involved in the neuroprotective effects of LPE.", {"entities": []}], ["Current findings suggest that LPE exerts neuroprotective effects against H 2 O 2 -induced apoptotic cell death by modulating p38 activation in SH-SY5Y cells.", {"entities": []}], ["Therefore, LPE has potential anti-apoptotic effects that may be neuroprotective in neurodegenerative diseases and aging-related dementia.", {"entities": [[128, 136, "DISEASE"]]}], ["The health transition theory argues that societal changes produce proportional changes in causes of disability and death.", {"entities": []}], ["The aim of this study was to identify long-term changes in main causes of hospitalization in working-age population within a nation that has experienced considerable societal change.", {"entities": []}], ["National trends in all-cause hospitalization and hospitalizations for the five main diagnostic categories were investigated in the data obtained from the Finnish Hospital Discharge Register.", {"entities": []}], ["The seven-cohort sample covered the period from 1976 to 2010 and consisted of 3,769,356 randomly selected Finnish residents, each cohort representing 25% sample of population aged 18 to 64 years.", {"entities": []}], ["Over the period of 35 years, the risk of hospitalization for cardiovascular diseases and respiratory diseases decreased.", {"entities": []}], ["Hospitalization for musculoskeletal diseases increased whereas mental and behavioral hospitalizations slightly decreased.", {"entities": []}], ["The risk of cancer hospitalization decreased marginally in men, whereas in women an upward trend was observed.", {"entities": [[12, 18, "DISEASE"]]}], ["A considerable health transition related to hospitalizations and a shift in the utilization of health care services of working-age men and women took place in Finland between 1976 and 2010.", {"entities": []}], ["Recently, mast cells have been recognized to express several Toll-like receptors (TLRs) on their membrane surfaces, and granulocyte-macrophage colony-stimulating factor (GM-CSF) was reported to be able to alter expression of TLRs and cytokine production in neutrophils.", {"entities": []}], ["However, whether GM-CSF modulates the expression of TLR and cytokine production in mast cells is not clear.", {"entities": []}], ["Using flow cytometry and real time PCR techniques, we found that GM-CSF upregulated expression of TLR3 and TLR7 in P815 cells in a concentration dependent manner.", {"entities": [[98, 102, "GENE"], [107, 111, "GENE"]]}], ["GM-CSF also provoked approximately up to 2.4 and 2.3 fold increase in IL-13 and IL-6 release from P815 cells, respectively following 16 h incubation.", {"entities": []}], ["GM-CSF induced IL-13 secretion, TLR3 and TLR7 expression appeared to be through activation of mitogen-activated protein kinase (MAPK) and phosphotidylinositol 3-kinase (PI3K)/Akt signaling pathways, whereas GM-CSF elicited IL-6 release seemed via Akt signaling pathway.", {"entities": [[32, 36, "GENE"], [41, 45, "GENE"]]}], ["At 10 ng/ml, GM-CSF significantly enhanced R-848-induced IL-6 release from P815 cells.", {"entities": []}], ["The ability of GM-CSF in modulation of expression of TLR3 and TLR7 in P815 mast cells and in stimulation of IL-13 and IL-6 release from P815 mast cells in vitro suggests that GM-CSF might play an important role in enhancing the innate immune responses of mast cell to viral infection", {"entities": [[53, 57, "GENE"], [62, 66, "GENE"]]}], ["Can spontaneous premature ovarian failure (POF) patients derived from population-based biobanks reveal the association between copy number variations (CNVs) and POF?", {"entities": [[16, 41, "DISEASE"]]}], ["CNVs can hamper the functional capacity of ovaries by disrupting key genes and pathways essential for proper ovarian function.", {"entities": []}], ["POF is defined as the cessation of ovarian function before the age of 40 years.", {"entities": []}], ["POF is a major reason for female infertility, although its cause remains largely unknown.", {"entities": [[33, 44, "DISEASE"]]}], ["The current retrospective CNV study included 301 spontaneous POF patients and 3188 control individuals registered between 2003 and 2014 at Estonian Genome Center at the University of Tartu (EGCUT) biobank.", {"entities": []}], ["DNA samples from 301 spontaneous POF patients were genotyped by Illumina HumanCoreExome (258 samples) and HumanOmniExpress (43 samples) BeadChip arrays.", {"entities": []}], ["Genotype and phenotype information was drawn from the EGCUT for the 3188 control population samples, previously genotyped with HumanCNV370 and HumanOmniExpress BeadChip arrays.", {"entities": []}], ["All identified CNVs were subjected to functional enrichment studies for highlighting the POF pathogenesis.", {"entities": []}], ["Real-time quantitative PCR was used to validate a subset of CNVs.", {"entities": []}], ["Whole-exome sequencing was performed on six patients carrying hemizygous deletions that encompass genes essential for meiosis or folliculogenesis.", {"entities": []}], ["Eleven novel microdeletions and microduplications that encompass genes relevant to POF were identified.", {"entities": []}], ["For example, FMN2 (1q43) and SGOL2 (2q33.1) are essential for meiotic progression, while TBP (6q27), SCARB1 (12q24.31), BNC1 (15q25) and ARFGAP3 (22q13.2) are involved in follicular growth and oocyte maturation.", {"entities": [[13, 17, "GENE"], [29, 34, "GENE"], [89, 92, "GENE"], [101, 107, "GENE"], [120, 124, "GENE"], [137, 144, "GENE"]]}], ["The importance of recently discovered hemizygous microdeletions of meiotic genes SYCE1 (10q26.3) and CPEB1 (15q25.2) in POF patients was also corroborated.", {"entities": [[81, 86, "GENE"], [101, 106, "GENE"]]}], ["This is a descriptive analysis and no functional studies were performed.", {"entities": []}], ["Anamnestic data obtained from population-based biobank lacked clinical, biological (hormone levels) or ultrasonographical data, and spontaneous POF was predicted retrospectively by excluding known extraovarian causes for premature menopause.", {"entities": [[221, 240, "DISEASE"]]}], ["The present study, with high number of spontaneous POF cases, provides novel data on associations between the genomic aberrations and premature menopause of ovarian cause and demonstrates that population-based biobanks are powerful source of biological samples and clinical data to reveal novel genetic lesions associated with human reproductive health and disease, including POF.", {"entities": [[134, 153, "DISEASE"]]}], ["This study was supported by the Estonian Ministry of Education and Research (IUT20-43, IUT20-60, IUT34-16, SF0180027s10 and 9205), Enterprise Estonia (EU30020 and EU48695), Eureka's EUROSTARS programme (NOTED, EU41564), grants from European Union's FP7 Marie Curie Industry-Academia Partnerships and Pathways (IAPP, SARM, |EU324509) and Horizon 2020 innovation programme (WIDENLIFE, 692065), Academy of Finland and the Sigrid Juselius Foundation.", {"entities": [[310, 314, "GENE"]]}], ["Wristbands are increasingly used for assessing personal chemical exposures.", {"entities": []}], ["Unlike some exposure assessment tools, guidelines for wristbands, such as preparation, applicable chemicals, and transport and storage logistics, are lacking.", {"entities": []}], ["We tested the wristband\u2019s capacity to capture and retain 148 chemicals including polychlorinated biphenyls (PCBs), pesticides, flame retardants, polycyclic aromatic hydrocarbons (PAHs), and volatile organic chemicals (VOCs).", {"entities": []}], ["The chemicals span a wide range of physical\u2013chemical properties, with log octanol\u2013air partitioning coefficients from 2.1 to 13.7.", {"entities": []}], ["All chemicals were quantitatively and precisely recovered from initial exposures, averaging 102% recovery with relative SD \u226421%.", {"entities": []}], ["In simulated transport conditions at +30\u2009\u00b0C, SVOCs were stable up to 1 month (average: 104%) and VOC levels were unchanged (average: 99%) for 7 days.", {"entities": []}], ["During long-term storage at \u221220\u2009\u00b0C up to 3 (VOCs) or 6 months (SVOCs), all chemical levels were stable from chemical degradation or diffusional losses, averaging 110%.", {"entities": []}], ["Applying a paired wristband/active sampler study with human participants, the first estimates of wristband\u2013air partitioning coefficients for PAHs are presented to aid in environmental air concentration estimates.", {"entities": []}], ["Extrapolation of these stability results to other chemicals within the same physical\u2013chemical parameters is expected to yield similar results.", {"entities": []}], ["As we better define wristband characteristics, wristbands can be better integrated in exposure science and epidemiological studies.", {"entities": []}], ["Poor sleep quality has been associated with increased risk of heart disease, diabetes and mortality.", {"entities": [[62, 75, "DISEASE"]]}], ["However, limited information exists on the distribution and determinants of sleep quality and its associations with cardio-metabolic risk factors in Chinese populations.", {"entities": []}], ["We aimed to evaluate this in the current study.", {"entities": []}], ["A cross-sectional survey conducted in 2005 of 1,458 men and 1,831 women aged 50\u201370 years from urban and rural areas of Beijing and Shanghai.", {"entities": []}], ["Using a questionnaire, sleep quality was measured in levels of well, common and poor.", {"entities": []}], ["Comprehensive measures of socio-demographical and health factors and biomarkers of cardio-metabolic disease were recorded.", {"entities": []}], ["These were evaluated in association with sleep quality using logistic regression models.", {"entities": []}], ["Half of the population reported good sleep quality.", {"entities": []}], ["After adjusting for potential confounders, women and Beijing residents had almost half the probability to report good sleep quality.", {"entities": []}], ["Good physical and mental health (good levels of self-rated health (OR 2.48; 95%CI 2.08 to 2.96) and no depression (OR 4.05; 95%CI 3.12 to 5.26)) related to an increased chance of reporting good sleep quality, whereas short sleep duration (<7 hrs OR 0.10; 95%CI 0.07 to 0.14)) decreased it substantially.", {"entities": []}], ["There were significant associations between levels of sleep quality and concentrations of plasma insulin, total and LDL cholesterol, and index of insulin resistance.", {"entities": []}], ["Levels of good sleep quality in middle-age and elderly Chinese were low.", {"entities": []}], ["Gender, geographical location, self-rated health, depression and sleep quantity were major factors associated with sleep quality.", {"entities": []}], ["Prospective studies are required to distil the factors that determine sleep quality and the effects that sleep patterns exert on cardio-metabolic health.", {"entities": []}], ["It is unknown whether a novel small-quantity lipid-based nutrient supplement (SQ-LNS) containing alpha-linolenic (ALA) and linoleic acids impacts maternal plasma lipids and fatty acid status.", {"entities": []}], ["We measured plasma fatty acids (wt%) and lipid concentrations at 36 wk gestation and breast milk fatty acids (wt%) at 6 months postpartum in a subsample of women enrolled in a randomized controlled trial studying the effects of SQ-LNS on birth outcomes and child growth.", {"entities": []}], ["Women\u226420 wk gestation in Ghana (n=1,320) and Malawi (n=1,391) were assigned to receive daily either: 1) iron-folic acid (pregnancy); 2) multiple micronutrients (pregnancy and lactation); or 3) SQ-LNS (pregnancy and lactation).", {"entities": []}], ["At 36 wk, plasma ALA levels were higher in those receiving SQ-LNS.", {"entities": []}], ["SQ-LNS increased breast milk ALA in Ghana but not Malawi.", {"entities": []}], ["There was no effect on plasma lipids or other selected fatty acids.", {"entities": []}], ["SQ-LNS may impact plasma and breast milk ALA levels depending on the population.", {"entities": []}], ["In streptozotocin-injected rats (STZ-rats), we previously demonstrated a role for angiotensin II (AT-II) in cardiac remodelling and insulin resistance partially counteracted by in vivo treatment with losartan, an AT-II receptor antagonist.", {"entities": []}], ["We now aimed to investigate the effect of treating diabetic STZ-rats with losartan on diabetes vascular response to vasoconstrictors.", {"entities": []}], ["Male Wistar rats were randomly divided in four groups, two of them were assigned to receive losartan in the drinking water (20 mg/kg/day) until the experiment ending (3 weeks afterward).", {"entities": []}], ["After 1 week, two groups, one of which receiving losartan, were injected in the tail vein with citrate buffer (normoglycemic, N and normoglycemic, losartan-treated, NL).", {"entities": []}], ["The remaining received a single injection of streptozotocin (50 mg/kg in citrate i.v.)", {"entities": []}], ["thus becoming diabetic (D) and diabetic losartan-treated (DL).", {"entities": []}], ["Plasma glycaemia and blood pressure were measured in all animals before the sacrifice (15 days after diabetes induction).", {"entities": []}], ["In aortic strips isolated from N, NL, D and DL rats we evaluated i) the isometric concentration-dependent contractile response to phenylephrine (Phe) and to AT-II; ii) the RhoA-kinase (ROCK1) activity and expression by enzyme-immunoassay and Western blot respectively.", {"entities": [[185, 190, "GENE"]]}], ["The concentration-dependent contractile effect of Phe was similar in aortas from all groups, whereas at all concentrations tested, AT-II contraction efficacy was 2 and half and 1 and half times higher in D and DL respectively in comparison with N and NL.", {"entities": []}], ["AT-II contracture was similarly reduced in all groups by AT-II receptor antagonists, irbesartan or irbesartan plus PD123319.", {"entities": []}], ["HA-1077 (10 \u03bcM), an inhibitor of ROCK1 activity, reduced AT-II efficacy (\u0394mg/mg tissue w.w.) by -3.5 \u00b1 1.0, -4.6 \u00b1 1.9, -22.1 \u00b1 2.2 and -11.4 \u00b1 1.3 in N, NL, D and DL respectively).", {"entities": [[33, 38, "GENE"]]}], ["ROCK1 activity and expression were higher in D than in N/NL and DL aortas.", {"entities": [[0, 5, "GENE"]]}], ["Aortas isolated from STZ-rats present hyper-contracture to AT-II mainly dependent on the up-regulation of ROCK1 expression/activity.", {"entities": [[106, 111, "GENE"]]}], ["In vivo losartan treatment partially corrects AT-II hyper-contracture, limiting the increase in ROCK1 expression/activity.", {"entities": [[96, 101, "GENE"]]}], ["These data offer a new molecular mechanism supporting the rationale for using losartan in the prevention of diabetic vascular complications.", {"entities": []}], ["Adolescence is a period of transition to adulthood.", {"entities": []}], ["Little is known about oral mucosal lesions (OMLs) in teenagers, in which the emergence of new habits, unfamiliar to children, could affect the type of lesions.", {"entities": []}], ["The aim of this study was to evaluate the distribution of oral mucosal lesions (OMLs) in a wide sample of adolescents.", {"entities": []}], ["A retrospective cross-sectional study was carried out examining all medical records of adolescents (aged 13\u201318\u00a0years) treated at the Dental Clinic of the University of Brescia (Italy) in the period from 2008 to 2014.", {"entities": []}], ["Cases with OMLs were selected.", {"entities": []}], ["Data regarding age, gender, type of OML, bad habits, systemic chronic diseases were collected.", {"entities": []}], ["A total of 6.374 medical records (mean age 15.2\u00a0+\u00a0\u22121.7\u00a0years) were examined.", {"entities": []}], ["We found 1544 cases (31.7%) of oral mucosal lesions; 36 different types of mucosal alterations were detected and the most frequent were: aphthous ulcers (18%), traumatic ulcerations (14.3%), herpes simplex virus (11%), geographic tongue (9.6%), candidiasis (5.5%), and morsicatio buccarum (4.7%).", {"entities": [[191, 205, "DISEASE"], [245, 256, "DISEASE"]]}], ["Papilloma virus lesions (1.7%), piercing-related lesions (4%), multiform erythema (0.13%), oral lichen planus (0.13%) and granular cell tumour (0.06%) were also diagnosed.", {"entities": [[96, 109, "DISEASE"]]}], ["The prevalence of OMLs in adolescents are different from those in children and, in some conditions, it could increase with age.", {"entities": []}], ["Mice exposed for 20 min daily to aerosolized ovalbumin (OVA) for 10 d at concentrations from 1 to 0.01% OVA made greatly reduced immunoglobulin (Ig)-E responses to subsequent immunogenic OVA challenges, given either intraperitoneally or by aerosol.", {"entities": []}], ["This IgE-specific unresponsiveness lasted for at least four months.", {"entities": []}], ["However, these aerosol-treated mice were primed for larger OVA-specific IgG1 and IgG2a responses.", {"entities": []}], ["The specific reduction in IgE responses was not due to preferential induction of a T helper (Th)-1 response as aerosol OVA\u2013 primed mice made greatly reduced Th2 and no detectable Th1 response after rechallenge in vitro.", {"entities": []}], ["Consistent with this, the increase in circulating eosinophils observed in control Th2-primed mice was absent in aerosol OVA\u2013treated animals.", {"entities": []}], ["Interferon (IFN)-\u03b3 was not required for this unresponsiveness, as IFN-\u03b3 knockout mice and anti\u2013IFN-\u03b3 antibody-treated wild-type mice had greatly reduced levels of IgE similar to wild-type controls.", {"entities": []}], ["CD8 2 microglobulin-deficient, or in anti-CD8\u2013treated wild-type mice as in normal mice after aerosol OVA treatment.", {"entities": []}], ["Similarly, T cell receptor (TCR)-\u03b3/\u03b4 T cells were not required for maximal inhibition of the IgE response.", {"entities": []}], ["These results demonstrate that exposure to inhaled protein antigens can induce a state of unresponsiveness of CD4", {"entities": [[110, 113, "GENE"]]}], ["The objective of this study was to test the primary hypothesis that parent proxy-report of pediatric health-related quality of life (HRQL) would prospectively predict pediatric healthcare costs over a two-year period.", {"entities": []}], ["The exploratory hypothesis tested anticipated that a relatively small group of children would account for a disproportionately large percent of healthcare costs.", {"entities": []}], ["317 children (157 girls) ages 2 to 18 years, members of a managed care health plan with prospective payment participated in a two-year prospective longitudinal study.", {"entities": []}], ["At Time 1, parents reported child HRQL using the Pediatric Quality of Life Inventory\u2122 (PedsQL\u2122 4.0) Generic Core Scales, and chronic health condition status.", {"entities": []}], ["Costs, based on health plan utilization claims and encounters, were derived for 6, 12, and 24 months.", {"entities": []}], ["In multiple linear regression equations, Time 1 parent proxy-reported HRQL prospectively accounted for significant variance in healthcare costs at 6, 12, and 24 months.", {"entities": []}], ["Adjusted regression models that included both HRQL scores and chronic health condition status accounted for 10.1%, 14.4%, and 21.2% of the variance in healthcare costs at 6, 12, and 24 months.", {"entities": []}], ["Parent proxy-reported HRQL and chronic health condition status together defined a 'high risk' group, constituting 8.7% of the sample and accounting for 37.4%, 59.2%, and 62% of healthcare costs at 6, 12, and 24 months.", {"entities": []}], ["The high risk group's per member per month healthcare costs were, on average, 12 times that of other enrollees' at 24 months.", {"entities": []}], ["While these findings should be further tested in a larger sample, our data suggest that parent proxy-reported HRQL can be used to prospectively predict healthcare costs.", {"entities": []}], ["When combined with chronic health condition status, parent proxy-reported HRQL can identify an at risk group of children as candidates for proactive care coordination.", {"entities": []}], ["Natural killer (NK) cells are critical in immune defense against infected, stressed or transformed cells.", {"entities": []}], ["Their function is regulated by the heterogeneous expression of a wide array of surface receptors that shape its phenotypic diversity.", {"entities": []}], ["Although NK cells develop in the bone marrow and secondary lymphoid tissues, substantive differentiation is apparent in the peripheral blood including known age-related variation.", {"entities": []}], ["In order to gain greater insight into phenotypic and functional variation within peripheral blood NK cells across age groups, we used multi-parametric, polyfunctional flow cytometry to interrogate the NK cell variability in 20 healthy adults and 15 5\u201310, 11\u201315 and 16\u201320 year-old children.", {"entities": []}], ["We found that the normative ranges in both adults and children displayed great inter-individual variation for most markers.", {"entities": []}], ["While the expression of several receptors did not differ, among those that did, the majority of the differences existed between adults and the three pediatric groups, rather than among children of different ages.", {"entities": []}], ["Interestingly, we also identified variation in the individual expression of some markers by sex and ethnicity.", {"entities": []}], ["Combinatorial analysis of NK cell receptors revealed intermediate subsets between the CD56", {"entities": []}], ["Based on attribution theory, this study hypthesized that past spousal supportiveness may act as a moderator of the link between one partner\u2019s current support behavior and the other partner\u2019s relationship satisfaction.", {"entities": []}], ["A sample of 88 patients with colorectal cancer and their partners completed questionnaires approximately 3 and 9\u00a0months after diagnosis.", {"entities": [[29, 46, "DISEASE"], [40, 46, "DISEASE"]]}], ["The data were analyzed employing dyadic data analytic approaches.", {"entities": []}], ["In the short-term, spousal active engagement\u2014which involved discussing feelings and engaging in joint problem solving\u2014was positively associated with relationship satisfaction in patients as well as in partners, but only when past spousal support was relatively low.", {"entities": []}], ["Spousal protective buffering\u2014which involved hiding worries and fears and avoiding talking about the disease\u2014was negatively associated with relationship satisfaction in patients, again only when past spousal support was relatively low.", {"entities": []}], ["If past spousal support was high, participants rated the quality of their relationship relatively high, regardless of their partner\u2019s current support behavior.", {"entities": []}], ["Over time, past spousal supportiveness was not found to mitigate the negative association between spousal protective buffering and relationship satisfaction.", {"entities": []}], ["Overall, our results indicate that relationship satisfaction can be maintained if past spousal supportiveness is high even if the partner is currently not very responsive to the individual\u2019s needs, at least in the short-term.", {"entities": []}], ["Previous studies have found associations between various health factors and behaviors and mental disorders.", {"entities": []}], ["However, knowledge of such associations with disability pension (DP) due to mental diagnoses is scarce.", {"entities": []}], ["Moreover, the influence of familial factors (genetics and family background) on the associations are mainly unknown.", {"entities": []}], ["The aim of the study was to investigate associations between health factors and behaviors and future DP due to mental diagnoses in a twin cohort, accounting for familial confounding.", {"entities": []}], ["A prospective cohort study of Swedish twins (N=28 613), including survey data and national register data on DP and other background factors was conducted.", {"entities": []}], ["Cox proportional hazards regression models were used to calculate hazard ratios (HR) with 95% confidence intervals (CI) for the whole twin cohort, and for discordant twin pairs.", {"entities": [[81, 83, "GENE"]]}], ["During follow-up 1998\u20132008 (median 10\u00a0years), 2.2% of the cohort was granted a DP with a mental diagnosis.", {"entities": []}], ["In the fully adjusted analyses of the whole cohort, the associations of poor or moderate self-rated health (SRH), under- or overweight, former or current tobacco use, or being an abstainer from alcohol were significantly associated with risk of DP due to mental diagnoses.", {"entities": []}], ["Analyses of discordant twin pairs confirmed all these associations, except for current tobacco use, being independent from familial confounding.", {"entities": []}], ["Exclusion of individuals with current or previous depression or anxiety at baseline did not influence the associations found.", {"entities": []}], ["Poor or moderate SRH, under- or overweight, former tobacco use or being an abstainer from alcohol seem to be strong direct predictors of DP due to mental diagnoses, independently of several confounders of this study, including familial factors.", {"entities": []}], ["Chronic pelvic pain is a common condition with a major impact on health-related quality of life, work productivity and health care utilisation.", {"entities": []}], ["The cause of the pain is not always obvious as no pathology is seen in 40\u201360% of the cases.", {"entities": []}], ["In the absence of pathology there is no established treatment.", {"entities": []}], ["The Lee-Frankenhauser sensory nerve plexuses and parasympathetic ganglia in the uterosacral ligaments carry pain from the uterus, cervix and other pelvic structures.", {"entities": []}], ["Interruption of these nerve trunks by laparoscopic uterosacral nerve ablation (LUNA) may alleviate pain.", {"entities": []}], ["However, the balance of benefits and risks of this intervention have not been reliably assessed.", {"entities": []}], ["LUNA has, nevertheless, been introduced into practice, although there remains controversy regarding indications for LUNA.", {"entities": []}], ["Hence, there is an urgent need for a randomised controlled trial to confirm, or refute, any worthwhile effectiveness.", {"entities": []}], ["The principal hypothesis is that, in women with chronic pelvic pain in whom diagnostic laparoscopy reveals either no pathology or mild endometriosis (AFS score \u2264 5) LUNA alleviates pain and improves life quality at 12 months.", {"entities": [[135, 148, "DISEASE"]]}], ["The principal objective is to test the hypothesis that in women with chronic pelvic pain in whom diagnostic laparoscopy reveals either no pathology or mild endometriosis (AFS score \u2264 5) LUNA alleviates pain and improves life quality at 12 months.", {"entities": [[156, 169, "DISEASE"]]}], ["A multi-centre, prospective, randomised-controlled-trial will be carried out with blind assessment of outcomes in eligible consenting patients randomised at diagnostic laparoscopy to LUNA (experimental group) or to no pelvic denervation (control group).", {"entities": []}], ["Postal questionnaires including visual analogue scale for pain (primary outcome), an index of sexual satisfaction and the EuroQoL 5D-EQ instrument (secondary outcomes) will be administered at 3, 6 and 12 months.", {"entities": []}], ["The primary assessment of the effectiveness of LUNA will be from comparison of outcomes at the one-year follow-up, although the medium-term and longer-term risks and benefits of LUNA will also be evaluated.", {"entities": []}], ["The sample size for this trial has been estimated as 420 patients in total using the hypothesis that LUNA will alleviate pain symptoms (i.e.", {"entities": []}], ["reduce pain scores on a VAS) more than no intervention at one-year following diagnostic laparoscopy and taking into consideration 20% loss to follow-up.", {"entities": []}], ["The intention to treat analysis to address the principal research questions will be conducted using the one-year follow-up data.", {"entities": []}], ["The perioperative use and relevance of protective ventilation in surgical patients is being increasingly recognized.", {"entities": []}], ["Obesity poses particular challenges to adequate mechanical ventilation in addition to surgical constraints, primarily by restricted lung mechanics due to excessive adiposity, frequent respiratory comorbidities (i.e.", {"entities": [[0, 7, "DISEASE"]]}], ["sleep apnea, asthma), and concerns of postoperative respiratory depression and other pulmonary complications.", {"entities": [[13, 19, "DISEASE"]]}], ["The number of surgical patients with obesity is increasing, and facing these challenges is common in the operating rooms and critical care units worldwide.", {"entities": [[37, 44, "DISEASE"]]}], ["In this review we summarize the existing literature which supports the following recommendations for the perioperative ventilation in obese patients: (1) the use of protective ventilation with low tidal volumes (approximately 8\u00a0mL/kg, calculated based on predicted -not actual- body weight) to avoid volutrauma; (2) a focus on lung recruitment by utilizing PEEP (8\u201315 cmH 2 O) in addition to recruitment maneuvers during the intraoperative period, as well as incentivized deep breathing and noninvasive ventilation early in the postoperative period, to avoid atelectasis, hypoxemia and atelectrauma; and (3) a judicious oxygen use (ideally less than 0.8) to avoid hypoxemia but also possible reabsorption atelectasis.", {"entities": []}], ["Obesity poses an additional challenge for achieving adequate protective ventilation during one-lung ventilation, but different lung isolation techniques have been adequately performed in obese patients by experienced providers.", {"entities": [[0, 7, "DISEASE"]]}], ["Postoperative efforts should be directed to avoid hypoventilation, atelectasis and hypoxemia.", {"entities": []}], ["Further studies are needed to better define optimum protective ventilation strategies and analyze their impact on the perioperative outcomes of surgical patients with obesity.", {"entities": [[167, 174, "DISEASE"]]}], ["The idiopathic inflammatory myopathies (IM) represent a heterogeneous group of autoimmune diseases, of which dermatomyositis (DM), polymyositis (PM), and sporadic inclusion body myositis (IBM) are the most common.", {"entities": [[163, 186, "DISEASE"], [178, 186, "DISEASE"], [109, 124, "DISEASE"]]}], ["The crucial role played by tumor necrosis factor alpha (TNF \u03b1 ) in the IM has long been recognized.", {"entities": [[56, 59, "GENE"]]}], ["However, so far, 18 other members of the TNF superfamily have been characterized, and many of these have not yet received the attention they deserve.", {"entities": [[41, 44, "GENE"]]}], ["In this paper, we summarize current findings for all TNF cytokines in IM, pinpointing what we know already and where current knowledge fails.", {"entities": [[53, 56, "GENE"]]}], ["For each TNF family member, possibilities for treating inflammatory diseases in general and the IM in particular are explored.", {"entities": [[9, 12, "GENE"]]}], ["Bowel disorders have destructive impacts on the patients social and mental aspects of life and can cause emotional distress.", {"entities": []}], ["The risk of developing bowel incontinence also increases with age.", {"entities": []}], ["The rate of incidence of inflammatory bowel disease in Manitoba, Canada, has been unusually raised.", {"entities": [[25, 51, "DISEASE"]]}], ["Therefore, it is important to identify trends in the incidence of bowel disorders that may suggest further epidemiological studies to identify risk factors and identify any changes in important factors.", {"entities": []}], ["An important part of spatial epidemiology is cluster detection as it has the potential to identify possible risk factors associated with disease, which in turn may lead to further investigations into the nature of diseases.", {"entities": []}], ["To test for potential disease clusters many methods have been proposed.", {"entities": []}], ["The focused detection methods including the circular spatial scan statistic (CSS), flexible spatial scan statistic (FSS), and Bayesian disease mapping (BYM) are among the most popular disease detection procedures.", {"entities": []}], ["A frequentist approach based on maximum likelihood estimation (MLE) has been recently used to identify potential focused clusters as well.", {"entities": []}], ["The aforementioned approaches are studied by analyzing a dataset of bowel disorders in the province of Manitoba, Canada, from 2001 to 2010.", {"entities": []}], ["The CSS method identified less regions than the FSS method in the south part of the province as potential clusters.", {"entities": []}], ["The same regions were identified by the BYM and MLE methods as being potential clusters of bowel disorders with a slightly different order of significance.", {"entities": []}], ["Most of these regions were also detected by the CSS or FSS methods.", {"entities": []}], ["Overall, we recommend using the methods BYM and MLE for cluster detection with the similar population and structure of regions as in Manitoba.", {"entities": []}], ["The potential clusters of bowel disorders are generally located in the southern part of the province including the eastern part of the city of Winnipeg.", {"entities": []}], ["These results may represent real increases in bowel disorders or they may be an indication of other covariates that were not adjusted for in the model used here.", {"entities": []}], ["Further investigation is needed to examine these findings, and also to explore the cause of these increases.", {"entities": []}], ["We have successfully developed a Loop-mediated isothermal amplification ( LAMP) assay that could specifically detect generic Escherichia coli ( E. coli ).", {"entities": []}], ["This assay was tested on 85 bacterial strains and successfully identified 54 E. coli strains (average threshold time, Tt = 21.26).", {"entities": []}], ["The sensitivity of this assay was evaluated on serial dilutions of bacterial cultures and spiked faeces.", {"entities": []}], ["The assay could detect 10 E. coli from 50 faecal samples obtained from indigenous individuals with 16% of the positive samples being verocytotoxin-producing E. coli (VTEC) positive.", {"entities": []}], ["VT1/VT2 allele was present in one faecal sample while the ratio of VT1 to VT2 was 6\u2009:\u20091.", {"entities": []}], ["Overall, our study had demonstrated high risk of VTEC infection among the indigenous community and most of the asymptomatic infection occurred among those aged below 15 years.", {"entities": []}], ["The role of asymptomatic human carriers as a source of dissemination should not be underestimated.", {"entities": []}], ["Large scale screening of the VTEC infection among indigenous populations and the potential contamination sources will be possible and easy with the aid of this newly developed rapid and simple LAMP assay.", {"entities": []}], ["VTX\u20101463 is a selective toll\u2010like receptor (TLR) 8 agonist that activates a subset of innate immune cells to produce a unique cytokine profile.", {"entities": []}], ["Delivery of VTX\u20101463 via nasal spray may modulate the nasal response in allergic rhinitis.", {"entities": [[72, 89, "DISEASE"], [81, 89, "DISEASE"]]}], ["The aim of this study was to determine the effects of VTX\u20101463 on the nasal response in a dog model of allergic rhinitis.", {"entities": [[103, 120, "DISEASE"], [112, 120, "DISEASE"]]}], ["Ragweed (RW)\u2010sensitized dogs were pretreated with increasing doses of VTX\u20101463 1 day prior to RW challenge or with two doses (4 or 8 days and 1 day prior to RW).", {"entities": []}], ["Changes in nasal cavity volume (NV) were determined by acoustic rhinometry and nasal lavage fluid was assessed for histamine, lipid mediators, and cellular infiltrates at sequential times following RW challenge.", {"entities": []}], ["VTX\u20101463 pretreatment significantly preserved NV during the acute response to RW challenge for all doses tested.", {"entities": []}], ["The area under the curve (AUC) for NV over the 1.5\u2009h assessment period in RW challenged vehicle controls averaged 51.5% (SEM: \u00b12.12%) of the baseline NV over all studies.", {"entities": []}], ["A single 100\u2009\u00b5g dose of VTX\u20101463 given 1 day prior to RW yielded an AUC for NV of 69.3% (\u00b16.59%) of baseline, while a 1000\u2009\u00b5g dose administered twice (8 days and 1 day prior to RW) resulted in an AUC for NV of 85.4% (\u00b14.74%, P \u2009<\u20090.05) of baseline.", {"entities": []}], ["For a single 1000\u2009\u00b5g VTX\u20101463 dose 1 day prior to RW, multiple mediators produced by mast cells, including histamine, PGE2, PGD2, and cysteinyl LTs, were significantly reduced relative to the vehicle control.", {"entities": []}], ["The selective TLR8 agonist, VTX\u20101463, preserved NV in a dose\u2010dependent manner in the acute phase of a nasal allergic response.", {"entities": [[14, 18, "GENE"]]}], ["The therapeutic effect appears to result from attenuated mast cell mediator release.", {"entities": []}], ["Modulating the local cytokine response via TLR8 agonism appears to have a therapeutic effect on the acute allergic nasal response.", {"entities": [[43, 47, "GENE"]]}], ["Communication between patients with limited English proficiency (LEP) and telephone triage services has not been previously explored.", {"entities": [[65, 68, "GENE"]]}], ["The purpose of this study was to determine the utilization characteristics of a primary care triage call center by patients with LEP.", {"entities": [[129, 132, "GENE"]]}], ["This was a retrospective cohort study of the utilization of a computer-aided, nurse-led telephone triage system by English proficiency status of patients empaneled to a large primary care practice network in the Midwest United States.", {"entities": []}], ["Interpreter Services (IS) need was used as a proxy for LEP.", {"entities": [[55, 58, "GENE"]]}], ["Call volumes between the 587 adult patients with LEP and an age-frequency matched cohort of English-Proficient (EP) patients were similar.", {"entities": [[49, 52, "GENE"]]}], ["Calls from patients with LEP were longer and more often made by a surrogate.", {"entities": [[25, 28, "GENE"]]}], ["Patients with LEP received recommendations for higher acuity care more frequently (49.4% versus 39.0%; P \u00a0<\u00a00.0004), and disagreed with recommendations more frequently (30.1% versus 20.9%; P \u00a0=\u00a00.0004).", {"entities": [[14, 17, "GENE"]]}], ["These associations remained after adjustment for comorbidities.", {"entities": []}], ["Patients with LEP were also less likely to follow recommendations (60.9% versus 69.4%; P \u00a0=\u00a00.0029), even after adjusting for confounders (adjusted odds ratio [AOR]\u00a0=\u00a00.65; 95% confidence interval [CI], 0.49, 0.85; P \u00a0<\u00a00.001).", {"entities": [[14, 17, "GENE"]]}], ["Patients with LEP who utilized a computer-aided, nurse-led telephone triage system were more likely to receive recommendations for higher acuity care compared to EP patients.", {"entities": [[14, 17, "GENE"]]}], ["They were also less likely to agree with, or follow, recommendations given.", {"entities": []}], ["Additional research is needed to better understand how telephone triage can better serve patients with LEP.", {"entities": [[103, 106, "GENE"]]}], ["The risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA) is thought to be increased following anti-tumour necrosis factor (anti-TNF) therapy, with a proposed differential risk between the anti-TNF drugs etanercept (ETA), infliximab (INF) and adalimumab (ADA).", {"entities": [[47, 67, "DISEASE"], [12, 24, "DISEASE"], [58, 67, "DISEASE"], [270, 273, "GENE"]]}], ["To compare directly the risk between drugs, to explore time to event, site of infection and the role of ethnicity.", {"entities": []}], ["Data from the British Society for Rheumatology Biologics Register (BSRBR), a national prospective observational study, were used to compare TB rates in 10 712 anti-TNF treated patients (3913 ETA, 3295 INF, 3504 ADA) and 3232 patients with active RA treated with traditional disease-modifying antirheumatic drugs.", {"entities": [[211, 214, "GENE"]]}], ["To April 2008, 40 cases of TB were reported, all in the anti-TNF cohort.", {"entities": []}], ["The rate of TB was higher for the monoclonal antibodies ADA (144 events/100 000 person-years) and INF (136/100 000 person-years) than for ETA (39/100 000 person-years).", {"entities": [[56, 59, "GENE"]]}], ["After adjustment, the incidence rate ratio compared with ETA-treated patients was 3.1 (95% CI 1.0 to 9.5) for INF and 4.2 (1.4 to 12.4) for ADA.", {"entities": [[140, 143, "GENE"]]}], ["The median time to event was lowest for INF (5.5 months) compared with ETA (13.4 months) and ADA (18.5 months).", {"entities": [[93, 96, "GENE"]]}], ["13/40 cases occurred after stopping treatment.", {"entities": []}], ["25/40 (62%) cases were extrapulmonary, of which 11 were disseminated.", {"entities": []}], ["Patients of non-white ethnicity had a sixfold increased risk of TB compared with white patients treated with anti-TNF therapy.", {"entities": []}], ["The rate of TB in patients with RA treated with anti-TNF therapy was three- to fourfold higher in patients receiving INF and ADA than in those receiving ETA.", {"entities": [[125, 128, "GENE"]]}], ["Leber Congenital Amaurosis (LCA), the most severe inherited retinal dystrophy, is genetically heterogeneous, with 14 genes accounting for 70% of patients.", {"entities": []}], ["Here, 91 LCA probands underwent LCA chip analysis and subsequent sequencing of 6 genes ( CEP290, CRB1, RPE65, GUCY2D, AIPL1 and CRX ), revealing mutations in 69% of the cohort, with major involvement of CEP290 (30%).", {"entities": [[89, 95, "GENE"], [203, 209, "GENE"], [97, 101, "GENE"], [103, 108, "GENE"], [110, 116, "GENE"], [118, 123, "GENE"], [128, 131, "GENE"], [89, 95, "GENE"], [203, 209, "GENE"]]}], ["In addition, 11 patients with early-onset retinal dystrophy (EORD) and 13 patients with Senior-Loken syndrome (SLS), LCA-Joubert syndrome (LCA-JS) or cerebello-oculo-renal syndrome (CORS) were included.", {"entities": [[101, 109, "DISEASE"], [129, 137, "DISEASE"], [172, 180, "DISEASE"]]}], ["Exhaustive re-inspection of the overall phenotypes in our LCA cohort revealed novel insights mainly regarding the CEP290 -related phenotype.", {"entities": [[114, 120, "GENE"]]}], ["The AHI1 gene was screened as a candidate modifier gene in three patients with the same CEP290 genotype but different neurological involvement.", {"entities": [[4, 8, "GENE"], [88, 94, "GENE"]]}], ["Interestingly, a heterozygous novel AHI1 mutation, p.Asn811Lys, was found in the most severely affected patient.", {"entities": [[36, 40, "GENE"]]}], ["Moreover, AHI1 screening in five other patients with CEP290 -related disease and neurological involvement revealed a second novel missense variant, p.His758Pro, in one LCA patient with mild mental retardation and autism.", {"entities": [[10, 14, "GENE"], [53, 59, "GENE"]]}], ["These two AHI1 mutations might thus represent neurological modifiers of CEP290 -related disease.", {"entities": [[10, 14, "GENE"], [72, 78, "GENE"]]}], ["\u00a9 2010 Wiley-Liss, Inc.", {"entities": []}], ["To describe recent developments in therapies which target the molecular mechanisms in atopic dermatitis.", {"entities": [[86, 103, "DISEASE"], [93, 103, "DISEASE"]]}], ["Current advances in the understanding of the molecular basis of atopic dermatitis are leading to the stratification of different atopic dermatitis phenotypes.", {"entities": [[64, 81, "DISEASE"], [129, 146, "DISEASE"], [71, 81, "DISEASE"], [136, 146, "DISEASE"]]}], ["New therapies offer the option to target-specific molecules involved in the pathophysiology of atopic dermatitis.", {"entities": [[95, 112, "DISEASE"], [102, 112, "DISEASE"]]}], ["Current new therapies under investigation aim to modulate specific inflammatory pathways associated with distinctive atopic dermatitis phenotypes, which would potentially translate into the development of personalized, targeted-specific treatments of atopic dermatitis.", {"entities": [[117, 134, "DISEASE"], [251, 268, "DISEASE"], [124, 134, "DISEASE"], [258, 268, "DISEASE"]]}], ["Despite the unmet need for well tolerated, effective, and personalized treatment of atopic dermatitis, the current standard treatments of atopic dermatitis do not focus on the individual pathogenesis of the disease.", {"entities": [[84, 101, "DISEASE"], [138, 155, "DISEASE"], [91, 101, "DISEASE"], [145, 155, "DISEASE"]]}], ["The development of targeted, phenotype-specific therapies has the potential to open a new promising era of individualized treatment of atopic dermatitis.", {"entities": [[135, 152, "DISEASE"], [142, 152, "DISEASE"]]}], ["The aim of this study was to assess the severity of depressive symptoms in postmenopausal women, depending on serum Mg and Zn levels.", {"entities": []}], ["The study involved 171 postmenopausal women from Poland, who were not using menopausal hormone therapy (MHT).", {"entities": []}], ["The intensity of depressive symptoms was evaluated using a standard research technique, the Beck Depression Inventory (BDI).", {"entities": []}], ["The plasma Mg and Zn concentrations were measured.", {"entities": []}], ["Depressive symptoms of different severity levels were diagnosed in 36.8\u00a0% of the women.", {"entities": []}], ["The mean serum Mg level was 1.53\u2009\u00b1\u20090.28\u00a0mg/dL, and Zn level was 72\u2009\u00b114\u00a0\u03bcg/dL.", {"entities": []}], ["The women with higher serum Mg and Zn levels had less depressive symptoms, and this observation is a precious information which can be used when planning depressive disorder prevention programmes.", {"entities": []}], ["This study aimed to update and validate a prediction rule for respiratory syncytial virus (RSV) hospitalization in preterm infants 33\u201335 weeks gestational age (WGA).", {"entities": []}], ["The RISK study consisted of 2 multicenter prospective birth cohorts in 41 hospitals.", {"entities": []}], ["Risk factors were assessed at birth among healthy preterm infants 33\u201335 WGA.", {"entities": []}], ["All hospitalizations for respiratory tract infection were screened for proven RSV infection by immunofluorescence or polymerase chain reaction.", {"entities": []}], ["Multivariate logistic regression analysis was used to update an existing prediction model in the derivation cohort (n\u200a=\u200a1,227).", {"entities": []}], ["In the validation cohort (n\u200a=\u200a1,194), predicted versus actual RSV hospitalization rates were compared to determine validity of the model.", {"entities": []}], ["RSV hospitalization risk in both cohorts was comparable (5.7% versus 4.9%).", {"entities": []}], ["In the derivation cohort, a prediction rule to determine probability of RSV hospitalization was developed using 4 predictors: family atopy (OR 1.9; 95%CI, 1.1\u20133.2), birth period (OR 2.6; 1.6\u20134.2), breastfeeding (OR 1.7; 1.0\u20132.7) and siblings or daycare attendance (OR 4.7; 1.7\u201313.1).", {"entities": []}], ["The model showed good discrimination (c-statistic 0.703; 0.64\u20130.76, 0.702 after bootstrapping).", {"entities": []}], ["External validation showed good discrimination and calibration (c-statistic 0.678; 0.61\u20130.74).", {"entities": []}], ["Our prospectively validated prediction rule identifies infants at increased RSV hospitalization risk, who may benefit from targeted preventive interventions.", {"entities": []}], ["This prediction rule can facilitate country-specific, cost-effective use of RSV prophylaxis in late preterm infants.", {"entities": []}], ["The infiltration of macrophages into adipose tissue and their interaction with adipocytes are essential for the chronic low-grade inflammation of obese adipose tissue.", {"entities": []}], ["In this study, we identified the serum amyloid A3 (Saa3 ) gene as a key adipocyte-derived factor that is affected by interaction with macrophages.", {"entities": []}], ["We showed that the Saa3 promoter in adipocytes actually responds to activated macrophages in a co-culture system.", {"entities": []}], ["Decreasing C/EBP\u03b2 abundance in 3T3-L1 adipocytes or point mutation of C/EBP\u03b2 elements suppressed the increased promoter activity in response to activated macrophages, suggesting an essential role of C/EBP\u03b2 in Saa3 promoter activation.", {"entities": []}], ["Bioluminescence based on Saa3 promoter activity in Saa3-luc mice was promoted in obese adipose tissue, showing that Saa3 promoter activity is most likely related to macrophage infiltration.", {"entities": []}], ["This study suggests that the level of expression of the Saa3 gene could be utilized for the number of infiltrated macrophages in obese adipose tissue.", {"entities": []}], ["Gli transcription factors of the Hedgehog (Hh) pathway have been reported to be drivers of malignant mesothelioma (MMe) cell survival.", {"entities": [[91, 113, "DISEASE"], [115, 118, "GENE"]]}], ["The Gli inhibitor GANT61 induces apoptosis in various cancer cell models, and has been associated directly with Gli inhibition.", {"entities": [[54, 60, "DISEASE"]]}], ["However various chemotherapeutics can induce cell death through generation of reactive oxygen species (ROS) but whether ROS mediates GANT61-induced apoptosis is unknown.", {"entities": []}], ["In this study human MMe cells were treated with GANT61 and the mechanisms regulating cell death investigated.", {"entities": [[20, 23, "GENE"]]}], ["Exposure of MMe cells to GANT61 led to G1 phase arrest and apoptosis, which involved ROS but not its purported targets, GLI1 or GLI2.", {"entities": [[12, 15, "GENE"], [120, 124, "GENE"], [128, 132, "GENE"]]}], ["GANT61 triggered ROS generation and quenching of ROS protected MMe cells from GANT61-induced apoptosis.", {"entities": [[63, 66, "GENE"]]}], ["Furthermore, we demonstrated that mitochondria are important in mediating GANT61 effects: (1) ROS production and apoptosis were blocked by mitochondrial inhibitor rotenone; (2) GANT61 promoted superoxide formation in mitochondria; and (3) mitochondrial DNA-deficient LO68 cells failed to induce superoxide, and were more resistant to apoptosis induced by GANT61 than wild-type cells.", {"entities": []}], ["Our data demonstrate for the first time that GANT61 induces apoptosis by promoting mitochondrial superoxide generation independent of Gli inhibition, and highlights the therapeutic potential of mitochondrial ROS-mediated anticancer drugs in MMe.", {"entities": [[241, 244, "GENE"]]}], ["Induced regulatory T-cells (iT-reg) and T helper type 17 (Th17) in the mouse share common CD4 progenitor cells and exhibit overlapping phenotypic and functional features.", {"entities": [[90, 93, "GENE"]]}], ["Here, we show that human Th17 cells endowed with suppressor activity (supTh17) can be derived following exposure of iT-reg populations to Th17 polarizing conditions.", {"entities": []}], ["In contrast to \u201cpathogenic\u201d Th17, supTh17 display immune suppressive function and express high levels of CD39, an ectonucleotidase that catalyzes the conversion of pro-inflammatory extracellular nucleotides ultimately generating nucleosides.", {"entities": []}], ["Accordingly, supTh17 exhibit nucleoside triphosphate diphosphohydrolase activity, as demonstrated by the efficient generation of extracellular AMP, adenosine and other purine derivatives.", {"entities": []}], ["In addition supTh17 cells are resistant to the effects of adenosine as result of the low expression of the A2A receptor and accelerated adenosine catalysis by adenosine deaminase (ADA).", {"entities": [[180, 183, "GENE"]]}], ["These supTh17 can be detected in the blood and in the lamina propria of healthy subjects.", {"entities": []}], ["However, these supTh17 cells are diminished in patients with Crohn\u2019s disease.", {"entities": []}], ["In summary, we describe a human Th17 subpopulation with suppressor activity, which expresses high levels of CD39 and consequently produces extracellular adenosine.", {"entities": []}], ["As these uniquely suppressive CD39", {"entities": []}], ["We undertook this study to investigate whether there is an association between atmospheric fine particles (PM 2.5 ) levels and inpatient admissions for chronic obstructive pulmonary disease (COPD) in Taipei, Taiwan.", {"entities": [[152, 189, "DISEASE"]]}], ["Data on inpatient admissions for COPD and ambient on air pollution levels in Taipei were obtained for years 2006 to 2010.", {"entities": []}], ["We estimated the relative risk of inpatient admissions for COPD using a case-crossover design with the following control variables: weather measures, day of the week, seasonality, and long-term time trends.", {"entities": []}], ["For the single-pollutant model (not controlling for other atmospheric pollutants), COPD admissions were significantly and positively associated with higher PM 2.5 levels during both warm days (>23 \u00b0C) and cool days (<23 \u00b0C), with an interquartile range increase of 12% (95% CI = 8\u201316%) and 3% (95% CI = 0\u20137%) in COPD admissions, respectively.", {"entities": []}], ["In the two-pollutant models, PM 2.5 remained significant even controlling for SO 2 or O 3 on both warm and cool days.", {"entities": []}], ["Taken as a whole, our study demonstrates that higher levels of PM 2.5 may increase the risk of inpatient admissions for COPD.", {"entities": []}], ["Continual progress in next-generation sequencing allows for generating increasingly large metagenomes which are over time or space.", {"entities": []}], ["Comparing and classifying the metagenomes with different microbial communities is critical.", {"entities": []}], ["Alignment-free supervised classification is important for discriminating between the multifarious components of metagenomic samples, because it can be accomplished independently of known microbial genomes.", {"entities": []}], ["We propose an alignment-free supervised metagenomic classification method called DectICO.", {"entities": []}], ["The intrinsic correlation of oligonucleotides provides the feature set, which is selected dynamically using a kernel partial least squares algorithm, and the feature matrices extracted with this set are sequentially employed to train classifiers by support vector machine (SVM).", {"entities": []}], ["We evaluated the classification performance of DectICO on three actual metagenomic sequencing datasets, two containing deep sequencing metagenomes and one of low coverage.", {"entities": []}], ["Validation results show that DectICO is powerful, performs well based on long oligonucleotides (i.e., 6-mer to 8-mer), and is more stable and generalized than a sequence-composition-based method.", {"entities": []}], ["The classifiers trained by our method are more accurate than non-dynamic feature selection methods and a recently published recursive-SVM-based classification approach.", {"entities": []}], ["The alignment-free supervised classification method DectICO can accurately classify metagenomic samples without dependence on known microbial genomes.", {"entities": []}], ["Selecting the ICO dynamically offers better stability and generality compared with sequence-composition-based classification algorithms.", {"entities": []}], ["Our proposed method provides new insights in metagenomic sample classification.", {"entities": []}], ["The online version of this article (doi:10.1186/s12859-015-0753-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["While reviews have been published on asthma management in pregnant women, none has examined the effectiveness of non-pharmacological healthcare interventions for optimizing asthma management in pregnant women.", {"entities": [[37, 43, "DISEASE"], [173, 179, "DISEASE"]]}], ["This systematic review aims to identify non-pharmacological healthcare interventions for optimizing asthma management during pregnancy and to examine their effects on maternal asthma control and neonatal outcomes.", {"entities": [[100, 106, "DISEASE"], [176, 182, "DISEASE"]]}], ["The Cochrane Central Register of Controlled Trials (CENTRAL, Cochrane Library), MEDLINE, EMBASE, PsycINFO, CINAHL Plus and International Pharmaceutical Abstracts (IPA) were searched.", {"entities": []}], ["Two reviewers independently assessed the identified studies against the eligibility criteria and extracted relevant information.", {"entities": []}], ["The effects of the intervention were assessed qualitatively.", {"entities": []}], ["Nine studies were identified, of which six were rejected according to the exclusion criteria.", {"entities": []}], ["The three studies included in the final review described an education program, progressive muscle relaxation (PMR) and Fraction of exhaled Nitric Oxide (FeNO) guided management of asthma in pregnant women.", {"entities": [[180, 186, "DISEASE"]]}], ["The PMR and FeNO-guided interventions showed significant improvements in maternal asthma control (lung function and quality of life) and neonatal outcomes (birth weight).", {"entities": [[82, 88, "DISEASE"]]}], ["Further evidence from well-designed studies evaluating non-pharmacological healthcare interventions for optimizing asthma management in pregnant women is required.", {"entities": [[115, 121, "DISEASE"]]}], ["Chronic disease is the leading global health threat and impairs patients\u2019 health-related quality of life (HRQoL).", {"entities": []}], ["Low health literacy is linked with chronic diseases prevalence and poor HRQoL.", {"entities": []}], ["However, the interaction of health literacy with chronic disease on HRQoL remains unknown.", {"entities": []}], ["Therefore, we examined how health literacy might modify the association between chronic disease and their HRQoL impacts.", {"entities": []}], ["We conducted a health survey of 913 poor rural women aged 23\u201357 years in Northwestern China.", {"entities": []}], ["We assessed health literacy and HRQol using the revised Chinese Adult Health Literacy Questionnaire (R-CAHLQ) and Euroqol-5D (EQ-5D), respectively.", {"entities": []}], ["Low health literacy was indicated by a cut-off of less than the mean of the factor score.", {"entities": []}], ["Self-reported preexisting physician-diagnosed chronic disease and socio-demographic characteristics were also included.", {"entities": []}], ["We fitted log-binomial regression models for each dimension of EQ-5D to examine its association with health literacy and chronic disease.", {"entities": []}], ["We also ran linear regression models for EQ VAS scores and utility scores.", {"entities": []}], ["The low health literacy group was 1.33 times more likely to have a chronic disease than the high health literacy group.", {"entities": []}], ["Pain/discomfort was the most prevalent impairment, and was more common in the low health literacy group (PR [prevalence ratio]\u2009=\u20091.23; 95% CI\u2009=\u20091.01, 1.50).", {"entities": []}], ["Chronic disease strongly predicted impairments in all the EQ-5D dimensions, with PRs ranging from 2.14 to 4.07.", {"entities": []}], ["The association between chronic disease and pain/discomfort varied by health literacy level (health literacy\u2009\u00d7\u2009chronic disease: P \u2009=\u20090.033), and was less pronounced in the low health literacy group (PR\u2009=\u20092.15; 95% CI\u2009=\u20091.76, 2.64) than in the high health literacy group (PR\u2009=\u20093.19; 95% CI\u2009=\u20092.52, 4.05).", {"entities": []}], ["The low health literacy group had lower VAS scores and utility scores, and slightly less decrement of VAS scores and utility scores associated with chronic disease.", {"entities": []}], ["Health literacy modified the impacts of chronic disease on HRQoL, and low health literacy group reported less HRQoL impacts related to chronic disease.", {"entities": []}], ["Research should address health literacy issues as well as root causes of health disparities for vulnerable populations.", {"entities": []}], ["Bariatric surgery particularly benefits patients with obesity-related comorbidities such as type 2 diabetes and obstructive sleep apnea.", {"entities": [[54, 61, "DISEASE"]]}], ["We aimed to examine whether the variables that influence treatment choice differ between morbidly obese patients undergoing bariatric surgery and those opting for conservative treatments.", {"entities": []}], ["A total of 505 consecutive morbidly obese patients (72% women; mean (SD) age 42 (12) years) who attended our tertiary care center between December 2005 and February 2007 were examined by a multidisciplinary team and offered surgical or conservative treatment.", {"entities": []}], ["The chi-square test, independent samples t test, and multiple logistic regression were used in the statistical analyses.", {"entities": []}], ["A total of 249 (49%) patients underwent bariatric surgery.", {"entities": []}], ["When compared to the conservative group of patients, the surgery group was characterized by a significantly higher mean (SD) BMI (46.5(6.2) vs. 43.2(5.5) kg/m p \u2009<\u20090.001), earlier onset of obesity (40% vs. 26% before 12\u00a0years of age, p \u2009<\u20090.001), and lower age (41(11) vs. 44(13) years, p \u2009=\u20090.002).", {"entities": [[189, 196, "DISEASE"]]}], ["In contrast, the groups did not differ significantly with respect to gender or obesity-related comorbidities.", {"entities": [[79, 86, "DISEASE"]]}], ["After adjustments for gender, age, onset of obesity, and the number of comorbidities, multiple regression revealed that patients with BMI 40\u201350 or >50\u00a0kg/m p \u2009<\u20090.001) and 6 (OR\u2009=\u20095.7; 95% CI 3.0\u201311.0, p \u2009<\u20090.001) times the chance of undergoing bariatric surgery when compared to patients with a BMI <40\u00a0kg/m Our data indicates that increasing BMI rather than obesity-related comorbidities, predicted treatment choice in morbidly obese patients.", {"entities": [[44, 51, "DISEASE"], [360, 367, "DISEASE"]]}], ["The role of Aspergillus fumigatus in the airways of chronic obstructive pulmonary disease (COPD) patients with bronchiectasis is currently unclear.", {"entities": [[52, 89, "DISEASE"], [111, 125, "DISEASE"]]}], ["We searched for a sensitive and noninvasive method for A. fumigatus detection in the sputum of COPD patients and addressed potential risk factors for its presence.", {"entities": []}], ["Induced sputum samples of 18 COPD patients and 17 COPD patients with bronchiectasis were analyzed for the presence of A. fumigatus by culture, galactomannan detection, and PCR.", {"entities": [[69, 83, "DISEASE"]]}], ["Of the patients with COPD\u2013bronchiectasis overlap, 23.5% had a positive culture for A. fumigatus versus 10.5% of COPD patients without bronchiectasis ( p = 0.39).", {"entities": [[26, 40, "DISEASE"], [134, 148, "DISEASE"]]}], ["The median sputum galactomannan optical density index was significantly higher in patients with COPD and bronchiectasis compared with patients with COPD alone ( p = 0.026) and ranged between the levels of healthy controls and A. fumigatus -colonized cystic fibrosis patients.", {"entities": [[105, 119, "DISEASE"], [250, 265, "DISEASE"]]}], ["Both the presence of bronchiectasis and the administration of systemic corticosteroids were associated with sputum galactomannan ( p = 0.0028 and p = 0.0044, respectively) and showed significant interaction ( p interaction = 0.022).", {"entities": [[21, 35, "DISEASE"]]}], ["PCR for Aspergillus was found to be a less sensitive method, but was critically dependent on the extraction technique.", {"entities": []}], ["The higher sputum galactomannan levels suggest a more abundant presence of A. fumigatus in the airways of patients with COPD\u2013bronchiectasis overlap compared with patients with COPD without bronchiectasis, particularly when systemic corticosteroids are administered.", {"entities": [[125, 139, "DISEASE"], [189, 203, "DISEASE"]]}], ["Breastfeeding is a cost-effective public health intervention that reduces infant morbidity and mortality in developing countries.", {"entities": []}], ["In Lebanon, breastfeeding exclusivity and continuation rates are disappointingly low.", {"entities": []}], ["This qualitative study aims at identifying barriers and promoters of breastfeeding in the Lebanese context by exploring mothers' perceptions and experiences in breastfeeding over a one year period.", {"entities": []}], ["We conducted focus group discussions in three hospitals in Beirut, Lebanon, and followed up 36 breastfeeding mothers with serial in-depth interviews for one year post-partum or until breastfeeding discontinuation.", {"entities": []}], ["Themes generated from baseline interviews revealed several positive and negative perceptions of breastfeeding.", {"entities": []}], ["Longitudinal follow up identified insufficient milk, fear of weight gain or breast sagging, pain, sleep deprivation, exhaustion, or maternal employment, as reasons for early breastfeeding discontinuation.", {"entities": []}], ["Women who continued breastfeeding for one year were more determined to succeed and overcome any barrier, relying mostly on family support and proper time management.", {"entities": []}], ["Increasing awareness of future mothers about breast feeding difficulties, its benefits to children, mothers, and society at large may further promote breastfeeding, and improve exclusivity and continuation rates in Lebanon.", {"entities": []}], ["A national strategy for early intervention during school years to increase young women's awareness may improve their self-confidence and determination to succeed in breastfeeding later.", {"entities": []}], ["Moreover, prolonging maternity leave, having day-care facilities at work, creation of lactation peer support groups and hotlines, and training of doctors and nurses in proper lactation support may positively impact breastfeeding exclusivity and continuation rates.", {"entities": []}], ["Further research is needed to assess the effectiveness of proposed interventions in the Lebanese context.", {"entities": []}], ["Clinically, we found the increased incidence of acquired colesteatoma in the patients with osteoporosis.", {"entities": [[91, 103, "DISEASE"]]}], ["In this study, we used a retrospective cohort to examine this association and to investigate the possible mechanism.", {"entities": []}], ["We conducted a population-based retrospective cohort study by using the National Health Insurance Research Database (NHIRD).", {"entities": []}], ["We identified an osteoporosis cohort comprising 37 124 patients newly diagnosed with osteoporosis aged 20 years or older.", {"entities": [[17, 29, "DISEASE"], [85, 97, "DISEASE"]]}], ["Patients in the comparison cohort had no history of osteoporosis and were frequency matched with the patients in the osteoporosis cohort according to sex, age, and index year.", {"entities": [[52, 64, "DISEASE"], [117, 129, "DISEASE"]]}], ["The acquired cholesteatoma incidence rates for the osteoporosis and comparison cohorts were 1.12 and 0.83 per 1000 person-years, respectively.", {"entities": [[13, 26, "DISEASE"], [51, 63, "DISEASE"]]}], ["After we adjusted for confounding factors, the osteoporosis cohort exhibited a 1.32-fold increased acquired cholesteatoma risk relative to the comparison cohort (hazard ratio [HR] = 1.32, 95% confidence interval [CI] = 1.11\u20131.57).", {"entities": [[108, 121, "DISEASE"], [47, 59, "DISEASE"], [176, 178, "GENE"]]}], ["In addition, patients with no history of otitis media (HR = 1.33, 95% CI = 1.11\u20131.59), cancer (HR = 1.34, 95% CI = 1.12\u20131.60), or COPD (HR = 1.26, 95% CI = 1.05\u20131.52) in the osteoporosis cohort exhibited an increased risk of subsequent acquired cholesteatoma relative to those in the comparison cohort.", {"entities": [[245, 258, "DISEASE"], [41, 53, "DISEASE"], [174, 186, "DISEASE"], [87, 93, "DISEASE"], [55, 57, "GENE"], [95, 97, "GENE"], [136, 138, "GENE"], [55, 57, "GENE"], [95, 97, "GENE"], [136, 138, "GENE"], [55, 57, "GENE"], [95, 97, "GENE"], [136, 138, "GENE"]]}], ["Our cohort study indicated that patients with osteoporosis had a 1.31-fold increased acquired cholesteatoma risk relative to the comparison cohort.", {"entities": [[94, 107, "DISEASE"], [46, 58, "DISEASE"]]}], ["This risk was further increased in patients with comorbid otitis media.", {"entities": [[58, 70, "DISEASE"]]}], ["Hence, we recommend that otolaryngologists evaluate the condition of the middle ear of patients with osteoporosis.", {"entities": [[101, 113, "DISEASE"]]}], ["Asthma is a common respiratory disease that is characterized by bronchial hyperresponsiveness and airway obstruction due to chronic airway inflammation.", {"entities": [[0, 6, "DISEASE"]]}], ["Atopic asthma is a typical IgE-mediated disease in which the enhanced production of IgE is driven by the activation of Th2 cells, which release a distinct pattern of cytokines, including interleukin 4 (IL4) and IL3, in response to specific antigen presentation.", {"entities": [[7, 13, "DISEASE"], [202, 205, "GENE"], [211, 214, "GENE"]]}], ["To evaluate the methylation status of the whole genomes of bronchial mucosa tissues from subjects who lacked or had sensitization to Dermatophagoides farina ( Df ) and Dermatophagoides pteronyssinus ( Dp ).", {"entities": []}], ["The genome-wide DNA methylation levels in the bronchial mucosa tissues of atopic asthmatics (N\u2009=\u200910), non-atopic asthmatics (N\u2009=\u20097), and normal controls (N\u2009=\u20097) were examined using microarrays.", {"entities": []}], ["In the bronchial mucosa of atopic asthmatics, hypermethylation was detected at 6 loci in 6 genes, while hypomethylation was detected at 49 loci in 48 genes compared to those of non-atopic asthmatics.", {"entities": []}], ["Genes that were assigned the ontologies of multicellular organismal process, response to organic substance, hormone metabolic process, and growth factor receptor binding were hypomethylated.", {"entities": []}], ["The methylation levels in the mucosa of asthmatics and normal controls were similar.", {"entities": []}], ["The bronchial mucosa of asthmatics who are atopic to Df or Dp have characteristic methylation patterns for 52 genes.", {"entities": []}], ["The genes and pathways identified in the present study may be associated with the presence of atopy in asthmatics and therefore represent attractive targets for future research.", {"entities": []}], ["As habitual self-stigma can have a tremendous negative impact on people with mental illness, it is of paramount importance to identify its risk factors.", {"entities": []}], ["The present study aims to examine the potential contributory role of attentional bias in habitual self-stigma.", {"entities": []}], ["People with mental illness having strong ( n = 47) and weak ( n = 47) habitual self-stigma completed a computerized emotional Stroop task which included stigma-related, positive, and non-affective words as stimuli.", {"entities": []}], ["The strong habit group was found to exhibit faster color-naming of stigma-related words (compared to non-affective words), whereas the weak habit group showed no difference in the speed of response to different stimuli.", {"entities": []}], ["These findings suggest that people with stronger habitual self-stigma may be more able to ignore the semantic meaning of stigma-related words and focus on the color-naming task.", {"entities": []}], ["Moreover, people with stronger habitual self-stigma may have greater attentional avoidance of stigma-related material.", {"entities": []}], ["The present study is the first to demonstrate a specific relationship between habitual self-stigma and biased processing of stigma-related information.", {"entities": []}], ["In order to further determine the role and the nature of attentional bias in habitual self-stigma, future research should employ a broader range of experimental paradigms and measurement techniques to examine stigma-related attentional bias in people with mental illness.", {"entities": []}], ["Red tides in the Gulf of Mexico are commonly formed by the fish-killing dinoflagellate Karenia brevis , which produces nine potent polyether brevetoxins (PbTxs).", {"entities": []}], ["Brevetoxins can be transferred from water to air in wind-powered white-capped waves.", {"entities": []}], ["Inhalation exposure to marine aerosol containing brevetoxins causes respiratory symptoms.", {"entities": []}], ["We describe detailed characterization of aerosols during an epidemiologic study of occupational exposure to Florida red tide aerosol in terms of its concentration, toxin profile, and particle size distribution.", {"entities": []}], ["This information is essential in understanding its source, assessing exposure to people, and estimating dose of inhaled aerosols.", {"entities": []}], ["Environmental sampling confirmed the presence of brevetoxins in water and air during a red tide exposure period (September 2001) and lack of significant toxin levels in the water and air during an unexposed period May 2002).", {"entities": []}], ["Water samples collected during a red tide bloom in 2001 showed moderate-to-high concentrations of K. brevis cells and PbTxs.", {"entities": []}], ["The daily mean PbTx concentration in water samples ranged from 8 to 28 \u03bcg/L from 7 to 11 September 2001; the daily mean PbTx concentration in air samples ranged from 1.3 to 27 ng/m", {"entities": []}], ["To investigate the effects of MnTE-2-PyP on some markers of antioxidant defence system in asthma mice model.", {"entities": [[90, 96, "DISEASE"]]}], ["Material and Methods .", {"entities": []}], ["The animals were divided into four groups: group 1, controls; group 2, injected with ovalbumin, group 3, treated with MnTE-2-PyP, and group 4, treated with ovalbumin and MnTE-2-PyP.", {"entities": []}], ["The activities of superoxide dismutase, catalase, glutathione peroxidase and nonprotein sulfhydryl groups content (NPSH) were determined in lung homogenate.", {"entities": []}], ["The activities of superoxide dismutase and catalase in group 2 decreased significantly as compared to control group.", {"entities": []}], ["The decrease of the same enzymes in group 4 was lower and significant as compared to group 2.", {"entities": []}], ["Changes in the glutathione peroxidase activity showed a similar dynamics.", {"entities": []}], ["The NPSH groups content decreased in group 2.", {"entities": []}], ["In group 4 this decrease was relatively lower as compared to group 2.", {"entities": []}], ["Conclusions .", {"entities": []}], ["The application of MnTE-2-PyP mitigated the effects of oxidative stress in asthma mice model.", {"entities": [[75, 81, "DISEASE"]]}], ["To investigate the effect of providing patients online access to their electronic health record (EHR) and linked transactional services on the provision, quality and safety of healthcare.", {"entities": []}], ["The objectives are also to identify and understand: barriers and facilitators for providing online access to their records and services for primary care workers; and their association with organisational/IT system issues.", {"entities": []}], ["Primary care.", {"entities": []}], ["A total of 143 studies were included.", {"entities": []}], ["17 were experimental in design and subject to risk of bias assessment, which is reported in a separate paper.", {"entities": []}], ["Detailed inclusion and exclusion criteria have also been published elsewhere in the protocol.", {"entities": []}], ["Our primary outcome measure was change in quality or safety as a result of implementation or utilisation of online records/transactional services.", {"entities": []}], ["No studies reported changes in health outcomes; though eight detected medication errors and seven reported improved uptake of preventative care.", {"entities": []}], ["Professional concerns over privacy were reported in 14 studies.", {"entities": []}], ["18 studies reported concern over potential increased workload; with some showing an increase workload in email or online messaging; telephone contact remaining unchanged, and face-to face contact staying the same or falling.", {"entities": []}], ["Owing to heterogeneity in reporting overall workload change was hard to predict.", {"entities": []}], ["10 studies reported how online access offered convenience, primarily for more advantaged patients, who were largely highly satisfied with the process when clinician responses were prompt.", {"entities": []}], ["Patient online access and services offer increased convenience and satisfaction.", {"entities": []}], ["However, professionals were concerned about impact on workload and risk to privacy.", {"entities": []}], ["Studies correcting medication errors may improve patient safety.", {"entities": []}], ["There may need to be a redesign of the business process to engage health professionals in online access and of the EHR to make it friendlier and provide equity of access to a wider group of patients.", {"entities": []}], ["PROSPERO CRD42012003091.", {"entities": []}], ["The aim of our study was to investigate the impact of interleukin (IL)-6 190C/T, IL-6 174G/C, IL-6 572G/C, tumor necrosis factor-alpha (TNF-\u03b1) 308G/A, and angiotensin-converting enzyme (ACE) I/D gene polymorphisms on Helicobacter pylori ( H. pylori ) infection in children.", {"entities": []}], ["A cross-sectional study was performed on 126 children (57 children with H. pylori infection and 69 children without H. pylori infection) aged between 3 and 18 years presenting to a Pediatrics Tertiary Hospital from Romania.", {"entities": []}], ["Children were assessed clinically, endoscopically, histopathologically, and genetically.", {"entities": []}], ["In our study, we found that the presence of the CT and CT+TT genotypes of IL-6 190C/T ( P \u200a<\u200a.002 and P \u200a=\u200a.04), allele G of IL-6 572\u200aG/C polymorphism ( P \u200a=\u200a.01), genotypes GA and AA of TNF- \u03b1 308\u200aG/A polymorphism ( P \u200a=\u200a.04, P \u200a=\u200a.01), and genotype II of ACE I/D polymorphism ( P \u200a=\u200a.02) were associated with H. pylori infection, while the CC genotype of IL-6 174G/C polymorphism was scarcely encountered in children with H. pylori infection [ P \u200a=\u200a.02, odds ratio (OR)\u200a=\u200a0.06; 95% confidence interval (95% CI): 0.003\u20130.128].", {"entities": []}], ["Taking under consideration the 4 variant genotypes (IL-6 572G/C , IL-6 190C/T , TNF- \u03b1 308G/A, and ACE I/D ), we noticed a 2 times higher incidence of H. pylori infection (OR\u200a=\u200a6.34; 95% CI: 2.15\u201325.8).", {"entities": []}], ["We may consider that the IL-6 190C/T , IL-6 174G/C , IL-6 572G/C, TNF- \u03b1 308G/A, and ACE I/D gene polymorphisms may increase the children's susceptibility for acquiring H. pylori infection; therefore, they may contribute to the pathogenesis of H. pylori gastritis.", {"entities": [[254, 263, "DISEASE"]]}], ["Inflammation and haemorrhage are the main characteristics of tissue injury in botropic envenomation.", {"entities": []}], ["Although some studies have shown that anti-venom prevents systemic reactions, it is not efficient in preventing tissue injury at the site of the bite.", {"entities": []}], ["Therefore, this work was undertaken to investigate the anti-inflammatory effects of the methanolic extract and fractions from D. elliptica and to evaluate the role of matrix metalloproteinases (MMPs) in this process.", {"entities": []}], ["Effects of the extract and fractions from D. elliptica were evaluated using a carrageenan-induced paw oedema model in rats, and leukocyte rolling was visualized by intravital.", {"entities": []}], ["The quantification of MMPs activities (MMP-2 and MMP-9) extracted from the dermis of mice treated with extract and fractions alone or incubated with venom was determined by zymographic analyses.", {"entities": []}], ["Our results show that intraperitoneal (i.p.)", {"entities": []}], ["injection of fractions significantly reduced paw oedema after the carrageenan challenge.", {"entities": []}], ["Treatment with the tannins fraction also resulted in considerable inhibition of the rolling of leukocytes and this fraction was able to decrease the activation of MMP-9.", {"entities": []}], ["These results confirmed the anti-inflammatory activity of the methanolic extract and tannins fraction of D. elliptica and showed that the dermonecrosis properties of B. jararaca venom might be mediated through the inhibition of MMP-9 activity.", {"entities": []}], ["Recent advances in lung cancer biology presuppose its inflammatory origin.", {"entities": [[19, 30, "DISEASE"], [24, 30, "DISEASE"]]}], ["In this regard, LTB-4 and IL-8 are recognized to play a crucial role in neutrophil recruitment into airways during lung cancer.", {"entities": [[115, 126, "DISEASE"], [120, 126, "DISEASE"]]}], ["Notwithstanding the intriguing hypothesis, the exact role of neutrophilic inflammation in tumour biology remains complex and not completely known.", {"entities": []}], ["The aim of this study was to give our contribution in this field by investigating LTB-4 and IL-8 in the breath condensate of NSCLC patients and verifying their role in cancer development and progression.", {"entities": [[168, 174, "DISEASE"]]}], ["We enrolled 50 NSCLC patients and 35 controls.", {"entities": []}], ["LTB-4 and IL-8 concentrations were measured in the breath condensate and the blood of all the subjects under study using EIA kits.", {"entities": []}], ["Thirty NSCLC patients and ten controls underwent induced sputum collection and analysis.", {"entities": []}], ["LTB-4 and IL-8 resulted higher in breath condensate and the blood of NSCLC patients compared to controls.", {"entities": []}], ["Significantly higher concentrations were found as the cancer stages progressed.", {"entities": [[54, 60, "DISEASE"]]}], ["A positive correlation was observed between exhaled IL-8 and LTB-4 and the percentage of neutrophils in the induced sputum.", {"entities": []}], ["The high concentrations of exhaled LTB-4 and IL-8 showed the presence of a neutrophilic inflammation in the airways of NSCLC patients and gave a further support to the inflammatory signalling in lung cancer.", {"entities": [[195, 206, "DISEASE"], [200, 206, "DISEASE"]]}], ["These exhaled proteins could represent a suitable non-invasive marker in the diagnosis and monitoring of lung cancer.", {"entities": [[105, 116, "DISEASE"], [110, 116, "DISEASE"]]}], ["The ventilatory management of patients with acute respiratory failure is supported by good evidence, aiming to reduce lung injury by pressure limitation and reducing the duration of ventilatory support by regular assessment for discontinuation.", {"entities": [[50, 69, "DISEASE"]]}], ["Certain patient groups, however, due to their altered physiology or disease-specific complications, may require some variation in usual ventilatory management.", {"entities": []}], ["The present manuscript reviews the ventilatory management in three special populations, namely the patient with brain injury, the pregnant patient and the morbidly obese patient.", {"entities": []}], ["The aetiology of osteoporotic fractures is multifactorial, but little is known about the way to evaluate patients with a recent clinical fracture for the presence of secondary osteoporosis.", {"entities": [[176, 188, "DISEASE"]]}], ["The purpose of this study was to determine the prevalence of contributors to secondary osteoporosis in patients presenting with a clinical vertebral or non-vertebral fracture.", {"entities": [[87, 99, "DISEASE"]]}], ["Identifying and correcting these contributors will enhance treatment effect aimed at reducing the risk of subsequent fractures.", {"entities": []}], ["In a multidisciplinary approach, including evaluation of bone and fall-related risk factors, 100 consecutive women (n = 73) and men (n = 27) older than 50 years presenting with a clinical vertebral or non-vertebral fracture and having osteoporosis (T-score \u2264-2.5) were further evaluated clinically and by laboratory testing for the presence of contributors to secondary osteoporosis.", {"entities": [[235, 247, "DISEASE"], [370, 382, "DISEASE"]]}], ["In 27 patients, 34 contributors were previously known, in 50 patients 52 new contributors were diagnosed (mainly vitamin D deficiency in 42) and 14 needed further exploration because of laboratory abnormalities (mainly abnormal thyroid stimulating hormone in 9).", {"entities": []}], ["The 57 patients with contributors were older (71 vs. 64 yrs, p < 0.01), had more vertebral deformities (67% vs. 44%, p < 0.05) and a higher calculated absolute 10-year risk for major (16.5 vs. 9.9%, p < 0.01) and for hip fracture (6.9 vs. 2.4%, p < 0.01) than patients without contributors.", {"entities": []}], ["The presence of contributors was similar between women and men and between patients with fractures associated with a low or high-energy trauma.", {"entities": []}], ["We conclude that more than one in two patients presenting with a clinical vertebral or non-vertebral fracture and BMD-osteoporosis have secondary contributors to osteoporosis, most of which were correctable.", {"entities": [[118, 130, "DISEASE"], [162, 174, "DISEASE"]]}], ["Identifying and correcting these associated disorders will enhance treatment effect aimed at reducing the risk of subsequent fractures in patients older than 50 years.", {"entities": []}], ["Contemporary genetic variation among Latin Americans human groups reflects population migrations shaped by complex historical, social and economic factors.", {"entities": []}], ["Consequently, admixture patterns may vary by geographic regions ranging from countries to neighborhoods.", {"entities": []}], ["We examined the geographic variation of admixture across the island of Puerto Rico and the degree to which it could be explained by historic and social events.", {"entities": []}], ["We analyzed a census-based sample of 642 Puerto Rican individuals that were genotyped for 93 ancestry informative markers (AIMs) to estimate African, European and Native American ancestry.", {"entities": []}], ["Socioeconomic status (SES) data and geographic location were obtained for each individual.", {"entities": []}], ["There was significant geographic variation of ancestry across the island.", {"entities": []}], ["In particular, African ancestry demonstrated a decreasing East to West gradient that was partially explained by historical factors linked to the colonial sugar plantation system.", {"entities": []}], ["SES also demonstrated a parallel decreasing cline from East to West.", {"entities": []}], ["However, at a local level, SES and African ancestry were negatively correlated.", {"entities": []}], ["European ancestry was strongly negatively correlated with African ancestry and therefore showed patterns complementary to African ancestry.", {"entities": []}], ["By contrast, Native American ancestry showed little variation across the island and across individuals and appears to have played little social role historically.", {"entities": []}], ["The observed geographic distributions of SES and genetic variation relate to historical social events and mating patterns, and have substantial implications for the design of studies in the recently admixed Puerto Rican population.", {"entities": []}], ["More generally, our results demonstrate the importance of incorporating social and geographic data with genetics when studying contemporary admixed populations.", {"entities": []}], ["Interactive multimedia is an emerging technology that is being used to facilitate interactions between patients and health professionals.", {"entities": []}], ["The purpose of this review was to identify and evaluate the impact of multimedia interventions (MIs), delivered in the context of paediatric healthcare, in order to inform the development of a MI to promote the communication of dietetic messages with overweight preadolescent children.", {"entities": []}], ["Of particular interest were the effects of these MIs on child engagement and participation in treatment, and the subsequent effect on health-related treatment outcomes.", {"entities": []}], ["An extensive search of 12 bibliographic databases was conducted in April 2012.", {"entities": []}], ["Studies were included if: one or more child-participant was 7 to 11-years-of-age; a MI was used to improve health-related behaviour; child-participants were diagnosed with a health condition and were receiving treatment for that condition at the time of the study.", {"entities": []}], ["Data describing study characteristics and intervention effects on communication, satisfaction, knowledge acquisition, changes in self-efficacy, healthcare utilisation, and health outcomes were extracted and summarised using qualitative and quantitative methods.", {"entities": []}], ["A total of 14 controlled trials, published between 1997 and 2006 met the selection criteria.", {"entities": []}], ["Several MIs had the capacity to facilitate engagement between the child and a clinician, but only one sought to utilise the MI to improve communication between the child and health professional.", {"entities": []}], ["In spite of concerns over the quality of some studies and small study populations, MIs were found useful in educating children about their health, and they demonstrated potential to improve children\u2019s health-related self-efficacy, which could make them more able partners in face-to-face communications with health professionals.", {"entities": []}], ["The findings of this review suggest that MIs have the capacity to support preadolescent child-clinician communication, but further research in this field is needed.", {"entities": []}], ["Particular attention should be given to designing appropriate MIs that are clinically relevant.", {"entities": []}], ["Patient: Female, 43 Final Diagnosis: \u2014 Symptoms: Diarrhea \u2022 generalized weakness \u2022 headache \u2022 lightheadedness \u2022 nausea \u2022 rash \u2022 short of breath \u2022 vomiting Medication: \u2014 Clinical Procedure: \u2014 Specialty: Pulmonology Rare diseae IFN-alpha-2b in combination with ribavirin is now the standard of care for the treatment of hepatitis C. Sarcoidosis is a chronic multisystem granulomatous disorder characterized by noncaseating granulomas in the involved organs.", {"entities": [[318, 327, "DISEASE"], [331, 342, "DISEASE"], [49, 57, "DISEASE"]]}], ["The pathologic hallmark of sarcoidosis is the presence of noncaseating granulomas in the interstitium that typically involve the lymphatics.", {"entities": [[27, 38, "DISEASE"]]}], ["A 43-year-old woman presented to our care with 2-week history of nausea, vomiting, diarrhea, shortness of breath, migraine headache, maculopapular rash, generalized weakness, and lightheadedness.", {"entities": [[114, 122, "DISEASE"], [83, 91, "DISEASE"]]}], ["She had been treated for hepatitis C with telaprevir, ribavirin, and interferon-alpha-2b for 6 months.", {"entities": [[25, 34, "DISEASE"]]}], ["Chest radiograph showed bilateral diffuse prominence of bronchovascular markings.", {"entities": []}], ["CT of the chest revealed bilateral diffuse centrilobular nodules with associated intralobular septal thickening, thickening of the central peribronchovascular interstitium, nodularity of the major fissures, and mediastinal lymphadenopathy.", {"entities": []}], ["These findings were suspicious for atypical pulmonary sarcoidosis, possibly interferon-induced.", {"entities": [[54, 65, "DISEASE"], [44, 65, "DISEASE"]]}], ["The pathology of the mediastinal lymph node biopsy revealed noncaseating granulomatous inflammation consistent with the diagnosis of pulmonary sarcoidosis.", {"entities": [[143, 154, "DISEASE"], [133, 154, "DISEASE"]]}], ["Pathology of the skin punch biopsy showed giant-cell granulomatous inflammation without necrosis.", {"entities": []}], ["The patient was started on prednisone 40 mg daily with a steroid tapering course for 8 weeks.", {"entities": []}], ["The management of IFN-induced sarcoidosis includes the discontinuation of IFN therapy with or without the administration of systemic corticosteroids.", {"entities": [[30, 41, "DISEASE"]]}], ["With the increasing prevalence of HCV in the United States, it is likely that more IFN-alpha-induced sarcoidosis will be encountered by clinicians.", {"entities": [[101, 112, "DISEASE"]]}], ["Because treadmill exercise testing is more representative of daily activity than cycle testing, we developed treadmill protocols to be used in various clinical settings as part of a two-year, multicenter, chronic obstructive pulmonary disease (COPD) trial evaluating the effect of tiotropium on exercise.", {"entities": [[205, 242, "DISEASE"]]}], ["We enrolled 519 COPD patients aged 64.6 \u00b1 8.3 years with a postbronchodilator forced expiratory volume in one second (FEV 1 ) of 1.25 \u00b1 0.42 L, 44.3% \u00b1 11.9% predicted.", {"entities": [[118, 121, "GENE"]]}], ["The patients performed symptom-limited treadmill tests where work rate ( \u1e86 ) was increased linearly using speed and grade adjustments every minute.", {"entities": []}], ["On two subsequent visits, they performed constant \u1e86 tests to exhaustion at 90% of maximum \u1e86 from the incremental test.", {"entities": []}], ["Mean incremental test duration was 522 \u00b1 172 seconds (range 20\u2013890), maximum work rate 66 \u00b1 34 watts.", {"entities": []}], ["For the first and second constant \u1e86 tests, both at 61 \u00b1 33 watts, mean endurance times were 317 \u00b1 61 seconds and 341 \u00b1 184 seconds, respectively.", {"entities": []}], ["The mean of two tests had an intraclass correlation coefficient of 0.85 ( P < 0.001).", {"entities": []}], ["During the second constant \u1e86 test, 88.2% of subjects stopped exercise because of breathing discomfort; 87.1% for Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stage II, 88.5% for GOLD Stage III, and 90.2% for GOLD Stage IV.", {"entities": []}], ["The symptom-limited incremental and constant work treadmill protocol was well tolerated and appeared to be representative of the physiologic limitations of COPD.", {"entities": []}], ["Objective \u2003Based on social ecological theory, this study was designed to examine the unique relationships between multi-level ecological factors and psychological symptoms in young adults with spina bifida (SB).", {"entities": [[193, 205, "DISEASE"]]}], ["Method \u2003A sample of 61 individuals with SB, 18\u201325 years of age, completed standardized self-report measures of attitude toward SB, satisfaction with family functioning, Chronic Care Model (CCM) services, and depressive and anxiety symptoms.", {"entities": []}], ["A chart review yielded SB clinical data.", {"entities": []}], ["Results \u2003High rates of depressive and anxiety symptoms were found.", {"entities": []}], ["Hierarchical regression analysis identified the proximal individual (attitude toward SB) and family (satisfaction with family functioning) factors as more strongly related to depressive symptoms than the distal healthcare system factor (CCM services).", {"entities": []}], ["Self-reported pain was the only ecological factor associated with anxiety symptoms.", {"entities": []}], ["Conclusions \u2003Study findings provide a potential foundation for multi-factor screening of young adults with SB at risk for psychological symptoms.", {"entities": []}], ["The purpose of this study was to assess the feasibility of the Spanish Diabetes Self-Management Program (SDSMP) in the primary care setting of the Basque Health Service and offer initial estimations of the randomized controlled trial (RCT) effects.", {"entities": []}], ["Ten health centers (HCs) participated in a single-arm pilot study with a 6-month follow-up period between February 2011 and June 2012.", {"entities": []}], ["Recruitment was performed via invitation letters, health professionals, and the local media.", {"entities": []}], ["Each intervention group consisted of 8\u201315 people.", {"entities": []}], ["The ability of each HC in forming up to 2 groups, participants' compliance with the course, and coordination and data collection issues were evaluated.", {"entities": []}], ["Glycated haemoglobin (HbA1c) was the main outcome variable.", {"entities": []}], ["Secondary outcomes were cardiovascular risk factors, drugs consumption, medical visits, quality of life, self-efficacy, physical exercise, and diet.", {"entities": []}], ["Two HCs did not organize a course.", {"entities": []}], ["A total of 173 patients initiated the program, 2 dropped out without baseline data, and 90% completed it.", {"entities": []}], ["No pre-post HbA1c differences existed.", {"entities": []}], ["Certain improvements were observed in blood pressure control, self-efficacy, physical activity, and some dietary habits.", {"entities": []}], ["Conclusion .", {"entities": []}], ["The SDSMP is feasible in our setting.", {"entities": []}], ["Our experience can be of interest when planning and conducting this program in similar health settings.", {"entities": []}], ["The trial is registered with ClinicalTrials.gov identifier NCT01642394 .", {"entities": []}], ["Diabetes is a chronic disease characterized by inadequate insulin secretion with resulting hyperglycemia.", {"entities": [[91, 104, "DISEASE"]]}], ["Diabetes complications include both microvascular and macrovascular disease, both of which are affected by optimal diabetes control.", {"entities": []}], ["Many individuals with diabetes rely on subcutaneous insulin administration by injection or continuous infusion to control glucose levels.", {"entities": []}], ["Novel routes of insulin administration are an area of interest in the diabetes field, given that insulin injection therapy is burdensome for many patients.", {"entities": []}], ["This review will discuss pulmonary delivery of insulin via inhalation.", {"entities": []}], ["The safety of inhaled insulin as well as the efficacy in comparison to subcutaneous insulin in the various populations with diabetes are covered.", {"entities": []}], ["In addition, the experience and pitfalls that face the development and marketing of inhaled insulin are discussed.", {"entities": []}], ["The physiopathology of dengue hemorrhagic fever (DHF), a severe form of Dengue Fever, is poorly understood.", {"entities": [[23, 47, "DISEASE"]]}], ["We are unable to identify patients likely to progress to DHF for closer monitoring and early intervention during epidemics, so most cases are sent home.", {"entities": []}], ["This study explored whether patients with selected co-morbidities are at higher risk of developing DHF.", {"entities": []}], ["A matched case-control study was conducted in a dengue sero-positive population in two Brazilian cities.", {"entities": []}], ["For each case of DHF, 7 sero-positive controls were selected.", {"entities": []}], ["Cases and controls were interviewed and information collected on demographic and socio-economic status, reported co-morbidities (diabetes, hypertension, allergy) and use of medication.", {"entities": [[139, 151, "DISEASE"]]}], ["Conditional logistic regression was used to calculate the strength of the association between the co-morbidities and occurrence of DHF.", {"entities": []}], ["170 cases of DHF and 1,175 controls were included.", {"entities": []}], ["Significant associations were found between DHF and white ethnicity (OR\u200a=\u200a4.70; 2.17\u201310.20), high income (OR\u200a=\u200a6.84; 4.09\u201311.43), high education (OR\u200a=\u200a4.67; 2.35\u20139.27), reported diabetes (OR\u200a=\u200a2.75; 1.12\u20136.73) and reported allergy treated with steroids (OR\u200a=\u200a2.94; 1.01\u20138.54).", {"entities": []}], ["Black individuals who reported being treated for hypertension had 13 times higher risk of DHF then black individuals reporting no hypertension.", {"entities": [[49, 61, "DISEASE"], [130, 142, "DISEASE"]]}], ["This is the first study to find an association between DHF and diabetes, allergy and hypertension.", {"entities": [[85, 97, "DISEASE"]]}], ["Given the high case fatality rate of DHF (1\u20135%), we believe that the evidence produced in this study, when confirmed in other studies, suggests that screening criteria might be used to identify adult patients at a greater risk of developing DHF with a recommendation that they remain under observation and monitoring in hospital.", {"entities": []}], ["Dengue is an arboviral disease that affects large areas of countries in tropical and subtropical regions of the world.", {"entities": []}], ["Around 500,000 cases and 22,000 deaths of dengue hemorrhagic fever (DHF)/Dengue Shock Syndrome (DSS), the most severe presentations of this disease, occur annually.", {"entities": [[42, 66, "DISEASE"]]}], ["It is unclear why some cases of dengue fever (0.5% to 4%) progress to DHF/DSS.", {"entities": []}], ["There is weak evidence that some diseases could have a role in this process, such as diabetes, hypertension, and allergies.", {"entities": [[95, 107, "DISEASE"]]}], ["In epidemics most dengue fever cases are sent home as there are too many to be kept in observation, but if it were possible to identify those with a higher risk of progression to DHF, they could be kept for observation, for early detection of signs, symptoms and alterations in laboratory tests suggestive of DHF, to enable timely and effective clinical management and early intervention.", {"entities": []}], ["We study this issue and we believe that the evidence produced in this study, when confirmed in other studies, suggests that screening criteria might be used to identify adult patients at a greater risk of developing DHF with a recommendation that they remain under observation and monitoring in a hospital.", {"entities": []}], ["To explore the association between postmenopausal hormone therapy (HT) and Alzheimer disease (AD).", {"entities": []}], ["Twenty-year follow-up data from the Kuopio Osteoporosis Risk Factor and Prevention study cohort were used.", {"entities": []}], ["Self-administered questionnaires were sent to all women aged 47\u201356 years, residing in Kuopio Province starting in 1989 until 2009, every 5th year.", {"entities": []}], ["Register-based information on HT prescriptions was available since 1995.", {"entities": []}], ["Probable AD cases, based on DSM-IV and National Institute of Neurological and Communicative Disorders and Stroke\u2013Alzheimer's Disease and Related Disorders Association criteria, were identified from the special reimbursement register (1999\u20132009).", {"entities": []}], ["The study population included 8,195 women (227 cases of incident AD).", {"entities": []}], ["Postmenopausal estrogen use was not associated with AD risk in register-based or self-reported data (hazard ratio/95% confidence interval 0.92/0.68\u20131.2, 0.99/0.75\u20131.3, respectively).", {"entities": []}], ["Long-term self-reported postmenopausal HT was associated with reduced AD risk (0.53/0.31\u20130.91).", {"entities": []}], ["Similar results were obtained with any dementia diagnosis in the hospital discharge register as an outcome.", {"entities": [[39, 47, "DISEASE"]]}], ["Our results do not provide strong evidence for a protective association between postmenopausal HT use and AD or dementia, although we observed a reduced AD risk among those with long-term self-reported HT use.", {"entities": [[112, 120, "DISEASE"]]}], ["Non-communicable diseases (NCDs) are a leading cause of death among adults in sub-Saharan Africa, and chronic kidney disease (CKD) is a growing public health threat.", {"entities": [[110, 124, "DISEASE"]]}], ["Understanding knowledge, attitudes, and practices associated with NCDs is vital to informing optimal policy and public health responses in the region, but few community-based assessments have been performed for CKD.", {"entities": []}], ["To address this gap, we conducted a cross-sectional survey of adults in northern Tanzania using a validated instrument.", {"entities": []}], ["Between January and June 2014, we administered a structured survey to a random sample of adults from urban and rural communities.", {"entities": []}], ["The validated instrument consisted of 25 items designed to measure knowledge, attitudes, and practices associated with kidney disease.", {"entities": [[119, 133, "DISEASE"]]}], ["Participants were also screened for CKD, diabetes, hypertension, and human immunodeficiency virus.", {"entities": [[51, 63, "DISEASE"]]}], ["We enrolled 606 participants from 431 urban and rural households.", {"entities": []}], ["Knowledge of the etiologies, symptoms, and treatments for kidney disease was low (mean score 3.28 out of 10; 95% CI 2.94, 3.63).", {"entities": [[58, 72, "DISEASE"]]}], ["There were no significant differences by CKD status.", {"entities": []}], ["Living in an urban setting and level of education had the strongest independent associations with knowledge score.", {"entities": []}], ["Attitudes were characterized by frequent concern about the health (27.3%; 20.2, 36.0%), economic (73.1%; 68.2, 77.5%), and social impact (25.4%; 18.6, 33.6%) of kidney disease.", {"entities": [[161, 175, "DISEASE"]]}], ["Practices included the use of traditional healers (15.2%; 9.1, 24.5%) and traditional medicines (33.8%; 25.0, 43.9%) for treatment of kidney disease as well as a willingness to engage with mobile-phone technology in CKD care (94.3%; 90.1, 96.8%).", {"entities": [[134, 148, "DISEASE"]]}], ["Community-based adults in northern Tanzania have limited knowledge of kidney disease.", {"entities": [[70, 84, "DISEASE"]]}], ["However, there is a modest knowledge base upon which to build public health programs to expand awareness and understanding of CKD, but these programs must also consider the variety of means by which adults in this population meet their healthcare needs.", {"entities": []}], ["Finally, our assessment of local attitudes suggested that such public health efforts would be well-received.", {"entities": []}], ["Although most reports describing patients infected with methicillin-resistant Staphylococcus aureus enterocolitis have been published in Japan, this concept remains a matter of debate and diagnostic criteria have not yet been defined.", {"entities": []}], ["The general status of a 74-year-old Japanese man referred to our hospital (day 1) with severe community-acquired pneumococcal pneumonia gradually improved with antibiotic therapy.", {"entities": [[126, 135, "DISEASE"]]}], ["Thereafter, up to 4\u00a0L/day of acute watery diarrhea that started on day 19 was refractory to metronidazole but responded immediately to oral vancomycin.", {"entities": [[42, 50, "DISEASE"]]}], ["Gram staining stool samples was positive for abundant fecal leukocytes from which dominant methicillin-resistant Staphylococcus aureus (10 Staphylococcus aureus enterocolitis.", {"entities": []}], ["High fever with methicillin-resistant Staphylococcus aureus bacteremia was evident at day 30, and suppurative right hip arthritis developed around day 71.", {"entities": [[120, 129, "DISEASE"]]}], ["All methicillin-resistant Staphylococcus aureus strains isolated from stools, blood and aspirated synovial fluid separated in the same manner on p ulsed-field gel electrophoresis, as well as two other strains isolated from sputum, belonged to the same clone as sequence type (ST) 764 (complex clonal 5), and carried SCC mec type II.", {"entities": []}], ["The clinical, microbiological and molecular biological findings of this patient indicated methicillin-resistant Staphylococcus aureus enterocolitis that led to septic methicillin-resistant Staphylococcus aureus arthritis.", {"entities": [[211, 220, "DISEASE"]]}], ["Food allergy can present as immediate hypersensitivity [manifestations mediated by immunoglobulin (Ig)E], delayed-type hypersensitivity (reactions associated with specific T lymphocytes), and inflammatory reactions caused by immune complexes.", {"entities": [[0, 12, "DISEASE"]]}], ["For reasons of ethics and efficacy, investigations in humans to determine sensitization and allergic responses of IgE production to innocuous food proteins are not feasible.", {"entities": []}], ["Therefore, animal models are used a) to bypass the innate tendency to develop tolerance to food proteins and induce specific IgE antibody of sufficient avidity/affinity to cause sensitization and upon reexposure to induce an allergic response, b) to predict allergenicity of novel proteins using characteristics of known food allergens, and c) to treat food allergy by using immunotherapeutic strategies to alleviate life-threatening reactions.", {"entities": [[353, 365, "DISEASE"]]}], ["The predominant hypothesis for IgE-mediated food allergy is that there is an adverse reaction to exogenous food proteins or food protein fragments, which escape lumen hydrolysis, and in a polarized helper T cell subset 2 (Th2) environment, immunoglobulin class switching to allergen-specific IgE is generated in the immune system of the gastrointestinal-associated lymphoid tissues.", {"entities": [[44, 56, "DISEASE"]]}], ["Traditionally, the immunologic characterization and toxicologic studies of small laboratory animals have provided the basis for development of animal models of food allergy; however, the natural allergic response in large animals, which closely mimic allergic diseases in humans, can also be useful as models for investigations involving food allergy.", {"entities": [[160, 172, "DISEASE"], [338, 350, "DISEASE"]]}], ["Despite evidence from other healthcare settings that language barriers negatively impact patient outcomes, the literature on language barriers in emergency medical services (EMS) has not been previously summarized.", {"entities": []}], ["The objective of this study is to systematically review existing studies of the impact of language barriers on prehospital emergency care and identify opportunities for future research.", {"entities": []}], ["A systematic review with narrative synthesis of publications with populations specific to the prehospital setting and outcome measures specific to language barriers was conducted.", {"entities": []}], ["A four-prong search strategy of academic databases (PubMed, Academic Search Complete, and Clinical Key) through March 2015, web-based search for gray literature, search of citation lists, and review of key conference proceedings using pre-defined eligibility criteria was used.", {"entities": []}], ["Language-related outcomes were categorized and reported as community-specific outcomes, EMS provider-specific outcomes, patient-specific outcomes, or health system-specific outcomes.", {"entities": []}], ["Twenty-two studies met eligibility criteria for review.", {"entities": []}], ["Ten publications (45%) focused on community-specific outcomes.", {"entities": []}], ["Language barriers are perceived as a barrier by minority language speaking communities to activating EMS.", {"entities": []}], ["Eleven publications (50%) reported outcomes specific to EMS providers, with six of these studies focused on EMS dispatch.", {"entities": []}], ["EMS dispatchers describe less accurate and delayed dispatch of resources when confronted with language discordant callers, as well as limitations in the ability to provide medical direction to callers.", {"entities": []}], ["There is a paucity of research on EMS treatment and transport decisions, and no studies provided patient-specific or health system-specific outcomes.", {"entities": []}], ["Key research gaps include identifying the mechanisms by which language barriers impact care, the effect of language barriers on EMS utilization and clinically significant outcomes, and the cost implications of addressing language barriers.", {"entities": []}], ["The existing research on prehospital language barriers is largely exploratory, and substantial gaps in understanding the interaction between language barriers and prehospital care have yet to be addressed.", {"entities": []}], ["Future research should be focused on clarifying the clinical and cost implications of prehospital language barriers.", {"entities": []}], ["Concerns have been raised about the adverse impact of Asian dust storms (ADS) on human health; however, few studies have examined the effect of these events on children\u2019s health.", {"entities": []}], ["Using databases from the Taiwan National Health Insurance and Taiwan Environmental Protection Agency, this study investigates the documented daily visits of children to respiratory clinics during and after ADS that occurred from 1997 to 2007 among 12 districts across Taipei City by applying a Bayesian structural additive regressive model controlled for spatial and temporal patterns.", {"entities": []}], ["This study finds that the significantly impact of elevated children\u2019s respiratory clinic visits happened after ADS.", {"entities": []}], ["Five of the seven lagged days had increasing percentages of relative rate, which was consecutively elevated from a 2-day to a 5-day lag by 0.63%\u223c2.19% for preschool children (i.e., 0\u223c6 years of age) and 0.72%\u223c3.17% for school children (i.e., 7\u223c14 years of age).", {"entities": []}], ["The spatial pattern of clinic visits indicated that geographical heterogeneity was possibly associated with the clinic\u2019s location and accessibility.", {"entities": []}], ["Moreover, day-of-week effects were elevated on Monday, Friday, and Saturday.", {"entities": []}], ["We concluded that ADS may significantly increase the risks of respiratory diseases consecutively in the week after exposure, especially in school children.", {"entities": []}], ["The aim of this study was to determine factors associated with active pulmonary tuberculosis seen in cases in Ambo Hospital, Ethiopia.", {"entities": [[80, 92, "DISEASE"], [70, 92, "DISEASE"]]}], ["A facility-based prospective case-control study.", {"entities": []}], ["Patients attending Ambo Hospital from 01 December 2011 to 29 March 2012.", {"entities": []}], ["The sample included 312 adult patients attending Ambo Hospital.", {"entities": []}], ["The main outcome measure was presence of active pulmonary tuberculosis (TB).", {"entities": [[58, 70, "DISEASE"], [48, 70, "DISEASE"]]}], ["Age, gender, occupation, educational status, marital status, place of residence, patient history of TB, family history of TB, human immunodeficiency virus (HIV) infection, smoking, alcohol intake, khat chewing, body mass index (BMI), employment, diabetes, history of asthma, previous history of worm infestation, history of hospitalisation, number of adults living in the household (HH), person per room, housing condition.", {"entities": [[267, 273, "DISEASE"]]}], ["A total of 312 study participants, including 104 active pulmonary tuberculosis (PTB) cases (cases) and 208 non-active PTB cases (controls), were recruited for the present study.", {"entities": [[66, 78, "DISEASE"], [56, 78, "DISEASE"]]}], ["Having one or more family member with a history of TB (OR = 4.4; 95% CI: 1.50\u201312.90), marital status (OR = 7.6; 95% CI: 2.2\u201312.6), male gender (OR = 3.2; 95% CI: 1.4\u20137), rural residence (OR = 3.3; P = 0.012), being a current or past smoker (OR = 2.8; 95% CI: 1.1\u20137.2), BMI < 18.5 (OR = 2.1; 95% CI: 1.03\u20134.2), HIV infection (OR = 8.8; 95% CI: 2.4\u201323.8) and a history of worm infestation (OR = 6.4; 95% CI: 2.6\u201315.4) remained significant independent host-related factors for active PTB.", {"entities": []}], ["Patients who came from a compound with more than two HHs were more likely to develop active PTB than those who came from a compound with only one HH.", {"entities": []}], ["Those who lived in houses with no windows were more likely to develop active PTB than those who lived in houses with one or more windows, had a family history of TB, lived in rural areas.", {"entities": []}], ["Sex of the patient was a predicting factor.", {"entities": []}], ["Not being the owner of the house was significantly more associated with active PTB.", {"entities": []}], ["Measures taken to reduce the prevalence and burden of active PTB should consider these determinant factors.", {"entities": []}], ["Although airway epithelia are primarily devoted to gas exchange, they have to fulfil a number of different tasks including organ maintenance and the epithelial immune response to fight airborne pathogens.", {"entities": []}], ["These different tasks are at least partially accomplished by specialized cell types in the epithelium.", {"entities": []}], ["In addition, a proximal to distal gradient mirroring the transition from airflow conduction to real gas exchange, is also operative.", {"entities": []}], ["We analysed the airway system of larval Drosophila melanogaster with respect to region-specific expression in the proximal to distal axis.", {"entities": []}], ["The larval airway system is made of epithelial cells only.", {"entities": []}], ["We found differential expression between major trunks of the airways and more distal ones comprising primary, secondary and terminal ones.", {"entities": []}], ["A more detailed analysis was performed using DNA-microarray analysis to identify cohorts of genes that are either predominantly expressed in the dorsal trunks or in the primary/secondary/terminal branches of the airways.", {"entities": []}], ["Among these differentially expressed genes are especially those involved in signal transduction.", {"entities": []}], ["Wnt -signalling associated genes for example are predominantly found in secondary/terminal airways.", {"entities": []}], ["In addition, some G-protein coupled receptors are differentially expressed between both regions of the airways, exemplified by those activated by octopamine or tyramine, the invertebrate counterparts of epinephrine and norepinephrine.", {"entities": []}], ["Whereas the OAMB is predominantly found in terminal airway regions, the oct3\u03b2R has higher expression levels in dorsal trunks.", {"entities": []}], ["In addition, we observed a significant association of both, genes predominantly expressed in dorsal trunks or in primary to terminal branches branches with those regulated by hypoxia.", {"entities": []}], ["Taken together, this observed differential expression is indicative for a proximal to distal transcriptional regionalization presumably reflecting functional differences in these parts of the fly\u2019s airway system.", {"entities": []}], ["Unique features of immunity early in life include a distinct immune system particularly reliant on innate immunity, with weak T helper (Th)1-polarizing immune responses, and impaired responses to certain vaccines leading to a heightened susceptibility to infection.", {"entities": []}], ["To these important aspects, we now add an increasingly appreciated concept that the innate immune system displays epigenetic memory of an earlier infection or vaccination, a phenomenon that has been named \u201c trained immunity \u201d.", {"entities": []}], ["Exposure of neonatal leukocytes in vitro or neonatal animals or humans in vivo to specific innate immune stimuli results in an altered innate immune set point.", {"entities": []}], ["Given the particular importance of innate immunity early in life, trained immunity to early life infection and/or immunization may play an important role in modulating both acute and chronic diseases.", {"entities": []}], ["Controlling bioaerosols has become more important with increasing participation in indoor activities.", {"entities": []}], ["Treatments using natural-product nanomaterials are a promising technique because of their relatively low toxicity compared to inorganic nanomaterials such as silver nanoparticles or carbon nanotubes.", {"entities": []}], ["In this study, antimicrobial filters were fabricated from natural Euscaphis japonica nanoparticles, which were produced by nebulizing E .", {"entities": []}], ["japonica extract.", {"entities": []}], ["The coated filters were assessed in terms of pressure drop, antimicrobial activity, filtration efficiency, major chemical components, and cytotoxicity.", {"entities": []}], ["Pressure drop and antimicrobial activity increased as a function of nanoparticle deposition time (590, 855, and 1150 \u00b5g/cm2 filter at 3-, 6-, and 9-min depositions, respectively).", {"entities": []}], ["In filter tests, the antimicrobial efficacy was greater against Staphylococcus epidermidis than Micrococcus luteus ; ~61, ~73, and ~82% of M .", {"entities": []}], ["luteus cells were inactivated on filters that had been coated for 3, 6, and 9 min, respectively, while the corresponding values were ~78, ~88, and ~94% with S .", {"entities": []}], ["epidermidis .", {"entities": []}], ["Although statistically significant differences in filtration performance were not observed between samples as a function of deposition time, the average filtration efficacy was slightly higher for S .", {"entities": []}], ["epidermidis aerosols (~97%) than for M .", {"entities": []}], ["luteus aerosols (~95%).", {"entities": []}], ["High-performance liquid chromatography (HPLC) and electrospray ionization-tandem mass spectrometry (ESI/MS) analyses confirmed that the major chemical compounds in the E .", {"entities": []}], ["japonica extract were 1(\u00df)- O -galloyl pedunculagin, quercetin-3- O -glucuronide, and kaempferol-3- O -glucoside.", {"entities": []}], ["In vitro cytotoxicity and disk diffusion tests showed that E .", {"entities": []}], ["japonica nanoparticles were less toxic and exhibited stronger antimicrobial activity toward some bacterial strains than a reference soluble nickel compound, which is classified as a human carcinogen.", {"entities": []}], ["This study provides valuable information for the development of a bioaerosol control system that is environmental friendly and suitable for use in indoor environments.", {"entities": []}], ["The molecular mechanisms that regulate B-cell development and tolerance remain incompletely understood.", {"entities": []}], ["In this study, we identify a critical role for the miR-17\u223c92 microRNA cluster in regulating B-cell central tolerance and demonstrate that these miRNAs control early B-cell development in a cell-intrinsic manner.", {"entities": []}], ["While the cluster member miR-19 suppresses the expression of Pten and plays a key role in regulating B-cell tolerance, miR-17 controls early B-cell development through other molecular pathways.", {"entities": [[61, 65, "GENE"], [119, 125, "GENE"]]}], ["These findings demonstrate differential control of two closely linked B-cell developmental stages by different members of a single microRNA cluster through distinct molecular pathways.", {"entities": []}], ["MicroRNA cluster 17\u223c92 plays a critical role in B-cell differentiation.", {"entities": []}], ["Here the authors show that miR-19 regulates B-cell tolerance via suppressing the expression of PTEN , whereas miR- 17 is essential for early B-cell development independently of Pten, Phlpp2, or Bim.", {"entities": [[95, 99, "GENE"], [177, 181, "GENE"], [95, 99, "GENE"], [177, 181, "GENE"], [183, 189, "GENE"]]}], ["Glucose is the main source of energy for organ function in neonates.", {"entities": []}], ["There are few published recent data on neonatal glucose levels during cesarean delivery.", {"entities": []}], ["A case (cesarean delivery) -control (vaginal delivery) study was conducted at Khartoum Hospital Sudan to compare blood glucose levels of term newborns born after elective cesarean delivery with those born vaginally.", {"entities": []}], ["Cord blood glucose levels at delivery were significantly lower in women who had a cesarean delivery compared with those who delivered vaginally (99.8\u2009\u00b1\u200920.6 vs. 106.8\u2009\u00b1\u200911.1\u00a0mg/dl, P\u2009=\u20090.026), but there was no significant difference (97.8\u2009\u00b1\u200916.7 vs. 102.1\u2009\u00b1\u20099.6, P\u2009=\u20090.110) in newborn glucose levels at 2\u00a0hours after delivery between the groups.", {"entities": []}], ["In linear regression, cesarean delivery (-6.475\u00a0mg/dl, P\u2009=\u20090.013) and maternal blood glucose levels at the time of delivery (+0.619\u00a0mg, P\u2009<\u20090.001) were significantly associated with mean cord glucose levels.", {"entities": []}], ["This study shows that cord blood glucose levels are significantly lower in cesarean-delivered neonates than vaginally-delivered neonates.", {"entities": []}], ["In addition, cord blood glucose levels are significantly associated with cesarean delivery and maternal blood glucose levels at delivery.", {"entities": []}], ["The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2011479878124993", {"entities": []}], ["Quantitative trait locus (QTL) analysis is a powerful tool for mapping genes for complex traits in mice, but its utility is limited by poor resolution.", {"entities": []}], ["A promising mapping approach is association analysis in outbred stocks or different inbred strains.", {"entities": []}], ["As a proof of concept for the association approach, we applied whole-genome association analysis to hepatic gene expression traits in an outbred mouse population, the MF1 stock, and replicated expression QTL (eQTL) identified in previous studies of F2 intercross mice.", {"entities": [[249, 251, "GENE"]]}], ["We found that the mapping resolution of these eQTL was significantly greater in the outbred population.", {"entities": []}], ["Through an example, we also showed how this precise mapping can be used to resolve previously identified loci (in intercross studies), which affect many different transcript levels (known as eQTL \u201chotspots\u201d), into distinct regions.", {"entities": []}], ["Our results also highlight the importance of correcting for population structure in whole-genome association studies in the outbred stock.", {"entities": []}], ["In rodents, as in humans, traits such as obesity or diabetes are under the influence of many genes spread throughout the genome.", {"entities": [[41, 48, "DISEASE"]]}], ["Using linkage analysis, the locations of the major contributing genes can be mapped only to very large regions of chromosomes, usually encompassing hundreds of genes.", {"entities": []}], ["This has made it difficult to identify the underlying genes and mutations.", {"entities": []}], ["Another approach, analogous to genome-wide association in human populations, is to use association analyses among outbred stocks of mice.", {"entities": []}], ["In this proof-of-principle article, we make use of common variations that locally perturb gene expression to demonstrate the greatly improved mapping resolution of association in mice.", {"entities": []}], ["Our results indicate that association analyses in mice are a powerful approach to the dissection of complex traits and their underlying molecular networks.", {"entities": []}], ["Previous work suggested that macrophage migration inhibitory factor (MIF) may be involved in bladder inflammation.", {"entities": [[69, 72, "GENE"]]}], ["Therefore, the location of MIF was determined immunohistochemically in the bladder, prostate, major pelvic ganglia, sympathetic chain, the L6-S1 dorsal root ganglia (DRG) and the lumbosacral spinal cord of the rat.", {"entities": [[27, 30, "GENE"]]}], ["In the pelvic organs, MIF immunostaining was prominent in the epithelia.", {"entities": [[22, 25, "GENE"]]}], ["MIF was widely present in neurons in the MPG and the sympathetic chain.", {"entities": [[0, 3, "GENE"], [41, 44, "GENE"]]}], ["Some of those neurons also co-localized tyrosine hydroxylase (TH).", {"entities": []}], ["In the DRGs, some of the neurons that stained for MIF also stained for Substance P. In the lumbosacral spinal cord, MIF immunostaining was observed in the white mater, the dorsal horn, the intermediolateral region and in the area around the central canal.", {"entities": [[50, 53, "GENE"], [116, 119, "GENE"], [50, 53, "GENE"], [116, 119, "GENE"]]}], ["Many cells were intensely stained for MIF and glial fibrillary acidic protein (GFAP) suggesting they were glial cells.", {"entities": [[38, 41, "GENE"], [79, 83, "GENE"]]}], ["However, some cells in the lumbosacral dorsal horn were MIF positive, GFAP negative cells suggestive of neurons.", {"entities": [[56, 59, "GENE"], [70, 74, "GENE"]]}], ["Therefore, MIF, a pro-inflammatory cytokine, is localized to pelvic organs and also in neurons of the peripheral and central nervous tissues that innervate those organs.", {"entities": [[11, 14, "GENE"]]}], ["Changes in MIF's expression at the end organ and at peripheral and central nervous system sites suggest that MIF is involved in pelvic viscera inflammation and may act at several levels to promote inflammatory changes.", {"entities": [[11, 14, "GENE"], [109, 112, "GENE"], [11, 14, "GENE"], [109, 112, "GENE"]]}], ["The efficacy, safety and tolerability of lumiracoxib, a novel selective cyclooxygenase-2 (COX-2) inhibitor, has been demonstrated in previous studies of patients with osteoarthritis (OA).", {"entities": [[167, 181, "DISEASE"]]}], ["As it is important to establish the long-term safety and efficacy of treatments for a chronic disease such as OA, the present study compared the effects of lumiracoxib at doses of 100 mg once daily (o.d.)", {"entities": []}], ["and 100 mg twice daily (b.i.d.)", {"entities": []}], ["with those of celecoxib 200 mg o.d.", {"entities": []}], ["on retention on treatment over 1 year.", {"entities": []}], ["In this 52-week, multicentre, randomised, double-blind, parallel-group study, male and female patients (aged at least 40 years) with symptomatic primary OA of the hip, knee, hand or spine were randomised (1:2:1) to lumiracoxib 100 mg o.d.", {"entities": []}], ["(n = 755), lumiracoxib 100 mg b.i.d.", {"entities": []}], ["(n = 1,519) or celecoxib 200 mg o.d.", {"entities": []}], ["The primary objective of the study was to demonstrate non-inferiority of lumiracoxib at either dose compared with celecoxib 200 mg o.d.", {"entities": []}], ["with respect to the 1-year retention on treatment rate.", {"entities": []}], ["Secondary outcome variables included OA pain in the target joint, patient's and physician's global assessments of disease activity, Short Arthritis assessment Scale (SAS) total score, rescue medication use, and safety and tolerability.", {"entities": [[138, 147, "DISEASE"]]}], ["Retention rates at 1 year were similar for the lumiracoxib 100 mg o.d., lumiracoxib 100 mg b.i.d.", {"entities": []}], ["and celecoxib 200 mg o.d.", {"entities": []}], ["groups (46.9% vs 47.5% vs 45.3%, respectively).", {"entities": []}], ["It was demonstrated that retention on treatment with lumiracoxib at either dose was non-inferior to celecoxib 200 mg o.d.", {"entities": []}], ["Similarly, Kaplan-Meier curves for the probability of premature discontinuation from the study for any reason were similar across the treatment groups.", {"entities": []}], ["All three treatments generally yielded comparable results for the secondary efficacy variables and all treatments were well tolerated.", {"entities": []}], ["Long-term treatment with lumiracoxib 100 mg o.d., the recommended dose for OA, was as effective and well tolerated as celecoxib 200 mg o.d.", {"entities": []}], ["in patients with OA.", {"entities": []}], ["clinicaltrials.gov NCT00145301", {"entities": []}], ["Multiple chemical sensitivity, commonly known as environmental illness, is a chronic disease in which exposure to low levels of chemicals causes correlated symptoms of varying intensity.", {"entities": []}], ["With the continuous introduction of new substances, people with MCS suffer significant limitations to their living environment and frequently to their workplace.", {"entities": []}], ["This paper describes the current situation as regards MCS and the critical points in its case definition, which is still not generally agreed upon; this makes it difficult to recognize with certainty, especially, its precise relationship with work.", {"entities": []}], ["Other problems arise in relation to the occupational physician's role in diagnosing and managing the worker with the disorder, the question of low levels of exposure to chemicals, and the best measures possible to prevent it.", {"entities": []}], ["A diagnostic \u201croute\u201d is proposed, useful as a reference for the occupational physician who is often called in first to identify cases suspected of having this disease and to manage MCS workers.", {"entities": []}], ["Work-related problems for people with MCS depend not only on occupational exposure but also on the incompatibility between their illness and their work.", {"entities": []}], ["More occupational physicians need to be \u201csensitive\u201d to MCS, so that these workers are recognized promptly, the work is adapted as necessary, and preventive measures are promoted in the workplace.", {"entities": []}], ["Collaborative writing applications (eg, wikis and Google Documents) hold the potential to improve the use of evidence in both public health and health care.", {"entities": []}], ["The rapid rise in their use has created the need for a systematic synthesis of the evidence of their impact as knowledge translation (KT) tools in the health care sector and for an inventory of the factors that affect their use.", {"entities": []}], ["Through the Levac six-stage methodology, a scoping review was undertaken to explore the depth and breadth of evidence about the effective, safe, and ethical use of wikis and collaborative writing applications (CWAs) in health care.", {"entities": []}], ["Multiple strategies were used to locate studies.", {"entities": []}], ["Seven scientific databases and 6 grey literature sources were queried for articles on wikis and CWAs published between 2001 and September 16, 2011.", {"entities": []}], ["In total, 4436 citations and 1921 grey literature items were screened.", {"entities": []}], ["Two reviewers independently reviewed citations, selected eligible studies, and extracted data using a standardized form.", {"entities": []}], ["We included any paper presenting qualitative or quantitative empirical evidence concerning health care and CWAs.", {"entities": []}], ["We defined a CWA as any technology that enables the joint and simultaneous editing of a webpage or an online document by many end users.", {"entities": []}], ["We performed qualitative content analysis to identify the factors that affect the use of CWAs using the Gagnon framework and their effects on health care using the Donabedian framework.", {"entities": []}], ["Of the 111 studies included, 4 were experimental, 5 quasi-experimental, 5 observational, 52 case studies, 23 surveys about wiki use, and 22 descriptive studies about the quality of information in wikis.", {"entities": []}], ["We classified them by theme: patterns of use of CWAs (n=26), quality of information in existing CWAs (n=25), and CWAs as KT tools (n=73).", {"entities": []}], ["A high prevalence of CWA use (ie, more than 50%) is reported in 58% (7/12) of surveys conducted with health care professionals and students.", {"entities": []}], ["However, we found only one longitudinal study showing that CWA use is increasing in health care.", {"entities": []}], ["Moreover, contribution rates remain low and the quality of information contained in different CWAs needs improvement.", {"entities": []}], ["We identified 48 barriers and 91 facilitators in 4 major themes (factors related to the CWA, users\u2019 knowledge and attitude towards CWAs, human environment, and organizational environment).", {"entities": []}], ["We also found 57 positive and 23 negative effects that we classified into processes and outcomes.", {"entities": []}], ["Although we found some experimental and quasi-experimental studies of the effectiveness and safety of CWAs as educational and KT interventions, the vast majority of included studies were observational case studies about CWAs being used by health professionals and patients.", {"entities": []}], ["More primary research is needed to find ways to address the different barriers to their use and to make these applications more useful for different stakeholders.", {"entities": []}], ["This study aims to (1) examine the variation in implementation of a 2-year chronic obstructive pulmonary disease (COPD) management programme called RECODE, (2) analyse the facilitators and barriers to implementation and (3) investigate the influence of this variation on health outcomes.", {"entities": [[75, 112, "DISEASE"]]}], ["Implementation variation among the 20 primary-care teams was measured directly using a self-developed scale and indirectly through the level of care integration as measured with the Patient Assessment of Chronic Illness Care (PACIC) and the Assessment of Chronic Illness Care (ACIC).", {"entities": []}], ["Interviews were held to obtain detailed information regarding the facilitators and barriers to implementation.", {"entities": []}], ["Multilevel models were used to investigate the association between variation in implementation and change in outcomes.", {"entities": []}], ["The teams implemented, on average, eight of the 19 interventions, and the specific package of interventions varied widely.", {"entities": []}], ["Important barriers and facilitators of implementation were (in)sufficient motivation of healthcare provider and patient, the high starting level of COPD care, the small size of the COPD population per team, the mild COPD population, practicalities of the information and communication technology (ICT) system, and hurdles in reimbursement.", {"entities": []}], ["Level of implementation as measured with our own scale and the ACIC was not associated with health outcomes.", {"entities": []}], ["A higher level of implementation measured with the PACIC was positively associated with improved self-management capabilities, but this association was not found for other outcomes.", {"entities": []}], ["There was a wide variety in the implementation of RECODE, associated with barriers at individual, social, organisational and societal level.", {"entities": []}], ["There was little association between extent of implementation and health outcomes.", {"entities": []}], ["Enzymatic activity measurements of the highly oxidative enzyme myeloperoxidase (MPO), which is implicated in many diseases, are widely used in the literature, but often suffer from nonspecificity and lack of uniformity.", {"entities": [[80, 83, "GENE"]]}], ["Thus, validation and standardization are needed to establish a robust method that is highly specific, sensitive, and reproducible for assaying MPO activity in biological samples.", {"entities": [[143, 146, "GENE"]]}], ["We found conflicting results between in vivo molecular MR imaging of MPO, which measures extracellular activity, and commonly used in vitro MPO activity assays.", {"entities": [[69, 72, "GENE"], [140, 143, "GENE"], [69, 72, "GENE"], [140, 143, "GENE"]]}], ["Thus, we established and validated a protocol to obtain extra- and intracellular MPO from murine organs.", {"entities": [[81, 84, "GENE"]]}], ["To validate the MPO activity assays, three different classes of MPO activity assays were used in spike and recovery experiments.", {"entities": [[16, 19, "GENE"], [64, 67, "GENE"], [16, 19, "GENE"], [64, 67, "GENE"]]}], ["However, these assay methods yielded inconsistent results, likely because of interfering substances and other peroxidases present in tissue extracts.", {"entities": []}], ["To circumvent this, we first captured MPO with an antibody.", {"entities": [[38, 41, "GENE"]]}], ["The MPO activity of the resultant samples was assessed by ADHP and validated against samples from MPO-knockout mice in murine disease models of multiple sclerosis, steatohepatitis, and myocardial infarction.", {"entities": [[144, 162, "DISEASE"], [185, 206, "DISEASE"], [4, 7, "GENE"], [98, 101, "GENE"]]}], ["We found the measurements performed using this protocol to be highly specific and reproducible, and when performed using ADHP, to be highly sensitive over a broad range.", {"entities": []}], ["In addition, we found that intracellular MPO activity correlated well with tissue neutrophil content, and can be used as a marker to assess neutrophil infiltration in the tissue.", {"entities": [[41, 44, "GENE"]]}], ["We validated a highly specific and sensitive assay protocol that should be used as the standard method for all MPO activity assays in biological samples.", {"entities": [[111, 114, "GENE"]]}], ["We also established a method to obtain extra- and intracellular MPO from murine organs.", {"entities": [[64, 67, "GENE"]]}], ["Extracellular MPO activity gives an estimate of the oxidative stress in inflammatory diseases, while intracellular MPO activity correlates well with tissue neutrophil content.", {"entities": [[14, 17, "GENE"], [115, 118, "GENE"], [14, 17, "GENE"], [115, 118, "GENE"]]}], ["A detailed step-by-step protocol is provided.", {"entities": []}], ["Toluene diisocyanate (TDI) is a highly reactive compound used in the production of, e.g., polyurethane foams and paints.", {"entities": []}], ["TDI is known to cause respiratory symptoms and diseases.", {"entities": []}], ["Because TDI causes symptoms in only a fraction of exposed workers, genetic factors may play a key role in disease susceptibility.", {"entities": []}], ["Workers (N = 132) exposed to TDI and a non-exposed group (N = 114) were analyzed for genotype (metabolising genes: CYP1A1 *2A, CYP1A1 *2B, GSTM1 *O, GSTM3 *B, GSTP1 I105V, GSTP1 A114V, GSTT1 *O, MPO -463, NAT1 *3, *4, *10, *11, *14, *15, NAT2 *5, *6, *7, SULT1A1 R213H; immune-related genes: CCL5 -403, HLA-DQB1 *05, TNF -308, TNF -863) and symptoms of the eyes, upper and lower airways (based on structured interviews).", {"entities": [[115, 121, "GENE"], [127, 133, "GENE"], [115, 121, "GENE"], [127, 133, "GENE"], [139, 144, "GENE"], [149, 154, "GENE"], [159, 164, "GENE"], [172, 177, "GENE"], [159, 164, "GENE"], [172, 177, "GENE"], [185, 190, "GENE"], [195, 198, "GENE"], [205, 209, "GENE"], [238, 242, "GENE"], [255, 262, "GENE"], [292, 296, "GENE"], [303, 311, "GENE"], [317, 320, "GENE"], [327, 330, "GENE"], [317, 320, "GENE"], [327, 330, "GENE"]]}], ["For three polymorphisms: CYP1A1 *2A, CYP1A1 *2B, and TNF -308 there was a pattern consistent with interaction between genotype and TDI exposure status for the majority of symptoms investigated, although it did reach statistical significance only for some symptoms: among TDI-exposed workers, the CYP1A1 variant carriers had increased risk ( CYP1A1 *2A and eye symptoms: variant carriers OR 2.0 95% CI 0.68\u20136.1, p-value for interaction 0.048; CYP1A1 *2B and wheeze: IV carriers OR = 12, 1.4\u2013110, p-value for interaction 0.057).", {"entities": [[25, 31, "GENE"], [37, 43, "GENE"], [296, 302, "GENE"], [341, 347, "GENE"], [442, 448, "GENE"], [25, 31, "GENE"], [37, 43, "GENE"], [296, 302, "GENE"], [341, 347, "GENE"], [442, 448, "GENE"], [53, 56, "GENE"], [25, 31, "GENE"], [37, 43, "GENE"], [296, 302, "GENE"], [341, 347, "GENE"], [442, 448, "GENE"], [25, 31, "GENE"], [37, 43, "GENE"], [296, 302, "GENE"], [341, 347, "GENE"], [442, 448, "GENE"], [25, 31, "GENE"], [37, 43, "GENE"], [296, 302, "GENE"], [341, 347, "GENE"], [442, 448, "GENE"]]}], ["TDI-exposed individuals with TNF -308 A were protected against the majority of symptoms, but it did not reach statistical significance.", {"entities": [[29, 32, "GENE"]]}], ["In the non-exposed group, however, TNF -308 A carriers showed higher risk of the majority of symptoms (eye symptoms: variant carriers OR = 2.8, 1.1\u20137.1, p-value for interaction 0.12; dry cough OR = 2.2, 0.69\u20137.2, p-value for interaction 0.036).", {"entities": [[35, 38, "GENE"]]}], ["Individuals with SULT1A1 213H had reduced risk both in the exposed and non-exposed groups.", {"entities": [[17, 24, "GENE"]]}], ["Other polymorphisms, showed associations to certain symptoms: among TDI-exposed, NAT1* 10 carriers had a higher risk of eye symptoms and CCL5 -403 AG+AA as well as HLA-DQB1 *05 carriers displayed increased risk of symptoms of the lower airways.", {"entities": [[137, 141, "GENE"], [164, 172, "GENE"]]}], ["GSTM1 , GSTM3 and GSTP1 only displayed effects on symptoms of the lower airways in the non-exposed group.", {"entities": [[0, 5, "GENE"], [8, 13, "GENE"], [18, 23, "GENE"]]}], ["Specific gene-TDI interactions for symptoms of the eyes and lower airways appear to exist.", {"entities": []}], ["The results suggest different mechanisms for TDI- and non-TDI-related symptoms of the eyes and lower airways.", {"entities": []}], ["The prevalence of natural rubber latex (NRL) allergy has been estimated to be 5-18% in health care workers, and latex exposure has been one of the leading causes of occupational asthma in the last several years.", {"entities": [[178, 184, "DISEASE"], [40, 43, "GENE"]]}], ["We present the cases of two nurses who developed sensitivity to NRL, both with dermatologic symptoms and respiratory symptoms that included asthma.", {"entities": [[140, 146, "DISEASE"], [64, 67, "GENE"]]}], ["They were referred to the University of Maryland for evaluation of their allergies, then for occupational and environmental consults.", {"entities": []}], ["The patients' allergy to NRL was confirmed on the basis of clinical history, a positive skin test to latex, and the presence of latex-specific immunoglobulin E (IgE) serology by radioallergosorbent test (RAST).", {"entities": [[25, 28, "GENE"]]}], ["Both patients worked in the same community hospital for approximately 20 years; one was an endoscopy nurse and the other worked in the emergency department.", {"entities": []}], ["Following the diagnosis of allergy to latex, both patients avoided direct skin contact with latex, but they continued to work in the same respective environments, where powdered latex gloves and other potentially sensitizing chemicals were used.", {"entities": []}], ["Instead of improving, the clinical condition of the patients worsened and they remained symptomatic, even after they were removed from their workplace.", {"entities": []}], ["Their airways reacted to low levels of a variety of sensitizers and irritants in the environment, and they became depressed.", {"entities": []}], ["Both nurses were referred for vocational rehabilitation.", {"entities": []}], ["Pregnancy is a physiological condition that requires immune tolerance to the product of conception.", {"entities": []}], ["Systemic lupus erythematosus (SLE) is a disease with well-represented immune mechanisms that disturb immune tolerance.", {"entities": [[9, 28, "DISEASE"], [0, 28, "DISEASE"]]}], ["The association of pregnancy with systemic lupus erythematosus creates a particular immune environment in which the immune tolerance specific of pregnancy is required to coexist with alterations of the immune system caused by SLE.", {"entities": [[43, 62, "DISEASE"], [34, 62, "DISEASE"]]}], ["The main role is played by T regulatory (Treg) cells, which attempt to regulate and adapt the immune system of the mother to the new conditions of pregnancy.", {"entities": []}], ["Other components of the immune system also participate to maintain maternal-fetal immune tolerance.", {"entities": []}], ["If the immune system of pregnant women with SLE is not able to maintain maternal immune tolerance to the fetus, pregnancy complications (miscarriage, fetal hypotrophy, and preterm birth) or maternal complications (preeclampsia or activation of SLE, especially in conditions of lupus nephritis) may occur.", {"entities": [[283, 292, "DISEASE"]]}], ["In certain situations this can be responsible for neonatal lupus.", {"entities": []}], ["At the same time, it must be noted that during pregnancy, the immune system is able to achieve immune tolerance while maintaining the anti-infectious immune capacity of the mother.", {"entities": []}], ["Immunological monitoring of pregnancy during SLE, as well as of the mother's disease, is required.", {"entities": []}], ["It is important to understand immune tolerance to grafts in transplant pathology.", {"entities": []}], ["With a rapidly ageing population and increasing life expectancy, programs directed at improving the mental health and quality of life (QOL) of older persons are extremely important.", {"entities": []}], ["This issue may be particularly relevant in the aged-care residential sector, where very high rates of depression and poor QOL are evident.", {"entities": []}], ["This study aims to investigate the fixed and modifiable risk factors of psychological distress and QOL in a cohort of Australians aged 60 and over living in residential and community settings.", {"entities": []}], ["The study examined the relationship between demographic, health and lifestyle factors and the outcome variables of self-reported QOL and psychological distress (K10 scores) based on data from 626 Australians aged 60 and over from the 45 and Up Study dataset.", {"entities": []}], ["Univariate and multivariate regression analyses (performed on a subset of 496) examined risk factors related to psychological distress and QOL adjusting for age and residential status.", {"entities": []}], ["Significant psychological distress was experienced by 15% of the residential sample and 7% of the community sample and in multivariate analyses was predicted by older age, more functional limitations, more time spent sleeping and lower levels of social support (accounting for 18% of the variance).", {"entities": []}], ["Poorer QOL was predicted by more functional limitations and greater levels of psychological distress.", {"entities": []}], ["Together these variables accounted for 35% of the variance in QOL ratings.", {"entities": []}], ["While psychological distress was more common in residential settings, programs targeting modifiable risk factors have the potential to improve QOL and reduce psychological distress in older persons living in both residential and community settings.", {"entities": []}], ["In particular, promoting health and mobility, optimising sleep-wake cycles and increasing social support may reduce levels of psychological distress and improve QOL.", {"entities": []}], ["Osteoporosis is one of the most serious complications of corticosteroid treatment.", {"entities": []}], ["Loss of bone mineral density (BMD) and fractures occur early in the course of corticosteroid treatment, and thus early recognition of fracture risk and effective intervention based on evidence-based-medicine (EBM) are needed.", {"entities": []}], ["A study of meta-analysis representing the highest level in a hierarchy of evidence showed that when the outcome measure of interest was limited to changes in lumbar spine BMD, bisphosphonates were the most effective of the agents studied in comparison with no therapy or treatment with calcium, and were also more efficacious than either vitamin D or calcitonin; the efficacy of bisphosphonates was enhanced when used in combination with vitamin D. Randomized controlled trials (RCTs) representing the second level in a hierarchy of evidence showed that bisphosphonates stabilized BMD not only in the lumbar spine, but also in the hip, and that parathyroid hormone (PTH) markedly increased lumbar spine BMD.", {"entities": [[666, 669, "GENE"]]}], ["According to the EBM, bisphosphonates and possibly PTH are suggested to be the most efficacious for preserving BMD.", {"entities": [[51, 54, "GENE"]]}], ["The efficacy of these agents in reducing the incidence of vertebral fractures in patients exposed to corticosteroids remains to be established in meta-analysis studies, although some RCTs have demonstrated the anti-fracture effects of etidronate, alendronate, and risedronate in the spine.", {"entities": []}], ["Further RCTs of fracture prevention conducted on a large number of patients and their meta-analysis are needed to confirm the efficacy of bisphosphonates, PTH, or other agents in preventing vertebral and nonvertebral fractures.", {"entities": [[155, 158, "GENE"]]}], ["We conducted an epigenome-wide association study (EWAS) on obesity in healthy youth and young adults and further examined to what extent identified signals influenced gene expression and were independent of cell type composition and obesity-related cardio-metabolic risk factors.", {"entities": [[59, 66, "DISEASE"], [233, 240, "DISEASE"]]}], ["Genome-wide DNA methylation data from leukocytes were obtained from 700 African Americans aged 14\u201336.", {"entities": []}], ["We also measured genome-wide DNA methylation data from neutrophils as well as genome-wide gene expression data from leukocytes in a subset of samples ( n \u2009=\u2009188).", {"entities": []}], ["The EWAS identified 76 obesity-related CpG sites in leukocytes with p \u2009<\u20091\u2009\u00d7\u200910 cis , of which 5 genes displayed differential expression between obese cases and lean controls.", {"entities": [[23, 30, "DISEASE"]]}], ["We also replicated 71.5% of obesity-related CpG sites previously reported.", {"entities": [[28, 35, "DISEASE"]]}], ["In this study of youth and young adults, we identified 29 novel CpG sites associated with obesity and replicated the majority of the CpG sites previously identified.", {"entities": [[90, 97, "DISEASE"]]}], ["We further demonstrated that the majority of the obesity-related CpG sites in leukocytes were not driven by cell composition or obesity-related cardio-metabolic risk factors.", {"entities": [[49, 56, "DISEASE"], [128, 135, "DISEASE"]]}], ["We also provided the direct link between DNA methylation-gene expression-obesity for 5 genes.", {"entities": [[73, 80, "DISEASE"]]}], ["The online version of this article (10.1186/s13148-017-0435-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Polymorphisms in the proinflammatory cytokine genes tumor necrosis factor-\u03b1 ( TNF ) and lymphotoxin-\u03b1 ( LTA , also called TNF- \u03b2) have been associated with asthma and atopy in some studies.", {"entities": [[156, 162, "DISEASE"], [78, 81, "GENE"], [122, 125, "GENE"], [104, 107, "GENE"]]}], ["Parental smoking is a consistent risk factor for childhood asthma.", {"entities": [[59, 65, "DISEASE"]]}], ["Secondhand smoke and ozone both stimulate TNF production.", {"entities": [[42, 45, "GENE"]]}], ["Our goal was to investigate whether genetic variation in TNF and LTA is associated with asthma and atopy and whether the association is modified by parental smoking in a Mexican population with high ozone exposure.", {"entities": [[88, 94, "DISEASE"], [57, 60, "GENE"], [65, 68, "GENE"]]}], ["We genotyped six tagging single nucleotide polymorphisms (SNPs) in TNF and LTA, including functional variants, in 596 nuclear families consisting of asthmatics 4\u201317 years of age and their parents in Mexico City.", {"entities": [[67, 70, "GENE"], [75, 78, "GENE"]]}], ["Atopy was determined by skin prick tests.", {"entities": []}], ["The A allele of the TNF -308 SNP was associated with increased risk of asthma [relative risk (RR) = 1.54; 95% confidence interval (CI), 1.04\u20132.28], especially among children of non-smoking parents (RR = 2.06; 95% CI, 1.19\u20133.55; p for interaction = 0.09).", {"entities": [[71, 77, "DISEASE"], [20, 23, "GENE"]]}], ["Similarly, the A allele of the TNF -238 SNP was associated with increased asthma risk among children of nonsmoking parents (RR = 2.21; 95% CI, 1.14\u20134.30; p for interaction = 0.01).", {"entities": [[74, 80, "DISEASE"], [31, 34, "GENE"]]}], ["LTA SNPs were not associated with asthma.", {"entities": [[34, 40, "DISEASE"], [0, 3, "GENE"]]}], ["Haplotype analyses reflected the single SNP findings in magnitude and direction.", {"entities": []}], ["TNF and LTA SNPs were not associated with the degree of atopy.", {"entities": [[0, 3, "GENE"], [8, 11, "GENE"]]}], ["Our results suggest that genetic variation in TNF may contribute to childhood asthma and that associations may be modified by parental smoking.", {"entities": [[78, 84, "DISEASE"], [46, 49, "GENE"]]}], ["Acute eosinophilic pneumonia (AEP) is an uncommon inflammatory lung disease, and limited data exist concerning the clinical characteristics and factors that influence its occurrence.", {"entities": [[19, 28, "DISEASE"], [6, 28, "DISEASE"], [63, 75, "DISEASE"]]}], ["We retrospectively reviewed the records of AEP patients treated at Korean military hospitals between January 2007 and December 2013.", {"entities": []}], ["In total, 333 patients were identified; their median age was 22 years, and all were men.", {"entities": []}], ["All patients presented with acute respiratory symptoms (cough, sputum, dyspnea, or fever) and had elevated levels of inflammatory markers including median values of 13,185/\u00b5L for white blood cell count and 9.51 mg/dL for C-reactive protein.", {"entities": []}], ["All patients showed diffuse ground glass opacity/consolidation, and most had pleural effusion (n = 265; 80%) or interlobular septal thickening (n = 265; 85%) on chest computed tomography.", {"entities": []}], ["Most patients had normal body mass index (n = 255; 77%), and only 30 (9%) patients had underlying diseases including rhinitis, asthma, or atopic dermatitis.", {"entities": [[138, 155, "DISEASE"], [117, 125, "DISEASE"], [127, 133, "DISEASE"], [145, 155, "DISEASE"]]}], ["Most patients had recently changed smoking habits (n = 288; 87%) and were Army personnel (n = 297; 89%).The AEP incidence was higher in the Army group compared to the Navy or Air Force group for every year ( P = 0.002).", {"entities": []}], ["Both the number of patients and patients with high illness severity (oxygen requirement, intensive care unit admission, and pneumonia severity score class \u2265 III) tended to increase as seasonal temperatures rose.", {"entities": [[124, 133, "DISEASE"]]}], ["We describe the clinical characteristics of AEP and demonstrate that AEP patients have recently changed smoking habits and work for the Army.", {"entities": []}], ["There is an increasing tendency in the numbers of patients and those with higher AEP severity with rising seasonal temperatures.", {"entities": []}], ["Women are advised to be vaccinated for influenza during pregnancy and may receive vaccine at any time during their pregnancy.", {"entities": [[39, 48, "DISEASE"]]}], ["In observational studies evaluating vaccine safety in pregnancy, to account for such time-varying vaccine exposure, a time-dependent predictor can be used in a proportional hazards model setting for outcomes such as spontaneous abortion or preterm delivery.", {"entities": []}], ["Also, due to the observational nature of pregnancy exposure cohort studies and relatively low event rates, propensity score (PS) methods are often used to adjust for potential confounders.", {"entities": []}], ["Using Monte Carlo simulation experiments, we compare two different ways to model the PS for vaccine exposure: (1) logistic regression treating the exposure status as binary yes or no; (2) Cox regression treating time to exposure as time-to-event.", {"entities": []}], ["Coverage probability of the nominal 95% confidence interval for the exposure effect is used as the main measure of performance.", {"entities": []}], ["The performance of the logistic regression PS depends largely on how the exposure data is generated.", {"entities": []}], ["In contrast, the Cox regression PS consistently performs well across the different data generating mechanisms that we have considered.", {"entities": []}], ["In addition, the Cox regression PS allows adjusting for potential time-varying confounders such as season of the year or exposure to additional vaccines.", {"entities": []}], ["The application of the Cox regression PS is illustrated using data from a recent study of the safety of pandemic H1N1 influenza vaccine during pregnancy.", {"entities": [[118, 127, "DISEASE"]]}], ["This paper presents a new Ubiquitous Sensor Network (USN) Architecture to be used in developing countries and reveals its usefulness by highlighting some of its key features.", {"entities": []}], ["In complement to a previous ITU proposal, our architecture referred to as \u201cUbiquitous Sensor Network for Development (USN4D)\u201d integrates in its layers features such as opportunistic data dissemination, long distance deployment and localisation of information to meet the requirements of the developing world.", {"entities": []}], ["Besides describing some of the most important requirements for the sensor equipment to be used in a USN4D setting, we present the main features and experiments conducted using the \u201cWaspNet\u201d as one of the wireless sensor deployment platforms that meets these requirements.", {"entities": []}], ["Furthermore, building upon \u201cWaspNet\u201d platform, we present an application to Air pollution Monitoring in the city of Cape Town, in South Africa as one of the first steps towards building community wireless sensor networks (CSN) in the developing world using off-the-shelf sensor equipment.", {"entities": []}], ["Pharmacy assistants are often the first point of contact for patients presenting in community pharmacies.", {"entities": []}], ["The current role of pharmacy assistants in the supply of asthma-reliever medications (short-acting \u03b2-agonists) was identified as a barrier to appropriate guideline-based care.", {"entities": [[57, 63, "DISEASE"]]}], ["The aim of this research was to devise and evaluate a team-based intervention to formalise the role of pharmacy assistants and to improve asthma guideline-based care in community pharmacy.", {"entities": [[138, 144, "DISEASE"]]}], ["A controlled pre-post intervention study was conducted in 336 metropolitan pharmacies located in Perth, Western Australia.", {"entities": []}], ["Pharmacies were stratified into 2 groups (187 intervention and 149 control) based on known confounders for asthma control.", {"entities": [[107, 113, "DISEASE"]]}], ["The intervention was designed using a common-sense approach and resources developed included a checklist, videos and web page.", {"entities": []}], ["Delivery was via workshops (25 pharmacies) or academic detailing (162 pharmacies).", {"entities": []}], ["Pharmacy practice was assessed preintervention and postintervention via covert simulated patient methodology.", {"entities": []}], ["Primary outcome measures included patient medical referral, device use demonstration and counselling, internal referral and/or direct involvement of a pharmacist in consultations.", {"entities": []}], ["There was a significant increase in patient medical referral in intervention pharmacies from 32% to 47% (p=0.0007) from preintervention to postintervention, while control pharmacies showed a non-significant decrease from 50% to 44% (p=0.22).", {"entities": []}], ["Device counselling was not routinely carried out at any stage or in any cohort of this research and no significant changes in internal referral were observed.", {"entities": []}], ["Increases in medical referral indicate that asthma guideline compliance can be improved in community pharmacy if implementation employs a team-based approach and involves pharmacy assistants.", {"entities": [[44, 50, "DISEASE"]]}], ["However, results were variable and the intervention did not improve practice related to device counselling or internal referral/pharmacist involvement.", {"entities": []}], ["Undertaking more workshops may have improved results.", {"entities": []}], ["Guideline implementation in community pharmacy should consider the role of pharmacy assistants and how to overcome logistical barriers to pharmacy participation in implementation activities.", {"entities": []}], ["To evaluate the level of matrix metalloproteinase (MMP)-2 and MMP-9 activities in patients with steroid induced posterior subcapsular cataract (PSC).", {"entities": [[134, 142, "DISEASE"]]}], ["This prospective, observational study comprised of 156 patients having either steroid induced PSC (n=50) or non-steroidal PSC (n=106) were performed to evaluate the level of MMP-2 and MMP-9 activities in the lens epithelial cells (LECs) and the serum.", {"entities": []}], ["Anterior lens capsules harboring LECs were obtained during phacoemulsification and peripheral blood was collected from patients before administration of anesthesia.", {"entities": []}], ["Serum was separated by centrifugation at 10,000\u00d7 g for 15 min at\u00a04\u00a0\u00b0C.", {"entities": []}], ["The LECs and serum samples were processed to analyze MMP-2 and MMP-9 activities using succinylated gelatin assay.", {"entities": []}], ["Quantitative real time-PCR (qRT\u2013PCR) was performed to determine the mRNA levels of MMP-2 and MMP-9 in LECs.", {"entities": []}], ["The mRNA levels were expressed as a ratio, using the delta-delta method for comparing the relative expression results between cases with steroid induced PSC and cases with non-steroidal PSC.", {"entities": []}], ["MMP-2 and MMP-9 levels were also compared in the two groups using immunolocalization.", {"entities": []}], ["The level of MMP-2 and MMP-9 activity was found to be high in LECs and serum of cases with steroid induced PSC.", {"entities": []}], ["Further in all steroid induced cases, a 1.4 fold increase was observed in MMP-2 activity in LECs and a 1.4 fold increase in MMP-9 activity in the serum.", {"entities": []}], ["Both qRT\u2013PCR and immunolocalization showed increased expression of MMP-2 and MMP-9 activity.", {"entities": []}], ["MMP-2 and MMP-9 activity in both LECs and serum was significantly higher in cases with steroid induced PSC.", {"entities": []}], ["The possible use of MMP-9 as a non-invasive biomarker in ascertaining the presence of steroid induced PSC should be evaluated using a larger sample size.", {"entities": []}], ["Assessing adverse effects from environmental chemical exposure is integral to public health policies.", {"entities": []}], ["Toxicology assays identifying early biological changes from chemical exposure are increasing our ability to evaluate links between early biological disturbances and subsequent overt downstream effects.", {"entities": []}], ["A workshop was held to consider how the resulting data inform consideration of an \u201cadverse effect\u201d in the context of hazard identification and risk assessment.", {"entities": []}], ["Our objective here is to review what is known about the relationships between chemical exposure, early biological effects (upstream events), and later overt effects (downstream events) through three case studies (thyroid hormone disruption, antiandrogen effects, immune system disruption) and to consider how to evaluate hazard and risk when early biological effect data are available.", {"entities": []}], ["Each case study presents data on the toxicity pathways linking early biological perturbations with downstream overt effects.", {"entities": []}], ["Case studies also emphasize several factors that can influence risk of overt disease as a result from early biological perturbations, including background chemical exposures, underlying individual biological processes, and disease susceptibility.", {"entities": []}], ["Certain effects resulting from exposure during periods of sensitivity may be irreversible.", {"entities": []}], ["A chemical can act through multiple modes of action, resulting in similar or different overt effects.", {"entities": []}], ["For certain classes of early perturbations, sufficient information on the disease process is known, so hazard and quantitative risk assessment can proceed using information on upstream biological perturbations.", {"entities": []}], ["Upstream data will support improved approaches for considering developmental stage, background exposures, disease status, and other factors important to assessing hazard and risk for the whole population.", {"entities": []}], ["The sequencing of the human genome has provided tools to gain a better understanding of the role of genes and their interaction with environmental factors in the development of disease.", {"entities": []}], ["However, much work remains in translating discoveries into new opportunities for disease prevention and health promotion.", {"entities": []}], ["Both public health academia and practice have important roles to play in bridging the gap between the growth in knowledge stemming from the Human Genome Project and its application in public health.", {"entities": []}], ["Recognizing this, the Centers for Disease Control and Prevention, through the Association of Schools of Public Health, established Centers for Genomics and Public Health at three schools of public health in 2001: the University of Michigan, the University of North Carolina, and the University of Washington.", {"entities": []}], ["This paper describes the experience of the University of Washington Center for Genomics and Public Health in forging partnerships with public health practitioners to translate genomic advances into public health practice.", {"entities": []}], ["Smoking is known to cause chronic inflammatory changes in the bronchi and to contribute to airway hyper-reactivity, such as in bronchial asthma.", {"entities": [[137, 143, "DISEASE"]]}], ["To study the effect of smoking on the endothelin system in rat airways, bronchial segments were exposed to DMSO-soluble smoking particles (DSP) from cigarette smoke, to nicotine and to DMSO, respectively.", {"entities": [[139, 142, "GENE"]]}], ["Isolated rat bronchial segments were cultured for 24 hours in the presence or absence of DSP, nicotine or DMSO alone.", {"entities": [[89, 92, "GENE"]]}], ["Contractile responses to sarafotoxin 6c (a selective agonist for ET B receptors) and endothelin-1 (an ET A and ET B receptor agonist) were studied by use of a sensitive myograph.", {"entities": []}], ["Before ET-1 was introduced, the ET B receptors were desensitized by use of S6c.", {"entities": []}], ["The remaining contractility observed was considered to be the result of selective activation of the ET A receptors.", {"entities": []}], ["ET A and ET B receptor mRNA expression was analyzed using real-time quantitative PCR.", {"entities": []}], ["The location and concentration of ET A and ET B receptors were studied by means of immunohistochemistry together with confocal microscopy after overnight incubation with selective antibodies.", {"entities": []}], ["After being cultured together with DSP for 24 hours the bronchial segments showed an increased contractility mediated by ET A and ET B receptors, whereas culturing them together with nicotine did not affect their contractility.", {"entities": [[35, 38, "GENE"]]}], ["The up-regulation of their contractility was blunted by cycloheximide treatment, a translational inhibitor.", {"entities": []}], ["No significant change in the expression of ET A and ET B receptor mRNA through exposure to DMSO or to nicotine exposure alone occurred, although immunohistochemistry revealed a clear increase in ET A and ET B receptors in the smooth muscle after incubation in the presence of DSP.", {"entities": [[276, 279, "GENE"]]}], ["Taken as a whole, this is seen as the presence of a translation mechanism.", {"entities": []}], ["The increased contractility of rat bronchi when exposed to DSP appears to be due to a translation mechanism.", {"entities": [[59, 62, "GENE"]]}], ["Aberrant O -glycosylation of serum immunoglobulin A1 (IgA1) represents a heritable pathogenic defect in IgA nephropathy, the most common form of glomerulonephritis worldwide, but specific genetic factors involved in its determination are not known.", {"entities": [[145, 163, "DISEASE"]]}], ["We performed a quantitative GWAS for serum levels of galactose-deficient IgA1 (Gd-IgA1) in 2,633 subjects of European and East Asian ancestry and discovered two genome-wide significant loci, in C1GALT1 (rs13226913, P = 3.2 x 10 C1GALT1C1 (rs5910940, P = 2.7 x 10 O -glycosylation of IgA1.", {"entities": [[194, 201, "GENE"], [228, 237, "GENE"]]}], ["We demonstrated that these two loci explain approximately 7% of variability in circulating Gd-IgA1 in Europeans, but only 2% in East Asians.", {"entities": []}], ["Notably, the Gd-IgA1-increasing allele of rs13226913 is common in Europeans, but rare in East Asians.", {"entities": []}], ["Moreover, rs13226913 represents a strong cis-eQTL for C1GALT1 that encodes the key enzyme responsible for the transfer of galactose to O -linked glycans on IgA1.", {"entities": [[54, 61, "GENE"]]}], ["By in vitro siRNA knock-down studies, we confirmed that mRNA levels of both C1GALT1 and C1GALT1C1 determine the rate of secretion of Gd-IgA1 in IgA1-producing cells.", {"entities": [[76, 83, "GENE"], [88, 97, "GENE"]]}], ["Our findings provide novel insights into the genetic regulation of O -glycosylation and are relevant not only to IgA nephropathy, but also to other complex traits associated with O -glycosylation defects, including inflammatory bowel disease, hematologic disease, and cancer.", {"entities": [[215, 241, "DISEASE"], [268, 274, "DISEASE"]]}], ["O -glycosylation is a common type of post-translational modification of proteins; specific abnormalities in the mechanism of O -glycosylation have been implicated in cancer, inflammatory and blood diseases.", {"entities": [[166, 172, "DISEASE"]]}], ["However, the molecular basis of abnormal O -glycosylation in these complex disorders is not known.", {"entities": []}], ["We studied the genetic basis of defective O -glycosylation of serum immunoglobulin A1 (IgA1), that represents the key pathogenic defect in IgA nephropathy, the most common form of primary glomerulonephritis worldwide.", {"entities": [[188, 206, "DISEASE"]]}], ["We report our results of the first genome-wide association study for this trait using serum assays in 2,633 individuals of European and East-Asian ancestry.", {"entities": []}], ["In our genome scan, we observed two significant signals with large effects, on chromosomes 7p21.3 and Xq24, jointly explaining about 7% of trait variability.", {"entities": []}], ["These signals implicate two genes that encode molecular partners essential for enzymatic O -glycosylation of IgA1 and mucins, and represent potential new targets for therapy.", {"entities": []}], ["Due to gendered inequalities in the division of domestic work, women with paid employment and family caregiving responsibilities can feel extremely tired with general distress and depression.", {"entities": []}], ["Therefore, the purpose of this study was to examine the association between the number of family members and stress level by gender among Korean adults using a nationally representative dataset.", {"entities": []}], ["We used a sample of 6,293 subjects aged 19 or older (3,629 female and 2,264 male) from the fifth Korea National Health and Nutrition Examination Survey.", {"entities": []}], ["A multivariable logistic regression analysis with sociodemographic and health-related characteristics was conducted.", {"entities": []}], ["Because there were gender differences, a stratified analysis was performed for each gender.", {"entities": []}], ["Age, number of family members, education level, occupational status, depression, self-rated health status, and chronic diseases were found to have a significant association with stress level in the study subjects ( p <0.05).", {"entities": []}], ["The probability of perceiving stress increased among females from family with two members (OR 1.521), three family members (OR 1.893), or four or more family members without spouse (OR 2.035) compared to those who live alone.", {"entities": []}], ["We found that unmarried women are more likely to be stressed as the number of family members increases.", {"entities": []}], ["Gender expectations giving women the main responsibility for domestic and care work may become a source of stress.", {"entities": []}], ["Reconciliation of family and work remains women\u2019s responsibility in Korea.", {"entities": []}], ["As family problems are recently becoming a big issue, our study shows the importance of considering gender difference in studies on stress according to family roles and functions.", {"entities": []}], ["Objective .", {"entities": []}], ["To longitudinally follow the osseointegration using Resonance Frequency Analysis (RFA) for different lengths of abutment on a new wide bone-anchored implant, introduced with the non-skin thinning surgical technique.", {"entities": []}], ["Study Design .", {"entities": []}], ["A single-center, prospective 1 year study following adults with bone-anchored hearing implants.", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["Implantation was performed and followed for a minimum of 1 year.", {"entities": []}], ["All patients were operated on according to the tissue preserving technique.", {"entities": []}], ["A 4.5\u2009mm wide fixture (Oticon Medical) with varying abutments (9 to 12\u2009mm) was used and RFA was tested 1 week, 7 weeks, 6 months, and 12 months later.", {"entities": []}], ["Implant Stability Quotient (ISQ), was measured from 1 to 100.", {"entities": []}], ["Stability was compared to a group of patients ( N = 7) implanted with another brand (Cochlear BI400) of 4.5\u2009mm fixtures.", {"entities": []}], ["All 10 adults concluded the study.", {"entities": []}], ["None of the participants lost their implant during the test period indicating a good anchoring of abutments to the wide fixture tested.", {"entities": []}], ["Stability testing was shown to vary depending on abutment length and time after surgery and with higher values for shorter abutments and increasing values over the first period of time.", {"entities": []}], ["One patient changed the abutment from 12 to 9\u2009mm and another from a 9 to a 12 during the year.", {"entities": []}], ["No severe skin problems, numbness around the implant, or cosmetic problems arose.", {"entities": []}], ["Conclusion .", {"entities": []}], ["After 1 year of follow-up, combination of a wide fixture implant and the non-skin thinning surgical technique indicates a safe procedure with good stability and no abutment losses.", {"entities": []}], ["Interscalene block (ISB) is commonly performed using 20-40 mL of local anesthetic.", {"entities": []}], ["Spread to adjacent structures and consequent adverse effects including paralysis of the ipsilateral hemidiaphragm are frequent.", {"entities": []}], ["Pain ratings, analgesic requirements, adverse events, satisfaction, function and diaphragmatic excursion were compared following interscalene block (ISB) with reduced initial bolus volumes.", {"entities": []}], ["Subjects undergoing arthroscopic rotator cuff repair were randomized to receive 5, 10, or 20 mL ropivacaine 0.75% for ISB in a double-blind fashion (N = 36).", {"entities": []}], ["Continuous infusion with ropivacaine 0.2% was maintained for 48 h. Pain and diaphragmatic excursion were assessed before block and in the recovery unit.", {"entities": []}], ["Pain ratings in the recovery room were generally less than 4 (0-10 NRS) for all treatment groups, but a statistically significant difference was noted between the 5 and 20 mL groups (NRS: 2.67 vs. 0.62 respectively; p = 0.04).", {"entities": []}], ["Pain ratings and supplemental analgesic use were similar among the groups at 24 h, 48 h and 12 weeks.", {"entities": []}], ["There were no differences in the quality of block for surgical anesthesia.", {"entities": []}], ["Dyspnea was significantly greater in the 20 mL group (p = 0.041).", {"entities": []}], ["Subjects with dyspnea had significant diaphragmatic impairment more frequently (Relative risk: 2.5; 95%CI: 1.3-4.8; p = 0.042).", {"entities": []}], ["Increased contralateral diaphragmatic motion was measured in 29 of the 36 subjects.", {"entities": []}], ["Physical shoulder function at 12 weeks improved over baseline in all groups (baseline mean SST: 6.3, SEM: 0.6; 95%CI: 5.1-7.5; 12 week mean SST: 8.2, SEM: 0.46; 95%CI: 7.3-9.2; p = 0.0035).", {"entities": [[91, 94, "GENE"], [140, 143, "GENE"], [91, 94, "GENE"], [140, 143, "GENE"]]}], ["ISB provided reliable surgical analgesia with 5 mL, 10 mL or 20 mL ropivacaine (0.75%).", {"entities": []}], ["The 20 mL volume was associated with increased complaints of dyspnea.", {"entities": []}], ["The 5 mL volume was associated with statistically higher pain scores in the immediate postoperative period.", {"entities": []}], ["Lower volumes resulted in a reduced incidence of dyspnea compared to 20 mL, however diaphragmatic impairment was not eliminated.", {"entities": []}], ["Compensatory increases in contralateral diaphragmatic movement may explain tolerance for ipsilateral paresis.", {"entities": []}], ["clinicaltrials.gov.", {"entities": []}], ["identifier: NCT00672100", {"entities": []}], ["Although health policy makers call for the transformation of health care organizations to health literacy responsive ones, there is limited evidence on the care experiences of patients with limited health literacy skills (HL) in respect to health care quality.", {"entities": []}], ["We explored if HL and patient-reported experiences regarding access to care and support in care-coordination in primary care organizations (PCO) have an impact on patients satisfaction with the care received by their personal general practitioner (GP).", {"entities": []}], ["A nationwide representative survey was administered in a random sample of 1125 German adults.", {"entities": []}], ["Binary logistic regression analyses were performed to determine whether HL and perceived access to and coordination of care were associated with satisfaction with care received in primary care adjusting for demographics and health status.", {"entities": []}], ["In the unadjusted as well as adjusted model, better accessibility of the primary care practice ( \u03b2 = 1.858; 2.032 p \u2009<\u20090.001) frequent support in care coordination by the general practitioner ( \u03b2 = 2.680; 2.820 p \u2009<\u20090.001) as well as sufficient HL ( \u03b2 = 0.888; 1.228 p \u2009<\u20090.05) were independent predictors of a higher satisfaction with care received in the general practice.", {"entities": []}], ["German adults with sufficient HL and positive experiences regarding care coordination and access to care are more satisfied with care received by their personal general practitioner.", {"entities": []}], ["This result is from major importance for primary care organizations intending to transform their processes and structures to respond to the health literacy needs of their patients more effectively.", {"entities": []}], ["The cost effective provision of quality care for chronic diseases is a major challenge for health care systems.", {"entities": []}], ["We describe a project to improve the care of patients with the highly prevalent disorders of diabetes and hypertension, conducted in one of the major cities of the United Arab Emirates.", {"entities": [[106, 118, "DISEASE"]]}], ["The project, using the principles of quality assurance cycles, was conducted in 4 stages.", {"entities": []}], ["The assessment stage consisted of a community survey and an audit of the health care system, with particular emphasis on chronic disease care.", {"entities": []}], ["The information gleaned from this stage provided feedback to the staff of participating health centers.", {"entities": []}], ["In the second stage, deficiencies in health care were identified and interventions were developed for improvements, including topics for continuing professional development.", {"entities": []}], ["In the third stage, these strategies were piloted in a single health centre for one year and the outcomes evaluated.", {"entities": []}], ["In the still ongoing fourth stage, the project was rolled out to all the health centers in the area, with continuing evaluation.", {"entities": []}], ["The intervention consisted of changes to establish a structured care model based on the predicted needs of this group of patients utilizing dedicated chronic disease clinics inside the existing primary health care system.", {"entities": []}], ["These clinics incorporated decision-making tools, including evidence-based guidelines, patient education and ongoing professional education.", {"entities": []}], ["The intervention was successfully implemented in all the health centers.", {"entities": []}], ["The health care quality indicators that showed the greatest improvement were the documentation of patient history (e.g.", {"entities": []}], ["smoking status and physical activity); improvement in recording physical signs (e.g.", {"entities": []}], ["body mass index (BMI)); and an improvement in the requesting of appropriate investigations, such as HbA1c and microalbuminurea.", {"entities": []}], ["There was also improvement in those parameters reflecting outcomes of care, which included HbA1c, blood pressure and lipid profiles.", {"entities": []}], ["Indicators related to lifestyle changes, such as smoking cessation and BMI, failed to improve.", {"entities": []}], ["Chronic disease care is a joint commitment by health care providers and patients.", {"entities": []}], ["This combined approach proved successful in most areas of the project, but the area of patient self management requires further improvement.", {"entities": []}], ["Glioblastoma (GBM) is the most malignant brain tumor.", {"entities": []}], ["Many abnormal secretion and expression of cytokines have been found in GBM, initially speculated that the occurrence of GBM may be involved in these abnormal secretion of cytokines.", {"entities": []}], ["This study aims to detect the association of cytokine genes with GBM.", {"entities": []}], ["We selected seven tag single nucleotide polymorphisms (tSNPs) in six cytokine genes, which previously reported to be associated with brain tumors, and analyzed their association with GBM in a Han Chinese population using \u03c7 We found two risk tSNPs and one protective tSNP.", {"entities": []}], ["By \u03c7 IL-4R showed an increased risk of GBM.", {"entities": []}], ["In the genetic model analysis, the genotype \u201cTC\u201d of rs20541 in IL-13 gene showed an increased risk of GBM in over-dominant model (OR\u2009=\u20092.00; 95% CI, 1.13-3.54, p \u2009=\u20090.015); the genotype \u201cCT\u201d of rs1800871 in the IL-10 gene showed a decrease risk in the over-dominant model (OR\u2009=\u20090.57; 95% CI, 0.33 \u2013 0.97; p \u2009=\u20090.037).", {"entities": []}], ["The genotype \u201cAG\u201d of rs1801275 in the IL-4R gene showed an increase risk in over-dominant model (OR\u2009=\u20092.29; 95% CI, 1.20 - 4.35; p \u2009=\u20090.0081) We further analyzed whether the six cytokine genes have a different effect on the disease in gender specific population, and found that the allele \u201cG\u201d of rs2243248 in the IL-4 gene showed a decrease risk of GBM in female (OR\u2009=\u20090.35, 95% CI, 0.13 - 0.94, p \u2009=\u20090.0032), but the allele \u201cT\u201d showed a decrease risk in male (OR\u2009=\u20090.30, 95% CI, 0.17 - 0.53, p \u2009=\u20090.0032).", {"entities": []}], ["Our findings, combined with previously reported results, suggest that cytokine genes have potential role in GBM development, which may be useful to early prognostics for GBM in the Han Chinese population.", {"entities": []}], ["Smoking is considered as the major causal factor of chronic obstructive pulmonary disease (COPD).", {"entities": [[52, 89, "DISEASE"]]}], ["Nevertheless, a minority of chronic heavy cigarette smokers develops COPD.", {"entities": []}], ["This suggests important contribution of other factors such as genetic predisposing.", {"entities": []}], ["Our objective was to investigate combined role of EPHX1, GSTP1, M1 and T1 gene polymorphisms in COPD risk, its phenotypes and lung function impairment.", {"entities": [[50, 55, "GENE"], [57, 62, "GENE"]]}], ["Prevalence of EPHX1, GSTP1, M1 and T1 gene polymorphisms were assessed in 234 COPD patients and 182 healthy controls from Tunisia.", {"entities": [[14, 19, "GENE"], [21, 26, "GENE"]]}], ["Genotypes of EPHX1 (Tyr113His; His139Arg) and GSTP1 (Ile105Val; Ala114Val) polymorphisms were performed by PCR-RFLP, while the deletion in GSTM1 and GSTT1 genes was determined using multiplex PCR.", {"entities": [[13, 18, "GENE"], [46, 51, "GENE"], [139, 144, "GENE"], [149, 154, "GENE"]]}], ["Analysis of combinations showed a significant association of 113His/His EPHX1/null-GSTM1 (OR = 4.07) and null-GSTM1/105Val/Val GSTP1 (OR = 3.56) genotypes with increased risk of COPD (respectively P=0.0094 and P=0.0153).", {"entities": [[127, 132, "GENE"]]}], ["The null-GSTM1/ null-GSTT1, 105Val/Val GSTP1/null GSTT1, 113His/His EPHX1/null-GSTM1 and null-GSTM1/105Val/Val GSTP1 genotypes were related to emphysema (respectively P = 0.01; P = 0.009; P = 0.008 and P = 0.001).", {"entities": [[21, 26, "GENE"], [50, 55, "GENE"], [39, 44, "GENE"], [111, 116, "GENE"]]}], ["Combination of 113His/His EPHX1/null-GSTM1 genotypes showed a significant association with the decrease of \u0394FEV1 in patients (P = 0.028).", {"entities": []}], ["In conclusion, our results suggest combined EPHX1, GSTP1, GSTM1 and GSTT1 genetic polymorphisms may play a significant role in the development of COPD, emphysema and decline of the lung function.", {"entities": [[44, 49, "GENE"], [51, 56, "GENE"], [58, 63, "GENE"], [68, 73, "GENE"]]}], ["Data mining approaches have been increasingly applied to the electronic health record and have led to the discovery of numerous clinical associations.", {"entities": []}], ["Recent data mining studies have suggested a potential association between cat bites and human depression.", {"entities": []}], ["To explore this possible association in more detail we first used administrative diagnosis codes to identify patients with either depression or bites, drawn from a population of 1.3 million patients.", {"entities": []}], ["We then conducted a manual chart review in the electronic health record of all patients with a code for a bite to accurately determine which were from cats or dogs.", {"entities": []}], ["Overall there were 750 patients with cat bites, 1,108 with dog bites, and approximately 117,000 patients with depression.", {"entities": []}], ["Depression was found in 41.3% of patients with cat bites and 28.7% of those with dog bites.", {"entities": []}], ["Furthermore, 85.5% of those with both cat bites and depression were women, compared to 64.5% of those with dog bites and depression.", {"entities": []}], ["The probability of a woman being diagnosed with depression at some point in her life if she presented to our health system with a cat bite was 47.0%, compared to 24.2% of men presenting with a similar bite.", {"entities": []}], ["The high proportion of depression in patients who had cat bites, especially among women, suggests that screening for depression could be appropriate in patients who present to a clinical provider with a cat bite.", {"entities": []}], ["Additionally, while no causative link is known to explain this association, there is growing evidence to suggest that the relationship between cats and human mental illness, such as depression, warrants further investigation.", {"entities": []}], ["Mucosa-associated epithelial chemokine (MEC; CCL28) is considered pivotal in mediating migration of CCR3 and CCR10-expressing skin-homing memory CLA This controlled longitudinal study was designed to evaluate the expression of CCL28 serum levels in childhood AD and bronchial asthma (BA) and its possible relations to disease severity and activity.", {"entities": [[276, 282, "DISEASE"], [45, 50, "GENE"], [227, 232, "GENE"], [100, 104, "GENE"], [45, 50, "GENE"], [227, 232, "GENE"]]}], ["Serum CCL28 levels were measured in 36 children with AD, 23 children with BA, and 14 children who had both conditions as well as in 21 healthy age and gender-matched subjects serving as controls.", {"entities": [[6, 11, "GENE"]]}], ["Sixteen patients in the AD group were followed-up and re-sampled for serum CCL28 after clinical remission.", {"entities": [[75, 80, "GENE"]]}], ["Serum CCL28 levels were correlated with some AD disease activity and severity variables.", {"entities": [[6, 11, "GENE"]]}], ["Serum CCL28 levels in patients with AD whether during flare (median = 1530; mean \u00b1 SD = 1590.4 \u00b1 724.3 pg/ml) or quiescence (median = 1477; mean \u00b1 SD = 1575.2 \u00b1 522.1 pg/ml) were significantly higher than the values in healthy children (median = 301; mean \u00b1 SD = 189.6 \u00b1 92.8 pg/ml).", {"entities": [[6, 11, "GENE"]]}], ["However, the levels during flare and quiescence were statistically comparable.", {"entities": []}], ["The serum levels in BA (median = 340; mean \u00b1 SD = 201.6 \u00b1 109.5 pg/ml) were significantly lower than the AD group and comparable with the healthy control values.", {"entities": []}], ["Serum CCL28 levels in severe AD were significantly higher as compared with mild and moderate cases and correlated positively to the calculated severity scores (LSS and SCORAD).", {"entities": [[6, 11, "GENE"], [160, 163, "GENE"]]}], ["CCL28 levels during exacerbation of AD could be positively correlated to the corresponding values during remission, the peripheral absolute eosinophil counts, and the serum lactate dehydrogenase levels.", {"entities": [[0, 5, "GENE"]]}], ["Serum CCL28 did not vary with the serum total IgE values in AD.", {"entities": [[6, 11, "GENE"]]}], ["Our data reinforce the concept that CCL28 might share in the pathogenesis of AD probably through selective migration and infiltration of effector/memory Th2 cells into the skin.", {"entities": [[36, 41, "GENE"]]}], ["It may also represent an objective prognostic marker for disease severity.", {"entities": []}], ["Further studies may pave the way for CCL28 antagonism among the adjuvant therapeutic strategies.", {"entities": [[37, 42, "GENE"]]}], ["To assess the prevalence of vitamin D deficiency and its associated factors in women and their newborns in the postpartum period.", {"entities": []}], ["This cross-sectional study evaluated vitamin D deficiency/insufficiency in 226 women and their newborns in Vi\u00e7osa (Minas Gerais, BR) between December 2011 and November 2012.", {"entities": []}], ["Cord blood and venous maternal blood were collected to evaluate the following biochemical parameters: vitamin D, alkaline phosphatase, calcium, phosphorus and parathyroid hormone.", {"entities": []}], ["Poisson regression analysis, with a confidence interval of 95%, was applied to assess vitamin D deficiency and its associated factors.", {"entities": []}], ["Multiple linear regression analysis was performed to identify factors associated with 25(OH)D deficiency in the newborns and women from the study.", {"entities": []}], ["The criteria for variable inclusion in the multiple linear regression model was the association with the dependent variable in the simple linear regression analysis, considering p <0.20.", {"entities": []}], ["Significance level was \u03b1 <5%.", {"entities": []}], ["From 226 women included, 200 (88.5%) were 20-44 years old; the median age was 28 years.", {"entities": []}], ["Deficient/insufficient levels of vitamin D were found in 192 (85%) women and in 182 (80.5%) neonates.", {"entities": []}], ["The maternal 25(OH)D and alkaline phosphatase levels were independently associated with vitamin D deficiency in infants.", {"entities": []}], ["This study identified a high prevalence of vitamin D deficiency and insufficiency in women and newborns and the association between maternal nutritional status of vitamin D and their infants' vitamin D status.", {"entities": []}], ["Avaliar a preval\u00eancia de defici\u00eancia de vitamina D e os fatores associados em mulheres e rec\u00e9m-nascidos no per\u00edodo p\u00f3s-parto.", {"entities": []}], ["Estudo de delineamento transversal; avaliou-se a defici\u00eancia/insufici\u00eancia de vitamina D em 226 mulheres e seus rec\u00e9m-nascidos no munic\u00edpio de Vi\u00e7osa (MG), entre dezembro de 2011 e novembro de 2012.", {"entities": []}], ["Coletaram-se 5mL de sangue do cord\u00e3o umbilical e sangue venoso materno a fim de avaliar os par\u00e2metros bioqu\u00edmicos: vitamina D, fosfatase alcalina, c\u00e1lcio, f\u00f3sforo e paratorm\u00f4nio.", {"entities": []}], ["Usou-se regress\u00e3o de Poisson e adotou-se a Raz\u00e3o de Preval\u00eancia (95% IC), a fim de se avaliar a defici\u00eancia de vitamina D e fatores associados.", {"entities": []}], ["Fez-se a an\u00e1lise de regress\u00e3o linear m\u00faltipla para identificar os fatores associados \u00e0 defici\u00eancia de 25(OH)D dos rec\u00e9m-nascidos e das mulheres do estudo.", {"entities": []}], ["O crit\u00e9rio para inclus\u00e3o das vari\u00e1veis na regress\u00e3o linear m\u00faltipla foi a rela\u00e7\u00e3o com a vari\u00e1vel dependente na an\u00e1lise de regress\u00e3o linear simples, considerando p <0,20.", {"entities": []}], ["O n\u00edvel de signific\u00e2ncia adotado foi \u03b1<5%.", {"entities": []}], ["Das 226 mulheres, 200 (88,5%) tinham entre 20 e 44 anos; a mediana foi de 28.", {"entities": []}], ["Encontrou-se preval\u00eancia de n\u00edveis deficientes/insuficientes de vitamina D em 192 (85%) mulheres e 182 (80,5%) rec\u00e9m-nascidos.", {"entities": []}], ["A 25(OH)D materna e a fosfatase alcalina materna se comportaram como preditores independentes da defici\u00eancia de vitamina D dos rec\u00e9m-nascidos.", {"entities": []}], ["Foi poss\u00edvel identificar a alta preval\u00eancia de defici\u00eancia e insufici\u00eancia de vitamina D nas mulheres e rec\u00e9m-nascidos em nosso meio e a rela\u00e7\u00e3o entre o estado nutricional materno de vitamina D e o do rec\u00e9m-nascido.", {"entities": []}], ["The widespread use of artesunate-amodiaquine (ASAQ) for treating uncomplicated malaria makes it important to gather and analyse information on its tolerability.", {"entities": [[79, 86, "DISEASE"]]}], ["An individual-patient tolerability analysis was conducted using data from eight randomized controlled clinical trials conducted at 17 sites in nine sub-Saharan countries comparing ASAQ to other anti-malarial treatments.", {"entities": []}], ["All patients who received at least one dose of the study drug were included in the analysis.", {"entities": []}], ["Differences in adverse event (AE) and treatment emergent adverse event (TEAE) were analysed by Day 28.", {"entities": []}], ["Of the 6,179 patients enrolled (74% <5\u2009years of age), 50% (n\u2009=\u20093,113) received ASAQ, 20% (n\u2009=\u20091,217) another ACT, and 30% (n\u2009=\u20091,849) a non-ACT (combination or single-agent) treatment.", {"entities": []}], ["Overall, 8,542 AEs were recorded.", {"entities": []}], ["The proportion of patients experiencing at least one gastro-intestinal AE on ASAQ was 43% (and higher than that with artemether-lumefantrine and dihydroartemisinin-piperaquine at two sites), and was 23% for any other AEs (not different from other treatments).", {"entities": []}], ["Specifically, the risk of diarrhoea, vomiting, cough and weakness was lower with artemether-lumefantrine; artemether-lumefantrine and dihydroartemisinin-piperaquine carried a higher risk of pruritus, chloroquine-SP had a higher risk of nausea.", {"entities": []}], ["Parasitological recurrence increased the risk of occurrence of any AE.", {"entities": []}], ["No other difference was detected.", {"entities": []}], ["Comparing AE to TEAE in patients who had pre-treatment occurrence and grades of intensity recorded, AEs were significantly more related to the pre-treatment prevalence of the symptom (p\u2009=\u20090.001, Fisher test); AEs overestimated TEAEs by a factor ranging from none to five-fold.", {"entities": []}], ["The overall incidence of serious AEs (SAEs) with ASAQ was nine per 1,000 (29/3,113) and mortality was one per 1,000 (three deaths, none drug-related); both were similar to other treatments.", {"entities": []}], ["ASAQ was comparatively well-tolerated.", {"entities": []}], ["Safety information is important, and must be collected and analysed in a standardized way.", {"entities": []}], ["TEAEs are a more objective measure of treatment-induced toxicity.", {"entities": []}], ["Childhood and adolescence are important developmental phases which influence health and well-being across the life span.", {"entities": []}], ["Social relationships are fundamental to child and adolescent development; yet studies have been limited to children\u2019s relationships with other humans.", {"entities": []}], ["This paper provides an evidence review for the potential associations between pet ownership and emotional; behavioural; cognitive; educational and social developmental outcomes.", {"entities": []}], ["As the field is in the early stages; a broad set of inclusion criteria was applied.", {"entities": []}], ["A systematic search of databases and grey literature sources found twenty-two studies meeting selection criteria.", {"entities": []}], ["The review found evidence for an association between pet ownership and a wide range of emotional health benefits from childhood pet ownership; particularly for self-esteem and loneliness.", {"entities": []}], ["The findings regarding childhood anxiety and depression were inconclusive.", {"entities": []}], ["Studies also showed evidence of an association between pet ownership and educational and cognitive benefits; for example, in perspective-taking abilities and intellectual development.", {"entities": []}], ["Evidence on behavioural development was unclear due to a lack of high quality research.", {"entities": []}], ["Studies on pet ownership and social development provided evidence for an association with increased social competence; social networks; social interaction and social play behaviour.", {"entities": []}], ["Overall, pet ownership and the significance of children\u2019s bonds with companion animals have been underexplored; there is a shortage of high quality and longitudinal studies in all outcomes.", {"entities": []}], ["Prospective studies that control for a wide range of confounders are required.", {"entities": []}], ["This study aimed to develop a methodological tool to analyze and monitor the green jobs in the context of Occupational Health and Safety.", {"entities": []}], ["A literature review in combination with an investigation of Occupational Health Indicators was performed.", {"entities": []}], ["The resulting tool of Occupational Health Indicators was based on the existing information of \"Single Report\" and was validated by national's experts.", {"entities": []}], ["The tool brings together 40 Occupational Health Indicators in four key fields established by World Health Organization in their conceptual framework \"Health indicators of sustainable jobs.\"", {"entities": []}], ["The tool proposed allows for assessing if the green jobs enabled to follow the principles and requirements of Occupational Health Indicators and if these jobs are as good for the environment as for the workers' health, so if they can be considered quality jobs.", {"entities": []}], ["This shows that Occupational Health Indicators are indispensable for the assessment of the sustainability of green jobs and should be taken into account in the definition and evaluation of policies and strategies of the sustainable development.", {"entities": []}], ["Seasonal influenza epidemic occurs every year in Guangzhou, which can affect all age groups.", {"entities": [[9, 18, "DISEASE"]]}], ["Young children are the most susceptible targets.", {"entities": []}], ["Parents can decide whether to vaccinate their children or not based on their own consideration in China.", {"entities": []}], ["The aim of this study was to identify factors that are important for parental decisions on vaccinating their children against seasonal influenza based on a modified health belief model (HBM).", {"entities": [[135, 144, "DISEASE"]]}], ["A cross-sectional study was conducted in Guangzhou, China.", {"entities": []}], ["A total of 335 parents who had at least on child aged between 6 months and 3 years were recruited from women and children's hospital in Guangzhou, China.", {"entities": []}], ["Each eligible subject was invited for a face-to-face interview based on a standardized questionnaire.", {"entities": []}], ["Uptake of seasonal influenza within the preceding 12 months among the target children who aged between 6 months and 36 months was 47.7%.", {"entities": [[19, 28, "DISEASE"]]}], ["Around 62.4% parents indicated as being \u201clikely/very likely\u201d to take their children for seasonal influenza vaccination in the next 12 months.", {"entities": [[97, 106, "DISEASE"]]}], ["The hierarchical logistic regression model showed that children's age (odds ratio [ OR ] =2.59, 95% confidence interval [ CI ]: 1.44\u20134.68), social norm ( OR = 2.08, 95% CI : 1.06\u20134.06) and perceived control ( OR = 2.96, 95% CI : 1.60\u20135.50) were significantly and positively associated with children's vaccination uptake within the preceding 12 months; children with a history of taking seasonal influenza vaccine ( OR = 2.50, 95% CI : 1.31\u20134.76), perceived children's health status ( OR = 3.36, 95% CI : 1.68\u20136.74), worry/anxious about their children influenza infection ( OR = 2.31, 95% CI : 1.19\u20134.48) and perceived control ( OR = 3.21, 95% CI : 1.65\u20136.22) were positively association with parental intention to vaccinate their children in the future 12 months.", {"entities": [[395, 404, "DISEASE"], [551, 560, "DISEASE"]]}], ["However, anticipated more regret about taking children for the vaccination was associated with less likely to vaccinate children within the preceding 12 months ( OR = 0.21, 95% CI : 0.08\u20130.52).", {"entities": []}], ["The modified HBM provided a good theoretical basic for understanding factors associated with parents\u2019 decisions on their children's vaccination against seasonal influenza.", {"entities": [[161, 170, "DISEASE"]]}], ["We have previously demonstrated the clinical efficacy of montelukast in a randomized double-blind controlled cross-over trial in patients with dyspepsia in association with duodenal eosinophilia.", {"entities": [[143, 152, "DISEASE"], [182, 194, "DISEASE"]]}], ["The mechanism of this clinical response is unknown but could involve a decrease in eosinophil density or activation.", {"entities": []}], ["Twenty-four dyspeptic patients 8\u201317 years of age underwent initial blood sampling and endoscopy with biopsy.", {"entities": []}], ["Eighteen of these patients had elevated duodenal eosinophil density and underwent repeat blood sampling and endoscopy following 21 days of therapy with montelukast (10 mg/day).", {"entities": []}], ["The following were determined: global clinical response on a 5-point Lickert-type scale, eosinophil density utilizing H & E staining, eosinophil activation determined by degranulation indices on electron microscopy, and serum cytokine concentrations.", {"entities": []}], ["On day 21, pharmacokinetics and duodenal mucosal drug concentrations were determined.", {"entities": []}], ["Eighty-three percent of the patients had a positive clinical response to montelukast with regard to relief of pain with 50% having a complete or nearly complete clinical response.", {"entities": []}], ["The response was unrelated to systemic drug exposure or to mucosal drug concentration.", {"entities": []}], ["Other than a mild decrease in eosinophil density in the second portion of the duodenum, there were no significant changes in eosinophil density, eosinophil activation, or serum cytokine concentrations following treatment with montelukast.", {"entities": []}], ["Pre-treatment TNF-\u03b1 concentration was negatively correlated with clinical response.", {"entities": []}], ["The short-term clinical response to montelukast does not appear to result from changes in eosinophil density or activation.", {"entities": []}], ["Whether the effect is mediated through specific mediators or non-inflammatory cells such as enteric nerves remains to be determined.", {"entities": []}], ["ClinicalTrials.gov; NCT00148603", {"entities": []}], ["Objective : Evaluate the safety of albuterol multidose dry powder inhaler (MDPI), a novel, inhalation-driven device that does not require coordination of actuation with inhalation, in patients with persistent asthma.", {"entities": [[209, 215, "DISEASE"]]}], ["Methods : We report pooled safety data from two 12-week, multicenter, randomized, double-blind, repeat-dose, parallel-group studies and the 12-week double-blind phase of a 52-week multicenter safety study as well as safety data from the 40-week open-label phase of the 52-week safety study.", {"entities": []}], ["In each study, eligible patients aged \u226512 years with persistent asthma received placebo MDPI or albuterol MDPI 180\u2009\u00b5g (2 inhalations\u2009\u00d7\u200990\u2009\u00b5g/inhalation) 4 times/day for 12 weeks.", {"entities": [[64, 70, "DISEASE"]]}], ["In the 40-week open-label phase of the 52-week safety study, patients received albuterol MDPI 180\u2009\u03bcg (2 inhalations\u2009\u00d7\u200990\u2009\u03bcg/inhalation) as needed (PRN).", {"entities": []}], ["Results : During both 12-week studies and the 12-week double-blind phase of the 52-week study, adverse events were more common with placebo MDPI (50%; n \u2009=\u2009333) than albuterol MDPI (40%; n \u2009=\u2009321); most frequent were upper respiratory tract infection (placebo MDPI 11%, albuterol MDPI 10%), nasopharyngitis (6%, 5%), and headache (6%, 4%).", {"entities": [[291, 306, "DISEASE"]]}], ["Incidences of \u03b2 2 -agonist-related events (excluding headache) during the pooled 12-week dosing periods were low (\u22641%) in both groups.", {"entities": []}], ["The safety profile with albuterol MDPI PRN during the 40-week open-label phase [most frequent adverse events: nasopharyngitis (12%), sinusitis (11%), upper respiratory tract infection (9%)] was similar to that observed during the 12-week pooled analysis.", {"entities": [[133, 142, "DISEASE"], [110, 125, "DISEASE"]]}], ["Conclusions : The safety profile of albuterol MDPI 180\u2009\u03bcg in these studies was comparable with placebo MDPI and consistent with the well-characterized profile of albuterol in patients with asthma.", {"entities": [[189, 195, "DISEASE"]]}], ["Many patients with chronic diseases use complementary therapies, often provided by their physicians.", {"entities": []}], ["In Germany, several physician-provided complementary therapies have been reimbursed by health insurance companies as part of health benefit programs.", {"entities": []}], ["In most of these therapies, the patient has a predominantly passive role.", {"entities": []}], ["In eurythmy therapy, however, patients actively exercise specific movements with the hands, the feet or the whole body.", {"entities": []}], ["The purpose of this study was to describe clinical outcomes in patients practising eurythmy therapy exercises for chronic diseases.", {"entities": []}], ["In conjunction with a health benefit program, 419 outpatients from 94 medical practices in Germany, referred to 118 eurythmy therapists, participated in a prospective cohort study.", {"entities": []}], ["Main outcomes were disease severity (Disease and Symptom Scores, physicians' and patients' assessment on numerical rating scales 0\u201310) and quality of life (adults: SF-36, children aged 8\u201316: KINDL, children 1\u20137: KITA).", {"entities": []}], ["Disease Score was documented after 0, 6 and 12 months, other outcomes after 0, 3, 6, 12, 18, 24, and (SF-36 and Symptom Score) 48 months.", {"entities": []}], ["Most common indications were mental disorders (31.7% of patients; primarily depression, fatigue, and childhood emotional disorder) and musculoskeletal diseases (23.4%).", {"entities": []}], ["Median disease duration at baseline was 3.0 years (interquartile range 1.0\u20138.5).", {"entities": []}], ["Median number of eurythmy therapy sessions was 12 (interquartile range 10\u201319), median therapy duration was 119 days (84\u2013188).", {"entities": []}], ["All outcomes improved significantly between baseline and all subsequent follow-ups (exceptions: KITA Psychosoma in first three months and KINDL).", {"entities": []}], ["Improvements from baseline to 12 months were: Disease Score from mean (standard deviation) 6.65 (1.81) to 3.19 (2.27) (p < 0.001), Symptom Score from 5.95 (1.75) to 3.49 (2.12) (p < 0.001), SF-36 Physical Component Summary from 43.13 (10.25) to 47.10 (9.78) (p < 0.001), SF-36 Mental Component Summary from 38.31 (11.67) to 45.01 (11.76) (p < 0.001), KITA Psychosoma from 69.53 (15.45) to 77.21 (13.60) (p = 0.001), and KITA Daily Life from 59.23 (21.78) to 68.14 (18.52) (p = 0.001).", {"entities": []}], ["All these improvements were maintained until the last follow-up.", {"entities": []}], ["Improvements were similar in patients not using diagnosis-related adjunctive therapies within the first six study months.", {"entities": []}], ["Adverse reactions to eurythmy therapy occurred in 3.1% (13/419) of patients.", {"entities": []}], ["No patient stopped eurythmy therapy due to adverse reactions.", {"entities": []}], ["Patients practising eurythmy therapy exercises had long-term improvement of chronic disease symptoms and quality of life.", {"entities": []}], ["Although the pre-post design of the present study does not allow for conclusions about comparative effectiveness, study findings suggest that eurythmy therapy can be useful for patients motivated for this therapy.", {"entities": []}], ["As one of smoke-free policies, communities have established the smoke-free ordinances since August 2010.", {"entities": []}], ["Thus, this study aimed to evaluate the effects of community-level smoke-free ordinances (SFO) on smoking rates in men using multiyear Community Health Survey (CHS) data.", {"entities": []}], ["Data on community-level SFO were collected from a website on Enhanced Local Laws and Regulation Information System.", {"entities": []}], ["Regional smoking-related data were obtained from CHS data from 2008 to 2012 and the age-standardized rates of current smoking in men, attempts to quit smoking, and smoke-free campaign experiences including the mean number of cigarettes smoked (smoking amount) were calculated.", {"entities": []}], ["Repeated measures analysis of variance was performed to evaluate the effects of regional implementation of SFO and the duration on change of smoking rates.", {"entities": []}], ["Overall current smoking rates and daily mean cigarettes smoked were lower in community where SFO had been implemented compared to those without implementation, and there was a significant difference in smoking rates between 2010 and 2008.", {"entities": []}], ["Cross-sectional analysis of the effects of regional SFO revealed clear difference in rate of current smoking, but longitudinal analysis showed no significant differences.", {"entities": []}], ["Stratifying by age groups, however, showed that groups less than 30 years of age had low smoking rates in community with ordinance compared to those without SFO since 2010.", {"entities": []}], ["Yearly surveys measuring the number of cigarettes smoked, attempts to quit smoking, and experiences of smoke-free campaigns showed regional differences in the duration of implementation, but these differences were not significant in longitudinal analysis.", {"entities": []}], ["Furthermore, there was a difference in regional socioeconomic characteristics between community with and without SFO implementation.", {"entities": []}], ["For effective smoking control, it is necessary to evaluate current policies and develop indices to evaluate the practical implementation of ordinances.", {"entities": []}], ["As more communities to pass the SFO, long-term observation and assessments required.", {"entities": []}], ["Intercellular signaling by cytokines is a vital feature of the innate immune system.", {"entities": []}], ["In skin, an inflammatory response is mediated by cytokines and an entwined network of cellular communication between T-cells and epidermal keratinocytes.", {"entities": []}], ["Dysregulated cytokine production, orchestrated by activated T-cells homing to the skin, is believed to be the main cause of psoriasis, a common inflammatory skin disorder.", {"entities": [[124, 133, "DISEASE"]]}], ["Cytokines are heavily regulated at the transcriptional level, but emerging evidence suggests that regulatory mechanisms that operate after transcription play a key role in balancing the production of cytokines.", {"entities": []}], ["Herein, we review the nature of cytokine signaling in psoriasis with particular emphasis on regulation by mRNA destabilizing elements and the potential targeting of cytokine-encoding mRNAs by miRNAs.", {"entities": [[54, 63, "DISEASE"]]}], ["The proposed linkage between mRNA decay mediated by AU-rich elements and miRNA association is described and discussed as a possible general feature of cytokine regulation in skin.", {"entities": []}], ["Moreover, we describe the latest attempts to therapeutically target cytokines at the RNA level in psoriasis by exploiting the cellular RNA interference machinery.", {"entities": [[98, 107, "DISEASE"]]}], ["The applicability of cytokine-encoding mRNAs as future clinical drug targets is evaluated, and advances and obstacles related to topical administration of RNA-based drugs targeting the cytokine circuit in psoriasis are described.", {"entities": [[205, 214, "DISEASE"]]}], ["Recent studies described the association between hematopoietic stem/progenitor cell (HSPC) expansion in the bone marrow (BM), leukocytosis in the peripheral blood, and accelerated atherosclerosis.", {"entities": [[180, 195, "DISEASE"]]}], ["We hypothesized that circulating HSPC may home to inflamed vessels, where they might contribute to inflammation and neointima formation.", {"entities": []}], ["We demonstrated that Lin 2 , which was responsible for LSK cell adhesion and migration toward ICAM-1 in vitro, and homing to injured arteries in vivo, all of which were blocked with an anti-CD18 blocking antibody.", {"entities": []}], ["When homed LSK cells were isolated from ligated artery and injected to irradiated recipients, they resulted in BM reconstitution.", {"entities": []}], ["Injection of CD18 2 function on HSPC.", {"entities": []}], ["In addition, integrin \u03b2 2 function could be regulated via ERK-independent LRP1 pathway.", {"entities": []}], ["Integrin \u03b2 2 expression on HSPC is regulated by hypercholesterolemia, specifically LDL, in pERK-dependent and -independent manners, leading to increased homing and localization of HSPC to injured arteries, which is highly correlated with arteriosclerosis.", {"entities": [[238, 254, "DISEASE"]]}], ["S tem C ells 2015;33:1230\u20131240", {"entities": []}], ["Mastocytosis is a rare disease consisting of a group of disorders characterized by a pathologic increase in the number of mast cells in one or more organ system.", {"entities": [[0, 12, "DISEASE"]]}], ["Treatment is symptomatic.", {"entities": []}], ["Oral sodium cromoglicate (SCG) is the only treatment licensed for the treatment of mastocytosis.", {"entities": [[83, 95, "DISEASE"]]}], ["In this case we report how in a mastocytosis patient being treated with H 1 and H 2 antihistamines, and oral sodium cromoglicate, the addition of inhaled sodium cromoglicate resulted in further improvement.", {"entities": [[32, 44, "DISEASE"]]}], ["This is the first report of this use of the drug in this disease.", {"entities": []}], ["The subject is a Caucasian woman aged 40 years.", {"entities": []}], ["Symptoms of mastocytosis began when she was aged 13 years, but the diagnosis was not made until after her first pregnancy aged 33 years.", {"entities": [[12, 24, "DISEASE"]]}], ["Symptoms improved with H 1 and H 2 antihistamines, and oral sodium cromoglicate, but it required the addition of inhaled sodium cromoglicate to produce further improvement, specifically in the symptoms of bone pain, fatigue and headache.", {"entities": []}], ["Doses of oral sodium cromoglicate had to be increased if challenged with a food to which the subject was sensitive.", {"entities": []}], ["Doses of inhaled sodium cromoglicate had to be increased during the menstrual period.", {"entities": []}], ["Patients suffering from the rare disease of mastocytosis have symptoms affecting many body systems.", {"entities": [[44, 56, "DISEASE"]]}], ["Symptoms result from the release of inflammatory mediators from mast cells.", {"entities": []}], ["Sodium cromoglicate, a drug that reduces the release of mediators from mast cells, is effective in controlling gastrointestinal symptoms, but less effective in those affecting other body systems.", {"entities": []}], ["In this case report we have shown that the addition of inhaled sodium cromoglicate controls the symptoms of bone pain, fatigue and headache and also that the doses have to be increased during the menstrual period.", {"entities": []}], ["Pseudomonas aeruginosa (P. aeruginosa) occupies an important niche in the pathogenic microbiome of bronchiectasis.", {"entities": [[99, 113, "DISEASE"]]}], ["The objective of this study is to evaluate the clinical characteristics and prognostic value of P. aeruginosa in Chinese adult patients with bronchiectasis.", {"entities": [[141, 155, "DISEASE"]]}], ["This retrospective and follow-up study enrolled 1188 patients diagnosed with bronchiectasis at Shanghai Pulmonary Hospital between January 2011 and December 2012.", {"entities": [[77, 91, "DISEASE"]]}], ["The patients\u2019 clinical data including anthropometry, clinical symptoms, serum biomarkers, radiographic manifestations and lung function indices were reviewed.", {"entities": []}], ["The median follow-up duration (IQR) was 44 (40-54) months, during which 289 patients were lost to follow-up.", {"entities": []}], ["Data from 899 patients were collected and analysed for the outcomes of mortality, annual exacerbation frequency and health-related quality of life.", {"entities": []}], ["P. aeruginosa was isolated from 232 patients, alongside other pathogens such as Aspergillus (n=75) and Candida albicans (n=72).", {"entities": []}], ["There were 74 deaths (12% of patients with P. aeruginosa , 7.3% of those without) over the course of the follow-up.", {"entities": []}], ["The isolation of P. aeruginosa was a risk factor for all-cause mortality (HR, 3.07; 95%\u2009CI 1.32 to 7.15) and was associated with high rates of exacerbations (ie, \u22653 exacerbations per year of follow-up) (HR, 2.40; 95%\u2009CI 1.20 to 4.79).", {"entities": [[74, 76, "GENE"], [203, 205, "GENE"], [74, 76, "GENE"], [203, 205, "GENE"]]}], ["Patients with P. aeruginosa also had worse scores on the Hospital Anxiety and Depression Scale (anxiety, p=0.005; depression, p<0.001), the Leicester Cough Questionnaire (p=0.033) and the modified Medical Research Council scale (p=0.001) compared with those without P. aeruginosa .", {"entities": []}], ["Isolation of P. aeruginosa in patients with bronchiectasis is a significant prognostic indicator and should be a major factor in the clinical management of the disease.", {"entities": [[44, 58, "DISEASE"]]}], ["Catecholaminergic polymorphic ventricular tachycardia ( CPVT ) is a stress\u2010provoked ventricular arrhythmia, which also manifests sinoatrial node ( SAN ) dysfunction.", {"entities": []}], ["We recently showed that SK 4 calcium\u2010activated potassium channels are important for automaticity of cardiomyocytes derived from human embryonic stem cells.", {"entities": []}], ["Here SK 4 channels were identified in human induced pluripotent stem cell\u2010derived cardiomyocytes (hiPSC\u2010 CM s) from healthy and CPVT 2 patients bearing a mutation in calsequestrin 2 ( CASQ 2\u2010D307H) and in SAN cells from WT and CASQ 2\u2010D307H knock\u2010in ( KI ) mice.", {"entities": []}], ["TRAM \u201034, a selective blocker of SK 4 channels, prominently reduced delayed afterdepolarizations and arrhythmic Ca CPVT 2\u2010derived hiPSC\u2010 CM s and in SAN cells from KI mice.", {"entities": []}], ["Strikingly, in\u00a0vivo ECG recording showed that intraperitoneal injection of the SK 4 channel blockers, TRAM \u201034 or clotrimazole, greatly reduced the arrhythmic features of CASQ 2\u2010D307H KI and CASQ 2 knockout mice at rest and following exercise.", {"entities": []}], ["This work demonstrates the critical role of SK 4 Ca CPVT .", {"entities": []}], ["While several studies suggest that traffic-related air pollutants are detrimental for respiratory health, few studies have examined relationships between residential proximity to a major roadway and asthma control in children.", {"entities": [[199, 205, "DISEASE"]]}], ["Furthermore, a major limitation of existing research is reliance on self-reported outcomes.", {"entities": []}], ["We therefore determined the spatial relationship between the distance from a major roadway and clinical, physiologic and inflammatory features of asthma in a highly characterized sample of asthmatic children 6\u201317 years of age across a wide range of severities.", {"entities": [[146, 152, "DISEASE"]]}], ["We hypothesized that a closer residential proximity to a major roadway would be associated with increased respiratory symptoms, altered pulmonary function and a greater magnitude of airway and systemic inflammation.", {"entities": []}], ["224 children 6\u201317 years with confirmed asthma completed questionnaires and underwent spirometry, plethysmography, exhaled nitric oxide determination, exhaled breath condensate collection and venipuncture.", {"entities": [[39, 45, "DISEASE"]]}], ["Residential distance from a major roadway was determined by mapping the geographic coordinates of the residential address in Geographic Information System software.", {"entities": []}], ["The distance between the home address and the nearest major roadway was calculated according to the shortest distance between the two points (i.e., \u201cas the crow flies\u201d).", {"entities": []}], ["Asthmatic children living in closer proximity to a major roadway had an increased frequency of wheezing associated with increased medication requirements and more hospitalizations even after controlling for potential confounders.", {"entities": []}], ["These children also had increased airway resistance, increased airway inflammation reflected by a lower breath condensate pH, and higher plasma EGF concentrations.", {"entities": [[144, 147, "GENE"]]}], ["These findings suggest that closer residential proximity to a major roadway is associated with poorer asthma control in school-age children.", {"entities": [[102, 108, "DISEASE"]]}], ["Assessment of residential proximity to major roadways may be useful in the clinical evaluation of asthma in children.", {"entities": [[98, 104, "DISEASE"]]}], ["The complement system, an important part of innate immunity, plays a critical role in pathogen clearance.", {"entities": []}], ["Unregulated complement activation is likely to play a crucial role in the pathogenesis of acute lung injury (ALI) induced by highly pathogenic virus including influenza A viruses H5N1, H7N9, and severe acute respiratory syndrome (SARS) coronavirus.", {"entities": [[159, 168, "DISEASE"], [220, 228, "DISEASE"], [195, 228, "DISEASE"], [230, 234, "GENE"]]}], ["In highly pathogenic virus-induced acute lung diseases, high levels of chemotactic and anaphylatoxic C5a were produced as a result of excessive complement activaiton.", {"entities": []}], ["Overproduced C5a displays powerful biological activities in activation of phagocytic cells, generation of oxidants, and inflammatory sequelae named \u201ccytokine storm\u201d, and so on.", {"entities": []}], ["Blockade of C5a signaling have been implicated in the treatment of ALI induced by highly pathogenic virus.", {"entities": []}], ["Herein, we review the literature that links C5a and ALI, and review our understanding of the mechanisms by which C5a affects ALI during highly pathogenic viral infection.", {"entities": []}], ["In particular, we discuss the potential of the blockade of C5a signaling to treat ALI induced by highly pathogenic viruses.", {"entities": []}], ["Lymphedema results from lymphatic insufficiency leading to a progressive inflammatory process that ultimately manifests as discomfort, recurrent infections, and, at times, secondary malignancy.", {"entities": [[0, 10, "DISEASE"]]}], ["Collectively, these morbidities contribute to an overall poor quality of life.", {"entities": []}], ["Although there have been recent advances in microsurgical interventions, a conservative palliative approach remains the mainstay of treatment for this disabling disease.", {"entities": []}], ["The absence of a cure is due to an incomplete understanding of the pathophysiological changes that result in lymphedema.", {"entities": [[109, 119, "DISEASE"]]}], ["A histological hallmark of lymphedema is inflammatory cell infiltration and recent studies with animal models and clinical biopsy specimens have suggested that this response plays a key role in the pathology of the disease.", {"entities": [[27, 37, "DISEASE"]]}], ["The purpose of this report is to provide an overview of the ongoing research in and the current understanding of the inflammatory manifestations of lymphedema.", {"entities": [[148, 158, "DISEASE"]]}], ["NOD1 is an intracellular pattern recognition receptor that recognizes diaminopimelic acid (DAP), a peptidoglycan component in gram negative bacteria.", {"entities": [[0, 4, "GENE"]]}], ["Upon ligand binding, NOD1 assembles with receptor-interacting protein (RIP)-2 kinase and initiates a signaling cascade leading to the production of pro-inflammatory cytokines.", {"entities": [[21, 25, "GENE"]]}], ["Increased NOD1 signaling has been associated with a variety of inflammatory disorders suggesting that small-molecule inhibitors of this signaling complex may have therapeutic utility.", {"entities": [[10, 14, "GENE"]]}], ["We utilized a cell-based screening approach with extensive selectivity profiling to search for small molecule inhibitors of the NOD1 signaling pathway.", {"entities": [[128, 132, "GENE"]]}], ["Via this process we identified three distinct chemical series, xanthines (SB711), quinazolininones (GSK223) and aminobenzothiazoles (GSK966) that selectively inhibited iE-DAP-stimulated IL-8 release via the NOD1 signaling pathway.", {"entities": [[207, 211, "GENE"]]}], ["All three of the newly identified compound series failed to block IL-8 secretion in cells following stimulation with ligands for TNF receptor, TLR2 or NOD2 and, in addition, none of the compound series directly inhibited RIP2 kinase activity.", {"entities": [[129, 132, "GENE"], [143, 147, "GENE"], [151, 155, "GENE"]]}], ["Our initial exploration of the structure-activity relationship and physicochemical properties of the three series directed our focus to the quinazolininone biarylsulfonamides (GSK223).", {"entities": []}], ["Further investigation allowed for the identification of significantly more potent analogs with the largest boost in activity achieved by fluoro to chloro replacement on the central aryl ring.", {"entities": []}], ["These results indicate that the NOD1 signaling pathway, similarly to activation of NOD2, is amenable to modulation by small molecules that do not target RIP2 kinase.", {"entities": [[32, 36, "GENE"], [83, 87, "GENE"]]}], ["These compounds should prove useful tools to investigate the importance of NOD1 activation in various inflammatory processes and have potential clinical utility in diseases driven by hyperactive NOD1 signaling.", {"entities": [[75, 79, "GENE"], [195, 199, "GENE"], [75, 79, "GENE"], [195, 199, "GENE"]]}], ["Perinatal probiotics supplementation has been shown to be effective in the primary prevention of atopic dermatitis (AD) in early childhood, although the long term effects of probiotics on AD and other allergic diseases is less certain.", {"entities": [[97, 114, "DISEASE"], [104, 114, "DISEASE"]]}], ["We have previously reported a significant reduction in the cumulative incidence of AD at 2\u00a0years after maternal probiotic supplementation.", {"entities": []}], ["In this study we present the effects of perinatal probiotics given to women from a general population on allergy related diseases in their offspring at 6\u00a0years.", {"entities": []}], ["Four hundred and fifteen pregnant women were randomised to receive probiotic or placebo milk in a double-blinded trial from 36\u00a0week gestation until 3\u00a0months postpartum.", {"entities": []}], ["Probiotic milk contained Lactobacillus rhamnosos GG, L. acidophilus La-5 and Bifidobacterium animalis subsp.", {"entities": []}], ["lactis Bb-12.", {"entities": []}], ["At 6\u00a0years, children were re-assessed for AD, atopic sensitisation, asthma and allergic rhinoconjunctivitis (ARC).", {"entities": [[68, 74, "DISEASE"]]}], ["At 6\u00a0years, 81 and 82 children were assessed for AD in the probiotic and placebo groups, respectively.", {"entities": []}], ["In a multiple imputation analysis, there was as trend towards a lower cumulative incidence of AD in the probiotic group compared to the placebo group (OR 0.64, 95\u00a0% CI 0.39-1.07, p \u2009=\u20090.086; NNT\u2009=\u200910).", {"entities": [[191, 194, "GENE"]]}], ["This finding was statistically significantly in the complete case analysis (OR 0.48, 95\u00a0% CI 0.25-0.92, p \u2009=\u20090.027, NNT\u2009=\u20096).", {"entities": [[116, 119, "GENE"]]}], ["The prevalence of asthma and atopic sensitisation, and the cumulative incidence of ARC were not significantly affected by the probiotic regime at 6\u00a0years of age.", {"entities": [[18, 24, "DISEASE"]]}], ["Maternal probiotic ingestion alone may be sufficient for long term reduction in the cumulative incidence of AD, but not other allergy related diseases.", {"entities": []}], ["ClinicalTrials.gov identifier: NCT00159523 The online version of this article (doi:10.1186/s12895-015-0030-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["G protein-coupled receptors are recognized as one of the largest families of membrane proteins.", {"entities": []}], ["Despite sharing a characteristic seven-transmembrane topology, G protein-coupled receptors regulate a wide range of cellular signaling pathways in response to various physical and chemical stimuli, and prevail as an important target for drug discovery.", {"entities": []}], ["Notably, the recent progress in crystallographic methods led to a breakthrough in elucidating the structures of membrane proteins.", {"entities": []}], ["The structures of \u03b2 2 -adrenergic receptor bound with a variety of ligands provide atomic details of the binding modes of agonists, antagonists and inverse agonists.", {"entities": []}], ["In this study, we selected four representative molecules from each functional class of ligands and investigated their impacts on \u03b2 2 -adrenergic receptor through a total of 12\u2009\u00d7\u2009100\u2009ns molecular dynamics simulations.", {"entities": []}], ["From the obtained trajectories, we generated molecular fingerprints exemplifying propensities of protein-ligand interactions.", {"entities": []}], ["For each functional class of compounds, we characterized and compared the fluctuation of the protein backbone, the volumes in the intracellular pockets, the water densities in the receptors, the domain interaction networks as well as the movements of transmembrane helices.", {"entities": []}], ["We discovered that each class of ligands exhibits a distinct mode of interactions with mainly TM5 and TM6, altering the shape and eventually the state of the receptor.", {"entities": []}], ["Our findings provide insightful prospective into GPCR targeted structure-based drug discoveries.", {"entities": []}], ["The repair protein trefoil factor 2 promotes Th2 responses to helminth infection and allergens in part by inducing IL-33.", {"entities": []}], ["The molecular mechanisms that drive mucosal T helper type 2 (T H 2) responses against parasitic helminths and allergens remain unclear.", {"entities": []}], ["In this study, we demonstrate in mice that TFF2 (trefoil factor 2), an epithelial cell\u2013derived repair molecule, is needed for the control of lung injury caused by the hookworm parasite Nippostrongylus brasiliensis and for type 2 immunity after infection.", {"entities": [[43, 47, "GENE"]]}], ["TFF2 is also necessary for the rapid production of IL-33, a T H 2-promoting cytokine, by lung epithelia, alveolar macrophages, and inflammatory dendritic cells in infected mice.", {"entities": [[0, 4, "GENE"]]}], ["TFF2 also increases the severity of allergic lung disease caused by house dust mite antigens or IL-13.", {"entities": [[45, 57, "DISEASE"], [0, 4, "GENE"]]}], ["Moreover, TFF2 messenger RNA expression is significantly increased in nasal mucosal brushings during asthma exacerbations in children.", {"entities": [[101, 107, "DISEASE"], [10, 14, "GENE"]]}], ["These experiments extend the biological functions of TFF2 from tissue repair to the initiation and maintenance of mucosal T H 2 responses.", {"entities": [[53, 57, "GENE"]]}], ["An air-conditioned coach is an important form of transportation in modern motorized society; as a result, there is an increasing concern of in-vehicle air pollution.", {"entities": []}], ["In this study, we aimed to identify and quantify the levels of volatile organic compounds (VOCs) and carbonyl compounds (CCs) in air samples collected from the cabins of newly produced, medium- and large-size coaches.", {"entities": [[121, 124, "GENE"]]}], ["Among the identified VOCs and CCs, toluene, ethylbenzene, xylene, formaldehyde, acetaldehyde, acrolein/acetone, and isovaleraldehyde were relatively abundant in the cabins.", {"entities": [[30, 33, "GENE"]]}], ["Time was found to affect the emissions of the contaminants in the coaches.", {"entities": []}], ["Except for benzaldehyde, valeraldehyde and benzene, the highest in-vehicle concentrations of VOCs and CCs were observed on the 15th day after coming off the assembly line, and the concentrations exhibited an approximately inverted U-shaped pattern as a function of time.", {"entities": [[102, 105, "GENE"]]}], ["Interestingly, this study also showed that the interior temperature of the coaches significantly affected the VOCs emissions from the interior materials, whereas the levels of CCs were mainly influenced by the relative humidity within the coaches.", {"entities": [[176, 179, "GENE"]]}], ["In China, guidelines and regulations for the in-vehicle air quality assessment of the coaches have not yet been issued.", {"entities": []}], ["The results of this study provide further understanding of the in-vehicle air quality of air-conditioned coaches and can be used in the development of both specific and general rules regarding medium- and large-size coaches.", {"entities": []}], ["Atherosclerosis (AS) is chronic inflammation in response to lipid accumulation.", {"entities": [[0, 15, "DISEASE"]]}], ["MicroRNA-155 (miR-155) is being increasingly studied to evaluate its potential as diagnostic biomarkers and therapeutic targets in many diseases.", {"entities": [[14, 21, "GENE"]]}], ["However, delineating the role of miR-155 in AS remains difficult.", {"entities": [[33, 40, "GENE"]]}], ["Here, we detected constitutive expression of several microRNAs (miRNAs) possibly associated with cardiovascular disease in foam cells and clinical specimens from patients with AS.", {"entities": []}], ["Among them, we found that the level of miR-155 in foam cells was the most significantly elevated in a dose- and time-dependent manner.", {"entities": [[39, 46, "GENE"]]}], ["In addition, the expression of miR-155 was elevated in the plasma and plaque of patients with AS.", {"entities": [[31, 38, "GENE"]]}], ["We also reported for the first time that miR-155 targets calcium-regulated heat stable protein 1 ( CARHSP1 ), which regulates the stability of tumor necrosis factor alpha (TNF-\u03b1) mRNA.", {"entities": [[41, 48, "GENE"], [99, 106, "GENE"]]}], ["Furthermore, we investigated the mechanism by which the miR-155 level is elevated.", {"entities": [[56, 63, "GENE"]]}], ["miR-155 upregulation is due to transcriptional regulation by nuclear factor (NF)-\u03baB, which is activated by the inflammatory factor TNF-\u03b1.", {"entities": [[0, 7, "GENE"]]}], ["In summary, increased miR-155 relieves chronic inflammation by a negative feedback loop and plays a protective role during atherosclerosis-associated foam cell formation by signaling through the miR-155\u2013CARHSP1\u2013TNF-\u03b1 pathway.", {"entities": [[123, 138, "DISEASE"], [22, 29, "GENE"], [195, 202, "GENE"]]}], ["Postresuscitation immune dysfunction contributes to the low survival rate after successful resuscitation, but its mechanism remains poorly understood.", {"entities": []}], ["The purpose of this study was to investigate whether splenic regulatory T-cell (Treg) apoptosis was involved in the postresuscitation immune dysfunction.", {"entities": []}], ["Thirty-eight pigs were randomly divided into sham-operated group (SHAM group, n = 8), 12 h post return of spontaneous circulation (ROSC) group, 24 h post-ROSC group, and 48 h post-ROSC group ( n = 10 per group).", {"entities": []}], ["A Wuzhishan miniature porcine model of 8-min ventricular fibrillation cardiac arrest (CA) was established.", {"entities": []}], ["The apoptosis rates of Treg in the spleen were tested by flow cytometry; the expressions of forkhead/winged helix transcription factor ( Foxp3 ) of Treg in the spleen were detected by real-time polymerase chain reaction; and the levels of interleukin-4 (IL-4), IL-10, and interferon gamma (IFN-\u03b3) of Treg in the spleen were detected by enzyme-linked immunosorbent assay.", {"entities": [[137, 142, "GENE"]]}], ["The apoptosis rates of Treg in all post-ROSC groups were significantly lower than that of SHAM group (7.7% \u00b1 1.9%, 7.1% \u00b1 1.8%, 6.2% \u00b1 0.4% vs. 13.1% \u00b1 1.6%; P < 0.05); the expression levels of Foxp3 and IL-10 were also decreased with the increase of apoptosis rates of Treg.", {"entities": [[194, 199, "GENE"]]}], ["Helper T-cells CD4 P < 0.01) at 12, 24, and 48 h after ROSC.", {"entities": [[15, 18, "GENE"]]}], ["Compared with SHAM group, the levels of IFN-\u03b3 (161.0 \u00b1 12.9, 167.7 \u00b1 10.5, 191.2 \u00b1 7.7 vs. 7.6 \u00b1 0.9 ng/L) and IL-4 (27.7 \u00b1 6.2, 35.9 \u00b1 3.5, 50.6 \u00b1 6.1 vs. 13.3 \u00b1 2.3 ng/L) and the ratio of IFN-\u03b3/IL-4 (8.6 \u00b1 2.3, 4.9 \u00b1 0.4, 4.5 \u00b1 0.9 vs. 0.8 \u00b1 0.2) were all greatly elevated in all post-ROSC groups ( P < 0.05).", {"entities": []}], ["Apoptosis rate of Treg was significantly decreased after CA, and thus the proportion of Treg was increased and the inhibitory effects were enhanced, which further led to the decrease of the amount of CD4", {"entities": [[200, 203, "GENE"]]}], ["Parasitic helminths need to suppress the host immune system to establish chronic infections.", {"entities": []}], ["Paradoxically, immunosuppression induced by the worm also benefits the host by limiting excessive inflammation and tissue damage, which remains the major cause leading to serious morbidity and mortality.", {"entities": []}], ["Regulatory T cells (Tregs) are key immune regulators of this mutualism.", {"entities": []}], ["The successive rise in Tregs during schistosome infection plays a critical role in immunoregulation.", {"entities": []}], ["We and others previously showed that Schistosoma japonicum ( S .", {"entities": []}], ["japonicum ) egg antigens (SEA) induce Tregs both in vitro and in vivo .", {"entities": []}], ["In addition, we identified that SjHSP60 derived from SEA significantly induces Tregs in vivo and in vitro .", {"entities": []}], ["However, the contribution of SjHSP60 in SEA to Treg induction and the related mechanisms of the Treg induction have not yet been identified.", {"entities": []}], ["In this study, we showed that S .", {"entities": []}], ["japonicum stress protein HSP60 (SjHSP60) was constitutively and extensively expressed in eggs of S .", {"entities": []}], ["japonicum .", {"entities": []}], ["SjHSP60 specially induced Tregs in vivo and in vitro without inducing other CD4 in vitro and displayed a significant impaired ability to induce Tregs in vivo .", {"entities": [[76, 79, "GENE"]]}], ["Finally, our study illustrated that the mechanisms of SjHSP60-mediated induction of Tregs are through both conversion of CD4 Collectively, our findings identify SjHSP60 as a major parasitic contributor of Treg induction in S .", {"entities": [[121, 124, "GENE"]]}], ["japonicum egg antigens, which not only contributes to the better understanding of the mechanism of immunoregulation during helminth infection, but also suggests its potential as a therapeutic target for control of immunopathology, allergic and autoimmune diseases.", {"entities": []}], ["Clara cell protein (CC16), the main secretory product of bronchiolar Clara cells, plays an important protective role in the respiratory tract against oxidative stress and inflammation.", {"entities": []}], ["The purpose of the study was to investigate the role of elemental carbon ultrafine particles (EC-UFP)-induced oxidative stress on Clara cells and CC16 in a mouse model of allergic lung inflammation.", {"entities": []}], ["Ovalbumin (OVA)-sensitized mice were exposed to EC-UFP (507 \u03bcg/m In non sensitized mice EC-UFP inhalation caused alterations in CC16 concentration, both at protein and mRNA level, and induced Clara cell hyperplasia.", {"entities": []}], ["In sensitized mice, inhalation of EC-UFP prior to OVA challenge caused most significant alterations of BALF and serum CC16 concentration, BALF total protein and TNF-\u03b1 relative expression compared to relevant controls; their Clara cells displayed the strongest morphological alterations and strongest goblet cell metaplasia occurred in the small airways.", {"entities": []}], ["NAC strongly reduced both functional and morphological alterations of Clara cells.", {"entities": []}], ["Our findings demonstrate that oxidative stress plays an important role in EC-UFP-induced augmentation of functional and morphological alterations of Clara cells in allergic lung inflammation.", {"entities": []}], ["Congenital Cytomegalovirus (CMV) infection and alpha 1-antitrypsin (A1AT) deficiency are separately well described entities, but their simultaneous occurrence can pose a special challenge to a clinician, especially dealing with optimal diagnostic as well as therapeutic approach.", {"entities": []}], ["Congenital CMV infection is the most common vertically transmitted infection in developed countries.", {"entities": []}], ["In 85\u201395% of newborns it runs asymptomatic, while in others it is presented with jaundice, petechias, hepatosplenomegaly and central nervous system damage.", {"entities": []}], ["A1AT deficiency is on the other hand, the most common genetic liver disease in children, and the clinical spectrum varies from the accidentally detected increased levels of transaminases through to the severe infant cholestasis that can progress to cirrhosis.", {"entities": [[216, 227, "DISEASE"], [62, 75, "DISEASE"]]}], ["The following case report describes a two-month old male with severe clinical presentation of congenital CMV infection probably exacerbated due to A1AT deficiency comorbidity.", {"entities": []}], ["The clinical manifestations and unusually difficult clinical signs this infant presented lead to assumption that the additional liver damage exists.", {"entities": []}], ["Extensive laboratory analyses were performed, including PCR for CMV DNA, A1AT serum concentration, A1AT genotyping, followed and confirmed with phenotyping.", {"entities": []}], ["Patient was treated parenteral with ganciclovir, what continued with oral valganciclovir and supportive therapy.", {"entities": []}], ["Intensive and thorough supportive treatment of the infant resulted in satisfactory progress and excellent outcome.", {"entities": []}], ["Patient was followed-up till the age of 18 months.", {"entities": []}], ["The presented case provides excellent example about successful overcoming obstacles in differential diagnosis of A1AT in neonates and infants.", {"entities": []}], ["Medical charts analysis was the methodology used in making this report.", {"entities": []}], ["Substantial progress has been made in human genetics and genomics research over the past ten years since the publication of the draft sequence of the human genome in 2001.", {"entities": []}], ["Findings emanating directly from the Human Genome Project, together with those from follow-on studies, have had an enormous impact on our understanding of the architecture and function of the human genome.", {"entities": []}], ["Major developments have been made in cataloguing genetic variation, the International HapMap Project, and with respect to advances in genotyping technologies.", {"entities": []}], ["These developments are vital for the emergence of genome-wide association studies in the investigation of complex diseases and traits.", {"entities": []}], ["In parallel, the advent of high-throughput sequencing technologies has ushered in the 'personal genome sequencing' era for both normal and cancer genomes, and made possible large-scale genome sequencing studies such as the 1000 Genomes Project and the International Cancer Genome Consortium.", {"entities": [[139, 145, "DISEASE"], [266, 272, "DISEASE"]]}], ["The high-throughput sequencing and sequence-capture technologies are also providing new opportunities to study Mendelian disorders through exome sequencing and whole-genome sequencing.", {"entities": []}], ["This paper reviews these major developments in human genetics and genomics over the past decade.", {"entities": []}], ["Dioscorea quinqueloba has been used for food substances, as well as in herbal medicines for allergic diseases such as asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["This study aimed to investigate the anti-atopic dermatitis (AD) effects of the total extract of D. quinqueloba rhizomes and active fractionson murine oxazolone- and 2,4-dinitrochlorobenzene-induced models of AD.", {"entities": [[41, 58, "DISEASE"], [48, 58, "DISEASE"]]}], ["Specific AD symptoms, such as erythema, ear swelling, and epidermis thickening, were significantly reduced in the oxazolone-mediated AD BALB/c mice upon topical application of D. quinqueloba rhizomes 95% EtOH extract (DQ).", {"entities": []}], ["DQEA ( D. quinqueloba rhizomes EtOAc fraction) was beneficial for protecting the skin barrier against AD in DNCB-sensitized SKH-1 hairless mice.", {"entities": []}], ["Decreased total serum IgE and IL-4 levels could be observed in atopic dorsal skin samples of the DQEA-treated group.", {"entities": []}], ["On the basis of the phytochemical analysis, DQEA was found to contain dioscin and gracillin as its main compounds.", {"entities": []}], ["Therapeutic applications with D. quinqueloba might be useful in the treatment of AD and related inflammatory skin diseases.", {"entities": []}], ["Reviews have shown that depression is a risk factor for the development of type 2 diabetes.", {"entities": []}], ["However, there is limited evidence for general psychological distress to be associated with incident diabetes.", {"entities": []}], ["The aim of the present study was to test whether persons who report higher levels of psychological distress are at increased risk to develop type 2 diabetes during 18 years follow up, adjusted for confounders.", {"entities": []}], ["A prospective analysis using data from 9,514 participants (41 years, SD=14; 44% men) of the British Household Panel Survey.", {"entities": []}], ["The General Health Questionnaire 12 item version was used to assess general psychological distress, diabetes was measured by means of self-report.", {"entities": []}], ["Cox proportional hazards regression models were used to calculate the multivariate-adjusted hazard ratio (HR) of incident diabetes during 18 years follow up, comparing participants with low versus high psychological distress at baseline (1991).", {"entities": [[106, 108, "GENE"]]}], ["A total of 472 participants developed diabetes 18 year follow up.", {"entities": []}], ["Those with a high level of psychological distress had a 33% higher hazard of developing diabetes (HR=1.33, 95% CI 1.10\u20131.61), relative to those with a low level of psychological distress, adjusted for age, sex, education level and household income.", {"entities": []}], ["After further adjustment for differences in level of energy, health status, health problems and activity level, higher psychological distress was no longer associated with incident diabetes (HR=1.10, 95% CI 0.91-1.34).", {"entities": []}], ["Higher levels of psychological distress are a risk factor for the development of diabetes during an 18 year follow up period.", {"entities": []}], ["This association may be potentially mediated by low energy level and impaired health status.", {"entities": []}], ["Long-chain n-3 polyunsaturated fatty acids (PUFAs) have immune regulating and anti-inflammatory effects.", {"entities": []}], ["However, their role in allergic disease is unclear.", {"entities": []}], ["Allergic diseases are immunologically heterogeneous, and we hypothesized that n-3 fatty acid composition in serum and breast milk may vary according to clinical manifestations.", {"entities": []}], ["Further, animal studies have shown reduction of serum-PUFA levels during allergic inflammation.", {"entities": []}], ["To investigate fatty acid composition in breast milk and serum from women with different atopic disease manifestations.", {"entities": []}], ["Secondly, to determine whether low PUFA levels reflected insufficient intakes.", {"entities": []}], ["Fatty acids were analysed in breast milk and serum of women with atopic eczema and respiratory allergy ( n =16), only respiratory allergy ( n =7), as well as healthy women ( n =22).", {"entities": []}], ["Dietary intake of foods expected to affect long-chain n-3 PUFA levels were estimated by food-frequency questionnaire.", {"entities": []}], ["The fatty acid pattern was related to diagnostic group and intake of relevant food items using a multivariate pattern recognition method (partial least squares projections to latent structures and discriminant analysis).", {"entities": []}], ["Women with a combination of eczema and respiratory allergy had lower breast milk levels of several PUFAs (arachidonic acid, eicosapentaenoic acid, EPA, docosahexaenoic acid, DHA, and docosapentaenoic acid, DPA), and a lower ratio of long-chain n-3 PUFAs/n-6 PUFAs.", {"entities": []}], ["Their PUFA levels differed not only from that of healthy women, but also from that of women with only respiratory allergy.", {"entities": []}], ["The latter had a fatty acid pattern similar to that of healthy women.", {"entities": []}], ["Despite low EPA, DHA and DPA levels women with eczema and respiratory allergy consumed no less fish than did healthy women.", {"entities": []}], ["Our data suggest that reduced levels of long-chain n-3 fatty acids in serum and breast milk characterize women with extensive allergic disease including eczema, and are not related to low fish intake.", {"entities": []}], ["Consumption of PUFAs during the allergic process may explain these findings.", {"entities": []}], ["Human Rhinovirus infection is an important precursor to asthma and chronic obstructive pulmonary disease exacerbations and the Human Viral Challenge model may provide a powerful tool in studying these and other chronic respiratory diseases.", {"entities": [[67, 104, "DISEASE"], [56, 62, "DISEASE"]]}], ["In this study we have reported the production and human characterisation of a new Wild-Type HRV-16 challenge virus produced specifically for this purpose.", {"entities": []}], ["A HRV-16 isolate from an 18 year old experimentally infected healthy female volunteer (University of Virginia Children\u2019s Hospital, USA) was obtained with appropriate medical history and consent.", {"entities": []}], ["We manufactured a new HRV-16 stock by minimal passage in a WI-38 cell line under Good Manufacturing Practice conditions.", {"entities": []}], ["Having first subjected the stock to rigorous adventitious agent testing and determining the virus suitability for human use, we conducted an initial safety and pathogenicity clinical study in adult volunteers in our dedicated clinical quarantine facility in London.", {"entities": []}], ["In this study we have demonstrated the new Wild-Type HRV-16 Challenge Virus to be both safe and pathogenic, causing an appropriate level of disease in experimentally inoculated healthy adult volunteers.", {"entities": []}], ["Furthermore, by inoculating volunteers with a range of different inoculum titres, we have established the minimum inoculum titre required to achieve reproducible disease.", {"entities": []}], ["We have demonstrated that although inoculation titres as low as 1 TCID 50 can produce relatively high infection rates, the optimal titre for progression with future HRV challenge model development with this virus stock was 10 TCID 50 .", {"entities": []}], ["Studies currently underway are evaluating the use of this virus as a challenge agent in asthmatics.", {"entities": []}], ["ClinicalTrials.gov NCT02522832", {"entities": []}], ["Epidemiological evidence suggests that hookworm infection protects against asthma.", {"entities": [[75, 81, "DISEASE"]]}], ["However, for ethical and safety reasons, before testing this hypothesis in a clinical trial in asthma it is necessary to establish whether experimental hookworm infection might exacerbate airway responsiveness during larval lung migration.", {"entities": [[95, 101, "DISEASE"]]}], ["To determine whether hookworm larval migration through the lungs increases airway responsiveness in allergic individuals with measurable airway responsiveness but not clinical asthma, and investigate the general tolerability of infection and effect on allergic symptoms.", {"entities": [[176, 182, "DISEASE"]]}], ["Thirty individuals with allergic rhinoconjunctivitis and measurable airway responsiveness to adenosine monophosphate (AMP) but not clinically diagnosed asthma were randomized, double-blind to cutaneous administration of either 10 hookworm larvae or histamine placebo, and followed for 12 weeks.", {"entities": [[152, 158, "DISEASE"]]}], ["The primary outcome was the maximum fall from baseline in provocative dose of inhaled AMP required to reduce 1-s forced expiratory volume by 10% (PD 10 AMP) measured at any time over the 4 weeks after active or placebo infection.", {"entities": []}], ["Secondary outcomes included peak flow variability in the 4 weeks after infection, rhinoconjunctivitis symptom severity and adverse effect diary scores over the 12-week study period, and change in allergen skin test responses between baseline and 12 weeks.", {"entities": []}], ["Mean maximum change in PD 10 AMP from baseline was slightly but not significantly greater in the hookworm than the placebo group (\u22121.67 and \u22121.16 doubling doses; mean difference \u22120.51, 95% confidence interval \u22121.80 to 0.78, P =0.42).", {"entities": []}], ["Symptom scores of potential adverse effects were more commonly reported in the hookworm group, but infection was generally well tolerated.", {"entities": []}], ["There were no significant differences in peak-flow variability, rhinoconjunctivitis symptoms or skin test responses between groups.", {"entities": []}], ["Hookworm infection did not cause clinically significant exacerbation of airway responsiveness and was well tolerated.", {"entities": []}], ["Suitably powered trials are now indicated to determine the clinical effectiveness of hookworm infection in allergic rhinoconjunctivitis and asthma.", {"entities": [[140, 146, "DISEASE"]]}], ["Scientific evidence combined with new health insurance coverage now enable a chronic illness management approach to the treatment of alcohol use disorders (AUDs), including regular monitoring of blood alcohol content (BAC), as a useful indicator of disease control.", {"entities": []}], ["Recent technical advances now permit many different types of remote, real-time monitoring of BAC.", {"entities": []}], ["However, there is no body of research to empirically guide clinicians in how to maximize the clinical potential of remote BAC monitoring.", {"entities": []}], ["As an initial step in guiding and supporting such research, the manufacturer of one remote BAC monitoring system sponsored a group of experienced clinicians and clinical researchers to discuss 8 issues that generally affect remote, clinical BAC monitoring of \u201cadults in outpatient AUD treatment.\u201d The expert panel unanimously agreed that remote BAC monitoring for at least 12 months during and after the outpatient treatment of AUD was a clinically viable deterrent to relapse.", {"entities": []}], ["There was also consensus that positive test results (ie, recent alcohol use) should lead to intensified care and monitoring.", {"entities": []}], ["However, there was no agreement on specific types of clinical intensification after a positive test.", {"entities": []}], ["The panel agreed that sharing positive and negative test results with members of the patient support group was helpful in reinforcing abstinence, yet they noted many practical issues regarding information sharing that remain concerning.", {"entities": []}], ["Significant differences within the panel on several important clinical issues underline the need for more clinical and implementation research to produce empirically-supported guidelines for the use of remote BAC monitoring in AUD treatment.", {"entities": []}], ["To determine the frequency of prescriptions of off-label drugs and drugs not approved for pediatric use in primary health care in medium-sized municipality of Rio Grande do Sul, Brazil.", {"entities": []}], ["Cross-sectional study with retrospective data collection, which analyzed prescriptions issued to 326 patients from August to December/2012 in two basic health units in the city of Viam\u00e3o, state of Rio Grande do Sul.", {"entities": []}], ["It included all prescriptions of patients whose medical records or service records were available and complete in relation to the date of presence, weight and date of birth.", {"entities": []}], ["Off-label prescriptions were those which, in relation to the drug leaflet, showed dose different the recommended range, frequency of prescription and/or different form of administration and younger age than the indicated range.", {"entities": []}], ["Descriptive statistics with absolute frequencies, means and standard deviations were used.", {"entities": []}], ["During the study period, a total of 731 drug prescriptions were issued and the frequency of off-label medications prescribed was 31.7%, especially antihistamines and antiasthmatics (32.3% and 31.5%, respectively).", {"entities": []}], ["The main type of off-label prescription was dose (38.8%), followed by age range (31.5%) and frequency of administration (29.3%).", {"entities": []}], ["Regarding the dose off-label prescription, overdose was more frequent (93.3%) than the underdose (6.7%).", {"entities": []}], ["Prescriptions of unapproved drugs were not identified.", {"entities": []}], ["The study showed that off label prescription is common in both assessed units.", {"entities": []}], ["The observed percentage of off label prescription was higher than that reported by European studies carried out in primary care.", {"entities": []}], ["On the other hand, the prescription of drugs not approved for children was not observed.", {"entities": []}], ["Determinar a frequ\u00eancia de prescri\u00e7\u00f5es de medicamentos off label e n\u00e3o licenciados para pediatria na aten\u00e7\u00e3o prim\u00e1ria \u00e0 sa\u00fade em munic\u00edpio de m\u00e9dio porte do Rio Grande do Sul, Brasil.", {"entities": []}], ["Estudo transversal, com coleta retrospectiva, que analisou prescri\u00e7\u00f5es a 326 pacientes emitidas de agosto a dezembro de 2012 em dois postos de sa\u00fade do munic\u00edpio de Viam\u00e3o.", {"entities": []}], ["Foram inclu\u00eddas todas as receitas de pacientes cujos prontu\u00e1rios ou fichas de atendimento estivessem dispon\u00edveis e completos em rela\u00e7\u00e3o \u00e0 data de atendimento, peso e data de nascimento.", {"entities": []}], ["Foram classificadas como prescri\u00e7\u00f5es off label aquelas que, em rela\u00e7\u00e3o \u00e0 bula do medicamento, apresentavam dose diferente da recomendada, frequ\u00eancia de prescri\u00e7\u00e3o e/ou forma de administra\u00e7\u00e3o diferente e idade inferior \u00e0quela indicada.", {"entities": []}], ["Foi usada estat\u00edstica descritiva, com frequ\u00eancias absolutas, m\u00e9dias e desvio padr\u00e3o.", {"entities": []}], ["Durante o per\u00edodo estudado houve a prescri\u00e7\u00e3o de 731 medicamentos e houve frequ\u00eancia de 31,7% de medicamentos prescritos off label , especialmente anti-histam\u00ednicos e antiasm\u00e1ticos (32,3% e 31,5%, respectivamente).", {"entities": []}], ["O principal tipo de prescri\u00e7\u00e3o off label foi dose (38,8%), seguida de idade (31,5%) e de frequ\u00eancia de administra\u00e7\u00e3o (29,3%).", {"entities": []}], ["Com rela\u00e7\u00e3o \u00e0 prescri\u00e7\u00e3o off label de dose, foi mais frequente a sobredose (93,3%) do que a subdose (6,7%).", {"entities": []}], ["N\u00e3o foram encontradas prescri\u00e7\u00f5es de medicamentos n\u00e3o licenciados.", {"entities": []}], ["O estudo mostrou que a prescri\u00e7\u00e3o off label \u00e9 comum nas duas unidades estudadas.", {"entities": []}], ["O percentual de prescri\u00e7\u00e3o off label observado foi superior ao relatado por estudos europeus feitos na aten\u00e7\u00e3o prim\u00e1ria.", {"entities": [[72, 75, "GENE"]]}], ["Por outro lado, n\u00e3o foi observada prescri\u00e7\u00e3o de medicamentos n\u00e3o licenciados para crian\u00e7as.", {"entities": [[0, 3, "GENE"]]}], ["Th9 cells protect hosts against helminthic infection but also mediate allergic disease.", {"entities": []}], ["Here we show that nitric oxide (NO) promotes Th9 cell polarization of murine and human CD4 Nos2", {"entities": [[87, 90, "GENE"], [91, 95, "GENE"]]}], ["Rhinoviruses (RVs) and respiratory enteroviruses (EVs) are leading causes of upper respiratory tract infections and among the most frequent infectious agents in humans worldwide.", {"entities": []}], ["Both are classified in the Enterovirus genus within the Picornaviridae family and they have been assigned to seven distinct species, RV-A, B, C and EV-A, B, C, D. As viral infections of public health significance, they represent an important financial burden on health systems worldwide.", {"entities": []}], ["However, the lack of efficient antiviral treatment or vaccines against these highly prevalent pathogens prevents an effective management of RV-related diseases.", {"entities": []}], ["Current advances in molecular diagnostic techniques have revealed the presence of RV in the lower respiratory tract and its role in lower airway diseases is increasingly reported.", {"entities": []}], ["In addition to an established etiological role in the common cold, these viruses demonstrate an unexpected capacity to spread to other body sites under certain conditions.", {"entities": [[54, 65, "DISEASE"]]}], ["Some of these viruses have received particular attention recently, such as EV-D68 that caused a large outbreak of respiratory illness in 2014, respiratory EVs from species C, or viruses within the newly-discovered RV-C species.", {"entities": []}], ["This review provides an update of the latest findings on clinical and fundamental aspects of RV and respiratory EV, including a summary of basic knowledge of their biology.", {"entities": []}], ["Dysfunction of the 5-hydroxytryptamine (5-HT) signaling pathway can lead to gastrointestinal motility and secretion abnormalities and to visceral hypersensitivity.", {"entities": []}], ["The aim of this study is to investigate the role of 5-HT in reflux-induced esophageal mucosal injury.", {"entities": []}], ["Fifty 8-week-old male Sprague-Dawley (SD) rats were randomly divided into a gastroesophageal reflux (GER) model group (30 rats) and a sham surgery control group (20 rats).", {"entities": []}], ["Four weeks after surgery, the esophageal mucosa was collected for histological evaluation, 5-HT concentrations, and 5-HT selective reuptake transporter (SERT) mRNA and 5-HT 4 receptor (5-HT 4 R) protein expressions.", {"entities": []}], ["Twenty-seven rats in the GER model group survived, and three rats died.", {"entities": []}], ["Histologically, in the GER model group, 20 rats had reflux esophagitis (RE group), and 7 rats had non-erosive reflux disease (NERD group).", {"entities": [[59, 70, "DISEASE"]]}], ["The 5-HT levels in the esophageal tissue from the RE group were significantly higher than those from the control and NERD groups.", {"entities": []}], ["Both the RE and NERD groups showed significant increases in SERT mRNA expression of the esophageal mucosa than that of the controls, and the SERT mRNA level in the RE group was significantly higher than that in the NERD group.", {"entities": []}], ["The 5-HT 4 R protein level of the esophageal mucosa in the RE group was significantly lower than that in the controls and the NERD group.", {"entities": []}], ["We conclude that a 5-HT signaling pathway disorder could be a major factor in the pathogenesis of GER and RE.", {"entities": []}], ["Studies on microbiome diversity are flooding the current literature, yet lessons from ecology clearly demonstrate that diversity is just one factor to consider when analyzing an ecosystem, along with its stability, structure and function.", {"entities": []}], ["Measures of diversity may be a useful tool for interpreting metagenomic data but the question remains as to how informative they are and what insight they may provide into the state of the microbiome.", {"entities": []}], ["A study utilizing mathematical modeling to investigate the ecological dynamics of microbial communities has shown that diversity and stability may not always be concomitant.", {"entities": []}], ["This finding is pertinent to the gut microbiome field, especially since diversity comparisons between healthy and pathological states frequently yield contradictory results.", {"entities": []}], ["There is a need to broaden our approach to the analysis of microbiome data if we are to better understand this complex ecological community and its role in human health and disease.", {"entities": []}], ["Human metapneumovirus (hMPV) is a recently isolated virus, mostly associated with acute lower respiratory infection in children, of which symptoms are similar to those of respiratory syncytial virus (RSV) infection.", {"entities": []}], ["The aim of our study was to determine the frequency of hMPV in hospitalized children with acute respiratory tract disease in Korea.", {"entities": []}], ["Nasal aspirates from hospitalized children with respiratory infections under 15 yr old between December 2003 and February 2005 were included in the study.", {"entities": []}], ["Each sample was analyzed for RSV, adenovirus, influenza virus A and B, and parainfluenza virus by indirect fluorescent assay (IFA).", {"entities": [[46, 55, "DISEASE"]]}], ["F-gene sequences were used for PCR for the detection and sequencing of hMPV.", {"entities": []}], ["In total 381 samples, negative samples in which any viral pathogen could not be identified by IFA were 231 cases.", {"entities": []}], ["hMPV was detected using reverse transcriptase-PCR (RT-PCR) in 28 of 231 (12.1%) children who were not infected with another respiratory viruses.", {"entities": []}], ["The hMPV-infected children were diagnosed as having pneumonia, bronchiolitis, bronchial asthma exacerbation, croup, and upper respiratory tract infection.", {"entities": [[109, 114, "DISEASE"], [52, 61, "DISEASE"], [88, 94, "DISEASE"], [63, 76, "DISEASE"]]}], ["Most of the RT-PCR positive samples for hMPV were collected in winter season.", {"entities": []}], ["These results suggest that hMPV may be a responsible pathogen causing acute respiratory tract infection in Korean children.", {"entities": []}], ["Preventative strategies that focus on addressing the social determinants of health to improve healthy eating and physical activity have become an important strategy in British Columbia and Ontario for combating chronic diseases.", {"entities": []}], ["What has not yet been examined is the extent to which healthy living initiatives implemented under these new policy frameworks successfully engage with and change the social determinants of health.", {"entities": []}], ["Initiatives active between January 1, 2006 and September 1, 2011 were found using provincial policy documents, web searches, health organization and government websites, and databases of initiatives that attempted to influence to nutrition and physical activity in order to prevent chronic diseases or improve overall health.", {"entities": []}], ["Initiatives were reviewed, analyzed and grouped using the descriptive codes: lifestyle-based, environment-based or structure-based.", {"entities": []}], ["Initiatives were also classified according to the mechanism by which they were administered: as direct programs (e.g.", {"entities": []}], ["directly delivered), blueprints (or frameworks to tailor developed programs), and building blocks (resources to develop programs).", {"entities": []}], ["60 initiatives were identified in Ontario and 61 were identified in British Columbia.", {"entities": []}], ["In British Columbia, 11.5% of initiatives were structure-based.", {"entities": []}], ["In Ontario, of 60 provincial initiatives identified, 15% were structure-based.", {"entities": []}], ["Ontario had a higher proportion of direct interventions than British Columbia for all intervention types.", {"entities": []}], ["However, in both provinces, as the intervention became more upstream and attempted to target the social determinants of health more directly, the level of direct support for the intervention lessened.", {"entities": []}], ["The paucity of initiatives in British Columbia and Ontario that address healthy eating and active living through action on the social determinants of health is problematic.", {"entities": []}], ["In the context of Canada's increasingly neoliberal political and economic policy, the public health sector may face significant barriers to addressing upstream determinants in a meaningful way.", {"entities": []}], ["If public health cannot directly affect broader societal conditions, interventions should be focused around advocacy and education about the social determinants of health.", {"entities": []}], ["It is necessary that health be seen for what it is: a political matter.", {"entities": []}], ["As such, the health sector needs to take a more political approach in finding solutions for health inequities.", {"entities": []}], ["The -1237T/C polymorphism of the Toll-like receptor 9 ( TLR9 ) gene has been implicated in the susceptibility of inflammatory bowel diseases (IBDs), but the results remain conflicting.", {"entities": [[56, 60, "GENE"]]}], ["We further investigated this association via meta-analysis.", {"entities": []}], ["Multiple electronic databases were extensively searched until February, 2015.", {"entities": []}], ["The strength of association was evaluated by calculating the pooled odds ratios (ORs) and 95% confidence intervals (CIs).", {"entities": []}], ["A total of 2987 cases and 2388 controls from eight studies were analyzed.", {"entities": []}], ["Overall, association was found between TLR9 -1237T/C polymorphism and the risk of IBDs when all the studies were pooled (recessive model, OR: 1.59, 95% CI: 1.02-2.47, p =0.04; homozygote comparison, OR: 1.62, 95% CI: 1.04-2.52, p =0.03; allele model, OR: 1.13, 95% CI: 1.00-1.27, p =0.05).", {"entities": [[39, 43, "GENE"]]}], ["Stratification by ethnicity indicated an association between TLR9 -1237T/C polymorphism and IBDs risk in Caucasians (recessive model, OR: 1.59, 95% CI: 1.02-2.47, p =0.04; homozygote comparison, OR: 1.62, 95% CI: 1.04-2.52, p =0.03; allele model, OR: 1.12, 95% CI: 1.00-1.27, p =0.05).", {"entities": [[61, 65, "GENE"]]}], ["When stratified by disease type, significant correlation were only found in the Crohn's disease subgroup (recessive model, OR: 1.69, 95% CI: 1.05-2.73, p =0.03; homozygote model, OR: 1.74, 95% CI: 1.07-2.82, p =0.02; allele model, OR: 1.15, 95% CI: 1.01-1.32, p =0.04).", {"entities": []}], ["The present study suggested that the TLR9 -1237T/C polymorphism might act as a risk factor in the development of IBDs, particularly in Caucasians.", {"entities": [[37, 41, "GENE"]]}], ["Systemic autoimmune diseases can damage nearly every tissue or cell type of the body.", {"entities": []}], ["Although a great deal of progress has been made in understanding the pathogenesis of autoimmune diseases, current therapies have not been improved, remain unspecific and are associated with significant side effects.", {"entities": []}], ["Because dendritic cells (DCs) play a major role in promoting immune tolerance against self-antigens (self-Ags), current efforts are focusing at generating new therapies based on the transfer of tolerogenic DCs (tolDCs) during autoimmunity.", {"entities": []}], ["However, the feasibility of this approach during systemic autoimmunity has yet to be evaluated.", {"entities": []}], ["TolDCs may ameliorate autoimmunity mainly by restoring T cell tolerance and, thus, indirectly modulating autoantibody development.", {"entities": []}], ["In vitro induction of tolDCs loaded with immunodominant self-Ags and subsequent cell transfer to patients would be a specific new therapy that will avoid systemic immunosuppression.", {"entities": []}], ["Herein, we review recent approaches evaluating the potential of tolDCs for the treatment of systemic autoimmune disorders.", {"entities": []}], ["There is accumulating evidence that oxidative stress plays an important role in the pathophysiology of chronic obstructive pulmonary disease (COPD).", {"entities": [[103, 140, "DISEASE"]]}], ["One current hypothesis is that the increased oxidant burden in these patients is not adequately counterbalanced by the lung antioxidant systems.", {"entities": []}], ["To determine the levels of oxidised human serum albumin (HSA) in COPD lung explants and the effect of oxidation on HSA degradation using an ex vivo lung explant model.", {"entities": []}], ["Parenchymal lung tissue was obtained from 38 patients (15F/23M) undergoing lung resection and stratified by smoking history and disease using the GOLD guidelines and the lower limit of normal for FEV 1 /FVC ratio.", {"entities": [[196, 199, "GENE"]]}], ["Lung tissue was homogenised and analysed by ELISA for total levels of HSA and carbonylated HSA.", {"entities": []}], ["To determine oxidised HSA degradation lung tissue explants were incubated with either 200 \u03bcg/ml HSA or oxidised HSA and supernatants collected at 1, 2, 4, 6, and 24 h and analysed for HSA using ELISA and immunoblot.", {"entities": []}], ["When stratified by disease, lung tissue from GOLD II (median = 38.2 \u03bcg/ml) and GOLD I (median = 48.4 \u03bcg/ml) patients had lower levels of HSA compared to patients with normal lung function (median = 71.9 \u03bcg/ml, P < 0.05).", {"entities": []}], ["In addition the number of carbonyl residues, which is a measure of oxidation was elevated in GOLD I and II tissue compared to individuals with normal lung function (P < 0.05).", {"entities": []}], ["When analysing smoking status current smokers had lower levels of HSA (median = 43.3 \u03bcg/ml, P < 0.05) compared to ex smokers (median = 71.9 \u03bcg/ml) and non-smokers (median = 71.2 \u03bcg/ml) and significantly greater number of carbonyl residues per HSA molecule (P < 0.05).", {"entities": []}], ["When incubated with either HSA or oxidised HSA lung tissue explants rapidly degraded the oxidised HSA but not unmodified HSA (P < 0.05).", {"entities": []}], ["We report on a reliable methodology for measuring levels of oxidised HSA in human lung tissue and cell culture supernatant.", {"entities": []}], ["We propose that differences in the levels of oxidised HSA within lung tissue from COPD patients and current smokers provides further evidence for an oxidant/antioxidant imbalance and has important biological implications for the disease.", {"entities": []}], ["Use of alcohol and illicit drugs by adolescents remains a problem in the U.S. Case identification and early treatment can occur within a broad variety of healthcare and non-healthcare settings, including acute care hospitals.", {"entities": []}], ["The objective of this study is to describe the extent and nature of adolescent admissions to the acute inpatient setting for substance abuse (SA).", {"entities": [[125, 140, "DISEASE"]]}], ["We use the Agency for Healthcare Research and Quality (AHRQ) 2000 Healthcare Cost and Utilization Project Kids Inpatient Database (HCUP-KID) which includes over 2.5 million admissions for youth age 20 and under to 2,784 hospitals in 27 states in the year 2000.", {"entities": []}], ["Specifically, this analysis estimates national number of admissions, mean total charges, and mean lengths of stay for adolescents between the ages of 12 and 17 admitted to an acute care hospital for the following diagnostic categories from the AHRQ's Clinical Classifications Software categories: \"alcohol-related mental disorders\" and \"substance-related mental disorders\".", {"entities": []}], ["Frequency and percentage of total admissions were calculated for demographic variables of age, gender and income and for hospital characteristic variables of urban/rural designation and children's hospital designation.", {"entities": []}], ["SA admissions represented 1.25 percent of adolescent admissions to acute care hospitals.", {"entities": []}], ["Nearly 90 percent of the admission occurred in non-Children's hospitals.", {"entities": []}], ["Most were for drug dependence (38%) or non-dependent use of alcohol or drugs (35%).", {"entities": [[14, 29, "DISEASE"]]}], ["Costs were highest for drug dependence admissions.", {"entities": [[23, 38, "DISEASE"]]}], ["Nearly half of admissions had comorbid mental health diagnoses.", {"entities": []}], ["Higher rates of admission were seen in boys, in older adolescents, and in \"self-pay\" patients.", {"entities": []}], ["Alcohol and drug rehabilitation/detoxification, alone or in combination with psychological and psychiatric evaluation and therapy, was documented for 38 percent of admissions.", {"entities": []}], ["Over 50 percent of cases had no documentation of treatment specific to substance use behavior.", {"entities": []}], ["General acute care hospitals have a significant and important opportunity to recognize, treat, and refer adolescents with substance abuse problems.", {"entities": [[122, 137, "DISEASE"]]}], ["These results suggest that inpatient facilities should develop and implement policies and processes to ensure that adolescent substance abusers admitted to their institutions receive appropriate care during the admission and appropriate referral to community care resources.", {"entities": []}], ["Heart failure (HF) and chronic obstructive pulmonary disease (COPD) are highly prevalent and associated with a large symptom burden, that is compounded in a dual HF-COPD diagnosis.", {"entities": [[23, 60, "DISEASE"]]}], ["Yoga has potential benefit for symptom relief; however functional impairment hinders access to usual yoga classes.", {"entities": []}], ["We developed a Tele-Yoga intervention and evaluated it in a controlled pilot trial.", {"entities": []}], ["This paper reports on the appropriateness and acceptability of the intervention and the evaluation design.", {"entities": []}], ["A controlled, non-randomised trial was conducted of an 8-week Tele-Yoga intervention versus an educational control (information leaflets mailed to participants with one phone call a week).", {"entities": []}], ["Biweekly one-hour Tele-Yoga classes were implemented via multipoint videoconferencing that connected participants to live classes via an Internet connection to their televisions.", {"entities": []}], ["Semi-structured qualitative interviews were conducted with participants post study exit to explore reasons for and experiences of participating, including views of study outcome measures and physiological tests.", {"entities": []}], ["Transcribed interviews were analysed using thematic content analysis.", {"entities": []}], ["Fifteen people participated in the pilot study (7 in the intervention group, 8 in the control).", {"entities": []}], ["Of these, 12 participants were interviewed, 6 in each group, mean age 71.2\u00a0years (SD 10.09); 3 were male.", {"entities": []}], ["Themes are reported in the following categories: acceptability and appropriateness of the intervention, potential active ingredients of the intervention, acceptability and appropriateness of the control, participation in the research, and acceptability of the testing procedures.", {"entities": []}], ["The intervention was acceptable and appropriate: the intervention group reported enjoying yoga and valuing the home-based aspect and participants described a high symptom burden and social isolation.", {"entities": []}], ["However, technological problems resulted in poor video-streaming quality for some participants.", {"entities": []}], ["Potential active ingredients included physical postures, breathing exercises and guidance in relaxation and meditation.", {"entities": []}], ["The educational control intervention was acceptable and appropriate, with participants reporting little effect on their well-being and no impact on mechanisms hypothesised to explain yoga\u2019s effectiveness.", {"entities": []}], ["The questionnaires and home physiological testing were acceptable to participants.", {"entities": []}], ["Tele-Yoga is an acceptable and appropriate intervention in people with HF and COPD and further research is warranted to refine the technology used in its delivery.", {"entities": []}], ["Findings provide guidance for researchers working in tele-interventions, yoga, and similar populations.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT02078739 (4 March 2014).", {"entities": []}], ["To investigate the association between rheumatoid arthritis (RA) and periodontitis with special emphasis on the role of antirheumatic drugs in periodontal health.", {"entities": [[39, 59, "DISEASE"], [69, 82, "DISEASE"], [50, 59, "DISEASE"]]}], ["Prospective follow-up study.", {"entities": []}], ["Patients with early untreated RA and chronic active RA were examined at baseline and 16\u2005months later.", {"entities": []}], ["Controls were examined once.", {"entities": []}], ["The study was conducted in Finland from September 2005 to May 2014 at the Helsinki University Hospital.", {"entities": []}], ["Overall, 124 participants were recruited for dental and medical examinations: 53 were patients with early disease-modifying antirheumatic drug (DMARD) na\u0457ve RA (ERA), 28 were patients with chronic RA (CRA) with insufficient response to conventional DMARDs.", {"entities": []}], ["After baseline examination, patients with ERA started treatment with synthetic DMARDs and patients with CRA with biological DMARDs.", {"entities": []}], ["Controls were 43 age-matched, gender-matched and community-matched participants.", {"entities": []}], ["Degree of periodontitis (defined according to the Center for Disease Control and Prevention and the American Academy of Periodontology).", {"entities": [[10, 23, "DISEASE"]]}], ["Prevalence of periodontal bacteria (analysed from plaque samples), clinical rheumatological status by Disease Activity Score, 28-joint count (DAS28), function by Health Assessment Questionnaire (HAQ) and treatment response by European League Against Rheumatism (EULAR) criteria.", {"entities": []}], ["Moderate periodontitis was present in 67.3% of patients with ERA, 64.3% of patients with CRA and 39.5% of control participants (p=0.001).", {"entities": [[9, 22, "DISEASE"]]}], ["Further, patients with RA had significantly more periodontal findings compared with controls, recorded with common periodontal indexes.", {"entities": []}], ["In the re-examination, patients with RA still showed poor periodontal health in spite of treatment with DMARDs after baseline examination.", {"entities": []}], ["The prevalence of Porphyromonas gingivalis was higher in patients with ERA with periodontal probing depth \u22654\u2005mm compared with patients with CRA and controls.", {"entities": []}], ["Antirheumatic medication did not seem to affect the results.", {"entities": []}], ["Moderate periodontitis was more frequent in patients with RA than in controls.", {"entities": [[9, 22, "DISEASE"]]}], ["Patients with ERA and CRA exhibited poorer periodontal health parameters when compared with controls.", {"entities": []}], ["There was no association between antirheumatic treatment and periodontal parameters.", {"entities": []}], ["Objective To examine mortality in a representative nationwide sample of homeless and marginally housed people living in shelters, rooming houses, and hotels.", {"entities": []}], ["Design Follow-up study.", {"entities": []}], ["Setting Canada 1991-2001.", {"entities": []}], ["Participants 15\u2009100 homeless and marginally housed people enumerated in 1991 census.", {"entities": []}], ["Main outcome measures Age specific and age standardised mortality rates, remaining life expectancies at age 25, and probabilities of survival from age 25 to 75.", {"entities": []}], ["Data were compared with data from the poorest and richest income fifths as well as with data for the entire cohort Results Of the homeless and marginally housed people, 3280 died.", {"entities": []}], ["Mortality rates among these people were substantially higher than rates in the poorest income fifth, with the highest rate ratios seen at younger ages.", {"entities": []}], ["Among those who were homeless or marginally housed, the probability of survival to age 75 was 32% (95% confidence interval 30% to 34%) in men and 60% (56% to 63%) in women.", {"entities": []}], ["Remaining life expectancy at age 25 was 42 years (42 to 43) and 52 years (50 to 53), respectively.", {"entities": []}], ["Compared with the entire cohort, mortality rate ratios for men and women, respectively, were 11.5 (8.8 to 15.0) and 9.2 (5.5 to 15.2) for drug related deaths, 6.4 (5.3 to 7.7) and 8.2 (5.0 to 13.4) for alcohol related deaths, 4.8 (3.9 to 5.9) and 3.8 (2.7 to 5.4) for mental disorders, and 2.3 (1.8 to 3.1) and 5.6 (3.2 to 9.6) for suicide.", {"entities": []}], ["For both sexes, the largest differences in mortality rates were for smoking related diseases, ischaemic heart disease, and respiratory diseases.", {"entities": [[104, 117, "DISEASE"]]}], ["Conclusions Living in shelters, rooming houses, and hotels is associated with much higher mortality than expected on the basis of low income alone.", {"entities": []}], ["Reducing the excessively high rates of premature mortality in this population would require interventions to address deaths related to smoking, alcohol, and drugs, and mental disorders and suicide, among other causes.", {"entities": []}], ["Knowledge on the factors associated with severe maternal morbidity enables a better understanding of the problem and serves as a foundation for the development of an effective preventive strategy.", {"entities": []}], ["However, various definitions of severe maternal morbidity have been applied, leading to inconsistencies between studies.", {"entities": []}], ["The objective of this study was to identify the sociodemographic characteristics, medical and gynaecological history, past and present obstetric performance and the provision of health care services as associated factors for severe maternal morbidity in Kelantan, Malaysia.", {"entities": []}], ["A comparative cross-sectional study was conducted in two tertiary referral hospitals in 2014.", {"entities": []}], ["Postpartum women with severe morbidity and without severe morbidity who fulfilled the inclusion and exclusion criteria were eligible as cases and controls, respectively.", {"entities": []}], ["The study population included all postpartum women regardless of their age.", {"entities": []}], ["Pregnancy at less than 22\u00a0weeks of gestation, more than 42\u00a0days after the termination of pregnancy and non-Malaysian citizens were excluded.", {"entities": []}], ["Consecutive sampling was applied for the selection of cases and for each case identified, one unmatched control from the same hospital was selected using computer-based simple random sampling.", {"entities": []}], ["Simple and multiple logistic regressions were performed using Stata Intercooled version 11.0.", {"entities": []}], ["A total of 23,422 pregnant women were admitted to these hospitals in 2014 and 395 women with severe maternal morbidity were identified, of which 353 were eligible as cases.", {"entities": []}], ["An age of 35 or more years old [Adj.", {"entities": []}], ["OR (95\u00a0% CI): 2.6 (1.67, 4.07)], women with past pregnancy complications [Adj.", {"entities": []}], ["OR (95\u00a0% CI): 1.7 (1.00, 2.79)], underwent caesarean section deliveries [Adj.", {"entities": []}], ["OR (95\u00a0% CI): 6.8 (4.68, 10.01)], preterm delivery [Adj.", {"entities": []}], ["OR (95\u00a0% CI): 3.4 (1.87, 6.32)] and referral to tertiary centres [Adj.", {"entities": []}], ["OR (95\u00a0% CI): 2.7 (1.87, 3.97)] were significant associated factors for severe maternal morbidity.", {"entities": []}], ["Our study suggests the enhanced screening and monitoring of women of advanced maternal age, women with past pregnancy complications, those who underwent caesarean section deliveries, those who delivered preterm and the mothers referred to tertiary centres as they are at increased risk of severe maternal morbidity.", {"entities": []}], ["Identifying these factors may contribute to specific and targeted strategies aimed at tackling the issues related to maternal morbidity.", {"entities": []}], ["Acute post-partum anaemia can be associated with significant morbidity including a predisposition for postnatal depression.", {"entities": []}], ["Lack of clear practice guidelines means a number of women are treated with multiple blood transfusions.", {"entities": []}], ["Intravenous iron has the potential to limit the need for multiple blood transfusions but its role in the post-partum setting is unclear.", {"entities": []}], ["IIBAPPA is a multi-centre randomised non-inferiority trial.", {"entities": []}], ["Women with a primary post-partum haemorrhage (PPH) >1000\u00a0mL and resultant haemoglobin (Hb) 5.5-8.0\u00a0g/dL after resuscitation with ongoing symptomatic anaemia who are otherwise stable (no active bleeding) are eligible to participate.", {"entities": []}], ["Patients with sepsis or conditions necessitating rapid Hb restoration are excluded.", {"entities": []}], ["Eligible participants are randomised to receive a blood transfusion or a single dose of intravenous iron polymaltose calculated using the Ganzoni formula.", {"entities": []}], ["Primary outcome measures include Hb, Ferritin and C-Reactive Protein levels on Day 7.", {"entities": []}], ["Secondary outcomes evaluate (i) Hb, Ferritin and CRP levels on Day 14, 28, (ii) anaemia symptoms on Day 0, 7, 14 and 28 using structured health related quality of life questionnaires, (iii) treatment safety by assessing adverse reactions and infection endpoints and (iv) the quantitative impact of anaemia on breast feeding quality using a hospital designed questionnaire.", {"entities": [[49, 52, "GENE"]]}], ["If equivalence in Hb and ferritin levels, symptom scores and safety endpoints is demonstrated, intravenous iron may become the preferred treatment for women with acute post-partum anaemia to minimise transfusion reactions and costs.", {"entities": []}], ["Australian and New Zealand Clinical Trials Registry: ACTRN12615001370594 on 16th December, 2015 (prospective approval).", {"entities": []}], ["Youth with rheumatologic diseases have a high prevalence of comorbid mental health disorders.", {"entities": []}], ["Individuals with comorbid mental health disorders are at increased risk for adverse outcomes related to mental health as well as their underlying rheumatologic disease.", {"entities": []}], ["Early identification and treatment of mental health disorders has been shown to improve outcomes, but current systems of care fall short in providing adequate mental health services to those in need.", {"entities": []}], ["Pediatric rheumatologists are uniquely positioned to provide mental health screening and intervention for youth with rheumatologic diseases due to the frequency of patient encounters and ongoing therapeutic relationship with patients and families.", {"entities": []}], ["However, additional training is likely required for pediatric rheumatologists to provide effective mental health care, and focusing efforts on providing trainees with mental health education is key to building competency.", {"entities": []}], ["Potential opportunities for improved mental health education include development of clinical guidelines regarding mental health screening and management within pediatric rheumatology settings and incorporation of mental health didactics, workshops, and interdisciplinary clinic experiences into pediatric rheumatology fellowship curricula.", {"entities": []}], ["Additional steps include mental health education for patients and families and focus on system change, targeting integration of medical and mental health care.", {"entities": []}], ["Research is needed to better define the scope of the problem, determine effective strategies for equipping pediatric rheumatologists with skills in mental health intervention, and develop and implement sustainable systems for delivery of optimal mental health care to youth with rheumatologic diseases.", {"entities": []}], ["Cancer-related fatigue (CRF) is a frequent and distressing symptom experienced after cancer treatment.", {"entities": [[0, 6, "DISEASE"], [85, 91, "DISEASE"]]}], ["RESTORE is the first web-based resource designed to enhance self-efficacy to manage CRF following curative-intent treatment.", {"entities": []}], ["The aim of this study is to test the proof of concept and inform the design of an effectiveness trial.", {"entities": []}], ["A multi-centre parallel-group two-armed (1:1) exploratory randomised controlled trial (RCT) with qualitative process evaluation was employed in the study.", {"entities": []}], ["Participants (\u226518\u00a0years; \u22645\u00a0years post treatment with moderate to severe fatigue) were recruited and randomly assigned to RESTORE or a leaflet.", {"entities": []}], ["Feasibility and acceptability were measured by recruitment, attrition, intervention adherence, completion of outcome measures and process evaluation.", {"entities": []}], ["Change in self-efficacy to manage CRF was also explored.", {"entities": []}], ["Outcome measures were completed at baseline (T0), 6\u00a0weeks (T1) and 12\u00a0weeks (T2).", {"entities": []}], ["Data were analysed using mixed-effects linear regression and directed content analysis.", {"entities": []}], ["One hundred and sixty-three people participated in the trial and 19 in the process evaluation.", {"entities": []}], ["The intervention was feasible (39\u00a0% of eligible patients consented) and acceptable (attrition rate 36\u00a0%).", {"entities": []}], ["There was evidence of higher fatigue self-efficacy at T1 in the intervention group vs comparator (mean difference 0.51 [\u22120.08 to 1.11]), though the difference in groups decreased by 12\u00a0weeks.", {"entities": []}], ["Time since diagnosis influenced perceived usefulness of the intervention.", {"entities": []}], ["Modifications were suggested.", {"entities": []}], ["Proof of concept was achieved.", {"entities": []}], ["The RESTORE intervention should be subject to a definitive trial with some adjustments.", {"entities": []}], ["Provision of an effective supportive resource would empower cancer survivors to manage CRF after treatment completion.", {"entities": [[60, 66, "DISEASE"]]}], ["ISRCTN67521059", {"entities": []}], ["Early-life respiratory tract infections (RTIs) and dental caries are among the most common infectious diseases worldwide.", {"entities": [[51, 64, "DISEASE"]]}], ["The relations between early RTIs and development of caries in permanent teeth have not been studied earlier.", {"entities": []}], ["We assessed childhood RTIs as potential predictors of caries in young adulthood in a 20-year prospective population-based cohort study (The Espoo Cohort Study).", {"entities": []}], ["Information on lower respiratory tract infections (LRTIs) that had required hospitalization was retrieved from the National Hospital Discharge Registry (n = 1623).", {"entities": []}], ["Additional information on LRTIs and upper RTIs (URTIs) was assessed based on the questionnaire reports that covered the preceding 12 months.", {"entities": []}], ["Caries was measured as the number of teeth with fillings (i.e.", {"entities": []}], ["filled teeth, FT) reported in the 20-year follow-up questionnaire.", {"entities": []}], ["The absolute and relative excess numbers of FT were estimated applying negative binomial regression.", {"entities": []}], ["The mean number of FT in young adulthood was 1.4 greater among subjects who had experienced LRTIs requiring hospitalization before the age of 2 years (SD 4.8) compared to those without any such infections (SD 3.4), and the adjusted relative excess number of FT was 1.5 (95% CI 1.0\u20132.2).", {"entities": []}], ["LRTIs up to 7 years were associated with an absolute increase of 0.9 in the mean FT number, the adjusted relative excess being 1.3 (1.0\u20131.8).", {"entities": []}], ["Also the questionnaire-based LRTIs (adjusted relative excess 1.3; 95% CI 0.9\u20131.8) and URTIs (adjusted relative excess 1.4, 1.0\u20131.8) before the age of 2 years predicted higher occurrence of FT.", {"entities": []}], ["Findings suggest that early RTIs have a role in the development of dental caries in permanent teeth.", {"entities": [[67, 80, "DISEASE"]]}], ["Influenza, an infectious respiratory disease, is one of the main causes of excess winter deaths (EWDs) in Europe.", {"entities": [[0, 9, "DISEASE"]]}], ["Annual flu epidemics are associated with high morbidity and mortality rates, especially among the elderly, those with underlying health conditions and pregnant women.", {"entities": []}], ["Health Care Workers (HCWs) are also considered at high risk of both contracting influenza and spreading the virus to vulnerable patients.", {"entities": [[80, 89, "DISEASE"]]}], ["During the 2014/2015 season, the excess winter mortality rates observed in countries of the northern hemisphere (EuroMOMO network) and in Italy (+13%) were strongly related to the intensity of influenza circulation.", {"entities": [[193, 202, "DISEASE"]]}], ["Influenza vaccination is the most important public health intervention to prevent seasonal influenza transmission and infection.", {"entities": [[0, 9, "DISEASE"], [91, 100, "DISEASE"]]}], ["However, to date, influenza vaccination coverage reported in Europe (including high-risk groups) is still largely unsatisfactory.", {"entities": [[18, 27, "DISEASE"]]}], ["This study analyzes some international and European guidelines on influenza vaccination and the rationale that underlies evidence- based public health intervention for the prevention of influenza among the principal high-risk groups: a) the elderly (subjects aged 65 years or older); b) subjects with underlying health conditions; c) pregnant women; d) healthcare workers.", {"entities": [[66, 75, "DISEASE"], [186, 195, "DISEASE"]]}], ["Only by achievement recommended influenza vaccination coverage among high-risk groups in all European countries can we reduce the burden of disease.", {"entities": [[32, 41, "DISEASE"]]}], ["Tooth decay is the most common chronic disease of childhood in the world.", {"entities": []}], ["Many children develop caries early in their lives, and go on to develop further caries and sepsis as they grow up, indicating failure in prevention.", {"entities": []}], ["As a result, many end up requiring general anaesthesia to undergo treatment for a disease that is completely preventable.", {"entities": []}], ["Previous studies have suggested that the families of these children need better oral health education as well as better support in implementing healthy practices at home, as they feel impeded by broader life challenges.", {"entities": []}], ["Parents of these children have suggested utilizing modern technologies, such as the internet, DVDs and video games as methods of delivery of education that might fit in with their busy lifestyles.", {"entities": []}], ["The aim of this investigation is to assess the acceptability and efficiency of an oral health education video game directed at these children and their families.", {"entities": []}], ["A two-armed phase-II randomized controlled trial will assess a children\u2019s oral health education video game in comparison with verbal oral health education in terms of: family satisfaction, effect on oral health knowledge, and effect on dietary and oral hygiene habits.", {"entities": []}], ["Up to 110 four- to ten-year-old children, referred for tooth extraction under general anaesthesia due to caries, will be recruited.", {"entities": []}], ["A sample of 45 participants in each group will be needed to provide 80 % statistical power.", {"entities": []}], ["The primary outcome measures for this study are: (1) parent and child satisfaction with the intervention, as indicated using a visual analogue scale; (2) improvement in the child\u2019s dietary knowledge measured by a pictorial dietary quiz; and (3) changes in the child\u2019s diet and oral hygiene habits, measured using a children\u2019s dietary questionnaire completed by the parent, and snacking and toothbrushing diaries completed by the child.", {"entities": []}], ["Measures will be taken at baseline, directly after the intervention, and three months later.", {"entities": []}], ["This study is a phase-II randomized controlled trial of an oral health education video game for high caries risk children and their families.", {"entities": []}], ["Few protocols such as this are available in this much-needed research area.", {"entities": []}], ["ISRCTN94617251 .", {"entities": []}], ["The objective of this study was to evaluate the influence of the environmental factors (meteorological factors, air pollutant levels, etc.)", {"entities": []}], ["on the number of clinic consultations for nonallergic rhinitis (NAR).", {"entities": [[54, 62, "DISEASE"]]}], ["Among the 9056 outpatients visiting a general internal medicine clinic in Japan between August 2012 and the end of July 2013 (counting return visitors as multiple cases), the total daily number of first visits for NAR plus the number of extraordinary visits by patients with NAR for acute exacerbation of the disease was investigated using electronic medical records and analyzed.", {"entities": []}], ["Major parameters with significant Spearman\u2019s correlation coefficients and significant correlation coefficients also in the multiple regression analysis were the mean vapor pressure (coefficient of determination 27.3 %) throughout the year, mean vapor pressure (58.4 %), mean temperature (44.4 %), maximum 10-min precipitation (12.0 %) only during the autumn-winter period, and temperature difference (13.3 %) only during the spring-summer period.", {"entities": []}], ["The mean vapor pressure is the most important environmental factor associated with acute exacerbation of NAR.", {"entities": []}], ["Narrative approaches and storytelling are emerging as powerful health promotion tools that can spark interest, increase understanding of determinants of health, and translate complex science.", {"entities": []}], ["A Story of Health, a multimedia e-book with continuing education credits was designed to harness the power of storytelling to increase environmental health literacy.", {"entities": []}], ["Health professionals are a key audience.", {"entities": []}], ["They recognize that patients may be suffering from preventable illnesses of environmental origin but often feel ill-equipped to educate individuals and families about risks associated with common exposures.", {"entities": []}], ["A Story of Health seeks to fill this gap and help readers develop the competencies they need in order to help patients make informed choices, reduce health risks, improve quality of life, and protect the environment.", {"entities": []}], ["Americans rate nurses and medical doctors as having the highest honesty and ethical standards of all professions.", {"entities": []}], ["These medical professionals can play a key role in changing patterns of patient behavior and influencing public policies.", {"entities": []}], ["The e-book provides an easily accessible method of developing environmental health competency.", {"entities": []}], ["The multimedia format with graphical interpretations allows for quick reviews of topics or for more in-depth analysis via links to additional resources.", {"entities": []}], ["The CE evaluations have been overwhelmingly positive.", {"entities": []}], ["In clinically stable asthma the exhaled NO values (F E NO) are generally higher than in control subjects.", {"entities": [[21, 27, "DISEASE"]]}], ["Therefore, reference values are of limited importance in clinical practice.", {"entities": []}], ["This is demonstrated in this case report, but it is also shown that NO parameters from non-linear modelling do have a clinical value.", {"entities": []}], ["A subject with asthma was treated with inhaled corticosteroids for 1 week.", {"entities": [[15, 21, "DISEASE"]]}], ["The non-linear NO model was used to measure the response to treatment.", {"entities": []}], ["The NO parameters from subjects with atopic rhinitis and asthma were fed into a computer program to generate theoretical F E NO 0.05 values, i.e.", {"entities": [[44, 52, "DISEASE"], [57, 63, "DISEASE"]]}], ["target values.", {"entities": []}], ["There was a dramatic decrease in F E NO 0.05 due to treatment, from 82 to 34 ppb, but it remained higher than in healthy controls.", {"entities": []}], ["This is due to the elevated diffusion rate of NO, unchanged by treatment.", {"entities": []}], ["When the NO parameters are known, a personal best value of F E NO 0.05 (fractional concentration of exhaled NO in the gas phase, 0.05 L/s) can be calculated, which can be the target value when only F E NO 0.05 can be monitored.", {"entities": []}], ["In conclusion, reference values for NO parameters are shown to be clinically useful.", {"entities": []}], ["It is essential that every patient receives his/her target value of F E NO 0.05 , when only a single NO measurement is available.", {"entities": []}], ["In our opinion, this is the reason why there are few successful studies of trying to target the NO value with inhaled corticosteroids.", {"entities": []}], ["Background: An emerging literature suggests that environmental chemicals may play a role in the development of childhood obesity and metabolic disorders, especially when exposure occurs early in life.", {"entities": [[121, 128, "DISEASE"]]}], ["Objective: Here we assess the association between these health outcomes and exposure to maternal smoking during pregnancy as part of a broader effort to develop a research agenda to better understand the role of environmental chemicals as potential risk factors for obesity and metabolic disorders.", {"entities": [[266, 273, "DISEASE"]]}], ["Methods: PubMed was searched up to 8 March 2012 for epidemiological and experimental animal studies related to maternal smoking or nicotine exposure during pregnancy and childhood obesity or metabolic disorders at any age.", {"entities": [[180, 187, "DISEASE"]]}], ["A total of 101 studies\u201483 in humans and 18 in animals\u2014were identified as the primary literature.", {"entities": []}], ["Discussion: Current epidemiological data support a positive association between maternal smoking and increased risk of obesity or overweight in offspring.", {"entities": [[119, 126, "DISEASE"]]}], ["The data strongly suggest a causal relation, although the possibility that the association is attributable to unmeasured residual confounding cannot be completely ruled out.", {"entities": []}], ["This conclusion is supported by findings from laboratory animals exposed to nicotine during development.", {"entities": []}], ["The existing literature on human exposures does not support an association between maternal smoking during pregnancy and type 1 diabetes in offspring.", {"entities": []}], ["Too few human studies have assessed outcomes related to type 2 diabetes or metabolic syndrome to reach conclusions based on patterns of findings.", {"entities": [[85, 93, "DISEASE"]]}], ["There may be a number of mechanistic pathways important for the development of aberrant metabolic outcomes following perinatal exposure to cigarette smoke, which remain largely unexplored.", {"entities": []}], ["Conclusions: From a toxicological perspective, the linkages between maternal smoking during pregnancy and childhood overweight/obesity provide proof-of-concept of how early-life exposure to an environmental toxicant can be a risk factor for childhood obesity.", {"entities": [[127, 134, "DISEASE"], [251, 258, "DISEASE"]]}], ["The ubiquitin associated and Src-homology 3 (SH3) domain containing A ( UBASH3a ) is a suppressor of T-cell receptor signaling, underscoring antigen presentation to T-cells as a critical shared mechanism of diseases pathogenesis.", {"entities": [[72, 79, "GENE"]]}], ["The aim of the present study was to determine whether the UBASH3a gene influence the susceptibility to systemic lupus erythematosus (SLE) in Caucasian populations.", {"entities": [[112, 131, "DISEASE"], [103, 131, "DISEASE"], [58, 65, "GENE"]]}], ["We evaluated five UBASH3a polymorphisms (rs2277798, rs2277800, rs9976767, rs13048049 and rs17114930), using TaqMan\u00ae allelic discrimination assays, in a discovery cohort that included 906 SLE patients and 1165 healthy controls from Spain.", {"entities": [[18, 25, "GENE"]]}], ["The SNPs that exhibit statistical significance difference were evaluated in a German replication cohort of 360 SLE patients and 379 healthy controls.", {"entities": []}], ["The case-control analysis in the Spanish population showed a significant association between the rs9976767 and SLE (Pc\u200a=\u200a9.9E-03 OR\u200a=\u200a1.21 95%CI\u200a=\u200a1.07\u20131.37) and a trend of association for the rs2277798 analysis (P\u200a=\u200a0.09 OR\u200a=\u200a0.9 95%CI\u200a=\u200a0.79\u20131.02).", {"entities": [[116, 118, "GENE"]]}], ["The replication in a German cohort and the meta-analysis confirmed that the rs9976767 (Pc\u200a=\u200a0.02; Pc\u200a=\u200a2.4E-04, for German cohort and meta-analysis, respectively) and rs2277798 (Pc\u200a=\u200a0.013; Pc\u200a=\u200a4.7E-03, for German cohort and meta-analysis, respectively) UBASH3a variants are susceptibility factors for SLE.", {"entities": [[87, 89, "GENE"], [98, 100, "GENE"], [178, 180, "GENE"], [190, 192, "GENE"], [87, 89, "GENE"], [98, 100, "GENE"], [178, 180, "GENE"], [190, 192, "GENE"], [87, 89, "GENE"], [98, 100, "GENE"], [178, 180, "GENE"], [190, 192, "GENE"], [87, 89, "GENE"], [98, 100, "GENE"], [178, 180, "GENE"], [190, 192, "GENE"], [255, 262, "GENE"]]}], ["Finally, a conditional regression analysis suggested that the most likely genetic variation responsible for the association was the rs9976767 polymorphism.", {"entities": []}], ["Our results suggest that UBASH3a gene plays a role in the susceptibility to SLE.", {"entities": [[25, 32, "GENE"]]}], ["Moreover, our study indicates that UBASH3a can be considered as a common genetic factor in autoimmune diseases.", {"entities": [[35, 42, "GENE"]]}], ["This report describes the case mix and outcome (mortality, intensive care unit (ICU) and hospital length of stay) for admissions to ICU for head injury and evaluates the predictive ability of five risk adjustment models.", {"entities": []}], ["A secondary analysis was conducted of data from the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme, a high quality clinical database, of 374,594 admissions to 171 adult critical care units across England, Wales and Northern Ireland from 1995 to 2005.", {"entities": []}], ["The discrimination and calibration of five risk prediction models, SAPS II, MPM II, APACHE II and III and the ICNARC model plus raw Glasgow Coma Score (GCS) were compared.", {"entities": []}], ["There were 11,021 admissions following traumatic brain injury identified (3% of all database admissions).", {"entities": []}], ["Mortality in ICU was 23.5% and in-hospital was 33.5%.", {"entities": []}], ["Median ICU and hospital lengths of stay were 3.2 and 24 days, respectively, for survivors and 1.6 and 3 days, respectively, for non-survivors.", {"entities": []}], ["The ICNARC model, SAPS II and MPM II discriminated best between survivors and non-survivors and were better calibrated than raw GCS, APACHE II and III in 5,393 patients eligible for all models.", {"entities": []}], ["Traumatic brain injury requiring intensive care has a high mortality rate.", {"entities": []}], ["Non-survivors have a short length of ICU and hospital stay.", {"entities": []}], ["APACHE II and III have poorer calibration and discrimination than SAPS II, MPM II and the ICNARC model in traumatic brain injury; however, no model had perfect calibration.", {"entities": []}], ["Present investigation deals with antimicrobial screening of ten medicinally important plants used by the inhabitants of district Haripur, Khyber Pakhtunkhwa (KPK) for different infectious diseases.", {"entities": []}], ["Aqueous, n-hexane and ethanolic extracts of each plant were tested for their antimicrobial activity against both Gram positive and Gram negative strains of bacteria, as well as strain of yeast.", {"entities": []}], ["Agar well diffusion and broth dilution methods were used to determine the antimicrobial activity of different plant extracts.", {"entities": []}], ["The results indicated that all plants exhibited antimicrobial activity against one or more test pathogens.", {"entities": []}], ["Interestingly, extracts of three plants showed strong and broad spectrum activity as compared to rest of the extracts which demonstrated the moderate activity.", {"entities": []}], ["On the whole ethanolic extracts exhibited maximum antimicrobial effect than their corresponding aqueous and n-hexane extracts, when compared with standard antibiotics i.e., Streptomycin and Tetracycline.", {"entities": []}], ["Among various extracts, only ethanloic extract of Azadirachta indica and aqueous and ethanolic extracts of Eucalyptus globulus and Bergenia ciliata and ethanolic extract of Punica granatum were found to have potentially promising activity against test microorganisms.", {"entities": []}], ["Different plant extracts show promising antimicrobial activity justifying their usage in traditional medicines.", {"entities": []}], ["This study will be continued to identify more plants with potential antimicrobial components.", {"entities": []}], ["In order to prevent central nervous system ( CNS ) involvement and improve the prognosis of primary intraocular lymphoma ( PIOL ), we prospectively evaluated the efficacy of combined therapy using intravitreal methotrexate ( MTX ) and systemic high\u2010dose MTX on treatment\u2010na\u00efve PIOL .", {"entities": [[100, 120, "DISEASE"], [112, 120, "DISEASE"]]}], ["Patients with newly diagnosed PIOL whose lymphoma was limited to the eyes were enrolled.", {"entities": [[41, 49, "DISEASE"]]}], ["The patients were treated with weekly intravitreal MTX until the ocular lesions were resolved, followed by five cycles of systemic high\u2010dose MTX (3.5 g/m MTX were mild and tolerable.", {"entities": []}], ["With a median follow\u2010up of 29.5 months, four patients (40%) experienced the CNS disease development and the mean CNS lymphoma\u2010free survival ( CLFS ) time was 51.1 months.", {"entities": [[117, 125, "DISEASE"]]}], ["Two\u2010year CLFS , which was the primary end\u2010point of the study, was 58.3% (95% confidence interval, 23.0\u201382.1%).", {"entities": []}], ["In contrast, eight patients were treated with intravitreal MTX alone in our institute, and their 2\u2010year CLFS was 37.5% (95% confidence interval, 8.7\u201367.4%).", {"entities": []}], ["In conclusion, systemic high\u2010dose MTX following intravitreal MTX is feasible and might be effective in preventing CNS involvement of PIOL .", {"entities": []}], ["Further arrangements are worth considering in order to improve the effects.", {"entities": []}], ["This study was registered with UMIN Clinical Trials Registry ( UMIN 000003921).", {"entities": []}], ["To characterize the availability of tracer medicines in pharmaceutical services in primary health care of the Brazilian Unified Health System (SUS).", {"entities": []}], ["This is a cross-sectional and evaluative study, part of the Pesquisa Nacional Sobre Acesso, Utiliza\u00e7\u00e3o e Promo\u00e7\u00e3o do Uso Racional de Medicamentos \u2013 Servi\u00e7os, 2015 (PNAUM \u2013 National Survey on Access, Use and Promotion of Rational Use of Medicines \u2013 Services, 2015).", {"entities": []}], ["To analyze the availability of medicines, we verified 50 items selected from the Rela\u00e7\u00e3o Nacional de Medicamentos Essenciais (Rename \u2013 National List of Essential Medicines) of 2012.", {"entities": []}], ["Observation scripts were applied to medicine dispensing services in the primary health care.", {"entities": []}], ["Interviews were carried out with patients, health care professionals, and public managers, using semi-structured questionnaires.", {"entities": []}], ["The availability index was presented as the percentage of health units where the medicines were available.", {"entities": []}], ["For statistical analysis, absolute, relative, and mean frequencies were presented (with 95% confidence intervals).", {"entities": []}], ["The comparison of groups was carried out by Pearson Chi-square tests or variance analysis, when needed.", {"entities": []}], ["One thousand, one hundred, and seventy-five observation scripts were filled in a national representative sample composed by 273 cities.", {"entities": []}], ["Statistically significant differences were observed regarding the type of unit, infrastructure, and presence of a pharmacist between regions of Brazil.", {"entities": []}], ["The average availability of tracer medicines in primary health care was 52.9%, with differences between regions and sampling strata.", {"entities": []}], ["This index increased to 62.5% when phytotherapic medicines were excluded.", {"entities": []}], ["We found limited availability of medicines for treatment of chronic and epidemiological diseases, such as tuberculosis and congenital syphilis.", {"entities": [[106, 118, "DISEASE"], [123, 142, "DISEASE"], [134, 142, "DISEASE"]]}], ["The low availability of essential medicines purchased centrally by the Brazilian Ministry of Health indicates deficiencies in supply chain management.", {"entities": []}], ["The different views on the availability of tracer medicines in SUS confirm the general availability verified in this study.", {"entities": []}], ["Among patients, about 60% said they obtain medicines in SUS units, data consistent with the lack of medicines reported by medicine dispensers and in line with physicians\u2019 evaluations.", {"entities": []}], ["To determine the prevalence of overweight and obesity in schoolchildren aged 10 to 16 years and its association with dietary and behavioral factors.", {"entities": [[46, 53, "DISEASE"]]}], ["Cross-sectional study that evaluated 505 adolescents using a structured questionnaire and anthropometric data.", {"entities": []}], ["The data was analyzed through the T Test for independent samples and Mann-Whitney Test to compare means and medians, respectively, and Chi Excess weight was observed in 30.9% of the schoolchildren: 18.2% of overweight and 12.7% of obesity.", {"entities": [[231, 238, "DISEASE"]]}], ["There was no association between weight alterations and dietary/behavioral habits in the bivariate and multivariate analyses.", {"entities": []}], ["However, associations were observed in relation to gender.", {"entities": []}], ["Daily consumption of sweets [PR=0.75 (0.64-0.88)] and soft drinks [PR=0.82 (0.70-0.97)] was less frequent among boys; having lunch daily was slightly more often reported by boys [OR=1.11 (1.02-1.22)].", {"entities": []}], ["Physical activity practice of (\u22653 times/week) was more often mentioned by boys and the association measures disclosed two-fold more physical activity in this group [PR=2.04 (1.56-2.67)] when compared to girls.", {"entities": []}], ["Approximately 30% of boys and 40% of girls stated they did not perform activities requiring energy expenditure during free periods, with boys being 32% less idle than girls [PR=0.68 (0.60-0.76)].", {"entities": []}], ["A high prevalence of both overweight and obesity was observed, as well as unhealthy habits in the study population, regardless of the presence of weight alterations.", {"entities": [[41, 48, "DISEASE"]]}], ["Health promotion strategies in schools should be encouraged, in order to promote healthy habits and behaviors among all students.", {"entities": []}], ["India contributes 24% of the global annual child deaths due to acute respiratory infections (ARIs).", {"entities": []}], ["According to WHO, nearly 50% of the deaths among children due to ARIs is because of indoor air pollution (IAP).", {"entities": []}], ["There is insufficient evidence on the relationship between IAP from the use of solid fuels and incidence of life threatening respiratory illnesses (LTRI) in children in India.", {"entities": []}], ["Panel data of children born during 2001\u201302, from the Young Lives Study (YLS) conducted in India during 2002 and 2006\u201307 was used to estimate the impact of household use of solid fuels for cooking on LTRI in children.", {"entities": []}], ["Multivariable two-stage random effects logistic regression model was used to estimate the odds of suffering from LTRI among children from households using solid fuels relative to children from households using other fuels (Gas/Electricity/Kerosene).", {"entities": []}], ["Bivariate results indicate that the probability of an episode of LTRI was considerably higher among children from households using solid fuels for cooking (18%) than among children from households using other fuels (10%).", {"entities": []}], ["Moreover, children from households using solid fuels in both the rounds of YLS were more likely to suffer from one or more than one episode of LTRI compared to children from households using solid fuels in only one round.", {"entities": []}], ["Two-stage random effects logistic regression result shows that children from households using solid fuels were 1.78 (95% CI: 1.05-2.99) times as likely to suffer from LTRI as those from households using other fuels.", {"entities": []}], ["The findings of this paper provide conclusive evidence on the harmful effects of the use of solid fuels for cooking on LTRI in India.", {"entities": []}], ["The Government of India must make people aware about the health risks associated with the use of solid fuels for cooking and strive to promote the use of cleaner fuels.", {"entities": []}], ["Background: Early nutrition affects the risk of atopy and infections through modifications of intestinal microbiota.", {"entities": []}], ["The Prebiotics in the Prevention of Atopy (PIPA) study was a 24-month randomised, double-blind, placebo-controlled trial.", {"entities": []}], ["It aimed to evaluate the effects of a galacto-oligosaccharide/polydextrose (GOS/PDX)-formula (PF) on atopic dermatitis (AD) and common infections in infants who were born to atopic parents and to investigate the relationship among early nutrition, gut microbiota and clinical outcomes.", {"entities": [[101, 118, "DISEASE"], [108, 118, "DISEASE"]]}], ["Methods: A total of 201 and 199 infants were randomized to receive a PF and standard formula (SF), respectively; 140 infants remained on exclusive breastfeeding (BF).", {"entities": []}], ["Results: The cumulative incidence of AD and its intensity and duration were not statistically different among the three groups.", {"entities": []}], ["The number of infants with at least one episode of respiratory infection (RI) and the mean number of episodes until 48 weeks of age were significantly lower in the PF group than in the SF group.", {"entities": []}], ["The number of patients with recurrent RIs and incidence of wheezing lower RIs until 96 weeks were lower in the PF group than the SF group, but similar to the BF group.", {"entities": []}], ["Bifidobacteria and Clostridium cluster I colonization increased over time in the PF group but decreased in the SF and BF groups.", {"entities": []}], ["Bifidobacteria had a protective role in RIs, whereas Clostridium cluster I was associated with atopy protection.", {"entities": []}], ["Conclusion: The early administration of PF protects against RIs and mediates a species-specific modulation of the intestinal microbiota.", {"entities": []}], ["Trial registration: clinicaltrial.gov Identifier: NCT02116452.", {"entities": []}], ["The goal of this study is to investigate associations between subjective memory complaint and objective cognitive performance in older people with previous major depression\u2013a high-risk sample for cognitive impairment and later dementia.", {"entities": [[227, 235, "DISEASE"]]}], ["A cross-sectional study was carried out in people aged 60 or over with previous major depression but not fulfilling current major depression criteria according to DSM-IV-TR.", {"entities": []}], ["People with dementia or Mini-Mental State Examination score less than 17 were excluded.", {"entities": [[12, 20, "DISEASE"]]}], ["Subjective memory complaint was defined on the basis of a score \u22674 on the subscale of Geriatric Mental State schedule, a maximum score of 8.", {"entities": []}], ["Older people aged equal or over 60 without any psychiatric diagnosis were enrolled as healthy controls.", {"entities": []}], ["Cognitive function was evaluated using a series of cognitive tests assessing verbal memory, attention/speed, visuospatial function, verbal fluency, and cognitive flexibility in all participants.", {"entities": []}], ["One hundred and thirteen older people with previous major depression and forty-six healthy controls were enrolled.", {"entities": []}], ["Subjective memory complaint was present in more than half of the participants with depression history (55.8%).", {"entities": []}], ["Among those with major depression history, subjective memory complaint was associated with lower total immediate recall and delayed verbal recall scores after adjustment.", {"entities": []}], ["The associations between subjective memory complaint and worse memory performance were stronger in participants with lower depressive symptoms (Hamilton Depression Rating Scale score<7).", {"entities": []}], ["The results suggest subjective memory complaint may be a valid appraisal of memory performance in older people with previous major depression and consideration should be given to more proactive assessment and follow-up in these clinical samples.", {"entities": []}], ["Heritability analyses of GWAS cohorts have yielded important insights into complex disease architecture, and increasing sample sizes hold the promise of further discoveries.", {"entities": []}], ["Here, we analyze the genetic architecture of schizophrenia in 49,806 samples from the PGC, and nine complex diseases in 54,734 samples from the GERA cohort.", {"entities": [[45, 58, "DISEASE"], [86, 89, "GENE"]]}], ["For schizophrenia, we infer an overwhelmingly polygenic disease architecture in which \u226571% of 1Mb genomic regions harbor \u22651 variant influencing schizophrenia risk.", {"entities": [[4, 17, "DISEASE"], [144, 157, "DISEASE"]]}], ["We also observe significant enrichment of heritability in GC-rich regions and in higher-frequency SNPs for both schizophrenia and GERA diseases.", {"entities": [[112, 125, "DISEASE"]]}], ["In bivariate analyses, we observe significant genetic correlations (ranging from 0.18 to 0.85) among several pairs of GERA diseases; genetic correlations were on average 1.3x stronger than correlations of overall disease liabilities.", {"entities": []}], ["To accomplish these analyses, we developed a fast algorithm for multi-component, multi-trait variance components analysis that overcomes prior computational barriers that made such analyses intractable at this scale.", {"entities": []}], ["Purinergic P2 receptors are a class of plasma membrane receptors that are express in many tissues and are ligated by extracellular nucleotides [such as adenosine triphosphate (ATP), adenosine diphosphate (ADP), uridine 5\u2013triphosphate (UTP) and uridine 5\u2013diphosphate (UDP)], which are released as a consequence of cell damage, cell stress, bacterial infection or other noxious stimuli.", {"entities": []}], ["According to the molecular structure, P2 receptors are divided into two subfamilies: P2X and P2Y receptors.", {"entities": []}], ["The P2X receptors are ligand-gated channels, whereas P2Y receptors are G-protein-coupled seven-membrane-spanning receptors.", {"entities": []}], ["Several studies indicate that nucleotides play an important role in immune response modulation through their action on multiple cell types, including monocytes, mast cells, dendritic cells, neutrophils, and eosinophils.", {"entities": []}], ["Recent work by our group and others identified extracellular nucleotides as chemotaxins for various human immune cells, including eosinophils, neutrophils and dendritic cells.", {"entities": []}], ["In this review, we summarise recent findings in this field and put forward a hypothesis on the role of P2 receptors in the early recruitment of human immune cells to the site of inflammation.", {"entities": []}], ["We demonstrate a unique growth mode to form complex 3D shapes in hydrogels by invoking the bottom-up approach analogous to cell enlargement and proliferation found in living animal tissues and plants.", {"entities": []}], ["For this purpose, we control the oxygen concentration to modulate polymerization of monomers in porous hydrogel, wherein postgelation networks continue to expand\u2013\u2013a process similar to the growth of living tissues in nature.", {"entities": []}], ["The applicability of this experimental technique to a variety of situations in biology is demonstrated with several examples of the formation of complex 3D architectures through successful biomimetics of tissue morphogenesis in both animals and plants.", {"entities": []}], ["These results offer possibilities for a diverse set of applications in tissue engineering, soft robotics, and flexible electronics.", {"entities": []}], ["Many applications in tissue engineering, flexible electronics, and soft robotics call for approaches that are capable of producing complex 3D architectures in soft materials.", {"entities": []}], ["Here we present a method using molecular self-assembly to generate hydrogel-based 3D architectures that resembles the appealing features of the bottom-up process in morphogenesis of living tissues.", {"entities": []}], ["Our strategy effectively utilizes the three essential components dictating living tissue morphogenesis to produce complex 3D architectures: modulation of local chemistry, material transport, and mechanics, which can be engineered by controlling the local distribution of polymerization inhibitor (i.e., oxygen), diffusion of monomers/cross-linkers through the porous structures of cross-linked polymer network, and mechanical constraints, respectively.", {"entities": []}], ["We show that oxygen plays a role in hydrogel polymerization which is mechanistically similar to the role of growth factors in tissue growth, and the continued growth of hydrogel enabled by diffusion of monomers/cross-linkers into the porous hydrogel similar to the mechanisms of tissue growth enabled by material transport.", {"entities": []}], ["The capability and versatility of our strategy are demonstrated through biomimetics of tissue morphogenesis for both plants and animals, and its application to generate other complex 3D architectures.", {"entities": []}], ["Our technique opens avenues to studying many growth phenomena found in nature and generating complex 3D structures to benefit diverse applications.", {"entities": []}], ["Vitamin D is a direct and indirect regulator of T cells.", {"entities": []}], ["The mechanisms by which vitamin D directly regulates T cells are reviewed and new primary data on the effects of 1,25 dihydroxyvitamin D (1,25(OH) 2 D) on human invariant natural killer (iNK)T cells is presented.", {"entities": []}], ["The in vivo effects of vitamin D on murine T cells include inhibition of T cell proliferation, inhibition of IFN-\u03b3, IL-17 and induction of IL-4.", {"entities": []}], ["Experiments in mice demonstrate that the effectiveness of 1,25(OH) 2 D requires NKT cells, IL-10, the IL-10R and IL-4.", {"entities": []}], ["Comparisons of mouse and human T cells show that 1,25(OH) 2 D inhibits IL-17 and IFN-\u03b3, and induces T regulatory cells and IL-4.", {"entities": []}], ["IL-4 was induced by 1,25(OH) 2 D in mouse and human iNKT cells.", {"entities": []}], ["Activation for 72h was required for optimal expression of the vitamin D receptor (VDR) in human and mouse T and iNKT cells.", {"entities": [[82, 85, "GENE"]]}], ["In addition, T cells are potential autocrine sources of 1,25(OH) 2 D but again only 48\u201372h after activation.", {"entities": []}], ["Together the data support the late effects of vitamin D on diseases like inflammatory bowel disease and multiple sclerosis where reducing IL-17 and IFN-\u03b3, while inducing IL-4 and IL-10, would be beneficial.", {"entities": [[73, 99, "DISEASE"], [104, 122, "DISEASE"]]}], ["The relationship between Lophomonas , a genus of multiflagellated protozoa, and respiratory pathology has recently received attention.", {"entities": []}], ["Here, we summarize the origin, mode of transmission, pathogenic mechanism and relevant clinical data of bronchopulmonary lophomoniasis.", {"entities": []}], ["Patients\u2019 knowledge and expectations may influence prescription of antibiotics.", {"entities": []}], ["Therefore, providing evidence-based information on cause of symptoms, self-management and treatment is essential.", {"entities": []}], ["However, providing information during consultations is challenging.", {"entities": []}], ["Patient information leaflets could facilitate consultations by increasing patients\u2019 knowledge, decrease unnecessary prescribing of antibiotics and decrease reconsultations for similar illnesses.", {"entities": []}], ["Our objective was to systematically review effectiveness of information leaflets used for informing patients about common infections during consultations in general practice.", {"entities": []}], ["We systematically searched PubMed/MEDLINE and EMBASE for studies evaluating information leaflets on common infections in general practice.", {"entities": []}], ["Two reviewers extracted data and assessed article quality.", {"entities": []}], ["Antibiotic use and reconsultation rates.", {"entities": []}], ["Of 2512 unique records, eight studies were eligible (7 randomised, controlled trials, 1 non-randomised study) accounting for 3407 patients.", {"entities": []}], ["Study quality varied from reasonable to good.", {"entities": []}], ["Five studies investigated effects of leaflets during consultations for respiratory tract infections; one concerned conjunctivitis, one urinary tract infections and one gastroenteritis and tonsillitis.", {"entities": [[188, 199, "DISEASE"], [168, 183, "DISEASE"], [115, 129, "DISEASE"]]}], ["Three of four studies presented data on antibiotic use and showed significant reductions of prescriptions in leaflet groups with a relative risk (RR) varying from 0.53 (0.40 to 0.69) to 0.96 (0.83 to 1.11).", {"entities": []}], ["Effects on reconsultation varied widely.", {"entities": []}], ["One large study showed lower reconsultation rates (RR 0.70 (0.53 to 0.91), two studies showed no effect, and one study showed increased reconsultation rates (RR 1.53 (1.03 to 2.27)).", {"entities": []}], ["Studies were too heterogenic to perform a meta-analysis.", {"entities": []}], ["Patient information leaflets during general practitioners consultations for common infections are promising tools to reduce antibiotic prescriptions.", {"entities": []}], ["Results on reconsultation rates for similar symptoms vary, with a tendency toward fewer reconsultations when patients are provided with a leaflet.", {"entities": []}], ["Use of information leaflets in cases of common infections should be encouraged.", {"entities": []}], ["Their contributing role in multifaceted interventions targeting management of common infections in primary care needs to further exploration.", {"entities": []}], ["The development and validation study of the Clinical Chronic Obstructive Disease (COPD) Questionnaire (CCQ) has recently been published in this journal.", {"entities": []}], ["The CCQ is the first questionnaire that incorporates both clinician and patient guideline goals in the clinical control evaluation of patients with COPD in general clinical practice.", {"entities": []}], ["The aim of this study is the validation of the CCQ questionnaire in Italian, in specific pulmonary disease clinical practice.", {"entities": []}], ["Validity was tested on a population of healthy subjects and patients with COPD, using the Italian validated version of the Short Form Health Survey (SF-36) and guideline recommended routine measurement in COPD patients (FEV 1 , FVC, BMI and functional dyspnoea).", {"entities": [[220, 223, "GENE"]]}], ["Test-retest reliability was tested by re-administering the CCQ after 2 weeks.", {"entities": []}], ["Responsiveness was tested by re-administering the CCQ after three weeks of hospital pulmonary rehabilitation.", {"entities": []}], ["Distance walked and Borg breathlessness rating were measured at the end of the six-minute walking test (6 MWT), before and after rehabilitation.", {"entities": []}], ["Cross-sectional data were collected from 175 subjects (55 healthy; 40 mild-moderate, 50 severe and 25 very severe COPD).", {"entities": []}], ["Cronbach's alpha was high (0.89).", {"entities": []}], ["The CCQ scores in patients were significantly worse than in healthy subjects.", {"entities": []}], ["The CCQ total score in patients with COPD was significantly worse in those with BMI < = 21.", {"entities": []}], ["Significant correlations were found between the CCQ total score and domains of the SF-36 (rho = -0.43 to rho = -0.72).", {"entities": []}], ["The correlation between the CCQ and FEV1 % predicted was rho = -0.57.", {"entities": []}], ["The correlation between the CCQ and MRC was rho = 0.63.", {"entities": []}], ["Test-retest reliability was determined in 112 subjects over a period of two weeks (Intra Class Coefficient = 0.99).", {"entities": []}], ["Forty-six patients with COPD showed significant improvement in CCQ scores, distance-walked and Borg breathlessness rating after 3 weeks of pulmonary rehabilitation, indicating CCQ responsiveness.", {"entities": []}], ["The CCQ is self-administered and has been specially developed to measure clinical control in patients with COPD.", {"entities": []}], ["Data support its validity, reliability and responsiveness in Italian and in specific pulmonary disease clinical practice.", {"entities": []}], ["The in vivo ovine model provides a clinically relevant platform to study cardiopulmonary mechanisms and treatments of disease; however, a robust ovine primary alveolar epithelial type II (ATII) cell culture model is lacking.", {"entities": []}], ["The objective of this study was to develop and optimize ovine lung tissue cryopreservation and primary ATII cell culture methodologies for the purposes of dissecting mechanisms at the cellular level to elucidate responses observed in vivo .", {"entities": []}], ["To address this, we established in vitro submerged and air-liquid interface cultures of primary ovine ATII cells isolated from fresh or cryopreserved lung tissues obtained from mechanically ventilated sheep (128 days gestation\u20146 months of age).", {"entities": []}], ["Presence, abundance, and mRNA expression of surfactant proteins was assessed by immunocytochemistry, Western Blot, and quantitative PCR respectively on the day of isolation, and throughout the 7 day cell culture study period.", {"entities": []}], ["All biomarkers were significantly greater from cells isolated from fresh than cryopreserved tissue, and those cultured in air-liquid interface as compared to submerged culture conditions at all time points.", {"entities": []}], ["Surfactant protein expression remained in the air-liquid interface culture system while that of cells cultured in the submerged system dissipated over time.", {"entities": []}], ["Despite differences in biomarker magnitude between cells isolated from fresh and cryopreserved tissue, cells isolated from cryopreserved tissue remained metabolically active and demonstrated a similar response as cells from fresh tissue through 72 hr period of hyperoxia.", {"entities": [[248, 250, "GENE"]]}], ["These data demonstrate a cell culture methodology using fresh or cryopreserved tissue to support study of ovine primary ATII cell function and responses, to support expanded use of biobanked tissues, and to further understanding of mechanisms that contribute to in vivo function of the lung.", {"entities": []}], ["Vitamin D plays an important role in the immune system, and its deficiency has been implicated in various skin diseases, including atopic dermatitis and psoriasis.", {"entities": [[153, 162, "DISEASE"], [131, 148, "DISEASE"], [138, 148, "DISEASE"]]}], ["Acne is a common inflammatory skin disease; however, the association with vitamin D remains unclear.", {"entities": [[0, 4, "DISEASE"], [30, 42, "DISEASE"]]}], ["We evaluated vitamin D levels in patients with acne to determine the effect of vitamin D supplementation.", {"entities": [[47, 51, "DISEASE"]]}], ["This study included 80 patients with acne and 80 healthy controls.", {"entities": [[37, 41, "DISEASE"]]}], ["Serum 25-hydroxyvitamin D (25(OH)D) levels were measured, and demographic data were collected.", {"entities": []}], ["Vitamin D-deficient patients were treated with oral cholecalciferol at 1000 IU/day for 2 months.", {"entities": []}], ["Deficiency in 25(OH)D was detected in 48.8% of patients with acne, but in only 22.5% of the healthy controls.", {"entities": [[61, 65, "DISEASE"]]}], ["The level of 25(OH)D was inversely associated with the severity of acne, and there was a significant negative correlation with inflammatory lesions.", {"entities": [[67, 71, "DISEASE"]]}], ["In a subsequent trial, improvement in inflammatory lesions was noted after supplementation with vitamin D in 39 acne patients with 25(OH)D deficiency.", {"entities": [[112, 116, "DISEASE"]]}], ["Limitations of the study include the small number of patients in the supplementation study and the natural fluctuation of acne.", {"entities": [[122, 126, "DISEASE"]]}], ["Vitamin D deficiency was more frequent in patients with acne, and serum 25(OH)D levels were inversely correlated with acne severity, especially in patients with inflammatory lesions.", {"entities": [[56, 60, "DISEASE"], [118, 122, "DISEASE"]]}], ["Allergen component analysis is now available in many laboratories.", {"entities": []}], ["The aim of this study was to examine the possible association between peanut allergen IgE components and severity of clinical reactions in patients with a history of peanut allergy.", {"entities": []}], ["Data and sera collected from 192 patients within the Manchester Allergy Research Database and Serum Bank were used in this retrospective study.", {"entities": []}], ["Sensitization to peanut specific IgE and Ara h 1, 2, 3, and 8 peanut IgE components, as measured by fluoroenzyme immunoassay, was not associated with anaphylaxis.", {"entities": []}], ["In contrast, sensitization to the lipid-transfer protein Ara h 9 was significantly more prevalent in patients with peanut-associated bronchospasm (26% versus 9% of patients), even after adjusting for potential confounding effects of age, gender, and severity of concomitant chronic atopic diseases.", {"entities": []}], ["Patients who were sensitized to Ara h 9 were more likely to have ingested rather than just have had skin contact with peanut and have a more rapid onset of symptoms.", {"entities": []}], ["These results are consistent with observations that sensitization to heat and protease resistant lipid-transfer protein components of hazelnut, grains, and fruit is predictive of anaphylaxis.", {"entities": []}], ["Metabolic syndrome (MetS) is associated with increased risks of diabetes and coronary artery disease (CAD).", {"entities": [[10, 18, "DISEASE"]]}], ["Despite the controversial inclusion of established diabetes in MetS, the association between MetS and CAD according to diabetes status has not been elucidated in the Asian population.", {"entities": []}], ["We evaluated the association between MetS and CAD using the parameters including any plaque, obstructive plaque, and coronary artery calcium score (CACS) >100 according to diabetes status in 2,869 symptomatic Korean subjects who underwent cardiac computed tomographic angiography.", {"entities": []}], ["The prevalence of MetS was significantly higher in the diabetic subjects than in the non-diabetic subjects (69% vs. 34%, P <0.001).", {"entities": []}], ["The incidence of any plaque (64% vs. 43%, P <0.001), obstructive plaque (26% vs. 13%, P\u2009=\u20090.006), and CACS >100 (23% vs. 12%, P\u2009=\u20090.012) was significantly higher in diabetic subjects than in non-diabetic subjects.", {"entities": []}], ["Among the MetS components, decreased high-density lipoprotein level was significantly associated with any plaque (odds ratio [OR] 1.35), obstructive plaque (OR 1.55), and CACS >100 (OR 1.57) in the non-diabetic subjects (P <0.01, respectively).", {"entities": []}], ["However, none of the MetS components were associated with all the parameters in the diabetic subjects.", {"entities": []}], ["Multivariate regression analysis revealed that MetS and the number of MetS components (MetSN) were independently associated with any plaque (MetS: OR 1.55, P <0.001; MetSN: OR 1.22, P <0.001), obstructive plaque (MetS: OR 1.52, P\u2009=\u20090.003; MetSN: OR 1.25, P <0.001), and CACS >100 (MetS: OR 1.46, P\u2009=\u20090.015; MetSN: OR 1.21, P\u2009=\u20090.004) only in the non-diabetic subjects, respectively.", {"entities": []}], ["MetS was independently associated with the presence and severity of CAD only in the non-diabetic subjects among the symptomatic Korean population.", {"entities": []}], ["In the 2015/16 influenza season, the Canadian National Advisory Committee on Immunization (NACI) recommended vaccination with quadrivalent inactivated influenza vaccine (QIV) for infants aged 6\u201323\u00a0months and trivalent inactivated influenza vaccines (TIVs) or QIVs in adults.", {"entities": [[15, 24, "DISEASE"], [151, 160, "DISEASE"], [230, 239, "DISEASE"]]}], ["The objective of this review (GSK study identifier: HO-13-14054) is to examine the epidemiology and disease burden of influenza in Canada and the economic benefits of vaccination.", {"entities": [[118, 127, "DISEASE"]]}], ["To inform this review, we performed a systematic literature search of relevant Canadian literature and National surveillance data.", {"entities": []}], ["Influenza B viruses from phylogenetically-distinct lineages (B/Yamagata and B/Victoria) co-circulate in Canada, and are an important cause of influenza complications.", {"entities": [[0, 9, "DISEASE"], [142, 151, "DISEASE"]]}], ["Modeling studies, including those postdating the search suggest that switching from TIV to QIV in Canada reduces the burden of influenza and would likely be cost-effective.", {"entities": [[127, 136, "DISEASE"]]}], ["However, more robust real-world outcomes data is required to inform health policy decision makers on appropriate influenza vaccination strategies for Canada.", {"entities": [[113, 122, "DISEASE"]]}], ["Organic diisocyanates are a common cause of occupational asthma, particularly in motor vehicle repair (MVR) workers.", {"entities": [[57, 63, "DISEASE"]]}], ["The UK Health & Safety Laboratory provides screening for urinary hexamethylenediamine (UHDA), a biomarker of exposure to 1,6-hexamethylene diisocyanate (HDI).", {"entities": []}], ["The UK Surveillance of Work-related and Occupational Respiratory Disease scheme (SWORD) has collected reports of occupational asthma since 1996.", {"entities": [[126, 132, "DISEASE"]]}], ["To compare trends in HDI exposure with trends in the incidence of work-related asthma attributed to isocyanates or paint spraying in MVR workers reported to SWORD.", {"entities": [[79, 85, "DISEASE"]]}], ["Two-level regression models were used to estimate trends in UHDA levels and work-related asthma in MVR workers reported to SWORD.", {"entities": [[89, 95, "DISEASE"]]}], ["The direction and magnitude of the trends were compared descriptively.", {"entities": []}], ["From 2006 to 2014, there was a significant decline in the number of urine samples with detectable levels of UHDA (odds ratio = 0.96; 95% confidence intervals 0.94\u20130.98) and minimal change in those over the guidance value (1.03; 1.00\u20131.06).", {"entities": []}], ["Over the same period, there was a significant decline in all asthma cases attributed to isocyanates or paint spraying reported to SWORD (0.90; 0.86\u20130.94) and a non-significant decline among MVR workers (0.94; 0.86\u20131.02).", {"entities": [[61, 67, "DISEASE"]]}], ["The simultaneous decrease in HDI exposure and incident cases of asthma reported to SWORD is temporally consistent with a reduction in exposure to airborne isocyanate leading to a reduction in asthma.", {"entities": [[64, 70, "DISEASE"], [192, 198, "DISEASE"]]}], ["Although this is not direct evidence of a causal relationship between the two trends, it is suggestive.", {"entities": []}], ["Arginase deficiency is a rare autosomal recessive disorder resulting from a loss of the liver arginase isoform, arginase 1 (ARG1), which is the final step in the urea cycle for detoxifying ammonia.", {"entities": [[124, 128, "GENE"]]}], ["ARG1 deficiency leads to hyperargininemia, characterized by progressive neurological impairment, persistent growth retardation and infrequent episodes of hyperammonemia.", {"entities": [[25, 41, "DISEASE"], [0, 4, "GENE"]]}], ["Using the Cre/loxP-directed conditional gene knockout system, we generated an inducible Arg1-deficient mouse model by crossing \u201cfloxed\u201d Arg1 mice with CreER", {"entities": [[88, 92, "GENE"], [136, 140, "GENE"]]}], ["Himalayan forests are the most important source of medicinal plants and with useful species for the local people.", {"entities": []}], ["Kedarnath Wildlife Sanctuary (KWLS) is situated in the interior part of the Garhwal Himalayan region.", {"entities": []}], ["The presented study was carried out in Madhmeshwar area of KWLS for the ecological status of medicinal plants and further focused on the ethnomedicinal uses of these plants in the study area.", {"entities": []}], ["Ecological information about ethnomedicinal plants were collected using random quadrats in a random sampling technique along an altitudinal gradient in the KWLS.", {"entities": []}], ["Information on medicinal properties of plants encountered in the present study was generated by questionnaire survey and was also compared with relevant literature.", {"entities": []}], ["A total of 152 medicinally important plant species were reported, in which 103 were found herbs, 32 shrubs and 17 were tree species which represented 123 genera of 61 families.", {"entities": []}], ["A total of 18 plant species fell into the rare, endangered (critically endangered) and vulnerable status categories.", {"entities": []}], ["The present study documented the traditional uses of medicinal plants, their ecological status and importance of these plants in the largest protected area of Garhwal Himalaya.", {"entities": []}], ["This study can serve as baseline information on medicinal plants and could be helpful to further strengthen the conservation of this important resource.", {"entities": []}], ["In Finland, a national programme for COPD prevention and treatment was developed in 1998.", {"entities": []}], ["The main goals of the programme were to diagnose COPD as early as possible and to encourage people to quit smoking.", {"entities": []}], ["The role of primary health care was emphasized in the programme.", {"entities": []}], ["Our aim was to investigate the use of spirometry and recording of smoking habits of COPD patients in primary health care before and during the COPD programme.", {"entities": []}], ["We compared patients with respiratory symptoms or diseases visiting primary health care during 1997 (before programme) and 2002 (during programme).", {"entities": []}], ["Patients with respiratory symptoms were divided into two groups: COPD patients and \"others\".", {"entities": []}], ["Patient records were thoroughly investigated and data retrieved from them.", {"entities": []}], ["There was a significant increase in the whole study group from 8.0% to 38.9% in the use of spirometry (p < 0.001).", {"entities": []}], ["This increase was significant both in the COPD group (from 32.0% to 79.6%, p < 0.001) and \"others\" (from 5.6% to 32.8%, p < 0.001).", {"entities": []}], ["Written information on smoking habits in patient records increased from 16.6% of all patients in 1997 to 53.2% in 2002 (p < 0.001), and in COPD group from 45.0% to 84.3% (p < 0.001).", {"entities": []}], ["We observed a significant increase in the use of spirometry and knowledge of smoking habits in COPD patients, which may be a result of the Finnish national COPD programme.", {"entities": []}], ["Nontuberculous mycobacteria (NTM) lung disease is increasing globally.", {"entities": [[34, 46, "DISEASE"], [29, 32, "GENE"]]}], ["Although the etiological epidemiology of NTM is different across regions, Mycobacterium avium complex (MAC) is the leading cause of NTM lung disease in most countries, including mainland Japan.", {"entities": [[136, 148, "DISEASE"], [41, 44, "GENE"], [132, 135, "GENE"], [41, 44, "GENE"], [132, 135, "GENE"]]}], ["Okinawa is located in the southernmost region of Japan and is the only prefecture categorized as a subtropical region in Japan, it is therefore likely the etiological epidemiology of NTM lung disease is different from mainland Japan.", {"entities": [[187, 199, "DISEASE"], [183, 186, "GENE"]]}], ["From 2009 to 2015, the medical records of patients, with respiratory specimens positive for NTMs, visiting or admitted to two Okinawan hospitals, were retrospectively analyzed.", {"entities": []}], ["NTM lung disease cases were defined according to the American Thoracic Society criteria and patient epidemiology and clinical information were evaluated.", {"entities": [[4, 16, "DISEASE"], [0, 3, "GENE"]]}], ["Results indicate four hundred sixteen patients had bacterial cultures positive for NTM.", {"entities": [[83, 86, "GENE"]]}], ["The most common NTM was M .", {"entities": [[16, 19, "GENE"]]}], ["abscessus complex (MABC) (n = 127; 30.5%), followed by M .", {"entities": []}], ["intracellulare (n = 85; 20.4%).", {"entities": []}], ["NTM lung disease was diagnosed in 114 patients.", {"entities": [[4, 16, "DISEASE"], [0, 3, "GENE"]]}], ["Of these cases, MABC was most common (n = 41; 36.0%), followed by M .", {"entities": []}], ["intracellulare (n = 31; 27.2%).", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) and tracheostomy patients were more likely to develop MABC than MAC lung disease.", {"entities": [[113, 125, "DISEASE"]]}], ["Multivariate analysis showed a probable association between COPD and MABC lung disease.", {"entities": [[74, 86, "DISEASE"]]}], ["Chest computed tomography (CT) evaluation revealed bronchiectasis, nodules, and consolidation were less frequently observed in MABC patients compared with MAC patients.", {"entities": [[51, 65, "DISEASE"]]}], ["Our data suggests Okinawa may be one of the few places where MABC is the predominant pathogen causing NTM lung disease and our results add new insight to MABC lung disease, which is not yet well understood.", {"entities": [[106, 118, "DISEASE"], [159, 171, "DISEASE"], [102, 105, "GENE"]]}], ["We aimed to study the pathogenic roles of High-Mobility Group Box 1 (HMGB1) / Receptor-for-Advanced-Glycation-End-products (RAGE) signaling and pro-inflammatory cytokines in patients with active pulmonary tuberculosis (PTB).", {"entities": [[205, 217, "DISEASE"], [195, 217, "DISEASE"], [69, 74, "GENE"]]}], ["A prospective study was conducted among non-HIV adults newly-diagnosed with active PTB at two acute-care hospitals (n = 80); age-and-sex matched asymptomatic individuals (tested for latent TB) were used for comparison (n = 45).", {"entities": []}], ["Plasma concentrations of 8 cytokines/chemokines, HMGB1, soluble-RAGE, and transmembrane-RAGE expressed on monocytes/dendritic cells, were measured.", {"entities": [[49, 54, "GENE"]]}], ["Gene expression (mRNA) of HMGB1, RAGE, and inflammasome-NALP3 was quantified.", {"entities": [[26, 31, "GENE"]]}], ["Patients\u2019 PBMCs were stimulated with recombinant-HMGB1 and MTB-antigen (lipoarabinomannan) for cytokine induction e x vivo .", {"entities": []}], ["In active PTB, plasma IL-8/CXCL8 [median(IQR), 6.0(3.6\u201315.1) vs 3.6(3.6\u20133.6) pg/ml, P<0.001] and IL-6 were elevated, which significantly correlated with mycobacterial load, extent of lung consolidation ( r s +0.509, P<0.001), severity-score ( r s +0.317, P = 0.004), and fever and hospitalization durations ( r s +0.407, P<0.001).", {"entities": []}], ["IL-18 and sTNFR1 also increased.", {"entities": []}], ["Plasma IL-8/CXCL8 (adjusted OR 1.12, 95%CI 1.02\u20131.23 per unit increase, P = 0.021) and HMGB1 (adjusted OR 1.42 per unit increase, 95%CI 1.08\u20131.87, P = 0.012) concentrations were independent predictors for respiratory failure, as well as for ICU admission/death.", {"entities": [[205, 224, "DISEASE"], [87, 92, "GENE"]]}], ["Gene expression of HMGB1, RAGE, and inflammasome-NALP3 were upregulated (1.2\u22122.8 fold).", {"entities": [[19, 24, "GENE"]]}], ["Transmembrane-RAGE was increased, whereas the decoy soluble-RAGE was significantly depleted.", {"entities": []}], ["RAGE and HMGB1 gene expressions positively correlated with cytokine levels (IL-8/CXCL8, IL-6, sTNFR1) and clinico-/radiographical severity (e.g.", {"entities": [[9, 14, "GENE"]]}], ["extent of consolidation r s +0.240, P = 0.034).", {"entities": []}], ["Ex vivo , recombinant-HMGB1 potentiated cytokine release (e.g.", {"entities": []}], ["TNF-\u03b1) when combined with lipoarabinomannan.", {"entities": []}], ["In patients with active PTB, HMGB1/RAGE signaling and pro-inflammatory cytokines may play important roles in pathogenesis and disease manifestations.", {"entities": []}], ["Our clinico-immunological data can provide basis for the development of new strategies for disease monitoring, management and control.", {"entities": []}], ["Pediatric emergency care medicine is an important field of health care.", {"entities": []}], ["This study aimed to investigate the 10-year pediatric emergency care in children aged 0-17\u00a0years old in Taiwan.", {"entities": []}], ["Systematic random samples from the National Health Insurance Research Database of Taiwan in the period 2000-2009 were analyzed.", {"entities": []}], ["Children recorded as undergoing emergency care were enrolled and divided into different age groups.", {"entities": []}], ["The frequency of emergency visits, age, cost per visit, seasonality, number of hospitalizations, and diagnosis were analyzed.", {"entities": []}], ["A total of 764,598 children were enrolled.", {"entities": []}], ["These children accounted for 25% of all emergency cases and their mean age was 6.1\u00a0years.", {"entities": []}], ["Children aged 0-5\u00a0years formed the largest group, with male predominance (57.5%).", {"entities": []}], ["The incidence of emergency visits was 29133\u2009\u00b1\u20093104 per 100,000 children per year (mean\u2009\u00b1\u2009SD).", {"entities": []}], ["Acute upper airway infection, fever, and acute gastrointestinal illness were the most common diagnoses among all non-hospitalized children.", {"entities": []}], ["Some (4.51%) required subsequent hospitalization and their most common diagnoses were fluid/electrolyte disorder, upper/lower airway infection, and acute gastrointestinal illness.", {"entities": []}], ["The group of children aged 12-17\u00a0years had cases of traumatic injury and childbirth.", {"entities": []}], ["In Taiwan, 25% of individuals seeking emergency care are children, mostly aged 0-5\u00a0years old.", {"entities": []}], ["Costs and disease patterns vary among different age groups.", {"entities": []}], ["Preventive measures targeting all children should focus on respiratory and gastrointestinal diseases, but should target different diseases for different age groups to improve child health.", {"entities": []}], ["Interleukin 9 (IL-9) has been implicated in mast cell-related inflammatory diseases, such as asthma, where vascular endothelial growth factor (VEGF) is involved.", {"entities": [[93, 99, "DISEASE"]]}], ["Here we report that IL-9 (10\u201320 ng/ml) induces gene expression and secretion of VEGF from human LAD2.", {"entities": []}], ["IL-9 does not induce mast cell degranulation or the release of other mediators (IL-1, IL-8, or TNF).", {"entities": [[95, 98, "GENE"]]}], ["VEGF production in response to IL-9 involves STAT-3 activation.", {"entities": []}], ["The effect is inhibited (about 80%) by the STAT-3 inhibitor, Stattic.", {"entities": []}], ["Gene-expression of IL-9 and IL-9 receptor is significantly increased in lesional skin areas of atopic dermatitis (AD) patients as compared to normal control skin, while serum IL-9 is not different from controls.", {"entities": [[95, 112, "DISEASE"], [102, 112, "DISEASE"]]}], ["These results imply that functional interactions between IL-9 and mast cells leading to VEGF release contribute to the initiation/propagation of the pathogenesis of AD, a skin inflammatory disease.", {"entities": []}], ["Rhinovirus (RV) infections cause exacerbations and development of severe asthma highlighting the importance of antiviral interferon (IFN) defence by airway cells.", {"entities": [[73, 79, "DISEASE"]]}], ["Little is known about bronchial smooth muscle cell (BSMC) production of IFNs and whether BSMCs have dsRNA-sensing receptors besides TLR3.", {"entities": [[132, 136, "GENE"]]}], ["dsRNA is a rhinoviral replication intermediate and necrotic cell effect mimic that mediates innate immune responses in bronchial epithelial cells.", {"entities": []}], ["We have explored dsRNA-evoked IFN-\u03b2 and IFN-\u03bb 1 production in human BSMCs and potential involvement of TLR3 and RIG-I-like receptors (RLRs).", {"entities": [[103, 107, "GENE"]]}], ["Primary BSMCs were stimulated with 0.1\u201310 \u00b5g/ml dsRNA, 0.1\u20131 \u00b5g/ml dsRNA in complex with the transfection agent LyoVec (dsRNA/LyoVec; selectively activating cytosolic RLRs) or infected with 0.05\u20130.5 MOI RV1B.", {"entities": []}], ["Both dsRNA stimuli evoked early (3 h), concentration-dependent IFN-\u03b2 and IFN-\u03bb 1 mRNA expression, which with dsRNA/LyoVec was much greater, and with dsRNA was much less, after 24 h. The effects were inhibited by dexamethasone.", {"entities": []}], ["Further, dsRNA and dsRNA/LyoVec concentration-dependently upregulated RIG-I and MDA5 mRNA and protein.", {"entities": []}], ["dsRNA and particularly dsRNA/LyoVec caused IFN-\u03b2 and IFN-\u03bb 1 protein production (24 h).", {"entities": []}], ["dsRNA- but not dsRNA/LyoVec-induced IFN expression was partly inhibited by chloroquine that suppresses endosomal TLR3 activation.", {"entities": [[113, 117, "GENE"]]}], ["RV1B dose-dependently increased BSMC expression of RIG-I, MDA5, IFN-\u03b2, and IFN-\u03bb 1 mRNA.", {"entities": []}], ["We suggest that BSMCs express functional RLRs and that both RLRs and TLR3 are involved in viral stimulus-induced BSMC expression of IFN-\u03b2 and IFN-\u03bb 1 .", {"entities": [[69, 73, "GENE"]]}], ["HMG-CoA reductase inhibitors (or \u201cstatins\u201d) are important and commonly used medications to lower cholesterol and prevent cardiovascular disease.", {"entities": []}], ["Nearly half of patients stop taking statin medications one year after they are prescribed leading to higher cholesterol, increased cardiovascular risk, and costs due to excess hospitalizations.", {"entities": []}], ["Identifying which patients are at highest risk for not adhering to long-term statin therapy is an important step towards individualizing interventions to improve adherence.", {"entities": []}], ["Electronic health records (EHR) are an increasingly common source of data that are challenging to analyze but have potential for generating more accurate predictions of disease risk.", {"entities": []}], ["The aim of this study was to build an EHR based model for statin adherence and link this model to biologic and clinical outcomes in patients receiving statin therapy.", {"entities": []}], ["We gathered EHR data from the Military Health System which maintains administrative data for active duty, retirees, and dependents of the United States armed forces military that receive health care benefits.", {"entities": []}], ["Data were gathered from patients prescribed their first statin prescription in 2005 and 2006.", {"entities": []}], ["Baseline billing, laboratory, and pharmacy claims data were collected from the two years leading up to the first statin prescription and summarized using non-negative matrix factorization.", {"entities": []}], ["Follow up statin prescription refill data was used to define the adherence outcome (> 80 percent days covered).", {"entities": []}], ["The subsequent factors to emerge from this model were then used to build cross-validated, predictive models of 1) overall disease risk using coalescent regression and 2) statin adherence (using random forest regression).", {"entities": []}], ["The predicted statin adherence for each patient was subsequently used to correlate with cholesterol lowering and hospitalizations for cardiovascular disease during the 5 year follow up period using Cox regression.", {"entities": []}], ["The analytical dataset included 138 731 individuals and 1840 potential baseline predictors that were reduced to 30 independent EHR \u201cfactors\u201d.", {"entities": []}], ["A random forest predictive model taking patient, statin prescription, predicted disease risk, and the EHR factors as potential inputs produced a cross-validated c-statistic of 0.736 for classifying statin non-adherence.", {"entities": []}], ["The addition of the first refill to the model increased the c-statistic to 0.81.", {"entities": []}], ["The predicted statin adherence was independently associated with greater cholesterol lowering (correlation = 0.14, p < 1e-20) and lower hospitalization for myocardial infarction, coronary artery disease, and stroke (hazard ratio = 0.84, p = 1.87E-06).", {"entities": [[156, 177, "DISEASE"]]}], ["Electronic health records data can be used to build a predictive model of statin adherence that also correlates with statins\u2019 cardiovascular benefits.", {"entities": []}], ["The aim of this study was to examine whether salivary exosomal miRNAs could be identified as aging biomarkers.", {"entities": []}], ["Fifteen young healthy volunteers (median age, 21.0 years) and 13 old individuals (median age, 66.0 years) were recruited.", {"entities": []}], ["Unstimulated whole saliva was collected, salivary exosomes were isolated, and total RNA was extracted.", {"entities": []}], ["In a microarray, 242 miRNAs were commonly detected in these two mixed samples.", {"entities": []}], ["Based on the cut-off values of 2- or 0.5-fold changes ( FC ) and regulatory power for aging process, six candidate miRNAs (miR-24-3p, miR-371a-5p, miR-3175, miR-3162-5p, miR-671-5p, and miR-4667-5p) were selected.", {"entities": [[147, 155, "GENE"], [170, 180, "GENE"]]}], ["After comparing each total RNA obtained by the 15 young and 13 old individuals to validate the FC values using quantitative real-time PCR, miR-24-3p was identified as a novel candidate aging biomarker.", {"entities": []}], ["This pilot study suggested that salivary exosomal miRNAs could be identified as candidate aging biomarkers.", {"entities": []}], ["To confirm whether miR-24-3p in salivary exosomes are suitable biomarkers of aging, further validation research is required.", {"entities": []}], ["Using in situ hybridization, we have shown that activated human peripheral blood eosinophils express mRNA for granulocyte/macrophage colony-stimulating factor (GM-CSF).", {"entities": []}], ["Between 15 and 27% of eosinophils gave positive hybridization signals for GM-CSF mRNA after stimulation with the calcium ionophore A23187 or interferon gamma, and 4 and 6% after incubation with interleukin 3 (IL-3) or IL-5.", {"entities": []}], ["Activated eosinophils also gave specific immunoreactivity with an anti-GM-CSF polyclonal antibody, suggesting translation of the mRNA.", {"entities": []}], ["These data indicate that eosinophils may be an important source of GM-CSF at sites of allergic inflammation.", {"entities": []}], ["Furthermore, the identification of GM-CSF production by human eosinophils suggests that the pro-inflammatory potential of this cell type may be substantially greater than hitherto recognized.", {"entities": []}], ["The first generation antihistamines, such as diphenhydramine, are fairly potent muscarinic antagonists in addition to being H1 selective antihistamines.", {"entities": []}], ["The antimuscarinic action is often not desirable since it is in part responsible for the drying of secretions in the airways and the sedative effect.", {"entities": []}], ["We therefore examined a number of antihistamines for antimuscarinic effects on ion transport by mucus gland cells isolated from the airways of swine.", {"entities": []}], ["Enzymatically isolated airway mucus gland cells were purified utilizing density gradients and grown in culture on porous inserts (Millicell HA\u2122) at an air interface.", {"entities": []}], ["Cells grown in this manner maintain phenotype and polarity.", {"entities": []}], ["Transport of ions, as short-circuit current measured under voltage-clamp, was measured in response to acetylcholine (ACh) or histamine applied to the serosal side of the gland cell layers.", {"entities": []}], ["Concentration-response relationships for ACh or histamine were generated in the presence and absence of various drugs.", {"entities": []}], ["The potencies against muscarinic receptor activation were estimated using the dose-ratio method of Schild.", {"entities": []}], ["Three known muscarinic antagonists were used to validate the system.", {"entities": []}], ["Atropine had a pA 2 of 9.4 \u00b1 0.1 (n = 9).", {"entities": []}], ["4-DAMP and methoctramine had pA 2 values of 8.6 \u00b1 0.1 and 5.6 \u00b1 0.1, respectively (n = 12, 11) all consistent with inhibition of an M3 subtype muscarinic receptor.", {"entities": []}], ["The rank order of potency of the antihistamines against the inhibition of M3 receptors was desloratadine = diphenhydramine > hydroxyzine (pA 2 ; 6.4, 6.2, 4.8, respectively).", {"entities": []}], ["pA 2 values for fexofenadine, loratadine and cetirizine were not determined since they had no effect on the cholinergic response at the highest drug concentrations tested (10, 10 and 100 \u03bcM, respectively).", {"entities": []}], ["The pA 2 values for the antihistamines against the histamine response could not be calculated, but the estimates of the rank order of potency were estimated to be desloratadine> cetirizine \u2248 hydroxyzine > fexofenadine > loratadine > diphenhydramine.", {"entities": []}], ["The rank order of selectivity for histamine receptors over muscarinic receptors was estimated to be cetirizine \u2248 fexofenadine > loratadine > desloratadine \u2265 hydroxyzine \u2265 diphenhydramine.", {"entities": []}], ["Endometriosis, a disease of reproductive age women, is a major cause of infertility, menstrual disorders and pelvic pain.", {"entities": [[72, 83, "DISEASE"], [0, 13, "DISEASE"]]}], ["Little is known about its etiopathology, but chronic pelvic inflammation is a common feature in affected women.", {"entities": []}], ["Beside symptomatic treatment of endometriosis-associated pain, only two main suboptimal therapeutic approaches (hormonal and invasive surgery) are generally recommended to patients and no specific targeted treatment is available.", {"entities": [[32, 45, "DISEASE"]]}], ["Our studies led to the detection of a marked increase in the expression of macrophage migration inhibitory factor (MIF) in the eutopic endometrium, the peripheral blood and the peritoneal fluid of women with endometriosis, and in early, vascularized and active endometriotic lesions.", {"entities": [[208, 221, "DISEASE"], [115, 118, "GENE"]]}], ["Herein, we developed a treatment model of endometriosis, where human endometrial tissue was first allowed to implant into the peritoneal cavity of nude mice, to assess in vivo the effect of a specific antagonist of MIF (ISO-1) on the progression of endometriosis and evaluate its efficacy as a potential therapeutic tool.", {"entities": [[42, 55, "DISEASE"], [249, 262, "DISEASE"], [215, 218, "GENE"]]}], ["Administration of ISO-1 led to a significant decline of the number, size and in situ dissemination of endometriotic lesions.", {"entities": []}], ["We further showed that ISO-1 may act by significantly inhibiting cell adhesion, tissue remodeling, angiogenesis and inflammation as well as by altering the balance of pro- and anti-apoptotic factors.", {"entities": []}], ["Actually, mice treatment with ISO-1 significantly reduced the expression of cell adhesion receptors \u03b1v and \u00df3 integrins (P<0.05), matrix metalloproteinases (MMP) 2 and 9 (P<0.05), vascular endothelial cell growth factor (VEGF) (P<0.01), interleukin 8 (IL8) (P<0.05), cyclooxygenease (COX)2 (P<0.001) and the anti-apoptotic protein Bcl2 (P<0.01), but significantly induced the expression of Bax (P<0.05), a potent pro-apoptotic protein.", {"entities": [[252, 255, "GENE"], [331, 335, "GENE"], [390, 393, "GENE"]]}], ["These data provide evidence that specific inhibition of MIF alters endometriotic tissue growth and progression in vivo and may represent a promising potential therapeutic avenue.", {"entities": [[56, 59, "GENE"]]}], ["The objective of this study was to examine how COPD patients were classified by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) spirometry-based severity system and the distribution of COPD severity using the new GOLD 2011 assessment framework.", {"entities": []}], ["This was an observational, retrospective cohort study conducted in a single tertiary center on a prospective database, which aimed to evaluate the prevalence, incidence, severity, and comorbidities of COPD.", {"entities": []}], ["Inclusion criteria were age \u226540 years and COPD diagnosis according to GOLD 2007 classification.", {"entities": []}], ["Clinical factors were compared between the categories in GOLD 2007 and 2011 groups by using the \u03c7 In total, 420 COPD patients were included in the analysis.", {"entities": []}], ["The distribution of patients into GOLD 2007 categories was as follows: 6.4% (n=27) of them were classified into subgroup I, 42.1% (n=177) into subgroup II, 37.9% (n=159) into subgroup III, and 13.6% (n=57) into subgroup IV.", {"entities": []}], ["The distribution of patients into GOLD 2011 categories was as follows: 16.4% (n=69) of them were classified into subgroup A (low risk and fewer symptoms), 32.1% (n=135) into subgroup B (low risk and more symptoms), 21.6% (n=91) into subgroup C (high risk and fewer symptoms), and 29.7% (n=125) into subgroup D (high risk and more symptoms).", {"entities": []}], ["After the application of the new GOLD 2011 (modified Medical Research Council [mMRC] system), 22% (n=94) of patients were upgraded to a higher level than their spirometry level, and 16.2% (n=68) of them were downgraded in their severity category, meaning that almost 40% of patients changed their severity assessment category.", {"entities": []}], ["In total, 22% of patients in stage I were allocated to group B, and 35% of patients in stage IV were allocated to group C. Patients in stage III were the most frequently upgraded to a higher risk group (D), taking into account mMRC and exacerbation history.", {"entities": []}], ["Classifying patients using the new GOLD 2011 criteria reallocated a relevant proportion of patients to a different risk category and identified larger proportions of patients in the mildest and more severe groups compared with GOLD 2007 classification.", {"entities": []}], ["Patient-reported quality of life is strongly affected by some dermatologic conditions.", {"entities": []}], ["We developed a Japanese version of the Dermatology Life Quality Index (DLQI-J) and used psychometric methods to examine its validity and reliability.", {"entities": []}], ["The Japanese version of the DLQI was created from the original (English) version, using a standard method.", {"entities": []}], ["The DLQI-J was then completed by 197 people, to examine its validity and reliability.", {"entities": []}], ["Some participants completed the DLQI-J a second time, 3 days later, to examine the reproducibility of their responses.", {"entities": []}], ["In addition to the DLQI-J, the participants completed parts of the SF-36 and gave data on their demographic and clinical characteristics.", {"entities": []}], ["Their physicians provided information on the location and clinical severity of the skin disease.", {"entities": [[83, 95, "DISEASE"]]}], ["The participants reported no difficulties in answering the DLQI-J items.", {"entities": []}], ["Their mean age was 24.8 years, 77.2% were female, and 78.7% had acne vulgaris.", {"entities": [[64, 68, "DISEASE"]]}], ["The mean score of DLQI was 3.99(SD: 3.99).", {"entities": []}], ["The responses were found to be reproducible and stable.", {"entities": []}], ["Results of principal-component and factor analysis suggested that this scale measured one construct.", {"entities": []}], ["The correlations of DLQI-J scores with sex or age were very poor, but those with SF-36 scores and with clinical severity were high.", {"entities": []}], ["The DLQI-J provides valid and reliable data despite having only a small number of items.", {"entities": []}], ["Since its discovery, many adhere to the view that asymmetric dimethylarginine (ADMA), as an inhibitor of the synthesis of nitric oxide (NO), contributes to the pathogenesis of various diseases.", {"entities": []}], ["Particularly, this is evident in disease of the cardiovascular system, in which endothelial dysfunction results in an imbalance between vasoconstriction and vasodilatation.", {"entities": []}], ["Even if increased ADMA concentrations are closely related to an endothelial dysfunction, several studies pointed to a potential beneficial effect of ADMA, mainly in the context of angioproliferative disease such as cancer and fibrosis.", {"entities": [[215, 221, "DISEASE"]]}], ["Antiproliferative properties of ADMA independent of NO have been identified in this context.", {"entities": []}], ["In particular, the regulation of ADMA by its degrading enzyme dimethylarginine dimethylaminohydrolase (DDAH) is the object of many studies.", {"entities": [[103, 107, "GENE"]]}], ["DDAH is discussed as a promising therapeutic target for the indirect regulation of NO.", {"entities": [[0, 4, "GENE"]]}], ["In hypoxia-related chronic respiratory diseases, this controversy discussion of ADMA and DDAH is particularly evident and is therefore subject of this review.", {"entities": [[89, 93, "GENE"]]}], ["Humans and dogs are both affected by the allergic skin disease atopic dermatitis (AD), caused by an interaction between genetic and environmental factors.", {"entities": [[63, 80, "DISEASE"], [50, 62, "DISEASE"], [70, 80, "DISEASE"]]}], ["The German shepherd dog (GSD) is a high-risk breed for canine AD (CAD).", {"entities": []}], ["In this study, we used a Swedish cohort of GSDs as a model for human AD.", {"entities": []}], ["Serum IgA levels are known to be lower in GSDs compared to other breeds.", {"entities": []}], ["We detected significantly lower IgA levels in the CAD cases compared to controls (p\u200a=\u200a1.1\u00d710 n cases \u200a=\u200a91, n controls \u200a=\u200a88).", {"entities": []}], ["IgA levels were included in the model, due to the high correlation between CAD and low IgA levels.", {"entities": []}], ["In addition, we detected a correlation between IgA levels and the age at the time of sampling (corr\u200a=\u200a0.42, p\u200a=\u200a3.0\u00d710 raw \u200a=\u200a3.1\u00d710 genome \u200a=\u200a0.03).", {"entities": []}], ["The total associated region was defined as a \u223c1.5-Mb-long haplotype including eight genes.", {"entities": []}], ["Through targeted re-sequencing and additional genotyping of a subset of identified SNPs, we defined 11 smaller haplotype blocks within the associated region.", {"entities": []}], ["Two blocks showed the strongest association to CAD.", {"entities": []}], ["The \u223c209-kb region, defined by the two blocks, harbors only the PKP2 gene, encoding Plakophilin 2 expressed in the desmosomes and important for skin structure.", {"entities": [[64, 68, "GENE"]]}], ["Our results may yield further insight into the genetics behind both canine and human AD.", {"entities": []}], ["Humans and dogs are both affected by the allergic skin disease atopic dermatitis (AD), caused by an interaction between genetic and environmental factors.", {"entities": [[63, 80, "DISEASE"], [50, 62, "DISEASE"], [70, 80, "DISEASE"]]}], ["The German shepherd dog (GSD) is a high-risk breed for canine AD (CAD), also affected by low serum IgA levels.", {"entities": []}], ["A Swedish cohort of GSDs was used as a model for human AD in this study.", {"entities": []}], ["We performed a genome-wide association analysis where a region associated with CAD was identified.", {"entities": []}], ["IgA levels were included in the model due to strong correlation with CAD.", {"entities": []}], ["Also, age at sampling was included in the model due to correlation with IgA levels.", {"entities": []}], ["The associated region, consisting of eight genes, was further fine-mapped with sequencing and additional genotyping.", {"entities": []}], ["Haplotype association analysis from the fine-mapping data indicates association of the gene, plakophilin 2 ( PKP2 ), known to be important for skin structure.", {"entities": [[109, 113, "GENE"]]}], ["We detected a division of the GSD breed into two subpopulations where one is more prone to develop CAD and to have lower serum IgA levels compared with the other.", {"entities": []}], ["Here, we present methods for performing genome-wide association analyses when the study population is complex and when the trait is affected by additional parameters.", {"entities": []}], ["The PKP2 gene found within the associated region became an interesting target for further study of its importance both in canine and human AD.", {"entities": [[4, 8, "GENE"]]}], ["Following a period of ischemia (local restriction of blood supply to a tissue), the restoration of blood supply to the affected area causes significant tissue damage.", {"entities": [[22, 30, "DISEASE"]]}], ["This is known as ischemia-reperfusion injury (IRI) and is a central pathological mechanism contributing to many common disease states.", {"entities": [[17, 25, "DISEASE"]]}], ["The medical complications caused by IRI in individuals with cerebrovascular or heart disease are a leading cause of death in developed countries.", {"entities": [[79, 92, "DISEASE"]]}], ["IRI is also of crucial importance in fields as diverse as solid organ transplantation, acute kidney injury and following major surgery, where post-operative organ dysfunction is a major cause of morbidity and mortality.", {"entities": []}], ["Given its clinical impact, novel interventions are urgently needed to minimize the effects of IRI, not least to save lives but also to reduce healthcare costs.", {"entities": []}], ["In this Review, we examine the experimental technique of ischemic conditioning, which entails exposing organs or tissues to brief sub-lethal episodes of ischemia and reperfusion, before, during or after a lethal ischemic insult.", {"entities": [[153, 161, "DISEASE"]]}], ["This approach has been found to confer profound tissue protection against IRI.", {"entities": []}], ["We discuss the translation of ischemic conditioning strategies from bench to bedside, and highlight where transition into human clinical studies has been less successful than in animal models, reviewing potential reasons for this.", {"entities": []}], ["We explore the challenges that preclude more extensive clinical translation of these strategies and emphasize the role that underlying comorbidities have in altering the efficacy of these strategies in improving patient outcomes.", {"entities": []}], ["Community-based health insurance has been associated with increased hospitalisation in low-income settings, but with limited analysis of the illnesses for which claims are submitted.", {"entities": []}], ["A review of claims submitted to VimoSEWA, an inpatient insurance scheme in Gujarat, India, found that fever, diarrhoea and hysterectomy, the latter at a mean age of 37\u00a0years, were the leading reasons for claims by adult women.", {"entities": []}], ["We compared the morbidity, outpatient treatment-seeking and hospitalisation patterns of VimoSEWA-insured women with uninsured women.", {"entities": []}], ["We utilised data from a cross-sectional survey of 1,934 insured and uninsured women in Gujarat, India.", {"entities": []}], ["Multivariable logistic regression identified predictors of insurance coverage and the association of insurance with hospitalisation.", {"entities": []}], ["Self-reported data on morbidity, outpatient care and hospitalisation were compared between insured and uninsured women.", {"entities": []}], ["Age, marital status and occupation of adult women were associated with insurance status.", {"entities": []}], ["Reported recent morbidity, type of illness and outpatient treatment were similar among insured and uninsured women.", {"entities": []}], ["Multivariable analysis revealed strong evidence of a higher odds of hospitalisation amongst the insured (OR\u2009=\u20092.7; 95% ci.", {"entities": []}], ["The leading reason for hospitalisation for uninsured and insured women was hysterectomy, at a similar mean age of 36, followed by common ailments such as fever and diarrhoea.", {"entities": []}], ["Insured women appeared to have a higher probability of being hospitalised than uninsured women for all causes, rather than specifically for fever, diarrhoea or hysterectomy.", {"entities": []}], ["Length of stay was similar while choice of hospital differed between insured and uninsured women.", {"entities": []}], ["Despite similar reported morbidity patterns and initial treatment-seeking behaviour, VimoSEWA members were more likely to be hospitalised.", {"entities": []}], ["The data did not provide strong evidence that inpatient hospitalisation replaced outpatient treatment for common illnesses or that insurance was the primary inducement for hysterectomy in the population.", {"entities": []}], ["Rather, it appears that VimoSEWA members behaved differently in deciding if, and where, to be hospitalised for any condition.", {"entities": []}], ["Further research is required to explore this decision-making process and roles, if any, played by adverse selection and moral hazard.", {"entities": []}], ["Lastly, these hospitalisation patterns raise concerns regarding population health needs and access to quality preventive and outpatient services.", {"entities": []}], ["We performed a comprehensive meta-analysis to determine the association between P2X7 -762T/C polymorphism and pulmonary tuberculosis susceptibility.", {"entities": [[120, 132, "DISEASE"], [110, 132, "DISEASE"]]}], ["Based on comprehensive searches of the PubMed, SCI, Elsevier, China National Knowledge Infrastructure (CNKI) and Wanfang Database, we identified eligible studies about the association between P2X7 -762T/C polymorphism and pulmonary tuberculosis risk.", {"entities": [[232, 244, "DISEASE"], [222, 244, "DISEASE"]]}], ["Pooled odds ratio (ORs) and 95% confidence intervals (95%CIs) were calculated in random-effects model.", {"entities": []}], ["A total of 2207 tuberculosis cases and 2220 controls in 8 case-control studies were included in this meta-analysis.", {"entities": [[16, 28, "DISEASE"]]}], ["Allele model (C vs. T: p\u200a=\u200a0.15; OR\u200a=\u200a0.83, 95% CI\u200a=\u200a0.65\u20131.07), homozygous model (CC vs. TT: p\u200a=\u200a0.23; OR\u200a=\u200a0.73, 95% CI\u200a=\u200a0.44 to 1.22), and heterozygous model (CT vs. TT: p\u200a=\u200a0.57; OR\u200a=\u200a0.92, 95% CI\u200a=\u200a0.68 to 1.24) did not show increased risk of developing pulmonary tuberculosis.", {"entities": [[270, 282, "DISEASE"], [260, 282, "DISEASE"]]}], ["Similarly, dominant model (CC+CT vs. TT: p\u200a=\u200a0.32; OR\u200a=\u200a0.84, 95% CI\u200a=\u200a0.59 to 1.19) and recessive model (CC vs. CT+TT: p\u200a=\u200a0.08; OR\u200a=\u200a0.77, 95% CI\u200a=\u200a0.57 to 1.04) failed to show increased risk of developing pulmonary tuberculosis.", {"entities": [[218, 230, "DISEASE"], [208, 230, "DISEASE"]]}], ["Subgroup analysis by ethnicity did not detect any significant association between P2X7 \u2013762T/C polymorphism and pulmonary tuberculosis susceptibility.", {"entities": [[122, 134, "DISEASE"], [112, 134, "DISEASE"]]}], ["P2X7 -762T/C gene polymorphism is not associated with pulmonary tuberculosis susceptibility.", {"entities": [[64, 76, "DISEASE"], [54, 76, "DISEASE"]]}], ["Mixed viral and bacterial infections are widely described in community-acquired pneumonia; however, the clinical implications of co-infection on the associated immunopathology remain poorly studied.", {"entities": [[80, 89, "DISEASE"]]}], ["In this study, microRNA, mRNA and cytokine/chemokine secretion profiling were investigated for human monocyte-derived macrophages infected in-vitro with Influenza virus A/H1N1 and/or Streptococcus pneumoniae.", {"entities": []}], ["We observed that the in-vitro co-infection synergistically increased interferon-\u03b3-induced protein-10 ( CXCL10 , IP-10) expression compared to the singly-infected cells conditions.", {"entities": [[103, 109, "GENE"]]}], ["We demonstrated that endogenous miRNA-200a-3p, whose expression was synergistically induced following co-infection, indirectly regulates CXCL10 expression by targeting suppressor of cytokine signaling-6 ( SOCS-6 ), a well-known regulator of the JAK-STAT signaling pathway.", {"entities": [[137, 143, "GENE"]]}], ["Additionally, in a subsequent clinical pilot study, immunomodulators levels were evaluated in samples from 74 children (\u22645 years-old) hospitalized with viral and/or bacterial community-acquired pneumonia.", {"entities": [[194, 203, "DISEASE"]]}], ["Clinically, among the 74 cases of pneumonia, patients with identified mixed-detection had significantly higher (3.6-fold) serum IP-10 levels than those with a single detection ( P \u2009=\u20090.03), and were significantly associated with severe pneumonia (P \u2009<\u20090.01).", {"entities": [[34, 43, "DISEASE"], [236, 245, "DISEASE"]]}], ["This study demonstrates that viral and bacterial co-infection modulates the JAK-STAT signaling pathway and leads to exacerbated IP-10 expression, which could play a major role in the pathogenesis of pneumonia.", {"entities": [[199, 208, "DISEASE"]]}], ["Depression and type 2 diabetes (T2D) contribute significantly to global burden of disease and often co-occur.", {"entities": []}], ["Underpinning type 2 diabetes is poor glycaemic control and glucose is also an obligatory substrate for brain metabolism, with potential implications for cognition, motivation and mood.", {"entities": []}], ["This research aimed to examine the relationships between fasting plasma glucose and depressive symptoms in a large, population representative sample of US adults, controlling for other demographic and lifestyle behavioural risk factors.", {"entities": []}], ["Using the 2013\u20132014 National Health and Nutrition Examination Survey (NHANES) data, this study first investigated the relationship between fasting plasma glucose and mental disorders at a population-level, accounting for demographic, health behavioural and weight-related factors known to co-occur with both type 2 diabetes and mental disorders.", {"entities": []}], ["Depressive symptoms were derived from the 9-item Patient Health Questionnaire.", {"entities": []}], ["Fasting plasma glucose was obtained through medical examination and demographic (age, household income, sex) and health characteristics (perceived diet quality, daily time sedentary) were self-reported.", {"entities": []}], ["Body mass index was calculated from objectively measured height and weight.", {"entities": []}], ["In the univariate model, higher fasting plasma glucose was associated with greater depressive symptoms among females ( b = 0.24, 95% CI = 0.05, 0.43, p < 0.05), but not males.", {"entities": []}], ["In the final fully adjusted model, the relationship between fasting plasma glucose and depressive symptoms was non-significant for both males and females.", {"entities": []}], ["Of all independent variables, self-appraised diet quality was strongly and significantly associated with depressive symptoms and this remained significant when individuals with diabetes were excluded.", {"entities": []}], ["Although diet quality was self-reported based on individuals\u2019 perceptions, these findings are consistent with a role for poor diet in the relationship between fasting plasma glucose and depressive symptoms.", {"entities": []}], ["Interleukin-10 (IL-10) is a multifunctional cytokine which participates in the development and progression of various malignant tumors.", {"entities": []}], ["To date, a number of case\u2013control studies were conducted to detect the association between IL-10 -592C>A polymorphism and cancer risk in humans.", {"entities": [[122, 128, "DISEASE"]]}], ["However, the results of these studies on the association remain conflicting.", {"entities": []}], ["In an effort to solve this controversy, we performed a meta-analysis based on 70 case\u2013control studies from 65 articles, including 16 785 cancer cases and 19 713 controls.", {"entities": [[137, 143, "DISEASE"]]}], ["We used odds ratios (ORs) with 95% confidence intervals (CIs) to assess the strength of the association.", {"entities": []}], ["The overall results suggested that the variant homozygote genotype AA of the IL-10 -592C>A polymorphism was associated with a moderately decreased risk of all cancer types (OR\u200a=\u200a0.90, 95% CI\u200a=\u200a0.83\u20130.98 for homozygote comparison, OR\u200a=\u200a0.92, 95% CI\u200a=\u200a0.86\u20130.98 for recessive model).", {"entities": [[159, 165, "DISEASE"]]}], ["In the stratified analyses, the risk remained for studies of smoking-related cancer, Asian populations and hospital-based studies.", {"entities": [[77, 83, "DISEASE"]]}], ["These results suggested that the IL-10 -592C>A polymorphism might contribute to the cancer susceptibility, especially in smoking-related cancer, Asians and hospital-based studies.", {"entities": [[84, 90, "DISEASE"], [137, 143, "DISEASE"]]}], ["Further studies are needed to confirm the relationship.", {"entities": []}], ["Prenatal maternal stress (PNMS) can impact a variety of outcomes in the offspring throughout childhood and persisting into adulthood as shown in human and animal studies.", {"entities": []}], ["Many of the effects of PNMS on offspring outcomes likely reflect the effects of epigenetic changes, such as DNA methylation, to the fetal genome.", {"entities": []}], ["However, no animal or human research can determine the extent to which the effects of PNMS on DNA methylation in human offspring is the result of the objective severity of the stressor to the pregnant mother, or her negative appraisal of the stressor or her resulting degree of negative stress.", {"entities": []}], ["We examined the genome-wide DNA methylation profile in T cells from 34 adolescents whose mothers had rated the 1998 Qu\u00e9bec ice storm's consequences as positive or negative (that is, cognitive appraisal).", {"entities": []}], ["The methylation levels of 2872 CGs differed significantly between adolescents in the positive and negative maternal cognitive appraisal groups.", {"entities": []}], ["These CGs are affiliated with 1564 different genes and with 408 different biological pathways, which are prominently featured in immune function.", {"entities": []}], ["Importantly, there was a significant overlap in the differentially methylated CGs or genes and biological pathways that are associated with cognitive appraisal and those associated with objective PNMS as we reported previously.", {"entities": []}], ["Our study suggests that pregnant women's cognitive appraisals of an independent stressor may have widespread effects on DNA methylation across the entire genome of their unborn children, detectable during adolescence.", {"entities": []}], ["Therefore, cognitive appraisals could be an important predictor variable to explore in PNMS research.", {"entities": []}], ["Disease maps of crude rates from routinely collected health data indexed at a small geographical resolution pose specific statistical problems due to the sparse nature of the data.", {"entities": []}], ["Spatial smoothers allow areas to borrow strength from neighboring regions to produce a more stable estimate of the areal value.", {"entities": []}], ["Geostatistical smoothers are able to quantify the uncertainty in smoothed rate estimates without a high computational burden.", {"entities": []}], ["In this paper, we introduce a uniform model extension of Bayesian Maximum Entropy (UMBME) and compare its performance to that of Poisson kriging in measures of smoothing strength and estimation accuracy as applied to simulated data and the real data example of HIV infection in North Carolina.", {"entities": []}], ["The aim is to produce more reliable maps of disease rates in small areas to improve identification of spatial trends at the local level.", {"entities": []}], ["In all data environments, Poisson kriging exhibited greater smoothing strength than UMBME.", {"entities": []}], ["With the simulated data where the true latent rate of infection was known, Poisson kriging resulted in greater estimation accuracy with data that displayed low spatial autocorrelation, while UMBME provided more accurate estimators with data that displayed higher spatial autocorrelation.", {"entities": []}], ["With the HIV data, UMBME performed slightly better than Poisson kriging in cross-validatory predictive checks, with both models performing better than the observed data model with no smoothing.", {"entities": []}], ["Smoothing methods have different advantages depending upon both internal model assumptions that affect smoothing strength and external data environments, such as spatial correlation of the observed data.", {"entities": []}], ["Further model comparisons in different data environments are required to provide public health practitioners with guidelines needed in choosing the most appropriate smoothing method for their particular health dataset.", {"entities": []}], ["To characterize the epidemiology of wasting and identify the main predictors of wasting, severe wasting and poor weight-for-height in children.", {"entities": []}], ["We analysed a nationally representative sample of 2028 children (Multiple Indicator Survey, 2010).", {"entities": []}], ["Royal Kingdom of Bhutan.", {"entities": []}], ["Children aged 0\u201323 months.", {"entities": []}], ["Wasting prevalence was significantly higher among infants aged 0\u201311 months than among children aged 12\u201323 months (12\u00b70 v .", {"entities": []}], ["6\u00b77 %; P =0\u00b7004) and among boys than girls (11\u00b70 v .", {"entities": []}], ["7\u00b75 %; P =0\u00b704).", {"entities": []}], ["Children from the Western region had 63 % higher odds of being wasted than children from the Central/Eastern regions (adjusted OR (AOR)=1\u00b763; 95 % CI 1\u00b714, 2\u00b734).", {"entities": []}], ["Poor feeding practices were among the most significant predictors of wasting and severe wasting.", {"entities": []}], ["Children who were given prelacteal feeds in the first days of life had 2\u00b75 times higher odds of being severely wasted than those who were not (AOR=2\u00b749; 95 % CI 1\u00b719, 5\u00b719); inadequate complementary feeding in children aged 0\u201323 months was associated with 58 % higher odds of being wasted (AOR=1\u00b758; 95 % CI 1\u00b702, 2\u00b747) and 2\u00b73 times higher odds of being severely wasted (AOR=2\u00b728; 95 % CI 1\u00b713, 4\u00b758).", {"entities": []}], ["The association of poor infant feeding practices with wasting and severe wasting was particularly significant in infants (0\u201311 months).", {"entities": []}], ["Programmes for the detection and treatment of severely wasted children need to prioritize very young children (0\u201311 months), particularly in the Western region.", {"entities": []}], ["Programmes for the prevention of wasting need to prioritize the improvement of complementary foods and feeding practices in children aged 6\u201323 months.", {"entities": []}], ["A genome wide association study (GWAS) typically results in a few highly significant \u2018hits\u2019 and a much larger set of suggestive signals (\u2018near-hits\u2019).", {"entities": []}], ["The latter group are expected to be a mixture of true and false associations.", {"entities": []}], ["One promising strategy to help separate these is to use functional annotations for prioritisation of variants for follow-up.", {"entities": []}], ["A key task is to determine which annotations might prove most valuable.", {"entities": []}], ["We address this question by examining the functional annotations of previously published GWAS hits.", {"entities": []}], ["We explore three annotation categories: non-synonymous SNPs (nsSNPs), promoter SNPs and cis expression quantitative trait loci (eQTLs) in open chromatin regions.", {"entities": []}], ["We demonstrate that GWAS hit SNPs are enriched for these three functional categories, and that it would be appropriate to provide a higher weighting for such SNPs when performing Bayesian association analyses.", {"entities": []}], ["For GWAS studies, our analyses suggest the use of a Bayes Factor of about 4 for cis eQTL SNPs within regions of open chromatin, 3 for nsSNPs and 2 for promoter SNPs.", {"entities": []}], ["Pain and sleep share mutual relations under the influence of cognitive and neuroendocrine changes.", {"entities": []}], ["Sleep is an important homeostatic feature and, when impaired, contributes to the development or worsening of pain-related diseases.", {"entities": []}], ["The aim of the present review is to provide a panoramic view for the generalist physician on sleep disorders that occur in pain-related diseases within the field of Internal Medicine, such as rheumatic diseases, acute coronary syndrome, digestive diseases, cancer, and headache.", {"entities": [[227, 235, "DISEASE"], [257, 263, "DISEASE"]]}], ["Neurotrophins (NTs) are able to activate lymphocytes and fibroblasts; they can modulate angiogenesis and sympathic vascular function.", {"entities": [[15, 18, "GENE"]]}], ["Thus, they can be implicated in the three pathogenic processes of systemic sclerosis (SSc).", {"entities": []}], ["The aims of this study are to determine blood levels of Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF) and Neurotrophin-3 (NT-3) in SSc and to correlate them with clinical and biological data.", {"entities": [[77, 80, "GENE"], [118, 122, "GENE"]]}], ["Serum samples were obtained from 55 SSc patients and 32 control subjects to measure NTs levels by ELISA and to determine their relationships with SSc profiles.", {"entities": [[84, 87, "GENE"]]}], ["Serum NGF levels were higher in SSc patients (288.26\u00b1170.34 pg/mL) than in control subjects (170.34\u00b150.8 pg/mL, p <0.001) and correlated with gammaglobulins levels and the presence of both anti-cardiolipin and anti-Scl-70 antibodies ( p <0.05).", {"entities": [[6, 9, "GENE"]]}], ["In contrast, BDNF levels were lower in SSc patients than in controls (1121.9\u00b1158.1 vs 1372.9\u00b1190.9 pg/mL, p <0.0001), especially in pulmonary arterial hypertension and diffuse SSc as compared to limited forms (all p< 0.05).", {"entities": [[151, 163, "DISEASE"], [13, 17, "GENE"]]}], ["NT-3 levels were similar in SSc and in the control group (2657.2\u00b12296 vs 2959.3\u00b12555 pg/mL, NS).", {"entities": []}], ["BDNF levels correlated negatively with increased NGF levels in the SSc group (and not in controls).", {"entities": [[0, 4, "GENE"], [49, 52, "GENE"]]}], ["Low BDNF serum levels were not previously documented in SSc, particularly in the diffuse SSc subset and in patients with pulmonary hypertension or anti-Scl-70 antibodies.", {"entities": [[131, 143, "DISEASE"], [121, 143, "DISEASE"], [4, 8, "GENE"]]}], ["The negative correlation between NGF and BDNF levels observed in SSc and not in healthy controls could be implicated in sympathic vascular dysfunction in SSc.", {"entities": [[33, 36, "GENE"], [41, 45, "GENE"]]}], ["Many preventable diseases such as ischemic heart diseases and breast cancer prevail at a large scale in the general population.", {"entities": [[62, 75, "DISEASE"], [69, 75, "DISEASE"]]}], ["Computerized decision support systems are one of the solutions for improving the quality of prevention strategies.", {"entities": []}], ["The system called EsPeR (Personalised Estimate of Risks) combines calculation of several risks with computerisation of guidelines (cardiovascular prevention, screening for breast cancer, colorectal cancer, uterine cervix cancer, and prostate cancer, diagnosis of depression and suicide risk).", {"entities": [[187, 204, "DISEASE"], [172, 185, "DISEASE"], [179, 185, "DISEASE"], [198, 204, "DISEASE"], [221, 227, "DISEASE"], [242, 248, "DISEASE"], [233, 248, "DISEASE"]]}], ["We present a qualitative evaluation of its ergonomics, as well as it's understanding and acceptance by a group of general practitioners.", {"entities": []}], ["We organised four focus groups each including 6\u201311 general practitioners.", {"entities": []}], ["Physicians worked on several structured clinical scenari os with the help of EsPeR , and three senior investigators leaded structured discussion sessions.", {"entities": []}], ["The initial sessions identified several ergonomic flaws of the system that were easily corrected.", {"entities": []}], ["Both clinical scenarios and discussion sessions identified several problems related to the insufficient comprehension (expression of risks, definition of familial history of disease), and difficulty for the physicians to accept some of the recommendations.", {"entities": []}], ["Educational, socio-professional and organisational components ( i.e.", {"entities": []}], ["time constraints for training and use of the EsPeR system during consultation) as well as acceptance of evidence-based decision-making should be taken into account before launching computerised decision support systems, or their application in randomised trials.", {"entities": []}], ["NK cells express several tetraspanin proteins, which differentially modulate NK cell activities.", {"entities": []}], ["The tetraspanin CD53 is expressed by all resting NK cells and was previously shown to decrease NK cell cytotoxicity upon ligation.", {"entities": [[16, 20, "GENE"]]}], ["Here, we show that CD53 ligation reduced degranulation of rat NK cells in response to tumour target cells, evoked redirected inhibition of killing of Fc-bearing targets, and reduced the IFN-\u03b3 response induced by plate-bound antibodies towards several activating NK cell receptors (Ly49s3, NKR-P1A, and NKp46).", {"entities": [[19, 23, "GENE"]]}], ["CD53 induced activation of the \u03b22 integrin LFA-1, which was further enhanced upon co-stimulation with activating NK cell receptors.", {"entities": [[0, 4, "GENE"]]}], ["Concordant with a role for CD53 in increasing NK cell adhesiveness, CD53 ligation induced a strong homotypic adhesion between NK cells.", {"entities": [[27, 31, "GENE"], [68, 72, "GENE"], [27, 31, "GENE"], [68, 72, "GENE"]]}], ["Further, the proliferative capacity of NK cells to a suboptimal dose of IL-2 was enhanced by CD53 ligation.", {"entities": [[93, 97, "GENE"]]}], ["Taken together, these data suggest that CD53 may shift NK cell responses from effector functions towards a proliferation phase.", {"entities": [[40, 44, "GENE"]]}], ["Recently the role of gastrointestinal nematodes in modulating the immune responses in inflammatory and immune-mediated conditions such as allergy and autoimmune diseases has been introduced.", {"entities": []}], ["This is mainly due to the suppressive effects of somatic and excretory secretory (ES) products of nematodes on the immune responses.", {"entities": []}], ["In this study, we evaluated the immunomodulatory potentials of somatic products of Marshallagia marshalli , a gastrointestinal nematodes of sheep, to suppress the immune-mediated responses in a murine model of allergic airway inflammation.", {"entities": []}], ["BALB/c mice were intraperitoneally (IP) sensitized with ovalbumin (OVA)/Alum and then challenged with 1% OVA.", {"entities": []}], ["Somatic products of M. marshalli were administered during each sensitization.", {"entities": []}], ["The effects of somatic products on development of allergic airway inflammation were evaluated by analyzing inflammatory cells recruitment, histopathological changes, cytokines production (IL-4, IL-13, IL-10, TGF-\u03b2) and serum antibody titers (IgG1, IgG2a).", {"entities": []}], ["Somatic products of M. marshalli were able to suppress the induction of allergic airway inflammation in mice.", {"entities": []}], ["Modulation of Th2 type responses (IL-4, IL-13, IgG1) via upregulations of IL-10 and TGF-\u03b2 production was observed after injection of somatic products of M. marshalli .", {"entities": []}], ["In addition, inflammatory cells infiltration and pathological disorders were significantly diminished following administration of somatic products.", {"entities": []}], ["Our data raised the possibility that helminths could be a potential therapeutic candidate to alleviate the inflammatory conditions in allergic asthma.", {"entities": [[134, 149, "DISEASE"], [143, 149, "DISEASE"]]}], ["According to these results, we concluded that M. marshalli may contain immune-modulatory molecules that attenuate allergic airway inflammation via induction of regulatory cytokines.", {"entities": []}], ["Further investigations are required to identify molecules that might have potentials for development of novel therapeutic targets.", {"entities": []}], ["Airway epithelial cells (AECs) are crucial for mucosal and adaptive immunity but whether these cells respond in a memory-dependent manner is poorly studied.", {"entities": []}], ["Previously, we have reported that LPS intratracheal instillation in rodents causes extensive neutrophilic inflammation and airway epithelial cell hyperplasia accompanied by mucous cell metaplasia (MCM).", {"entities": []}], ["And the resolution process required a period of 40 d for the inflammation to subside and the lung epithelia to resemble the non-exposed condition.", {"entities": []}], ["Therefore, the present study investigated the memory-dependent response of airway epithelial cells to a secondary LPS challenge after the initial inflammation was resolved.", {"entities": []}], ["Airway epithelial and mucous cells were assessed in response to a secondary LPS challenge in F344/N rats, and in C57BL/6 wild-type (Foxn1 LPS-pretreated F344/N rats responded with elevated numbers of AECs after saline challenge and with 3-4-fold increased MCM following the LPS challenge in LPS- compared with saline-pretreated rats.", {"entities": [[132, 137, "GENE"]]}], ["LPS-pretreated rats showed 5-fold higher number of AECs expressing TLR4 apically than saline-pretreated rats.", {"entities": [[67, 71, "GENE"]]}], ["Also, the expression of EGFR was increased in LPS-pretreated rats along with the number of AECs with active or nuclear pERK, and the levels were further increased upon LPS challenge.", {"entities": [[24, 28, "GENE"]]}], ["LPS-pretreated Foxn1 Together, these data suggest that AECs preserve an \u2018innate memory\u2019 that drives a rapid mucous phenotype via spatiotemporal regulation of TLR4 and EGFR.", {"entities": [[15, 20, "GENE"], [158, 162, "GENE"], [167, 171, "GENE"]]}], ["Further, T cells may suppress the sustained elevated expression of TLR4 and EGFR and thereby the hyperactive epithelial response.", {"entities": [[67, 71, "GENE"], [76, 80, "GENE"]]}], ["The online version of this article (doi:10.1186/s12931-016-0446-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The effects of cancer and associated treatments have a considerable impact on the well-being and quality of life of pediatric oncology patients.", {"entities": [[15, 21, "DISEASE"]]}], ["To support children and their families, complementary and alternative medicines are seen by nurses and doctors as practical to integrate to the services offered by hospitals.", {"entities": []}], ["The purpose of this paper is to examine if the practice of complementary and alternative medicine, specifically spiritual care and treatments based on body manipulation, is likely to improve the health and well-being of children suffering from cancer.", {"entities": [[244, 250, "DISEASE"]]}], ["This objective is achieved through a systematic review of the literature.", {"entities": []}], ["The level of evidence associated with each practice of complementary and alternative medicine was assessed according to the methodological design used by the studies reviewed.", {"entities": []}], ["Studies reviewed are of a methodological quality that could be described as fair due to the small sample size of patients and the existence of a number of biases in the conduct and analysis of these studies.", {"entities": []}], ["However, results obtained are consistent from one study to another, allowing us to make certain recommendations.", {"entities": []}], ["It is thus advisable to consider the introduction of hypnotherapy in pediatric oncology services.", {"entities": []}], ["Based on the data collected, it is the complementary and alternative medicine with the most evidence in favor of effectiveness of the well-being of pediatric oncology patients, especially during painful procedures.", {"entities": []}], ["It is also recommended to use art therapy and music therapy.", {"entities": []}], ["Conversely, too little evidence is present to be able to recommend the use of acupuncture, chiropractic or osteopathy.", {"entities": []}], ["Metabolites of arachidonic acid such as prostacyclin (PGI 2 ) have been shown to participate in the pathogenesis of pulmonary fibrosis by inhibiting the expression of pro-inflammatory and pro-fibrotic mediators.", {"entities": [[116, 134, "DISEASE"]]}], ["In this investigation, we examined whether iloprost, a stable PGI 2 analogue, could prevent bleomycin-induced pulmonary inflammation and fibrosis in a mouse model.", {"entities": []}], ["Mice received a single intratracheal injection of bleomycin with or without intraperitoneal iloprost.", {"entities": []}], ["Pulmonary inflammation and fibrosis were analysed by histological evaluation, cellular composition of bronchoalveolar lavage (BAL) fluid, and hydroxyproline content.", {"entities": []}], ["Lung mechanics were measured.", {"entities": []}], ["We also analysed the expression of inflammatory mediators in BAL fluid and lung tissue.", {"entities": []}], ["Administration of iloprost significantly improved survival rate and reduced weight loss in the mice induced by bleomycin.", {"entities": []}], ["The severe inflammatory response and fibrotic changes were significantly attenuated in the mice treated with iloprost as shown by reduction in infiltration of inflammatory cells into the airways and pulmonary parenchyma, diminution in interstitial collagen deposition, and lung hydroxyproline content.", {"entities": []}], ["Iloprost significantly improved lung static compliance and tissue elastance.", {"entities": []}], ["It increased the expression of IFN\u03b3 and CXCL10 in lung tissue measured by RT-PCR and their levels in BAL fluid as measured by ELISA.", {"entities": [[40, 46, "GENE"]]}], ["Levels of TNF\u03b1, IL-6 and TGF\u03b21 were lowered by iloprost.", {"entities": []}], ["Iloprost prevents bleomycin-induced pulmonary fibrosis, possibly by upregulating antifibrotic mediators (IFN\u03b3 and CXCL10) and downregulating pro-inflammatory and pro-fibrotic cytokines (TNF\u03b1, IL-6, and TGF\u03b21).", {"entities": [[36, 54, "DISEASE"], [114, 120, "GENE"]]}], ["Prostacyclin may represent a novel pharmacological agent for treating pulmonary fibrotic diseases.", {"entities": []}], ["Recent toxicological and epidemiological evidence suggests that chronic psychosocial stress may modify pollution effects on health.", {"entities": []}], ["Thus, there is increasing interest in refined methods for assessing and incorporating non-chemical exposures, including social stressors, into environmental health research, towards identifying whether and how psychosocial stress interacts with chemical exposures to influence health and health disparities.", {"entities": []}], ["We present a flexible, GIS-based approach for examining spatial patterns within and among a range of social stressors, and their spatial relationships with air pollution, across New York City, towards understanding their combined effects on health.", {"entities": []}], ["We identified a wide suite of administrative indicators of community-level social stressors (2008\u20132010), and applied simultaneous autoregressive models and factor analysis to characterize spatial correlations among social stressors, and between social stressors and air pollutants, using New York City Community Air Survey (NYCCAS) data (2008-2009).", {"entities": []}], ["Finally, we provide an exploratory ecologic analysis evaluating possible modification of the relationship between nitrogen dioxide (NO 2 ) and childhood asthma Emergency Department (ED) visit rates by social stressors, to demonstrate how the methods used to assess stressor exposure (and/or consequent psychosocial stress) may alter model results.", {"entities": [[153, 159, "DISEASE"]]}], ["Administrative indicators of a range of social stressors (e.g., high crime rate, residential crowding rate) were not consistently correlated (rho\u2009=\u2009- 0.44 to 0.89), nor were they consistently correlated with indicators of socioeconomic position (rho\u2009=\u2009- 0.54 to 0.89).", {"entities": []}], ["Factor analysis using 26 stressor indicators suggested geographically distinct patterns of social stressors, characterized by three factors: violent crime and physical disorder, crowding and poor access to resources, and noise disruption and property crimes.", {"entities": [[159, 176, "DISEASE"]]}], ["In an exploratory ecologic analysis, these factors were differentially associated with area-average NO 2 and childhood asthma ED visits.", {"entities": [[119, 125, "DISEASE"]]}], ["For example, only the \u2018violent crime and disorder\u2019 factor was significantly associated with asthma ED visits, and only the \u2018crowding and resource access\u2019 factor modified the association between area-level NO 2 and asthma ED visits.", {"entities": [[92, 98, "DISEASE"], [214, 220, "DISEASE"]]}], ["This spatial approach enabled quantification of complex spatial patterning and confounding between chemical and non-chemical exposures, and can inform study design for epidemiological studies of separate and combined effects of multiple urban exposures.", {"entities": []}], ["The online version of this article (doi:10.1186/1476-069X-13-91) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Low socioeconomic status (SES) has been linked to higher morbidity in patients with chronic diseases, but may be particularly relevant to asthma, as asthmatics of lower SES may have higher exposures to indoor (e.g., cockroaches, tobacco smoke) and outdoor (e.g., urban pollution) allergens, thus increasing risk for exacerbations.", {"entities": [[138, 144, "DISEASE"]]}], ["This study assessed associations between adult SES (measured according to educational level) and asthma morbidity, including asthma control; asthma-related emergency health service use; asthma self-efficacy, and asthma-related quality of life, in a Canadian cohort of 781 adult asthmatics.", {"entities": [[97, 103, "DISEASE"], [125, 131, "DISEASE"], [141, 147, "DISEASE"], [186, 192, "DISEASE"], [212, 218, "DISEASE"]]}], ["All patients underwent a sociodemographic and medical history interview and pulmonary function testing on the day of their asthma clinic visit, and completed a battery of questionnaires (Asthma Control Questionnaire, Asthma Quality of Life Questionnaire, and Asthma Self-Efficacy Scale).", {"entities": [[123, 129, "DISEASE"], [187, 193, "DISEASE"], [217, 223, "DISEASE"], [259, 265, "DISEASE"]]}], ["General Linear Models assessed associations between SES and each morbidity measure.", {"entities": []}], ["Lower SES was associated with worse asthma control (F = 11.63, p < .001), greater emergency health service use (F = 5.09, p = .024), and worse asthma self-efficacy (F = 12.04, p < .01), independent of covariates.", {"entities": [[36, 42, "DISEASE"], [143, 149, "DISEASE"]]}], ["Logistic regression analyses revealed that patients with <12 years of education were 55% more likely to report an asthma-related emergency health service visit in the last year (OR = 1.55, 95%CI = 1.05-2.27).", {"entities": [[114, 120, "DISEASE"]]}], ["Lower SES was not related to worse asthma-related quality of life.", {"entities": [[35, 41, "DISEASE"]]}], ["Results suggest that lower SES (measured according to education level), is associated with several indices of worse asthma morbidity, particularly worse asthma control, in adult asthmatics independent of disease severity.", {"entities": [[116, 122, "DISEASE"], [153, 159, "DISEASE"]]}], ["Results are consistent with previous studies linking lower SES to worse asthma in children, and add asthma to the list of chronic diseases affected by individual-level SES.", {"entities": [[72, 78, "DISEASE"], [100, 106, "DISEASE"]]}], ["It is unclear how Th2 immunity is induced in response to allergens like house dust mite (HDM).", {"entities": []}], ["Here, we show that HDM inhalation leads to the TLR4/MyD88-dependent recruitment of IL-4 competent basophils and eosinophils, and of inflammatory DCs to the draining mediastinal nodes.", {"entities": []}], ["Depletion of basophils only partially reduced Th2 immunity, and depletion of eosinophils had no effect on the Th2 response.", {"entities": []}], ["Basophils did not take up inhaled antigen, present it to T cells, or express antigen presentation machinery, whereas a population of FceRI", {"entities": []}], ["Arginase I (Arg I) and inducible nitric oxide synthase (iNOS) are important in regulating immune functions through their metabolites.", {"entities": []}], ["Previous studies have revealed that the expression of Arg I is increased and the expression of iNOS is reduced in the serum and peripheral blood mononuclear cells of human immunodeficiency virus (HIV)-infected patients.", {"entities": []}], ["As one of the most important immune organs and HIV replication sites, whether similar changes are present in the lymph nodes following HIV infection remains to be elucidated.", {"entities": []}], ["To investigate this, the present study collected lymph node and blood specimens from 52 HIV-infected patients to measure the expression levels of Arg I and iNOS by immunohistochemistry and fluoresence-based flow cytometry.", {"entities": []}], ["Compared with control subjects without HIV infection, the patients with HIV had significantly higher expression levels of Arg I in the lymph nodes and higher frequencies of Arg I", {"entities": []}], ["The large surface area for gas exchange makes the respiratory system particularly susceptible to oxidative stress-mediated injury.", {"entities": []}], ["Both endogenous and exogenous pro-oxidants (e.g.", {"entities": []}], ["cigarette smoke) trigger activation of leukocytes and host defenses.", {"entities": []}], ["These mechanisms interact in a \u201cmultilevel cycle\u201d responsible for the control of the oxidant/antioxidant homeostasis.", {"entities": []}], ["Several studies have demonstrated the presence of increased oxidative stress and decreased antioxidants (e.g.", {"entities": []}], ["reduced glutathione [GSH]) in subjects with chronic obstructive pulmonary disease (COPD), but the contribution of oxidative stress to the pathophysiology of COPD is generally only minimally discussed.", {"entities": [[44, 81, "DISEASE"]]}], ["The aim of this review was to provide a comprehensive overview of the role of oxidative stress in the pathogenesis of respiratory diseases, particularly COPD, and to examine the available clinical and experimental evidence on the use of the antioxidant N-acetylcysteine (NAC), a precursor of GSH, as an adjunct to standard therapy for the treatment of COPD.", {"entities": []}], ["The proposed concept of \u201cmultilevel cycle\u201d helps understand the relationship between respiratory diseases and oxidative stress, thus clarifying the rationale for using NAC in COPD.", {"entities": []}], ["Until recently, antioxidant drugs such as NAC have been regarded only as mucolytic agents.", {"entities": []}], ["Nevertheless, several clinical trials indicate that NAC may reduce the rate of COPD exacerbations and improve small airways function.", {"entities": []}], ["The most plausible explanation for the beneficial effects observed in patients with COPD treated with NAC lies in the mucolytic and antioxidant effects of this drug.", {"entities": []}], ["Modulation of bronchial inflammation by NAC may further account for these favorable clinical results.", {"entities": []}], ["Bronchial thermoplasty is an endoscopic therapy for severe asthma.", {"entities": [[59, 65, "DISEASE"]]}], ["The previously reported, randomised sham-controlled AIR2 (Asthma Intervention Research 2) trial showed a significant reduction in severe asthma exacerbations, emergency department visits and hospitalisations after bronchial thermoplasty.", {"entities": [[58, 64, "DISEASE"], [137, 143, "DISEASE"]]}], ["More \u201creal-world\u201d clinical outcome data is needed.", {"entities": []}], ["This article compares outcomes in bronchial thermoplasty subjects with 3\u2005years of follow-up from the ongoing, post-market PAS2 (Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma) study with those from the AIR2 trial.", {"entities": [[216, 222, "DISEASE"]]}], ["279 subjects were treated with bronchial thermoplasty in the PAS2 study.", {"entities": []}], ["We compared the first 190 PAS2 subjects with the 190 bronchial thermoplasty-treated subjects in the AIR2 trial at 3 years of follow-up.", {"entities": []}], ["The PAS2 subjects were older (mean age 45.9 versus 40.7\u2005years) and more obese (mean body mass index 32.5 versus 29.3\u2005kg\u00b7m versus 1961\u2005\u03bcg\u00b7day versus 52%) and hospitalisations (15.3% versus 4.2%) in the 12\u2005months prior to bronchial thermoplasty.", {"entities": []}], ["At year\u20053 after bronchial thermoplasty, the percentage of PAS2 subjects with severe exacerbations, emergency department visits and hospitalisations significantly decreased by 45%, 55% and 40%, respectively, echoing the AIR2 results.", {"entities": []}], ["The PAS2 study demonstrates similar improvements in asthma control after bronchial thermoplasty compared with the AIR2 trial despite enrolling subjects who may have had poorer asthma control.", {"entities": [[52, 58, "DISEASE"], [176, 182, "DISEASE"]]}], ["A comparison of the results obtained thus far in PAS2 with AIR2 evaluating bronchial thermoplasty in severe asthma http://ow.ly/sB0X30csDuE", {"entities": [[108, 114, "DISEASE"]]}], ["Psychological factors, such as intolerance of uncertainty (IU), have been shown to impact on the quality of medical care.", {"entities": []}], ["However, this psychological measure has not been studied in the chiropractic profession.", {"entities": []}], ["Our objective was to investigate if higher levels of IU in chiropractic students were related to poor choices of management in specific clinical scenarios.", {"entities": []}], ["Also, we sought to investigate if levels of IU were related to students\u2019 intentions to adopt a prescriptive chiropractic technique system and evaluate their levels of self-belief.", {"entities": []}], ["Between October and November of 2016, students from two Australian chiropractic programs ( N \u00a0=\u00a0444) answered a questionnaire on measures of IU levels, patient case scenarios for neck and low back pain, and questions about self-ratings of their future chiropractic abilities and perceived need for the adoption of a chiropractic technique system.", {"entities": []}], ["Associations were tested by the IU score and the therapeutic choices relating to a) a neck pain case scenario, b) a low back pain scenario, c) various technique systems, and d) the self-rated competence level treating the IU score both as a continuous and a categorical variable.", {"entities": []}], ["There was an overall response rate of 53%.", {"entities": []}], ["Those students who were high in levels of IU were significantly more likely to make incorrect clinical decisions than those with normal or low levels of IU for the neck pain case scenario.", {"entities": []}], ["No differences were found on the low back pain scenario, on preferences to use a technique system in the future, or on predicted self-rating of competence after graduation.", {"entities": []}], ["Psychological factors, such as IU, may have an impact on chiropractic students\u2019 clinical decisions.", {"entities": []}], ["However, it does not impact on all aspects of practice.", {"entities": []}], ["This finding has implications for chiropractic educators, especially when dealing with neck pain.", {"entities": []}], ["However, it may be relevant to continue the search for specific personality profiles in relation to various favourable and unfavourable practice patterns, as it is unknown whether these dynamics are important for other aspects of chiropractic education.", {"entities": []}], ["The online version of this article (doi:10.1186/s12998-017-0150-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is one of the most prevalent chronic conditions in the United Sates, yet despite the existence of national guidelines, nearly three fourths of patients with asthma do not have adequate control and clinical adherence to guidelines is low.", {"entities": [[0, 6, "DISEASE"], [164, 170, "DISEASE"]]}], ["While there are many reasons for this, physician inertia with respect to treatment change is partly to blame.", {"entities": []}], ["Research suggests that patients who ask for specific tests and treatments are more likely to receive them.", {"entities": []}], ["This study investigated the impact and experience of using an interactive patient website designed to give patients individual feedback about their condition and to suggest tailored questions for patients to ask their physician.", {"entities": []}], ["The website was designed to be used prior to a physician visit, to increase the likelihood that patients would receive recommended tests and treatments.", {"entities": []}], ["A total of 37 adult patients with asthma participated in semi-structured telephone interviews aimed at eliciting information about their experiences with the website.", {"entities": [[34, 40, "DISEASE"]]}], ["Transcripts were coded using qualitative data analysis techniques and software.", {"entities": []}], ["Themes were developed from subsets of codes generated through the analysis.", {"entities": []}], ["In addition, 26 physicians were surveyed regarding their impressions of the website.", {"entities": []}], ["Opportunities exist for improving website feedback, although the majority of both patient and physician respondents held favorable opinions about the site.", {"entities": []}], ["Two major themes emerged regarding patients\u2019 experiences with the website.", {"entities": []}], ["First, many patients who used the website had a positive shift in their attitudes regarding interactions with their physicians.", {"entities": []}], ["Second, use of the website prompted patients to become more actively involved in their asthma care.", {"entities": [[87, 93, "DISEASE"]]}], ["No patient reported any negative experiences as a result of using the website.", {"entities": []}], ["Physicians rated the website positively.", {"entities": []}], ["Patients perceived that the interactive website intervention improved communication and interaction with their physicians, suggesting that patients can play a role in overcoming the clinical inertia of providers.", {"entities": []}], ["Although the design and content of the website can be improved upon, the main findings suggest that use of the website is well accepted and is perceived to improve the quality of care that patients receive.", {"entities": []}], ["Airway epithelial cells play a central role in the physiopathology of asthma.", {"entities": [[70, 76, "DISEASE"]]}], ["They release eotaxins when treated with T H 2 cytokines such as interleukin (IL)-4 or IL-13, and these chemokines attract eosinophils and potentiate the biosynthesis of cysteinyl leukotrienes (cysLTs), which in turn induce bronchoconstriction and mucus secretion.", {"entities": []}], ["These effects of cysLTs mainly mediated by CysLT 1 and CysLT 2 receptors on epithelial cell functions remain largely undefined.", {"entities": []}], ["Because the release of inflammatory cytokines, eotaxins, and cysLTs occur relatively at the same time and location in the lung tissue, we hypothesized that they regulate inflammation cooperatively rather than redundantly.", {"entities": []}], ["We therefore investigated whether cysLTs and the T H 2 cytokines would act in concert to augment the release of eotaxins by airway epithelial cells.", {"entities": []}], ["A549 cells or human primary bronchial epithelial cells were incubated with or without IL-4, IL-13, and/or LTD 4 .", {"entities": []}], ["The release of eotaxin-3 and the expression of cysLT receptors were assessed by ELISA, RT-PCR, and flow cytometry, respectively.", {"entities": []}], ["IL-4 and IL-13 induced the release of eotaxin-3 by airway epithelial cells.", {"entities": []}], ["LTD 4 weakly induced the release of eotaxin-3 but clearly potentiated the IL-13-induced eotaxin-3 release.", {"entities": []}], ["LTD 4 had no effect on IL-4-stimulated cells.", {"entities": []}], ["Epithelial cells expressed CysLT 1 but not CysLT 2 .", {"entities": []}], ["CysLT 1 expression was increased by IL-13 but not by IL-4 and/or LTD 4 .", {"entities": []}], ["Importantly, the upregulation of CysLT 1 by IL-13 preceded eotaxin-3 release.", {"entities": []}], ["These results demonstrate a stepwise cooperation between IL-13 and LTD 4 .", {"entities": []}], ["IL-13 upregulates CysLT 1 expression and consequently the response to cysLTs This results in an increased release of eotaxin-3 by epithelial cells which at its turn increases the recruitment of leukocytes and their biosynthesis of cysLTs.", {"entities": []}], ["This positive amplification loop involving epithelial cells and leukocytes could be implicated in the recruitment of eosinophils observed in asthmatics.", {"entities": []}], ["Micro Electromechanical Systems (MEMS) based microfluidic devices have gained popularity in biomedicine field over the last few years.", {"entities": []}], ["In this paper, a comprehensive overview of microfluidic devices such as micropumps and microneedles has been presented for biomedical applications.", {"entities": []}], ["The aim of this paper is to present the major features and issues related to micropumps and microneedles, e.g., working principles, actuation methods, fabrication techniques, construction, performance parameters, failure analysis, testing, safety issues, applications, commercialization issues and future prospects.", {"entities": []}], ["Based on the actuation mechanisms, the micropumps are classified into two main types, i.e.", {"entities": []}], [", mechanical and non-mechanical micropumps.", {"entities": []}], ["Microneedles can be categorized according to their structure, fabrication process, material, overall shape, tip shape, size, array density and application.", {"entities": []}], ["The presented literature review on micropumps and microneedles will provide comprehensive information for researchers working on design and development of microfluidic devices for biomedical applications.", {"entities": []}], ["Acceptable occupational exposure levels for hundreds of airborne concentrations of dusts, vapors, fumes, and gases have been set by consensus organizations and regulatory bodies for decades.", {"entities": []}], ["These levels have established tremendous precedent and are tempting reference values in the relatively new field of indoor air quality evaluations where validated criteria are greatly needed.", {"entities": []}], ["The American Conference of Government Industrial Hygienists (ACGIH) has been the most visible and productive group setting these guidelines for industrial exposure.", {"entities": []}], ["The ACGIH Chemical Substances Committee has published an annual list of threshold limit values (TLVs) for more than 40 years.", {"entities": []}], ["Currently the list covers more than 400 substances.", {"entities": []}], ["In 1989, the Occupational Safety and Health Administration (OSHA) published updated permissible exposure limits (PELs) for approximately 600 substances.", {"entities": []}], ["Most PELs before this update were adopted from the 1968 ACGIH list of TLVs and consensus standards of the American Standards Association.", {"entities": []}], ["This OSHA update has resulted in reductions of 212 PELs and the addition of 164 new levels.", {"entities": []}], ["The magnitude of the problem of protecting workers can be seen by the small fraction that the OSHA PELs represent of the more than 60,000 entries in the National Institute for Occupational Safety and Health's Registry of Toxic Effects of Chemical Substances.", {"entities": []}], ["None of these levels, whether guidelines or regulatory requirements, are established based on any possible synergistic effect with other chemicals.", {"entities": []}], ["The only guidance given by the ACGIH for synergistic effects is that such cases must be determined individually.", {"entities": []}], ["Clearly, there are major drawbacks in using occupational standards and guidelines for evaluating the health effects of chemical agents that can be found in office settings, often in concentrations orders of magnitude less than what is routinely measured in the workplace.", {"entities": []}], ["These guidelines are even less valuable when the concern is the complex mixing of chemicals in nonoccupational environments.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is currently the third leading cause of death in the world.", {"entities": []}], ["Although smoking is the main risk factor for this disease, only a minority of smokers develop COPD.", {"entities": []}], ["Why this happens is largely unknown.", {"entities": []}], ["Recent discoveries by the human microbiome project have shed new light on the importance and richness of the bacterial microbiota at different body sites in human beings.", {"entities": []}], ["The microbiota plays a particularly important role in the development and functional integrity of the immune system.", {"entities": []}], ["Shifts or perturbations in the microbiota can lead to disease.", {"entities": []}], ["COPD is in part mediated by dysregulated immune responses to cigarette smoke and other environmental insults.", {"entities": []}], ["Although traditionally the lung has been viewed as a sterile organ, by using highly sensitive genomic techniques, recent reports have identified diverse bacterial communities in the human lung that may change in COPD.", {"entities": []}], ["This review summarizes the current knowledge concerning the lung microbiota in COPD and its potential implications for pathogenesis of the disease.", {"entities": []}], ["Previous studies of Greenlandic children\u2019s disease pattern and contacts to the health care system are sparse and have focused on the primary health care sector.", {"entities": []}], ["We aimed to identify the disease pattern and use of health care facilities of children aged 0\u201310 in two Greenlandic cohorts.", {"entities": []}], ["In a retrospective, descriptive follow-up of the Ivaaq (The Greenland Child Cohort) and the CLEAR (climate changes, environmental contaminants and reproductive health) birth cohorts (total n=1,000), we reviewed medical records of children aged 6\u201310 in 2012 with residence in Nuuk or Ilulissat (n=332).", {"entities": []}], ["Data on diseases and health care system contacts were extracted.", {"entities": []}], ["Diagnoses were validated retrospectively.", {"entities": []}], ["Primary health care contacts were reviewed for a random sample of 1:6.", {"entities": []}], ["In 311 children with valid social security number, the total number of health care system contacts was 12,471 equalling 4.6 contacts per child per year.", {"entities": []}], ["The annual incidence rate of hospital admissions was 1:10 children (total n=266, 1,220 days, 4.6 days/admission), outpatient contacts 2:10 children and primary care 3.6 per child.", {"entities": []}], ["Contacts were overall more frequent in boys compared with girls, 39.5 versus 34.6 during the study period, p=0.02.", {"entities": []}], ["The highest annual contact rates for diseases were: hospitalisations/acute respiratory diseases 13.9:1,000; outpatient contacts/otitis media 5.1:1,000; primary care/conjunctivitis or nasopharyngitis 410:1,000 children.", {"entities": [[128, 140, "DISEASE"], [183, 198, "DISEASE"], [165, 179, "DISEASE"]]}], ["Outpatient screening for respiratory tuberculosis accounted 6.2:1,000, primary care non-disease (Z-diagnosis) 2,081:1,000 annually.", {"entities": [[37, 49, "DISEASE"]]}], ["Complete adherence to the child vaccination programme was seen in 40%, while 5% did not receive any vaccinations.", {"entities": []}], ["In this first study of its kind, the health care contact pattern in Greenlandic children showed a relatively high hospitalisation rate and duration per admission, and a low primary health care contact rate.", {"entities": []}], ["The overall contact rate and disease pattern resembled those in Denmark, except for tuberculosis screening.", {"entities": [[84, 96, "DISEASE"]]}], ["Adherence to the vaccination programme was low.", {"entities": []}], ["These findings may be helpful for the organisation and dimensioning of the Greenlandic health care system for children.", {"entities": []}], ["This article reports on the use of domestic or table salt for its perceived health effects and healing properties in a Latino farmworker community.", {"entities": []}], ["It explores how contemporary salt usage beliefs can be seen to have roots in long-standing humoral theories of medicine and health.", {"entities": []}], ["This qualitative investigation comprised 30 in-depth individual interviews and five focus groups conducted in Spanish with Mexican and Central American immigrants in one small city in California\u2019s Central Valley ( N \u2009=\u200961 total participants).", {"entities": []}], ["Interviews and focus groups were audiotaped, translated into English and transcribed.", {"entities": []}], ["Several researchers independently and iteratively read transcripts, developed and applied codes, and engaged in thematic analysis.", {"entities": []}], ["Strongly emergent themes identified the importance of balance in health, and beliefs about the effects on salt on health.", {"entities": []}], ["Valued for its culinary role, for bringing out the flavors in food, and used by people of all ages, salt use is part of a robust set of cultural practices.", {"entities": []}], ["Salt was regularly mixed with foods in different combinations and ingested to restore balance, prevent disequilibrium or reduce vulnerability to diverse illnesses, promote rehydration, and address symptoms of exposure to extremes of temperature or physical or emotional stress.", {"entities": []}], ["Statements made and practices engaged in by participants were highly suggestive of health and healing beliefs common to humoral belief systems based primarily on a hot-cold dichotomy in classifications of foods and healing behaviors.", {"entities": []}], ["We evaluate these statements and practices in the context of the existing literature on historical and contemporary humoral beliefs in Latin American communities, in Mexico and Central America, and in the United States.", {"entities": []}], ["Humoral theory is a useful framework for understanding contemporary rural Latino migrant farmworkers\u2019 perceptions of the importance of salt for their health.", {"entities": []}], ["Sustainable practices meet the needs of the present without compromising the ability of future generations to meet their needs.", {"entities": []}], ["Applying these concepts to food and feed production, nutritional sustainability is the ability of a food system to provide sufficient energy and essential nutrients required to maintain good health in a population without compromising the ability of future generations to meet their nutritional needs.", {"entities": []}], ["Ecological, social, and economic aspects must be balanced to support the sustainability of the overall food system.", {"entities": []}], ["The nutritional sustainability of a food system can be influenced by several factors, including the ingredient selection, nutrient composition, digestibility, and consumption rates of a diet.", {"entities": []}], ["Carbon and water footprints vary greatly among plant- and animal-based ingredients, production strategy, and geographical location.", {"entities": []}], ["Because the pet food industry is based largely on by-products and is tightly interlinked with livestock production and the human food system, however, it is quite unique with regard to sustainability.", {"entities": []}], ["Often based on consumer demand rather than nutritional requirements, many commercial pet foods are formulated to provide nutrients in excess of current minimum recommendations, use ingredients that compete directly with the human food system, or are overconsumed by pets, resulting in food wastage and obesity.", {"entities": [[302, 309, "DISEASE"]]}], ["Pet food professionals have the opportunity to address these challenges and influence the sustainability of pet ownership through product design, manufacturing processes, public education, and policy change.", {"entities": []}], ["A coordinated effort across the industry that includes ingredient buyers, formulators, and nutritionists may result in a more sustainable pet food system.", {"entities": []}], ["Our aim was to compare the longitudinal lung function growth of Mexican children and adolescents with the collated spirometric reference proposed for international use and with that of Mexican-Americans from the National Health State Examination Survey III (NHANES) III study.", {"entities": []}], ["A cohort of Mexican children in third year of primary school was followed with spirometry twice a year through secondary school.", {"entities": []}], ["Multilevel mixed-effects lineal models separated by gender were fit for the spirometric variables of 2,641 respiratory-healthy Mexican children expressed as Z-scores of tested reference equations.", {"entities": []}], ["Impact of adjustment by sitting height on differences with Mexican-American children was observed in a subsample of 1,987 children.", {"entities": []}], ["At same gender, age, and height, Mexican children had increasingly higher forced expiratory volume in 1 s (FEV 1 ) and Forced vital capacity (FVC) than the children from the collated reference study (mean Z-score, 0.68 for FEV 1 and 0.51 for FVC) and than Mexican-American children (Z-score, 0.23 for FEV 1 and 0.21 for FVC) respectively.", {"entities": [[107, 110, "GENE"], [223, 226, "GENE"], [301, 304, "GENE"], [107, 110, "GENE"], [223, 226, "GENE"], [301, 304, "GENE"], [107, 110, "GENE"], [223, 226, "GENE"], [301, 304, "GENE"]]}], ["Differences with Mexican-Americans were not reduced by adjusting by sitting height.", {"entities": []}], ["For reasons that remain unclear, the gender-, age-, and height-adjusted lung function of children from Mexico City is higher than that reported by several international studies.", {"entities": []}], ["Ceramide is the central substrate of sphingolipid metabolism and plays a key role in cellular signal transduction pathways, regulating apoptosis, differentiation, and chemotaxis.", {"entities": []}], ["Alterations in airway ceramide levels are observed in multiple pulmonary diseases and recent human genetic association studies have linked dysregulation of sphingolipid regulatory genes with asthma pathogenesis.", {"entities": [[191, 197, "DISEASE"]]}], ["Utilizing myriocin, a potent inhibitor of sphingolipid synthesis, we evaluated the immune regulatory role of de novo ceramide generation in vitro and in vivo .", {"entities": []}], ["Intratracheal myriocin was administered alone or during house dust mite sensitization (HDM) of BALB/C mice and airway hyper\u2010responsiveness (AHR) was evaluated by invasive plethysmography followed by bronchial lavage (BAL) cytology and cytokine quantification.", {"entities": [[140, 143, "GENE"]]}], ["Myriocin inhibits and HDM exposure activates de novo ceramide synthesis in bone marrow\u2010derived dendritic cells.", {"entities": []}], ["Mice receiving intratracheal myriocin developed a mild airway neutrophilic infiltrate without inducing a significant increase in AHR.", {"entities": [[129, 132, "GENE"]]}], ["CXCL1 was elevated in the BAL fluid of myriocin\u2010treated mice while the neutrophilic chemotactic factors anaphylatoxin C5a, leukotriene B4, and IL\u201017 were unaffected.", {"entities": [[0, 5, "GENE"]]}], ["HDM treatment combined with myriocin led to a dramatic enhancement of AHR (63% increase over HDM alone, p \u2009<\u20090.001) and increased granulocyte pulmonary infiltrates versus HDM or myriocin alone.", {"entities": [[70, 73, "GENE"]]}], ["Elevated Th2 T cell counts and Th2 cytokines/chemokines (IL5, IL13, CCL17) were observed in mice treated with combined HDM/myriocin compared to HDM alone.", {"entities": [[57, 60, "GENE"], [62, 66, "GENE"], [68, 73, "GENE"]]}], ["Myriocin\u2010treated pulmonary CD11c+ cells stimulated with HDM secreted significantly more CXCL1 than cells stimulated with HDM alone while HDM stimulated airway epithelial cells showed no change in CXCL1 secretion following myriocin treatment.", {"entities": [[88, 93, "GENE"], [196, 201, "GENE"], [88, 93, "GENE"], [196, 201, "GENE"]]}], ["Intratracheal myriocin, likely acting via ceramide synthesis inhibition, enhances allergen\u2010induced airway inflammation, granulocyte and Th2 lymphocyte recruitment, and allergen\u2010induced AHR.", {"entities": [[185, 188, "GENE"]]}], ["Sphingolipid pathways may represent novel targets for possible future anti\u2010inflammatory asthma medications.", {"entities": [[88, 94, "DISEASE"]]}], ["Intragastric balloon (IGB) is an effective and safe method of weight reduction.", {"entities": []}], ["However, IGBs have been associated with a high rate of weight regain post removal.", {"entities": []}], ["Accordingly, ways to improve sustained weight reduction including concomitant treatment with Glucagon-like peptide 1 (GLP-1) agonists have been proposed.", {"entities": []}], ["This study aims to evaluate the effect of adding Liraglutide to IGB insertion on sustained weight reduction.", {"entities": []}], ["A retrospective analysis of all cases treated with IGB with or without Liraglutide was performed.", {"entities": []}], ["Outcomes were statistically compared.", {"entities": []}], ["A total of 108 patients were included; 64 were treated with IGB alone and 44 with IGB + Liraglutide.", {"entities": []}], ["Six months after removing IGB, patients treated with IGB + Liraglutide had a higher mean weight loss post treatment completion (10.2 \u00b1 6.7 vs. 18.5 \u00b1 7.6, P = <0.0001) than those treated with IGB alone.", {"entities": []}], ["After adjusting for covariates, patients treated with IGB alone demonstrated a higher mean body weight loss at the time of IGB removal (coefficient 7.71, 95% CI = 4.78\u201310.63), and a higher odds of treatment success 6 months post IGB removal (OR = 5.74, 95% CI = 1.79\u2013188.42).", {"entities": []}], ["Baseline body mass index appeared to be a significant predictor of mean body weight loss at the time of balloon removal.", {"entities": []}], ["Adding Liraglutide to IGB does not appear to decrease the risk of weight regain 6 months post IGB removal.", {"entities": []}], ["To our knowledge, no prior population-based study has been published wherein the primary aim was to evaluate whether an association between psychotropic drug prescription and cervical cancer exists.", {"entities": [[184, 190, "DISEASE"], [175, 190, "DISEASE"]]}], ["Herein we have conducted the first study that primarily aimed to determine the association between antidepressants use and risk of invasive cervical cancer in the general population.", {"entities": [[149, 155, "DISEASE"], [140, 155, "DISEASE"]]}], ["This is a population-based study utilizing Taiwan's National Health Insurance Research Database.", {"entities": []}], ["We identified 26,262 cases with invasive cervical cancer and 129,490 controls.", {"entities": [[50, 56, "DISEASE"], [41, 56, "DISEASE"]]}], ["We adopted the conditional logistic regression model as the statistical method and adjusted for potential confounding factors.", {"entities": []}], ["The prescription of selective serotonin reuptake inhibitors (SSRIs) (adjusted OR\u200a=\u200a0.93, 95% CI\u200a=\u200a0.84\u20131.04), tricyclic antidepressants (TCAs), monoamine oxidase inhibitors (MAOIs), serotonin norepinephrine reuptake inhibitors (SNRIs), mirtazapine and bupropion, adjusting for cumulative dose, was not associated with an increased, or decreased, risk for invasive cervical cancer.", {"entities": [[373, 379, "DISEASE"], [364, 379, "DISEASE"]]}], ["An association between trazodone prescription and invasive cervical cancer was observed (adjusted OR\u200a=\u200a1.22, 95% CI\u200a=\u200a1.03\u20131.43).", {"entities": [[68, 74, "DISEASE"], [59, 74, "DISEASE"]]}], ["An association between the major classes of antidepressants and invasive cervical cancer was not observed herein.", {"entities": [[82, 88, "DISEASE"], [73, 88, "DISEASE"]]}], ["Our preliminary finding regarding a possible association between trazodone and cervical cancer requires replication.", {"entities": [[88, 94, "DISEASE"], [79, 94, "DISEASE"]]}], ["Eosinophilic esophagitis (EoE) is an allergic inflammatory disease of the esophagus featuring increased esophageal interleukin 13 (IL-13) levels and impaired barrier function.", {"entities": [[13, 24, "DISEASE"]]}], ["Herein, we investigated leucine-rich repeat\u2013containing protein 31 (LRRC31) in human EoE esophageal tissue and IL-13\u2013treated esophageal epithelial cells.", {"entities": []}], ["LRRC31 had basal mRNA expression in colonic and airway mucosal epithelium.", {"entities": []}], ["Esophageal LRRC31 mRNA and protein increased in active EoE and strongly correlated with esophageal eosinophilia and IL13 and CCL26 mRNA expression.", {"entities": [[99, 111, "DISEASE"], [116, 120, "GENE"], [125, 130, "GENE"]]}], ["IL-13 treatment increased LRRC31 mRNA and protein in air-liquid interface\u2013differentiated esophageal epithelial cells (EPC2s).", {"entities": []}], ["At baseline, differentiated LRRC31-overexpressing EPC2s had increased barrier function (1.9-fold increase in transepithelial electrical resistance [ P < 0.05] and 2.8-fold decrease in paracellular flux [ P < 0.05]).", {"entities": []}], ["RNA sequencing analysis of differentiated LRRC31-overexpressing EPC2s identified 38 dysregulated genes ( P < 0.05), including 5 kallikrein (KLK) serine proteases.", {"entities": []}], ["Notably, differentiated LRRC31-overexpressing EPC2s had decreased KLK expression and activity, whereas IL-13\u2013treated, differentiated LRRC31 gene-silenced EPC2s had increased KLK expression and suprabasal epithelial detachment.", {"entities": []}], ["We identified similarly dysregulated KLK expression in the esophagus of patients with active EoE and in IL-13\u2013treated esophageal epithelial cells.", {"entities": []}], ["We propose that LRRC31 is induced by IL-13 and modulates epithelial barrier function, potentially through KLK regulation.", {"entities": []}], ["Parents\u2019 perceived informal social control, defined as the informal ways residents intervene to create a safe and orderly neighbourhood environment, may influence young children\u2019s physical activity (PA) in the neighbourhood.", {"entities": []}], ["This study aimed to develop and test the reliability of a scale of PA-related informal social control relevant to Chinese parents/caregivers of pre-schoolers (children aged 3 to 5\u00a0years) living in Hong Kong.", {"entities": []}], ["Nominal Group Technique (NGT), a structured, multi-step brainstorming technique, was conducted with two groups of caregivers (mainly parents; n \u2009=\u200911) of Hong Kong pre-schoolers in June 2011.", {"entities": []}], ["Items collected in the NGT sessions and those generated by a panel of experts were used to compile a list of items (n\u2009=\u200922) for a preliminary version of a questionnaire of informal social control.", {"entities": []}], ["The newly-developed scale was tested with 20 Chinese-speaking parents/caregivers using cognitive interviews (August 2011).", {"entities": []}], ["The modified scale, including all 22 original items of which a few were slightly reworded, was subsequently administered on two occasions, a week apart, to 61 Chinese parents/caregivers of Hong Kong pre-schoolers in early 2012.", {"entities": []}], ["The test-retest reliability and internal consistency of the items and scale were examined using intraclass correlation coefficients (ICC), paired t-tests, relative percentages of shifts in responses to items, and Cronbach\u2019s \u03b1 coefficient.", {"entities": []}], ["Thirteen items generated by parents/caregivers and nine items generated by the panel of experts (total 22 items) were included in a first working version of the scale and classified into three subscales: \u201cPersonal involvement and general informal supervision\u201d, \u201cCivic engagement for the creation of a better neighbourhood environment\u201d and \u201cEducating and assisting neighbourhood children\u201d.", {"entities": []}], ["Twenty out of 22 items showed moderate to excellent test-test reliability (ICC range: 0.40-0.81).", {"entities": []}], ["All three subscales of informal social control showed acceptable levels of internal consistency (Cronbach's \u03b1 >0.70).", {"entities": []}], ["A reliable scale examining PA-related informal social control relevant to Chinese parents/caregivers of pre-schoolers living in Hong Kong was developed.", {"entities": []}], ["Further studies should examine the factorial validity of the scale, its associations with Chinese children\u2019s PA and its appropriateness for other populations of parents of young children.", {"entities": []}], ["Cigarette smoking is associated with numerous diseases and poses a serious challenge to the current healthcare system worldwide.", {"entities": []}], ["Smoking impacts both innate and adaptive immunity and plays dual roles in regulating immunity by either exacerbation of pathogenic immune responses or attenuation of defensive immunity.", {"entities": []}], ["Adaptive immune cells affected by smoking mainly include T helper cells (Th1/Th2/Th17), CD4+CD25+ regulatory T cells, CD8+ T cells, B cells and memory T/B lymphocytes while innate immune cells impacted by smoking are mostly DCs, macrophages and NK cells.", {"entities": []}], ["Complex roles of cigarette smoke have resulted in numerous diseases, including cardiovascular, respiratory and autoimmune diseases, allergies, cancers and transplant rejection etc.", {"entities": []}], ["Although previous reviews have described the effects of smoking on various diseases and regional immunity associated with specific diseases, a comprehensive and updated review is rarely seen to demonstrate impacts of smoking on general immunity and, especially on major components of immune cells.", {"entities": []}], ["Here, we aim to systematically and objectively review the influence of smoking on major components of both innate and adaptive immune cells, and summarize cellular and molecular mechanisms underlying effects of cigarette smoking on the immune system.", {"entities": []}], ["The molecular pathways impacted by cigarette smoking involve NF\u03baB, MAP kinases and histone modification.", {"entities": []}], ["Further investigations are warranted to understand the exact mechanisms responsible for smoking-mediated immunopathology and to answer lingering questions over why cigarette smoking is always harmful rather than beneficial even though it exerts dual effects on immune responses.", {"entities": []}], ["In contrast with northern Australia and Thailand, in Singapore the incidence of melioidosis and co-incidence of melioidosis and pneumonia have declined.", {"entities": [[80, 91, "DISEASE"], [112, 123, "DISEASE"], [128, 137, "DISEASE"]]}], ["Burkholderia pseudomallei deep abscesses increased 20.4% during 2003\u20132014.", {"entities": []}], ["These trends could not be explained by the environmental and climatic factors conventionally ascribed to melioidosis.", {"entities": [[105, 116, "DISEASE"]]}], ["We assessed the accuracy of questionnaire reports of cat and dog ownership and presence of cockroaches in predicting measured allergen concentrations in house dust.", {"entities": []}], ["We collected dust samples in the homes of 932 newborns living in New England.", {"entities": []}], ["Dust samples were taken from the main living area and the infant's bedding.", {"entities": []}], ["Allergen content of house dust was measured by enzyme-linked immunosorbent assays (ELISA) and related to questionnaire information on past and current cat and dog ownership and presence of cockroaches.", {"entities": []}], ["Allergen levels were dichotomized using the limit of detection and the following cut points: 1.0 microg/g and 8.0 microg/g for cat, 2.0 microg/g and 10.0 microg/g for dog, and 2 U/g and 8 U/g for cockroach allergen.", {"entities": []}], ["For the upper cut point, both specificity and sensitivity of questionnaire-reported cat and dog ownership and presence of cockroaches were high.", {"entities": []}], ["For the limit of detection and lower cut point, specificity was high (> 80%), whereas sensitivity was low, particularly for current cat and dog ownership (21-60%).", {"entities": []}], ["Taking pet ownership during the preceding 2 years into account increased the sensitivity by 10%, but it remained relatively poor.", {"entities": []}], ["In conclusion, questionnaire-reported pet ownership and presence of cockroaches predicts allergen levels above the upper cut point but is a relatively poor measure of allergen exposure above the limit of detection and the lower cut point.", {"entities": []}], ["Knowledge of past pet ownership can improve pet allergen exposure assessment by means of questionnaire.", {"entities": []}], ["However, for epidemiologic purposes, measured concentrations of allergens are necessary.", {"entities": []}], ["Variants associated with meconium ileus in cystic fibrosis (CF) were identified in 3,763 patients by GWAS.", {"entities": [[34, 39, "DISEASE"], [43, 58, "DISEASE"]]}], ["Five SNPs at two loci near SLC6A14 (min P =1.28\u00d710 SLC26A9 (min P =9.88\u00d710 P =0.001 and 0.0001 respectively).", {"entities": [[27, 34, "GENE"], [51, 58, "GENE"]]}], ["By incorporating that disease-causing mutations in CFTR alter electrolyte and fluid flux across epithelia into an hypothesis-driven genome-wide analysis (GWAS-HD), we identified the same SLC6A14 and SLC26A9 associated SNPs, while establishing evidence for the involvement of SNPs in a third solute carrier gene, SLC9A3.", {"entities": [[51, 55, "GENE"], [187, 194, "GENE"], [199, 206, "GENE"], [312, 318, "GENE"]]}], ["In addition, GWAS-HD provided evidence of association between meconium ileus and multiple constituents of the apical plasma membrane where CFTR resides ( P =0.0002, testing 155 apical genes jointly and replicated, P =0.022).", {"entities": [[71, 76, "DISEASE"], [139, 143, "GENE"]]}], ["These findings suggest that modulating activities of apical membrane constituents could complement current therapeutic paradigms for cystic fibrosis.", {"entities": [[133, 148, "DISEASE"]]}], ["Dysfunction of central and skin Hypothalamic-Pituitary-Adrenal (HPA) axis play important roles in pathogenesis of atopic dermatitis (AD).", {"entities": [[114, 131, "DISEASE"], [121, 131, "DISEASE"]]}], ["Our previous studies showed that several Chinese herbs could improve HPA axis function.", {"entities": []}], ["In this study, we evaluated the anti-inflammatory effects of BuShenYiQi granule (BSYQ), a Chinese herbs formula, in AD mice and explored the effective mechanism from regulation of HPA axis.", {"entities": []}], ["The ovalbumin (OVA) induced AD mice model were established and treated with BSYQ.", {"entities": []}], ["We evaluated dermatitis score and histology analysis of dorsal skin lesions, meanwhile, serum corticosterone (CORT), adrenocorticotropic hormone (ACTH), corticotropin-releasing hormone (CRH) and inflammatory cytokines were determined by ELISA.", {"entities": [[13, 23, "DISEASE"], [110, 114, "GENE"], [186, 189, "GENE"]]}], ["The changes of CRH/proopiomelanocortin(POMC) axis elements, corresponding functional receptors and crucial genes of glucocorticosteroidogenesis in the skin were measured by quantitative real-time PCR and western blot, respectively.", {"entities": [[39, 43, "GENE"]]}], ["The symptoms and pathological changes in skin of AD mice were significantly improved and several markers of inflammation and allergy descended obviously after BSYQ treatment.", {"entities": []}], ["We found that AD mice had insufficient central HPA tone, but these conditions were markedly improved after BSYQ treatment.", {"entities": []}], ["The AD mice also showed a disturbed expression of skin HPA.", {"entities": []}], ["In lesion skin of AD mice, the mRNA and protein expressions of CRH decreased significantly, on the contrary, POMC and cytochrome P450 side-chain cleavage enzyme (CYP11A1) increased markedly, meanwhile, NR3C1 (mouse GR), CRHR2 and 11-hydroxylase type 1(CYP11B1) were reduced locally.", {"entities": [[63, 66, "GENE"], [109, 113, "GENE"], [162, 169, "GENE"], [202, 207, "GENE"], [220, 225, "GENE"], [252, 259, "GENE"]]}], ["Most of these tested indexes were improved after BSYQ treatment.", {"entities": []}], ["AD mice displayed the differential expression pattern of central and skin HPA axis and BSYQ treatment significantly alleviated the symptoms of AD mice and presented anti-inflammatory and anti-allergic effects via regulating the expression of central and skin HPA axis.", {"entities": []}], ["Viral bronchiolitis is the most common cause of hospitalization in infants under 6 months of age, and 70% of all cases of bronchiolitis are caused by respiratory syncytial virus (RSV).", {"entities": [[6, 19, "DISEASE"], [122, 135, "DISEASE"]]}], ["Early RSV infection is associated with respiratory problems such as asthma and wheezing later in life.", {"entities": [[68, 74, "DISEASE"]]}], ["RSV infection is usually spread by contaminated secretions and infects the upper then lower respiratory tracts.", {"entities": []}], ["Infected cells release proinflammatory cytokines and chemokines, including IL-1, tumor necrosis factor-\u03b1, IL-6, and IL-8.", {"entities": []}], ["These activate other cells and recruit inflammatory cells, including macrophages, neutrophils, eosinophils, and T lymphocytes, into the airway wall and surrounding tissues.", {"entities": []}], ["The pattern of cytokine production by T lymphocytes can be biased toward 'T-helper-1' or 'T-helper-2' cytokines, depending on the local immunologic environment, infection history, and host genetics.", {"entities": []}], ["T-helper-1 responses are generally efficient in antiviral defense, but young infants have an inherent bias toward T-helper-2 responses.", {"entities": []}], ["The ideal intervention for RSV infection would be preventive, but the options are currently limited.", {"entities": []}], ["Vaccines based on protein subunits, live attenuated strains of RSV, DNA vaccines, and synthetic peptides are being developed; passive antibody therapy is at present impractical in otherwise healthy children.", {"entities": []}], ["Effective vaccines for use in neonates continue to be elusive but simply delaying infection beyond the first 6 months of life might reduce the delayed morbidity associated with infantile disease.", {"entities": []}], ["Physical activity is beneficial for reducing pain and improving health-related quality of life among people with arthritis.", {"entities": [[113, 122, "DISEASE"]]}], ["However, physical inactivity is prevalent among people with arthritis.", {"entities": [[60, 69, "DISEASE"]]}], ["Health care providers\u2019 recommendations act as a catalyst for changes in health behavior.", {"entities": []}], ["However, information about the effectiveness of such recommendations is limited in the arthritis literature.", {"entities": [[87, 96, "DISEASE"]]}], ["We examined the association between providers\u2019 recommendations for physical activity and adherence to physical activity guidelines for adults with arthritis and whether adults\u2019 age influenced this association.", {"entities": [[147, 156, "DISEASE"]]}], ["We used combined data of adult respondents aged 45 years or older with provider-diagnosed arthritis (N = 10,892) from the 2011 Behavioral Risk Factor Surveillance System to conduct a retrospective, cross-sectional study.", {"entities": [[90, 99, "DISEASE"]]}], ["We used a multivariable logistic regression model to examine the association between health care providers\u2019 recommendations and adherence to physical activity guidelines among adults with arthritis.", {"entities": [[188, 197, "DISEASE"]]}], ["Adults with arthritis who received health care providers\u2019 recommendations for physical activity were more likely (odds ratio, 1.22; 95% confidence interval, 1.12\u20131.32) to adhere to physical activity guidelines than those who did not, after controlling for relevant covariates.", {"entities": [[12, 21, "DISEASE"]]}], ["Adults\u2019 age did not influence the association between providers\u2019 recommendations and adherence to physical activity (odds ratio, 1.00; 95% confidence interval, 0.99\u20131.00), after controlling for covariates.", {"entities": []}], ["Health care providers\u2019 recommendations are associated with adherence to physical activity guidelines among adults with arthritis.", {"entities": [[119, 128, "DISEASE"]]}], ["Providers should recommend physical activity to adults with arthritis.", {"entities": [[60, 69, "DISEASE"]]}], ["The incidence of nontuberculous mycobacteria (NTM) infections is increasing worldwide, however formal evaluations of the epidemiology of NTM infections are limited.", {"entities": [[46, 49, "GENE"], [137, 140, "GENE"], [46, 49, "GENE"], [137, 140, "GENE"]]}], ["Understanding the trends and true prevalence of NTM is a major priority for optimizing infection control programmes and resources.", {"entities": [[48, 51, "GENE"]]}], ["The purpose of this study was to investigate the epidemiology, clinical manifestations, and radiologic findings in NTM-infected patients at specialized Tuberculosis (Tb) treatment centre in South Korea, which is endemic to Tb, and find solutions to control NTM infections.", {"entities": [[115, 118, "GENE"], [257, 260, "GENE"]]}], ["A retrospective descriptive study was conducted among patients who were diagnosed with NTM from November 2011 to January 2016 at Seoul Metropolitan Government Seobuk hospital, Korea, using medical records and chest radiography results.", {"entities": [[87, 90, "GENE"]]}], ["Prevalence of NTM using national health insurance data was compared to the prevalence and incidence of Tb using National statistics data.", {"entities": [[14, 17, "GENE"]]}], ["The age- and sex- adjusted prevalence of NTM infection per 100,000 population increased between 2009 (9.4) and 2016 (36.1).", {"entities": [[41, 44, "GENE"]]}], ["However, the prevalence and incidence of Tb per 100,000 population decreased from 106.5 to 74.4, and 81.2 to 61.8, respectively.", {"entities": []}], ["In total, 64 patients (37 [57.8%] men) were enrolled in the study.", {"entities": []}], ["Among 33 (51.6%) patients with slowly growing nontuberculous mycobacteria (SGM) infection, 29 were detected with Mycobacterium avium complex ( n \u00a0=\u00a013, M. avium ; n \u00a0=\u00a016, M. intracellulare ), and 4 with M. kansasii .", {"entities": []}], ["Among 31 (48.4%) patients with rapidly growing nontuberculous mycobacteria (RGM) infection, 27 and 4 patients were detected with M. abscessus complex and M. fortuitum complex, respectively.", {"entities": []}], ["RGM patients were more likely to have current Tb ( P\u00a0= \u00a00.041), cough ( P \u00a0<\u00a00.05), and sputum ( P \u00a0<\u00a00.01) than SGM patients in the univariate analysis, but not in the multivariate analysis.", {"entities": []}], ["Given the increasing prevalence of NTM infections, precise epidemiological and surveillance data should be obtained by reporting NTM infections to public health authorities.", {"entities": [[35, 38, "GENE"], [129, 132, "GENE"], [35, 38, "GENE"], [129, 132, "GENE"]]}], ["Introducing nucleic acid amplification tests to differentiate between Tb and NTM in smear-positive specimens should be considered.", {"entities": [[77, 80, "GENE"]]}], ["Geographic Information Systems (GIS) have been used increasingly to map instances of environmental injustice, the disproportionate exposure of certain populations to environmental hazards.", {"entities": []}], ["Some of the technical and analytic difficulties of mapping environmental injustice are outlined in this article, along with suggestions for using GIS to better assess and predict environmental health and equity.", {"entities": []}], ["I examine 13 GIS-based environmental equity studies conducted within the past decade and use a study of noxious land use locations in the Bronx, New York, to illustrate and evaluate the differences in two common methods of determining exposure extent and the characteristics of proximate populations.", {"entities": []}], ["Unresolved issues in mapping environmental equity and health include lack of comprehensive hazards databases; the inadequacy of current exposure indices; the need to develop realistic methodologies for determining the geographic extent of exposure and the characteristics of the affected populations; and the paucity and insufficiency of health assessment data.", {"entities": []}], ["GIS have great potential to help us understand the spatial relationship between pollution and health.", {"entities": []}], ["Refinements in exposure indices; the use of dispersion modeling and advanced proximity analysis; the application of neighborhood-scale analysis; and the consideration of other factors such as zoning and planning policies will enable more conclusive findings.", {"entities": []}], ["The environmental equity studies reviewed in this article found a disproportionate environmental burden based on race and/or income.", {"entities": []}], ["It is critical now to demonstrate correspondence between environmental burdens and adverse health impacts--to show the disproportionate effects of pollution rather than just the disproportionate distribution of pollution sources.", {"entities": []}], ["Neurotoxic shellfish poisoning (NSP) is caused by consumption of molluscan shellfish contaminated with brevetoxins primarily produced by the dinoflagellate, Karenia brevis.", {"entities": []}], ["Blooms of K. brevis , called Florida red tide, occur frequently along the Gulf of Mexico.", {"entities": []}], ["Many shellfish beds in the US (and other nations) are routinely monitored for presence of K. brevis and other brevetoxin-producing organisms.", {"entities": []}], ["As a result, few NSP cases are reported annually from the US.", {"entities": []}], ["However, infrequent larger outbreaks do occur.", {"entities": []}], ["Cases are usually associated with recreationally-harvested shellfish collected during or post red tide blooms.", {"entities": []}], ["Brevetoxins are neurotoxins which activate voltage-sensitive sodium channels causing sodium influx and nerve membrane depolarization.", {"entities": []}], ["No fatalities have been reported, but hospitalizations occur.", {"entities": []}], ["NSP involves a cluster of gastrointestinal and neurological symptoms: nausea and vomiting, paresthesias of the mouth, lips and tongue as well as distal paresthesias, ataxia, slurred speech and dizziness.", {"entities": []}], ["Neurological symptoms can progress to partial paralysis; respiratory distress has been recorded.", {"entities": []}], ["Recent research has implicated new species of harmful algal bloom organisms which produce brevetoxins, identified additional marine species which accumulate brevetoxins, and has provided additional information on the toxicity and analysis of brevetoxins.", {"entities": []}], ["A review of the known epidemiology and recommendations for improved NSP prevention are presented.", {"entities": []}], ["Healthcare-associated pneumonia (HCAP) has more similarities to nosocomial pneumonia than to community-acquired pneumonia (CAP).", {"entities": [[22, 31, "DISEASE"], [75, 84, "DISEASE"], [112, 121, "DISEASE"]]}], ["However, there have only been a few epidemiological studies of HCAP in South Korea.", {"entities": []}], ["We aimed to determine the differences between HCAP and CAP in terms of clinical features, pathogens, and outcomes, and to clarify approaches for initial antibiotic management.", {"entities": []}], ["We conducted a retrospective, observational study of 527 patients with HCAP or CAP who were hospitalized at Severance Hospital in South Korea between January and December 2008.", {"entities": []}], ["Of these patients, 231 (43.8%) had HCAP, and 296 (56.2%) had CAP.", {"entities": []}], ["Potentially drug-resistant (PDR) bacteria were more frequently isolated in HCAP than CAP (12.6% vs. 4.7%; P = 0.001), especially in the low-risk group of the PSI classes (41.2% vs. 13.9%; P = 0.027).", {"entities": []}], ["In-hospital mortality was higher for HCAP than CAP patients (28.1% vs. 10.8%, P < 0.001), especially in the low-risk group of PSI classes (16.4% vs. 3.1%; P = 0.001).", {"entities": []}], ["Moreover, tube feeding and prior hospitalization with antibiotic treatment within 90 days of pneumonia onset were significant risk factors for PDR pathogens, with odds ratios of 14.94 (95% CI 4.62-48.31; P < 0.001) and 2.68 (95% CI 1.32-5.46; P = 0.007), respectively.", {"entities": [[93, 102, "DISEASE"]]}], ["For HCAP patients with different backgrounds, various pathogens and antibiotic resistance of should be considered, and careful selection of patients requiring broad-spectrum antibiotics is important when physicians start initial antibiotic treatments.", {"entities": []}], ["Families with lower socioeconomic status are less likely to adopt household smoking bans (HSB).", {"entities": []}], ["The aim of this study was to determine whether socioeconomic disparities in HSB prevalence in Italy decreased 7\u20139 years after the introduction of the Italian ban on smoking in public places.", {"entities": []}], ["A longitudinal, 12-year, two-wave study was conducted on a sample of 3091 youths aged 6\u201314 years in 2002; 1763 (57%) were re-interviewed in 2012\u20132014.", {"entities": []}], ["A Poisson regression with a robust error variance was used to assess the association between socioeconomic disparities and HSB prevalence.", {"entities": []}], ["The adoption of HSBs significantly increased from 60% in 2002 to 75% in 2012\u20132014, with the increase recorded in youths with \u22651 smoking parent only (from 22% at baseline to 46% at follow-up).", {"entities": []}], ["The presence of HSBs at baseline was more likely in families with \u22651 graduate parent compared to those with no graduate parents (prevalence ratio (PR) = 1.34, 95% confidence interval (CI) = 1.15\u20131.57), either in families with \u22651 smoking parent (PR = 1.36, 95% CI = 1.17\u20131.58) or in families with non-smoking parents (PR = 1.61, 95% CI = 1.01\u20132.56).", {"entities": []}], ["Conversely, at follow-up socioeconomic disparities dropped since families with no graduate parents were 1.5-fold more likely to introduce a HSB between the two waves.", {"entities": []}], ["The Italian ban on smoking in public places may have increased the adoption of smoke-free homes in families with smoking and non-graduate parents, causing the drop of the socioeconomic gap in smoke-free homes.", {"entities": []}], ["We aimed to study the diagnostic influence of adding a routine cardiovascular ultrasound screening of the cardiac anatomy and function, the pericardium, the pleura and the abdominal great vessels by the new pocket-size ultrasound device (pUS) with grey scale and colour Doppler imaging.", {"entities": []}], ["In 119 randomly selected patients admitted to a cardiac unit at a non-university hospital, routinely adding a cardiovascular ultrasonography of only 4.4 min with a pocket-size device corrected the primary diagnosis in 16% of patients.", {"entities": []}], ["In addition, 29% had the primary diagnosis verified and in 10% an additional important diagnosis was made.", {"entities": []}], ["Higher age predicted any diagnostic influence of pUS screening with an increase of 61% ( P = 0.003) per 10 years of higher age.", {"entities": []}], ["Overall, the pUS screening had a sensitivity and specificity with respect to detecting at least moderate pathology of 97 and 93%.", {"entities": []}], ["Positive and negative predictive values were 93 and 87%, respectively.", {"entities": []}], ["In the sub-group of subjects with a change in the primary diagnosis following pUS there was no false-negative or false-positive findings.", {"entities": []}], ["Screening by pUS assessed vascular and cardiac anatomy and function accurately and enabled correction of the diagnosis in 16% of patients admitted to a cardiac unit.", {"entities": []}], ["In 55% of the participants, the cardiovascular ultrasound screening had important diagnostic influence.", {"entities": []}], ["We suggest that it would be appropriate to implement strategies and systems for routinely adding an ultrasound cardiovascular examination to patients in cardiac units.", {"entities": []}], ["Micro RNAs (miRNAs) are promising disease biomarkers due to their high stability.", {"entities": []}], ["Their expression in serum is altered in type 1 diabetes, but whether deviations exist in individuals with high risk for type 1 diabetes remains unexplored.", {"entities": []}], ["We therefore assessed serum miRNAs in high-risk individuals (n = 21) positive for multiple islet autoantibodies, age-matched healthy children (n = 17) and recent-onset type 1 diabetes patients (n = 8), using Serum/Plasma Focus microRNA PCR Panels from Exiqon.", {"entities": []}], ["The miRNA levels in the high-risk group were similar to healthy controls, and no specific miRNA profile was identified for the high-risk group.", {"entities": []}], ["However, serum miRNAs appeared to reflect glycemic status and ongoing islet autoimmunity in high-risk individuals, since several miRNAs were associated to glucose homeostasis and autoantibody titers.", {"entities": []}], ["High-risk individuals progressing to clinical disease after the sampling could not be clearly distinguished from non-progressors, while miRNA expression in the type 1 diabetes group deviated significantly from high-risk individuals and healthy controls, perhaps explained by major metabolic disturbances around the time of diagnosis.", {"entities": []}], ["Dyslipidemia, and inflammatory markers: high-sensitivity C-reactive protein (hs-CRP), myeloperoxidase (MPO), lipoprotein associated phospholipase A 2 (Lp-PLA 2 ), and lipid peroxides (LP) are insufficient to predict the onset, extent, and prognosis of CHD.", {"entities": [[103, 106, "GENE"]]}], ["Lipoxins (LXs), resolvins, and protectins are derived from \u03c9-3 fatty acids: eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), and \u03c9-6 arachidonic acid in the presence of aspirin; whereas nitrolipids are formed due to the interaction between polyunsaturated fatty acids and nitric oxide (NO).", {"entities": []}], ["LXs, resolvins, protectins, and nitrolipids are endogenous anti-inflammatory lipid molecules that inhibit production of interleukin-6 (IL-6) and tumor necrosis factor- \u03b1 (TNF-\u03b1), suppress free radical generation, enhance NO generation; and accelerate tissue repair.", {"entities": []}], ["Thus, beneficial actions of EPA/DHA and aspirin in CHD could be attributed to the formation of LXs, resolvins, protectins, and nitrolipids and suggest that their plasma levels aid in the prediction and prognosis of CHD.", {"entities": []}], ["Experimental autoimmune encephalomyelitis (EAE) is an animal model that captures many of the hallmarks of human multiple sclerosis (MS), including blood\u2013brain barrier (BBB) breakdown, inflammation, demyelination and axonal destruction.", {"entities": [[112, 130, "DISEASE"], [24, 41, "DISEASE"]]}], ["The standard clinical score measurement of disease severity and progression assesses functional changes in animal mobility; however, it does not offer information regarding the underlying pathophysiology of the disease in real time.", {"entities": []}], ["The purpose of this study was to apply a novel optical imaging technique that offers the advantage of rapid imaging of relevant biomarkers in live animals.", {"entities": []}], ["Advances in non-invasive fluorescence molecular tomographic (FMT) imaging, in combination with a variety of biological imaging agents, offer a unique, sensitive and quantifiable approach to assessing disease biology in living animals.", {"entities": []}], ["Using vascular (AngioSense 750EX) and protease-activatable cathepsin B (Cat B 680 FAST) near infrared (NIR) fluorescence imaging agents to detect BBB breakdown and inflammation, respectively, we quantified brain and spinal cord changes in mice with relapsing-remitting PLP 139-151 -induced EAE and in response to tolerogenic therapy.", {"entities": []}], ["FMT imaging and analysis techniques were carefully characterized and non-invasive imaging results corroborated by both ex vivo tissue imaging and comparison to clinical score results and histopathological analysis of CNS tissue.", {"entities": []}], ["FMT imaging showed clear differences between control and diseased mice, and immune tolerance induction by antigen-coupled PLGA nanoparticles effectively blocked both disease induction and accumulation of imaging agents in the brain and spinal cord.", {"entities": []}], ["Cat B 680 FAST and AngioSense 750EX offered the combination best able to detect disease in both the brain and spinal cord, as well as the downregulation of disease by antigen-specific tolerance.", {"entities": []}], ["Non-invasive optical tomographic imaging thus offers a unique approach to monitoring neuroinflammatory disease and therapeutic intervention in living mice with EAE.", {"entities": []}], ["Our earlier work showed that knockout of hematopoietic prostaglandin D synthase (HPGDS, an enzyme that produces prostaglandin D 2 ) caused more adenomas in Apc 2 (PGD 2 ) binds to the prostaglandin D 2 receptor known as PTGDR (or DP1).", {"entities": [[81, 86, "GENE"], [156, 159, "GENE"], [163, 166, "GENE"], [220, 225, "GENE"]]}], ["PGD 2 metabolites bind to peroxisome proliferator-activated receptor \u03b3 (PPARG).", {"entities": [[0, 3, "GENE"], [72, 77, "GENE"]]}], ["We hypothesized that Ptgdr or Pparg knockouts may raise numbers of tumors, if these receptors take part in tumor suppression by PGD 2 .", {"entities": [[21, 26, "GENE"], [30, 35, "GENE"], [128, 131, "GENE"]]}], ["To assess, we produced Apc Ptgdr knockouts (147 mice).", {"entities": [[23, 26, "GENE"], [27, 32, "GENE"]]}], ["In separate experiments, we produced Apc Pparg knockouts (104 mice).", {"entities": [[37, 40, "GENE"], [41, 46, "GENE"]]}], ["Homozygous Ptgdr knockouts raised total numbers of tumors by 30\u201340% at 6 and 14\u00a0weeks.", {"entities": [[11, 16, "GENE"]]}], ["Colon tumors were not affected.", {"entities": []}], ["Heterozygous Pparg knockouts alone did not affect tumor numbers in Apc Pparg knockout assessment also included mice with highly expressed PTGDS transgenes.", {"entities": [[13, 18, "GENE"], [71, 76, "GENE"], [67, 70, "GENE"], [13, 18, "GENE"], [71, 76, "GENE"], [138, 143, "GENE"]]}], ["Apc Pparg knockouts appeared to blunt the tumor-suppressing effect of transgenic PTGDS.", {"entities": [[0, 3, "GENE"], [4, 9, "GENE"], [81, 86, "GENE"]]}], ["However, tumor suppression by PGD 2 was more clearly mediated by receptor PTGDR in our experiments.", {"entities": [[30, 33, "GENE"], [74, 79, "GENE"]]}], ["The suppression mechanism did not appear to involve changes in microvessel density or slower proliferation of tumor cells.", {"entities": []}], ["The data support a role for PGD 2 signals acting through PTGDR in suppression of intestinal tumors.", {"entities": [[28, 31, "GENE"], [57, 62, "GENE"]]}], ["Interleukin-19 (IL-19) is a newly discovered cytokine belonging to the Interleukin-10(IL-10) family.", {"entities": []}], ["IL-19 have indispensable functions in many inflammatory processes and also can induce the angiogenic potential of endothelial cells.", {"entities": []}], ["The purpose of present study was to investigate the relation of serum interleukin-19 (IL-19) levels with diabetic nephropathy (DN).", {"entities": []}], ["Two hundred study groups of patients with type 2 diabetes mellitus (T2DM) (109 males and 91 females) were recruited, included normoalbuminuria( n \u2009=\u2009102), microalbuminuria( n \u2009=\u200972) and macroalbuminuria( n \u2009=\u200926) .", {"entities": [[49, 66, "DISEASE"], [42, 66, "DISEASE"]]}], ["The 50 healthy blood donors were enrolled for the control group.", {"entities": []}], ["All subjects were assessed for: IL-19, High-sensitivity C-reactive protein (Hs-CRP), Cystatin C, urinary albumin excretion rate (UAE) and glycosylated hemoglobin A1c(HbA1c).", {"entities": []}], ["The serum IL-19 levels in DN patients were found to be significantly higher compared to controls.", {"entities": []}], ["IL-19 levels were significantly positively correlated with Hs-CRP, Cystatin C, UAE and HbA1c( r \u2009=\u20090.623, 0.611,0.591 and 0.526 respectively, P \u2009<\u20090.01).", {"entities": []}], ["Multivariable logistic regression analysis showed IL-19 levels ( P \u2009=\u20090.01) were found to be independently associated with patients with DN.", {"entities": []}], ["IL-19 is significantly positive correlated with UAE and Cystatin C. IL-19 may play an important role that contributes to the progression of diabetic nephropathy.", {"entities": []}], ["The clinical significance of eosinophilia after allogeneic hematopoietic stem cell transplantation is controversial.", {"entities": [[29, 41, "DISEASE"]]}], ["This study aimed to retrospectively study the impact of eosinophilia on the outcome of allogeneic hematopoietic stem cell transplantation by taking into account the influence of corticosteroid therapy.", {"entities": [[56, 68, "DISEASE"]]}], ["We retrospectively studied 204 patients with acute myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndrome who underwent allogeneic hematopoietic stem cell transplantation from January 2001 to December 2010.", {"entities": [[51, 67, "DISEASE"], [119, 127, "DISEASE"], [45, 67, "DISEASE"], [59, 67, "DISEASE"], [89, 97, "DISEASE"], [75, 97, "DISEASE"]]}], ["The median age was 43 years (minimum-maximum: 17-65 years).", {"entities": []}], ["Myeloablative conditioning was used in 153 patients and reduced intensity conditioning was employed in 51 patients.", {"entities": []}], ["Donor cells were from bone marrow in 132 patients, peripheral blood in 34, and cord blood in 38.", {"entities": []}], ["Eosinophilia was detected in 71 patients and there was no significant predictor of eosinophilia by multivariate analysis.", {"entities": [[0, 12, "DISEASE"], [83, 95, "DISEASE"]]}], ["There was no relationship between occurrence of eosinophilia and the incidence or grade of acute graft-versus-host disease when the patients were stratified according to corticosteroid treatment.", {"entities": [[48, 60, "DISEASE"]]}], ["Although eosinophilia was a prognostic factor for 5-year overall survival by univariate analysis, it was not a significant indicator by multivariate analysis.", {"entities": [[9, 21, "DISEASE"]]}], ["These results suggest that the clinical significance of eosinophilia in patients receiving allogeneic hematopoietic stem cell transplantation should be assessed with consideration of systemic corticosteroid administration.", {"entities": [[56, 68, "DISEASE"]]}], ["Previous research suggests the association of glutathione S-transferase ( GST ) gene polymorphisms or diet, but no interactions between these factors in atopic dermatitis (AD).", {"entities": [[153, 170, "DISEASE"], [160, 170, "DISEASE"]]}], ["We conducted a community-based case-control study including 194 AD and 244 matched non-AD preschoolers.", {"entities": []}], ["Glutathione S-transferase M1 (GSTM1 ) and T1 (GSTT1) present/null genotypes were evaluated uisng a multiplex PCR method.", {"entities": [[30, 35, "GENE"], [46, 51, "GENE"]]}], ["We measured dietary intakes by a validated food frequency questionnaire and constructed three dietary patterns such as \u201ctraditional healthy\u201d, \u201canimal foods\u201d, and \u201csweets\u201d diets.", {"entities": []}], ["In stratified analyses by GST genotypes, the \u201ctraditional healthy\u201d diet and reduced AD showed association only in the GSTM1-present group (odd ratio (OR) 0.31, 95% confidence interval (CI) 0.13\u20130.75).", {"entities": []}], ["A similar pattern of the association existed in the combined GSTM1/T1 genotype that indicated the inverse association between the \u201ctraditional healthy\u201d diet and AD in the double GSTM1/T1-present genotype group (OR 0.24, 95% CI 0.06\u20130.93).", {"entities": []}], ["Results from the multiplicative test analyses showed that the \u201ctraditional healthy\u201d diet on reduced AD was significant or borderline significant in the GSTM1-present group (OR 0.71, 95% CI 0.54\u20130.92 vs. GSTM1-null group) or the GSTM1/T1 double present group (OR 0.63, 95% CI 0.39\u20131.03 vs. GSTM1/T1 double null group).", {"entities": []}], ["These findings demonstrate that the present type of GSTM1 may increase susceptibility to the potential effect of the \u201ctraditional healthy\u201d diet on AD.", {"entities": [[52, 57, "GENE"]]}], ["Strength of T cell receptor (TCR) signaling, coreceptors, costimulation, antigen-presenting cell type, and cytokines all play crucial roles in determining the efficiency with which type 2 T lymphocytes (Th2, Tc2) develop from uncommitted precursors.", {"entities": []}], ["To investigate in vivo regulatory mechanisms that control the population of type 2 T cells and disease susceptibility, we have created lines of transgenic mice in which expression of a chimeric cytokine receptor (the mouse interleukin 2 receptor \u03b2 chain [IL-2R\u03b2] extracellular domain fused to the cytoplasmic tail of IL-4R\u03b1) is targeted to the T lymphoid lineage using the proximal lck promoter.", {"entities": [[382, 385, "GENE"]]}], ["This chimera transduced IL-4\u2013specific signals in response to IL-2 binding and dramatically enhanced type 2 responses (IL-4, IL-5, and immunoglobulin E production) upon in vitro TCR stimulation or in vivo antigen challenge.", {"entities": []}], ["Thus, type 2 effector function was augmented by IL-4 signals transduced through a chimeric receptor expressed in a T cell\u2013specific manner.", {"entities": []}], ["This influence was sufficient for establishment of antigen-induced allergic airway hyperresponsiveness on a disease-resistant background (C57BL/6).", {"entities": []}], ["Introduction .", {"entities": []}], ["Folic acid (FA) supplementation is recommended worldwide in the periconceptional period for the prevention of neural tube defects.", {"entities": []}], ["Due to its involvement in a number of cellular processes, its role in other pregnancy outcomes such as miscarriage, recurrent miscarriage, low birth weight, preterm birth (PTB), preeclampsia, abruptio placentae, and stillbirth has been investigated.", {"entities": []}], ["PTB is a leading cause of perinatal mortality and morbidity; therefore its association with FA supplementation is of major interest.", {"entities": []}], ["The analysis of a small number of randomized clinical trials (RCTs) has not found a beneficial role of FA in reducing the rate of PTBs.", {"entities": []}], ["Aim of the Study .", {"entities": []}], ["The aim of this review was to examine the results from recent observational studies about the effect of FA supplementation on PTB.", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["We carried out a search on Medline and by manual search of the observational studies from 2009 onwards that analyzed the rate of PTB in patients who received supplementation with FA before and/or throughout pregnancy.", {"entities": []}], ["The results from recent observational studies suggest a slight reduction of PTBs that is not consistent with the results from RCTs.", {"entities": []}], ["Further research is needed to better understand the role of FA supplementation before and during pregnancy in PTB.", {"entities": []}], ["In a previous study, we found that induced expression of Heme Oxygenase-1 (HO-1) is responsible for the resistance of human osteosarcoma MG63 cells to the chemotherapeutic agent arsenic trioxide (ATO).", {"entities": [[124, 136, "DISEASE"]]}], ["The present study was aimed at investigating the molecular mechanisms underlying the induction of HO-1 that occurs after exposure of MG63 cells to ATO.", {"entities": []}], ["First, using RT-QPCT and Western-blot, we found that ATO strongly induced the expression of heme oxygenase-1 (HO-1) in these human osteosarcoma cells.", {"entities": [[131, 143, "DISEASE"]]}], ["Then by analyzing HO-1 mRNA of MG63 cells exposed to ATO in the presence and absence of a transcription inhibitor Actinomycin-D (Act-D), we demonstrated that ATO activates HO-1 expression in MG63 cells by regulating the transcription of the gene.", {"entities": []}], ["Finally, through the analysis of the NFE2L2 protein levels among the total cellular and nuclear proteins by Western-blot and Immunocytochemical staning, we determined that ATO enhanced the nuclear translocation of nuclear factor erythroid 2-like 2 (NFE2L2) , also known as Nrf2.", {"entities": [[37, 43, "GENE"], [249, 255, "GENE"], [37, 43, "GENE"], [249, 255, "GENE"]]}], ["From these results we have concluded that transcription activation of HO-1 resulting from the nuclear translocation of NFE2L2 is the underlying molecular mechanism for its high induction, which, in turn, is responsible for the resistance of human osteosarcoma cells to ATO treatment.", {"entities": [[247, 259, "DISEASE"], [119, 125, "GENE"]]}], ["Since the now-famous storm of September 1999, the name \"Floyd\" has taken on new associations for many people in eastern North Carolina: devastation and environmental catastrophe.", {"entities": []}], ["On 12 November 1999, representatives from state and federal agencies and local universities met on the NIEHS campus in Research Triangle Park, North Carolina, to discuss the environmental health implications of the floods following Hurricane Floyd.", {"entities": []}], ["In addition to determining the potential long-term human health and ecological problems, participants hoped to develop strategies, collaborations, and partnerships to be used in the restoration of eastern North Carolina.", {"entities": []}], ["Staphylococcal enterotoxins are classified as superantigens that act by linking T-cell receptor with MHC class II molecules, which are expressed on classical antigen-presenting cells (APC).", {"entities": [[184, 187, "GENE"]]}], ["Evidence shows that MHC class II is also expressed in neutrophils and eosinophils.", {"entities": []}], ["This study aimed to investigate the role of MHC class II and IFN-\u03b3 on chemotactic and adhesion properties of neutrophils and eosinophils after incubation with SEA.", {"entities": []}], ["Bone marrow (BM) cells obtained from BALB/c mice were resuspended in culture medium, and incubated with SEA (3\u201330 ng/ml; 1\u20134 h), after which chemotaxis and adhesion were evaluated.", {"entities": []}], ["Incubation with SEA significantly reduced the chemotactic and adhesive responses in BM neutrophils activated with IL-8 (200 ng/ml).", {"entities": []}], ["Likewise, SEA significantly reduced the chemotactic and adhesive responses of BM eosinophils activated with eotaxin (300 ng/ml).", {"entities": []}], ["The inhibitory effects of SEA on cell chemotaxis and adhesion were fully prevented by prior incubation with an anti-MHC class II blocking antibody (2 \u03bcg/ml).", {"entities": []}], ["SEA also significantly reduced the intracellular Ca P < 0.05) the INF-\u03b3 levels in BM cells.", {"entities": []}], ["Incubation of BM leukocytes with IFN-\u03b3 (10 ng/ml, 2 h) reduced both neutrophil and eosinophil chemotaxis and adhesion, which were prevented by prior incubation with anti-MHC class II antibody (2 \u03bcg/ml).", {"entities": []}], ["In conclusion, SEA inhibits neutrophil and eosinophil by MHC class II-dependent mechanism, which may be modulated by concomitant release of IFN-\u03b3.", {"entities": []}], ["Abnormal Savda Munziq (ASMq) is a traditional prescription in Uyghur Medicine, and its treatment of complex diseases such as tumors and asthma has been proven to be effective in Uyghur medical clinical practice.", {"entities": [[136, 142, "DISEASE"]]}], ["The efficacy-enhancing and toxicity-reducing properties of ASMq were studied on mice with transplanted cervical cancer (U27) tumors, which were treated with 5-fluorouracil (5-FU) in this work.", {"entities": [[112, 118, "DISEASE"], [103, 118, "DISEASE"]]}], ["To investigate the synergistic effect of ASMq and 5-FU on U27 cells, inhibitory effects on cell proliferation were determined through a MTT assay.", {"entities": []}], ["48 Kunming mice which were randomly divided in to 6 groups: control group, model group, 5-FU group, 5-FU combine with ASMq low-dose group, 5-FU combine with ASMq medium-dose group, and 5-FU combine with ASMq high- dose group, the inhibition rate of the tumor, the viscera indexes, and the content of serum tumor necrosis factor-\u03b1 (TNF-\u03b1), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined.", {"entities": []}], ["The expression levels of transforming growth factor-\u03b21 (TGF-\u03b21) and human papillomavirus type 16 E2 (HPV16 E2) protein were assessed by Western blot.", {"entities": []}], ["Pathological changes in the liver were observed.", {"entities": []}], ["The inhibition rates of tumors, the 5-FU\u00a0+\u00a0ASMq.H group(80.64%), 5-FU\u00a0+\u00a0ASMq.M group (90.67%), 5-FU\u00a0+\u00a0ASMq.L group (72.03%) and 5-FU group (66.89%), clearly indicated that the effects of tumor inhibition.", {"entities": []}], ["The thymus index and spleen index were increased, and the serum concentration of TNF-\u03b1 increased while ALT and AST concentrations were decreased, and TNF-\u03b1 protein expression were increased while TGF-\u03b21 and HPV16 E2 were decreased.", {"entities": []}], ["ASMq might can improve livers central vein hyperemia and interstitial edema, and preserve the radial structure of the hepatic cords.", {"entities": []}], ["The results suggested that ASMq might reduce toxicity and enhance the efficacy of the chemotherapeutic drug 5-fluorouracil in the treatment of cervical carcinoma.", {"entities": [[152, 161, "DISEASE"]]}], ["The oral prednisolone test is widely used to distinguish chronic obstructive pulmonary disease (COPD) patients who might benefit from inhaled steroid treatment.", {"entities": [[57, 94, "DISEASE"]]}], ["Previous studies used selected patient groups that did not represent the large COPD population in primary care.", {"entities": []}], ["The study included smokers and exsmokers with chronic bronchitis or COPD from primary care, who underwent prednisolone testing (30 mg for 14 days) before randomization in a three-year follow-up randomized controlled trial (COOPT Study).", {"entities": [[54, 64, "DISEASE"]]}], ["Spirometry was performed before and after the test.", {"entities": []}], ["Responders and nonresponders were classified according to international criteria.", {"entities": []}], ["Effectiveness of inhaled fluticasone relative to placebo was compared in terms of health status (Chronic Respiratory Disease Questionnaire), exacerbations, and postbronchodilator forced expiratory volume in one second (FEV 1 ), using repeated measurement analysis.", {"entities": [[219, 222, "GENE"]]}], ["Two hundred eighty-six patients recruited from 44 primary care practices were randomized.", {"entities": []}], ["Nine percent to 16% of the COPD population was classified as responder, depending on the international guideline criteria used.", {"entities": []}], ["On average, responders did not reach the minimum clinically important difference in health status (0.29 points/year, P = 0.05), although a borderline significant effect of inhaled fluticasone was noted.", {"entities": []}], ["Possible clinically relevant reductions in exacerbation rate (rate ratio 0.67) and FEV 1 decline (39 mL/year) occurred in responders, but did not reach statistical significance.", {"entities": [[83, 86, "GENE"]]}], ["Oral steroid testing identifies a limited proportion of COPD patients, but does not reveal any clinically relevant benefit from inhaled steroid treatment on health status.", {"entities": []}], ["No significant effects on exacerbation rate and lung function decline occurred.", {"entities": []}], ["BACKGROUND: Rat trachea display a differential topographical distribution of connective tissue mast cells (CTMC) and mucosal mast cells (MMC) that may imply regional differences in the release of allergic mediators such as tumor necrosis factor-alpha (TNF-alpha) and eicosanoids.", {"entities": []}], ["AIM: To evaluate the role of CTMC and MMC for release of TNF-alpha and eicosanoids after allergenic challenge in distinct segments of rat trachea.", {"entities": []}], ["MATERIALS AND METHODS: Proximal trachea (PT) and distal trachea (DT) from ovalbumin (OVA)-sensitized rats, treated or not with compound 48/80 (48/80) or dexamethasone, were incubated in culture medium.", {"entities": []}], ["After OVA challenge, aliquots were collected to study release of TNF-alpha and eicosanoids.", {"entities": []}], ["RESULTS: Release of TNF-alpha by PT upon OVA challenge peaked at 90 min and decayed at 6 and 24 h. Release from DT peaked at 30-90 min and decayed 6 and 24 h later.", {"entities": []}], ["When CTMC were depleted with 48/80, OVA challenge exacerbated the TNF-alpha release by PT at all time intervals, while DT exacerbated TNF-alpha levels 6 and 24 h later only.", {"entities": []}], ["Dexamethasone reduced TNF-alpha production after 90 min of OVA challenge in PT and at 3 and 6h in DT.", {"entities": []}], ["OVA challenge increased prostaglandin D2) in DT and leukotriene B4 in both segments but did not modify prostaglandin E2 and leukotriene C4 release.", {"entities": []}], ["CONCLUSION: OVA challenge induces TNF-alpha release from MMC, which is negatively regulated by CTMC.", {"entities": []}], ["The profile of TNF-alpha and eicosanoids depends on the time after OVA challenge and of the tracheal segment considered.", {"entities": []}], ["Gene expression data were analysed using bioinformatic tools to demonstrate molecular mechanisms underlying the glioma CpG island methylator phenotype (CIMP).", {"entities": []}], ["A gene expression data set (accession no.", {"entities": []}], ["GSE30336) was downloaded from Gene Expression Omnibus, including 36 CIMP", {"entities": []}], ["The interrelationship between ionizing radiation and the immune system is complex, multifactorial, and dependent on radiation dose/quality and immune cell type.", {"entities": []}], ["High-dose radiation usually results in immune suppression.", {"entities": []}], ["On the contrary, low-dose radiation (LDR) modulates a variety of immune responses that have exhibited the properties of immune hormesis.", {"entities": []}], ["Although the underlying molecular mechanism is not fully understood yet, LDR has been used clinically for the treatment of autoimmune diseases and malignant tumors.", {"entities": []}], ["These advancements in preclinical and clinical studies suggest that LDR-mediated immune modulation is a well-orchestrated phenomenon with clinical potential.", {"entities": []}], ["We summarize recent developments in the understanding of LDR-mediated immune modulation, with an emphasis on its potential clinical applications.", {"entities": []}], ["Policy makers should understand the attitudes and beliefs of their constituents regarding smoke-free air legislation.", {"entities": []}], ["The purpose of this study was to evaluate the effect of selected personal characteristics on attitudes and beliefs about secondhand smoke in Indiana and on support for smoke-free air laws.", {"entities": []}], ["Data were obtained from the 2008 Indiana Adult Tobacco Survey of 2,140 adults and included 11 sociodemographic variables.", {"entities": []}], ["Chi-square and multiple logistic regression analyses were used to test for significant associations between sociodemographic characteristics and support for statewide or community smoke-free air legislation.", {"entities": []}], ["Most respondents (72.3%) indicated that they supported laws making work places smoke-free.", {"entities": []}], ["After adjusting for the effects of the other variables, 3 were found to be significant predictors of support: being a never or former smoker, being female, and being aware of the health hazards of secondhand smoke.", {"entities": []}], ["Age, race/ethnicity, income, urban or rural county of residence, employment status, and having children in the household were not significant when adjusting for the other characteristics.", {"entities": []}], ["Most Indiana residents support smoke-free air legislation for workplaces.", {"entities": []}], ["The support was constant among most groups across the state, suggesting policy makers would have the backing of their constituents to pass such legislation.", {"entities": []}], ["The results of this study suggest that efforts to gain support for smoke-free air laws should focus on men, people unaware of the health hazards from secondhand smoke, and smokers and former smokers.", {"entities": []}], ["The sensitization to more allergens, such as polysenitization, is becoming a frequent characteristic of allergic patients, since the childhood.", {"entities": []}], ["However, this phenomenon is considered an obstacle to prescribe immunotherapy by many doctors.", {"entities": []}], ["This study investigated the relevance of polysensitization in a cohort of allergic children and evaluated the number of allergen extracts prescribed for these children.", {"entities": []}], ["There are allergens that are frequent, but not prescribed.", {"entities": []}], ["This issue should be matter of adequate debate for Italian paediatricians.", {"entities": []}], ["Women who smoke have higher risk of lung function impairment, COPD and lung cancer than smoking men.", {"entities": [[71, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["An influence of sex hormones has been demonstrated, but the mechanisms are unclear and the associations often subject to confounding.", {"entities": []}], ["This was a study of wheeze in relation to smoking and sex with adjustment for important confounders.", {"entities": []}], ["In 2008 the Global Allergy and Asthma European Network (GA Any wheeze and asthmatic wheeze was reported by 17.3% and 7.1% of women, vs. 15.8% and 6.1% of men (both p<0.001).", {"entities": [[31, 37, "DISEASE"]]}], ["Although smoking prevalence was similar in both sexes, men had greater cumulative exposure, 16.2 pack-years vs. 12.8 in women (p<0.001).", {"entities": []}], ["Most other exposures and characteristics associated with wheeze were significantly overrepresented in men.", {"entities": []}], ["Adjusted for these potential confounders and pack-years, current smoking was a stronger risk factor for any wheeze in women aged <53 years, adjusted odds ratio (aOR) 1.85 (1.56\u20132.19) vs. 1.60 (1.30\u20131.96) in men.", {"entities": []}], ["Cumulative smoke exposure and current smoking each interacted significantly with female sex, aOR 1.02 per pack-year (p<0.01) and aOR 1.28 (p\u200a=\u200a0.04) respectively.", {"entities": []}], ["Female compared to male current smokers also had greater risk of asthmatic wheeze, aOR 1.53 vs. 1.03, interaction aOR 1.52 (p\u200a=\u200a0.02).", {"entities": []}], ["These interactions were not seen in age \u226553 years.", {"entities": []}], ["In addition to the increased risk of COPD and lung cancer female, compared to male, smokers are at greater risk of significant wheezing symptoms in younger age.", {"entities": [[46, 57, "DISEASE"], [51, 57, "DISEASE"]]}], ["This became clearer after adjustment for important confounders including cumulative smoke exposure.", {"entities": []}], ["Estrogen has previously been shown to increase the bioactivation of several compounds in tobacco smoke, which may enhance smoke-induced airway inflammation in fertile women.", {"entities": []}], ["Scabies is a common and distressing disease caused by the mite Sarcoptes scabiei var.", {"entities": [[0, 7, "DISEASE"]]}], ["Psychiatric disorder in childhood is an important disease and easily neglected.", {"entities": []}], ["There are several similarities in scabies and psychiatric disorders in childhood (PDC).", {"entities": [[34, 41, "DISEASE"], [82, 85, "GENE"]]}], ["Both of them may present with pruritus.", {"entities": []}], ["They are relatively common in patients with lower socioeconomic status and crowded environment.", {"entities": []}], ["Furthermore, immune-mediated inflammatory processes play a role in the pathophysiology in both diseases.", {"entities": []}], ["An association between scabies and psychiatric disorders may exist.", {"entities": [[23, 30, "DISEASE"]]}], ["This nationwide population-based cohort study utilized data from the National Health Insurance Research Database to investigate the relationship between scabies and PDC.", {"entities": [[153, 160, "DISEASE"], [165, 168, "GENE"]]}], ["A total of 2137 children with scabies were identified as the study group and 8548 age- and sex-matched children were selected as the control group.", {"entities": [[30, 37, "DISEASE"]]}], ["A total of 607 (5.68%) children developed PDC during the 7-year follow-up period.", {"entities": [[42, 45, "GENE"]]}], ["The overall incidences of PDC are similar but patients with scabies had a higher risk of developing intellectual disability (ID) (scabies group vs control group: 1.3% vs 0.6%, adjusted hazard ratio: 2.04 and 95% confidence interval: 1.25\u20133.32).", {"entities": [[60, 67, "DISEASE"], [130, 137, "DISEASE"], [100, 123, "DISEASE"], [26, 29, "GENE"]]}], ["The immune-mediated inflammatory processes of both diseases were reviewed and may contribute to the 104% increased risk of interleukin in patients with scabies.", {"entities": [[152, 159, "DISEASE"]]}], ["We suggest a more comprehensive management in treating patients with scabies or ID.", {"entities": [[69, 76, "DISEASE"]]}], ["Early and comprehensive treatment of scabies and other risk factors may decrease the risk of subsequent ID.", {"entities": [[37, 44, "DISEASE"]]}], ["When we approach patients with ID, concurrent evaluation of scabies and other risk factors may contribute to successful management.", {"entities": [[60, 67, "DISEASE"]]}], ["Uncovering the underlying genetic component of any disease is key to the understanding of its pathophysiology and may open new avenues for development of therapeutic strategies and biomarkers.", {"entities": []}], ["In the past several years, there has been an explosion of genome-wide association studies (GWAS) resulting in the discovery of novel candidate genes conferring risk for complex diseases, including neurodegenerative diseases.", {"entities": []}], ["Despite this success, there still remains a substantial genetic component for many complex traits and conditions that is unexplained by the GWAS findings.", {"entities": []}], ["Additionally, in many cases, the mechanism of action of the newly discovered disease risk variants is not inherently obvious.", {"entities": []}], ["Furthermore, a genetic region with multiple genes may be identified via GWAS, making it difficult to discern the true disease risk gene.", {"entities": []}], ["Several alternative approaches are proposed to overcome these potential shortcomings of GWAS, including the use of quantitative, biologically relevant phenotypes.", {"entities": []}], ["Gene expression levels represent an important class of endophenotypes.", {"entities": []}], ["Genetic linkage and association studies that utilize gene expression levels as endophenotypes determined that the expression levels of many genes are under genetic influence.", {"entities": []}], ["This led to the postulate that there may exist many genetic variants that confer disease risk via modifying gene expression levels.", {"entities": []}], ["Results from the handful of genetic studies which assess gene expression level endophenotypes in conjunction with disease risk suggest that this combined phenotype approach may both increase the power for gene discovery and lead to an enhanced understanding of their mode of action.", {"entities": []}], ["This review summarizes the evidence in support of gene expression levels as promising endophenotypes in the discovery and characterization of novel candidate genes for complex diseases, which may also represent a novel approach in the genetic studies of Alzheimer's and other neurodegenerative diseases.", {"entities": []}], ["We propose CHI3L1 as a prognostic biomarker for patients with epithelial ovarian carcinoma (EOC) and also suggest possible biological functions of CHI3L1.", {"entities": [[81, 90, "DISEASE"], [73, 90, "DISEASE"], [11, 17, "GENE"], [147, 153, "GENE"], [11, 17, "GENE"], [147, 153, "GENE"]]}], ["We measured CHI3L1 expression with quantitative real time-polymerase chain reaction (qRT-PCR) in 180 women with EOC and evaluated correlations between CHI3L1 expression, clinicopathological characteristics, and the outcomes of the patients.", {"entities": [[12, 18, "GENE"], [151, 157, "GENE"], [12, 18, "GENE"], [151, 157, "GENE"]]}], ["The expression of CHI3L1 was higher in cancerous tissues than in normal tissues.", {"entities": [[18, 24, "GENE"]]}], ["The expression of CHI3L1 was also higher in patients with a serous histological type, advanced stage, and chemoresistance.", {"entities": [[18, 24, "GENE"]]}], ["Patients with high CHI3L1 expression had a shorter progression-free survival ( p < 0.001) and overall survival ( p < 0.001).", {"entities": [[19, 25, "GENE"]]}], ["Patients with high CHI3L1 expression also had a high risk of recurrence ( p < 0.001) and death ( p < 0.001).", {"entities": [[19, 25, "GENE"]]}], ["In vitro studies showed that CHI3L1 up-regulated the expression of anti-apoptotic Mcl-1 protein and hampered paclitaxel-induced apoptosis of ovarian cancer cells.", {"entities": [[141, 155, "DISEASE"], [149, 155, "DISEASE"], [29, 35, "GENE"]]}], ["These results suggest that CHI3L1 shows potential as a prognostic biomarker for EOC.", {"entities": [[27, 33, "GENE"]]}], ["CHI3L1 may promote chemoresistance via inhibition of drug-induced apoptosis by up-regulating Mcl-1.", {"entities": [[0, 6, "GENE"]]}], ["Myocardial infarction (MI) is an ischaemic heart condition caused by the occlusion of coronary arteries.", {"entities": []}], ["Following MI, lactic acid from anaerobic glycolysis increases and infiltrating immune cells produce severe inflammation, which leads to acidosis in the ischaemic heart.", {"entities": []}], ["However, the physiological implication of this pH reduction remains largely unknown.", {"entities": []}], ["T-cell death-associated gene 8 (TDAG8) is a proton-sensing G protein-coupled receptor found on cardiac macrophages that recognise increases in extracellular protons.", {"entities": []}], ["We demonstrated that TDAG8 negatively regulates the transcription of the chemokine Ccl20 .", {"entities": [[83, 88, "GENE"]]}], ["The infarcted hearts of TDAG8 KO mice showed an increase in CCL20 expression and the number of infiltrating IL-17A-producing \u03b3\u03b4T cells that express CCR6, a receptor for CCL20.", {"entities": [[60, 65, "GENE"], [169, 174, "GENE"], [148, 152, "GENE"], [60, 65, "GENE"], [169, 174, "GENE"]]}], ["Accordingly, excessive IL-17A production, which is linked to the functional deterioration after MI, was observed in MI-operated TDAG8 KO mice.", {"entities": []}], ["The survival rate and cardiac function significantly decreased in TDAG8 KO mice compared with those in wild-type mice after MI.", {"entities": []}], ["Thus, our results suggest that TDAG8 is a key regulator of MI and a potential therapeutic target.", {"entities": []}], ["Early identification of predictors for a poor long-term outcome in patients who survive the initial phase of out-of-hospital cardiac arrest (OHCA) may facilitate future clinical research, the process of care and information provided to relatives.", {"entities": []}], ["The aim of this study was to determine the association between variables available from the patient\u2019s history and status at intensive care admission with outcome in unconscious survivors of OHCA.", {"entities": []}], ["Using the cohort of the Target Temperature Management trial, we performed a post hoc analysis of 933 unconscious patients with OHCA of presumed cardiac cause who had a complete 6-month follow-up.", {"entities": []}], ["Outcomes were survival and neurological function as defined by the Cerebral Performance Category (CPC) scale at 6\u00a0months after OHCA.", {"entities": []}], ["After multiple imputations to compensate for missing data, backward stepwise multivariable logistic regression was applied to identify factors independently predictive of a poor outcome (CPC 3\u20135).", {"entities": []}], ["On the basis of these factors, a risk score for poor outcome was constructed.", {"entities": []}], ["We identified ten independent predictors of a poor outcome: older age, cardiac arrest occurring at home, initial rhythm other than ventricular fibrillation/tachycardia, longer duration of no flow, longer duration of low flow, administration of adrenaline, bilateral absence of corneal and pupillary reflexes, Glasgow Coma Scale motor response 1, lower pH and a partial pressure of carbon dioxide in arterial blood value lower than 4.5 kPa at hospital admission.", {"entities": []}], ["A risk score based on the impact of each of these variables in the model yielded a median (range) AUC of 0.842 (0.840\u20130.845) and good calibration.", {"entities": []}], ["Internal validation of the score using bootstrapping yielded a median (range) AUC corrected for optimism of 0.818 (0.816\u20130.821).", {"entities": []}], ["Among variables available at admission to intensive care, we identified ten independent predictors of a poor outcome at 6\u00a0months for initial survivors of OHCA.", {"entities": []}], ["They reflected pre-hospital circumstances (six variables) and patient status on hospital admission (four variables).", {"entities": []}], ["By using a simple and easy-to-use risk scoring system based on these variables, patients at high risk for a poor outcome after OHCA may be identified early.", {"entities": []}], ["To determine the portion sizes of traditional and non-traditional foods being consumed by Inuit adults in three remote communities in Nunavut, Canada.", {"entities": []}], ["A cross-sectional study was carried out between June and October, 2008.", {"entities": []}], ["Trained field workers collected dietary data using a culturally appropriate, validated quantitative food frequency questionnaire (QFFQ) developed specifically for the study population.", {"entities": []}], ["Caribou, muktuk (whale blubber and skin) and Arctic char (salmon family), were the most commonly consumed traditional foods; mean portion sizes for traditional foods ranged from 10\u2009g for fermented seal fat to 424\u2009g for fried caribou.", {"entities": []}], ["Fried bannock and white bread were consumed by >85% of participants; mean portion sizes for these foods were 189\u2009g and 70\u2009g, respectively.", {"entities": []}], ["Sugar-sweetened beverages and energy-dense, nutrient-poor foods were also widely consumed.", {"entities": []}], ["Mean portion sizes for regular pop and sweetened juices with added sugar were 663\u2009g and 572\u2009g, respectively.", {"entities": []}], ["Mean portion sizes for potato chips, pilot biscuits, cakes, chocolate and cookies were 59\u2009g, 59\u2009g, 106\u2009g, 59\u2009g, and 46\u2009g, respectively.", {"entities": []}], ["The present study provides further evidence of the nutrition transition that is occurring among Inuit in the Canadian Arctic.", {"entities": []}], ["It also highlights a number of foods and beverages that could be targeted in future nutritional intervention programs aimed at obesity and diet-related chronic disease prevention in these and other Inuit communities.", {"entities": [[127, 134, "DISEASE"]]}], ["The development of many common complex diseases depends on the interactions between genetic factors (GF) and environmental factors (EF).", {"entities": []}], ["Non-coding RNAs have been identified as major players in regulation of gene expression responding to environmental cues.", {"entities": []}], ["In recent years, lots of studies have reported that the dysfunctions of long non-coding RNA (lncRNAs), EFs and their inter-actions have strong effects on phenotypes.", {"entities": [[103, 106, "GENE"]]}], ["However, compared with protein coding genes and microRNAs, there is a paucity of bioinformatics resource platform for understanding the disease mechanism in the level of lncRNA-EF interactions.", {"entities": []}], ["In this study, we constructed the Disease Related LncRNA-EF Interaction Database (DLREFD), which contains a comprehensive collection and curation of experimentally supported interactions among lncRNAs, EFs and phenotypes.", {"entities": [[202, 205, "GENE"]]}], ["It integrated 835 entries, 475 LncRNAs, 153 EFs and 124 phenotypes.", {"entities": [[44, 47, "GENE"]]}], ["The names of lncRNAs, phenotypes, EFs, conditions of EFs, samples, species, evidence and references were further annotated.", {"entities": [[34, 37, "GENE"], [53, 56, "GENE"], [34, 37, "GENE"], [53, 56, "GENE"]]}], ["We hope DLREFD will be a useful resource for researches on lncRNAs, EFs and diseases.", {"entities": [[68, 71, "GENE"]]}], ["Database URL: http://chengroup.cumt.edu.cn/DLREFD", {"entities": []}], ["Depression may be accompanied by increased oxidative stress and decreased circulating anti-oxidants.", {"entities": []}], ["This study examines the association between depressive symptoms, F2-isoprostanes and carotenoids in a US community sample.", {"entities": []}], ["The study includes 3009 participants (mean age 40.3, 54.2% female) from CARDIA (Coronary Artery Risk Development in Young Adults).", {"entities": []}], ["Cross-sectional analyses were performed on data from the year 15 examination (2000\u20132001) including subjects whose depressive symptoms were assessed with the Center for Epidemiologic Studies Depression Scale (CES-D) and had measurements of plasma F2-isoprostanes (gas chromatography/mass spectrometry) or serum carotenoids (high-performance liquid chromatography).", {"entities": []}], ["Carotenoids zeaxanthin/lutein, \u03b2-cryptoxanthin, lycopene, \u03b1-carotene, \u03b2-carotene were standardized and summed.", {"entities": []}], ["Longitudinal analyses were conducted using the data from other examinations at 5-year intervals.", {"entities": []}], ["Cross-lagged analyses investigated whether CES-D predicted F2-isoprostanes or carotenoids at the following exam, and vice versa.", {"entities": []}], ["Regression analyses were controlled for sociodemographics, health and lifestyle factors.", {"entities": []}], ["F2-isoprostanes were higher in subjects with depressive symptoms (CES-D\u2a7e16) after adjustment for sociodemographics (55.7 vs 52.0 pg\u2009ml d =0.14, P <0.001).", {"entities": []}], ["There was no difference in F2-isoprostanes after further adjustment for health and lifestyle factors.", {"entities": []}], ["Carotenoids were lower in those with CES-D scores \u2a7e16, even after adjustment for health and lifestyle factors (standardized sum 238.7 vs 244.0, Cohen's d =\u22120.16, P <0.001).", {"entities": []}], ["Longitudinal analyses confirmed that depression predicts subsequent F2-isoprostane and carotenoid levels.", {"entities": []}], ["Neither F2-isoprostanes nor carotenoids predicted subsequent depression.", {"entities": []}], ["In conclusion, depressive symptoms were cross-sectionally and longitudinally associated with increased F2-isoprostanes and decreased carotenoids.", {"entities": []}], ["The association with F2-isoprostanes can largely be explained by lifestyle factors, but lower carotenoids were independently associated with depressive symptoms.", {"entities": []}], ["Studies of the genetics of gene expression reveal expression SNPs that explain variation in transcript abundance.", {"entities": []}], ["Here we address the robustness of eSNP associations to environmental geography and population structure in a comparison of 194 Arab and Amazigh individuals from a city and two villages in southern Morocco.", {"entities": []}], ["Gene expression differed between pairs of locations for up to a third of all transcripts, with notable enrichment for ribosomal biosynthesis and oxidative phosphorylation.", {"entities": []}], ["Robust associations were observed in the leukocyte samples with cis -eSNPs ( P < 10 trans -eSNPs ( P < 10 trans -acting mediators of the pervasive environmental influence was found and instead genetic and environmental factors acted in a largely additive manner.", {"entities": []}], ["About 50% of patients do not take their long-term therapy for chronic conditions as prescribed.", {"entities": []}], ["Many studies have centered on patients\u2019 adherence to a specific treatment or single conditions, but few have taken all chronic conditions into consideration from a patient\u2019s perspective.", {"entities": []}], ["This study aims to explore factors that impact on drug compliance and to identify strategies to improve this from the perspective of patients with at least one chronic condition.", {"entities": []}], ["Patients were recruited by healthcare professionals from a hospital pharmacy, four community pharmacies, patient associations, and a primary care center in Barcelona.", {"entities": []}], ["Five focus groups were conducted ( N \u00a0=\u00a036).", {"entities": []}], ["Conversations were audiotaped and transcribed verbatim to allow qualitative analysis.", {"entities": []}], ["Study subjects were aged 39\u201390\u00a0years (mean 65\u00a0years) and the mean number of comorbidities per patient was 2.3 (range 1\u20137).", {"entities": []}], ["The main modifiers of therapeutic conduct were: patients\u2019 health beliefs, patient\u2013prescriber relationships, and patients\u2019 motivation and perception of illness control.", {"entities": []}], ["Study participants wanted greater participation in decision-making concerning their health and increased education about their illness and medication.", {"entities": []}], ["They also wanted individualized healthcare that took their preferences and personal and emotional issues into account.", {"entities": []}], ["Our results highlight how the patient\u2013prescriber\u2019s relationship and factors such as health beliefs, motivation and perception of illness control impact on medication adherence in chronic patients.", {"entities": []}], ["Future interventions to optimize adherence to treatment should focus on shared decision-making and more extensive health education.", {"entities": []}], ["Celgene Corporation.", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-016-0394-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Near-perfect adherence to antiretroviral therapy (ART) is required to achieve the best possible prevention and treatment outcomes.", {"entities": []}], ["Yet, there have been particular concerns about the challenges of adherence among patients living in resource-limited settings in sub-Saharan Africa.", {"entities": []}], ["The primary objective of this study was to explore adherence in a low-resourced, rural community of high HIV prevalence in South Africa and to identify specific individual and structural factors that can either challenge or support adherence in this context.", {"entities": []}], ["We applied digital stories as a qualitative research tool to gain insights into personal contexts of HIV and ART adherence.", {"entities": []}], ["Through an inductive thematic analysis of twenty story texts, soundtracks and drawings, we explored experiences, understandings, and contexts of the participants and identified potential barriers and facilitators for those on lifelong treatment.", {"entities": []}], ["We found that many of the stories reflected a growing confidence in the effectiveness of ART, which should be viewed as a key facilitator to successful adherence since this attitude can promote disclosure and boost access to social support.", {"entities": []}], ["Nevertheless, stories also highlighted the complexity of the issues that individuals and households face as they deal with HIV and ART in this setting and it is clear that an overburdened local healthcare system has often struggled to meet the demands of a rapidly expanding epidemic and to provide the necessary medical and emotional support.", {"entities": []}], ["Our analysis suggests several opportunities for further research and the design of novel health interventions to support optimal adherence.", {"entities": []}], ["Firstly, future health promotion campaigns should encourage individuals to test together, or at least accompany each other for testing, to encourage social support from the outset.", {"entities": []}], ["Additionally, home-based testing and ART club interventions might be recommended to make it easier for individuals to adhere to their treatment regimens and to provide a sense of support and solidarity.", {"entities": []}], ["Assessing change remains a challenge in patient-reported outcomes.", {"entities": []}], ["In June 2009, a group of psychometricians, biostatisticians, and behavioral researchers from other disciplines convened as a Longitudinal Analysis of Patient-Reported Outcomes Working group as part of the Statistical and Applied Mathematical Sciences Institute Summer Psychometric program to discuss the complex issues that arise when conceptualizing and operationalizing \u201cchange\u201d in patient-reported outcome (PRO) measures and related constructs.", {"entities": []}], ["This white paper summarizes these issues and provides recommendations and possible paths for dealing with the complexities of measuring change.", {"entities": []}], ["This article presents and discusses issues associated with: (1) conceptualizing and operationalizing change in PRO measures; (2) modeling change using state-of-the-art statistical methods; (3) impediments to detecting true change; (4) new developments to deal with these challenges; and (5) important gaps that are fertile ground for future research.", {"entities": []}], ["There was a consensus that important research still needs to be performed in order develop and refine high-quality PRO measures and statistical methods to analyze and model change in PRO constructs.", {"entities": []}], ["It has been established that sublingual (SL) route of misoprostol has a great potential to be developed for medical abortion, but there is dearth of evidence to reveal satisfaction rate and safety profile among patients of oral and SL routes.", {"entities": []}], ["Thus, this study was conducted to provide an insight into the acceptability and safety profile of the same.", {"entities": []}], ["A randomized controlled trial was carried out by giving 200 mg mifepristone orally, followed by administration of 600 \u03bc g misoprostol orally to 50 women and sublingually to 50 women.", {"entities": []}], ["The primary endpoints of study were measurements of acceptability and safety profile parameters (average blood loss, nausea, vomiting, diarrhea, hot flushes, fever) of both the groups.", {"entities": [[135, 143, "DISEASE"]]}], ["The secondary endpoints of the study were number of doses required for complete abortion, success rate and the induction to evacuation interval in both the groups.", {"entities": []}], ["SL route of administration was more acceptable than the oral route ( P = 0.009).", {"entities": []}], ["Average blood loss was higher in the oral group than in the SL group ( P = 0.001).", {"entities": []}], ["Amongst the side effects, 34% in the SL group and 52% in the oral group had nausea ( P = 0.264), 22% in the SL group and 44% in the oral group had vomiting ( P = 0.031), 48% in the SL group and 86% in the oral group had diarrhea ( P < 0.05), hot flushes were presented by 24% in the SL group and 50% in the oral group ( P < 0.05), fever was presented by 20% in the SL group and 44% in the oral group ( P < 0.05), and the number of cases aborted with only one dose was higher (86%) in the SL group as compared to 63% in the oral group ( P = 0.004).", {"entities": [[220, 228, "DISEASE"]]}], ["The evacuation (success) rates were 92% in the SL group and 84% in the oral group ( P = 0.218) and the mean \u00b1 SD induction to evacuation intervals in the SL and oral groups were 5.6 \u00b1 4.54 hours and 9.44 \u00b1 5.61 hours, respectively ( P = 0.0002).", {"entities": []}], ["The SL route had fewer undesirable effects, was more satisfactory, required less number of doses and was more acceptable to the patient compared to the oral route.", {"entities": []}], ["Obliterative bronchiolitis (OB) is an irreversible lung disease characterized by progressive fibrosis in the small airways with eventual occlusion of the airway lumens.", {"entities": [[51, 63, "DISEASE"], [13, 26, "DISEASE"]]}], ["OB is most commonly associated with lung transplant rejection; however, OB has also been diagnosed in workers exposed to artificial butter flavoring (ABF) vapors.", {"entities": []}], ["Research has been limited by the lack of an adequate animal model of OB, and as a result the mechanism(s) is unclear and there are no effective treatments for this condition.", {"entities": []}], ["Exposure of rats to the ABF component, 2,3-pentanedione (PD) results in airway lesions that are histopathologically similar to those in human OB.", {"entities": []}], ["We used this animal model to evaluate changes in gene expression in the distal bronchi of rats with PD-induced OB.", {"entities": []}], ["Male Wistar Han rats were exposed to 200 ppm PD or air 6 h/d, 5 d/wk for 2-wks.", {"entities": []}], ["Bronchial tissues were laser microdissected from serial sections of frozen lung.", {"entities": []}], ["In exposed lungs, both fibrotic and non-fibrotic airways were collected.", {"entities": []}], ["Following RNA extraction and microarray analysis, differential gene expression was evaluated.", {"entities": []}], ["In non-fibrotic bronchi of exposed rats, 4683 genes were significantly altered relative to air-exposed controls with notable down-regulation of many inflammatory cytokines and chemokines.", {"entities": []}], ["In contrast, in fibrotic bronchi, 3807 genes were significantly altered with a majority of genes being up-regulated in affected pathways.", {"entities": []}], ["Tgf-\u03b22 and downstream genes implicated in fibrosis were significantly up-regulated in fibrotic lesions.", {"entities": []}], ["Genes for collagens and extracellular matrix proteins were highly up-regulated.", {"entities": []}], ["In addition, expression of genes for peptidases and peptidase inhibitors were significantly altered, indicative of the tissue remodeling that occurs during airway fibrosis.", {"entities": []}], ["Our data provide new insights into the molecular mechanisms of OB.", {"entities": []}], ["This new information is of potential significance with regard to future therapeutic targets for treatment.", {"entities": []}], ["Airway epithelial cells (AEC) act as the first line of defence in case of lung infections.", {"entities": []}], ["They constitute a physical barrier against pathogens and they participate in the initiation of the immune response.", {"entities": []}], ["Yet, the modalities of pathogen recognition by AEC and the consequences on the epithelial barrier remain poorly documented.", {"entities": []}], ["We investigated the response of primary human AEC to viral (polyinosinic-polycytidylic acid, poly(I:C)) and bacterial (lipopolysaccharide, LPS) stimulations in combination with the lung remodeling factor Transforming Growth Factor-\u03b2 (TGF-\u03b2).", {"entities": []}], ["We showed a strong production of pro-inflammatory cytokines (Interleukin (IL)-6, Tumor Necrosis Factor \u03b1, TNF\u03b1) or chemokines (CCL2, CCL3, CCL4, CXCL10, CXCL11) by AEC stimulated with poly(I:C).", {"entities": [[127, 131, "GENE"], [133, 137, "GENE"], [139, 143, "GENE"], [145, 151, "GENE"], [153, 159, "GENE"]]}], ["Cytokine and chemokine production, except CXCL10, was Toll Like Receptor (TLR)-3 dependent and although they express TLR4, we found no cytokine production after LPS stimulation.", {"entities": [[42, 48, "GENE"], [117, 121, "GENE"]]}], ["Poly(I:C), but not LPS, synergised with TGF-\u03b2 for the production of matrix metalloproteinase-9 (MMP-9) and fibronectin.", {"entities": []}], ["Mechanistic analyses suggest the secretion of Wnt ligands by AEC along with a degradation of the cellular junctions after poly(I:C) exposure, leading to the release of \u03b2-catenin from the cell membrane and stimulation of the Wnt/\u03b2-catenin pathway.", {"entities": []}], ["Our results highlight the cross talk between TGF-\u03b2 and TLR signaling in bronchial epithelium and its impact on the remodeling process.", {"entities": []}], ["The online version of this article (10.1186/s12931-017-0690-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We have recently shown by formally modelling human protein interaction networks (PINs) as metric spaces and classified proteins into zones based on their distance from the topological centre that hub proteins are primarily centrally located.", {"entities": []}], ["We also showed that zones closest to the network centre are enriched for critically important proteins and are also functionally very specialised for specific \u2018house keeping\u2019 functions.", {"entities": []}], ["We proposed that proteins closest to the network centre may present good therapeutic targets.", {"entities": []}], ["Here, we present multiple pieces of novel functional evidence that provides strong support for this hypothesis.", {"entities": []}], ["We found that the human PINs has a highly connected signalling core, with the majority of proteins involved in signalling located in the two zones closest to the topological centre.", {"entities": []}], ["The majority of essential, disease related, tumour suppressor, oncogenic and approved drug target proteins were found to be centrally located.", {"entities": []}], ["Similarly, the majority of proteins consistently expressed in 13 types of cancer are also predominantly located in zones closest to the centre.", {"entities": [[74, 80, "DISEASE"]]}], ["Proteins from zones 1 and 2 were also found to comprise the majority of proteins in key KEGG pathways such as MAPK-signalling, the cell cycle, apoptosis and also pathways in cancer, with very similar patterns seen in pathways that lead to cancers such as melanoma and glioma, and non-neoplastic diseases such as measles, inflammatory bowel disease and Alzheimer\u2019s disease.", {"entities": [[321, 347, "DISEASE"], [312, 319, "DISEASE"], [255, 263, "DISEASE"], [174, 180, "DISEASE"]]}], ["Based on the diversity of evidence uncovered, we propose that when considered holistically, proteins located centrally in the human PINs that also have similar functions to existing drug targets are good candidate targets for novel therapeutics.", {"entities": []}], ["Similarly, since disease pathways are dominated by centrally located proteins, candidates shortlisted in genome scale disease studies can be further prioritized and contextualised based on whether they occupy central positions in the human PINs.", {"entities": []}], ["Preexposure prophylaxis is a highly protective HIV prevention strategy, yet nonadherence can significantly reduce its effectiveness.", {"entities": []}], ["We conducted a mixed methods evaluation of a mobile health intervention (iText) that utilized weekly bidirectional text or e-mail support messages to encourage preexposure prophylaxis (PrEP) adherence among participants in the multi-site iPrEx open-label extension study.", {"entities": []}], ["A convenience sample of PrEP users from the San Francisco and Chicago sites participated in a 12-week pilot study.", {"entities": []}], ["Fifty-six men who have sex with men were enrolled; a quarter of them were less than 30 years of age, 13% were black/African American, 11% were Latino, and most (88%) completed some college.", {"entities": []}], ["Two-thirds opted for text message delivery.", {"entities": []}], ["Of the 667 messages sent, only 1 individual requested support; initial nonresponse was observed in 22% and was higher among e-mail compared to text message recipients.", {"entities": []}], ["Poststudy, a majority of participants would recommend the intervention to others, especially during PrEP initiation.", {"entities": []}], ["Moreover, younger participants and men of color were more likely to report that they would use the iText strategy if it were available to them.", {"entities": []}], ["Several participants commented that while they were aware that the messages were automated, they felt supported and encouraged that \u201csomeone was always there.\u201d Study staff reported that the intervention is feasible to administer and can be incorporated readily into clinic flow.", {"entities": []}], ["A pre\u2013post intervention regression discontinuity analysis using clinic-based pill counts showed a 50% reduction in missed doses [95% confidence interval (CI) 16\u201371; p \u2009=\u20090.008] and 77% (95% CI 33\u201392; p \u2009=\u20090.007) when comparing pill counts at quarterly visits just before and after iText enrollment.", {"entities": []}], ["A mobile health intervention using weekly bidirectional messaging was highly acceptable and demonstrated promising effects on PrEP adherence warranting further evaluation for efficacy in a randomized controlled trial.", {"entities": []}], ["Chronic conditions and multimorbidity have become one of the main challenges in health care worldwide.", {"entities": []}], ["However, data on the burden of multimorbidity are still scarce.", {"entities": []}], ["The purpose of this study is to examine the association between multimorbidity and the health care utilization and costs in the Swiss community-dwelling population, taking into account several sociodemographic factors.", {"entities": []}], ["The study population consists of 229'493 individuals aged 65 or older who were insured in 2013 by the Helsana Group, the leading health insurer in Switzerland, covering all 26 Swiss cantons.", {"entities": []}], ["Multimorbidity was defined as the presence of two or more chronic conditions of a list of 22 conditions that were identified using an updated measure of the Pharmacy-based Cost Group model.", {"entities": []}], ["The number of consultations (total and divided by primary care physicians and specialists), the number of different physicians contacted, the type of physician contact (face-to-face, phone, and home visits), the number of hospitalisations and the length of stay were assessed separately for the multimorbid and non-multimorbid sample.", {"entities": []}], ["The costs (total and divided by inpatient and outpatient costs) covered by the compulsory health insurance were calculated for both samples.", {"entities": []}], ["Multiple linear regression modelling was conducted to adjust for influencing factors: age, sex, linguistic region, purchasing power, insurance plan, and nursing dependency.", {"entities": []}], ["Prevalence of multimorbidity was 76.6%.", {"entities": []}], ["The mean number of consultations per year was 15.7 in the multimorbid compared to 4.4 in the non-multimorbid sample.", {"entities": []}], ["Total costs were 5.5 times higher in multimorbid patients.", {"entities": []}], ["Each additional chronic condition was associated with an increase of 3.2 consultations and increased costs of 33%.", {"entities": []}], ["Strong positive associations with utilization and costs were also found for nursing dependency.", {"entities": []}], ["Multimorbid patients were 5.6 times more likely to be hospitalised.", {"entities": []}], ["Furthermore, results revealed a significant age-gender interaction and a socioeconomic gradient.", {"entities": []}], ["Multimorbidity is associated with substantial higher health care utilization and costs in Switzerland.", {"entities": []}], ["Quantified data on the current burden of multimorbidity are fundamental for the management of patients in health service delivery systems and for health care policy debates about resource allocation.", {"entities": []}], ["Strategies for a better coordination of multimorbid patients are urgently needed.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-015-0698-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study investigated whether sick building syndrome (SBS) complaints among office workers were associated with the indoor air quality.", {"entities": [[46, 54, "DISEASE"], [32, 54, "DISEASE"]]}], ["With informed consent, 417 employees in 87 office rooms of eight high-rise buildings completed a self-reported questionnaire for symptoms experienced at work during the past month.", {"entities": []}], ["Carbon dioxide (CO 2 ), temperature, humidity and total volatile organic compounds (TVOCs) in each office were simultaneously measured for eight office hours using portable monitors.", {"entities": []}], ["Time-averaged workday difference between the indoor and the outdoor CO 2 concentrations (dCO 2 ) was calculated as a surrogate measure of ventilation efficiency for each office unit.", {"entities": []}], ["The prevalence rates of SBS were 22.5% for eye syndrome, 15.3% for upper respiratory and 25.4% for non-specific syndromes.", {"entities": [[47, 55, "DISEASE"]]}], ["Tiredness (20.9%), difficulty in concentrating (14.6%), eye dryness (18.7%) were also common complaints.", {"entities": []}], ["The generalized estimating equations multivariate logistic regression analyses showed that adjusted odds ratios (aORs) and 95% confidence interval (CI) per 100 ppm increase in dCO 2 were significantly associated with dry throat (1.10, 95% CI = (1.00\u20131.22)), tiredness (1.16, 95% CI = (1.04\u20131.29)) and dizziness (1.22, 95% CI = (1.08\u20131.37)).", {"entities": []}], ["The ORs for per 100 ppb increases in TVOCs were also associated with upper respiratory symptoms (1.06, 95% CI = (1.04\u20131.07)), dry throat (1.06, 95% CI = (1.03\u20131.09)) and irritability (1.02, 95% CI = (1.01\u20131.04)).", {"entities": []}], ["In conclusion, the association between some SBS symptoms and the exposure to CO 2 and total VOCs are moderate but may be independently significant.", {"entities": []}], ["Microbial exposure early in life influences immune maturation and potentially also the development of immune-mediated disease.", {"entities": []}], ["Here we studied early-life gut colonization in relation to cytokine responses at two years of age.", {"entities": []}], ["Fecal samples were collected from infants during the first two months of life.", {"entities": []}], ["DNA was extracted from the fecal samples and Bifidobacterium (B.)", {"entities": []}], ["adolescentis , B. breve , B. bifidum , a group of lactobacilli ( L. casei , L. paracasei and L. rhamnosus ) as well as Staphylococcus (S.) aureus were detected with real time PCR.", {"entities": []}], ["Peripheral mononuclear cells were stimulated with phytohaemagglutinin (PHA) and numbers of IL-4\u2212, IL-10\u2212 and IFN-\u03b3 secreting cells were evaluated using ELISpot.", {"entities": []}], ["We further stimulated peripheral blood mononuclear cells with bacterial supernatants in vitro and assessed the IL-4\u2212, IL-10\u2212 and IFN-\u03b3 inducing capacity by flow cytometry and ELISA.", {"entities": []}], ["Early S. aureus colonization associated with higher numbers of IL-4\u2212 (p\u200a=\u200a0.022) and IL-10 (p\u200a=\u200a0.016) producing cells at two years of age.", {"entities": []}], ["In contrast to colonization with S. aureus alone, co-colonization with lactobacilli associated with suppression of IL-4\u2212 (p\u200a=\u200a0.004), IL-10\u2212 (p\u200a=\u200a0.004) and IFN-\u03b3 (p\u200a=\u200a0.034) secreting cells.", {"entities": []}], ["In vitro stimulations of mononuclear cells with bacterial supernatants supported a suppressive role of L. rhamnosus GG on S. aureus -induced cytokine responses.", {"entities": []}], ["We demonstrate that the early gut colonization pattern associates with the PHA-induced cytokine profile at two years of age and our in vitro findings support that specific bacterial species influence the T helper cell subsets.", {"entities": []}], ["This suggests that dysbiosis in the early microbiota may modulate the risk of developing inflammatory conditions like allergy.", {"entities": []}], ["Pediatric rheumatic diseases have a significant impact on children\u2019s quality of life and family functioning.", {"entities": []}], ["Disease control and management of the symptoms are important to minimize disability and pain.", {"entities": []}], ["Specialist clinical nurses play a key role in supporting medical teams, recognizing poor disease control and the need for treatment changes, providing a resource to patients on treatment options and access to additional support and advice, and identifying best practices to achieve optimal outcomes for patients and their families.", {"entities": []}], ["This highlights the importance of investigating follow-up telenursing (TN) consultations with experienced, specialist clinical nurses in rheumatology to provide this support to children and their families.", {"entities": []}], ["This randomized crossover, experimental longitudinal study will compare the effects of standard care against a novel telenursing consultation on children\u2019s and family outcomes.", {"entities": []}], ["It will examine children below 16\u00a0years old, recently diagnosed with inflammatory rheumatic diseases, who attend the pediatric rheumatology outpatient clinic of a tertiary referral hospital in western Switzerland, and one of their parents.", {"entities": []}], ["The telenursing consultation, at least once a month, by a qualified, experienced, specialist nurse in pediatric rheumatology will consist of providing affective support, health information, and aid to decision-making.", {"entities": []}], ["Cox\u2019s Interaction Model of Client Health Behavior serves as the theoretical framework for this study.", {"entities": []}], ["The primary outcome measure is satisfaction and this will be assessed using mixed methods (quantitative and qualitative data).", {"entities": []}], ["Secondary outcome measures include disease activity, quality of life, adherence to treatment, use of the telenursing service, and cost.", {"entities": []}], ["We plan to enroll 56 children.", {"entities": []}], ["The telenursing consultation is designed to support parents and children/adolescents during the course of the disease with regular follow-up.", {"entities": []}], ["This project is novel because it is based on a theoretical standardized intervention, yet it allows for individualized care.", {"entities": []}], ["We expect this trial to confirm the importance of support by a clinical specialist nurse in improving outcomes for children and adolescents with inflammatory rheumatisms.", {"entities": []}], ["ClinicalTrial.gov identifier: NCT01511341 (December 1", {"entities": []}], ["The prevalence of atopic dermatitis (AD) is low in North Africa.", {"entities": [[18, 35, "DISEASE"], [25, 35, "DISEASE"]]}], ["We describe the epidemiology of this atopic condition among school children in Tunisia.", {"entities": []}], ["We conducted a Cross-sectional survey study of 5 to 6-year-old schoolchildren from 21 primary schools of Sfax.", {"entities": []}], ["The diagnosis of AD was based on the U.K.", {"entities": []}], ["Working Party diagnostic criteria.", {"entities": []}], ["A questionnaire including these criteria and some risk factors of AD was issued to the children.", {"entities": []}], ["All children were examined by one dermatologist.", {"entities": []}], ["Among the 1617 examined children, ten had AD giving a one-year prevalence of 0.65%.", {"entities": []}], ["The overall sex ratio was 2.33.", {"entities": []}], ["The disease occurred before the age of 2 years in 3 children.", {"entities": []}], ["Pure AD without concomitant respiratory allergies was noted in 3 cases.", {"entities": []}], ["One first-degree family member with atopy was at least noted in seven children.", {"entities": []}], ["The strongest associated factor was the presence of AD in at least one parent and maternal age at the time of the child birth.", {"entities": []}], ["Nor breast-feeding neither environmental characteristics of the house did correlate with AD.", {"entities": []}], ["The prevalence of AD in Tunisian schoolchildren is low but comparable to those of other developing countries.", {"entities": []}], ["Family history of atopy and maternal age at the birth time was the most important associated factors.", {"entities": []}], ["Fentanyl-induced cough is not an uncommon condition during the induction of general anesthesia.", {"entities": []}], ["A preliminary randomized controlled study was designed to observe the effects of different priming doses of propofol on fentanyl-induced cough during anesthesia induction.", {"entities": []}], ["A total of 120 patients were randomized into 4 groups ( n = 30) to receive the intravenous injection of intralipid (group I), propofol 1 mg\u00b7kg P < 0.05).", {"entities": []}], ["Groups III and IV had a lower incidence and less severity of cough than group II ( P < 0.05).", {"entities": []}], ["In summary, a priming dose of more than 1 mg\u00b7kg", {"entities": []}], ["Diabetes mellitus (DM) belongs to the group of five leading important diseases causing death globally and remains a major health problem in Africa.", {"entities": []}], ["A number of factors such as poverty, poor eating habit, and hormonal imbalance are responsible for the occurrence of the disease.", {"entities": []}], ["It poses a major health challenge in Africa continent today and the prevalence continues to increase at an alarming rate.", {"entities": []}], ["Various treatment options particularly the usage of herbs have been effective against diabetes because they have no adverse effects.", {"entities": []}], ["Interestingly, South Africa, especially the Basotho tribe, is blessed with numerous medicinal plants whose usage in the treatment of DM has been effective since the conventional drugs are expensive and often unaffordable.", {"entities": []}], ["The present study attempted to update the various scientific evidence on the twenty-three (23) plants originating from different parts of the world but widely used by the Sotho people in the management of DM.", {"entities": []}], ["Asteraceae topped the list of sixteen (16) plant families and remained the most investigated according to this review.", {"entities": []}], ["Although limited information was obtained on the antidiabetic activities of these plants, it is however anticipated that government parastatals and scientific communities will pay more attention to these plants in future research.", {"entities": []}], ["Financial incentives appear to be effective in promoting smoking cessation in pregnancy.", {"entities": []}], ["The mechanisms by which they might operate however, are poorly understood.", {"entities": []}], ["The present study examines how financial incentives for smoking cessation during pregnancy may work, by exploring pregnant women's experiences of trying to stop smoking, within and outside of a financial incentives scheme.", {"entities": []}], ["Thirty-six (n = 36) UK-based pregnant smokers (n = 36), offered standard NHS Stop-Smoking Services, of whom twenty (n = 20) were enrolled in a financial incentives scheme for smoking cessation (n = 20) and sixteen (n = 16) were not, were interviewed about (i) their motivation to stop smoking, and (ii) the factors they perceived as influencing their quitting efforts.", {"entities": [[73, 76, "GENE"]]}], ["Framework Analysis was used to analyse the data.", {"entities": []}], ["Women in the two groups reported similar reasons for wanting to stop smoking during pregnancy.", {"entities": []}], ["However, they described dissimilar experiences of the Stop-Smoking Services, which they perceived to have differentially influenced their quit attempts.", {"entities": []}], ["Women who were incentivised reported using the services more than women who were not incentivised.", {"entities": []}], ["In addition, they described the motivating experience of being monitored and receiving feedback on their progress.", {"entities": []}], ["Non-incentivised women reported problems receiving the appropriate Nicotine Replacement Therapy, which they described as having a detrimental effect on their quitting efforts.", {"entities": []}], ["Women participating in a financial incentives scheme to stop smoking reported greater engagement with the Stop-Smoking Services, from which they described receiving more help in quitting than women who were not part of the scheme.", {"entities": []}], ["These results highlight the complexity of financial incentives schemes and the intricacies surrounding the ways in which they operate to affect smoking cessation.", {"entities": []}], ["These might involve influencing individuals' motivation and self-regulation, changing engagement with and provision of support services, or a combination of these.", {"entities": []}], ["Urologic and kidney problems are common in women across their life span and affect their daily life, including physical activity, sexual relations, social life, and future health.", {"entities": []}], ["Urological health in women is still understudied and the underlying mechanisms of female urological dysfunctions are not fully understood.", {"entities": []}], ["The Society for Women's Health Research (SWHR", {"entities": []}], ["NAFLD impacts patient reported outcomes (PROs).", {"entities": []}], ["Our aim was to assess the impact of NAFLD on patients\u2019 HRQOL.", {"entities": []}], ["National Health and Nutrition Examination Survey (NHANES) 2001\u20132011 data were used to identify adult patients with NAFLD [Fatty Liver Index (FLI)\u2009>\u200960 in absence of other liver disease and excessive alcohol >20\u00a0g/day for men, >10\u00a0g/day for women].", {"entities": [[171, 184, "DISEASE"]]}], ["Patients with other chronic diseases (ex.", {"entities": []}], ["HIV, cancer, end-stage kidney disease) were excluded.", {"entities": [[23, 37, "DISEASE"], [5, 11, "DISEASE"]]}], ["Subjects without any of these conditions were healthy controls.", {"entities": []}], ["HCV RNA (+) patients were HCV-controls.", {"entities": []}], ["All patients completed NHANES HRQOL-4 questionnaire.", {"entities": []}], ["Linear regression determined the association between NAFLD and HRQOL components adjusting for age, gender, race, and BMI.", {"entities": []}], ["Participants with complete data were included ( n \u2009=\u20099661); 3333 NAFLD (age 51\u00a0years and BMI 34\u00a0kg/m p \u2009<\u20090.001).", {"entities": []}], ["HRQOL-4 components scores 2\u20134 were lowest for HCV, followed by NAFLD and then healthy controls (p-values p \u2009=\u20090.011 to\u2009<\u2009.0001).", {"entities": []}], ["After adjustment for age, gender, race, and BMI, NAFLD patients were 18\u201320\u00a0% more likely to report days when their physical health wasn\u2019t good or were unable to perform daily activities as a result ( p \u2009<\u2009.0001).", {"entities": []}], ["NAFLD causes impairment of HRQOL.", {"entities": []}], ["As NAFLD is becoming the most important cause of CLD, its clinical and PRO impact must be assessed.", {"entities": []}], ["The properties and function of large-conductance calcium- and voltage-activated potassium (BK) channels are modified by the tissue-specific expression of regulatory \u03b21-subunits.", {"entities": []}], ["Although the short cytosolic N-terminal domain of the \u03b21-subunit is important for controlling both BK channel trafficking and function, whether the same, or different, regions of the N terminus control these distinct processes remains unknown.", {"entities": []}], ["Here we demonstrate that the first six N-terminal residues including Lys-3, Lys-4, and Leu-5 are critical for controlling functional regulation, but not trafficking, of BK channels.", {"entities": []}], ["This membrane-distal region has features of an amphipathic helix that is predicted to control the orientation of the first transmembrane-spanning domain (TM1) of the \u03b21-subunit.", {"entities": []}], ["In contrast, a membrane-proximal leucine residue (Leu-17) controls trafficking without affecting functional coupling, an effect that is in part dependent on controlling efficient endoplasmic reticulum exit of the pore-forming \u03b1-subunit.", {"entities": []}], ["Thus cell surface trafficking and functional coupling with BK channels are controlled by distinct domains of the \u03b21-subunit N terminus.", {"entities": []}], ["The purpose of this paper is to describe the background and methods of a prospective study of medical care utilization and morbidity in a fixed cohort of over 500 preschool children whose families belonged to a prepaid group practice affiliated with Yale University.", {"entities": []}], ["Following baseline interviews with their mothers, study children were followed for 12 months between 1981 and 1982.", {"entities": []}], ["Information concerning the subjects' contacts with the health care facility serving members of the group practice was collected from accompanying adults, attending clinicians, and medical records.", {"entities": []}], ["Using these data, we were able to identify episodes of care, linking all clinical visits and phone calls for single occurrences of an illness or injury.", {"entities": []}], ["The major aim of the study is to identify psychosocial determinants of pediatric utilization (for both acute and preventive care) and of childhood morbidity.", {"entities": []}], ["The possible predictors of principal interest are factors associated with the family environment, such as social stress and strain, family structure, and different aspects of the mother's social network.", {"entities": []}], ["The dual emphasis on both illness and behavior outcomes is based on the important interrelationship between epidemiologic and health services research, especially when examining psychosocial effects.", {"entities": []}], ["CXCR1, a classic GPCR that binds IL-8, plays a key role in neutrophil activation and migration by activating phospholipase C (PLC)\u03b2 through G\u03b1 15 and G\u03b1 i which generates diacylglycerol and inositol phosphates (IPs).", {"entities": [[0, 5, "GENE"]]}], ["In this study, two conserved amino acid residues of CXCR1 on the transmembrane domain (TM) 3 and TM6, Leu128 15 .", {"entities": [[52, 57, "GENE"]]}], ["The V247N mutant also constitutively activated the G\u03b1 i protein.", {"entities": []}], ["These results indicate that L128 on TM3.43 is involved in G protein coupling and receptor activation but is unimportant for ligand binding.", {"entities": []}], ["On the other hand, V247 on TM6.40 plays a critical role in maintaining the receptor in the inactive state, and the substitution of V247 impaired the receptor constraint and stabilized an active conformation.", {"entities": []}], ["Functionally, there was an increase in chemotaxis in response to IL-8 in cells expressing V247A and V247N.", {"entities": []}], ["Our findings indicate that Leu128", {"entities": []}], ["Chronic stress has been found to be a major risk factor for various human pathologies.", {"entities": []}], ["Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, which is tightly regulated via, among others, the glucocorticoid receptor (GR).", {"entities": []}], ["The activity of the GR is modulated by a variety of proteins, including the co-chaperone FK506 binding protein 51 (FKBP5).", {"entities": [[115, 120, "GENE"]]}], ["Although FKBP5 has been associated with risk for affective disorders and has been implicated in GR sensitivity, previous studies focused mainly on peripheral blood, while information about basal distribution and induction in the central nervous system are sparse.", {"entities": [[9, 14, "GENE"]]}], ["In the present study, we describe the basal expression pattern of Fkbp5 mRNA in the brain of adult male mice and show the induction of Fkbp5 mRNA via dexamethasone treatment or different stress paradigms.", {"entities": [[66, 71, "GENE"], [135, 140, "GENE"], [66, 71, "GENE"], [135, 140, "GENE"]]}], ["We could show that Fkbp5 is often, but not exclusively, expressed in regions also known for GR expression, for example the hippocampus.", {"entities": [[19, 24, "GENE"]]}], ["Furthermore, we were able to induce Fkbp5 expression via dexamethasone in the CA1 and DG subregions of the hippocampus, the paraventricular nucleus (PVN) and the central amygdala (CeA).", {"entities": [[36, 41, "GENE"], [78, 81, "GENE"]]}], ["Increase of Fkbp5 mRNA was also found after restrained stress and 24 hours of food deprivation in the PVN and the CeA, while in the hippocampus only food deprivation caused an increase in Fkbp5 mRNA.", {"entities": [[12, 17, "GENE"], [188, 193, "GENE"], [12, 17, "GENE"], [188, 193, "GENE"]]}], ["Interestingly, regions with a low basal expression showed higher increase in Fkbp5 mRNA following induction than regions with high basal expression, supporting the hypothesis that GR sensitivity is, at least partly, mediated via Fkbp5 .", {"entities": [[77, 82, "GENE"], [229, 234, "GENE"], [77, 82, "GENE"], [229, 234, "GENE"]]}], ["In addition, this also supports the use of Fkbp5 gene expression as a marker for GR sensitivity.", {"entities": [[43, 48, "GENE"]]}], ["In summary, we were able to give an overview of the basal expression of fkbp5 mRNA as well as to extend the findings of induction of Fkbp5 and its regulatory influence on GR sensitivity from peripheral blood to the brain.", {"entities": [[72, 77, "GENE"], [133, 138, "GENE"], [72, 77, "GENE"], [133, 138, "GENE"]]}], ["Vitamin D supplementation has been proposed to improve clinical symptoms during respiratory tract infections (RTIs), but results from randomized, placebo-controlled trials (RCT) are inconclusive.", {"entities": []}], ["Previously, we performed an RCT in patients with various immune-disorders and observed that supplementation with 4000 IU vitamin D/day during 12 months significantly reduced antibiotic consumption and RTIs.", {"entities": []}], ["This formed the basis for new guidelines at our unit; i.e.", {"entities": []}], ["patients with insufficient levels of 25-hydroxyvitamin D (\u226475 nmol/L) are now offered vitamin D supplementation.", {"entities": []}], ["The aim of this prospective follow-up study was to evaluate the outcome of these new recommendations with regard to antibiotic consumption in our unit.", {"entities": []}], ["277 patients with insufficiency were supplemented with vitamin D 3 , 1500\u20131600 IU/day for 12 months.", {"entities": []}], ["Each patient was its own control and data on antibiotic consumption was monitored 12 months before and 12 months after initiation of vitamin D 3 supplementation.", {"entities": []}], ["Vitamin D 3 supplementation resulted in a significantly reduced antibiotic consumption, from 20 to 15 days/patient (p<0.05).", {"entities": []}], ["The number of antibiotic-free patients increased from 52 to 81 after vitamin D 3 supplementation; OR 1.79; 95% CI 1.20\u20132.66 (p<0.01).", {"entities": []}], ["The number of antibiotic-prescriptions decreased significantly, a finding that mainly was attributed to a reduction of respiratory tract antibiotics (p<0.05).", {"entities": []}], ["Subgroup analysis showed that only patients without immunoglobulin substitution (n = 135) had a significant effect of vitamin D supplementation.", {"entities": []}], ["Vitamin D 3 supplementation of 1600 IE /day is safe to use in immunodeficient patients with 25-OHD levels less than 75 nmol/L and significantly reduced the antibiotic consumption in patients without immunoglobulin substitution.", {"entities": []}], ["The defining physical and legal characteristics of slums profoundly affect the health of these communities and may also serve as potential targets for immediate intervention.", {"entities": []}], ["Inflammation and remodeling play a role in the pathogenesis of pulmonary arterial hypertension (PAH).", {"entities": [[82, 94, "DISEASE"]]}], ["Nuclear factor-\u03baB (NF-\u03baB) and nuclear factor of activated T cells-1 (NFAT-1) participate in inflammation and remodeling in a number of diseases.", {"entities": []}], ["As a tryptophan hydroxylase inhibitor, 4-chloro-DL-phenylalanine (PCPA) had been reported to exert anti-inflammatory and remodeling effects.", {"entities": []}], ["Therefore, we hypothesized that PCPA may attenuate monocrotaline (MCT)-induced PAH through the NFAT-1 and NF-\u03baB signaling pathways.", {"entities": []}], ["In order to confirm our hypothesis, we divided 68 Sprague-Dawley male rats into 4 groups as follows: the control, MCT, MCT + P1 and MCT + P2 groups.", {"entities": []}], ["MCT was administered at a dose of 60 mg/kg once via intraperitoneal injection.", {"entities": []}], ["PCPA was administered via intraperitoneal injection at a dose of 50 or 100 mg/kg once daily for 21 consecutive days.", {"entities": []}], ["We then measured the hemodynamic index and morphological analysis was carried out on the lung tissues.", {"entities": []}], ["Western blot analysis and immunohistochemistry were used to examine the levels of NFAT-1 and NF-\u03baB p-65.", {"entities": []}], ["The expression levels of phosphorylated inhibitor of NF-\u03baB kinase (p-IKK), IKK, phosphorylated extracellular signal-regulated kinase (p-ERK), ERK, intercellular adhesion molecule-1 (ICAM-1) and interleukin-6 (IL-6) were examined by western blot analysis.", {"entities": []}], ["MCT was found to significantly induce PAH, with inflammation and remodeling of the lung tissues.", {"entities": []}], ["This was associatd with an increased expression of NFAT-1, p-IKK, p-ERK and nuclear p65.", {"entities": []}], ["PCPA significantly attenuated MCT-induced inflammation and arterial remodeling, and decreased the expression of NFAT-1, as well as that of relevant proteins of the NF-\u03baB signaling pathway.", {"entities": []}], ["The above-mentioned findings suggest that the inhibitory effects of PCPA on MCT-induced inflammation and arterial remodeling are related to the downregulation of the NFAT-1 and NF-\u03baB signaling pathways in rats with PAH.", {"entities": []}], ["Current progress in wearable and implanted health monitoring technologies has strong potential to alter the future of healthcare services by enabling ubiquitous monitoring of patients.", {"entities": []}], ["A typical health monitoring system consists of a network of wearable or implanted sensors that constantly monitor physiological parameters.", {"entities": []}], ["Collected data are relayed using existing wireless communication protocols to a base station for additional processing.", {"entities": []}], ["This article provides researchers with information to compare the existing low-power communication technologies that can potentially support the rapid development and deployment of WBAN systems, and mainly focuses on remote monitoring of elderly or chronically ill patients in residential environments.", {"entities": []}], ["Hygiene hypothesis demonstrates that the lack of microbial exposure would promote the development of allergic airway disease (AAD).", {"entities": []}], ["Therefore, the gut microbiota, including Escherichia coli ( E. coli ), would probably offer a potential strategy for AAD.", {"entities": []}], ["To investigate whether E. coli infection is able to suppress the induction of AAD and to elucidate the underlying mechanisms.", {"entities": []}], ["Nonpathogenic E. coli ATCC 25922 was infected by gavage before AAD phase in three patterns: 10 E. coli , especially neonatally infected with an optimal dose, attenuated allergic responses, including a decrease in nasal rubbing and sneezing, a reduction in eosinophil inflammation and goblet cell metaplasia in subepithelial mucosa, decreased serum levels of OVA-specific IgE, and reduced Th2 (IL-4) cytokines.", {"entities": []}], ["In contrast, this effect came with an increase of Th1 (IFN-r and IL-2) cytokines, and an enhancement of IL-10-secreting Tregs in paratracheal lymph nodes (PTLN).", {"entities": []}], ["E. coli suppresses allergic responses in mice, probably via a shift from Th1 to Th2 and/or induction of Tregs.", {"entities": []}], ["Moreover, this infection is age- and dose-dependent, which may open up novel possibilities for new therapeutic interventions.", {"entities": []}], ["Foreign-born, HIV-infected persons are at risk for sub-clinical parasitic infections acquired in their countries of origin.", {"entities": []}], ["The long-term consequences of co-infections can be severe, yet few data exist on parasitic infection prevalence in this population.", {"entities": []}], ["This cross-sectional study evaluated 128 foreign-born persons at one HIV clinic.", {"entities": []}], ["We performed stool studies and serologic testing for strongyloidiasis, schistosomiasis, filarial infection, and Chagas disease based on the patient's country of birth.", {"entities": [[53, 69, "DISEASE"], [71, 86, "DISEASE"]]}], ["Eosinophilia and symptoms were examined as predictors of helminthic infection.", {"entities": [[0, 12, "DISEASE"]]}], ["Of the 128 participants, 86 (67%) were male, and the median age was 40 years; 70 were Mexican/Latin American, 40 African, and 18 from other countries or regions.", {"entities": []}], ["Strongyloides stercoralis antibodies were detected in 33/128 (26%) individuals.", {"entities": []}], ["Of the 52 persons from schistosomiasis-endemic countries, 15 (29%) had antibodies to schistosome antigens; 7 (47%) had antibodies to S. haematobium , 5 (33%) to S. mansoni , and 3 (20%) to both species.", {"entities": [[23, 38, "DISEASE"]]}], ["Stool ova and parasite studies detected helminths in 5/85 (6%) persons.", {"entities": []}], ["None of the patients tested had evidence of Chagas disease (n\u200a=\u200a77) or filarial infection (n\u200a=\u200a52).", {"entities": []}], ["Eosinophilia >400 cells/mm Given the high prevalence of certain helminths and the potential lack of suggestive symptoms and signs, selected screening for strongyloidiasis and schistosomiasis or use of empiric antiparasitic therapy may be appropriate among foreign-born, HIV-infected patients.", {"entities": [[154, 170, "DISEASE"], [0, 12, "DISEASE"], [175, 190, "DISEASE"]]}], ["Identifying and treating helminth infections could prevent long-term complications.", {"entities": []}], ["Undiagnosed and untreated parasitic infections can have severe consequences for human immunodeficiency virus (HIV)-infected persons.", {"entities": []}], ["An estimated 2 billion people worldwide are infected with soil-transmitted helminths and schistosomiasis, yet there are few data on the prevalence in HIV-infected immigrants to more developed countries.", {"entities": [[89, 104, "DISEASE"]]}], ["This information could help clinicians determine what testing is needed and what signs or symptoms to expect.", {"entities": []}], ["We performed serologic, stool, and urine testing for selected parasites in 128 foreign-born persons receiving care at an HIV clinic in Atlanta, Georgia.", {"entities": []}], ["We found that 26% had serologic evidence of infection with Strongyloides stercoralis and 29% had serologic evidence of schistosomiasis.", {"entities": [[119, 134, "DISEASE"]]}], ["Because these were likely chronic processes, symptoms and signs were often absent; only weight loss was significantly associated with strongyloidiasis.", {"entities": [[134, 150, "DISEASE"]]}], ["High eosinophil counts were also associated with parasitic infection.", {"entities": []}], ["This study suggests the need for targeted screening of foreign-born, HIV-infected persons for parasitic infections (mainly strongyloidiasis and schistosomiasis) or the use of empiric antiparasitic therapy, particularly among those with unexplained eosinophilia.", {"entities": [[123, 139, "DISEASE"], [248, 260, "DISEASE"], [144, 159, "DISEASE"]]}], ["Although there are established guidelines for screening of refugees, health care providers should consider the risk of these organisms in patients who have entered the United States through other pathways.", {"entities": []}], ["Reducing carbon dioxide (CO 2 ) emissions from power plants can have important \u201cco-benefits\u201d for public health by reducing emissions of air pollutants.", {"entities": []}], ["Here, we examine the costs and health co-benefits, in monetary terms, for a policy that resembles the U.S. Environmental Protection Agency\u2019s Clean Power Plan.", {"entities": []}], ["We then examine the spatial distribution of the co-benefits and costs, and the implications of a range of cost assumptions in the implementation year of 2020.", {"entities": []}], ["Nationwide, the total health co-benefits were $29 billion 2010 USD (95% CI: $2.3 to $68 billion), and net co-benefits under our central cost case were $12 billion (95% CI: -$15 billion to $51 billion).", {"entities": []}], ["Net co-benefits for this case in the implementation year were positive in 10 of the 14 regions studied.", {"entities": []}], ["The results for our central case suggest that all but one region should experience positive net benefits within 5 years after implementation.", {"entities": []}], ["To identify respiratory symptoms and evaluate lung function in mine workers.", {"entities": []}], ["This was a cross-sectional observational study involving production sector workers of a pyrochlore mining company.", {"entities": []}], ["The subjects completed the British Medical Research Council questionnaire, which is designed to evaluate respiratory symptoms, occupational exposure factors, and smoking status.", {"entities": []}], ["In addition, they underwent pulmonary function tests with a portable spirometer.", {"entities": []}], ["The study involved 147 workers (all male).", {"entities": []}], ["The mean age was 41.37 \u00b1 8.71 years, and the mean duration of occupational exposure was 12.26 \u00b1 7.09 years.", {"entities": []}], ["We found that 33 (22.44%) of the workers had respiratory symptoms and that 26 (17.69%) showed abnormalities in the spirometry results.", {"entities": []}], ["However, we found that the spirometry results did not correlate significantly with the presence of respiratory symptoms or with the duration of occupational exposure.", {"entities": []}], ["The frequencies of respiratory symptoms and spirometric changes were low when compared with those reported in other studies involving occupational exposure to dust.", {"entities": []}], ["No significant associations were observed between respiratory symptoms and spirometry results.", {"entities": []}], ["The goal of this study was to determine the prevalence of asthma in school children in the tri-island Caribbean nation of Grenada.", {"entities": [[58, 64, "DISEASE"]]}], ["This was a self-report study provided to the guardians of all primary school children between ages 6 and 7 throughout Grenada, Carriacou and Petite Martinique in 2013.", {"entities": []}], ["Of the 2362 surveys provided, 1374 were returned, resulting in a response rate of 58.2%.", {"entities": []}], ["Only responders listing birthdays between 1 January 2006 and 31 December 2007 were included in the analysis, resulting in 1165 qualifying responders.", {"entities": []}], ["Asthma diagnosis was based on previous physician diagnosed asthma and/or self-reported presence of wheeze in the past 12\u2005months (current wheeze).", {"entities": [[0, 6, "DISEASE"], [59, 65, "DISEASE"]]}], ["Severity of asthma, medication usage, environmental exposures, physician and emergency department visits were compared among respondents.", {"entities": [[12, 18, "DISEASE"]]}], ["The prevalence of wheezing in the past year was 30.5\u00b11.8%, and of these 68.4% were previously diagnosed with asthma.", {"entities": [[109, 115, "DISEASE"]]}], ["Of the current wheeze participants, 39.9\u00b19.2% reported moderate to severe asthma symptoms and increased exposure to cigarette smoke, excessive dust, burning brush and landfills.", {"entities": [[74, 80, "DISEASE"]]}], ["Carriacou and Petite Martinique, the two smaller islands, had a lower incidence of current wheeze (14.1\u00b17.7%) and exposure rates to cigarette smoke and burning brush as compared to the larger, denser island of Grenada.", {"entities": []}], ["Although 65.7% of respondents diagnosed with asthma reported taking medication, the number of annual doctor and emergency department visits were high (2.82 and 0.86, respectively).", {"entities": [[45, 51, "DISEASE"]]}], ["Respondents with the most severe asthma symptoms reported the most emergency department visits with an average of 1.05 visits annually, whereas respondents with moderate asthma symptoms had the most doctor visits with an average of 3.33 visits annually.", {"entities": [[33, 39, "DISEASE"], [170, 176, "DISEASE"]]}], ["This study indicates that the prevalence of childhood asthma in Grenada is very high and warrants policy consideration in public health and education to decrease its morbidity.", {"entities": [[54, 60, "DISEASE"]]}], ["Angiotensin II (Ang II) and transforming growth factor \u03b2 (TGF\u03b2) are closely involved in the pathogenesis of diabetic complications.", {"entities": [[16, 19, "GENE"]]}], ["We aimed to determine whether an aberrant thrombospondin 1 (TSP1)\u2013mediated TGF\u03b21/Smads signaling pathway specifically affects vascular fibrosis in diabetic rats and whether valsartan, an Ang II subtype 1 receptor blocker, has an anti-fibrotic effect.", {"entities": [[187, 190, "GENE"]]}], ["Age-matched male Wistar rats were randomly divided into 3 groups: control (n\u2009=\u20098), diabetes (n\u2009=\u200916) and valsartan (30\u00a0mg/kg/day) (n\u2009=\u200916).", {"entities": []}], ["Type 2 diabetes mellitus (T2DM) was induced by a high-calorie diet and streptozotocin injection.", {"entities": [[7, 24, "DISEASE"]]}], ["Morphological and biomechanical properties of the thoracic aorta were assessed by echocardiography and cardiac catheterization.", {"entities": []}], ["Masson staining was used for histological evaluation of extracellular matrix (ECM).", {"entities": []}], ["The expression of components in the TSP1\u2013mediated TGF\u03b21/Smads signaling pathway was analyzed by immunohistochemistry and real-time quantitative reverse transcription polymerase chain reaction.", {"entities": []}], ["As compared with controls, diabetic aortas showed reduced distensibility and compliance, with excess ECM deposition.", {"entities": []}], ["Components in the TSP1-mediated TGF\u03b21/Smads signaling pathway, including TSP1, TGF\u03b21, TGF\u03b2 type II receptor (T\u03b2RII), Smad2 and Smad3, were accumulated in vascular smooth muscle cytoplasm of diabetic aortas and their protein and mRNA levels were upregulated.", {"entities": [[117, 122, "GENE"], [127, 132, "GENE"]]}], ["All these abnormalities were attenuated by valsartan.", {"entities": []}], ["TSP1-mediated TGF\u03b21/Smads pathway activation plays an important role in marcovascular remodeling in T2DM in rat.", {"entities": []}], ["Valsartan can block the pathway and ameliorate vascular fibrosis.", {"entities": []}], ["The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1053842818141195", {"entities": []}], ["Acute cough is a common problem in general practice and is often caused by a self-limiting, viral infection.", {"entities": []}], ["Nonetheless, antibiotics are often prescribed in this situation, which may lead to unnecessary side effects and, even worse, the development of antibiotic resistant microorganisms worldwide.", {"entities": []}], ["This study assessed the role of point-of-care C-reactive protein (CRP) testing and other predictors of antibiotic prescription in patients who present with acute cough in general practice.", {"entities": [[66, 69, "GENE"]]}], ["Patient characteristics, symptoms, signs, and laboratory and X-ray findings from 348 patients presenting to 39 general practitioners with acute cough, as well as the GPs themselves, were recorded by fourth-year medical students during their three-week clerkships in general practice.", {"entities": []}], ["Patient and clinician characteristics of those prescribed and not-prescribed antibiotics were compared using a mixed-effects model.", {"entities": []}], ["Of 315 patients included in the study, 22% were prescribed antibiotics.", {"entities": []}], ["The two groups of patients, those prescribed antibiotics and those treated symptomatically, differed significantly in age, demand for antibiotics, days of cough, rhinitis, lung auscultation, haemoglobin level, white blood cell count, CRP level and the GP\u2019s license to self-dispense antibiotics.", {"entities": [[162, 170, "DISEASE"], [234, 237, "GENE"]]}], ["After regression analysis, only the CRP level, the white blood cell count and the duration of the symptoms were statistically significant predictors of antibiotic prescription.", {"entities": [[36, 39, "GENE"]]}], ["The antibiotic prescription rate of 22% in adult patients with acute cough in the Swiss primary care setting is low compared to other countries.", {"entities": []}], ["GPs appear to use point-of-care CRP testing in addition to the duration of clinical symptoms to help them decide whether or not to prescribe antibiotics.", {"entities": [[32, 35, "GENE"]]}], ["Data on the long\u2010term impact of hydrolyzed formulas on allergies are scarce.", {"entities": []}], ["To assess the association between early intervention with hydrolyzed formulas in high\u2010risk children and allergic outcomes in adolescence.", {"entities": []}], ["GINI trial participants ( n \u00a0=\u00a02252) received one of four formulas in the first four months of life as breastmilk substitute if necessary: partial or extensive whey hydrolyzate ( pHF \u2010W, eHF \u2010W), extensive casein hydrolyzate ( eHF \u2010C) or standard cow\u2032s milk formula ( CMF ) as reference.", {"entities": [[187, 190, "GENE"], [227, 230, "GENE"], [187, 190, "GENE"], [227, 230, "GENE"]]}], ["Associations between these formulas and the cumulative incidence and prevalence of parent\u2010reported physician\u2010diagnosed asthma, allergic rhinitis ( AR ) and eczema, as well as spirometric indices and sensitization, were examined using generalized linear models.", {"entities": [[127, 144, "DISEASE"], [136, 144, "DISEASE"], [119, 125, "DISEASE"]]}], ["Between 11 and 15\u00a0years, the prevalence of asthma was reduced in the eHF \u2010C group compared to CMF (odds ratio ( OR ) 0.49, 95% confidence interval ( CI ) 0.26\u20130.89), which is consistent with the spirometric results.", {"entities": [[43, 49, "DISEASE"], [69, 72, "GENE"]]}], ["The cumulative incidence of AR was lower in eHF \u2010C (risk ratio ( RR ) 0.77, 95% CI 0.59\u20130.99]) and the AR prevalence in pHF \u2010W ( OR 0.67, 95% CI 0.47\u20130.95) and eHF \u2010C ( OR 0.59, 95% CI 0.41\u20130.84).", {"entities": [[44, 47, "GENE"], [160, 163, "GENE"], [44, 47, "GENE"], [160, 163, "GENE"]]}], ["The cumulative incidence of eczema was reduced in pHF \u2010W ( RR 0.75, 95% CI 0.59\u20130.96) and eHF \u2010C ( RR 0.60, 95% CI 0.46\u20130.77), as was the eczema prevalence between 11 and 15\u00a0years in eHF \u2010C ( OR 0.42, 95% CI 0.23\u20130.79).", {"entities": [[90, 93, "GENE"], [183, 186, "GENE"], [90, 93, "GENE"], [183, 186, "GENE"]]}], ["No significant effects were found in the eHF \u2010W group on any manifestation,nor was there an effect on sensitization with any formula.", {"entities": [[41, 44, "GENE"]]}], ["In high\u2010risk children, early intervention using different hydrolyzed formulas has variable preventative effects on asthma, allergic rhinitis and eczema up to adolescence.", {"entities": [[123, 140, "DISEASE"], [132, 140, "DISEASE"], [115, 121, "DISEASE"]]}], ["Identifying preventable exposures that lead to asthma and associated allergies has proved challenging, partly because of the difficulty in differentiating phenotypes that define homogeneous disease groups.", {"entities": [[47, 53, "DISEASE"]]}], ["Understanding the socioeconomic patterns of disease phenotypes can help distinguish which exposures are preventable.", {"entities": []}], ["In the present study, we identified disease phenotypes that are susceptible to socioeconomic variation, and we determined which life-course exposures were associated with these inequalities in a contemporary birth cohort.", {"entities": []}], ["Participants included children from the Avon Longitudinal Study of Parents and Children, a population-based birth cohort in England, who were born in 1991 and 1992 and attended the clinic at 7\u20138 years of age ( n = 6,378).", {"entities": []}], ["Disease phenotypes included asthma, atopy, wheezing, altered lung function, and bronchial reactivity phenotypes.", {"entities": [[28, 34, "DISEASE"]]}], ["Combining atopy with a diagnosis of asthma from a doctor captured the greatest socioeconomic variation, including opposing patterns between phenotype groups: Children with a low socioeconomic position (SEP) had more asthma alone (adjusted multinomial odds ratio = 1.50, 95% confidence interval: 1.21, 1.87) but less atopy alone (adjusted multinomial odds ratio = 0.80, 95% confidence interval: 0.66, 0.98) than did children with high SEP.", {"entities": [[36, 42, "DISEASE"], [216, 222, "DISEASE"]]}], ["Adjustment for maternal exposure to tobacco smoke during pregnancy and childhood exposure to tobacco smoke reduced the odds of asthma alone in children with a low SEP. Current inequalities among children who have asthma but not atopy can be prevented by eliminating exposure to tobacco smoke.", {"entities": [[127, 133, "DISEASE"], [213, 219, "DISEASE"]]}], ["Other disease phenotypes were not socially patterned or had SEP patterns that were not related to smoke exposure.", {"entities": []}], ["High bone mineral density on routine dual energy X-ray absorptiometry (DXA) may indicate an underlying skeletal dysplasia.", {"entities": []}], ["Two hundred fifty-eight individuals with unexplained high bone mass (HBM), 236 relatives (41% with HBM) and 58 spouses were studied.", {"entities": []}], ["Cases could not float, had mandible enlargement, extra bone, broad frames, larger shoe sizes and increased body mass index (BMI).", {"entities": []}], ["HBM cases may harbour an underlying genetic disorder.", {"entities": [[36, 52, "DISEASE"]]}], ["High bone mineral density is a sporadic incidental finding on routine DXA scanning of apparently asymptomatic individuals.", {"entities": []}], ["Such individuals may have an underlying skeletal dysplasia, as seen in LRP5 mutations.", {"entities": [[71, 75, "GENE"]]}], ["We aimed to characterize unexplained HBM and determine the potential for an underlying skeletal dysplasia.", {"entities": []}], ["Two hundred fifty-eight individuals with unexplained HBM (defined as L1 Z-score\u2009\u2265\u2009+3.2 plus total hip Z-score\u2009\u2265\u2009+1.2, or total hip Z-score\u2009\u2265\u2009+3.2) were recruited from 15 UK centres, by screening 335,115 DXA scans.", {"entities": []}], ["Unexplained HBM affected 0.181% of DXA scans.", {"entities": []}], ["Next 236 relatives were recruited of whom 94 (41%) had HBM (defined as L1 Z-score + total hip Z-score\u2009\u2265\u2009+3.2).", {"entities": []}], ["Fifty-eight spouses were also recruited together with the unaffected relatives as controls.", {"entities": []}], ["Phenotypes of cases and controls, obtained from clinical assessment, were compared using random-effects linear and logistic regression models, clustered by family, adjusted for confounders, including age and sex.", {"entities": []}], ["Individuals with unexplained HBM had an excess of sinking when swimming (7.11 [3.65, 13.84], p \u2009<\u20090.001; adjusted odds ratio with 95% confidence interval shown), mandible enlargement (4.16 [2.34, 7.39], p \u2009<\u20090.001), extra bone at tendon/ligament insertions (2.07 [1.13, 3.78], p \u2009=\u20090.018) and broad frame (3.55 [2.12, 5.95], p \u2009<\u20090.001).", {"entities": []}], ["HBM cases also had a larger shoe size (mean difference 0.4 [0.1, 0.7] UK sizes, p \u2009=\u20090.009) and increased BMI (mean difference 2.2 [1.3, 3.1]\u2009kg/m p \u2009<\u20090.001).", {"entities": []}], ["Individuals with unexplained HBM have an excess of clinical characteristics associated with skeletal dysplasia and their relatives are commonly affected, suggesting many may harbour an underlying genetic disorder affecting bone mass.", {"entities": [[196, 212, "DISEASE"]]}], ["The online version of this article (doi:10.1007/s00198-011-1603-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The prevalence of diagnosed autism has increased rapidly over the last several decades among U.S. children.", {"entities": []}], ["Environmental factors are thought to be driving this increase and a list of the top ten suspected environmental toxins was published recently.", {"entities": []}], ["Temporal trends in autism for birth years 1970\u20132005 were derived from a combination of data from the California Department of Developmental Services (CDDS) and the United States Individuals with Disabilities Education Act (IDEA).", {"entities": []}], ["Temporal trends in suspected toxins were derived from data compiled during an extensive literature survey.", {"entities": []}], ["Toxin and autism trends were compared by visual inspection and computed correlation coefficients.", {"entities": []}], ["Using IDEA data, autism prevalence vs. birth year trends were calculated independently from snapshots of data from the most recent annual report, and by tracking prevalence at a constant age over many years of reports.", {"entities": []}], ["The ratio of the snapshot:tracking trend slopes was used to estimate the \"real\" fraction of the increase in autism.", {"entities": []}], ["The CDDS and IDEA data sets are qualitatively consistent in suggesting a strong increase in autism prevalence over recent decades.", {"entities": []}], ["The quantitative comparison of IDEA snapshot and constant-age tracking trend slopes suggests that ~75-80% of the tracked increase in autism since 1988 is due to an actual increase in the disorder rather than to changing diagnostic criteria.", {"entities": []}], ["Most of the suspected environmental toxins examined have flat or decreasing temporal trends that correlate poorly to the rise in autism.", {"entities": []}], ["Some, including lead, organochlorine pesticides and vehicular emissions, have strongly decreasing trends.", {"entities": []}], ["Among the suspected toxins surveyed, polybrominated diphenyl ethers, aluminum adjuvants, and the herbicide glyphosate have increasing trends that correlate positively to the rise in autism.", {"entities": []}], ["Diagnosed autism prevalence has risen dramatically in the U.S over the last several decades and continued to trend upward as of birth year 2005.", {"entities": []}], ["The increase is mainly real and has occurred mostly since the late 1980s.", {"entities": []}], ["In contrast, children\u2019s exposure to most of the top ten toxic compounds has remained flat or decreased over this same time frame.", {"entities": []}], ["Environmental factors with increasing temporal trends can help suggest hypotheses for drivers of autism that merit further investigation.", {"entities": []}], ["The online version of this article (doi:10.1186/1476-069X-13-73) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Respiratory distress syndrome is responsible for 40 to 60 percent mortality.", {"entities": [[21, 29, "DISEASE"]]}], ["An over mortality of about 10 percent could result from additional lung injury and inflammation due to the life-support mechanical ventilation, which stretches the lung.", {"entities": []}], ["It has been recently demonstrated, in vitro, that pharmacological activation of the alpha 7 nicotinic receptors (\u03b17-nAChR) could down regulate intracellular mediators involved in lung cell inflammatory response to stretch.", {"entities": []}], ["Our aim was to test in vivo the protective effect of the pharmacological activation of the \u03b17-nAChR against ventilator-induced lung injury (VILI).", {"entities": []}], ["Anesthetized rats were ventilated for two hours with a high stretch ventilation mode delivering a stroke volume large enough to generate 25-cmH 2 O airway pressure, and randomly assigned to four groups: pretreated with parenteral injection of saline or specific agonist of the \u03b17-nAChR (PNU-282987), or submitted to bilateral vagus nerve electrostimulation while pre-treated or not with the \u03b17-nAChR antagonist methyllycaconitine (MLA).", {"entities": []}], ["Controls ventilated with a conventional stroke volume of 10 mL/kg gave reference data.", {"entities": []}], ["Physiological indices (compliance of the respiratory system, lung weight, blood oxygenation, arterial blood pressure) and lung contents of inflammatory mediators (IL-6 measured by ELISA, substance P assessed using HPLC) were severely impaired after two hours of high stretch ventilation (sham group).", {"entities": []}], ["Vagal stimulation was able to maintain the respiratory parameters close to those obtained in Controls and reduced lung inflammation except when associated to nicotinic receptor blockade (MLA), suggesting the involvement of \u03b17-nAChR in vagally-mediated protection against VILI.", {"entities": []}], ["Pharmacological pre-treatment with PNU-282987 strongly decreased lung injury and lung IL-6 and substance P contents, and nearly abolished the increase in plasmatic IL-6 levels.", {"entities": []}], ["Pathological examination of the lungs confirmed the physiological differences observed between the groups.", {"entities": []}], ["In conclusion, these data suggest that the stimulation of \u03b17-nAChR is able to attenuate VILI in rats.", {"entities": []}], ["Glioma is the most common malignant tumor in the central nervous system.", {"entities": []}], ["This study aims to explore the potential mechanism and identify gene signatures of glioma.", {"entities": []}], ["The glioma gene expression profile GSE4290 was analyzed for differentially expressed genes (DEGs).", {"entities": []}], ["Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were applied for the enriched pathways.", {"entities": []}], ["A protein-protein interaction (PPI) network was constructed to find the hub genes.", {"entities": []}], ["Survival analysis was conducted to screen and validate critical genes.", {"entities": []}], ["In this study, 775 downregulated DEGs were identified.", {"entities": []}], ["GO analysis demonstrated that the DEGs were enriched in cellular protein modification, regulation of cell communication, and regulation of signaling.", {"entities": []}], ["KEGG analysis indicated that the DEGs were enriched in the MAPK signaling pathway, endocytosis, oxytocin signaling, and calcium signaling.", {"entities": []}], ["PPI network and module analysis found 12 hub genes, which were enriched in synaptic vesicle cycling rheumatoid arthritis and collecting duct acid secretion.", {"entities": [[100, 120, "DISEASE"], [111, 120, "DISEASE"]]}], ["The four key genes CDK17, GNA13, PHF21A, and MTHFD2 were identified in both generation (GSE4412) and validation (GSE4271) dataset, respectively.", {"entities": [[19, 24, "GENE"], [26, 31, "GENE"], [33, 39, "GENE"], [45, 51, "GENE"]]}], ["Regression analysis showed that CDK13, PHF21A, and MTHFD2 were independent predictors.", {"entities": [[32, 37, "GENE"], [39, 45, "GENE"], [51, 57, "GENE"]]}], ["The results suggested that CDK17, GNA13, PHF21A, and MTHFD2 might play important roles and potentially be valuable in the prognosis and treatment of glioma.", {"entities": [[27, 32, "GENE"], [34, 39, "GENE"], [41, 47, "GENE"], [53, 59, "GENE"]]}], ["Objective .", {"entities": []}], ["Herein, we aimed to study the mechanism whereby poly-L-arginine (PLA) and lipopolysaccharide (LPS) can synergistically induce the release of interleukin-6 (IL-6) and IL-8 in NCI-H292 cells.", {"entities": []}], ["NCI-H292 cells were divided into control, PLA, LPS, and PLA+LPS groups.", {"entities": []}], ["At various time points, the phosphorylation of JNK in each group was measured by western blotting.", {"entities": []}], ["Additionally, the productions of IL-6 and IL-8 were assessed using an enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["The effects of SP600125, an inhibitor of the JNK pathway, on the increase of p-JNK, IL-6, and IL-8 were also studied.", {"entities": []}], ["Our results showed that either PLA or LPS treatment alone can significantly increase the phosphorylation level of JNK in NCI-H292 cells.", {"entities": []}], ["Of interest was the combined use of PLA and LPS that has a synergistic effect on the phosphorylation of JNK, as well as synergistically inducing the release of IL-6 and IL-8 in NCI-H292 cells.", {"entities": []}], ["Furthermore, SP600125 significantly inhibited the activation of JNK signal, as well as reducing the productions of IL-6 and IL-8 in response to PLA+LPS stimulation.", {"entities": []}], ["Conclusions .", {"entities": []}], ["The JNK signaling pathway contributes to the release of IL-6 and IL-8, which is stimulated by the synergistic actions of PLA+LPS in NCI-H292 cells.", {"entities": []}], ["Overweight/obesity in women of childbearing age is a serious public-health problem.", {"entities": [[11, 18, "DISEASE"]]}], ["In China, the incidence of maternal overweight/obesity has been increasing.", {"entities": [[47, 54, "DISEASE"]]}], ["However, there is not a meta-analysis to determine if pre-pregnancy body mass index (BMI) is related to infant birth weight (BW) and offspring overweight/obesity.", {"entities": [[154, 161, "DISEASE"]]}], ["Three electronic bibliographic databases (MEDLINE, EMBASE and CINAHL) were searched systematically from January 1970 to November 2012.", {"entities": []}], ["The dichotomous data on pre-pregnancy overweight/obesity and BW or offspring overweight/obesity were extracted.", {"entities": [[49, 56, "DISEASE"], [88, 95, "DISEASE"]]}], ["Summary statistics (odds ratios, ORs) were used by Review Manager, version 5.1.7.", {"entities": []}], ["After screening 665 citations from three electronic databases, we included 45 studies (most of high or medium quality).", {"entities": []}], ["Compared with normal-weight mothers, pre-pregnancy underweight increased the risk of small for gestational age (SGA) (odds ratios [OR], 1.81; 95% confidence interval [CI], 1.76\u20131.87); low BW (OR, 1.47; 95% CI, 1.27\u20131.71).", {"entities": []}], ["Pre-pregnancy overweight/obesity increased the risk of being large for gestational age (LGA) (OR, 1.53; 95% CI, 1.44\u20131.63; and OR, 2.08; 95% CI; 1.95\u20132.23), high BW (OR, 1.53; 95% CI, 1.44\u20131.63; and OR, 2.00; 95% CI; 1.84\u20132.18), macrosomia (OR, 1.67; 95% CI, 1.42\u20131.97; and OR, 3.23; 95% CI, 2.39\u20134.37), and subsequent offspring overweight/obesity (OR, 1.95; 95% CI, 1.77\u20132.13; and OR, 3.06; 95% CI, 2.68\u20133.49), respectively.", {"entities": [[25, 32, "DISEASE"], [340, 347, "DISEASE"]]}], ["Sensitivity analyses revealed that sample size, study method, quality grade of study, source of pre-pregnancy BMI or BW had a strong impact on the association between pre-pregnancy obesity and LGA.", {"entities": [[181, 188, "DISEASE"]]}], ["No significant evidence of publication bias was observed.", {"entities": []}], ["Pre-pregnancy underweight increases the risk of SGA and LBW; pre-pregnancy overweight/obesity increases the risk of LGA, HBW, macrosomia, and subsequent offspring overweight/obesity.", {"entities": [[86, 93, "DISEASE"], [174, 181, "DISEASE"]]}], ["A potential effect modification by maternal age, ethnicity, gestational weight gain, as well as the role of gestational diseases should be addressed in future studies.", {"entities": []}], ["Adenotonsillectomy is the most commonly performed operation for pediatric snoring/sleep disordered breathing (S/SDB).", {"entities": []}], ["However, 20\u201340% of patients will fail to improve.", {"entities": []}], ["Drug-induced sleep endoscopy (DISE) may provide a more individualized surgical plan and limit unsuccessful surgeries.", {"entities": []}], ["The aim of this study was to assess the impact of DISE on surgical decision-making in surgically na\u00efve children with S/SDB.", {"entities": []}], ["A retrospective observational cohort study was undertaken at the Stollery Children\u2019s Hospital.", {"entities": []}], ["Patients 3\u201317 years of age who underwent DISE-directed surgery for S/SDB between January 2009 and December 2015 were eligible.", {"entities": []}], ["We excluded other indications for tonsillectomy and syndromic children.", {"entities": []}], ["The primary outcome was the level of agreement between a DISE-based surgical decision and the reference standard based on the American Academy of Pediatrics (AAP) guidelines via un-weighted Cohen\u2019s kappa.", {"entities": []}], ["Secondary outcomes included the frequency and type of alternate surgical targets identified by DISE.", {"entities": []}], ["The agreement on tonsil size between in-office physical assessment and DISE was also calculated.", {"entities": []}], ["The effectiveness of DISE-directed surgery on postoperative S/SDB was not investigated.", {"entities": []}], ["Five hundred fifty-eight patients were included.", {"entities": []}], ["DISE changed the surgical plan in 35% of patients.", {"entities": []}], ["Agreement between DISE-based and AAP clinical practice guidelines-based management was low (\u03ba\u2009=\u20090.354 +/- 0.021 [95% CI 0.312\u20130.395]).", {"entities": []}], ["An alternate diagnosis or surgical target was identified by DISE in 54% of patients.", {"entities": []}], ["There was moderate agreement on tonsil size (\u03ba\u2009=\u20090.44 [0.33\u20130.55]) between DISE and in-office clinical assessment.", {"entities": []}], ["This is a first phase diagnostic study, which demonstrates that DISE affects decision-making in surgically na\u00efve children with S/SDB in up to 35% of patients.", {"entities": []}], ["It has utility in individualizing first stage surgical treatments as well as identifying alternate targets for further surgical or medical therapy, while potentially limiting unsuccessful surgeries.", {"entities": []}], ["Further studies to examine the effect of DISE on surgical outcomes are required.", {"entities": []}], ["Fibrosis is a significant health problem associated with a chronic inflammatory reaction.", {"entities": []}], ["The precise mechanisms involved in the fibrotic process are still poorly understood.", {"entities": []}], ["However, given that inflammation is a major causative factor, immunomodulation is a possible therapeutic approach to reduce fibrosis.", {"entities": []}], ["The vitamin D receptor (VDR) that is present in all hematopoietic cells has been associated with immunomodulation.", {"entities": [[24, 27, "GENE"]]}], ["We investigated whether the intraperitoneal administration of paricalcitol, a specific activator of the VDR, modulates peritoneal dialysis fluid (PDF)-induced peritoneal fibrosis.", {"entities": [[104, 107, "GENE"]]}], ["We characterized the inflammatory process in the peritoneal cavity of mice treated or not treated with paricalcitol and analyzed the ensuing fibrosis.", {"entities": []}], ["The treatment reduced peritoneal IL-17 levels, which strongly correlated with a significantly lower peritoneal fibrotic response.", {"entities": []}], ["In vitro studies demonstrate that both CD4 in vivo .", {"entities": [[39, 42, "GENE"]]}], ["In conclusion, the activation of immunological regulatory mechanisms by VDR signaling could prevent or reduce fibrosis, as shown in peritoneal fibrosis induced by PDF exposure in mice.", {"entities": [[72, 75, "GENE"]]}], ["In 2009, pregnant women were specifically targeted by a national vaccination campaign against pandemic A/H1N1 influenza virus.", {"entities": [[110, 119, "DISEASE"]]}], ["The objectives of the COFLUPREG study, initially set up to assess the incidence of serious forms of A/H1N1 influenza, were to assess the consequences of maternal vaccination on pregnancy outcomes and maternal seroprotection at delivery.", {"entities": [[107, 116, "DISEASE"]]}], ["Pregnant women, between 12 and 35 weeks of gestation, non vaccinated against A/H1N1 2009 influenza were randomly selected to be included in a prospective cohort study conducted in three maternity centers in Paris (France) during pandemic period.", {"entities": [[89, 98, "DISEASE"]]}], ["Blood samples were planned to assess hemagglutination inhibition (HI) antibody against A/H1N1 2009 influenza at inclusion and at delivery.", {"entities": [[99, 108, "DISEASE"]]}], ["Among the 877 pregnant women included in the study, 678 (77.3%) had serum samples both at inclusion and delivery, and 320 (36.5%) received pandemic A/H1N1 2009 influenza vaccine with a median interval between vaccination and delivery of 92 days (95% CI 48\u2013134).", {"entities": [[160, 169, "DISEASE"]]}], ["At delivery, the proportion of women with seroprotection (HI antibodies titers against A/H1N1 2009 influenza of 1\u223640 or greater) was 69.9% in vaccinated women.", {"entities": [[99, 108, "DISEASE"]]}], ["Of the 422 non-vaccinated women with serological data, 11 (2.6%; 95%CI: 1.3\u20134.6) had laboratory documented A/H1N1 2009 influenza (1 with positive PCR and 10 with serological seroconversion).", {"entities": [[119, 128, "DISEASE"]]}], ["None of the 877 study\u2019s women was hospitalized for flu.", {"entities": []}], ["No difference on pregnancy outcomes was evidenced between vaccinated women, non-vaccinated women without seroconversion and non-vaccinated women with flu.", {"entities": []}], ["Despite low vaccine coverage, incidence of pandemic flu was low in this cohort of pregnant women.No effect on pregnancy and delivery outcomes was evidenced after vaccination.", {"entities": []}], ["Faunal resources have played an extensive range of roles in human life from the initial days of recorded history.", {"entities": []}], ["In addition to their importance, animals have been acknowledged in religion, art, music and literature and several other different cultural manifestations of mankind.", {"entities": []}], ["Human beings are acquainted with use of animals for foodstuff, cloth, medicine, etc.", {"entities": []}], ["since ancient times.", {"entities": []}], ["Huge work has been carried out on ethnobotany and traditional medicine.", {"entities": []}], ["Animal and their products are also holding medicinal properties that can be exploited for the benefit of human beings like plants.", {"entities": []}], ["In Tanzania, many tribal communities are spread all over the country and these people are still totally depended on local customary medicinal system for their health care.", {"entities": []}], ["In the world Tanzania is gifted with wide range of floral and faunal biodiversity.", {"entities": []}], ["The use of traditional medicine from animals by Sukuma ethnic group of Busega district is the aim of the present study.", {"entities": []}], ["In order to collect the information on ethnozoological use about animal and their products predominant among this tribe in Busega district, a study was carried out from August 2012, to July 2013.", {"entities": []}], ["Data were collected through semi-structured questionnaire and open interview with 180 (118 male and 62 females) selected people.", {"entities": []}], ["The people from whom the data were collected comprise old age community members, traditional health practicener, fishermen and cultural officers.", {"entities": []}], ["The name of animal and other ethnozoological information were documented.", {"entities": []}], ["Pictures and discussion were also recorded with the help of camera and voice recorder.", {"entities": []}], ["A total of 42 various animal species were used in nearly 30 different medicinal purposes including STD, stoppage of bleeding, reproductive disorders, asthma, weakness, tuberculosis, cough, paralysis and wound and for other religious beliefs.", {"entities": [[168, 180, "DISEASE"], [150, 156, "DISEASE"]]}], ["It has been noticed that animal used by Sukuma tribe, comprise of seventeen mammals, seven birds, four reptiles, eight arthropods and two mollusks.", {"entities": []}], ["Some of the protected species were also used as important medicinal resources.", {"entities": []}], ["We also found that cough, tuberculosis, asthma and other respiratory diseases are the utmost cited disease, as such, a number of traditional medicines are available for the treatment.", {"entities": [[26, 38, "DISEASE"], [40, 46, "DISEASE"]]}], ["The present work indicates that 42 animal species were being used to treat nearly 30 different ailments and results show that ethnozoological practices are an important alternative medicinal practice by the Sukuma tribe living in Bungesa district.", {"entities": []}], ["The present study also indicates the very rich ethnozoological knowledge of these people in relation to traditional medicine.", {"entities": []}], ["So there is a critical need to properly document to keep a record of the ethnozoological information.", {"entities": []}], ["We hope that the information generated in this study will be useful for further research in the field of ethnozoology, ethnopharmacology and conservation approach.", {"entities": []}], ["Cystic fibrosis-related diabetes affects up to half of cystic fibrosis patients and is associated with increased mortality and more frequent pulmonary exacerbations.", {"entities": [[0, 15, "DISEASE"], [55, 70, "DISEASE"]]}], ["However, it is unclear to what degree good glycemic control might mitigate these risks and clinical outcomes have not previously been studied in relation to glucose from the lower airways, the site of infection and CF disease progression.", {"entities": []}], ["We initially hypothesized that diabetic cystic fibrosis patients with glycosylated hemoglobin (HbA 1c ) > 6.5% have worse pulmonary function, longer and more frequent exacerbations and also higher sputum glucose levels than patients with HbA 1c \u2264 6.5% or cystic fibrosis patients without diabetes.", {"entities": [[40, 55, "DISEASE"], [255, 270, "DISEASE"]]}], ["To test this, we analyzed spontaneously expectorated sputum samples from 88 cystic fibrosis patients.", {"entities": [[76, 91, "DISEASE"]]}], ["The median sputum glucose concentration was 0.70 mM (mean, 4.75 mM; range, 0-64.6 mM).", {"entities": []}], ["Sputum glucose was not correlated with age, sex, body mass index, diabetes diagnosis, glycemic control, exacerbation frequency or length, or pulmonary function.", {"entities": []}], ["Surprisingly, sputum glucose was highest in subjects with normal glucose tolerance, suggesting the dynamics of glycemic control, sputum glucose and pulmonary infections are more complex than previously thought.", {"entities": []}], ["Two-year mean HbA 1c was positively correlated with the length of exacerbation admission (p < 0.01), and negatively correlated with measures of pulmonary function (p < 0.01).", {"entities": []}], ["While total number of hospitalizations for exacerbations were not significantly different, subjects with an HbA 1c > 6.5% were hospitalized on average 6 days longer than those with HbA 1c \u2264 6.5% (p < 0.01).", {"entities": []}], ["Current clinical care guidelines for cystic fibrosis-related diabetes target HbA 1c \u2264 7% to limit long-term microvascular damage, but more stringent glycemic control (HbA 1c \u2264 6.5%) may further reduce the short-term pulmonary complications.", {"entities": [[37, 52, "DISEASE"]]}], ["Two young girls without a notable medical history except for asthma presented with an acute toxic encephalopathy with very low serine concentrations both in plasma and cerebrospinal fluid (CSF) comparable to patients with 3-phosphoglycerate dehydrogenase (3-PGDH) deficiency.", {"entities": [[92, 112, "DISEASE"], [61, 67, "DISEASE"]]}], ["Clinical symptoms and enzyme measurement (in one patient) excluded 3-PGDH deficiency.", {"entities": []}], ["Deficiencies in other serine biosynthesis enzymes were highly unlikely on clinical grounds.", {"entities": []}], ["On basis of the fasting state, ketone bodies and lactate in plasma, urine and CSF, we speculate that reduced serine levels were due to its use as gluconeogenic substrate, conversion to pyruvate by brain serine racemase or decreased L-serine production because of a lack of glucose.", {"entities": []}], ["These are the first strikingly similar cases of patients with a clear secondary serine deficiency associated with a toxic encephalopathy.", {"entities": [[80, 97, "DISEASE"], [116, 136, "DISEASE"]]}], ["Although self-rated health has been extensively studied in community older people, its determinants have seldom been investigated in institutional settings.", {"entities": []}], ["We carried out a cross-sectional study to describe the physical, mental, and social factors associated with self-rated health in nursing homes and other geriatric facilities.", {"entities": []}], ["A representative sample of 800 subjects 65 years of age and older living in 19 public and 30 private institutions of Madrid was randomly selected through stratified cluster sampling.", {"entities": []}], ["Residents, caregivers, physicians, and nurses were interviewed by trained geriatricians using standardized instruments to assess self-rated health, chronic illnesses, functional capacity, cognitive status, depressive symptoms, vision and hearing problems, and social support.", {"entities": []}], ["Of the 669 interviewed residents (response rate 84%), 55% rated their health as good or very good.", {"entities": []}], ["There was no association with sex or age.", {"entities": []}], ["Residents in private facilities and those who completed primary education had significantly better health perception.", {"entities": []}], ["The adjusted odds ratio (95% confidence interval) for worse health perception was 1.18 (1.07\u20131.28) for each additional chronic condition, 2.37 (1.38\u20134.06) when comparing residents with moderate dependency to those functionally independent, and 10.45 (5.84\u201318.68) when comparing residents with moderate/severe depressive symptoms to those without symptoms.", {"entities": []}], ["Visual problems were also associated with worse health perception.", {"entities": []}], ["Similar results were obtained in subgroup analyses, except for inconsistencies in cognitively impaired individuals.", {"entities": []}], ["Chronic conditions, functional status, depressive symptoms and socioeconomic factors were the main determinants of perceived health among Spanish institutionalized elderly persons.", {"entities": []}], ["Doubts remain about the proper assessment of subjective health in residents with altered cognition.", {"entities": []}], ["Objective Envenomation by Mesobuthus tamulus scorpion sting can result in serious cardiovascular effects.", {"entities": []}], ["Scorpion antivenom is a specific treatment for scorpion sting.", {"entities": []}], ["Evidence for the benefit of scorpion antivenom and its efficacy compared with that of commonly used vasodilators, such as prazosin, is scarce.", {"entities": []}], ["We assessed the efficacy of prazosin combined with scorpion antivenom, compared with prazosin alone, in individuals with autonomic storm caused by scorpion sting.", {"entities": []}], ["Design Prospective, open label randomised controlled trial.", {"entities": []}], ["Setting General hospital inpatients (Bawaskar Hospital and Research Centre Mahad Dist-Raigad Maharashtra, India).", {"entities": []}], ["Participants Seventy patients with grade 2 scorpion envenomation, older than six months, with no cardiorespiratory or central nervous system abnormalities.", {"entities": []}], ["Intervention Scorpion antivenom plus prazosin (n=35) or prazosin alone (n=35) assigned by block randomisation.", {"entities": []}], ["Treatment was not masked.", {"entities": []}], ["Analysis was by intention to treat.", {"entities": []}], ["Main outcome measures The primary end point was the proportion of patients achieving resolution of the clinical syndrome (sweating, salivation, cool extremities, priapism, hypertension or hypotension, tachycardia) 10 hours after administration of study drugs.", {"entities": [[172, 184, "DISEASE"], [112, 120, "DISEASE"], [162, 170, "DISEASE"]]}], ["Secondary end points were time required for complete resolution of clinical syndrome, prevention of deterioration to higher grade, doses of prazosin required overall and within 10 hours, and adverse events.", {"entities": [[76, 84, "DISEASE"]]}], ["The study protocol was approved by the independent ethics committee of Mumbai.", {"entities": []}], ["Results Mean (SD) recovery times in hours for the prazosin plus scorpion antivenom group compared with the prazosin alone groups were: sweating 3 (1.1) v 6.6 (2.6); salivation 1.9 (0.9) v 3 (1.9); priapism 4.7 (1.5) v 9.4 (1.5).", {"entities": [[197, 205, "DISEASE"]]}], ["Mean (SD) doses of prazosin in the groups were 2 (2.3) and 4 (3.5), respectively.", {"entities": []}], ["32 patients (91.4%, 95% confidence interval 76.9% to 97.8%) in the prazosin plus antivenom group showed complete resolution of the clinical syndrome within 10 hours of administration of treatment compared with eight patients in the prazosin group (22.9%, 11.8% to 39.3%).", {"entities": [[140, 148, "DISEASE"]]}], ["Patients from the antivenom plus prazosin group recovered earlier (mean 8 hours, 95% CI 6.5 to 9.5) than those in the control group (17.7 hours, 15.4 to 19.9; mean difference \u22129.7 hours, \u22126.9 to \u221212.4).", {"entities": []}], ["The number of patients whose condition deteriorated to a higher grade was similar in both groups (antivenom plus prazosin four of 35, prazosin alone five of 35).", {"entities": []}], ["Hypotension was reported in fewer patients in the antivenom plus prazosin group (12 of 35, 34.3%) than in the prazosin group (19 of 35, 54.3%), but the difference was not statistically significant.", {"entities": []}], ["No difference was noted in change in blood pressure and pulse rate over time between two groups.", {"entities": []}], ["Conclusion Recovery from scorpion sting is hastened by simultaneous administration of scorpion antivenom plus prazosin compared with prazosin alone.", {"entities": []}], ["Trial registration number CTRI/2010/091/000584 (Clinical Trials Registry India).", {"entities": []}], ["Identifying simple, low-cost and scalable means of supporting lifestyle change and medication adherence for patients following a cardiovascular (CV) event is important.", {"entities": []}], ["The TEXTMEDS (TEXT messages to improve MEDication adherence and Secondary prevention) study aims to investigate whether a cardiac education and support programme sent via mobile phone text message improves medication adherence and risk factor levels in patients following an acute coronary syndrome (ACS).", {"entities": [[290, 298, "DISEASE"]]}], ["A single-blind, multicentre, randomised clinical trial of 1400 patients after an ACS with 12 months follow-up.", {"entities": []}], ["The intervention group will receive multiple weekly text messages that provide information, motivation, support to adhere to medications, quit smoking (if relevant) and recommendations for healthy diet and exercise.", {"entities": []}], ["The primary endpoint is the percentage of patients who are adherent to cardioprotective medications and the key secondary outcomes are mean systolic blood pressure (BP) and low-density lipoprotein cholesterol.", {"entities": []}], ["Secondary outcomes will also include total cholesterol, mean diastolic BP, the percentage of participants who are adherent to each cardioprotective medication class, the percentage of participants who achieve target levels of CV risk factors, major vascular events, hospital readmissions and all-cause mortality.", {"entities": []}], ["The study will be augmented by formal economic and process evaluations to assess acceptability, utility and cost-effectiveness.", {"entities": []}], ["The study will provide multicentre randomised trial evidence of the effects of a text message-based programme on cardioprotective medication adherence and levels of CV risk factors.", {"entities": []}], ["Primary ethics approval was received from Western Sydney Local Health District Human Research Ethics Committee (HREC2012/12/4.1 (3648) AU RED HREC/13/WMEAD/15).", {"entities": []}], ["Results will be disseminated via peer-reviewed publications and presentations at international conferences.", {"entities": []}], ["ACTRN12613000793718; Pre-results.", {"entities": []}], ["Allergic diseases are sustained by a T-helper 2 polarization leading to interleukin-4 secretion, IgE-dependent inflammation, and mast cell and eosinophil activation.", {"entities": []}], ["HLA-G molecules, both in membrane-bound and in soluble forms, play a central role in modulation of immune responses.", {"entities": [[0, 5, "GENE"]]}], ["Elevated levels of soluble HLA-G (sHLA-G) molecules are detected in serum of patients with allergic rhinitis to seasonal and perennial allergens and correlate with allergen-specific IgE levels, clinical severity, drug consumption, and response to allergen-specific immunotherapy.", {"entities": [[91, 108, "DISEASE"], [100, 108, "DISEASE"], [27, 32, "GENE"]]}], ["sHLA-G molecules are also found in airway epithelium of patients with allergic asthma and high levels of sHLA-G molecules are detectable in plasma and bronchoalveolar lavage of asthmatic patients correlating with allergen-specific IgE levels.", {"entities": [[70, 85, "DISEASE"], [79, 85, "DISEASE"]]}], ["Finally, HLA-G molecules are expressed by T cells, monocytes-macrophages, and Langerhans cells infiltrating the dermis of atopic dermatitis patients.", {"entities": [[122, 139, "DISEASE"], [129, 139, "DISEASE"], [9, 14, "GENE"]]}], ["Collectively, although at present it is difficult to completely define the role of HLA-G molecules in allergic diseases, it may be suggested that they are expressed and secreted by immune cells during the allergic reaction in an attempt to suppress allergic inflammation.", {"entities": [[83, 88, "GENE"]]}], ["The pathological outcomes of schistosomiasis are largely dependent on the molecular and cellular mechanisms of the host immune response.", {"entities": [[29, 44, "DISEASE"]]}], ["In this study, we investigated the contribution of variations in host gene expression to the contrasting hepatic pathology observed between two inbred mouse strains following Schistosoma japonicum infection.", {"entities": []}], ["Whole genome microarray analysis was employed in conjunction with histological and immunohistochemical analysis to define and compare the hepatic gene expression profiles and cellular composition associated with the hepatopathology observed in S. japonicum- infected BALB /c and CBA mice.", {"entities": []}], ["We show that the transcriptional profiles differ significantly between the two mouse strains with high statistical confidence.", {"entities": []}], ["We identified specific genes correlating with the more severe pathology associated with CBA mice, as well as genes which may confer the milder degree of pathology associated with BALB/c mice.", {"entities": []}], ["In BALB/c mice, neutrophil genes exhibited striking increases in expression, which coincided with the significantly greater accumulation of neutrophils at granulomatous regions seen in histological sections of hepatic tissue.", {"entities": []}], ["In contrast, up-regulated expression of the eosinophil chemokine CCL24 in CBA mice paralleled the cellular influx of eosinophils to the hepatic granulomas.", {"entities": [[65, 70, "GENE"]]}], ["Additionally, there was greater down-regulation of genes involved in metabolic processes in CBA mice, reflecting the more pronounced hepatic damage in these mice.", {"entities": []}], ["Profibrotic genes showed similar levels of expression in both mouse strains, as did genes associated with Th1 and Th2 responses.", {"entities": []}], ["However, imbalances in expression of matrix metalloproteinases (e.g.", {"entities": []}], ["MMP12, MMP13 ) and tissue inhibitors of metalloproteinases ( TIMP1 ) may contribute to the contrasting pathology observed in the two strains.", {"entities": [[0, 5, "GENE"], [7, 12, "GENE"], [61, 66, "GENE"]]}], ["Overall, these results provide a more complete picture of the molecular and cellular mechanisms which govern the pathological outcome of hepatic schistosomiasis.", {"entities": [[145, 160, "DISEASE"]]}], ["This improved understanding of the immunopathogenesis in the murine model schistosomiasis provides the basis for a better appreciation of the complexities associated with chronic human schistosomiasis.", {"entities": [[74, 89, "DISEASE"], [185, 200, "DISEASE"]]}], ["Schistosomiasis is a significant cause of morbidity and mortality in the tropical world although its true burden has been historically underestimated.", {"entities": [[0, 15, "DISEASE"]]}], ["Millions of people currently endure severe pathology as a result of schistosome infections, although some individuals appear to be less susceptible to infection despite constant parasite exposure.", {"entities": []}], ["A similar range of disease susceptibility is evident in different strains of inbred mice infected with schistosomes, thereby mirroring the clinical situation.", {"entities": []}], ["Granuloma formation in the liver of both humans and mice is a characteristic manifestation of chronic schistosomiasis, and is largely controlled by gene signalling pathways.", {"entities": [[102, 117, "DISEASE"]]}], ["Certain genes expressed in particular cohorts of mice and humans may be associated with the development of severe pathology, or may confer a protective phenotype.", {"entities": []}], ["This murine study highlights some key molecular aspects of chronic schistosomiasis which may be responsible for the development of both mild and severe pathology, and provides a bench mark for studying the mechanisms of schistosome-induced disease in humans.", {"entities": [[67, 82, "DISEASE"]]}], ["Odors can affect health and quality of life.", {"entities": []}], ["Industrialized animal agriculture creates odorant compounds that are components of a mixture of agents that could trigger symptoms reported by neighbors of livestock operations.", {"entities": []}], ["We quantified swine odor episodes reported by neighbors and the relationships of these episodes with environmental measurements.", {"entities": []}], ["Between September 2003 and September 2005, 101 nonsmoking volunteers living within 1.5 mi of industrial swine operations in 16 neighborhoods in eastern North Carolina completed twice-daily odor diaries for approximately 2 weeks.", {"entities": []}], ["Meteorological conditions, hydrogen sulfide, and particulate matter \u2264 10 \u03bcm in aerodynamic diameter (PM 10 ) were monitored in each neighborhood.", {"entities": []}], ["We used mixed models to partition odor variance within and between people and between neighborhoods, and to quantify relationships between environmental factors and odor.", {"entities": []}], ["Participants reported 1,655 episodes of swine odor.", {"entities": []}], ["In nine neighborhoods, odor was reported on more than half of study-days.", {"entities": []}], ["Odor ratings were related to temperature, PM 10 , and semivolatile PM 10 in standard but not mixed models.", {"entities": []}], ["In mixed models, odor increased 0.15 \u00b1 0.05 units (mean \u00b1 SE) for a 1-ppb increase in H 2 S, and 0.45 \u00b1 0.14 units for a 10-\u03bcg/m 10 at wind speeds > 6.75 miles per hour.", {"entities": []}], ["The odds of reporting a change in daily activities due to odor increased 62% for each unit increase in average odor during the prior 12 hr ( t -value = 7.17).", {"entities": [[136, 138, "GENE"]]}], ["This study indicates that malodor from swine operations is commonly present in these communities and that the odors reported by neighbors are related to objective environmental measurements and interruption of activities of daily life.", {"entities": []}], ["This work presents results from the long-term measurements of particle number carried out at an urban background station in Zabrze, Poland.", {"entities": []}], ["Ambient particles with aerodynamic diameters of between 28\u2009nm and 10\u2009 \u03bc m were investigated by means of a DEKATI thirteen-stage electrical low pressure impactor (ELPI).", {"entities": []}], ["The particle number-size distribution was bimodal, whilst its density function had the local maxima in the aerodynamic diameter intervals 0.056\u20130.095\u2009 \u03bc m and 0.157\u20130.263\u2009 \u03bc m. The average particle number in winter was nearly twice as high as in summer.", {"entities": []}], ["The greatest number concentrations in winter were those of the particles with diameters of between 0.617 and 2.41\u2009 \u03bc m, that is, the anthropogenic particles from fossil fuel combustion.", {"entities": []}], ["Approximately 99% of the particles observed in Zabrze had aerodynamic diameters \u22641\u2009 \u03bc m\u2014they may have originated from the combustion of biomass, liquid, and gaseous fuels in domestic stoves or in car engines.", {"entities": []}], ["The daily variation of particle number was similar for both seasons\u2014the highest values were observed in the morning (traffic rush hour) and in the afternoon/late evening (traffic and house heating emissions).", {"entities": []}], ["An additional maximum (0.028\u20130.056\u2009 \u03bc m) observed in the early afternoon in summer was due to the intensive formation of new PM particles from gas precursors.", {"entities": []}], ["Comparative data on the burden of atopic dermatitis (AD) in adults relative to the general population are limited.", {"entities": [[34, 51, "DISEASE"], [41, 51, "DISEASE"]]}], ["We performed a large-scale evaluation of the burden of disease among US adults with AD relative to matched non-AD controls, encompassing comorbidities, healthcare resource utilization (HCRU), and costs, using healthcare claims data.", {"entities": []}], ["The impact of AD disease severity on these outcomes was also evaluated.", {"entities": []}], ["Adult AD patients in the Commercial ( n \u00a0=\u00a083,106), Medicare ( n \u00a0=\u00a031,060), and Medi-Cal ( n \u00a0=\u00a05550) databases were matched (1:1) to non-AD controls by demographic characteristics.", {"entities": []}], ["AD patients were stratified by disease severity (higher, lower) using treatment as a surrogate measure of severity.", {"entities": []}], ["The comorbidity burden, HCRU, and costs were evaluated during a 12-month follow-up period.", {"entities": []}], ["In the Commercial, Medicare, and Medi-Cal populations, patients with AD had a significantly higher overall comorbidity burden ( P \u00a0<\u00a00.0001), an increased risk of asthma and allergic rhinitis (both P \u00a0<\u00a00.0001), higher HCRU ( P \u00a0<\u00a00.05), and higher mean total per patient costs (Commercial: US$10,461 versus US$7187; Medicare: US$16,914 versus US$13,714; Medi-Cal; US$19,462 versus US$10,408; all P \u00a0<\u00a00.0001), compared with matched non-AD controls.", {"entities": [[174, 191, "DISEASE"], [183, 191, "DISEASE"], [163, 169, "DISEASE"]]}], ["Higher disease severity was associated with an increased comorbidity burden ( P \u00a0<\u00a00.0001), HCRU ( P \u00a0<\u00a00.05), and total costs (Commercial: US$14,580 versus US$7192; Medicare: US$21,779 versus US$12,490; Medi-Cal; US$22,123 versus US$16,639; all P \u00a0<\u00a00.0001) relative to lower severity disease.", {"entities": []}], ["In this large-scale, healthcare claims database analysis, AD patients had a significantly higher comorbidity burden, HCRU, and costs compared with matched non-AD controls.", {"entities": []}], ["Higher disease severity was associated with an even greater comorbidity and economic burden.", {"entities": []}], ["Sanofi and Regeneron Pharmaceuticals, Inc.", {"entities": []}], ["The online version of this article (doi:10.1007/s12325-017-0582-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Respiratory diseases are one of the causes of childhood morbidity and mortality as well as hospitalization globally.", {"entities": []}], ["The patterns of different respiratory illnesses in several parts of the world have been reported but there are few on the combined burden of the diseases.", {"entities": []}], ["Determination of the burden of respiratory diseases as a group will help ascertain their collective impact on the health systems in order to develop intervention measures.", {"entities": []}], ["Data from case notes of children with respiratory diseases admitted to the University of Nigeria Teaching Hospital Enugu, Nigeria over a six year period were extracted.", {"entities": []}], ["Age, gender, admission rates, types of respiratory illness, duration of admission, season of presentation and outcome were analysed.", {"entities": []}], ["Descriptive and inferential (Chi square) statistics were used to describe the various disease types and ascertain association of the disease outcome, seasonal pattern with the types of diseases.", {"entities": []}], ["Of the total of 8974 children admissions, 2214 (24.7%) were due to respiratory diseases.", {"entities": []}], ["The mean age of all the children with respiratory diseases was 3.3\u2009years (SD 3.9).", {"entities": []}], ["Communicable diseases were the common cause of admission cases throughout the seasons, p < 0.001.", {"entities": []}], ["The highest admission rates were for pneumonia, (34.0%), acute bronchial asthma, (27.7%) and rhinosinusitis (14.6%) p < 0.001.", {"entities": [[37, 46, "DISEASE"], [73, 79, "DISEASE"]]}], ["The frequency of respiratory disease decreases with age and children less than five years of age and of low socio-economic status were commonly affected, p\u2009=\u20090.01.", {"entities": []}], ["The median duration of hospital stay was two days [range 1 to 8\u2009days], children less than five years old and those of low socio-economic status, spent more than four days (p\u2009=\u20090.01 and p < 0.001 respectively).", {"entities": []}], ["The all-cause mortality was 0.5% (11/2214) of which 81.8% (9/11) was due to pneumonia.", {"entities": [[76, 85, "DISEASE"]]}], ["Respiratory diseases constitute a significant burden of childhood illnesses in our centre.", {"entities": []}], ["Efforts are required to reduce the impact as part of the steps towards the achievement of the Millennium Development Goals.", {"entities": []}], ["Yoga is associated with reduced stress and increased well-being, although the molecular basis for these benefits is not clear.", {"entities": []}], ["Mounting evidence implicates the immune response, with current studies focused on protein immune markers (such as cytokines) in clinical populations.", {"entities": []}], ["To explore the molecular impact, this pilot study uses a subsample ( n =28) from a randomised waitlist control trial investigating the impact of an 8-week yoga intervention in a community population of women reporting psychological distress ( N =116).", {"entities": []}], ["We measured interleukin-6 (IL-6), tumour necrosis factor (TNF) and C-reactive protein (CRP) protein levels, and the DNA methylation of these genes and the global indicator, LINE-1 .", {"entities": [[58, 61, "GENE"], [87, 90, "GENE"]]}], ["Correlations between these and psychological variables were explored, identifying moderate correlations with CRP protein levels, and methylation of IL-6 , CRP and LINE-1 .", {"entities": [[109, 112, "GENE"], [155, 158, "GENE"], [109, 112, "GENE"], [155, 158, "GENE"]]}], ["Many cytokine samples were below detection, however a Mann\u2013Whitney U demonstrated a trend of moderate between-group effect for elevated IL-6 in the yoga group.", {"entities": []}], ["Methylation analyses applied cross-sectional and non-controlled longitudinal analyses.", {"entities": []}], ["Waist-to-height ratio and age were covaried.", {"entities": []}], ["We demonstrated reduced methylation of the TNF region in the yoga group relative to the waitlist control group.", {"entities": [[43, 46, "GENE"]]}], ["No other genes demonstrated a significant difference.", {"entities": []}], ["Longitudinal analysis further supported these results.", {"entities": []}], ["This study is one of the first to explore yoga and immunological markers in a non-clinical population, and is the first study to explore DNA methylation.", {"entities": []}], ["These findings indicate that further research into molecular impact of yoga on markers of immune function is warranted, with larger studies required.", {"entities": []}], ["In this article three research questions are addressed: (1) Is there an association between socioeconomic status (SES) and patient-reported outcomes in a cohort of multimorbid patients?", {"entities": []}], ["(2) Does the association vary according to SES indicator used (income, education, occupational position)?", {"entities": []}], ["(3) Can the association between SES and patient-reported outcomes (self-rated health, health-related quality of life and functional status) be (partly) explained by burden of disease?", {"entities": []}], ["Analyses are based on the MultiCare Cohort Study, a German multicentre, prospective, observational cohort study of multimorbid patients from general practice.", {"entities": []}], ["We analysed baseline data and data from the first follow-up after 15\u00a0months (N\u2009=\u20092,729).", {"entities": []}], ["To assess burden of disease we used the patients\u2019 morbidity data from standardized general practitioner (GP) interviews based on a list of 46 groups of chronic conditions including the GP\u2019s severity rating of each chronic condition ranging from marginal to very severe.", {"entities": []}], ["In the cross-sectional analyses SES was significantly associated with the patient-reported outcomes at baseline.", {"entities": []}], ["Associations with income were more consistent and stronger than with education and occupational position.", {"entities": []}], ["Associations were partly explained (17% to 44%) by burden of disease.", {"entities": []}], ["In the longitudinal analyses only income (but not education and occupational position) was significantly related to the patient-reported outcomes at follow-up.", {"entities": []}], ["Associations between income and the outcomes were reduced by 18% to 27% after adjustment for burden of disease.", {"entities": []}], ["Results indicate social inequalities in self-rated health, functional status and health related quality of life among older multimorbid patients.", {"entities": []}], ["As associations with education and occupational position were inconsistent, these inequalities were mainly due to income.", {"entities": []}], ["Inequalities were partly explained by burden of disease.", {"entities": []}], ["However, even among patients with a similar disease burden, those with a low income were worse off in terms of the three patient-reported outcomes under study.", {"entities": []}], ["The online version of this article (doi:10.1186/s12939-015-0142-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Surgery for refractory gastroesophageal reflux disease (GERD) and hiatal hernia leads to recurrence or persisting dysphagia in a minority of patients.", {"entities": [[23, 54, "DISEASE"]]}], ["Redo antireflux surgery in GERD and hiatal hernia is known for higher morbidity and mortality.", {"entities": []}], ["This study aims to evaluate conventional versus robot-assisted laparoscopic redo antireflux surgery, with the objective to detect possible advantages for the robot-assisted approach.", {"entities": []}], ["A single institute cohort of 75 patients who underwent either conventional laparoscopic or robot-assisted laparoscopic redo surgery for recurrent GERD or severe dysphagia between 2008 and 2013 were included in the study.", {"entities": []}], ["Baseline characteristics, symptoms, medical history, procedural data, hospital stay, complications and outcome were prospectively gathered.", {"entities": []}], ["The main indications for redo surgery were dysphagia, pyrosis or a combination of both in combination with a proven anatomic abnormality.", {"entities": []}], ["The mean time to redo surgery was 1.9 and 2.0\u00a0years after primary surgery for the conventional and robot-assisted groups, respectively.", {"entities": []}], ["The number of conversions was lower in the robot-assisted group compared to conventional laparoscopy (1/45 vs. 5/30, p \u00a0=\u00a00.035) despite a higher proportion of patients with previous surgery by laparotomy (9/45 vs. 1/30, p \u00a0=\u00a00.038).", {"entities": []}], ["Median hospital stay was reduced by 1\u00a0day (3 vs. 4, p \u00a0=\u00a00.042).", {"entities": []}], ["There were no differences in mortality, complications or outcome.", {"entities": []}], ["Robotic support, when available, can be regarded beneficial in redo surgery for GERD and hiatal hernia.", {"entities": []}], ["Results of this observational study suggest technical feasibility for minimal-invasive robot-assisted redo surgery after open primary antireflux surgery, a reduced number of conversions and shorter hospital stay.", {"entities": []}], ["Most of current strategies for antiviral therapeutics target the virus specifically and directly, but an alternative approach to drug discovery might be to enhance the immune response to a broad range of viruses.", {"entities": []}], ["Based on clinical observation in humans and successful genetic strategies in experimental models, we reasoned that an improved interferon (IFN) signaling system might better protect against viral infection.", {"entities": []}], ["Here we aimed to identify small molecular weight compounds that might mimic this beneficial effect and improve antiviral defense.", {"entities": []}], ["Accordingly, we developed a cell-based high-throughput screening (HTS) assay to identify small molecules that enhance the IFN signaling pathway components.", {"entities": []}], ["The assay is based on a phenotypic screen for increased IFN-stimulated response element (ISRE) activity in a fully automated and robust format (Z\u2032>0.7).", {"entities": []}], ["Application of this assay system to a library of 2240 compounds (including 2160 already approved or approvable drugs) led to the identification of 64 compounds with significant ISRE activity.", {"entities": []}], ["From these, we chose the anthracycline antibiotic, idarubicin, for further validation and mechanism based on activity in the sub-\u00b5M range.", {"entities": []}], ["We found that idarubicin action to increase ISRE activity was manifest by other members of this drug class and was independent of cytotoxic or topoisomerase inhibitory effects as well as endogenous IFN signaling or production.", {"entities": []}], ["We also observed that this compound conferred a consequent increase in IFN-stimulated gene (ISG) expression and a significant antiviral effect using a similar dose-range in a cell-culture system inoculated with encephalomyocarditis virus (EMCV).", {"entities": []}], ["The antiviral effect was also found at compound concentrations below the ones observed for cytotoxicity.", {"entities": []}], ["Taken together, our results provide proof of concept for using activators of components of the IFN signaling pathway to improve IFN efficacy and antiviral immune defense as well as a validated HTS approach to identify small molecules that might achieve this therapeutic benefit.", {"entities": []}], ["About 20% to 30% of patients are difficult to wean from invasive mechanical ventilation.", {"entities": []}], ["The pathophysiology of difficult weaning is complex.", {"entities": []}], ["Accordingly, determining the reason for difficult weaning and subsequently developing a treatment strategy require a dedicated clinician with in-depth knowledge of the pathophysiology of weaning failure.", {"entities": []}], ["This review presents a structural framework ('ABCDE') for the assessment and treatment of difficult-to-wean patients.", {"entities": []}], ["Earlier recognition of the underlying causes may expedite weaning from mechanical ventilation.", {"entities": []}], ["A joint study group on cow's milk allergy was convened by the Emilia-Romagna Working Group for Paediatric Allergy and by the Emilia-Romagna Working Group for Paediatric Gastroenterology to focus best practice for diagnosis, management and follow-up of cow's milk allergy in children and to offer a common approach for allergologists, gastroenterologists, general paediatricians and primary care physicians.", {"entities": []}], ["The report prepared by the study group was discussed by members of Working Groups who met three times in Italy.", {"entities": []}], ["This guide is the result of a consensus reached in the following areas.", {"entities": []}], ["Cow's milk allergy should be suspected in children who have immediate symptoms such as acute urticaria/angioedema, wheezing, rhinitis, dry cough, vomiting, laryngeal edema, acute asthma with severe respiratory distress, anaphylaxis.", {"entities": [[93, 102, "DISEASE"], [125, 133, "DISEASE"], [179, 185, "DISEASE"], [103, 113, "DISEASE"]]}], ["Late reactions due to cow's milk allergy are atopic dermatitis, chronic diarrhoea, blood in the stools, iron deficiency anaemia, gastroesophageal reflux disease, constipation, chronic vomiting, colic, poor growth (food refusal), enterocolitis syndrome, protein-losing enteropathy with hypoalbuminemia, eosinophilic oesophagogastroenteropathy.", {"entities": [[162, 174, "DISEASE"], [45, 62, "DISEASE"], [243, 251, "DISEASE"], [253, 279, "DISEASE"], [129, 160, "DISEASE"], [52, 62, "DISEASE"]]}], ["An overview of acceptable means for diagnosis is included.", {"entities": []}], ["According to symptoms and infant diet, three different algorithms for diagnosis and follow-up have been suggested.", {"entities": []}], ["This paper describes efforts to generate evidence for community-developed programs to enhance family relationships in the Chinese culture of Hong Kong, within the framework of community-based participatory research (CBPR).", {"entities": []}], ["The CBPR framework was applied to help maximize the development of the intervention and the public health impact of the studies, while enhancing the capabilities of the social service sector partners.", {"entities": []}], ["Four academic-community research teams explored the process of designing and implementing randomized controlled trials in the community.", {"entities": []}], ["In addition to the expected cultural barriers between teams of academics and community practitioners, with their different outlooks, concerns and languages, the team navigated issues in utilizing the principles of CBPR unique to this Chinese culture.", {"entities": []}], ["Eventually the team developed tools for adaptation, such as an emphasis on building the relationship while respecting role delineation and an iterative process of defining the non-negotiable parameters of research design while maintaining scientific rigor.", {"entities": []}], ["Lessons learned include the risk of underemphasizing the size of the operational and skills shift between usual agency practices and research studies, the importance of minimizing non-negotiable parameters in implementing rigorous research designs in the community, and the need to view community capacity enhancement as a long term process.", {"entities": []}], ["The four pilot studies under the FAMILY Project demonstrated that nuanced design adaptations, such as wait list controls and shorter assessments, better served the needs of the community and led to the successful development and vigorous evaluation of a series of preventive, family-oriented interventions in the Chinese culture of Hong Kong.", {"entities": []}], ["Activation of mast cells (MCs) can be achieved by the high-affinity receptor for IgE (Fc\u03b5RI) as well as by additional receptors such as the lipopolysaccharide (LPS) receptor and the receptor tyrosine kinase Kit (stem cell factor [SCF] receptor).", {"entities": []}], ["Thus, pharmacological interventions which stabilize MCs in response to different receptors would be preferable in diseases with pathological systemic MC activation such as systemic mastocytosis.", {"entities": [[181, 193, "DISEASE"], [172, 193, "DISEASE"]]}], ["1,4-Benzodiazepines (BDZs) have been reported to suppress MC effector functions.", {"entities": []}], ["In the present study, our aim was to analyze molecularly the effects of BDZs on MC activation by comparison of the effects of the two BDZs Ro5-4864 and clonazepam, which markedly differ in their affinities for the archetypical BDZ recognition sites, i.e., the GABA A receptor and TSPO (previously termed peripheral-type BDZ receptor).", {"entities": [[280, 284, "GENE"]]}], ["Ro5-4864 is a selective agonist at TSPO, whereas clonazepam is a selective agonist at the GABA A receptor.", {"entities": [[35, 39, "GENE"]]}], ["Ro5-4864 suppressed pro-inflammatory MC effector functions in response to antigen (Ag) (degranulation/cytokine production) and LPS and SCF (cytokine production), whereas clonazepam was inactive.", {"entities": []}], ["Signaling pathway analyses revealed inhibitory effects of Ro5-4864 on Ag-triggered production of reactive oxygen species, calcium mobilization and activation of different downstream kinases.", {"entities": []}], ["The initial activation of Src family kinases was attenuated by Ro5-4864 offering a molecular explanation for the observed impacts on various downstream signaling elements.", {"entities": [[26, 29, "GENE"]]}], ["In conclusion, BDZs structurally related to Ro5-4864 might serve as multifunctional MC stabilizers without the sedative effect of GABA A receptor-interacting BDZs.", {"entities": []}], ["The population of persons living with HIV (PLWH) is growing older and more prone to developing other chronic health conditions.", {"entities": []}], ["Disease progression has been shown to be related to quality of life (QoL).", {"entities": []}], ["However, descriptions of chronic comorbid illnesses and the unique QoL challenges of older adults living with HIV are not well understood and have not been examined in multiple geographic locations.", {"entities": []}], ["About 452 PLWH aged 50 years or older were recruited from AIDS Service Organizations in nine states.", {"entities": []}], ["Participants completed a telephone survey that included measures of other chronic health conditions, perceived stress, depression, and health-related quality of life.", {"entities": []}], ["As much as 94% of the sample reported a chronic health condition in addition to HIV (mode = 2).", {"entities": []}], ["The highest reported conditions were hypertension, chronic pain, hepatitis, and arthritis.", {"entities": [[37, 49, "DISEASE"], [65, 74, "DISEASE"], [80, 89, "DISEASE"]]}], ["Despite relatively high rates of depression, overall QoL was moderately high for the sample.", {"entities": []}], ["Physical functioning was most impacted by the addition of other chronic health problems.", {"entities": []}], ["Social functioning, mental health functioning, stress, and depression were also strongly associated with chronic disease burden.", {"entities": []}], ["Additional chronic health problems are the norm for PLWH aged 50 years and older.", {"entities": []}], ["QoL is significantly related to the addition of chronic health problems.", {"entities": []}], ["As increasing numbers of PLWH reach older age, this raises challenges for providing comprehensive healthcare to older PLWH with multiple chronic conditions.", {"entities": []}], ["5-Lipoxygenase (5-LO) catalyzes leukotriene (LT) biosynthesis by a mechanism that involves interactions with 5-lipoxygenase activating protein (FLAP) and coactosin-like protein (CLP).", {"entities": [[45, 47, "GENE"]]}], ["5-LO splice variants were recently identified in human myeloid and lymphoid cells, including the catalytically inactive \u220613 isoform (5-LO\u220613) whose transcript lacks exon 13.", {"entities": []}], ["5-LO\u220613 inhibits 5-LO product biosynthesis when co-expressed with active full length 5-LO (5-LO1).", {"entities": []}], ["The objective of this study was to investigate potential mechanisms by which 5-LO\u220613 interferes with 5-LO product biosynthesis in transfected HEK293 cells.", {"entities": []}], ["When co-expressed with 5-LO1, 5-LO\u220613 inhibited LT but not 5-hydroxyeicosatetraenoic acid (5-HETE) biosynthesis.", {"entities": [[48, 50, "GENE"]]}], ["This inhibition was independent of 5-LO\u220613\u2014FLAP interactions since it occurred in cells expressing FLAP or not.", {"entities": []}], ["In cell-free assays CLP enhances 5-LO activity through interactions with tryptophan-102 of 5-LO.", {"entities": []}], ["In the current study, the requirement for W102 was extended to whole cells, as cells expressing the 5-LO1-W102A mutant produced little 5-LO products.", {"entities": []}], ["W102A mutants of 5-LO\u220613 inhibited 5-LO product biosynthesis as effectively as 5-LO\u220613 suggesting that inhibition is independent of interactions with CLP.", {"entities": []}], ["Confocal microscopy showed that 5-LO1 was primarily in the nucleoplasm whereas W102A mutants showed a diffuse cellular expression.", {"entities": []}], ["Despite the retention of known nuclear localisation sequences, 5-LO\u220613 was cytosolic and concentrated in ER-rich perinuclear regions where its effect on LT biosynthesis may occur.", {"entities": [[153, 155, "GENE"]]}], ["W102A mutants of 5-LO\u220613 showed the same pattern.", {"entities": []}], ["Consistent with subcellular distribution patterns, 5-LO\u220613 was hyper-phosphorylated on S523 and S273 compared to 5-LO1.", {"entities": []}], ["Together, these results reveal a role for W102 in nuclear targeting of 5-LO1 suggesting that interactions with CLP are required for nuclear localization of 5-LO1, and are an initial characterisation of the 5-LO\u220613 isoform whose inhibition of LT biosynthesis appears independent of interactions with CLP and FLAP.", {"entities": [[242, 244, "GENE"]]}], ["Better knowledge of the regulation and properties of alternative 5-LO isoforms will contribute to understanding the complex regulation of LT biosynthesis.", {"entities": [[138, 140, "GENE"]]}], ["The objective of this study was to compare the oil extraction yield and essential oil composition of Indian and Iranian Nigella sativa L. extracted by using Supercritical Fluid Extraction (SFE) and solvent extraction methods.", {"entities": []}], ["In this study, a gas chromatography equipped with a mass spectrophotometer detector was employed for qualitative analysis of the essential oil composition of Indian and Iranian N. sativa L. The results indicated that the main fatty acid composition identified in the essential oils extracted by using SFE and solvent extraction were linoleic acid (22.4%\u201361.85%) and oleic acid (1.64%\u201318.97%).", {"entities": []}], ["Thymoquinone (0.72%\u201321.03%) was found to be the major volatile compound in the extracted N. sativa oil.", {"entities": []}], ["It was observed that the oil extraction efficiency obtained from SFE was significantly ( P <0.05) higher than that achieved by the solvent extraction technique.", {"entities": []}], ["The present study showed that SFE can be used as a more efficient technique for extraction of N. Sativa L. essential oil, which is composed of higher linoleic acid and thymoquinone contents compared to the essential oil obtained by the solvent extraction technique.", {"entities": []}], ["Multimorbidity has become one of the main challenges in the recent years for patients, health care providers and the health care systems globally.", {"entities": []}], ["However, literature describing the burden of multimorbidity in the elderly population, especially longitudinal trends is very limited.", {"entities": []}], ["Physical activity is recommended as one of the main lifestyle changes in the prevention and management of multiple chronic diseases worldwide; however, the evidence on its association with multimorbidity remains inconclusive.", {"entities": []}], ["Therefore, we aimed to assess the longitudinal trends of multimorbidity and the association between multimorbidity and physical activity in a nationally representative cohort of the English population aged \u226550\u00a0years between 2002 and 2013.", {"entities": []}], ["We used data on 15,688 core participants from six waves of the English Longitudinal Study of Ageing, with complete information on physical activity.", {"entities": []}], ["Self-reported physical activity was categorised as inactive, mild, moderate and vigorous levels of physical activity.", {"entities": []}], ["We calculated the number of morbidities and the prevalence of multimorbidity (more than 2 chronic conditions) between 2002 and 2013 overall and by levels of self-reported physical activity.", {"entities": []}], ["We estimated the odds ratio (OR) and 95\u00a0% confidence intervals (CI) for multimorbidity by each category of physical activity, adjusting for potential confounders.", {"entities": []}], ["There was a progressive decrease over time in the proportion of participants without any chronic conditions (33.9\u00a0% in 2002/2003 vs. 26.8\u00a0% in 2012/2013).", {"entities": []}], ["In contrast, the prevalence of multimorbidity steadily increased over time (31.7\u00a0% in 2002/2003 vs. 43.1\u00a0% in 2012/2013).", {"entities": []}], ["Compared to the physically inactive group, the OR for multimorbidity was 0.84 (95\u00a0% CI 0.78 to 0.91) in mild, 0.61 (95\u00a0% CI 0.56 to 0.66) in moderate and 0.45 (95\u00a0% CI 0.41 to 0.49) in the vigorous physical activity group.", {"entities": []}], ["This study demonstrated an inverse dose-response association between levels of physical activity and multimorbidity, however, given the increasing prevalence of multimorbidity over time, there is a need to explore causal associations between physical activity and multimorbidity and its impact as a primary prevention strategy to prevent the occurrence of chronic conditions later in life and reduce the burden of multimorbidity.", {"entities": []}], ["The online version of this article (doi:10.1186/s12966-016-0330-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Missing data is a common problem in epidemiological studies, and is particularly prominent in longitudinal data, which involve multiple waves of data collection.", {"entities": []}], ["Traditional multiple imputation (MI) methods (fully conditional specification (FCS) and multivariate normal imputation (MVNI)) treat repeated measurements of the same time-dependent variable as just another \u2018distinct\u2019 variable for imputation and therefore do not make the most of the longitudinal structure of the data.", {"entities": []}], ["Only a few studies have explored extensions to the standard approaches to account for the temporal structure of longitudinal data.", {"entities": []}], ["One suggestion is the two-fold fully conditional specification (two-fold FCS) algorithm, which restricts the imputation of a time-dependent variable to time blocks where the imputation model includes measurements taken at the specified and adjacent times.", {"entities": []}], ["To date, no study has investigated the performance of two-fold FCS and standard MI methods for handling missing data in a time-varying covariate with a non-linear trajectory over time \u2013 a commonly encountered scenario in epidemiological studies.", {"entities": []}], ["We simulated 1000 datasets of 5000 individuals based on the Longitudinal Study of Australian Children (LSAC).", {"entities": []}], ["Three missing data mechanisms: missing completely at random (MCAR), and a weak and a strong missing at random (MAR) scenarios were used to impose missingness on body mass index (BMI) for age z-scores; a continuous time-varying exposure variable with a non-linear trajectory over time.", {"entities": []}], ["We evaluated the performance of FCS, MVNI, and two-fold FCS for handling up to 50% of missing data when assessing the association between childhood obesity and sleep problems.", {"entities": [[148, 155, "DISEASE"]]}], ["The standard two-fold FCS produced slightly more biased and less precise estimates than FCS and MVNI.", {"entities": []}], ["We observed slight improvements in bias and precision when using a time window width of two for the two-fold FCS algorithm compared to the standard width of one.", {"entities": []}], ["We recommend the use of FCS or MVNI in a similar longitudinal setting, and when encountering convergence issues due to a large number of time points or variables with missing values, the two-fold FCS with exploration of a suitable time window.", {"entities": []}], ["The online version of this article (doi:10.1186/s12874-017-0372-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The growth potential of the tumor\u2010like Echinococcus multilocularis metacestode (causing alveolar echinococcosis, AE) is directly linked to the nature/function of the periparasitic host immune\u2010mediated processes.", {"entities": [[97, 111, "DISEASE"], [88, 111, "DISEASE"]]}], ["Previous studies had shown that regulatory T cells (Tregs) become gradually up\u2010regulated in the course of both chronic human and murine AE.", {"entities": []}], ["Thus we now tackled the role of FoxP3 The infection outcome in E. multilocularis \u2010infected DEREG mice was measured upon determining parasite load (wet weight of parasitic metacestode tissue).", {"entities": [[32, 37, "GENE"]]}], ["Flow cytometry and qRT\u2010PCR were used to assess Treg, Th17\u2010, Th1\u2010, Th2\u2010type immune responses and antigen presenting cell activation.", {"entities": []}], ["We showed that E. multilocularis \u2010infected DEREG\u2010mice treated with DT (as compared to infected control DEREG\u2010mice without DT application) exhibited a significantly lower parasite load, associated with a persisting capacity of co\u2010stimulation, and an increased Th1/Th17\u2010polarization.", {"entities": []}], ["The inositol trisphosphate receptor ( ) is one of the most important cellular components responsible for oscillations in the cytoplasmic calcium concentration.", {"entities": []}], ["Over the past decade, two major questions about the have arisen.", {"entities": []}], ["Firstly, how best should the be modeled?", {"entities": []}], ["In other words, what fundamental properties of the allow it to perform its function, and what are their quantitative properties?", {"entities": []}], ["Secondly, although calcium oscillations are caused by the stochastic opening and closing of small numbers of , is it possible for a deterministic model to be a reliable predictor of calcium behavior?", {"entities": []}], ["Here, we answer these two questions, using airway smooth muscle cells (ASMC) as a specific example.", {"entities": []}], ["Firstly, we show that periodic calcium waves in ASMC, as well as the statistics of calcium puffs in other cell types, can be quantitatively reproduced by a two-state model of the , and thus the behavior of the is essentially determined by its modal structure.", {"entities": []}], ["The structure within each mode is irrelevant for function.", {"entities": []}], ["Secondly, we show that, although calcium waves in ASMC are generated by a stochastic mechanism, stochasticity is not essential for a qualitative prediction of how oscillation frequency depends on model parameters, and thus deterministic models demonstrate the same level of predictive capability as do stochastic models.", {"entities": []}], ["We conclude that, firstly, calcium dynamics can be accurately modeled using simplified models, and, secondly, to obtain qualitative predictions of how oscillation frequency depends on parameters it is sufficient to use a deterministic model.", {"entities": []}], ["The inositol trisphosphate receptor ( ) is one of the most important cellular components responsible for calcium oscillations.", {"entities": []}], ["Over the past decade, two major questions about the have arisen.", {"entities": []}], ["Firstly, what fundamental properties of the allow it to perform its function?", {"entities": []}], ["Secondly, although calcium oscillations are caused by the stochastic properties of small numbers of is it possible for a deterministic model to be a reliable predictor of calcium dynamics?", {"entities": []}], ["Using airway smooth muscle cells as an example, we show that calcium dynamics can be accurately modeled using simplified models, and, secondly, that deterministic models are qualitatively accurate predictors of calcium dynamics.", {"entities": []}], ["These results are important for the study of calcium dynamics in many cell types.", {"entities": []}], ["Little is known about depressive and anxious symptoms and quality of life (QOL) in caregivers of children with cystic fibrosis (CF).", {"entities": [[111, 126, "DISEASE"]]}], ["The aims of this study were to: (1) assess rates of female and male caregiver depressive and anxious symptoms, and (2) evaluate relations between depressive and anxious symptoms, caregiver QOL, and health outcomes.", {"entities": []}], ["Eligible participants were caregivers of children with CF who completed three questionnaires assessing depressive and anxious symptoms and caregiver QOL during routine CF Clinic appointments.", {"entities": []}], ["Rates of depressive and anxious symptoms were elevated in female and male caregivers of children with CF.", {"entities": []}], ["Rates were higher for anxious (51% for females, 43% for males) than depressive symptoms (20\u201328% for females; 14\u201331% for males).", {"entities": []}], ["Female caregiver depressive symptoms increased as child lung functioning decreased.", {"entities": []}], ["As depressive and anxious symptoms increased, caregiver QOL decreased.", {"entities": []}], ["In addition, female caregiver depressive and anxious symptoms were positively correlated with male caregiver anxious and depressive symptoms in a small subsample of couples.", {"entities": []}], ["CF disease severity and caregiver depressive symptoms predicted caregiver QOL.", {"entities": []}], ["Rates of depressive and anxious symptoms are high among caregivers of children with CF.", {"entities": []}], ["The results of this study highlight the need to screen for female and male caregiver depressive and anxious symptoms in the CF Clinic as CF Team members are well positioned to provided assistance around solving CF-related challenges.", {"entities": []}], ["In addition, alleviation of depressive and anxious symptoms could potentially lead to improvements in the psychological functioning and well-being of caregivers of children with CF.", {"entities": []}], ["Pediatr Pulmonol.", {"entities": []}], ["2009; 44:784\u2013792.", {"entities": []}], ["\u00a9 2009 Wiley-Liss, Inc.", {"entities": []}], ["For almost two decades, cell-based therapies have been tested in modern regenerative medicine to either replace or regenerate human cells, tissues, or organs and restore normal function.", {"entities": []}], ["Secreted paracrine factors are increasingly accepted to exert beneficial biological effects that promote tissue regeneration.", {"entities": []}], ["These factors are called the cell secretome and include a variety of proteins, lipids, microRNAs, and extracellular vesicles, such as exosomes and microparticles.", {"entities": []}], ["The stem cell secretome has most commonly been investigated in pre-clinical settings.", {"entities": []}], ["However, a growing body of evidence indicates that other cell types, such as peripheral blood mononuclear cells (PBMCs), are capable of releasing significant amounts of biologically active paracrine factors that exert beneficial regenerative effects.", {"entities": []}], ["The apoptotic PBMC secretome has been successfully used pre-clinically for the treatment of acute myocardial infarction, chronic heart failure, spinal cord injury, stroke, and wound healing.", {"entities": [[98, 119, "DISEASE"], [92, 119, "DISEASE"]]}], ["In this review we describe the benefits of choosing PBMCs instead of stem cells in regenerative medicine and characterize the factors released from apoptotic PBMCs.", {"entities": []}], ["We also discuss pre-clinical studies with apoptotic cell-based therapies and regulatory issues that have to be considered when conducting clinical trials using cell secretome-based products.", {"entities": []}], ["This should allow the reader to envision PBMC secretome-based therapies as alternatives to all other forms of cell-based therapies.", {"entities": []}], ["Microarray experiments are capable of determining the relative expression of tens of thousands of genes simultaneously, thus resulting in very large databases.", {"entities": []}], ["The analysis of these databases and the extraction of biologically relevant knowledge from them are challenging tasks.", {"entities": []}], ["The identification of potential cancer biomarker genes is one of the most important aims for microarray analysis and, as such, has been widely targeted in the literature.", {"entities": [[32, 38, "DISEASE"]]}], ["However, identifying a set of these genes consistently across different experiments, researches, microarray platforms, or cancer types is still an elusive endeavor.", {"entities": [[122, 128, "DISEASE"]]}], ["Besides the inherent difficulty of the large and nonconstant variability in these experiments and the incommensurability between different microarray technologies, there is the issue of the users having to adjust a series of parameters that significantly affect the outcome of the analyses and that do not have a biological or medical meaning.", {"entities": []}], ["In this study, the identification of potential cancer biomarkers from microarray data is casted as a multiple criteria optimization (MCO) problem.", {"entities": [[47, 53, "DISEASE"]]}], ["The efficient solutions to this problem, found here through data envelopment analysis (DEA), are associated to genes that are proposed as potential cancer biomarkers.", {"entities": [[148, 154, "DISEASE"]]}], ["The method does not require any parameter adjustment by the user, and thus fosters repeatability.", {"entities": []}], ["The approach also allows the analysis of different microarray experiments, microarray platforms, and cancer types simultaneously.", {"entities": [[101, 107, "DISEASE"]]}], ["The results include the analysis of three publicly available microarray databases related to cervix cancer.", {"entities": [[100, 106, "DISEASE"]]}], ["This study points to the feasibility of modeling the selection of potential cancer biomarkers from microarray data as an MCO problem and solve it using DEA.", {"entities": [[76, 82, "DISEASE"]]}], ["Using MCO entails a new optic to the identification of potential cancer biomarkers as it does not require the definition of a threshold value to establish significance for a particular gene and the selection of a normalization procedure to compare different experiments is no longer necessary.", {"entities": [[65, 71, "DISEASE"]]}], ["Compelling evidence suggests that excessive alcohol consumption increases the risk of atrial fibrillation ( AF ), but the effect of light\u2010moderate alcohol consumption is less certain.", {"entities": []}], ["We investigated the association between alcohol consumption within recommended limits and AF risk in a light\u2010drinking population.", {"entities": []}], ["Among 47\u00a0002 participants with information on alcohol consumption in a population\u2010based cohort study in Norway, conducted from October 2006 to June 2008, 1697 validated AF diagnoses were registered during the 8\u00a0years of follow\u2010up.", {"entities": []}], ["We used Cox proportional hazard models with fractional polynomials to analyze the association between alcohol intake and AF .", {"entities": []}], ["Population attributable risk for drinking within the recommended limit (ie, at most 1 drink per day for women and 2 drinks per day for men without risky drinking) compared with nondrinking was also calculated.", {"entities": []}], ["The average alcohol intake was 3.8\u00b14.8\u00a0g/d.", {"entities": []}], ["The adjusted hazard ratio for AF was 1.38 (95% confidence interval, 1.06\u20131.80) when we compared participants consuming >7 drinks per week with abstainers.", {"entities": []}], ["When we modeled the quantity of alcohol intake as a continuous variable, the risk increased in a curvilinear manner.", {"entities": []}], ["It was higher with heavier alcohol intake, but there was virtually no association at <1 drink per day for women and <2 drinks per day for men in the absence of risky drinking.", {"entities": []}], ["The population attributable risk among nonrisky drinkers was 0.07% (95% confidence interval, \u22120.01% to 0.13%).", {"entities": []}], ["Although alcohol consumption was associated with a curvilinearly increasing risk of AF in general, the attributable risk of alcohol consumption within recommended limits among participants without binge or problem drinking was negligible in this population.", {"entities": []}], ["Due to the increasing applications of nanomaterials and nanotechnology, potential danger of nanoparticle exposure has become a critical issue.", {"entities": []}], ["However, recent nanotoxicity studies have mainly focused on the health risks to healthy adult population.", {"entities": []}], ["The nanotoxicity effects on susceptible populations (such as pregnant, neonate, diseased, and aged populations) have been overlooked.", {"entities": []}], ["Due to the alterations in physiological structures and functions in susceptible populations, they often suffer more damage from the same exposure.", {"entities": []}], ["Thus, it is urgent to understand the effects of nanoparticle exposure on these populations.", {"entities": []}], ["In order to fill this gap, the potential effects of nanoparticles to pregnant females, neonate, diseased, and aged population, as well as the possible underlying mechanisms are reviewed in this article.", {"entities": []}], ["Investigations show that responses from susceptible population to nanoparticle exposure are often more severe.", {"entities": []}], ["Reduced protection mechanism, compromised immunity, and impaired self-repair ability in these susceptible populations may contribute to the aggravated toxicity effects.", {"entities": []}], ["This review will help minimize adverse effects of nanoparticles to susceptible population in future nanotechnology applications.", {"entities": []}], ["Understanding emerging areas of a multidisciplinary research field is crucial for researchers, policymakers and other stakeholders.", {"entities": []}], ["For them a knowledge structure based on longitudinal bibliographic data can be an effective instrument.", {"entities": []}], ["But with the vast amount of available online information it is often hard to understand the knowledge structure for data.", {"entities": []}], ["In this paper, we present a novel approach for retrieving online bibliographic data and propose a framework for exploring knowledge structure.", {"entities": []}], ["We also present several longitudinal analyses to interpret and visualize the last 20 years of published obesity research data.", {"entities": [[104, 111, "DISEASE"]]}], ["Occupational reaction to natural rubber latex (NRL) glove use by healthcare employees has been an area of increasing concern.", {"entities": [[47, 50, "GENE"]]}], ["Unfortunately, there is little data demonstrating the prevalence and severity of actual reactivity to NRL.", {"entities": [[102, 105, "GENE"]]}], ["Occupational reaction to NRL was estimated using workers' compensation claims filed by healthcare employees in Oregon for the period of 1987\u20131998.", {"entities": [[25, 28, "GENE"]]}], ["For the first ten years, these claims were estimated by source and conditions consistent with NRL glove reactions, while in the last two years a specific code developed in 1997 for NRL glove reactions was also employed.", {"entities": [[94, 97, "GENE"], [181, 184, "GENE"], [94, 97, "GENE"], [181, 184, "GENE"]]}], ["The claim rate was on average 0.58 per 10,000 healthcare workers annually, which constituted 0.29% of all workers' compensation claims.", {"entities": []}], ["The most common condition experienced was dermatitis (80%) and most common body part affected was the hands (55.4%).", {"entities": [[42, 52, "DISEASE"]]}], ["The majority of claimants, 45 (69.2%), reported taking less than a month off work, suggesting most reactions were minor in nature, although one fatality was reported.", {"entities": []}], ["The average NRL claim cost was $8,309.48.", {"entities": [[12, 15, "GENE"]]}], ["Overall the average cost per insured healthcare worker was approximately $0.50 per year.", {"entities": []}], ["The occupational groups with the highest number of claims were nurses (30.8% of claimants) and nursing aides and orderlies (24.6% of claimants).", {"entities": []}], ["In comparison with other workers' compensation claims filed by healthcare workers during this period, 0.25% of the total was potentially related to NRL gloves.", {"entities": [[148, 151, "GENE"]]}], ["The rare incidence of respiratory and ocular claims is inconsistent with the hypothesis that asthmatic or conjunctival reactions to NRL gloves are common.", {"entities": [[132, 135, "GENE"]]}], ["Immobilisation in the intensive care unit (ICU) leads to muscle weakness and is associated with increased costs and long-term functional disability.", {"entities": []}], ["Previous studies showed early mobilisation of medical ICU patients improves clinical outcomes.", {"entities": []}], ["The Surgical ICU Optimal Mobilisation Score (SOMS) trial aims to test whether a budget-neutral intervention to facilitate goal-directed early mobilisation in the surgical ICU improves participant mobilisation and associated clinical outcomes.", {"entities": []}], ["The SOMS trial is an international, multicentre, randomised clinical study being conducted in the USA and Europe.", {"entities": []}], ["We are targeting 200 patients.", {"entities": []}], ["The primary outcome is average daily SOMS level and key secondary outcomes are ICU length of stay until discharge readiness and \u2018mini\u2019 modified Functional Independence Measure (mmFIM) at hospital discharge.", {"entities": []}], ["Additional secondary outcomes include quality of life assessed at 3\u2005months after hospital discharge and global muscle strength at ICU discharge.", {"entities": []}], ["Exploratory outcomes will include: ventilator-free days, ICU and hospital length of stay and 3-month mortality.", {"entities": []}], ["We will explore genetic influences on the effectiveness of early mobilisation and centre-specific effects of early mobilisation on outcomes.", {"entities": []}], ["Following\u00a0Institutional Review Board (IRB) approval in three institutions, we started study recruitment and plan to expand to additional centres in Germany and Italy.", {"entities": []}], ["Safety monitoring will be the domain of the Data and Safety Monitoring Board (DSMB).", {"entities": []}], ["The SOMS trial will also explore the feasibility of a transcontinental study on early mobilisation in the surgical ICU.", {"entities": []}], ["The results of this study, along with those of ancillary studies, will be made available in the form of manuscripts and presentations at national and international meetings.", {"entities": []}], ["This study has been registered at clinicaltrials.gov (NCT01363102).", {"entities": []}], ["Hospital volume has been suggested to be one of the best indicators of adverse orthopedic events in patients undergoing THR surgery.", {"entities": []}], ["We therefore evaluated the effect of hospital volume on the length of stay, re-admissions, and complications of THR at the population level in Finland.", {"entities": []}], ["30,266 THRs performed for primary osteoarthritis were identified from the Hospital Discharge Register.", {"entities": [[34, 48, "DISEASE"]]}], ["Hospitals were classified into 4 groups according to the number of THRs performed on an annual basis over the whole study period: 1\u201350 (group 1), 51\u2013150 (group 2), 151\u2013300 (group 3), and > 300 (group 4).", {"entities": []}], ["In 2005, the length of the period of surgical treatment was 5.5 days in group 4 and 6.8 days in group 1 (the reference group).", {"entities": []}], ["During the whole study period (1998\u20132005), the length of surgical treatment period was shorter in group 4 than in group 1 (p < 0.001).", {"entities": []}], ["The odds ratio for dislocations (0.7, 95% CI: 0.6\u20130.9) was lower in group 3 than in group 1.", {"entities": []}], ["Hip replacements performed in high-volume hospitals reduce costs by shortening the length of stay, and they may reduce the dislocation rate.", {"entities": []}], ["Obesity and ageing are emerging issues in the management of captive primates, including Chimpanzees, Pan troglodytes .", {"entities": [[0, 7, "DISEASE"]]}], ["Studies on humans show that obesity and old age can independently increase the risk of inflammatory-associated diseases indicated by elevated levels of pro-inflammatory cells and proteins in the blood of older or obese compared to levels in younger or non-obese individuals.", {"entities": [[28, 35, "DISEASE"]]}], ["In humans, sex can influence the outcomes of these risks.", {"entities": []}], ["Health management of these problems in chimpanzee populations requires an understanding of similarities and differences of factors influencing inflammatory disease risks in humans and in chimpanzees.", {"entities": []}], ["We examined the relationship between age, sex and Body Mass Index (BMI) with hematological biomarkers of inflammatory disease risk established for humans which include the neutrophil to lymphocyte ratio (NLR), and neutrophil, white blood cell (WBC), platelet microparticle and platelet counts.", {"entities": []}], ["We found that higher values of NLR, neutrophil count and platelet microparticle count were associated with higher BMI values and older age indicating increased inflammation risk in these groups; a similar pattern to humans.", {"entities": []}], ["There was a strong sex by age interaction on inflammation risk, with older males more at risk than older females.", {"entities": []}], ["In contrast to human studies, total WBC count was not influenced by BMI, but like humans, WBC and platelet counts were lower in older individuals compared to younger individuals.", {"entities": []}], ["Our findings are similar to those of humans and suggest that further insight on managing chimpanzees can be gained from extensive studies of ageing and obesity in humans.", {"entities": [[152, 159, "DISEASE"]]}], ["We suggest that managing BMI should be an integral part of health management in captive chimpanzee populations in order to partially reduce the risk of diseases associated with inflammation.", {"entities": []}], ["These results also highlight parallels in inflammation risk between humans and chimpanzees and have implications for understanding the evolution of inflammation related diseases in apes.", {"entities": []}], ["Currently available Interferon-\u03b3 release assay (IGRA) cannot reliably differentiate active TB (ATB) from non-active TB (non-ATB).", {"entities": []}], ["A study was performed to evaluate the value of Mycobacterium tuberculosis (MTB) specific Th1 cell immune responses which test IFN-\u03b3 and IL-2 simultaneous for differentiating ATB from non-ATB.", {"entities": [[61, 73, "DISEASE"]]}], ["Forty-nine newly diagnosed inpatients with ATB (26 pulmonary TB and 23 extrapulmonary TB) were enrolled as the ATB group.", {"entities": []}], ["Forty-five volunteers with latent tuberculosis infection (LTBI) and twenty with evidence of previous TB were enrolled during the same period as the non-ATB group.", {"entities": [[34, 46, "DISEASE"]]}], ["Clinical examination and MTB specific Th1 cell immune responses were performed for all participants.", {"entities": []}], ["After being stimulated with ESAT-6 and CFP-10, the median frequencies of single IL-2-, single IFN-\u03b3-, and dual IFN-\u03b3/IL-2-secreting T-cells were all higher in the ATB group than in the non-ATB group (20(8\u201345) vs. 7(3\u201313), P<0.001;131(44\u2013308) vs. 10(6\u201327), P<0.001;25(9\u201374) vs. 7(3\u201323), P = 0.001, respectively).", {"entities": []}], ["Evaluation of the diagnostic performance of detecting single IFN-\u03b3-secreting T cells for pulmonary TB employed a cutoff value of 35 iSFCs/250,000 PBMC.", {"entities": []}], ["The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), and negative likelihood ratio (NLR) were 92.3%, 80.0%, 64.9%, 96.3%, 4.62, and 0.10, respectively.", {"entities": []}], ["For extrapulmonary TB, using a cutoff value of 23 iSFCs/ 250,000 PBMC, the sensitivity, specificity, PPV, NPV, PLR, and NLR were 91.3%, 76.9%, 58.3%, 96.2%, 3.96, and 0.11, respectively.", {"entities": []}], ["When combining frequencies and proportion of single IFN-\u03b3-secreting T cells, the test sensitivity was 100% in parallel tests and the specificity was 87.7% in serial tests for pulmonary TB.", {"entities": []}], ["MTB specific Th1 cell immune responses (FluoroSpot) had value for the differentiation of ATB and non-ATB.", {"entities": []}], ["Further confirmatory studies are indicated.", {"entities": []}], ["Ethiopia has fairly good coverage but very low utilization of health care services.", {"entities": []}], ["Emergency medical care services require fast, correct and curious services to clients as they present with acute problems.", {"entities": []}], ["In Ethiopia and Gondar in particular, the quality of emergency medical care has not been studied.", {"entities": []}], ["The main aim of this study was to assess the disease profile and patients\u2019 satisfaction in Gondar University Referral Hospital (GURH).", {"entities": []}], ["A facility based cross-sectional study was conducted among patients visiting GURH for emergency care.", {"entities": []}], ["Ethical clearance was obtained from the Institutional Review Board of University of Gondar.", {"entities": []}], ["Patients were selected by systematic random sampling, using patient flow list in the day and night emergency services.", {"entities": []}], ["Data were collected using a standard Press Ganey questionnaire by BSc health science graduates.", {"entities": []}], ["Data were entered in to Epi Info 3.5.3 software and exported to SPSS version 20.0 for windows for analysis.", {"entities": []}], ["A total of 963 patients (response rate\u2009=\u200996.8%) were studied.", {"entities": []}], ["The mean (+ s.d.)", {"entities": []}], ["age of patients was 28.4 (+17.9) years.", {"entities": []}], ["The overall satisfaction using the mean score indicates that 498 (51.7%) 95%CI: (48.4% - 54.9%) were satisfied with the service, the providers and the facility suitability whereas 465(48.3%) 95%CI: (45.1%- 51.6%) were not satisfied.", {"entities": []}], ["Seven hundred and six (73.3%) 95%CI: 70.4%-76.1%, patients reported that they have been discriminated or treated badly during the service provision in the hospital.", {"entities": []}], ["OPD site visited (p\u2009<\u20090.0001), visiting days of the week (P\u2009<\u20090.049), medical condition on arrival (P\u2009<\u20090.0001), degree of confidence in the hospital (AOR\u2009=\u20091.9, 95%CI: 1.1, 3.1), reported discrimination/bad treatment of patients with service (AOR\u2009=\u20090.4, 95%CI: 0.2, 0.7), were significantly associated determinants of patient satisfaction.", {"entities": []}], ["Non-communicable disease emergencies like injuries and cardiovascular diseases are common.", {"entities": []}], ["There is a low level of patient satisfaction related to lack of confidence in the hospital for treatment, discrimination towards patient care, and under and delayed treatment of patients who were not in serious medical conditions.", {"entities": []}], ["Hospitals shall prepare themselves to address the increasing challenge of non-communicable disease emergencies.", {"entities": []}], ["It is important to revise the service delivery in the emergency department to improve staff courtesy and politeness, commitment, reduce discrimination and bad treatment and proper triage of emergencies at all points of care to increase patient satisfaction giving emphasis to earlier working days.", {"entities": []}], ["Protease-activated receptors (PARs) are G-protein-coupled receptors which initiate inflammatory responses when activated by specific serine proteases.", {"entities": []}], ["This study was conducted to examine whether human conjunctival epithelial cells (HCECs) express functionally active PAR1 and PAR2 using Chang conjunctival epithelial cells as in vitro model.", {"entities": []}], ["We performed RT-PCR and immunofluorescence analyses to determine the expression of PAR1 and PAR2, and monitored the production of IL-6 after activating HCECs with PAR1 activating agents (thrombin or TFLLRN) or PAR2 activating agents (tryptase, trypsin, or SLIGKV).", {"entities": []}], ["The results show that HCECs constitutively express PAR1 and PAR2 mRNA and proteins, and produce significant amounts of IL-6 when incubated with specific PAR-activating enzymes or agonist peptides.", {"entities": []}], ["Thrombin- and tryptase-induced HCEC activation was blocked by PAR1 and PAR2 neutralizing antibodies, respectively, and by specific enzyme inhibitors.", {"entities": []}], ["The constitutive expression of PAR1 and PAR2, and their activation by thrombin and tryptase, respectively, may have important implications in ocular inflammation.", {"entities": []}], ["Laparoscopic Nissen fundoplication (LNF) provides long-term improvement in the typical symptoms of gastroesophageal reflux disease.", {"entities": [[99, 130, "DISEASE"]]}], ["Few studies have prospectively addressed LNF in the community hospital or the effect of LNF on specific atypical symptoms, other related gastrointestinal symptoms, and weight change.", {"entities": []}], ["Data were collected prospectively on consecutive patients having LNF.", {"entities": []}], ["Three typical, 6 atypical, and 3 other gastrointestinal symptoms were studied.", {"entities": []}], ["Short-term data on 91 patients and long-term data on 84 patients were studied.", {"entities": []}], ["Overall long-term improvement was 98%.", {"entities": []}], ["Regarding typical symptoms, the greatest improvement occurred in heartburn and regurgitation.", {"entities": []}], ["Regarding atypical symptoms, the greatest improvement occurred in cough and sore throat, but chest pain, hoarseness, and throat clearing also showed significant durable improvement.", {"entities": []}], ["Bloating, nausea, and diarrhea showed no significant change from preoperative to postoperative surveys.", {"entities": [[22, 30, "DISEASE"]]}], ["Mild weight loss was common.", {"entities": []}], ["LNF can be safely performed in a community hospital with results equal to those of university hospitals.", {"entities": []}], ["Improvement in typical symptoms was greater than improvement in atypical symptoms, but results for both were significant and durable.", {"entities": []}], ["Nonspecific gastrointestinal symptoms, such as nausea, bloating, and diarrhea, may be unrelated to Nissen fundoplication.", {"entities": [[69, 77, "DISEASE"]]}], ["Tenascin-C (TNC) is highly expressed in cancer tissues.", {"entities": [[40, 46, "DISEASE"], [12, 15, "GENE"]]}], ["Its cellular sources are cancer and stromal cells, including fibroblasts/myofibroblasts, and also vascular cells.", {"entities": [[25, 31, "DISEASE"]]}], ["TNC expressed in cancer tissues dominantly contains large splice variants.", {"entities": [[17, 23, "DISEASE"], [0, 3, "GENE"]]}], ["Deposition of the stroma promotes the epithelial-mesenchymal transition, proliferation, and migration of cancer cells.", {"entities": [[105, 111, "DISEASE"]]}], ["It also facilitates the formation of cancer stroma including desmoplasia and angiogenesis.", {"entities": [[37, 43, "DISEASE"]]}], ["Integrin receptors that mediate the signals of TNC have also been discussed.", {"entities": [[47, 50, "GENE"]]}], ["The start of the new year signals that it is time for mAbs\u2019 annual review of the therapeutic monoclonal antibodies (mAbs) in active Phase 2/3 or Phase 3 clinical studies.", {"entities": []}], ["The entire clinical pipeline currently includes ~350 mAbs, but most of these are in early development.", {"entities": []}], ["As of the beginning of 2013, our \u201cAntibodies to watch\u201d list includes 28 single mAbs and one mAb mixture that are undergoing evaluation in Phase 3 studies for inflammatory or immunological disorders, cancers, high cholesterol, osteoporosis, Alzheimer disease and infectious disease.", {"entities": [[226, 238, "DISEASE"]]}], ["In alphabetical order, the 28 mabs are alirocumab, AMG 145, elotuzumab, epratuzumab, farletuzumab, gantenerumab, gevokizumab, inotuzumab ozogamicin, itolizumab, ixekizumab, lebrikizumab, mepolizumab, naptumomab estafenatox, necitumumab, nivolumab, obinutuzumab, ocrelizumab, onartuzumab, racotumomab, ramucirumab, reslizumab, romosozumab, sarilumab, secukinumab, sirukumab, solanezumab, tabalumab, and vedolizumab.", {"entities": []}], ["The mixture of actoxumab and bezlotoxumab is being evaluated in two Phase 3 studies as a treatment for Clostridium difficile infection.", {"entities": []}], ["Despite the emergence of stereotactic body radiotherapy (SBRT) for treatment of medically inoperable early-stage non-small-cell lung cancer patients, the molecular effects of focal exposure of limited lung volumes to high-dose radiation have not been fully characterized.", {"entities": [[128, 139, "DISEASE"], [133, 139, "DISEASE"]]}], ["This study was designed to identify molecular changes induced by focal high-dose irradiation using a mouse model of SBRT.", {"entities": []}], ["Central areas of the mouse left lung were focally-irradiated (3\u00a0mm in diameter) with a single high-dose of radiation (90\u00a0Gy).", {"entities": []}], ["Temporal changes in gene expression in the irradiated and non-irradiated neighboring lung regions were analyzed by microarray.", {"entities": []}], ["For comparison, the long-term effect (12\u00a0months) of 20\u00a0Gy radiation on a diffuse region of lung was also measured.", {"entities": []}], ["The majority of genes were down-regulated in the focally-irradiated lung areas at 2 to 3\u00a0weeks after irradiation.", {"entities": []}], ["This pattern of gene expression was clearly different than gene expression in the diffuse region of lungs exposed to low-dose radiation.", {"entities": []}], ["Ontological and pathway analyses indicated these down-regulated genes were mainly associated with organ development.", {"entities": []}], ["Although the number was small, genes that were up-regulated after focal irradiation were associated with immune-related functions.", {"entities": []}], ["The temporal patterns of gene expression and the associated biological functions were also similar in non-irradiated neighboring lung regions, although statistical significance was greatly reduced when compared with those from focally-irradiated areas of the lung.", {"entities": []}], ["From network analysis of temporally regulated genes, we identified inter-related modules associated with diverse functions, including organ development and the immune response, in both the focally-irradiated regions and non-irradiated neighboring lung regions.", {"entities": []}], ["Focal exposure of lung tissue to high-dose radiation induced expression of genes associated with organ development and the immune response.", {"entities": []}], ["This pattern of gene expression was also observed in non-irradiated neighboring areas of lung tissue, indicating a global lung response to focal high-dose irradiation.", {"entities": []}], ["The online version of this article (doi:10.1186/s12863-016-0338-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["No previous study has raised the effects of RIF on lung function data of chronic obstructive pulmonary disease (COPD) patients.", {"entities": [[73, 110, "DISEASE"]]}], ["The objective of the present study was to assess the effects of RIF on spirometric data measured in male patients with a stable COPD.", {"entities": []}], ["Sixteen patients with stable COPD (mean \u00b1 SD of age: 64 \u00b1 7 years) who fasted during Ramadan volunteered to the study.", {"entities": []}], ["Three sessions (Before-R, End-R, and After-R) were selected for spirometry tests that were consistently performed 2.5\u20134.5 hr before fasting break.", {"entities": [[122, 124, "GENE"]]}], ["Assessment sessions comprised: forced vital capacity (FVC), 1st s forced expiratory volume (FEV 1 ), FEV 1 /FVC, peak expiratory flow (PEF), maximal mid-expiratory flow (MMEF), and forced expiratory flow rate at the x% of FVC to be exhaled (FEFx%).", {"entities": [[92, 95, "GENE"], [101, 104, "GENE"], [92, 95, "GENE"], [101, 104, "GENE"]]}], ["A reversibility test was performed only during the Before-Ramadan session.", {"entities": []}], ["Spirometric data were expressed in percentages of local reference values.", {"entities": []}], ["Findings were analyzed by applying repeated measures analysis of variance.", {"entities": []}], ["The mean \u00b1 SD of the postbronchodilator FEV 1 /FVC ratio and the FEV 1 were, respectively, 0.52 \u00b1 0.14 and 48 \u00b1 19%.", {"entities": [[40, 43, "GENE"], [65, 68, "GENE"], [40, 43, "GENE"], [65, 68, "GENE"]]}], ["The mean \u00b1 SD of FEV 1 (Before-R: 47 \u00b1 19, End-R: 45 \u00b1 18, After-R: 44 \u00b1 19%), FVC (Before-R: 73 \u00b1 18, End-R: 71 \u00b1 16, After-R: 69 \u00b1 17%), FEV 1 /FVC (Before-R: 67 \u00b1 16, End-R: 66 \u00b1 16, After-R: 65 \u00b1 16%), PEF (Before-R: 46 \u00b1 19, End-R: 47 \u00b1 22, After-R: 45 \u00b1 21%), MMEF (Before-R: 19 \u00b1 10, End-R: 18 \u00b1 8, After-R: 18 \u00b1 9%), FEF 25% (Before-R: 16 \u00b1 6, End-R: 16 \u00b1 5, After-R: 15 \u00b1 5%), FEF 50% (Before-R: 21 \u00b1 14, End-R: 20 \u00b1 12, After-R: 20 \u00b1 12%) and FEF 75% (Before-R: 27 \u00b1 19, End-R: 27 \u00b1 19, After-R: 27 \u00b1 19%) were not significantly influenced by RIF.", {"entities": [[17, 20, "GENE"], [139, 142, "GENE"], [17, 20, "GENE"], [139, 142, "GENE"]]}], ["RIF did not bring about any significant changes in the spirometric data of stable COPD male patients fasting the 2016 holy month of Ramadan.", {"entities": []}], ["There is rising evidence of an inverse association between chronic diseases and diets characterized by rich fruit and vegetable consumption.", {"entities": []}], ["Dietary components may act directly or indirectly on the human genome and modulate multiple processes involved in disease risk and disease progression.", {"entities": []}], ["However, there is currently no exhaustive resource on the health benefits associated to specific dietary interventions, or a resource covering the broad molecular content of food.", {"entities": []}], ["Here we present the first release of NutriChem, available at http://cbs.dtu.dk/services/NutriChem-1.0 , a database generated by text mining of 21 million MEDLINE abstracts for information that links plant-based foods with their small molecule components and human disease phenotypes.", {"entities": []}], ["NutriChem contains text-mined data for 18478 pairs of 1772 plant-based foods and 7898 phytochemicals, and 6242 pairs of 1066 plant-based foods and 751 diseases.", {"entities": []}], ["In addition, it includes predicted associations for 548 phytochemicals and 252 diseases.", {"entities": []}], ["To the best of our knowledge this database is the only resource linking the chemical space of plant-based foods with human disease phenotypes and provides a foundation for understanding mechanistically the consequences of eating behaviors on health.", {"entities": []}], ["To investigate the effects of matrix metalloproteinase-1 ( MMP-1 ) gene polymorphisms on the onset of osteomyelitis in Chinese Han population.", {"entities": [[102, 115, "DISEASE"]]}], ["In all, 80 osteomyelitis patients (case group) and 81 healthy people (control group) were recruited into this case-control study.", {"entities": [[11, 24, "DISEASE"]]}], ["Polymerase chain reaction-restriction fragment length polymorphism method was utilized to examine the genotypes of MMP-1 polymorphisms (\u22121607 2G/1G and \u2212519A/G) in the 2 groups.", {"entities": []}], ["Genotype and allele differences between the case and control groups were analyzed by chi-square test.", {"entities": []}], ["Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated to present the association strength between MMP-1 gene polymorphisms and osteomyelitis.", {"entities": [[146, 159, "DISEASE"]]}], ["Frequencies of \u22121607 2G/2G genotype between the case and control groups were statistically significant ( P \u200a=\u200a.025).", {"entities": []}], ["Compared with 1G/1G genotype carriers, the 2G/2G genotype carriers had 1.605 times risk of developing osteomyelitis (OR 2.605, 95% CI 1.116\u20136.082).", {"entities": [[102, 115, "DISEASE"]]}], ["Meanwhile, the 2G allele significantly associated with the risk of osteomyelitis (OR 1.735, 95% CI 1.115\u20132.701).", {"entities": [[67, 80, "DISEASE"]]}], ["In addition, frequency of \u2212519GG genotype was obviously higher in case group than that in control group ( P \u200a=\u200a.024), and GG genotype related to an increased risk of osteomyelitis (OR 2.792, 95% CI 1.127\u20136.917).", {"entities": [[166, 179, "DISEASE"]]}], ["Whereas, the \u2212519G allele may be a susceptible factor for osteomyelitis (OR 1.622, 95% CI 1.038\u20132.536).", {"entities": [[58, 71, "DISEASE"]]}], ["The MMP-1 \u22121607 (2G/1G) and \u2212519 (A/G) polymorphisms may contribute to the onset of osteomyelitis.", {"entities": [[84, 97, "DISEASE"]]}], ["Breathlessness can be debilitating for those with chronic conditions, requiring continual management.", {"entities": []}], ["Yet, the meaning of breathlessness for those who live with it is poorly understood in respect of its subjective, cultural, and experiential significance.", {"entities": []}], ["This article discusses a number of current issues in understanding the experience of breathlessness.", {"entities": []}], ["Effective communication concerning the experience of breathlessness is crucial for diagnosis, to identify appropriate treatment, and to provide patients with the capacity to self-manage their condition.", {"entities": []}], ["However, there is an evident disconnect between the way breathlessness is understood between clinical and lay perspectives, in terms of awareness of breathlessness, the way symptoms are expressed, and acknowledgement of how it affects the daily lives of patients.", {"entities": []}], ["The review highlights the need for integrated multidisciplinary work on breathlessness, and suggests that effective understanding and management of breathlessness considers its wider subjective and social significance.", {"entities": []}], ["Childhood overweight and obesity is a major public health concern.", {"entities": [[25, 32, "DISEASE"]]}], ["Knowledge on modifiable risk factors is needed to design effective intervention programs.", {"entities": []}], ["This study aimed to assess associations of children\u2019s sedentary behaviors (television viewing and computer game use) and physical activity behaviors (sports participation, outdoor play, and active transport to/from school) with three indicators of body fat, i.e., percent fat mass, body mass index (BMI) standard deviation scores, and weight status (normal weight, overweight).", {"entities": []}], ["Cross-sectional data from 5913 6-year-old ethnically diverse children were analyzed.", {"entities": []}], ["Children\u2019s weight and height were objectively measured and converted to BMI.", {"entities": []}], ["Weight status was defined according to age- and sex-specific cut-off points of the International Obesity Task Force.", {"entities": [[97, 104, "DISEASE"]]}], ["BMI standard deviation scores were created, based on Dutch reference growth curves.", {"entities": []}], ["Fat mass was measured my dual-energy X-ray absorptiometry (DXA).", {"entities": []}], ["Sedentary and physical activity behaviors were assessed by parent-reported questionnaires.", {"entities": []}], ["Series of logistic and linear regression analyses were performed, controlling for confounders (i.e., socio-demographic factors, family lifestyle factors, and other sedentary behaviors and physical activity behaviors).", {"entities": []}], ["Sports participation was inversely associated with fat mass (p < 0.001), even after adjustment for socio-demographic factors, family lifestyle factors, and other sedentary behaviors and physical activity behaviors.", {"entities": []}], ["No other independent associations were observed.", {"entities": []}], ["The results of this study indicate that sports participation is inversely associated with percent body fat among ethnically diverse 6-year-old children.", {"entities": []}], ["More research in varied populations including objective measurements and longitudinal designs are needed to confirm these current results.", {"entities": []}], ["It is vital to understand the associations between the medication event monitoring systems (MEMS) and self-reported questionnaires (SRQs) because both are often used to measure medication adherence and can produce different results.", {"entities": []}], ["In addition, the economic implication of using alternative measures is important as the cost of electronic monitoring devices is not covered by insurance, while self-reports are the most practical and cost-effective method in the clinical settings.", {"entities": []}], ["This meta-analysis examined the correlations of two measurements of medication adherence: MEMS and SRQs.", {"entities": []}], ["The literature search (1980-2009) used PubMed, OVID MEDLINE, PsycINFO (EBSCO), CINAHL (EBSCO), OVID HealthStar, EMBASE (Elsevier), and Cochrane Databases.", {"entities": []}], ["Studies were included if the correlation coefficients [Pearson (r p ) or Spearman (r s )] between adherences measured by both MEMS and SRQs were available or could be calculated from other statistics in the articles.", {"entities": []}], ["Data were independently abstracted in duplicate with standardized protocol and abstraction form including 1) first author's name; 2) year of publication; 3) disease status of participants; 4) sample size; 5) mean age (year); 6) duration of trials (month); 7) SRQ names if available; 8) adherence (%) measured by MEMS; 9) adherence (%) measured by SRQ; 10) correlation coefficient and relative information, including p-value, 95% confidence interval (CI).", {"entities": []}], ["A meta-analysis was conducted to pool the correlation coefficients using random-effect model.", {"entities": []}], ["Eleven studies (N = 1,684 patients) met the inclusion criteria.", {"entities": []}], ["The mean of adherence measured by MEMS was 74.9% (range 53.4%-92.9%), versus 84.0% by SRQ (range 68.35%-95%).", {"entities": []}], ["The correlation between adherence measured by MEMS and SRQs ranged from 0.24 to 0.87.", {"entities": []}], ["The pooled correlation coefficient for 11 studies was 0.45 (p = 0.001, 95% confidence interval [95% CI]: 0.34-0.56).", {"entities": []}], ["The subgroup meta-analysis on the seven studies reporting r p and four studies reporting r s reported the pooled correlation coefficient: 0.46 (p = 0.011, 95% CI: 0.33-0.59) and 0.43 (p = 0.0038, 95% CI: 0.23-0.64), respectively.", {"entities": []}], ["No differences were found for other subgroup analyses.", {"entities": []}], ["Medication adherence measured by MEMS and SRQs tends to be at least moderately correlated, suggesting that SRQs give a good estimate of medication adherence.", {"entities": []}], ["Cardiovascular disease (CVD) is the leading cause of death in the developed world.", {"entities": []}], ["Human genetic studies, including genome-wide sequencing and SNP-array approaches, promise to reveal disease genes and mechanisms representing new therapeutic targets.", {"entities": []}], ["In practice, however, identification of the actual genes contributing to disease pathogenesis has lagged behind identification of associated loci, thus limiting the clinical benefits.", {"entities": []}], ["To aid in localizing causal genes, we develop a machine learning approach, O bjective P rioritization for E nhanced N ovelty (OPEN), which quantitatively prioritizes gene-disease associations based on a diverse group of genomic features.", {"entities": []}], ["This approach uses only unbiased predictive features and thus is not hampered by a preference towards previously well-characterized genes.", {"entities": []}], ["We demonstrate success in identifying genetic determinants for CVD-related traits, including cholesterol levels, blood pressure, and conduction system and cardiomyopathy phenotypes.", {"entities": [[155, 169, "DISEASE"]]}], ["Using OPEN, we prioritize genes, including FLNC , for association with increased left ventricular diameter, which is a defining feature of a prevalent cardiovascular disorder, dilated cardiomyopathy or DCM.", {"entities": [[184, 198, "DISEASE"], [176, 198, "DISEASE"], [43, 47, "GENE"]]}], ["Using a zebrafish model, we experimentally validate FLNC and identify a novel FLNC splice-site mutation in a patient with severe DCM.", {"entities": [[52, 56, "GENE"], [78, 82, "GENE"], [52, 56, "GENE"], [78, 82, "GENE"]]}], ["Our approach stands to assist interpretation of large-scale genetic studies without compromising their fundamentally unbiased nature.", {"entities": []}], ["The online version of this article (doi:10.1186/s13059-014-0534-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A growing number of studies suggest that maternal stress during pregnancy promotes atopic disorders in the offspring.", {"entities": []}], ["This is the first systematic review to address prenatal maternal stress ( PNMS ) and the subsequent risk of atopy\u2010related outcomes in the child.", {"entities": []}], ["The review was performed in accordance to the PRISMA criteria.", {"entities": []}], ["We searched and selected studies in PubMed, Scopus, Embase and Psych INFO until November 2014.", {"entities": []}], ["Sixteen (with 25 analyses) of 426 identified articles met the review criteria.", {"entities": []}], ["Five main PNMS exposures (negative life events, anxiety/depression, bereavement, distress and job strain) and five main atopic outcomes (asthma, wheeze, atopic dermatitis, allergic rhinitis and IgE) were assessed across the studies.", {"entities": [[172, 189, "DISEASE"], [153, 170, "DISEASE"], [181, 189, "DISEASE"], [137, 143, "DISEASE"], [160, 170, "DISEASE"]]}], ["Overall, 21 of the 25 analyses suggested a positive association between PNMS and atopic outcomes.", {"entities": []}], ["Of the 11 exposure\u2013response analyses reported, six found statistically significant trends.", {"entities": []}], ["This systematic review suggests a relationship between maternal stress during pregnancy and atopic disorders in the child.", {"entities": []}], ["However, the existing studies are of diverse quality.", {"entities": []}], ["The wide definitions of often self\u2010reported stress exposures imply a substantial risk for information bias and false\u2010positive results.", {"entities": []}], ["Research comparing objective and subjective measures of PNMS exposure as well as objective measures for atopic outcome is needed.", {"entities": []}], ["In asthma interleukin (IL)-13 is increased in the airway compared with non-asthmatic eosinophilic bronchitis.", {"entities": [[3, 9, "DISEASE"], [98, 108, "DISEASE"]]}], ["Whether this differential expression is specific to the airway or is more generalised is uncertain.", {"entities": []}], ["We sought to examine IL-13 expression in peripheral blood T-cells and eosinophils in asthma and non-asthmatic eosinophilic bronchitis.", {"entities": [[85, 91, "DISEASE"], [123, 133, "DISEASE"]]}], ["Peripheral blood CD3+ cell and eosinophil intracellular IL-13 expression from subjects with asthma, non-asthmatic eosinophilic bronchitis and healthy controls was assessed.", {"entities": [[92, 98, "DISEASE"], [127, 137, "DISEASE"]]}], ["The effect of priming by asthmatic serum on the release of IL-13 by peripheral blood mononuclear cells from healthy subjects was examined and the serum from these subjects was analysed for a range of chemokines and cytokines.", {"entities": []}], ["The median (IQR)% intracellular IL-13 expression by CD3+ cells was increased in asthma [5.3 (2.7\u20139.8)%; n = 12] compared to non-asthmatic eosinophilic bronchitis [1.1 (0.5\u20133)%; n = 7] and healthy controls [1.7 (0.2\u20133%); n = 9] (p = 0.02), but was not significantly different in eosinophils across the groups.", {"entities": [[80, 86, "DISEASE"], [151, 161, "DISEASE"]]}], ["IL-13 released from healthy peripheral blood mononuclear cells (n = 10) was increased by asthmatic serum [117 (47.8\u2013198)pg/ml] compared to control [78.5 (42.6\u2013128)pg/ml; p = 0.02), but was not affected by non-asthmatic serum.", {"entities": []}], ["Our findings support the view that IL-13 expression is increased in peripheral blood-derived T cells in asthma and that asthmatic serum up-regulates IL-13 release from healthy peripheral blood mononuclear cells.", {"entities": [[104, 110, "DISEASE"]]}], ["Existing studies have examined the high prevalence of LBP along with the high treatment costs of patients with low back pain (LBP).", {"entities": [[54, 57, "GENE"], [126, 129, "GENE"], [54, 57, "GENE"], [126, 129, "GENE"]]}], ["Various factors have been shown to be correlated or predictive of chronic or episodic LBP including the characteristics of the initial episode, pain, comorbid conditions, psychosocial issues, and opiate use.", {"entities": [[86, 89, "GENE"]]}], ["This study replicates and extends earlier studies by examining the association of patient characteristics including baseline comorbidities with patterns of healthcare service use and cost.", {"entities": []}], ["This is a retrospective analysis of measures of comorbidities, healthcare use, and cost for patients identified with LBP, stratified by the number of LBP episodes.", {"entities": [[117, 120, "GENE"], [150, 153, "GENE"], [117, 120, "GENE"], [150, 153, "GENE"]]}], ["Administrative data associated with outpatient and hospital based care for the years 1996 through 2001, were used to identify adult patients with LBP.", {"entities": [[146, 149, "GENE"]]}], ["LBP patients continuously enrolled for 12 months prior and 24 months after their initial LBP event were included in the study.", {"entities": [[0, 3, "GENE"], [89, 92, "GENE"], [0, 3, "GENE"], [89, 92, "GENE"]]}], ["A LBP episode was identified as the number of 30-day periods where a patient had one or more healthcare events with a diagnosis consistent with LBP.", {"entities": [[2, 5, "GENE"], [144, 147, "GENE"], [2, 5, "GENE"], [144, 147, "GENE"]]}], ["Chi-square and multivariate regression analyses were employed to estimate the variation in utilization and costs.", {"entities": []}], ["Of 16,567 patients enrolled, 67% were identified with only one LBP episode and 4.5% had \u22656.", {"entities": [[63, 66, "GENE"]]}], ["The prevalence of comorbidities, analgesic use, and healthcare service use, varied by the number of back pain episodes.", {"entities": []}], ["Diabetes, rheumatoid arthritis, anxiety, psychotic illness, depression, use of opiates and NSAIDs were associated with significant incremental increases in costs ( P < .003).", {"entities": [[10, 30, "DISEASE"], [21, 30, "DISEASE"]]}], ["Physical and mental health co-morbidities and measures of analgesic use were associated with chronicity, healthcare utilization and costs.", {"entities": []}], ["Given the association of comorbidities and cost for patients with LBP, management approaches that are effective across chronic illnesses may prove to be beneficial for high cost patients identified with LBP.", {"entities": [[66, 69, "GENE"], [203, 206, "GENE"], [66, 69, "GENE"], [203, 206, "GENE"]]}], ["Sepsis is the 10th leading cause of death in the United States.", {"entities": []}], ["The National Center for Health Statistics' multiple-cause-of-death (MCOD) dataset is a large, publicly available, population-based source of information on disease burden in the United States.", {"entities": []}], ["We have analysed MCOD data from 1999 to 2005 to investigate trends, assess disparities and provide population-based estimates of sepsis-associated mortality during this period.", {"entities": []}], ["Sepsis-associated deaths occurring in the United States from 1999 to 2005 were identified in MCOD data using International Classification of Disease, 10th Revision (ICD-10) codes.", {"entities": []}], ["Population-based mortality rates were calculated using bridged-race population estimates from the National Center for Health Statistics.", {"entities": []}], ["Comparisons across age, sex and racial/ethnic groups were achieved by calculating mortality rate ratios.", {"entities": []}], ["From 1999 to 2005 there were 16,948,482 deaths in the United States.", {"entities": []}], ["Of these, 1,017,616 were associated with sepsis (6.0% of all deaths).", {"entities": []}], ["The age-adjusted rate of sepsis-associated mortality was 50.37 deaths per 100,000 (95% confidence interval (CI) = 50.28 to 50.47).", {"entities": []}], ["There were significant disparities in sepsis-associated mortality in race/ethnicity and sex groups ( P < 0.0001).", {"entities": []}], ["After controlling for age, Asians were less likely than whites to experience sepsis-related death (rate ratio (RR) = 0.78, 95% CI = 0.77 to 0.78), while Blacks (RR = 2.24, 95% CI = 2.23 to 2.24), American Indians/Alaska Natives (RR = 1.24, 95% CI = 1.24 to 1.25) and Hispanics (RR = 1.14, 95% CI = 1.13 to 1.14) were more likely than whites to experience sepsis-related death.", {"entities": []}], ["Men were at increased risk for sepsis-associated death in all race/ethnicity categories (RR = 1.27, 95% CI = 1.27 to 1.28), but the degree of increased susceptibility associated with being male differed among racial/ethnic groups ( P < 0.0001).", {"entities": []}], ["Although crude sepsis-associated mortality increased by 0.67% per year during the study period ( P < 0.0001), the age-adjusted mortality rate decreased by 0.18% per year ( P < 0.01).", {"entities": []}], ["The rapid rise in sepsis mortality seen in previous decades has slowed, but population ageing continues to drive the growth of sepsis-associated mortality in the United States.", {"entities": []}], ["Disparities in sepsis-associated mortality mirror those previously reported for sepsis incidence.", {"entities": []}], ["Sepsis in Asians, Hispanics and American Indian/Alaska Natives should be studied separately because aggregate measures may obscure important differences among these groups.", {"entities": []}], ["Ageing of society is a significant challenge to public health, both socially and health wise.", {"entities": []}], ["Adaptation to illness and its acceptance play an important role in control and patients\u2019 self-control in many diseases of old age.", {"entities": []}], ["The right attitude of doctors to patients, especially, geriatric patients determines, among others, a patient\u2019s quality of life and acceptance of illness.", {"entities": []}], ["Recently, there has been observed the rapid development of research on interactions between pain as a physiological process and its perception by an individual.", {"entities": []}], ["The aim of the study was to evaluate the acceptance of illness, perception of pain and expectations of geriatric patients for physicians among the inhabitants of Bialystok (Poland) over the age of 60.", {"entities": []}], ["The study included 300 people, inhabitants of Bialystok and the surrounding area \u2013 aged over 60: 100 elderly residents of a nursing home, 100 students of the University of the Third Age in Bialystok and 100 students of the University of Healthy Senior.", {"entities": []}], ["The study used three standardised psychometric scales: Patient Request Form (PRF), Acceptance of Illness Scale (AIS) and The Beliefs about Pain Control Questionnaire (BPCQ).", {"entities": []}], ["The median of the overall score of AIS was 26 points, which is considered average in terms of acceptance of illness.", {"entities": []}], ["The median value of the influence of internal factors on the control of pain in case of BPCQ scale was generally16 of 30 points, the influence of physicians \u2013 15 of 24 points, while random events \u2013 14 of 24 points.", {"entities": []}], ["The overall result for PRF scale proved that the respondents were the least expected to look for emotional support (5 of 12 points).", {"entities": []}], ["It was established that the group affiliation significantly affected the result of AIS ( p \u2009<\u20090.001).", {"entities": []}], ["There was also noted a negative relation between AIS and the search for emotional support (PRF) depending on the group.", {"entities": []}], ["The higher the AIS value, the lower the score in case of search for emotional support (PRF).", {"entities": []}], ["Neither gender nor age played a significant role in acceptance of illness, control of pain or expectations for physicians.", {"entities": []}], ["The key variable determining the occurrence of dependencies between the studied features was being a part of a group.", {"entities": []}], ["The elderly residents of the nursing home were negatively distinguished from the other two studied groups.", {"entities": []}], ["The respondents, in regard to other groups described in the literature, were characterised by relatively high values in illness acceptance, pain control and expectations for physicians.", {"entities": []}], ["Pulmonary infection is the most common risk factor for acute lung injury (ALI).", {"entities": []}], ["Innate immune responses induced by Microbe-Associated Molecular Pattern (MAMP) molecules are essential for lung defense but can lead to tissue injury.", {"entities": []}], ["Little is known about how MAMP molecules are degraded in the lung or how MAMP degradation/inactivation helps prevent or ameliorate the harmful inflammation that produces ALI.", {"entities": []}], ["Acyloxyacyl hydrolase (AOAH) is a host lipase that inactivates Gram-negative bacterial endotoxin (lipopolysaccharide, or LPS).", {"entities": [[23, 27, "GENE"]]}], ["We report here that alveolar macrophages increase AOAH expression upon exposure to LPS and that Aoah Aoah Klebsiella pneumoniae .", {"entities": [[50, 54, "GENE"], [96, 100, "GENE"], [101, 105, "GENE"], [50, 54, "GENE"], [96, 100, "GENE"], [101, 105, "GENE"], [50, 54, "GENE"], [96, 100, "GENE"], [101, 105, "GENE"]]}], ["Aoah Aoah Aoah Little is known about how MAMP molecules are degraded/inactivated and how inactivating them alters the course of inflammation in vivo .", {"entities": [[0, 4, "GENE"], [5, 9, "GENE"], [10, 14, "GENE"], [0, 4, "GENE"], [5, 9, "GENE"], [10, 14, "GENE"], [0, 4, "GENE"], [5, 9, "GENE"], [10, 14, "GENE"]]}], ["Our studies demonstrate that deficiency of acyloxyacyl hydrolase (AOAH, a host enzyme that inactivates LPS), prolongs pulmonary inflammation and acute lung injury in mice challenged with LPS or Klebsiella pneumoniae .", {"entities": [[66, 70, "GENE"]]}], ["This is the strongest evidence to date that disabling a MAMP molecule promotes recovery of infection-induced tissue injury.", {"entities": []}], ["Degradation/inactivation of MAMP molecules is especially important because alveolar macrophages, unlike macrophages in many other tissues, do not become \u201ctolerant\u201d when they are exposed to LPS.", {"entities": []}], ["In other words, they lack this general mechanism for down-regulating inflammation.", {"entities": []}], ["Our findings indicate that inactivating LPS can compensate to a large extent for this deficiency\u2013without AOAH, the LPS- or Klebsiella -challenged mice failed to resolve acute lung injury and were more likely to die.", {"entities": [[105, 109, "GENE"]]}], ["We reported previously that persistently bioactive LPS can maintain tolerance in peritoneal macrophages for many weeks in AOAH-deficient mice.", {"entities": []}], ["The new findings show that the inability to inactivate a MAMP has different consequences in the lungs and peritoneum, in keeping with evidence that innate immune responses are compartmentalized.", {"entities": []}], ["Inactivation of MAMP molecules can be an important and non-redundant prerequisite for inflammation resolution.", {"entities": []}], ["Atopic dermatitis (AD) is the initial step of the atopic march: the progression from AD to allergic rhinitis and asthma.", {"entities": [[91, 108, "DISEASE"], [0, 17, "DISEASE"], [100, 108, "DISEASE"], [113, 119, "DISEASE"], [7, 17, "DISEASE"]]}], ["There is a close association between skin barrier abnormalities and the development of AD and the atopic march.", {"entities": []}], ["One of cardinal features of AD is that the lesional skin of the majority of AD patients is chronically colonized with Staphylococcus aureus with half isolates producing superantigen enterotoxin B (SEB).", {"entities": []}], ["Although diverse roles of SEB in the pathogenesis and severity of AD have been recognized, whether SEB contributes to the dermal inflammation that drives lung inflammation and airway hyperresponsiveness (AHR) has not been examined.", {"entities": [[204, 207, "GENE"]]}], ["Here we show a novel role of S. aureus superantigen SEB in augmenting allergen ovalbumin (Ova) induced atopic march through an IL-17A dependent mechanism.", {"entities": []}], ["When mice epicutaneously (EC) sensitized with allergen Ova, addition of topical SEB led to not only augmented systemic Th2 responses but also a markedly exaggerated systemic Th17/IL-17 immune environment.", {"entities": []}], ["The ability of SEB in enhancing Th17/IL-17 was mediated through stimulating lymphocytes in spleen and draining lymph nodes to promote IL-6 production.", {"entities": []}], ["Epicutaneous sensitization of mice with a combination of Ova and SEB significantly enhanced Ova-induced AHR and granulocytic lung inflammation than Ova allergen alone.", {"entities": [[104, 107, "GENE"]]}], ["When IL-17A was deleted genetically, the effects of SEB on augmenting lung inflammation and AHR were markedly diminished.", {"entities": [[92, 95, "GENE"]]}], ["These findings suggest that chronic heavy colonization of enterotoxin producing S. aureus in the skin of patients with atopic dermatitis may have an important role in the development of atopic march via an IL-17A dependent mechanism.", {"entities": [[119, 136, "DISEASE"], [126, 136, "DISEASE"]]}], ["Breast cancer incidence may be increasing in Thailand but very little research has assessed core breast cancer risk factors in this country.", {"entities": [[0, 13, "DISEASE"], [97, 110, "DISEASE"], [7, 13, "DISEASE"], [104, 110, "DISEASE"]]}], ["We used baseline questionnaire data from a national cohort study of Thai Open University students in an exploratory case-control study of breast cancer.", {"entities": [[138, 151, "DISEASE"], [145, 151, "DISEASE"]]}], ["The study included 43 female cases and 860 age-matched controls selected from the remaining 47,271 female cohort participants.", {"entities": []}], ["Odds ratios and 95% confidence intervals were calculated using conditional logistic regression.", {"entities": []}], ["The women were predominantly premenopausal.", {"entities": []}], ["Taller women had an increased risk of breast cancer (OR\u00a0=\u00a02.3, 95% CI 1.1\u20134.8, for height \u2265160\u00a0cm vs \u2264154\u00a0cm) as did women with non-insulin dependent diabetes mellitus (OR\u00a0=\u00a08.4, 95% CI 1.7\u201341).", {"entities": [[38, 51, "DISEASE"], [45, 51, "DISEASE"], [150, 167, "DISEASE"]]}], ["Women with older siblings had a reduced risk of breast cancer compared to those firstborn (OR\u00a0=\u00a00.3, 95% CI0.2\u20130.7).", {"entities": [[48, 61, "DISEASE"], [55, 61, "DISEASE"]]}], ["Although limited by small case numbers, our findings suggest substantial increases in breast cancer rates in Thailand could be expected in the future.", {"entities": [[86, 99, "DISEASE"], [93, 99, "DISEASE"]]}], ["Diabetes self-management education has been shown to be effective in controlled trials.", {"entities": []}], ["However, few programs that meet American Association of Diabetes Educators standards have been translated into widespread practice.", {"entities": []}], ["This study examined the translation of the evidence-based Better Choices, Better Health-Diabetes program in both Internet and face-to-face versions.", {"entities": []}], ["We administered the Internet program nationally in the United States (n=1010).", {"entities": []}], ["We conducted face-to-face workshops in Atlanta, Georgia; Indianapolis, Indiana; and St. Louis, Missouri (n=232).", {"entities": []}], ["Self-report questionnaires collected health indicator, health behavior, and health care utilization measures.", {"entities": []}], ["Questionnaires were administered on the Web or by mail.", {"entities": []}], ["We determined hemoglobin A 1c (HbA 1c ) from blood samples collected via mailed kits.", {"entities": []}], ["Paired t tests determined whether changes between baseline and 6 months differed significantly from no change.", {"entities": []}], ["Subgroup analyses determined whether participants with specific conditions benefited (high HbA 1c , depression, hypoglycemia, nonadherence to medication taking, and no aerobic exercise).", {"entities": [[112, 124, "DISEASE"]]}], ["We calculated the percentage of participants with improvements of at least 0.4 effect size in at least one of the 5 above measures.", {"entities": []}], ["Of the 1242 participants, 884 provided 6-month follow-up questionnaires.", {"entities": []}], ["There were statistically significant improvements in 6 of 7 health indicators (including HbA 1c ) and in 7 of 7 behaviors.", {"entities": []}], ["For each of the 5 conditions, there were significant improvements among those with the condition (effect sizes 0.59\u20131.1).", {"entities": []}], ["A total of 662 (75.0%) of study participants improved at least 0.4 effect size in at least one criterion, and 327 (37.1%) improved in 2 or more.", {"entities": []}], ["The Diabetes Self-Management Program, offered in two modes, was successfully disseminated to a heterogeneous national population of members of either insured or administered health plans.", {"entities": []}], ["Participants had small but significant benefits in multiple measures.", {"entities": []}], ["The program appears effective in improving diabetes management.", {"entities": []}], ["An integrated environmental health impact assessment of road transport in New Zealand was carried out, using a rapid assessment.", {"entities": []}], ["The disease and injury burden was assessed from traffic-related accidents, air pollution, noise and physical (in)activity, and impacts attributed back to modal source.", {"entities": []}], ["In total, road transport was found to be responsible for 650 deaths in 2012 (2.1% of annual mortality): 308 from traffic accidents, 283 as a result of air pollution, and 59 from noise.", {"entities": []}], ["Together with morbidity, these represent a total burden of disease of 26,610 disability-adjusted life years (DALYs).", {"entities": []}], ["An estimated 40 deaths and 1874 DALYs were avoided through active transport.", {"entities": []}], ["Cars are responsible for about 52% of attributable deaths, but heavy goods vehicles (6% of vehicle kilometres travelled, vkt) accounted for 21% of deaths.", {"entities": [[0, 4, "GENE"]]}], ["Motorcycles (1 per cent of vkt) are implicated in nearly 8% of deaths.", {"entities": []}], ["Overall, impacts of traffic-related air pollution and noise are low compared to other developed countries, but road accident rates are high.", {"entities": []}], ["Results highlight the need for policies targeted at road accidents, and especially at heavy goods vehicles and motorcycles, along with more general action to reduce the reliance on private road transport.", {"entities": []}], ["The study also provides a framework for national indicator development.", {"entities": []}], ["Since use of non-steroidal anti-inflammatory drugs (NSAIDs) during pregnancy is common, small increases in the risk of birth defects may have significant implications for public health.", {"entities": []}], ["Results of human studies on the teratogenic risks of NSAIDs are inconsistent.", {"entities": []}], ["Therefore, we evaluated the risk of selected birth defects after prenatal exposure to prescribed and over-the-counter NSAIDs.", {"entities": []}], ["We used data on 69,929 women enrolled in the Norwegian Mother and Child Cohort Study between 1999 and 2006.", {"entities": []}], ["Data on NSAID exposure were available from a self-administered questionnaire completed around gestational week 17.", {"entities": []}], ["Information on pregnancy outcome was obtained from the Medical Birth Registry of Norway.", {"entities": []}], ["Only birth defects suspected to be associated with NSAID exposure based upon proposed teratogenic mechanisms and previous studies were included in the multivariable logistic regression analyses.", {"entities": []}], ["A total of 3,023 women used NSAIDs in gestational weeks 0\u201312 and 64,074 women did not report NSAID use in early pregnancy.", {"entities": []}], ["No associations were observed between overall exposure to NSAIDs during pregnancy and the selected birth defects separately or as a group (adjusted odds ratio 0.7, 95% confidence interval 0.4\u20131.1).", {"entities": []}], ["Associations between maternal use of specific types of NSAIDs and the selected birth defects were not found either, although an increased risk was seen for septal defects and exposure to multiple NSAIDs based on small numbers (2 exposed cases; crude odds ratio 3.9, 95% confidence interval 0.9\u201315.7).", {"entities": []}], ["Exposure to NSAIDs during the first 12 weeks of gestation does not seem to be associated with an increased risk of the selected birth defects.", {"entities": []}], ["However, due to the small numbers of NSAID-exposed infants for the individual birth defect categories, increases in the risks of specific birth defects could not be excluded.", {"entities": []}], ["Natural history of chronic obstructive pulmonary disease (COPD) is punctuated by exacerbations; however, little is known about prognosis of the first-ever COPD exacerbation and variables predicting its outcomes.", {"entities": [[19, 56, "DISEASE"]]}], ["A population-based cohort study among COPD patients with their first-ever exacerbations requiring hospitalizations was conducted.", {"entities": []}], ["Main outcomes were in-hospital mortality and one-year mortality after discharge.", {"entities": []}], ["Demographics, comorbidities, medications and in-hospital events were obtained to explore outcome predictors.", {"entities": []}], ["The cohort comprised 4204 hospitalized COPD patients, of whom 175 (4%) died during the hospitalization.", {"entities": []}], ["In-hospital mortality was related to higher age (odds ratio [OR]: 1.05 per year; 95% confidence interval [CI]: 1.03\u20131.06) and Charlson comorbidity index score (OR: 1.08 per point; 95% CI: 1.01\u20131.15); angiotensin II receptor blockers (OR: 0.61; 95% CI: 0.38\u20130.98) and \u03b2 blockers (OR: 0.63; 95% CI: 0.41\u20130.95) conferred a survival benefit.", {"entities": []}], ["At one year after discharge, 22% (871/4029) of hospital survivors were dead.", {"entities": []}], ["On multivariate Cox regression analysis, age and Charlson comorbidity index remained independent predictors of one-year mortality.", {"entities": []}], ["Longer hospital stay (hazard ratio [HR] 1.01 per day; 95% CI: 1.01\u20131.01) and ICU admission (HR: 1.33; 95% CI: 1.03\u20131.73) during the hospitalization were associated with higher mortality risks.", {"entities": [[36, 38, "GENE"], [92, 94, "GENE"], [36, 38, "GENE"], [92, 94, "GENE"]]}], ["Prescription of \u03b2 blockers (HR: 0.79; 95% CI: 0.67\u20130.93) and statins (HR: 0.66; 95% CI: 0.47\u20130.91) on hospital discharge were protective against one-year mortality.", {"entities": [[28, 30, "GENE"], [70, 72, "GENE"], [28, 30, "GENE"], [70, 72, "GENE"]]}], ["Even the first-ever severe COPD exacerbation signifies poor prognosis in COPD patients.", {"entities": []}], ["Comorbidities play a crucial role in determining outcomes and should be carefully assessed.", {"entities": []}], ["Angiotensin II receptor blockers, \u03b2 blockers and statins may, in theory, have dual cardiopulmonary protective properties and probably alter prognosis of COPD patients.", {"entities": []}], ["Nevertheless, the limitations inherent to a claims database study, such as the diagnostic accuracy of COPD and its exacerbation, should be born in mind.", {"entities": []}], ["Comprehensive evidence exists regarding the discrepancy between children's reports and parents' by proxy reports on emotional and behavioural problems.", {"entities": []}], ["However, little is yet known about factors influencing the extent to which child self- and parent by proxy reports differ in respect of child Quality of Life (QoL).", {"entities": []}], ["The aim of the study was to investigate the degree of discrepancy between child and parent by proxy reports as measured by two different QoL instruments.", {"entities": []}], ["A representative Norwegian sample of 1997 school children aged 8\u201316 years, and their parents were studied using the Inventory of Life Quality (ILC) and the 'Kinder Lebensqualit\u00e4t Fragebogen' (KINDL).", {"entities": []}], ["Child and parent reports were compared by t-test, and correlations were calculated by Pearson product moment coefficient.", {"entities": []}], ["Psychometric aspects were examined in regard to both translated QoL instruments (internal consistency by Cronbach's alpha and test-retest reliability by intraclass correlation coefficients).", {"entities": []}], ["Parents evaluated the QoL of their children significantly more positively than did the children.", {"entities": []}], ["Correlations between mother-child and father-child reports were significant (p < 0.01) and similar but low to moderate (r = 0.32; and r = 0.30, respectively, for the KINDL, and r = 0.30 and r = 0.26, respectively, for the ILC).", {"entities": []}], ["Mother and father reports correlated moderately highly (r = 0.54 and r = 0.61 for the KINDL and ILC, respectively).", {"entities": []}], ["No significant differences between correlations of mother-daughter/son and father-daughter/son pairs in regard to reported child QoL were observed on either of the two instruments.", {"entities": []}], ["In the present general population sample, parents reported higher child QoL than did their children.", {"entities": []}], ["Concordance between child and parent by proxy report was low to moderate.", {"entities": []}], ["The level of agreement between mothers and fathers in regard to their child's QoL was moderate.", {"entities": []}], ["No significant impact of parent and child gender in regard to agreement in ratings of child QoL was found.", {"entities": []}], ["Both the child and parent versions of the Norwegian translations of the KINDL and ILC can be used in surveys of community populations, but in regard to the self-report of 9\u201310 years old children, only the KINDL total QoL scale or the ILC are recommended.", {"entities": []}], ["A recently recognized human rhinovirus species C (HRV-C) is associated with up to half of HRV infections in young children.", {"entities": []}], ["We for the first time propagated two HRV-C isolates ex vivo in organ culture of nasal epithelial cells, sequenced a new C15 isolate, and developed the first reverse genetics system for HRV-C.", {"entities": []}], ["Using contact points for the known HRV receptors, intercellular adhesion molecule 1 (ICAM-1) and low density lipoprotein receptor (LDLR), inter- and intraspecies footprint analysis predicted a unique cell attachment site for HRV-Cs.", {"entities": [[131, 135, "GENE"]]}], ["Antibodies directed to binding sites for HRV-A and -B failed to inhibit HRV-C attachment, consistent with the alternative receptor footprint.", {"entities": []}], ["HRV-A and -B infected HeLa and WisL cells, but HRV-C did not.", {"entities": []}], ["However, HRV-C RNA synthesized in vitro and transfected into both cell types resulted in cytopathic effect and recovery of functional virus, indicating that the viral attachment mechanism is a primary distinguishing feature of HRV-C.", {"entities": []}], ["Randomized controlled trials are considered the \u201cgold standard\u201d for scientific rigor in the assessment of benefits and harms of interventions in healthcare.", {"entities": []}], ["They may not always be feasible, however, when evaluating quality improvement interventions in real-world healthcare settings.", {"entities": []}], ["Non-randomized controlled trials (NCTs) are designed to answer questions of effectiveness of interventions in routine clinical practice to inform a decision or process.", {"entities": []}], ["The on-off NCT design is a relatively new design where participant allocation is by alternation.", {"entities": []}], ["In alternation, eligible patients are allocated to the intervention \u201c on \u201d or control \u201c off \u2009\u201d groups in time series dependent sequential clusters.", {"entities": []}], ["We used two quality improvement studies undertaken in a Canadian primary care setting to illustrate the features of the on-off design.", {"entities": []}], ["We also explored the perceptions and experiences of healthcare providers tasked with implementing the on-off study design.", {"entities": []}], ["The on-off design successfully allocated patients to intervention and control groups.", {"entities": []}], ["Imbalances between baseline variables were attributed to chance, with no detectable biases.", {"entities": []}], ["However, healthcare providers\u2019 perspectives and experiences with the design in practice reveal some conflict.", {"entities": []}], ["Specifically, providers described the process of allocating patients to the off group as unethical and immoral, feeling it was in direct conflict with their professional principle of providing care for all.", {"entities": []}], ["The degree of dissatisfaction seemed exacerbated by: 1) the patient population involved (e.g., patient population viewed as high-risk (e.g., depressed or suicidal)), 2) conducting assessments without taking action (e.g., administering the PHQ-9 and not acting on the results), and 3) the (non-blinded) allocation process.", {"entities": []}], ["Alternation, as in the on-off design, is a credible form of allocation.", {"entities": []}], ["The conflict reported by healthcare providers in implementing the design, while not unique to the on-off design, may be alleviated by greater emphasis on the purpose of the research and having research assistants allocate patients and collect data instead of the healthcare providers implementing the trial.", {"entities": []}], ["In addition, consultation with front-line staff implementing the trials with an on-off design on appropriateness to the setting (e.g., alignment with professional values and the patient population served) may be beneficial.", {"entities": []}], ["Health Eating and Active Living with Diabetes: ClinicalTrials.gov identifier: NCT00991380 Date registered: 7 October 2009.", {"entities": []}], ["Controlled trial of a collaborative primary care team model for patients with diabetes and depression: Clintrials.gov Identifier: NCT01328639 Date registered: 30 March 2011.", {"entities": []}], ["Targeted gene panels can be used to establish molecular diagnoses in paediatric cohorts.", {"entities": []}], ["Reid et al .", {"entities": []}], ["report that this approach is accurate, efficient and can be preferred to whole-exome or genome sequencing for patients with neurological symptomatology and clues suggestive of an inherited metabolic disorder.", {"entities": [[179, 207, "DISEASE"]]}], ["Targeted gene panels can be used to establish molecular diagnoses in paediatric cohorts.", {"entities": []}], ["Reid et al .", {"entities": []}], ["report that this approach is accurate, efficient and can be preferred to whole-exome or genome sequencing for patients with neurological symptomatology and clues suggestive of an inherited metabolic disorder.", {"entities": [[179, 207, "DISEASE"]]}], ["Targeted gene panels can be used to establish molecular diagnoses in paediatric cohorts.", {"entities": []}], ["Reid et al .", {"entities": []}], ["report that this approach is accurate, efficient and can be preferred to whole-exome or genome sequencing for patients with neurological symptomatology and clues suggestive of an inherited metabolic disorder.", {"entities": [[179, 207, "DISEASE"]]}], ["Neurometabolic disorders are markedly heterogeneous, both clinically and genetically, and are characterized by variable neurological dysfunction accompanied by suggestive neuroimaging or biochemical abnormalities.", {"entities": []}], ["Despite early specialist input, delays in diagnosis and appropriate treatment initiation are common.", {"entities": []}], ["Next-generation sequencing approaches still have limitations but are already enabling earlier and more efficient diagnoses in these patients.", {"entities": []}], ["We designed a gene panel targeting 614 genes causing inborn errors of metabolism and tested its diagnostic efficacy in a paediatric cohort of 30 undiagnosed patients presenting with variable neurometabolic phenotypes.", {"entities": []}], ["Genetic defects that could, at least partially, explain observed phenotypes were identified in 53% of cases.", {"entities": []}], ["Where biochemical abnormalities pointing towards a particular gene defect were present, our panel identified diagnoses in 89% of patients.", {"entities": []}], ["Phenotypes attributable to defects in more than one gene were seen in 13% of cases.", {"entities": []}], ["The ability of in silico tools, including structure-guided prediction programmes to characterize novel missense variants were also interrogated.", {"entities": []}], ["Our study expands the genetic, clinical and biochemical phenotypes of well-characterized ( POMGNT1 , TPP1 ) and recently identified disorders ( PGAP2 , ACSF3 , SERAC1 , AFG3L2 , DPYS ).", {"entities": [[91, 98, "GENE"], [101, 105, "GENE"], [144, 149, "GENE"], [152, 157, "GENE"], [160, 166, "GENE"], [169, 175, "GENE"], [178, 182, "GENE"]]}], ["Overall, our panel was accurate and efficient, demonstrating good potential for applying similar approaches to clinically and biochemically diverse neurometabolic disease cohorts.", {"entities": []}], ["Medicare and other payers have launched initiatives to reduce hospital utilization, especially targeting readmissions within 30 days of discharge.", {"entities": []}], ["Hospital managers have traditionally contended that hospitals would prosper better by ignoring the penalties for high readmission rates and keeping the beds more full.", {"entities": []}], ["We aimed to test the financial effects of admissions and readmissions by persons with and without specified chronic conditions in one regional hospital.", {"entities": []}], ["This is a management case study with a descriptive brief report.", {"entities": []}], ["This study was conducted at Winchester Memorial Hospital, a general hospital in a largely rural area of Virginia, 2010-2015.", {"entities": []}], ["The total margin per admission varied by diagnosis, with the average patient diagnosed with chronic obstructive pulmonary disease, heart failure, pneumonia, or chronic renal disease having negative margins.", {"entities": [[146, 155, "DISEASE"], [92, 129, "DISEASE"]]}], ["The largest per-patient losses were in diagnostic categories coinciding with the highest readmission rates.", {"entities": []}], ["The margin declined into substantial losses with an increasing number of chronic conditions, which also corresponded with higher readmission rates.", {"entities": []}], ["Patients with 5 or more clinical conditions had highest risk of readmission within 30 days (24.8%) and had an average total loss of $865 per admission in 2015.", {"entities": []}], ["The adverse financial effects worsened between 2010 and 2015.", {"entities": []}], ["This hospital might improve its finances by investing in strategies to reduce chronic illness hospitalizations, especially those with multiple chronic conditions and high risk of readmission.", {"entities": []}], ["These findings counter the common claim that the hospital would do better to fill beds rather than to work on efficient utilization.", {"entities": []}], ["Other hospitals could replicate these analyses to understand their situations.", {"entities": []}], ["To investigate the pathologic mechanisms of toll-like receptor 4 (TLR4) in lung injury and atherosclerosis, ApoE \u03b3 ), tumor necrosis factor (TNF- \u03b1 ), and interleukin-1 (IL-1 \u03b2 ) were assessed by ELISA.", {"entities": [[91, 106, "DISEASE"], [66, 70, "GENE"], [108, 112, "GENE"]]}], ["Hematoxylin and eosin (HE) and Perl's stains for lung pathomorphology as well as HE staining for atherosclerosis were employed.", {"entities": [[97, 112, "DISEASE"]]}], ["TLR4 in macrophages was detected by double immunofluorescent staining.", {"entities": [[0, 4, "GENE"]]}], ["While protein expressions of TLR4, nuclear factor-kappa B p65 (NF- \u03ba B p65), and B cell activating factor belonging to the TNF family (BAFF) were examined by immunohistochemistry.", {"entities": [[29, 33, "GENE"], [123, 126, "GENE"]]}], ["We found that serum autoantibody (ANA and anti-dsDNA), cytokines (IFN- \u03b3 , TNF- \u03b1 , IL-1 \u03b2 ), lung inflammation, and intima-media thickness in brachiocephalic artery were obviously increased after LPS challenge in both genotypes, but to a lesser extent in wild-type strains.", {"entities": []}], ["And those alterations were alleviated by coadministration of LPS and TAK-242.", {"entities": []}], ["Mechanistically, upregulation of TLR4, NF- \u03ba b, and BAFF was involved.", {"entities": [[33, 37, "GENE"]]}], ["We concluded that TLR4/NF- \u03ba b/BAFF in macrophages might be a possible common autoimmune pathway that caused lung injury and atherosclerosis.", {"entities": [[125, 140, "DISEASE"]]}], ["TLR4 signal will be a therapeutic target in atherosclerosis and immune-mediated lung injury.", {"entities": [[44, 59, "DISEASE"], [0, 4, "GENE"]]}], ["The obese-asthma phenotype is not well defined.", {"entities": [[10, 16, "DISEASE"]]}], ["The aim of this study was to examine both mechanical and inflammatory influences, by comparing lung function with body composition and airway inflammation in overweight and obese asthma.", {"entities": [[179, 185, "DISEASE"]]}], ["Overweight and obese (BMI 28-40 kg/m In females, android and thoracic fat tissue and total body lean tissue were inversely correlated with expiratory reserve volume (ERV).", {"entities": []}], ["Conversely in males, fat tissue was not correlated with lung function, however there was a positive association between android and thoracic lean tissue and ERV.", {"entities": []}], ["Lower body (gynoid and leg) lean tissue was positively associated with sputum %neutrophils in females, while leptin was positively associated with android and thoracic fat tissue in males.", {"entities": []}], ["This study suggests that both body composition and inflammation independently affect lung function, with distinct differences between males and females.", {"entities": []}], ["Lean tissue exacerbates the obese-asthma phenotype in females and the mechanism responsible for this finding warrants further investigation.", {"entities": [[34, 40, "DISEASE"]]}], ["Mammalian genomes encode genes for more than 30 phospholipase A 2 s (PLA 2 s) or related enzymes, which are subdivided into several subgroups based on their structures, catalytic mechanisms, localizations and evolutionary relationships.", {"entities": []}], ["More than one third of the PLA 2 enzymes belong to the secreted PLA 2 (sPLA 2 ) family, which consists of low-molecular-weight, Ca 2 isoforms exhibit unique tissue and cellular localizations and enzymatic properties, suggesting their distinct pathophysiological roles.", {"entities": []}], ["Recent studies using transgenic and knockout mice for several sPLA 2 isoforms, in combination with lipidomics approaches, have revealed their distinct contributions to various biological events.", {"entities": []}], ["Herein, we will describe several examples of sPLA 2 -mediated phospholipid metabolism in vivo, as revealed by integrated analysis of sPLA 2 transgenic/knockout mice and lipid mass spectrometry.", {"entities": []}], ["Knowledge obtained from this approach greatly contributes to expanding our understanding of the sPLA 2 biology and pathophysiology.", {"entities": []}], ["During the present study, we explored the protective effects of autophagy on endoplasmic reticulum (ER) stress (ERS) induced apoptosis belonging to alveolar epithelial cells (AECs) in rat models with chronic obstructive pulmonary disease (COPD).", {"entities": [[200, 237, "DISEASE"]]}], ["Fifty-six 12-week-old male Sprague\u2013Dawley (SD) rats were randomly assigned into the COPD group (rats exposed to cigarette smoke (CS)), the 3-methyladenine (3-MA) intervention group (COPD rats were administrated with 10 mg/kg autophagy inhibitors), the chloroquine (CQ)-intervention group (COPD rats were administrated 40 mg/kg CQ), and the control group (rats breathed in normal saline).", {"entities": [[129, 131, "GENE"]]}], ["The forced expiratory volume in 0.3 s/forced vital capacity (FEV 0.3 /FVC%), inspiratory resistance (RI), and dynamic lung compliance (Cdyn) were measured and recorded.", {"entities": [[61, 64, "GENE"]]}], ["The expressions of PKR-like ER kinase (PERK) and CCAAT/enhancer-binding protein-homologous protein (CHOP) were detected by immunohistochemistry.", {"entities": []}], ["The cell apoptotic rates of AECs were analyzed by terminal deoxynucleotidyl transferase (TdT) mediated dUTP-biotin nick end-labeling (TUNEL) staining.", {"entities": []}], ["The expression levels of light chain 3 (LC3-II), p62, Beclin-1, ATG5, ATG7, Caspase-12, and Caspase-3 were detected by Western blotting.", {"entities": [[64, 68, "GENE"], [70, 74, "GENE"]]}], ["Results showed that the COPD group exhibited a lower FEV 0.3 /FVC% and Cdyn, and a higher RI than the control group.", {"entities": [[53, 56, "GENE"]]}], ["Compared with the control group, the integrated optical density (IOD) values of PERK and CHOP, the apoptotic rate of AECs, and expressions of LC3-II, Beclin-1, ATG5, ATG7, Caspase-3, and Caspase-12 expressions were significantly higher, whereas p62 expression was significantly lower in the COPD group.", {"entities": [[160, 164, "GENE"], [166, 170, "GENE"]]}], ["Based on the results obtained during the present study, it became clear that the inhibition of autophagy could attenuate the ERS-induced apoptosis of AECs in rats with COPD.", {"entities": []}], ["Musculoskeletal pain is associated with comorbidity, extensive use of health services, long-term disability and reduced quality of life.", {"entities": []}], ["The scientific literature on effects of treatment for musculoskeletal pain is inconclusive.", {"entities": []}], ["The purpose of this study is to compare a multidisciplinary intervention (MI), including use of the novel Interdisciplinary Structured Interview with a Visual Educational Tool (ISIVET), with a brief intervention (BI), on effects on mental and physical symptoms, functioning ability, use of health services and coping in patients sick-listed due to musculoskeletal pain.", {"entities": []}], ["Two hundred eighty-four adults aged 18\u201360, referred to a specialist clinic in physical rehabilitation, were randomized to MI or BI.", {"entities": []}], ["Patients received a medical examination at baseline and completed a comprehensive questionnaire at baseline, 3\u00a0months and 12\u00a0months.", {"entities": []}], ["Both groups reported improvements in mental and physical symptoms, including pain, and improved functioning ability at 3 and 12\u00a0months, but the MI group improved faster than the BI group except from reports of pain, which had a similar course.", {"entities": []}], ["Significant interactions between group and time were found on mental symptoms (anxiety ( p \u2009<\u20090.05), depression ( p \u2009<\u20090.01), somatization ( p \u2009<\u20090.01)) and functioning ability ( p \u2009<\u20090.01) due to stronger effects in the MI group at 3\u00a0months.", {"entities": []}], ["At 3 and 12\u00a0months, the MI group reported significantly less use of health services (general practitioner ( p \u2009<\u20090.05)).", {"entities": []}], ["At 12\u00a0months, the MI group reported better self-evaluated capability of coping with complaints ( p \u2009<\u20090.001) and they took better care of their own health ( p \u2009<\u20090.001), compared to the BI group.", {"entities": []}], ["The results indicate that the MI may represent an important supplement in the treatment of musculoskeletal pain.", {"entities": []}], ["The pattern of development of allergen-specific T cell cytokine responses in early childhood and their relation to later disease is poorly understood.", {"entities": []}], ["Here we describe longitudinal changes in allergen-stimulated T cell cytokine responses and their relation to asthma and allergic disease during the first 8 years of life.", {"entities": [[109, 115, "DISEASE"]]}], ["Subjects with a family history of asthma, who were enrolled antenatally in the Childhood Asthma Prevention Study (public trials registration number ACTRN12605000042640), had skin prick tests, clinical evaluation for asthma and eczema, and in vitro assessment of T cell cytokine responses to HDM extract performed at ages 18 months (n\u200a=\u200a281), 3 years (n\u200a=\u200a349), 5 years (n\u200a=\u200a370) and 8 years (n\u200a=\u200a275).", {"entities": [[34, 40, "DISEASE"], [89, 95, "DISEASE"], [216, 222, "DISEASE"]]}], ["We measured interleukin (IL-) 13 at 3, 5 and 8 years, and IL-5, IL-10, and interferon-\u03b3 (IFN-\u03b3), at 18 months, 3, 5 and 8 years by ELISA.", {"entities": []}], ["A cohort analysis was undertaken.", {"entities": []}], ["Independent effects of cytokine responses at each age on the risk of asthma and allergic outcomes at age 8 years were estimated by multivariable logistic regression.", {"entities": [[69, 75, "DISEASE"]]}], ["HDM-specific IL-5 responses increased with age.", {"entities": []}], ["HDM-specific IL-13 and IL-10 responses peaked at age 5 years.", {"entities": []}], ["HDM-specific IL-5 responses at 3 years, 5 years and 8 years were significantly associated with the presence of asthma and atopy at 8 years.", {"entities": [[111, 117, "DISEASE"]]}], ["IL-13 responses at 3 years, 5 years and 8 years were significantly associated with atopy at 8 years, but this association was not independent of the effect of IL-5.", {"entities": []}], ["Other HDM-specific cytokine responses were not independently related to asthma or eczema at 8 years.", {"entities": [[72, 78, "DISEASE"]]}], ["HDM-specific IL-5 responses at age 3 years or later are the best measure of T cell function for predicting asthma at age 8 years.", {"entities": [[107, 113, "DISEASE"]]}], ["One of the most neglected areas of biomedical Text Mining (TM) is the development of systems based on carefully assessed user needs.", {"entities": []}], ["We have recently investigated the user needs of an important task yet to be tackled by TM -- Cancer Risk Assessment (CRA).", {"entities": []}], ["Here we take the first step towards the development of TM technology for the task: identifying and organizing the scientific evidence required for CRA in a taxonomy which is capable of supporting extensive data gathering from biomedical literature.", {"entities": []}], ["The taxonomy is based on expert annotation of 1297 abstracts downloaded from relevant PubMed journals.", {"entities": []}], ["It classifies 1742 unique keywords found in the corpus to 48 classes which specify core evidence required for CRA.", {"entities": []}], ["We report promising results with inter-annotator agreement tests and automatic classification of PubMed abstracts to taxonomy classes.", {"entities": []}], ["A simple user test is also reported in a near real-world CRA scenario which demonstrates along with other evaluation that the resources we have built are well-defined, accurate, and applicable in practice.", {"entities": []}], ["We present our annotation guidelines and a tool which we have designed for expert annotation of PubMed abstracts.", {"entities": []}], ["A corpus annotated for keywords and document relevance is also presented, along with the taxonomy which organizes the keywords into classes defining core evidence for CRA.", {"entities": []}], ["As demonstrated by the evaluation, the materials we have constructed provide a good basis for classification of CRA literature along multiple dimensions.", {"entities": []}], ["They can support current manual CRA as well as facilitate the development of an approach based on TM.", {"entities": []}], ["We discuss extending the taxonomy further via manual and machine learning approaches and the subsequent steps required to develop TM technology for the needs of CRA.", {"entities": []}], ["Successful implantation is dependent on the appropriate decidualization of endometrial stromal cells\u00a0for the establishment of pregnancy in women.", {"entities": []}], ["Mycobacterial heat shock protein 65 (HSP65) is involved in pathogenesis of the genital tuberculosis (GTB), one of the common causes of infertility in emerging countries.", {"entities": [[87, 99, "DISEASE"], [135, 146, "DISEASE"]]}], ["Though implantation failure appears to be the major cause, understanding the status of decidualizaiton process in women diagnosed with GTB has not been thoroughly addressed.", {"entities": []}], ["We, therefore, explored the effect of HSP65 protein on the endometrial cell metabolism during in vitro decidualization.", {"entities": []}], ["In order to identify the cellular metabolism of decidual cells with and without HSP65 treatment, proton NMR based characterization of metabolites extracted from cells and culture media were performed.", {"entities": []}], ["In presence of HSP65, significant reduction in the decidual phenotype of endometrial stromal cells and prolactin expression is suggestive of impairment in decidualization.", {"entities": []}], ["The intracellular and extracellular metabolic changes in HSP65 treated endometrial stromal cells produced a distinct pattern, reflecting the interaction between the protein and cellular metabolism.", {"entities": []}], ["HSP65 mediated dysregulation in cellular metabolism is associated with poor decidualization.", {"entities": []}], ["Besides enriching the present knowledge on metabolic changes underlying stromal cells decidualization, these findings assist in identifying potential molecular causes for decidualization failure in GTB women.", {"entities": []}], ["We previously demonstrated pharmacokinetic differences among manufacturing batches of a US Food and Drug Administration (FDA)\u2010approved dry powder inhalation product (Advair Diskus 100/50) large enough to establish between\u2010batch bio\u2010inequivalence.", {"entities": []}], ["Here, we provide independent confirmation of pharmacokinetic bio\u2010inequivalence among Advair Diskus 100/50 batches, and quantify residual and between\u2010batch variance component magnitudes.", {"entities": []}], ["These variance estimates are used to consider the type I error rate of the FDA's current two\u2010way crossover design recommendation.", {"entities": []}], ["When between\u2010batch pharmacokinetic variability is substantial, the conventional two\u2010way crossover design cannot accomplish the objectives of FDA's statistical bioequivalence test (i.e., cannot accurately estimate the test/reference ratio and associated confidence interval).", {"entities": []}], ["The two\u2010way crossover, which ignores between\u2010batch pharmacokinetic variability, yields an artificially narrow confidence interval on the product comparison.", {"entities": []}], ["The unavoidable consequence is type I error rate inflation, to \u223c25%, when between\u2010batch pharmacokinetic variability is nonzero.", {"entities": []}], ["This risk of a false bioequivalence conclusion is substantially higher than asserted by regulators as acceptable consumer risk (5%).", {"entities": []}], ["The evaluation of the quality of a sputum specimen prior to bacterial culture has been an accepted practice.", {"entities": []}], ["However, optimal sputum criteria for pulmonary tuberculosis (TB) are not well established.", {"entities": [[47, 59, "DISEASE"], [37, 59, "DISEASE"]]}], ["We investigated indicators for sputum acceptability in tuberculosis cultures and acid-fast bacilli (AFB) smear.", {"entities": [[55, 67, "DISEASE"]]}], ["A post-hoc analysis of a randomized trial with 228 sputum specimens from 77 patients was conducted.", {"entities": []}], ["In the trial, pulmonary TB suspects were requested for collecting three sputum specimens.", {"entities": []}], ["We performed both TB study (AFB smear and M. tuberculosis culture) and Gram staining in each specimen.", {"entities": [[45, 57, "DISEASE"]]}], ["By using generalized estimating equations, the association between sputum characteristics and positive TB testings were analyzed.", {"entities": []}], ["Although acceptable specimens for bacterial pneumonia showed higher TB-culture positive rates than unacceptable specimens (adjusted odds ratio [aOR]=1.66; 95% confidence interval [CI]=1.11-2.49), a specimen with \u226525 white blood cells/low-power field was the better predictor for positive M. tuberculosis cultures (aOR=2.30; 95% CI=1.48-3.58) and acid-fast bacilli smears (aOR=1.85; 95% CI=1.05-3.25).", {"entities": [[44, 53, "DISEASE"], [291, 303, "DISEASE"], [34, 53, "DISEASE"]]}], ["Sputum leukocytosis could be an indicator of sputum acceptability for diagnosing pulmonary tuberculosis.", {"entities": [[91, 103, "DISEASE"], [81, 103, "DISEASE"]]}], ["The significance of pneumatosis intestinalis (PI) and portal venous gas (PVG) is controversial.", {"entities": []}], ["This retrospective study evaluated the risk factors for bowel necrosis in patients with PI and/or PVG.", {"entities": []}], ["Between 2002 and 2015, 52 patients were diagnosed with PI and/or PVG and were included in this study.", {"entities": []}], ["The patients were classified according to the presence or absence of bowel necrosis in surgical findings or at autopsy.", {"entities": []}], ["Patient characteristics and clinical findings related to bowel necrosis were investigated.", {"entities": []}], ["Bowel necrosis was diagnosed in 17 (32.7\u00a0%) patients.", {"entities": []}], ["Amongst these 17, 10 patients received salvage surgical intervention, and seven of those diagnosed with bowel necrosis survived after the operation.", {"entities": []}], ["The remaining 35 patients received conservative treatment with or without exploratory laparotomy.", {"entities": []}], ["Between patients with and without bowel necrosis, laboratory data revealed significant differences in the levels of C-reactive protein ( P \u2009=\u20090.0038), creatinine ( P \u2009=\u20090.0054), and lactate ( P \u2009=\u20090.045); clinical findings showed differences in abdominal pain ( P \u2009=\u20090.019) and peritoneal irritation signs ( P \u2009=\u20090.016); computed tomography detected ascites ( P \u2009=\u20090.011) and changes of bowel wall enhancement ( P \u2009=\u20090.03) that were significantly higher in patients with bowel necrosis.", {"entities": []}], ["The rate of PI and/or PVG detected in patients postoperatively was significantly higher in patients with bowel necrosis ( P \u2009<\u20090.0001).", {"entities": []}], ["Multivariate analysis showed that bowel necrosis was significantly more likely when PI or PVG was detected in postoperative patients than in patients who had not had surgery ( P \u2009=\u20090.003).", {"entities": []}], ["PI and/or PVG, alone, are not automatically indicative of bowel necrosis.", {"entities": []}], ["However, when these conditions occur postoperatively, they indicate bowel necrosis requiring reoperation.", {"entities": []}], ["Placebo medications, by definition, are composed of inactive ingredients that have no physiological effect on symptoms.", {"entities": []}], ["Nonetheless, administration of placebo in randomized controlled trials (RCTs) and in clinical settings has been demonstrated to have significant impact on many physical and psychological complaints.", {"entities": []}], ["Until recently, conventional wisdom has suggested that patients must believe that placebo pills actually contain (or, at least, might possibly contain) active medication in order to elicit a response to placebo.", {"entities": []}], ["However, several recent RCTs, including patients with irritable bowel syndrome (IBS), chronic low back pain, and episodic migraine, have demonstrated that individuals receiving open-label placebo (OLP) can still experience symptomatic improvement and benefit from honestly described placebo treatment.", {"entities": [[54, 78, "DISEASE"], [122, 130, "DISEASE"], [70, 78, "DISEASE"]]}], ["This paper describes an innovative multidisciplinary trial design ( n \u2009=\u2009280) that attempts to replicate and expand upon an earlier IBS OLP study.", {"entities": []}], ["The current study will compare OLP to double-blind placebo (DBP) administration which is made possible by including a nested, double-blind RCT comparing DBP and peppermint oil.", {"entities": [[60, 63, "GENE"], [153, 156, "GENE"], [60, 63, "GENE"], [153, 156, "GENE"]]}], ["The study also examines possible genetic and psychological predictors of OLP and seeks to better understand participants\u2019 experiences with OLP and DBP through a series of extensive interviews with a randomly selected subgroup.", {"entities": [[147, 150, "GENE"]]}], ["OLP treatment is a novel strategy for ethically harnessing placebo effects.", {"entities": []}], ["It has potential to re-frame theories of placebo and to influence how physicians can optimize watch-and-wait strategies for common, subjective symptoms.", {"entities": []}], ["The current study aims to dramatically expand what we know about OLP by comparing, for the first time, OLP and DBP administration.", {"entities": [[111, 114, "GENE"]]}], ["Adopting a unique, multidisciplinary approach, the study also explores genetic, psychological and experiential dimensions of OLP.", {"entities": []}], ["The paper ends with an extensive discussion of the \u201cculture\u201d of the trial as well as potential mechanisms of OLP and ethical implications.", {"entities": []}], ["ClinicalTrials.gov, identifier: NCT02802241 .", {"entities": []}], ["Registered on 14 June 2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-1964-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Dental caries remains a significant public health problem, prevalence being linked to social and economic deprivation.", {"entities": [[0, 13, "DISEASE"]]}], ["Occlusal surfaces of first permanent molars are the most susceptible site in the developing permanent dentition.", {"entities": []}], ["Cochrane reviews have shown pit and fissure sealants (PFS) and fluoride varnish (FV) to be effective over no intervention in preventing caries.", {"entities": []}], ["However, the comparative cost and effectiveness of these treatments is uncertain.", {"entities": []}], ["The primary aim of the trial described in this protocol is to compare the clinical effectiveness of PFS and FV in preventing dental caries in first permanent molars in 6-7 year-olds.", {"entities": [[125, 138, "DISEASE"]]}], ["Secondary aims include: establishing the costs and the relative cost-effectiveness of PFS and FV delivered in a community/school setting; examining the impact of PFS and FV on children and their parents/carers in terms of quality of life/treatment acceptability measures; and examining the implementation of treatment in a community setting.", {"entities": []}], ["The trial design comprises a randomised, assessor-blinded, two-arm, parallel group trial in 6\u20137 year old schoolchildren.", {"entities": []}], ["Clinical procedures and assessments will be performed at 66 primary schools, in deprived areas in South Wales.", {"entities": []}], ["Treatments will be delivered via a mobile dental clinic.", {"entities": []}], ["In total, 920 children will be recruited (460 per trial arm).", {"entities": []}], ["At baseline and annually for 36 months dental caries will be recorded using the International Caries Detection and Assessment System (ICDAS) by trained and calibrated dentists.", {"entities": [[39, 52, "DISEASE"]]}], ["PFS and FV will be applied by trained dental hygienists.", {"entities": []}], ["The FV will be applied at baseline, 6, 12, 18, 24 and 30 months.", {"entities": []}], ["The PFS will be applied at baseline and re-examined at 6, 12, 18, 24, and 30 months, and will be re-applied if the existing sealant has become detached/is insufficient.", {"entities": []}], ["The economic analysis will estimate the costs of providing the PFS versus FV.", {"entities": []}], ["The process evaluation will assess implementation and acceptability through acceptability scales, a schools questionnaire and interviews with children, parents, dentists, dental nurses and school staff.", {"entities": []}], ["The primary outcome measure will be the proportion of children developing new caries on any one of up to four treated first permanent molars.", {"entities": []}], ["The objectives of this study have been identified by the National Institute for Health Research as one of importance to the National Health Service in the UK.", {"entities": []}], ["The results of this trial will provide guidance on which of these technologies should be adopted for the prevention of dental decay in the most susceptible tooth-surface in the most at risk children.", {"entities": []}], ["ISRCTN ref: ISRCTN17029222 EudraCT: 2010-023476-23 UKCRN ref: 9273", {"entities": []}], ["The genetic bases of many common diseases have been identified through genome-wide association studies in the past decade.", {"entities": []}], ["However, the application of this approach on public healthcare planning has not been well established.", {"entities": []}], ["Using Macau with population of around 650,000 as a basis, we conducted a pilot study to evaluate the feasibility of population genomic research and its potential on public health decisions.", {"entities": []}], ["By performing genome-wide SNP genotyping of over a thousand Macau individuals, we evaluated the population genetic risk profiles of 47 non-communicable diseases and traits, as well as two traits associated with influenza infection.", {"entities": [[211, 220, "DISEASE"]]}], ["We found that for most of the diseases, the genetic risks of Macau population were different from those of Caucasian, but with similar profile with mainland Chinese.", {"entities": []}], ["We also identified a panel of diseases that Macau population may have a high or elevated genetic risks.", {"entities": []}], ["This pilot study showed that (1) population genomic study is feasible in Asian regions like Macau; (2) Macau may have different profile of population-based genetic risks than Caucasians, (3) the different prevalence of genetic risk profile indicates the importance of Asian-specific studies for Asian populations; and (4) the results generated may have an impact for going forward healthcare planning.", {"entities": []}], ["In order to identify novel loci associated with Alzheimer's disease (AD), we conducted a genome-wide association study (GWAS) in the Spanish population.", {"entities": []}], ["We genotyped 1,128 individuals using the Affymetrix Nsp I 250K chip.", {"entities": []}], ["A sample of 327 sporadic AD patients and 801 controls with unknown cognitive status from the Spanish general population were included in our initial study.", {"entities": []}], ["To increase the power of the study, we combined our results with those of four other public GWAS datasets by applying identical quality control filters and the same imputation methods, which were then analyzed with a global meta-GWAS.", {"entities": []}], ["A replication sample with 2,200 sporadic AD patients and 2,301 controls was genotyped to confirm our GWAS findings.", {"entities": []}], ["Meta-analysis of our data and independent replication datasets allowed us to confirm a novel genome-wide significant association of AD with the membrane-spanning 4-domains subfamily A ( MS4A ) gene cluster (rs1562990, P = 4.40E-11, odds ratio = 0.88, 95% confidence interval 0.85 to 0.91, n = 10,181 cases and 14,341 controls).", {"entities": []}], ["Our results underscore the importance of international efforts combining GWAS datasets to isolate genetic loci for complex diseases.", {"entities": []}], ["The objective of this study was to evaluate the prevalence of self-diagnosis of malaria and other febrile illnesses in Bo, Sierra Leone.", {"entities": [[80, 87, "DISEASE"]]}], ["All households in two neighboring sections of Bo were invited to participate in a cross-sectional survey.", {"entities": []}], ["A total of 882 households (an 85% participation rate) that were home to 5410 individuals participated in the study.", {"entities": []}], ["Of the 910 individuals reported to have had what the household considered to be malaria in the past month, only 41% were diagnosed by a healthcare professional or a laboratory test.", {"entities": [[80, 87, "DISEASE"]]}], ["Of the 1402 individuals reported to have had any type of febrile illness within the past six months, only 34% had sought a clinical or laboratory diagnosis.", {"entities": []}], ["Self-diagnosis of influenza, yellow fever, typhoid, and pneumonia was also common.", {"entities": [[18, 27, "DISEASE"], [56, 65, "DISEASE"], [29, 41, "DISEASE"]]}], ["Self-diagnosis and presumptive treatment with antimalarial drugs and other antibiotic medications that are readily available without a prescription may compromise health outcomes for febrile adults and children.", {"entities": []}], ["Prevalence and morbidity of allergic diseases have increased over the last decades.", {"entities": []}], ["Based on the recently recognized differences in asthma prevalence between the sexes, we have examined the effect of endogenous estrogens on a key element of the allergic response.", {"entities": [[48, 54, "DISEASE"]]}], ["Some lipophilic pollutants have estrogen-like activities and are termed environmental estrogens.", {"entities": []}], ["These pollutants tend to degrade slowly in the environment and to bioaccumulate and bioconcentrate in the food chain; they also have long biological half-lives.", {"entities": []}], ["Our goal in this study was to identify possible pathogenic roles for environmental estrogens in the development of allergic diseases.", {"entities": []}], ["We screened a number of environmental estrogens for their ability to modulate the release of allergic mediators from mast cells.", {"entities": []}], ["We incubated a human mast cell line and primary mast cell cultures derived from bone marrow of wild type and estrogen receptor \u03b1 (ER-\u03b1 )\u2013deficient mice with environmental estrogens with and without estradiol or IgE and allergens.", {"entities": []}], ["We assessed degranulation of mast cells by quantifying the release of \u03b2 -hexosaminidase.", {"entities": []}], ["All of the environmental estrogens tested caused rapid, dose-related release of \u03b2 -hexosaminidase from mast cells and enhanced IgE-mediated release.", {"entities": []}], ["The combination of physiologic concentrations of 17\u03b2 -estradiol and several concentrations of environmental estrogens had additive effects on mast cell degranulation.", {"entities": []}], ["Comparison of bone marrow mast cells from ER-\u03b1 \u2013sufficient and ER-\u03b1 \u2013deficient mice indicated that much of the effect of environmental estrogens was mediated by ER-\u03b1 .", {"entities": []}], ["Our findings suggest that estrogenic environmental pollutants might promote allergic diseases by inducing and enhancing mast cell degranulation by physiologic estrogens and exposure to allergens.", {"entities": []}], ["Viscum album has shown inhibitory effect on different smooth muscles but underlying mechanisms in gut and vascular smooth muscles are not well defined.", {"entities": []}], ["Additionally, the plant has also importance in managing hyperactive gut and cardiovascular disorders.", {"entities": []}], ["The current study was aimed to probe a pharmacological base of the smooth muscle relaxant effect of V. album in gut and vascular preparations.", {"entities": []}], ["V. album crude extract (Va. Cr) and its ethyl acetate fraction (Va. EtAc) were studied using in vitro techniques.", {"entities": []}], ["The antispasmodic activity was performed using isolated rabbit jejunum while the vasorelaxant effects were studied in rabbit aortic rings.", {"entities": []}], ["Va. Cr and Va. EtAc inhibited spontaneous and high K 50 values of 0.31\u00a0mg/mL (0.15\u20130.57) and 0.62\u00a0mg/mL (0.3\u20130.95), respectively.", {"entities": []}], ["This advocates an antispasmodic effect probably operated through calcium channels blockade (CBB).", {"entities": []}], ["The proposed mechanism was confirmed by a pretreatment of the tissue with Va. Cr (0.01\u20130.3\u00a0mg/mL), which shifted the Ca These data indicated that Va. Cr possesses smooth muscle relaxant effect mediated through voltage-dependent Ca V. album in gut spasm and possibly hypertension.", {"entities": [[266, 278, "DISEASE"]]}], ["There has been a dramatic increase in the use of complementary medicines over recent decades.", {"entities": []}], ["Glucosamine is one of the most commonly used complementary medicines in Western societies.", {"entities": []}], ["An understanding of glucosamine consumption is of significance for public health and future health promotion.", {"entities": []}], ["This paper, drawing upon the largest dataset to date with regards to glucosamine use (n\u200a=\u200a266,844), examines the use and users of glucosamine amongst a sample of older Australians.", {"entities": []}], ["Analysis of the self-reported data on use of glucosamine, demographics and health status as extracted from the dataset of the 45 and Up Study, which is the largest study of healthy ageing ever undertaken in the Southern Hemisphere involving over 265,000 participants aged 45 and over.", {"entities": []}], ["Analysis reveals that 58,630 (22.0%) participants reported using glucosamine in the 4 weeks prior to the survey.", {"entities": []}], ["Use was higher for those who were female, non-smokers, residing in inner/outer regional areas, with higher income and private health insurance.", {"entities": []}], ["Of all the health conditions examined only osteoarthritis was positively associated with use of glucosamine, while cancer, heart attack or angina and other heart disease were all negatively associated with glucosamine use.", {"entities": [[156, 169, "DISEASE"], [43, 57, "DISEASE"], [115, 121, "DISEASE"]]}], ["This study suggests that a considerable proportion of the Australia population aged 45 and over consume glucosamine.", {"entities": []}], ["There is a need for health care practitioners to enquire with their patients about their use of glucosamine and for further attention to be directed to providing good quality information for patients and providers with regards to glucosamine products.", {"entities": []}], ["Atopic dermatitis (AD) is a chronic pruritic skin disease.", {"entities": [[45, 57, "DISEASE"], [7, 17, "DISEASE"]]}], ["It results from a complex interplay between strong genetic and environmental factors.", {"entities": []}], ["The aim of this work was to study some biochemical markers of the dermatosis.", {"entities": []}], ["This included detection of R576 interleukin-4 receptor alpha allele gene.", {"entities": []}], ["Twenty five patients with AD and 25 controls participated in this study.", {"entities": []}], ["If patients are to participate fully in their care and in the management of a long term condition such as chronic obstructive pulmonary disease, good communication is essential.", {"entities": [[106, 143, "DISEASE"]]}], ["However, not all patients are able to use the written word and we need to be aware of the size of this problem and its implications for the way in which we give information and conduct medical consultations.", {"entities": []}], ["The impact of health literacy on outcomes can be considerable and improvements can be made by being aware of the problem, offering information in several different forms, and by reinforcing the spoken word with pictorial images.", {"entities": []}], ["Depression is a major comorbidity in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[51, 88, "DISEASE"]]}], ["The aim of this prospective study was to investigate socio-demographic and clinical factors and serum markers of inflammation, including cytokines that, may be a cause or an association with COPD-related depression.", {"entities": []}], ["This study enrolled 53 patients who were hospitalized in the Department of Respiratory Medicine of Hefei First People\u2019s Hospital, China between October 2015 and October 2016.", {"entities": []}], ["Patients were consecutively recruited who were diagnosed with COPD and without lower respiratory tract disease, psychiatric disorders, or a family history of cognitive disorders.", {"entities": [[79, 110, "DISEASE"]]}], ["All patients were investigated for symptoms of depression.", {"entities": []}], ["Lung function testing included forced expiratory volume in 1 second (FEV 1 ).", {"entities": [[69, 72, "GENE"]]}], ["Serum levels of C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-8 (IL-8) and tumor necrosis factor-\u03b1 (TNF-\u03b1) were measured.", {"entities": [[36, 39, "GENE"]]}], ["Of the 53 patients with COPD, 40 (75.47%) patients had symptoms of depression.", {"entities": []}], ["Univariate analysis showed that gender, smoking, a high level of education, duration of a cough, FEV 1 , and serum CRP level were associated with depression.", {"entities": [[97, 100, "GENE"], [115, 118, "GENE"]]}], ["A multivariate logistic regression model identified two risk factors for depression in patients with COPD: serum CRP level and FEV 1 .", {"entities": [[113, 116, "GENE"], [127, 130, "GENE"]]}], ["The findings of this study showed that the risk factors for COPD-related depression included male gender, heavy smoking, higher academic qualifications, and duration of cough, but the two strongest risk factors were a high serum CRP level and low FEV 1 .", {"entities": [[229, 232, "GENE"], [247, 250, "GENE"]]}], ["Headache is one of the most common neurological symptom reported in childhood and adolescence, leading to high levels of school absences and being associated with several comorbid conditions, particularly in neurological, psychiatric and cardiovascular systems.", {"entities": []}], ["Neurological and psychiatric disorders, that are associated with migraine, are mainly depression, anxiety disorders, epilepsy and sleep disorders, ADHD and Tourette syndrome.", {"entities": [[65, 73, "DISEASE"], [165, 173, "DISEASE"]]}], ["It also has been shown an association with atopic disease and cardiovascular disease, especially ischemic stroke and patent foramen ovale (PFO).", {"entities": [[117, 137, "DISEASE"]]}], ["Case definition has long been an issue for comparability of results obtained for musculoskeletal pain prevalence, however the test-retest reliability of questions used to determine joint pain prevalence has not been examined.", {"entities": []}], ["The objective of this study was to determine question reliability and the impact of question wording, ordering and the time between questions on responses.", {"entities": []}], ["A Computer Assisted Telephone Interviewing (CATI) survey was used to re-administer questions collected as part of a population-based longitudinal cohort study.", {"entities": []}], ["On two different occasions questions were asked of the same sample of 203 community dwelling respondents (which were initially randomly selected) aged 18\u00a0years and over at two time points 14 to 27\u00a0days apart (average 15\u00a0days).", {"entities": []}], ["Reliability of the questions was assessed using Cohen\u2019s kappa (\u03ba) and intraclass correlation coefficient (ICC) and whether question wording and period effects existed was assessed using a crossover design.", {"entities": []}], ["The self-reported prevalence of doctor diagnosed arthritis demonstrated excellent reliability (\u03ba\u2009=\u20090.84 and \u03ba\u2009=\u20090.79 for questionnaires 1 and 2 respectively).", {"entities": [[49, 58, "DISEASE"]]}], ["The reliability of questions relating to musculoskeletal pain and/or stiffness ranged from moderate to excellent for both types of questions, that is, those related to ever having joint pain on most days for at least a month (\u03ba\u2009=\u20090.52 to \u03ba\u2009=\u20090.95) and having pain and/or stiffness on most days for the last month (\u03ba\u2009=\u20090.52 to \u03ba\u2009=\u20090.90).", {"entities": []}], ["However there was an effect of question wording on the results obtained for hand, foot and back pain and/or stiffness indicating that the area of pain may influence prevalence estimates.", {"entities": []}], ["Joint pain and stiffness questions are reliable and can be used to determine prevalence.", {"entities": []}], ["However, question wording and pain area may impact on estimates with issues such as pain perception and effect on activities playing a possible role in the recall of musculoskeletal pain.", {"entities": []}], ["Ambient air is polluted with a mixture of pulmonary toxicants.", {"entities": []}], ["Previous studies indicate that prior exposure to atmospheric oxidant pollutants such as ozone may significantly alter the response to other pollutants, such as 1-nitronaphthalene (1-NN).", {"entities": []}], ["1-NN, a component of the particulate exhaust from diesel engines, has been found at low concentrations in ambient air.", {"entities": []}], ["Using a metabolomic approach, we investigated inflammatory responses in arachidonic and linoleic acid biochemical cascades (35 metabolites) and the expression of 19 cytokines/chemokines at three time points (2, 6, and 24 hr) following exposure to 1-NN with and without prior long-term O 3 exposure.", {"entities": [[221, 223, "GENE"]]}], ["Long-term O 3 exposure is associated with biochemical changes that have been shown to render the lung resistant to further O 3 exposure.", {"entities": []}], ["This study indicates that airways of O 3 -tolerant rats exhibited a low level of chronic inflammation, rendering the lungs more susceptible to other environmental pollutants such as 1-NN.", {"entities": []}], ["Specifically, a 12.5-mg/kg dose of 1-NN to O 3 -tolerant rats produced significantly higher levels of cysteinyl-leukotrienes in bronchiolar lavage fluid even when compared to a 50-mg/kg dose of 1-NN in rats exposed to filtered air.", {"entities": []}], ["Collectively, these results indicate that the combination of exposures as encountered in polluted ambient air are considerably more injurious to the lung than would be anticipated from previous studies employing single exposures.", {"entities": []}], ["The observed synergism between O 3 and 1-NN may be causally related to a shift in a T-helper 1 to T-helper 2 immune response in the airways.", {"entities": []}], ["Diabetic type 1 patients are often advised to use dose adjustment guidelines to calculate their doses of insulin.", {"entities": []}], ["Conventional methods of measuring patients' adherence are not applicable to these cases, because insulin doses are not determined in advance.", {"entities": []}], ["We propose a method and a number of indicators to measure patients' conformance to these insulin dosing guidelines.", {"entities": []}], ["We used a database of logbooks of type 1 diabetic patients who participated in a summer camp.", {"entities": []}], ["Patients used a guideline to calculate the doses of insulin lispro and glargine four times a day, and registered their injected doses in the database.", {"entities": []}], ["We implemented the guideline in a computer system to calculate recommended doses.", {"entities": []}], ["We then compared injected and recommended doses by using five indicators that we designed for this purpose: absolute agreement (AA): the two doses are the same; relative agreement (RA): there is a slight difference between them; extreme disagreement (ED): the administered and recommended doses are merely opposite; Under-treatment (UT) and over-treatment (OT): the injected dose is not enough or too high, respectively.", {"entities": []}], ["We used weighted linear regression model to study the evolution of these indicators over time.", {"entities": []}], ["We analyzed 1656 insulin doses injected by 28 patients during a three weeks camp.", {"entities": []}], ["Overall indicator rates were AA = 45%, RA = 30%, ED = 2%, UT = 26% and OT = 30%.", {"entities": []}], ["The highest rate of absolute agreement is obtained for insulin glargine (AA = 70%).", {"entities": []}], ["One patient with alarming behavior (AA = 29%, RA = 24% and ED = 8%) was detected.", {"entities": []}], ["The monitoring of these indicators over time revealed a crescendo curve of adherence rate which fitted well in a weighted linear model (slope = 0.85, significance = 0.002).", {"entities": []}], ["This shows an improvement in the quality of therapeutic decision-making of patients during the camp.", {"entities": []}], ["Our method allowed the measurement of patients' adherence to their insulin adjustment guidelines.", {"entities": []}], ["The indicators that we introduced were capable of providing quantitative data on the quality of patients' decision-making for the studied population as a whole, for each individual patient, for all injections, and for each time of injection separately.", {"entities": []}], ["They can be implemented in monitoring systems to detect non-adherent patients.", {"entities": []}], ["Here, we illustrate the complexity of ILC subsets, we discuss novel functions, focusing on emerging ILCs crosstalk with other immune cells and the microbiota.", {"entities": []}], ["Furthermore, we highlight recent insights into the development of ILCs, the common pathways they share as well as points of divergence between ILC groups and subsets.", {"entities": []}], ["Breast cancer is the most commonly diagnosed cancer among the rapidly growing population of Asian Americans; it is also the most common cause of cancer mortality among Filipinas.", {"entities": [[7, 13, "DISEASE"], [45, 51, "DISEASE"], [145, 151, "DISEASE"]]}], ["Asian women continue to have lower rates of mammographic screening than women of most other racial/ethnic groups.", {"entities": []}], ["While prior studies have described the effects of sociodemographic and other characteristics of women on non-adherence to screening guidelines, they have not identified the distinct segments of the population who remain at highest risk of not being screened.", {"entities": []}], ["To better describe characteristics of Asian women associated with not having a mammogram in the last two years, we applied recursive partitioning to population-based data (N = 1521) from the 2001 California Health Interview Survey (CHIS), for seven racial/ethnic groups of interest: Chinese, Japanese, Filipino, Korean, South Asian, Vietnamese, and all Asians combined.", {"entities": []}], ["We identified two major subgroups of Asian women who reported not having a mammogram in the past two years and therefore, did not follow mammography screening recommendations: 1) women who have never had a pap exam to screen for cervical cancer (68% had no mammogram), and 2) women who have had a pap exam, but have no women's health issues (osteoporosis, using menopausal hormone therapies, and/or hysterectomy) nor a usual source of care (62% had no mammogram).", {"entities": [[342, 354, "DISEASE"], [238, 244, "DISEASE"], [229, 244, "DISEASE"]]}], ["Only 19% of Asian women who have had pap screening and have women's health issues did not have a mammogram in the past two years.", {"entities": []}], ["In virtually all ethnic subgroups, having had pap or colorectal screening were the strongest delineators of mammography usage.", {"entities": []}], ["Other characteristics of women least likely to have had a mammogram included: Chinese non-U.S. citizens or citizens without usual source of health care, Filipinas with no health insurance, Koreans without women's health issues and public or no health insurance, South Asians less than age 50 who were unemployed or non-citizens, and Vietnamese women who were never married.", {"entities": []}], ["We identified distinct subgroups of Asian women at highest risk of not adhering to mammography screening guidelines; these data can inform outreach efforts aimed at reducing the disparity in mammography screening among Asian women.", {"entities": []}], ["Tungsten carbide (WC) is a widely used engineering material which is usually prepared at high temperature.", {"entities": []}], ["A new mechanism for synthesizing nanoscaled WC at ultralow temperature has been discovered.", {"entities": []}], ["This discovery opens a novel route to synthesize valuable WC and other carbides at a cost-efficient way.", {"entities": []}], ["The novel formation mechanism is based on an ion-exchange resin as carbon source to locally anchor the W and Fe species.", {"entities": []}], ["As an intermediate, FeWO 4 can be formed at lower temperature, which can be directly converted into WC along with the carbonization of resin.", {"entities": []}], ["The size of WC can be less than 2\u2005nm.", {"entities": []}], ["The catalyst made with Pt nanoparticles supported on nanosized WC-GC (WC-graphitized carbon) shows enhanced electrocatalytic activity for oxygen reduction reaction.", {"entities": []}], ["The result also indicates that the Pt nanoparticles deposited on WC-GC are dominated by Pt (111) plane and shows a mass activity of 257.7\u2005mA mg Pt @0.9\u2005V.", {"entities": []}], ["To measure changes in air quality during surgery.", {"entities": []}], ["Operating room (OR) and hallway air quality was continuously monitored over a 3-month period.", {"entities": []}], ["Rooftop monitoring was used to control for environmental changes and to account for the infiltration of outdoor air pollutants.", {"entities": []}], ["Air quality measurements were correlated with operative times and electro-dissection equipment used.", {"entities": []}], ["OR air is cooler and drier compared to the adjacent hallway.", {"entities": []}], ["Volatile organic compounds and other gases are below indoor air exposure limit guidelines.", {"entities": []}], ["Lasers create greater 2.5\u00a0\u03bcm particulate matter (PM 2.5 ) mass concentration, and greater fine and coarse particle number than cautery or cold tissue dissection.", {"entities": []}], ["Cautery produces more ultrafine particles (UFP) than other dissection techniques.", {"entities": []}], ["OR air has lower particle counts than outdoor environmental air by virtue of air conditioning HEPA filtration.", {"entities": []}], ["Compared to the outside air, operating room air has lower particle counts.", {"entities": []}], ["Lasers produce higher concentrations of PM 2.5 mass and, fine and coarse particle number counts.", {"entities": []}], ["Cautery produces higher concentrations of UFP number counts than other modalities and warrants consideration of the use of masks with ultrafine particle filtration capacity.", {"entities": []}], ["Operating room air is consistently cooler with decreased humidity, which may cause airway irritation.", {"entities": []}], ["Rheumatoid arthritis (RA) is now suspected to be driven by pathogenic Th17 cells that secrete interleukin (IL)-17 and can be regulated by IL-4.", {"entities": [[11, 20, "DISEASE"]]}], ["A single-nucleotide polymorphism (SNP), I50V, in the coding region of the human IL-4 receptor (IL-4R) is associated with rapid development of erosive disease in RA.", {"entities": []}], ["The present study was undertaken to determine whether this SNP renders the IL-4R less able to transduce signals that regulate IL-17 production.", {"entities": []}], ["Peripheral blood mononuclear cells were activated under Th17-stimulating conditions in the presence or absence of IL-4, and IL-17 production was measured by both enzyme-linked immunosorbent assay (ELISA) and flow cytometry.", {"entities": []}], ["Serum IL-17 was also measured by ELISA.", {"entities": []}], ["Paired comparisons were performed using the two-tailed t -test.", {"entities": []}], ["IL-4 receptor gene alleles were determined by polymerase chain reaction.", {"entities": []}], ["In healthy individuals, IL-4 significantly inhibited IL-17 production by cells from subjects with the I/I genotype ( P = 0.0079) and the I/V genotype ( P = 0.013), but not the V/V genotype ( P > 0.05).", {"entities": []}], ["In a cross-sectional sample of patients with established RA, the magnitude of the in vitro effect of IL-4 was lower and was not associated with a specific IL-4R allele.", {"entities": []}], ["Serum IL-17 levels were higher in RA patients than in healthy individuals, as was the percentage of CD4 These results indicate that an inherited polymorphism of the IL-4R controls the ability of the human immune system to regulate the magnitude of IL-17 production.", {"entities": [[100, 103, "GENE"]]}], ["However, in established RA, this pattern may be altered, possibly due to secondary effects of both RA itself as well as immunomodulatory medications.", {"entities": []}], ["Ineffective control of Th17 immune responses is a potential mechanism to explain why IL-4R is an important severity gene in RA, but this issue will require careful study of a cohort of new-onset RA patients.", {"entities": []}], ["Immunocompromised patients are vulnerable to severe or complicated influenza infection.", {"entities": [[67, 76, "DISEASE"]]}], ["Vaccination is widely recommended for this group.", {"entities": []}], ["This systematic review and meta-analysis assesses influenza vaccination for immunocompromised patients in terms of preventing influenza-like illness and laboratory confirmed influenza, serological response and adverse events.", {"entities": [[50, 59, "DISEASE"], [126, 135, "DISEASE"], [174, 183, "DISEASE"]]}], ["Electronic databases and grey literature were searched and records were screened against eligibility criteria.", {"entities": []}], ["Data extraction and risk of bias assessments were performed in duplicate.", {"entities": []}], ["Infection prevention and control strategies should recommend vaccinating immunocompromised patients.", {"entities": []}], ["Potential for bias and confounding and the presence of heterogeneity mean the evidence reviewed is generally weak, although the directions of effects are consistent.", {"entities": []}], ["Areas for further research are identified.", {"entities": []}], ["The intestinal microbiota is essential to the maturation and homeostasis of the immune system.", {"entities": []}], ["Immunoblot assays were used to establish the prevalence of serum IgG, IgM, and IgA antibodies specific for Bifidobacterium adolescentis , Bifidobacterium longum , and Lactobacillus rhamnosus GG proteins in young children presenting with or without type 1 diabetes (T1D).", {"entities": []}], ["We demonstrated that children between the ages of 6 and 12 months had a substantial increase in the frequency of IgG antibodies specific for L. rhamnosus GG proteins.", {"entities": []}], ["We measured IgG, IgM, and IgA class antibody reactivity against B. adolescentis DSM 20083, B. adolescentis DSM 20086, and B. longum DSM 20088 proteins demonstrating significantly higher IgA responses against B. adolescentis DSM 20083 strain proteins in children who developed islet autoimmunity and T1D later in life.", {"entities": []}], ["B. adolescentis strains showed more IgM type antibodies in children who developed T1D later in life, but the difference was not statistically significant.", {"entities": []}], ["B. longum proteins were recognized by IgG and IgA antibodies to a higher extent compared to other bacteria studied.", {"entities": []}], ["These results confirm that differences in immune reactivity against some commensal strains in young children may represent a different risk factor for developing T1D.", {"entities": []}], ["Immunoglobulin G4-related sialadenitis (IgG4-RS) is a newly recognized immune-mediated systemic disease.", {"entities": [[26, 38, "DISEASE"]]}], ["Despite its good response to steroid therapy, its treatment protocol is not standardized and the long-term outcome is controversial.", {"entities": []}], ["The study was conducted to determine the short-term and long-term outcomes of IgG4-RS patients treated with glucocorticoids and steroid-sparing immunosuppressive agents, to analyze secretory function, serological and radiological changes in salivary glands and to assess the usefulness of serum IgG4 level as an indicator of disease activity.", {"entities": []}], ["IgG4-RS patients who were treated for more than 3\u00a0months were enrolled.", {"entities": []}], ["Serological tests, salivary gland function assessment and computed tomography (CT) were performed before treatment and during follow up.", {"entities": []}], ["The treatment outcomes in the short and the long term were evaluated, and the relationship between serum IgG4 level and salivary gland volume was analyzed.", {"entities": []}], ["Glucocorticoids were used in all 43 patients and steroid-sparing immunosuppressive agents in 38 patients (88.4%).", {"entities": []}], ["The follow-up period was 24.6\u2009\u00b1\u200914.9\u00a0months.", {"entities": []}], ["Clinical remission was achieved in all patients after induction therapy.", {"entities": []}], ["During short-term observation, salivary gland secretion significantly increased, and the serum IgG4 levels, the volumes and CT values of submandibular and parotid gland decreased significantly ( P \u2009<\u20090.001).", {"entities": []}], ["For long term, relapse occurred in 32.5% patients within 55\u00a0months in the regularly treated group, while all seven irregularly treated patients relapsed.", {"entities": []}], ["However, the relapse-free survival curves were not significantly different between the steroid monotherapy and the combination therapy groups ( P \u2009=\u20090.566).", {"entities": []}], ["Submandibular glands, lacrimal glands, sublingual glands, nasal and paranasal cavity were commonly relapsing organs.", {"entities": []}], ["In clinically stable patients, a serologically unstable condition occurred in 54.9% patients within 55\u00a0months and medication adjustment was performed accordingly.", {"entities": []}], ["Volume changes in the submandibular and parotid glands were associated with serum IgG4 levels and time of follow up ( R adjusted \u2009=\u20090.905, P \u2009<\u20090.0001 and R adjusted \u2009=\u20090.9334, P \u2009<\u20090.0001, respectively).", {"entities": []}], ["The combination of glucocorticoid and steroid-sparing agents could be effective for treating IgG4-RS, and restoring salivary gland function.", {"entities": []}], ["Serum IgG4 levels could predict disease activity.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-017-1507-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Recent research has shown that the pattern of change over time, or trajectory, of body mass index (BMI) varies among children.", {"entities": []}], ["However, the factors that underlie the heterogeneity in these trajectories remain largely unexplored.", {"entities": []}], ["Our aim was to use a growth mixture model to empirically identify classes of BMI trajectories (from birth to 11.5 years) and examine the effects of breastfeeding, introduction of solids, as well as food and nutrient intake at 18 months on these BMI trajectories.", {"entities": []}], ["We identified three BMI growth trajectories between birth and age 11.5 years, separately in boys and girls.", {"entities": []}], ["Breastfeeding duration less than six months and the early introduction of solids did not adversely influence BMI trajectories in our sample but high intakes of meat, particularly high fat varieties, and high intakes of carbohydrate at age around 18 months were associated with a high BMI trajectory in boys.", {"entities": []}], ["It is not clear whether these dietary factors confer a direct risk of higher BMI in childhood or are markers for other dietary patterns that are present early and/or develop through childhood and contribute to higher BMI.", {"entities": []}], ["Many randomised trials have count outcomes, such as the number of falls or the number of asthma exacerbations.", {"entities": [[89, 95, "DISEASE"]]}], ["These outcomes have been treated as counts, continuous outcomes or dichotomised and analysed using a variety of analytical methods.", {"entities": []}], ["This study examines whether different methods of analysis yield estimates of intervention effect that are similar enough to be reasonably pooled in a meta-analysis.", {"entities": []}], ["Data were simulated for 10,000 randomised trials under three different amounts of overdispersion, four different event rates and two effect sizes.", {"entities": []}], ["Each simulated trial was analysed using nine different methods of analysis: rate ratio, Poisson regression, negative binomial regression, risk ratio from dichotomised data, survival to the first event, two methods of adjusting for multiple survival times, ratio of means and ratio of medians.", {"entities": []}], ["Individual patient data was gathered from eight fall prevention trials, and similar analyses were undertaken.", {"entities": []}], ["All methods produced similar effect sizes when there was no difference between treatments.", {"entities": []}], ["Results were similar when there was a moderate difference with two exceptions when the event became more common: (1) risk ratios computed from dichotomised count outcomes and hazard ratios from survival analysis of the time to the first event yielded intervention effects that differed from rate ratios estimated from the negative binomial model (reference model) and (2) the precision of the estimates differed depending on the method used, which may affect both the pooled intervention effect and the observed heterogeneity.", {"entities": []}], ["The results of the case study of individual data from eight trials evaluating exercise programmes to prevent falls in older people supported the simulation study findings.", {"entities": []}], ["Information about the differences in treatments is lost when event rates increase and the outcome is dichotomised or time to the first event is analysed otherwise similar results are obtained.", {"entities": []}], ["Further research is needed to examine the effect of differing variances from the different methods on the confidence intervals of pooled estimates.", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-015-0144-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Pseudomonas aeruginosa ( Pa ) is the leading cause of chronic lung infection in Cystic Fibrosis (CF) patients.", {"entities": []}], ["It is well recognized that CF epithelial cells fail to develop an appropriate response to infection, allowing bacterial colonization and a chronic inflammatory response.", {"entities": []}], ["Since long non-coding RNAs (lncRNAs), are known to play a key role in regulating mammalian innate immune response, we hypothesized that CF cells exposed to Pa could express a specific lncRNA signature responsible of the maladaptative CF response.", {"entities": []}], ["We analyzed transcriptomic datasets to compare the expression profiles of lncRNAs in primary CF and non-CF epithelial cells infected with Pa at 0, 2, 4, and 6 h of infection.", {"entities": []}], ["Our analysis identified temporal expression signatures of 25, 73, 15, and 26 lncRNA transcripts differentially expressed at 0, 2, 4, and 6 h post-infection respectively, between CF and non-CF cells.", {"entities": []}], ["In addition, we identified profiles specific to CF and non-CF cells.", {"entities": []}], ["The differential expression of two candidate lncRNAs were independently validated using real-time PCR.", {"entities": []}], ["We identified a specific CF signature of lncRNA expression in a context of Pa infection that could potentially play a role in the maladaptive immune response of CF patients.", {"entities": []}], ["The lung responds to a variety of insults in a remarkably consistent fashion but with inconsistent outcomes that vary from complete resolution and return to normal to the destruction of normal architecture and progressive fibrosis.", {"entities": []}], ["Increasing evidence indicates that diffuse lung disease results from an imbalance between the pro-inflammatory and anti-inflammatory mechanisms, with a persistent imbalance that favors pro-inflammatory mediators dictating the development of chronic diffuse lung disease.", {"entities": [[43, 55, "DISEASE"], [257, 269, "DISEASE"]]}], ["This review focuses on the mediators that influence this imbalance.", {"entities": []}], ["The purpose of this study was to investigate the nationwide prevalence of childhood asthma, eczema and other allergic diseases in Korean school-age children (8-11 yr old) and to assess the difference between residential areas.", {"entities": [[84, 90, "DISEASE"]]}], ["Among 6,279 elementary schools, 427 schools were randomly selected according to residential area (metropolitan, provincial, rural, and industrial area) by the cluster sampling method.", {"entities": []}], ["Parents of students completed a modified Korean version of a questionnaire formulated by the International Study of Asthma and Allergies in Childhood (ISAAC).", {"entities": [[116, 122, "DISEASE"]]}], ["Among 50,200 subjects, 31,026 (61.8%) responded, and 30,893 (99.6%) were analyzed.", {"entities": []}], ["The 12-month prevalence of wheeze, flexural rash, and allergic rhinitis symptoms were 4.8%, 15.3%, and 32.9%, respectively.", {"entities": [[54, 71, "DISEASE"], [63, 71, "DISEASE"]]}], ["The prevalence of diagnosis of allergic diseases in boys was higher than that in girls, with the exception of eczema.", {"entities": []}], ["In both boys and girls, the difference of the prevalence of allergic diseases among industrial, metropolitan and provincial areas was not statistically significant, but the differences between rural area and other areas were significant.", {"entities": []}], ["Our results support the importance of contextual effect associated with residential area as causative agents of allergic diseases among Korean school-age children.", {"entities": []}], ["Genetic variation in C-type lectins influences infectious disease susceptibility but remains poorly understood.", {"entities": []}], ["We employed allelic mRNA expression imbalance (AEI) technology for SP-A1, SP-A2, SP-D, DC-SIGN, MRC1, and Dectin-1, expressed in human macrophages and/or lung tissues.", {"entities": [[96, 100, "GENE"]]}], ["Frequent AEI, an indicator of regulatory polymorphisms, was observed in SP-A2, SP-D , and DC-SIGN .", {"entities": []}], ["AEI was measured for SP-A2 in 38 lung tissues using four marker SNPs and was confirmed by next generation sequencing of one lung RNA sample.", {"entities": []}], ["Genomic DNA at the SP-A2 DNA locus was sequenced by Ion Torrent technology in 16 samples.", {"entities": []}], ["Correlation analysis of genotypes with AEI identified a haplotype block, and, specifically, the intronic SNP rs1650232 (30% MAF); the only variant consistently associated with an approximately two-fold change in mRNA allelic expression.", {"entities": [[124, 127, "GENE"]]}], ["Previously shown to alter a NAGNAG splice acceptor site with likely effects on SP-A2 expression, rs1650232 generates an alternative splice variant with three additional bases at the start of exon 3.", {"entities": []}], ["Validated as a regulatory variant, rs1650232 is in partial LD with known SP-A2 marker SNPs previously associated with risk for respiratory diseases including tuberculosis.", {"entities": [[158, 170, "DISEASE"]]}], ["Applying functional DNA variants in clinical association studies, rather than marker SNPs, will advance our understanding of genetic susceptibility to infectious diseases.", {"entities": []}], ["Undernutrition during critical periods of growth and development may permanently affect lung physiology and function.", {"entities": []}], ["To investigate whether acute undernutrition in childhood or young adulthood increases the risk of later hospitalization for obstructive airways disease, chronic obstructive pulmonary disease (COPD), or asthma.", {"entities": [[153, 190, "DISEASE"], [202, 208, "DISEASE"]]}], ["We studied 7,841 women from Prospect-EPIC who experienced the 1944\u201345 Dutch famine between ages 0 and 21.", {"entities": []}], ["Pulmonary outcomes were measured by registered hospital admissions and exposure-blinded computed tomography (CT) in a subgroup of 295 women.", {"entities": []}], ["With Cox proportional hazard regression we explored effects of famine exposure on risk of hospitalization for obstructive airways disease, COPD, and asthma.", {"entities": [[149, 155, "DISEASE"]]}], ["With logistic regression we explored effects of famine on risk of CT evidence of pulmonary disease.", {"entities": []}], ["Risks of hospitalization for obstructive airways disease, COPD, and asthma were increased after moderate famine exposure, and significantly increased after severe famine exposure: hazard ratios for obstructive airways disease were 1.31 (95% CI: 0.97 to 1.77) and 1.57 (95% CI: 1.10 to 2.23) respectively.", {"entities": [[68, 74, "DISEASE"]]}], ["Associations between famine exposure and hospitalization for COPD were stronger in ever-smokers than in never-smokers.", {"entities": []}], ["Acute undernutrition in childhood or young adulthood is associated with an increased risk of later COPD and asthma hospitalization, possibly through increased sensitivity for tobacco smoke.", {"entities": [[108, 114, "DISEASE"]]}], ["To build a fuzzy computational model to estimate the number of hospitalizations of children aged up to 10 years due to respiratory conditions based on pollutants and climatic factors in the city of S\u00e3o Jos\u00e9 do Rio Preto, Brazil.", {"entities": []}], ["A computational model was constructed using the fuzzy logic.", {"entities": []}], ["The model has 4 inputs, each with 2 membership functions generating 16 rules, and the output with 5 pertinence functions, based on the Mamdani\u2019s method, to estimate the association between the pollutants and the number of hospitalizations.", {"entities": []}], ["Data from hospitalizations, from 2011-2013, were obtained in DATASUS - and the pollutants Particulate Matter (PM 10 ) and Nitrogen Dioxide (NO 2 ), wind speed and temperature were obtained by the Environmental Company of S\u00e3o Paulo State (Cetesb).", {"entities": []}], ["A total of 1,161 children were hospitalized in the period and the mean of pollutants was 36 and 51 \u00b5g/m 10 and NO 2 , respectively.", {"entities": []}], ["The best values of the Pearson correlation (0.34) and accuracy measured by the Receiver Operating Characteristic (ROC) curve (NO 2 - 96.7% and PM 10 - 90.4%) were for hospitalizations on the same day of exposure.", {"entities": []}], ["The model was effective in predicting the number of hospitalizations of children and could be used as a tool in the hospital management of the studied region.", {"entities": []}], ["Depression is a major cause of disability in working populations and the reduction of socioeconomic inequalities in disability is an important public health challenge.", {"entities": []}], ["We examined work disability due to depression with four indicators of socioeconomic status.", {"entities": []}], ["A prospective cohort study of 125 355 Finnish public sector employees was linked to national register data on work disability (>9 days) due to depressive disorders (International Classification of Diseases, codes F32\u2013F34) from January 2005 to December 2011.", {"entities": []}], ["Primary outcomes were the onset of work disability due to depressive disorders and, among those with such disability, return to work after and recurrent episodes of work disability due to depression.", {"entities": []}], ["We found a consistent inverse socioeconomic gradient in work disability due to depression.", {"entities": []}], ["Lower occupational position, lower educational level, smaller residence size, and rented (vs. owner-occupied) residence were all associated with an increased risk of work disability.", {"entities": []}], ["Return to work was slower for employees with basic education (cumulative odds ratio\u200a=\u200a1.21, 95% CI: 1.05\u20131.39) compared to those with higher education.", {"entities": []}], ["Recurrent work disability episodes due to depression were less common among upper-grade non-manual workers (the highest occupational group) than among lower-grade non-manual (hazard ratio\u200a=\u200a1.16, 95% CI: 1.07\u20131.25) and manual (hazard ratio\u200a=\u200a1.14, 95% CI: 1.02\u20131.26) workers.", {"entities": []}], ["These data from Finnish public sector employees show persistent socioeconomic inequalities in work disability due to depression from 2005 to 2011 in terms of onset, recovery and recurrence.", {"entities": []}], ["Atopic Dermatitis is a chronic relapsing eczematous skin disease with increasing prevalence and rising costs.", {"entities": [[52, 64, "DISEASE"]]}], ["It has a clear impact on a patient's quality of life.", {"entities": []}], ["Many patients are worried about the use of usual care techniques, such as corticosteroids and antihistamine due to the widespread fear of adverse effects.", {"entities": []}], ["Complementary and alternative medical approaches have been employed to relieve symptoms of Atopic Dermatitis.", {"entities": []}], ["Hwangryunhaedoktang is among the most strongly preferred and widely used herbal medicines for Atopic Dermatitis in Korea, as it causes very few serious adverse effects.", {"entities": []}], ["We aim to establish basic clinical efficacy and safety data for Hwangryunhaedoktang, which is approved as an herbal medication by the Korean Food and Drug Administration, in adult patients with Atopic Dermatitis.", {"entities": []}], ["This study is a randomised, double blind, placebo-controlled, two-centre trial with two parallel arms (Hwangryunhaedoktang and a placebo).", {"entities": []}], ["The diagnosis of Atopic Dermatitis will be made according to the criteria of Hanifin and Rajka by two different Oriental medicine doctors.", {"entities": []}], ["We will include participants experiencing typical conditions of intermittent or continuous Atopic Eczema for six or more months.", {"entities": []}], ["Participants will receive Hwangryunhaedoktang or a placebo-drug for eight weeks.", {"entities": []}], ["The total duration of each arm is eleven weeks.", {"entities": []}], ["Each participant will be examined for signs and symptoms of Atopic Dermatitis before and after taking medication.", {"entities": []}], ["A follow-up to evaluate the maintenance of safety will be performed two weeks after the final administration of medication.", {"entities": []}], ["This trial will utilize high quality trial methodologies in accordance with consolidated standards of reporting trials guidelines.", {"entities": []}], ["It will provide evidence for the clinical efficacy and safety evaluation of Hwangryunhaedoktang in adult patients with Atopic Dermatitis.", {"entities": []}], ["Moreover, we will also employ health-related quality of life questionnaires to assess the changes in quality of life.", {"entities": []}], ["Current Controlled Trials ISRCTN26218532", {"entities": []}], ["The Korean national health security system covers the entire population and all medical facilities.", {"entities": []}], ["We aimed to estimate epilepsy prevalence, anticonvulsant utilization pattern and the cost.", {"entities": []}], ["We identified prevalent epilepsy patients by the prescription of anticonvulsants under the diagnostic codes suggesting seizure or epilepsy from 2007 Korean National Health Insurance databases.", {"entities": []}], ["The information of demography, residential area, the kind of medical security service reflecting economic status, anticonvulsants, and the costs was extracted.", {"entities": []}], ["The overall prevalence of treated epilepsy patients was 2.41/1,000, and higher for men than women.", {"entities": []}], ["The age-specific prevalence was the lowest in those in their thirties and forties.", {"entities": []}], ["Epilepsy was more prevalent among lower-income individuals receiving medical aid.", {"entities": []}], ["The regional prevalence was the highest in Jeju Island and lowest in Ulsan city.", {"entities": []}], ["New anticonvulsants were more frequently used than old anticonvulsants in the younger age group.", {"entities": []}], ["The total annual cost of epilepsy or seizure reached 0.46% of total medical expenditure and 0.27% of total expenditure on health.", {"entities": []}], ["This is the first nationwide epidemiological report issued on epilepsy in Korea.", {"entities": []}], ["Epilepsy prevalence in Korea is comparable to those in developed countries.", {"entities": []}], ["Economic status and geography affect the prevalence of epilepsy.", {"entities": []}], ["Eosinophilic esophagitis (EoE) is a chronic inflammatory condition characterized by symptoms of esophageal dysfunction and eosinophilic infiltration of the esophageal mucosa.", {"entities": [[13, 24, "DISEASE"]]}], ["The diagnosis requires esophageal biopsies demonstrating at least 15 eosinophils per high-powered field following a course of high-dose proton pump inhibitors.", {"entities": []}], ["Management of EoE consists of the three Ds: drugs, dietary therapy, and esophageal dilation.", {"entities": []}], ["In this review, we discuss the epidemiology, pathogenesis, diagnosis, and treatment of EoE to include the role of emerging therapies.", {"entities": []}], ["To identify the risk factors and source of infection leading to human infections with the Influenza A(H7N9) virus in urban and rural areas.", {"entities": []}], ["We conducted a case-control investigation to identify potential exposures and risk factors.", {"entities": []}], ["Controls were randomly selected from the same community as the cases using random digit dialing.", {"entities": []}], ["We used exact conditional logistic regression to evaluate the exposures and risk factors, stratified by urban and rural residence.", {"entities": []}], ["Buying live or freshly slaughtered poultry from a market was significantly associated with illness onset among both urban [48% of 25 case-patients and 12% of 125 control-persons, adjusted odds ratio (AOR)\u200a=\u200a19, 95% CI: 2.3\u2013929] and rural (33% of 18 case-patients and 8.9% of 90 control-persons, AOR\u200a=\u200a13, 95% CI:1.5\u2013\u221e) residents.", {"entities": []}], ["In rural area, tending to home-raised poultry (56% of 18 case-patients and 10% of 90 control-persons, AOR\u200a=\u200a57, 95% CI: 7.5\u2013\u221e) and existence of a poultry farm in the vicinity of the residence (28% of 18 case-patients and 5.6% of 90 control-persons, AOR\u200a=\u200a37, 95% CI: 3.8\u2013\u221e) were also significantly associated with disease onset.", {"entities": []}], ["Presence of underlying medical conditions was a significant risk factor for urban residents (76% of 25 case-patients and 13% of 125 control-persons, AOR\u200a=\u200a49, 95% CI: 7.1\u20132132).", {"entities": []}], ["Buying live or freshly slaughtered poultry from a market is a risk factor for both urban and rural residents, tending to home-raised poultry and existence of a poultry farm in the vicinity of the residence are risk factors unique for rural residents.", {"entities": []}], ["The virus might have been in stealth circulation in the poultry population before infecting humans.", {"entities": []}], ["We recommend strict poultry market management and multisectoral collaboration to identify the extent of poultry infection in China.", {"entities": []}], ["There is increasing evidence that environmental factors such as air pollution from mine dumps, increase the risk of chronic respiratory symptoms and diseases.", {"entities": []}], ["The aim of this study was to investigate the association between proximity to mine dumps and prevalence of chronic respiratory disease in people aged 55\u00a0years and older.", {"entities": []}], ["Elderly persons in communities 1-2\u00a0km (exposed) and 5\u00a0km (unexposed), from five pre-selected mine dumps in Gauteng and North West Province, in South Africa were included in a cross-sectional study.", {"entities": []}], ["Structured interviews were conducted with 2397 elderly people, using a previously validated ATS-DLD-78 questionnaire from the British Medical Research Council.", {"entities": []}], ["Exposed elderly persons had a significantly higher prevalence of chronic respiratory symptoms and diseases than those who were unexposed., Results from the multiple logistic regression analysis indicated that living close to mine dumps was significantly associated with asthma (OR\u2009=\u20091.57; 95% CI: 1.20 \u2013 2.05), chronic bronchitis (OR\u2009=\u20091.74; 95 CI: 1.25 \u2013 2.39), chronic cough (OR\u2009=\u20092.02; 95% CI: 1.58 \u2013 2.57), emphysema (OR\u2009=\u20091.75; 95% CI: 1.11 \u2013 2.77), pneumonia (OR\u2009=\u20091.38; 95% CI: 1.07 \u2013 1.77) and wheeze (OR\u2009=\u20092.01; 95% CI: 1.73 \u2013 2.54).", {"entities": [[455, 464, "DISEASE"], [270, 276, "DISEASE"], [319, 329, "DISEASE"]]}], ["Residing in exposed communities, current smoking, ex-smoking, use of paraffin as main residential cooking/heating fuel and low level of education emerged as independent significant risk factors for chronic respiratory symptoms and diseases.", {"entities": []}], ["This study suggests that there is a high level of chronic respiratory symptoms and diseases among elderly people in communities located near to mine dumps in South Africa.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-015-0018-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chitosan oligosaccharide (COS) is widely consumed as a functional food due to its multiple health effects, but few studies about COS supplement on placental antioxidant and nutrition transport capacity were reported.", {"entities": []}], ["Taken pregnant sow as a model, we aimed to investigate the effects of dietary COS supplementation during late gestation on placental amino acids transport and antioxidant defense capacity of sows.", {"entities": []}], ["From day (d) 85 of gestation to parturition, sixteen pregnant sows were divided into a control group (basal diet without COS supplementation) and a COS group (30\u00a0mg COS/kg basal diet).", {"entities": []}], ["Plasma sample of sow was collected on d 110 of gestation, and placenta tissue was obtained during parturition.", {"entities": []}], ["Then plasma antioxidant enzyme\u2019s activities, the relative level of oxidant stress related genes, amino acids transport related genes and mTOR pathway molecules in placenta were determined.", {"entities": [[137, 141, "GENE"]]}], ["Results showed that maternal dietary supplementation with COS increased ( P \u2009<\u20090.05) plasma total SOD, caused a downtrend in plasma MDA (0.05\u2009<\u2009 P \u2009<\u20090.10) on d 110 of gestation.", {"entities": []}], ["Interestingly, the mRNA expression of some antioxidant genes in the placenta were increased ( P \u2009<\u20090.05) and pro-inflammatory cytokines were reduced ( P \u2009<\u20090.05) by COS supplement, whereas no significant difference was observed in the activities of placental total SOD and CAT between two groups.", {"entities": []}], ["Additionally, further study demonstrated that COS feeding stimulated mTOR signaling pathway, increased amino acids transporters expression in placenta.", {"entities": [[69, 73, "GENE"]]}], ["These observations suggested that COS supplement in sow\u2019s diet during late gestation enhanced antioxidant defense capacity of sows, promoted placental amino acids transport, which may contribute to the health of sows and development of fetus during gestation.", {"entities": []}], ["Background : Observational studies from the USA have suggested that patients with low health literacy (HL) have higher health care costs and use an inefficient mix of health care services.", {"entities": []}], ["To date, there were no studies from Europe that investigated the impact of HL on the use of the health system.", {"entities": []}], ["The purpose of this study was to measure functional HL among persons having type 2 diabetes and to investigate the relationship between functional HL and health care costs and utilization.", {"entities": []}], ["Methods : The study population were insured persons of the basic health insurance plan of the largest health insurer in Switzerland.", {"entities": []}], ["Persons selected for participation had been reimbursed for diabetes medications in 2010\u201311, were aged 35\u201370 years and did not live in a long-term care institution.", {"entities": []}], ["The level of functional HL was measured by one screening question.", {"entities": []}], ["The following dependent variables were used: total costs, outpatient costs, inpatient costs, days admitted and number of physician visits attended.", {"entities": []}], ["All multiple regression analyses were adjusted for age, gender, education, duration of diabetes, treatment with insulin (yes/no) and other chronic disease (yes/no).", {"entities": []}], ["Results : High levels of functional HL were associated with lower total costs ( P = 0.007), lower outpatient costs ( P = 0.004) and less physician visits ( P = 0.001).", {"entities": []}], ["In the standard insurance plan with free access to all health professionals subgroup, the effects found were more pronounced.", {"entities": []}], ["Conclusions : Persons with low functional HL need extra medical support, and therefore have higher health care costs.", {"entities": []}], ["The purpose of the study was to address the association between hemorrhoid and the subsequent risk of coronary heart disease (CHD) development.", {"entities": [[111, 124, "DISEASE"], [102, 124, "DISEASE"], [64, 74, "DISEASE"]]}], ["This retrospective cohort study used reimbursement claims data from the Longitudinal Health Insurance Database 2000 in Taiwan.", {"entities": []}], ["Thirty-three thousand thirty-four patients with hemorrhoids and 132,136 age-, gender-, and index year matched controls between 2000 and 2010 were identified.", {"entities": []}], ["Cox model was performed to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) of CHD development for the hemorrhoid cohort compared with the nonhemorrhoid cohort.", {"entities": [[122, 132, "DISEASE"]]}], ["During a follow-up period of 12 years, the overall incidence rate of CHD was 9.91 per 1000 person-years in the hemorrhoid patients and was 1.36-fold higher than in the nonhemorrhoid cohort (7.28 per 1000 person-years) with an adjusted hazard ratio (aHR) of 1.27 (95% CI\u200a=\u200a1.21\u20131.34).", {"entities": [[111, 121, "DISEASE"], [249, 252, "GENE"]]}], ["Moreover, compared with the nonhemorrhoid patients without these comorbidities, among patients with hemorrhoids, those with any 2 comorbidities were at a significantly increased risk of CHD (HR\u200a=\u200a7.12, 95% CI\u200a=\u200a6.61\u20137.67; P \u200a<\u200a.001), followed by those with any 1 comorbidity (HR\u200a=\u200a3.23, 95% CI\u200a=\u200a2.94\u20133.54; P \u200a<\u200a.001).", {"entities": [[191, 193, "GENE"], [276, 278, "GENE"], [191, 193, "GENE"], [276, 278, "GENE"]]}], ["We found that hemorrhoid patients had a 1.27-fold higher risk of CHD compared with those without hemorrhoids after adjusting for the potential confounding factors.", {"entities": [[14, 24, "DISEASE"]]}], ["There is an emerging paradigm that the human microbiome is central to many aspects of health and may have a role in preventing enteric infection.", {"entities": []}], ["Entamoeba histolytica is a major cause of amebic diarrhea in developing countries.", {"entities": [[49, 57, "DISEASE"]]}], ["It colonizes the colon lumen in close proximity to the gut microbiota.", {"entities": []}], ["Interestingly, not all individuals are equally susceptible to\u00a0 E.\u00a0histolytica \u00a0infection.", {"entities": []}], ["Therefore, as the microbiota is highly variable within individuals, we sought to determine if a component of the microbiota could regulate susceptibility to\u00a0infection.", {"entities": []}], ["In studies utilizing a murine model, we demonstrated that colonization of the gut with the commensal Clostridia -related bacteria known as segmented filamentous bacteria (SFB) is protective during\u00a0 E.\u00a0histolytica infection.", {"entities": []}], ["SFB colonization in this model was associated with elevated cecal levels of interleukin 17A (IL-17A), dendritic cells, and neutrophils.", {"entities": []}], ["Bone marrow-derived dendritic cells (BMDCs) from SFB-colonized mice had higher levels of IL-23 production in response to stimulation with trophozoites.", {"entities": []}], ["Adoptive transfer of BMDCs from an SFB E.\u00a0histolytica .", {"entities": []}], ["IL-17A induction during BMDC transfer was necessary for this protection.", {"entities": []}], ["This work demonstrates that intestinal colonization with a specific commensal bacterium can provide protection during amebiasis in a murine model.", {"entities": [[118, 127, "DISEASE"]]}], ["Most importantly, this work demonstrates that the microbiome can mediate protection against an enteric infection via extraintestinal effects on bone marrow-derived dendritic cells.", {"entities": []}], ["Entamoeba histolytica is the causative agent of amebiasis, an infectious disease that contributes significantly to morbidity and mortality due to diarrhea in the developing world.", {"entities": [[48, 57, "DISEASE"], [146, 154, "DISEASE"]]}], ["We showed in a murine model that colonization with the commensal members of the Clostridia known as SFB provides protection against E.\u00a0histolytica and that dendritic cells from SFB-colonized mice alone can recapitulate protection.", {"entities": []}], ["Understanding interactions between enteropathogens, commensal intestinal bacteria, and the mucosal immune response, including dendritic cells, will help in the development of effective treatments for this disease and other infectious and inflammatory diseases.", {"entities": []}], ["The demonstration of immune-mediated protection due to communication from the microbiome to the bone marrow represents an emerging field of study that will yield unique approaches to the development of these treatments.", {"entities": []}], ["Interleukin 33 (IL-33) represents a potential link between the airway epithelium and induction of Th2-type inflammatory responses associated with the development of asthma.", {"entities": [[165, 171, "DISEASE"]]}], ["This study investigated the potential of IL-33 to exacerbate antigen driven asthma responses.", {"entities": [[76, 82, "DISEASE"]]}], ["An ovalbumin (OVA) asthma model was used in which sensitized C57BL/6 mice were exposed to IL-33 before each OVA challenge.", {"entities": [[19, 25, "DISEASE"]]}], ["IL-33 given to sensitized mice acted synergistically with antigen and aggravated airway inflammation, hyperresponsiveness and remodeling compared with mice that were only OVA sensitized and challenged and mice that were only exposed to IL-33.", {"entities": []}], ["Elevated levels of local and systemic mast cell protease mMCP-1, as well as antigen-specific IgE production, were observed following IL-33 administration to sensitized mice.", {"entities": []}], ["Similarly, exposing OVA-sensitized mice to IL-33 increased the Th2 cytokine levels, including IL-4, IL-5 and IL-13.", {"entities": []}], ["Furthermore, IL-33 and OVA administration to OVA-sensitized mice increased ILC2s in the lung, suggesting a role for ILC2s in IL-33-mediated exacerbation of OVA-induced airway responses.", {"entities": []}], ["Collectively, these findings show that IL-33 aggravates important features of antigen-driven asthma, which may have implications for asthma exacerbations.", {"entities": [[93, 99, "DISEASE"], [133, 139, "DISEASE"]]}], ["The label \u2018Translational Research\u2019 (TR) has become ever more popular in the biomedical domain in recent years.", {"entities": []}], ["It is usually presented as an attempt to bridge a supposed gap between knowledge produced at the lab bench and its use at the clinical bedside.", {"entities": []}], ["This is claimed to help society harvest the benefits of its investments in scientific research.", {"entities": []}], ["The rhetorical as well as moral force of the label TR obscure, however, that it is actually used in very different ways.", {"entities": []}], ["In this paper, we analyse the scientific discourse on TR, with the aim to disentangle and critically evaluate the different meanings of the label.", {"entities": []}], ["We start with a brief reconstruction of the history of the concept.", {"entities": []}], ["Subsequently, we unravel how the label is actually used in a sample of scientific publications on TR and examine the presuppositions implied by different views of TR.", {"entities": []}], ["We argue that it is useful to distinguish different views of TR on the basis of three dimensions, related to (1) the construction of the \u2018translational gap\u2019; (2) the model of the translational process; and (3) the cause of the perceived translational gap.", {"entities": []}], ["We conclude that the motive to make society benefit from its investments in biomedical science may be laudable, but that it is doubtful whether the dominant views of TR will contribute to this end.", {"entities": []}], ["Effect of indoor air pollution (IAP) on birth weight remains largely unexplored but yet purported as the most important environmental exposure for pregnant women in developing countries due to the effects of second-hand smoke.", {"entities": []}], ["We investigated the associations between the determinants of indoor air quality in households and birth weight.", {"entities": []}], ["A cross-sectional study of 592 mothers and their newborns using postnatal services at the Korle Bu Teaching Hospital located in Accra, Ghana was conducted in 2010 to collect information on characteristics of indoor environment and other potential determinants of fetal growth.", {"entities": []}], ["Birth weight was recorded from hospital records.", {"entities": []}], ["Household cooking fuel choices and garbage burning practices were determinants of birth weight.", {"entities": []}], ["Multivariate linear regression analysis adjusting for age, social class, marital status and gravidity of mothers, and sex of neonate resulted in a 243g (95% CI: 496, 11) and 178g (95% CI: 421, 65) reduction in birth weight for use of charcoal, and garbage burning respectively compared with use of LPG only.", {"entities": []}], ["The estimated reductions in birth weight was not statistically significant.", {"entities": []}], ["Applying the ordinal scale exposure parameter nonetheless revealed a significant exposure-response relationship between maternal exposures from charcoal use and garbage burning, and birth weight.", {"entities": []}], ["Generalized linear models adjusting for confounders resulted in a 41% (risk ratio [RR] = 1.41; 95% CI: 0.62, 3.23) and 195% (RR=2.95; 95% CI: 1.10, 7.92) increase in the risk of low birth weight (LBW) for use of charcoal, and garbage burning respectively compared with use of LPG only.", {"entities": []}], ["A combination of charcoal use and household garbage burning during pregnancy on fetal growth resulted in a 429g (95% CI: 259, 599) reduction in birth weight and 316% (RR=4.16; 95% CI: 2.02, 8.59) excess risk of LBW.", {"entities": []}], ["Sensitivity analysis performed by restricting the analysis to term births produced similar results.", {"entities": []}], ["Maternal use of charcoal as a cooking fuel during pregnancy and burning of garbage at home are strong determinants of average fetal growth and risk of LBW.", {"entities": []}], ["Efforts to reduce maternal exposures to IAP are thus important to improve birth outcomes.", {"entities": []}], ["Epigenetic modulation of gene activity occurs in response to non-genetic factors such as body weight status, physical activity, dietary factors, and environmental toxins.", {"entities": []}], ["In addition, each of these factors is thought to affect and be affected by the gut microbiome.", {"entities": []}], ["A primary mechanism that links these various factors together in mediating control of gene expression is the production of metabolites that serve as critical cofactors and allosteric regulators of epigenetic processes.", {"entities": []}], ["Here, we review the involvement of the gut microbiota and its interactions with dietary factors, many of which have known cellular bioactivity, focusing on particular epigenetic processes affected and the influence they have on human health and disease, particularly cancer and response to treatment.", {"entities": [[267, 273, "DISEASE"]]}], ["Advances in DNA sequencing have expanded the capacity for studying the microbiome.", {"entities": []}], ["Combining this with rapidly improving techniques to measure the metabolome provides opportunities to understand complex relationships that may underlie the development and progression of cancer as well as treatment-related sequelae.", {"entities": [[187, 193, "DISEASE"]]}], ["Given broad reaching and fundamental biology, both at the cellular and organismal levels, we propose that interactive research programs, which utilize a wide range of mutually informative experimental model systems\u2014each one optimally suited for answering particular questions\u2014provide the best path forward for breaking ground on new knowledge and ultimately understanding the epigenetic significance of the gut microbiome and its response to dietary factors in cancer prevention and therapy.", {"entities": [[461, 467, "DISEASE"]]}], ["After 40 years of deriving metric values for health status or health-related quality of life, the effective quantification of subjective health outcomes is still a challenge.", {"entities": []}], ["Here, two of the best measurement tools, the discrete choice and the Rasch model, are combined to create a new model for deriving health values.", {"entities": []}], ["First, existing techniques to value health states are briefly discussed followed by a reflection on the recent revival of interest in patients\u2019 experience with regard to their possible role in health measurement.", {"entities": []}], ["Subsequently, three basic principles for valid health measurement are reviewed, namely unidimensionality, interval level, and invariance.", {"entities": []}], ["In the main section, the basic operation of measurement is then discussed in the framework of probabilistic discrete choice analysis (random utility model) and the psychometric Rasch model.", {"entities": []}], ["It is then shown how combining the main features of these two models yields an integrated measurement model, called the multi-attribute preference response (MAPR) model, which is introduced here.", {"entities": []}], ["This new model transforms subjective individual rank data into a metric scale using responses from patients who have experienced certain health states.", {"entities": []}], ["Its measurement mechanism largely prevents biases such as adaptation and coping.", {"entities": []}], ["Several extensions of the MAPR model are presented.", {"entities": []}], ["The MAPR model can be applied to a wide range of research problems.", {"entities": []}], ["If extended with the self-selection of relevant health domains for the individual patient, this model will be more valid than existing valuation techniques.", {"entities": []}], ["Natural medicine is a system of therapy that administrates natural agents and their derivatives to treat human diseases.", {"entities": []}], ["This medicine has been used to treat many kinds of human diseases for thousands of years.", {"entities": []}], ["The treatment protocols of natural medicine are integrative in nature, and are required to utilize the most appropriate therapies to address the needs of the individual patient.", {"entities": []}], ["Because of the relative convenience, safety and efficacy, natural medicine is now increasing worldwide.", {"entities": []}], ["Naturopathic doctors are licensed in many areas of the world and regulated partly by law in these areas, which is quite different from various other forms of complementary and alternative medicine.", {"entities": []}], ["Liver diseases, such as hepatitis, liver cirrhosis and liver carcinoma, are serious health problems worldwide.", {"entities": [[61, 70, "DISEASE"], [35, 50, "DISEASE"], [24, 33, "DISEASE"], [55, 70, "DISEASE"]]}], ["Nearly half of the natural agents used in treatment of liver diseases today are natural products and their derivatives.", {"entities": []}], ["Although natural medicine is beneficial and safe, physicians should pay close attention to the potential side-effects of the naturopathic agents, which lead to liver injury, interstitial pneumonia and acute respiratory failure.", {"entities": [[207, 226, "DISEASE"], [187, 196, "DISEASE"]]}], ["Therefore, when administrating naturopathic protocols to patients for the treatment of liver diseases, we should try our best to prevent and avoid as much as possible the negative impact of these medicines.", {"entities": []}], ["This article highlights the current practice and recommended improvement of natural medicines in the treatment of liver diseases and gives some specific examples to emphasize the prevention and management of adverse reactions of the natural agents and suggests that natural medicine should be cautiously used to treat liver problems.", {"entities": []}], ["Few studies have measured the effect of short-term exposure to industrial emissions on the respiratory health of children.", {"entities": []}], ["Here we estimate the risk of hospitalization for asthma and bronchiolitis in young children associated with their recent exposure to emissions from an aluminum smelter.", {"entities": [[49, 55, "DISEASE"], [60, 73, "DISEASE"]]}], ["We used a case\u2013crossover design to assess the risk of hospitalization, February 1999\u2013December 2008, in relation to short-term variation in levels of exposure among children 0\u20134 years old living less than 7.5\u2009km from the smelter.", {"entities": []}], ["The percentage of hours per day that the residence of a hospitalized child was in the shadow of winds crossing the smelter was used to estimate the effect of wind-borne emissions on case and crossover days.", {"entities": []}], ["Community-wide pollutant exposure was estimated through daily mean and daily maximum SO 2 and PM 2.5 concentrations measured at a fixed monitoring site near the smelter.", {"entities": []}], ["Odds ratios (OR) were estimated using conditional logistic regressions.", {"entities": []}], ["The risk of same-day hospitalization for asthma or bronchiolitis increased with the percentage of hours in a day that a child's residence was downwind of the smelter.", {"entities": [[41, 47, "DISEASE"], [51, 64, "DISEASE"]]}], ["For children aged 2\u20134 years, the OR was 1.27 (95% CI=1.03\u20131.56; n =103 hospitalizations), for an interquartile range (IQR) of 21% of hours being downwind.", {"entities": []}], ["In this age group, the OR with PM 2.5 daily mean levels was slightly smaller than with the hours downwind (OR: 1.22 for an IQR of 15.7\u2009 \u03bc g/m n =94 hospitalizations).", {"entities": []}], ["Trends were observed between hospitalizations and levels of SO 2 for children 2\u20134 years old.", {"entities": []}], ["Increasing short-term exposure to emissions from a Quebec aluminum smelter was associated with an increased risk of hospitalization for asthma and bronchiolitis in young children who live nearby.", {"entities": [[136, 142, "DISEASE"], [147, 160, "DISEASE"]]}], ["Estimating exposure through records of wind direction allows for the integration of exposure to all pollutants carried from the smelter stack.", {"entities": []}], ["In recent years there has been an increasing interest in overprotective parenting and the potential role it plays in child development.", {"entities": []}], ["While some have argued that a trend towards increased parental fear and reduced opportunity for independent mobility may be linked to increasing rates of child overweight and obesity, there is limited empirical information available to support this claim.", {"entities": [[175, 182, "DISEASE"]]}], ["Using data from the Longitudinal Study of Australian Children , this study aimed to examine the longitudinal relationships between maternal protectiveness and child overweight and obesity.", {"entities": [[180, 187, "DISEASE"]]}], ["A cohort of 4\u20135 year old children was followed up at 6\u20137, 8\u20139 and 10\u201311 years of age (n \u200a=\u200a 2596).", {"entities": []}], ["Measures included a protective parenting scale administered when children were 6\u20137 and 8\u20139 years of age, child body mass index (BMI), family characteristics including household income, neighbourhood disadvantage, child's position amongst siblings, and maternal BMI, education, employment, mental health and age at first birth.", {"entities": []}], ["International Obesity Taskforce age- and sex-specific BMI cut points were used to determine if children were in the normal, overweight or obese BMI range.", {"entities": [[14, 21, "DISEASE"]]}], ["There was no association between maternal protectiveness and the odds of children being overweight or obese at age 4\u20135, 6\u20137 or 8\u20139 years.", {"entities": []}], ["However at age 10\u201311 years, a 1 standard deviation increase in maternal protectiveness was associated with a 13% increase in the odds of children being overweight or obese.", {"entities": []}], ["The results provide evidence of a relationship between maternal protectiveness and child overweight and obesity, however further research is required to understand the mechanism(s) that links the two concepts.", {"entities": [[104, 111, "DISEASE"]]}], ["In the last decade unconventional oil and gas (UOG) extraction has rapidly proliferated throughout the United States (US) and the world.", {"entities": []}], ["This occurred largely because of the development of directional drilling and hydraulic fracturing which allows access to fossil fuels from geologic formations that were previously not cost effective to pursue.", {"entities": []}], ["This process is known to use greater than 1,000 chemicals such as solvents, surfactants, detergents, and biocides.", {"entities": []}], ["In addition, a complex mixture of chemicals, including heavy metals, naturally-occurring radioactive chemicals, and organic compounds are released from the formations and can enter air and water.", {"entities": []}], ["Compounds associated with UOG activity have been linked to adverse reproductive and developmental outcomes in humans and laboratory animal models, which is possibly due to the presence of endocrine active chemicals.", {"entities": []}], ["Using systematic methods, electronic searches of PubMed and Web of Science were conducted to identify studies that measured chemicals in air near sites of UOG activity.", {"entities": []}], ["Records were screened by title and abstract, relevant articles then underwent full text review, and data were extracted from the studies.", {"entities": []}], ["A list of chemicals detected near UOG sites was generated.", {"entities": []}], ["Then, the potential endocrine activity of the most frequently detected chemicals was explored via searches of literature from PubMed.", {"entities": []}], ["Evaluation of 48 studies that sampled air near sites of UOG activity identified 106 chemicals detected in two or more studies.", {"entities": []}], ["Ethane, benzene and n-pentane were the top three most frequently detected.", {"entities": []}], ["Twenty-one chemicals have been shown to have endocrine activity including estrogenic and androgenic activity and the ability to alter steroidogenesis.", {"entities": []}], ["Literature also suggested that some of the air pollutants may affect reproduction, development, and neurophysiological function, all endpoints which can be modulated by hormones.", {"entities": []}], ["These chemicals included aromatics (i.e., benzene, toluene, ethylbenzene, and xylene), several polycyclic aromatic hydrocarbons, and mercury.", {"entities": []}], ["These results provide a basis for prioritizing future primary studies regarding the endocrine disrupting properties of UOG air pollutants, including exposure research in wildlife and humans.", {"entities": []}], ["Further, we recommend systematic reviews of the health impacts of exposure to specific chemicals, and comprehensive environmental sampling of a broader array of chemicals.", {"entities": []}], ["The online version of this article (10.1186/s12940-018-0368-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chitosan is prepared by the deacetylation of chitin, the second-most abundant biopolymer in nature, and has applicability in the removal of dyes, heavy metals and radioactive waste for pollution control.", {"entities": []}], ["In weight-reduction remedies, chitosan is used to form hydrogels with lipids and to depress the intestinal absorption of lipids.", {"entities": []}], ["In this study, an experimental method was implemented to simulate the effect of chitosan on the adsorption of humic acid in the gastrointestinal tract.", {"entities": []}], ["The adsorption capacity of chitosan was measured by its adsorption isotherm and analyzed using the Langmuir equation.", {"entities": []}], ["The results showed that 3.3 grams of humic acid was absorbed by 1 gram of chitosan.", {"entities": []}], ["The adsorption capacity of chitosan was much greater than that of chitin, diethylaminoethyl-cellulose or activated charcoal.", {"entities": []}], ["Cellulose and carboxymethyl-cellulose, a cellulose derivative with a negative charge, could not adsorb humic acid in the gastrointestinal tract.", {"entities": []}], ["This result suggests that chitosan entraps humic acid because of its positive charge.", {"entities": []}], ["Bladder cancer frequently shows mutational activation of the oncogene Ras, which is associated with bladder carcinogenesis.", {"entities": [[8, 14, "DISEASE"]]}], ["However, the signaling pathway downstream of Ras remains to be fully elucidated.", {"entities": []}], ["N -butyl- N -(4-hydroxybutyl) nitrosamine (BBN) is able to induce bladder cancer by driving the clonal expansion of initiated cells carrying the activated form of Ras.", {"entities": [[74, 80, "DISEASE"]]}], ["Phospholipase C\u03b5 (PLC\u03b5) is the main target of BBN, while the tumor promoting role of PLC\u03b5 remains controversial.", {"entities": []}], ["The present study examined the role of PLC\u03b5 in BBN-induced bladder carcinogenesis of mice with genetically inactivated PLC\u03b5.", {"entities": []}], ["Using light and electron microscopy, the present study demonstrated that PLC\u03b5", {"entities": []}], ["Transforming growth factor (TGF)-\u03b2 and interleukin (IL)-13 play a crucial role in the pathogenesis of systemic sclerosis (SSc), partly through activation of collagen production that leads to fibrosis.", {"entities": []}], ["The aim of the present study was to determine whether TFG-\u03b2 alters IL-13 production in T lymphocytes from patients with SSc from that seen in those of healthy donors.", {"entities": []}], ["IL-13 mRNA and protein synthesis under TFG-\u03b2 exposure was measured in circulating T lymphocytes from healthy donors and patients with SSc and also in the Jurkat Th2 T-cell line, using quantitative real-time PCR and fluorescence-activated cell sorting analysis, respectively.", {"entities": []}], ["The involvement of Smad and GATA-3 transcription factors was assessed by using specific inhibitors and small interfering RNA, and the binding capacity of GATA-3 to the IL-13 gene promoter was evaluated by chromatin immunoprecipitation assay.", {"entities": []}], ["TGF-\u03b2 induced a significant decrease in IL-13 mRNA and protein levels in lymphocytes from healthy donors (mean [\u00b1SD] inhibition of 30\u00a0%\u2009\u00b1\u200910\u00a0% and 20\u00a0%\u2009\u00b1\u20097\u00a0%, respectively; p \u2009<\u20090.05).", {"entities": []}], ["In contrast, TGF-\u03b2 promoted a significant increase in IL-13 mRNA levels and IL-13 synthesis by CD4 These results demonstrate that TGF-\u03b2 upregulates IL-13 synthesis through GATA-3 expression in the T lymphocytes of patients with SSc, confirming that the GATA-3 transcription factor can be regarded as a novel therapeutic target in patients with SSc.", {"entities": [[95, 98, "GENE"]]}], ["Pleiotrophin (PTN) is a secreted cytokine that is expressed in various cancer cell lines and human tumor such as colon cancer, lung cancer, gastric cancer and melanoma.", {"entities": [[127, 138, "DISEASE"], [113, 125, "DISEASE"], [159, 167, "DISEASE"], [71, 77, "DISEASE"], [119, 125, "DISEASE"], [132, 138, "DISEASE"], [148, 154, "DISEASE"], [14, 17, "GENE"]]}], ["It plays significant roles in angiogenesis, metastasis, differentiation and cell growth.", {"entities": []}], ["The expression of PTN in the adult is limited to the hippocampus in an activity-dependent manner, making it a very attractive target for cancer therapy.", {"entities": [[137, 143, "DISEASE"], [18, 21, "GENE"]]}], ["RNA interference (RNAi) offers great potential as a new powerful therapeutic strategy based on its highly specific and efficient silencing of a target gene.", {"entities": []}], ["However, efficient delivery of small interfering RNA (siRNA) in vivo remains a significant hurdle for its successful therapeutic application.", {"entities": []}], ["In this study, we first identified, on a cell-based experiment, applying a 1:1 mixture of two PTN specific siRNA engenders a higher silencing efficiency on both mRNA and protein level than using any of them discretely at the same dose.", {"entities": [[94, 97, "GENE"]]}], ["As a consequence, slower melanoma cells growth was also observed for using two specific siRNA combinatorially.", {"entities": [[25, 33, "DISEASE"]]}], ["To establish a robust way for siRNA delivery in vivo and further investigate how silence of PTN affects tumor growth, we tested three different methods to deliver siRNA in vivo : first non-targeted in-vivo delivery of siRNA via jetPEI; second lung targeted delivery of siRNA via microbubble coated jetPEI; third tumor cell targeted delivery of siRNA via transferrin-polyethylenimine (Tf-PEI).", {"entities": [[92, 95, "GENE"]]}], ["As a result, we found that all three in-vivo siRNAs delivery methods led to an evident inhibition of melanoma growth in non-immune deficiency C57BL/6 mice without a measureable change of ALT and AST activities.", {"entities": [[101, 109, "DISEASE"]]}], ["Both targeted delivery methods showed more significant curative effect than jetPEI.", {"entities": []}], ["The lung targeted delivery by microbubble coated jetPEI revealed a comparable therapeutic effect with Tf-PEI, indicating its potential application for target delivery of siRNA in vivo .", {"entities": []}], ["Mycoplasma pneumoniae (MP) infection is the dominant cause of pneumonia in children.", {"entities": [[62, 71, "DISEASE"]]}], ["We sought to determine the relationship between MP infection and secondary allergic disease and to clarify the associated mechanisms of inflammatory response.", {"entities": []}], ["A prospective study was performed among 1330 patients diagnosed with pneumonia to investigate the patient immune status by determining the correlation between MP infection, immunoglobulin E (IgE) levels, and a spectrum of associated serum cytokines.", {"entities": [[69, 78, "DISEASE"]]}], ["Serum IgE, IL-4, IL-6, and IL-10 levels for MPP patients in the acute phase were obviously higher than those in the recovery phase ( P < 0.01).", {"entities": []}], ["MPP patients with allergic conditions had increased serum IgE levels and increased IL-4/INF- \u03b3 ratio, and IgE and Eosinophil Cationic Protein were further elevated in patients who eventually developed secondary asthma changes.", {"entities": [[211, 217, "DISEASE"]]}], ["Patients with severe pneumonia and high clinical pulmonary infection scores presented higher levels of IL-4 and IL-5 in serum than those with low scores ( P < 0.01).", {"entities": [[21, 30, "DISEASE"]]}], ["The proportion of CD4+ and CD8+ T cells that secreted IL-4 was significantly increased in MPP patients with elevated IgE.", {"entities": []}], ["Our data demonstrate a significant correlation between MP infection and IgE levels, which is associated with a Th1/Th2 cytokine imbalance.", {"entities": []}], ["Mast cells play a critical role in the innate immune response to bacterial infection.", {"entities": []}], ["They internalize and kill a variety of bacteria and process antigen for presentation to T cells via MHC molecules.", {"entities": []}], ["Although mast cell phagocytosis appears to play a significant role during bacterial infection, little is known about the proteins involved in its regulation.", {"entities": []}], ["In this study, we demonstrate that the SNARE protein SNAP29 is involved in mast cell phagocytosis.", {"entities": []}], ["SNAP29 is localized in the endocytic pathway and is transiently recruited to Escherichia coli ( E. coli) -containing phagosomes.", {"entities": []}], ["Interestingly, overexpression of SNAP29 significantly increases the internalization and killing of E. coli , while it does not affect mast cell exocytosis of inflammatory mediators.", {"entities": []}], ["To our knowledge, these data are the first to demonstrate a novel function of SNAP29 in mast cell phagocytosis and have implications in protection against bacterial infection.", {"entities": []}], ["Studies have shown that a significant proportion of people with epilepsy use complementary and alternative medicine (CAM).", {"entities": []}], ["CAM use is known to vary between different ethnic groups and cultural contexts; however, little attention has been devoted to inter-ethnic differences within the UK population.", {"entities": []}], ["We studied the use of biomedicine, complementary and alternative medicine, and ethnomedicine in a sample of people with epilepsy of South Asian origin living in the north of England.", {"entities": []}], ["Interviews were conducted with 30 people of South Asian origin and 16 carers drawn from a sampling frame of patients over 18 years old with epilepsy, compiled from epilepsy registers and hospital databases.", {"entities": []}], ["All interviews were tape-recorded, translated if required and transcribed.", {"entities": []}], ["A framework approach was adopted to analyse the data.", {"entities": []}], ["All those interviewed were taking conventional anti-epileptic drugs.", {"entities": []}], ["Most had also sought help from traditional South Asian practitioners, but only two people had tried conventional CAM.", {"entities": []}], ["Decisions to consult a traditional healer were taken by families rather than by individuals with epilepsy.", {"entities": []}], ["Those who made the decision to consult a traditional healer were usually older family members and their motivations and perceptions of safety and efficacy often differed from those of the recipients of the treatment.", {"entities": []}], ["No-one had discussed the use of traditional therapies with their doctor.", {"entities": []}], ["The patterns observed in the UK mirrored those reported among people with epilepsy in India and Pakistan.", {"entities": []}], ["The health care-seeking behaviour of study participants, although mainly confined within the ethnomedicine sector, shared much in common with that of people who use global CAM.", {"entities": []}], ["The appeal of traditional therapies lay in their religious and moral legitimacy within the South Asian community, especially to the older generation who were disproportionately influential in the determination of treatment choices.", {"entities": []}], ["As a second generation made up of people of Pakistani origin born in the UK reach the age when they are the influential decision makers in their families, resort to traditional therapies may decline.", {"entities": []}], ["People had long experience of navigating plural systems of health care and avoided potential conflict by maintaining strict separation between different sectors.", {"entities": []}], ["Health care practitioners need to approach these issues with sensitivity and to regard traditional healers as potential allies, rather than competitors or quacks.", {"entities": []}], ["The histamine H3 receptor (H3R) has been recognized as a promising target for the treatment of various central and peripheral nervous system diseases.", {"entities": []}], ["In this study, a non-imidazole compound, ZEL-H16, was identified as a novel histamine H3 receptor agonist.", {"entities": []}], ["ZEL-H16 was found to bind to human H3R with a Ki value of approximately 2.07 nM and 4.36 nM to rat H3R.", {"entities": []}], ["Further characterization indicated that ZEL-H16 behaved as a partial agonist on the inhibition of forskolin-stimulated cAMP accumulation (the efficacy was 60% of that of histamine) and activation of ERK1/2 signaling (the efficacy was 50% of that of histamine) at H3 receptors, but acted as a full agonist just like histamin in the guinea-pig ileum contraction assay.", {"entities": []}], ["These effects were blocked by pertussis toxin and H3 receptor specific antagonist thioperamide.", {"entities": [[30, 39, "DISEASE"]]}], ["ZEL-H16 showed no agonist or antagonist activities at the cloned human histamine H1, H2, and H4 receptors and other biogenic amine GPCRs in the CRE-driven reporter assay.", {"entities": []}], ["Furthermore, our present data demonstrated that treatment of ZEL-H16 resulted in intensive H3 receptor internalization and delayed recycling to the cell surface as compared to that of control with treatment of histamine.", {"entities": []}], ["Thus, ZEL-H16 is a novel and potent nonimidazole agonist of H3R, which might serve as a pharmacological tool for future investigations or as possible therapeutic agent of H3R.", {"entities": []}], ["Recent investigations suggest that histone deacetylase 1 ( HDAC1 ) and HDAC2 may be target molecules to predict therapeutic responses to corticosteroids.", {"entities": [[59, 64, "GENE"], [71, 76, "GENE"]]}], ["We evaluated the effects of variation in HDAC1 and HDAC2 on the response to corticosteroids in asthmatics.", {"entities": [[41, 46, "GENE"], [51, 56, "GENE"]]}], ["Two single nucleotide polymorphisms (SNPs) were selected after resequencing HDAC1 and HDAC2 .", {"entities": [[76, 81, "GENE"], [86, 91, "GENE"]]}], ["For the first analysis, we evaluated the association between those SNPs and asthma severity in 477 asthmatics.", {"entities": [[76, 82, "DISEASE"]]}], ["For the second analysis, we evaluated the effects of these SNPs on lung function improvements in response to corticosteroid treatment in 35 independent adult asthmatics and 70 childhood asthmatics.", {"entities": []}], ["We found that one SNP in HDAC1 (rs1741981) was significantly related to asthma severity in a recessive model (corrected p = 0.036).", {"entities": [[72, 78, "DISEASE"], [25, 30, "GENE"]]}], ["Adult asthmatics who were homozygous for the minor allele of rs1741981 showed significantly lower % forced expiratory volume in 1 second (%FEV 1 ) increases in response to systemic corticosteroids treatment compared with the heterozygotes or those homozygous for the major allele (12.7% \u00b1 7.2% vs. 37.4% \u00b1 33.7%, p = 0.018).", {"entities": [[139, 142, "GENE"]]}], ["Similarly, childhood asthmatics who were homozygous for the minor allele of rs1741981 showed significantly lower %FEV 1 increases in response to inhaled corticosteroid treatment compared with the heterozygotes or those homozygous for the major allele (14.1% \u00b1 5.9% vs. 19.4% \u00b1 8.9%, p = 0.035).", {"entities": [[114, 117, "GENE"]]}], ["The present study demonstrated that rs1741981 in HDAC1 was significantly associated with the response to corticosteroid treatment in asthmatics.", {"entities": [[49, 54, "GENE"]]}], ["In eukaryotes, exposure to hypertonic conditions activates a MAPK (Hog1 in Saccharomyces cerevisiae and ortholog p38 in human cells).", {"entities": []}], ["In yeast, intracellular glycerol accumulates to counterbalance the high external osmolarity.", {"entities": []}], ["To prevent glycerol efflux, Hog1 action impedes the function of the aquaglyceroporin Fps1, in part, by displacing channel co-activators (Rgc1/2).", {"entities": []}], ["However, Fps1 closes upon hyperosmotic shock even in hog1 \u2206 cells, indicating another mechanism to prevent Fps1-mediated glycerol efflux.", {"entities": []}], ["In our prior proteome-wide screen, Fps1 was identified as a target of TORC2-dependent protein kinase Ypk1 ( DOI: http://dx.doi.org/10.7554/eLife.09336.001", {"entities": []}], ["Arthralgia is a common toxicity among women taking aromatase inhibitors (AIs) and can lead to premature discontinuation of therapy.", {"entities": []}], ["We evaluated the association between arthralgia, co-morbid fatigue and/or insomnia, and inflammatory biomarkers among women taking AIs.", {"entities": []}], ["Women taking AIs for early-stage breast cancer completed a modified version of the Brief Pain Inventory, the Brief Fatigue Inventory, and the Insomnia Severity Index and provided blood samples for simultaneous assessment of 34 inflammatory biomarkers with a Luminex kit.", {"entities": [[33, 46, "DISEASE"], [40, 46, "DISEASE"]]}], ["Two-sided t tests were used to compare inflammatory biomarker concentrations for patients with or without moderate to severe arthralgia.", {"entities": []}], ["Multivariate linear regression analyses were performed to evaluate the relationship between comorbid arthralgia, fatigue, and insomnia with identified biomarker concentrations.", {"entities": []}], ["Among 203 participants, the severity of arthralgia, fatigue, and insomnia were significantly correlated with each other ( p \u2009<\u20090.001 for all comparisons).", {"entities": []}], ["After controlling for race, chemotherapy history, non-steroidal anti-inflammatory drug use, age, and body mass index, the coexistence of arthralgia, fatigue, and insomnia was associated with elevated C-reactive protein (CRP) (\u03b2\u2009=\u200993.1; 95\u00a0% confidence interval (CI): 25.1\u2013161.1; p \u2009=\u20090.008), eotaxin (\u03b2\u2009=\u200979.9; 95\u00a0% CI: 32.5\u2013127.2; p \u2009=\u20090.001), monocyte chemoattractant protein (MCP)-1 (\u03b2\u2009=\u2009151.2; 95\u00a0% CI: 32.7\u2013269.8; p \u2009=\u20090.013), and vitamin D\u2013binding protein (VDBP) (\u03b2\u2009=\u200919,422; 95\u00a0% CI: 5500.5\u201333,344; p \u2009=\u20090.006).", {"entities": [[220, 223, "GENE"]]}], ["Among women taking AIs, the coexistence of arthralgia, fatigue, and insomnia was associated with increased levels of inflammatory biomarkers (elevated CRP, eotaxin, MCP-1, and VDBP).", {"entities": [[151, 154, "GENE"]]}], ["These findings suggest a possible shared inflammatory mechanism underlying these common symptoms.", {"entities": []}], ["The online version of this article (doi:10.1186/s13058-015-0599-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background: Using multipollutant models to understand combined health effects of exposure to multiple pollutants is becoming more common.", {"entities": []}], ["However, complex relationships between pollutants and differing degrees of exposure error across pollutants can make health effect estimates from multipollutant models difficult to interpret.", {"entities": []}], ["Objectives: We aimed to quantify relationships between multiple pollutants and their associated exposure errors across metrics of exposure and to use empirical values to evaluate potential attenuation of coefficients in epidemiologic models.", {"entities": []}], ["Methods: We used three daily exposure metrics (central-site measurements, air quality model estimates, and population exposure model estimates) for 193 ZIP codes in the Atlanta, Georgia, metropolitan area from 1999 through 2002 for PM 2.5 and its components (EC and SO 4 ), as well as O 3 , CO, and NO x , to construct three types of exposure error: \u03b4 spatial (comparing air quality model estimates to central-site measurements), \u03b4 population (comparing population exposure model estimates to air quality model estimates), and \u03b4 total (comparing population exposure model estimates to central-site measurements).", {"entities": []}], ["We compared exposure metrics and exposure errors within and across pollutants and derived attenuation factors (ratio of observed to true coefficient for pollutant of interest) for single- and bipollutant model coefficients.", {"entities": []}], ["Results: Pollutant concentrations and their exposure errors were moderately to highly correlated (typically, > 0.5), especially for CO, NO x , and EC (i.e., \u201clocal\u201d pollutants); correlations differed across exposure metrics and types of exposure error.", {"entities": []}], ["Spatial variability was evident, with variance of exposure error for local pollutants ranging from 0.25 to 0.83 for \u03b4 spatial and \u03b4 total .", {"entities": []}], ["The attenuation of model coefficients in single- and bipollutant epidemiologic models relative to the true value differed across types of exposure error, pollutants, and space.", {"entities": []}], ["Conclusions: Under a classical exposure-error framework, attenuation may be substantial for local pollutants as a result of \u03b4 spatial and \u03b4 total with true coefficients reduced by a factor typically < 0.6 (results varied for \u03b4 population and regional pollutants).", {"entities": []}], ["Citation: Dionisio KL, Baxter LK, Chang HH.", {"entities": [[19, 21, "GENE"]]}], ["An empirical assessment of exposure measurement error and effect attenuation in bipollutant epidemiologic models.", {"entities": []}], ["Environ Health Perspect 122:1216\u20131224;\u2002 http://dx.doi.org/10.1289/ehp.1307772", {"entities": []}], ["Significant racial and ethnic health care disparities experienced by Hispanic children with special health care needs (CSHCN) create barriers to enacting culturally competent rehabilitation services.", {"entities": []}], ["One way to minimize the impact of disparities in rehabilitation is to equip practitioners with culturally relevant functional assessments to accurately determine service needs.", {"entities": []}], ["Current approaches to culturally adapting assessments have three major limitations: use of inconsistent translation processes; current processes assess for some, but not all, elements of cultural equivalence; and limited evidence to guide decision making about whether to undertake cultural adaptation with and without language translation.", {"entities": []}], ["The aims of this observational study are (a) to examine similarities and differences of culturally adapting a pediatric functional assessment with and without language translation, and (b) to examine the feasibility of cultural adaptation processes.", {"entities": []}], ["The Young Children\u2019s Participation and Environment Measure (YC-PEM), a pediatric functional assessment, underwent cultural adaptation (i.e., language translation and cognitive testing) to establish Spanish and English pilot versions for use by caregivers of young CSHCN of Mexican descent.", {"entities": []}], ["Following language translation to develop a Spanish YC-PEM pilot version, 7 caregivers (4 Spanish-speaking; 3 English-speaking) completed cognitive testing to inform decisions regarding content revisions to English and Spanish YC-PEM versions.", {"entities": []}], ["Participant responses were content coded to established cultural equivalencies.", {"entities": []}], ["Coded data were summed to draw comparisons on the number of revisions needed to achieve cultural equivalence between the two versions.", {"entities": []}], ["Feasibility was assessed according to process data and data quality.", {"entities": []}], ["Results suggest more revisions are required to achieve cultural equivalence for the translated (Spanish) version of the YC-PEM.", {"entities": []}], ["However, issues around how the participation outcome is conceptualized were identified in both versions.", {"entities": []}], ["Feasibility results indicate that language translation processes require high resource investment, but may increase translation quality.", {"entities": []}], ["However, use of questionnaires versus interview methods for cognitive testing may have limited data saturation.", {"entities": []}], ["Results lend preliminary support to the need for and feasibility of cultural adaptation with and without language translation.", {"entities": []}], ["Results inform decisions surrounding cultural adaptations with and without language translation and thereby enhance cultural competence and quality assessment of healthcare need within pediatric rehabilitation.", {"entities": []}], ["Objective\u2002 We sought to estimate age\u2010specific hospitalization rates attributed to influenza and other virus for adults.", {"entities": [[82, 91, "DISEASE"]]}], ["Methods\u2002 Admissions from Canada\u2019s national hospitalization database (Canadian Institute of Health Information), from 1994/95 to 1999/2000, were modeled as a function of proxy variables for influenza, respiratory syncytial virus (RSV) and other viral activity, seasonality and trend using a Poisson regression model and stratified by age group.", {"entities": [[189, 198, "DISEASE"]]}], ["Results\u2002 The average annual influenza\u2010attributed hospitalization rate for all adults, 20\u2003years of age or older, over the study period, which included three severe seasons, was an estimated 65/100\u2003000 population (95% CI 63\u201367).", {"entities": [[28, 37, "DISEASE"]]}], ["Among persons aged 65 and over, 270\u2013340 admissions per 100\u2003000 population per year were attributed to influenza, while 30\u2013110, 60\u201390 and 130\u2013350 per 100\u2003000 were attributed to RSV, parainfluenza (PIV) and other respiratory viruses, respectively.", {"entities": [[102, 111, "DISEASE"]]}], ["Although marked season\u2010to\u2010season variation in age\u2010specific hospitalization rates attributable to influenza was observed in persons 50\u2003years of age and older, increasing risk with age was preserved at all time periods.", {"entities": [[97, 106, "DISEASE"]]}], ["Conclusions\u2002 Influenza, RSV, PIV and other respiratory viruses were all associated with morbidity requiring hospitalization, while influenza was responsible for peak respiratory admissions.", {"entities": [[13, 22, "DISEASE"], [131, 140, "DISEASE"]]}], ["The burden of health care utilization associated with respiratory viruses is appreciable beginning in the sixth decade and increases significantly with age.", {"entities": []}], ["Understanding the differences in characteristics, gender, and common causes for admission in hospitalized elderly diabetic patients provides a theoretical basis for their successful management.", {"entities": []}], ["This study explored the reasons and gender differences in hospitalizations of elderly patients with diabetes mellitus.", {"entities": [[100, 117, "DISEASE"]]}], ["Patients aged \u226560\u00a0years who had received a diagnosis of diabetes by the time of discharge, from 1 January 2011 to 1 January 2014, were retrospectively enrolled.", {"entities": []}], ["Hospitalization data of the patients were collected, and reasons for hospitalization were analyzed based on chief complaints and principle diagnosis.", {"entities": []}], ["The most frequent reasons stated for admission were related to the chronic complications of diabetes (42.1\u00a0%), seconded by hyperglycemia (26.4\u00a0%) and infection (15.7\u00a0%).", {"entities": [[123, 136, "DISEASE"]]}], ["Ketonuria, ketonemia, or diabetic ketoacidosis was more commonly seen in women than men, whereas diabetic nephropathy and neoplasms were more frequently found in men than women.", {"entities": [[25, 46, "DISEASE"]]}], ["Regarding infection as a cause of hospitalization, the 4 main types were respiratory tract (44.5\u00a0%), urinary tract (20.3\u00a0%), gastrointestinal (14.8\u00a0%), and skin and soft tissue (10.9\u00a0%).", {"entities": []}], ["Respiratory tract infection was significantly more common in men (61.4\u00a0%) than women (31\u00a0%, P \u2009=\u20090.001), whereas urinary tract infection was more frequent in women (29.6\u00a0%) than men (8.8\u00a0%, P \u2009=\u20090.004).", {"entities": []}], ["The most frequent reasons for hospital admission in elderly diabetic patients were chronic complications of diabetes, hyperglycemia, and infection.", {"entities": [[118, 131, "DISEASE"]]}], ["Men and women differed in reasons for hospital admission.", {"entities": []}], ["Gui-Zhi-Shao-Yao-Zhi-Mu (GSZ) decoction is a Traditional Chinese Medicine (TCM) formula commonly used for the treatment of Rheumatoid Arthritis (RA).", {"entities": [[123, 143, "DISEASE"], [134, 143, "DISEASE"]]}], ["The therapeutic effect of GSZ for RA treatment is supported by our clinical retrospective study.", {"entities": []}], ["To uncover the potential mechanism underlying GSZ formula, we identified 1,327 targets of 673 compounds from 9 herbs that involve in Fc epsilon RI signaling pathway and regulation of immunoglobulin production.", {"entities": []}], ["Comparison between formula targets with 79 RA drug targets and 675 RA disease genes showed that formula targets covered 31.6% RA drug targets and 19.9% RA disease genes.", {"entities": []}], ["Formula specific targets presented expression patterns highly similar to the disease genes and drug targets based on the expression profiles of RA samples.", {"entities": []}], ["Investigation of 10 inferred gene clusters from expression profiles with a target association network revealed that formula specific targets directly or indirectly interacted with disease genes that were essential for immune related biological processes (e.g.", {"entities": []}], ["inflammatory responses, treatment response of rheumatoid arthritis, etc.).", {"entities": [[46, 66, "DISEASE"], [57, 66, "DISEASE"]]}], ["Our result indicated that GSZ disrupted the RA disease dysfunction modules and restored homeostasis in the human body.", {"entities": []}], ["The systemic approach to infer therapeutic mechanisms of GSZ for RA treatment provides a new insight in the understanding of this TCM formula.", {"entities": []}], ["Bisphenol A (BPA) is an environmental compounds is known to possess endocrine disruption potentials.", {"entities": []}], ["Bisphenol A has epigenetic effects as deregulated expression of microRNAs; such epigenetic marks can induce up/down alterations in gene expression that may persist throughout a lifetime.", {"entities": []}], ["Bisphenol A (BPA) exposure has been documented in pregnant women, but consequences for development of offspring after BPA exposure during pregnancy are not yet widely studied.", {"entities": []}], ["Therefore, the aim of this study was to gain a comprehensive understanding of microRNAs changes in the placenta transcriptome from pregnant women subjected to therapeutic abortion for fetal malformation and correlate the impact of gestational exposure to BPA on these developmental changes.", {"entities": []}], ["We performed a comparative analysis of genome wide miRNA expression in placentas from pregnant women exposed to BPA using microarray technology to identify miRNAs which were aberrantly expressed in placentas from malformed fetuses.", {"entities": []}], ["The expression changes of differential expressed miRNAs in the samples used for microarray were confirmed by qPCR .", {"entities": []}], ["Beside, we applied various bioinformatics tools to predict the target genes of the identified miR-146a and explore their biological function and downstream pathways.", {"entities": [[94, 102, "GENE"]]}], ["We found that miR-146a was significant overexpressed and correlated significantly with BPA accumulation in the placenta from pregnant women living in a polluted area and undergoing therapeutic abortion due to fetal malformations.", {"entities": [[14, 22, "GENE"]]}], ["Beside, we applied various bioinformatics tools to predict the target genes of miR-146a and explore their biological function and downstream pathways.", {"entities": [[79, 87, "GENE"]]}], ["For the first time, we found, in humans, that miR-146a was significant over-expressed and correlated significantly with BPA accumulation in the placenta.", {"entities": [[46, 54, "GENE"]]}], ["Our results lead to the suggestion that miRNAs could be potential biomarkers to clarify the mechanisms of environmental diseases.", {"entities": []}], ["Calibrated fMRI based on arterial spin-labeling (ASL) and blood oxygen-dependent contrast (BOLD), combined with periods of hypercapnia and hyperoxia, can provide information on cerebrovascular reactivity (CVR), resting blood flow (CBF), oxygen extraction fraction (OEF), and resting oxidative metabolism (CMRO 2 ).", {"entities": [[49, 52, "GENE"]]}], ["Vascular and metabolic integrity are believed to be affected in Alzheimer's disease (AD), thus, the use of calibrated fMRI in AD may help understand the disease and monitor therapeutic responses in future clinical trials.", {"entities": []}], ["In the present work, we applied a calibrated fMRI approach referred to as Quantitative O2 (QUO2) in a cohort of probable AD dementia and age-matched control participants.", {"entities": [[124, 132, "DISEASE"]]}], ["The resulting CBF, OEF and CMRO 2 values fell within the range from previous studies using positron emission tomography (PET) with 2 can be imaged with \u2022 An advanced calibrated fMRI method is employed to explore brain physiology in AD.", {"entities": []}], ["\u2022 A pattern of hypoperfusion and hypometabolism was observed as in PET studies.", {"entities": []}], ["\u2022 The method provides several potential biomarkers of interest in AD.", {"entities": []}], ["\u2022 The technique may help by providing new insights into the pathophysiology of AD.", {"entities": []}], ["An advanced calibrated fMRI method is employed to explore brain physiology in AD.", {"entities": []}], ["A pattern of hypoperfusion and hypometabolism was observed as in PET studies.", {"entities": []}], ["The method provides several potential biomarkers of interest in AD.", {"entities": []}], ["The technique may help by providing new insights into the pathophysiology of AD.", {"entities": []}], ["Accurate and timely diagnosis of community-acquired bacterial infections in patients with systemic inflammation remains challenging both for clinician and laboratory.", {"entities": []}], ["Combinations of markers, as opposed to single ones, may improve diagnosis and thereby survival.", {"entities": []}], ["We therefore compared the diagnostic characteristics of novel and routinely used biomarkers of sepsis alone and in combination.", {"entities": []}], ["This prospective cohort study included patients with systemic inflammatory response syndrome who were suspected of having community-acquired infections.", {"entities": [[84, 92, "DISEASE"]]}], ["It was conducted in a medical emergency department and department of infectious diseases at a university hospital.", {"entities": []}], ["A multiplex immunoassay measuring soluble urokinase-type plasminogen activator (suPAR) and soluble triggering receptor expressed on myeloid cells (sTREM)-1 and macrophage migration inhibitory factor (MIF) was used in parallel with standard measurements of C-reactive protein (CRP), procalcitonin (PCT), and neutrophils.", {"entities": [[200, 203, "GENE"], [276, 279, "GENE"]]}], ["Two composite markers were constructed \u2013 one including a linear combination of the three best performing markers and another including all six \u2013 and the area under the receiver operating characteristic curve (AUC) was used to compare their performance and those of the individual markers.", {"entities": []}], ["A total of 151 patients were eligible for analysis.", {"entities": []}], ["Of these, 96 had bacterial infections.", {"entities": []}], ["The AUCs for detection of a bacterial cause of inflammation were 0.50 (95% confidence interval [CI] 0.40 to 0.60) for suPAR, 0.61 (95% CI 0.52 to 0.71) for sTREM-1, 0.63 (95% CI 0.53 to 0.72) for MIF, 0.72 (95% CI 0.63 to 0.79) for PCT, 0.74 (95% CI 0.66 to 0.81) for neutrophil count, 0.81 (95% CI 0.73 to 0.86) for CRP, 0.84 (95% CI 0.71 to 0.91) for the composite three-marker test, and 0.88 (95% CI 0.81 to 0.92) for the composite six-marker test.", {"entities": [[196, 199, "GENE"], [317, 320, "GENE"]]}], ["The AUC of the six-marker test was significantly greater than that of the single markers.", {"entities": []}], ["Combining information from several markers improves diagnostic accuracy in detecting bacterial versus nonbacterial causes of inflammation.", {"entities": []}], ["Measurements of suPAR, sTREM-1 and MIF had limited value as single markers, whereas PCT and CRP exhibited acceptable diagnostic characteristics.", {"entities": [[35, 38, "GENE"], [92, 95, "GENE"]]}], ["NCT 00389337", {"entities": []}], ["Der p 7 is an important house dust mite allergen.", {"entities": []}], ["However, antigenic determinants of Der p 7 are largely unknown.", {"entities": []}], ["The purpose of this study is to analyze the determinants of Der p 7 and determine the structural basis of interactions between Der p 7 and WH9, an IgE-binding inhibition mouse monoclonal antibody (MoAb).", {"entities": []}], ["IgE and WH9-reactive determinant(s) was identified by immunoblot using allergen mutants.", {"entities": []}], ["A 3-D binary complex structure of Der p 7 and WH9 was simulated with homology modeling and docking methods.", {"entities": []}], ["Our results obtained showed that among the five Der p 7 mutants (S156A, I157A, L158A, D159A, P160A), serum no.", {"entities": []}], ["1045 with IgE-binding against Der p 7 exhibited a reduced IgE immunoblot reactivity against Der p 7 L158A and D159A mutants.", {"entities": []}], ["WH9 showed reduced immunoblot reactivity against S156A, L158A, D159A and P160A and the observation was confirmed by immunoblot inhibition.", {"entities": []}], ["The WH9-binding determinant on Der p 7 containing S156, L158, D159 and P160 assumes a loop-like structure.", {"entities": []}], ["The structural model of the Der p 7-WH9 complex suggests residues S156, I157, L158, D159 and P160 of Der p 7 contribute to WH9 binding via potential hydrogen bonds, electrostatic and hydrophobic interactions.", {"entities": []}], ["In conclusion, MoAb WH9 interacts with critical residues L158 and D159 of Der p 7 and inhibits IgE-binding to Der p 7.", {"entities": []}], ["Results obtained advance our understanding on molecular and structural bases of the antigenicity of Der p 7, its interactions with MoAb WH9 and facilitate the design of safer immunotherapy of human atopic disorders.", {"entities": []}], ["Triclosan\u2014a ubiquitous chemical in toothpastes, soaps, and household cleaning supplies\u2014has the potential to alter both gut microbiota and endocrine function and thereby affect body weight.", {"entities": []}], ["We investigated the relationship between triclosan and body mass index (BMI) using National Health and Nutrition Examination Surveys (NHANES) from 2003\u20132008.", {"entities": []}], ["BMI and spot urinary triclosan levels were obtained from adults.", {"entities": []}], ["Using two different exposure measures\u2014either presence vs. absence or quartiles of triclosan\u2014we assessed the association between triclosan and BMI.", {"entities": []}], ["We also screened all NHANES serum and urine biomarkers to identify correlated factors that might confound observed associations.", {"entities": []}], ["Compared with undetectable triclosan, a detectable level was associated with a 0.9-point increase in BMI ( p <0.001).", {"entities": []}], ["In analysis by quartile, compared to the lowest quartile, the 2nd, 3rd and 4th quartiles of urinary triclosan were associated with BMI increases of 1.5 ( p <0.001), 1.0 ( p \u200a=\u200a0.002), and 0.3 ( p \u200a=\u200a0.33) respectively.", {"entities": []}], ["The one strong correlate of triclosan identified in NHANES was its metabolite, 2,4-dichlorophenol (\u03c1\u200a=\u200a0.4); its association with BMI, however, was weaker than that of triclosan.", {"entities": []}], ["No other likely confounder was identified.", {"entities": []}], ["Triclosan exposure is associated with increased BMI.", {"entities": []}], ["Stronger effect at moderate than high levels suggests a complex mechanism of action.", {"entities": []}], ["There are numerous pesticides and toxic chemicals in the environment that have yet to be evaluated for potential to cause developmental neurotoxicity.", {"entities": []}], ["Recent legislation and testing initiatives provide an impetus to generating more information about potential hazards to children.", {"entities": []}], ["In the United States, the 1996 Food Quality Protection Act (FQPA) required the U.S. Environmental Protection Agency (U.S. EPA) to make a finding that a pesticide food use is safe for children.", {"entities": []}], ["In addition, the law requires U.S. EPA to incorporate an additional 10-fold factor in risk assessments for pesticide residue tolerances to take into account the special sensitivities of infants and children as well as incomplete data with respect to toxicity and exposures.", {"entities": []}], ["The potential of chemicals in food and drinking water to cause endocrine disruption will also be examined via the Endocrine Disruptor Screening and Testing Program required by the FQPA and the 1996 Safe Drinking Water Act.", {"entities": []}], ["In addition, a new voluntary chemical information program will provide screening-level information for the some 2,800 high-volume chemicals in commerce in the United States.", {"entities": []}], ["These initiatives will need to be accompanied by research focused on developmental toxicity for children, including developmental disabilities.", {"entities": []}], ["Developmental disabilities exact a large toll on children's health in the United States.", {"entities": []}], ["Three major developmental disabilities--autism, cerebral palsy, and severe mental retardation--each affect substantial numbers of children.", {"entities": [[48, 62, "DISEASE"]]}], ["We know very little about the etiology of these conditions.", {"entities": []}], ["A number of priority areas for research are suggested, including a large environmental prospective study of developmental neurotoxicity.", {"entities": []}], ["With increasing morbidity and mortality attributable to non-communicable disease, primary healthcare providers are urged to increasingly support people in making healthy lifestyle choices.", {"entities": []}], ["Many chronic physical diseases associated with lifestyle behaviours have been linked to neuromusculoskeletal disorders and pain.", {"entities": []}], ["Chiropractors, as primary healthcare professionals, are in a position to provide preventative and promotional healthcare to patients, however, it is unknown to what extent such care is provided, particularly in the United Kingdom (UK).", {"entities": []}], ["This study was a cross sectional online questionnaire distributed to four UK chiropractic associations.", {"entities": []}], ["The responses were collected over a period of two months from March 26th 2012 to May 25th 2012.", {"entities": []}], ["Descriptive analyses were performed to identify the trends in current practice of chiropractors in the UK.", {"entities": []}], ["Additionally, subgroup analyses of all items were performed using Pearson Chi-Square tests to determine statistically significant differences between respondents based on gender, years in practice, educational institution and association membership.", {"entities": []}], ["Of the 2,448 members in the four participating associations, 509 chiropractors (approximately 21%) completed the survey.", {"entities": []}], ["The great majority of UK chiropractors surveyed report evaluating and monitoring patients in regards to posture (97.1%), inactivity/overactivity (90.8%) and movement patterns (88.6%).", {"entities": []}], ["Slightly fewer provide this type of care for psychosocial stress (82.3%), nutrition (74.1%) and disturbed sleep (72.9%).", {"entities": []}], ["Still fewer do so for smoking (60.7%) and over-consumption of alcohol (56.4%).", {"entities": []}], ["Verbal advice given by the chiropractor was reported as the most successful resource to encourage positive lifestyle changes as reported by 68.8% of respondents.", {"entities": []}], ["Goal-setting is utilised by 70.7% to 80.4% of respondents concerning physical fitness issues.", {"entities": []}], ["For all other lifestyle issues, goal-setting is used by approximately two-fifths (41.7%) or less.", {"entities": []}], ["For smoking and over-consumption of alcohol, a mere one-fifth (20.0% and 20.6% respectively) of the responding chiropractors set goals.", {"entities": []}], ["UK chiropractors are participating in promoting positive lifestyle changes in areas common to preventative healthcare and health promotion areas; however, more can be done, particularly in the areas of smoking and over-consumption of alcohol.", {"entities": []}], ["In addition, goal-setting to support patient-provider relationships should be more widespread, potentially increasing the utility of such valuable advice and resources.", {"entities": []}], ["With the looming expansion of the elderly population of the US, a thorough understanding of \u201cnormal\u201d aging-related changes on the respiratory system is paramount.", {"entities": []}], ["The respiratory system undergoes various anatomical, physiological and immunological changes with age.", {"entities": []}], ["The structural changes include chest wall and thoracic spine deformities which impairs the total respiratory system compliance leading to increase work of breathing.", {"entities": []}], ["The lung parenchyma loses its supporting structure causing dilation of air spaces: \u201csenile emphysema\u201d.", {"entities": []}], ["Respiratory muscle strength decreases with age and can impair effective cough, which is important for airway clearance.", {"entities": []}], ["The lung matures by age 20\u201325 years, and thereafter aging is associated with progressive decline in lung function.", {"entities": []}], ["The alveolar dead space increases with age, affecting arterial oxygen without impairing the carbon dioxide elimination.", {"entities": []}], ["The airways receptors undergo functional changes with age and are less likely to respond to drugs used in younger counterparts to treat the same disorders.", {"entities": []}], ["Older adults have decreased sensation of dyspnea and diminished ventilatory response to hypoxia and hypercapnia, making them more vulnerable to ventilatory failure during high demand states (ie, heart failure, pneumonia, etc) and possible poor outcomes.", {"entities": [[210, 219, "DISEASE"]]}], ["Aim: We investigated on parental history and IgE serum level in 2588 consecutive newborns to individuate babies \u201cat risk\u201d of atopy at birth and we analysed the polymorphisms of class III region to evaluate the association with immunogenetic markers of HLA: C4A, C4B, LTA, RAGE and TNFA genes; we performed TNF and IgE receptor (FCERB1) physiologically related gene polymorphisms.", {"entities": [[252, 255, "GENE"], [257, 260, "GENE"], [262, 265, "GENE"], [267, 270, "GENE"], [306, 309, "GENE"]]}], ["Result: 791 babies/2588 (30.6%) were considered \u201cat risk\u201d for atopy and followed-up: 400 had familial history of atopy (at least one parent or sibling), 256 had IgE > 0.35 kUA/l at birth and during the follow-up and 135 were positive for both conditions.", {"entities": []}], ["The allele C4B2 was significantly more frequent in the sample of babies at risk (22.1% vs 10%, p < 0.001).", {"entities": []}], ["Furthermore, the mean value of IgE at birth in babies carrying the allele C4B2 was 2.26 KUA/l versus 0.74 KUA/l in those not carrying this allele ( p = 0.01).", {"entities": []}], ["No signi\ufb01cant association emerged for RAGE at the centromeric end of class III region and for LTA, TNFA at the telomeric one.", {"entities": [[94, 97, "GENE"]]}], ["TNFRI, TNFRII and FCERB1 gene polymorphisms also seemed not implicated.", {"entities": []}], ["Conclusion : Our study confirms that HLA class III region seems involved in familial predisposition to atopy, and C4B gene probably acts as a marker of a more restricted subregion.", {"entities": [[37, 40, "GENE"], [114, 117, "GENE"]]}], ["Changes in reimbursement have been compelling for Dutch primary care practices to apply a disease management approach for patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[136, 173, "DISEASE"]]}], ["This approach includes individual patient consultations with a practice nurse, who coaches patients in COPD management.", {"entities": []}], ["The aim of this study was to gauge the feasibility of adding a web-based patient self-management support application, by assessing patients\u2019 self-management, patients\u2019 health status, the impact on the organization of care, and the level of application use and appreciation.", {"entities": []}], ["The study employed a mixed methods design.", {"entities": []}], ["Six practice nurses recruited COPD patients during a consultation.", {"entities": []}], ["The e-Health application included a questionnaire that captured information on demographics, self-management related behaviors (smoking cessation, physical activity and medication adherence) and their determinants, and nurse recommendations.", {"entities": []}], ["The application provided tailored feedback messages to patients and provided the nurse with reports.", {"entities": []}], ["Data were collected through questionnaires and medical record abstractions at baseline and one year later.", {"entities": []}], ["Semi-structured interviews with patients and nurses were conducted.", {"entities": []}], ["Descriptive statistics were calculated for quantitative data and content analysis was used to analyze the qualitative data.", {"entities": []}], ["Eleven patients, recruited by three nurses, used the application 1 to 7 times (median 4).", {"entities": []}], ["Most patients thought that the application supported self-management, but their interest diminished after multiple uses.", {"entities": []}], ["Impact on patients\u2019 health could not be determined due to the small sample size.", {"entities": []}], ["Nurses reported benefits for the organization of care and made suggestions to optimize the use of the reports.", {"entities": []}], ["Results suggest that it is possible to integrate a web-based COPD self-management application into the current primary care disease management process.", {"entities": []}], ["The pilot study also revealed opportunities to improve the application and reports, in order to increase technology use and appreciation.", {"entities": []}], ["In this video Q&A, we talk to Dr Alfred William Frankland about the highlights of his career, including working alongside Sir Alexander Fleming, co-founding the British Allergy Society, and introducing pollen counts to UK weather forecasts.", {"entities": []}], ["We also discuss his opinions on why misconceptions about allergies and allergen immunotherapy still exist.", {"entities": []}], ["Please see related article: http://www.biomedcentral.com/1741-7015/11/255 .", {"entities": []}], ["Increasing numbers of older patients with type 2 diabetes, and their improved survival from cardiovascular events is seeing a massive increase in patients with both diabetes and heart failure.", {"entities": []}], ["Already, at least a third of all patients with heart failure have diabetes.", {"entities": []}], ["This close association is partly because all the major risk factors for heart failure also cluster in patients with type 2 diabetes, including obesity, hypertension, advanced age, sleep apnoea, dyslipidaemia, anaemia, chronic kidney disease, and coronary heart disease.", {"entities": [[152, 164, "DISEASE"], [226, 240, "DISEASE"], [255, 268, "DISEASE"], [246, 268, "DISEASE"], [143, 150, "DISEASE"]]}], ["However, diabetes may also cause cardiac dysfunction in the absence of overt macrovascular disease, as well as complicate the response to therapy.", {"entities": []}], ["Current management is focused on targeting modifiable risk factors for heart failure including hyperglycaemia, dyslipidaemia, hypertension, obesity and anemia.", {"entities": [[126, 138, "DISEASE"], [140, 147, "DISEASE"], [152, 158, "DISEASE"]]}], ["But although these are important risk markers, none of these interventions substantially prevents heart failure or improves its outcomes.", {"entities": []}], ["Much more needs to be done to focus on this issue, including the inclusion of hospital admission for heart failure as a pre-specified component of the primary composite cardiovascular outcomes and new trials in heart failure management specifically in the context of diabetes.", {"entities": []}], ["Linaclotide is a guanylate cyclase-C agonist approved in the United States, Canada, and Mexico at a once-daily 145-\u03bcg dose for the treatment of chronic idiopathic constipation (CIC); a once-daily 72-\u03bcg dose for CIC recently received FDA approval.", {"entities": [[163, 175, "DISEASE"], [177, 180, "GENE"], [211, 214, "GENE"], [177, 180, "GENE"], [211, 214, "GENE"]]}], ["The trial objective was to evaluate the efficacy and safety of a 72-\u03bcg linaclotide dose in CIC patients.", {"entities": [[91, 94, "GENE"]]}], ["This double-blind, placebo-controlled trial randomized patients with CIC (Rome III criteria) to once-daily linaclotide 72\u2009\u03bcg or 145\u2009\u03bcg, or placebo for 12 weeks.", {"entities": [[69, 72, "GENE"]]}], ["The primary endpoint, 12-week complete spontaneous bowel movement (CSBM) overall responder, required patients to have \u22653 CSBMs and an increase of \u22651 CSBM per week from baseline in the same week for \u22659 of 12 weeks of the treatment period.", {"entities": []}], ["Secondary endpoints included 12-week change from baseline in bowel (SBM and CSBM frequency, stool consistency, straining) and abdominal (bloating, discomfort) symptoms, monthly CSBM responders, and 12-week CSBM responders among patients who averaged >1 SBM/week at baseline.", {"entities": []}], ["Sustained response (12-week CSBM overall responders who met weekly criteria for 3 of the 4 final weeks (weeks 9\u201312) of treatment) was evaluated as an additional endpoint.", {"entities": []}], ["Adverse events (AEs) were monitored.", {"entities": []}], ["The intent-to-treat population included 1,223 patients (mean age=46 years, female=77%, white=71%).", {"entities": []}], ["The primary endpoint was met by 13.4% of linaclotide 72-\u03bcg patients vs. 4.7% of placebo patients ( P <0.0001, odds ratio=3.0; statistically significant controlling for multiplicity).", {"entities": []}], ["Sustained response was achieved by 12.4% of linaclotide 72-\u03bcg patients vs. 4.2% of placebo patients (nominal P <0.0001).", {"entities": []}], ["Linaclotide 72-\u03bcg patients met 9-of-10 secondary endpoints vs. placebo ( P <0.05; abdominal discomfort, P =0.1028).", {"entities": []}], ["Patients treated with linaclotide 145\u2009\u03bcg also improved CIC symptoms for the primary (12.4%) and sustained responder endpoint parameters (11.4%) and for all 10 of the secondary endpoint parameters including abdominal discomfort ( P <0.05).", {"entities": [[55, 58, "GENE"]]}], ["Diarrhea, the most common AE, was mild in most instances and resulted in discontinuation of 0, 2.4%, and 3.2% of patients in the placebo, linaclotide 72-\u03bcg, and linaclotide 145-\u03bcg groups, respectively.", {"entities": [[0, 8, "DISEASE"]]}], ["Once-daily linaclotide 72\u2009\u03bcg significantly improved CIC symptoms in both men and women with a low rate of discontinuation due to diarrhea over 12 weeks of treatment.", {"entities": [[129, 137, "DISEASE"], [52, 55, "GENE"]]}], ["The main concern in formulation of antibodies is the intrinsic instability of these labile compounds.", {"entities": []}], ["To evaluate the physicochemical stability of antibody in dry powder formulations, physical stability of IgG 1 and a monoclonal antibody (trastuzumab) during the spray drying process was studied in a parallel study and the efficacy of some sugar based excipients in protection of antibodies was studied.", {"entities": []}], ["The SDS-PAGE analysis showed no fragmentation of antibodies after spray drying in all formulations.", {"entities": []}], ["The secondary structure of antibodies contained 40.13 to 70.19% of \u03b2 structure in dry state.", {"entities": []}], ["Also, CD spectroscopy showed the similar secondary structure for trastuzumab after reconstitution in water.", {"entities": []}], ["ELISA analysis and cell culture studies were conducted in order to evaluate bioactivity of monoclonal antibody.", {"entities": []}], ["Formulations containing combination of excipients provided maximum tendency of trastuzumab to attach to the ELISA antigen (86.46%\u2009\u00b1\u20092.3) and maximum bioactivity when incubated with SKBr 3 cell line (the cell viability was decreased to 65.99%\u2009\u00b1\u20094.6).", {"entities": []}], ["Incubation of formulations with L929 cell line proved the biocompatibility of the excipients and non-toxic composition of formulations.", {"entities": []}], ["The IgG 1 and trastuzumab demonstrated similar behavior in spray drying process.", {"entities": []}], ["The combination of excipients containing trahalose, hydroxypropyl beta cyclodextrin and beta cyclodextrin with proper ratio improved the physical and chemical stability of both IgG 1 and monoclonal antibody.", {"entities": []}], ["Environmental opportunistic mycobacteria, including Mycobacterium avium , M. terrae , and the new species M. immunogenum, have been implicated in outbreaks of hypersensitivity pneumonitis or respiratory problems in a wide variety of settings.", {"entities": []}], ["One common feature of the outbreaks has been exposure to aerosols.", {"entities": []}], ["Aerosols have been generated from metalworking fluid during machining and grinding operations as well as from indoor swimming pools, hot tubs, and water-damaged buildings.", {"entities": []}], ["Environmental opportunistic mycobacteria are present in drinking water, resistant to disinfection, able to provoke inflammatory reactions, and readily aerosolized.", {"entities": []}], ["In all outbreaks, the water sources of the aerosols were disinfected.", {"entities": []}], ["Disinfection may select for the predominance and growth of mycobacteria.", {"entities": []}], ["Therefore, mycobacteria may be responsible, in part, for many outbreaks of hypersensitivity pneumonitis and other respiratory problems in the workplace and home.", {"entities": []}], ["Highly sensitive troponin T (hs-TnT) assay has improved clinical decision-making for patients admitted with chest pain.", {"entities": []}], ["However, this assay\u2019s performance in detecting myocardial ischaemia in a lowrisk population has been poorly documented.", {"entities": []}], ["To assess hs-TnT assay\u2019s performance to detect myocardial ischaemia at positron emission tomography/CT (PET-CT) in low-risk patients admitted with chest pain.", {"entities": []}], ["Patients admitted for chest pain with a nonconclusive ECG and negative standard cardiac troponin T results at admission and after 6 hours were prospectively enrolled.", {"entities": []}], ["Their hs-TnT samples were at T0, T2 and T6.", {"entities": []}], ["Physicians were blinded to hs-TnT results.", {"entities": []}], ["All patients underwent a PET-CT at rest and during adenosine-induced stress.", {"entities": []}], ["All patients with a positive PET-CT result underwent a coronary angiography.", {"entities": []}], ["Forty-eight patients were included.", {"entities": []}], ["Six had ischaemia at PET-CT. All of them had \u22651 significant stenosis at coronary angiography.", {"entities": []}], ["Areas under the curve (95% CI) for predicting significant ischaemia at PET-CT using hs-TnT were 0.764 (0.515 to 1.000) at T0, 0.812(0.616 to 1.000) at T2 and 0.813(0.638 to 0.989) at T6.", {"entities": []}], ["The receiver operating characteristicbased optimal cut-off value for hs-TnT at T0, T2 and T6 needed to exclude significant ischaemia at PET-CT was <4 ng/L.", {"entities": []}], ["Using this value, sensitivity, specificity, positive and negative predictive values of hs-TnT to predict significant ischaemia were 83%/38%/16%/94% at T0, 100%/40%/19%/100% at T2 and 100%/43%/20%/100% at T6, respectively.", {"entities": []}], ["Our findings suggest that in low-risk patients, using the hs-TnT assay with a cut-off value of 4 ng/L demonstrates excellent negative predictive value to exclude myocardial ischaemia detection at PET-CT, at the expense of weak specificity and positive predictive value.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT01374607.", {"entities": []}], ["Hepatocellular carcinoma has a poor prognosis; few patients can undergo surgical curative treatment according to Barcelona Clinic Liver Cancer guidelines.", {"entities": [[0, 24, "DISEASE"], [15, 24, "DISEASE"]]}], ["Progress in surgical techniques has led to operations for more patients outside these guidelines.", {"entities": []}], ["Our case shows a patient with intermediate stage hepatocellular carcinoma presenting a good outcome after curative treatment.", {"entities": [[49, 73, "DISEASE"], [64, 73, "DISEASE"]]}], ["We report the case of an 80-year-old Moroccan man, who was positive for hepatitis c virus, presenting an intermediate stage hepatocellular carcinoma (three lesions between 20 and 60\u00a0mm).", {"entities": [[124, 148, "DISEASE"], [72, 83, "DISEASE"], [139, 148, "DISEASE"], [72, 81, "DISEASE"]]}], ["He presented a complete tumor necrosis after portal vein embolization and achieved 24-month disease-free survival after surgery.", {"entities": []}], ["Perioperative care in liver surgery and multidisciplinary discussion can help to extend indications for liver resection for hepatocellular carcinoma outside European Association for the Study of the Liver/American Association for the Study of Liver Diseases recommendations and offer a curative approach to selected patients with intermediate and advanced stage hepatocellular carcinoma.", {"entities": [[124, 148, "DISEASE"], [362, 386, "DISEASE"], [139, 148, "DISEASE"], [377, 386, "DISEASE"]]}], ["Although international guidelines on pulmonary rehabilitation acknowledge that psychological factors contribute to exercise intolerance in patients with chronic obstructive pulmonary disease (COPD), the few empirical studies investigating this association have found inconsistent results.", {"entities": [[153, 190, "DISEASE"]]}], ["The purpose of this study is to investigate whether negative affect and beliefs about exercise of patients with COPD would be related to baseline 6-min walk (6-MW) test results in a pulmonary rehabilitation setting, after correction for physical variables (sex, age, height, weight, and lung function).", {"entities": []}], ["A second aim was to examine whether patients' beliefs are associated with treatment outcomes, as measured by an improvement in 6-MW distance.", {"entities": []}], ["A 12-week pulmonary rehabilitation program was completed by 166 patients.", {"entities": []}], ["Beliefs (perceived necessity and concerns) about exercise and negative affect were assessed by a questionnaire.", {"entities": []}], ["Clinical data were obtained from medical records.", {"entities": []}], ["Baseline 6-MW distance was positively related to younger age, male gender, better pulmonary function, and having fewer concerns about exercise.", {"entities": []}], ["After rehabilitation, patients had increased their walk distance by 12% (32\u00a0m), on average.", {"entities": []}], ["Baseline physiological and psychological variables were unrelated to patients' response to treatment (increase in walk distance).", {"entities": []}], ["However, subgroup analysis showed that for patients with mild to moderate airflow obstruction, concerns about exercise were negatively related to response to treatment.", {"entities": []}], ["We conclude that patients' beliefs about the negative consequences of exercise are associated with baseline 6-MW test performance and response to treatment for patients with mild to moderate COPD.", {"entities": []}], ["We recommend that patients' concerns about exercise are discussed and, if necessary, corrected during the intake phase.", {"entities": []}], ["Yu-ping-feng-san (YPFS) is a Chinese medical formula that is used clinically for allergic diseases and characterized by reducing allergy relapse.", {"entities": []}], ["Our previous studies demonstrated that YPFS efficiently inhibited T helper 2 cytokines in allergic inflammation.", {"entities": []}], ["The underlying mechanisms of action of YPFS and its effective components remain unclear.", {"entities": []}], ["In this study, it was shown that YPFS significantly inhibited production of thymic stromal lymphopoietin (TSLP), an epithelial cell-derived initiative factor in allergic inflammation, in vitro and in vivo .", {"entities": [[106, 110, "GENE"]]}], ["A method of human bronchial epithelial cell (16HBE) binding combined with HPLC-MS (named 16HBE-HPLC-MS) was established to explore potential active components of YPFS.", {"entities": []}], ["The following five components bound to 16HBE cells: calycosin-7-glucoside, ononin, claycosin, sec-o-glucosylhamaudol and formononetin.", {"entities": []}], ["Serum from YPFS-treated mice was analyzed and three major components were detected claycosin, formononetin and cimifugin.", {"entities": []}], ["Among these, claycosin and formononetin were detected by 16HBE-HPLC-MS and in the serum of YPFS-treated mice.", {"entities": []}], ["Claycosin and formononetin decreased the level of TSLP markedly at the initial stage of allergic inflammation in vivo .", {"entities": [[50, 54, "GENE"]]}], ["Nuclear factor (NF)-\u03baB, a key transcription factor in TSLP production, was also inhibited by claycosin and formononetin, either in terms of transcriptional activation or its nuclear translocation in vitro .", {"entities": [[54, 58, "GENE"]]}], ["Allergic inflammation was reduced by claycosin and formononetin when they are administered only at the initial stage in a murine model of atopic contact dermatitis.", {"entities": [[145, 163, "DISEASE"], [153, 163, "DISEASE"]]}], ["Thus, epithelial cell binding combined with HPLC-MS is a valid method for screening active components from complex mixtures of Chinese medicine.", {"entities": []}], ["It was demonstrated that the compounds screened from YPFS significantly attenuated allergic inflammation probably by reducing TSLP production via regulating NF-\u03baB activation.", {"entities": [[126, 130, "GENE"]]}], ["During 2012\u20132015, we tested respiratory specimens from patients with severe respiratory illness (SRI), patients with influenza-like illness (ILI), and controls in South Africa by real-time PCR for Mycoplasma pneumoniae , followed by culture and molecular characterization of positive samples.", {"entities": [[117, 126, "DISEASE"]]}], ["M. pneumoniae prevalence was 1.6% among SRI patients, 0.7% among ILI patients, and 0.2% among controls (p<0.001).", {"entities": []}], ["Age <5 years (adjusted odd ratio 7.1; 95% CI 1.7\u201328.7) and HIV infection (adjusted odds ratio 23.8; 95% CI 4.1\u2013138.2) among M. pneumonia \u2013positive persons were associated with severe disease.", {"entities": [[127, 136, "DISEASE"]]}], ["The detection rate attributable to illness was 93.9% (95% CI 74.4%\u201398.5%) in SRI patients and 80.7% (95% CI 16.7%\u201395.6%) in ILI patients.", {"entities": []}], ["The hospitalization rate was 28 cases/100,000 population.", {"entities": []}], ["We observed the macrolide-susceptible M. pneumoniae genotype in all cases and found P1 types 1, 2, and a type 2 variant with multilocus variable number tandem repeat types 3/6/6/2, 3/5/6/2, and 4/5/7/2.", {"entities": []}], ["To measure the value the patients place on different aspects of person-centred care.", {"entities": []}], ["We systematically identified four attributes of person-centred care.", {"entities": []}], ["We then measured their value to 923 people with either chronic pain or chronic lung disease over three discrete choice experiments (DCEs) about services to support self-management.", {"entities": [[79, 91, "DISEASE"]]}], ["We calculated the value of each attribute for all respondents and identified groups of people with similar preferences using latent class modelling.", {"entities": []}], ["DCEs conducted online via a commercial survey company.", {"entities": []}], ["Adults with either chronic pain (two DCEs, n=517\u2009and 206, respectively) or breathlessness due to chronic respiratory disease (n=200).", {"entities": []}], ["Participants were more likely to choose services with higher level person-centred attributes.", {"entities": []}], ["They most valued services that took account of a person\u2019s current situation likelihood of selection increased by 16.9% (95%\u2009CI=15.4 to 18.3) and worked with the person on what they wanted to get from life (15.8%; 14.5 to 17.1).", {"entities": []}], ["More personally relevant information was valued less than these (12.3%; 11.0 to 13.6).", {"entities": []}], ["A friendly and personal communicative style was valued least (3.8%; 2.7 to 4.8).", {"entities": []}], ["Latent class models indicated that a substantial minority of participants valued personally relevant information over the other attributes.", {"entities": []}], ["This is the first study to measure the value patients place on different aspects of person-centred care.", {"entities": []}], ["Professional training needs to emphasise the substance of clinical communication\u2014working responsively with individuals on what matters to them\u2014as well as the style of its delivery.", {"entities": []}], ["Musculoskeletal problems such as low back pain, neck, knee and shoulder pain are leading causes of disability and activity limitation in adults and are most frequently managed within primary care.", {"entities": []}], ["There is a clear trend towards large, high quality trials testing the effectiveness of common non-pharmacological interventions for these conditions showing, at best, small to moderate benefits.", {"entities": []}], ["This paper summarises the main lessons learnt from recent trials of the effectiveness of non-pharmacological therapies for common musculoskeletal conditions in primary care and provides agreed research priorities for future clinical trials.", {"entities": []}], ["Consensus development using nominal group techniques through national (UK) and international workshops.", {"entities": []}], ["During a national Clinical Trials Thinktank workshop in April 2007 in the UK, a group of 30 senior researchers experienced in clinical trials for musculoskeletal conditions and 2 patient representatives debated the possible explanations for the findings of recent high quality trials of non-pharmacological interventions.", {"entities": []}], ["Using the qualitative method of nominal group technique, these experts developed and ranked a set of priorities for future research, guided by the evidence from recent trials of treatments for common musculoskeletal problems.", {"entities": []}], ["The recommendations from the national workshop were presented and further ranked at an international symposium (hosted in Canada) in June 2007.", {"entities": []}], ["22 recommended research priorities were developed, of which 12 reached consensus as priorities for future research from the UK workshop.", {"entities": []}], ["The 12 recommendations were reduced to 7 agreed priorities at the international symposium.", {"entities": []}], ["These were: to increase the focus on implementation (research into practice); to develop national musculoskeletal research networks in which large trials can be sited and smaller trials supported; to use more innovative trial designs such as those based on stepped care and subgrouping for targeted treatment models; to routinely incorporate health economic analysis into future trials; to include more patient-centred outcome measures; to develop a core set of outcomes for new trials of interventions for musculoskeletal problems; and to focus on studies that advance methodological approaches for clinical trials in this field.", {"entities": []}], ["A set of research priorities for future trials of non-pharmacological therapies for common musculoskeletal conditions has been developed and agreed through national (UK) and international consensus processes.", {"entities": []}], ["These priorities provide useful direction for researchers and research funders alike and impetus for improvement in the quality and methodology of clinical trials in this field.", {"entities": []}], ["Rhinoviruses, formerly known as Human rhinoviruses , are the most common cause of air-borne upper respiratory tract infections in humans.", {"entities": []}], ["Rhinoviruses belong to the family Picornaviridae and are divided into three species namely, Rhinovirus A, -B and - C , which are antigenically diverse.", {"entities": []}], ["Genetic recombination is found to be one of the important causes for diversification of Rhinovirus species.", {"entities": []}], ["Although emerging lineages within Rhinoviruses have been reported, their population structure has not been studied yet.", {"entities": []}], ["The availability of complete genome sequences facilitates study of population structure, genetic diversity and underlying evolutionary forces, such as mutation, recombination and selection pressure.", {"entities": []}], ["Analysis of complete genomes of Rhinoviruses using a model-based population genetics approach provided a strong evidence for existence of seven genetically distinct subpopulations.", {"entities": []}], ["As a result of diversification, Rhinovirus A and -C populations are divided into four and two subpopulations, respectively.", {"entities": []}], ["Genetically, the Rhinovirus B population was found to be homogeneous.", {"entities": []}], ["Intra-species recombination was observed to be prominent in Rhinovirus A and -C species.", {"entities": []}], ["Significant evidence of episodic positive selection was obtained for several sites within coding sequences of structural and non-structural proteins.", {"entities": []}], ["This corroborates well with known phenotypic properties such as antigenicity of structural proteins.", {"entities": []}], ["Episodic positive selection appears to be responsible for emergence of new lineages especially in Rhinovirus A .", {"entities": []}], ["In summary, the Rhinovirus population is an ensemble of seven distinct lineages.", {"entities": []}], ["In case of Rhinovirus A, intra-species recombination and episodic positive selection contribute to its further diversification.", {"entities": []}], ["In case of Rhinovirus C, intra- and inter-species recombinations are responsible for observed diversity.", {"entities": []}], ["Population genetics approach was further useful to analyze phylogenetic tree topologies pertaining to recombinant strains, especially when trees are derived using complete genomes.", {"entities": []}], ["Understanding of population structure serves as a foundation for designing new vaccines and drugs as well as to explain emergence of drug resistance amongst subpopulations.", {"entities": []}], ["Allergen specific immunotherapy (AIT) can modulate the allergic response causing a long-term symptom subsidence/abolishment which leads to reduced drug use and prevention of new sensitization.", {"entities": []}], ["AIT of house dust mite allergy (HDM) using the mite crude extract (CE) as the therapeutic agent is not only less effective than the AIT for many other allergens, but also frequently causes adverse effects during the treatment course.", {"entities": []}], ["In this study, mouse model of Dermatophagoides pteronyssinus (Dp) allergy was invented for testing therapeutic efficacies of intranasally administered liposome (L) encapsulated vaccines made of single Dp major allergens (L-Der p 1, L-Der p 2), combined allergens (L-Der p 1 and Der p 2), and crude Dp extract (L-CE).", {"entities": []}], ["The allergen sparing intranasal route was chosen as it is known that the effective cells induced at the nasal-associated lymphoid tissue can exert their activities at the lower respiratory tissue due to the common mucosal traffic.", {"entities": []}], ["Liposome was chosen as the vaccine delivery vehicle and adjuvant as the micelles could reduce toxicity of the entrapped cargo.", {"entities": []}], ["The Dp-CE allergic mice received eight doses of individual vaccines/placebo on alternate days.", {"entities": []}], ["All vaccine formulations caused reduction of the Th2 response of the Dp allergic mice.", {"entities": []}], ["However, only the vaccines made of single refined allergens induced expressions of immunosuppressive cytokines ( TGF-\u03b2 , IL-35 and/or IL-10 ) which are the imperative signatures of successful AIT.", {"entities": []}], ["The data emphasize the superior therapeutic efficacy of single refined major allergen vaccines than the crude allergenic extract vaccine.", {"entities": []}], ["Volatile organic compounds (VOCs) are small molecules that exhibit high vapor pressure under ambient conditions and have low boiling points.", {"entities": []}], ["Although VOCs contribute only a small proportion of the total metabolites produced by living organisms, they play an important role in chemical ecology specifically in the biological interactions between organisms and ecosystems.", {"entities": []}], ["VOCs are also important in the health care field as they are presently used as a biomarker to detect various human diseases.", {"entities": []}], ["Information on VOCs is scattered in the literature until now; however, there is still no available database describing VOCs and their biological activities.", {"entities": []}], ["To attain this purpose, we have developed KNApSAcK Metabolite Ecology Database, which contains the information on the relationships between VOCs and their emitting organisms.", {"entities": []}], ["The KNApSAcK Metabolite Ecology is also linked with the KNApSAcK Core and KNApSAcK Metabolite Activity Database to provide further information on the metabolites and their biological activities.", {"entities": []}], ["The VOC database can be accessed online.", {"entities": []}], ["To assess the cross-sectional construct validity of the Health Utilities Index Mark 3 (HUI3) in lung transplantation.", {"entities": []}], ["Two hundred and thirteen patients (103 pre-transplant and 110 post-transplant) with mean age 53 years old (SD 13) were recruited during a randomized controlled clinical trial at the out-patient clinic in a tertiary institution.", {"entities": []}], ["At baseline, patients self-completed measures that included the HUI3, EuroQol EQ-5D, Hospital Anxiety and Depression Scale (HADS) and socio-demographic questionnaire.", {"entities": []}], ["Six-minute walk test scores and forced expiratory volume in 1 second data were collected from patient's medical records.", {"entities": []}], ["A priori hypotheses were formulated by members of the transplant team about the expected degree of association between the measures.", {"entities": []}], ["Correlation coefficients of < 0.1 were considered as negligible, 0.1 to < 0.3 as small, 0.3 to < 0.5 as medium, and \u22650.5 as large.", {"entities": []}], ["Of the ninety predictions made, forty three were correct but in 31 the correlation was slightly lower than predicted and in 7 the correlations were much higher than predicted.", {"entities": []}], ["In 48% of the cases, predicted and observed associations were in agreement.", {"entities": []}], ["Predictions of associations were off by one category in 42% of the cases; in 10% of the cases the predictions were off by two categories.", {"entities": []}], ["This is the first study providing evidence of cross-sectional construct validity of HUI3 in lung transplantation.", {"entities": []}], ["Results indicate that the HUI3 was able to capture the burden of lung disease before transplantation and that post-transplant patients enjoyed higher health-related quality of life than pre-transplant patients.", {"entities": [[65, 77, "DISEASE"]]}], ["Patient: Male, 41 Final Diagnosis: Sick Sinus Syndrome and absent left main coronary artery \u2022 separate ostia of left anterior descending and circumflex arteries in Holt-Oram Syndrome Symptoms: Conduction disturbance \u2022 seizure-like activity \u2022 upper extremity malformations Medication: \u2014 Clinical Procedure: Electro physiology study \u2022 coronary catheterization \u2022 pacemaker Specialty: Cardiology Congenital defects/diseases Holt-Oram syndrome (HOS) is a rare but significant syndrome consisting of structural heart defects, conduction abnormalities, and upper extremity anomalies.", {"entities": [[35, 54, "DISEASE"], [46, 54, "DISEASE"], [174, 182, "DISEASE"], [430, 438, "DISEASE"], [471, 479, "DISEASE"]]}], ["It was first described in the British Heart Journal in 1960 by Mary Holt and Samuel Oram as a report of atrial septal defect, conduction disturbances, and hand malformations occurring in family members.", {"entities": []}], ["Patients can present with heart blocks or symptoms of underlying congenital heart defects.", {"entities": []}], ["A 41-year-old man with Holt-Oram syndrome presented with seizure-like activity and was found to have an underlying conduction disturbance.", {"entities": [[33, 41, "DISEASE"]]}], ["Physical exam showed bilateral atrophic upper extremities with anatomic disfiguration, and weakness of the intrinsic hand muscles.", {"entities": []}], ["Cardiovascular exam revealed a slow heart rate with irregular rhythm.", {"entities": []}], ["EKG showed sinus arrest with junctional escape rhythm.", {"entities": []}], ["Cardiac catheterization revealed coronary anomalies, including absent left main coronary artery and separate ostia of the left anterior ascending and left circumflex coronary artery.", {"entities": []}], ["Coronary arteries were patent.", {"entities": []}], ["Following electrophysiology study, sick sinus syndrome and AV block were diagnosed, and the patient received implantation of a permanent pacemaker.", {"entities": [[35, 54, "DISEASE"], [46, 54, "DISEASE"]]}], ["This patient presented with a seizure-like episode attributed to hypoxia during asystole from an underlying cardiac conduction defect associated with Holt-Oram syndrome.", {"entities": [[160, 168, "DISEASE"]]}], ["Arrhythmias and heart blocks are seen in these patients, and conduction defects are highly associated with congenital heart defects.", {"entities": []}], ["Holt-Oram syndrome rarely presents with coronary artery anomalies.", {"entities": [[10, 18, "DISEASE"]]}], ["There is no reported case of separate coronary ostia and absent left main coronary artery.", {"entities": []}], ["Prompt diagnosis is important since anomalies in coronary and upper extremity vasculature might be challenging for invasive procedures.", {"entities": []}], ["Myeloid Dendritic cells are key drivers of inflammation in smoke-related lung diseases, whereas plasmacytoid DCs play a crucial role in the defense against infections.", {"entities": []}], ["Effects of inhaled corticosteroids (ICS) on airway DCs in smokers are unknown.", {"entities": []}], ["In this randomized, double-blind, placebo-controlled clinical trial, 45 active cigarette smokers inhaled placebo, fluticasone or fluticasone plus salmeterol twice daily for 4\u00a0weeks.", {"entities": []}], ["Bronchoalveolar lavage fluid DCs were analyzed using four-color flow cytometry before and after the inhalation period.", {"entities": []}], ["In addition, fluticasone effects were tested on T-cell proliferation in co-cultures with blood myeloid DCs from smokers.", {"entities": []}], ["Inhalation of fluticasone plus salmeterol, but not fluticasone alone or placebo, reduced endobronchial concentrations of myeloid DCs (median decrease: 24%), macrophages (median decrease: 26%) and neutrophils (median decrease: 76%).", {"entities": []}], ["In contrast, fluticasone reduced plasmacytoid DC concentrations independently of salmeterol.", {"entities": []}], ["There were no changes in the expression of function-associated surface molecules on myeloid DC (such as CD1a, Langerin, BDCA-1, CD83 or CCR5) in all groups after treatment.", {"entities": [[104, 108, "GENE"], [128, 132, "GENE"], [136, 140, "GENE"]]}], ["Fluticasone (either alone or in combination with salmeterol) suppressed T-cell proliferation in co-cultures with blood myeloid DCs from smokers.", {"entities": []}], ["Resistance to ICS monotherapy in smokers might in part be due to lacking effects on airway myeloid DCs, whereas the increased risk for infections during ICS therapy could be attributable to a reduction in plasmacytoid DCs.", {"entities": []}], ["Combination therapy of fluticasone with salmeterol is associated with a reduction in airway myeloid DCs, but also airway macrophages and neutrophils.", {"entities": []}], ["Registered at ClinicalTrials.gov (identifier: NCT00908362 ) and the European Clinical Trial Database, EudraCT (identifier: 2009-009459-40 ).", {"entities": []}], ["The purpose of this study was to examine the inter- and intra-rater reliability of an electronic inspiratory loading device for the assessment of pulmonary functions: maximum inspiratory pressure, peak inspiratory flow, and vital capacity.", {"entities": []}], ["Subjects were 50 patient volunteers in a rehabilitation hospital who had experienced their first episode of unilateral stroke with hemiparesis during the previous 6 months (26 men, 24 women; mean age [\u00b1SD], 55.96 [\u00b112.81] years), with no use of medications that could induce drowsiness, evidence of restrictive lung disease, history of asthma, use of psychotropic drugs, or alcohol consumption habit.", {"entities": [[336, 342, "DISEASE"], [311, 323, "DISEASE"]]}], ["Maximum inspiratory pressure, peak inspiratory flow, and vital capacity for pulmonary functions were assessed using an electronic inspiratory loading device (PowerBreathe, K5, 2010) by 2 examiners, with patients in an unassisted sitting position, and 1 examiner re-assessed with same patients at the same time of a day after 1 week.", {"entities": []}], ["Intra-class correlation coefficients were used to assess reliability.", {"entities": []}], ["Intra-rater reliability ranged from intra-class correlation coefficients (ICCs)=0.959 to 0.986 in variables.", {"entities": []}], ["For the inter-rater reliability between 2 examiners, the ICCs ranged from 0.933 to 0.985.", {"entities": []}], ["Intra-rater and inter-rater reliability were good in variables (maximal inspiratory pressure, peak inspiratory flow, and vital capacity).", {"entities": []}], ["The intra- and inter-examiner reliability of the pulmonary function measurements, maximum inspiratory pressure, peak inspiratory flow, and vital capacity, for the post-stroke patients was very high.", {"entities": []}], ["The results suggest that the electronic inspiratory loading device would be useful for clinical rehabilitative assessment of pulmonary function.", {"entities": []}], ["Eotaxin is a member of the C-C family of chemokines and is related during antigen challenge in a guinea pig model of allergic airway inflammation (asthma).", {"entities": [[147, 153, "DISEASE"]]}], ["Consistent with its putative role in eosinophilic inflammation, eotaxin induces the selective infiltration of eosinophils when injected into the lung and skin.", {"entities": []}], ["Using a guinea pig lung cDNA library, we have cloned full-length eotaxin cDNA.", {"entities": []}], ["The cDNA encodes a protein of 96 amino acids, including a putative 23-amino acid hydrophobic leader sequence, followed by 73 amino acids composing the mature active eotaxin protein.", {"entities": []}], ["The protein-coding region of this cDNA is 73, 71, 50, and 48% identical in nucleic acid sequence to those of human macrophage chemoattractant protein (MCP) 3, MCP-1, macrophage inflammatory protein (MIP) 1 alpha, and RANTES, respectively.", {"entities": [[199, 202, "GENE"]]}], ["Analysis of genomic DNA suggested that there is a single eotaxin gene in guinea pig which is apparently conserved in mice.", {"entities": []}], ["High constitutive levels of eotaxin mRNA expression were observed in the lung, while the intestines, stomach, spleen, liver, heart, thymus, testes, and kidney expressed lower levels.", {"entities": []}], ["To determine if eotaxin mRNA levels are elevated during allergen-induced eosinophilic airway inflammation, ovalbumin (OVA)-sensitized guinea pigs were challenged with aerosolized antigen.", {"entities": []}], ["Compared with the lungs from saline-challenged animals, eotaxin mRNA levels increased sixfold within 3 h and returned to baseline by 6 h. Thus, eotaxin mRNA levels are increased in response to allergen challenge during the late phase response.", {"entities": []}], ["The identification of constitutive eotaxin mRNA expression in multiple tissues suggests that in addition to regulating airway eosinophilia, eotaxin is likely to be involved in eosinophil recruitment into other tissues as well as in baseline tissue homing.", {"entities": [[126, 138, "DISEASE"]]}], ["BACKGROUND: Long-term administration of macrolide antibiotics is recognized to be able to favorably modify the clinical condition of inflammatory diseases, such as diffuse panbronchiolitis and cystic fibrosis.", {"entities": [[193, 208, "DISEASE"]]}], ["However, the precise mechanisms by which macrolide antibiotics could improve clinical conditions of the patients are not well understood.", {"entities": []}], ["AIM: The present study was designed to examine the influence of macrolide antibiotics on effector cell functions responsible for inflammation through the choice of roxithromycin (RXM) and mast cell.", {"entities": []}], ["METHODS: Mast cells were induced by long-term culture of splenocytes from BALB/c mice.", {"entities": []}], ["RXM was added to the cultures at seeding and then every 4-5 days, when the culture medium was replaced with a fresh one.", {"entities": []}], ["The influence of RXM on mast cell growth was evaluated by counting the number of cells grown on the 16th day.", {"entities": []}], ["We also examined the influence of RXM on mast cell activation by examining histamine release and inflammatory cytokine secretion.", {"entities": []}], ["RESULTS AND CONCLUSION: RXM could not inhibit mast cell growth, even when splenocytes were exposed to 100 microg/ml of RXM throughout the entire culture periods.", {"entities": []}], ["RXM also could not suppress histamine release from cultured mast cells in response to non-immunological and immunological stimulations.", {"entities": []}], ["However, RXM could suppress inflammatory cytokine, interleukin-1beta, interleukin-6, granulocyte macrophage-colony stimulating factor and tumor necrosis factor-alpha, secretions induced by concanavalin A stimulation at a concentration of as little as 0.5 microg/ml.", {"entities": []}], ["These results may suggest that RXM modulated the ability of mast cells to secrete inflammatory cytokines and results in improvement of clinical condition of chronic inflammatory diseases.", {"entities": []}], ["Type II Diabetes (T2DM) dramatically impairs the tendon healing response, resulting in decreased collagen organization and mechanics relative to non-diabetic tendons.", {"entities": []}], ["Despite this burden, there remains a paucity of information regarding the mechanisms that govern impaired healing of diabetic tendons.", {"entities": []}], ["Mice were placed on either a high fat diet (T2DM) or low fat diet (lean) and underwent flexor tendon transection and repair surgery.", {"entities": []}], ["Healing was assessed via mechanical testing, histology and changes in gene expression associated with collagen synthesis, matrix remodeling, and macrophage polarization.", {"entities": []}], ["Obese/diabetic tendons healed with increased scar formation and impaired mechanical properties.", {"entities": []}], ["Consistent with this, prolonged and excess expression of extracellular matrix (ECM) components were observed in obese/T2DM tendons.", {"entities": []}], ["Macrophages are involved in both inflammatory and matrix deposition processes during healing.", {"entities": []}], ["Obese/T2DM tendons healed with increased expression of markers of pro-inflammatory M1 macrophages, and elevated and prolonged expression of M2 macrophages markers that are involved in ECM deposition.", {"entities": []}], ["Here we demonstrate that tendons from obese/diabetic mice heal with increased scar formation and increased M2 polarization, identifying excess M2 macrophage activity and matrix synthesis as a potential mechanism of the fibrotic healing phenotype observed in T2DM tendons, and as such a potential target to improve tendon healing in T2DM.", {"entities": []}], ["Aegle marmelos leaf, seed and fruit from earlier studies is known to affect male fertility in reversible manner.", {"entities": []}], ["However they had delayed onset and recovery was found to be prolonged.", {"entities": []}], ["The present study was undertaken with an aim to evaluate the effect of Aegle marmelos bark extract on rats as the extract is found to be a rich source of marmin and fagarine known for reducing male fertility.", {"entities": []}], ["Three different concentration of methanolic bark extracts of Aegle marmelos (L.) were evaluated for male antifertility activity on albino wistar rats.", {"entities": []}], ["Methanolic bark extract of Aegle marmelos at the dose of 200, 400, and 600 mg/Kg b.w was administered orally for 60 days.", {"entities": []}], ["Treatments were stopped thereafter and animals were sacrificed after a recovery period of 30 days.", {"entities": []}], ["Control animal were administered vehicle (0.5% CMC for 60 days).", {"entities": []}], ["Lonidamine was used as standard drug to compare the effect of extract.", {"entities": []}], ["Methanolic extract causes a dose & duration dependent infertility via reducing reproductive organ weight and serum testosterone levels.", {"entities": [[54, 65, "DISEASE"]]}], ["Sperm analysis results showed reduction in sperm density, motility, viability and sperm acrosomal integrity without interfering libido and vital organ body weight.", {"entities": []}], ["Histopathological studies of testes revealed exfoliation of elongated spermatids, nuclear chromatin condensation, degeneration and prominent spaces detected within the germinal epithelium signifying testicular cytotoxicity and necrosis.", {"entities": []}], ["Time dependent complete infertility was observed in all dose levels.", {"entities": [[24, 35, "DISEASE"]]}], ["Animals after the withdrawal from treatment, for 30 days showed restoration of the morphological as well as physiological parameters in extract treated rats.", {"entities": []}], ["Methanolic extract showed lipid lowering activity compared to control, suggestive good candidature of this plant for further studies.", {"entities": []}], ["Our studies suggested Aegle marmelos barks methanolic extract as strong candidate for male contraceptive via its ability to produce complete inhibition of pregnancy, rapid restoration of fertility after withdrawal from treatment and its lipid correcting ability proving further beneficial effects.", {"entities": []}], ["MUC5AC was deemed to be involved in gastric carcinogenesis since aberrant MUC5AC expression has been repeatedly detected in patients with gastric cancer (GC).", {"entities": [[146, 152, "DISEASE"], [154, 156, "GENE"]]}], ["In this study, length polymorphisms in a complicated repetitive region adjacent to MUC5AC promoter were assessed in 230 patients with GC and 328 cancer-free controls.", {"entities": [[145, 151, "DISEASE"], [134, 136, "GENE"]]}], ["Alleles of 1.4 and 1.8 kb were significantly more prevalent in GC group than in controls.", {"entities": [[63, 65, "GENE"]]}], ["In contrast, 2.3 and 2.8 kb alleles occurred at significantly lower frequencies in patients than in controls.", {"entities": []}], ["Alleles were then classified into susceptible (S; 1.4 and 1.8 kb), protective (P; 2.3 and 2.8 kb) and null (N; all other alleles) categories with respect to their linkage with the susceptibility to GC.", {"entities": [[198, 200, "GENE"]]}], ["Individuals with genotype SS had a 2.7-fold increased risk of GC occurrence, but PN genotype was associated with a significantly reduced risk of this cancer.", {"entities": [[150, 156, "DISEASE"], [62, 64, "GENE"]]}], ["Moreover, homozygous or heterozygous individuals with one or two copies of 1.4 kb allele showed an earlier age of onset and more advanced metastasis stage compared with patients without this allele (Bonferroni corrected p\u200a=\u200a1.35\u00d710 MUC5AC upstream repetitive region are associated with the susceptibility and progression of GC.", {"entities": [[324, 326, "GENE"]]}], ["Urinary incontinence (UI) is associated with worse health among older adults.", {"entities": []}], ["Little is known however, about its relation with loneliness or the role of mental health in this association.", {"entities": []}], ["This study examined these factors among older adults in Ireland.", {"entities": []}], ["Data were analyzed from 6903 community-dwelling adults aged\u2009\u2265\u200950 collected in the first wave of The Irish Longitudinal Study on Ageing (TILDA) in 2009\u201311.", {"entities": []}], ["Information was obtained on the self-reported occurrence (yes/no) and severity (frequency/activity limitations) of UI in the past 12\u00a0months.", {"entities": []}], ["Loneliness was measured using the UCLA Loneliness Scale short form.", {"entities": []}], ["Information was also obtained on depression (CES-D), anxiety (HADS-A) and other sociodemographic variables.", {"entities": []}], ["Logistic regression analysis was used to examine the association between variables.", {"entities": []}], ["In a model adjusted for all potential confounders except mental disorders, compared to no UI, any UI was associated with significantly higher odds for loneliness (odds ratio: 1.51).", {"entities": []}], ["When depression was included in the analysis, the association was attenuated and became non-significant while the inclusion of anxiety had a much smaller effect.", {"entities": []}], ["Similarly, although frequency of UI and activity limitations due to UI were both significantly associated with loneliness prior to adjustment for mental disorders, neither association remained significant after adjustment for both depression and anxiety.", {"entities": []}], ["UI is associated with higher odds for loneliness among older community-dwelling adults but this association is largely explained by comorbid mental health problems, in particular, depression.", {"entities": []}], ["Antimicrobial peptides (AMPs) are endogenous antibiotics that directly affect microorganisms, and also have a variety of receptor-mediated functions.", {"entities": []}], ["One such AMP, Tilapia piscidin 4 (TP4), was isolated from Nile tilapia ( Oreochromis niloticus ); TP4 has antibacterial effects and regulates the innate immune system.", {"entities": []}], ["The aim of the present study was to characterize the role of TP4 in the regulation of wound closure in mice and proliferation of a keratinocyte cell line (HaCaT) and fibroblast cell line (Hs-68).", {"entities": []}], ["In vitro , TP4 stimulated cell proliferation and activated collagen I, collagen III, and keratinocyte growth factor (KGF) gene expression in Hs-68 cells, which induces keratin production by HaCaT cells.", {"entities": []}], ["This effect was detectable at TP4 concentrations of 6.25 \u00b5g/mL in both cell lines.", {"entities": []}], ["In vivo , TP4 was found to be highly effective at combating peritonitis and wound infection caused by MRSA in mouse models, without inducing adverse behavioral effects or liver or kidney toxicity.", {"entities": [[60, 71, "DISEASE"]]}], ["Taken together, our results indicate that TP4 enhances the survival rate of mice infected with the bacterial pathogen MRSA through both antimicrobial and wound closure activities mediated by epidermal growth factor (EGF), transforming growth factor (TGF), and vascular endothelial growth factor (VEGF).", {"entities": [[216, 219, "GENE"]]}], ["The peptide is likely involved in antibacterial processes and regulation of tissue homeostasis in infected wounds in mice.", {"entities": []}], ["Overall, these results suggest that TP4 may be suitable for development as a novel topical agent for wound dressing.", {"entities": []}], ["Nurses\u2019 risk assessments of patients at risk of deterioration are sometimes suboptimal.", {"entities": []}], ["Advances in clinical simulation mean higher quality information can be used as an alternative to traditional paper-based approaches as a means of improving judgement.", {"entities": []}], ["This paper tests the hypothesis that nurses\u2019 judgement strategies and policies change as the quality of information used by nurses in simulation changes.", {"entities": []}], ["Sixty-three student nurses and 34 experienced viewed 25 paper-case based and 25 clinically simulated scenarios, derived from real cases, and judged whether the (simulated) patient was at \u2018risk\u2019 of acute deterioration.", {"entities": []}], ["Criteria of judgement \u201ccorrectness\u201d came from the same real cases.", {"entities": []}], ["Information relative weights were calculated to examine judgement policies of individual nurses.", {"entities": []}], ["Group comparisons of nurses and students under both paper and clinical simulation conditions were undertaken using non parametric statistical tests.", {"entities": []}], ["Judgment policies were also compared to the ecological statistical model.", {"entities": []}], ["Cumulative relative weights were calculated to assess how much information nurses used when making judgements.", {"entities": []}], ["Receiver operating characteristic (ROC) curves were generated to examine predictive accuracy amongst the nurses.", {"entities": []}], ["There were significant variations between nurses\u2019 judgement policies and those optimal policies determined by the ecological model.", {"entities": []}], ["Nurses significantly underused the cues of consciousness level, respiration rate, and systolic blood pressure than the ecological model requires.", {"entities": []}], ["However, in clinical simulations, they tended to make appropriate use of heart rate, with non-significant difference in the relative weights of heart rate between clinical simulations and the ecological model.", {"entities": []}], ["Experienced nurses paid substantially more attention to respiration rate in the simulated setting compared to paper cases, while students maintained a similar attentive level to this cue.", {"entities": []}], ["This led to a non-significant difference in relative weights of respiration rate between experienced nurses and students.", {"entities": []}], ["Improving the quality of information by clinical simulations significantly impacted on nurses\u2019 judgement policies of risk assessments.", {"entities": []}], ["Nurses\u2019 judgement strategies also varied with the increased years of experience.", {"entities": []}], ["Such variations in processing clinical information may contribute to nurses\u2019 suboptimal judgements in clinical practice.", {"entities": []}], ["Constructing predictive models of common judgement situations, and increasing nurses\u2019 awareness of information weightings in such models may help improve judgements made by nurses.", {"entities": []}], ["The online version of this article (doi:10.1186/s12911-016-0243-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Eosinophils are multifunctional leukocytes that reside in the gastrointestinal (GI) lamina propria, where their basal function remains largely unexplored.", {"entities": []}], ["In this study, by examining mice with a selective deficiency of systemic eosinophils (by lineage ablation) or GI eosinophils (eotaxin-1/2 double\u2013deficient or CC chemokine receptor 3\u2013deficient), we show that eosinophils support immunoglobulin A (IgA) class switching, maintain intestinal mucus secretions, affect intestinal microbial composition, and promote the development of Peyer\u2019s patches.", {"entities": []}], ["Eosinophil-deficient mice showed reduced expression of mediators of secretory IgA production, including intestinal interleukin 1\u03b2 (IL-1\u03b2), inducible nitric oxide synthase, lymphotoxin (LT) \u03b1, and LT-\u03b2, and reduced levels of retinoic acid-related orphan receptor gamma t\u2013positive (ROR-\u03b3t", {"entities": [[185, 187, "GENE"], [196, 198, "GENE"]]}], ["Picrorhiza kurrooa Royle ex Benth.", {"entities": []}], ["is an endangered plant species of medicinal importance.", {"entities": []}], ["The medicinal property is attributed to monoterpenoids picroside I and II, which are modulated by temperature.", {"entities": []}], ["The transcriptome information of this species is limited with the availability of few hundreds of expressed sequence tags (ESTs) in the public databases.", {"entities": []}], ["In order to gain insight into temperature mediated molecular changes, high throughput de novo transcriptome sequencing and analyses were carried out at 15\u00b0C and 25\u00b0C, the temperatures known to modulate picrosides content.", {"entities": []}], ["Using paired-end (PE) Illumina sequencing technology, a total of 20,593,412 and 44,229,272 PE reads were obtained after quality filtering for 15\u00b0C and 25\u00b0C, respectively.", {"entities": []}], ["Available (e.g., De-Bruijn/Eulerian graph) and in-house developed bioinformatics tools were used for assembly and annotation of transcriptome.", {"entities": []}], ["A total of 74,336 assembled transcript sequences were obtained, with an average coverage of 76.6 and average length of 439.5.", {"entities": []}], ["Guanine-cytosine (GC) content was observed to be 44.6%, while the transcriptome exhibited abundance of trinucleotide simple sequence repeat (SSR; 45.63%) markers.", {"entities": [[18, 20, "GENE"]]}], ["Large scale expression profiling through \"read per exon kilobase per million (RPKM)\", showed changes in several biological processes and metabolic pathways including cytochrome P450s ( CYPs ), UDP-glycosyltransferases ( UGTs ) and those associated with picrosides biosynthesis.", {"entities": []}], ["RPKM data were validated by reverse transcriptase-polymerase chain reaction using a set of 19 genes, wherein 11 genes behaved in accordance with the two expression methods.", {"entities": []}], ["Study generated transcriptome of P. kurrooa at two different temperatures.", {"entities": []}], ["Large scale expression profiling through RPKM showed major transcriptome changes in response to temperature reflecting alterations in major biological processes and metabolic pathways, and provided insight of GC content and SSR markers.", {"entities": [[209, 211, "GENE"]]}], ["Analysis also identified putative CYPs and UGTs that could help in discovering the hitherto unknown genes associated with picrosides biosynthesis.", {"entities": []}], ["Precise cancer classification is a central challenge in clinical cancer research such as diagnosis, prognosis and metastasis prediction.", {"entities": [[8, 14, "DISEASE"], [65, 71, "DISEASE"]]}], ["Most existing cancer classification methods based on gene or metabolite biomarkers were limited to single genomics or metabolomics, and lacked integration and utilization of multiple \u2018omics\u2019 data.", {"entities": [[14, 20, "DISEASE"]]}], ["The accuracy and robustness of these methods when applied to independent cohorts of patients must be improved.", {"entities": []}], ["In this study, we propose a directed random walk-based method to evaluate the topological importance of each gene in a reconstructed gene\u2013metabolite graph by integrating information from matched gene expression profiles and metabolomic profiles.", {"entities": []}], ["The joint use of gene and metabolite information contributes to accurate evaluation of the topological importance of genes and reproducible pathway activities.", {"entities": []}], ["We constructed classifiers using reproducible pathway activities for precise cancer classification and risk metabolic pathway identification.", {"entities": [[77, 83, "DISEASE"]]}], ["We applied the proposed method to the classification of prostate cancer.", {"entities": [[65, 71, "DISEASE"], [56, 71, "DISEASE"]]}], ["Within-dataset experiments and cross-dataset experiments on three independent datasets demonstrated that the proposed method achieved a more accurate and robust overall performance compared to several existing classification methods.", {"entities": []}], ["The resulting risk pathways and topologically important differential genes and metabolites provide biologically informative models for prostate cancer prognosis and therapeutic strategies development.", {"entities": [[144, 150, "DISEASE"], [135, 150, "DISEASE"]]}], ["Radotinib, developed as a BCR/ABL tyrosine kinase inhibitor (TKI), is approved for the second-line treatment of chronic myeloid leukemia (CML) in South Korea.", {"entities": [[112, 136, "DISEASE"], [120, 136, "DISEASE"], [128, 136, "DISEASE"]]}], ["However, therapeutic effects of radotinib in acute myeloid leukemia (AML) are unknown.", {"entities": [[51, 67, "DISEASE"], [45, 67, "DISEASE"], [59, 67, "DISEASE"]]}], ["In the present study, we demonstrate that radotinib significantly decreases the viability of AML cells in a dose-dependent manner.", {"entities": []}], ["Kasumi-1 cells were more sensitive to radotinib than NB4, HL60, or THP-1 cell lines.", {"entities": []}], ["Furthermore, radotinib induced CD11b expression in NB4, THP-1, and Kasumi-1 cells either in presence or absence of all trans-retinoic acid (ATRA).", {"entities": []}], ["We found that radotinib promoted differentiation and induced CD11b expression in AML cells by downregulating LYN.", {"entities": [[109, 112, "GENE"]]}], ["However, CD11b expression induced by ATRA in HL60 cells was decreased by radotinib through upregulation of LYN.", {"entities": [[107, 110, "GENE"]]}], ["Furthermore, radotinib mainly induced apoptosis of CD11b \u0394\u03a8 m ) in CD11b", {"entities": []}], ["Presepsin levels are known to be increased in sepsis.", {"entities": []}], ["The aim of this study was to evaluate the early diagnostic and prognostic value of Presepsin compared with procalcitonin (PCT), Mortality in Emergency Department Sepsis (MEDS) score and Acute Physiology and Chronic Health Evaluation II (APACHE II) score in septic patients in an emergency department (ED) and to investigate Presepsin as a new biomarker of sepsis.", {"entities": []}], ["This study enrolled 859 consecutive patients with at least two diagnostic criteria for systemic inflammatory response syndrome (SIRS) who were admitted to Beijing Chao-yang Hospital ED from December 2011 to October 2012, and 100 age-matched healthy controls.", {"entities": [[118, 126, "DISEASE"]]}], ["Patients were stratified into four groups: SIRS, sepsis, severe sepsis, and septic shock.", {"entities": []}], ["Plasma Presepsin and serum PCT were measured, and MEDS score and APACHE II score were calculated at enrollment.", {"entities": []}], ["Comparisons were analyzed using the Kruskal-Wallis and Mann\u2013Whitney U tests.", {"entities": []}], ["On admission, the median levels of plasma Presepsin increased with sepsis severity.", {"entities": []}], ["The areas under the receiver operating characteristic (AUC) curves of Presepsin were greater than those of PCT in diagnosing sepsis, and predicting severe sepsis and septic shock.", {"entities": []}], ["The AUC of Presepsin for predicting 28-day mortality in septic patients was slightly lower than that of PCT, MEDS score and APACHE II score.", {"entities": []}], ["The AUC of a combination of Presepsin and MEDS score or APACHE II score was significantly higher than that of MEDS score or APACHE II score alone in predicting severe sepsis, and was markedly higher than that of Presepsin alone in predicting septic shock and 28-day mortality in septic patients, respectively.", {"entities": []}], ["Plasma Presepsin levels in septic patients were significantly higher in non-survivors than in survivors at 28\u00a0days\u2019 follow-up.", {"entities": []}], ["Presepsin, MEDS score and APACHE II score were found to be independent predictors of severe sepsis, septic shock and 28-day mortality in septic patients.", {"entities": []}], ["The levels of plasma Presepsin were positively correlated with PCT, MEDS score and APACHE II score in every septic group.", {"entities": []}], ["Presepsin is a valuable biomarker for early diagnosis of sepsis, risk stratification, and evaluation of prognosis in septic patients in the ED.", {"entities": []}], ["In Taiwan, oral cancer has causally been associated with environmental carcinogens.", {"entities": [[16, 22, "DISEASE"]]}], ["Intercellular adhesion molecule (ICAM)-1, a cell adhesion molecule with a key role in inflammation and immunosurveillance, was implicated in carcinogenesis by facilitating instability in the tumor environment.", {"entities": []}], ["The current study explored the combined effect of ICAM-1 gene polymorphisms and exposure to environmental carcinogens on the susceptibility of developing oral squamous cell carcinoma (OSCC) and the clinicopathological characteristics of the tumors.", {"entities": [[173, 182, "DISEASE"], [159, 182, "DISEASE"]]}], ["Four single-nucleotide polymorphisms (SNPs) of the ICAM-1 gene from 595 patients with oral cancer and 561 non-cancer controls were analyzed by a real-time PCR.", {"entities": [[91, 97, "DISEASE"], [110, 116, "DISEASE"]]}], ["We found that the ICAM-1 rs5498 polymorphism and the TAGG or TACG haplotype of 4 ICAM-1 SNPs (rs3093030, rs5491, rs281432, and rs5498) combined were associated with oral-cancer susceptibility.", {"entities": [[170, 176, "DISEASE"]]}], ["Among 727 smokers, ICAM-1 polymorphisms carriers with the betel-nut chewing habit had a 27.49\u201336.23-fold greater risk of having oral cancer compared to ICAM-1 wild-type (WT) carriers without the betel-nut chewing habit.", {"entities": [[133, 139, "DISEASE"]]}], ["Among 549 betel-nut chewers, ICAM-1 polymorphisms carriers who smoked had a 9.93\u201314.27-fold greater risk of having oral cancer compared to those who carried the WT but did not smoke.", {"entities": [[120, 126, "DISEASE"]]}], ["Finally, patients with oral cancer who had at least 1 T allele of ICAM-1 rs5491 or 1 G allele of rs281432 were at lower risk of developing an advanced clinical stage (III/IV) ( p <0.05), compared to those patients with AA or CC homozygotes.", {"entities": [[28, 34, "DISEASE"]]}], ["Our results suggest that the ICAM-1 rs5498 SNP and either of 2 haplotypes of 4 SNPs combined have potential predictive significance in oral carcinogenesis.", {"entities": []}], ["Gene-environment interactions of ICAM-1 polymorphisms, smoking, and betel-nut chewing might alter oral-cancer susceptibility.", {"entities": [[103, 109, "DISEASE"]]}], ["ICAM-1 rs5491 and rs281432 may be applied as factors to predict the clinical stage in OSCC patients.", {"entities": []}], ["The most simple and commonly used approach for genetic associations is the case-control study design of unrelated people.", {"entities": []}], ["This design is susceptible to population stratification.", {"entities": []}], ["This problem is obviated in family-based studies, but it is usually difficult to accumulate large enough samples of well-characterized families.", {"entities": []}], ["We addressed empirically whether the two designs give similar estimates of association in 93 investigations where both unrelated case-control and family-based designs had been employed.", {"entities": []}], ["Estimated odds ratios differed beyond chance between the two designs in only four instances (4%).", {"entities": []}], ["The summary relative odds ratio (ROR) (the ratio of odds ratios obtained from unrelated case-control and family-based studies) was close to unity (0.96 [95% confidence interval, 0.91\u20131.01]).", {"entities": []}], ["There was no heterogeneity in the ROR across studies (amount of heterogeneity beyond chance I p < 0.05) or not with the two designs were common (opposite classification rates 14% and 17%); this reflected largely differences in power.", {"entities": []}], ["Conclusions were largely similar in diverse subgroup analyses.", {"entities": []}], ["Unrelated case-control and family-based designs give overall similar estimates of association.", {"entities": []}], ["We cannot rule out rare large biases or common small biases.", {"entities": []}], ["Different types of designs are used for the assessment of genetic associations for complex diseases.", {"entities": []}], ["Case-control studies of unrelated people and family-based designs are the most widely used.", {"entities": []}], ["Each has its advantages and disadvantages.", {"entities": []}], ["This paper compares the estimates of the two types of design using a meta-analytic approach, i.e.", {"entities": []}], ["a systematic selection of data and quantitative synthesis of results across many studies.", {"entities": []}], ["The authors examined 93 associations where both unrelated case-control and family-based designs had been employed.", {"entities": []}], ["Both designs gave overall similar estimates of association and the conclusions were very similar in subgroup analyses that considered various design features that might affect in theory the degree of agreement between the two designs.", {"entities": []}], ["No heterogeneity between studies was observed.", {"entities": []}], ["Hence, there was no consistent pattern of over-estimation or under-estimation of the probed association with one or the other design.", {"entities": []}], ["However, one cannot exclude the possibility that rare large differences or common small differences may occur between the two designs.", {"entities": []}], ["Post hoc analyses from the B-type natriuretic peptide for Acute Shortness of Breath Evaluation (BASEL)-II-ICU study suggest an association between beta-blocker usage at admission and improved mortality in patients treated in the intensive care unit for acute respiratory failure.", {"entities": [[259, 278, "DISEASE"]]}], ["Although this evidence is encouraging, there is a need for a phase 2 proof-of-concept randomized controlled trial of beta-blocker therapy in patients admitted with acute respiratory failure.", {"entities": [[170, 189, "DISEASE"]]}], ["Despite significant research efforts on cancer therapy, diagnostics and imaging, many challenges remain unsolved.", {"entities": [[40, 46, "DISEASE"]]}], ["There are many unknown details regarding the interaction of nanoparticles (NPs) and biological systems.", {"entities": [[75, 78, "GENE"]]}], ["The structure and properties of gold nanoparticles (GNPs) make them useful for a wide array of biological applications.", {"entities": []}], ["However, for the application of GNPs in therapy and drug delivery, knowledge regarding their bioaccumulation and associated local or systemic toxicity is necessary.", {"entities": []}], ["Information on the biological fate of NPs, including distribution, accumulation, metabolism, and organ specific toxicity is still minimal.", {"entities": [[38, 41, "GENE"]]}], ["Studies specifically dealing with the toxicity of NPs are rare.", {"entities": [[50, 53, "GENE"]]}], ["The aim of the present study was to investigate the effects of intraperitoneal administration of GNPs on histological alterations of the heart tissue of rats in an attempt to identify and understand the toxicity and the potential role of GNPs as a therapeutic and diagnostic tool.", {"entities": []}], ["A total of 40 healthy male Wistar-Kyoto rats received 50 \u03bcl infusions of 10, 20 and 50 nm GNPs for 3 or 7 days.", {"entities": []}], ["Animals were randomly divided into groups: 6 GNP-treated rats groups and one control group (NG).", {"entities": []}], ["Groups 1, 2 and 3 received infusions of 50 \u03bcl GNPs of size 10 nm (3 or 7 days), 20 nm (3 or 7 days) and 50 nm (3 or 7 days), respectively.", {"entities": []}], ["In comparison with the respective control rats, exposure to GNPs doses produced heart muscle disarray with a few scattered chronic inflammatory cells infiltrated by small lymphocytes, foci of hemorrhage with extravasation of red blood cells, some scattered cytoplasmic vacuolization and congested and dilated blood vessels.", {"entities": []}], ["None of the above alterations were observed in the heart muscle of any member of the control group.", {"entities": []}], ["The alterations induced by intraperitoneal administration of GNPs were size-dependent, with smaller ones inducing greater affects, and were also related to the time exposure to GNPs.", {"entities": []}], ["These alterations may indicate scattered cytoplasmic vacuolization, which may induce the toxicity effect through an inability to deal with the accumulated residues resulting from metabolic and structural disturbances caused by these NPs.", {"entities": [[233, 236, "GENE"]]}], ["These histological alterations were more prominent with 10 nm size particles than with the larger ones.", {"entities": []}], ["The interaction of GNPs with proteins and various cell types should be considered as part of the toxicological evaluation.", {"entities": []}], ["Additional experiments related to plasma, tissues cytokine, antioxidant defense mechanism, lipid peroxidation, histomorphologcal and ultrastructure will be performed to identify and understand the toxicity and the potential use of GNPs as therapeutic and diagnostic tools.", {"entities": []}], ["Local and regional scientific journals are important factors in bridging gaps in health knowledge translation in low-and middle-income countries.", {"entities": []}], ["We assessed indexing, citations and publishing standards of journals from the Eastern Mediterranean region.", {"entities": []}], ["For journals from 22 countries in the collection of the Index Medicus for the Eastern Mediterranean Region (IMEMR), we analyzed indexing in bibliographical databases and citations during 2006\u20132009 to published items in 2006 in Web of Science (WoS) and SCOPUS.", {"entities": []}], ["Adherence to editorial and publishing standards was assessed using a special checklist.", {"entities": []}], ["Out of 419 journals in IMEMR, 19 were indexed in MEDLINE, 23 in WoS and 46 in SCOPUS.", {"entities": []}], ["Their impact factors ranged from 0.016 to 1.417.", {"entities": []}], ["For a subset of 175 journals with available tables of contents from 2006, articles published in 2006 from 93 journals received 2068 citations in SCOPUS (23.5% self-citations) and articles in 86 journals received 1579 citations in WoS (24.3% self-citations) during 2006\u20132009.", {"entities": []}], ["Citations to articles came mostly from outside of the Eastern Mediterranean region (76.8% in WoS and 75.4% in SCOPUS).", {"entities": []}], ["Articles receiving highest number of citations presented topics specific for the region.", {"entities": []}], ["Many journals did not follow editorial and publishing standards, such addressing requirements about the patient\u2019s privacy rights (68.0% out of 244 analyzed), policy on managing conflicts of interest (66.4%), and ethical conduct in clinical and animal research (66.4%).", {"entities": []}], ["Journals from the Eastern Mediterranean are visible in and have impact on global scientific community.", {"entities": []}], ["Coordinated effort of all stakeholders in journal publishing, including researchers, journal editors and owners, policy makers and citation databases, is needed to further promote local journals as windows to the research in the developing world and the doors for valuable regional research to the global scientific community.", {"entities": []}], ["The incidence of pulmonary nontuberculous mycobacterial (NTM) infections has increased in recent decades.", {"entities": [[57, 60, "GENE"]]}], ["Nevertheless, NTM pleurisy is still a rare disease.", {"entities": [[18, 26, "DISEASE"], [14, 17, "GENE"]]}], ["The objective of the present study was to elucidate the clinical features and outcomes of NTM pleurisy.", {"entities": [[94, 102, "DISEASE"], [90, 93, "GENE"]]}], ["A retrospective study was undertaken of consecutive patients whose pleural effusion culture yielded NTM, from 2002 to 2016 at a respiratory hospital in Japan.", {"entities": [[100, 103, "GENE"]]}], ["The clinical features, treatment, and outcomes of these patients were analyzed.", {"entities": []}], ["The 12 patients with NTM pleurisy were predominantly male, with a median age of 69 years (range, 48-93 years).", {"entities": [[25, 33, "DISEASE"], [21, 24, "GENE"]]}], ["They included eight patients with a history of smoking and six patients with immunosuppressive comorbidities such as malignancy, diabetes mellitus, and conditions requiring steroid administration.", {"entities": [[129, 146, "DISEASE"]]}], ["Fibrocavitary disease was the most common radiographic feature of these patients, and Mycobacterium avium complex was the most common pathogen.", {"entities": []}], ["Pneumothorax was complicated in 11 patients.", {"entities": [[0, 12, "DISEASE"]]}], ["Surgery was performed on seven patients, in addition to thoracic drainage for the treatment of pleurisy and pneumothorax.", {"entities": [[95, 103, "DISEASE"], [108, 120, "DISEASE"]]}], ["Three patients died of respiratory failure.", {"entities": [[23, 42, "DISEASE"]]}], ["Pneumothorax is a frequent complication of NTM pleurisy, often making the condition difficult to treat.", {"entities": [[47, 55, "DISEASE"], [0, 12, "DISEASE"], [43, 46, "GENE"]]}], ["Surgery at an appropriate time should therefore considered for refractory cases.", {"entities": []}], ["A promoter polymorphism of the osteopontin (OPN) gene (rs28357094) has been associated with multiple inflammatory states, severity of Duchenne muscular dystrophy (DMD) and muscle size in healthy young adults.", {"entities": [[143, 161, "DISEASE"], [163, 166, "GENE"]]}], ["We sought to define the mechanism of action of the polymorphism, using allele-specific in vitro reporter assays in muscle cells, and a genotype-stratified intervention in healthy controls.", {"entities": []}], ["In vitro reporter constructs showed the G allele to respond to estrogen treatment, whereas the T allele showed no transcriptional response.", {"entities": []}], ["Young adult volunteers ( n = 187) were enrolled into a baseline study, and subjects with specific rs28357094 genotypes enrolled into an eccentric muscle challenge intervention [ n = 3 TT; n = 3 GG/GT (dominant inheritance model)].", {"entities": []}], ["Female volunteers carrying the G allele showed significantly greater inflammation and increased muscle volume change as determined by magnetic resonance imaging T1- and T2-weighted images after eccentric challenge, as well as greater decrement in biceps muscle force.", {"entities": []}], ["Our data suggest a model where the G allele enables enhanced activities of upstream enhancer elements due to loss of Sp1 binding at the polymorphic site.", {"entities": [[117, 120, "GENE"]]}], ["This results in significantly greater expression of the pro-inflammatory OPN cytokine during tissue remodeling in response to challenge in G allele carriers, promoting muscle hypertrophy in normal females, but increased damage in DMD patients.", {"entities": [[230, 233, "GENE"]]}], ["Galectins are a family of animal lectins comprising 15 members in vertebrates.", {"entities": []}], ["These proteins are involved in many biological processes including epithelial homeostasis and tumor progression by displaying intracellular and extracellular activities.", {"entities": []}], ["Hence Galectins can be found either in the cytoplasm or the nucleus, associated with membranes or in the extracellular matrix.", {"entities": []}], ["Current studies aim at understanding the roles of Galectins in cell-cell and cell-matrix adhesion, cellular polarity and motility.", {"entities": []}], ["This review discusses recent progress in defining the specificities and mechanisms of action of Galectins as cell regulators in epithelial cells.", {"entities": []}], ["Physiological, cellular and molecular aspects of Galectin specificities will be treated successively.", {"entities": []}], ["To determine if the effective use of Health Information Technologies (HIT) and the Electronic Medical Record (EMR) affects emergency department (ED) usage in a complicated frequently presenting patient population.", {"entities": []}], ["A retrospective, observational study of 45 patients enrolled in our Frequent User Program called Community Resources for Emergency Department Overuse (CREDO) between June 2005 and July 2007.", {"entities": []}], ["The study was conducted at an urban hospital with greater than 95,000 annual visits.", {"entities": []}], ["Patients served as their own historical controls.", {"entities": []}], ["In this pre-post study, the pre-intervention control period was determined by the number of months the patient had been enrolled in the program.", {"entities": []}], ["The pre- and post-intervention time periods were the same for each patient but varied between patients.", {"entities": []}], ["The intervention included using HIT to identify the most frequently presenting patients and creating individualized care plans for those patients.", {"entities": []}], ["The care plans were made available through the EMR to all healthcare providers.", {"entities": []}], ["Study variables in this study intervention included ED charges, lab studies ordered, number of ED visits, length of stay (LOS), and Total Emergency Department Contact Time (TEDCT), which is the product of the number of visits and the LOS.", {"entities": []}], ["We analyzed these variables using paired T-tests.", {"entities": []}], ["This study was approved by the institutional review board.", {"entities": []}], ["Forty-five patients were enrolled, but nine were excluded for no post enrollment visits; thus, statistical analysis was conducted with n=36.", {"entities": []}], ["The ED charges decreased by 24% from $64,721 to $49,208 (p=0.049).", {"entities": []}], ["The number of lab studies ordered decreased by 28% from 1847 to 1328 (p=0.04).", {"entities": []}], ["The average number of ED visits/patient decreased by 25% from 67.4 to 50.5 (p=0.046).", {"entities": []}], ["The TEDCT decreased by 39% from 443.7 hours to 270.6 hours (p=0.003).", {"entities": []}], ["In this pre-post analysis of an intervention targeting ED frequent users, the use of HIT and the EMR to identify patients and store easily accessible care plans significantly reduced ED charges, labs ordered, number of ED visits, and the TEDCT.", {"entities": []}], ["AGRICOH is a recently formed consortium of agricultural cohort studies involving 22 cohorts from nine countries in five continents: South Africa (1), Canada (3), Costa Rica (2), USA (6), Republic of Korea (1), New Zealand (2), Denmark (1), France (3) and Norway (3).", {"entities": []}], ["The aim of AGRICOH, initiated by the US National Cancer Institute (NCI) and coordinated by the International Agency for Research on Cancer (IARC), is to promote and sustain collaboration and pooling of data to investigate the association between a wide range of agricultural exposures and a wide range of health outcomes, with a particular focus on associations that cannot easily be addressed in individual studies because of rare exposures (e.g., use of infrequently applied chemicals) or relatively rare outcomes (e.g., certain types of cancer, neurologic and auto-immune diseases).", {"entities": [[49, 55, "DISEASE"], [132, 138, "DISEASE"], [540, 546, "DISEASE"]]}], ["To facilitate future projects the need for data harmonization of selected variables is required and is underway.", {"entities": []}], ["Altogether, AGRICOH provides excellent opportunities for studying cancer, respiratory, neurologic, and auto-immune diseases as well as reproductive and allergic disorders, injuries and overall mortality in association with a wide array of exposures, prominent among these the application of pesticides.", {"entities": [[66, 72, "DISEASE"]]}], ["Palytoxin (PLTX), one the most potent marine toxins, and/or its analogs, have been identified in different marine organisms, such as Palythoa soft corals, Ostreopsis dinoflagellates, and Trichodesmium cyanobacteria.", {"entities": []}], ["Although the main concern for human health is PLTXs entrance in the human food chain, there is growing evidence of adverse effects associated with inhalational, cutaneous, and/or ocular exposure to aquarium soft corals contaminated by PLTXs or aquaria waters.", {"entities": []}], ["Indeed, the number of case reports describing human poisonings after handling these cnidarians is continuously increasing.", {"entities": []}], ["In general, the signs and symptoms involve mainly the respiratory (rhinorrhea and coughing), skeletomuscular (myalgia, weakness, spasms), cardiovascular (electrocardiogram alterations), gastrointestinal (nausea), and nervous (paresthesia, ataxia, tremors) systems or apparates.", {"entities": []}], ["The widespread phenomenon, the entity of the signs and symptoms of poisoning and the lack of control in the trade of corals as aquaria decorative elements led to consider these poisonings an emerging sanitary problem.", {"entities": []}], ["This review summarizes literature data on human poisonings due to, or ascribed to, PLTX-containing soft corals, focusing on the different PLTX congeners identified in these organisms and their toxic potential.", {"entities": []}], ["Diallyl disulfide (DADS) is the main organosulfur ingredient in garlic, with known antioxidant and anti-inflammatory activities.", {"entities": []}], ["The aim of the present study was to investigate the effect of DADS on reducing the inflammation and redox imbalance in a rat emphysema model that was induced by intraperitoneal injection of cigarette smoke extract (CSE).", {"entities": []}], ["Briefly, DADS exerted an anti-inflammation effect on emphysema rats through decreasing cell influx in the bronchoalveolar lavage fluid (BALF) and suppressing pro-inflammation cytokine production including tumor necrosis factor alpha (TNF-\u03b1), interleukin-1\u03b2 (IL-1\u03b2), interleukin-6 (IL-6) via inhibiting the NF-\u03baB pathway.", {"entities": []}], ["In addition, levels of oxidative stress markers including malondialdehyde (MDA) and myeloperoxidase (MPO) were reduced, while the activities of glutathione (GSH), glutathione peroxidase (GSH-PX), superoxide dismutase (SOD) and total antioxidant capacity (T-AOC) were markedly enhanced by DADS.", {"entities": [[101, 104, "GENE"]]}], ["Moreover, MMP-9 and TIMP-1 expression were down-regulated by DADS.", {"entities": []}], ["Furthermore, the regulation effects of DADS on CD4", {"entities": [[47, 50, "GENE"]]}], ["In the United Arab Emirates (UAE) 35% of the population are aged 0\u201324\u00a0years.", {"entities": []}], ["A significant proportion of these young people are living with chronic conditions (e.g., asthma, type 1 diabetes, cardiac conditions, and genetically-transmitted conditions such as thalassemia and cystic fibrosis).", {"entities": [[181, 192, "DISEASE"], [197, 212, "DISEASE"], [89, 95, "DISEASE"]]}], ["This group has increased vulnerability to developmental delays and mental health problems, and is increasingly coming to the attention of service providers in mainstream schools, primary healthcare centers, and pediatric hospitals.", {"entities": []}], ["Despite the government directing attention to improving the mental health of the UAE population, there is concern that mental health services are not growing at the rate needed to meet the mental health needs of children and young people with chronic conditions.", {"entities": []}], ["A cross sectional survey design was used to determine the mental health literacy of nurses and other healthcare professionals working with children with chronic illnesses.", {"entities": []}], ["Participants completed a culturally-adapted mental health literacy questionnaire comprising three vignettes of fictional characters meeting diagnostic criteria for posttraumatic stress disorder, psychosis, and depression with suicidal thoughts.", {"entities": []}], ["Participants also completed the Kessler Psychological Distress Scale (K10).", {"entities": []}], ["Participants were 317 healthcare professionals from across the UAE.", {"entities": []}], ["The majority were nurses.", {"entities": []}], ["Correct identification of the diagnosis for each vignette was limited, with the highest level of accuracy achieved for the psychosis vignette ( n \u2009=\u2009113, 54.3%).", {"entities": []}], ["Accurate identification of appropriate evidence-based interventions was also limited.", {"entities": []}], ["K10 scores indicated 40% of participants had moderate to high levels of psychological distress.", {"entities": []}], ["These findings are concerning and provide important data to inform the development of undergraduate and continuing education programs for nurses.", {"entities": []}], ["The K10 scores suggest healthcare professionals are under considerable stress, highlighting the need to support healthcare professionals who experience multiple psychosocial stressors.", {"entities": []}], ["Interleukin-10 (IL-10) has been associated with wheezing and asthma in children and the genetic variation of the IL-10 cytokine production may be linked to post-bronchiolitis lung function.", {"entities": [[61, 67, "DISEASE"], [161, 174, "DISEASE"]]}], ["We used impulse oscillometry (IOS) to evaluate the associations of IL10 polymorphisms with lung function at a median age of 6.3 years in children hospitalised for bronchiolitis before six months of age.", {"entities": [[163, 176, "DISEASE"], [67, 71, "GENE"]]}], ["We performed baseline and post-exercise IOS on 103 former bronchiolitis patients.", {"entities": [[58, 71, "DISEASE"]]}], ["Data on single nucleotide polymorphisms (SNP) of IL10 rs1800896 (\u20131082G/A), rs1800871 (\u2013819C/T), rs1800872 (\u2013592C/A) were available for 99 children and of IL10 rs1800890 (\u20133575T/A) for 98 children.", {"entities": [[49, 53, "GENE"], [155, 159, "GENE"], [49, 53, "GENE"], [155, 159, "GENE"]]}], ["IL10 rs1800896, rs1800871 and rs1800872 combined genotype AA+CT+CA and carriage of haplotype ATA, respectively, were associated with higher resistance and lower reactance in baseline IOS in adjusted analyses.", {"entities": [[0, 4, "GENE"]]}], ["At IL10 rs1800890, the A/A-genotype and carriers of A-allele were associated with lower reactance in baseline IOS.", {"entities": [[3, 7, "GENE"]]}], ["There were no significant associations between the studied SNPs and airway hyper-reactivity to exercise.", {"entities": []}], ["Low-IL-10-producing polymorphisms in the IL-10 encoding gene were associated with obstructive lung function parameters, suggesting an important role for IL-10 in development of lung function deficit in early bronchiolitis patients.", {"entities": [[208, 221, "DISEASE"]]}], ["The study aims to assess the clinical evidence, outcome and cost of off-label use of medicines in the hospital setting.", {"entities": []}], ["A multicentric prospective cohort study of patients treated with off-label medicines was carried out in five tertiary hospitals from May 2011 to May 2012.", {"entities": []}], ["Information on clinical characteristics of patients, drugs, outcomes and costs was collected.", {"entities": []}], ["Patients were followed up to 6\u00a0months, and information was assessed by reviewing clinical records and interviewing physicians.", {"entities": []}], ["A total of 226 patients were included.", {"entities": []}], ["The median (interquartile range (IQR)) age of patients was 46 (33\u201362)\u2009years; 59\u00a0% were women.", {"entities": []}], ["Patients had received a median of three previous treatments, and a lack of response (or suboptimal) was the main reason for off-label use (72.1\u00a0%).", {"entities": []}], ["A total of 232 off-label medicines were administered for 102 different indications.", {"entities": []}], ["The most frequent medicines were rituximab (49; 21.1\u00a0%), botulinum toxin (25; 10.7\u00a0%) and omalizumab (14; 6.0\u00a0%).", {"entities": []}], ["In 117 (51.8\u00a0%) cases, the level of clinical evidence for their use was low.", {"entities": []}], ["A partial clinical response was observed in 82 patients (36.3\u00a0%), complete response in 71 (31.4\u00a0%) and stabilization in 11 (4.9\u00a0%).", {"entities": []}], ["A total of 58 (26.5\u00a0%) patients had adverse effects, which in 11 (4.9\u00a0%) were severe.", {"entities": []}], ["The median (IQR) cost per patient was \u20ac2,943.07 (541.9\u20135,872.54).", {"entities": []}], ["There was a high variability of off-label medicines and indications.", {"entities": []}], ["Although the clinical evidence of off-label medicines was often low, clinical response was observed in many patients with previous multiple treatment failure, but at the expense of some adverse effects and a high cost.", {"entities": []}], ["Registers of patients would be helpful for clinical decisions, although clinical trials are needed.", {"entities": []}], ["The online version of this article (doi:10.1007/s00228-014-1746-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This study aimed to examine vitamin D status as a determinant for development of type 2 diabetes and deterioration of glucose homeostasis.", {"entities": []}], ["A random sample of the general population of Copenhagen, Denmark, was taken as part of the Inter99 study.", {"entities": []}], ["Included were 6,405 men and women aged 30\u201365 years at baseline (1999\u20132001), with 4,296 participating in the follow-up examination 5 years later (2004\u20132006).", {"entities": []}], ["Vitamin D was determined at baseline as serum 25-hydroxyvitamin D [25(OH)D].", {"entities": []}], ["Diabetes was defined based on an oral glucose tolerance test and a glycosylated hemoglobin (HbA 1c ) test.", {"entities": []}], ["Secondary outcomes included continuous markers of glucose homeostasis.", {"entities": []}], ["The risk of incident diabetes associated with a 10 nmol/L increase in 25(OH)D was odds ratio (OR) 0.91 (95% CI 0.84\u20130.97) in crude analyses.", {"entities": []}], ["The association became statistically nonsignificant after adjustment for confounders, with an OR per 10 nmol/L of 0.94 (0.86\u20131.03).", {"entities": []}], ["Low 25(OH)D status was significantly associated with unfavorable longitudinal changes in continuous markers of glucose homeostasis after adjustment for confounders.", {"entities": []}], ["Fasting and 2-h glucose and insulin as well as the degree of insulin resistance increased significantly more during follow-up among those with low 25(OH)D levels compared with those with higher levels.", {"entities": []}], ["Low 25(OH)D status was not significantly associated with incident diabetes after adjustment for confounders.", {"entities": []}], ["However, it was significantly associated with unfavorable longitudinal changes in continuous markers of glucose homeostasis, indicating that low vitamin D status could be related to deterioration of glucose homeostasis.", {"entities": []}], ["Previous studies have reported volatile organic compounds (VOCs) in breath as biomarkers of breast cancer and abnormal mammograms, apparently resulting from increased oxidative stress and cytochrome p450 induction.", {"entities": [[92, 105, "DISEASE"], [99, 105, "DISEASE"]]}], ["We evaluated a six-minute point-of-care breath test for VOC biomarkers in women screened for breast cancer at centers in the USA and the Netherlands.", {"entities": [[93, 106, "DISEASE"], [100, 106, "DISEASE"]]}], ["244 women had a screening mammogram (93/37 normal/abnormal) or a breast biopsy (cancer/no cancer 35/79).", {"entities": [[80, 86, "DISEASE"], [90, 96, "DISEASE"]]}], ["A mobile point-of-care system collected and concentrated breath and air VOCs for analysis with gas chromatography and surface acoustic wave detection.", {"entities": []}], ["Chromatograms were segmented into a time series of alveolar gradients (breath minus room air).", {"entities": []}], ["Segmental alveolar gradients were ranked as candidate biomarkers by C-statistic value (area under curve [AUC] of receiver operating characteristic [ROC] curve).", {"entities": []}], ["Multivariate predictive algorithms were constructed employing significant biomarkers identified with multiple Monte Carlo simulations and cross validated with a leave-one-out (LOO) procedure.", {"entities": []}], ["Performance of breath biomarker algorithms was determined in three groups: breast cancer on biopsy versus normal screening mammograms (81.8% sensitivity, 70.0% specificity, accuracy 79% (73% on LOO) [C-statistic value], negative predictive value 99.9%); normal versus abnormal screening mammograms (86.5% sensitivity, 66.7% specificity, accuracy 83%, 62% on LOO); and cancer versus no cancer on breast biopsy (75.8% sensitivity, 74.0% specificity, accuracy 78%, 67% on LOO).", {"entities": [[75, 88, "DISEASE"], [82, 88, "DISEASE"], [368, 374, "DISEASE"], [385, 391, "DISEASE"]]}], ["A pilot study of a six-minute point-of-care breath test for volatile biomarkers accurately identified women with breast cancer and with abnormal mammograms.", {"entities": [[113, 126, "DISEASE"], [120, 126, "DISEASE"]]}], ["Breath testing could potentially reduce the number of needless mammograms without loss of diagnostic sensitivity.", {"entities": []}], ["Purpose: To evaluate the safety and ocular hypotensive efficacy of 4 trabodenoson doses administered twice daily over 14 or 28 days in subjects with ocular hypertension or primary open-angle glaucoma (POAG).", {"entities": [[156, 168, "DISEASE"], [149, 168, "DISEASE"], [191, 199, "DISEASE"], [180, 199, "DISEASE"]]}], ["Methods: In this multicenter, randomized, double-masked, placebo-controlled, dose-escalation Phase 2 study, patients received unilateral topical twice-daily trabodenoson (50, 100, or 200\u2009mcg) or placebo for 14 days, or 500\u2009mcg trabodenoson or placebo for 28 days.", {"entities": []}], ["Ocular and systemic safety and tolerability were assessed by examinations, clinical and laboratory studies.", {"entities": []}], ["Intraocular pressure (IOP) was assessed using Goldmann tonometry.", {"entities": []}], ["Results: Trabodenoson was well tolerated; no clinically meaningful ocular or systemic side effects were identified.", {"entities": []}], ["Trabodenoson produced a dose-dependent IOP reduction.", {"entities": []}], ["IOP reductions in the 500\u2009mcg group were significantly greater than placebo at all time points at Day 28.", {"entities": []}], ["Mean IOP reductions from diurnal baseline ranged from \u22123.5 to \u22125.0\u2009mmHg with a mean change of \u22124.1\u2009mmHg in the 500\u2009mcg group compared \u22121.0 to \u22122.5\u2009mmHg with a mean change of \u22121.6\u2009mmHg for the placebo group, and the Day 28 drop was significantly greater than at Day 14 ( P \u2009=\u20090.0163) indicating improvement in IOP lowering with longer treatment time.", {"entities": []}], ["IOP remained significantly reduced 24\u2009h after the final 500\u2009mcg dose ( P \u2009=\u20090.048).", {"entities": []}], ["Conclusion: Twice-daily ocular doses of trabodenoson, from 50 to 500\u2009mcg, were well tolerated and showed a dose-related decrease in IOP that was statistically significant and clinically relevant at 500\u2009mcg in patients with ocular hypertension or POAG.", {"entities": [[230, 242, "DISEASE"], [223, 242, "DISEASE"]]}], ["Background .", {"entities": []}], ["Angiogenesis has a key role in several conditions and is regulated by several factors such as the platelet-derived growth factor (PDGF) or the vascular endothelial growth factor (VEGF).", {"entities": []}], ["The goal of this study was to investigate the possible role of PDGF and VEGF in a group of patients with severe food allergy.", {"entities": [[112, 124, "DISEASE"]]}], ["We design a prospective longitudinal study ( n = 30) with patients with persistent cow's milk proteins (CMP) allergy.", {"entities": []}], ["After achieving a CMP rush desensitization protocol, a clinical followup including SPT and blood samples to determine sIgE, protein levels, PDGF, and VEGF-A and a panel of the most representative Th 1 , Th 2 , T reg , and Th 17 cytokines were also monitored.", {"entities": []}], ["Baseline levels of PDGF and VEGF in the CMP allergic patients (1170\u2009pg/mL and 253\u2009pg/mL) were different compared to those nonallergic CMP control subjects (501\u2009pg/mL and 108\u2009pg/mL).", {"entities": []}], ["Both PDGF and VEGF were significantly downregulated ( P < 0.05) 6 months after completion of the CMP desensitization process and remained significantly decreased 12 months later.", {"entities": []}], ["Conclusion .", {"entities": []}], ["The present study shows a significant increase of PDGF and VEGF in anaphylaxis suffering children compared to a control group.", {"entities": []}], ["Interestingly, both VEGF and PDGF were significantly downregulated after completing a full CMP rush IgE desensitization.", {"entities": []}], ["Carbon monoxide (CO) is generated during incomplete combustion of carbon-containing compounds and leads to acute and chronic toxicity in animals and humans depending on the concentration and exposure time.", {"entities": []}], ["In addition to exogenous sources, CO is also produced endogenously by the activity of heme oxygenases (HOs) and the physiological significance of HO-derived CO has only recently emerged.", {"entities": []}], ["CO exerts vasoactive, anti-proliferative, anti-oxidant, anti-inflammatory and anti-apoptotic effects and contributes substantially to the important role of the inducible isoform HO-1 as a mediator of tissue protection and host defense.", {"entities": []}], ["Exogenous application of low doses of gaseous CO might provide a powerful tool to protect organs and tissues under various stress conditions.", {"entities": []}], ["Experimental evidence strongly suggests a beneficial effect under pathophysiological conditions such as organ transplantation, ischemia/reperfusion, inflammation, sepsis, or shock states.", {"entities": [[127, 135, "DISEASE"]]}], ["The cellular and molecular mechanisms mediating CO effects are only partially characterized.", {"entities": []}], ["So far, only a few studies in humans are available, which, however, do not support the promising results observed in experimental studies.", {"entities": []}], ["The protective effects of exogenous CO may strongly depend on the pathological condition, the mode, time point and duration of application, the administered concentration, and on the target tissue and cell.", {"entities": []}], ["Differences in bioavailability of endogenous CO production and exogenous CO supplementation might also provide an explanation for the lack of protective effects observed in some experimental and clinical studies.", {"entities": []}], ["Further randomized, controlled clinical studies are needed to clarify whether exogenous application of CO may turn into a safe and effective preventive and therapeutic strategy to treat pathophysiological conditions associated with inflammatory or oxidative stress.", {"entities": []}], ["To examine the association between body mass index (BMI) in young adulthood and cardiovascular risks, including venous thromboembolism, before 55\u2005years of age.", {"entities": []}], ["Cohort study using population-based medical databases.", {"entities": []}], ["Outcomes registered from all hospitals in Denmark from 1977 onwards.", {"entities": []}], ["6502 men born in 1955 and eligible for conscription in Northern Denmark.", {"entities": []}], ["Follow-up began at participants\u2019 22nd birthday and continued until death, emigration or 55\u2005years of age, whichever came first.", {"entities": []}], ["Using regression analyses, we calculated the risks and HRs, adjusting for cognitive test score and years of education.", {"entities": []}], ["48% of all obese young men (BMI \u226530\u2005kg/m In this cohort of young men, obesity was strongly associated with adverse cardiometabolic events before 55\u2005years of age, including venous thromboembolism.", {"entities": [[70, 77, "DISEASE"]]}], ["Compared with those of normal weight, young obese men had an absolute risk increase for type 2 diabetes, cardiovascular morbidity or premature death of almost 30%.", {"entities": []}], ["There is increasing evidence that autoimmune disease is associated with development of chronic obstructive pulmonary disease (COPD).", {"entities": [[87, 124, "DISEASE"]]}], ["We aim to assess the relationship between systemic lupus erythematosus (SLE) and COPD risk in a nationwide population.", {"entities": [[51, 70, "DISEASE"], [42, 70, "DISEASE"]]}], ["We conducted a retrospective cohort study using the catastrophic illness registry of the Taiwan National Health Insurance Research Database (NHIRD).", {"entities": []}], ["We identified 10,623 patients with SLE newly diagnosed between 2000 and 2010.", {"entities": []}], ["Each patient was randomly frequency-matched with four people without SLE on age, sex, and index year from the general population.", {"entities": []}], ["Both cohorts were followed up until the end of 2010 to measure the incidence of COPD.", {"entities": []}], ["The risk of COPD was analyzed using Cox proportional hazards regression models including age, sex, index year and comorbidities.", {"entities": []}], ["The overall incidence rate of COPD was 1.73\u2013fold higher in the SLE cohort than in the control cohort (17.4 vs. 10.1 per 10,000 person-years, 95% CI\u200a=\u200a1.62\u20131.84).", {"entities": []}], ["Age related analysis showed increased incidence of COPD with age in both SLE and control cohorts.", {"entities": []}], ["However, adjusted HR maximum was observed in the youngest age group (adjusted HR: 4.33, 95% CI, 2.39\u20137.85) while adjusted HR minimum was witnessed in the oldest age group (adjusted HR: 1.19, 95% CI, 0.85\u20131.22).", {"entities": [[18, 20, "GENE"], [78, 80, "GENE"], [122, 124, "GENE"], [181, 183, "GENE"], [18, 20, "GENE"], [78, 80, "GENE"], [122, 124, "GENE"], [181, 183, "GENE"], [18, 20, "GENE"], [78, 80, "GENE"], [122, 124, "GENE"], [181, 183, "GENE"], [18, 20, "GENE"], [78, 80, "GENE"], [122, 124, "GENE"], [181, 183, "GENE"]]}], ["Patients with SLE have a significant risk of developing COPD than the control population.", {"entities": []}], ["Based on the findings from this study, it can be hypothesized that in addition to cigarette smoke SLE may be a determining factor for COPD incidence.", {"entities": []}], ["However, further investigation is needed to corroborate this hypothesis.", {"entities": []}], ["Engineered nanomaterials (ENMs) interact with different biomolecules as soon as they are in contact, resulting in the formation of a biomolecule \u2018corona\u2019.", {"entities": []}], ["Hence, the \u2018corona\u2019 defines the biological identity of the ENMs and could affect the response of the immune system to ENM exposure.", {"entities": []}], ["With up to 40\u00a0% of the world population suffering from type I allergy, a possible modulation of allergen effects by binding to ENMs is highly relevant with respect to work place and consumer safety.", {"entities": []}], ["Therefore, the aim of this present study was to gain an insight into the interactions of gold nanoparticles with different seasonally and perennially occurring outdoor and indoor allergens.", {"entities": []}], ["Gold nanoparticles (AuNPs) were conjugated with the major allergens of birch pollen (Bet v 1), timothy grass pollen (Phl p 5) and house dust mite (Der p 1).", {"entities": []}], ["The AuNP-allergen conjugates were characterized by means of TEM negative staining, dynamic light scattering (DLS), z-potential measurements and hyperspectral imaging.", {"entities": []}], ["Furthermore, 3D models were constructed, based on the characterization data, to visualize the interaction between the allergens and the AuNPs surface.", {"entities": []}], ["Differences in the activation of human basophil cells derived from birch/grass pollen- and house dust mite-allergic patients in response to free allergen and AuNP-allergen conjugates were determined using the basophil activation assay (BAT).", {"entities": []}], ["Potential allergen corona replacement during BAT was controlled for using Western blotting.", {"entities": []}], ["The protease activity of AuNP-Der p 1 conjugates compared to free Der p 1 was assessed, by an enzymatic activity assay and a cellular assay pertaining to lung type II alveolar epithelial cell tight junction integrity.", {"entities": []}], ["The formation of a stable corona was found for all three allergens used.", {"entities": []}], ["Our data suggest, that depending on the allergen, different effects are observed after binding to ENMs, including enhanced allergic responses against Der p 1 and also, for some patients, against Bet v 1.", {"entities": []}], ["Moreover elevated protease activity of AuNP-Der p 1 conjugates compared to free Der p 1 was found.", {"entities": []}], ["In summary, this study presents that conjugation of allergens to ENMs can modulate the human allergic response, and that protease activity can be increased.", {"entities": []}], ["Graphical Abstract Cross-linking of IgE receptors and degranulation of human basophils due to epitope alignment of nanoparticle-coated allergens.", {"entities": []}], ["Cross-linking of IgE receptors and degranulation of human basophils due to epitope alignment of nanoparticle-coated allergens.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-016-0113-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In recent years T cell based interferon gamma release assays (IGRA) have been developed for immunodiagnosis of M. tuberculosis infection.", {"entities": [[114, 126, "DISEASE"]]}], ["At present these assays do not discriminate between disease and latency.", {"entities": []}], ["Therefore, more promising antigens and diagnostic tools are continuously being searched for tuberculosis immunodiagnostics.", {"entities": [[92, 104, "DISEASE"]]}], ["The heparin binding hemagglutinin (HBHA) is a surface protein of M. tuberculosis which promotes bacterial aggregation and adhesion to non-phagocytic cells.", {"entities": [[68, 80, "DISEASE"]]}], ["It has been previously assumed that native, methylated form of this protein would be a promising antigen to discriminate latent from active infection.", {"entities": []}], ["We performed a pilot investigation to study humoral and T-cell mediated immunological responses to recombinant HBHA produced in M. smegmatis or to synthetic peptides in patients with recent or past tuberculosis, with atypical mycobacteriosis, or in healthy vaccinated individuals.", {"entities": [[198, 210, "DISEASE"]]}], ["The T cell reactivities to HBHA were compared to the respective reactivities towards Purified Protein Derivative (PPD) and two surface secreted proteins, ie.", {"entities": []}], ["Early Secretory Antigen Target-6 (ESAT-6) and Culture Filtrate Protein-10 (CFP-10).", {"entities": []}], ["Our pilot results indicate that methylated recombinant HBHA induced a strong T cell mediated immune response and the production of IgG and IgM-class antibodies in all patient groups, most surprisingly in young Finnish vaccinees, as well.", {"entities": []}], ["We observed a positive correlation between the reactivities to HBHA and non-specific PPD among all studied subjects.", {"entities": []}], ["As expected, ESAT-6 and CFP-10 were the most powerful antigens to discriminate disease from immunity caused by vaccination.", {"entities": []}], ["On the basis of results of this exploratory investigation we raise concerns that in countries like Finland, where BCG vaccination was routinely used, HBHA utility might not be sufficient for diagnostics because of inability to explicitly discriminate tuberculosis infection from immunoreactivity caused by previous BCG vaccination.", {"entities": [[251, 263, "DISEASE"]]}], ["To identify association of IL18 -607 C/A and -137 G/C polymorphism with susceptibility to gout in Chinese Han male population, We evaluate the genetic contribution of the IL18 -607 C/A and -137 G/C polymorphism in 202 gout male patients and 493 gout-free control of Chinese Han population by allele-specific polymerase chain reaction assay.", {"entities": [[90, 94, "DISEASE"], [218, 222, "DISEASE"], [245, 249, "DISEASE"], [27, 31, "GENE"], [171, 175, "GENE"], [27, 31, "GENE"], [171, 175, "GENE"]]}], ["Our results reveal no significant association between the polymorphisms -607C/A and -137G/C in IL18 with gout.", {"entities": [[105, 109, "DISEASE"], [95, 99, "GENE"]]}], ["Our study might suggest that -607 C/A and -137 G/C polymorphisms in the promoter of IL18 are not associated with susceptibility to gout and thus do not play a major role in the development of gout in the Chinese Han male population.", {"entities": [[131, 135, "DISEASE"], [192, 196, "DISEASE"], [84, 88, "GENE"]]}], ["It has been demonstrated that neutrophils from healthy donors or from patients with inflammatory disorders can bind immunoglobulin (Ig) E proteins through binding to Mac-2/epsilon bp.", {"entities": []}], ["Functional responses to allergens were assessed by measuring the respiratory burst and intracellular Ca2+ levels, and binding of allergens to neutrophils was assessed by flow cytometry analysis and fluorescence microscopy.", {"entities": []}], ["In this article, we demonstrate that neutrophils sensitized to specific allergens (from allergic patients), but not from healthy donors, are sensitive to allergens of the same type as those that produce clinical allergic symptoms.", {"entities": []}], ["The activation of neutrophils was analyzed by the induction of a respiratory burst that was detected with luminol- dependent chemiluminescence.", {"entities": []}], ["Intracellular Ca2+ levels increased parallel to those of the inducing allergens.", {"entities": []}], ["In addition, the specific binding of allergens on the cell surface was revealed by flow cytometry and allergen-FITC-labeled staining analyses.", {"entities": []}], ["The present data suggest a restricted recognition of allergen by sensitive neutrophils, probably associated with the specific binding of the allergen to its corresponding IgE molecule, which is bound to the Mac-2/epsilon bp structure.", {"entities": []}], ["These findings demonstrate a functional role of allergen- associated neutrophils during the allergic state.", {"entities": []}], ["The histaminergic system (HS) has a critical role in cognition, sleep and other behaviors.", {"entities": []}], ["Although not well studied in autism spectrum disorder (ASD), the HS is implicated in many neurological disorders, some of which share comorbidity with ASD, including Tourette syndrome (TS).", {"entities": [[175, 183, "DISEASE"], [29, 53, "DISEASE"]]}], ["Preliminary studies suggest that antagonism of histamine receptors 1\u20133 reduces symptoms and specific behaviors in ASD patients and relevant animal models.", {"entities": []}], ["In addition, the HS mediates neuroinflammation, which may be heightened in ASD.", {"entities": []}], ["Together, this suggests that the HS may also be altered in ASD.", {"entities": []}], ["Using RNA sequencing (RNA-seq), we investigated genome-wide expression, as well as a focused gene set analysis of key HS genes ( HDC , HNMT , HRH1 , HRH2 , HRH3 and HRH4 ) in postmortem dorsolateral prefrontal cortex (DLPFC) initially in 13 subjects with ASD and 39 matched controls.", {"entities": [[129, 132, "GENE"], [135, 139, "GENE"], [142, 146, "GENE"], [149, 153, "GENE"], [156, 160, "GENE"], [165, 169, "GENE"]]}], ["At the genome level, eight transcripts were differentially expressed (false discovery rate\u2009<0.05), six of which were small nucleolar RNAs (snoRNAs).", {"entities": []}], ["There was no significant diagnosis effect on any of the individual HS genes but expression of the gene set of HNMT , HRH1 , HRH2 and HRH3 was significantly altered.", {"entities": [[110, 114, "GENE"], [117, 121, "GENE"], [124, 128, "GENE"], [133, 137, "GENE"]]}], ["Curated HS gene sets were also significantly differentially expressed.", {"entities": []}], ["Differential expression analysis of these gene sets in an independent RNA-seq ASD data set from DLPFC of 47 additional subjects confirmed these findings.", {"entities": []}], ["Understanding the physiological relevance of an altered HS may suggest new therapeutic options for the treatment of ASD.", {"entities": []}], ["Mycoplasma pneumoniae is a cell wall-less bacterial pathogen of the human respiratory tract that accounts for > 20% of all community-acquired pneumonia (CAP).", {"entities": [[142, 151, "DISEASE"]]}], ["At present the most effective means for detection and strain-typing is quantitative polymerase chain reaction (qPCR), which can exhibit excellent sensitivity and specificity but requires separate tests for detection and genotyping, lacks standardization between available tests and between labs, and has limited practicality for widespread, point-of-care use.", {"entities": []}], ["We have developed and previously described a silver nanorod array-surface enhanced Raman Spectroscopy (NA-SERS) biosensing platform capable of detecting M .", {"entities": []}], ["pneumoniae with statistically significant specificity and sensitivity in simulated and true clinical throat swab samples, and the ability to distinguish between reference strains of the two main genotypes of M .", {"entities": []}], ["pneumoniae .", {"entities": []}], ["Furthermore, we have established a qualitative lower endpoint of detection for NA-SERS of < 1 genome equivalent (cell/\u03bcl) and a quantitative multivariate detection limit of 5.3 \u00b1 1 cells/\u03bcl.", {"entities": []}], ["Here we demonstrate using partial least squares- discriminatory analysis (PLS-DA) of sample spectra that NA-SERS correctly identified M .", {"entities": []}], ["pneumoniae clinical isolates from globally diverse origins and distinguished these from a panel of 12 other human commensal and pathogenic mycoplasma species with 100% cross-validated statistical accuracy.", {"entities": []}], ["Furthermore, PLS-DA correctly classified by strain type all 30 clinical isolates with 96% cross-validated accuracy for type 1 strains, 98% cross-validated accuracy for type 2 strains, and 90% cross-validated accuracy for type 2V strains.", {"entities": []}], ["This study aimed to estimate the association between eczema in early childhood and the onset of asthma and rhinitis later in life in children.", {"entities": [[107, 115, "DISEASE"], [96, 102, "DISEASE"]]}], ["A total of 3,124 children aged 1\u20132\u2009years were included in the Dampness in Building and Health (DBH) study in the year 2000, and followed up 5\u2009years later by a parental questionnaire based on an International Study of Asthma and Allergies in Childhood protocol.", {"entities": [[217, 223, "DISEASE"], [95, 98, "GENE"]]}], ["The association between eczema in early childhood and the incidence of asthma and rhinitis later in life was estimated by univariable and multivariable logistic regression modelling.", {"entities": [[82, 90, "DISEASE"], [71, 77, "DISEASE"]]}], ["The prevalence of eczema in children aged 1\u20132\u2009years was 17.6% at baseline.", {"entities": []}], ["Children with eczema had a 3-fold increased odds of developing asthma (adjusted odds ratio [aOR], 3.07; 95% confidence interval (CI) 1.79\u20135.27), and a nearly 3-fold increased odds of developing rhinitis (aOR, 2.63; 1.85\u20133.73) at follow-up compared with children without eczema, adjusted for age, sex, parental allergic disease, parental smoking, length of breastfeeding, site of living, polyvinylchloride flooring material, and concomitant allergic disease.", {"entities": [[194, 202, "DISEASE"], [63, 69, "DISEASE"]]}], ["When eczema was divided into subgroups, moderate to severe eczema (aOR, 3.56; 1.62\u20137.83 and aOR, 3.87; 2.37\u20136.33, respectively), early onset of eczema (aOR, 3.44; 1.94\u20136.09 and aOR, 4.05; 2.82\u20135.81; respectively), and persistence of eczema (aOR, 5.16; 2.62\u201310.18 and aOR, 4.00; 2.53\u20136.22, respectively) further increased the odds of developing asthma and rhinitis.", {"entities": [[355, 363, "DISEASE"], [344, 350, "DISEASE"]]}], ["Further independent risk factors increasing the odds of developing asthma were a parental history of allergic disease (aOR, 1.83; 1.29\u20132.60) and a period of breast feeding shorter than 6\u2009months (aOR, 1.57; 1.03\u20132.39).", {"entities": [[67, 73, "DISEASE"]]}], ["The incidence of rhinitis was increased for parental history of allergic disease (aOR, 2.00; 1.59\u20132.51) and polyvinylchloride flooring (aOR, 1.60; 1.02\u20132.51).", {"entities": [[17, 25, "DISEASE"]]}], ["Eczema in infancy is associated with development of asthma and rhinitis during the following 5-year period, and eczema is one of the strongest risk factors.", {"entities": [[63, 71, "DISEASE"], [52, 58, "DISEASE"]]}], ["Early identification is valuable for prediction of the atopic march.", {"entities": []}], ["We have previously shown that Th2-polarized airway inflammation facilitates sensitization towards new, protein antigens.", {"entities": []}], ["In this context, we could demonstrate that IL-4 needs to act on cells of the hematopoetic and the structural compartment in order to facilitate sensitization towards new antigens.", {"entities": []}], ["We thus aimed to elucidate possible mechanisms of action of IL-4 on structural cells choosing to analyze pulmonary epithelial cells as an important part of the lung's structural system.", {"entities": []}], ["We used a co-culture system of DC- or APC-dependent in vitro priming of T cells, co-cultivated on a layer of cells of a murine pulmonary epithelial cell line (LA-4) pretreated with or without IL-4.", {"entities": []}], ["Effects on T cell priming were analyzed via CFSE-dilution and flow cytometric assessment of activation status.", {"entities": []}], ["Pulmonary epithelial cells suppressed T cell proliferation in vitro but this effect was attenuated by pre-treatment of the epithelial cells with IL-4.", {"entities": []}], ["Transwell experiments suggest that epithelial-mediated suppression of T cell activation is mostly cell-contact dependent and leads to attenuation in an early naive T cell phenotype.", {"entities": []}], ["Secretion of soluble factors like TARC, TSLP, GM-CSF and CCL20 by epithelial cells did not change after IL-4 treatment.", {"entities": [[40, 44, "GENE"], [57, 62, "GENE"]]}], ["However, analysis of co-stimulatory expression on pulmonary epithelial cells revealed that pre-treatment of epithelial cells with IL-4 changed expression GITR-L, suggesting a possible mechanism for the effects observed.", {"entities": []}], ["Our studies provide new insight into the role of IL-4 during the early phases of pulmonary sensitization: The inhibitory activity of pulmonary epithelial cells in homeostasis is reversed in the presence of IL-4, which is secreted in the context of Th2-dominated allergic airway inflammation.", {"entities": []}], ["This mechanism might serve to explain facilitated sensitization in the clinical context of polysensitization where due to a pre-existing sensitization increased levels of IL-4 in the airways might facilitate T cell priming towards new antigens.", {"entities": []}], ["Self-management has become increasingly popular in the management of chronic diseases.", {"entities": []}], ["There are many different self-management models.", {"entities": []}], ["Meta analyses of arthritis self-management have concluded that it is difficult to recommend any one program in preference to another due to inconsistencies in the study designs used to evaluate different programs.", {"entities": [[17, 26, "DISEASE"]]}], ["The Stanford Arthritis Self-Management Program (ASMP), most commonly delivered by trained lay leaders, is a generic program widely used for people with rheumatological disorders.", {"entities": [[13, 22, "DISEASE"]]}], ["We have developed a more specific program expressly for people with osteoarthritis of the knee (OAKP).", {"entities": [[68, 82, "DISEASE"]]}], ["It includes information designed to be delivered by health professionals and results in improvements in pain, function and quality of life.", {"entities": []}], ["Aim: To determine whether, for people with osteoarthritis (OA) of the knee, the OAKP implemented in a primary health care setting can achieve and maintain clinically meaningful improvements in more participants than ASMP delivered in the same environment.", {"entities": [[43, 57, "DISEASE"]]}], ["The effectiveness of the programs will be compared in a single-blind randomized study.", {"entities": []}], ["Participants: 146 participants with established OA knee will be recruited.", {"entities": []}], ["Volunteers with coexistent inflammatory joint disease or serious co-morbidities will be excluded.", {"entities": []}], ["Interventions : Participants will be randomised into either OAKP or ASMP groups and followed for 6 months.", {"entities": []}], ["Measurements : Assessments will be immediately before and after the intervention and at 6 months.", {"entities": []}], ["Primary outcome measures will be WOMAC and SF-36 questionnaires and a VAS for pain.", {"entities": []}], ["Secondary outcomes will include balance, tested using a timed single leg balance test and a timed step test and self-efficacy.", {"entities": []}], ["Data will be analysed using repeated measures ANOVA.", {"entities": []}], ["With an aging population the health care costs for people with arthritis are ever increasing.", {"entities": [[63, 72, "DISEASE"]]}], ["Although cost analysis is beyond the scope of this study, it is reasonable to expect that costs will be greater when health professionals deliver self-management programs as opposed to lay leaders.", {"entities": []}], ["Consequently it is critical to examine the relative effectiveness of the primary care management strategies available for OA.", {"entities": []}], ["This study is registered with the Australian New Zealand Clinical Trials Registry: 12607000031460", {"entities": []}], ["Endocrine disrupting chemicals (EDCs) can mimic natural hormone to interact with receptors in the endocrine system and thus disrupt the functions of the endocrine system, raising concerns on the public health.", {"entities": []}], ["In addition to disruption of the endocrine system, some EDCs have been found associated with many diseases such as breast cancer, prostate cancer, infertility, asthma, stroke, Alzheimer\u2019s disease, obesity, and diabetes mellitus.", {"entities": [[115, 128, "DISEASE"], [197, 204, "DISEASE"], [147, 158, "DISEASE"], [160, 166, "DISEASE"], [122, 128, "DISEASE"], [139, 145, "DISEASE"], [210, 227, "DISEASE"], [130, 145, "DISEASE"]]}], ["EDCs that binding androgen receptor have been reported associated with diabetes mellitus in in vitro, animal, and clinical studies.", {"entities": [[71, 88, "DISEASE"]]}], ["In this review, we summarize the structural basis and interactions between androgen receptor and EDCs as well as the associations of various types of diabetes mellitus with the EDCs mediated through androgen receptor binding.", {"entities": [[150, 167, "DISEASE"]]}], ["We also discuss the perspective research for further understanding the impact and mechanisms of EDCs on the risk of diabetes mellitus.", {"entities": [[116, 133, "DISEASE"]]}], ["This study assesses the relationship between daily numbers of deaths and variations in ambient temperature within the city of Skopje, R. Macedonia.", {"entities": []}], ["The daily number of deaths from all causes, during the period 1996\u20132000, as well as those deaths from cardiovascular diseases, occurring within the city of Skopje were related to the average daily temperature on the same day using Multiple Regression statistical analyses.", {"entities": []}], ["Temperature was measured within the regression model as two complementary variables: 'Warm' and 'Cold'.", {"entities": []}], ["Excess winter mortality was calculated as winter deaths (deaths occurring in December to March) minus the average of non-winter deaths (April to July of the current year and August to November of the previous year).", {"entities": []}], ["In this study the average daily total of deaths was 7% and 13% greater in the cold when compared to the whole period and warm period respectively.", {"entities": []}], ["The same relationship was noticed for deaths caused by cardiovascular diseases.", {"entities": []}], ["The Regression Beta Coefficient (b = -0.19) for the total mortality as a function of the temperature in Skopje during the period 1996\u20132000 was statistically significant with negative connotation as was the circulatory mortality due to average temperature (statistically significant regression Beta coefficient (b = -0.24)).", {"entities": []}], ["A measure of this increase is provided, on an annual basis, in the form of the excess winter mortality figure.", {"entities": []}], ["Mortality with in the city of Skopje displayed a marked seasonality, with peaks in the winter and relative troughs in the summer.", {"entities": []}], ["Vascular endothelial growth factor (VEGF) is an important mediator of angiogenesis.", {"entities": []}], ["However, little is known about the potential use of serum levels of VEGF as a biomarker for asthma.", {"entities": [[92, 98, "DISEASE"]]}], ["We investigated the differences in VEGF levels among normal controls, stable asthma patients, and those with exacerbation of acute asthma.", {"entities": [[77, 83, "DISEASE"], [131, 137, "DISEASE"]]}], ["All subjects were young males.", {"entities": []}], ["We measured VEGF levels in each patient group, and examined any serial changes in those with acute exacerbation.", {"entities": []}], ["VEGF levels were significantly higher in stable asthmatic patients and even more so in acute asthmatic patients, compared to healthy controls.", {"entities": []}], ["However, there was no correlation between VEGF levels and forced expiratory volume in 1 second in patients with stable asthma.", {"entities": [[119, 125, "DISEASE"]]}], ["In addition, there were no correlations between VEGF levels and asthma control test scores.", {"entities": [[64, 70, "DISEASE"]]}], ["In patients with acute exacerbation, VEGF levels significantly increased during the acute period; their levels decreased gradually at 7 and 14 days after treatment.", {"entities": []}], ["Compared to normal control patients, the serum levels of VEGF were elevated in stable asthma patients and even more elevated in patients with acute exacerbation.", {"entities": [[86, 92, "DISEASE"]]}], ["However, the role of VEGF as a biomarker in stable asthma is limited.", {"entities": [[51, 57, "DISEASE"]]}], ["In patients with acute exacerbation, VEGF levels were associated with clinical improvements.", {"entities": []}], ["Allergic disease can be characterized as manifestations of an exaggerated inflammatory response to environmental allergens triggers.", {"entities": []}], ["Mite allergen Der-p2 is one of the major allergens of the house dust mite, which contributes to TLR4 expression and function in B cells in allergic patients.", {"entities": [[96, 100, "GENE"]]}], ["However, the precise mechanisms of Der-p2 on B cells remain obscure.", {"entities": []}], ["We investigated the effects of Der-p2 on proinflammatory cytokines responses and Toll-like receptor-4 (TLR4)-related signaling in human B cells activation.", {"entities": [[103, 107, "GENE"]]}], ["We demonstrated that Der-p2 activates pro-inflammatory cytokines, TLR4 and its co-receptor MD2.", {"entities": [[66, 70, "GENE"]]}], ["ERK inhibitor PD98059 significantly enhanced TLR4/MD2 expression in Der-p2-treated B cells.", {"entities": []}], ["Der-p2 markedly activated mitogen-activated protein kinase (MAPK) phosphatase-1 (MKP-1) and decreased p38 phosphorylation in B cells.", {"entities": []}], ["MKP-1-siRNA downregulated TLR4/MD2 expression in Der-p2-treated B cells.", {"entities": []}], ["In addition, Der-p2 significantly up-regulated expression of co-stimulatory molecules and increased B cell proliferation.", {"entities": []}], ["Neutralizing Der-p2 antibody could effectively abrogate the Der-p2-induced B cell proliferation.", {"entities": []}], ["Der-p2 could also markedly induce NF-\u03baB activation in B cells, which could be counteracted by dexamethasone.", {"entities": []}], ["These results strongly suggest that Der-p2 is capable of triggering B cell activation and MKP-1-activated p38/MAPK dephosphorylation-regulated TLR4 induction, which subsequently enhances host immune, defense responses and development of effective allergic disease therapeutics in B cells.", {"entities": [[143, 147, "GENE"]]}], ["Plant made biologics have elicited much attention over recent years for their potential in assisting those in developing countries who have poor access to modern medicine.", {"entities": []}], ["Additional applications such as the stockpiling of vaccines against pandemic infectious diseases or potential biological warfare agents are also under investigation.", {"entities": []}], ["Plant virus expression vectors represent a technology that enables high levels of pharmaceutical proteins to be produced in a very short period of time.", {"entities": []}], ["Recent advances in research and development have brought about the generation of superior virus expression systems which can be readily delivered to the host plant in a manner that is both efficient and cost effective.", {"entities": []}], ["This review presents recent innovations in plant virus expression systems and their uses for producing biologics from plants.", {"entities": []}], ["Overviews of reviews (overviews) compile information from multiple systematic reviews (SRs) to provide a single synthesis of relevant evidence for decision-making.", {"entities": []}], ["It is recommended that authors assess and report the methodological quality of SRs in overviews\u2014for example, using A MeaSurement Tool to Assess systematic Reviews (AMSTAR).", {"entities": []}], ["Currently, there is variation in whether and how overview authors assess and report SR quality, and limited guidance is available.", {"entities": []}], ["Our objectives were to: examine methodological considerations involved in using AMSTAR to assess the quality of Cochrane and non-Cochrane SRs in overviews of healthcare interventions; identify challenges (and develop potential decision rules) when using AMSTAR in overviews; and examine the potential impact of considering methodological quality when making inclusion decisions in overviews.", {"entities": []}], ["We selected seven overviews of healthcare interventions and included all SRs meeting each overview\u2019s inclusion criteria.", {"entities": []}], ["For each SR, two reviewers independently conducted AMSTAR assessments with consensus and discussed challenges encountered.", {"entities": []}], ["We also examined the correlation between AMSTAR assessments and SR results/conclusions.", {"entities": []}], ["Ninety-five SRs were included (30 Cochrane, 65 non-Cochrane).", {"entities": []}], ["Mean AMSTAR assessments (9.6/11 vs. 5.5/11; p \u2009<\u20090.001) and inter-rater reliability (AC1 statistic: 0.84 vs. 0.69; \u201calmost perfect\u201d vs. \u201csubstantial\u201d using the Landis & Koch criteria) were higher for Cochrane compared to non-Cochrane SRs.", {"entities": []}], ["Four challenges were identified when applying AMSTAR in overviews: the scope of the SRs and overviews often differed; SRs examining similar topics sometimes made different methodological decisions; reporting of non-Cochrane SRs was sometimes poor; and some non-Cochrane SRs included other SRs as well as primary studies.", {"entities": []}], ["Decision rules were developed to address each challenge.", {"entities": []}], ["We found no evidence that AMSTAR assessments were correlated with SR results/conclusions.", {"entities": []}], ["Results indicate that the AMSTAR tool can be used successfully in overviews that include Cochrane and non-Cochrane SRs, though decision rules may be useful to circumvent common challenges.", {"entities": []}], ["Findings support existing recommendations that quality assessments of SRs in overviews be conducted independently, in duplicate, with a process for consensus.", {"entities": []}], ["Results also suggest that using methodological quality to guide inclusion decisions (e.g., to exclude poorly conducted and reported SRs) may not introduce bias into the overview process.", {"entities": []}], ["The online version of this article (doi:10.1186/s12874-017-0325-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Short-term exposures to outdoor air pollutants have been associated with lower lung function, but the results are inconsistence.", {"entities": []}], ["The effects of different pollutant levels on lung function changes are still unclear.", {"entities": []}], ["We quantified the effects of outdoor air pollution exposure (NO 2 , PM 10 , O 3 , and PM 2.5 ) on lung function among 1,694 female non-smokers from the Wuhan-Zhuhai Cohort in China by using linear mixed model.", {"entities": []}], ["We further investigated the associations in the two cities with different air quality levels separately to quantify the effects of different pollutant level exposure on lung function.", {"entities": []}], ["We found the moving averages of NO 2 , PM 10 , and PM 2.5 concentrations were significantly associated with reduced FVC.", {"entities": []}], ["In city at high pollutant level, the moving average of NO 2 , PM 10 , O 3 , and PM 2.5 exposures were significantly associated with both FVC and FEV 1 reductions.", {"entities": [[145, 148, "GENE"]]}], ["In the low-level air pollution city, PM 10 (Lag03-Lag05) and O 3 concentrations (Lag01-Lag03) were significantly associated with reduced FVC, while PM 10 (Lag03-Lag05), O 3 (Lag0-Lag03), and PM 2.5 (Lag04-Lag06) exposure were significantly associated with reduced FEV 1 .", {"entities": [[264, 267, "GENE"]]}], ["Our results suggest that outdoor air pollution is associated with short-term adverse effects on lung function among female non-smokers.", {"entities": []}], ["The adverse effects may persist for longer durations within 7 days at higher air pollutant levels.", {"entities": []}], ["To study the demographic and clinical profile of patients with vernal keratoconjunctivitis (VKC) at a tertiary eye care center in India.", {"entities": [[70, 90, "DISEASE"]]}], ["Retrospective chart analysis of 468 patients of VKC seen from January 2006 to December 2006.", {"entities": []}], ["Mean age at presentation was 12 years.", {"entities": []}], ["Majority of the patients had mixed pattern disease (72%).", {"entities": []}], ["Chronic perennial disease was seen in 36% patients.", {"entities": []}], ["Personal or family history of allergies was noted in 5% patients.", {"entities": []}], ["Severe disease based on clinical grading was present in 37% patients.", {"entities": []}], ["Moderate to severe vision loss was seen in 12% of total population.", {"entities": []}], ["Persistent disease beyond 20 years of age was found in 12% patients.", {"entities": []}], ["VKC-related complications such as corneal scarring (11%), shield ulcer (3%), keratoconus (6%), and limbal stem cell deficiency (1.2%) were seen.", {"entities": [[77, 88, "DISEASE"]]}], ["Treatment-related complications like corticosteroid-induced cataract and glaucoma were seen in 6% and 4% of patients, respectively.", {"entities": [[60, 68, "DISEASE"], [73, 81, "DISEASE"]]}], ["Clinical pattern of VKC seen in the tropical climate of India is essentially similar to that seen in other tropical countries.", {"entities": []}], ["Few distinct features that we noted represent chronic perennial disease, low association with atopy, and higher propensity for disease and treatment-related complications.", {"entities": []}], ["The roles of interleukin-10 (IL-10) have been emphasized in several models of glomerulonephritis (GN).", {"entities": [[78, 96, "DISEASE"]]}], ["Three biallelic polymorphisms within the IL-10 promoter region, at positions -1,082, -819, and -592 from the transcription initiation site, were shown to affect the level of IL-10 production.", {"entities": []}], ["To investigate the effect of IL-10 promoter polymorphisms on the predisposition to development of GN in Korea, IL-10 promoter polymorphisms were assayed by polymerase chain reaction followed by restriction fragment length polymorphism in 108 patients with IgA nephropathy (IgAN), 49 focal segmental glomerulosclerosis (FSGS), and 100 healthy controls.", {"entities": [[283, 317, "DISEASE"]]}], ["In comparison with the control, the frequency of -1,082*G alleles were lower in IgAN and the frequencies of -592*C and -819*C were lower in FSGS, respectively.", {"entities": []}], ["As for the haplotype, GCC haplotype was less frequent among IgAN than the control and ATA haplotype was more frequent among FSGS than the control ( p <0.05).", {"entities": []}], ["The frequency of intermediate producer genotypes (GCC/ACC and GCC/ATA) were lower among IgAN or FSGS than the control.", {"entities": []}], ["Our findings suggested that IL-10 promoter polymorphism predisposed to the development of IgAN and FSGS in Korean patients.", {"entities": []}], ["Aerosolized drugs are increasingly being used to treat chronic lung diseases or to deliver therapeutics systemically through the lung.", {"entities": []}], ["The influence of disease, such as emphysema, on particle deposition is not fully understood.", {"entities": []}], ["With the use of magnetic resonance imaging (MRI), the deposition pattern of iron oxide particles with a mass median aerodynamic diameter of 1.2 \u03bcm was assessed in the lungs of healthy and elastase-treated rats.", {"entities": []}], ["Tracheostomized rats were ventilated with particles, at a tidal volume of 2.2 ml, and a breathing frequency of 80 breaths/min.", {"entities": []}], ["Maximum airway pressure was significantly lower in the elastase-treated (P aw = 7.71 \u00b1 1.68 cmH 2 O) than in the healthy rats (P aw = 10.43 \u00b1 1.02 cmH 2 O; P < 0.01).", {"entities": []}], ["This is consistent with an increase in compliance characteristic of an emphysema-like lung structure.", {"entities": []}], ["Following exposure, lungs were perfusion fixed and imaged in a 3T MR scanner.", {"entities": []}], ["Particle concentration in the different lobes was determined based on a relationship with the MR signal decay rate, R 2 E,part = 3.03 \u00b1 0.61 \u03bcm/ml) compared with the healthy rats (C H,part = 1.84 \u00b1 0.35 \u03bcm/ml; P < 0.01).", {"entities": []}], ["However, when particle deposition in each lobe was normalized by total deposition in the lung, there was no difference between the experimental groups.", {"entities": []}], ["However, the relative dispersion [RD = standard deviation/mean] of R 2 E = 0.32 \u00b1 0.02) compared with the healthy rats (RD H = 0.25 \u00b1 0.02; P < 0.01).", {"entities": [[34, 36, "GENE"], [120, 122, "GENE"], [34, 36, "GENE"], [120, 122, "GENE"]]}], ["These data show that particle deposition is higher and more heterogeneously distributed in emphysematous lungs compared with healthy lungs.", {"entities": []}], ["Recent advances in understanding CD4", {"entities": [[33, 36, "GENE"]]}], ["The purpose of this article is to report on the quality of the existing evidence base regarding the effectiveness of clinical pathway (CPW) research in the hospital setting.", {"entities": []}], ["The analysis is based on a recently published Cochrane review of the effectiveness of CPWs.", {"entities": []}], ["An integral component of the review process was a rigorous appraisal of the methodological quality of published CPW evaluations.", {"entities": []}], ["This allowed the identification of strengths and limitations of the evidence base for CPW effectiveness.", {"entities": []}], ["We followed the validated Cochrane Effective Practice and Organisation of Care Group (EPOC) criteria for randomized and non-randomized clinical pathway evaluations.", {"entities": []}], ["In addition, we tested the hypotheses that simple pre-post studies tend to overestimate CPW effects reported.", {"entities": []}], ["Out of the 260 primary studies meeting CPW content criteria, only 27 studies met the EPOC study design criteria, with the majority of CPW studies (more than 70\u2009%) excluded from the review on the basis that they were simple pre-post evaluations, mostly comparing two or more annual patient cohorts.", {"entities": []}], ["Methodologically poor study designs are often used to evaluate CPWs and this compromises the quality of the existing evidence base.", {"entities": []}], ["Cochrane EPOC methodological criteria, including the selection of rigorous study designs along with detailed descriptions of CPW development and implementation processes, are recommended for quantitative evaluations to improve the evidence base for the use of CPWs in hospitals.", {"entities": []}], ["During spring 1984, 2334 second and 2000 fifth-grade schoolchildren living in three Haifa Bay areas on the eastern Mediterranean coast with different levels of air pollution were studied.", {"entities": []}], ["The parents of these children filled out American Thoracic Society and National Heart and Lung Institute health questionnaires, and the children performed the following pulmonary function tests (PFT); FVC, FEV1, FEV1/FEV, PEF, FEF50, and FEF75.", {"entities": []}], ["A trend of higher prevalence of most reported respiratory symptoms was found for schoolchildren growing up in the medium and high pollution areas as compared with the low pollution area.", {"entities": []}], ["Part of the reported respiratory diseases were significantly more common among children from the high pollution area.", {"entities": []}], ["Models fitted for the respiratory conditions that differed significantly among the three areas of residence also included background variables that could be responsible for these differences.", {"entities": []}], ["Relative risk values, which were calculated from the logistic models, were in the range of 1.38 for sputum with cold and 1.81 for sputum without cold for children from the high pollution area as compared with 1.00 for children from the low pollution area.", {"entities": []}], ["All the measured values of PFT were within the normal range.", {"entities": []}], ["There was no consistent trend of reduced pulmonary function that characterized any residential area.", {"entities": []}], ["Increased lung macrophage numbers in COPD may arise from upregulation of blood monocyte recruitment into the lungs.", {"entities": []}], ["CCR5 is a monocyte chemokine receptor regulated by interleukin-6 (IL-6); the concentration of CCR5 ligands are known to be elevated in COPD lungs.", {"entities": [[0, 4, "GENE"], [94, 98, "GENE"], [0, 4, "GENE"], [94, 98, "GENE"]]}], ["The objective of this study was to investigate mechanisms of monocyte recruitment to the lung in COPD, including the role of CCR5 signalling.", {"entities": [[125, 129, "GENE"]]}], ["Ninety one COPD patients, 29 smokers (S) and 37 non-smokers (NS) underwent sputum induction, plasma sampling (to measure IL-6 and soluble IL-6 receptor [sIL-6R] by immunoassay), monocyte characterization (by flow cytometry) and monocyte isolation for cell migration and quantitative polymerase chain reaction studies.", {"entities": []}], ["Lung tissue was used for immunohistochemistry.", {"entities": []}], ["Plasma IL-6 and sIL-6R levels were increased in COPD.", {"entities": []}], ["Greater proportions of COPD CD14 p \u2009<\u20090.05).", {"entities": [[28, 32, "GENE"]]}], ["Pulmonary microvessels showed reduced monocyte recruitment (% marginated cells) in COPD compared to NS, (9.3% vs 83.1%, respectively).", {"entities": []}], ["The proportion of replicating Ki67 COPD monocytes show decreased migratory ability despite increased CCR5 expression.", {"entities": [[101, 105, "GENE"]]}], ["Increased COPD lung macrophage numbers may be due to delayed apoptosis.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0569-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The purpose of this study was to examine the relationship of meeting the recommended levels of physical activity (PA) with health status and preventive health behavior in adults.", {"entities": []}], ["A total of 5630 adults 18 years of age or older were included in this study.", {"entities": []}], ["PA was assessed using a series of questions that categorized activities based on their metabolic equivalent values and then categorized individuals based on the reported frequency and duration of such activities.", {"entities": []}], ["Participants reporting 150 minutes or more of moderate-intensity PA per week were considered to have met the PA guidelines.", {"entities": []}], ["Multiple logistic regression was used to model the relationships between meeting PA guidelines and health status and preventive health behavior, while controlling for confounding variables.", {"entities": []}], ["Overall, 53.9% (95% confidence interval [CI], 51.9 to 55.9%) of adults reported meeting the recommended levels of PA.", {"entities": []}], ["Among adults with good general health, 56.9% (95% CI, 54.7 to 59.1%) reported meeting the recommended levels of PA versus 43.1% (95% CI, 40.9 to 45.3%) who did not.", {"entities": []}], ["Adults who met the PA guidelines were significantly more likely not to report high cholesterol, diabetes, chronic obstructive pulmonary disease, arthritis, asthma, depression, or overweight.", {"entities": [[106, 143, "DISEASE"], [145, 154, "DISEASE"], [156, 162, "DISEASE"]]}], ["Furthermore, adults meeting the PA guidelines were significantly more likely to report having health insurance, consuming fruits daily, consuming vegetables daily, and not being a current cigarette smoker.", {"entities": []}], ["In this study, we found meeting the current guidelines for PA to have a protective relationship with both health status and health behavior in adults.", {"entities": []}], ["Health promotion programs should focus on strategies that help individuals meet the current guidelines of at least 150 minutes per week of moderate-intensity PA.", {"entities": []}], ["Centella asiatica has potent antioxidant and anti-inflammatory properties.", {"entities": []}], ["However, its anti-dermatitic effect has not yet been reported.", {"entities": []}], ["In this study, we investigated the anti-dermatitic effects of titrated extract of Centella asiatica (TECA) in a phthalic anhydride (PA)-induced atopic dermatitis (AD) animal model as well as in vitro model.", {"entities": [[144, 161, "DISEASE"], [151, 161, "DISEASE"]]}], ["An AD-like lesion was induced by the topical application of five percent PA to the dorsal skin or ear of Hos:HR-1 mouse.", {"entities": []}], ["After AD induction, 100 \u03bcL of 0.2% and 0.4% of TECA (40 \u03bcg or 80 \u03bcg/cm", {"entities": []}], ["Sulfuric acid aerosols occur in the ambient particulate mode due to atmospheric conversion from sulfur dioxide (SO2).", {"entities": []}], ["This paper describes the response of the rabbit tracheobronchial tree to daily exposures to sulfuric acid (H2SO4) aerosol, relating physiological and morphological parameters.", {"entities": []}], ["Rabbits were exposed to filtered air (sham control) or to submicrometer-sized H2SO4 at 250 micrograms/m3 H2SO4, for 1 hr/day, 5 days/week, with sacrifices after 4, 8, and 12 months of acid (or sham) exposure; some rabbits were allowed a 3-month recovery after all exposures ended.", {"entities": []}], ["H2SO4 produced a slowing of tracheobronchial mucociliary clearance during the first weeks of exposure; this change became significantly greater with continued exposures and did not improve after exposures ended.", {"entities": []}], ["Airway hyperresponsiveness was evident by 4 months of acid exposure; the condition worsened by 8 months of exposure and appeared to stabilize after this time.", {"entities": []}], ["Standard pulmonary mechanics parameters showed no significant trends with repeated acid exposure, except for a decline in dynamic lung compliance in animals exposed to acid for 12 months.", {"entities": []}], ["Lung tissue samples obtained from exposed animals showed a shift toward a greater frequency of smaller airways compared to control, an increase in epithelial secretory cell density in smaller airways, and a shift from neutral to acidic glycoproteins in the secretory cells.", {"entities": []}], ["The effect on airway diameter resolved after the exposures ceased, but the secretory cell response did not return to normal within the recovery period.", {"entities": []}], ["No evidence of inflammatory cell infiltration was found due to H2SO4 exposure.", {"entities": []}], ["Thus, significant alterations in the physiology of the tracheobronchial tree have been demonstrated due to repeated 1-hr exposures to a concentration of H2SO4 that is one-fourth the current 8-hr threshold limit value for exposure in the work environment.", {"entities": []}], ["The cumulative dose inhaled by the rabbits is similar to current peak daily doses from ambient exposure in North America.", {"entities": []}], ["The results obtained in the rabbit model provide insight into early changes in the tracheobronchial tree due to repeated irritant exposure and may be involved in the pathogenesis of chronic airway disease.", {"entities": []}], ["This research aims to assess the response to acid suppression therapy in gastroesophageal reflux disease (GERD)-related chronic laryngitis (CL).", {"entities": [[128, 138, "DISEASE"], [120, 138, "DISEASE"], [73, 104, "DISEASE"]]}], ["Data were extracted from Web of Knowledge, Embase, and PubMed for English language article published up to March 2016.", {"entities": []}], ["Pooled overall response rate (ORR) rates were evaluated to determine acid suppression treatment efficacy.", {"entities": []}], ["Random effects model was used with standard approaches to sensitivity analysis, quality assessment, heterogeneity, and exploration of publication bias.", {"entities": []}], ["Pooled data from 21 reports (N\u200a=\u200a2864, antireflux medicine: 2741; antireflux surgery: 123, study duration 4\u2013108 week) were analyzed.", {"entities": []}], ["With the random-effect model, the ORR was 66% (95% confidence interval [CI] 54%\u201378%).", {"entities": []}], ["The ORRs were 80% for antireflux surgery (95% CI 67%\u201393%, 3 studies, 123 patients), whereas 64% for antireflux medicine (95% CI 50%\u201377%, 18 studies, 2741 patients), and the ORR was 70% (95% CI 55%\u201385%, 15 reports, 2731 patients) for >8 weeks\u2019 therapy duration, whereas 57% (95% CI 48%\u201365%, 6 reports, 133 patients) for \u22648 weeks\u2019 duration of therapy.", {"entities": []}], ["Acid suppression seems to be an effective therapy for GERD-related CL.", {"entities": []}], ["There was an increase in effect among patients with surgery therapeutic method and longer therapy duration.", {"entities": []}], ["Lung function measures are heritable traits that predict population morbidity and mortality and are essential for the diagnosis of chronic obstructive pulmonary disease (COPD).", {"entities": [[131, 168, "DISEASE"]]}], ["Variations in many genes have been reported to affect these traits, but attempts at replication have provided conflicting results.", {"entities": []}], ["Recently, we undertook a meta-analysis of Genome Wide Association Study (GWAS) results for lung function measures in 20,288 individuals from the general population (the SpiroMeta consortium).", {"entities": []}], ["To comprehensively analyse previously reported genetic associations with lung function measures, and to investigate whether single nucleotide polymorphisms (SNPs) in these genomic regions are associated with lung function in a large population sample.", {"entities": []}], ["We analysed association for SNPs tagging 130 genes and 48 intergenic regions (+/\u221210 kb), after conducting a systematic review of the literature in the PubMed database for genetic association studies reporting lung function associations.", {"entities": []}], ["The analysis included 16,936 genotyped and imputed SNPs.", {"entities": []}], ["No loci showed overall significant association for FEV 1 or FEV 1 /FVC traits using a carefully defined significance threshold of 1.3\u00d710 1 include SNPs tagging MACROD2 ( P \u200a=\u200a6.81\u00d710 CNTN5 ( P \u200a=\u200a4.37\u00d710 TRPV4 ( P \u200a=\u200a1.58\u00d710 SERPINA1 showed the most significant association with FEV 1 ( P \u200a=\u200a8.41\u00d710 PDE4D ( P \u200a=\u200a1.22\u00d710 1 /FVC ratio was observed with ABCC1 ( P \u200a=\u200a4.38\u00d710 ESR1 ( P \u200a=\u200a5.42\u00d710 Polymorphisms spanning previously associated lung function genes did not show strong evidence for association with lung function measures in the SpiroMeta consortium population.", {"entities": [[51, 54, "GENE"], [60, 63, "GENE"], [279, 282, "GENE"], [51, 54, "GENE"], [60, 63, "GENE"], [279, 282, "GENE"], [160, 167, "GENE"], [183, 188, "GENE"], [204, 209, "GENE"], [225, 233, "GENE"], [51, 54, "GENE"], [60, 63, "GENE"], [279, 282, "GENE"], [300, 305, "GENE"], [352, 357, "GENE"], [373, 377, "GENE"]]}], ["Common SERPINA1 polymorphisms may affect FEV 1 among smokers in the general population.", {"entities": [[7, 15, "GENE"], [41, 44, "GENE"]]}], ["Research into chronic infection by bacterial pathogens, such as Pseudomonas aeruginosa , uses various in vitro and live host models.", {"entities": []}], ["While these have increased our understanding of pathogen growth, virulence, and evolution, each model has certain limitations.", {"entities": []}], ["In vitro models cannot recapitulate the complex spatial structure of host organs, while experiments on live hosts are limited in terms of sample size and infection duration for ethical reasons; live mammal models also require specialized facilities which are costly to run.", {"entities": []}], ["To address this, we have developed an ex vivo pig lung (EVPL) model for quantifying Pseudomonas aeruginosa growth, quorum sensing (QS), virulence factor production, and tissue damage in an environment that mimics a chronically infected cystic fibrosis (CF) lung.", {"entities": [[236, 251, "DISEASE"], [56, 60, "GENE"]]}], ["In a first test of our model, we show that lasR mutants, which do not respond to 3-oxo-C 12 -homoserine lactone (HSL)-mediated QS, exhibit reduced virulence factor production in EVPL.", {"entities": [[178, 182, "GENE"]]}], ["We also show that lasR mutants grow as well as or better than a corresponding wild-type strain in EVPL.", {"entities": [[98, 102, "GENE"]]}], ["lasR mutants frequently and repeatedly arise during chronic CF lung infection, but the evolutionary forces governing their appearance and spread are not clear.", {"entities": []}], ["Our data are not consistent with the hypothesis that lasR mutants act as social \u201ccheats\u201d in the lung; rather, our results support the hypothesis that lasR mutants are more adapted to the lung environment.", {"entities": []}], ["More generally, this model will facilitate improved studies of microbial disease, especially studies of how cells of the same and different species interact in polymicrobial infections in a spatially structured environment.", {"entities": []}], ["Caloric restriction (CR) is generally linked to lifespan extension in various organisms and may limit age-associated diseases.", {"entities": []}], ["Processes through which caloric restriction promotes lifespan include obesity-countering weight loss, increased DNA repair, control of ribosomal and telomeric DNA repeats, mitochondrial regulation, activation of antioxidants, and protective autophagy.", {"entities": [[70, 77, "DISEASE"]]}], ["Several of these protective cellular processes are linked to the suppression of TOR (target of rapamycin) or the activation of sirtuins.", {"entities": []}], ["In stark contrast, CR fails to extend or even shortens lifespan in certain settings.", {"entities": []}], ["CR-dependent lifespan shortening is linked to weight loss in the non-obese, mitochondrial hyperactivity, genomic inflexibility, and several other processes.", {"entities": []}], ["Deciphering the balance between positive and negative effects of CR is critical to understanding its ultimate impact on aging.", {"entities": []}], ["This knowledge is especially needed in order to fulfil the promise of using CR or its mimetic drugs to counteract age-associated diseases and unhealthy aging.", {"entities": []}], ["Methylarginines are endogenous nitric oxide synthase inhibitors that have been implicated in animal models of lung disease but have not previously been examined for their association with spirometric measures of lung function in humans.", {"entities": [[110, 122, "DISEASE"]]}], ["This study measured serum concentrations of asymmetric and symmetric dimethylarginine in a representative sample of older community-dwelling adults and determined their association with spirometric lung function measures.", {"entities": []}], ["Data on clinical, lifestyle, and demographic characteristics, methylated arginines, and L-arginine (measured using LC-MS/MS) were collected from a population-based sample of older Australian adults from the Hunter Community Study.", {"entities": []}], ["The five key lung function measures included as outcomes were Forced Expiratory Volume in 1 second, Forced Vital Capacity, Forced Expiratory Volume in 1 second to Forced Vital Capacity ratio, Percent Predicted Forced Expiratory Volume in 1 second, and Percent Predicted Forced Vital Capacity.", {"entities": []}], ["In adjusted analyses there were statistically significant independent associations between a) higher asymmetric dimethylarginine, lower Forced Expiratory Volume in 1 second and lower Forced Vital Capacity; and b) lower L-arginine/asymmetric dimethylarginine ratio, lower Forced Expiratory Volume in 1 second, lower Percent Predicted Forced Expiratory Volume in 1 second and lower Percent Predicted Forced Vital Capacity.", {"entities": []}], ["By contrast, no significant associations were observed between symmetric dimethylarginine and lung function.", {"entities": []}], ["After adjusting for clinical, demographic, biochemical, and pharmacological confounders, higher serum asymmetric dimethylarginine was independently associated with a reduction in key measures of lung function.", {"entities": []}], ["Further research is needed to determine if methylarginines predict the decline in lung function.", {"entities": []}], ["Various studies have shown that non-communicable diseases (NCDs) especially diabetes and hypertension are prevalent among older women living in South African urban areas, placing a heavy burden on the healthcare system.", {"entities": [[89, 101, "DISEASE"]]}], ["This study aimed to understand the health-seeking behaviour, healthcare practices and prevalence of traditional herbal medicine (THM) use among older women self-reporting NCDs from the Prospective Urban Rural Epidemiology study (PURE).", {"entities": []}], ["A homogenous purposive sampling of PURE participants was used to recruit women who were 50\u00a0years or older ( n \u2009=\u2009250).", {"entities": []}], ["Descriptive statistics were used to examine the number of NCDs reported by the study sample, health seeking behaviour and practices as well as THM use.", {"entities": []}], ["Logistic regression was also employed to investigate possible associations between reported conditions and THM use or medical pluralism.", {"entities": []}], ["Within the study sample, 72\u00a0% self-reported an NCD.", {"entities": []}], ["Of those with self-reported NCDs, 46\u00a0% had one, and 54\u00a0% had two or more NCDs.", {"entities": []}], ["Those with NCDs usually visited public clinics (80\u00a0%), relied on doctors (90\u00a0%) and nurses (85\u00a0%) for health information, and mostly used conventional medicine (CM) to manage high blood pressure (81\u00a0%).", {"entities": []}], ["About 30\u00a0% of those with NCDs indicated using THM, of whom 29 (53\u00a0%) reported practicing medical pluralism.", {"entities": []}], ["Participants with dental problems (OR: 3.24, 95\u00a0% CI: 1.30\u20138.20), headaches (OR: 2.42, 95\u00a0% CI: 1.24\u20134.94), heart burn (OR: 2.30, 95\u00a0% CI: 1.18\u20134.48) and severe tiredness (OR: 2.05, 95\u00a0% CI: 1.08\u20133.99) were more likely to use THM.", {"entities": []}], ["Anxiety and allergies increased the likelihood to practise medical pluralism by five and 20 times, respectively.", {"entities": []}], ["Self-reported NCD with co-morbidities was prevalent among the participants in the study.", {"entities": []}], ["Most of the study participants utilized state-owned clinics and hospitals for the management of their chronic conditions.", {"entities": []}], ["THM use was not very common.", {"entities": []}], ["However, among those who used THM, medical pluralism was prevalent.", {"entities": []}], ["Family history was the most common reason for THM use, with many THM patrons utilizing these for treatment of a health condition.", {"entities": []}], ["Older black women with anxiety and allergies were more likely to practise medical pluralism.", {"entities": []}], ["Nasal potential difference (NPD), a well-established in vivo clinical test for cystic fibrosis, reflects transepithelial cation and anion transport in the respiratory epithelium.", {"entities": [[79, 94, "DISEASE"]]}], ["To analyze whether NPD can be applied to diagnose hypoxic lung injury, we searched PubMed, EMBASE, Scopus, Web of Science, Ovid MEDLINE, and Google Scholar, and analyzed data retrieved from eleven unbiased studies for high altitude pulmonary edema (HAPE) and respiratory distress syndrome (RDS) using the software RevMan and R. There was a significant reduction in overall basal (WMD \u22125.27\u2009mV, 95%\u2009CI: \u22126.03 to \u22124.52, P\u2009<\u20090.00001, I 2 correlated with ENaC-associated NPD positively in patients only, but apparently related to CFTR-contributed NPD level inversely.", {"entities": [[280, 288, "DISEASE"], [232, 247, "DISEASE"]]}], ["These correlations were confirmed by the opposite associations between NPD values and altitude, which had a negative regression with SpO 2 level.", {"entities": []}], ["Basal NPD was significantly associated with amiloride-resistant but not ENaC fraction.", {"entities": []}], ["Our analyses demonstrate that acute lung injury associated with systemic hypoxia is characterized by dysfunctional NPD.", {"entities": []}], ["Lower respiratory tract infection (LRTI) is a major contributor to respiratory failure requiring intubation and mechanical ventilation.", {"entities": [[67, 86, "DISEASE"]]}], ["LRTI also occurs during mechanical ventilation, increasing the morbidity and mortality of intubated patients.", {"entities": []}], ["We sought to understand the dynamics of respiratory tract microbiota following intubation and the relationship between microbial community structure and infection.", {"entities": []}], ["We enrolled a cohort of 15 subjects with respiratory failure requiring intubation and mechanical ventilation from the medical intensive care unit at an academic medical center.", {"entities": [[41, 60, "DISEASE"]]}], ["Oropharyngeal (OP) and deep endotracheal (ET) secretions were sampled within 24\u00a0h of intubation and every 48\u201372\u00a0h thereafter.", {"entities": []}], ["Bacterial community profiling was carried out by purifying DNA, PCR amplification of 16S ribosomal RNA (rRNA) gene sequences, deep sequencing, and bioinformatic community analysis.", {"entities": []}], ["We compared enrolled subjects to a cohort of healthy subjects who had lower respiratory tract sampling by bronchoscopy.", {"entities": []}], ["In contrast to the diverse upper respiratory tract and lower respiratory tract microbiota found in healthy controls, critically ill subjects had lower initial diversity at both sites.", {"entities": []}], ["Diversity further diminished over time on the ventilator.", {"entities": []}], ["In several subjects, the bacterial community was dominated by a single taxon over multiple time points.", {"entities": []}], ["The clinical diagnosis of LRTI ascertained by chart review correlated with low community diversity and dominance of a single taxon.", {"entities": []}], ["Dominant taxa matched clinical bacterial cultures where cultures were obtained and positive.", {"entities": []}], ["In several cases, dominant taxa included bacteria not detected by culture, including Ureaplasma parvum and Enterococcus faecalis .", {"entities": []}], ["Longitudinal analysis of respiratory tract microbiota in critically ill patients provides insight into the pathogenesis and diagnosis of LRTI.", {"entities": []}], ["16S rRNA gene sequencing of endotracheal aspirate samples holds promise for expanded pathogen identification.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-016-0151-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to investigate the correlation of the qualitative transmural extent of hypoperfusion areas (HPA) using stress dynamic whole-heart computed tomography perfusion (CTP) imaging by 256-slice CT with CTP-derived myocardial blood flow (MBF) for the estimation of the severity of coronary artery stenosis.", {"entities": []}], ["Eleven patients underwent adenosine triphosphate (0.16 mg/kg/min, 5 min) stress dynamic CTP by 256-slice CT (coverage: 8 cm, 0.27 s/rotation), and 9 of the 11 patients underwent coronary angiography (CAG).", {"entities": []}], ["Stress dynamic CTP (whole\u2013heart datasets over 30 consecutive heart beats in systole without spatial and temporal gaps) was acquired with prospective ECG gating (effective radiation dose: 10.4 mSv).", {"entities": []}], ["The extent of HPAs was visually graded using a 3-point score (normal, subendocardial, transmural).", {"entities": []}], ["MBF (ml/100g/min) was measured by deconvolution.", {"entities": []}], ["Differences in MBF (mean \u00b1 standard error) according to HPA and CAG results were evaluated.", {"entities": []}], ["In 27 regions (3 major coronary territories in 9 patients), 11 coronary stenoses (> 50% reduction in diameter) were observed.", {"entities": []}], ["In 353 myocardial segments, HPA was significantly related to MBF ( P < 0.05; normal 295 \u00b1 94; subendocardial 186 \u00b1 67; and transmural 80 \u00b1 53).", {"entities": []}], ["Coronary territory analysis revealed a significant relationship between coronary stenosis severity and MBF ( P < 0.05; non-significant stenosis [< 50%], 284 \u00b1 97; moderate stenosis [50\u201370%], 184 \u00b1 74; and severe stenosis [> 70%], 119 \u00b1 69).", {"entities": [[72, 89, "DISEASE"]]}], ["The qualitative transmural extent of HPA using stress whole-heart dynamic CTP imaging by 256-slice CT exhibits a good correlation with quantitative CTP-derived MBF and may aid in assessing the hemodynamic significance of coronary artery disease.", {"entities": []}], ["Pre-pregnancy maternal obesity is associated with adverse offspring outcomes at birth and later in life.", {"entities": [[23, 30, "DISEASE"]]}], ["Individual studies have shown that epigenetic modifications such as DNA methylation could contribute.", {"entities": []}], ["Within the Pregnancy and Childhood Epigenetics (PACE) Consortium, we meta-analysed the association between pre-pregnancy maternal BMI and methylation at over 450,000 sites in newborn blood DNA, across 19 cohorts (9,340 mother-newborn pairs).", {"entities": []}], ["We attempted to infer causality by comparing the effects of maternal versus paternal BMI and incorporating genetic variation.", {"entities": []}], ["In four additional cohorts (1,817 mother-child pairs), we meta-analysed the association between maternal BMI at the start of pregnancy and blood methylation in adolescents.", {"entities": []}], ["In newborns, maternal BMI was associated with small (<0.2% per BMI unit (1 kg/m P < 1.06 \u00d7 10", {"entities": []}], ["To investigate the relationships between symptoms compatible with the sick building syndrome (SBS) in adults and building dampness and ventilation in single-family houses.", {"entities": [[84, 92, "DISEASE"], [70, 92, "DISEASE"]]}], ["Within the Swedish BETSI study, a national sample of single-family houses were inspected by professional building experts, and adults living in the houses answered a questionnaire on SBS.", {"entities": []}], ["Relationships between building factors and SBS were analysed using logistic regression.", {"entities": []}], ["Of the respondents, 23% reported having had weekly SBS symptoms during the last three months.", {"entities": []}], ["A large proportion of houses exhibited building or construction problems.", {"entities": []}], ["In total, 40% of houses had dampness problems in the foundation, and this was related to a higher prevalence of both mucous and dermal symptoms, and any SBS symptoms.", {"entities": []}], ["Furthermore, high air humidity was related to more symptoms, with the relationship with absolute humidity being stronger than that with relative humidity or moisture load.", {"entities": []}], ["Symptoms were also more prevalent in houses with a high U value, reflecting a poor thermal insulation.", {"entities": []}], ["Compared to natural ventilation, living in a house with mechanical supply and exhaust ventilation was related to a lower prevalence of general symptoms and any SBS symptoms, but there were only weak associations between measured air exchange rate and symptoms.", {"entities": []}], ["A large proportion of single-family houses have dampness problems in the foundation, and pollutants may enter the living space of the house and affect the health of the occupants.", {"entities": []}], ["Furthermore, absolute air humidity should be measured more often in indoor air studies.", {"entities": []}], ["To investigate patient characteristics of an unselected primary care population associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (AECOPD).", {"entities": [[171, 208, "DISEASE"]]}], ["Retrospective open cohort using pseudonymised electronic primary care data linked to secondary care data.", {"entities": []}], ["Primary care; Lothian (population approximately 800\u2005000), Scotland.", {"entities": []}], ["Data from 7002 patients from 72 general practices with a COPD diagnosis date between 2000 and 2008 recorded in their primary care record.", {"entities": []}], ["Patients were followed up until 2010, death or they left a participating practice.", {"entities": []}], ["First and subsequent admissions for AECOPD (International Classification of Diseases (ICD) 10 codes J44.0, J44.1 in any diagnostic position) after COPD diagnosis in primary care.", {"entities": []}], ["1756 (25%) patients had at least 1 AECOPD admission; 794 (11%) had at least 1 readmission and the risk of readmission increased with each admission.", {"entities": []}], ["Older age at diagnosis, more severe COPD, low body mass index (BMI), current smoking, increasing deprivation, COPD admissions and interventions for COPD prior to diagnosis in primary care, and comorbidities were associated with higher risk of first AECOPD admission in an adjusted Cox proportional hazards regression model.", {"entities": []}], ["More severe COPD and COPD admission prior to primary care diagnosis were associated with increased risk of AECOPD readmission in an adjusted Prentice-Williams-Peterson model.", {"entities": []}], ["High BMI was associated with a lower risk of first AECOPD admission and readmission.", {"entities": []}], ["Several patient characteristics were associated with first AECOPD admission in a primary care cohort of people with COPD but fewer were associated with readmission.", {"entities": []}], ["Prompt diagnosis in primary care may reduce the risk of AECOPD admission and readmission.", {"entities": []}], ["The study highlights the important role of primary care in preventing or delaying a first AECOPD admission.", {"entities": []}], ["Metastable epialleles (MEs) are mammalian genomic loci where epigenetic patterning occurs before gastrulation in a stochastic fashion leading to systematic interindividual variation within one species.", {"entities": []}], ["Importantly, periconceptual nutritional influences may modulate the establishment of epigenetic changes, such as DNA methylation at MEs.", {"entities": []}], ["Based on these characteristics, we exploited Infinium HumanMethylation450 BeadChip kits in a 2-tissue parallel screen on peripheral blood leukocyte and colonic mucosal DNA from 10 children without identifiable large intestinal disease.", {"entities": [[216, 234, "DISEASE"]]}], ["This approach led to the delineation of 1776 CpG sites meeting our criteria for MEs, which associated with 1013 genes.", {"entities": []}], ["The list of ME candidates exhibited overlaps with recently identified human genes (including CYP2E1 and MGMT , where methylation has been associated with Parkinson disease and glioblastoma, respectively) in which perinatal DNA methylation levels where linked to maternal periconceptual nutrition.", {"entities": [[176, 188, "DISEASE"], [93, 99, "GENE"], [104, 108, "GENE"]]}], ["One hundred 18 (11.6%) of the ME candidates overlapped with genes where DNA methylation correlated (r > 0.871; p < 0.055) with expression in the colon mucosa of 5 independent control children.", {"entities": []}], ["Genes involved in homophilic cell adhesion (including cadherin-associated genes) and developmental processes were significantly overrepresented in association with MEs.", {"entities": []}], ["Additional filtering of gene expression-correlated MEs defined 35 genes, associated with 2 or more CpG sites within a 10 kb genomic region, fulfilling the ME criteria.", {"entities": []}], ["DNA methylation changes at a number of these genes have been linked to various forms of human disease, including cancers, such as asthma and acute myeloid leukemia ( ALOX12 ), gastric cancer ( EBF3 ), breast cancer ( NAV1 ), colon cancer and acute lymphoid leukemia ( KCNK15 ), Wilms tumor (protocadherin gene cluster; PCDHAs ) and colorectal cancer ( TCERG1L ), suggesting a potential etiologic role for MEs in tumorigenesis and underscoring the possible developmental origins of these malignancies.", {"entities": [[248, 265, "DISEASE"], [332, 349, "DISEASE"], [201, 214, "DISEASE"], [147, 163, "DISEASE"], [225, 237, "DISEASE"], [141, 163, "DISEASE"], [155, 163, "DISEASE"], [257, 265, "DISEASE"], [130, 136, "DISEASE"], [184, 190, "DISEASE"], [208, 214, "DISEASE"], [231, 237, "DISEASE"], [343, 349, "DISEASE"], [166, 172, "GENE"], [193, 197, "GENE"], [217, 221, "GENE"], [268, 274, "GENE"], [352, 359, "GENE"]]}], ["The presented compendium of ME candidates may accelerate our understanding of the epigenetic origins of common human disorders.", {"entities": []}], ["Research focusing on management of foot health has become more evident over the past decade, especially related to chronic conditions such as diabetes.", {"entities": []}], ["The level of methodological rigour across this body of work however is varied and outputs do not appear to have been developed or translated into clinical practice.", {"entities": []}], ["The aim of this systematic review was to assess the latest guidelines, standards of care and current recommendations relative to people with chronic conditions to ascertain the level of supporting evidence concerning the management of foot health.", {"entities": []}], ["A systematic search of electronic databases (Medline, Embase, Cinahl, Web of Science, SCOPUS and The Cochrane Library) for literature on recommendations for foot health management for people with chronic conditions was performed between 2000 and 2016 using predefined criteria.", {"entities": []}], ["Data from the included publications was synthesised via template analysis, employing a thematic organisation and structure.", {"entities": []}], ["The methodological quality of all included publications was appraised using the Appraisal for Research and Evaluation (AGREE II) instrument.", {"entities": []}], ["A more in-depth analysis was carried out that specifically considered the levels of evidence that underpinned the strength of their recommendations concerning management of foot health.", {"entities": []}], ["The data collected revealed 166 publications in which the majority (102) were guidelines, standards of care or recommendations related to the treatment and management of diabetes.", {"entities": []}], ["We noted a trend towards a systematic year on year increase in guidelines standards of care or recommendations related to the treatment and management of long term conditions other than diabetes over the past decade.", {"entities": []}], ["The most common recommendation is for preventive care or assessments (e.g.", {"entities": []}], ["vascular tests), followed by clinical interventions such as foot orthoses, foot ulcer care and foot health education.", {"entities": []}], ["Methodological quality was spread across the range of AGREE II scores with 62 publications falling into the category of high quality (scores 6\u20137).", {"entities": []}], ["The number of publications providing a recommendation in the context of a narrative but without an indication of the strength or quality of the underlying evidence was high (79 out of 166).", {"entities": []}], ["It is clear that evidence needs to be accelerated and in place to support the future of the Podiatry workforce.", {"entities": []}], ["Whilst high level evidence for podiatry is currently low in quantity, the methodological quality is growing.", {"entities": []}], ["Where levels of evidence have been given in in high quality guidelines, standards of care or recommendations, they also tend to be strong-moderate quality such that further strategically prioritised research, if performed, is likely to have an important impact in the field.", {"entities": []}], ["The online version of this article (10.1186/s13047-017-0232-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A drug interaction is a process by which a drug or any other substance interacts with another drug and affects its activity by increasing or decreasing its effect, causing a side effect or producing a new effect unrelated to the effect of either.", {"entities": []}], ["Interactions may be of various types-drug-drug interactions, drug-food interactions, drug-medical condition interactions, or drug-herb interactions.", {"entities": []}], ["Interactions may occur by single or multiple mechanisms.", {"entities": []}], ["They may occur in vivo or in vitro (pharmaceutical reactions).", {"entities": []}], ["In vivo interactions may be further subdivided into pharmacodynamic or pharmacokinetic reactions.", {"entities": []}], ["Topical drug interactions which may be agonistic or antagonistic may occur between two drugs applied topically or between a topical and a systemic drug.", {"entities": []}], ["Topical drug-food interaction (for example, grape fruit juice and cyclosporine) and drug-disease interactions (for example, topical corticosteroid and aloe vera) may also occur.", {"entities": []}], ["It is important for the dermatologist to be aware of such interactions to avoid complications of therapy in day-to-day practice.", {"entities": []}], ["Management guidelines for chronic obstructive pulmonary disease (COPD) recommend that inhaled corticosteroids (ICS) are prescribed to patients with the most severe symptoms.", {"entities": [[26, 63, "DISEASE"]]}], ["However, these guidelines have not been widely implemented by physicians, leading to widespread use of ICS in patients with mild-to-moderate COPD.", {"entities": []}], ["Of particular concern is the potential risk of worsening diabetic control associated with ICS use.", {"entities": []}], ["Here we investigate whether ICS therapy in patients with COPD and comorbid type 2 diabetes mellitus (T2DM) has a negative impact on diabetic control, and whether these negative effects are dose-dependent.", {"entities": [[82, 99, "DISEASE"], [75, 99, "DISEASE"]]}], ["This was a historical matched cohort study utilising primary care medical record data from two large UK databases.", {"entities": []}], ["We selected patients aged \u226540 years with COPD and T2DM, prescribed ICS (n = 1360) or non-ICS therapy (n = 2642) between 2008 and 2012.", {"entities": []}], ["The primary endpoint was change in HbA 1c between the baseline and outcome periods.", {"entities": []}], ["After 1:1 matching, each cohort consisted of 682 patients.", {"entities": []}], ["Over the 12\u201318-month outcome period, patients prescribed ICS had significantly greater increases in HbA 1c values compared with those prescribed non-ICS therapies; adjusted difference 0.16% (95% confidence interval [CI]: 0.05\u20130.27%) in all COPD patients, and 0.25% (95% CI: 0.10\u20130.40%) in mild-to-moderate COPD patients.", {"entities": []}], ["Patients in the ICS cohort also had significantly more diabetes-related general practice visits per year and received more frequent glucose strip prescriptions, compared with those prescribed non-ICS therapies.", {"entities": []}], ["Patients prescribed higher cumulative doses of ICS (>250 mg) had greater odds of increased HbA 1c and/or receiving additional antidiabetic medication, and increased odds of being above the Quality and Outcomes Framework (QOF) target for HbA 1c levels, compared with those prescribed lower cumulative doses (\u2264125 mg).", {"entities": []}], ["For patients with COPD and comorbid T2DM, ICS therapy may have a negative impact on diabetes control.", {"entities": []}], ["Patients prescribed higher cumulative doses of ICS may be at greater risk of diabetes progression.", {"entities": []}], ["ENCePP ENCEPP/SDPP/6804", {"entities": []}], ["The size of inhaled particles influences where they deposit and theoretically should be important for the development of airway inflammation and responsiveness.", {"entities": []}], ["Our aim was to assess if sensitization to smaller-sized aeroallergens relates to higher prevalence of treated asthma, increased airway responsiveness, and airway and systemic inflammation.", {"entities": [[110, 116, "DISEASE"]]}], ["Molecular-based IgE antibody determination was done in 467 subjects.", {"entities": []}], ["Sensitized subjects were grouped based on the particle size of the aeroallergen: (1) Large particles only (mainly pollen); (2) Medium-sized particles (sensitized to mainly mite and mold and possibly to large particles); and 3) Small particles (sensitized to pet allergens and possibly to medium- and/or large-sized particles).", {"entities": []}], ["Airway responsiveness to methacholine, exhaled nitric oxide (F E NO), and serum eosinophil cationic protein (S-ECP) were measured.", {"entities": []}], ["Asthma and rhinitis were questionnaire-assessed.", {"entities": [[11, 19, "DISEASE"], [0, 6, "DISEASE"]]}], ["Subjects sensitized to small particles had higher prevalence of treated asthma (35% versus 10%, P \u2009<\u20090.001), higher F E NO 50 (32 versus 17 ppb, P \u2009<\u20090.001), higher S-ECP (10 versus 7.5 ng/mL, P \u2009=\u20090.04), and increased bronchial responsiveness (dose-response slope, 5.6 versus 7.5, P \u2009<\u20090.001) compared with non-atopics.", {"entities": [[72, 78, "DISEASE"]]}], ["This was consistent after adjusting for potential confounders.", {"entities": []}], ["Sensitization to only large or to medium and possibly also large aeroallergen particles was not related to any of these outcomes after adjustments.", {"entities": []}], ["Sensitization to smaller particles was associated with a higher prevalence of asthma under treatment, higher airway responsiveness, and airway and systemic inflammation.", {"entities": [[78, 84, "DISEASE"]]}], ["Mapping of IgE sensitization to small particles might help to detect subjects having increased airway and systemic inflammation and bronchial responsiveness, indicating increased risk of developing asthma.", {"entities": [[198, 204, "DISEASE"]]}], ["We evaluated the spatiotemporal distributions of black carbon (BC) and particulate matters with aerodynamic diameters of less than 2.5 m (PM 2.5 ) concentrations at urban diesel engine emission (DEE) hotspots of South Korea.", {"entities": []}], ["Concentrations of BC and PM 2.5 were measured at the entrance gate of two diesel bus terminals and a train station, in 2014.", {"entities": []}], ["Measurements were conducted simultaneously at the hotspot (Site 1) and at its adjacent, randomly selected, residential areas, apartment complex near major roadways, located with the same direction of 300 m (Site 2) and 500 m (Site 3) away from Site 1 on 4 different days over the season, thrice per day; morning ( n = 120 measurements for each day and site), evening ( n = 120), and noon ( n = 120).", {"entities": []}], ["The median (interquartile range) PM 2.5 ranged from 12.6 (11.3\u201314.3) to 60.1 (47.0\u201376.0) \u03bcg/m 2.5 concentrations between sites (slopes 0.89\u20130.9, the coefficient of determination 0.89\u20130.96) while the relationship for BC concentrations between sites was relatively weak (slopes 0.76\u20130.85, the coefficient of determination 0.54\u20130.72).", {"entities": []}], ["PM 2.5 concentrations were changed from 4% to 140% by unit increase of BC concentration, depending on site and time while likely supporting the necessity of monitoring of BC as well as PM 2.5 , especially at urban DEE related hotspot areas.", {"entities": []}], ["The study of ethnobotany relating to any tribe is in itself a very intricate or convoluted process.", {"entities": []}], ["This paper documents the traditional knowledge of medicinal plants that are in use by the indigenous Jaintia tribes residing in few isolated pockets of northeast India.", {"entities": []}], ["The present study was done through structured questionnaires in consultations with the tribal practitioners and has resulted in the documentation of 39 medicinal plant species belonging to 27 families and 35 genera.", {"entities": []}], ["For curing diverse form of ailments, the use of aboveground plant parts was higher (76.59%) than the underground plant parts (23.41%).", {"entities": []}], ["Of the aboveground plant parts, leaf was used in the majority of cases (23 species), followed by fruit (4).", {"entities": []}], ["Different underground plant forms such as root, tuber, rhizome, bulb and pseudo-bulb were also found to be in use by the Jaintia tribe as a medicine.", {"entities": []}], ["Altogether, 30 types of ailments have been reported to be cured by using these 39 medicinal plant species.", {"entities": []}], ["The study thus underlines the potentials of the ethnobotanical research and the need for the documentation of traditional ecological knowledge pertaining to the medicinal plant utilization for the greater benefit of mankind.", {"entities": []}], ["Luteal support with progesterone is necessary for successful implantation of the embryo following egg collection and embryo transfer in an in-vitro fertilization (IVF) cycle.", {"entities": []}], ["Progesterone has been used for as little as 2 weeks and for as long as 12 weeks of gestation.", {"entities": []}], ["The optimal length of treatment is unresolved at present and it remains unclear how long to treat women receiving luteal supplementation.", {"entities": []}], ["The trial is a prospective, randomized, double-blind, placebo-controlled trial to investigate the effect of the duration of luteal support with progesterone in IVF cycles.", {"entities": []}], ["Following 2 weeks standard treatment and a positive biochemical pregnancy test, this randomized control trial will allocate women to a supplementary 8 weeks treatment with vaginal progesterone or 8 weeks placebo.", {"entities": []}], ["Further studies would be required to investigate whether additional supplementation with progesterone is beneficial in early pregnancy.", {"entities": []}], ["Currently at the Hewitt Centre, approximately 32.5% of women have a positive biochemical pregnancy test 2 weeks after embryo transfer.", {"entities": []}], ["It is this population that is eligible for trial entry and randomization.", {"entities": []}], ["Once the patient has confirmed a positive urinary pregnancy test they will be invited to join the trial.", {"entities": []}], ["Once the consent form has been completed by the patient a trial prescription sheet will be sent to pharmacy with a stated collection time.", {"entities": []}], ["The patient can then be randomized and the drugs dispensed according to pharmacy protocol.", {"entities": []}], ["A blood sample will then be drawn for measurement of baseline hormone levels (progesterone, estradiol, free beta-human chorionic gonadotrophin, pregnancy-associated plasma protein-A, Activin A, Inhibin A and Inhibin B).", {"entities": []}], ["The primary outcome measure is the proportion of all randomized women that continue successfully to a viable pregnancy (at least one fetus with fetal heart rate >100 beats/minute) on transabdominal/transvaginal ultrasound at 10 weeks post embryo transfer/12 weeks gestation (that is at the end of 8 weeks supplementary trial treatment).", {"entities": []}], ["ISRCTN05696887", {"entities": []}], ["Fusarium species is a ubiquitous fungus that causes opportunistic infections.", {"entities": []}], ["We present 26 cases of invasive fusariosis categorized according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria of fungal infections.", {"entities": [[32, 42, "DISEASE"]]}], ["All cases (20 proven and 6 probable) were treated from January 2000 until January 2010.", {"entities": []}], ["We also review 97 cases reported since 2000.", {"entities": []}], ["The most important risk factors for invasive fusariosis in our patients were compromised immune system, specifically lung transplantation (n = 6) and hematologic malignancies (n = 5), and burns (n = 7 patients with skin fusariosis), while the most commonly infected site was the skin in 11 of 26 patients.", {"entities": [[45, 55, "DISEASE"], [220, 230, "DISEASE"]]}], ["The mortality rates among our patients with disseminated, skin, and pulmonary fusariosis were 50%, 40%, and 37.5%, respectively.", {"entities": [[78, 88, "DISEASE"]]}], ["Fusarium solani was the most frequent species, isolated from 49% of literature cases.", {"entities": []}], ["Blood cultures were positive in 82% of both current study and literature patients with disseminated fusariosis, while the remaining 16% had 2 noncontiguous sites of infection but negative blood cultures.", {"entities": [[100, 110, "DISEASE"]]}], ["Surgical removal of focal lesions was effective in both current study and literature cases.", {"entities": []}], ["Skin lesions in immunocompromised patients should raise the suspicion for skin or disseminated fusariosis.", {"entities": [[95, 105, "DISEASE"]]}], ["The combination of medical monotherapy with voriconazole or amphotericin B and surgery in such cases is highly suggested.", {"entities": []}], ["Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) is a rapidly progressing and frequently fatal condition.", {"entities": [[0, 9, "DISEASE"]]}], ["The aim of this study was to determine whether interleukin- (IL-) 33 and soluble ST2 (sST2) were associated with disease severity and mortality in HBV-ACLF.", {"entities": []}], ["We found that plasma levels of sST2 but not IL-33 were higher in HBV-ACLF patients compared with chronic hepatitis B (CHB) patients and healthy controls.", {"entities": [[105, 114, "DISEASE"]]}], ["However, plasma levels of IL-33, TNF- \u03b1 , IFN- \u03b3 , and IL-10 did not correlate with sST2 levels.", {"entities": []}], ["Similarly, immunohistochemistry revealed low IL-33 expression and high ST2 expression in liver sections of patients with HBV-ACLF.", {"entities": []}], ["Evaluation of dynamic changes of sST2 in HBV-ACLF showed that plasma sST2 levels increased over time in patients who died during the 180-day follow-up but decreased in those who survived.", {"entities": []}], ["In addition, plasma sST2 level after week 1 correlated with disease severity, as assessed by total bilirubin, prothrombin time, and model for end-stage liver disease score.", {"entities": [[152, 165, "DISEASE"]]}], ["Results of Kaplan-Meier survival analysis showed that higher sST2 concentration (\u226587\u2009ng/mL) at week 3 was associated with poor survival.", {"entities": []}], ["These findings indicate the potential usefulness of sST2 as a predictor of disease severity and in making treatment decisions for patients with HBV-ACLF.", {"entities": []}], ["Systematic review (SR) and meta-analysis (MA) have potential to contribute substantially to environmental health (EH) risk assessment and policy-making, provided study questions are clear and methods sound.", {"entities": []}], ["We undertook a systematic review of the published epidemiological literature for studies using both SR and MA examining associations between chronic low-dose chemical exposures and adverse health outcomes in general populations and compared actual methods and reporting with a checklist based on available published guidelines.", {"entities": []}], ["We identified 48 EH SRMAs meeting these criteria.", {"entities": []}], ["Associations were mainly positive and statistically significant, often involving large populations.", {"entities": []}], ["A majority of studies followed most general SRMA guidance, although we identified weaknesses in problem formulation, study search, selection and data extraction, and integrating policy implications.", {"entities": []}], ["Fewer studies followed EH-specific SRMA recommendations, particularly regarding exposure heterogeneity and other risks of bias.", {"entities": []}], ["Development and adoption of EH-specific SRMA guidelines would contribute to strengthening these tools for public health decision-making.", {"entities": []}], ["The online version of this article (doi:10.1007/s40572-015-0062-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The annual burden of disease caused indoor air pollution, including polluted outdoor air used to ventilate indoor spaces, is estimated to correspond to a loss of over 2 million healthy life years in the European Union (EU).", {"entities": []}], ["Based on measurements of the European Environment Agency (EEA), approximately 90\u00a0% of EU citizens live in areas where the World Health Organization (WHO) guidelines for air quality of particulate matter sized\u2009<\u20092.5\u00a0mm (PM 2.5 ) are not met.", {"entities": []}], ["Since sources of pollution reside in both indoor and outdoor air, selecting the most appropriate ventilation strategy is not a simple and straightforward task.", {"entities": []}], ["A framework for developing European health-based ventilation guidelines was created in 2010\u20132013 in the EU-funded HEALTHVENT project.", {"entities": []}], ["As a part of the project, the potential efficiency of control policies to health effects caused by residential indoor exposures of fine particulate matter (PM 2.5 ), outdoor bioaerosols, volatile organic compounds (VOC), carbon oxide (CO) radon and dampness was estimated.", {"entities": []}], ["The analysis was based on scenario comparison, using an outdoor-indoor mass-balance model and varying the ventilation rates.", {"entities": []}], ["Health effects were estimated with burden of diseases (BoD) calculations taking into account asthma, cardiovascular (CV) diseases, acute toxication, respiratory infections, lung cancer and chronic obstructive pulmonary disease (COPD).", {"entities": [[173, 184, "DISEASE"], [189, 226, "DISEASE"], [93, 99, "DISEASE"], [178, 184, "DISEASE"]]}], ["The quantitative comparison of three main policy approaches, (i) optimising ventilation rates only; (ii) filtration of outdoor air; and (iii) indoor source control, showed that all three approaches are able to provide substantial reductions in the health risks, varying from approximately 20\u00a0% to 44\u00a0%, corresponding to 400 000 and 900 000 saved healthy life years in EU-26.", {"entities": []}], ["PM 2.5 caused majority of the health effects in all included countries, but the importance of the other pollutants varied by country.", {"entities": []}], ["The present modelling shows, that combination of controlling the indoor air sources and selecting appropriate ventilation rate was the most effective to reduce health risks.", {"entities": []}], ["If indoor sources cannot be removed or their emissions cannot be limited to an accepted level, ventilation needs to be increased to remove remaining pollutants.", {"entities": []}], ["In these cases filtration of outdoor air may be needed to prevent increase of health risks.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-016-0101-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Our understanding of how comorbid diseases influence health-related quality of life (HRQL) in patients with chronic obstructive pulmonary disease (COPD) is limited and in need of improvement.", {"entities": [[108, 145, "DISEASE"]]}], ["The aim of this study was to examine the associations between comorbidities and HRQL as measured by the instruments EuroQol-5 dimension (EQ-5D) and the COPD Assessment Test (CAT).", {"entities": []}], ["Information on patient characteristics, chronic bronchitis, cardiovascular disease, diabetes, renal impairment, musculoskeletal symptoms, osteoporosis, depression, and EQ-5D and CAT questionnaire results was collected from 373 patients with Forced Expiratory Volume in one second (FEV 1 ) <50% of predicted value from 27 secondary care respiratory units in Sweden.", {"entities": [[138, 150, "DISEASE"], [48, 58, "DISEASE"], [281, 284, "GENE"]]}], ["Correlation analyses and multiple linear regression models were performed using EQ-5D index, EQ-5D visual analog scale (VAS), and CAT scores as response variables.", {"entities": []}], ["Having more comorbid conditions was associated with a worse HRQL as assessed by all instruments.", {"entities": []}], ["Chronic bronchitis was significantly associated with a worse HRQL as assessed by EQ-5D index (adjusted regression coefficient [95% confidence interval] \u22120.07 [\u22120.13 to \u22120.02]), EQ-5D VAS (\u22125.17 [\u22129.42 to \u22120.92]), and CAT (3.78 [2.35 to 5.20]).", {"entities": [[8, 18, "DISEASE"]]}], ["Musculoskeletal symptoms were significantly associated with worse EQ-5D index (\u22120.08 [\u22120.14 to \u22120.02]), osteoporosis with worse EQ-5D VAS (\u22124.65 [\u22129.27 to \u22120.03]), and depression with worse EQ-5D index (\u22120.10 [\u22120.17 to \u22120.04]).", {"entities": [[104, 116, "DISEASE"]]}], ["In stratification analyses, the associations of musculoskeletal symptoms, osteoporosis, and depression with HRQL were limited to female patients.", {"entities": [[74, 86, "DISEASE"]]}], ["The instruments EQ-5D and CAT complement each other and emerge as useful for assessing HRQL in patients with COPD.", {"entities": []}], ["Chronic bronchitis, musculoskeletal symptoms, osteoporosis, and depression were associated with worse HRQL.", {"entities": [[46, 58, "DISEASE"], [8, 18, "DISEASE"]]}], ["We conclude that comorbid conditions, in particular chronic bronchitis, depression, osteoporosis, and musculoskeletal symptoms, should be taken into account in the clinical management of patients with severe COPD.", {"entities": [[84, 96, "DISEASE"], [60, 70, "DISEASE"]]}], ["The purpose of this study was to evaluate the relationship of long-term concentrations of ambient air pollutants and risk of incident lung cancer in nonsmoking California adults.", {"entities": [[134, 145, "DISEASE"], [139, 145, "DISEASE"]]}], ["A cohort study of 6,338 nonsmoking, non-Hispanic, white Californian adults, ages 27-95, was followed from 1977 to 1992 for newly diagnosed cancers.", {"entities": []}], ["Monthly ambient air pollution data were interpolated to zip code centroids according to home and work location histories, cumulated, and then averaged over time.", {"entities": []}], ["The increased relative risk (RR) of incident lung cancer in males associated with an interquartile range (IQR) increase in 100 ppb ozone (O3) was 3.56 [95% confidence interval (CI), 1.35-9.42].", {"entities": [[45, 56, "DISEASE"], [50, 56, "DISEASE"]]}], ["Incident lung cancer in males was also positively associated with IQR increases for mean concentrations of particulate matter <10 microm (PM10; RR = 5.21; CI, 1.94-13.99) and SO2 (RR = 2.66; CI, 1.62-4.39).", {"entities": [[9, 20, "DISEASE"], [14, 20, "DISEASE"]]}], ["For females, incident lung cancer was positively associated with IQR increases for SO2 (RR = 2.14; CI, 1.36-3.37) and IQR increases for PM10 exceedance frequencies of 50 microg/m3 (RR = 1.21; CI, 0.55-2.66) and 60 microg/m3 (RR = 1.25; CI, 0.57-2.71).", {"entities": [[22, 33, "DISEASE"], [27, 33, "DISEASE"]]}], ["Increased risks of incident lung cancer were associated with elevated long-term ambient concentrations of PM10 and SO2 in both genders and with O3 in males.", {"entities": [[28, 39, "DISEASE"], [33, 39, "DISEASE"]]}], ["The gender differences for the O3 and PM10 results appeared to be partially due to gender differences in exposure.", {"entities": []}], ["Influenza viruses display a high mutation rate and complex evolutionary patterns.", {"entities": [[0, 9, "DISEASE"]]}], ["Next-generation sequencing (NGS) has been widely used for qualitative and semi-quantitative assessment of genetic diversity in complex biological samples.", {"entities": []}], ["The \u201cdeep sequencing\u201d approach, enabled by the enormous throughput of current NGS platforms, allows the identification of rare genetic viral variants in targeted genetic regions, but is usually limited to a small number of samples.", {"entities": []}], ["We designed a proof-of-principle study to test whether redistributing sequencing throughput from a high depth-small sample number towards a low depth-large sample number approach is feasible and contributes to influenza epidemiological surveillance.", {"entities": [[210, 219, "DISEASE"]]}], ["Using 454-Roche sequencing, we sequenced at a rather low depth, a 307 bp amplicon of the neuraminidase gene of the Influenza A(H1N1) pandemic (A(H1N1)pdm) virus from cDNA amplicons pooled in 48 barcoded libraries obtained from nasal swab samples of infected patients (n \u200a=\u200a 299) taken from May to November, 2009 pandemic period in Mexico.", {"entities": [[115, 124, "DISEASE"]]}], ["This approach revealed that during the transition from the first (May-July) to second wave (September-November) of the pandemic, the initial genetic variants were replaced by the N248D mutation in the NA gene, and enabled the establishment of temporal and geographic associations with genetic diversity and the identification of mutations associated with oseltamivir resistance.", {"entities": []}], ["NGS sequencing of a short amplicon from the NA gene at low sequencing depth allowed genetic screening of a large number of samples, providing insights to viral genetic diversity dynamics and the identification of genetic variants associated with oseltamivir resistance.", {"entities": []}], ["Further research is needed to explain the observed replacement of the genetic variants seen during the second wave.", {"entities": []}], ["As sequencing throughput rises and library multiplexing and automation improves, we foresee that the approach presented here can be scaled up for global genetic surveillance of influenza and other infectious diseases.", {"entities": [[177, 186, "DISEASE"]]}], ["Little is known about the impact of weekend admission on acute variceal hemorrhage (AVH).", {"entities": []}], ["Thus, we investigated whether day of admission due to AVH influenced in-hospital mortality.", {"entities": []}], ["We retrospectively reviewed the medical records of 294 patients with cirrhosis admitted between January 2005 and February 2009 for the management of AVH.", {"entities": []}], ["Clinical characteristics were compared between patients with weekend and weekday admission, and independent risk factors for in-hospital mortality were determined by multivariate binary logistic regression analysis.", {"entities": []}], ["No demographic differences were observed between patients according to admission day or in the clinical course during hospitalization.", {"entities": []}], ["Seventeen (23.0%) of 74 patients with weekend admission and 48 (21.8%) of 220 with weekday admission died during hospitalization ( p =0.872).", {"entities": []}], ["Univariate and subsequent multivariate analysis showed that initial presentation with hematochezia [ p =0.042; hazard ratio (HR), 2.605; 95% confidence interval (CI), 1.038-6.541], in-patient status at the time of bleeding ( p =0.003; HR, 4.084; 95% CI, 1.598-10.435), Child-Pugh score ( p <0.001; HR, 1.877; 95% CI, 1.516-2.324), and number of endoscopy sessions for complete hemostasis ( p =0.001; HR, 3.864; 95% CI, 1.802-8.288) were independent predictors for in-hospital mortality.", {"entities": [[125, 127, "GENE"], [235, 237, "GENE"], [298, 300, "GENE"], [400, 402, "GENE"], [125, 127, "GENE"], [235, 237, "GENE"], [298, 300, "GENE"], [400, 402, "GENE"], [125, 127, "GENE"], [235, 237, "GENE"], [298, 300, "GENE"], [400, 402, "GENE"], [125, 127, "GENE"], [235, 237, "GENE"], [298, 300, "GENE"], [400, 402, "GENE"]]}], ["Weekend admission did not influence in-hospital mortality in patients with cirrhosis who presented AVH.", {"entities": []}], ["Background: Indoor air pollutants (IAPs) cause multiple health impacts.", {"entities": []}], ["Prioritizing mitigation options that differentially affect individual pollutants and comparing IAPs with other environmental health hazards require a common metric of harm.", {"entities": []}], ["Objectives: Our objective was to demonstrate a methodology to quantify and compare health impacts from IAPs.", {"entities": []}], ["The methodology is needed to assess population health impacts of large-scale initiatives\u2014including energy efficiency upgrades and ventilation standards\u2014that affect indoor air quality (IAQ).", {"entities": []}], ["Methods: Available disease incidence and disease impact models for specific pollutant\u2013disease combinations were synthesized with data on measured concentrations to estimate the chronic heath impact, in disability-adjusted life-years (DALYs) lost, due to inhalation of a subset of IAPs in U.S. residences.", {"entities": []}], ["Model results were compared with independent estimates of DALYs lost due to disease.", {"entities": []}], ["Results: Particulate matter \u2264 2.5 \u03bcm in aerodynamic diameter (PM 2.5 ), acrolein, and formaldehyde accounted for the vast majority of DALY losses caused by IAPs considered in this analysis, with impacts on par or greater than estimates for secondhand tobacco smoke and radon.", {"entities": []}], ["Confidence intervals of DALYs lost derived from epidemiology-based response functions are tighter than those derived from toxicology-based, interspecies extrapolations.", {"entities": []}], ["Statistics on disease incidence in the United States indicate that the upper-bound confidence interval for aggregate IAP harm is implausibly high.", {"entities": []}], ["Conclusions: The approach demonstrated in this study may be used to assess regional and national initiatives that affect IAQ at the population level.", {"entities": []}], ["Cumulative health impacts from inhalation in U.S. residences of the IAPs assessed in this study are estimated at 400\u20131,100 DALYs lost annually per 100,000 persons.", {"entities": []}], ["Epigenetic studies have shown that low\u2010birth\u2010weight ( LBW ) and growth restriction has been associated with reduced immune function in humans and reduced passive immunity in pigs.", {"entities": []}], ["To examine the immune responses of high\u2010birth\u2010weight ( HBW ) and LBW groups of pigs, influenza A virus infection was used as an exemplifier of neonatal respiratory disease.", {"entities": [[85, 94, "DISEASE"]]}], ["The objectives of this study were (i) to compare clinical, immunological, and pathological outcome of influenza infection in HBW to LBW pigs and (ii) to establish standardized sampling sites, score each site independently with set criteria, and compare scores between sites.", {"entities": [[102, 111, "DISEASE"]]}], ["Sixty\u2010eight 4\u2010week\u2010old pigs originating from either HBW or LBW litters were intratracheally inoculated with 10 TCID 50 /ml of A/swine/Texas/4199\u20102/1998 H3N2 and euthanized 48\u00a0hours later.", {"entities": []}], ["Samples were collected 2\u00b75\u00a0cm from the tip of both cranial and middle lung lobes.", {"entities": []}], ["The formalin\u2010fixed paraffin\u2010embedded tissue sections were scored in a blinded manner by a single pathologist using established scoring criteria for routine and immunohistochemical stains.", {"entities": []}], ["Clinical parameters, lung and nasal swab virus titers, and cytokine levels for interferon\u2010alpha and interleukin\u20101\u2010beta, IL \u20106, and IL \u20108 were measured.", {"entities": []}], ["Lung lesion severity and influenza staining intensity were significantly lower in LBW compared with HBW pigs ( P\u00a0 < \u00a0 0\u00b705).", {"entities": [[25, 34, "DISEASE"]]}], ["Additionally, examining just the LBW group, the significant difference between lobes ( P\u00a0 = \u00a0 0\u00b7009) showed that the mean score for the right cranial lung lobe was higher compared with the other three lobes.", {"entities": []}], ["Many formulae of traditional Chinese medicines (TCMs) have been used for antiasthma treatment dating back many centuries.", {"entities": []}], ["There is evidence to suggest that TCMs are effective as a cure for this allergenic disease administered via gastric tubes in animal studies; however, their efficacy, safety and side effects as an asthmatic therapy are still unclear.", {"entities": []}], ["In this study, guinea pigs sensitized with ovalbumin (OVA) were used as an animal model for asthma challenge, and the sensitization of animals by bronchial reactivity to methacholine (Mch) and the IgE concentration in the serum after OVA challenge were estimated.", {"entities": [[92, 98, "DISEASE"]]}], ["Complex traditional Chinese herbs (CTCM) were administered to the animals by nebulization, and the leukocytes were evaluated from bronchoalveolar lavage fluid (BALF).", {"entities": []}], ["The results showed that inhalation of CTCM could abolish the increased lung resistance (13-fold increase) induced by challenge with OVA in the early asthmatic response (EAR), reducing to as low as baseline (1-fold).", {"entities": []}], ["Moreover, our results indicated higher IgE levels (range, 78-83 ng/ml) in the serum of sensitized guinea pigs than in the unsensitized controls (0.9 \u00b1 0.256 ng/ml).", {"entities": []}], ["In addition, increased total leukocytes and higher levels of eosinophils and neutrophils were seen 6 hours after challenge, and the increased inflammatory cells were reduced by treatment with CTCM inhalation.", {"entities": []}], ["The interleukin-5 (IL-5) level in BALF was also reduced by CTCM.", {"entities": []}], ["Our findings indicate a novel method of administering traditional Chinese medicines for asthma treatment in an animal model that may be more effective than traditional methods.", {"entities": [[88, 94, "DISEASE"]]}], ["Exacerbations associated with chronic lung infection with Pseudomonas aeruginosa are a major contributor to morbidity, mortality and premature death in cystic fibrosis.", {"entities": [[152, 167, "DISEASE"]]}], ["Such exacerbations are treated with antibiotics, which generally lead to an improvement in lung function and reduced sputum P .", {"entities": []}], ["aeruginosa density.", {"entities": []}], ["This potentially suggests a role for the latter in the pathogenesis of exacerbations.", {"entities": []}], ["However, other data suggesting that changes in P .", {"entities": []}], ["aeruginosa sputum culture status may not reliably predict an improvement in clinical status, and data indicating no significant changes in either total bacterial counts or in P .", {"entities": []}], ["aeruginosa numbers in sputum samples collected prior to pulmonary exacerbation sheds doubt on this assumption.", {"entities": []}], ["We used our recently developed lung segmental model of chronic Pseudomonas infection in sheep to investigate the lung microbiota changes associated with chronic P .", {"entities": []}], ["aeruginosa lung infection and the impact of systemic therapy with colistimethate sodium (CMS).", {"entities": []}], ["We collected protected specimen brush (PSB) samples from sheep (n = 8) both prior to and 14 days after establishment of chronic local lung infection with P aeruginosa .", {"entities": []}], ["Samples were taken from both directly infected lung segments (direct) and segments spatially remote to such sites (remote).", {"entities": []}], ["Four sheep were treated with daily intravenous injections of CMS between days 7 and 14, and four were treated with a placebo.", {"entities": []}], ["Necropsy examination at d14 confirmed the presence of chronic local lung infection and lung pathology in every direct lung segment.", {"entities": []}], ["The predominant orders in lung microbiota communities before infection were Bacillales, Actinomycetales and Clostridiales.", {"entities": []}], ["While lung microbiota samples were more likely to share similarities with other samples derived from the same lung, considerable within- and between-animal heterogeneity could be appreciated.", {"entities": []}], ["Pseudomonadales joined the aforementioned list of predominant orders in lung microbiota communities after infection.", {"entities": []}], ["Whilst treatment with CMS appeared to have little impact on microbial community composition after infection, or the change undergone by communities in reaching that state, when Gram negative organisms (excluding Pseudomonadales) were considered together as a group there was a significant decrease in their relative proportion that was only observed in the sheep treated with CMS.", {"entities": []}], ["With only one exception the reduction was seen in both direct and remote lung segments.", {"entities": []}], ["This reduction, coupled with generally increasing or stable levels of Pseudomonadales, meant that the proportion of the latter relative to total Gram negative bacteria increased in all bar one direct and one remote lung segment.", {"entities": []}], ["The proportional increase in Pseudomonadales relative to other Gram negative bacteria in the lungs of sheep treated with systemic CMS highlights the potential for such therapies to inadvertently select or create a niche for bacteria seeding from a persistent source of chronic infection.", {"entities": []}], ["We evaluated 76 adenovirus type 7 (Ad7) isolates collected in Iowa from 1992 to 2002 and found that genome type Ad7d2 became increasingly prevalent.", {"entities": []}], ["By 2002, it had supplanted all other Ad7 genome types.", {"entities": []}], ["The association of Ad7d2 with severe illness and death calls for heightened public health concern.", {"entities": []}], ["Evolution of resistance among insects to action of pesticides has led to the discovery of several insecticides (neonicotinoids and organophosphates) with new targets in insect nervous system.", {"entities": []}], ["Present study evaluates the mode of inhibition of acetylchlonesterase (AChE), biochemical efficacy, and molecular docking of 2,3-dimethylmaleic anhydride, against Periplaneta americana and Sitophilus oryzae .", {"entities": []}], ["The knockdown activity of 2,3-dimethylmaleic anhydride was associated with in vivo inhibition of AChE.", {"entities": []}], ["At KD 99 dosage, the 2,3-dimethylmaleic anhydride showed more than 90% inhibition of AChE activity in test insects.", {"entities": []}], ["A significant impairment in antioxidant system was observed, characterized by alteration in superoxide dismutase and catalase activities along with increase in reduced glutathione levels.", {"entities": []}], ["Computational docking programs provided insights in to the possible interaction between 2,3-dimethylmaleic anhydride and AChE of P .", {"entities": []}], ["americana .", {"entities": []}], ["Our study reveals that 2,3-dimethylmaeic anhydride elicits toxicity in S .", {"entities": []}], ["oryzae and P .", {"entities": []}], ["americana primarily by AChE inhibition along with oxidative stress.", {"entities": []}], ["Severe asthma occurs more often in older adult patients.", {"entities": [[7, 13, "DISEASE"]]}], ["We hypothesized that the greater risk for severe asthma in older individuals is due to aging, and is independent of asthma duration.", {"entities": [[49, 55, "DISEASE"], [116, 122, "DISEASE"]]}], ["This is a cross-sectional study of prospectively collected data from adult participants (N=1130; 454 with severe asthma) enrolled from 2002 \u2013 2011 in the Severe Asthma Research Program.", {"entities": [[113, 119, "DISEASE"], [161, 167, "DISEASE"]]}], ["The association between age and the probability of severe asthma, which was performed by applying a Locally Weighted Scatterplot Smoother, revealed an inflection point at age 45 for risk of severe asthma.", {"entities": [[58, 64, "DISEASE"], [197, 203, "DISEASE"]]}], ["The probability of severe asthma increased with each year of life until 45 years and thereafter increased at a much slower rate.", {"entities": [[26, 32, "DISEASE"]]}], ["Asthma duration also increased the probability of severe asthma but had less effect than aging.", {"entities": [[0, 6, "DISEASE"], [57, 63, "DISEASE"]]}], ["After adjustment for most comorbidities of aging and for asthma duration using logistic regression, asthmatics older than 45 maintained the greater probability of severe asthma [OR: 2.73 (95 CI: 1.96; 3.81)].", {"entities": [[57, 63, "DISEASE"], [170, 176, "DISEASE"]]}], ["After 45, the age-related risk of severe asthma continued to increase in men, but not in women.", {"entities": [[41, 47, "DISEASE"]]}], ["Overall, the impact of age and asthma duration on risk for asthma severity in men and women is greatest over times of 18-45 years of age; age has a greater effect than asthma duration on risk of severe asthma.", {"entities": [[31, 37, "DISEASE"], [59, 65, "DISEASE"], [168, 174, "DISEASE"], [202, 208, "DISEASE"]]}], ["Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder of uncertain etiology.", {"entities": [[17, 25, "DISEASE"]]}], ["Recent studies suggested that insulin resistance (IR) plays an important role in the development of PCOS.", {"entities": []}], ["In the current study, we aimed to investigate the molecular mechanism of IR in PCOS.", {"entities": []}], ["We employed genome-wide methylated DNA immunoprecipitation (MeDIP) analysis to characterize genes that are differentially methylated in PCOS patients vs. healthy controls.", {"entities": []}], ["Besides, we also identified the differentially methylated genes between patients with PCOS-non-insulin resistance (PCOS-NIR) and PCOS-insulin resistance (PCOS-IR).", {"entities": []}], ["A total of 79 genes were differentially methylated between PCOS-NIR vs. PCOS-IR patients, and 40 genes were differentially methylated in PCOS patients vs. healthy controls.", {"entities": []}], ["We analyzed these differentially methylated genes by constructing regulatory networks and protein-protein interaction (PPI) networks.", {"entities": []}], ["Further, Gene Ontology (GO) and pathway enrichment analysis were also performed to investigate the biological functions of networks.", {"entities": []}], ["We identified multiple categories of genes that were differentially methylated between PCOS-NIR and PCOS-IR patients, or between PCOS patients and healthy controls.", {"entities": []}], ["Significantly, GO categories of immune response were differentially methylated in PCOS-IR vs. PCOS-NIR.", {"entities": []}], ["Further, genes in cancer pathways were also differentially methylated in PCOS-NIR vs. PCOS-IR patients or in PCOS patients vs. healthy controls.", {"entities": [[18, 24, "DISEASE"]]}], ["The results of this current study will help to further understand the mechanism of PCOS.", {"entities": []}], ["Mucociliary clearance (MCC) is a critical host innate defense mechanism in airways, and it is impaired in cystic fibrosis (CF) and other obstructive lung diseases.", {"entities": [[106, 121, "DISEASE"], [23, 26, "GENE"]]}], ["Epithelial fluid secretion and absorption modify MCC velocity (MCCV).", {"entities": [[49, 52, "GENE"]]}], ["We tested the hypotheses that inhibiting fluid absorption accelerates MCCV, whereas inhibiting fluid secretion decelerates it.", {"entities": []}], ["In airways, ENaC is mainly responsible for fluid absorption, while anion channels, including CFTR and Ca inh -172, modestly reduced MCCV-increases induced by forskolin or isoproterenol but not increases induced by carbachol.", {"entities": [[93, 97, "GENE"]]}], ["The ENaC inhibitor benzamil increased basal MCCV as well as MCCV increases produced by forskolin or carbachol.", {"entities": []}], ["MCC velocity was most dramatically accelerated by the synergistic combination of forskolin and carbachol, which produced near-maximal clearance rates regardless of prior treatment with CFTR or ENaC inhibitors.", {"entities": [[0, 3, "GENE"], [185, 189, "GENE"]]}], ["In CF airways, where CFTR-mediated secretion (and possibly synergistic MCC) is lost, ENaC inhibition via exogenous agents may provide therapeutic benefit, as has long been proposed.", {"entities": [[71, 74, "GENE"]]}], ["The immune system of mammals is subject to continuous development during the postnatal phase of life.", {"entities": []}], ["Studies following the longitudinal development of the immune system in healthy children are limited both by ethical considerations and sample volumes.", {"entities": []}], ["Horses represent a particular valuable large animal model for T regulatory (Treg) cells and allergy research.", {"entities": []}], ["We have recently characterised Treg cells from horses, demonstrated their regulatory capability and showed both their expansion and induction in vitro .", {"entities": []}], ["Insect bite hypersensitivity (IBH) is a common allergy in horses resembling atopic dermatitis and studies have shown that first exposure to allergens in adult life results in an increased incidence of IBH.", {"entities": [[76, 93, "DISEASE"], [83, 93, "DISEASE"]]}], ["The aim of the present study was to characterize circulating CD4 in vitro from CD4", {"entities": [[61, 64, "GENE"], [79, 82, "GENE"], [61, 64, "GENE"], [79, 82, "GENE"]]}], ["General practice accounts for the vast majority of drug prescribing in the Nordic countries.", {"entities": []}], ["Various methods have been used to promote rational drug prescribing.", {"entities": []}], ["Awareness of own prescribing profile may be a first crucial step in the quality assessment and improvement process.", {"entities": []}], ["To analyse awareness among general practitioners of their drug prescribing profile during two outreach visits one year apart.", {"entities": []}], ["All 94 practices with a total of 166 general practitioners in the former Storstr\u00f8m County, Denmark, were invited to participate in a project launching outreach visits led by a general practitioner; 88 practices with 160 general practitioners agreed to participate.", {"entities": []}], ["During the first round of outreach visits the general practitioners were asked to rate their own prescribing level of 13 major drug groups as being in the lowest 25%, the middle 26%\u201374%, or the highest 25% of the distribution across all 88 practices.", {"entities": []}], ["The result was better than chance (chi-square = 337, 4 df, r = 0.37, both P < 0.0001).", {"entities": []}], ["After the assessment a one-hour discussion on rational drug prescribing was held.", {"entities": []}], ["One year later a new round of outreach visits was held.", {"entities": []}], ["This time the assessment accuracy was generally greatly improved (chi-square = 724, 4 df, r = 0.48, both P < 0.0001).", {"entities": []}], ["The main determinants for the improved accuracy during the second round were high accuracy during the first round, and the number of general practitioners in the practice.", {"entities": []}], ["General practitioners' awareness of their prescribing volumes was substantially improved by a single outreach visit with discussion on rational drug prescribing.", {"entities": []}], ["Reference genes are frequently used to normalise mRNA levels between different samples.", {"entities": []}], ["The expression level of these genes, however, may vary between tissues or cells and may change under certain circumstances.", {"entities": []}], ["Cytoskeleton genes have served as multifunctional tools for experimental studies as reference genes.", {"entities": []}], ["Our previous studies have demonstrated that the expression of vimentin, one cytoskeletal protein, was increased in ultraviolet B (UVB)-irradiated fibroblasts.", {"entities": []}], ["Thus, we examined the expression of other cytoskeleton protein genes, ACTB ( actin, beta ), TUBA1A ( tubulin, alpha 1a ), and TUBB1 ( tubulin, beta 1 ), in human dermal fibroblasts irradiated by UVB to determine which of these candidates were the most appropriate reference genes.", {"entities": [[70, 74, "GENE"], [92, 98, "GENE"], [126, 131, "GENE"]]}], ["Quantitative real-time PCR followed by analysis with the NormFinder and geNorm software programmes was performed.", {"entities": []}], ["The initial screening of the expression patterns demonstrated that the expression of VIM was suppressed after UVB irradiation at doses \u226525 mJ/cm TUBA1A was significantly reduced by UVB doses \u226575 mJ/cm ACTB to be the most stably expressed gene, followed by GAPDH ( aglyceraldehyde-3-phosphate dehydrogenase ), under these experimental conditions.", {"entities": [[145, 151, "GENE"], [201, 205, "GENE"], [256, 261, "GENE"]]}], ["By contrast, VIM was found to be the least stable gene.", {"entities": []}], ["The combination of ACTB and TUBB1 was revealed to be the gene pair that introduced the least systematic error into the data normalisation.", {"entities": [[19, 23, "GENE"], [28, 33, "GENE"]]}], ["The data herein provide evidence that ACTB and TUBB1 are suitable reference genes in human skin fibroblasts irradiated by UVB, whereas VIM and TUBA1A are not and should therefore be excluded as reference genes in any gene expression studies involving UVB-irradiated human skin fibroblasts.", {"entities": [[38, 42, "GENE"], [47, 52, "GENE"], [143, 149, "GENE"]]}], ["Exposure to environmental tobacco smoke is a major threat to public health.", {"entities": []}], ["Greece, having the highest smoking prevalence in the European Union is seriously affected by passive smoking.", {"entities": []}], ["The purpose of this study was to measure environmental tobacco smoke (ETS) exposure in the non smoking areas of hospitality venues and offices in Greece and to compare the levels of exposure to levels in the US, UK and Ireland before and after the implementation of a smoking ban.", {"entities": []}], ["Experimental measurements of particulate matter 2.5 \u03bcm (PM 2.5 ), performed during a cross sectional study of 49 hospitality venues and offices in Athens and Crete, Greece during February \u2013 March 2006.", {"entities": []}], ["Levels of ETS ranged from 19 \u03bcg/m Designated non-smoking areas of hospitality venues in Greece are significantly more polluted with ETS than outdoor air and similar venues in Europe and the United States.", {"entities": []}], ["The implementation of a total indoor smoking ban in hospitality venues has been shown to have a positive effect on workers and patrons' health.", {"entities": []}], ["The necessity of such legislation in Greece is thus warranted.", {"entities": []}], ["People with COPD have a decline in functional status, but little is known about the rate of decline and factors that contribute.", {"entities": []}], ["Of particular concern is the decline in cognitive and functional performance.", {"entities": []}], ["Decrease in cognitive and functional performance will finally lead to decreased health status, sedentary life style and premature frailty.", {"entities": []}], ["The aim of this study is to compare functional performance and cognitive status in patients with COPD of different ages and to examine the changes in extrapulmonary effects.", {"entities": []}], ["This study included 62 patients with COPD risk class D who were divided into two groups (<70 years, N=30 and >70 years, N=32).", {"entities": []}], ["Patients first completed the Montreal Cognitive Assessment (MoCA), which is a 30-point test that assesses different cognitive domains, while isometric knee extension (IKE) was measured using a digital handheld dynamometer, and functional exercise level was assessed using the 6-minute walking distance (6MWD) test.", {"entities": []}], ["The patients\u2019 older age (age higher than 70 years) was associated with a significantly lower body mass index (BMI, 27.50 vs 24.24 kg/m P =0.020), higher vital capacity parameters, forced vital capacity (FVC, 2.74 vs 2.82 L; P =0.799), FVC (%) (73.00 vs 66.50, P =132), forced expiratory volume in the first second (FEV 1 , 0.93 vs 1.13 L; P =0.001) and FEV 1 (%) (28.50 vs 30.50, P =0.605).", {"entities": [[315, 318, "GENE"], [353, 356, "GENE"], [315, 318, "GENE"], [353, 356, "GENE"]]}], ["In addition, patients at older age presented a significantly reduced physical activity capacity, 6MWD (385.93 vs 320.84 m, P <0.001) and IKE (24.75 vs 22.55 kgf, P =0.005), as well as higher values for inflammatory biomarkers, C-reactive protein (8.77 vs 3.34 mg/L, P =0.022).", {"entities": []}], ["Moreover, patients at older age presented significantly lower score at the cognitive assessment, MoCA (23.50 vs 20.00, P <0.001).", {"entities": []}], ["Elderly COPD patients have reduced exercise capacity and muscle strength, deteriorated cognitive function and increased inflammatory markers.", {"entities": []}], ["Furthermore, inflammation markers were significantly correlated with muscle strength, walking distance and cognitive impairment.", {"entities": []}], ["In chronic obstructive pulmonary disease (COPD), the response of the forced expiratory volume in 1 second (FEV1) after bronchodilator application is weak.", {"entities": [[3, 40, "DISEASE"]]}], ["Inspiratory parameters like the forced inspiratory volume in 1 second (FIV1) and inspiratory capacity (IC) can be responsive to bronchodilators.", {"entities": []}], ["In an individual patient with COPD, a significant bronchodilator response must at least exceed the random variation for that parameter.", {"entities": []}], ["Therefore, it is important that the type of scatter is homoscedastic, as the chance of underestimating or overestimating the random variation for low or high parameter values is minimized.", {"entities": []}], ["The aim of this study is to investigate the random variation (type and quantity) of inspiratory parameters.", {"entities": []}], ["In 79 stable COPD patients, spirometry was performed.", {"entities": []}], ["The forced inspiratory volume in 1 second (FIV1), inspiratory capacity (IC), maximal inspiratory flow at 50% (MIF50) and peak inspiratory flow (PIF) were measured five times in one day and again within two weeks of the first measurement.", {"entities": []}], ["The values of these parameters, taken within one hour, within one day and between two different days, were compared.", {"entities": []}], ["The coefficient of repeatability (CR) was calculated, and, in addition, linear regression was performed to investigate the type of scatter (homo- or heteroscedastic) of the measured parameters.", {"entities": []}], ["The type of scatter was heteroscedastic for all of the parameters when the differences were expressed as absolute values; however, when the differences were expressed as the percent change from the initial values, we found a more homoscedastic scatter.", {"entities": []}], ["The CR within one hour of each parameter expressed as the percent change from the initial value was: IC, 19%; FIV1, 14%; PIF, 18%; MEF50, 21%.", {"entities": []}], ["To obtain a more homoscedastic scatter, percentage changes in FIV1, IC and MIF50 are more appropriate than absolute changes.", {"entities": []}], ["In an individual patient with COPD, a significant improvement for a particular parameter must at least exceed the above-mentioned CR.", {"entities": []}], ["Health state utility values (HSUVs) are important in the assessment of the cost effectiveness of new interventions.", {"entities": []}], ["In the case of visual conditions, models generally tend have tended to be built around a set of health states defined by visual acuity (VA).", {"entities": []}], ["The aim of this review was to assess the impact of VA on HSUVs in patients with diabetic retinopathy, diabetic macular oedema or age-related macular degeneration.", {"entities": [[80, 100, "DISEASE"], [141, 161, "DISEASE"]]}], ["A systematic literature search was undertaken in major bibliographic databases to identify articles reporting on the relationship between HSUVs and vision.", {"entities": []}], ["Data were extracted for population characteristics, visual levels and estimated utilities.", {"entities": []}], ["Evidence from reported statistical models, where available, was considered in the evaluation of vision in the better-seeing eye and the worse-seeing eye.", {"entities": []}], ["Due to the heterogeneity of included studies, a narrative synthesis was undertaken.", {"entities": []}], ["Of the 17 relevant studies, 9 studies had data that could be used in the analysis of the impact of vision on HSUVs.", {"entities": []}], ["Visual loss was associated with a marked impact on health utilities.", {"entities": []}], ["However, the relationship was not comparable between conditions or by measure of HSUVs.", {"entities": []}], ["Key results included the finding that overall, self-rated time-trade off estimates were more likely to discriminate between different VA levels than EQ-5D values.", {"entities": []}], ["Additionally, a stronger correlation was observed between HSUVs and better-seeing eye VA compared to worse-seeing eye VA.", {"entities": []}], ["Visual acuity has a significant impact on HSUVs.", {"entities": []}], ["Nevertheless, care must be taken in the interpretation and use of estimates in cost-effectiveness models due to differences in measures and population diversity.", {"entities": []}], ["Inflammation is an essential process in many pulmonary diseases in which kinins are generated by protease action on kininogen, a phenomenon that is blocked by protease inhibitors.", {"entities": []}], ["We evaluated kinin release in an in vivo lung inflammation model in rats, in the presence or absence of CeKI ( C. echinata kallikrein inhibitor), a plasma kallikrein, cathepsin G, and proteinase-3 inhibitor, and rCeEI (recombinant C. echinata elastase inhibitor), which inhibits these proteases and also neutrophil elastase.", {"entities": []}], ["Wistar rats were intravenously treated with buffer (negative control) or inhibitors and, subsequently, lipopolysaccharide was injected into their lungs.", {"entities": []}], ["Blood, bronchoalveolar lavage fluid (BALF), and lung tissue were collected.", {"entities": []}], ["In plasma, kinin release was higher in the LPS-treated animals in comparison to CeKI or rCeEI groups.", {"entities": []}], ["rCeEI-treated animals presented less kinin than CeKI-treated group.", {"entities": []}], ["Our data suggest that kinins play a pivotal role in lung inflammation and may be generated by different enzymes; however, neutrophil elastase seems to be the most important in the lung tissue context.", {"entities": []}], ["These results open perspectives for a better understanding of biological process where neutrophil enzymes participate and indicate these plant inhibitors and their recombinant correlates for therapeutic trials involving pulmonary diseases.", {"entities": []}], ["Background .", {"entities": []}], ["A reliable asthma diagnosis is challenging in preschool wheezing children.", {"entities": [[11, 17, "DISEASE"]]}], ["As inhaled corticosteroids (ICS) are more effective in asthmatics than in children with transient wheeze, an ICS response might be helpful in early asthma diagnosis.", {"entities": [[148, 154, "DISEASE"]]}], ["175 children (aged two\u2013four years) with recurrent wheeze received 200\u2009 \u03bc g Beclomethasone extra-fine daily for eight weeks.", {"entities": []}], ["Changes in Exhaled Breath Condensate (EBC) biomarkers (pH, interleukin (IL)-1 \u03b1 , IL-2, IL-4, IL-5, IL-10, IFN- \u03b3 , sICAM, and CCL-11), Fractional exhaled Nitric Oxide (FeNO), airway resistance, and symptoms were assessed.", {"entities": []}], ["At six years of age a child was diagnosed as transient wheezer or asthmatic.", {"entities": []}], ["Adjusted logistic regression analysis was performed with multiple testing correction.", {"entities": []}], ["106 transient wheezers and 64 asthmatics were analysed at six years of age.", {"entities": []}], ["Neither changes in EBC biomarkers, nor FeNO, airway resistance, or symptoms during ICS trial at preschool age were related to asthma diagnosis at six years of age.", {"entities": [[126, 132, "DISEASE"]]}], ["However, asthmatics had more airway symptoms before the start of the ICS trial than transient wheezers ( P < 0.01).", {"entities": []}], ["Discussion .", {"entities": []}], ["Although symptom score in preschool wheezing children at baseline was associated with asthma at six years of age, EBC biomarkers, airway resistance, or symptom response to ICS at preschool age could not predict asthma diagnosis at six years of age.", {"entities": [[86, 92, "DISEASE"], [211, 217, "DISEASE"]]}], ["WU polyomavirus is a recently described polyomavirus found in patients with respiratory infections.", {"entities": []}], ["Of 2,637 respiratory samples tested in St. Louis, Missouri, 2.7% were positive for WU polyomavirus by PCR, and 71% were coinfected with other respiratory viruses.", {"entities": []}], ["Persistent human infection with WU polyomavirus is described.", {"entities": []}]]